Citrus Sinensis ID: 001544
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 1057 | 2.2.26 [Sep-21-2011] | |||||||
| C0LGP4 | 1010 | Probable LRR receptor-lik | yes | no | 0.898 | 0.940 | 0.376 | 1e-174 | |
| C0LGT6 | 1031 | LRR receptor-like serine/ | no | no | 0.841 | 0.862 | 0.382 | 1e-158 | |
| Q9FL28 | 1173 | LRR receptor-like serine/ | no | no | 0.904 | 0.815 | 0.363 | 1e-151 | |
| C0LGQ5 | 1249 | LRR receptor-like serine/ | no | no | 0.912 | 0.772 | 0.360 | 1e-150 | |
| Q9FIZ3 | 1252 | LRR receptor-like serine/ | no | no | 0.970 | 0.819 | 0.326 | 1e-143 | |
| Q9SD62 | 1025 | Putative receptor-like pr | no | no | 0.850 | 0.877 | 0.379 | 1e-142 | |
| Q9LVP0 | 1102 | Probable leucine-rich rep | no | no | 0.951 | 0.912 | 0.337 | 1e-137 | |
| Q9ZUI0 | 980 | Putative leucine-rich rep | no | no | 0.767 | 0.827 | 0.358 | 1e-133 | |
| Q9SHI2 | 1101 | Leucine-rich repeat recep | no | no | 0.913 | 0.877 | 0.328 | 1e-132 | |
| O49318 | 1124 | Probable leucine-rich rep | no | no | 0.945 | 0.888 | 0.314 | 1e-132 |
| >sp|C0LGP4|Y3475_ARATH Probable LRR receptor-like serine/threonine-protein kinase At3g47570 OS=Arabidopsis thaliana GN=At3g47570 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 612 bits (1579), Expect = e-174, Method: Compositional matrix adjust.
Identities = 399/1059 (37%), Positives = 566/1059 (53%), Gaps = 109/1059 (10%)
Query: 26 DIDQDALLALKDHITYDPTNFFAKNWLTNSTMVCNWTGVTCDINQRRVTALNISYLSLTG 85
+ D+ ALL K ++ D +W +S +CNW GVTC +RVT L
Sbjct: 23 ETDRQALLQFKSQVSED-KRVVLSSW-NHSFPLCNWKGVTCGRKNKRVTHL--------- 71
Query: 86 NIPRQLGNLSSLEILDLNFNRLSGEIPWELGNLAKLEKLLLHNNFLTGTIPFSIFKLSSL 145
ELG L L G I SI LS L
Sbjct: 72 ----------------------------ELGRLQ-----------LGGVISPSIGNLSFL 92
Query: 146 LDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQLSGSIPSFIFKISSLQALHFGNNRLS 205
+ L L +N GTIP +G LS L+ LD+ N L G IP ++ S L L +NRL
Sbjct: 93 VSLDLYENFFGGTIP-QEVGQLSRLEYLDMGINYLRGPIPLGLYNCSRLLNLRLDSNRLG 151
Query: 206 GELPANICDNLPFLNFFSVYKNMFYGGISSTLSNCKHLRILDLSFNDLWGDIPKEIGNLT 265
G +P S L + +L L+L N++ G +P +GNLT
Sbjct: 152 GSVP-------------------------SELGSLTNLVQLNLYGNNMRGKLPTSLGNLT 186
Query: 266 KLKELFLDFNILQGEIPHTVGNLHNLEYLSLVNNELVGTVPATIFNVSTLKLIELSNNTF 325
L++L L N L+GEIP V L + L LV N G P ++N+S+LKL+ + N F
Sbjct: 187 LLEQLALSHNNLEGEIPSDVAQLTQIWSLQLVANNFSGVFPPALYNLSSLKLLGIGYNHF 246
Query: 326 FGSLPSSTDVQLPNLEELYLWGNNFSGTLPSFIFNASNLSKLSLGDNSFSGLIPNTFGNL 385
G L + LPNL + GN F+G++P+ + N S L +L + +N+ +G IP TFGN+
Sbjct: 247 SGRLRPDLGILLPNLLSFNMGGNYFTGSIPTTLSNISTLERLGMNENNLTGSIP-TFGNV 305
Query: 386 RNLKRLRLYNNYL---TSPELSFLSSLSNCKYLEIIALSGNPLNGIIPMSAGNLSHSLEE 442
NLK L L+ N L +S +L FL+SL+NC LE + + N L G +P+S NLS L
Sbjct: 306 PNLKLLFLHTNSLGSDSSRDLEFLTSLTNCTQLETLGIGRNRLGGDLPISIANLSAKLVT 365
Query: 443 LFMPDCNVSGRIPKEIGNLANLVTLDLGGNKFNGSIPIALGKLQKLQLLNLDDNKLEGSI 502
L + +SG IP +IGNL NL L L N +G +P +LGKL L+ L+L N+L G I
Sbjct: 366 LDLGGTLISGSIPYDIGNLINLQKLILDQNMLSGPLPTSLGKLLNLRYLSLFSNRLSGGI 425
Query: 503 PDDICGLVELYKLALGDNKLSGQIPACFGNLASLRELWLGPNELISFIPSTFWNIKDIMY 562
P I + L L L +N G +P GN + L ELW+G N+L IP I+ ++
Sbjct: 426 PAFIGNMTMLETLDLSNNGFEGIVPTSLGNCSHLLELWIGDNKLNGTIPLEIMKIQQLLR 485
Query: 563 VNFSSNFLTGPLPLEIENLKALTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQGSI 622
++ S N L G LP +I L+ L TL N LSG +P T+G ++ LFL N G I
Sbjct: 486 LDMSGNSLIGSLPQDIGALQNLGTLSLGDNKLSGKLPQTLGNCLTMESLFLEGNLFYGDI 545
Query: 623 PDSVGDLISLKSLNLSNNNLSGPIPTSLEKLSDLKELNLSFNKLEGEIPRGGPFVNFSAK 682
PD G L+ +K ++LSNN+LSG IP S L+ LNLSFN LEG++P G F N +
Sbjct: 546 PDLKG-LVGVKEVDLSNNDLSGSIPEYFASFSKLEYLNLSFNNLEGKVPVKGIFENATTV 604
Query: 683 SFMGNNLLCGS-PNLQVPPCRASIDHISKKNA-----LLLGIILPFS---TIFVIVIILL 733
S +GNN LCG Q+ PC + + KK++ +++G+ + + +F+ + L+
Sbjct: 605 SIVGNNDLCGGIMGFQLKPCLSQAPSVVKKHSSRLKKVVIGVSVGITLLLLLFMASVTLI 664
Query: 734 ISRYQTRGENVPNEVNVPLEATWRRFSYLELFQATNGFSENNLIGRGSFGSVYIARLQNG 793
R + + + N LE + SY +L ATNGFS +N++G GSFG+VY A L
Sbjct: 665 WLRKRKKNKETNNPTPSTLEVLHEKISYGDLRNATNGFSSSNMVGSGSFGTVYKALLLTE 724
Query: 794 IE-VAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCSNED-----FKALILEYM 847
+ VAVK ++Q A KSF ECE +K IRHRNL K++++CS+ D F+ALI E+M
Sbjct: 725 KKVVAVKVLNMQRRGAMKSFMAECESLKDIRHRNLVKLLTACSSIDFQGNEFRALIYEFM 784
Query: 848 RNGSLEKCL--------YSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSN 899
NGSL+ L + + L + +RLNI IDVAS L+YLH P+ HCDLKPSN
Sbjct: 785 PNGSLDMWLHPEEVEEIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEPIAHCDLKPSN 844
Query: 900 VLLDDNMVAHLSDFGIAKLLIGEDQ-----SMTQTQTLATLGYMAPEYGREGRVSTKGDV 954
VLLDD++ AH+SDFG+A+LL+ D+ ++ T+GY APEYG G+ S GDV
Sbjct: 845 VLLDDDLTAHVSDFGLARLLLKFDEESFFNQLSSAGVRGTIGYAAPEYGVGGQPSINGDV 904
Query: 955 YSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHFAAKEQ 1014
YSFGILL+E FT ++PT+E+F G TL + LP ++ I+D ++L + +
Sbjct: 905 YSFGILLLEMFTGKRPTNELFGGNFTLNSYTKSALPERILDIVDESILHIGLRVGFPVVE 964
Query: 1015 CASSVFNLAMECTVESPDERITAKEIVRRLLKIRDFLLR 1053
C + VF + + C ESP R+ +V+ L+ IR+ +
Sbjct: 965 CLTMVFEVGLRCCEESPMNRLATSIVVKELISIRERFFK 1003
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|C0LGT6|EFR_ARATH LRR receptor-like serine/threonine-protein kinase EFR OS=Arabidopsis thaliana GN=EFR PE=1 SV=1 | Back alignment and function description |
|---|
Score = 558 bits (1438), Expect = e-158, Method: Compositional matrix adjust.
Identities = 359/938 (38%), Positives = 519/938 (55%), Gaps = 49/938 (5%)
Query: 145 LLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQLSGSIPSFIFKISSLQALHFGNNRL 204
++ L L LTG I S ++GNLS L+LL+L+DN +IP + ++ LQ L+ N L
Sbjct: 75 VISLNLGGFKLTGVI-SPSIGNLSFLRLLNLADNSFGSTIPQKVGRLFRLQYLNMSYNLL 133
Query: 205 SGELPANICDNLPFLNFFSVYKNMFYGGISSTLSNCKHLRILDLSFNDLWGDIPKEIGNL 264
G +P+++ N L+ + N G+ S L + L ILDLS N+L G+ P +GNL
Sbjct: 134 EGRIPSSL-SNCSRLSTVDLSSNHLGHGVPSELGSLSKLAILDLSKNNLTGNFPASLGNL 192
Query: 265 TKLKELFLDFNILQGEIPHTVGNLHNLEYLSLVNNELVGTVPATIFNVSTLKLIELSNNT 324
T L++L +N ++GEIP V L + + + N G P ++N+S+L+ + L++N+
Sbjct: 193 TSLQKLDFAYNQMRGEIPDEVARLTQMVFFQIALNSFSGGFPPALYNISSLESLSLADNS 252
Query: 325 FFGSLPSSTDVQLPNLEELYLWGNNFSGTLPSFIFNASNLSKLSLGDNSFSGLIPNTFGN 384
F G+L + LPNL L L N F+G +P + N S+L + + N SG IP +FG
Sbjct: 253 FSGNLRADFGYLLPNLRRLLLGTNQFTGAIPKTLANISSLERFDISSNYLSGSIPLSFGK 312
Query: 385 LRNLKRLRLYNNYLTSPEL---SFLSSLSNCKYLEIIALSGNPLNGIIPMSAGNLSHSLE 441
LRNL L + NN L + F+ +++NC LE + + N L G +P S NLS +L
Sbjct: 313 LRNLWWLGIRNNSLGNNSSSGLEFIGAVANCTQLEYLDVGYNRLGGELPASIANLSTTLT 372
Query: 442 ELFMPDCNVSGRIPKEIGNLANLVTLDLGGNKFNGSIPIALGKLQKLQLLNLDDNKLEGS 501
LF+ +SG IP +IGNL +L L L N +G +P++ GKL LQ+++L N + G
Sbjct: 373 SLFLGQNLISGTIPHDIGNLVSLQELSLETNMLSGELPVSFGKLLNLQVVDLYSNAISGE 432
Query: 502 IPDDICGLVELYKLALGDNKLSGQIPACFGNLASLRELWLGPNELISFIPSTFWNIKDIM 561
IP + L KL L N G+IP G L +LW+ N L IP I +
Sbjct: 433 IPSYFGNMTRLQKLHLNSNSFHGRIPQSLGRCRYLLDLWMDTNRLNGTIPQEILQIPSLA 492
Query: 562 YVNFSSNFLTGPLPLEIENLKALTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQGS 621
Y++ S+NFLTG P E+ L+ L L S N LSG +P IGG +++LF+ N G+
Sbjct: 493 YIDLSNNFLTGHFPEEVGKLELLVGLGASYNKLSGKMPQAIGGCLSMEFLFMQGNSFDGA 552
Query: 622 IPDSVGDLISLKSLNLSNNNLSGPIPTSLEKLSDLKELNLSFNKLEGEIPRGGPFVNFSA 681
IPD + L+SLK+++ SNNNLSG IP L L L+ LNLS NK EG +P G F N +A
Sbjct: 553 IPD-ISRLVSLKNVDFSNNNLSGRIPRYLASLPSLRNLNLSMNKFEGRVPTTGVFRNATA 611
Query: 682 KSFMGNNLLCGS-PNLQVPPC--RASIDH---ISKKNALLLGIILPFSTIFVIVIILLIS 735
S GN +CG +Q+ PC +AS +S + ++ GI + +++ +I+I+ +
Sbjct: 612 VSVFGNTNICGGVREMQLKPCIVQASPRKRKPLSVRKKVVSGICIGIASLLLIIIVASLC 671
Query: 736 RYQTRGENVPNEVNVPLEAT-----WRRFSYLELFQATNGFSENNLIGRGSFGSVYIARL 790
+ R + P ++T + SY EL AT+ FS NLIG G+FG+V+ L
Sbjct: 672 WFMKRKKKNNASDGNPSDSTTLGMFHEKVSYEELHSATSRFSSTNLIGSGNFGNVFKGLL 731
Query: 791 --QNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCSN-----EDFKALI 843
+N + VAVK +L A KSF ECE K IRHRNL K+I+ CS+ DF+AL+
Sbjct: 732 GPENKL-VAVKVLNLLKHGATKSFMAECETFKGIRHRNLVKLITVCSSLDSEGNDFRALV 790
Query: 844 LEYMRNGSLEKCLY--------SGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDL 895
E+M GSL+ L + L ++LNI IDVASALEYLH PV HCD+
Sbjct: 791 YEFMPKGSLDMWLQLEDLERVNDHSRSLTPAEKLNIAIDVASALEYLHVHCHDPVAHCDI 850
Query: 896 KPSNVLLDDNMVAHLSDFGIAKLLIGEDQ-----SMTQTQTLATLGYMAPEYGREGRVST 950
KPSN+LLDD++ AH+SDFG+A+LL D+ + T+GY APEYG G+ S
Sbjct: 851 KPSNILLDDDLTAHVSDFGLAQLLYKYDRESFLNQFSSAGVRGTIGYAAPEYGMGGQPSI 910
Query: 951 KGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHFA 1010
+GDVYSFGILL+E F+ +KPTDE F+G+ L + L T
Sbjct: 911 QGDVYSFGILLLEMFSGKKPTDESFAGDYNLHSYTKSILSG-----------CTSSGGSN 959
Query: 1011 AKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKIR 1048
A ++ V + ++C+ E P +R+ E VR L+ IR
Sbjct: 960 AIDEGLRLVLQVGIKCSEEYPRDRMRTDEAVRELISIR 997
|
Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of elongation factor Tu (EF-Tu), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Reduces transformation by Rhizobium radiobacter probably by inducing plant defense during the interaction. Binding to the effector AvrPto1 from P.syringae blocks the downstream plant immune response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FL28|FLS2_ARATH LRR receptor-like serine/threonine-protein kinase FLS2 OS=Arabidopsis thaliana GN=FLS2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 536 bits (1382), Expect = e-151, Method: Compositional matrix adjust.
Identities = 374/1029 (36%), Positives = 561/1029 (54%), Gaps = 73/1029 (7%)
Query: 77 NISYLSL-----TGNIPRQLGNLSSLEILDLNFNRLSGEIPWELGNLAKLEKLLLHNNFL 131
NI YL L +G++P ++ SSL ++ ++N L+G+IP LG+L L+ + N L
Sbjct: 145 NIFYLDLRNNLLSGDVPEEICKTSSLVLIGFDYNNLTGKIPECLGDLVHLQMFVAAGNHL 204
Query: 132 TGTIPFSIFKLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQLSGSIPSFIFKI 191
TG+IP SI L++L DL LS N LTG IP + GNL +LQ L L++N L G IP+ I
Sbjct: 205 TGSIPVSIGTLANLTDLDLSGNQLTGKIP-RDFGNLLNLQSLVLTENLLEGDIPAEIGNC 263
Query: 192 SSLQALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGGISSTLSNCKHLRILDLSFN 251
SSL L +N+L+G++PA + NL L +YKN I S+L L L LS N
Sbjct: 264 SSLVQLELYDNQLTGKIPAEL-GNLVQLQALRIYKNKLTSSIPSSLFRLTQLTHLGLSEN 322
Query: 252 DLWGDIPKEIG------------------------NLTKLKELFLDFNILQGEIPHTVGN 287
L G I +EIG NL L L + FN + GE+P +G
Sbjct: 323 HLVGPISEEIGFLESLEVLTLHSNNFTGEFPQSITNLRNLTVLTVGFNNISGELPADLGL 382
Query: 288 LHNLEYLSLVNNELVGTVPATIFNVSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYLWG 347
L NL LS +N L G +P++I N + LKL++LS+N G +P NL + +
Sbjct: 383 LTNLRNLSAHDNLLTGPIPSSISNCTGLKLLDLSHNQMTGEIPRGFGRM--NLTFISIGR 440
Query: 348 NNFSGTLPSFIFNASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNYLTSPELSFLS 407
N+F+G +P IFN SNL LS+ DN+ +G + G L+ L+ L++ N LT P
Sbjct: 441 NHFTGEIPDDIFNCSNLETLSVADNNLTGTLKPLIGKLQKLRILQVSYNSLTGP---IPR 497
Query: 408 SLSNCKYLEIIALSGNPLNGIIPMSAGNLSHSLEELFMPDCNVSGRIPKEIGNLANLVTL 467
+ N K L I+ L N G IP NL+ L+ L M ++ G IP+E+ ++ L L
Sbjct: 498 EIGNLKDLNILYLHSNGFTGRIPREMSNLTL-LQGLRMYSNDLEGPIPEEMFDMKLLSVL 556
Query: 468 DLGGNKFNGSIPIALGKLQKLQLLNLDDNKLEGSIPDDICGLVELYKLALGDNKLSGQIP 527
DL NKF+G IP KL+ L L+L NK GSIP + L L + DN L+G IP
Sbjct: 557 DLSNNKFSGQIPALFSKLESLTYLSLQGNKFNGSIPASLKSLSLLNTFDISDNLLTGTIP 616
Query: 528 ACFGNLASLRELWL----GPNELISFIPSTFWNIKDIMYVNFSSNFLTGPLPLEIENLKA 583
LASL+ + L N L IP ++ + ++ S+N +G +P ++ K
Sbjct: 617 GEL--LASLKNMQLYLNFSNNLLTGTIPKELGKLEMVQEIDLSNNLFSGSIPRSLQACKN 674
Query: 584 LTTLDFSMNNLSGVIPTTI-GGLKGLQYLFLGHNRLQGSIPDSVGDLISLKSLNLSNNNL 642
+ TLDFS NNLSG IP + G+ + L L N G IP S G++ L SL+LS+NNL
Sbjct: 675 VFTLDFSQNNLSGHIPDEVFQGMDMIISLNLSRNSFSGEIPQSFGNMTHLVSLDLSSNNL 734
Query: 643 SGPIPTSLEKLSDLKELNLSFNKLEGEIPRGGPFVNFSAKSFMGNNLLCGSPNLQVPPC- 701
+G IP SL LS LK L L+ N L+G +P G F N +A MGN LCGS + PC
Sbjct: 735 TGEIPESLANLSTLKHLKLASNNLKGHVPESGVFKNINASDLMGNTDLCGSKK-PLKPCT 793
Query: 702 -RASIDHISKKNALLLGII--------LPFSTIFVIVIILLISRYQTRGENVPNEVNVPL 752
+ H SK+ ++L I+ + + + + + E+ +++ L
Sbjct: 794 IKQKSSHFSKRTRVILIILGSAAALLLVLLLVLILTCCKKKEKKIENSSESSLPDLDSAL 853
Query: 753 EATWRRFSYLELFQATNGFSENNLIGRGSFGSVYIARLQNGIEVAVKTFDLQH--ERAFK 810
+ +RF EL QAT+ F+ N+IG S +VY +L++G +AVK +L+ + K
Sbjct: 854 K--LKRFEPKELEQATDSFNSANIIGSSSLSTVYKGQLEDGTVIAVKVLNLKEFSAESDK 911
Query: 811 SFDTECEVMKSIRHRNLTKIIS-SCSNEDFKALILEYMRNGSLEKCLY-SGNYILDIFQR 868
F TE + + ++HRNL KI+ + + KAL+L +M NG+LE ++ S I + ++
Sbjct: 912 WFYTEAKTLSQLKHRNLVKILGFAWESGKTKALVLPFMENGNLEDTIHGSAAPIGSLLEK 971
Query: 869 LNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL-IGEDQSMT 927
+++ + +AS ++YLH GY P++HCDLKP+N+LLD + VAH+SDFG A++L ED S T
Sbjct: 972 IDLCVHIASGIDYLHSGYGFPIVHCDLKPANILLDSDRVAHVSDFGTARILGFREDGSTT 1031
Query: 928 QTQTL--ATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPT--DEIFSGEMTLKH 983
+ + T+GY+APE+ +V+TK DV+SFGI++ME T+++PT ++ S +MTL+
Sbjct: 1032 ASTSAFEGTIGYLAPEFAYMRKVTTKADVFSFGIIMMELMTKQRPTSLNDEDSQDMTLRQ 1091
Query: 984 WVNDFL---PISMMKIIDANLLITEDKHFAAKEQCASSVF-NLAMECTVESPDERITAKE 1039
V + M++++D L D + K++ A F L + CT P++R E
Sbjct: 1092 LVEKSIGNGRKGMVRVLDMEL---GDSIVSLKQEEAIEDFLKLCLFCTSSRPEDRPDMNE 1148
Query: 1040 IVRRLLKIR 1048
I+ L+K+R
Sbjct: 1149 ILTHLMKLR 1157
|
Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of flagellin (flg22), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Flagellin-binding to the receptor is the first step to initiate the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6), resulting in enhanced resistance against pathogens. Binding to the effector AvrPto1 from Pseudomonas syringae blocks the downstream plant immune response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 533 bits (1372), Expect = e-150, Method: Compositional matrix adjust.
Identities = 381/1058 (36%), Positives = 536/1058 (50%), Gaps = 93/1058 (8%)
Query: 72 RVTALNISYLSLTGNIPRQLGNLSSLEILDLNFNRLSGEIPWELGNLAKLEKLLLHNNFL 131
RV +L + L G IP +LGN S L + N L+G IP ELG L LE L L NN L
Sbjct: 192 RVQSLILQDNYLEGPIPAELGNCSDLTVFTAAENMLNGTIPAELGRLENLEILNLANNSL 251
Query: 132 TGTIPFSIFKLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQLSGSIPSFIFKI 191
TG IP + ++S L L L N L G IP +L +L +LQ LDLS N L+G IP + +
Sbjct: 252 TGEIPSQLGEMSQLQYLSLMANQLQGLIPK-SLADLGNLQTLDLSANNLTGEIPEEFWNM 310
Query: 192 SSLQALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGGISSTLSNCKHLRILDLSFN 251
S L L NN LSG LP +IC N L + G I LS C+ L+ LDLS N
Sbjct: 311 SQLLDLVLANNHLSGSLPKSICSNNTNLEQLVLSGTQLSGEIPVELSKCQSLKQLDLSNN 370
Query: 252 DLWGDIPK------------------------EIGNLTKLKELFLDFNILQGEIPHTVGN 287
L G IP+ I NLT L+ L L N L+G++P +
Sbjct: 371 SLAGSIPEALFELVELTDLYLHNNTLEGTLSPSISNLTNLQWLVLYHNNLEGKLPKEISA 430
Query: 288 LHNLEYLSLVNNELVGTVPATIFNVSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYLWG 347
L LE L L N G +P I N ++LK+I++ N F G +P S +L L L+L
Sbjct: 431 LRKLEVLFLYENRFSGEIPQEIGNCTSLKMIDMFGNHFEGEIPPSIG-RLKELNLLHLRQ 489
Query: 348 NNFSGTLPSFIFNASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNYLTSPELSFLS 407
N G LP+ + N L+ L L DN SG IP++FG L+ L++L LYNN L +
Sbjct: 490 NELVGGLPASLGNCHQLNILDLADNQLSGSIPSSFGFLKGLEQLMLYNNSLQG---NLPD 546
Query: 408 SLSNCKYLEIIALSGNPLNGIIPMSAGNLSHSLEELFMPDCNVSGRIPKEIGNLANLVTL 467
SL + + L I LS N LNG I G S S + + IP E+GN NL L
Sbjct: 547 SLISLRNLTRINLSHNRLNGTIHPLCG--SSSYLSFDVTNNGFEDEIPLELGNSQNLDRL 604
Query: 468 DLGGNKFNGSIPIALGKLQKLQLLNLDDNKLEGSIPDDICGLVELYKLALGDNKLSGQIP 527
LG N+ G IP LGK+++L LL++ N L G+IP + +L + L +N LSG IP
Sbjct: 605 RLGKNQLTGKIPWTLGKIRELSLLDMSSNALTGTIPLQLVLCKKLTHIDLNNNFLSGPIP 664
Query: 528 ACFGNLASLRELWLGPNELISFIPSTFWNIKDIMYVNFSSNFLTGPLPLEIENLKALTTL 587
G L+ L EL L N+ + +P+ +N ++ ++ N L G +P EI NL AL L
Sbjct: 665 PWLGKLSQLGELKLSSNQFVESLPTELFNCTKLLVLSLDGNSLNGSIPQEIGNLGALNVL 724
Query: 588 DFSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQGSIPDSVGDLISLKS-LNLSNNNLSGPI 646
+ N SG +P +G L L L L N L G IP +G L L+S L+LS NN +G I
Sbjct: 725 NLDKNQFSGSLPQAMGKLSKLYELRLSRNSLTGEIPVEIGQLQDLQSALDLSYNNFTGDI 784
Query: 647 PTSLEKLSDLKELNLSFNKLEGEIPR------------------GGP----FVNFSAKSF 684
P+++ LS L+ L+LS N+L GE+P GG F + A SF
Sbjct: 785 PSTIGTLSKLETLDLSHNQLTGEVPGSVGDMKSLGYLNVSFNNLGGKLKKQFSRWPADSF 844
Query: 685 MGNNLLCGSPNLQVPPCRASIDH--ISKKNALLLGIILPFSTIFVIVIILLI-------- 734
+GN LCGSP + R++ +S ++ +++ I + I ++++++ +
Sbjct: 845 LGNTGLCGSPLSRCNRVRSNNKQQGLSARSVVIISAISALTAIGLMILVIALFFKQRHDF 904
Query: 735 -------SRYQTRGENVPNEVNVPL---EATWRRFSYLELFQATNGFSENNLIGRGSFGS 784
S T + + PL A+ + ++ +AT+ SE +IG G G
Sbjct: 905 FKKVGHGSTAYTSSSSSSQATHKPLFRNGASKSDIRWEDIMEATHNLSEEFMIGSGGSGK 964
Query: 785 VYIARLQNGIEVAVKTFDLQHE-RAFKSFDTECEVMKSIRHRNLTKIISSCS--NEDFKA 841
VY A L+NG VAVK + + + KSF E + + IRHR+L K++ CS +E
Sbjct: 965 VYKAELENGETVAVKKILWKDDLMSNKSFSREVKTLGRIRHRHLVKLMGYCSSKSEGLNL 1024
Query: 842 LILEYMRNGSLEKCLYSGNYI-------LDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 894
LI EYM+NGS+ L+ + LD RL I + +A +EYLH P++H D
Sbjct: 1025 LIYEYMKNGSIWDWLHEDKPVLEKKKKLLDWEARLRIAVGLAQGVEYLHHDCVPPIVHRD 1084
Query: 895 LKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTL--ATLGYMAPEYGREGRVSTKG 952
+K SNVLLD NM AHL DFG+AK+L + T + T + GY+APEY + + K
Sbjct: 1085 IKSSNVLLDSNMEAHLGDFGLAKVLTENCDTNTDSNTWFACSYGYIAPEYAYSLKATEKS 1144
Query: 953 DVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPI---SMMKIIDANLLITEDKHF 1009
DVYS GI+LME T + PTD +F EM + WV L + + K+ID L
Sbjct: 1145 DVYSMGIVLMEIVTGKMPTDSVFGAEMDMVRWVETHLEVAGSARDKLIDPKL----KPLL 1200
Query: 1010 AAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKI 1047
+E A V +A++CT SP ER ++++ LL +
Sbjct: 1201 PFEEDAACQVLEIALQCTKTSPQERPSSRQACDSLLHV 1238
|
Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 509 bits (1312), Expect = e-143, Method: Compositional matrix adjust.
Identities = 405/1242 (32%), Positives = 594/1242 (47%), Gaps = 216/1242 (17%)
Query: 6 LFIHCLIHSLIIAASANTSIDIDQDALLALKDHITYDPTNF-FAKNWLTNSTMVCNWTGV 64
LF C L S D LL LK+ +P ++W + S CNWTGV
Sbjct: 10 LFFLCFSSGL---GSGQPGQRDDLQTLLELKNSFITNPKEEDVLRDWNSGSPSYCNWTGV 66
Query: 65 TCDINQRRVTALNISYLSLTGNIPRQLGNLSSLEILDLNFNRL----------------- 107
TC R + LN+S L LTG+I +G ++L +DL+ NRL
Sbjct: 67 TC--GGREIIGLNLSGLGLTGSISPSIGRFNNLIHIDLSSNRLVGPIPTTLSNLSSSLES 124
Query: 108 --------SGEIPWELGNLAKLEKLLLHNNFLTGTIPFSIFKLSSLLDLKLSDNNLTGTI 159
SG+IP +LG+L L+ L L +N L GTIP + L +L L L+ LTG I
Sbjct: 125 LHLFSNLLSGDIPSQLGSLVNLKSLKLGDNELNGTIPETFGNLVNLQMLALASCRLTGLI 184
Query: 160 PSH-----------------------NLGNLSSLQLLDLSDNQLSGSIPSFIFKISSLQA 196
PS +GN +SL L + N+L+GS+P+ + ++ +LQ
Sbjct: 185 PSRFGRLVQLQTLILQDNELEGPIPAEIGNCTSLALFAAAFNRLNGSLPAELNRLKNLQT 244
Query: 197 LHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGGISSTLSNCKHLRILDLSFNDL--- 253
L+ G+N SGE+P+ + D L + + ++ N G I L+ +L+ LDLS N+L
Sbjct: 245 LNLGDNSFSGEIPSQLGD-LVSIQYLNLIGNQLQGLIPKRLTELANLQTLDLSSNNLTGV 303
Query: 254 -----W----------------GDIPKEI-GNLTKLKELFLDFNILQGEIPHTVGNLHNL 291
W G +PK I N T LK+LFL L GEIP + N +L
Sbjct: 304 IHEEFWRMNQLEFLVLAKNRLSGSLPKTICSNNTSLKQLFLSETQLSGEIPAEISNCQSL 363
Query: 292 EYLSLVNNELVGTVPATIFNVSTLKLIELSNNTFFGSLPSS----TDVQ----------- 336
+ L L NN L G +P ++F + L + L+NN+ G+L SS T++Q
Sbjct: 364 KLLDLSNNTLTGQIPDSLFQLVELTNLYLNNNSLEGTLSSSISNLTNLQEFTLYHNNLEG 423
Query: 337 --------LPNLEELYLWGNNFSGTLPSFIFNASNLSKLSLGDNSFSGLIPNTFGNLRNL 388
L LE +YL+ N FSG +P I N + L ++ N SG IP++ G L++L
Sbjct: 424 KVPKEIGFLGKLEIMYLYENRFSGEMPVEIGNCTRLQEIDWYGNRLSGEIPSSIGRLKDL 483
Query: 389 KRLRLYNNYLTSPELSFLSSLSNCKYLEIIALSGNPLNGIIPMS---------------- 432
RL L N L + +SL NC + +I L+ N L+G IP S
Sbjct: 484 TRLHLRENELVG---NIPASLGNCHQMTVIDLADNQLSGSIPSSFGFLTALELFMIYNNS 540
Query: 433 -AGNLSHSLEEL----------------FMPDCNVS-------------GRIPKEIGNLA 462
GNL SL L P C S G IP E+G
Sbjct: 541 LQGNLPDSLINLKNLTRINFSSNKFNGSISPLCGSSSYLSFDVTENGFEGDIPLELGKST 600
Query: 463 NLVTLDLGGNKFNGSIPIALGKLQKLQLLNLDDNKLEGSIPDDICGLVELYKLALGDNKL 522
NL L LG N+F G IP GK+ +L LL++ N L G IP ++ +L + L +N L
Sbjct: 601 NLDRLRLGKNQFTGRIPRTFGKISELSLLDISRNSLSGIIPVELGLCKKLTHIDLNNNYL 660
Query: 523 SGQIPACFGNLASLRELWLGPNELISFIPSTFWNIKDIMYVNFSSNFLTGPLPLEIENLK 582
SG IP G L L EL L N+ + +P+ +++ +I+ + N L G +P EI NL+
Sbjct: 661 SGVIPTWLGKLPLLGELKLSSNKFVGSLPTEIFSLTNILTLFLDGNSLNGSIPQEIGNLQ 720
Query: 583 ALTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQGSIPDSVGDLISLKS-LNLSNNN 641
AL L+ N LSG +P+TIG L L L L N L G IP +G L L+S L+LS NN
Sbjct: 721 ALNALNLEENQLSGPLPSTIGKLSKLFELRLSRNALTGEIPVEIGQLQDLQSALDLSYNN 780
Query: 642 LSGPIPTSLEKLSDLKELNLSFNKLEGEIPR----------------------GGPFVNF 679
+G IP+++ L L+ L+LS N+L GE+P F +
Sbjct: 781 FTGRIPSTISTLPKLESLDLSHNQLVGEVPGQIGDMKSLGYLNLSYNNLEGKLKKQFSRW 840
Query: 680 SAKSFMGNNLLCGSPNLQVPPC-RASIDH---ISKKNALLLGIILPFSTI--FVIVIILL 733
A +F+GN LCGSP + C RA + +S K +++ I + I V+VIIL
Sbjct: 841 QADAFVGNAGLCGSP---LSHCNRAGSKNQRSLSPKTVVIISAISSLAAIALMVLVIILF 897
Query: 734 ISR-----YQTRG-----ENVPNEVNVPL---EATWRRFSYLELFQATNGFSENNLIGRG 780
+ + RG + + PL + ++ +AT+ +E +IG G
Sbjct: 898 FKQNHDLFKKVRGGNSAFSSNSSSSQAPLFSNGGAKSDIKWDDIMEATHYLNEEFMIGSG 957
Query: 781 SFGSVYIARLQNGIEVAVKTFDLQHE-RAFKSFDTECEVMKSIRHRNLTKIISSCSN--E 837
G VY A L+NG +AVK + + + KSF+ E + + +IRHR+L K++ CS+ +
Sbjct: 958 GSGKVYKAELKNGETIAVKKILWKDDLMSNKSFNREVKTLGTIRHRHLVKLMGYCSSKAD 1017
Query: 838 DFKALILEYMRNGSLEKCLYSG-----NYILDIFQRLNIMIDVASALEYLHFGYSAPVIH 892
LI EYM NGS+ L++ +L RL I + +A +EYLH+ P++H
Sbjct: 1018 GLNLLIYEYMANGSVWDWLHANENTKKKEVLGWETRLKIALGLAQGVEYLHYDCVPPIVH 1077
Query: 893 CDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTL--ATLGYMAPEYGREGRVST 950
D+K SNVLLD N+ AHL DFG+AK+L G + T++ T+ + GY+APEY + +
Sbjct: 1078 RDIKSSNVLLDSNIEAHLGDFGLAKILTGNYDTNTESNTMFAGSYGYIAPEYAYSLKATE 1137
Query: 951 KGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPI-----SMMKIIDANLLITE 1005
K DVYS GI+LME T + PT+ +F E + WV L + K+ID+ L
Sbjct: 1138 KSDVYSMGIVLMEIVTGKMPTEAMFDEETDMVRWVETVLDTPPGSEAREKLIDSEL---- 1193
Query: 1006 DKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKI 1047
+E+ A V +A++CT P ER ++++ LL +
Sbjct: 1194 KSLLPCEEEAAYQVLEIALQCTKSYPQERPSSRQASEYLLNV 1235
|
Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SD62|Y3471_ARATH Putative receptor-like protein kinase At3g47110 OS=Arabidopsis thaliana GN=At3g47110 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 506 bits (1303), Expect = e-142, Method: Compositional matrix adjust.
Identities = 356/937 (37%), Positives = 520/937 (55%), Gaps = 38/937 (4%)
Query: 155 LTGTIPSHNLGNLSSLQLLDLSDNQLSGSIPSFIFKISSLQALHFGNNRLSGELPANICD 214
LTG + S +GNLS L+ L+L+DN G+IPS + + LQ L+ NN G +P +
Sbjct: 93 LTGVV-SPFVGNLSFLRSLNLADNFFHGAIPSEVGNLFRLQYLNMSNNLFGGVIPV-VLS 150
Query: 215 NLPFLNFFSVYKNMFYGGISSTLSNCKHLRILDLSFNDLWGDIPKEIGNLTKLKELFLDF 274
N L+ + N G+ + L +L L N+L G P +GNLT L+ L +
Sbjct: 151 NCSSLSTLDLSSNHLEQGVPLEFGSLSKLVLLSLGRNNLTGKFPASLGNLTSLQMLDFIY 210
Query: 275 NILQGEIPHTVGNLHNLEYLSLVNNELVGTVPATIFNVSTLKLIELSNNTFFGSLPSSTD 334
N ++GEIP + L + + + N+ G P I+N+S+L + ++ N+F G+L
Sbjct: 211 NQIEGEIPGDIARLKQMIFFRIALNKFNGVFPPPIYNLSSLIFLSITGNSFSGTLRPDFG 270
Query: 335 VQLPNLEELYLWGNNFSGTLPSFIFNASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLY 394
LPNL+ LY+ N+F+GT+P + N S+L +L + N +G IP +FG L+NL L L
Sbjct: 271 SLLPNLQILYMGINSFTGTIPETLSNISSLRQLDIPSNHLTGKIPLSFGRLQNLLLLGLN 330
Query: 395 NNY---LTSPELSFLSSLSNCKYLEIIALSGNPLNGIIPMSAGNLSHSLEELFMPDCNVS 451
NN +S +L FL +L+NC L+ + + N L G +P+ NLS L EL + +S
Sbjct: 331 NNSLGNYSSGDLDFLGALTNCSQLQYLNVGFNKLGGQLPVFIANLSTQLTELSLGGNLIS 390
Query: 452 GRIPKEIGNLANLVTLDLGGNKFNGSIPIALGKLQKLQLLNLDDNKLEGSIPDDICGLVE 511
G IP IGNL +L TLDLG N G +P +LG+L +L+ + L N L G IP + +
Sbjct: 391 GSIPHGIGNLVSLQTLDLGENLLTGKLPPSLGELSELRKVLLYSNGLSGEIPSSLGNISG 450
Query: 512 LYKLALGDNKLSGQIPACFGNLASLRELWLGPNELISFIPSTFWNIKDIMYVNFSSNFLT 571
L L L +N G IP+ G+ + L +L LG N+L IP + ++ +N S N L
Sbjct: 451 LTYLYLLNNSFEGSIPSSLGSCSYLLDLNLGTNKLNGSIPHELMELPSLVVLNVSFNLLV 510
Query: 572 GPLPLEIENLKALTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQGSIPDSVGDLIS 631
GPL +I LK L LD S N LSG IP T+ L++L L N G IPD G L
Sbjct: 511 GPLRQDIGKLKFLLALDVSYNKLSGQIPQTLANCLSLEFLLLQGNSFVGPIPDIRG-LTG 569
Query: 632 LKSLNLSNNNLSGPIPTSLEKLSDLKELNLSFNKLEGEIPRGGPFVNFSAKSFMGNNLLC 691
L+ L+LS NNLSG IP + S L+ LNLS N +G +P G F N SA S GN LC
Sbjct: 570 LRFLDLSKNNLSGTIPEYMANFSKLQNLNLSLNNFDGAVPTEGVFRNTSAMSVFGNINLC 629
Query: 692 GS-PNLQVPPCRASI--DHISKKNALLLGIILPFSTIFVIVIILLISRY------QTRGE 742
G P+LQ+ PC + H S + + + + + + ++ + ++ + R
Sbjct: 630 GGIPSLQLQPCSVELPRRHSSVRKIITICVSAVMAALLLLCLCVVYLCWYKLRVKSVRAN 689
Query: 743 NVPNEVNV-PLEATWRRFSYLELFQATNGFSENNLIGRGSFGSVYIARL-QNGIEVAVKT 800
N N+ + P+++ + + SY EL++ T GFS +NLIG G+FG+V+ L VA+K
Sbjct: 690 NNENDRSFSPVKSFYEKISYDELYKTTGGFSSSNLIGSGNFGAVFKGFLGSKNKAVAIKV 749
Query: 801 FDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCSNE-----DFKALILEYMRNGSLEKC 855
+L A KSF ECE + IRHRNL K+++ CS+ DF+AL+ E+M NG+L+
Sbjct: 750 LNLCKRGAAKSFIAECEALGGIRHRNLVKLVTICSSSDFEGNDFRALVYEFMPNGNLDMW 809
Query: 856 LY------SGN--YILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMV 907
L+ +GN L +F RLNI IDVASAL YLH P+ HCD+KPSN+LLD ++
Sbjct: 810 LHPDEIEETGNPSRTLGLFARLNIAIDVASALVYLHTYCHNPIAHCDIKPSNILLDKDLT 869
Query: 908 AHLSDFGIAKLLIGEDQSMTQTQ-----TLATLGYMAPEYGREGRVSTKGDVYSFGILLM 962
AH+SDFG+A+LL+ D+ Q T+GY APEYG G S GDVYSFGI+L+
Sbjct: 870 AHVSDFGLAQLLLKFDRDTFHIQFSSAGVRGTIGYAAPEYGMGGHPSIMGDVYSFGIVLL 929
Query: 963 ETFTRRKPTDEIFSGEMTLKHWVNDFL-PISMMKIIDANLLI-TEDKHFAAKEQCASSVF 1020
E FT ++PT+++F +TL + L + I D +L +HF E C + VF
Sbjct: 930 EIFTGKRPTNKLFVDGLTLHSFTKSALQKRQALDITDETILRGAYAQHFNMVE-CLTLVF 988
Query: 1021 NLAMECTVESPDERITAKEIVRRLLKIRDFLLRNVES 1057
+ + C+ ESP RI+ E + +L+ IR+ R+ E+
Sbjct: 989 RVGVSCSEESPVNRISMAEAISKLVSIRESFFRDEET 1025
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LVP0|Y5639_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g63930 OS=Arabidopsis thaliana GN=At5g63930 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 490 bits (1261), Expect = e-137, Method: Compositional matrix adjust.
Identities = 362/1074 (33%), Positives = 544/1074 (50%), Gaps = 68/1074 (6%)
Query: 23 TSIDIDQDALLALKDHITYDPTNFFAKNWLTNSTMVCNWTGVTCDINQR----------- 71
T ++++ LL +K N +NW +N ++ C WTGV C
Sbjct: 25 TGLNLEGQYLLEIKSKFVDAKQNL--RNWNSNDSVPCGWTGVMCSNYSSDPEVLSLNLSS 82
Query: 72 ---------------RVTALNISYLSLTGNIPRQLGNLSSLEILDLNFNRLSGEIPWELG 116
+ L++SY L+G IP+++GN SSLEIL LN N+ GEIP E+G
Sbjct: 83 MVLSGKLSPSIGGLVHLKQLDLSYNGLSGKIPKEIGNCSSLEILKLNNNQFDGEIPVEIG 142
Query: 117 NLAKLEKLLLHNNFLTGTIPFSIFKLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLS 176
L LE L+++NN ++G++P I L SL L NN++G +P ++GNL L
Sbjct: 143 KLVSLENLIIYNNRISGSLPVEIGNLLSLSQLVTYSNNISGQLP-RSIGNLKRLTSFRAG 201
Query: 177 DNQLSGSIPSFIFKISSLQALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGGISST 236
N +SGS+PS I SL L N+LSGELP I L L+ +++N F G I
Sbjct: 202 QNMISGSLPSEIGGCESLVMLGLAQNQLSGELPKEI-GMLKKLSQVILWENEFSGFIPRE 260
Query: 237 LSNCKHLRILDLSFNDLWGDIPKEIGNLTKLKELFLDFNILQGEIPHTVGNLHNLEYLSL 296
+SNC L L L N L G IPKE+G+L L+ L+L N L G IP +GNL +
Sbjct: 261 ISNCTSLETLALYKNQLVGPIPKELGDLQSLEFLYLYRNGLNGTIPREIGNLSYAIEIDF 320
Query: 297 VNNELVGTVPATIFNVSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSGTLPS 356
N L G +P + N+ L+L+ L N G++P L NL +L L N +G +P
Sbjct: 321 SENALTGEIPLELGNIEGLELLYLFENQLTGTIPVELST-LKNLSKLDLSINALTGPIPL 379
Query: 357 FIFNASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNYLTSPELSFLSSLSNCKYLE 416
L L L NS SG IP G +L L + +N+L+ S+L SN +
Sbjct: 380 GFQYLRGLFMLQLFQNSLSGTIPPKLGWYSDLWVLDMSDNHLSGRIPSYLCLHSN---MI 436
Query: 417 IIALSGNPLNGIIPMSAGNLSHSLEELFMPDCNVSGRIPKEIGNLANLVTLDLGGNKFNG 476
I+ L N L+G IP +L +L + N+ GR P + N+ ++LG N+F G
Sbjct: 437 ILNLGTNNLSGNIPTGI-TTCKTLVQLRLARNNLVGRFPSNLCKQVNVTAIELGQNRFRG 495
Query: 477 SIPIALGKLQKLQLLNLDDNKLEGSIPDDICGLVELYKLALGDNKLSGQIPACFGNLASL 536
SIP +G LQ L L DN G +P +I L +L L + NKL+G++P+ N L
Sbjct: 496 SIPREVGNCSALQRLQLADNGFTGELPREIGMLSQLGTLNISSNKLTGEVPSEIFNCKML 555
Query: 537 RELWLGPNELISFIPSTFWNIKDIMYVNFSSNFLTGPLPLEIENLKALTTLDFSMNNLSG 596
+ L + N +PS ++ + + S+N L+G +P+ + NL LT L N +G
Sbjct: 556 QRLDMCCNNFSGTLPSEVGSLYQLELLKLSNNNLSGTIPVALGNLSRLTELQMGGNLFNG 615
Query: 597 VIPTTIGGLKGLQ-YLFLGHNRLQGSIPDSVGDLISLKSLNLSNNNLSGPIPTSLEKLSD 655
IP +G L GLQ L L +N+L G IP + +L+ L+ L L+NNNLSG IP+S LS
Sbjct: 616 SIPRELGSLTGLQIALNLSYNKLTGEIPPELSNLVMLEFLLLNNNNLSGEIPSSFANLSS 675
Query: 656 LKELNLSFNKLEGEIPRGGPFVNFSAKSFMGNNLLCGSP---NLQVPPCRASID------ 706
L N S+N L G IP N S SF+GN LCG P +Q P S
Sbjct: 676 LLGYNFSYNSLTGPIPL---LRNISMSSFIGNEGLCGPPLNQCIQTQPFAPSQSTGKPGG 732
Query: 707 -HISKKNALLLGIILPFSTIFVIVIILLISR-----YQTRGENVPNEVNVPLEATWRR-F 759
SK A+ +I S + + +I+ L+ R + + P+E+++ + + F
Sbjct: 733 MRSSKIIAITAAVIGGVSLMLIALIVYLMRRPVRTVASSAQDGQPSEMSLDIYFPPKEGF 792
Query: 760 SYLELFQATNGFSENNLIGRGSFGSVYIARLQNGIEVAVKTFDLQHE-----RAFKSFDT 814
++ +L AT+ F E+ ++GRG+ G+VY A L G +AVK HE SF
Sbjct: 793 TFQDLVAATDNFDESFVVGRGACGTVYKAVLPAGYTLAVKKLASNHEGGNNNNVDNSFRA 852
Query: 815 ECEVMKSIRHRNLTKIISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMID 874
E + +IRHRN+ K+ C+++ L+ EYM GSL + L+ + LD +R I +
Sbjct: 853 EILTLGNIRHRNIVKLHGFCNHQGSNLLLYEYMPKGSLGEILHDPSCNLDWSKRFKIALG 912
Query: 875 VASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLAT 934
A L YLH + H D+K +N+LLDD AH+ DFG+AK +I S + + +
Sbjct: 913 AAQGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAK-VIDMPHSKSMSAIAGS 971
Query: 935 LGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMM 994
GY+APEY +V+ K D+YS+G++L+E T + P I G + +WV ++ +
Sbjct: 972 YGYIAPEYAYTMKVTEKSDIYSYGVVLLELLTGKAPVQPIDQGGDVV-NWVRSYIRRDAL 1030
Query: 995 K--IIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLK 1046
++DA L + ED+ + +V +A+ CT SP R + +++V L++
Sbjct: 1031 SSGVLDARLTL-EDERIVSH---MLTVLKIALLCTSVSPVARPSMRQVVLMLIE 1080
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZUI0|Y2241_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g24130 OS=Arabidopsis thaliana GN=At2g24130 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 476 bits (1225), Expect = e-133, Method: Compositional matrix adjust.
Identities = 319/891 (35%), Positives = 474/891 (53%), Gaps = 80/891 (8%)
Query: 231 GGISSTLSNCKHLRILDLSFNDLWGDIPKEIGNLTK-LKELFLDFNILQGEIPHTVGNLH 289
G IS +++N L +LDLS N G IP EIG+L + LK+L L N+L G IP +G L+
Sbjct: 80 GEISPSIANLTGLTVLDLSRNFFVGKIPPEIGSLHETLKQLSLSENLLHGNIPQELGLLN 139
Query: 290 NLEYLSLVNNELVGTVPATIF---NVSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYLW 346
L YL L +N L G++P +F + S+L+ I+LSNN+ G +P + L L L LW
Sbjct: 140 RLVYLDLGSNRLNGSIPVQLFCNGSSSSLQYIDLSNNSLTGEIPLNYHCHLKELRFLLLW 199
Query: 347 GNNFSGTLPSFIFNASNLSKLSLGDNSFSGLIPN-TFGNLRNLKRLRLYNNYLTSPE--- 402
N +GT+PS + N++NL + L N SG +P+ + L+ L L N+ S
Sbjct: 200 SNKLTGTVPSSLSNSTNLKWMDLESNMLSGELPSQVISKMPQLQFLYLSYNHFVSHNNNT 259
Query: 403 --LSFLSSLSNCKYLEIIALSGNPLNGIIPMSAGNLSHSLEELFMPDCNVSGRIP----- 455
F +SL+N L+ + L+GN L G I S +LS +L ++ + + G IP
Sbjct: 260 NLEPFFASLANSSDLQELELAGNSLGGEITSSVRHLSVNLVQIHLDQNRIHGSIPPEISN 319
Query: 456 -------------------KEIGNLANLVTLDLGGNKFNGSIPIALGKLQKLQLLNLDDN 496
+E+ L+ L + L N G IP+ LG + +L LL++ N
Sbjct: 320 LLNLTLLNLSSNLLSGPIPRELCKLSKLERVYLSNNHLTGEIPMELGDIPRLGLLDVSRN 379
Query: 497 KLEGSIPDDICGLVELYKLALGDNKLSGQIPACFGNLASLRELWLGPNELISFIP----S 552
L GSIPD L +L +L L N LSG +P G +L L L N L IP S
Sbjct: 380 NLSGSIPDSFGNLSQLRRLLLYGNHLSGTVPQSLGKCINLEILDLSHNNLTGTIPVEVVS 439
Query: 553 TFWNIKDIMYVNFSSNFLTGPLPLEIENLKALTTLDFSMNNLSGVIPTTIGGLKGLQYLF 612
N+K +Y+N SSN L+GP+PLE+ + + ++D S N LSG IP +G L++L
Sbjct: 440 NLRNLK--LYLNLSSNHLSGPIPLELSKMDMVLSVDLSSNELSGKIPPQLGSCIALEHLN 497
Query: 613 LGHNRLQGSIPDSVGDLISLKSLNLSNNNLSGPIPTSLEKLSDLKELNLSFNKLEGEIPR 672
L N ++P S+G L LK L++S N L+G IP S ++ S LK LN SFN L G +
Sbjct: 498 LSRNGFSSTLPSSLGQLPYLKELDVSFNRLTGAIPPSFQQSSTLKHLNFSFNLLSGNVSD 557
Query: 673 GGPFVNFSAKSFMGNNLLCGS-PNLQVPPCRASIDH-ISKKNALLLGIILPFSTIFVIVI 730
G F + +SF+G++LLCGS +Q C+ + LL I P +F +
Sbjct: 558 KGSFSKLTIESFLGDSLLCGSIKGMQA--CKKKHKYPSVLLPVLLSLIATPVLCVFGYPL 615
Query: 731 I---------LLISRYQTRGENVPNEVNVPLEATWRRFSYLELFQATNGFSENNLIGRGS 781
+ + ++ + E N+ N P + R SY +L AT GF+ ++LIG G
Sbjct: 616 VQRSRFGKNLTVYAKEEVEDEEKQNQ-NDP---KYPRISYQQLIAATGGFNASSLIGSGR 671
Query: 782 FGSVYIARLQNGIEVAVKTFDLQHERAFK-SFDTECEVMKSIRHRNLTKIISSCSNEDFK 840
FG VY L+N +VAVK D + F SF EC+++K RHRNL +II++CS F
Sbjct: 672 FGHVYKGVLRNNTKVAVKVLDPKTALEFSGSFKRECQILKRTRHRNLIRIITTCSKPGFN 731
Query: 841 ALILEYMRNGSLEKCLYSGNYI---LDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKP 897
AL+L M NGSLE+ LY G Y LD+ Q +NI DVA + YLH V+HCDLKP
Sbjct: 732 ALVLPLMPNGSLERHLYPGEYSSKNLDLIQLVNICSDVAEGIAYLHHYSPVKVVHCDLKP 791
Query: 898 SNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLA----------TLGYMAPEYGREGR 947
SN+LLDD M A ++DFGI++L+ G +++++ +++ ++GY+APEYG R
Sbjct: 792 SNILLDDEMTALVTDFGISRLVQGVEETVSTDDSVSFGSTDGLLCGSVGYIAPEYGMGKR 851
Query: 948 VSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDK 1007
ST GDVYSFG+LL+E + R+PTD + + +L ++ P S+ II+ L + K
Sbjct: 852 ASTHGDVYSFGVLLLEIVSGRRPTDVLVNEGSSLHEFMKSHYPDSLEGIIEQAL--SRWK 909
Query: 1008 HFAAKEQCAS-------SVFNLAMECTVESPDERITAKEIVRRLLKIRDFL 1051
E+C + L + CT +P R ++ + +++++L
Sbjct: 910 PQGKPEKCEKLWREVILEMIELGLVCTQYNPSTRPDMLDVAHEMGRLKEYL 960
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SHI2|Y1723_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230 OS=Arabidopsis thaliana GN=At1g17230 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 475 bits (1222), Expect = e-132, Method: Compositional matrix adjust.
Identities = 353/1075 (32%), Positives = 522/1075 (48%), Gaps = 109/1075 (10%)
Query: 44 TNFFAKNWLTNSTMVCNWTGVTC---------DINQRRVTA--------------LNISY 80
+N + +W + CNWTG+ C D+N ++ LN+S
Sbjct: 41 SNGYLASWNQLDSNPCNWTGIACTHLRTVTSVDLNGMNLSGTLSPLICKLHGLRKLNVST 100
Query: 81 LSLTGNIPRQLGNLSSLEILDLNFNRLSGEIPWELGNLAKLEKLLLHNNFLTGTIPFSIF 140
++G IP+ L SLE+LDL NR G IP +L + L+KL L N+L G+IP I
Sbjct: 101 NFISGPIPQDLSLCRSLEVLDLCTNRFHGVIPIQLTMIITLKKLYLCENYLFGSIPRQIG 160
Query: 141 KLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQLSGSIPSFIFKISSLQALHFG 200
LSSL +L + NNLTG IP ++ L L+++ N SG IPS I SL+ L
Sbjct: 161 NLSSLQELVIYSNNLTGVIPP-SMAKLRQLRIIRAGRNGFSGVIPSEISGCESLKVLGLA 219
Query: 201 NNRLSGELPANICDNLPFLNFFSVYKNMFYGGISSTLSNCKHLRILDLSFNDLWGDIPKE 260
N L G LP + + L L +++N G I ++ N L +L L N G IP+E
Sbjct: 220 ENLLEGSLPKQL-EKLQNLTDLILWQNRLSGEIPPSVGNISRLEVLALHENYFTGSIPRE 278
Query: 261 IGNLTKLKELFLDFNILQGEIPHTVGNLHNLEYLSLVNNELVGTVPATIFNVSTLKLIEL 320
IG LTK+K L+L N L GEIP +GNL + + N+L G +P ++ LKL+ L
Sbjct: 279 IGKLTKMKRLYLYTNQLTGEIPREIGNLIDAAEIDFSENQLTGFIPKEFGHILNLKLLHL 338
Query: 321 SNNTFFGSLPSS----------------------TDVQ-LPNLEELYLWGNNFSGTLPSF 357
N G +P ++Q LP L +L L+ N G +P
Sbjct: 339 FENILLGPIPRELGELTLLEKLDLSINRLNGTIPQELQFLPYLVDLQLFDNQLEGKIPPL 398
Query: 358 IFNASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNYLTSPELSFLSSLSNCKYLEI 417
I SN S L + NS SG IP F + L L L +N L+ + L CK L
Sbjct: 399 IGFYSNFSVLDMSANSLSGPIPAHFCRFQTLILLSLGSNKLSG---NIPRDLKTCKSLTK 455
Query: 418 IALSGNPLNGIIPMSAGNLSHSLEELFMPDCNVSGRIPKEIGNLANLVTLDLGGNKFNGS 477
+ L N L G +P+ NL +L L + +SG I ++G L NL L L N F G
Sbjct: 456 LMLGDNQLTGSLPIELFNL-QNLTALELHQNWLSGNISADLGKLKNLERLRLANNNFTGE 514
Query: 478 IPIALGKLQKLQLLNLDDNKLEGSIPDDICGLVELYKLALGDNKLSGQIPACFGNLASLR 537
IP +G L K+ N+ N+L G IP ++ V + +L L NK SG I G L L
Sbjct: 515 IPPEIGNLTKIVGFNISSNQLTGHIPKELGSCVTIQRLDLSGNKFSGYIAQELGQLVYLE 574
Query: 538 ELWLGPNELISFIPSTFWNIKDIMYVNFSSNFLTGPLPLEIENLKALT-TLDFSMNNLSG 596
L L N L IP +F ++ +M + N L+ +P+E+ L +L +L+ S NNLSG
Sbjct: 575 ILRLSDNRLTGEIPHSFGDLTRLMELQLGGNLLSENIPVELGKLTSLQISLNISHNNLSG 634
Query: 597 VIPTTIGGLKGLQYLFLGHNRLQGSIPDSVGDLISLKSLNLSNNNLSGPIPTSLEKLSDL 656
IP ++G L+ L+ L+L N+L G IP S+G+L+SL N+SNNNL G +P +
Sbjct: 635 TIPDSLGNLQMLEILYLNDNKLSGEIPASIGNLMSLLICNISNNNLVGTVPDT------- 687
Query: 657 KELNLSFNKLEGEIPRGGPFVNFSAKSFMGNNLLCGSPNLQVPPCRASIDHI-------- 708
F + +F GN+ LC S Q C+ + H
Sbjct: 688 -----------------AVFQRMDSSNFAGNHGLCNS---QRSHCQPLVPHSDSKLNWLI 727
Query: 709 --SKKNALLLGIILPFSTIFVIVIILL---ISRYQTRGENVPNEVNVPLEATW----RRF 759
S++ +L + ++F+I + L I R + + ++ + ++ + F
Sbjct: 728 NGSQRQKILTITCIVIGSVFLITFLGLCWTIKRREPAFVALEDQTKPDVMDSYYFPKKGF 787
Query: 760 SYLELFQATNGFSENNLIGRGSFGSVYIARLQNGIEVAVKTFDLQHERAFK--SFDTECE 817
+Y L AT FSE+ ++GRG+ G+VY A + G +AVK + + E A SF E
Sbjct: 788 TYQGLVDATRNFSEDVVLGRGACGTVYKAEMSGGEVIAVKKLNSRGEGASSDNSFRAEIS 847
Query: 818 VMKSIRHRNLTKIISSCSNEDFKALILEYMRNGSLEKCLYSG--NYILDIFQRLNIMIDV 875
+ IRHRN+ K+ C +++ L+ EYM GSL + L G N +LD R I +
Sbjct: 848 TLGKIRHRNIVKLYGFCYHQNSNLLLYEYMSKGSLGEQLQRGEKNCLLDWNARYRIALGA 907
Query: 876 ASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATL 935
A L YLH ++H D+K +N+LLD+ AH+ DFG+AK LI S + + +
Sbjct: 908 AEGLCYLHHDCRPQIVHRDIKSNNILLDERFQAHVGDFGLAK-LIDLSYSKSMSAVAGSY 966
Query: 936 GYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLP--ISM 993
GY+APEY +V+ K D+YSFG++L+E T + P + G L +WV + I
Sbjct: 967 GYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKPPVQPLEQGG-DLVNWVRRSIRNMIPT 1025
Query: 994 MKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKIR 1048
+++ DA L T DK + S V +A+ CT SP R T +E+V + + R
Sbjct: 1026 IEMFDAR-LDTNDKRTVHE---MSLVLKIALFCTSNSPASRPTMREVVAMITEAR 1076
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49318|Y2317_ARATH Probable leucine-rich repeat receptor-like protein kinase At2g33170 OS=Arabidopsis thaliana GN=At2g33170 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 474 bits (1221), Expect = e-132, Method: Compositional matrix adjust.
Identities = 357/1134 (31%), Positives = 551/1134 (48%), Gaps = 135/1134 (11%)
Query: 1 MMIRLLFIHCLIHSLIIAASANTSIDIDQDALLALKDHITYDPTNFFAKNWLTNSTMVCN 60
M + +LF+ L + + S++ D LL LK+ D N NW CN
Sbjct: 15 MFVGVLFL------LTLLVWTSESLNSDGQFLLELKNRGFQDSLNRL-HNWNGIDETPCN 67
Query: 61 WTGVTCDINQRR-------VTALNISYLSLTGNIPRQLGNLSSLEILDLNFNRLSGEIPW 113
W GV C VT+L++S ++L+G + +G L +L L+L +N L+G+IP
Sbjct: 68 WIGVNCSSQGSSSSSNSLVVTSLDLSSMNLSGIVSPSIGGLVNLVYLNLAYNALTGDIPR 127
Query: 114 ELGNLAKLEKLLLHNNFLTGTIPFSIFKLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLL 173
E+GN +KLE + L+NN G+IP I KLS L + +N L+G +P +G+L +L+ L
Sbjct: 128 EIGNCSKLEVMFLNNNQFGGSIPVEINKLSQLRSFNICNNKLSGPLPEE-IGDLYNLEEL 186
Query: 174 DLSDNQLSGSIPSFIFKISSLQALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGGI 233
N L+G +P + ++ L G N SG +P I
Sbjct: 187 VAYTNNLTGPLPRSLGNLNKLTTFRAGQNDFSGNIPTEI--------------------- 225
Query: 234 SSTLSNCKHLRILDLSFNDLWGDIPKEIGNLTKLKELFLDFNILQGEIPHTVGNLHNLEY 293
C +L++L L+ N + G++PKEIG L KL+E+ L N G IP +GNL +LE
Sbjct: 226 ----GKCLNLKLLGLAQNFISGELPKEIGMLVKLQEVILWQNKFSGFIPKDIGNLTSLET 281
Query: 294 LSLVNNELVGTVPATIFNVSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSGT 353
L+L N LVG +P+ I N+ +LK + L N G++P +L + E+ N SG
Sbjct: 282 LALYGNSLVGPIPSEIGNMKSLKKLYLYQNQLNGTIPKELG-KLSKVMEIDFSENLLSGE 340
Query: 354 LPSFIFNASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNYLTSPELSFLSSLSNCK 413
+P + S L L L N +G+IPN LRNL +L L N LT P +L++ +
Sbjct: 341 IPVELSKISELRLLYLFQNKLTGIIPNELSKLRNLAKLDLSINSLTGPIPPGFQNLTSMR 400
Query: 414 YLEIIALSGNPLNGIIPMSAGNLSHSLEELFMPDCNVSGRIPKEIGNLANLVTLDLGGNK 473
L++ N L+G+IP G L L + + +SG+IP I +NL+ L+LG N+
Sbjct: 401 QLQLFH---NSLSGVIPQGLG-LYSPLWVVDFSENQLSGKIPPFICQQSNLILLNLGSNR 456
Query: 474 FNGSIPIALGKLQKLQLLNLDDNKLEGSIPDDICGLVELYKLALGDNKLSGQIPACFGNL 533
G+IP + + + L L + N+L G P ++C LV L + L N+ SG +P G
Sbjct: 457 IFGNIPPGVLRCKSLLQLRVVGNRLTGQFPTELCKLVNLSAIELDQNRFSGPLPPEIGTC 516
Query: 534 ASLRELWLGPNELISFIPSTFWNIKDIMYVNFSSNFLTGPLPLEIENLKALTTLDFSMNN 593
L+ L L N+ S +P+ + +++ N SSN LTGP+P EI N K L LD S N+
Sbjct: 517 QKLQRLHLAANQFSSNLPNEISKLSNLVTFNVSSNSLTGPIPSEIANCKMLQRLDLSRNS 576
Query: 594 LSGVIPTTIGGLKGLQYLFLGHNRLQGSIPDSVGDLISLKS------------------- 634
G +P +G L L+ L L NR G+IP ++G+L L
Sbjct: 577 FIGSLPPELGSLHQLEILRLSENRFSGNIPFTIGNLTHLTELQMGGNLFSGSIPPQLGLL 636
Query: 635 ------------------------------LNLSNNNLSGPIPTSLEKLSDLKELNLSFN 664
L+L+NN+LSG IPT+ E LS L N S+N
Sbjct: 637 SSLQIAMNLSYNDFSGEIPPEIGNLHLLMYLSLNNNHLSGEIPTTFENLSSLLGCNFSYN 696
Query: 665 KLEGEIPRGGPFVNFSAKSFMGNNLLCGSPNLQVPPCRASIDHISKKNA---------LL 715
L G++P F N + SF+GN LCG P +S HIS A ++
Sbjct: 697 NLTGQLPHTQIFQNMTLTSFLGNKGLCGGHLRSCDPSHSSWPHISSLKAGSARRGRIIII 756
Query: 716 LGIILPFSTIFVIVIILLISR--------YQTRGENVPNEVN---VPLEATWRRFSYLEL 764
+ ++ ++ +I I++ R Y E E + VP E RF+ ++
Sbjct: 757 VSSVIGGISLLLIAIVVHFLRNPVEPTAPYVHDKEPFFQESDIYFVPKE----RFTVKDI 812
Query: 765 FQATNGFSENNLIGRGSFGSVYIARLQNGIEVAVKTFD-------LQHERAFKSFDTECE 817
+AT GF ++ ++GRG+ G+VY A + +G +AVK + SF E
Sbjct: 813 LEATKGFHDSYIVGRGACGTVYKAVMPSGKTIAVKKLESNREGNNNNSNNTDNSFRAEIL 872
Query: 818 VMKSIRHRNLTKIISSCSNEDFKA--LILEYMRNGSLEKCLYSG-NYILDIFQRLNIMID 874
+ IRHRN+ ++ S C ++ + L+ EYM GSL + L+ G ++ +D R I +
Sbjct: 873 TLGKIRHRNIVRLYSFCYHQGSNSNLLLYEYMSRGSLGELLHGGKSHSMDWPTRFAIALG 932
Query: 875 VASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLAT 934
A L YLH +IH D+K +N+L+D+N AH+ DFG+AK +I S + + +
Sbjct: 933 AAEGLAYLHHDCKPRIIHRDIKSNNILIDENFEAHVGDFGLAK-VIDMPLSKSVSAVAGS 991
Query: 935 LGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMM 994
GY+APEY +V+ K D+YSFG++L+E T + P + G L W + + +
Sbjct: 992 YGYIAPEYAYTMKVTEKCDIYSFGVVLLELLTGKAPVQPLEQGG-DLATWTRNHIRDHSL 1050
Query: 995 --KIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLK 1046
+I+D L ED +V +A+ CT SP +R T +E+V L++
Sbjct: 1051 TSEILDPYLTKVEDDVILNH---MITVTKIAVLCTKSSPSDRPTMREVVLMLIE 1101
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 1057 | ||||||
| 359483198 | 1087 | PREDICTED: probable LRR receptor-like se | 0.979 | 0.952 | 0.516 | 0.0 | |
| 255572272 | 1089 | serine-threonine protein kinase, plant-t | 0.987 | 0.958 | 0.491 | 0.0 | |
| 359483685 | 1046 | PREDICTED: LRR receptor-like serine/thre | 0.952 | 0.962 | 0.507 | 0.0 | |
| 359497186 | 1140 | PREDICTED: LRR receptor-like serine/thre | 0.967 | 0.897 | 0.471 | 0.0 | |
| 359485453 | 1202 | PREDICTED: probable LRR receptor-like se | 0.950 | 0.836 | 0.507 | 0.0 | |
| 359483677 | 1229 | PREDICTED: LRR receptor-like serine/thre | 0.915 | 0.787 | 0.517 | 0.0 | |
| 147776333 | 1205 | hypothetical protein VITISV_000078 [Viti | 0.924 | 0.810 | 0.522 | 0.0 | |
| 147852480 | 1229 | hypothetical protein VITISV_039533 [Viti | 0.914 | 0.786 | 0.522 | 0.0 | |
| 147769371 | 1241 | hypothetical protein VITISV_010511 [Viti | 0.926 | 0.788 | 0.496 | 0.0 | |
| 449465016 | 1092 | PREDICTED: probable LRR receptor-like se | 0.973 | 0.942 | 0.478 | 0.0 |
| >gi|359483198|ref|XP_002271405.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 971 bits (2511), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 555/1075 (51%), Positives = 704/1075 (65%), Gaps = 40/1075 (3%)
Query: 11 LIHSLIIAASANTSIDI----DQDALLALKDHITYDPTNFFAKNWLTNSTMVCNWTGVTC 66
+I I+ SA ++ + DQ +LLALK HIT DP + A NW T ++ C W GV+C
Sbjct: 11 IISVFIVQFSACVAMSLSNFTDQSSLLALKAHITLDPHHVLAGNWSTKTSF-CEWIGVSC 69
Query: 67 DINQRRVTALNISYLSLTGNIPRQLGNLSSLEILDLN----------------------- 103
+ Q+RV AL++S L L G IP LGNLS L LDL+
Sbjct: 70 NAQQQRVIALDLSNLGLRGTIPPDLGNLSFLVSLDLSSNNFHGPVPVEVGQLTSLLSMNL 129
Query: 104 -FNRLSGEIPWELGNLAKLEKLLLHNNFLTGTIPFSIFKLSSLLDLKLSDNNLTGTIPSH 162
+N LSG+IP GNL +L+ L L NN TGTIP SI +S L L L N+L G IP
Sbjct: 130 QYNLLSGQIPPSFGNLNRLQSLFLGNNSFTGTIPPSIGNMSMLETLGLGGNHLQGNIP-E 188
Query: 163 NLGNLSSLQLLDLSDNQLSGSIPSFIFKISSLQALHFGNNRLSGELPANICDN-LPFLNF 221
+G LS++++LD+ NQL G+IPS IF ISSLQ + N LSG+LP+++C++ L L
Sbjct: 189 EIGKLSTMKILDIQSNQLVGAIPSAIFNISSLQEIALTYNSLSGDLPSSMCNHELSALRG 248
Query: 222 FSVYKNMFYGGISSTLSNCKHLRILDLSFNDLWGDIPKEIGNLTKLKELFLDFNILQGEI 281
+ N F G I S LS C L+ L LSFN G IP+ I +LTKL L L N L GE+
Sbjct: 249 IRLSANRFTGPIPSNLSKCGELQTLYLSFNKFTGGIPRSIDSLTKLTMLSLAANSLSGEV 308
Query: 282 PHTVGNLHNLEYLSLVNNELVGTVPATIFNVSTLKLIELSNNTFFGSLPSSTDVQLPNLE 341
P +G+L L L++ +N L G +P IFN+S++ L+ N G+LP + LPNLE
Sbjct: 309 PCEIGSLCTLNVLNIEDNSLTGHIPFQIFNISSMVSGSLTRNNLSGNLPPNFGSYLPNLE 368
Query: 342 ELYLWGNNFSGTLPSFIFNASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNYLTSP 401
L L N SG +PS I NAS L L G N +G IP+ G+LR L+RL L N L
Sbjct: 369 NLILEINWLSGIIPSSIGNASKLRSLDFGYNMLTGSIPHALGSLRFLERLNLGVNNLKGE 428
Query: 402 ----ELSFLSSLSNCKYLEIIALSGNPLNGIIPMSAGNLSHSLEELFMPDCNVSGRIPKE 457
ELSFL+SL+NCK L I+ LS NPL GI+P+S GNLS SL+ C + G IP E
Sbjct: 429 SYIQELSFLTSLTNCKRLRILYLSFNPLIGILPISIGNLSTSLQRFEANTCKLKGNIPTE 488
Query: 458 IGNLANLVTLDLGGNKFNGSIPIALGKLQKLQLLNLDDNKLEGSIPDDICGLVELYKLAL 517
IGNL+NL L L N G+IP ++G+LQKLQ L L NKL+GSIP+DIC L L +L L
Sbjct: 489 IGNLSNLYLLSLNNNDLTGTIPPSIGQLQKLQGLYLPSNKLQGSIPNDICQLRNLGELFL 548
Query: 518 GDNKLSGQIPACFGNLASLRELWLGPNELISFIPSTFWNIKDIMYVNFSSNFLTGPLPLE 577
+N+LSG IPAC G L LR L+LG N+L S IPST W++ I+ ++ SSNFL G LP +
Sbjct: 549 TNNQLSGSIPACLGELTFLRHLYLGSNKLNSTIPSTLWSLIHILSLDMSSNFLVGYLPSD 608
Query: 578 IENLKALTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQGSIPDSVGDLISLKSLNL 637
+ NLK L +D S N LSG IP+ IGGL+ L L L HNR +G I S +L SL+ ++L
Sbjct: 609 MGNLKVLVKIDLSRNQLSGEIPSNIGGLQDLTSLSLAHNRFEGPILHSFSNLKSLEFMDL 668
Query: 638 SNNNLSGPIPTSLEKLSDLKELNLSFNKLEGEIPRGGPFVNFSAKSFMGNNLLCGSPNLQ 697
S+N L G IP SLE L LK L++SFN L GEIP GPF NFSA+SFM N LCGSP L+
Sbjct: 669 SDNALFGEIPKSLEGLVYLKYLDVSFNGLYGEIPPEGPFANFSAESFMMNKALCGSPRLK 728
Query: 698 VPPCRASIDHISKKNALLLGIILP--FSTIFVIVIILLISRYQTRGENVPNEVNVPLEAT 755
+PPCR + + LLL ILP ST+ + +I + +R + R +P + L AT
Sbjct: 729 LPPCRTGTRWSTTISWLLLKYILPAILSTLLFLALIFVWTRCRKRNAVLPTQSESLLTAT 788
Query: 756 WRRFSYLELFQATNGFSENNLIGRGSFGSVYIARLQNGIEVAVKTFDLQHERAFKSFDTE 815
WRR SY E+FQATNGFS NL+GRGS GSVY L +G A+K F+LQ E AFKSFD E
Sbjct: 789 WRRISYQEIFQATNGFSAGNLLGRGSLGSVYRGTLSDGKNAAIKVFNLQEEAAFKSFDAE 848
Query: 816 CEVMKSIRHRNLTKIISSCSNE--DFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMI 873
CEVM IRHRNL KI+SSCSN DFKAL+LEY+ NGSLE+ LYS NY LDI QRLNIMI
Sbjct: 849 CEVMHHIRHRNLIKIVSSCSNSYIDFKALVLEYVPNGSLERWLYSHNYCLDILQRLNIMI 908
Query: 874 DVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLA 933
DVA A+EYLH G S PV+HCDLKPSN+LLD++ H+ DFGIAKLL E++S+ +TQTLA
Sbjct: 909 DVALAMEYLHHGCSTPVVHCDLKPSNILLDEDFGGHVGDFGIAKLL-REEESIRETQTLA 967
Query: 934 TLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISM 993
T+GYMAP+Y G V+T GDVYS+GI+LMETFTRR+PTDEIFS EM++K+WV D+L S+
Sbjct: 968 TIGYMAPKYVSNGIVTTSGDVYSYGIVLMETFTRRRPTDEIFSEEMSMKNWVWDWLCGSI 1027
Query: 994 MKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKIR 1048
+++DANLL ED+ F AK+QC S + LAM+C +SP+ERI K++V L KI+
Sbjct: 1028 TEVVDANLLRGEDEQFMAKKQCISLILGLAMDCVADSPEERIKMKDVVTTLKKIK 1082
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255572272|ref|XP_002527075.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223533580|gb|EEF35319.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 957 bits (2473), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 532/1083 (49%), Positives = 700/1083 (64%), Gaps = 39/1083 (3%)
Query: 5 LLFIHCLIHSLIIAASANTSIDIDQDALLALKDHITYDPTNFFAKNWLTNSTMVCNWTGV 64
LL L SL I S T D ALL LK+H +DP F +KNW +++T C+W GV
Sbjct: 12 LLLTRWLQFSLAIPKSNLT----DLSALLVLKEHSNFDP--FMSKNW-SSATSFCHWYGV 64
Query: 65 TCDINQRRVTALNISYLSLTGNIPRQLGNLSSLEILDLNFNRLSGEIPWELGNLAKLEKL 124
TC RV AL +S + + G +P +GNLS L +D++ N SG +P ELGNL +L+ +
Sbjct: 65 TCSERHNRVVALTLSNMGIKGIVPPHIGNLSFLVHIDMSNNSYSGHLPNELGNLHRLKFM 124
Query: 125 LLHNNFLTGTIPFS-----------------------IFKLSSLLDLKLSDNNLTGTIPS 161
NN G IP S IF +++L L L+DN L G I
Sbjct: 125 NFSNNSFVGEIPSSLAMLPKLQHLLLANNSLTAGRSSIFNITTLNTLDLNDNLLGGNILD 184
Query: 162 HNLGNLSSLQLLDLSDNQLSGSIPSFIFKISSLQALHFGNNRLSGELPANICDNLPFLNF 221
+ GNLS+LQ+L++ NQLSGS P I + SL+ ++ N LSG L +C+ L
Sbjct: 185 NIGGNLSNLQVLNMGLNQLSGSFPPKILDLPSLKFIYLQVNNLSGNLKEILCNQNSKLQL 244
Query: 222 FSVYKNMFYGGISSTLSNCKHLRILDLSFNDLWGDIPKEIGNLTKLKELFLDFNILQGEI 281
++ N YG I S L CK LR L L N G IP+ IGNLTKLK L L N L G I
Sbjct: 245 LNLAGNQLYGQIPSDLYKCKELRSLALHANKFTGSIPRTIGNLTKLKWLSLGRNNLTGRI 304
Query: 282 PHTVGNLHNLEYLSLVNNELVGTVPATIFNVSTLKLIELSNNTFFGSLPSSTDVQLPNLE 341
P +GNL NL+ + L N L G++P +FN+ST+K I +++N G+LP+S + LPNL
Sbjct: 305 PLEIGNLQNLQIVHLSFNNLNGSIPHALFNISTMKWIAMTSNNLLGNLPTSLGLHLPNLI 364
Query: 342 ELYLWGNNFSGTLPSFIFNASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNYL--- 398
LYL N SG +PS+I NAS L+ L L NSF+G IP++ G+LRNL+ L+L N L
Sbjct: 365 WLYLGINKLSGPIPSYISNASKLTILELPSNSFTGFIPDSLGDLRNLQTLKLGANLLSSK 424
Query: 399 -TSPELSFLSSLSNCKYLEIIALSGNPLNGIIPMSAGNLSHSLEELFMPDCNVSGRIPKE 457
TS EL+ SSL NC+ L+ + LS NPL+G +P S GNLS+SLE D + G + +
Sbjct: 425 KTSQELTIFSSLKNCQNLKYLWLSYNPLDGYLPHSVGNLSNSLESFLASDGLIKGSVHES 484
Query: 458 IGNLANLVTLDLGGNKFNGSIPIALGKLQKLQLLNLDDNKLEGSIPDDICGLVELYKLAL 517
IGNL++L L+LG N G IP +G L+ LQ L L N L+GSIP ++C L LY L L
Sbjct: 485 IGNLSSLTRLNLGNNDLTGRIPTTIGTLKHLQGLYLHGNDLDGSIPSELCDLRTLYNLEL 544
Query: 518 GDNKLSGQIPACFGNLASLRELWLGPNELISFIPSTFWNIKDIMYVNFSSNFLTGPLPLE 577
NKLSG IP CF NL SLR L+L N +S I ST W +KDI+ VN +SN+LTG LP E
Sbjct: 545 TGNKLSGSIPTCFSNLTSLRNLFLASNRFVSTISSTLWTLKDILQVNLASNYLTGSLPSE 604
Query: 578 IENLKALTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQGSIPDSVGDLISLKSLNL 637
IENL+A+ ++ S N LSG IP +IGGL+ L L+L N+LQG IP SVGD+ SL+ L+L
Sbjct: 605 IENLRAVYMINISKNQLSGEIPISIGGLQDLAQLYLSGNKLQGPIPQSVGDIKSLEFLDL 664
Query: 638 SNNNLSGPIPTSLEKLSDLKELNLSFNKLEGEIPRGGPFVNFSAKSFMGNNLLCGSPNLQ 697
S+NNLSG IP SL+ L LK N+SFN L+GEIP GG F NFSA+SF+GN LCGS LQ
Sbjct: 665 SSNNLSGMIPKSLDNLLYLKYFNVSFNYLQGEIPEGGSFSNFSAQSFIGNEALCGSARLQ 724
Query: 698 VPPCRASIDHISKK--NALLLGIILP--FSTIFVIVIILLISRYQTRGENVPNEVNVPLE 753
V PC+ ++ + ++L +LP +FV+ ++++ RY R E +
Sbjct: 725 VSPCKDDNSRATETPGSKIVLRYVLPAIVFAVFVLAFVIMLKRYCERKAKFSIEDDFLAL 784
Query: 754 ATWRRFSYLELFQATNGFSENNLIGRGSFGSVYIARLQNGIEVAVKTFDLQHERAFKSFD 813
T RR SY EL ATNGF E+N +G GSFGSVY L +G +A K F+LQ ERAFKSFD
Sbjct: 785 TTIRRISYHELQLATNGFQESNFLGMGSFGSVYKGTLSDGTVIAAKVFNLQLERAFKSFD 844
Query: 814 TECEVMKSIRHRNLTKIISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMI 873
TECEV++++RHRNL KII+SCS +FKAL+LE+M N SLEK LYS +Y L+ QRLNIM+
Sbjct: 845 TECEVLRNLRHRNLVKIITSCSGPNFKALVLEFMPNWSLEKWLYSDDYFLNNLQRLNIML 904
Query: 874 DVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLA 933
DVAS LEYLH GY+ P+ HCD+KPSNVLL+++MVA L+DFGI+KLL GE+ S+ QT TLA
Sbjct: 905 DVASVLEYLHHGYTIPMAHCDIKPSNVLLNEDMVAFLADFGISKLL-GEEGSVMQTMTLA 963
Query: 934 TLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISM 993
T+GYMAPEYG EG VS +GDVYS+G+LLMETFT++KPTD++F+ +++LK WV L +
Sbjct: 964 TIGYMAPEYGSEGIVSVRGDVYSYGVLLMETFTQKKPTDKMFTEQLSLKSWVEQSLSCEV 1023
Query: 994 MKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKIRDFLLR 1053
++IDANLL E+ H AAK+ C S+ LA++C+ + P +RI K +V L KI+ LR
Sbjct: 1024 TQVIDANLLGIEEDHLAAKKDCIVSILKLALQCSADLPHDRIDMKHVVTTLQKIKTKFLR 1083
Query: 1054 NVE 1056
++
Sbjct: 1084 DIR 1086
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359483685|ref|XP_002263372.2| PREDICTED: LRR receptor-like serine/threonine-protein kinase EFR-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 951 bits (2459), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 536/1057 (50%), Positives = 694/1057 (65%), Gaps = 50/1057 (4%)
Query: 27 IDQDALLALKDHITYDPTNFFAKNWLTNSTMVCNWTGVTCDINQRRVTALNISYLSLTGN 86
+D+ AL+ALK HITYD A NW T S+ CNW G++C+ Q+RV+A+N+S + L G
Sbjct: 8 VDEFALIALKAHITYDSQGILATNWSTKSS-YCNWYGISCNAPQQRVSAINLSNMGLEGT 66
Query: 87 IPRQLGNLSSLEILDLNFNRLSGEIPWELGNLAKLEKLLLHNNFLTGTIPF--------- 137
I Q+GNLS L LDL +N +G IP +GNL +L++L L NN LTG IP
Sbjct: 67 IAPQVGNLSFLVSLDLTYNDFTGSIPNGIGNLVELQRLSLRNNSLTGEIPSNLSHCRELR 126
Query: 138 ---------------SIFKLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQLSG 182
+I LS+L +L L+ N LTG IP +GNLS+L +L L N +SG
Sbjct: 127 GLSLSINQFTGGIPQAIGSLSNLEELYLNYNKLTGGIP-REIGNLSNLNILQLGSNGISG 185
Query: 183 SIPSFIFKISSLQALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGGISSTLSNCKH 242
IP+ IF +SSLQ + F NN LSG LP +IC +LP L + +N G + +TLS C+
Sbjct: 186 PIPAEIFTVSSLQRIIFANNSLSGSLPMDICKHLPNLQGLYLSQNHLSGQLPTTLSLCRE 245
Query: 243 LRILDLSFNDLWGDIPKEIGNLTKLKELFLDFNILQGEIPHTVGNLHNLEYLSLVNNELV 302
L L L N G IP+EIGNL+KL+E+ L N L G IP + GNL L++LS
Sbjct: 246 LLSLALPMNKFTGSIPREIGNLSKLEEIDLSENSLIGSIPTSFGNLMTLKFLS------- 298
Query: 303 GTVPATIFNVSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSGTLPSFIFNAS 362
FN+S L+ + L N GSLPSS LP+LE LY+ N FSGT+P I N S
Sbjct: 299 -------FNISKLQTLGLVQNHLSGSLPSSIGTWLPDLEGLYIGINEFSGTIPMSISNMS 351
Query: 363 NLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNYLTSPELS----FLSSLSNCKYLEII 418
L+ LSL DNSF+G +P NL L+ L L N LT L+ FL+SL+NCK+L +
Sbjct: 352 KLTVLSLSDNSFTGNVPKDLCNLTKLQFLDLAYNQLTDEHLASGVGFLTSLTNCKFLRNL 411
Query: 419 ALSGNPLNGIIPMSAGNLSHSLEELFMPDCNVSGRIPKEIGNLANLVTLDLGGNKFNGSI 478
+ NPL G +P S GNL +LE C G IP IGNL NL+ LDLG N GSI
Sbjct: 412 WIGYNPLTGTLPNSLGNLPIALEIFIASACQFRGTIPTGIGNLTNLIWLDLGANDLTGSI 471
Query: 479 PIALGKLQKLQLLNLDDNKLEGSIPDDICGLVELYKLALGDNKLSGQIPACFGNLASLRE 538
P LG+LQKLQ L++ N++ GSIP+D+C L L L L NKLSG IP+CFG+L +LRE
Sbjct: 472 PTTLGQLQKLQALSIVGNRIRGSIPNDLCHLKNLGYLRLSYNKLSGSIPSCFGDLPALRE 531
Query: 539 LWLGPNELISFIPSTFWNIKDIMYVNFSSNFLTGPLPLEIENLKALTTLDFSMNNLSGVI 598
L L N L IP +FW+++D++ +N SSNFLTG LP E+ N+K++TTLD S N +SG I
Sbjct: 532 LSLDSNVLAFNIPMSFWSLRDLLVLNLSSNFLTGNLPPEVGNMKSITTLDLSKNLVSGYI 591
Query: 599 PTTIGGLKGLQYLFLGHNRLQGSIPDSVGDLISLKSLNLSNNNLSGPIPTSLEKLSDLKE 658
P+ +G L+ L L L N+LQG IP GDL+SL+SL+LS NNLSG IP +LE L LK
Sbjct: 592 PSRMGKLQNLITLSLSQNKLQGPIPVEFGDLVSLESLDLSQNNLSGTIPKTLEALIYLKY 651
Query: 659 LNLSFNKLEGEIPRGGPFVNFSAKSFMGNNLLCGSPNLQVPPCRAS--IDHISKKNALLL 716
LN+SFNKL+GEIP GGPFV F+A+SFM N LCG+P+ QV C + K+ +L
Sbjct: 652 LNVSFNKLQGEIPNGGPFVKFTAESFMFNEALCGAPHFQVMACDKNNRTQSWKTKSFILK 711
Query: 717 GIILPF-STIFVIVIILLISRYQTRGENVPNEVNVPLEATWRRFSYLELFQATNGFSENN 775
I+LP ST+ ++V I+L R + E +P ++ L T + S+ +L ATN F E+N
Sbjct: 712 YILLPVGSTVTLVVFIVLWIRRRDNME-IPTPIDSWLPGTHEKISHQQLLYATNDFGEDN 770
Query: 776 LIGRGSFGSVYIARLQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCS 835
LIG+GS G VY L NG+ VA+K F+L+ + A +SF++ECEVM+ IRHRNL +II+ CS
Sbjct: 771 LIGKGSQGMVYKGVLSNGLTVAIKVFNLEFQGALRSFNSECEVMQGIRHRNLVRIITCCS 830
Query: 836 NEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDL 895
N DFKAL+L+YM NGSLEK LYS Y LD+ QRLNIMIDVASALEYLH S+ V+HCDL
Sbjct: 831 NLDFKALVLKYMPNGSLEKLLYSHYYFLDLIQRLNIMIDVASALEYLHHDCSSLVVHCDL 890
Query: 896 KPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVY 955
KPSNVLLDD+MVAH++DFGIAKLL E +SM QT+TL+T+GYMAPE+G G VSTK DVY
Sbjct: 891 KPSNVLLDDDMVAHVADFGIAKLLT-ETESMQQTKTLSTIGYMAPEHGSAGIVSTKSDVY 949
Query: 956 SFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHFAAKEQC 1015
S+GILLME F R+KP DE+F+G++TLK WV + L S+++++D NLL ED+ A K C
Sbjct: 950 SYGILLMEVFARKKPMDEMFTGDLTLKTWV-ESLSNSVIQVVDVNLLRREDEDLATKLSC 1008
Query: 1016 ASSVFNLAMECTVESPDERITAKEIVRRLLKIRDFLL 1052
SS+ LA+ CT +SP+ERI K+ V L K R LL
Sbjct: 1009 LSSIMALALACTTDSPEERIDMKDAVVELKKSRIKLL 1045
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359497186|ref|XP_003635448.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 942 bits (2435), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 535/1135 (47%), Positives = 707/1135 (62%), Gaps = 112/1135 (9%)
Query: 27 IDQDALLALKDHITYDPTNFFAKNWLTNSTMVCNWTGVTCDINQRRVTALNISYLSLTGN 86
+D+ AL+ALK HITYD A NW T S C+W G++C+ Q+ V+A+N+S + L G
Sbjct: 8 VDEFALIALKAHITYDSQGILATNWSTKSPH-CSWIGISCNAPQQSVSAINLSNMGLEGT 66
Query: 87 IPRQLGNLSSLEILDLNFNRLSGEIPWELG------------------------NLAKLE 122
I Q+GNLS L LDL+ N G +P ++G NL+KLE
Sbjct: 67 IAPQVGNLSFLVSLDLSDNYFHGSLPKDIGKCKELQQLNLFNNKLVGGIPEAICNLSKLE 126
Query: 123 KLLLHNNFL------------------------TGTIPFSIFKLSSLLDLKLSDNNLTGT 158
+L L NN L TG+IP +IF +SSLL++ LS+NNL+G+
Sbjct: 127 ELYLGNNQLIGEIPKKMNHLQNLKVLSFPMNNLTGSIPATIFNISSLLNISLSNNNLSGS 186
Query: 159 IP---------------SHN---------LGNLSSLQLLDLSDNQLSGSIPSFI------ 188
+P S N LG LQ++ L+ N +GSIPS I
Sbjct: 187 LPMDMCYANPKLKELNLSSNHLSGKIPTGLGQCIQLQVISLAYNDFTGSIPSGIDNLVEL 246
Query: 189 -------------------------FKISSLQALHFGNNRLSGELPANICDNLPFLNFFS 223
F +SSLQ + F +N LSG LP +IC +LP L S
Sbjct: 247 QRLSLQNNSFTAFKDISKALLFAEIFNVSSLQVIAFTDNSLSGSLPKDICKHLPNLQGLS 306
Query: 224 VYKNMFYGGISSTLSNCKHLRILDLSFNDLWGDIPKEIGNLTKLKELFLDFNILQGEIPH 283
+ +N G + +TLS C L L LSFN G IPKEIGNL+KL+E++L N L G IP
Sbjct: 307 LSQNHLSGQLPTTLSLCGELLFLSLSFNKFRGSIPKEIGNLSKLEEIYLGTNSLIGSIPT 366
Query: 284 TVGNLHNLEYLSLVNNELVGTVPATIFNVSTLKLIELSNNTFFGSLPSSTDVQLPNLEEL 343
+ GNL L++L+L N L GTVP IFN+S L+ + + N GSLPSS LP+LE L
Sbjct: 367 SFGNLKALKFLNLGINNLTGTVPEAIFNISKLQSLAMVKNHLSGSLPSSIGTWLPDLEGL 426
Query: 344 YLWGNNFSGTLPSFIFNASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNYLT---- 399
++ GN FSG +P I N S L+ L L NSF+G +P GNL LK L L N LT
Sbjct: 427 FIAGNEFSGIIPMSISNMSKLTVLGLSANSFTGNVPKDLGNLTKLKVLDLAGNQLTDEHV 486
Query: 400 SPELSFLSSLSNCKYLEIIALSGNPLNGIIPMSAGNLSHSLEELFMPDCNVSGRIPKEIG 459
+ E+ FL+SL+NCK+L+ + + P G +P S GNL +LE C G IP IG
Sbjct: 487 ASEVGFLTSLTNCKFLKNLWIGNIPFKGTLPNSLGNLPIALESFIASACQFRGTIPTGIG 546
Query: 460 NLANLVTLDLGGNKFNGSIPIALGKLQKLQLLNLDDNKLEGSIPDDICGLVELYKLALGD 519
NL NL+ LDLG N GSIP LG+LQKLQ L + N++ GSIP+D+C L +L L L
Sbjct: 547 NLTNLIRLDLGANDLTGSIPTTLGQLQKLQWLYIAGNRIRGSIPNDLCHLKDLGYLFLSS 606
Query: 520 NKLSGQIPACFGNLASLRELWLGPNELISFIPSTFWNIKDIMYVNFSSNFLTGPLPLEIE 579
NKLSG IP+CFG+L +L+EL+L N L IP++ W+++D++ +N SSNFLTG LP E+
Sbjct: 607 NKLSGSIPSCFGDLLALQELFLDSNVLAFNIPTSLWSLRDLLALNLSSNFLTGNLPPEVG 666
Query: 580 NLKALTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQGSIPDSVGDLISLKSLNLSN 639
N+K++TTLD S N +SG IP+ +G L+ L L L NRLQG IP GDL+SL+SL+LS
Sbjct: 667 NMKSITTLDLSKNLVSGYIPSKMGKLQSLITLSLSQNRLQGPIPIEFGDLVSLESLDLSQ 726
Query: 640 NNLSGPIPTSLEKLSDLKELNLSFNKLEGEIPRGGPFVNFSAKSFMGNNLLCGSPNLQVP 699
NNLSG IP SLE L LK LN+S NKL+GEIP GGPF+NF+A+SFM N LCG+P+ QV
Sbjct: 727 NNLSGTIPKSLEALIYLKYLNVSLNKLQGEIPNGGPFINFTAESFMFNEALCGAPHFQVM 786
Query: 700 PCRAS--IDHISKKNALLLGIILPFSTIFVIVIILLISRYQTRGENVPNEVNVPLEATWR 757
C + K+ +L I+LP +I +V+ +++ + +P ++ L T
Sbjct: 787 ACDKNNRTQSWKTKSFILKYILLPVGSIVTLVVFIVLWIRRRDNMEIPTPIDSWLPGTHE 846
Query: 758 RFSYLELFQATNGFSENNLIGRGSFGSVYIARLQNGIEVAVKTFDLQHERAFKSFDTECE 817
+ S+ +L ATN F E+NLIG+GS G VY L NG+ VA+K F+L+ + A +SFD+ECE
Sbjct: 847 KISHQQLLYATNDFGEDNLIGKGSQGMVYKGVLSNGLTVAIKVFNLEFQGALRSFDSECE 906
Query: 818 VMKSIRHRNLTKIISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVAS 877
VM+ IRHRNL +II+ CSN DFKAL+LEYM NGSLEK LYS NY LD+ QRLNIMIDVAS
Sbjct: 907 VMQGIRHRNLVRIITCCSNLDFKALVLEYMPNGSLEKWLYSHNYFLDLIQRLNIMIDVAS 966
Query: 878 ALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGY 937
ALEYLH S+ V+HCDLKP+NVLLDD+MVAH++DFGI KLL + +SM QT+TL T+GY
Sbjct: 967 ALEYLHHDCSSLVVHCDLKPNNVLLDDDMVAHVADFGITKLLT-KTESMQQTKTLGTIGY 1025
Query: 938 MAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKII 997
MAPE+G +G VSTK DVYS+GILLME F+R+KP DE+F+G +TLK WV + L S+++++
Sbjct: 1026 MAPEHGSDGIVSTKSDVYSYGILLMEVFSRKKPMDEMFTGGLTLKTWV-ESLSNSVIQVV 1084
Query: 998 DANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKIRDFLL 1052
DANLL ED+ A K C SS+ LA+ CT SP++R+ K+ V L K + LL
Sbjct: 1085 DANLLRREDEDLATKLSCLSSIMALALACTTNSPEKRLNMKDAVVELKKSKMKLL 1139
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359485453|ref|XP_003633276.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 928 bits (2399), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 532/1049 (50%), Positives = 684/1049 (65%), Gaps = 44/1049 (4%)
Query: 33 LALKDHITYDPTNFFAKNWLTNSTMVCNWTGVTCDINQRRVTALNISYLSLTGNIPRQLG 92
L + + I P F + L N ++ N + ++ +V L S+ TG+IPR +G
Sbjct: 154 LQMNNLIGSIPATIFNISSLLNISLSYNSLSGSLPMDMLQVIYL--SFNEFTGSIPRAIG 211
Query: 93 NLSSLEILDLNFNRLSGEIPWELGNLAKLEKLLLHNNFLTGTIPFSIFKLSSLLDLKLSD 152
NL LE L L N L+GEIP L N+++L+ L L N L G IP S+ L L LS
Sbjct: 212 NLVELERLSLRNNSLTGEIPQSLFNISRLKFLSLAANNLKGEIPSSLLHCRELRLLDLSI 271
Query: 153 NNLTGTIPSHNLGNLSSLQLLDLSDNQL------------------------SGSIPSFI 188
N TG IP +G+LS+L+ L L NQL SG IP+ I
Sbjct: 272 NQFTGFIP-QAIGSLSNLETLYLGFNQLAGGIPGEIGNLSNLNLLNSASSGLSGPIPAEI 330
Query: 189 FKISSLQALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGGISSTLSNCKHLRILDL 248
F ISSLQ + F NN LSG LP +IC +LP L + + N G + +TLS C L L L
Sbjct: 331 FNISSLQEIGFANNSLSGSLPMDICKHLPNLQWLLLSLNQLSGQLPTTLSLCGELLTLTL 390
Query: 249 SFNDLWGDIPKEIGNLTKLKELFLDFNILQGEIPHTVGNLHNLEYLSLVNNELVGTVPAT 308
++N+ G IP+EIGNL+KL++++ + G IP +GNL NL++LSL N L G VP
Sbjct: 391 AYNNFTGSIPREIGNLSKLEQIYFRRSSFTGNIPKELGNLVNLQFLSLNVNNLTGIVPEA 450
Query: 309 IFNVSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSGTLPSFIFNASNLSKLS 368
IFN+S L+++ L+ N GSLPSS LPNLE+L + GN FSG +P I N SNL L
Sbjct: 451 IFNISKLQVLSLAGNHLSGSLPSSIGSWLPNLEQLLIGGNEFSGIIPMSISNMSNLISLD 510
Query: 369 LGDNSFSGLIPNTFGNLRNLKRLRLYNNYLT----SPELSFLSSLSNCKYLEIIALSGNP 424
+ DN F G +P GNLR L+ L L +N LT + EL+FL+SL+NC +L +++S NP
Sbjct: 511 ISDNFFIGNVPKDLGNLRQLQLLGLSHNQLTNEHSASELAFLTSLTNCIFLRTLSISDNP 570
Query: 425 LNGIIPMSAGNLSHSLEELFMPDCNVSGRIPKEIGNLANLVTLDLGGNKFNGSIPIALGK 484
L G+IP S GNLS SLE ++ DC + G IP I NL NL+ L L N G IP G+
Sbjct: 571 LKGMIPNSLGNLSISLEIIYASDCQLRGTIPTGISNLTNLIGLRLDDNDLTGLIPTPFGR 630
Query: 485 LQKLQLLNLDDNKLEGSIPDDICGLVELYKLALGDNKLSGQIPACFGNLASLRELWLGPN 544
LQKLQ+L++ N++ GSIP +C L L L L NKLSG IP+C GNL LR ++L N
Sbjct: 631 LQKLQMLSISQNRIHGSIPSGLCHLTNLAFLDLSSNKLSGTIPSCSGNLTGLRNVYLHSN 690
Query: 545 ELISFIPSTFWNIKDIMYVNFSSNFLTGPLPLEIENLKALTTLDFSMNNLSGVIPTTIGG 604
L S IPS+ N++ ++ +N SSNFL LPL++ N+K+L LD S N SG IP+TI
Sbjct: 691 GLASEIPSSLCNLRGLLVLNLSSNFLNSQLPLQVGNMKSLVALDLSKNQFSGNIPSTISL 750
Query: 605 LKGLQYLFLGHNRLQGSIPDSVGDLISLKSLNLSNNNLSGPIPTSLEKLSDLKELNLSFN 664
L+ L L+L HN+LQG IP + GDL+SL+SL+LS NNLSG IP SLE L L+ LN+SFN
Sbjct: 751 LQNLLQLYLSHNKLQGHIPPNFGDLVSLESLDLSGNNLSGTIPKSLEHLKYLEYLNVSFN 810
Query: 665 KLEGEIPRGGPFVNFSAKSFMGNNLLCGSPNLQVPPCRASIDHISKKN--ALLLGIILP- 721
KL+GEIP GGPF NF+A+SF+ N LCG+P QV C S+KN +LLL I+P
Sbjct: 811 KLQGEIPNGGPFANFTAESFISNLALCGAPRFQVMACEKD----SRKNTKSLLLKCIVPL 866
Query: 722 ---FSTIFVIVIILLISRYQTRGENVPNEVNVPLEATWRRFSYLELFQATNGFSENNLIG 778
STI ++V+ + R QT+ E P +V++ L R + EL ATN F E+NLIG
Sbjct: 867 SVSLSTIILVVLFVQWKRRQTKSE-TPIQVDLSLPRMHRMIPHQELLYATNYFGEDNLIG 925
Query: 779 RGSFGSVYIARLQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCSNED 838
+GS G VY L +G+ VAVK F+L+ + AFKSF+ ECEVM++IRHRNL KIISSCSN D
Sbjct: 926 KGSLGMVYKGVLSDGLIVAVKVFNLELQGAFKSFEVECEVMRNIRHRNLAKIISSCSNLD 985
Query: 839 FKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPS 898
FKAL+LEYM NGSLEK LYS NY LD QRL IMIDVAS LEYLH YS PV+HCDLKPS
Sbjct: 986 FKALVLEYMPNGSLEKWLYSHNYYLDFVQRLKIMIDVASGLEYLHHYYSNPVVHCDLKPS 1045
Query: 899 NVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFG 958
NVLLDD+MVAH+SDFGIAKLL+G + M +T+TL T+GYMAPEYG EG VSTKGD+YS+G
Sbjct: 1046 NVLLDDDMVAHISDFGIAKLLMG-SEFMKRTKTLGTVGYMAPEYGSEGIVSTKGDIYSYG 1104
Query: 959 ILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHFAAKEQCASS 1018
ILLMETF R+KPTDE+F E+TLK WV ++M++IDANLL ED+ FA K C SS
Sbjct: 1105 ILLMETFVRKKPTDEMFVEELTLKSWVESSTN-NIMEVIDANLLTEEDESFALKRACFSS 1163
Query: 1019 VFNLAMECTVESPDERITAKEIVRRLLKI 1047
+ LA++CTVE P++RI K++V RL K+
Sbjct: 1164 IMTLALDCTVEPPEKRINTKDVVVRLKKL 1192
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359483677|ref|XP_003633000.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO2-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 926 bits (2393), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 506/977 (51%), Positives = 660/977 (67%), Gaps = 9/977 (0%)
Query: 82 SLTGNIPRQLGNLSSLEILDLNFNRLSGEIPWELGNLAKLEKLLLHNNFLTGTIPFSIFK 141
S TG IP+ L N+SSL L+L N L GEIP L + +L L L N TG IP +I
Sbjct: 255 SFTGEIPQLLFNISSLRFLNLAVNNLEGEIPSNLSHCRELRVLSLSFNQFTGGIPQAIGS 314
Query: 142 LSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQLSGSIPSFIFKISSLQALHFGN 201
LS+L +L LS N LTG IP +GNLS+L +L LS N +SG IP+ IF +SSLQ + F +
Sbjct: 315 LSNLEELYLSHNKLTGGIP-REIGNLSNLNILQLSSNGISGPIPAEIFNVSSLQVIAFTD 373
Query: 202 NRLSGELPANICDNLPFLNFFSVYKNMFYGGISSTLSNCKHLRILDLSFNDLWGDIPKEI 261
N LSG LP +IC +LP L S+ +N G + +TLS C L L LSFN G IPKEI
Sbjct: 374 NSLSGSLPKDICKHLPNLQGLSLSQNHLSGQLPTTLSLCGELLFLSLSFNKFRGSIPKEI 433
Query: 262 GNLTKLKELFLDFNILQGEIPHTVGNLHNLEYLSLVNNELVGTVPATIFNVSTLKLIELS 321
GNL+KL++++L N L G IP + GNL L++L+L N L GTVP IFN+S L+ + +
Sbjct: 434 GNLSKLEKIYLGTNSLIGSIPTSFGNLKALKFLNLGINNLTGTVPEAIFNISKLQSLAMV 493
Query: 322 NNTFFGSLPSSTDVQLPNLEELYLWGNNFSGTLPSFIFNASNLSKLSLGDNSFSGLIPNT 381
N GSLPSS L +LE L++ GN FSG +P I N S L+ L L NSF+G +P
Sbjct: 494 KNHLSGSLPSSIGTWLSDLEGLFIAGNEFSGIIPMSISNMSKLTVLGLSANSFTGNVPKD 553
Query: 382 FGNLRNLKRLRLYNNYLT----SPELSFLSSLSNCKYLEIIALSGNPLNGIIPMSAGNLS 437
GNL LK L L N LT + E+ FL+SL+NCK+L+ + + NP G +P S GNL
Sbjct: 554 LGNLTKLKVLDLAGNQLTDEHVASEVGFLTSLTNCKFLKNLWIGNNPFKGTLPNSLGNLP 613
Query: 438 HSLEELFMPDCNVSGRIPKEIGNLANLVTLDLGGNKFNGSIPIALGKLQKLQLLNLDDNK 497
+LE C G IP IGNL NL+ LDLG N GSIP LG+L+KLQ L++ N+
Sbjct: 614 IALESFIASACQFRGTIPTRIGNLTNLIWLDLGANDLTGSIPTTLGRLKKLQKLHIVGNR 673
Query: 498 LEGSIPDDICGLVELYKLALGDNKLSGQIPACFGNLASLRELWLGPNELISFIPSTFWNI 557
L GSIP+D+C L L L L NKLSG IP+CFG+L +L+EL+L N L IP++ W++
Sbjct: 674 LRGSIPNDLCHLKNLGYLHLSSNKLSGSIPSCFGDLPALQELFLDSNVLAFNIPTSLWSL 733
Query: 558 KDIMYVNFSSNFLTGPLPLEIENLKALTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNR 617
+D++ +N SSNFLTG LP E+ N+K++TTLD S N +SG IP +G + L L L N+
Sbjct: 734 RDLLVLNLSSNFLTGNLPPEVGNMKSITTLDLSKNLVSGHIPRKMGEQQNLAKLSLSQNK 793
Query: 618 LQGSIPDSVGDLISLKSLNLSNNNLSGPIPTSLEKLSDLKELNLSFNKLEGEIPRGGPFV 677
LQG IP GDL+SL+SL+LS NNLSG IP SLE L LK LN+S NKL+GEIP GGPF+
Sbjct: 794 LQGPIPIEFGDLVSLESLDLSQNNLSGTIPKSLEALIYLKYLNVSLNKLQGEIPNGGPFI 853
Query: 678 NFSAKSFMGNNLLCGSPNLQVPPCRAS--IDHISKKNALLLGIILPFSTIFVIVIILLIS 735
NF+A+SFM N LCG+P+ QV C + K+ +L I+LP +I +V+ +++
Sbjct: 854 NFTAESFMFNEALCGAPHFQVMACDKNNRTQSWKTKSFILKYILLPVGSIVTLVVFIVLW 913
Query: 736 RYQTRGENVPNEVNVPLEATWRRFSYLELFQATNGFSENNLIGRGSFGSVYIARLQNGIE 795
+ +P ++ L T + S+ +L ATN F E+NLIG+GS G VY L NG+
Sbjct: 914 IRRRDNMEIPTPIDSWLPGTHEKISHQQLLYATNDFGEDNLIGKGSQGMVYKGVLSNGLT 973
Query: 796 VAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEYMRNGSLEKC 855
VA+K F+L+ + A +SFD+ECEVM+ IRHRNL +II+ CSN DFKAL+LEYM NGSLEK
Sbjct: 974 VAIKVFNLEFQGALRSFDSECEVMQGIRHRNLVRIITCCSNLDFKALVLEYMPNGSLEKW 1033
Query: 856 LYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGI 915
LYS NY LD+ QRLNIMIDVASALEYLH S+ V+HCDLKP+NVLLDD+MVAH++DFGI
Sbjct: 1034 LYSHNYFLDLIQRLNIMIDVASALEYLHHDCSSLVVHCDLKPNNVLLDDDMVAHVADFGI 1093
Query: 916 AKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIF 975
KLL + +SM QT+TL T+GYMAPE+G +G VSTK DVYS+GILLME F+R+KP DE+F
Sbjct: 1094 TKLLT-KTESMQQTKTLGTIGYMAPEHGSDGIVSTKSDVYSYGILLMEVFSRKKPMDEMF 1152
Query: 976 SGEMTLKHWVNDFLPISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERI 1035
+G++TLK WV + L S+++++DANLL ED+ A K C SS+ LA+ CT +SP+ER+
Sbjct: 1153 TGDLTLKTWV-ESLSNSVIQVVDANLLRREDEDLATKLSCLSSIMALALACTTDSPEERL 1211
Query: 1036 TAKEIVRRLLKIRDFLL 1052
K+ V L K R LL
Sbjct: 1212 NMKDAVVELKKSRMKLL 1228
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147776333|emb|CAN72034.1| hypothetical protein VITISV_000078 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 923 bits (2385), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 516/988 (52%), Positives = 662/988 (67%), Gaps = 11/988 (1%)
Query: 72 RVTALNISYLSLTGNIPRQLGNLSSLEILDLNFNRLSGEIPWELGNLAKLEKLLLHNNFL 131
++ ++++Y TG+IP +GNL L+ L L N L+GEIP L + +L L N
Sbjct: 221 KLQVISLAYNDFTGSIPNGIGNLVELQRLSLRNNSLTGEIPSNLSHCRELRVLSSSFNQF 280
Query: 132 TGTIPFSIFKLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQLSGSIPSFIFKI 191
TG IP +I L +L +L L+ N LTG IP +GNLS+L +L L N +SG IP+ IF I
Sbjct: 281 TGGIPQAIGSLCNLEELYLAFNKLTGGIP-REIGNLSNLNILQLGSNGISGPIPAEIFNI 339
Query: 192 SSLQALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGGISSTLSNCKHLRILDLSFN 251
SSLQ + F NN LSG LP IC +LP L + +N G + +TLS C L L LSFN
Sbjct: 340 SSLQVIDFTNNSLSGSLPMGICKHLPNLQGLYLAQNHLSGQLPTTLSLCGELLFLSLSFN 399
Query: 252 DLWGDIPKEIGNLTKLKELFLDFNILQGEIPHTVGNLHNLEYLSLVNNELVGTVPATIFN 311
G IP+EIGNL+KL+ + L N L G IP + GNL L++L+L N L GTVP IFN
Sbjct: 400 KFRGSIPREIGNLSKLEHIDLRSNSLVGSIPTSFGNLKALKFLNLGINFLTGTVPEAIFN 459
Query: 312 VSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSGTLPSFIFNASNLSKLSLGD 371
+S L+ + L N GSLPSS LP+LE LY+ N FSGT+P I N S L+ LSL D
Sbjct: 460 ISELQNLALVQNHLSGSLPSSIGTWLPDLEGLYIGANEFSGTIPMSISNMSKLTVLSLSD 519
Query: 372 NSFSGLIPNTFGNLRNLKRLRLYNNYLTSPELS----FLSSLSNCKYLEIIALSGNPLNG 427
NSF+G +P NL LK L L +N LT L+ FL+SL+NCK+L + + NPL G
Sbjct: 520 NSFTGNVPKDLCNLTKLKFLNLAHNQLTDEHLASGVGFLTSLTNCKFLRYLWIGYNPLKG 579
Query: 428 IIPMSAGNLSHSLEELFMPDCNVSGRIPKEIGNLANLVTLDLGGNKFNGSIPIALGKLQK 487
+P S GNL +LE C G IP IGNL NL+ LDLG N GSIP LG+LQK
Sbjct: 580 TLPNSLGNLPIALESFTAYACQFRGTIPTGIGNLTNLIWLDLGANDLTGSIPTTLGRLQK 639
Query: 488 LQLLNLDDNKLEGSIPDDICGLVELYKLALGDNKLSGQIPACFGNLASLRELWLGPNELI 547
LQ L++ N++ GSIP+D+C L L L L NKLSG P+CFG+L +LREL+L N L
Sbjct: 640 LQRLHIAGNRIRGSIPNDLCHLKNLGYLGLSSNKLSGSTPSCFGDLLALRELFLDSNALA 699
Query: 548 SFIPSTFWNIKDIMYVNFSSNFLTGPLPLEIENLKALTTLDFSMNNLSGVIPTTIGGLKG 607
IP++ W+++D++ +N SSNFLTG LP E+ N+K++TTLD S N +SG IP+ +G L+
Sbjct: 700 FNIPTSLWSLRDLLVLNLSSNFLTGNLPPEVGNMKSITTLDLSKNLVSGYIPSRMGKLQY 759
Query: 608 LQYLFLGHNRLQGSIPDSVGDLISLKSLNLSNNNLSGPIPTSLEKLSDLKELNLSFNKLE 667
L L L NRLQG I GDL+SL+SL+LS+NNLSG IP SLE L LK LN+SFNKL+
Sbjct: 760 LITLSLSQNRLQGPIXVEFGDLVSLESLDLSHNNLSGTIPKSLEALIYLKYLNVSFNKLQ 819
Query: 668 GEIPRGGPFVNFSAKSFMGNNLLCGSPNLQVPPCRAS--IDHISKKNALLLGIILPF-ST 724
GEIP GGPFV F+A+SFM N LCG+P+ QV C + K+ +L I+LP ST
Sbjct: 820 GEIPNGGPFVKFTAESFMFNEALCGAPHFQVMACDKNNRTQSWKTKSFILKYILLPVGST 879
Query: 725 IFVIVIILLISRYQTRGENVPNEVNVPLEATWRRFSYLELFQATNGFSENNLIGRGSFGS 784
+ ++V I+L R + E +P ++ L T + S+ +L ATN F E+NLIG+GS G
Sbjct: 880 VTLVVFIVLWIRRRDNME-IPTPIDSWLLGTHEKISHQQLLYATNDFGEDNLIGKGSQGM 938
Query: 785 VYIARLQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALIL 844
VY L NG+ VA+K F+L+ + A +SFD+ECEVM+ IRHRNL +II+ CSN DFKAL+L
Sbjct: 939 VYKGVLSNGLNVAIKVFNLEFQGALRSFDSECEVMQGIRHRNLVRIITCCSNLDFKALVL 998
Query: 845 EYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDD 904
EYM NGSLEK LYS NY LD+ QRLNIMIDVASALEYLH S+ V+HCDLKPSNVLLDD
Sbjct: 999 EYMPNGSLEKWLYSHNYFLDLIQRLNIMIDVASALEYLHHDCSSLVVHCDLKPSNVLLDD 1058
Query: 905 NMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMET 964
+MVAH++DFGIAKLL E +SM QT+TL T+GYMAPE+G G VSTK DVYS+GILLME
Sbjct: 1059 DMVAHVADFGIAKLLT-ETESMQQTKTLGTIGYMAPEHGSAGIVSTKSDVYSYGILLMEV 1117
Query: 965 FTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHFAAKEQCASSVFNLAM 1024
F R+KP DE+F+G++TLK WV + L S+++++D NLL ED+ A K C SS+ LA+
Sbjct: 1118 FARKKPMDEMFTGDLTLKTWV-ESLSNSVIQVVDVNLLRREDEDLATKLSCLSSIMALAL 1176
Query: 1025 ECTVESPDERITAKEIVRRLLKIRDFLL 1052
CT +SP ERI K+ V L K R LL
Sbjct: 1177 ACTTDSPKERIDMKDAVVELKKSRIKLL 1204
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147852480|emb|CAN78527.1| hypothetical protein VITISV_039533 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 918 bits (2372), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 511/978 (52%), Positives = 660/978 (67%), Gaps = 11/978 (1%)
Query: 82 SLTGNIPRQLGNLSSLEILDLNFNRLSGEIPWELGNLAKLEKLLLHNNFLTGTIPFSIFK 141
SLTG IP+ L N+SSL +L+L N L GEIP L + +L L L N TG IP +I
Sbjct: 255 SLTGEIPQLLFNISSLRLLNLAVNNLEGEIPSNLSHCRELRVLSLSINRFTGGIPQAIGS 314
Query: 142 LSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQLSGSIPSFIFKISSLQALHFGN 201
LS L +L L N LTG IP +GNLS+L +L L N +SG IP+ IF ISSLQ + F N
Sbjct: 315 LSDLEELYLGYNKLTGGIP-REIGNLSNLNILQLGSNGISGPIPAEIFNISSLQGIGFSN 373
Query: 202 NRLSGELPANICDNLPFLNFFSVYKNMFYGGISSTLSNCKHLRILDLSFNDLWGDIPKEI 261
N LSG LP +IC +LP L + + N G + +TLS C+ L +L LSFN G IP+EI
Sbjct: 374 NSLSGSLPMDICKHLPNLQWLDLALNHLSGQLPTTLSLCRELLVLSLSFNKFRGSIPREI 433
Query: 262 GNLTKLKELFLDFNILQGEIPHTVGNLHNLEYLSLVNNELVGTVPATIFNVSTLKLIELS 321
GNL+KL+ + L N L G IP + GNL L++L+L N L GTVP IFN+S L+ + ++
Sbjct: 434 GNLSKLEWIDLSSNSLVGSIPTSFGNLMALKFLNLGINNLTGTVPEAIFNISKLQSLAMA 493
Query: 322 NNTFFGSLPSSTDVQLPNLEELYLWGNNFSGTLPSFIFNASNLSKLSLGDNSFSGLIPNT 381
N GSLPSS LP+LE L++ GN FSG +P I N S L++L + NSF G +P
Sbjct: 494 INHLSGSLPSSIGTWLPDLEGLFIGGNEFSGIIPVSISNMSKLTQLDVSRNSFIGNVPKD 553
Query: 382 FGNLRNLKRLRLYNNYLT----SPELSFLSSLSNCKYLEIIALSGNPLNGIIPMSAGNLS 437
GNL L+ L L N T + E+SFL+SL+NCK+L+ + + NP G +P S GNL
Sbjct: 554 LGNLTKLEVLNLAGNQFTNEHLASEVSFLTSLTNCKFLKNLWIGNNPFKGTLPNSLGNLP 613
Query: 438 HSLEELFMPDCNVSGRIPKEIGNLANLVTLDLGGNKFNGSIPIALGKLQKLQLLNLDDNK 497
+LE C G IP IGNL NL+ LDLG N GSIP LG+L+KLQ L++ N+
Sbjct: 614 IALESFIASACQFRGTIPTGIGNLTNLIWLDLGANDLTGSIPTILGRLKKLQRLHIAGNR 673
Query: 498 LEGSIPDDICGLVELYKLALGDNKLSGQIPACFGNLASLRELWLGPNELISFIPSTFWNI 557
L GSIP+D+C L L L L NKLSG IP+CFG+L +L+EL+L N L IP++ W++
Sbjct: 674 LRGSIPNDLCHLKNLGYLHLSSNKLSGSIPSCFGDLPALQELFLDSNVLAFNIPTSLWSL 733
Query: 558 KDIMYVNFSSNFLTGPLPLEIENLKALTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNR 617
+D++ +N SSNFLTG LP E+ N+K++TTLD S N +SG IP +G + L L L NR
Sbjct: 734 RDLLVLNLSSNFLTGNLPPEVGNMKSITTLDLSKNLVSGYIPRRMGEQQNLAKLSLSQNR 793
Query: 618 LQGSIPDSVGDLISLKSLNLSNNNLSGPIPTSLEKLSDLKELNLSFNKLEGEIPRGGPFV 677
LQG IP GDL+SL+SL+LS NNLSG IP SLE L LK LN+S NKL+GEIP GGPFV
Sbjct: 794 LQGPIPVEFGDLVSLESLDLSQNNLSGTIPKSLEALIYLKYLNVSSNKLQGEIPNGGPFV 853
Query: 678 NFSAKSFMGNNLLCGSPNLQVPPCRAS--IDHISKKNALLLGIILPF-STIFVIVIILLI 734
NF+A+SFM N LCG+P+ QV C + K+ +L I+LP STI ++V I+L
Sbjct: 854 NFTAESFMFNEALCGAPHFQVMACDKNNRTQSWKTKSFILKYILLPVGSTITLVVFIVLW 913
Query: 735 SRYQTRGENVPNEVNVPLEATWRRFSYLELFQATNGFSENNLIGRGSFGSVYIARLQNGI 794
R + E +P ++ L T + S+ L ATN F E+NLIG+GS G VY L NG+
Sbjct: 914 IRRRDNME-IPTPIDSWLPGTHEKISHQRLLYATNDFGEDNLIGKGSQGMVYKGVLSNGL 972
Query: 795 EVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEYMRNGSLEK 854
VA+K F+L+ + A +SFD+ECEVM+ IRHRNL +II+ CSN DFKAL+L+YM NGSLEK
Sbjct: 973 IVAIKVFNLEFQGALRSFDSECEVMQGIRHRNLVRIITCCSNLDFKALVLKYMPNGSLEK 1032
Query: 855 CLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFG 914
LYS NY LD+ QRLNIMIDVASALEYLH S+ V+HCDLKPSNVLLDD+MVAH++DFG
Sbjct: 1033 WLYSHNYFLDLIQRLNIMIDVASALEYLHHDCSSLVVHCDLKPSNVLLDDDMVAHVADFG 1092
Query: 915 IAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEI 974
I KLL + +SM QT+TL T+GYMAPE+G +G VSTK DVYS+GILLME F R+KP DE+
Sbjct: 1093 ITKLLT-KTESMQQTKTLGTIGYMAPEHGSDGIVSTKSDVYSYGILLMEVFARKKPMDEM 1151
Query: 975 FSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDER 1034
F+G++TLK WV + L S+++++D NLL ED+ A K C SS+ LA+ CT +SP+ER
Sbjct: 1152 FTGDLTLKTWV-ESLSNSVIQVVDVNLLRREDEDLATKLSCLSSIMALALACTNDSPEER 1210
Query: 1035 ITAKEIVRRLLKIRDFLL 1052
+ K+ V L K R LL
Sbjct: 1211 LDMKDAVVELKKSRMKLL 1228
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147769371|emb|CAN72496.1| hypothetical protein VITISV_010511 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 914 bits (2362), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 514/1036 (49%), Positives = 672/1036 (64%), Gaps = 57/1036 (5%)
Query: 71 RRVTALNISYLSLTGNIPRQLGNLSSLEILDLNFNRLSGEIPWELGNLAKLEKLLLHNNF 130
R + L++S+ TG IP+ +G+L +LE L L FN+L+G IP E+GNL+KL L L +N
Sbjct: 208 RELRGLSLSFNQFTGGIPQAIGSLCNLEELYLAFNKLTGGIPREIGNLSKLNILQLSSNG 267
Query: 131 LTGTIPFSIFKLSSLLDLKLSDNNLTGTIPSH---------------------------- 162
++G IP IF +SSL ++ S+N+LTG IPS+
Sbjct: 268 ISGPIPTEIFNISSLQEIDFSNNSLTGEIPSNLSHCRELRVLSLSFNQFTGGIPQAIGSL 327
Query: 163 -------------------NLGNLSSLQLLDLSDNQLSGSIPSFIFKISSLQALHFGNNR 203
+GNLS+L +L L N +SG IP+ IF ISSLQ + F NN
Sbjct: 328 SNLEGLYLSYNKLTGGIPREIGNLSNLNILQLGSNGISGPIPAEIFNISSLQIIDFSNNS 387
Query: 204 LSGELPANICDNLPFLNFFSVYKNMFYGGISSTLSNCKHLRILDLSFNDLWGDIPKEIGN 263
LSG LP +IC +LP L + +N G + +TLS C L L L+ N G IP+EIGN
Sbjct: 388 LSGSLPMDICKHLPNLQGLYLLQNHLSGQLPTTLSLCGELLYLSLAVNKFRGSIPREIGN 447
Query: 264 LTKLKELFLDFNILQGEIPHTVGNLHNLEYLSLVNNELVGTVPATIFNVSTLKLIELSNN 323
L+KL+++ L N L G IP + GNL L+YL L N L GTVP IFN+S L+++ L N
Sbjct: 448 LSKLEDISLRSNSLVGSIPTSFGNLMALKYLDLGMNFLTGTVPEAIFNISELQILVLVQN 507
Query: 324 TFFGSLPSSTDVQLPNLEELYLWGNNFSGTLPSFIFNASNLSKLSLGDNSFSGLIPNTFG 383
GSLP S LP+LE LY+ N FSGT+P I N S L +L + DNSF+G +P G
Sbjct: 508 HLSGSLPPSIGTWLPDLEGLYIGSNKFSGTIPMSISNMSKLIQLQVWDNSFTGNVPKDLG 567
Query: 384 NLRNLKRLRLYNNYLTSPELS----FLSSLSNCKYLEIIALSGNPLNGIIPMSAGNLSHS 439
NL L+ L L N LT+ L+ FL+SL+NCK+L + + NP G +P S GNL +
Sbjct: 568 NLTKLEVLNLAANQLTNEHLASGVGFLTSLTNCKFLRHLWIDDNPFKGTLPNSLGNLPIA 627
Query: 440 LEELFMPDCNVSGRIPKEIGNLANLVTLDLGGNKFNGSIPIALGKLQKLQLLNLDDNKLE 499
LE C G IP IGNL NL+ LDLG N SIP LG+LQKLQ L++ N++
Sbjct: 628 LESFTASACQFRGTIPTGIGNLTNLIELDLGANDLTRSIPTTLGRLQKLQRLHIAGNRIR 687
Query: 500 GSIPDDICGLVELYKLALGDNKLSGQIPACFGNLASLRELWLGPNELISFIPSTFWNIKD 559
GSIP+D+C L L L L NKLSG IP+CFG+L +L+EL+L N L IP++ W+++D
Sbjct: 688 GSIPNDLCHLKNLGYLHLXSNKLSGSIPSCFGDLPALQELFLDSNVLAFNIPTSLWSLRD 747
Query: 560 IMYVNFSSNFLTGPLPLEIENLKALTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQ 619
++ +N SSNFLTG LP E+ N+K++TTLD S N +SG IP +G + L L L NRLQ
Sbjct: 748 LLVLNLSSNFLTGNLPPEVGNMKSITTLDLSKNLVSGYIPRRMGEQQNLAKLSLSQNRLQ 807
Query: 620 GSIPDSVGDLISLKSLNLSNNNLSGPIPTSLEKLSDLKELNLSFNKLEGEIPRGGPFVNF 679
G IP GDL+SL+SL+LS NNLSG IP SLE L LK LN+S NKL+GEIP GGPF NF
Sbjct: 808 GPIPXEFGDLVSLESLDLSQNNLSGTIPKSLEALIYLKYLNVSSNKLQGEIPNGGPFXNF 867
Query: 680 SAKSFMGNNLLCGSPNLQVPPCRAS--IDHISKKNALLLGIILPF-STIFVIVIILLISR 736
+A+SFM N LCG+P+ QV C + K+ +L I+LP STI ++V I+L R
Sbjct: 868 TAESFMFNEALCGAPHFQVMACDKNNRTQSWKTKSFILKYILLPVGSTITLVVFIVLWIR 927
Query: 737 YQTRGENVPNEVNVPLEATWRRFSYLELFQATNGFSENNLIGRGSFGSVYIARLQNGIEV 796
+ E + ++ L T + S+ +L ATN F E+NLIG+GS G VY L NG+ V
Sbjct: 928 RRDNME-IXTPIDSWLPGTHEKISHQQLLYATNDFGEDNLIGKGSQGMVYKGVLSNGLIV 986
Query: 797 AVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEYMRNGSLEKCL 856
A+K F+L+ + A +SFD+ECEVM+ IRHRNL +II+ CSN DFKAL+L+YM NGSLEK L
Sbjct: 987 AIKVFNLEFQGALRSFDSECEVMQGIRHRNLVRIITCCSNLDFKALVLKYMPNGSLEKWL 1046
Query: 857 YSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIA 916
YS NY LD+ QRLNIMIDVASALEYLH S+ V+HCDLKPSNVLLDDBMVAH++DFGIA
Sbjct: 1047 YSHNYFLDLIQRLNIMIDVASALEYLHHDCSSLVVHCDLKPSNVLLDDBMVAHVTDFGIA 1106
Query: 917 KLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFS 976
KLL + +SM QT+TL T+GYMAPE+G +G VSTK DVYS+GILLME F R+KP DE+F+
Sbjct: 1107 KLLT-KTESMQQTKTLGTIGYMAPEHGSDGIVSTKSDVYSYGILLMEVFARKKPMDEMFT 1165
Query: 977 GEMTLKHWVNDFLPISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERIT 1036
G++TLK WV + L S+++++D NLL ED+ A K C SS+ LA+ CT +SP+ER+
Sbjct: 1166 GDLTLKTWV-ESLSNSVIQVVDVNLLRREDEDLATKLSCLSSIMALALACTNDSPEERLD 1224
Query: 1037 AKEIVRRLLKIRDFLL 1052
K+ V L K R LL
Sbjct: 1225 MKDAVVELKKSRMKLL 1240
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449465016|ref|XP_004150225.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 908 bits (2346), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 521/1088 (47%), Positives = 701/1088 (64%), Gaps = 59/1088 (5%)
Query: 25 IDIDQDALLALKDHITYDPTNFFAKNWLTNSTMVCNWTGVTCDINQRRVTALNISYLSLT 84
I DQ ALLAL+ HIT DP NW + +T VCNW G+ C + +RVT+LN S++ LT
Sbjct: 7 ITTDQAALLALRAHITSDPFGITTNNW-SATTSVCNWVGIICGVKHKRVTSLNFSFMGLT 65
Query: 85 GNIPRQLG------------------------NLSSLEILDLNFNRLSGEIPWELGNLAK 120
G P ++G NL L+++ L N SGEIP +G L +
Sbjct: 66 GTFPPEVGTLSFLTYVTIKNNSFHDPLPIELTNLPRLKMMSLGNNNFSGEIPTWIGRLPR 125
Query: 121 LEKLLLHNNFLTGTIPFSIFKLSSLLDLKLSDNNLTGTIPSH------------------ 162
+E+L L+ N +G IP S+F L+SL+ L L +N L+G+IP
Sbjct: 126 MEELYLYGNQFSGLIPTSLFNLTSLIMLNLQENQLSGSIPREIGNLTLLQDLYLNSNQLT 185
Query: 163 ----NLGNLSSLQLLDLSDNQLSGSIPSFIFKISSLQALHFGNNRLSGELPANICDNLPF 218
+G L SL+ LD+ N SG IP FIF +SSL L N G LP +IC++LP
Sbjct: 186 EIPTEIGTLQSLRTLDIEFNLFSGPIPLFIFNLSSLVILGLSGNNFIGGLPDDICEDLPS 245
Query: 219 LNFFSVYKNMFYGGISSTLSNCKHLRILDLSFNDLWGDIPKEIGNLTKLKELFLDFNILQ 278
L + N G + STL C++L + L++N G IP+ +GNLT++K++FL N L
Sbjct: 246 LGGLYLSYNQLSGQLPSTLWKCENLEDVALAYNQFTGSIPRNVGNLTRVKQIFLGVNYLS 305
Query: 279 GEIPHTVGNLHNLEYLSLVNNELVGTVPATIFNVSTLKLIELSNNTFFGSLPSSTDVQLP 338
GEIP+ +G L NLEYL++ N GT+P TIFN+S L I L N G+LP+ V LP
Sbjct: 306 GEIPYELGYLQNLEYLAMQENFFNGTIPPTIFNLSKLNTIALVKNQLSGTLPADLGVGLP 365
Query: 339 NLEELYLWGNNFSGTLPSFIFNASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRL-YNNY 397
NL +L L N +GT+P I N+S L+ +GDNSFSGLIPN FG NL+ + L NN+
Sbjct: 366 NLVQLMLGRNELTGTIPESITNSSMLTLFDVGDNSFSGLIPNVFGRFENLRWINLELNNF 425
Query: 398 LT-SP--ELSFLSSLSNCKYLEIIALSGNPLNGIIPMSAGNLSHSLEELFMPDCNVSGRI 454
T SP E S L+N L + LS NPLN +P S N S S + L M + + G I
Sbjct: 426 TTESPPSERGIFSFLTNLTSLVRLELSHNPLNIFLPSSFVNFSSSFQYLSMVNTGIKGMI 485
Query: 455 PKEIGN-LANLVTLDLGGNKFNGSIPIALGKLQKLQLLNLDDNKLEGSIPDDICGLVELY 513
PK+IGN L +L+ L + N+ G+IP ++GKL++LQ L+L +N LEG+IP +IC L L
Sbjct: 486 PKDIGNFLRSLIVLVMDDNQITGTIPTSIGKLKQLQGLHLSNNSLEGNIPAEICQLENLD 545
Query: 514 KLALGDNKLSGQIPACFGNLASLRELWLGPNELISFIPSTFWNIKDIMYVNFSSNFLTGP 573
+L L +NKLSG IP CF NL++LR L LG N L S +PS+ W++ I+++N SSN L G
Sbjct: 546 ELYLANNKLSGAIPECFDNLSALRTLSLGSNNLNSTMPSSLWSLSYILHLNLSSNSLRGS 605
Query: 574 LPLEIENLKALTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQGSIPDSVGDLISLK 633
LP+EI NL+ + +D S N LSG IP++IGGL L L L HN L+GSIPDS G+L++L+
Sbjct: 606 LPVEIGNLEVVLDIDVSKNQLSGEIPSSIGGLINLVNLSLLHNELEGSIPDSFGNLVNLE 665
Query: 634 SLNLSNNNLSGPIPTSLEKLSDLKELNLSFNKLEGEIPRGGPFVNFSAKSFMGNNLLC-G 692
L+LS+NNL+G IP SLEKLS L++ N+SFN+LEGEIP GGPF NFSA+SF+ N LC
Sbjct: 666 ILDLSSNNLTGVIPRSLEKLSHLEQFNVSFNQLEGEIPNGGPFSNFSAQSFISNIGLCSA 725
Query: 693 SPNLQVPPCRASIDHISKKNALLLGIILP---FSTIFVIVIILLISRYQTRGENVPNEVN 749
S QV PC S + L ILP + + +I+++L ++ + E V +
Sbjct: 726 SSRFQVAPCTTKTSQGSGRKTNKLVYILPSILLAMLSLILLLLFMTYRHRKKEQVREDTP 785
Query: 750 VPLEATWRRFSYLELFQATNGFSENNLIGRGSFGSVYIARLQNGIEVAVKTFDLQHERAF 809
+P + WRR +Y EL QAT+GFSE+NLIGRGSFGSVY A L +G AVK FDL + A
Sbjct: 786 LPYQPAWRRTTYQELSQATDGFSESNLIGRGSFGSVYKATLSDGTIAAVKIFDLLTQDAN 845
Query: 810 KSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRL 869
KSF+ ECE++ +IRHRNL KII+SCS+ DFKALILEYM NG+L+ LY+ + L++ +RL
Sbjct: 846 KSFELECEILCNIRHRNLVKIITSCSSVDFKALILEYMPNGNLDMWLYNHDCGLNMLERL 905
Query: 870 NIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQT 929
+I+IDVA AL+YLH GY P++HCDLKP+N+LLD +MVAHL+DFGI+KLL G D S+TQT
Sbjct: 906 DIVIDVALALDYLHNGYGKPIVHCDLKPNNILLDGDMVAHLTDFGISKLLGGGD-SITQT 964
Query: 930 QTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFS-GEMTLKHWVNDF 988
TLAT+GYMAPE G +G VS K DVYS+GILLMETFTR+KPTDE+FS GEM+L+ WV
Sbjct: 965 ITLATVGYMAPELGLDGIVSRKCDVYSYGILLMETFTRKKPTDEMFSAGEMSLREWVAKA 1024
Query: 989 LPISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKIR 1048
P S+ ++D +LL +DK F +C SS+ LA+ CT ESP++R ++K+++ L KI+
Sbjct: 1025 YPHSINNVVDPDLL-NDDKSFNYASECLSSIMLLALTCTAESPEKRASSKDVLNSLNKIK 1083
Query: 1049 DFLLRNVE 1056
+L E
Sbjct: 1084 AMILTYSE 1091
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 1057 | ||||||
| TAIR|locus:2079142 | 1010 | AT3G47570 [Arabidopsis thalian | 0.634 | 0.664 | 0.361 | 3.2e-149 | |
| TAIR|locus:2075631 | 1009 | AT3G47090 [Arabidopsis thalian | 0.632 | 0.663 | 0.354 | 1e-141 | |
| TAIR|locus:2079157 | 1011 | AT3G47580 [Arabidopsis thalian | 0.633 | 0.662 | 0.341 | 5.8e-137 | |
| UNIPROTKB|Q40640 | 1025 | Xa21 "Receptor kinase-like pro | 0.771 | 0.796 | 0.374 | 9.8e-135 | |
| TAIR|locus:2170483 | 1173 | FLS2 "FLAGELLIN-SENSITIVE 2" [ | 0.906 | 0.816 | 0.327 | 8.7e-127 | |
| TAIR|locus:2120362 | 1249 | GSO1 "GASSHO1" [Arabidopsis th | 0.742 | 0.628 | 0.288 | 2.7e-77 | |
| TAIR|locus:2075661 | 1025 | AT3G47110 [Arabidopsis thalian | 0.635 | 0.655 | 0.339 | 2.2e-96 | |
| TAIR|locus:2046525 | 1124 | AT2G33170 [Arabidopsis thalian | 0.684 | 0.643 | 0.299 | 3.8e-114 | |
| TAIR|locus:2085949 | 1141 | AT3G24240 [Arabidopsis thalian | 0.934 | 0.865 | 0.301 | 1.8e-112 | |
| TAIR|locus:2156349 | 1252 | GSO2 "GASSHO 2" [Arabidopsis t | 0.812 | 0.686 | 0.301 | 1.1e-92 |
| TAIR|locus:2079142 AT3G47570 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1019 (363.8 bits), Expect = 3.2e-149, Sum P(2) = 3.2e-149
Identities = 250/692 (36%), Positives = 362/692 (52%)
Query: 184 IPSFIFKISSLQALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGGISSTLSNCKHL 243
IP + ++S L+ L G N L G +P + + LN + N G + S L + +L
Sbjct: 106 IPQEVGQLSRLEYLDMGINYLRGPIPLGLYNCSRLLNL-RLDSNRLGGSVPSELGSLTNL 164
Query: 244 RILDLSFNDLWGDIPKEIGNLTKLKELFLDFNILQGEIPHTVGNLHNLEYLSLVNNELVG 303
L+L N++ G +P +GNLT L++L L N L+GEIP V L + L LV N G
Sbjct: 165 VQLNLYGNNMRGKLPTSLGNLTLLEQLALSHNNLEGEIPSDVAQLTQIWSLQLVANNFSG 224
Query: 304 TVPATIFNVSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSGTLPSFIFNASN 363
P ++N+S+LKL+ + N F G L + LPNL + GN F+G++P+ + N S
Sbjct: 225 VFPPALYNLSSLKLLGIGYNHFSGRLRPDLGILLPNLLSFNMGGNYFTGSIPTTLSNIST 284
Query: 364 LSKLSLGDNSFSGLIPNTFGXX---XXXXXXXXXXXXXTSPELSFLSSLSNCKYLEIIAL 420
L +L + +N+ +G IP TFG +S +L FL+SL+NC LE + +
Sbjct: 285 LERLGMNENNLTGSIP-TFGNVPNLKLLFLHTNSLGSDSSRDLEFLTSLTNCTQLETLGI 343
Query: 421 SGNPLNGIIPMSAGNLSHSLEELFMPDCNVSGRIPKEIGNLANLVTLDLGGNKFNGSIPI 480
N L G +P+S NLS L L + +SG IP +IGNL NL L L N +G +P
Sbjct: 344 GRNRLGGDLPISIANLSAKLVTLDLGGTLISGSIPYDIGNLINLQKLILDQNMLSGPLPT 403
Query: 481 ALGKXXXXXXXXXXXXXXEGSIPDDICGLVELYKLALGDNKLSGQIPACFGNLASLRELW 540
+LGK G IP I + L L L +N G +P GN + L ELW
Sbjct: 404 SLGKLLNLRYLSLFSNRLSGGIPAFIGNMTMLETLDLSNNGFEGIVPTSLGNCSHLLELW 463
Query: 541 LGPNELISFIPSTFWNIKDIMYVNFSSNFLTGPLPLEIENLKALTTLDFSMNNLSGVIPT 600
+G N+L IP I+ ++ ++ S N L G LP +I L+ L TL N LSG +P
Sbjct: 464 IGDNKLNGTIPLEIMKIQQLLRLDMSGNSLIGSLPQDIGALQNLGTLSLGDNKLSGKLPQ 523
Query: 601 TIGGLKGLQYLFLGHNRLQGSIPDSVGDLIXXXXXXXXXXXXXGPIPTSLEKLSDLKELN 660
T+G ++ LFL N G IPD G L+ G IP S L+ LN
Sbjct: 524 TLGNCLTMESLFLEGNLFYGDIPDLKG-LVGVKEVDLSNNDLSGSIPEYFASFSKLEYLN 582
Query: 661 LSFNKLEGEIPRGGPFVNFSAKSFMGNNLLCGS-PNLQVPPCRASIDHISKKNA-----L 714
LSFN LEG++P G F N + S +GNN LCG Q+ PC + + KK++ +
Sbjct: 583 LSFNNLEGKVPVKGIFENATTVSIVGNNDLCGGIMGFQLKPCLSQAPSVVKKHSSRLKKV 642
Query: 715 LLGIILPFSTI---FVIVIILLISRYQTRGENVPNEVNVPLEATWRRFSYLELFQATNGF 771
++G+ + + + F+ + L+ R + + + N LE + SY +L ATNGF
Sbjct: 643 VIGVSVGITLLLLLFMASVTLIWLRKRKKNKETNNPTPSTLEVLHEKISYGDLRNATNGF 702
Query: 772 SENNLIGRGSFGSVYIARLQNGIEV-AVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKI 830
S +N++G GSFG+VY A L +V AVK ++Q A KSF ECE +K IRHRNL K+
Sbjct: 703 SSSNMVGSGSFGTVYKALLLTEKKVVAVKVLNMQRRGAMKSFMAECESLKDIRHRNLVKL 762
Query: 831 ISSCSNEDF-----KALILEYMRNGSLEKCLY 857
+++CS+ DF +ALI E+M NGSL+ L+
Sbjct: 763 LTACSSIDFQGNEFRALIYEFMPNGSLDMWLH 794
|
|
| TAIR|locus:2075631 AT3G47090 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 957 (341.9 bits), Expect = 1.0e-141, Sum P(2) = 1.0e-141
Identities = 246/693 (35%), Positives = 354/693 (51%)
Query: 184 IPSFIFKISSLQALHFGNNRLSGELPANI--CDNLPFLNFFSVYKNMFYGGISSTLSNCK 241
IP + + L+ L G N L GE+PA++ C L +L+ FS N G+ S L + +
Sbjct: 106 IPQEMGNLFRLKYLAVGFNYLEGEIPASLSNCSRLLYLDLFS---NNLGDGVPSELGSLR 162
Query: 242 HLRILDLSFNDLWGDIPKEIGNLTKLKELFLDFNILQGEIPHTVGNLHNLEYLSLVNNEL 301
L L L NDL G P I NLT L L L +N L+GEIP + L + L+L N
Sbjct: 163 KLLYLYLGLNDLKGKFPVFIRNLTSLIVLNLGYNHLEGEIPDDIAMLSQMVSLTLTMNNF 222
Query: 302 VGTVPATIFNVSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSGTLPSFIFNA 361
G P +N+S+L+ + L N F G+L LPN+ EL L GN +G +P+ + N
Sbjct: 223 SGVFPPAFYNLSSLENLYLLGNGFSGNLKPDFGNLLPNIHELSLHGNFLTGAIPTTLANI 282
Query: 362 SNLSKLSLGDNSFSGLIPNTFGXXXXXXXXXXXXXXXTS---PELSFLSSLSNCKYLEII 418
S L +G N +G I FG S +L+FL +L+NC +L +
Sbjct: 283 STLEMFGIGKNRMTGSISPNFGKLENLHYLELANNSLGSYSFGDLAFLDALTNCSHLHGL 342
Query: 419 ALSGNPLNGIIPMSAGNLSHSLEELFMPDCNVSGRIPKEIGNLANLVTLDLGGNKFNGSI 478
++S N L G +P S N+S L L + + G IP +IGNL L +L L N G +
Sbjct: 343 SVSYNRLGGALPTSIVNMSTELTVLNLKGNLIYGSIPHDIGNLIGLQSLLLADNLLTGPL 402
Query: 479 PIALGKXXXXXXXXXXXXXXEGSIPDDICGLVELYKLALGDNKLSGQIPACFGNLASLRE 538
P +LG G IP I L +L KL L +N G +P G+ + + +
Sbjct: 403 PTSLGNLVGLGELILFSNRFSGEIPSFIGNLTQLVKLYLSNNSFEGIVPPSLGDCSHMLD 462
Query: 539 LWLGPNELISFIPSTFWNIKDIMYVNFSSNFLTGPLPLEIENLKALTTLDFSMNNLSGVI 598
L +G N+L IP I ++++N SN L+G LP +I L+ L L NNLSG +
Sbjct: 463 LQIGYNKLNGTIPKEIMQIPTLVHLNMESNSLSGSLPNDIGRLQNLVELLLGNNNLSGHL 522
Query: 599 PTTIGGLKGLQYLFLGHNRLQGSIPDSVGDLIXXXXXXXXXXXXXGPIPTSLEKLSDLKE 658
P T+G ++ ++L N G+IPD G L+ G I E S L+
Sbjct: 523 PQTLGKCLSMEVIYLQENHFDGTIPDIKG-LMGVKNVDLSNNNLSGSISEYFENFSKLEY 581
Query: 659 LNLSFNKLEGEIPRGGPFVNFSAKSFMGNNLLCGS-PNLQVPPCRASIDHISKKN-ALLL 716
LNLS N EG +P G F N + S GN LCGS L++ PC A + ++ +LL
Sbjct: 582 LNLSDNNFEGRVPTEGIFQNATLVSVFGNKNLCGSIKELKLKPCIAQAPPVETRHPSLLK 641
Query: 717 GIILPFSTIFVIVIILLI---SRYQTRGEN--VPNEVNVPLEATWRRFSYLELFQATNGF 771
+ + S ++++L I S ++ R N + N LE + SY +L AT+GF
Sbjct: 642 KVAIGVSVGIALLLLLFIVSLSWFKKRKNNQKINNSAPFTLEIFHEKLSYGDLRNATDGF 701
Query: 772 SENNLIGRGSFGSVYIARLQ--NGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTK 829
S +N++G GSFG+V+ A LQ N I VAVK ++Q A KSF ECE +K IRHRNL K
Sbjct: 702 SSSNIVGSGSFGTVFKALLQTENKI-VAVKVLNMQRRGAMKSFMAECESLKDIRHRNLVK 760
Query: 830 IISSCSNEDF-----KALILEYMRNGSLEKCLY 857
++++C++ DF +ALI E+M NGSL+K L+
Sbjct: 761 LLTACASIDFQGNEFRALIYEFMPNGSLDKWLH 793
|
|
| TAIR|locus:2079157 AT3G47580 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 918 (328.2 bits), Expect = 5.8e-137, Sum P(2) = 5.8e-137
Identities = 237/694 (34%), Positives = 349/694 (50%)
Query: 184 IPSFIFKISSLQALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGGISSTLSNCKHL 243
IP + + L+ L+ N L G +PA + + LN +Y N G+ S L + L
Sbjct: 106 IPREVGNLFRLEHLYMAFNSLEGGIPATLSNCSRLLNL-DLYSNPLRQGVPSELGSLTKL 164
Query: 244 RILDLSFNDLWGDIPKEIGNLTKLKEL-FLDFNILQGEIPHTVGNLHNLEYLSLVNNELV 302
ILDL N+L G +P+ +GNLT LK L F D NI +GE+P + L + L L N+
Sbjct: 165 VILDLGRNNLKGKLPRSLGNLTSLKSLGFTDNNI-EGEVPDELARLSQMVGLGLSMNKFF 223
Query: 303 GTVPATIFNVSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSGTLPSFIFNAS 362
G P I+N+S L+ + L + F GSL LPN+ EL L N+ G +P+ + N S
Sbjct: 224 GVFPPAIYNLSALEDLFLFGSGFSGSLKPDFGNLLPNIRELNLGENDLVGAIPTTLSNIS 283
Query: 363 NLSKLSLGDNSFSG-LIPNTFGXXXXXXXXXXXXX---XXTSPELSFLSSLSNCKYLEII 418
L K + N +G + PN FG T +L F+ SL+NC +L+++
Sbjct: 284 TLQKFGINKNMMTGGIYPN-FGKVPSLQYLDLSENPLGSYTFGDLEFIDSLTNCTHLQLL 342
Query: 419 ALSGNPLNGIIPMSAGNLSHSLEELFMPDCNVSGRIPKEIGNLANLVTLDLGGNKFNGSI 478
++ L G +P S N+S L L + + G IP++IGNL L L LG N G +
Sbjct: 343 SVGYTRLGGALPTSIANMSTELISLNLIGNHFFGSIPQDIGNLIGLQRLQLGKNMLTGPL 402
Query: 479 PIALGKXXXXXXXXXXXXXXEGSIPDDICGLVELYKLALGDNKLSGQIPACFGNLASLRE 538
P +LGK G IP I L +L L L +N G +P G + + +
Sbjct: 403 PTSLGKLLRLGLLSLYSNRMSGEIPSFIGNLTQLEILYLSNNSFEGIVPPSLGKCSHMLD 462
Query: 539 LWLGPNELISFIPSTFWNIKDIMYVNFSSNFLTGPLPLEIENLKALTTLDFSMNNLSGVI 598
L +G N+L IP I ++ ++ N L+G LP +I +L+ L L N SG +
Sbjct: 463 LRIGYNKLNGTIPKEIMQIPTLVNLSMEGNSLSGSLPNDIGSLQNLVKLSLENNKFSGHL 522
Query: 599 PTTIGGLKGLQYLFLGHNRLQGSIPDSVGDLIXXXXXXXXXXXXXGPIPTSLEKLSDLKE 658
P T+G ++ LFL N G+IP+ G L+ G IP S L+
Sbjct: 523 PQTLGNCLAMEQLFLQGNSFDGAIPNIRG-LMGVRRVDLSNNDLSGSIPEYFANFSKLEY 581
Query: 659 LNLSFNKLEGEIPRGGPFVNFSAKSFMGNNLLCGS-PNLQVPPCRAS---ID--HIS--K 710
LNLS N G++P G F N + GN LCG +L++ PC A ++ H S K
Sbjct: 582 LNLSINNFTGKVPSKGNFQNSTIVFVFGNKNLCGGIKDLKLKPCLAQEPPVETKHSSHLK 641
Query: 711 KNALLLGIILPFSTIFVIV-IILLISRYQTRGENVPNEVNVPLEATWRRFSYLELFQATN 769
K A+L+ I + + VI ++L R + + + N V LE + SY +L ATN
Sbjct: 642 KVAILVSIGIALLLLLVIASMVLCWFRKRRKNQQTNNLVPSKLEIFHEKISYGDLRNATN 701
Query: 770 GFSENNLIGRGSFGSVYIARLQNGIE-VAVKTFDLQHERAFKSFDTECEVMKSIRHRNLT 828
GFS +N++G GSFG+V+ A L + VAVK ++Q A KSF ECE +K RHRNL
Sbjct: 702 GFSSSNMVGSGSFGTVFKALLPTESKIVAVKVLNMQRRGAMKSFMAECESLKDTRHRNLV 761
Query: 829 KIISSCSNEDF-----KALILEYMRNGSLEKCLY 857
K++++C++ DF +ALI EY+ NGS++ L+
Sbjct: 762 KLLTACASTDFQGNEFRALIYEYLPNGSVDMWLH 795
|
|
| UNIPROTKB|Q40640 Xa21 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)] | Back alignment and assigned GO terms |
|---|
Score = 1320 (469.7 bits), Expect = 9.8e-135, P = 9.8e-135
Identities = 317/847 (37%), Positives = 464/847 (54%)
Query: 184 IPSFIFKISSLQALHFGNNRLSGELPANI--CDNLPFLNFFSVYKNMFYGGISSTL-SNC 240
IP + ++S LQ L +N + G +PA I C L L+ + N G I + ++
Sbjct: 119 IPPELSRLSRLQLLELSDNSIQGSIPAAIGACTKLTSLD---LSHNQLRGMIPREIGASL 175
Query: 241 KHLRILDLSFNDLWGDIPKEIGNLTKLKELFLDFNILQGEIPHTVGNLHNLEYLSLVNNE 300
KHL L L N L G+IP +GNLT L+E L FN L G IP ++G L +L ++L N
Sbjct: 176 KHLSNLYLYKNGLSGEIPSALGNLTSLQEFDLSFNRLSGAIPSSLGQLSSLLTMNLGQNN 235
Query: 301 LVGTVPATIFNVSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSGTLPSFIFN 360
L G +P +I+N+S+L+ + N G +P++ L LE + + N F G +P+ + N
Sbjct: 236 LSGMIPNSIWNLSSLRAFSVRENKLGGMIPTNAFKTLHLLEVIDMGTNRFHGKIPASVAN 295
Query: 361 ASNLSKLSLGDNSFSGLIPNTFGXXXXXXXXXXXXXXXTSPELS---FLSSLSNCKYLEI 417
AS+L+ + + N FSG+I + FG + E F+S L+NC L+
Sbjct: 296 ASHLTVIQIYGNLFSGIITSGFGRLRNLTELYLWRNLFQTREQDDWGFISDLTNCSKLQT 355
Query: 418 IALSGNPLNGIIPMSAGNLSHSLEELFMPDCNVSGRIPKEIGNLANLVTLDLGGNKFNGS 477
+ L N L G++P S NLS SL L + ++G IPK+IGNL L L L N F GS
Sbjct: 356 LNLGENNLGGVLPNSFSNLSTSLSFLALELNKITGSIPKDIGNLIGLQHLYLCNNNFRGS 415
Query: 478 IPIALGKXXXXXXXXXXXXXXEGSIPDDICGLVELYKLALGDNKLSGQIPACFGNLASLR 537
+P +LG+ GSIP I L EL L LG NK SG IP NL +L
Sbjct: 416 LPSSLGRLKNLGILLAYENNLSGSIPLAIGNLTELNILLLGTNKFSGWIPYTLSNLTNLL 475
Query: 538 ELWLGPNELISFIPSTFWNIKDI-MYVNFSSNFLTGPLPLEIENLKALTTLDFSMNNLSG 596
L L N L IPS +NI+ + + +N S N L G +P EI +LK L N LSG
Sbjct: 476 SLGLSTNNLSGPIPSELFNIQTLSIMINVSKNNLEGSIPQEIGHLKNLVEFHAESNRLSG 535
Query: 597 VIPTTIGGLKGLQYLFLGHNRLQGSIPDSVGDLIXXXXXXXXXXXXXGPIPTSLEKLSDL 656
IP T+G + L+YL+L +N L GSIP ++G L G IPTSL ++ L
Sbjct: 536 KIPNTLGDCQLLRYLYLQNNLLSGSIPSALGQLKGLETLDLSSNNLSGQIPTSLADITML 595
Query: 657 KELNLSFNKLEGEIPRGGPFVNFSAKSFMGNNLLCGS-PNLQVPPCRASIDHISKKNALL 715
LNLSFN GE+P G F S S GN LCG P+L +P C +++ L
Sbjct: 596 HSLNLSFNSFVGEVPTIGAFAAASGISIQGNAKLCGGIPDLHLPRCCPLLENRKHFPVLP 655
Query: 716 LGIILPFSTIFVIVIILLISRYQTRGENVPNEVNVPLEATWRRFSYLELFQATNGFSENN 775
+ + L + + + LLI+ ++ + P+ ++ SY +L +AT+GF+ N
Sbjct: 656 ISVSLAAALAILSSLYLLITWHKRTKKGAPSRTSMKGHPL---VSYSQLVKATDGFAPTN 712
Query: 776 LIGRGSFGSVYIARLQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCS 835
L+G GSFGSVY +L VAVK L++ +A KSF ECE ++++RHRNL KI++ CS
Sbjct: 713 LLGSGSFGSVYKGKLNIQDHVAVKVLKLENPKALKSFTAECEALRNMRHRNLVKIVTICS 772
Query: 836 N-----EDFKALILEYMRNGSLEKCLY------SGNYILDIFQRLNIMIDVASALEYLHF 884
+ DFKA++ ++M NGSLE ++ + L++ +R+ I++DVA AL+YLH
Sbjct: 773 SIDNRGNDFKAIVYDFMPNGSLEDWIHPETNDQADQRHLNLHRRVTILLDVACALDYLHR 832
Query: 885 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQT-----LATLGYMA 939
PV+HCD+K SNVLLD +MVAH+ DFG+A++L+ + S+ Q T + T+GY A
Sbjct: 833 HGPEPVVHCDIKSSNVLLDSDMVAHVGDFGLARILV-DGTSLIQQSTSSMGFIGTIGYAA 891
Query: 940 PEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDA 999
PEYG ST GD+YS+GIL++E T ++PTD F ++ L+ +V L + ++D
Sbjct: 892 PEYGVGLIASTHGDIYSYGILVLEIVTGKRPTDSTFRPDLGLRQYVELGLHGRVTDVVDT 951
Query: 1000 NLLITED 1006
L++ +
Sbjct: 952 KLILDSE 958
|
|
| TAIR|locus:2170483 FLS2 "FLAGELLIN-SENSITIVE 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1245 (443.3 bits), Expect = 8.7e-127, P = 8.7e-127
Identities = 327/1000 (32%), Positives = 506/1000 (50%)
Query: 76 LNISYLSLTGNIPRQLGNLSSLEILDLNFNRLSGEIPWXXXXXXXXXXXXXXXXFLTGTI 135
+ Y +LTG IP LG+L L++ N L+G IP LTG I
Sbjct: 173 IGFDYNNLTGKIPECLGDLVHLQMFVAAGNHLTGSIPVSIGTLANLTDLDLSGNQLTGKI 232
Query: 136 PFSIFXXXXXXXXXXXXXXXTGTIPSHNXXXXXXXXXXXXXXXXXXXXIPSFIFKISSLQ 195
P G IP+ IP+ + + LQ
Sbjct: 233 PRDFGNLLNLQSLVLTENLLEGDIPAE-IGNCSSLVQLELYDNQLTGKIPAELGNLVQLQ 291
Query: 196 ALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGGISSTLSNCKHLRILDLSFNDLWG 255
AL N+L+ +P+++ L L + +N G IS + + L +L L N+ G
Sbjct: 292 ALRIYKNKLTSSIPSSLF-RLTQLTHLGLSENHLVGPISEEIGFLESLEVLTLHSNNFTG 350
Query: 256 DIPKEIGNLTKLKELFLDFNILQGEIPHTVGNLHNLEYLSLVNNELVGTVPATIFNVSTL 315
+ P+ I NL L L + FN + GE+P +G L NL LS +N L G +P++I N + L
Sbjct: 351 EFPQSITNLRNLTVLTVGFNNISGELPADLGLLTNLRNLSAHDNLLTGPIPSSISNCTGL 410
Query: 316 KLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSGTLPSFIFNASNLSKLSLGDNSFS 375
KL++LS+N G +P NL + + N+F+G +P IFN SNL LS+ DN+ +
Sbjct: 411 KLLDLSHNQMTGEIPRGFGRM--NLTFISIGRNHFTGEIPDDIFNCSNLETLSVADNNLT 468
Query: 376 GLIPNTFGXXXXXXXXXXXXXXXTSPELSFLSSLSNCKYLEIIALSGNPLNGIIPMSAGN 435
G + G T P + N K L I+ L N G IP N
Sbjct: 469 GTLKPLIGKLQKLRILQVSYNSLTGP---IPREIGNLKDLNILYLHSNGFTGRIPREMSN 525
Query: 436 LSHSLEELFMPDCNVSGRIPKEIGNLANLVTLDLGGNKFNGSIPIALGKXXXXXXXXXXX 495
L+ L+ L M ++ G IP+E+ ++ L LDL NKF+G IP K
Sbjct: 526 LT-LLQGLRMYSNDLEGPIPEEMFDMKLLSVLDLSNNKFSGQIPALFSKLESLTYLSLQG 584
Query: 496 XXXEGSIPDDICGLVELYKLALGDNKLSGQIPACFGNLASLR--ELWLG-PNELIS-FIP 551
GSIP + L L + DN L+G IP LASL+ +L+L N L++ IP
Sbjct: 585 NKFNGSIPASLKSLSLLNTFDISDNLLTGTIPGEL--LASLKNMQLYLNFSNNLLTGTIP 642
Query: 552 STFWNIKDIMYVNFSSNFLTGPLPLEIENLKALTTLDFSMNNLSGVIPTTI-GGLKGLQY 610
++ + ++ S+N +G +P ++ K + TLDFS NNLSG IP + G+ +
Sbjct: 643 KELGKLEMVQEIDLSNNLFSGSIPRSLQACKNVFTLDFSQNNLSGHIPDEVFQGMDMIIS 702
Query: 611 LFLGHNRLQGSIPDSVGDLIXXXXXXXXXXXXXGPIPTSLEKLSDLKELNLSFNKLEGEI 670
L L N G IP S G++ G IP SL LS LK L L+ N L+G +
Sbjct: 703 LNLSRNSFSGEIPQSFGNMTHLVSLDLSSNNLTGEIPESLANLSTLKHLKLASNNLKGHV 762
Query: 671 PRGGPFVNFSAKSFMGNNLLCGSPNLQVPPC--RASIDHISKKNALLLGIILPFST--IF 726
P G F N +A MGN LCGS + PC + H SK+ ++L IIL + +
Sbjct: 763 PESGVFKNINASDLMGNTDLCGSKK-PLKPCTIKQKSSHFSKRTRVIL-IILGSAAALLL 820
Query: 727 VIVIILLISRYQTRGENVPN--EVNVP-LEATWR--RFSYLELFQATNGFSENNLIGRGS 781
V++++L+++ + + + + N E ++P L++ + RF EL QAT+ F+ N+IG S
Sbjct: 821 VLLLVLILTCCKKKEKKIENSSESSLPDLDSALKLKRFEPKELEQATDSFNSANIIGSSS 880
Query: 782 FGSVYIARLQNGIEVAVKTFDLQHERAF--KSFDTECEVMKSIRHRNLTKIIS-SCSNED 838
+VY +L++G +AVK +L+ A K F TE + + ++HRNL KI+ + +
Sbjct: 881 LSTVYKGQLEDGTVIAVKVLNLKEFSAESDKWFYTEAKTLSQLKHRNLVKILGFAWESGK 940
Query: 839 FKALILEYMRNGSLEKCLY-SGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKP 897
KAL+L +M NG+LE ++ S I + +++++ + +AS ++YLH GY P++HCDLKP
Sbjct: 941 TKALVLPFMENGNLEDTIHGSAAPIGSLLEKIDLCVHIASGIDYLHSGYGFPIVHCDLKP 1000
Query: 898 SNVLLDDNMVAHLSDFGIAKLL-IGEDQSMTQTQTL--ATLGYMAPEYGREGRVSTKGDV 954
+N+LLD + VAH+SDFG A++L ED S T + + T+GY+APE+ +V+TK DV
Sbjct: 1001 ANILLDSDRVAHVSDFGTARILGFREDGSTTASTSAFEGTIGYLAPEFAYMRKVTTKADV 1060
Query: 955 YSFGILLMETFTRRKPT--DEIFSGEMTLKHWVNDFLPIS---MMKIIDANLLITEDKHF 1009
+SFGI++ME T+++PT ++ S +MTL+ V + M++++D L D
Sbjct: 1061 FSFGIIMMELMTKQRPTSLNDEDSQDMTLRQLVEKSIGNGRKGMVRVLDMEL---GDSIV 1117
Query: 1010 AAKEQCASSVF-NLAMECTVESPDERITAKEIVRRLLKIR 1048
+ K++ A F L + CT P++R EI+ L+K+R
Sbjct: 1118 SLKQEEAIEDFLKLCLFCTSSRPEDRPDMNEILTHLMKLR 1157
|
|
| TAIR|locus:2120362 GSO1 "GASSHO1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 785 (281.4 bits), Expect = 2.7e-77, P = 2.7e-77
Identities = 236/818 (28%), Positives = 364/818 (44%)
Query: 76 LNISYLSLTGNIPRQLGNLSSLEILDLNFNRLSGEIPWXXXXXXXXXXXXXXXXFLTGTI 135
LN++ SLTG IP QLG +S L+ L L N+L G IP LTG I
Sbjct: 244 LNLANNSLTGEIPSQLGEMSQLQYLSLMANQLQGLIPKSLADLGNLQTLDLSANNLTGEI 303
Query: 136 PFSIFXXXXXXXXXXXXXXXTGTIPSHNXXXXXXXXXXXXXXXXXXXXIPSFIFKISSLQ 195
P + +G++P IP + K SL+
Sbjct: 304 PEEFWNMSQLLDLVLANNHLSGSLPKSICSNNTNLEQLVLSGTQLSGEIPVELSKCQSLK 363
Query: 196 ALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGGISSTLSNCKHLRILDLSFNDLWG 255
L NN L+G +P + + + + + ++ N G +S ++SN +L+ L L N+L G
Sbjct: 364 QLDLSNNSLAGSIPEALFELVELTDLY-LHNNTLEGTLSPSISNLTNLQWLVLYHNNLEG 422
Query: 256 DIPKEIGNLTKLKELFLDFNILQGEIPHTVGNLHNLEYLSLVNNELVGTVPATIFNVSTL 315
+PKEI L KL+ LFL N GEIP +GN +L+ + + N G +P +I + L
Sbjct: 423 KLPKEISALRKLEVLFLYENRFSGEIPQEIGNCTSLKMIDMFGNHFEGEIPPSIGRLKEL 482
Query: 316 KLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSGTLPSFIFNASNLSKLSLGDNSFS 375
L+ L N G LP+S L L L N SG++PS L +L L +NS
Sbjct: 483 NLLHLRQNELVGGLPASLG-NCHQLNILDLADNQLSGSIPSSFGFLKGLEQLMLYNNSLQ 541
Query: 376 GLIPNTFGXXXXXXXXXXXXXXXTSPELSFLSSLSNCKYLEIIALSGNPLNGIIPMSAGN 435
G +P++ S S YL ++ N IP+ GN
Sbjct: 542 GNLPDSLISLRNLTRINLSHNRLNGTIHPLCGSSS---YLSF-DVTNNGFEDEIPLELGN 597
Query: 436 LSHSLEELFMPDCNVSGRIPKEIGNLANLVTLDLGGNKFNGSIPIALGKXXXXXXXXXXX 495
S +L+ L + ++G+IP +G + L LD+ N G+IP+ L
Sbjct: 598 -SQNLDRLRLGKNQLTGKIPWTLGKIRELSLLDMSSNALTGTIPLQLVLCKKLTHIDLNN 656
Query: 496 XXXEGSIPDDICGLVELYKLALGDNKLSGQIPACFGNLASLRELWLGPNELISFIPSTFW 555
G IP + L +L +L L N+ +P N L L L N L IP
Sbjct: 657 NFLSGPIPPWLGKLSQLGELKLSSNQFVESLPTELFNCTKLLVLSLDGNSLNGSIPQEIG 716
Query: 556 NIKDIMYVNFSSNFLTGPLPLEIENLKALTTLDFSMNNLSGVIPTTIGGLKGLQY-LFLG 614
N+ + +N N +G LP + L L L S N+L+G IP IG L+ LQ L L
Sbjct: 717 NLGALNVLNLDKNQFSGSLPQAMGKLSKLYELRLSRNSLTGEIPVEIGQLQDLQSALDLS 776
Query: 615 HNRLQGSIPDSVGDLIXXXXXXXXXXXXXGPIPTSLEKLSDLKELNLSFNKLEGEIPRGG 674
+N G IP ++G L G +P S+ + L LN+SFN L G++ +
Sbjct: 777 YNNFTGDIPSTIGTLSKLETLDLSHNQLTGEVPGSVGDMKSLGYLNVSFNNLGGKLKK-- 834
Query: 675 PFVNFSAKSFMGNNLLCGSPNLQVPPCRASIDH--ISKKNALLLGIILPFSTIFVIVIIL 732
F + A SF+GN LCGSP + R++ +S ++ +++ I + I ++++++
Sbjct: 835 QFSRWPADSFLGNTGLCGSPLSRCNRVRSNNKQQGLSARSVVIISAISALTAIGLMILVI 894
Query: 733 LI---SRYQ------------TRGENVPNEVNVPL---EATWRRFSYLELFQATNGFSEN 774
+ R+ T + + PL A+ + ++ +AT+ SE
Sbjct: 895 ALFFKQRHDFFKKVGHGSTAYTSSSSSSQATHKPLFRNGASKSDIRWEDIMEATHNLSEE 954
Query: 775 NLIGRGSFGSVYIARLQNGIEVAVKTFDLQHE-RAFKSFDTECEVMKSIRHRNLTKIISS 833
+IG G G VY A L+NG VAVK + + + KSF E + + IRHR+L K++
Sbjct: 955 FMIGSGGSGKVYKAELENGETVAVKKILWKDDLMSNKSFSREVKTLGRIRHRHLVKLMGY 1014
Query: 834 CSN--EDFKALILEYMRNGSLEKCLYSGNYILDIFQRL 869
CS+ E LI EYM+NGS+ L+ +L+ ++L
Sbjct: 1015 CSSKSEGLNLLIYEYMKNGSIWDWLHEDKPVLEKKKKL 1052
|
|
| TAIR|locus:2075661 AT3G47110 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 958 (342.3 bits), Expect = 2.2e-96, P = 2.2e-96
Identities = 235/693 (33%), Positives = 352/693 (50%)
Query: 184 IPSFIFKISSLQALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGGISSTLSNCKHL 243
IPS + + LQ L+ NN G +P + N L+ + N G+ + L
Sbjct: 121 IPSEVGNLFRLQYLNMSNNLFGGVIPV-VLSNCSSLSTLDLSSNHLEQGVPLEFGSLSKL 179
Query: 244 RILDLSFNDLWGDIPKEIGNLTKLKELFLDFNILQGEIPHTVGNLHNLEYLSLVNNELVG 303
+L L N+L G P +GNLT L+ L +N ++GEIP + L + + + N+ G
Sbjct: 180 VLLSLGRNNLTGKFPASLGNLTSLQMLDFIYNQIEGEIPGDIARLKQMIFFRIALNKFNG 239
Query: 304 TVPATIFNVSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSGTLPSFIFNASN 363
P I+N+S+L + ++ N+F G+L LPNL+ LY+ N+F+GT+P + N S+
Sbjct: 240 VFPPPIYNLSSLIFLSITGNSFSGTLRPDFGSLLPNLQILYMGINSFTGTIPETLSNISS 299
Query: 364 LSKLSLGDNSFSGLIPNTFGXXXXXXXXXXXXXXX---TSPELSFLSSLSNCKYLEIIAL 420
L +L + N +G IP +FG +S +L FL +L+NC L+ + +
Sbjct: 300 LRQLDIPSNHLTGKIPLSFGRLQNLLLLGLNNNSLGNYSSGDLDFLGALTNCSQLQYLNV 359
Query: 421 SGNPLNGIIPMSAGNLSHSLEELFMPDCNVSGRIPKEIGNLANLVTLDLGGNKFNGSIPI 480
N L G +P+ NLS L EL + +SG IP IGNL +L TLDLG N G +P
Sbjct: 360 GFNKLGGQLPVFIANLSTQLTELSLGGNLISGSIPHGIGNLVSLQTLDLGENLLTGKLPP 419
Query: 481 ALGKXXXXXXXXXXXXXXEGSIPDDICGLVELYKLALGDNKLSGQIPACFGNLASLRELW 540
+LG+ G IP + + L L L +N G IP+ G+ + L +L
Sbjct: 420 SLGELSELRKVLLYSNGLSGEIPSSLGNISGLTYLYLLNNSFEGSIPSSLGSCSYLLDLN 479
Query: 541 LGPNELISFIPSTFWNIKDIMYVNFSSNFLTGPLPLEIENLKALTTLDFSMNNLSGVIPT 600
LG N+L IP + ++ +N S N L GPL +I LK L LD S N LSG IP
Sbjct: 480 LGTNKLNGSIPHELMELPSLVVLNVSFNLLVGPLRQDIGKLKFLLALDVSYNKLSGQIPQ 539
Query: 601 TIGGLKGLQYLFLGHNRLQGSIPDSVGDLIXXXXXXXXXXXXXGPIPTSLEKLSDLKELN 660
T+ L++L L N G IPD G L G IP + S L+ LN
Sbjct: 540 TLANCLSLEFLLLQGNSFVGPIPDIRG-LTGLRFLDLSKNNLSGTIPEYMANFSKLQNLN 598
Query: 661 LSFNKLEGEIPRGGPFVNFSAKSFMGNNLLCGS-PNLQVPPCRASID--HISKKNALLLG 717
LS N +G +P G F N SA S GN LCG P+LQ+ PC + H S + + +
Sbjct: 599 LSLNNFDGAVPTEGVFRNTSAMSVFGNINLCGGIPSLQLQPCSVELPRRHSSVRKIITIC 658
Query: 718 IILPFSTIFVIVI-ILLISRYQTRGENVP--NEVN----VPLEATWRRFSYLELFQATNG 770
+ + + ++ + ++ + Y+ R ++V N N P+++ + + SY EL++ T G
Sbjct: 659 VSAVMAALLLLCLCVVYLCWYKLRVKSVRANNNENDRSFSPVKSFYEKISYDELYKTTGG 718
Query: 771 FSENNLIGRGSFGSVYIARL-QNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTK 829
FS +NLIG G+FG+V+ L VA+K +L A KSF ECE + IRHRNL K
Sbjct: 719 FSSSNLIGSGNFGAVFKGFLGSKNKAVAIKVLNLCKRGAAKSFIAECEALGGIRHRNLVK 778
Query: 830 IISSCSNEDF-----KALILEYMRNGSLEKCLY 857
+++ CS+ DF +AL+ E+M NG+L+ L+
Sbjct: 779 LVTICSSSDFEGNDFRALVYEFMPNGNLDMWLH 811
|
|
| TAIR|locus:2046525 AT2G33170 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 754 (270.5 bits), Expect = 3.8e-114, Sum P(2) = 3.8e-114
Identities = 224/749 (29%), Positives = 334/749 (44%)
Query: 76 LNISYLSLTGNIPRQLGNLSSLEILDLNFNRLSGEIPWXXXXXXXXXXXXXXXXFLTGTI 135
LN++Y +LTG+IPR++GN S LE++ LN N+ G IP L+G +
Sbjct: 114 LNLAYNALTGDIPREIGNCSKLEVMFLNNNQFGGSIPVEINKLSQLRSFNICNNKLSGPL 173
Query: 136 PFSIFXXXXXXXXXXXXXXXTGTIPSHNXXXXXXXXXXXXXXXXXXXXIPSFIFKISSLQ 195
P I TG +P + IP+ I K +L+
Sbjct: 174 PEEIGDLYNLEELVAYTNNLTGPLP-RSLGNLNKLTTFRAGQNDFSGNIPTEIGKCLNLK 232
Query: 196 ALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGGISSTLSNCKHLRILDLSFNDLWG 255
L N +SGELP I L L +++N F G I + N L L L N L G
Sbjct: 233 LLGLAQNFISGELPKEI-GMLVKLQEVILWQNKFSGFIPKDIGNLTSLETLALYGNSLVG 291
Query: 256 DIPKEIGNLTKLKELFLDFNILQGEIPHTVGNLHNLEYLSLVNNELVGTVPATIFNVSTL 315
IP EIGN+ LK+L+L N L G IP +G L + + N L G +P + +S L
Sbjct: 292 PIPSEIGNMKSLKKLYLYQNQLNGTIPKELGKLSKVMEIDFSENLLSGEIPVELSKISEL 351
Query: 316 KLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSGTLPSFIFNASNLSKLSLGDNSFS 375
+L+ L N G +P+ +L NL +L L N+ +G +P N +++ +L L NS S
Sbjct: 352 RLLYLFQNKLTGIIPNELS-KLRNLAKLDLSINSLTGPIPPGFQNLTSMRQLQLFHNSLS 410
Query: 376 GLIPNTFGXXXXXXXXXXXXXXXTSPELSFLSSLSNCKYLEIIALSGNPLNGIIPMSAGN 435
G+IP G + F+ SN L ++ L N + G IP
Sbjct: 411 GVIPQGLGLYSPLWVVDFSENQLSGKIPPFICQQSN---LILLNLGSNRIFGNIPPGVLR 467
Query: 436 LSHSLEELFMPDCNVSGRIPKEIGNLANLVTLDLGGNKFNGSIPIALGKXXXXXXXXXXX 495
SL +L + ++G+ P E+ L NL ++L N+F+G +P +G
Sbjct: 468 CK-SLLQLRVVGNRLTGQFPTELCKLVNLSAIELDQNRFSGPLPPEIGTCQKLQRLHLAA 526
Query: 496 XXXEGSIPDDICGLVELYKLALGDNKLSGQIPACFGNLASLRELWLGPNELISFIPSTFW 555
++P++I L L + N L+G IP+ N L+ L L N I +P
Sbjct: 527 NQFSSNLPNEISKLSNLVTFNVSSNSLTGPIPSEIANCKMLQRLDLSRNSFIGSLPPELG 586
Query: 556 NIKDIMYVNFSSNFLTGPLPLEIENLKALTTLDFSMNNLSGVIPTTIGGLKGLQYLF-LG 614
++ + + S N +G +P I NL LT L N SG IP +G L LQ L
Sbjct: 587 SLHQLEILRLSENRFSGNIPFTIGNLTHLTELQMGGNLFSGSIPPQLGLLSSLQIAMNLS 646
Query: 615 HNRLQGSIPDSVGDLIXXXXXXXXXXXXXGPIPTSLEKLSDLKELNLSFNKLEGEIPRGG 674
+N G IP +G+L G IPT+ E LS L N S+N L G++P
Sbjct: 647 YNDFSGEIPPEIGNLHLLMYLSLNNNHLSGEIPTTFENLSSLLGCNFSYNNLTGQLPHTQ 706
Query: 675 PFVNFSAKSFMGNNLLCGSPNLQVPPCRASIDHIS--KKNALLLG-IILPFSTIFVIVII 731
F N + SF+GN LCG P +S HIS K + G II+ S++ + +
Sbjct: 707 IFQNMTLTSFLGNKGLCGGHLRSCDPSHSSWPHISSLKAGSARRGRIIIIVSSVIGGISL 766
Query: 732 LLISRYQTRGENVPNEVNVPL----EATWR----------RFSYLELFQATNGFSENNLI 777
LLI+ N P E P E ++ RF+ ++ +AT GF ++ ++
Sbjct: 767 LLIAIVVHFLRN-PVEPTAPYVHDKEPFFQESDIYFVPKERFTVKDILEATKGFHDSYIV 825
Query: 778 GRGSFGSVYIARLQNGIEVAVKTFDLQHE 806
GRG+ G+VY A + +G +AVK + E
Sbjct: 826 GRGACGTVYKAVMPSGKTIAVKKLESNRE 854
|
|
| TAIR|locus:2085949 AT3G24240 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1110 (395.8 bits), Expect = 1.8e-112, P = 1.8e-112
Identities = 311/1033 (30%), Positives = 481/1033 (46%)
Query: 43 PTNFFAKNWLTNSTMVCN-WTGVTCDINQRRVTALNISYLSLTGNIPRQLGNLSSLEILD 101
P++ NW + CN WT +TC +Q +T ++I + L ++P+ L SL+ L
Sbjct: 53 PSSLSLFNWNSIDNTPCNNWTFITCS-SQGFITDIDIESVPLQLSLPKNLPAFRSLQKLT 111
Query: 102 LNFNRLSGEIPWXXXXXXXXXXXXXXXXFLTGTIPFSIFXXXXXXXXXXXXXXXTGTIPS 161
++ L+G +P L G IP+S+ TG IP
Sbjct: 112 ISGANLTGTLPESLGDCLGLKVLDLSSNGLVGDIPWSLSKLRNLETLILNSNQLTGKIPP 171
Query: 162 HNXXXXXXXXXXXXXXXXXXXXIPSFIFKISSLQALHFGNNR-LSGELPANI--CDNLPF 218
+ IP+ + K+S L+ + G N+ +SG++P+ I C NL
Sbjct: 172 -DISKCSKLKSLILFDNLLTGSIPTELGKLSGLEVIRIGGNKEISGQIPSEIGDCSNLTV 230
Query: 219 LNFFSVYKNMFYGGISSTLSNCKHLRILDLSFNDLWGDIPKEIGNLTKLKELFLDFNILQ 278
L + + G + S+L K L L + + G+IP ++GN ++L +LFL N L
Sbjct: 231 LG---LAETSVSGNLPSSLGKLKKLETLSIYTTMISGEIPSDLGNCSELVDLFLYENSLS 287
Query: 279 GEIPHTVGNLHNLEYLSLVNNELVGTVPATIFNVSTLKLIELSNNTFFGSLPSSTDVQLP 338
G IP +G L LE L L N LVG +P I N S LK+I+LS N GS+PSS +L
Sbjct: 288 GSIPREIGQLTKLEQLFLWQNSLVGGIPEEIGNCSNLKMIDLSLNLLSGSIPSSIG-RLS 346
Query: 339 NLEELYLWGNNFSGTLPSFIFNASNLSKLSLGDNSFSGLIPNTFGXXXXXXXXXXXXXXX 398
LEE + N FSG++P+ I N S+L +L L N SGLIP+ G
Sbjct: 347 FLEEFMISDNKFSGSIPTTISNCSSLVQLQLDKNQISGLIPSELGTLTKLTLFFAWSNQL 406
Query: 399 TSPELSFLSSLSNCKYLEIIALSGNPLNGIIPMSAGNLSHSLEELFMPDCNVSGRIPKEI 458
E S L++C L+ + LS N L G IP L +L +L + ++SG IP+EI
Sbjct: 407 ---EGSIPPGLADCTDLQALDLSRNSLTGTIPSGLFML-RNLTKLLLISNSLSGFIPQEI 462
Query: 459 GNLANLVTLDLGGNKFNGSIPIALGKXXXXXXXXXXXXXXEGSIPDDICGLVELYKLALG 518
GN ++LV L LG N+ G IP +G G +PD+I EL + L
Sbjct: 463 GNCSSLVRLRLGFNRITGEIPSGIGSLKKINFLDFSSNRLHGKVPDEIGSCSELQMIDLS 522
Query: 519 DNKLSGQIPACFGNLASLRELWLGPNELISFIPSTFWNIKDIMYVNFSSNFLTGPLPLEI 578
+N L G +P +L+ L+ L + N+ IP++ + + + S N +G +P +
Sbjct: 523 NNSLEGSLPNPVSSLSGLQVLDVSANQFSGKIPASLGRLVSLNKLILSKNLFSGSIPTSL 582
Query: 579 ENLKALTTLDFSMNNLSGVIPTTIGGLKGLQY-LFLGHNRLQGSIPDSVGDLIXXXXXXX 637
L LD N LSG IP+ +G ++ L+ L L NRL G IP + L
Sbjct: 583 GMCSGLQLLDLGSNELSGEIPSELGDIENLEIALNLSSNRLTGKIPSKIASLNKLSILDL 642
Query: 638 XXXXXXGPIPTSLEKLSDLKELNLSFNKLEGEIPRGGPFVNFSAKSFMGNNLLCGSPN-- 695
G + L + +L LN+S+N G +P F S + GN LC S
Sbjct: 643 SHNMLEGDL-APLANIENLVSLNISYNSFSGYLPDNKLFRQLSPQDLEGNKKLCSSTQDS 701
Query: 696 --LQVPPCRASIDH--ISKKNALLLGIILPFSTIFVIVIILLISRYQTRGENVPNEVNVP 751
L D S+ L L + L + V++I+ ++ + R N+ NE +
Sbjct: 702 CFLTYRKGNGLGDDGDASRTRKLRLTLALLITLTVVLMILGAVAVIRAR-RNIDNERDSE 760
Query: 752 LEAT--WRRFSYLEL-F---QATNGFSENNLIGRGSFGSVYIARLQNGIEVAVKTF---- 801
L T W+ + +L F Q E N+IG+G G VY A + NG +AVK
Sbjct: 761 LGETYKWQFTPFQKLNFSVDQIIRCLVEPNVIGKGCSGVVYRADVDNGEVIAVKKLWPAM 820
Query: 802 -DLQHERAFK----SFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEYMRNGSLEKCL 856
+ H+ K SF E + + +IRH+N+ + + C N + + L+ +YM NGSL L
Sbjct: 821 VNGGHDEKTKNVRDSFSAEVKTLGTIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLL 880
Query: 857 YSGN-YILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGI 915
+ LD R I++ A L YLH P++H D+K +N+L+ + +++DFG+
Sbjct: 881 HERRGSSLDWDLRYRILLGAAQGLAYLHHDCLPPIVHRDIKANNILIGLDFEPYIADFGL 940
Query: 916 AKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIF 975
AKL+ D + GY+APEYG +++ K DVYS+G++++E T ++P D
Sbjct: 941 AKLVDEGDIGRCSNTVAGSYGYIAPEYGYSMKITEKSDVYSYGVVVLEVLTGKQPIDPTV 1000
Query: 976 SGEMTLKHWVNDFLPISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERI 1035
+ L WV ++++D+ L + A E V A+ C SPDER
Sbjct: 1001 PEGIHLVDWVRQNR--GSLEVLDSTLRSRTEAE--ADEMM--QVLGTALLCVNSSPDERP 1054
Query: 1036 TAKEIVRRLLKIR 1048
T K++ L +I+
Sbjct: 1055 TMKDVAAMLKEIK 1067
|
|
| TAIR|locus:2156349 GSO2 "GASSHO 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 923 (330.0 bits), Expect = 1.1e-92, P = 1.1e-92
Identities = 271/900 (30%), Positives = 422/900 (46%)
Query: 67 DINQ-RRVTALNISYLSLTGNIPRQLGNLSSLEILDLNFNRLSGEIPWXXXXXXXXXXXX 125
++N+ + + LN+ S +G IP QLG+L S++ L+L N+L G IP
Sbjct: 235 ELNRLKNLQTLNLGDNSFSGEIPSQLGDLVSIQYLNLIGNQLQGLIPKRLTELANLQTLD 294
Query: 126 XXXXFLTGTIPFSIFXXXXXXXXXXXXXXXTGTIPSHNXXXXXXXXXXXXXXXXXXXXIP 185
LTG I + +G++P IP
Sbjct: 295 LSSNNLTGVIHEEFWRMNQLEFLVLAKNRLSGSLPKTICSNNTSLKQLFLSETQLSGEIP 354
Query: 186 SFIFKISSLQALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGGISSTLSNCKHLRI 245
+ I SL+ L NN L+G++P ++ + N + + N G +SS++SN +L+
Sbjct: 355 AEISNCQSLKLLDLSNNTLTGQIPDSLFQLVELTNLY-LNNNSLEGTLSSSISNLTNLQE 413
Query: 246 LDLSFNDLWGDIPKEIGNLTKLKELFLDFNILQGEIPHTVGNLHNLEYLSLVNNELVGTV 305
L N+L G +PKEIG L KL+ ++L N GE+P +GN L+ + N L G +
Sbjct: 414 FTLYHNNLEGKVPKEIGFLGKLEIMYLYENRFSGEMPVEIGNCTRLQEIDWYGNRLSGEI 473
Query: 306 PATIFNVSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSGTLPSFIFNASNLS 365
P++I + L + L N G++P+S + + L N SG++PS + L
Sbjct: 474 PSSIGRLKDLTRLHLRENELVGNIPASLG-NCHQMTVIDLADNQLSGSIPSSFGFLTALE 532
Query: 366 KLSLGDNSFSGLIPNTFGXXXXXXXXXXXXXXXTSPELSFLSSLSNCKYLEIIALSGNPL 425
+ +NS G +P++ + +S L S+ YL ++ N
Sbjct: 533 LFMIYNNSLQGNLPDSL-INLKNLTRINFSSNKFNGSISPLCGSSS--YLSF-DVTENGF 588
Query: 426 NGIIPMSAGNLSHSLEELFMPDCNVSGRIPKEIGNLANLVTLDLGGNKFNGSIPIALGKX 485
G IP+ G S +L+ L + +GRIP+ G ++ L LD+ N +G IP+ LG
Sbjct: 589 EGDIPLELGK-STNLDRLRLGKNQFTGRIPRTFGKISELSLLDISRNSLSGIIPVELGLC 647
Query: 486 XXXXXXXXXXXXXEGSIPDDICGLVELYKLALGDNKLSGQIPACFGNLASLRELWLGPNE 545
G IP + L L +L L NK G +P +L ++ L+L N
Sbjct: 648 KKLTHIDLNNNYLSGVIPTWLGKLPLLGELKLSSNKFVGSLPTEIFSLTNILTLFLDGNS 707
Query: 546 LISFIPSTFWNIKDIMYVNFSSNFLTGPLPLEIENLKALTTLDFSMNNLSGVIPTTIGGL 605
L IP N++ + +N N L+GPLP I L L L S N L+G IP IG L
Sbjct: 708 LNGSIPQEIGNLQALNALNLEENQLSGPLPSTIGKLSKLFELRLSRNALTGEIPVEIGQL 767
Query: 606 KGLQY-LFLGHNRLQGSIPDSVGDLIXXXXXXXXXXXXXGPIPTSLEKLSDLKELNLSFN 664
+ LQ L L +N G IP ++ L G +P + + L LNLS+N
Sbjct: 768 QDLQSALDLSYNNFTGRIPSTISTLPKLESLDLSHNQLVGEVPGQIGDMKSLGYLNLSYN 827
Query: 665 KLEGEIPRGGPFVNFSAKSFMGNNLLCGSPNLQVPPC-RASIDH---ISKKNALLLGIIL 720
LEG++ + F + A +F+GN LCGSP + C RA + +S K +++ I
Sbjct: 828 NLEGKLKK--QFSRWQADAFVGNAGLCGSP---LSHCNRAGSKNQRSLSPKTVVIISAIS 882
Query: 721 PFSTI--FVIVIILLISRY-----QTRGENVPNEVN-----VPLEATWRRFSYL---ELF 765
+ I V+VIIL + + RG N N PL + S + ++
Sbjct: 883 SLAAIALMVLVIILFFKQNHDLFKKVRGGNSAFSSNSSSSQAPLFSNGGAKSDIKWDDIM 942
Query: 766 QATNGFSENNLIGRGSFGSVYIARLQNGIEVAVKTFDLQHE-RAFKSFDTECEVMKSIRH 824
+AT+ +E +IG G G VY A L+NG +AVK + + + KSF+ E + + +IRH
Sbjct: 943 EATHYLNEEFMIGSGGSGKVYKAELKNGETIAVKKILWKDDLMSNKSFNREVKTLGTIRH 1002
Query: 825 RNLTKIISSCSN--EDFKALILEYMRNGSLEKCLYSGNY-----ILDIFQRLNIMIDVAS 877
R+L K++ CS+ + LI EYM NGS+ L++ +L RL I + +A
Sbjct: 1003 RHLVKLMGYCSSKADGLNLLIYEYMANGSVWDWLHANENTKKKEVLGWETRLKIALGLAQ 1062
Query: 878 ALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGY 937
+EYLH+ P++H D+K SNVLLD N+ AHL DFG+AK+L G + T++ T+ Y
Sbjct: 1063 GVEYLHYDCVPPIVHRDIKSSNVLLDSNIEAHLGDFGLAKILTGNYDTNTESNTMFAGSY 1122
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| C0LGP4 | Y3475_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.3767 | 0.8987 | 0.9405 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.824 |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 1057 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-125 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-49 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-47 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-45 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-45 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-43 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-43 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-43 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 5e-38 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 6e-33 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 6e-32 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-30 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 5e-30 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-29 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-29 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 8e-29 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-28 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-27 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-27 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-27 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 6e-27 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-26 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-26 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 5e-25 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 6e-25 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 9e-25 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-24 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-24 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-24 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-24 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-24 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 4e-24 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 5e-24 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-23 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-23 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 5e-23 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 7e-23 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-22 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-22 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-22 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 4e-22 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-21 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-21 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-21 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 3e-21 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-21 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 5e-21 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 6e-21 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 7e-21 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-20 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-20 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-20 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 4e-20 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 4e-20 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 5e-20 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 7e-20 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 7e-20 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 7e-20 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 8e-20 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 8e-20 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 9e-20 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-19 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-19 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-19 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-19 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-19 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 4e-19 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 6e-19 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 8e-19 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-18 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-18 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-18 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-18 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 5e-18 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 6e-18 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 7e-18 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-17 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-17 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-17 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-17 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-17 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-17 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-17 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 4e-17 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 5e-17 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 8e-17 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 9e-17 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-16 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-16 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-16 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-16 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-16 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-16 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-16 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-16 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-16 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-16 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-16 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-16 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-16 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 3e-16 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 4e-16 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 4e-16 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 4e-16 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 6e-16 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 6e-16 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 7e-16 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 8e-16 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-15 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-15 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-15 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-15 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-15 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-15 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-15 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-15 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 4e-15 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 8e-15 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-14 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-14 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-14 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-14 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-14 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 4e-14 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 4e-14 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 5e-14 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 6e-14 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 6e-14 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 7e-14 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 8e-14 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 9e-14 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 9e-14 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 9e-14 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-13 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-13 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-13 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-13 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-13 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-13 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-13 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-13 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-13 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-13 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-13 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-13 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-13 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 5e-13 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 5e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 6e-13 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 6e-13 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 6e-13 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 7e-13 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 7e-13 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 7e-13 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 8e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-12 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-12 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-12 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-12 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-12 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-12 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-12 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-12 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-12 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 4e-12 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 4e-12 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 4e-12 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 5e-12 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 7e-12 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 7e-12 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 8e-12 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 8e-12 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 8e-12 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-11 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-11 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-11 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-11 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-11 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-11 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-11 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-11 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-11 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-11 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-11 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-11 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-11 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 3e-11 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 4e-11 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 4e-11 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 4e-11 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 5e-11 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 5e-11 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 9e-11 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-10 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-10 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-10 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 3e-10 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-10 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-10 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-10 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 4e-10 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 4e-10 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 4e-10 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 4e-10 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 4e-10 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 5e-10 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 5e-10 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 5e-10 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 6e-10 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 6e-10 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 6e-10 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 6e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 7e-10 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 8e-10 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-09 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-09 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-09 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-09 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-09 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 3e-09 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-09 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-09 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-09 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-09 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-09 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-09 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-09 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-09 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-09 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 4e-09 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 5e-09 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 6e-09 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 6e-09 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 6e-09 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 6e-09 | |
| pfam08263 | 42 | pfam08263, LRRNT_2, Leucine rich repeat N-terminal | 7e-09 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 8e-09 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 9e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-08 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-08 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-08 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-08 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-08 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-08 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-08 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-08 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-08 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 4e-08 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 4e-08 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 4e-08 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 5e-08 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 5e-08 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 5e-08 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 6e-08 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 6e-08 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 6e-08 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 7e-08 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 7e-08 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 7e-08 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 9e-08 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 1e-07 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-07 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-07 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-07 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-07 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-07 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-07 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-07 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-07 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-07 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-07 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-07 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-07 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 4e-07 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 4e-07 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 4e-07 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 4e-07 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 5e-07 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 8e-07 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 9e-07 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 9e-07 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 1e-06 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 1e-06 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 1e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-06 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-06 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-06 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-06 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 3e-06 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 3e-06 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 3e-06 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 5e-06 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 5e-06 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 6e-06 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 6e-06 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 7e-06 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 9e-06 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 9e-06 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 9e-06 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-05 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-05 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-05 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-05 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-05 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-05 | |
| PLN03210 | 1153 | PLN03210, PLN03210, Resistant to P | 2e-05 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-05 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-05 | |
| PLN03210 | 1153 | PLN03210, PLN03210, Resistant to P | 6e-05 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 7e-05 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 1e-04 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-04 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 2e-04 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 3e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 3e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 3e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 4e-04 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 5e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 5e-04 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 6e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 8e-04 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 8e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.001 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.002 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 0.002 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 0.002 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 0.002 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 0.002 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 0.003 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.004 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 0.004 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 405 bits (1041), Expect = e-125
Identities = 314/1032 (30%), Positives = 487/1032 (47%), Gaps = 136/1032 (13%)
Query: 32 LLALKDHITYDPTNFFAKNWLTNSTMVCNWTGVTCDINQRRVTALNISYLSLTGNIPRQL 91
LL+ K I DP + + NW +++ VC W G+TC+ N RV ++++S +++G I +
Sbjct: 34 LLSFKSSIN-DPLKYLS-NWNSSAD-VCLWQGITCN-NSSRVVSIDLSGKNISGKISSAI 89
Query: 92 GNLSSLEILDLNFNRLSGEIPWELGNLAKLEKLLLHNNFLTGTIPFSIFKLSSLLDLKLS 151
L ++ ++L+ N+LSG IP + F T SSL L LS
Sbjct: 90 FRLPYIQTINLSNNQLSGPIP--------------DDIFTTS---------SSLRYLNLS 126
Query: 152 DNNLTGTIPSHNLGNLSSLQLLDLSDNQLSGSIPSFIFKISSLQALHFGNNRLSGELPAN 211
+NN TG+IP G++ +L+ LDLS+N LSG IP+ I SSL+ L G N L G++P +
Sbjct: 127 NNNFTGSIPR---GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNS 183
Query: 212 ICDNLPFLNFFSVYKNMFYGGISSTLSNCKHLRILDLSFNDLWGDIPKEIGNLTKLKELF 271
+ NL L F ++ N G I L K L+ + L +N+L G+IP EIG LT L L
Sbjct: 184 LT-NLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLD 242
Query: 272 LDFNILQGEIPHTVGNLHNLEYLSLVNNELVGTVPATIFNVSTLKLIELSNNTFFGSLPS 331
L +N L G IP ++GNL NL+YL L N+L G +P +IF++ L ++LS+N+ G +P
Sbjct: 243 LVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPE 302
Query: 332 STDVQLPNLEELYLWGNNFSGTLPSFIFNASNLSKLSLGDNSFSGLIPNTFGNLRNLKRL 391
+QL NLE L+L+ NNF+G +P + + L L L N FSG IP G NL L
Sbjct: 303 LV-IQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVL 361
Query: 392 RLYNNYLTSPELSFLSSLSNCKYLEIIALSGNPLNGIIPMSAGNLSHSLEELFMPDCNVS 451
L N N++
Sbjct: 362 DLSTN----------------------------------------------------NLT 369
Query: 452 GRIPKEIGNLANLVTLDLGGNKFNGSIPIALGKLQKLQLLNLDDNKLEGSIPDDICGLVE 511
G IP+ + + NL L L N G IP +LG + L+ + L DN G +P + L
Sbjct: 370 GEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPL 429
Query: 512 LYKLALGDNKLSGQIPACFGNLASLRELWLGPNELISFIPSTFWNIKDIMYVNFSSNFLT 571
+Y L + +N L G+I + ++ SL+ L L N+ +P +F + K + ++ S N +
Sbjct: 430 VYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGS-KRLENLDLSRNQFS 488
Query: 572 GPLPLEIENLKALTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQGSIPDSVGDLIS 631
G +P ++ +L L L S N LSG IP + K L L L HN+L G IP S ++
Sbjct: 489 GAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPV 548
Query: 632 LKSLNLSNNNLSGPIPTSLEKLSDLKELNLSFNKLEGEIPRGGPFVNFSAKSFMGNNLLC 691
L L+LS N LSG IP +L + L ++N+S N L G +P G F+ +A + GN LC
Sbjct: 549 LSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLC 608
Query: 692 GSPNLQ-VPPCRASIDHISKKNALLLGIILPFSTIFVIVIILLISRYQTRGENVPNEVNV 750
G +PPC+ +K I F+++ ++ RG N V
Sbjct: 609 GGDTTSGLPPCK-----RVRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRV 663
Query: 751 PLE-ATWRRFSYLELFQAT-----------NGFSENNLIGRGSFGSVYIAR-LQNGIEVA 797
E TW L+ F + + E N+I RG G+ Y + ++NG++
Sbjct: 664 ENEDGTWE----LQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFV 719
Query: 798 VKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEYMRNGSLEKCLY 857
VK + S + M ++H N+ K+I C +E LI EY+ +L + L
Sbjct: 720 VKEIN-DVNSIPSSEIAD---MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR 775
Query: 858 SGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK 917
+ L +R I I +A AL +LH S V+ +L P +++D HL +
Sbjct: 776 N----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPG 830
Query: 918 LLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSG 977
LL T T+ + Y+APE ++ K D+Y FG++L+E T + P D F
Sbjct: 831 LLC------TDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGV 884
Query: 978 EMTLKHWV-----NDFLPISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPD 1032
++ W + L + + I ++ + +++ V NLA+ CT P
Sbjct: 885 HGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNE--------IVEVMNLALHCTATDPT 936
Query: 1033 ERITAKEIVRRL 1044
R A ++++ L
Sbjct: 937 ARPCANDVLKTL 948
|
Length = 968 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 175 bits (445), Expect = 3e-49
Identities = 85/269 (31%), Positives = 132/269 (49%), Gaps = 24/269 (8%)
Query: 777 IGRGSFGSVYIARLQN-GIEVAVKTFDLQHER--AFKSFDTECEVMKSIRHRNLTKIISS 833
+G GSFG+VY A+ + G VAVK + E+ ++ E +++ + H N+ ++I +
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66
Query: 834 CSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHC 893
++D L++EY G L L G L + I + + LEYLH S +IH
Sbjct: 67 FEDKDHLYLVMEYCEGGDLFDYLSRGG-PLSEDEAKKIALQILRGLEYLH---SNGIIHR 122
Query: 894 DLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGR-VSTKG 952
DLKP N+LLD+N V ++DFG+AK L+ S+T T T YMAPE G K
Sbjct: 123 DLKPENILLDENGVVKIADFGLAKKLLKSSSSLT-TFV-GTPWYMAPEVLLGGNGYGPKV 180
Query: 953 DVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHFAAK 1012
DV+S G++L E T + P FSGE + +++I L +
Sbjct: 181 DVWSLGVILYELLTGKPP----FSGE----------NILDQLQLIRRILGPPLEFDEPKW 226
Query: 1013 EQCASSVFNLAMECTVESPDERITAKEIV 1041
+ +L +C + P +R TA+EI+
Sbjct: 227 SSGSEEAKDLIKKCLNKDPSKRPTAEEIL 255
|
Length = 260 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 169 bits (430), Expect = 3e-47
Identities = 76/274 (27%), Positives = 125/274 (45%), Gaps = 28/274 (10%)
Query: 777 IGRGSFGSVYIARL-----QNGIEVAVKTFDLQH-ERAFKSFDTECEVMKSIRHRNLTKI 830
+G G+FG VY L +VAVKT E + F E +MK + H N+ ++
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 831 ISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPV 890
+ C+ + ++ EYM G L L L + L + + +A +EYL S
Sbjct: 67 LGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE---SKNF 123
Query: 891 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVST 950
+H DL N L+ +N+V +SDFG+++ + +D + + +MAPE ++G+ ++
Sbjct: 124 VHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGKFTS 183
Query: 951 KGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHFA 1010
K DV+SFG+LL E FT GE P M + L+ +
Sbjct: 184 KSDVWSFGVLLWEIFTL---------GEQ----------PYPGMSNEEVLELLEDGYRLP 224
Query: 1011 AKEQCASSVFNLAMECTVESPDERITAKEIVRRL 1044
E C ++ L ++C P++R T E+V L
Sbjct: 225 RPENCPDELYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 163 bits (415), Expect = 1e-45
Identities = 68/191 (35%), Positives = 101/191 (52%), Gaps = 9/191 (4%)
Query: 777 IGRGSFGSVYIAR-LQNGIEVAVKTFDLQHE-RAFKSFDTECEVMKSIRHRNLTKIISSC 834
+G G FG+VY+AR + G +VA+K + + E E++K + H N+ K+
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 835 SNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 894
+E+ L++EY GSL+ L L + L I++ + LEYLH S +IH D
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLH---SNGIIHRD 117
Query: 895 LKPSNVLLD-DNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGR-EGRVSTKG 952
LKP N+LLD DN L+DFG++KLL + T YMAPE +G S K
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLL--TSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKS 175
Query: 953 DVYSFGILLME 963
D++S G++L E
Sbjct: 176 DIWSLGVILYE 186
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 164 bits (418), Expect = 1e-45
Identities = 79/271 (29%), Positives = 125/271 (46%), Gaps = 28/271 (10%)
Query: 775 NLIGRGSFGSVYIAR-LQNGIEVAVKTFDLQHERAF-KSFDTECEVMKSIRHRNLTKIIS 832
+G GSFG VY+AR + G VA+K + + + E +++K ++H N+ ++
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 833 SCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIH 892
+ED L++EY G L L L + + + SALEYLH S ++H
Sbjct: 65 VFEDEDKLYLVMEYCEGGDLFDLLKK-RGRLSEDEARFYLRQILSALEYLH---SKGIVH 120
Query: 893 CDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKG 952
DLKP N+LLD++ L+DFG+A+ L D T + T YMAPE
Sbjct: 121 RDLKPENILLDEDGHVKLADFGLARQL---DPGEKLTTFVGTPEYMAPEVLLGKGYGKAV 177
Query: 953 DVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHFAAK 1012
D++S G++L E T + P F G+ L + K I F
Sbjct: 178 DIWSLGVILYELLTGKPP----FPGDDQLLE---------LFKKI-----GKPKPPFPPP 219
Query: 1013 EQCAS-SVFNLAMECTVESPDERITAKEIVR 1042
E S +L + V+ P++R+TA+E ++
Sbjct: 220 EWDISPEAKDLIRKLLVKDPEKRLTAEEALQ 250
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 158 bits (403), Expect = 1e-43
Identities = 80/280 (28%), Positives = 134/280 (47%), Gaps = 35/280 (12%)
Query: 774 NNLIGRGSFGSVYIARL-----QNGIEVAVKTFDLQH-ERAFKSFDTECEVMKSIRHRNL 827
+G G+FG VY +L + +EVAVKT E+ + F E +M+ + H N+
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63
Query: 828 TKIISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYS 887
K++ C+ E+ +++EYM G L L L + L+ + +A +EYL S
Sbjct: 64 VKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLE---S 120
Query: 888 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGR 947
IH DL N L+ +N+V +SDFG+++ + +D + + +MAPE +EG+
Sbjct: 121 KNFIHRDLAARNCLVGENLVVKISDFGLSRD-LYDDDYYRKRGGKLPIRWMAPESLKEGK 179
Query: 948 VSTKGDVYSFGILLMETFTR-RKPTDEIFSGEMTLKHWV--NDFLPISMMKIIDANLLIT 1004
++K DV+SFG+LL E FT +P + S E + ++ LP
Sbjct: 180 FTSKSDVWSFGVLLWEIFTLGEQPYPGM-SNE-EVLEYLKNGYRLPQP------------ 225
Query: 1005 EDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRL 1044
C +++L ++C E P++R T E+V L
Sbjct: 226 --------PNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 158 bits (403), Expect = 1e-43
Identities = 79/281 (28%), Positives = 130/281 (46%), Gaps = 36/281 (12%)
Query: 774 NNLIGRGSFGSVYIARL-----QNGIEVAVKTFDLQH-ERAFKSFDTECEVMKSIRHRNL 827
+G G+FG VY L +EVAVKT E+ + F E +M+ + H N+
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63
Query: 828 TKIISSCSNEDFKALILEYMRNGSLEKCL-YSGNYILDIFQRLNIMIDVASALEYLHFGY 886
K++ C+ E+ +++EYM G L L + L + L+ + +A +EYL
Sbjct: 64 VKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE--- 120
Query: 887 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREG 946
S IH DL N L+ +N+V +SDFG+++ + +D + +MAPE +EG
Sbjct: 121 SKNFIHRDLAARNCLVGENLVVKISDFGLSR-DLYDDDYYKVKGGKLPIRWMAPESLKEG 179
Query: 947 RVSTKGDVYSFGILLMETFTR-RKPTDEIFSGEMTLKHWV--NDFLPISMMKIIDANLLI 1003
+ ++K DV+SFG+LL E FT +P + S + ++ LP
Sbjct: 180 KFTSKSDVWSFGVLLWEIFTLGEEPYPGM-SNA-EVLEYLKKGYRLPKP----------- 226
Query: 1004 TEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRL 1044
C ++ L ++C E P++R T E+V L
Sbjct: 227 ---------PNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 158 bits (402), Expect = 2e-43
Identities = 80/284 (28%), Positives = 130/284 (45%), Gaps = 37/284 (13%)
Query: 775 NLIGRGSFGSVYIARLQNG----IEVAVKTFDLQHERAFKS-FDTECEVMKSIRHRNLTK 829
+G G+FG VY +L+ EVAVKT + F E VMK + H N+ +
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 830 IISSCSNEDFKALILEYMRNGSLEKCL--------YSGNYILDIFQRLNIMIDVASALEY 881
++ C+ E+ L+LEYM G L L L + L+ I +A +EY
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 882 LHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPE 941
L S +H DL N L+ +++V +SDFG+++ + +D +T + +MAPE
Sbjct: 121 LA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPE 177
Query: 942 YGREGRVSTKGDVYSFGILLMETFTR-RKPTDEIFSGEMTLKHWVNDFLPISMMKIIDAN 1000
++G ++K DV+SFG+LL E FT P + + E+ L++
Sbjct: 178 SLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEV-LEY----------------- 219
Query: 1001 LLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRL 1044
+ + E C ++ L + C P++R T E+V RL
Sbjct: 220 --LRKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERL 261
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 5e-38
Identities = 82/292 (28%), Positives = 129/292 (44%), Gaps = 61/292 (20%)
Query: 775 NLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQH--ERAFKSFDTECEVMKSIRHRNLTKII 831
L+GRGSFGSVY+A + G +AVK+ +L E ++ + E ++ S++H N+ +
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 832 SSCSNEDFKAL--ILEYMRNGSLEKCLYSGNYILDIFQRLNI------MIDVASALEYLH 883
S +E+ L LEY+ GSL +L F +L + L YLH
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSS-------LLKKFGKLPEPVIRKYTRQILEGLAYLH 118
Query: 884 FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLA-TLGYMAPEY 942
S ++H D+K +N+L+D + V L+DFG AK +G+ ++ T ++ T +MAPE
Sbjct: 119 ---SNGIVHRDIKGANILVDSDGVVKLADFGCAK-RLGDIETGEGTGSVRGTPYWMAPEV 174
Query: 943 GREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPIS-MMKIIDANL 1001
R D++S G ++E T + P W P++ + KI +
Sbjct: 175 IRGEEYGRAADIWSLGCTVIEMATGKPP-------------WSELGNPMAALYKIGSSGE 221
Query: 1002 L--ITED-----KHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLK 1046
I E K F K C P +R TA E LL+
Sbjct: 222 PPEIPEHLSEEAKDFLRK-------------CLRRDPKKRPTADE----LLQ 256
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 6e-33
Identities = 82/276 (29%), Positives = 127/276 (46%), Gaps = 42/276 (15%)
Query: 776 LIGRGSFGSVYIARLQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCS 835
IG+G FG V + + G +VAVK A ++F E VM ++RH NL +++
Sbjct: 13 TIGKGEFGDVMLGDYR-GQKVAVKCLK-DDSTAAQAFLAEASVMTTLRHPNLVQLLGVVL 70
Query: 836 NEDFKALILEYMRNGSLEKCLYS-GNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 894
+ ++ EYM GSL L S G ++ + Q+L +DV +EYL +H D
Sbjct: 71 QGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVHRD 127
Query: 895 LKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGDV 954
L NVL+ +++VA +SDFG+AK + S Q + + APE RE + STK DV
Sbjct: 128 LAARNVLVSEDLVAKVSDFGLAK-----EASQGQDSGKLPVKWTAPEALREKKFSTKSDV 182
Query: 955 YSFGILLMETFT------RRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKH 1008
+SFGILL E ++ R P ++ + H +
Sbjct: 183 WSFGILLWEIYSFGRVPYPRIPLKDV------VPHVEKGY-------------------R 217
Query: 1009 FAAKEQCASSVFNLAMECTVESPDERITAKEIVRRL 1044
A E C V+ + +C P +R T K++ +L
Sbjct: 218 MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQL 253
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 6e-32
Identities = 73/275 (26%), Positives = 122/275 (44%), Gaps = 25/275 (9%)
Query: 771 FSENNLIGRGSFGSVYIARLQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKI 830
F+ +G G FG V+ +N + VA+K + F E + +K +RH++L +
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 831 ISSCSNEDFKALILEYMRNGSLEKCLYSGN-YILDIFQRLNIMIDVASALEYLHFGYSAP 889
+ CS + +I E M GSL L S +L + +++ VA + YL
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQN 124
Query: 890 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVS 949
IH DL N+L+ +++V ++DFG+A+L+ ++ + + APE G S
Sbjct: 125 SIHRDLAARNILVGEDLVCKVADFGLARLI--KEDVYLSSDKKIPYKWTAPEAASHGTFS 182
Query: 950 TKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHF 1009
TK DV+SFGILL E FT G++ P M + IT
Sbjct: 183 TKSDVWSFGILLYEMFTY---------GQV----------PYPGMNNHEVYDQITAGYRM 223
Query: 1010 AAKEQCASSVFNLAMECTVESPDERITAKEIVRRL 1044
+C ++ + +EC P++R + K + L
Sbjct: 224 PCPAKCPQEIYKIMLECWAAEPEDRPSFKALREEL 258
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 1e-30
Identities = 67/194 (34%), Positives = 102/194 (52%), Gaps = 12/194 (6%)
Query: 777 IGRGSFGSVYIARLQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCSN 836
+G G FG V++ +VAVKT + ++F E ++MK +RH L ++ + CS
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLK-PGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSE 72
Query: 837 EDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMID----VASALEYLHFGYSAPVIH 892
E+ ++ EYM GSL L SG RL ++D +A + YL S IH
Sbjct: 73 EEPIYIVTEYMSKGSLLDFLKSGE---GKKLRLPQLVDMAAQIAEGMAYLE---SRNYIH 126
Query: 893 CDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKG 952
DL N+L+ +N+V ++DFG+A+ LI +D+ + + + APE GR + K
Sbjct: 127 RDLAARNILVGENLVCKIADFGLAR-LIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKS 185
Query: 953 DVYSFGILLMETFT 966
DV+SFGILL E T
Sbjct: 186 DVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 5e-30
Identities = 62/195 (31%), Positives = 95/195 (48%), Gaps = 7/195 (3%)
Query: 777 IGRGSFGSVYIAR-LQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCS 835
IG+G FG VY AR + G EVA+K L+ + + E +++K +H N+ K S
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67
Query: 836 NEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDL 895
+D +++E+ GSL+ L S N L Q + ++ LEYLH S +IH D+
Sbjct: 68 KKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLH---SNGIIHRDI 124
Query: 896 KPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVY 955
K +N+LL + L DFG++ L T + T +MAPE K D++
Sbjct: 125 KAANILLTSDGEVKLIDFGLSAQLSDTKARNT---MVGTPYWMAPEVINGKPYDYKADIW 181
Query: 956 SFGILLMETFTRRKP 970
S GI +E + P
Sbjct: 182 SLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 79/293 (26%), Positives = 127/293 (43%), Gaps = 48/293 (16%)
Query: 777 IGRGSFGSVYIARLQNGIE------VAVKTF-DLQHERAFKSFDTECEVMKSIRHRNLTK 829
+G G+FG V++ + VAVKT + A K F+ E E++ + +H N+ K
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 830 IISSCSNEDFKALILEYMRNGSLEKCLYSGN-------------YILDIFQRLNIMIDVA 876
C+ D ++ EYM +G L K L S L + Q L I + +A
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 877 SALEYL---HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLA 933
S + YL HF +H DL N L+ ++V + DFG+++ + D T+
Sbjct: 133 SGMVYLASQHF------VHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTML 186
Query: 934 TLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISM 993
+ +M PE + +T+ DV+SFG++L E FT K S E ++
Sbjct: 187 PIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIEC---------- 236
Query: 994 MKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLK 1046
IT+ + C S V+++ + C P +RI K+I RL K
Sbjct: 237 ---------ITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 3e-29
Identities = 65/215 (30%), Positives = 103/215 (47%), Gaps = 25/215 (11%)
Query: 775 NLIGRGSFGSVYIAR-LQNGIEVAVKTFDL------QHERAFKSFDTECEVMKSIRHRNL 827
IG+GSFG VY+ R +G +K DL + E A E +++K + H N+
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALN----EVKILKKLNHPNI 61
Query: 828 TKIISSCSNEDFKALILEYMRNGSL----EKCLYSGNYILDIFQRLNIMIDVASALEYLH 883
K S + +++EY G L +K G + Q L+ + + AL+YLH
Sbjct: 62 IKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPE-EQILDWFVQLCLALKYLH 120
Query: 884 FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYG 943
S ++H D+KP N+ L N + L DFGI+K+L + +T + T Y++PE
Sbjct: 121 ---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLS-STVDLAKTV-VGTPYYLSPELC 175
Query: 944 REGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGE 978
+ + K D++S G +L E T + P F GE
Sbjct: 176 QNKPYNYKSDIWSLGCVLYELCTLKHP----FEGE 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 8e-29
Identities = 85/281 (30%), Positives = 127/281 (45%), Gaps = 45/281 (16%)
Query: 775 NLIGRGSFGSVYIA-RLQNGIEVAVKTFDLQ--HERAFKSFDTECEVMKSIRHRNLTKII 831
+LIGRG+FG VY L+ G VA+K L+ E A KS E +++K+++H N+ K I
Sbjct: 6 DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65
Query: 832 SSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLN------IMIDVASALEYLHFG 885
S D +ILEY NGSL + I+ F + V L YLH
Sbjct: 66 GSIETSDSLYIILEYAENGSLRQ-------IIKKFGPFPESLVAVYVYQVLQGLAYLH-- 116
Query: 886 YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGRE 945
VIH D+K +N+L + V L+DFG+A L + + T +MAPE
Sbjct: 117 -EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK--DDASVVGTPYWMAPEVIEM 173
Query: 946 GRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITE 1005
ST D++S G ++E T P ++ D P++ + I +
Sbjct: 174 SGASTASDIWSLGCTVIELLTGNPP------------YY--DLNPMAAL------FRIVQ 213
Query: 1006 DKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLK 1046
D H E + + + M+C + P+ R TAK+ LLK
Sbjct: 214 DDHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQ----LLK 250
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 3e-28
Identities = 75/271 (27%), Positives = 124/271 (45%), Gaps = 28/271 (10%)
Query: 777 IGRGSFGSVYIARLQNGIEVAVKTFDLQHERAF--KSFDTECEVMKSIRHRNLTKIISSC 834
+G G FG V++ + + I+VA+K E A F E +VM + H NL ++ C
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMI---REGAMSEDDFIEEAKVMMKLSHPNLVQLYGVC 68
Query: 835 SNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 894
+ + ++ EYM NG L L L L++ DV A+EYL S IH D
Sbjct: 69 TKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRD 125
Query: 895 LKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGDV 954
L N L+ ++ V +SDFG+A+ ++ +DQ + T + + PE R S+K DV
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARYVL-DDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDV 184
Query: 955 YSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHFAAKEQ 1014
+SFG+L+ E F+ K E FS ++ +S + +
Sbjct: 185 WSFGVLMWEVFSEGKMPYERFSNSEVVES-------VSAGYRLY------------RPKL 225
Query: 1015 CASSVFNLAMECTVESPDERITAKEIVRRLL 1045
+ V+ + C E P++R K+++ +L
Sbjct: 226 APTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 71/192 (36%), Positives = 103/192 (53%), Gaps = 13/192 (6%)
Query: 777 IGRGSFGSVYIARLQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCSN 836
IG+G FG V + + G +VAVK ++++ ++F E VM +RH NL +++
Sbjct: 14 IGKGEFGDVMLGDYR-GNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 837 EDFKALIL-EYMRNGSLEKCLYS-GNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 894
E I+ EYM GSL L S G +L L +DV A+EYL + +H D
Sbjct: 71 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRD 127
Query: 895 LKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGDV 954
L NVL+ ++ VA +SDFG+ K + S TQ + + APE RE + STK DV
Sbjct: 128 LAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKSDV 182
Query: 955 YSFGILLMETFT 966
+SFGILL E ++
Sbjct: 183 WSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 66/193 (34%), Positives = 102/193 (52%), Gaps = 6/193 (3%)
Query: 776 LIGRGSFGSVYIARLQNGIEVAVKT--FDLQHERAFKSFDTECEVMKSIRHRNLTKIISS 833
IG+G+FG VY L+ EVAVKT L + K F E E++K H N+ K+I
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRK-FLQEAEILKQYDHPNIVKLIGV 60
Query: 834 CSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHC 893
C + +++E + GSL L L + + L + +D A+ +EYL S IH
Sbjct: 61 CVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLE---SKNCIHR 117
Query: 894 DLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGD 953
DL N L+ +N V +SDFG+++ G +++ + + APE GR +++ D
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESD 177
Query: 954 VYSFGILLMETFT 966
V+S+GILL ETF+
Sbjct: 178 VWSYGILLWETFS 190
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 4e-27
Identities = 80/264 (30%), Positives = 124/264 (46%), Gaps = 31/264 (11%)
Query: 777 IGRGSFGSVYIARLQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCSN 836
+G G FG V+ N VAVKT K F E ++MK +RH L ++ + C+
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDP-KDFLAEAQIMKKLRHPKLIQLYAVCTL 72
Query: 837 EDFKALILEYMRNGSLEKCLY-SGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDL 895
E+ ++ E M+ GSL + L L + Q +++ VAS + YL + IH DL
Sbjct: 73 EEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHRDL 129
Query: 896 KPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVY 955
NVL+ +N + ++DFG+A++ I ED + + + APE R S K DV+
Sbjct: 130 AARNVLVGENNICKVADFGLARV-IKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVW 188
Query: 956 SFGILLMETFTR-RKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHF--AAK 1012
SFGILL E T R P + G MT +A +L D+ +
Sbjct: 189 SFGILLTEIVTYGRMP----YPG-MT-----------------NAEVLQQVDQGYRMPCP 226
Query: 1013 EQCASSVFNLAMECTVESPDERIT 1036
C ++++ ++C E PD+R T
Sbjct: 227 PGCPKELYDIMLDCWKEDPDDRPT 250
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 114 bits (284), Expect = 6e-27
Identities = 85/299 (28%), Positives = 128/299 (42%), Gaps = 33/299 (11%)
Query: 776 LIGRGSFGSVYIARLQNGIEVAVKTFDLQHER---AFKSFDTECEVMKSIRH-RNLTKII 831
+G GSFG VY+AR + VA+K + E + F E +++ S+ H N+ K+
Sbjct: 7 KLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64
Query: 832 SSCSNEDFKALILEYMRNGSLEK--CLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAP 889
+E L++EY+ GSLE L + L I+ + SALEYLH S
Sbjct: 65 DFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKG 121
Query: 890 VIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLIGEDQSMTQTQTLA----TLGYMAPEY-- 942
+IH D+KP N+LLD D V L DFG+AKLL + + + T GYMAPE
Sbjct: 122 IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLL 181
Query: 943 -GREGRVSTKGDVYSFGILLMETFTRRKP---TDEIFSGEMTLKHWVNDFLPISMMKIID 998
S+ D++S GI L E T P + TLK + P +
Sbjct: 182 GLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSP 241
Query: 999 ANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKIRDFLLRNVES 1057
+N E + + +L + + P R+++ + L L + S
Sbjct: 242 SN-----------PELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLS 289
|
Length = 384 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 74/295 (25%), Positives = 130/295 (44%), Gaps = 41/295 (13%)
Query: 775 NLIGRGSFGSVYIARL-----QNGIEVAVKTFDLQH---ERAFKSFDTECEVMKSIRHRN 826
+G G FG V + R G +VAVK+ L H E+ F+ E E+++++ H N
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKS--LNHSGEEQHRSDFEREIEILRTLDHEN 67
Query: 827 LTKIISSCSNEDFKA--LILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHF 884
+ K C ++ LI+EY+ +GSL L +++ + L + ++YL
Sbjct: 68 IVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG- 126
Query: 885 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL-IGEDQSMTQTQTLATLGYMAPEYG 943
S IH DL N+L++ + +SDFG+AK+L +D + + + + APE
Sbjct: 127 --SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECL 184
Query: 944 REGRVSTKGDVYSFGILLMETFTRRKPTDE----------IFSGEMTLKHWVNDFLPISM 993
R + S+ DV+SFG+ L E FT P+ I G+M + +
Sbjct: 185 RTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE------- 237
Query: 994 MKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKIR 1048
L+ E + C V++L C P +R + +++ + ++R
Sbjct: 238 --------LLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 75/293 (25%), Positives = 128/293 (43%), Gaps = 48/293 (16%)
Query: 777 IGRGSFGSVYIARL------QNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKI 830
+G G+FG V++A Q+ + VAVK E A + F E E++ ++H+++ +
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 831 ISSCSNEDFKALILEYMRNGSLEKCLYSGN---YILD-----------IFQRLNIMIDVA 876
C+ ++ EYMR+G L + L S IL + Q L I +A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 877 SALEYL---HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLA 933
S + YL HF +H DL N L+ +V + DFG+++ + D +T+
Sbjct: 133 SGMVYLASLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 186
Query: 934 TLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISM 993
+ +M PE + +T+ D++SFG++L E FT K + W +S
Sbjct: 187 PIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGK------------QPWYQ----LSN 230
Query: 994 MKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLK 1046
+ I+ IT+ + C V+ + C P +R+ K+I RL
Sbjct: 231 TEAIEC---ITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 5e-25
Identities = 72/271 (26%), Positives = 126/271 (46%), Gaps = 30/271 (11%)
Query: 777 IGRGSFGSVYIARLQNGIEVAVKTFDLQHERAF--KSFDTECEVMKSIRHRNLTKIISSC 834
IG G FG V++ +VA+KT E A + F E +VM + H L ++ C
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTI---REGAMSEEDFIEEAQVMMKLSHPKLVQLYGVC 68
Query: 835 SNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 894
+ L+ E+M +G L L + L + +DV + YL S+ VIH D
Sbjct: 69 TERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE---SSNVIHRD 125
Query: 895 LKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGDV 954
L N L+ +N V +SDFG+ + ++ +DQ + T T + + +PE + S+K DV
Sbjct: 126 LAARNCLVGENQVVKVSDFGMTRFVL-DDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDV 184
Query: 955 YSFGILLMETFTR-RKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHFAAKE 1013
+SFG+L+ E F+ + P + + E +++ I+A + + +
Sbjct: 185 WSFGVLMWEVFSEGKTPYENRSNSE--------------VVETINAGFRLYKPR------ 224
Query: 1014 QCASSVFNLAMECTVESPDERITAKEIVRRL 1044
+ SV+ L C E P++R + ++ +L
Sbjct: 225 LASQSVYELMQHCWKERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 6e-25
Identities = 77/290 (26%), Positives = 131/290 (45%), Gaps = 44/290 (15%)
Query: 777 IGRGSFGSVYIARL------QNGIEVAVKTFDLQHERAFKS-FDTECEVMKSIRHRNLTK 829
+G G+FG VY L + VA+KT E + F E E+M ++H N+
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 830 IISSCSNEDFKALILEYMRNGSLEKCLYS---------------GNYILDIFQRLNIMID 874
++ C+ E ++ EY+ +G L + L LD L+I I
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 875 VASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLAT 934
+A+ +EYL S +H DL N L+ + + +SDFG+++ + D Q+++L
Sbjct: 133 IAAGMEYLS---SHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189
Query: 935 LGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMM 994
+ +M PE G+ +T+ D++SFG++L E IFS + + + S
Sbjct: 190 VRWMPPEAILYGKFTTESDIWSFGVVLWE----------IFS------YGLQPYYGFSNQ 233
Query: 995 KIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRL 1044
++I+ +I + E C + V+ L +EC E P R K+I RL
Sbjct: 234 EVIE---MIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 9e-25
Identities = 69/272 (25%), Positives = 120/272 (44%), Gaps = 37/272 (13%)
Query: 777 IGRGSFGSVYIARLQ-NGIEVAVKTFDLQHERAF-KSFDTECEVMKSIRHRNLTKIISSC 834
+G+GS G VY R + G A+K + + F K E + ++S + K C
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVK----C 64
Query: 835 SNEDFK----ALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPV 890
+K +++LEYM GSL L I + I + L+YLH +
Sbjct: 65 YGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAY-IARQILKGLDYLH--TKRHI 121
Query: 891 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQT-LATLGYMAPEYGREGRVS 949
IH D+KPSN+L++ ++DFGI+K+L + ++ Q T + T+ YM+PE + S
Sbjct: 122 IHRDIKPSNLLINSKGEVKIADFGISKVL---ENTLDQCNTFVGTVTYMSPERIQGESYS 178
Query: 950 TKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHF 1009
D++S G+ L+E + P + G+ + +M+ I +
Sbjct: 179 YAADIWSLGLTLLECALGKFPF--LPPGQPS---------FFELMQA------ICDGPPP 221
Query: 1010 AAKEQCASSVFN--LAMECTVESPDERITAKE 1039
+ + S F ++ C + P +R +A E
Sbjct: 222 SLPAEEFSPEFRDFISA-CLQKDPKKRPSAAE 252
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 1e-24
Identities = 76/263 (28%), Positives = 126/263 (47%), Gaps = 30/263 (11%)
Query: 777 IGRGSFGSVYIARLQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCSN 836
+G+G FG V++ VA+KT + ++F E +VMK +RH L ++ + S
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 72
Query: 837 EDFKALILEYMRNGSLEKCLYSGNY--ILDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 894
E ++ EYM GSL L G L + Q +++ +AS + Y+ +H D
Sbjct: 73 EPI-YIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 127
Query: 895 LKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLA-TLGYMAPEYGREGRVSTKGD 953
L+ +N+L+ +N+V ++DFG+A+L+ ED T Q + + APE GR + K D
Sbjct: 128 LRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185
Query: 954 VYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHFAAKE 1013
V+SFGILL E T+ G + VN +++D +
Sbjct: 186 VWSFGILLTELTTK---------GRVPYPGMVN-------REVLDQ---VERGYRMPCPP 226
Query: 1014 QCASSVFNLAMECTVESPDERIT 1036
+C S+ +L +C + P+ER T
Sbjct: 227 ECPESLHDLMCQCWRKEPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 75/273 (27%), Positives = 120/273 (43%), Gaps = 30/273 (10%)
Query: 776 LIGRGSFGSVYIARLQNGIEVAVKTF--DLQHERAFKSFDTECEVMKSIRHRNLTKIISS 833
L+G+G+FG V+ L++ VAVKT DL E K F +E ++K H N+ K+I
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIK-FLSEARILKQYDHPNIVKLIGV 60
Query: 834 CSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHC 893
C+ +++E + G L L Q + +D A+ + YL S IH
Sbjct: 61 CTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLE---SKNCIHR 117
Query: 894 DLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATL--GYMAPEYGREGRVSTK 951
DL N L+ +N V +SDFG+++ ED + + L + + APE GR S++
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSR---QEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSE 174
Query: 952 GDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHFAA 1011
DV+S+GILL ETF+ P M A + + +
Sbjct: 175 SDVWSYGILLWETFSL-------------------GVCPYPGMTNQQAREQVEKGYRMSC 215
Query: 1012 KEQCASSVFNLAMECTVESPDERITAKEIVRRL 1044
++C V+ + C P+ R E+ + L
Sbjct: 216 PQKCPDDVYKVMQRCWDYKPENRPKFSELQKEL 248
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 72/207 (34%), Positives = 103/207 (49%), Gaps = 18/207 (8%)
Query: 775 NLIGRGSFGSVYIA-RLQNGIEVAVKTFDLQHER--AFKSFDTECEVMKSIRHRNLTKII 831
N IG G+FG VY A L G +AVK +Q K E +V++ ++H NL K
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 832 SSCSNEDFKALI-LEYMRNGSLEKCLYSGNYILD--IFQRLNIMIDVASALEYLHFGYSA 888
K I +EY G+LE+ L G ILD + + + + L YLH S
Sbjct: 66 G-VEVHREKVYIFMEYCSGGTLEELLEHGR-ILDEHVIRVYTLQL--LEGLAYLH---SH 118
Query: 889 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSM-TQTQTLA-TLGYMAPEYGREG 946
++H D+KP+N+ LD N V L DFG A L +M + Q+LA T YMAPE G
Sbjct: 119 GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGG 178
Query: 947 RVSTKG---DVYSFGILLMETFTRRKP 970
+ G D++S G +++E T ++P
Sbjct: 179 KGKGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 76/289 (26%), Positives = 123/289 (42%), Gaps = 52/289 (17%)
Query: 776 LIGRGSFGSVYIARLQ-NGIEVAVKTFDLQH---ERAFKSFDTECEVM-KSIRHRNLTKI 830
+IG GSF +V +A+ + E A+K D + E+ K E EV+ + H + K+
Sbjct: 8 IIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKL 67
Query: 831 ISSCSNEDFKALILEYMRNGSLEKCL-YSGNYILDIFQRLNIMIDVASALEYLHFGYSAP 889
+ +E+ +LEY NG L + + G+ LD ++ ALEYLH S
Sbjct: 68 YYTFQDEENLYFVLEYAPNGELLQYIRKYGS--LDEKCTRFYAAEILLALEYLH---SKG 122
Query: 890 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLG------------- 936
+IH DLKP N+LLD +M ++DFG AK+L + S + AT
Sbjct: 123 IIHRDLKPENILLDKDMHIKITDFGTAKVL-DPNSSPESNKGDATNIDSQIEKNRRRFAS 181
Query: 937 ------YMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLP 990
Y++PE E D+++ G ++ + T + P F G N++L
Sbjct: 182 FVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP----FRG-------SNEYL- 229
Query: 991 ISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKE 1039
+ KI+ + AK +L + V P +R+ E
Sbjct: 230 -TFQKILKLEYSFPPNFPPDAK--------DLIEKLLVLDPQDRLGVNE 269
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 2e-24
Identities = 76/292 (26%), Positives = 130/292 (44%), Gaps = 49/292 (16%)
Query: 777 IGRGSFGSVYIARLQN------GIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKI 830
+G G+FG V++A N + VAVK A K F E E++ +++H ++ K
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 831 ISSCSNEDFKALILEYMRNGSLEKCLYS---------------GNYILDIFQRLNIMIDV 875
C + D ++ EYM++G L K L + L + Q L+I +
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 876 ASALEYL---HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTL 932
AS + YL HF +H DL N L+ N++ + DFG+++ + D T+
Sbjct: 133 ASGMVYLASQHF------VHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 186
Query: 933 ATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPIS 992
+ +M PE + +T+ DV+SFG++L E FT K + W +S
Sbjct: 187 LPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGK------------QPWFQ----LS 230
Query: 993 MMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRL 1044
++I+ IT+ + C V+++ + C P +R+ KEI + L
Sbjct: 231 NTEVIEC---ITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKIL 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 4e-24
Identities = 62/265 (23%), Positives = 114/265 (43%), Gaps = 24/265 (9%)
Query: 777 IGRGSFGSVYIARLQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCSN 836
+G G FG V + + +VA+K + + F E +VM + H L ++ C+
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTK 70
Query: 837 EDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLK 896
+ ++ EYM NG L L Q L + DV + YL S IH DL
Sbjct: 71 QRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLA 127
Query: 897 PSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYS 956
N L+DD +SDFG+++ ++ +D+ + + + + PE + S+K DV++
Sbjct: 128 ARNCLVDDQGCVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWA 186
Query: 957 FGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHFAAKEQCA 1016
FG+L+ E ++ K E F+ T++ +++ +
Sbjct: 187 FGVLMWEVYSLGKMPYERFNNSETVEK-------------------VSQGLRLYRPHLAS 227
Query: 1017 SSVFNLAMECTVESPDERITAKEIV 1041
V+ + C E +ER T ++++
Sbjct: 228 EKVYAIMYSCWHEKAEERPTFQQLL 252
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 5e-24
Identities = 62/192 (32%), Positives = 88/192 (45%), Gaps = 12/192 (6%)
Query: 777 IGRGSFGSVYIAR-LQNGIEVAVKTFDLQHERAFKSFD---TECEVMKSIRHRNLTKIIS 832
+G+GSFG V + R G A+K + K + TE ++ I H + K+
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 833 SCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIH 892
+ E+ L+LEY G L L + R ++ ALEYLH S +I+
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARF-YAAEIVLALEYLH---SLGIIY 116
Query: 893 CDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLA-TLGYMAPEYGREGRVSTK 951
DLKP N+LLD + L+DFG+AK L E +T T T Y+APE
Sbjct: 117 RDLKPENILLDADGHIKLTDFGLAKELSSEGS---RTNTFCGTPEYLAPEVLLGKGYGKA 173
Query: 952 GDVYSFGILLME 963
D +S G+LL E
Sbjct: 174 VDWWSLGVLLYE 185
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 60/188 (31%), Positives = 91/188 (48%), Gaps = 7/188 (3%)
Query: 777 IGRGSFGSVYIA-RLQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCS 835
IG G+ G VY A G EVA+K L+ + + E +MK +H N+ S
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMRLRKQNK-ELIINEILIMKDCKHPNIVDYYDSYL 85
Query: 836 NEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDL 895
D +++EYM GSL + ++ Q + +V LEYLH S VIH D+
Sbjct: 86 VGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDI 142
Query: 896 KPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVY 955
K N+LL + L+DFG A L +++S + + T +MAPE + K D++
Sbjct: 143 KSDNILLSKDGSVKLADFGFAAQL-TKEKSKRNSV-VGTPYWMAPEVIKRKDYGPKVDIW 200
Query: 956 SFGILLME 963
S GI+ +E
Sbjct: 201 SLGIMCIE 208
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 71/271 (26%), Positives = 127/271 (46%), Gaps = 32/271 (11%)
Query: 777 IGRGSFGSVYIARLQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCSN 836
IG G FG+V G +VAVK +++ + ++F E VM + H+NL +++ +
Sbjct: 14 IGEGEFGAVLQGEYT-GQKVAVK--NIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILH 70
Query: 837 EDFKALILEYMRNGSLEKCLYS-GNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDL 895
+++E M G+L L + G ++ + Q L +DVA +EYL S ++H DL
Sbjct: 71 NGLY-IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDL 126
Query: 896 KPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVY 955
N+L+ ++ VA +SDFG+A++ SM + + + APE + + S+K DV+
Sbjct: 127 AARNILVSEDGVAKVSDFGLARV-----GSMGVDNSKLPVKWTAPEALKHKKFSSKSDVW 181
Query: 956 SFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHFAAKEQC 1015
S+G+LL E F+ + P M + + + + E C
Sbjct: 182 SYGVLLWEVFSYGRA-------------------PYPKMSLKEVKECVEKGYRMEPPEGC 222
Query: 1016 ASSVFNLAMECTVESPDERITAKEIVRRLLK 1046
+ V+ L C P +R + ++ +L K
Sbjct: 223 PADVYVLMTSCWETEPKKRPSFHKLREKLEK 253
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 5e-23
Identities = 75/262 (28%), Positives = 121/262 (46%), Gaps = 28/262 (10%)
Query: 777 IGRGSFGSVYIARLQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCSN 836
+G G FG V++ +VAVKT + +SF E ++MK +RH L ++ + S
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLK-PGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSE 72
Query: 837 EDFKALILEYMRNGSLEKCLYSGN-YILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDL 895
E ++ EYM GSL L G L + +++ VA+ + Y+ IH DL
Sbjct: 73 EPI-YIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDL 128
Query: 896 KPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLA-TLGYMAPEYGREGRVSTKGDV 954
+ +N+L+ D +V ++DFG+A+L+ ED T Q + + APE GR + K DV
Sbjct: 129 RSANILVGDGLVCKIADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 955 YSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHFAAKEQ 1014
+SFGILL E T+ + +P M + + +
Sbjct: 187 WSFGILLTELVTKGR-------------------VPYPGMNNREVLEQVERGYRMPCPQD 227
Query: 1015 CASSVFNLAMECTVESPDERIT 1036
C S+ L ++C + P+ER T
Sbjct: 228 CPISLHELMLQCWKKDPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 99.0 bits (246), Expect = 7e-23
Identities = 76/267 (28%), Positives = 124/267 (46%), Gaps = 30/267 (11%)
Query: 777 IGRGSFGSVYIARLQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCSN 836
+G+G FG V++ +VA+KT ++F E ++MK +RH L + + S
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLK-PGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSE 72
Query: 837 EDFKALILEYMRNGSLEKCLYSGN-YILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDL 895
E ++ E+M GSL L G+ L + Q +++ +A + Y+ IH DL
Sbjct: 73 EPI-YIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDL 128
Query: 896 KPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLA-TLGYMAPEYGREGRVSTKGDV 954
+ +N+L+ DN+V ++DFG+A+L+ ED T Q + + APE GR + K DV
Sbjct: 129 RAANILVGDNLVCKIADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 955 YSFGILLMETFTR-RKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHFAAKE 1013
+SFGILL E T+ R P + + E+ + + +
Sbjct: 187 WSFGILLTELVTKGRVPYPGMVNREVLEQ--------------------VERGYRMPCPQ 226
Query: 1014 QCASSVFNLAMECTVESPDERITAKEI 1040
C S+ L C + PDER T + I
Sbjct: 227 GCPESLHELMKLCWKKDPDERPTFEYI 253
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.2 bits (248), Expect = 1e-22
Identities = 76/299 (25%), Positives = 124/299 (41%), Gaps = 61/299 (20%)
Query: 777 IGRGSFGSVYIAR-LQNGIEVAVKTFDLQHERAFKSFDT----ECEVMKSIRHRNLTKII 831
IG G++G VY AR + G VA+K +++E+ + F E ++++ +RH N+ ++
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRMENEK--EGFPITAIREIKLLQKLRHPNIVRLK 64
Query: 832 ----SSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYS 887
S + ++ EYM + L L S Q M + L+YLH S
Sbjct: 65 EIVTSKGKGSIY--MVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLH---S 118
Query: 888 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPE------ 941
++H D+K SN+L++++ V L+DFG+A+ S T + TL Y PE
Sbjct: 119 NGILHRDIKGSNILINNDGVLKLADFGLARPYTKR-NSADYTNRVITLWYRPPELLLGAT 177
Query: 942 -YGREGRVSTKGDVYSFGILLMETFTRR--------------------KPTDEIFSGEMT 980
YG + D++S G +L E F + PTDE + G
Sbjct: 178 RYG------PEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSK 231
Query: 981 LKHWVNDFLPISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKE 1039
L + + P K L KH S +L + P +RI+A +
Sbjct: 232 LPWF-ENLKPKKPYK----RRLREFFKHL-----IDPSALDLLDKLLTLDPKKRISADQ 280
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 1e-22
Identities = 76/277 (27%), Positives = 120/277 (43%), Gaps = 36/277 (12%)
Query: 777 IGRGSFGSVY--IARLQNG--IEVAVKTFDLQHERAFKS-FDTECEVMKSIRHRNLTKII 831
+G G+FGSV + +++G +EVAVKT +H A K F E VM + H + ++I
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 832 SSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYL---HFGYSA 888
C E L++E G L K L + + + VA + YL HF
Sbjct: 63 GVCKGEPL-MLVMELAPLGPLLKYL-KKRREIPVSDLKELAHQVAMGMAYLESKHF---- 116
Query: 889 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL-IGEDQSMTQTQTLATLGYMAPEYGREGR 947
+H DL NVLL + A +SDFG+++ L G D T L + APE G+
Sbjct: 117 --VHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGK 174
Query: 948 VSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDK 1007
S+K DV+S+G+ L E F+ P MK + ++ +
Sbjct: 175 FSSKSDVWSYGVTLWEAFSYGAK-------------------PYGEMKGAEVIAMLESGE 215
Query: 1008 HFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRL 1044
E+C ++++ + C P++R T E+
Sbjct: 216 RLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTF 252
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 98.6 bits (245), Expect = 2e-22
Identities = 76/282 (26%), Positives = 130/282 (46%), Gaps = 40/282 (14%)
Query: 777 IGRGSFGSVYIARL------QNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKI 830
+G G+FG V++A Q+ I VAVKT + A K F E E++ +++H ++ K
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 831 ISSCSNEDFKALILEYMRNGSLEKCLYS----------GNYILDIFQR--LNIMIDVASA 878
C D ++ EYM++G L K L + GN ++ Q L+I +A+
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 879 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYM 938
+ YL S +H DL N L+ +N++ + DFG+++ + D T+ + +M
Sbjct: 133 MVYLA---SQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 189
Query: 939 APEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIID 998
PE + +T+ DV+S G++L E FT K + W +S ++I+
Sbjct: 190 PPESIMYRKFTTESDVWSLGVVLWEIFTYGK------------QPWYQ----LSNNEVIE 233
Query: 999 ANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEI 1040
IT+ + C V++L + C P R+ KEI
Sbjct: 234 C---ITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEI 272
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 4e-22
Identities = 71/268 (26%), Positives = 121/268 (45%), Gaps = 26/268 (9%)
Query: 775 NLIGRGSFGSVYIARLQN-GIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISS 833
+ +G G +G VY + + VAVKT + + F E VMK I+H NL +++
Sbjct: 12 HKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 70
Query: 834 CSNEDFKALILEYMRNGSLEKCLYSGN-YILDIFQRLNIMIDVASALEYLHFGYSAPVIH 892
C+ E +I E+M G+L L N ++ L + ++SA+EYL IH
Sbjct: 71 CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIH 127
Query: 893 CDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKG 952
DL N L+ +N + ++DFG+++L+ G D + + APE + S K
Sbjct: 128 RDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKS 186
Query: 953 DVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHFAAK 1012
DV++FG+LL E T + ++ + I + ++ + L+ +
Sbjct: 187 DVWAFGVLLWEIAT----------------YGMSPYPGIDLSQVYE---LLEKGYRMERP 227
Query: 1013 EQCASSVFNLAMECTVESPDERITAKEI 1040
E C V+ L C +P +R + EI
Sbjct: 228 EGCPPKVYELMRACWQWNPSDRPSFAEI 255
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 1e-21
Identities = 73/295 (24%), Positives = 125/295 (42%), Gaps = 45/295 (15%)
Query: 776 LIGRGSFGSVYIARL------QNGIEVAVKTF-DLQHERAFKSFDTECEVMKSI-RHRNL 827
+G G+FG V A VAVK D E+ +E E+MK I +H+N+
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78
Query: 828 TKIISSCSNEDFKALILEYMRNGSLEKCLYS-------GNYILDIFQRLNIMI------- 873
++ C+ E +++EY +G+L L + + +
Sbjct: 79 INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138
Query: 874 -DVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTL 932
VA +E+L S IH DL NVL+ ++ V ++DFG+A+ + D T
Sbjct: 139 YQVARGMEFLA---SKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGR 195
Query: 933 ATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPIS 992
+ +MAPE + + + DV+SFG+LL E FT G + + I
Sbjct: 196 LPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT--------LGG--------SPYPGIP 239
Query: 993 MMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKI 1047
+ ++ L+ E + C +++L +C E P +R T K++V L ++
Sbjct: 240 VEELFK---LLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 1e-21
Identities = 69/262 (26%), Positives = 121/262 (46%), Gaps = 27/262 (10%)
Query: 777 IGRGSFGSVYIARLQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCSN 836
+G G FG V++ N +VAVKT + ++F E +MK+++H L ++ + +
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLK-PGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTK 72
Query: 837 EDFKALILEYMRNGSLEKCLYS--GNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 894
E+ +I EYM GSL L S G +L + + ++ +A + Y+ IH D
Sbjct: 73 EEPIYIITEYMAKGSLLDFLKSDEGGKVL-LPKLIDFSAQIAEGMAYIE---RKNYIHRD 128
Query: 895 LKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGDV 954
L+ +NVL+ ++++ ++DFG+A+ +I +++ + + + APE G + K DV
Sbjct: 129 LRAANVLVSESLMCKIADFGLAR-VIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDV 187
Query: 955 YSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHFAAKEQ 1014
+SFGILL E T K +P M D + E
Sbjct: 188 WSFGILLYEIVTYGK-------------------IPYPGMSNSDVMSALQRGYRMPRMEN 228
Query: 1015 CASSVFNLAMECTVESPDERIT 1036
C ++++ C E +ER T
Sbjct: 229 CPDELYDIMKTCWKEKAEERPT 250
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 95.0 bits (237), Expect = 2e-21
Identities = 62/207 (29%), Positives = 96/207 (46%), Gaps = 18/207 (8%)
Query: 777 IGRGSFGSVYIA-RLQNGIEVAVKTFDL----QHERAFKSFDTECEVMKSIRHRNLTKII 831
IG+GSFG+V R +G + K D + E+ + +E +++ ++H N+ +
Sbjct: 8 IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEK--QQLVSEVNILRELKHPNIVRYY 65
Query: 832 SSCSNEDFKAL--ILEYMRNGSL----EKCLYSGNYILDIFQRLNIMIDVASALEYLHFG 885
+ + L ++EY G L +KC YI + F I+ + AL H
Sbjct: 66 DRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFI-WRILTQLLLALYECHNR 124
Query: 886 YSAP--VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYG 943
V+H DLKP+N+ LD N L DFG+AK+L G D S +T + T YM+PE
Sbjct: 125 SDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL-GHDSSFAKT-YVGTPYYMSPEQL 182
Query: 944 REGRVSTKGDVYSFGILLMETFTRRKP 970
K D++S G L+ E P
Sbjct: 183 NHMSYDEKSDIWSLGCLIYELCALSPP 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 3e-21
Identities = 75/284 (26%), Positives = 124/284 (43%), Gaps = 36/284 (12%)
Query: 775 NLIGRGSFGSVYIARL----QNGIEVAVKTF----DLQHERAFKSFDTECEVMKSIRHRN 826
+IG+G FG VY L I AVK+ DL+ F E +MK H N
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFL---KEGIIMKDFSHPN 57
Query: 827 LTKIISSC-SNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFG 885
+ ++ C +E ++L YM++G L + S + + + + VA +EYL
Sbjct: 58 VLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLA-- 115
Query: 886 YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATL--GYMAPEYG 943
S +H DL N +LD++ ++DFG+A+ + ++ T A L +MA E
Sbjct: 116 -SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESL 174
Query: 944 REGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLI 1003
+ + +TK DV+SFG+LL E TR P P + D + +
Sbjct: 175 QTQKFTTKSDVWSFGVLLWELMTRGAP-------------------PYPDVDSFDITVYL 215
Query: 1004 TEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKI 1047
+ + E C ++ + + C P+ R T E+V R+ +I
Sbjct: 216 LQGRRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI 259
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 3e-21
Identities = 77/285 (27%), Positives = 128/285 (44%), Gaps = 40/285 (14%)
Query: 771 FSENN---LIGRGSFGSVYIAR-LQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRN 826
+ EN ++G+G++G VY AR L + +A+K + R + E + ++HRN
Sbjct: 7 YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRN 66
Query: 827 LTKIISSCSNEDFKALILEYMRNGSLEKCLYS------GNYILDIFQRLNIMIDVASALE 880
+ + + S S F + +E + GSL L S N IF I+ L+
Sbjct: 67 IVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQIL----EGLK 122
Query: 881 YLHFGYSAPVIHCDLKPSNVLLDD-NMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMA 939
YLH ++H D+K NVL++ + V +SDFG +K L G + T+T T TL YMA
Sbjct: 123 YLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN-PCTETFT-GTLQYMA 177
Query: 940 PEYGREGR--VSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKII 997
PE +G D++S G ++E T + P E+ + + + M KI
Sbjct: 178 PEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAM-------FKVGMFKI- 229
Query: 998 DANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVR 1042
H E ++ N + C PD+R +A ++++
Sbjct: 230 ----------HPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 93.9 bits (234), Expect = 5e-21
Identities = 59/206 (28%), Positives = 91/206 (44%), Gaps = 8/206 (3%)
Query: 777 IGRGSFGSVYIARLQ-NGIEVAVKTFDL-QHERAFKSFDTECEVMKSIRHRNLTKIISSC 834
+G G+ G V + G +AVKT L +E K E +++ + +
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68
Query: 835 SNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 894
N ++ +EYM GSL+K L + I + V L YLH + +IH D
Sbjct: 69 YNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK--IIHRD 126
Query: 895 LKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGDV 954
+KPSN+L++ L DFG++ L+ S+ +T T YMAPE + S K D+
Sbjct: 127 VKPSNILVNSRGQIKLCDFGVSGQLV---NSLAKTFV-GTSSYMAPERIQGNDYSVKSDI 182
Query: 955 YSFGILLMETFTRRKPTDEIFSGEMT 980
+S G+ L+E T R P
Sbjct: 183 WSLGLSLIELATGRFPYPPENDPPDG 208
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 6e-21
Identities = 73/277 (26%), Positives = 125/277 (45%), Gaps = 29/277 (10%)
Query: 774 NNLIGRGSFGSVYIARLQ----NGIEVAVKTFDLQH-ERAFKSFDTECEVMKSIRHRNLT 828
+IG G FG V RL+ I+VA+KT ++ F TE +M H N+
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68
Query: 829 KIISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYL-HFGYS 887
++ + +I EYM NGSL+K L + + Q + ++ +AS ++YL Y
Sbjct: 69 RLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNY- 127
Query: 888 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGR 947
+H DL N+L++ N+V +SDFG+++ L + + T + + APE +
Sbjct: 128 ---VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRK 184
Query: 948 VSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDK 1007
++ DV+SFGI++ E + GE N +I A + +
Sbjct: 185 FTSASDVWSFGIVMWEVMS---------YGERPYWDMSNQ-------DVIKA---VEDGY 225
Query: 1008 HFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRL 1044
C S+++ L ++C + +ER T +IV L
Sbjct: 226 RLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTL 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 7e-21
Identities = 83/304 (27%), Positives = 134/304 (44%), Gaps = 46/304 (15%)
Query: 771 FSENNLI-----GRGSFGSVYIAR---LQN--GIEVAVKTFDLQHERA--FKSFDTECEV 818
F E +L G+G+FGSV + R LQ+ G VAVK LQH A + F+ E E+
Sbjct: 1 FEERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVK--KLQHSTAEHLRDFEREIEI 58
Query: 819 MKSIRHRNLTKIISSCSNEDFKA--LILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVA 876
+KS++H N+ K C + + L++EY+ GSL L LD + L +
Sbjct: 59 LKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQIC 118
Query: 877 SALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL-IGEDQSMTQTQTLATL 935
+EYL S +H DL N+L++ + DFG+ K+L ++ + + +
Sbjct: 119 KGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPI 175
Query: 936 GYMAPEYGREGRVSTKGDVYSFGILLMETFT----RRKPTDEIFS-------GEMTLKHW 984
+ APE E + S DV+SFG++L E FT P E G+M + H
Sbjct: 176 FWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHL 235
Query: 985 VNDFLPISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRL 1044
+ L+ + A C + ++ + EC P +R + E+ ++
Sbjct: 236 IE---------------LLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQV 280
Query: 1045 LKIR 1048
IR
Sbjct: 281 EAIR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 1e-20
Identities = 78/292 (26%), Positives = 122/292 (41%), Gaps = 47/292 (16%)
Query: 775 NLIGRGSFGSVYIARLQN-------GIEVAVKTFDL-QHERAFKSFDTECEVMKSIRHRN 826
N +G G+FG VY + I VAVKT ++ K F E +M + H N
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 827 LTKIISSCSNEDFKALILEYMRNGSL------EKCLYSGNYILDIFQRLNIMIDVASALE 880
+ K++ C + + +I+E M G L + G +L + + L+I +DVA
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 881 YL---HFGYSAPVIHCDLKPSNVLL-----DDNMVAHLSDFGIAKLLIGEDQSMTQTQTL 932
YL HF IH DL N L+ D + V + DFG+A+ + D + + L
Sbjct: 121 YLEQMHF------IHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGL 174
Query: 933 ATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPIS 992
+ +MAPE +G+ +T+ DV+SFG+L+ E +TL P
Sbjct: 175 LPVRWMAPESLLDGKFTTQSDVWSFGVLMWEI--------------LTLGQQ-----PYP 215
Query: 993 MMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRL 1044
+ + +T E C ++ L C + P ER T I L
Sbjct: 216 ALNNQEVLQHVTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEIL 267
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 1e-20
Identities = 73/276 (26%), Positives = 119/276 (43%), Gaps = 31/276 (11%)
Query: 777 IGRGSFGSVYIAR-LQNGIEVAVKTFDLQHERA-FKSFDTECEVMKSIRHRNLTKIISSC 834
IG G+ VY A L N +VA+K DL+ + E + M H N+ K +S
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF 68
Query: 835 SNEDFKALILEYMRNGSLEKCLYSGNY--ILDIFQRLNIMIDVASALEYLHFGYSAPVIH 892
D L++ Y+ GSL + S LD ++ +V LEYLH S IH
Sbjct: 69 VVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---SNGQIH 125
Query: 893 CDLKPSNVLLDDNMVAHLSDFGIAKLLI--GEDQSMTQTQTLATLGYMAPEYGREGRVST 950
D+K N+LL ++ ++DFG++ L G+ + + T +MAPE +
Sbjct: 126 RDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYD 185
Query: 951 -KGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDAN---LLITED 1006
K D++SFGI +E T P +S +K +M + + L D
Sbjct: 186 FKADIWSFGITAIELATGAAP----YSKYPPMK---------VLMLTLQNDPPSLETGAD 232
Query: 1007 KHFAAKEQCASSVFNLAMECTVESPDERITAKEIVR 1042
++ + S + C + P +R TA+E+++
Sbjct: 233 -----YKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 1e-20
Identities = 67/270 (24%), Positives = 124/270 (45%), Gaps = 28/270 (10%)
Query: 777 IGRGSFGSVYIARLQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCSN 836
+G G FG V++ + + I+VA+K + + + + F E +VM + H L ++ C+
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAIN-EGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ 70
Query: 837 EDFKALILEYMRNGSLEKCLYS--GNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 894
+ ++ E+M NG L L G D+ L++ DV +EYL IH D
Sbjct: 71 QKPLYIVTEFMENGCLLNYLRQRQGKLSKDML--LSMCQDVCEGMEYLE---RNSFIHRD 125
Query: 895 LKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGDV 954
L N L+ V +SDFG+ + ++ +D+ + + + + PE + S+K DV
Sbjct: 126 LAARNCLVSSTGVVKVSDFGMTRYVL-DDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDV 184
Query: 955 YSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHFAAKEQ 1014
+SFG+L+ E FT G+M + N ++++ I+ +
Sbjct: 185 WSFGVLMWEVFTE---------GKMPFEKKSN-------YEVVEM---ISRGFRLYRPKL 225
Query: 1015 CASSVFNLAMECTVESPDERITAKEIVRRL 1044
+ +V+ + C E P+ R T E++R +
Sbjct: 226 ASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 4e-20
Identities = 61/209 (29%), Positives = 101/209 (48%), Gaps = 18/209 (8%)
Query: 776 LIGRGSFGSVYIA-RLQNGIEVAVKTFDL---------QHERAFKSFDTECEVMKSIRHR 825
LIG GSFGSVY+ +G +AVK +L + + E ++K ++H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 826 NLTKIISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFG 885
N+ + + S + D + LEY+ GS+ L + + R N + + L YLH
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVR-NFVRQILKGLNYLH-- 123
Query: 886 YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLG----YMAPE 941
+ +IH D+K +N+L+D+ +SDFGI+K L S +L +MAPE
Sbjct: 124 -NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPE 182
Query: 942 YGREGRVSTKGDVYSFGILLMETFTRRKP 970
++ + K D++S G L++E T + P
Sbjct: 183 VVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 4e-20
Identities = 70/262 (26%), Positives = 116/262 (44%), Gaps = 28/262 (10%)
Query: 777 IGRGSFGSVYIARLQ-NGIEVAVKTFDLQHERAFKS-FDTECEVMKSIRHRNLTKIISSC 834
IGRG+FG V+ RL+ + VAVK+ K+ F E ++K H N+ ++I C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 835 SNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 894
+ + +++E ++ G L + L + + + ++ + A+ +EYL S IH D
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLE---SKHCIHRD 119
Query: 895 LKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATL--GYMAPEYGREGRVSTKG 952
L N L+ + V +SDFG+++ ED T + + + APE GR S++
Sbjct: 120 LAARNCLVTEKNVLKISDFGMSRE--EEDGVYASTGGMKQIPVKWTAPEALNYGRYSSES 177
Query: 953 DVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHFAAK 1012
DV+SFGILL E F+ S + T + I +
Sbjct: 178 DVWSFGILLWEAFSLGAVPYANLSNQQTRE-------------------AIEQGVRLPCP 218
Query: 1013 EQCASSVFNLAMECTVESPDER 1034
E C +V+ L C P +R
Sbjct: 219 ELCPDAVYRLMERCWEYDPGQR 240
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 5e-20
Identities = 74/276 (26%), Positives = 128/276 (46%), Gaps = 31/276 (11%)
Query: 777 IGRGSFGSVYIARLQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCSN 836
+G G FG V++ +VA+K+ Q + ++F E +MK ++H L ++ + +
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLK-QGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQ 72
Query: 837 EDFKALILEYMRNGSLEKCLYSGNYI-LDIFQRLNIMIDVASALEYLHFGYSAPVIHCDL 895
E +I EYM NGSL L + I L I + +++ +A + ++ IH DL
Sbjct: 73 EPI-YIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDL 128
Query: 896 KPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVY 955
+ +N+L+ + + ++DFG+A+L I +++ + + + APE G + K DV+
Sbjct: 129 RAANILVSETLCCKIADFGLARL-IEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVW 187
Query: 956 SFGILLMETFTR-RKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHFAAKEQ 1014
SFGILL E T R P + + E+ NL +
Sbjct: 188 SFGILLTEIVTYGRIPYPGMTNPEVI------------------QNL--ERGYRMPRPDN 227
Query: 1015 CASSVFNLAMECTVESPDERITAKEIVRRLLKIRDF 1050
C ++ L C E P+ER T E +R +L+ DF
Sbjct: 228 CPEELYELMRLCWKEKPEERPTF-EYLRSVLE--DF 260
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 7e-20
Identities = 74/279 (26%), Positives = 132/279 (47%), Gaps = 30/279 (10%)
Query: 776 LIGRGSFGSVYIARLQ----NGIEVAVKTFDLQH-ERAFKSFDTECEVMKSIRHRNLTKI 830
+IG G FG V RL+ I VA+KT + E+ + F +E +M H N+ +
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 831 ISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLH-FGYSAP 889
+ ++ EYM NGSL+ L + + Q + ++ +AS ++YL GY
Sbjct: 71 EGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGY--- 127
Query: 890 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGE-DQSMTQTQTLATLGYMAPEYGREGRV 948
+H DL N+L++ N+V +SDFG++++L + + + T + + APE +
Sbjct: 128 -VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKF 186
Query: 949 STKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKH 1008
++ DV+S+GI++ E + GE +W +S +I A I E
Sbjct: 187 TSASDVWSYGIVMWEVMS---------YGER--PYW-----EMSNQDVIKA---IEEGYR 227
Query: 1009 FAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKI 1047
A C +++ L ++C + +ER ++IV L K+
Sbjct: 228 LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 7e-20
Identities = 70/287 (24%), Positives = 134/287 (46%), Gaps = 32/287 (11%)
Query: 769 NGFSENNLIGRGSFGSVYIARLQ----NGIEVAVKTFDLQH-ERAFKSFDTECEVMKSIR 823
+ ++ +IG G FG V+ L+ + VA+KT + E+ + F +E +M
Sbjct: 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFS 64
Query: 824 HRNLTKIISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLH 883
H N+ ++ + +I EYM NG+L+K L + +Q + ++ +A+ ++YL
Sbjct: 65 HHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLS 124
Query: 884 FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLG--YMAPE 941
+H DL N+L++ N+ +SDFG++++L +D T T + + + APE
Sbjct: 125 ---DMNYVHRDLAARNILVNSNLECKVSDFGLSRVL-EDDPEGTYTTSGGKIPIRWTAPE 180
Query: 942 YGREGRVSTKGDVYSFGILLMETFTR-RKPTDEIFSGEMTLKHWVNDFLPISMMKIIDAN 1000
+ ++ DV+SFGI++ E + +P ++ + E +MK I+
Sbjct: 181 AIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE--------------VMKAIN-- 224
Query: 1001 LLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKI 1047
+ A C S+V+ L ++C + R +IV L K+
Sbjct: 225 ----DGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 7e-20
Identities = 67/272 (24%), Positives = 121/272 (44%), Gaps = 29/272 (10%)
Query: 777 IGRGSFGSVYIARLQN-GIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCS 835
+G G+FG VY A+ + G+ A K ++ E + F E +++ +H N+ + +
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 836 NEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDL 895
E+ +++E+ G+L+ + L Q + + AL +LH S VIH DL
Sbjct: 73 YENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDL 129
Query: 896 KPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEY-----GREGRVST 950
K N+LL + L+DFG++ Q + + T +MAPE ++
Sbjct: 130 KAGNILLTLDGDVKLADFGVSAKNKSTLQK--RDTFIGTPYWMAPEVVACETFKDNPYDY 187
Query: 951 KGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHFA 1010
K D++S GI L+E P E ++ M+++ +L +E
Sbjct: 188 KADIWSLGITLIELAQMEPPHHE-----------------LNPMRVL-LKILKSEPPTLD 229
Query: 1011 AKEQCASSVFNLAMECTVESPDERITAKEIVR 1042
+ +SS + C V+ PD+R TA E+++
Sbjct: 230 QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK 261
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 8e-20
Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 23/211 (10%)
Query: 770 GFSENNLIGRGSFGSVYIARL-QNGIEVAVKTFDLQ---HERAFKSFDTECEVMKSIRHR 825
F +IG+G+FG V I + A+K + Q + + ++ E +++ + H
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 826 NLTKIISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLN------IMIDVASAL 879
L + S +E+ L+++ + G L Y L + + + ++ AL
Sbjct: 61 FLVNLWYSFQDEENMYLVVDLLLGGDLR-------YHLSQKVKFSEEQVKFWICEIVLAL 113
Query: 880 EYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMA 939
EYLH S +IH D+KP N+LLD+ H++DF IA + ++T T T T GYMA
Sbjct: 114 EYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKV--TPDTLT-TSTSGTPGYMA 167
Query: 940 PEYGREGRVSTKGDVYSFGILLMETFTRRKP 970
PE S D +S G+ E ++P
Sbjct: 168 PEVLCRQGYSVAVDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 8e-20
Identities = 70/292 (23%), Positives = 129/292 (44%), Gaps = 48/292 (16%)
Query: 777 IGRGSFGSVYIARLQ-NGIE----VAVKTF-DLQHERAFKSFDTECEVMKSIRHRNLTKI 830
+G +FG +Y L G++ VA+KT D+ + + + F E +M + H N+ +
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 831 ISSCSNEDFKALILEYMRNGSLEKCLY----------------SGNYILDIFQRLNIMID 874
+ + E ++ EY+ G L + L + LD L+I I
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132
Query: 875 VASALEYL--HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTL 932
+A+ +EYL HF +H DL N+L+ + + +SD G+++ + D Q ++L
Sbjct: 133 IAAGMEYLSSHF-----FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSL 187
Query: 933 ATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPIS 992
+ +M PE G+ S+ D++SFG++L E F+ + + S
Sbjct: 188 LPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS----------------FGLQPYYGFS 231
Query: 993 MMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRL 1044
++I+ ++ + + E C +++L EC E P R K+I RL
Sbjct: 232 NQEVIE---MVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 9e-20
Identities = 80/280 (28%), Positives = 131/280 (46%), Gaps = 46/280 (16%)
Query: 776 LIGRGSFGSVYIAR-LQNGIEVAVKTFDLQHERAFKSFDT-----ECEVMKSIRH---RN 826
LIGRG++G+VY + + G VA+K +L D E ++ +R N
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTP----DDDVSDIQREVALLSQLRQSQPPN 63
Query: 827 LTKIISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGY 886
+TK S +I+EY GS+ + +G I + + + I+ +V AL+Y+H
Sbjct: 64 ITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGP-IAEKYISV-IIREVLVALKYIH--- 118
Query: 887 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGY-MAPEYGRE 945
VIH D+K +N+L+ + L DFG+A LL +Q+ ++ T Y MAPE E
Sbjct: 119 KVGVIHRDIKAANILVTNTGNVKLCDFGVAALL---NQNSSKRSTFVGTPYWMAPEVITE 175
Query: 946 GRV-STKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLIT 1004
G+ TK D++S GI + E T P +S + +MM I +
Sbjct: 176 GKYYDTKADIWSLGITIYEMATGNPP----YSDVDAFR---------AMMLIPKSKPPRL 222
Query: 1005 EDKHFAA--KEQCASSVFNLAMECTVESPDERITAKEIVR 1042
ED ++ +E A+ C E P ER++A+E+++
Sbjct: 223 EDNGYSKLLREFVAA--------CLDEEPKERLSAEELLK 254
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 1e-19
Identities = 68/287 (23%), Positives = 117/287 (40%), Gaps = 42/287 (14%)
Query: 777 IGRGSFGSVY------IARLQNGIEVAVKTF---DLQHERAFKSFDTECEVMKSIRHRNL 827
+G+GSFG VY + + + VA+KT ER F E VMK ++
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRER--IEFLNEASVMKEFNCHHV 71
Query: 828 TKIISSCSNEDFKALILEYMRNGSLEKCLYS---------GNYILDIFQRLNIMIDVASA 878
+++ S +++E M G L+ L S G + + + + ++A
Sbjct: 72 VRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADG 131
Query: 879 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYM 938
+ YL + +H DL N ++ +++ + DFG+ + + D + L + +M
Sbjct: 132 MAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 188
Query: 939 APEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIID 998
APE ++G +TK DV+SFG++L E T E + N+ ++K +
Sbjct: 189 APESLKDGVFTTKSDVWSFGVVLWEMATL---------AEQPYQGLSNE----EVLKFVI 235
Query: 999 ANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLL 1045
H E C + L C +P R T EIV L
Sbjct: 236 DG------GHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 89.2 bits (221), Expect = 2e-19
Identities = 66/285 (23%), Positives = 128/285 (44%), Gaps = 38/285 (13%)
Query: 771 FSENNLIGRGSFGSVYIARLQNGIEVAVKTFDLQ------HERAFKSFDTECEVMKSIRH 824
+++ ++G+G++G+VY G +AVK +L E+ ++ E +++KS++H
Sbjct: 2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKH 61
Query: 825 RNLTKIISSCSNEDFKALILEYMRNGSLEKCLYS-GNYILDIFQRLNIMIDVASALEYLH 883
N+ + + +C +++ ++ +E++ GS+ L G +F + I + YLH
Sbjct: 62 VNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQI--LDGVAYLH 119
Query: 884 FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLG----YMA 939
+ V+H D+K +NV+L N + L DFG A+ L T + L ++ +MA
Sbjct: 120 ---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMA 176
Query: 940 PEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDA 999
PE E K D++S G + E T + P + ++ M I A
Sbjct: 177 PEVINESGYGRKSDIWSIGCTVFEMATGKPP-------------LAS-MDRLAAMFYIGA 222
Query: 1000 N--LLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVR 1042
+ L+ F+A + + C ER +A +++R
Sbjct: 223 HRGLMPRLPDSFSA------AAIDFVTSCLTRDQHERPSALQLLR 261
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 2e-19
Identities = 61/216 (28%), Positives = 94/216 (43%), Gaps = 30/216 (13%)
Query: 771 FSENNLIGRGSFGSVYIAR-LQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTK 829
F +G GS+GSVY A + G VA+K + E + E ++K + K
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPV--EEDLQEIIKEISILKQCDSPYIVK 62
Query: 830 IISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLN----------IMIDVASAL 879
S +++EY GS + DI + N I+ L
Sbjct: 63 YYGSYFKNTDLWIVMEYCGAGS----------VSDIMKITNKTLTEEEIAAILYQTLKGL 112
Query: 880 EYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLA-TLGYM 938
EYLH S IH D+K N+LL++ A L+DFG++ L +M + T+ T +M
Sbjct: 113 EYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTD---TMAKRNTVIGTPFWM 166
Query: 939 APEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEI 974
APE +E + K D++S GI +E + P +I
Sbjct: 167 APEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDI 202
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 89.9 bits (224), Expect = 3e-19
Identities = 65/216 (30%), Positives = 100/216 (46%), Gaps = 39/216 (18%)
Query: 775 NLIGRGSFGSVYIAR-LQNGIEVAVK----TFDLQHE--RAFKSFDTECEVMKSIRHRNL 827
IG G++G V A + G +VA+K FD + R + E ++++ +RH N+
Sbjct: 6 KPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILR----EIKLLRHLRHENI 61
Query: 828 TK---IISSCSNEDFKALIL--EYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYL 882
I+ S EDF + + E M L K + S + D + + + L+YL
Sbjct: 62 IGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQY-FLYQILRGLKYL 119
Query: 883 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQT--LATLGYMAP 940
H SA VIH DLKPSN+L++ N + DFG+A+ + D+ T + T Y AP
Sbjct: 120 H---SANVIHRDLKPSNILVNSNCDLKICDFGLAR-GVDPDEDEKGFLTEYVVTRWYRAP 175
Query: 941 E-------YGREGRVSTKG-DVYSFGILLMETFTRR 968
E Y TK D++S G + E TR+
Sbjct: 176 ELLLSSSRY-------TKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 3e-19
Identities = 66/221 (29%), Positives = 114/221 (51%), Gaps = 31/221 (14%)
Query: 776 LIGRGSFGSVYIA-RLQNGIEVAVKTFDL------QHERAFKS----FDTECEVMKSIRH 824
LIG+G++G VY+A + G +AVK +L +H+ K +E E +K + H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 825 RNLTKIISSCSNEDFKALILEYMRNGSLEKCLYS-GNYILDIFQRLNIMIDVASALEYLH 883
N+ + + + E++ ++ LEY+ GS+ CL + G + + + V L YLH
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFF--TEQVLEGLAYLH 125
Query: 884 FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL---LIGEDQSMTQTQTLATLGYMAP 940
S ++H DLK N+L+D + + +SDFGI+K + DQ+M+ ++ +MAP
Sbjct: 126 ---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQ---GSVFWMAP 179
Query: 941 E----YGREGRVSTKGDVYSFGILLMETFTRRKP--TDEIF 975
E Y + S K D++S G +++E F R+P +E
Sbjct: 180 EVIHSYSQG--YSAKVDIWSLGCVVLEMFAGRRPWSDEEAI 218
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 4e-19
Identities = 67/278 (24%), Positives = 102/278 (36%), Gaps = 29/278 (10%)
Query: 776 LIGRGSFGSVYIARLQNG----IEVAVKTF-DLQHERAFKSFDTECEVMKSIRHRNLTKI 830
+G GSFG V I VAVK + F E +M S+ H NL ++
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 831 ISSCSNEDFKALILEYMRNGSLEKCLY-SGNYILDIFQRLNIMIDVASALEYLHFGYSAP 889
++ E GSL L I + + +A+ + YL S
Sbjct: 62 YGVVLTHPLM-MVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SKR 117
Query: 890 VIHCDLKPSNVLLDDNMVAHLSDFGIAK-LLIGEDQSMTQTQTLATLGYMAPEYGREGRV 948
IH DL N+LL + + DFG+ + L ED + + + APE R
Sbjct: 118 FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTF 177
Query: 949 STKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKH 1008
S DV+ FG+ L E FT GE ++K ID +
Sbjct: 178 SHASDVWMFGVTLWEMFT---------YGEEPWAGLSG----SQILKKIDKEG-----ER 219
Query: 1009 FAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLK 1046
E C ++N+ ++C +P +R T + L +
Sbjct: 220 LERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLPE 257
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 6e-19
Identities = 71/292 (24%), Positives = 123/292 (42%), Gaps = 41/292 (14%)
Query: 770 GFSENNLIGRGSFGSVYIARLQNGIE------VAVKTFDLQH---ERAFKSFDTECEVMK 820
E +GRG FG V++A+ + E V VK LQ E F E ++ +
Sbjct: 6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKA--LQKTKDENLQSEFRRELDMFR 63
Query: 821 SIRHRNLTKIISSCSNEDFKALILEYMRNGSLEKCL--------YSGNYILDIFQRLNIM 872
+ H+N+ +++ C + +ILEY G L++ L L Q++ +
Sbjct: 64 KLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALC 123
Query: 873 IDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTL 932
+A +++L +A +H DL N L+ +S ++K + + + L
Sbjct: 124 TQIALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLR-NAL 179
Query: 933 ATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPIS 992
L ++APE +E STK DV+SFG+L+ E FT GE+ ++
Sbjct: 180 IPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT---------QGELPFYGLSDE----E 226
Query: 993 MMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRL 1044
++ + A L E C S ++ L C +P +R + E+V L
Sbjct: 227 VLNRLQAGKL-----ELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSAL 273
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 8e-19
Identities = 65/214 (30%), Positives = 96/214 (44%), Gaps = 27/214 (12%)
Query: 770 GFSENNLIGRGSFGSVY-IARLQNGIEVAVKTFDL----QHERAFKSFDTECEVMKSIRH 824
F +G+GS+GSVY + RL + A+K DL Q ER E ++ S+ H
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKERE--DAVNEIRILASVNH 58
Query: 825 RNLTKIISSCSNEDF-----KALILEYMRNGSLEKCLYSGNYILDIFQR---LNIMIDVA 876
N+ E F +++EY G L K + + I I +
Sbjct: 59 PNI-----ISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLL 113
Query: 877 SALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLG 936
L+ LH ++H DLK +N+LL N + + D GI+K+L ++M +TQ T
Sbjct: 114 RGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVL---KKNMAKTQI-GTPH 166
Query: 937 YMAPEYGREGRVSTKGDVYSFGILLMETFTRRKP 970
YMAPE + S K D++S G LL E T P
Sbjct: 167 YMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 1e-18
Identities = 72/282 (25%), Positives = 130/282 (46%), Gaps = 34/282 (12%)
Query: 776 LIGRGSFGSVYIARLQ----NGIEVAVKTFDLQH-ERAFKSFDTECEVMKSIRHRNLTKI 830
+IG G FG V RL+ I VA+KT + E+ + F +E +M H N+ +
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 831 ISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPV 890
+ +I E+M NG+L+ L + + Q + ++ +A+ ++YL
Sbjct: 71 EGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLS---EMNY 127
Query: 891 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLG-----YMAPEYGRE 945
+H DL N+L++ N+V +SDFG+++ L ED + T T + G + APE
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRFL--EDDTSDPTYTSSLGGKIPIRWTAPEAIAY 185
Query: 946 GRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITE 1005
+ ++ DV+S+GI++ E + GE +W +S +I+A I +
Sbjct: 186 RKFTSASDVWSYGIVMWEVMS---------YGER--PYW-----DMSNQDVINA---IEQ 226
Query: 1006 DKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKI 1047
D C +++ L ++C + + R +IV L K+
Sbjct: 227 DYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 1e-18
Identities = 71/290 (24%), Positives = 122/290 (42%), Gaps = 41/290 (14%)
Query: 776 LIGRGSFGSVYIARLQNG----IEVAVKTF--DLQHERAFKSFDTECEVMKSIRHRNLTK 829
++G G FGSV +L ++VAVKT D+ + F +E MK H N+ K
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 830 IISSC----SNEDFKA--LILEYMRNGSLEKCLYS-----GNYILDIFQRLNIMIDVASA 878
+I C S + +IL +M++G L L L + L M+D+A
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 879 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYM 938
+EYL + IH DL N +L ++M ++DFG++K + D + ++
Sbjct: 126 MEYLS---NRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 182
Query: 939 APEYGREGRVSTKGDVYSFGILLMETFTR-RKPTDEIFSGEMTLKHWVNDFLPISMMKII 997
A E + ++K DV++FG+ + E TR + P + + E+
Sbjct: 183 AIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIY----------------- 225
Query: 998 DANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKI 1047
+ L ++ E C +++L C P +R T ++ L I
Sbjct: 226 --DYLRHGNR-LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 2e-18
Identities = 68/297 (22%), Positives = 118/297 (39%), Gaps = 52/297 (17%)
Query: 777 IGRGSFGSVYIARLQNGIE-----------------VAVKTF-DLQHERAFKSFDTECEV 818
+G G FG V++ + VAVK + A + F E ++
Sbjct: 13 LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKI 72
Query: 819 MKSIRHRNLTKIISSCSNEDFKALILEYMRNGSLEKCLY--------SGNYILDIFQR-- 868
+ + N+ +++ C+ + +I+EYM NG L + L +
Sbjct: 73 LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTL 132
Query: 869 LNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQ 928
L + +AS + YL S +H DL N L+ N ++DFG+++ L D Q
Sbjct: 133 LYMATQIASGMRYLE---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQ 189
Query: 929 TQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFT--RRKPTDEIFSGEMTLKHWVN 986
+ + +MA E G+ +TK DV++FG+ L E T R +P + +T V
Sbjct: 190 GRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYE-----HLT-DQQV- 242
Query: 987 DFLPISMMKIIDANLLITEDK---HFAAKEQCASSVFNLAMECTVESPDERITAKEI 1040
I +A +D + C ++ L +EC ++R T +EI
Sbjct: 243 ---------IENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREI 290
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 3e-18
Identities = 75/290 (25%), Positives = 118/290 (40%), Gaps = 45/290 (15%)
Query: 777 IGRGSFGSVYIARLQ-----NGIEVAVKTFD----LQHERAFKSFDTECEVMKSIRHRNL 827
+G G FG V + G VAVKT Q+ +K E ++K++ H N+
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKK---EINILKTLYHENI 68
Query: 828 TKIISSCSNEDFKA--LILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFG 885
K CS + K LI+EY+ GSL L L++ Q L + + YLH
Sbjct: 69 VKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK--LNLAQLLLFAQQICEGMAYLH-- 124
Query: 886 YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL-IGEDQSMTQTQTLATLGYMAPEYGR 944
S IH DL NVLLD++ + + DFG+AK + G + + + + + A E +
Sbjct: 125 -SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLK 183
Query: 945 EGRVSTKGDVYSFGILLMETFTRRKPTD----------EIFSGEMTLKHWVNDFLPISMM 994
E + S DV+SFG+ L E T G+MT ++
Sbjct: 184 ENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMT------------VV 231
Query: 995 KIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRL 1044
++I+ L+ + C V+ L C R T + ++ L
Sbjct: 232 RLIE---LLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPIL 278
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 5e-18
Identities = 79/302 (26%), Positives = 129/302 (42%), Gaps = 59/302 (19%)
Query: 777 IGRGSFGSVYIA--------RLQNGIEVAVKTF-DLQHERAFKSFDTECEVMKSI-RHRN 826
+G G FG V +A + + + VAVK D E+ +E E+MK I +H+N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 827 LTKIISSCSNEDFKALILEYMRNGSLEKCLYSG-----NYILDI---------FQRL-NI 871
+ ++ +C+ + +I+EY G+L + L + Y DI F+ L +
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 872 MIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQT 931
VA +EYL S IH DL NVL+ +N V ++DFG+A+ + D T
Sbjct: 143 TYQVARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199
Query: 932 LATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRK------PTDEIFSGEMTLKHWV 985
+ +MAPE + + + DV+SFG+L+ E FT P +E+F
Sbjct: 200 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK--------- 250
Query: 986 NDFLPISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLL 1045
L+ E C + ++ + +C P R T K++V L
Sbjct: 251 ----------------LLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLD 294
Query: 1046 KI 1047
+I
Sbjct: 295 RI 296
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 6e-18
Identities = 57/202 (28%), Positives = 92/202 (45%), Gaps = 31/202 (15%)
Query: 777 IGRGSFGSVYIAR-LQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCS 835
IG G++G VY AR + G VA+K L+ F+ E ++K RH N+ S
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70
Query: 836 NEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLN----------IMIDVASALEYLHFG 885
D +++EY GSL+ DI+Q + + L YLH
Sbjct: 71 RRDKLWIVMEYCGGGSLQ----------DIYQVTRGPLSELQIAYVCRETLKGLAYLH-- 118
Query: 886 YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTL-ATLGYMAPEYG- 943
IH D+K +N+LL ++ L+DFG++ L ++ + ++ T +MAPE
Sbjct: 119 -ETGKIHRDIKGANILLTEDGDVKLADFGVSAQL---TATIAKRKSFIGTPYWMAPEVAA 174
Query: 944 --REGRVSTKGDVYSFGILLME 963
R+G K D+++ GI +E
Sbjct: 175 VERKGGYDGKCDIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 7e-18
Identities = 79/265 (29%), Positives = 125/265 (47%), Gaps = 34/265 (12%)
Query: 777 IGRGSFGSVYIARLQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCSN 836
+G G FG V++A +VAVKT + ++F E VMK+++H L K+ + +
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK 72
Query: 837 EDFKALILEYMRNGSLEKCLYS--GNYILDIFQRLNIMIDVASAL-EYLHFGYSAPVIHC 893
E +I E+M GSL L S G+ Q L +ID ++ + E + F IH
Sbjct: 73 EPI-YIITEFMAKGSLLDFLKSDEGSK-----QPLPKLIDFSAQIAEGMAFIEQRNYIHR 126
Query: 894 DLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLA-TLGYMAPEYGREGRVSTKG 952
DL+ +N+L+ ++V ++DFG+A+++ ED T + + + APE G + K
Sbjct: 127 DLRAANILVSASLVCKIADFGLARVI--EDNEYTAREGAKFPIKWTAPEAINFGSFTIKS 184
Query: 953 DVYSFGILLMETFTR-RKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHFAA 1011
DV+SFGILLME T R P + + E +I A +
Sbjct: 185 DVWSFGILLMEIVTYGRIPYPGMSNPE-----------------VIRA---LERGYRMPR 224
Query: 1012 KEQCASSVFNLAMECTVESPDERIT 1036
E C ++N+ M C P+ER T
Sbjct: 225 PENCPEELYNIMMRCWKNRPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 84.4 bits (208), Expect = 1e-17
Identities = 78/293 (26%), Positives = 129/293 (44%), Gaps = 44/293 (15%)
Query: 771 FSENNLIGRGSFGSVYIARLQNGIE------VAVKTFDLQH-ERAFKSFDTECEVMKSIR 823
F++ IG+GSFG V+ GI+ VA+K DL+ E + E V+
Sbjct: 6 FTKLEKIGKGSFGEVF-----KGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCD 60
Query: 824 HRNLTKIISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLH 883
+TK S + +I+EY+ GS L G LD Q I+ ++ L+YLH
Sbjct: 61 SPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLH 118
Query: 884 FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYG 943
S IH D+K +NVLL ++ L+DFG+A L D + + + T +MAPE
Sbjct: 119 ---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAPEVI 173
Query: 944 REGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLI 1003
++ +K D++S GI +E P E+ P+ ++ +I N
Sbjct: 174 KQSAYDSKADIWSLGITAIELAKGEPPHSELH--------------PMKVLFLIPKNNPP 219
Query: 1004 TEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKIRDFLLRNVE 1056
T + ++ + + C + P R TAKE+++ F++R +
Sbjct: 220 TLEGNY------SKPLKEFVEACLNKEPSFRPTAKELLK-----HKFIVRFAK 261
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 1e-17
Identities = 54/200 (27%), Positives = 90/200 (45%), Gaps = 18/200 (9%)
Query: 777 IGRGSFGSVYIAR-LQNGIEVAVKTFDLQHE------RAFKSFDTECEVMKSIRHRNLTK 829
IG G++G VY AR G VA+K L+ E A + E +++K + H N+ K
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALR----EIKLLKELNHPNIIK 62
Query: 830 IISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAP 889
++ ++ L+ E+M L K + L + + + L + H S
Sbjct: 63 LLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHG 118
Query: 890 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVS 949
++H DLKP N+L++ V L+DFG+A+ T + T Y APE +
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARSFGS--PVRPYTHYVVTRWYRAPELLLGDKGY 176
Query: 950 TKG-DVYSFGILLMETFTRR 968
+ D++S G + E +RR
Sbjct: 177 STPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.2 bits (209), Expect = 1e-17
Identities = 83/287 (28%), Positives = 121/287 (42%), Gaps = 50/287 (17%)
Query: 771 FSENNLIGRGSFGSVYIAR-LQNGIEVAVKTFDLQH-ERAFKSFDTECEVMKSIRHRNLT 828
F+ IG+GSFG VY A + VA+K DL+ E + E + + R +T
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 829 KIISSCSNEDFK-ALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYS 887
K S + K +I+EY GS L G LD I+ +V LEYLH
Sbjct: 63 KYYGSFL-KGSKLWIIMEYCGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLH---E 116
Query: 888 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQT-----LATLGYMAPEY 942
IH D+K +N+LL + L+DFG++ G+ +T T + + T +MAPE
Sbjct: 117 EGKIHRDIKAANILLSEEGDVKLADFGVS----GQ---LTSTMSKRNTFVGTPFWMAPEV 169
Query: 943 GREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPIS-MMKIIDANL 1001
++ K D++S GI E+ GE L +D P+ + I N
Sbjct: 170 IKQSGYDEKADIWSLGI----------TAIELAKGEPPL----SDLHPMRVLFLIPKNNP 215
Query: 1002 LITEDKHF--AAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLK 1046
E F K+ + C + P ER +AKE LLK
Sbjct: 216 PSLEGNKFSKPFKDFVSL--------CLNKDPKERPSAKE----LLK 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 1e-17
Identities = 73/304 (24%), Positives = 123/304 (40%), Gaps = 66/304 (21%)
Query: 777 IGRGSFGSVYIARL------QNGIEVAVK------TFDLQHERAFKSFDTECEVMKSIRH 824
IG+G+FG V+ AR + VAVK + D+Q + F E +M H
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQAD-----FQREAALMAEFDH 67
Query: 825 RNLTKIISSCSNEDFKALILEYMRNGSLEKCL--------------------YSGNYI-L 863
N+ K++ C+ L+ EYM G L + L N + L
Sbjct: 68 PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPL 127
Query: 864 DIFQRLNIMIDVASALEYL---HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLI 920
++L I VA+ + YL F +H DL N L+ +NMV ++DFG+++ +
Sbjct: 128 SCTEQLCIAKQVAAGMAYLSERKF------VHRDLATRNCLVGENMVVKIADFGLSRNIY 181
Query: 921 GEDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMT 980
D + +M PE R +T+ DV+++G++L E F+ + E
Sbjct: 182 SADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEV 241
Query: 981 LKHWVNDFLPISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEI 1040
+ + + D N+L + + C ++NL C + P +R + I
Sbjct: 242 IYY------------VRDGNVL-------SCPDNCPLELYNLMRLCWSKLPSDRPSFASI 282
Query: 1041 VRRL 1044
R L
Sbjct: 283 NRIL 286
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 1e-17
Identities = 55/205 (26%), Positives = 93/205 (45%), Gaps = 11/205 (5%)
Query: 777 IGRGSFGSVY----IARLQN-GIEVAVKTF-DLQHERAFKSFDTECEVMKSIRHRNLTKI 830
+G G+FG+VY I + I VA+K + +A K E VM S+ H ++ ++
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 831 ISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPV 890
+ C + LI + M G L + + + LN + +A + YL +
Sbjct: 75 LGICLSSQV-QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLE---EKRL 130
Query: 891 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVST 950
+H DL NVL+ ++DFG+AKLL +++ + +MA E +
Sbjct: 131 VHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTH 190
Query: 951 KGDVYSFGILLMETFT-RRKPTDEI 974
K DV+S+G+ + E T KP + I
Sbjct: 191 KSDVWSYGVTVWELMTFGAKPYEGI 215
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 2e-17
Identities = 63/211 (29%), Positives = 100/211 (47%), Gaps = 19/211 (9%)
Query: 771 FSENNLIGRGSFGSVYIARLQNGIE------VAVKTFDLQH-ERAFKSFDTECEVMKSIR 823
F++ IG+GSFG V+ GI+ VA+K DL+ E + E V+
Sbjct: 6 FTKLERIGKGSFGEVF-----KGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCD 60
Query: 824 HRNLTKIISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLH 883
+TK S +I+EY+ GS L +G + D FQ ++ ++ L+YLH
Sbjct: 61 SPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPF--DEFQIATMLKEILKGLDYLH 118
Query: 884 FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYG 943
S IH D+K +NVLL + L+DFG+A L D + + + T +MAPE
Sbjct: 119 ---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAPEVI 173
Query: 944 REGRVSTKGDVYSFGILLMETFTRRKPTDEI 974
++ +K D++S GI +E P ++
Sbjct: 174 QQSAYDSKADIWSLGITAIELAKGEPPNSDM 204
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 2e-17
Identities = 64/264 (24%), Positives = 119/264 (45%), Gaps = 30/264 (11%)
Query: 777 IGRGSFGSVY--IARLQNG-IEVAVKTFDLQHERAFK-SFDTECEVMKSIRHRNLTKIIS 832
+G G+FG V + +++ I+VA+K ++E++ + E E+M + + + ++I
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 833 SCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIH 892
C E L++E G L K L + + + +M V+ ++YL +H
Sbjct: 63 VCEAEAL-MLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLE---GKNFVH 118
Query: 893 CDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLAT--LGYMAPEYGREGRVST 950
DL NVLL + A +SDFG++K L G D S + ++ L + APE + S+
Sbjct: 119 RDLAARNVLLVNQHYAKISDFGLSKAL-GADDSYYKARSAGKWPLKWYAPECINFRKFSS 177
Query: 951 KGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHFA 1010
+ DV+S+GI + E F+ + + P MK + I + K
Sbjct: 178 RSDVWSYGITMWEAFS--------YGQK-----------PYKKMKGPEVMSFIEQGKRLD 218
Query: 1011 AKEQCASSVFNLAMECTVESPDER 1034
+C ++ L +C + ++R
Sbjct: 219 CPAECPPEMYALMKDCWIYKWEDR 242
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 4e-17
Identities = 69/220 (31%), Positives = 95/220 (43%), Gaps = 36/220 (16%)
Query: 769 NGFSENNLIGRGSFGSVYIARL-QNGIEVAVKTF------DLQHERAFKSFDTECEVMKS 821
E + +G G+ GSV RL G+ A+KT DLQ K E E+ KS
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQ-----KQILRELEINKS 55
Query: 822 IRHRNLTKIISSCSNEDFK--ALILEYMRNGSLEKCLYS---------GNYILDIFQRLN 870
+ + K + +E + +EY GSL+ +Y G +L
Sbjct: 56 CKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDS-IYKKVKKRGGRIGEKVL-----GK 109
Query: 871 IMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQ 930
I V L YLH S +IH D+KPSN+LL L DFG++ L+ S+ T
Sbjct: 110 IAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELV---NSLAGTF 163
Query: 931 TLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKP 970
T T YMAPE + S DV+S G+ L+E R P
Sbjct: 164 T-GTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFP 202
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 5e-17
Identities = 61/205 (29%), Positives = 94/205 (45%), Gaps = 20/205 (9%)
Query: 776 LIGRGSFGSVYIA-RLQNGIEVAVKTFDL-----QHERAFKSFDTECEVMKSIRHRNLTK 829
L+G GSFGSVY L +G AVK L + A K + E ++ ++H N+ +
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 830 IISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAP 889
+ + ED + LE + GSL K L + LEYLH
Sbjct: 67 YLGTEREEDNLYIFLELVPGGSLAK-LLKKYGSFPEPVIRLYTRQILLGLEYLH---DRN 122
Query: 890 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLG---YMAPEY-GRE 945
+H D+K +N+L+D N V L+DFG+AK Q + + + G +MAPE ++
Sbjct: 123 TVHRDIKGANILVDTNGVVKLADFGMAK------QVVEFSFAKSFKGSPYWMAPEVIAQQ 176
Query: 946 GRVSTKGDVYSFGILLMETFTRRKP 970
G D++S G ++E T + P
Sbjct: 177 GGYGLAADIWSLGCTVLEMATGKPP 201
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 8e-17
Identities = 61/220 (27%), Positives = 105/220 (47%), Gaps = 32/220 (14%)
Query: 767 ATNGFSE---NNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQHERAFK-SFDTECEVMKS 821
A SE N IG G+ G+VY + G A+K HE + E E+++
Sbjct: 69 AAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRD 128
Query: 822 IRHRNLTKIISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEY 881
+ H N+ K + ++LE+M GSLE G +I D ++ + S + Y
Sbjct: 129 VNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLE-----GTHIADEQFLADVARQILSGIAY 183
Query: 882 LHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQ-TQTLATLGYMAP 940
LH ++H D+KPSN+L++ ++DFG++++L Q+M ++ T+ YM+P
Sbjct: 184 LH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRIL---AQTMDPCNSSVGTIAYMSP 237
Query: 941 EYGREGRVSTK----------GDVYSFGILLMETFTRRKP 970
E R++T GD++S G+ ++E + R P
Sbjct: 238 E-----RINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 9e-17
Identities = 66/285 (23%), Positives = 118/285 (41%), Gaps = 37/285 (12%)
Query: 777 IGRGSFGSVYIARL-----QNGIEVAVKTFDLQH-ERAFKSFDTECEVMKSIRHRNLTKI 830
+G G FG V + R G +VAVK+ + E E+++++ H N+ K
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 831 ISSCSNEDFKA--LILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSA 888
C+ + LI+E++ +GSL++ L +++ Q+L + + ++YL S
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG---SR 128
Query: 889 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTL-ATLGYMAPEYGREGR 947
+H DL NVL++ + DFG+ K + + + T L + + + APE + +
Sbjct: 129 QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSK 188
Query: 948 VSTKGDVYSFGILLMETFT----RRKPTDEIFS------GEMTLKHWVNDFLPISMMKII 997
DV+SFG+ L E T P G+MT+ V
Sbjct: 189 FYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR----------- 237
Query: 998 DANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVR 1042
++ E K C V+ L +C P +R T + ++
Sbjct: 238 ----VLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIE 278
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 1e-16
Identities = 86/334 (25%), Positives = 135/334 (40%), Gaps = 77/334 (23%)
Query: 750 VPLEATWRRFSYLELFQATNGFSENNLI-----GRGSFGSVYIA--------RLQNGIEV 796
+PL+ W F + L+ G G FG V A R + V
Sbjct: 1 LPLDPKWE-------------FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTV 47
Query: 797 AVKTF-DLQHERAFKSFDTECEVMKSI-RHRNLTKIISSCSNEDFKALILEYMRNGSLEK 854
AVK D ++ +E E+MK I +H+N+ ++ C+ E +I+EY G+L +
Sbjct: 48 AVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLRE 107
Query: 855 CLYS-----GNYILDI---------FQRL-NIMIDVASALEYLHFGYSAPVIHCDLKPSN 899
L + +Y DI F+ L + VA +EYL S IH DL N
Sbjct: 108 FLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARN 164
Query: 900 VLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGI 959
VL+ ++ V ++DFG+A+ + D + + +MAPE + + + DV+SFGI
Sbjct: 165 VLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGI 224
Query: 960 LLMETFTRRK------PTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHFAAKE 1013
L+ E FT P +E+F L+ E
Sbjct: 225 LMWEIFTLGGSPYPGIPVEELFK-------------------------LLREGHRMDKPS 259
Query: 1014 QCASSVFNLAMECTVESPDERITAKEIVRRLLKI 1047
C ++ L EC P +R T K++V L K+
Sbjct: 260 NCTHELYMLMRECWHAVPTQRPTFKQLVEALDKV 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 1e-16
Identities = 47/160 (29%), Positives = 79/160 (49%), Gaps = 25/160 (15%)
Query: 563 VNFSSNFLTGPLPLEIENLKALTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQGSI 622
+ + L G +P +I L+ L +++ S N++ G IP ++G + L+ L L +N GSI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 623 PDSVGDLISLKSLNLSNNNLSGPIPTSLEKLSDLKELNLSFNKLEGEIPRGGPFVNFSAK 682
P+S+G L SL+ LNL+ N+LSG +P +L GG ++ ++
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAAL----------------------GGRLLHRASF 520
Query: 683 SFMGNNLLCGSPNLQVPPCRASIDHISKKNALLLGIILPF 722
+F N LCG P L C + + K + G+ + F
Sbjct: 521 NFTDNAGLCGIPGL--RACGPHLS-VGAKIGIAFGVSVAF 557
|
Length = 623 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 1e-16
Identities = 71/286 (24%), Positives = 114/286 (39%), Gaps = 39/286 (13%)
Query: 774 NNLIGRGSFGSVYIARLQN----GIEVAVKTF--DLQHERAFKSFDTECEVMKSIRHRNL 827
IG G FG VY + I VAVKT K F E +M+ H ++
Sbjct: 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREK-FLQEAYIMRQFDHPHI 69
Query: 828 TKIISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYS 887
K+I + E+ +++E G L L Y LD+ + +++AL YL S
Sbjct: 70 VKLIGVIT-ENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE---S 125
Query: 888 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSM-TQTQTLATLGYMAPEYGREG 946
+H D+ NVL+ L DFG+++ L ED+S ++ + +MAPE
Sbjct: 126 KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYL--EDESYYKASKGKLPIKWMAPESINFR 183
Query: 947 RVSTKGDVYSFGILLMETFTR-RKPTDEIFSGEMTLKHWV--NDFLPISMMKIIDANLLI 1003
R ++ DV+ FG+ + E KP V ND + +I + L
Sbjct: 184 RFTSASDVWMFGVCMWEILMLGVKPF-----------QGVKNNDVI----GRIENGERL- 227
Query: 1004 TEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKIRD 1049
C ++++L +C P +R E+ +L I
Sbjct: 228 ------PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 1e-16
Identities = 59/209 (28%), Positives = 98/209 (46%), Gaps = 26/209 (12%)
Query: 775 NLIGRGSFGSVYIARLQ---NGIEVAVKTF-DLQHERAFKSFDTECEVM-KSIRHRNLTK 829
++IG G+FG V A ++ + A+K + E + F E EV+ K H N+
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67
Query: 830 IISSCSNEDFKALILEYMRNGSLEKCLYSGNYI---------------LDIFQRLNIMID 874
++ +C N + + +EY G+L L + L Q L D
Sbjct: 68 LLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127
Query: 875 VASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLAT 934
VA+ ++YL IH DL NVL+ +N+ + ++DFG+++ GE+ + +T
Sbjct: 128 VATGMQYLS---EKQFIHRDLAARNVLVGENLASKIADFGLSR---GEEVYVKKTMGRLP 181
Query: 935 LGYMAPEYGREGRVSTKGDVYSFGILLME 963
+ +MA E +TK DV+SFG+LL E
Sbjct: 182 VRWMAIESLNYSVYTTKSDVWSFGVLLWE 210
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 1e-16
Identities = 55/200 (27%), Positives = 91/200 (45%), Gaps = 14/200 (7%)
Query: 777 IGRGSFGSVYIAR-LQNGIEVAVKTF---DLQHERAFKSFDTECEVMKSIRHRNLTKIIS 832
I +G++G V++A+ G A+K D+ + TE +++ + + K+
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 833 SCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIH 892
S + L++EY+ G L L + LD + ++ ALEYLH S +IH
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLENVGS-LDEDVARIYIAEIVLALEYLH---SNGIIH 116
Query: 893 CDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQ------TQTLATLGYMAPEYGREG 946
DLKP N+L+D N L+DFG++K+ + Q + + T Y+APE
Sbjct: 117 RDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQ 176
Query: 947 RVSTKGDVYSFGILLMETFT 966
S D +S G +L E
Sbjct: 177 GHSKTVDWWSLGCILYEFLV 196
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 1e-16
Identities = 56/210 (26%), Positives = 94/210 (44%), Gaps = 12/210 (5%)
Query: 768 TNGFSENNLIGRGSFGSVYIAR-LQNGIEVAVKT---FDLQHERAFKSFDTECEVMKSIR 823
F IG+G F VY A L +G VA+K F++ +A + E +++K +
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 824 HRNLTKIISSCSNEDFKALILEYMRNGSLE---KCLYSGNYILDIFQRLNIMIDVASALE 880
H N+ K ++S + ++LE G L K ++ + + SALE
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 881 YLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAP 940
++H S ++H D+KP+NV + V L D G+ + ++ + T YM+P
Sbjct: 121 HMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVGTPYYMSP 175
Query: 941 EYGREGRVSTKGDVYSFGILLMETFTRRKP 970
E E + K D++S G LL E + P
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 2e-16
Identities = 74/290 (25%), Positives = 119/290 (41%), Gaps = 46/290 (15%)
Query: 775 NLIGRGSFGSVYIA--RLQNG----IEVAVKTF-DLQHERAFKSFDTECEVMKSIRHRNL 827
+G G+FG VY R ++G ++VAVKT + E+ F E +M H+N+
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 828 TKIISSCSNEDFKALILEYMRNGSLEKCLYSGN------YILDIFQRLNIMIDVASALEY 881
++I + ++LE M G L+ L L + L DVA +Y
Sbjct: 72 VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131
Query: 882 L---HFGYSAPVIHCDLKPSNVLLDD---NMVAHLSDFGIAKLLIGEDQSMTQTQTLATL 935
L HF IH D+ N LL VA ++DFG+A+ + + + +
Sbjct: 132 LEENHF------IHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPI 185
Query: 936 GYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFS-GEMTLKHWVNDFLPISMM 994
+M PE +G ++K DV+SFG+LL E IFS G M N
Sbjct: 186 KWMPPEAFLDGIFTSKTDVWSFGVLLWE----------IFSLGYMPYPGRTNQ------- 228
Query: 995 KIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRL 1044
+ +T + C V+ + +C +P++R I+ R+
Sbjct: 229 ---EVMEFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERI 275
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 2e-16
Identities = 60/193 (31%), Positives = 93/193 (48%), Gaps = 18/193 (9%)
Query: 777 IGRGSFGSVYIA-RLQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCS 835
IG+G+ G+VY A + G EVA+K +LQ + + E VM+ +H N+ + S
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86
Query: 836 NEDFKALILEYMRNGSL-----EKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPV 890
D +++EY+ GSL E C+ G Q + + ALE+LH S V
Sbjct: 87 VGDELWVVMEYLAGGSLTDVVTETCMDEG-------QIAAVCRECLQALEFLH---SNQV 136
Query: 891 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVST 950
IH D+K N+LL + L+DFG + E ++ + T +MAPE
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGP 194
Query: 951 KGDVYSFGILLME 963
K D++S GI+ +E
Sbjct: 195 KVDIWSLGIMAIE 207
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.6 bits (200), Expect = 2e-16
Identities = 76/300 (25%), Positives = 119/300 (39%), Gaps = 68/300 (22%)
Query: 777 IGRGSFGSVYIAR-LQNGIEVAVKTFDLQHE---------RAFKSFDTECEVMKSIRHRN 826
+G G++G VY AR + G VA+K L +E R E ++K ++H N
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALR-------EISLLKELKHPN 59
Query: 827 LTKIISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGY 886
+ K++ E L+ EY L+K L L +IM + L Y H
Sbjct: 60 IVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH--- 115
Query: 887 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPE----- 941
S ++H DLKP N+L++ + V L+DFG+A+ ++ T + TL Y APE
Sbjct: 116 SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY--THEVVTLWYRAPEILLGS 173
Query: 942 --YGREGRVSTKGDVYSFGILLMETFTRR--------------------KPTDEIFSGEM 979
Y ST D++S G + E T + PT+E + G
Sbjct: 174 KHY------STAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVT 227
Query: 980 TLKHWVNDFLPISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKE 1039
L + F L +K + +L + +P +RI+AKE
Sbjct: 228 KLPDYKPTF------PKFPPKDL---EKVLPRLD---PEGIDLLSKMLQYNPAKRISAKE 275
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 2e-16
Identities = 68/268 (25%), Positives = 118/268 (44%), Gaps = 28/268 (10%)
Query: 777 IGRGSFGSVYIAR-LQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCS 835
IG GS G V IA G +VAVK DL+ ++ + E +M+ +H N+ ++ SS
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL 86
Query: 836 NEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDL 895
D +++E++ G+L + ++ Q + + V AL +LH + VIH D+
Sbjct: 87 VGDELWVVMEFLEGGALTDIVTHTR--MNEEQIATVCLAVLKALSFLH---AQGVIHRDI 141
Query: 896 KPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGY-MAPEYGREGRVSTKGDV 954
K ++LL + LSDFG + + + + ++L Y MAPE T+ D+
Sbjct: 142 KSDSILLTSDGRVKLSDFGFCAQV---SKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDI 198
Query: 955 YSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHFAAKEQ 1014
+S GI+++E P + N+ P+ MK I N +
Sbjct: 199 WSLGIMVIEMVDGEPP-------------YFNE-PPLQAMKRIRDN----LPPKLKNLHK 240
Query: 1015 CASSVFNLAMECTVESPDERITAKEIVR 1042
+ + + V P +R TA E++
Sbjct: 241 VSPRLRSFLDRMLVRDPAQRATAAELLN 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 80.0 bits (198), Expect = 2e-16
Identities = 65/234 (27%), Positives = 100/234 (42%), Gaps = 41/234 (17%)
Query: 777 IGRGSFGSVYIARLQN-GIEVAVK------TFDLQHERAFKSFDTECEVMKSIRHRNLTK 829
+G G FG V + ++++ A+K + + S E E+++ H + K
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFS---EKEILEECNHPFIVK 57
Query: 830 IISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAP 889
+ + ++ + +++EY G L L D + + V A EYLH +
Sbjct: 58 LYRTFKDKKYIYMLMEYCLGGELWTILRDRGL-FDEYTARFYIACVVLAFEYLH---NRG 113
Query: 890 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTL-ATLGYMAPEYGREGRV 948
+I+ DLKP N+LLD N L DFG AK L +S +T T T Y+APE +
Sbjct: 114 IIYRDLKPENLLLDSNGYVKLVDFGFAKKL----KSGQKTWTFCGTPEYVAPEI-----I 164
Query: 949 STKG-----DVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKII 997
KG D +S GILL E T R P F + D P+ + I
Sbjct: 165 LNKGYDFSVDYWSLGILLYELLTGRPP----FGED--------DEDPMEIYNDI 206
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 3e-16
Identities = 58/222 (26%), Positives = 112/222 (50%), Gaps = 11/222 (4%)
Query: 776 LIGRGSFGSVYIARLQNG-IEVAVKTFDLQH--ERAFKSFDTECEVMKSIRHRNLTKIIS 832
++GRG+FG V++ R + V +K ++ + + EC+V+K + H N+ +
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66
Query: 833 SCSNEDFKALILEYMRNGSLEKCLYS-GNYILDIFQRLNIMIDVASALEYLHFGYSAPVI 891
+ + +++EY G+L + + N +LD L+ + + AL ++H + ++
Sbjct: 67 NFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH---TKLIL 123
Query: 892 HCDLKPSNVLLDDN-MVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVST 950
H DLK N+LLD + MV + DFGI+K+L + ++ T + T Y++PE +
Sbjct: 124 HRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT---VVGTPCYISPELCEGKPYNQ 180
Query: 951 KGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPIS 992
K D+++ G +L E + ++ + + LK F PIS
Sbjct: 181 KSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPIS 222
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 80.3 bits (199), Expect = 3e-16
Identities = 57/207 (27%), Positives = 98/207 (47%), Gaps = 25/207 (12%)
Query: 775 NLIGRGSFGSVYIAR-LQNGIEVAVKTFDLQHERAFK---SFDT--ECEVMKSIRHRNLT 828
+G G++ VY AR + G VA+K L + K +F E ++++ ++H N+
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65
Query: 829 KIISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSA 888
++ ++ L+ E+M LEK + + +L + M+ LEYLH +
Sbjct: 66 GLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW-- 122
Query: 889 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPE------- 941
++H DLKP+N+L+ + V L+DFG+A+ ++ MT Q + T Y APE
Sbjct: 123 -ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMT-HQ-VVTRWYRAPELLFGARH 179
Query: 942 YGREGRVSTKGDVYSFGILLMETFTRR 968
YG D++S G + E R
Sbjct: 180 YG------VGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 3e-16
Identities = 76/302 (25%), Positives = 128/302 (42%), Gaps = 59/302 (19%)
Query: 777 IGRGSFGSVYIA--------RLQNGIEVAVKTF-DLQHERAFKSFDTECEVMKSI-RHRN 826
+G G FG V +A + + VAVK D ++ +E E+MK I +H+N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 827 LTKIISSCSNEDFKALILEYMRNGSLEKCLYSG-----NYILD---------IFQRL-NI 871
+ ++ +C+ + +++EY G+L + L + +Y D F+ L +
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 872 MIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQT 931
VA +EYL S IH DL NVL+ ++ V ++DFG+A+ + D T
Sbjct: 140 AYQVARGMEYLA---SQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196
Query: 932 LATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRK------PTDEIFSGEMTLKHWV 985
+ +MAPE + + + DV+SFG+LL E FT P +E+F
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK--------- 247
Query: 986 NDFLPISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLL 1045
L+ E C ++ + EC P +R T K++V L
Sbjct: 248 ----------------LLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLD 291
Query: 1046 KI 1047
++
Sbjct: 292 RV 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 4e-16
Identities = 63/234 (26%), Positives = 101/234 (43%), Gaps = 21/234 (8%)
Query: 771 FSENNLIGRGSFGSVYIA-RLQNGIEVAVKTFDLQHERAFKSFDT--ECEVMKSIRHRNL 827
F N IG+GSFG V+ R + A+K DL + + E V+ + +
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 828 TKIISSCSNEDFKALILEYMRNGSLEKCLYSG-------NYILDIFQRLNIMIDVASALE 880
+ S ++ +++EY NG L K L + + F I + L
Sbjct: 62 IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFF------IQILLGLA 115
Query: 881 YLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAP 940
+LH S ++H D+K N+ LD + D G+AKLL D + + T Y++P
Sbjct: 116 HLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLL--SDNTNFANTIVGTPYYLSP 170
Query: 941 EYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMM 994
E + + K DV++ G++L E T + P D G + LK F P+S M
Sbjct: 171 ELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQM 224
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 4e-16
Identities = 60/222 (27%), Positives = 100/222 (45%), Gaps = 51/222 (22%)
Query: 776 LIGRGSFGSVYIAR-LQNGIEVAVKTFDLQHE-----RAFKSFDTECEVMKSIRHRNLTK 829
L+G+G+FG VY+ + G E+AVK + + + + E +++K+++H + +
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68
Query: 830 IISSCSNEDFKALI-LEYMRNGSLEKCL---------YSGNYILDIFQRLNIMIDVASAL 879
C +D I +EYM GS++ L + Y I + +
Sbjct: 69 YYG-CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILE----------GV 117
Query: 880 EYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQT-----LAT 934
EYLH S ++H D+K +N+L D L DFG +K L Q++ + T T
Sbjct: 118 EYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRL----QTICSSGTGMKSVTGT 170
Query: 935 LGYMAPE------YGREGRVSTKGDVYSFGILLMETFTRRKP 970
+M+PE YGR K DV+S G ++E T + P
Sbjct: 171 PYWMSPEVISGEGYGR------KADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 4e-16
Identities = 62/214 (28%), Positives = 101/214 (47%), Gaps = 20/214 (9%)
Query: 771 FSENNLIGRGSFGSVYIARLQ----NGIEVAVKTF--DLQHERAFKSFDTECEVMKSIRH 824
F+ ++G+G FGSV A+L+ + +VAVK D+ + F E MK H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 825 RNLTKIISSCSNEDFKA------LILEYMRNGSLEKCLYSGN-----YILDIFQRLNIMI 873
N+ K+I K +IL +M++G L L + L + + MI
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 874 DVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLA 933
D+AS +EYL S IH DL N +L++NM ++DFG++K + D +
Sbjct: 121 DIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177
Query: 934 TLGYMAPEYGREGRVSTKGDVYSFGILLMETFTR 967
+ ++A E + +T DV++FG+ + E TR
Sbjct: 178 PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTR 211
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 6e-16
Identities = 64/207 (30%), Positives = 101/207 (48%), Gaps = 19/207 (9%)
Query: 777 IGRGSFGSVYIARLQNG---IEVAVKTFDLQ--HERAFKSFDTECEVMKSIRHRNLTKII 831
+G G FGSV +L ++VAVKT + + F +E MK H N+ ++I
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 832 SSC----SNEDFKA--LILEYMRNGSLEK-CLYS--GN--YILDIFQRLNIMIDVASALE 880
C +E + + +IL +M++G L LYS G+ L + M D+AS +E
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 881 YLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAP 940
YL S IH DL N +L++NM ++DFG++K + D + ++A
Sbjct: 127 YLS---SKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183
Query: 941 EYGREGRVSTKGDVYSFGILLMETFTR 967
E + +TK DV+SFG+ + E TR
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEIATR 210
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 6e-16
Identities = 62/206 (30%), Positives = 94/206 (45%), Gaps = 27/206 (13%)
Query: 777 IGRGSFGSVYIAR-LQNGIEVAVKTFDL---QHERAFKSFDTECEVMKSIRHRNLTKIIS 832
IG GSFG+VY AR ++ VA+K Q ++ E ++ +RH N +
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82
Query: 833 SCSNEDFKALILEYMRNGSLEKCLYSGNYILDI----FQRLNIMIDVASALEYLHFGYSA 888
E L++EY CL S + IL++ Q + I AL+ L + +S
Sbjct: 83 CYLREHTAWLVMEY--------CLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSH 134
Query: 889 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQT-LATLGYMAPEY---GR 944
IH D+K N+LL + L+DFG A L ++ + + T +MAPE
Sbjct: 135 ERIHRDIKAGNILLTEPGTVKLADFGSASL-------VSPANSFVGTPYWMAPEVILAMD 187
Query: 945 EGRVSTKGDVYSFGILLMETFTRRKP 970
EG+ K DV+S GI +E R+ P
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKPP 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 7e-16
Identities = 72/301 (23%), Positives = 129/301 (42%), Gaps = 52/301 (17%)
Query: 777 IGRGSFGSV------YIARLQNGIEVAVKTF-DLQHERAFKSFDTECEVMKSIRHRNLTK 829
+G G FG V + VAVK + + +E ++K + H ++ K
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 830 IISSCSNEDFKALILEYMRNGSLEKCLYSG-----NYILDIFQRLNIMID---------- 874
+ +CS + LI+EY + GSL L +Y+ R + +D
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 875 --------VASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSM 926
++ ++YL ++H DL NVL+ + +SDFG+++ + ED +
Sbjct: 128 DLISFAWQISRGMQYLA---EMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184
Query: 927 TQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVN 986
+++ + +MA E + +T+ DV+SFG+LL E T G N
Sbjct: 185 KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT--------LGG--------N 228
Query: 987 DFLPISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLK 1046
+ I+ ++ NLL T + E C+ ++NL + C + PD+R T +I + L K
Sbjct: 229 PYPGIAPERLF--NLLKTGYR-MERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEK 285
Query: 1047 I 1047
+
Sbjct: 286 M 286
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 78.7 bits (195), Expect = 8e-16
Identities = 62/209 (29%), Positives = 93/209 (44%), Gaps = 49/209 (23%)
Query: 777 IGRGSFGSVYIARL-QNGIEVAVKTFDLQHERAFKSFD---TECEVMKSIRHRNLTKIIS 832
+G GSFG V + R +G A+K K + E +++SIRH L +
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG 68
Query: 833 SCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIM----IDVA--------SALE 880
S ++ L++EY+ G ++F L VA ALE
Sbjct: 69 SFQDDSNLYLVMEYVPGG-------------ELFSHLRKSGRFPEPVARFYAAQVVLALE 115
Query: 881 YLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTL-ATLGYMA 939
YLH S +++ DLKP N+LLD + ++DFG AK + G +T TL T Y+A
Sbjct: 116 YLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG------RTYTLCGTPEYLA 166
Query: 940 PEYGREGRVSTKG-----DVYSFGILLME 963
PE + +KG D ++ GIL+ E
Sbjct: 167 PEI-----ILSKGYGKAVDWWALGILIYE 190
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 2e-15
Identities = 39/87 (44%), Positives = 56/87 (64%), Gaps = 1/87 (1%)
Query: 124 LLLHNNFLTGTIPFSIFKLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQLSGS 183
L L N L G IP I KL L + LS N++ G IP +LG+++SL++LDLS N +GS
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPP-SLGSITSLEVLDLSYNSFNGS 481
Query: 184 IPSFIFKISSLQALHFGNNRLSGELPA 210
IP + +++SL+ L+ N LSG +PA
Sbjct: 482 IPESLGQLTSLRILNLNGNSLSGRVPA 508
|
Length = 623 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 2e-15
Identities = 76/302 (25%), Positives = 125/302 (41%), Gaps = 59/302 (19%)
Query: 777 IGRGSFGSVYIA--------RLQNGIEVAVKTFDLQ-HERAFKSFDTECEVMKSI-RHRN 826
+G G FG V +A + +VAVK E+ +E E+MK I +H+N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 827 LTKIISSCSNEDFKALILEYMRNGSLEKCL---------YSGN------YILDIFQRLNI 871
+ ++ +C+ + +I+EY G+L + L Y N L ++
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 872 MIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQT 931
VA +EYL S IH DL NVL+ ++ V ++DFG+A+ + D T
Sbjct: 146 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202
Query: 932 LATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRK------PTDEIFSGEMTLKHWV 985
+ +MAPE + + + DV+SFG+LL E FT P +E+F
Sbjct: 203 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK--------- 253
Query: 986 NDFLPISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLL 1045
L+ E C + ++ + +C P +R T K++V L
Sbjct: 254 ----------------LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 297
Query: 1046 KI 1047
+I
Sbjct: 298 RI 299
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 2e-15
Identities = 58/213 (27%), Positives = 94/213 (44%), Gaps = 23/213 (10%)
Query: 771 FSENNL-----IGRGSFGSVY------IARLQNGIEVAVK----TFDLQHERAFKSFDTE 815
F NNL +G G+FG V +++ ++VAVK T A S E
Sbjct: 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMS---E 88
Query: 816 CEVMKSI-RHRNLTKIISSCSNEDFKALILEYMRNGSLEKCLYSGNY-ILDIFQRLNIMI 873
++M + H N+ ++ +C+ +I EY G L L L + L+
Sbjct: 89 LKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSY 148
Query: 874 DVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLA 933
VA + +L S IH DL NVLL + + DFG+A+ ++ + + +
Sbjct: 149 QVAKGMAFLA---SKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARL 205
Query: 934 TLGYMAPEYGREGRVSTKGDVYSFGILLMETFT 966
+ +MAPE + + DV+S+GILL E F+
Sbjct: 206 PVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 2e-15
Identities = 59/207 (28%), Positives = 95/207 (45%), Gaps = 12/207 (5%)
Query: 771 FSENNLIGRGSFGSVYIAR-LQNGIEVAVKT---FDLQHERAFKSFDTECEVMKSIRHRN 826
F IGRG F VY A L +G+ VA+K FDL +A E +++K + H N
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63
Query: 827 LTKIISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNI---MIDVASALEYLH 883
+ K +S ++ ++LE G L + + + + + + SALE++H
Sbjct: 64 VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH 123
Query: 884 FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYG 943
S V+H D+KP+NV + V L D G+ + ++ + T YM+PE
Sbjct: 124 ---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVGTPYYMSPERI 178
Query: 944 REGRVSTKGDVYSFGILLMETFTRRKP 970
E + K D++S G LL E + P
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 2e-15
Identities = 76/289 (26%), Positives = 119/289 (41%), Gaps = 47/289 (16%)
Query: 771 FSENNLIGRGSFGSVYIARLQNGIE------VAVKTFDLQH-ERAFKSFDTECEVMKSIR 823
F++ IG+GSFG VY GI+ VA+K DL+ E + E V+
Sbjct: 6 FTKLERIGKGSFGEVY-----KGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCD 60
Query: 824 HRNLTKIISSCSNEDFKALILEYMRNGSLEKCLYSG----NYILDIFQRLNIMIDVASAL 879
+T+ S +I+EY+ GS L G YI I + ++ L
Sbjct: 61 SPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILR------EILKGL 114
Query: 880 EYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMA 939
+YLH S IH D+K +NVLL + L+DFG+A L D + + + T +MA
Sbjct: 115 DYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLT--DTQIKRNTFVGTPFWMA 169
Query: 940 PEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDA 999
PE ++ K D++S GI +E P +D P+ ++
Sbjct: 170 PEVIKQSAYDFKADIWSLGITAIELAKGEPPN--------------SDLHPMRVL----- 210
Query: 1000 NLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKIR 1048
LI ++ + Q + C + P R TAKE+++ R
Sbjct: 211 -FLIPKNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITR 258
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 3e-15
Identities = 73/300 (24%), Positives = 127/300 (42%), Gaps = 47/300 (15%)
Query: 777 IGRGSFGSVYIAR---LQNGIEVAVKTFDLQ-------------HERAFKSFDTECEVMK 820
+G G FG V++ L + FD Q + A F E ++M
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72
Query: 821 SIRHRNLTKIISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLN---------- 870
+++ N+ +++ C ++D +I EYM NG L + L S I F N
Sbjct: 73 RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFL-SQREIESTFTHANNIPSVSIANL 131
Query: 871 --IMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQ 928
+ + +AS ++YL S +H DL N L+ ++ ++DFG+++ L D Q
Sbjct: 132 LYMAVQIASGMKYLA---SLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQ 188
Query: 929 TQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFT--RRKPTDEIFSGEMTLKHWVN 986
+ + + +MA E G+ +T DV++FG+ L E FT + +P + S E +++
Sbjct: 189 GRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPY-SLLSDEQVIEN-TG 246
Query: 987 DFLPISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLK 1046
+F +I + + C S VF L M C +R T +I L +
Sbjct: 247 EFFRNQGRQI-----------YLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 3e-15
Identities = 62/273 (22%), Positives = 123/273 (45%), Gaps = 29/273 (10%)
Query: 777 IGRGSFGS-VYIARLQNGIEVAVKTFDLQH--ERAFKSFDTECEVMKSIRHRNLTKIISS 833
+G+G+FG R ++ V K +L E+ + E ++ ++H N+ +
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNH 67
Query: 834 CSNEDFKALILEYMRNGSL-EKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIH 892
+++ + +EY G+L +K + + + L + + SA+ Y+H A ++H
Sbjct: 68 FMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH---KAGILH 124
Query: 893 CDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKG 952
D+K N+ L + L DFGI+K+L G + SM +T + T YM+PE + + + K
Sbjct: 125 RDIKTLNIFLTKAGLIKLGDFGISKIL-GSEYSMAET-VVGTPYYMSPELCQGVKYNFKS 182
Query: 953 DVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHFAAK 1012
D+++ G +L E T ++ F ++KI+ N +
Sbjct: 183 DIWALGCVLYELLTLKR----TFDA---------TNPLNLVVKIVQGN-------YTPVV 222
Query: 1013 EQCASSVFNLAMECTVESPDERITAKEIVRRLL 1045
+S + +L + P++R TA E++ + L
Sbjct: 223 SVYSSELISLVHSLLQQDPEKRPTADEVLDQPL 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 3e-15
Identities = 67/216 (31%), Positives = 109/216 (50%), Gaps = 35/216 (16%)
Query: 775 NLIGRGSFGSVYIARLQN-GIEVAVKTFDLQHERAFKSFDT----ECEVMKSIRHRNLTK 829
IG G++G VY AR ++ G VA+K L +E+ + F E ++++ + HRN+
Sbjct: 13 GQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK--EGFPITAIREIKILRQLNHRNIVN 70
Query: 830 IISSCSNE----DFKA------LILEYMRN---GSLEKCL--YSGNYILDIFQRLNIMID 874
+ +++ DFK L+ EYM + G LE L +S ++I ++L
Sbjct: 71 LKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQL----- 125
Query: 875 VASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLAT 934
LE L++ + +H D+K SN+LL++ L+DFG+A+L E+ T + T
Sbjct: 126 ----LEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRP-YTNKVIT 180
Query: 935 LGYMAPE--YGREGRVSTKGDVYSFGILLMETFTRR 968
L Y PE G E R DV+S G +L E FT++
Sbjct: 181 LWYRPPELLLGEE-RYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 4e-15
Identities = 70/225 (31%), Positives = 106/225 (47%), Gaps = 35/225 (15%)
Query: 771 FSENNL-----IGRGSFGSVYIARLQN-GIEVAVK----TFDLQHERAFKSFDTECE-VM 819
F+ +L IGRG+FG+V + G +AVK T D E+ K + + VM
Sbjct: 1 FTAEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVD---EKEQKRLLMDLDVVM 57
Query: 820 KSIRHRNLTKIISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRL---NIMIDVA 876
+S + K + E + +E M + SL+K Y Y+ ++ + + I+ +A
Sbjct: 58 RSSDCPYIVKFYGALFREGDCWICMELM-DISLDK-FY--KYVYEVLKSVIPEEILGKIA 113
Query: 877 ----SALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTL 932
AL YL +IH D+KPSN+LLD N L DFGI+ L+ S+ +T+
Sbjct: 114 VATVKALNYLK--EELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV---DSIAKTRDA 168
Query: 933 ATLGYMAPE----YGREGRVSTKGDVYSFGILLMETFTRRKPTDE 973
YMAPE R+G + DV+S GI L E T + P +
Sbjct: 169 GCRPYMAPERIDPSARDG-YDVRSDVWSLGITLYEVATGKFPYPK 212
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 8e-15
Identities = 63/226 (27%), Positives = 104/226 (46%), Gaps = 49/226 (21%)
Query: 777 IGRGSFGSVYIA-RLQNGIEVAVKTFDLQHERAFKSFDT---------ECEVMKSIRHRN 826
IG G++G V A ++G +VA+K + +FD E ++++ +H N
Sbjct: 13 IGSGAYGVVCSAIDTRSGKKVAIK-------KIPHAFDVPTLAKRTLRELKILRHFKHDN 65
Query: 827 LTKI--ISSCSNEDFKA--LILEYMRNGSLEKCLYSG--------NYILDIFQRLNIMID 874
+ I I DFK ++++ M + L ++S Y L +Q L
Sbjct: 66 IIAIRDILRPPGADFKDVYVVMDLMES-DLHHIIHSDQPLTEEHIRYFL--YQLLR---- 118
Query: 875 VASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIG--EDQSMTQTQTL 932
L+Y+H SA VIH DLKPSN+L++++ + DFG+A+ L + T+ +
Sbjct: 119 ---GLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYV 172
Query: 933 ATLGYMAPEYGRE-GRVSTKGDVYSFGILLMETFTRRKPTDEIFSG 977
AT Y APE +T D++S G + E RR ++F G
Sbjct: 173 ATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRR----QLFPG 214
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 1e-14
Identities = 65/265 (24%), Positives = 112/265 (42%), Gaps = 32/265 (12%)
Query: 777 IGRGSFGSV---YIARLQNGIEVAVKTF--DLQHERAFKSFDTECEVMKSIRHRNLTKII 831
+G G+FG+V ++ VAVK D E VM+ + + + ++I
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 832 SSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVI 891
C E + L++E G L K L ++ + ++ V+ ++YL +
Sbjct: 63 GICEAESW-MLVMELAELGPLNKFLQKNKHVTE-KNITELVHQVSMGMKYLE---ETNFV 117
Query: 892 HCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLAT--LGYMAPEYGREGRVS 949
H DL NVLL A +SDFG++K L G D++ + +T + + APE + S
Sbjct: 118 HRDLAARNVLLVTQHYAKISDFGLSKAL-GADENYYKAKTHGKWPVKWYAPECMNYYKFS 176
Query: 950 TKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHF 1009
+K DV+SFG+L+ E F+ + P MK + +I +
Sbjct: 177 SKSDVWSFGVLMWEAFSYGQK-------------------PYKGMKGNEVTQMIESGERM 217
Query: 1010 AAKEQCASSVFNLAMECTVESPDER 1034
++C +++L C DER
Sbjct: 218 ECPQRCPPEMYDLMKLCWTYGVDER 242
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 2e-14
Identities = 69/241 (28%), Positives = 113/241 (46%), Gaps = 24/241 (9%)
Query: 777 IGRGSFGSVYIARLQNGIE-VAVKTFDLQHERAFKSFDTECEV--MKSIRHRNLTKIISS 833
IG GSFG +Y+A+ ++ E +K DL + ++ EV + ++H N+ +S
Sbjct: 8 IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFAS 67
Query: 834 CSNEDFKALILEYMRNGSLEK-------CLYSGNYILDIFQRLNIMIDVASALEYLHFGY 886
+++EY G L K L+S + IL F + ++ L+++H
Sbjct: 68 FQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWF------VQISLGLKHIH--- 118
Query: 887 SAPVIHCDLKPSNVLLDDN-MVAHLSDFGIAKLLIGEDQSMTQTQTLA-TLGYMAPEYGR 944
++H D+K N+ L N MVA L DFGIA+ L + SM T T Y++PE +
Sbjct: 119 DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQL---NDSMELAYTCVGTPYYLSPEICQ 175
Query: 945 EGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLIT 1004
+ K D++S G +L E T + P + ++ LK F PIS D LI+
Sbjct: 176 NRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLIS 235
Query: 1005 E 1005
+
Sbjct: 236 Q 236
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 2e-14
Identities = 59/200 (29%), Positives = 94/200 (47%), Gaps = 18/200 (9%)
Query: 777 IGRGSFGSVYIAR-LQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCS 835
IG+G+ G+VY A + G EVA++ +LQ + + E VM+ ++ N+ + S
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 836 NEDFKALILEYMRNGSL-----EKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPV 890
D +++EY+ GSL E C+ G Q + + ALE+LH S V
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVTETCMDEG-------QIAAVCRECLQALEFLH---SNQV 137
Query: 891 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVST 950
IH D+K N+LL + L+DFG + E ++ + T +MAPE
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGP 195
Query: 951 KGDVYSFGILLMETFTRRKP 970
K D++S GI+ +E P
Sbjct: 196 KVDIWSLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.2 bits (183), Expect = 3e-14
Identities = 61/222 (27%), Positives = 101/222 (45%), Gaps = 27/222 (12%)
Query: 771 FSENNLIGRGSFGSVYIAR-LQNGIEVAVKTFDLQHERAFKSFDT--ECEVMKSIR---H 824
+ E IG G++G+VY AR L G VA+K + T E ++K + H
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60
Query: 825 RNLTKIISSCSNEDFK-----ALILEYMR---NGSLEKCLYSGNYILDIFQRLNIMIDVA 876
N+ +++ C L+ E++ L KC G L ++M +
Sbjct: 61 PNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPG---LPPETIKDLMRQLL 117
Query: 877 SALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLG 936
+++LH S ++H DLKP N+L+ + ++DFG+A++ M T + TL
Sbjct: 118 RGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARIY---SFEMALTSVVVTLW 171
Query: 937 YMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGE 978
Y APE + +T D++S G + E F RR+P +F G
Sbjct: 172 YRAPEVLLQSSYATPVDMWSVGCIFAELF-RRRP---LFRGT 209
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.0 bits (181), Expect = 3e-14
Identities = 58/209 (27%), Positives = 102/209 (48%), Gaps = 26/209 (12%)
Query: 775 NLIGRGSFGSVYIARLQ-NGIEV--AVKTF-DLQHERAFKSFDTECEVM-KSIRHRNLTK 829
++IG G+FG V AR++ +G+ + A+K + + + F E EV+ K H N+
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 830 IISSCSNEDFKALILEYMRNGSLEKCLYSGNYI---------------LDIFQRLNIMID 874
++ +C + + L +EY +G+L L + L Q L+ D
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 875 VASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLAT 934
VA ++YL IH DL N+L+ +N VA ++DFG+++ G++ + +T
Sbjct: 121 VARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLP 174
Query: 935 LGYMAPEYGREGRVSTKGDVYSFGILLME 963
+ +MA E +T DV+S+G+LL E
Sbjct: 175 VRWMAIESLNYSVYTTNSDVWSYGVLLWE 203
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 4e-14
Identities = 69/268 (25%), Positives = 117/268 (43%), Gaps = 29/268 (10%)
Query: 777 IGRGSFGSV-YIARLQNGIEVAVKTFDLQHERAF-KSFDTECEVMKSIRHRNLTKIISSC 834
+G G+ GSV + + G +A K + + + K E ++M R + +
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72
Query: 835 SNEDFKALILEYMRNGSLEKCLYSGNYI-LDIFQRLNIMIDVASALEYLHFGYSAPVIHC 893
NE+ + +E+M GSL++ G I ++I + I + V L YL+ ++H
Sbjct: 73 LNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGK--IAVAVVEGLTYLY--NVHRIMHR 128
Query: 894 DLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGD 953
D+KPSN+L++ L DFG++ LI S+ T + T YM+PE + G+ + K D
Sbjct: 129 DIKPSNILVNSRGQIKLCDFGVSGELI---NSIADT-FVGTSTYMSPERIQGGKYTVKSD 184
Query: 954 VYSFGILLMETFTRRKP------TDEIFSGEMT----LKHWVN--------DFLPISMMK 995
V+S GI ++E + P D+ M L+ V P +
Sbjct: 185 VWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDLRD 244
Query: 996 IIDANLLITEDKHFAAKEQCASSVFNLA 1023
+DA LL + ++ CA F A
Sbjct: 245 FVDACLLKDPTERPTPQQLCAMPPFIQA 272
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 4e-14
Identities = 52/199 (26%), Positives = 87/199 (43%), Gaps = 11/199 (5%)
Query: 777 IGRGSFGSVYIARLQN-GIEVAVKTFD---LQHERAFKSFDTECEVMKSIRHRNLTKIIS 832
+G+G FG V +++ G A K D L+ + + E ++++ + R + +
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 833 SCSNEDFKALILEYMRNGSLEKCLYS-GNYILDIFQRLNIMIDVASALEYLHFGYSAPVI 891
+ +D L++ M G L+ +Y+ G + + + LE+LH ++
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLH---QRRIV 117
Query: 892 HCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTK 951
+ DLKP NVLLDD+ +SD G+A L G T GYMAPE +
Sbjct: 118 YRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKGRAGTPGYMAPEVLQGEVYDFS 174
Query: 952 GDVYSFGILLMETFTRRKP 970
D ++ G L E R P
Sbjct: 175 VDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 74.0 bits (181), Expect = 5e-14
Identities = 75/291 (25%), Positives = 129/291 (44%), Gaps = 46/291 (15%)
Query: 771 FSENNLIGRGSFGSVYIARLQNGIEV-AVKTFDL---QHERAFKSFDTECEVMKSIRHRN 826
F++ IG GSFG+VY AR EV A+K Q ++ E + ++ I+H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 827 LTKIISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVAS----ALEYL 882
+ E L++EY CL S + +L++ ++ +++A+ AL+ L
Sbjct: 87 SIEYKGCYLREHTAWLVMEY--------CLGSASDLLEVHKKPLQEVEIAAITHGALQGL 138
Query: 883 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEY 942
+ +S +IH D+K N+LL + L+DFG A + + + T +MAPE
Sbjct: 139 AYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASI------ASPANSFVGTPYWMAPEV 192
Query: 943 ---GREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDA 999
EG+ K DV+S GI +E RKP P+ M + A
Sbjct: 193 ILAMDEGQYDGKVDVWSLGITCIE-LAERKP-------------------PLFNMNAMSA 232
Query: 1000 NLLITEDKHFAAKEQCASSVF-NLAMECTVESPDERITAKEIVRRLLKIRD 1049
I +++ + S F N C + P +R T++E+++ + +R+
Sbjct: 233 LYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRE 283
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 6e-14
Identities = 59/195 (30%), Positives = 99/195 (50%), Gaps = 8/195 (4%)
Query: 777 IGRGSFGSVYIARLQ-NGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCS 835
IG GS G V IAR + +G +VAVK DL+ ++ + E +M+ +H+N+ ++ S
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88
Query: 836 NEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDL 895
+ +++E+++ G+L + L+ Q + V AL YLH S VIH D+
Sbjct: 89 VGEELWVLMEFLQGGALTDIV--SQTRLNEEQIATVCESVLQALCYLH---SQGVIHRDI 143
Query: 896 KPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVY 955
K ++LL + LSDFG I +D ++ + T +MAPE T+ D++
Sbjct: 144 KSDSILLTLDGRVKLSDFGFCA-QISKDVPKRKS-LVGTPYWMAPEVISRTPYGTEVDIW 201
Query: 956 SFGILLMETFTRRKP 970
S GI+++E P
Sbjct: 202 SLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 6e-14
Identities = 62/200 (31%), Positives = 95/200 (47%), Gaps = 18/200 (9%)
Query: 777 IGRGSFGSVYIA-RLQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCS 835
IG+G+ G+VY A + G EVA+K +LQ + + E VM+ ++ N+ + S
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86
Query: 836 NEDFKALILEYMRNGSL-----EKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPV 890
D +++EY+ GSL E C+ G Q + + AL++LH S V
Sbjct: 87 VGDELWVVMEYLAGGSLTDVVTETCMDEG-------QIAAVCRECLQALDFLH---SNQV 136
Query: 891 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVST 950
IH D+K N+LL + L+DFG + E QS T + T +MAPE
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-QSKRSTM-VGTPYWMAPEVVTRKAYGP 194
Query: 951 KGDVYSFGILLMETFTRRKP 970
K D++S GI+ +E P
Sbjct: 195 KVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 7e-14
Identities = 60/208 (28%), Positives = 97/208 (46%), Gaps = 24/208 (11%)
Query: 777 IGRGSFGSVYIAR-LQNGIEVAVKTFDLQHERAFKSFDTECEV-----MKSIRHRNLTKI 830
IG G++G+VY AR +G VA+K+ +Q T EV +++ H N+ ++
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 831 ISSCSN-----EDFKALILEYMRN---GSLEKCLYSGNYILDIFQRLNIMIDVASALEYL 882
+ C+ E L+ E++ L+K G L ++M L++L
Sbjct: 68 MDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPG---LPAETIKDLMRQFLRGLDFL 124
Query: 883 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEY 942
H ++H DLKP N+L+ L+DFG+A++ M T + TL Y APE
Sbjct: 125 HANC---IVHRDLKPENILVTSGGQVKLADFGLARIY---SCQMALTPVVVTLWYRAPEV 178
Query: 943 GREGRVSTKGDVYSFGILLMETFTRRKP 970
+ +T D++S G + E F RRKP
Sbjct: 179 LLQSTYATPVDMWSVGCIFAEMF-RRKP 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 8e-14
Identities = 64/215 (29%), Positives = 101/215 (46%), Gaps = 39/215 (18%)
Query: 775 NLIGRGSFGSVYIA-RLQNGIEVAVK--------TFDLQHERAFKSFDTECEVMKSIRHR 825
+ IG G++G V A G++VA+K TF + R E ++++ +H
Sbjct: 11 SYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLR-------EIKILRRFKHE 63
Query: 826 NLTKI---ISSCSNEDFKA--LILEYMRNGSLEKCLYSGNYILD-----IFQRLNIMIDV 875
N+ I I S E F ++ E M L K + + + D ++Q L
Sbjct: 64 NIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIKTQHLSNDHIQYFLYQILR----- 117
Query: 876 ASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLI-GEDQSMTQTQTLAT 934
L+Y+H SA V+H DLKPSN+LL+ N + DFG+A++ D + T+ +AT
Sbjct: 118 --GLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVAT 172
Query: 935 LGYMAPEYGREGRVSTKG-DVYSFGILLMETFTRR 968
Y APE + TK D++S G +L E + R
Sbjct: 173 RWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 9e-14
Identities = 63/209 (30%), Positives = 99/209 (47%), Gaps = 25/209 (11%)
Query: 777 IGRGSFGSVYIAR-LQNGIE-VAVKTFDLQHERAFKSFDTECEV-----MKSIRHRNLTK 829
IG G++G V+ AR L+NG VA+K +Q T EV +++ H N+ +
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 830 IISSCS-----NEDFKALILEYMRNG---SLEKCLYSGNYILDIFQRLNIMIDVASALEY 881
+ C+ E L+ E++ L+K G I ++M + L++
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETI---KDMMFQLLRGLDF 125
Query: 882 LHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPE 941
LH S V+H DLKP N+L+ + L+DFG+A++ M T + TL Y APE
Sbjct: 126 LH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVTLWYRAPE 179
Query: 942 YGREGRVSTKGDVYSFGILLMETFTRRKP 970
+ +T D++S G + E F RRKP
Sbjct: 180 VLLQSSYATPVDLWSVGCIFAEMF-RRKP 207
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 9e-14
Identities = 65/281 (23%), Positives = 124/281 (44%), Gaps = 30/281 (10%)
Query: 776 LIGRGSFGSVYIA-RLQNG----IEVAVKTF-DLQHERAFKSFDTECEVMKSIRHRNLTK 829
L+G G FG+V+ + G I VA+KT D + F+ M S+ H + +
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73
Query: 830 IISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAP 889
++ C + L+ + GSL + LD + LN + +A + YL
Sbjct: 74 LLGICPGASLQ-LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLE---EHR 129
Query: 890 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVS 949
++H +L N+LL + + ++DFG+A LL +D+ ++ + +MA E GR +
Sbjct: 130 MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYT 189
Query: 950 TKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHF 1009
+ DV+S+G+ + E + + E P + M+ + L+ + +
Sbjct: 190 HQSDVWSYGVTVWEMMS--------YGAE-----------PYAGMRPHEVPDLLEKGERL 230
Query: 1010 AAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKI-RD 1049
A + C V+ + ++C + + R T KE+ ++ RD
Sbjct: 231 AQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD 271
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 9e-14
Identities = 43/106 (40%), Positives = 56/106 (52%), Gaps = 9/106 (8%)
Query: 871 IMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQ 930
I + + ALEYLH S VIH D+KPSNVL++ N L DFGI+ L+ S+ +T
Sbjct: 108 IAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYLV---DSVAKTI 162
Query: 931 TLATLGYMAPEY----GREGRVSTKGDVYSFGILLMETFTRRKPTD 972
YMAPE + K DV+S GI ++E T R P D
Sbjct: 163 DAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYD 208
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 1e-13
Identities = 32/74 (43%), Positives = 51/74 (68%), Gaps = 1/74 (1%)
Query: 67 DINQ-RRVTALNISYLSLTGNIPRQLGNLSSLEILDLNFNRLSGEIPWELGNLAKLEKLL 125
DI++ R + ++N+S S+ GNIP LG+++SLE+LDL++N +G IP LG L L L
Sbjct: 437 DISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILN 496
Query: 126 LHNNFLTGTIPFSI 139
L+ N L+G +P ++
Sbjct: 497 LNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 1e-13
Identities = 61/195 (31%), Positives = 95/195 (48%), Gaps = 8/195 (4%)
Query: 777 IGRGSFGSVYIAR-LQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCS 835
IG+G+ G+V+ A + G EVA+K +LQ + + E VMK +++ N+ + S
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86
Query: 836 NEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDL 895
D +++EY+ GSL + +D Q + + ALE+LH + VIH D+
Sbjct: 87 VGDELFVVMEYLAGGSLTDVVTET--CMDEAQIAAVCRECLQALEFLH---ANQVIHRDI 141
Query: 896 KPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVY 955
K NVLL + L+DFG + E QS T + T +MAPE K D++
Sbjct: 142 KSDNVLLGMDGSVKLTDFGFCAQITPE-QSKRSTM-VGTPYWMAPEVVTRKAYGPKVDIW 199
Query: 956 SFGILLMETFTRRKP 970
S GI+ +E P
Sbjct: 200 SLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 1e-13
Identities = 56/209 (26%), Positives = 100/209 (47%), Gaps = 26/209 (12%)
Query: 775 NLIGRGSFGSVYIARLQNG---IEVAVKTF-DLQHERAFKSFDTECEVMKSI-RHRNLTK 829
++IG G+FG V AR++ ++ A+K + + + F E EV+ + H N+
Sbjct: 13 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 72
Query: 830 IISSCSNEDFKALILEYMRNGSLEKCLYSGNYI---------------LDIFQRLNIMID 874
++ +C + + L +EY +G+L L + L Q L+ D
Sbjct: 73 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 132
Query: 875 VASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLAT 934
VA ++YL IH DL N+L+ +N VA ++DFG+++ G++ + +T
Sbjct: 133 VARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLP 186
Query: 935 LGYMAPEYGREGRVSTKGDVYSFGILLME 963
+ +MA E +T DV+S+G+LL E
Sbjct: 187 VRWMAIESLNYSVYTTNSDVWSYGVLLWE 215
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 1e-13
Identities = 51/188 (27%), Positives = 81/188 (43%), Gaps = 16/188 (8%)
Query: 791 QNGIEVAVKTFDLQH---ERAFKSFDTECEVMKSIRHRNLTKIISSCSNED-FKALILEY 846
G EVA+K E F E + + H N+ ++ S + EY
Sbjct: 1 MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEY 60
Query: 847 MRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLL---D 903
+ +L + L + + L + +M+ V AL H + ++H DLKP N+++
Sbjct: 61 VPGRTLREVL-AADGALPAGETGRLMLQVLDALACAH---NQGIVHRDLKPQNIMVSQTG 116
Query: 904 DNMVAHLSDFGIAKLLIGEDQSMTQTQTLAT--LG---YMAPEYGREGRVSTKGDVYSFG 958
A + DFGI LL G + T T T LG Y APE R V+ D+Y++G
Sbjct: 117 VRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWG 176
Query: 959 ILLMETFT 966
++ +E T
Sbjct: 177 LIFLECLT 184
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 1e-13
Identities = 63/211 (29%), Positives = 97/211 (45%), Gaps = 25/211 (11%)
Query: 771 FSENNLIGRGSFGSVYIAR-LQNGIEVAVKTFDL---QHERAFKSFDTECEVMKSIRHRN 826
FS+ IG GSFG+VY AR ++N VA+K Q ++ E ++ +RH N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 827 LTKIISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDI----FQRLNIMIDVASALEYL 882
+ E L++EY CL S + +L++ Q + I AL+ L
Sbjct: 77 TIQYRGCYLREHTAWLVMEY--------CLGSASDLLEVHKKPLQEVEIAAVTHGALQGL 128
Query: 883 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEY 942
+ +S +IH D+K N+LL + + L DFG A ++ + T +MAPE
Sbjct: 129 AYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANXFVGTPYWMAPEV 182
Query: 943 ---GREGRVSTKGDVYSFGILLMETFTRRKP 970
EG+ K DV+S GI +E R+ P
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIELAERKPP 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 1e-13
Identities = 65/290 (22%), Positives = 120/290 (41%), Gaps = 44/290 (15%)
Query: 777 IGRGSFGSVYIARL------QNGIEVAVKTFDLQHERAFKS-FDTECEVMKSIRHRNLTK 829
+G FG VY L + VA+KT + E + F E + ++H N+
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72
Query: 830 IISSCSNEDFKALILEYMRNGSLEKCLY---------------SGNYILDIFQRLNIMID 874
++ + E ++I Y + L + L + L+ ++I+
Sbjct: 73 LLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQ 132
Query: 875 VASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLAT 934
+A+ +E+L S V+H DL NVL+ D + +SD G+ + + D +L
Sbjct: 133 IAAGMEFLS---SHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLP 189
Query: 935 LGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMM 994
+ +M+PE G+ S D++S+G++L E F+ + + + S
Sbjct: 190 IRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS----------------YGLQPYCGYSNQ 233
Query: 995 KIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRL 1044
+I+ +I + + C + V+ L +EC E P R K+I RL
Sbjct: 234 DVIE---MIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 53/197 (26%), Positives = 95/197 (48%), Gaps = 10/197 (5%)
Query: 777 IGRGSFGSVYIAR-LQNGIEVAVKTFDLQH--ERAFKSFDTECEVMKSIRHRNLTKIISS 833
+G+GS+G V + R +G + +K +L++ R K+ + E +++ ++H N+ S
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67
Query: 834 CSNED-FKALILEYMRNGSL-EKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVI 891
ED +++ + G L K +L Q + + +A AL+YLH ++
Sbjct: 68 WEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH---EKHIL 124
Query: 892 HCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTK 951
H DLK NV L + + D GIA++L E+Q + + T YM+PE + K
Sbjct: 125 HRDLKTQNVFLTRTNIIKVGDLGIARVL--ENQCDMASTLIGTPYYMSPELFSNKPYNYK 182
Query: 952 GDVYSFGILLMETFTRR 968
DV++ G + E T +
Sbjct: 183 SDVWALGCCVYEMATLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 2e-13
Identities = 66/284 (23%), Positives = 117/284 (41%), Gaps = 38/284 (13%)
Query: 777 IGRGSFGSVY------IARLQNGIEVAVKTFDLQHE-RAFKSFDTECEVMKSIRHRNLTK 829
+G+GSFG VY I + + VAVKT + R F E VMK ++ +
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 830 IISSCSNEDFKALILEYMRNGSLEKCLYS---------GNYILDIFQRLNIMIDVASALE 880
++ S +++E M +G L+ L S G + + + + ++A +
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 881 YLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAP 940
YL+ + +H DL N ++ + + DFG+ + + D + L + +MAP
Sbjct: 134 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190
Query: 941 EYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDAN 1000
E ++G +T D++SFG++L E + + + S E LK
Sbjct: 191 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK------------------ 232
Query: 1001 LLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRL 1044
+ + + + C V +L C +P R T EIV L
Sbjct: 233 -FVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLL 275
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 2e-13
Identities = 60/201 (29%), Positives = 95/201 (47%), Gaps = 19/201 (9%)
Query: 777 IGRGSFGSVYIAR-LQNGIEVAVKT--FDLQHERAFKSFDTECEVMKSIRHRNLTKIISS 833
IG G++G VY AR G VA+K D + E + E ++K + H N+ K++
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 67
Query: 834 CSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASA-----LEYLHFGYSA 888
E+ L+ E++ + L+K +D I + + + L+ L F +S
Sbjct: 68 IHTENKLYLVFEFL-HQDLKK-------FMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH 119
Query: 889 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRV 948
V+H DLKP N+L++ L+DFG+A+ T T + TL Y APE +
Sbjct: 120 RVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLGCKY 177
Query: 949 -STKGDVYSFGILLMETFTRR 968
ST D++S G + E TRR
Sbjct: 178 YSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 3e-13
Identities = 48/178 (26%), Positives = 84/178 (47%), Gaps = 22/178 (12%)
Query: 777 IGRGSFGSVYIAR-LQNGIEVAVKTFDLQ--HERAFKSFDTECEVMKSIRHRNLTKII-- 831
IG G+ G V+ A+ + G VA+K L+ E + +++ +H + K++
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 832 ----SSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYS 887
S L++EYM L + L L Q + M + + Y+H +
Sbjct: 68 FPHGSGFV------LVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH---A 117
Query: 888 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPE--YG 943
++H DLKP+N+L+ + V ++DFG+A+L E++ + +AT Y APE YG
Sbjct: 118 NGIMHRDLKPANLLISADGVLKIADFGLARLF-SEEEPRLYSHQVATRWYRAPELLYG 174
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-13
Identities = 65/214 (30%), Positives = 102/214 (47%), Gaps = 27/214 (12%)
Query: 776 LIGRGSFGSVYIA-RLQNGIEVAVKT--FDLQHERAFKSFDT-ECEV--MKSIRHRNLTK 829
L+GRG+FG VY+ G E+AVK FD + K + ECE+ +K++RH + +
Sbjct: 9 LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68
Query: 830 IISSCSNEDFKAL--ILEYMRNGSLEKCLYS-GNYILDIFQRLNIMIDVASALEYLHFGY 886
+ + K L +EYM GS++ L + G ++ +R I + YLH
Sbjct: 69 YYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQI--LQGVSYLH--- 123
Query: 887 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGY-MAPE---- 941
S ++H D+K +N+L D L DFG +K + S T +++ Y M+PE
Sbjct: 124 SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISG 183
Query: 942 --YGREGRVSTKGDVYSFGILLMETFTRRKPTDE 973
YGR K DV+S ++E T + P E
Sbjct: 184 EGYGR------KADVWSVACTVVEMLTEKPPWAE 211
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-13
Identities = 59/212 (27%), Positives = 99/212 (46%), Gaps = 15/212 (7%)
Query: 777 IGRGSFGSVYIAR-LQNGIEVAVKT---FDLQHERAFKSFDTECEVMKSIRHRNLTKIIS 832
IGRG F VY A L + VA+K F++ +A + E +++K + H N+ K +
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69
Query: 833 SCSNEDFKALILEYMRNGSLEKCL-YSGNYILDIFQRL--NIMIDVASALEYLHFGYSAP 889
S ++ ++LE G L + + Y I +R + + SA+E++H S
Sbjct: 70 SFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH---SRR 126
Query: 890 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVS 949
V+H D+KP+NV + V L D G+ + ++ + T YM+PE E +
Sbjct: 127 VMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVGTPYYMSPERIHENGYN 184
Query: 950 TKGDVYSFGILLMETFTRRKPTDEIFSGEMTL 981
K D++S G LL E + P + +M L
Sbjct: 185 FKSDIWSLGCLLYEMAALQSP---FYGDKMNL 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 3e-13
Identities = 65/234 (27%), Positives = 102/234 (43%), Gaps = 40/234 (17%)
Query: 755 TWRRFSYLELFQATNGFSENNLIGRGSFGSVYIA-RLQNGIEVAVKT--FDLQHERAFKS 811
WRR L+G+G+FG VY+ + G E+A K FD + K
Sbjct: 3 NWRR---------------GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKE 47
Query: 812 FDT-ECEV--MKSIRHRNLTKIISSCSNEDFKAL--ILEYMRNGSLEKCLYSGNYILDIF 866
ECE+ +K+++H + + + K L +EYM GS++ L + + +
Sbjct: 48 VSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESV 107
Query: 867 QRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSM 926
R + + YLH S ++H D+K +N+L D L DFG +K L S
Sbjct: 108 TR-KYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSG 163
Query: 927 TQTQTLATLGY-MAPE------YGREGRVSTKGDVYSFGILLMETFTRRKPTDE 973
T +++ Y M+PE YGR K DV+S G ++E T + P E
Sbjct: 164 TGIRSVTGTPYWMSPEVISGEGYGR------KADVWSLGCTVVEMLTEKPPWAE 211
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 5e-13
Identities = 56/214 (26%), Positives = 92/214 (42%), Gaps = 32/214 (14%)
Query: 776 LIGRGSFGSVYIAR-LQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIR------HRNLT 828
+G G+F S Y AR ++ G +AVK + + + + K IR H ++
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 829 KIISSCSNEDFKALILEYMRNGSLEKCLY---------SGNYILDIFQRLNIMIDVASAL 879
+++ + + L +E+M GS+ L NY + + L
Sbjct: 67 RMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLR----------GL 116
Query: 880 EYLHFGYSAPVIHCDLKPSNVLLDDN-MVAHLSDFGIAKLLI--GEDQSMTQTQTLATLG 936
YLH +IH D+K +N+L+D ++DFG A L G Q Q L T+
Sbjct: 117 SYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIA 173
Query: 937 YMAPEYGREGRVSTKGDVYSFGILLMETFTRRKP 970
+MAPE R + DV+S G +++E T + P
Sbjct: 174 FMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 5e-13
Identities = 75/293 (25%), Positives = 121/293 (41%), Gaps = 51/293 (17%)
Query: 771 FSENNLIGRGSFGSVYIAR-LQNGIEVAVKTFDLQHERAFKSFDT--ECEVMKSIRHRNL 827
F + N IG G++G VY AR +G VA+K + +ER + E ++ ++RH N+
Sbjct: 9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNI 68
Query: 828 TK----IISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLH 883
+ ++ + F L++EY L L + Q +M+ + L+YLH
Sbjct: 69 VELKEVVVGKHLDSIF--LVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLH 125
Query: 884 FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYG 943
+ +IH DLK SN+LL D ++DFG+A+ + M T + TL Y APE
Sbjct: 126 ENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPM--TPKVVTLWYRAPELL 180
Query: 944 REGRVSTKG-DVYSFGILLMETFTRR--------------------KPTDEIFSG----- 977
T D+++ G +L E + P + I+ G
Sbjct: 181 LGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLP 240
Query: 978 ---EMTLKHWVNDFLPISMMKIIDA-----NLLITED--KHFAAKEQCASSVF 1020
+ TL + L + +A N L+ D K A+E SS F
Sbjct: 241 LVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYF 293
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 6e-13
Identities = 36/105 (34%), Positives = 58/105 (55%), Gaps = 4/105 (3%)
Query: 61 WTGVTC--DINQRR--VTALNISYLSLTGNIPRQLGNLSSLEILDLNFNRLSGEIPWELG 116
W+G C D + + + L + L G IP + L L+ ++L+ N + G IP LG
Sbjct: 404 WSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLG 463
Query: 117 NLAKLEKLLLHNNFLTGTIPFSIFKLSSLLDLKLSDNNLTGTIPS 161
++ LE L L N G+IP S+ +L+SL L L+ N+L+G +P+
Sbjct: 464 SITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPA 508
|
Length = 623 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 6e-13
Identities = 70/307 (22%), Positives = 124/307 (40%), Gaps = 60/307 (19%)
Query: 777 IGRGSFGSVYIARLQNGIEVAVKTFDLQ------------------HERAFKSFDTECEV 818
+G G FG V++ + + K F L ++ A F E ++
Sbjct: 13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72
Query: 819 MKSIRHRNLTKIISSCSNEDFKALILEYMRNGSLEKCL---------YSGNYILDIFQRL 869
M ++ N+ ++++ C D +I EYM NG L + L + + + L
Sbjct: 73 MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTL 132
Query: 870 NIM-IDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQ 928
M +AS ++YL S +H DL N L+ N ++DFG+++ L D Q
Sbjct: 133 IFMATQIASGMKYLS---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQ 189
Query: 929 TQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFT--RRKP----TDEIF---SGEM 979
+ + + +M+ E G+ +T DV++FG+ L E T + +P +DE +GE
Sbjct: 190 GRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGEF 249
Query: 980 TLKHWVNDFLPISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKE 1039
+LP + C S++ L + C + ER + +E
Sbjct: 250 FRDQGRQVYLPKPAL--------------------CPDSLYKLMLSCWRRNAKERPSFQE 289
Query: 1040 IVRRLLK 1046
I LL+
Sbjct: 290 IHATLLE 296
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 6e-13
Identities = 53/205 (25%), Positives = 98/205 (47%), Gaps = 11/205 (5%)
Query: 771 FSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQHERAFKSFD---TECEVMKSIRHRN 826
F + ++G+G FG V +++ G A K + + + K E ++++ + R
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 827 LTKIISSCSNEDFKALILEYMRNGSLEKCLYS-GNYILDIFQRLNIMIDVASALEYLHFG 885
+ + + +D L+L M G L+ +Y G + + + ++ LE LH
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH-- 119
Query: 886 YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGRE 945
+++ DLKP N+LLDD+ +SD G+A + + E Q++ + T+GYMAPE +
Sbjct: 120 -QERIVYRDLKPENILLDDHGHIRISDLGLA-VHVPEGQTI--KGRVGTVGYMAPEVVKN 175
Query: 946 GRVSTKGDVYSFGILLMETFTRRKP 970
R + D ++ G LL E + P
Sbjct: 176 ERYTFSPDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 7e-13
Identities = 56/195 (28%), Positives = 92/195 (47%), Gaps = 8/195 (4%)
Query: 777 IGRGSFGSVYIA-RLQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCS 835
IG GS G V IA G +VAVK DL+ ++ + E +M+ H N+ + +S
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 836 NEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDL 895
D +++E++ G+L + ++ Q + + V AL YLH + VIH D+
Sbjct: 90 VGDELWVVMEFLEGGALTDIVTHTR--MNEEQIATVCLSVLRALSYLH---NQGVIHRDI 144
Query: 896 KPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVY 955
K ++LL + LSDFG + E + + T +MAPE T+ D++
Sbjct: 145 KSDSILLTSDGRIKLSDFGFCAQVSKEVPK--RKSLVGTPYWMAPEVISRLPYGTEVDIW 202
Query: 956 SFGILLMETFTRRKP 970
S GI+++E P
Sbjct: 203 SLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 7e-13
Identities = 53/212 (25%), Positives = 97/212 (45%), Gaps = 11/212 (5%)
Query: 777 IGRGSFGSVYIAR-LQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCS 835
+G G+FG VY A+ + G A K + + E + + E E++ + H + K++ +
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 836 NEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDL 895
+ +++E+ G+++ + + L I + LE L + +S +IH DL
Sbjct: 80 WDGKLWIMIEFCPGGAVDAIMLELDRGL---TEPQIQVICRQMLEALQYLHSMKIIHRDL 136
Query: 896 KPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEY-----GREGRVST 950
K NVLL + L+DFG++ + Q + + T +MAPE ++
Sbjct: 137 KAGNVLLTLDGDIKLADFGVSAKNVKTLQR--RDSFIGTPYWMAPEVVMCETMKDTPYDY 194
Query: 951 KGDVYSFGILLMETFTRRKPTDEIFSGEMTLK 982
K D++S GI L+E P E+ + LK
Sbjct: 195 KADIWSLGITLIEMAQIEPPHHELNPMRVLLK 226
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 7e-13
Identities = 68/267 (25%), Positives = 119/267 (44%), Gaps = 26/267 (9%)
Query: 777 IGRGSFGSVYIARLQN-GIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCS 835
IG GS G V IA +++ G VAVK DL+ ++ + E +M+ +H N+ ++ +S
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 836 NEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDL 895
D +++E++ G+L + ++ Q + + V AL LH + VIH D+
Sbjct: 88 VGDELWVVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLKALSVLH---AQGVIHRDI 142
Query: 896 KPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVY 955
K ++LL + LSDFG + E + + T +MAPE + D++
Sbjct: 143 KSDSILLTHDGRVKLSDFGFCAQVSKEVPR--RKSLVGTPYWMAPELISRLPYGPEVDIW 200
Query: 956 SFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHFAAKEQC 1015
S GI+++E P + N+ P+ MK+I NL +
Sbjct: 201 SLGIMVIEMVDGEPP-------------YFNE-PPLKAMKMIRDNL----PPKLKNLHKV 242
Query: 1016 ASSVFNLAMECTVESPDERITAKEIVR 1042
+ S+ V P +R TA E+++
Sbjct: 243 SPSLKGFLDRLLVRDPAQRATAAELLK 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 8e-13
Identities = 69/278 (24%), Positives = 120/278 (43%), Gaps = 48/278 (17%)
Query: 777 IGRGSFGSVYIA-RLQNGIEVAVK------TFDLQHERAFKSFDTECEVMKSIRHRNLTK 829
+G G+ G+VY A L +AVK T +LQ K +E E++ +
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQ-----KQIMSELEILYKCDSPYIIG 63
Query: 830 IISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRL------NIMIDVASALEYLH 883
+ E+ ++ E+M GSL D+++++ I + V L YL
Sbjct: 64 FYGAFFVENRISICTEFMDGGSL-----------DVYRKIPEHVLGRIAVAVVKGLTYL- 111
Query: 884 FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYG 943
+S ++H D+KPSN+L++ L DFG++ L+ S+ +T + T YMAPE
Sbjct: 112 --WSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV---NSIAKTY-VGTNAYMAPERI 165
Query: 944 REGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLI 1003
+ DV+S GI ME R P +I + +L +P+ +++ I +
Sbjct: 166 SGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSL-------MPLQLLQCI-----V 213
Query: 1004 TEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIV 1041
ED Q + + +C + P ER + ++
Sbjct: 214 DEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLM 251
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 1e-12
Identities = 34/85 (40%), Positives = 50/85 (58%), Gaps = 1/85 (1%)
Query: 425 LNGIIPMSAGNLSHSLEELFMPDCNVSGRIPKEIGNLANLVTLDLGGNKFNGSIPIALGK 484
L G IP L H L+ + + ++ G IP +G++ +L LDL N FNGSIP +LG+
Sbjct: 430 LRGFIPNDISKLRH-LQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQ 488
Query: 485 LQKLQLLNLDDNKLEGSIPDDICGL 509
L L++LNL+ N L G +P + G
Sbjct: 489 LTSLRILNLNGNSLSGRVPAALGGR 513
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 1e-12
Identities = 31/96 (32%), Positives = 53/96 (55%), Gaps = 1/96 (1%)
Query: 546 LISFIPSTFWNIKDIMYVNFSSNFLTGPLPLEIENLKALTTLDFSMNNLSGVIPTTIGGL 605
L FIP+ ++ + +N S N + G +P + ++ +L LD S N+ +G IP ++G L
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489
Query: 606 KGLQYLFLGHNRLQGSIPDSVGD-LISLKSLNLSNN 640
L+ L L N L G +P ++G L+ S N ++N
Sbjct: 490 TSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDN 525
|
Length = 623 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 2e-12
Identities = 56/203 (27%), Positives = 91/203 (44%), Gaps = 21/203 (10%)
Query: 776 LIGRGSFGSVYIARLQN-GIEVAVKTFDLQH--ERAFKSFDTECEVMKSIRHRNLTKIIS 832
++G G++G V R + G VA+K F E K+ E +V++ +RH N+ +
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67
Query: 833 SCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIH 892
+ + L+ EY+ LE L + L + + + A+ Y H S +IH
Sbjct: 68 AFRRKGRLYLVFEYVERTLLEL-LEASPGGLPPDAVRSYIWQLLQAIAYCH---SHNIIH 123
Query: 893 CDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPE-------YGRE 945
D+KP N+L+ ++ V L DFG A+ L S T +AT Y APE YG+
Sbjct: 124 RDIKPENILVSESGVLKLCDFGFARALRARPAS-PLTDYVATRWYRAPELLVGDTNYGKP 182
Query: 946 GRVSTKGDVYSFGILLMETFTRR 968
DV++ G ++ E
Sbjct: 183 ------VDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.1 bits (170), Expect = 2e-12
Identities = 66/225 (29%), Positives = 106/225 (47%), Gaps = 48/225 (21%)
Query: 777 IGRGSFGSVYIAR-LQNGIEVAVKTFDLQHERAFKSFDTEC----EVMKSIR----HRNL 827
+G G+FGSVY+AR + G VA+K ++ F S++ EC EV KS+R H N+
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKM----KKKFYSWE-ECMNLREV-KSLRKLNEHPNI 60
Query: 828 TKIISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRL-------NIMIDVASALE 880
K+ D + EYM E LY + D + +I+ + L
Sbjct: 61 VKLKEVFRENDELYFVFEYM-----EGNLY--QLMKDRKGKPFSESVIRSIIYQILQGLA 113
Query: 881 YLH-FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSM-TQTQTLATLGYM 938
++H G+ H DLKP N+L+ V ++DFG+A+ E +S T ++T Y
Sbjct: 114 HIHKHGF----FHRDLKPENLLVSGPEVVKIADFGLAR----EIRSRPPYTDYVSTRWYR 165
Query: 939 APE-YGREGRVSTKGDVYSFGILLMETFTRRKP-------TDEIF 975
APE R S+ D+++ G ++ E +T R P D+++
Sbjct: 166 APEILLRSTSYSSPVDIWALGCIMAELYTLR-PLFPGSSEIDQLY 209
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-12
Identities = 66/258 (25%), Positives = 108/258 (41%), Gaps = 41/258 (15%)
Query: 777 IGRGSFGSVYIAR-LQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCS 835
+G G+FG VY A+ + G+ A K D + E + + E +++ S H N+ K++ +
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 836 NEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDL 895
E+ +++E+ G+++ + L Q + AL YLH +IH DL
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDL 129
Query: 896 KPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTL-------ATLGYMAPEY-----G 943
K N+L + L+DFG+ S T+T+ T +MAPE
Sbjct: 130 KAGNILFTLDGDIKLADFGV---------SAKNTRTIQRRDSFIGTPYWMAPEVVMCETS 180
Query: 944 REGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLK-------------HW---VND 987
++ K DV+S GI L+E P E+ + LK W D
Sbjct: 181 KDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKD 240
Query: 988 FLPISMMKIIDANLLITE 1005
FL + K +DA T+
Sbjct: 241 FLKKCLEKNVDARWTTTQ 258
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 57/202 (28%), Positives = 93/202 (46%), Gaps = 24/202 (11%)
Query: 776 LIGRGSFGSVYIARLQN-GIEVAVKTF-DLQHERAFKSFDT-ECEVMKSIRHRNLTKIIS 832
L+G GS+G V + + G VA+K F + + ++ K E ++K +RH NL +I
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 833 SCSNEDFKALILEYMRNGSLEKC-LYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVI 891
+ L+ E++ + L+ Y LD + + + +E+ H S +I
Sbjct: 68 VFRRKKRLYLVFEFVDHTVLDDLEKYPNG--LDESRVRKYLFQILRGIEFCH---SHNII 122
Query: 892 HCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPE-------YGR 944
H D+KP N+L+ + V L DFG A+ L + T +AT Y APE YGR
Sbjct: 123 HRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY--TDYVATRWYRAPELLVGDTKYGR 180
Query: 945 EGRVSTKGDVYSFGILLMETFT 966
D+++ G L+ E T
Sbjct: 181 ------AVDIWAVGCLVTEMLT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 2e-12
Identities = 63/214 (29%), Positives = 100/214 (46%), Gaps = 38/214 (17%)
Query: 776 LIGRGSFGSVYIARLQNGIEV----AVKTFDLQHERAFKSFDTECE--VMKSIRHRNLTK 829
++G+GSFG V++ R G + A+K + T+ E ++ + H + K
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVK 62
Query: 830 IISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLN--IMI----------DVAS 877
+ + E LIL+++R G D+F RL+ +M ++A
Sbjct: 63 LHYAFQTEGKLYLILDFLRGG-------------DLFTRLSKEVMFTEEDVKFYLAELAL 109
Query: 878 ALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGY 937
AL++LH S +I+ DLKP N+LLD+ L+DFG++K I D T+ Y
Sbjct: 110 ALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESI--DHEKKAYSFCGTVEY 164
Query: 938 MAPE-YGREGRVSTKGDVYSFGILLMETFTRRKP 970
MAPE R G + D +SFG+L+ E T P
Sbjct: 165 MAPEVVNRRGH-TQSADWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 2e-12
Identities = 56/199 (28%), Positives = 93/199 (46%), Gaps = 12/199 (6%)
Query: 777 IGRGSFGSVYIAR-LQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCS 835
IG G++G VY AR + G A+K L+ F E +MK +H N+ S
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76
Query: 836 NEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDL 895
D + +E+ GSL+ +Y L Q + + L YLH S +H D+
Sbjct: 77 RRDKLWICMEFCGGGSLQD-IYHVTGPLSESQIAYVSRETLQGLYYLH---SKGKMHRDI 132
Query: 896 KPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQT-LATLGYMAPEYG---REGRVSTK 951
K +N+LL DN L+DFG++ + ++ + ++ + T +MAPE R+G +
Sbjct: 133 KGANILLTDNGHVKLADFGVSAQITA---TIAKRKSFIGTPYWMAPEVAAVERKGGYNQL 189
Query: 952 GDVYSFGILLMETFTRRKP 970
D+++ GI +E + P
Sbjct: 190 CDIWAVGITAIELAELQPP 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 3e-12
Identities = 33/80 (41%), Positives = 48/80 (60%)
Query: 452 GRIPKEIGNLANLVTLDLGGNKFNGSIPIALGKLQKLQLLNLDDNKLEGSIPDDICGLVE 511
G IP +I L +L +++L GN G+IP +LG + L++L+L N GSIP+ + L
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTS 491
Query: 512 LYKLALGDNKLSGQIPACFG 531
L L L N LSG++PA G
Sbjct: 492 LRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-12
Identities = 65/281 (23%), Positives = 119/281 (42%), Gaps = 38/281 (13%)
Query: 777 IGRGSFGSVY------IARLQNGIEVAVKTFDLQHE-RAFKSFDTECEVMKSIRHRNLTK 829
+G+GSFG VY + + + VA+KT + R F E VMK ++ +
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 830 IISSCSNEDFKALILEYMRNGSLEKCLYS------GNYIL---DIFQRLNIMIDVASALE 880
++ S +I+E M G L+ L S N + + + + + ++A +
Sbjct: 74 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133
Query: 881 YLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAP 940
YL+ + +H DL N ++ ++ + DFG+ + + D + L + +M+P
Sbjct: 134 YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 190
Query: 941 EYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDAN 1000
E ++G +T DV+SFG++L E T + + S E L+ +++
Sbjct: 191 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRF------------VMEGG 238
Query: 1001 LLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIV 1041
LL D C +F L C +P R + EI+
Sbjct: 239 LLDKPD-------NCPDMLFELMRMCWQYNPKMRPSFLEII 272
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-12
Identities = 56/199 (28%), Positives = 94/199 (47%), Gaps = 11/199 (5%)
Query: 777 IGRGSFGSVYIARLQN-GIEVAVKTFD---LQHERAFKSFDTECEVMKSIRHRNLTKIIS 832
+G+G FG V +++N G A K D L+ + K E E+++ + + +
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 833 SCSNEDFKALILEYMRNGSLEKCLYS-GNYILDIFQRLNIMIDVASALEYLHFGYSAPVI 891
+ ++ L++ M G L+ +Y+ G L++ + ++ + + +LH S ++
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMDIV 117
Query: 892 HCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTK 951
+ D+KP NVLLDD LSD G+A L T TQ T GYMAPE +E S
Sbjct: 118 YRDMKPENVLLDDQGNCRLSDLGLAVELKD---GKTITQRAGTNGYMAPEILKEEPYSYP 174
Query: 952 GDVYSFGILLMETFTRRKP 970
D ++ G + E R P
Sbjct: 175 VDWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 4e-12
Identities = 37/104 (35%), Positives = 54/104 (51%), Gaps = 9/104 (8%)
Query: 871 IMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQ 930
+ + + AL YL + VIH D+KPSN+LLD + L DFGI+ L+ S +T+
Sbjct: 119 MTVAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRLV---DSKAKTR 173
Query: 931 TLATLGYMAPEY----GREGRVSTKGDVYSFGILLMETFTRRKP 970
+ YMAPE + + DV+S GI L+E T + P
Sbjct: 174 SAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 4e-12
Identities = 56/205 (27%), Positives = 95/205 (46%), Gaps = 15/205 (7%)
Query: 776 LIGRGSFGSVYIARLQNG--------IEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNL 827
++G G++G V++ R G ++V K +Q + + TE V++ +R
Sbjct: 7 VLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPF 66
Query: 828 TKIISSCSNEDFKA-LILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGY 886
+ + K LIL+Y+ G + LY + + R ++ ALE+LH
Sbjct: 67 LVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSG-EIILALEHLH--- 122
Query: 887 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREG 946
+++ D+K N+LLD L+DFG++K + E++ T + T+ YMAPE R
Sbjct: 123 KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYS-FCGTIEYMAPEIIRGK 181
Query: 947 RVSTKG-DVYSFGILLMETFTRRKP 970
K D +S GIL+ E T P
Sbjct: 182 GGHGKAVDWWSLGILIFELLTGASP 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 4e-12
Identities = 57/218 (26%), Positives = 103/218 (47%), Gaps = 23/218 (10%)
Query: 777 IGRGSFGSVYIARLQNGIE-VAVKTFD---LQHERAFKSFDTECEVMKSIRHRNLTKIIS 832
+G+G +G V++A+ ++ E VA+K L + TE +++ + + L K++
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 833 SCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLH-FGYSAPVI 891
+ ++++ L +EY+ G + L + +L M ++ A++ LH GY I
Sbjct: 69 AFQDDEYLYLAMEYVPGGDF-RTLLNNLGVLSEDHARFYMAEMFEAVDALHELGY----I 123
Query: 892 HCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTK 951
H DLKP N L+D + L+DFG++K ++ S+ + + YMAPE R
Sbjct: 124 HRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSV-----VGSPDYMAPEVLRGKGYDFT 178
Query: 952 GDVYSFGILLMETFTRRKP-----TDEIFSGEMTLKHW 984
D +S G +L E P +E + LK+W
Sbjct: 179 VDYWSLGCMLYEFLCGFPPFSGSTPNETWE---NLKYW 213
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 5e-12
Identities = 57/205 (27%), Positives = 96/205 (46%), Gaps = 16/205 (7%)
Query: 777 IGRGSFGSVYIARLQNG--------IEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLT 828
+G G++G V++ R G ++V K +Q + + TE +V++++R
Sbjct: 8 LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFL 67
Query: 829 KIISSCSNEDFKA-LILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYS 887
+ D K LIL+Y+ G L LY + + R+ I ++ AL++LH
Sbjct: 68 VTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIA-EIVLALDHLH---Q 123
Query: 888 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEY--GRE 945
+I+ D+K N+LLD L+DFG++K + E++ + T+ YMAPE G
Sbjct: 124 LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYS-FCGTIEYMAPEVIRGGS 182
Query: 946 GRVSTKGDVYSFGILLMETFTRRKP 970
G D +S G+L E T P
Sbjct: 183 GGHDKAVDWWSLGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 7e-12
Identities = 60/276 (21%), Positives = 120/276 (43%), Gaps = 42/276 (15%)
Query: 776 LIGRGSFGSVYIARLQNGIE--VAVKTFDLQH----------ERAFKSFDTECEVMK-SI 822
+G G+FG VY R +N + +A+K ++ + +++ +E ++K +
Sbjct: 7 HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66
Query: 823 RHRNLTKIISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIF--QRL-NIMIDVASAL 879
RH N+ + + D ++++ + L + S F +R+ NI + + AL
Sbjct: 67 RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLAL 126
Query: 880 EYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMA 939
YLH ++H DL P+N++L ++ ++DFG+AK + + T + T+ Y
Sbjct: 127 RYLH--KEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQK-QPESKL--TSVVGTILYSC 181
Query: 940 PEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISM-MKIID 998
PE + K DV++FG +L + T + P +S M +S+ KI++
Sbjct: 182 PEIVKNEPYGEKADVWAFGCILYQMCTLQPP---FYSTNM-----------LSLATKIVE 227
Query: 999 ANLLITEDKHFAAKEQCASSVFNLAMECTVESPDER 1034
A + ++ V ++ C + R
Sbjct: 228 AVYEPLPEGMYSED------VTDVITSCLTPDAEAR 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 7e-12
Identities = 61/192 (31%), Positives = 90/192 (46%), Gaps = 11/192 (5%)
Query: 777 IGRGSFGSVYIAR-LQNGIEVAVKTFDLQH---ERAFKSFDTECEVM-KSIRHRNLTKII 831
IG+GSFG V +A+ +G AVK + ++ K E V+ K+++H L +
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 832 SSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVI 891
S D +L+Y+ G L L + R ++ASAL YLH S +I
Sbjct: 63 YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARF-YAAEIASALGYLH---SLNII 118
Query: 892 HCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTK 951
+ DLKP N+LLD L+DFG+ K G + S T + T Y+APE R+
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGLCKE--GIEHSKTTSTFCGTPEYLAPEVLRKQPYDRT 176
Query: 952 GDVYSFGILLME 963
D + G +L E
Sbjct: 177 VDWWCLGAVLYE 188
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 8e-12
Identities = 61/214 (28%), Positives = 103/214 (48%), Gaps = 27/214 (12%)
Query: 776 LIGRGSFGSVYIA-RLQNGIEVAVKT--FDLQHERAFKSFDT-ECEV--MKSIRHRNLTK 829
L+G+G+FG VY+ G E+AVK FD + K + ECE+ +K++ H + +
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 830 IISSCSN--EDFKALILEYMRNGSLEKCLYS-GNYILDIFQRLNIMIDVASALEYLHFGY 886
+ E ++ +E+M GS++ L S G ++ ++ I LE + + +
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQI-----LEGVSYLH 123
Query: 887 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGY-MAPE---- 941
S ++H D+K +N+L D L DFG +K L S T +++ Y M+PE
Sbjct: 124 SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISG 183
Query: 942 --YGREGRVSTKGDVYSFGILLMETFTRRKPTDE 973
YGR K D++S G ++E T + P E
Sbjct: 184 EGYGR------KADIWSVGCTVVEMLTEKPPWAE 211
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 8e-12
Identities = 63/236 (26%), Positives = 105/236 (44%), Gaps = 36/236 (15%)
Query: 771 FSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQHERAFKSFD---TECEVMKSIRHRN 826
F +G GSFG V IA+ + G A+K + K E ++ + H
Sbjct: 20 FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPF 79
Query: 827 LTKIISSCSNEDFKALILEYMRNGSLEKCLYS-GNYILDIFQRLNIMIDVASALEYLHFG 885
+ ++ S +E+ +LE++ G L L G + D+ + + ++ A EYLH
Sbjct: 80 IVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHA--ELVLAFEYLH-- 135
Query: 886 YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTL-ATLGYMAPEYGR 944
S +I+ DLKP N+LLD+ ++DFG AK + +T TL T Y+APE
Sbjct: 136 -SKDIIYRDLKPENLLLDNKGHVKVTDFGFAK------KVPDRTFTLCGTPEYLAPEV-- 186
Query: 945 EGRVSTKG-----DVYSFGILLMETFTRRKP---------TDEIFSGEMTLKHWVN 986
+ +KG D ++ G+LL E P ++I +G + +W +
Sbjct: 187 ---IQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFD 239
|
Length = 329 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 8e-12
Identities = 60/226 (26%), Positives = 96/226 (42%), Gaps = 48/226 (21%)
Query: 776 LIGRGSFGSVYIARLQNGIEV-AVKTFDLQHERAFKSFDTEC-EVMKSI-----RHRNLT 828
++G+GSFG V +A L+ E+ AVK L+ + + D EC K + +H LT
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKV--LKKDVILQDDDVECTMTEKRVLALAGKHPFLT 59
Query: 829 KIISSCSNEDFKALILEYMRNGSL----EKC---------LYSGNYILDIFQRLNIMIDV 875
++ S +D ++EY+ G L ++ Y+ ++
Sbjct: 60 QLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAA--------------EI 105
Query: 876 ASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTL-AT 934
L++LH +I+ DLK NVLLD ++DFG+ K I + T T T
Sbjct: 106 VLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT---TSTFCGT 159
Query: 935 LGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKP-----TDEIF 975
Y+APE D ++ G+LL E + P DE+F
Sbjct: 160 PDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELF 205
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 1e-11
Identities = 59/212 (27%), Positives = 96/212 (45%), Gaps = 20/212 (9%)
Query: 776 LIGRGSFGSVYIARLQNGIEV-AVKTFDLQHERAFKSFDTECEVMK------SIRHRNLT 828
++G+GSFG V +A L+ EV A+K L+ + + D +C + + + +H LT
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKV--LKKDVILQDDDVDCTMTEKRILALAAKHPFLT 59
Query: 829 KIISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSA 888
+ +D ++EY+ G L + + R +V AL +LH
Sbjct: 60 ALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRF-YAAEVTLALMFLH---RH 115
Query: 889 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRV 948
VI+ DLK N+LLD L+DFG+ K I +T T T Y+APE +E
Sbjct: 116 GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--VTTTTFCGTPDYIAPEILQELEY 173
Query: 949 STKGDVYSFGILLMETFTRRKP-----TDEIF 975
D ++ G+L+ E + P D++F
Sbjct: 174 GPSVDWWALGVLMYEMMAGQPPFEADNEDDLF 205
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 1e-11
Identities = 52/207 (25%), Positives = 89/207 (42%), Gaps = 24/207 (11%)
Query: 777 IGRGSFGSVYIARLQNGI---EVAVKTF----DLQHERAFKSFDTECEVMKSIRHRNLTK 829
IG G FG V + + +G +V VK +Q + F E + +S++H NL +
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLE---EAQPYRSLQHSNLLQ 59
Query: 830 IISSCSNEDFKALILEYMR----NGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFG 885
+ C+ L++E+ G L C + D + ++A L +LH
Sbjct: 60 CLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH-- 117
Query: 886 YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGRE 945
IH DL N LL ++ + D+G++ ED +T Q L ++APE E
Sbjct: 118 -KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDE 176
Query: 946 --GRV-----STKGDVYSFGILLMETF 965
G + + + +V+S G+ + E F
Sbjct: 177 VHGNLLVVDQTKESNVWSLGVTIWELF 203
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 54/205 (26%), Positives = 96/205 (46%), Gaps = 11/205 (5%)
Query: 771 FSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQHERAFKSFD---TECEVMKSIRHRN 826
F + ++G+G FG V +++ G A K + + + K E ++++ + +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 827 LTKIISSCSNEDFKALILEYMRNGSLEKCLYS-GNYILDIFQRLNIMIDVASALEYLHFG 885
+ + + +D L+L M G L+ +Y+ GN + + L ++ LE LH
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH-- 119
Query: 886 YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGRE 945
++ DLKP N+LLDD +SD G+A + I E +S+ + T+GYMAPE
Sbjct: 120 -RENTVYRDLKPENILLDDYGHIRISDLGLA-VKIPEGESI--RGRVGTVGYMAPEVLNN 175
Query: 946 GRVSTKGDVYSFGILLMETFTRRKP 970
R + D + G L+ E + P
Sbjct: 176 QRYTLSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 56/199 (28%), Positives = 93/199 (46%), Gaps = 12/199 (6%)
Query: 777 IGRGSFGSVYIAR-LQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCS 835
+G G++G VY AR L G AVK L+ F E ++K +H N+ S
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76
Query: 836 NEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDL 895
+ + + +EY GSL+ +Y L Q + + L YLH S +H D+
Sbjct: 77 SREKLWICMEYCGGGSLQD-IYHVTGPLSELQIAYVCRETLQGLAYLH---SKGKMHRDI 132
Query: 896 KPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQT-LATLGYMAPEYG---REGRVSTK 951
K +N+LL DN L+DFG+A + ++ + ++ + T +MAPE + G +
Sbjct: 133 KGANILLTDNGDVKLADFGVAAKITA---TIAKRKSFIGTPYWMAPEVAAVEKNGGYNQL 189
Query: 952 GDVYSFGILLMETFTRRKP 970
D+++ GI +E + P
Sbjct: 190 CDIWAVGITAIELAELQPP 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 66.8 bits (164), Expect = 1e-11
Identities = 74/221 (33%), Positives = 113/221 (51%), Gaps = 32/221 (14%)
Query: 777 IGRGSFGSVYIAR-LQNGIEVAVK-TFDLQHERAFK-SFD---TECEVM--KSIR-HRNL 827
+G+G++G V+ A + VA+K FD AF+ + D T E+M + + H N+
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALKKIFD-----AFRNATDAQRTFREIMFLQELGDHPNI 69
Query: 828 TK---IISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHF 884
K +I + +++D L+ EYM L + + IL+ + IM + AL+Y+H
Sbjct: 70 VKLLNVIKAENDKDI-YLVFEYMET-DLHAVIRAN--ILEDVHKRYIMYQLLKALKYIH- 124
Query: 885 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL--IGEDQSM-TQTQTLATLGYMAPE 941
S VIH DLKPSN+LL+ + L+DFG+A+ L + E+ T +AT Y APE
Sbjct: 125 --SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPE 182
Query: 942 YGREGRVSTKG-DVYSFGILLMETFTRRKPTDEIFSGEMTL 981
TKG D++S G +L E KP +F G TL
Sbjct: 183 ILLGSTRYTKGVDMWSVGCILGEML-LGKP---LFPGTSTL 219
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-11
Identities = 61/205 (29%), Positives = 92/205 (44%), Gaps = 25/205 (12%)
Query: 777 IGRGSFGSVYIARLQNGIE-VAVKTFDL---QHERAFKSFDTECEVMKSIRHRNLTKIIS 832
IG GSFG+VY A + E VAVK Q ++ E + ++ ++H N +
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 833 SCSNEDFKALILEYMRNGSLEKCLYSGNYILDI----FQRLNIMIDVASALEYLHFGYSA 888
E L++EY CL S + +L++ Q + I AL+ L + +S
Sbjct: 89 CYLKEHTAWLVMEY--------CLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH 140
Query: 889 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEY---GRE 945
+IH D+K N+LL + L+DFG A S + T +MAPE E
Sbjct: 141 NMIHRDIKAGNILLTEPGQVKLADFGSASK------SSPANSFVGTPYWMAPEVILAMDE 194
Query: 946 GRVSTKGDVYSFGILLMETFTRRKP 970
G+ K DV+S GI +E R+ P
Sbjct: 195 GQYDGKVDVWSLGITCIELAERKPP 219
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 2e-11
Identities = 52/210 (24%), Positives = 94/210 (44%), Gaps = 22/210 (10%)
Query: 777 IGRGSFGSVYIARLQ-NGIEVAVKTF---DLQHERAFKSFDTECEVMKSIRHR-NLTKII 831
I +G+FGSVY+A+ + G A+K D+ + + E +M + K+
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63
Query: 832 SSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVI 891
S ++D+ L++EY+ G + + + + + + + +V +E LH +I
Sbjct: 64 YSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAK-QYIAEVVLGVEDLH---QRGII 119
Query: 892 HCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTK 951
H D+KP N+L+D L+DFG+++ G + + T Y+APE G K
Sbjct: 120 HRDIKPENLLIDQTGHLKLTDFGLSR--NGL----ENKKFVGTPDYLAPET-ILGVGDDK 172
Query: 952 -GDVYSFGILLMETFTRRKP-----TDEIF 975
D +S G ++ E P D +F
Sbjct: 173 MSDWWSLGCVIFEFLFGYPPFHAETPDAVF 202
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 2e-11
Identities = 69/286 (24%), Positives = 113/286 (39%), Gaps = 38/286 (13%)
Query: 777 IGRGSFGSVYIARLQNGIEVA-VKTFDLQHERAFKSFDT---ECEVMKSIRHRNLTKIIS 832
IG G FG V + G+ A V +L+ E + + + H N+ + +
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 833 SCSNEDFKALILEYMRNGSLEKCLYSGNYIL------DIFQRLNIMIDVASALEYLHFGY 886
C L+LE+ G L+ L S ++ D+ QR+ +VAS L +LH
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRM--ACEVASGLLWLH--- 117
Query: 887 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGRE- 945
A IH DL N L ++ + D+G+A ED +T+ L ++APE
Sbjct: 118 QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIR 177
Query: 946 ------GRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDA 999
+ K +++S G+ + E FT S E LK V + +K+
Sbjct: 178 GQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVRE----QDIKLPKP 233
Query: 1000 NLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLL 1045
L + + + + C + P+ R TA+E V LL
Sbjct: 234 QLDLKYSDRW----------YEVMQFCWL-DPETRPTAEE-VHELL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 2e-11
Identities = 70/240 (29%), Positives = 105/240 (43%), Gaps = 57/240 (23%)
Query: 776 LIGRGSFGSVYIARLQNGIE----VAVKTF----------DLQHERAFKSFDTECEVMKS 821
++G+G +G V+ R G + A+K D H +A E ++++
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKA------ERNILEA 56
Query: 822 IRHRNLTKIISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNI-MIDVAS--- 877
++H + +I + LILEY+ G L L +R I M D A
Sbjct: 57 VKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHL----------EREGIFMEDTACFYL 106
Query: 878 -----ALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTL 932
ALE+LH +I+ DLKP N+LLD L+DFG+ K I E ++T T
Sbjct: 107 SEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG-TVTHT-FC 161
Query: 933 ATLGYMAPE-YGREGRVSTKG-DVYSFGILLMETFT---------RRKPTDEIFSGEMTL 981
T+ YMAPE R G K D +S G L+ + T R+K D+I G++ L
Sbjct: 162 GTIEYMAPEILMRSGH--GKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNL 219
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 57/201 (28%), Positives = 94/201 (46%), Gaps = 31/201 (15%)
Query: 776 LIGRGSFGSVYIARLQNGIE-VAVKTF------DLQHERAFKSFDTECEVMKSIRHRNLT 828
+G G+FG V++ R + A+K L+ E+ + E V+K + H +
Sbjct: 8 TVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHN---EKRVLKEVSHPFII 64
Query: 829 KIISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSA 888
++ + ++ F +++EY+ G L L + + ++ ALEYLH S
Sbjct: 65 RLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLF-YASEIVCALEYLH---SK 120
Query: 889 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTL-ATLGYMAPEYGREGR 947
+++ DLKP N+LLD L+DFG AK L +T TL T Y+APE
Sbjct: 121 EIVYRDLKPENILLDKEGHIKLTDFGFAKKLR------DRTWTLCGTPEYLAPEV----- 169
Query: 948 VSTKG-----DVYSFGILLME 963
+ +KG D ++ GIL+ E
Sbjct: 170 IQSKGHNKAVDWWALGILIYE 190
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 76/302 (25%), Positives = 126/302 (41%), Gaps = 64/302 (21%)
Query: 777 IGRGSFGSVYIAR-LQNGIEVAVKTFDLQHER------AFKSFDTECEVMKSIRHRNLTK 829
IG G++G VY R + G VA+K L+ E A + E ++K ++H N+
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIR----EISLLKELQHPNIVC 63
Query: 830 IISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLH------ 883
+ E LI E++ + L+K L S +D YL+
Sbjct: 64 LQDVLMQESRLYLIFEFL-SMDLKKYLDS--------LPKGQYMDAELVKSYLYQILQGI 114
Query: 884 -FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPE- 941
F +S V+H DLKP N+L+D+ V L+DFG+A+ G + T + TL Y APE
Sbjct: 115 LFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLAR-AFGIPVRV-YTHEVVTLWYRAPEV 172
Query: 942 -YGREGRVSTKGDVYSFGILLMETFTRR--------------------KPTDEIFSGEMT 980
G R ST D++S G + E T++ PT++++ G +
Sbjct: 173 LLGSP-RYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTS 231
Query: 981 LKHWVNDFLPISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEI 1040
L + N F P + + + + +L + + P +RI+AK+
Sbjct: 232 LPDYKNTF-PKWKKGSLRSAV-----------KNLDEDGLDLLEKMLIYDPAKRISAKKA 279
Query: 1041 VR 1042
+
Sbjct: 280 LN 281
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 3e-11
Identities = 36/114 (31%), Positives = 55/114 (48%), Gaps = 25/114 (21%)
Query: 173 LDLSDNQLSGSIPSFIFKISSLQALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGG 232
L L + L G IP+ I K+ LQ+++ N + G +P ++ G
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSL------------------GS 464
Query: 233 ISSTLSNCKHLRILDLSFNDLWGDIPKEIGNLTKLKELFLDFNILQGEIPHTVG 286
I+S L +LDLS+N G IP+ +G LT L+ L L+ N L G +P +G
Sbjct: 465 ITS-------LEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 3e-11
Identities = 52/213 (24%), Positives = 100/213 (46%), Gaps = 34/213 (15%)
Query: 777 IGRGSFGSVYIAR-LQNGIEVAVKTFDLQHERAFKSFDT----ECEVMKSIRHRNLTKII 831
IG+G+FG V+ AR + VA+K +++E+ + F E ++++ ++H N+ +I
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKVLMENEK--EGFPITALREIKILQLLKHENVVNLI 77
Query: 832 SSCSNE-----DFKA---LILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLH 883
C + +K L+ E+ + L L + N + + +M + + L Y+H
Sbjct: 78 EICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIH 136
Query: 884 FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK--LLIGEDQSMTQTQTLATLGYMAPE 941
++H D+K +N+L+ + + L+DFG+A+ L + T + TL Y PE
Sbjct: 137 RN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPE 193
Query: 942 -------YGREGRVSTKGDVYSFGILLMETFTR 967
YG D++ G ++ E +TR
Sbjct: 194 LLLGERDYG------PPIDMWGAGCIMAEMWTR 220
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 3e-11
Identities = 57/240 (23%), Positives = 107/240 (44%), Gaps = 47/240 (19%)
Query: 777 IGRGSFGSVYIARLQNGIEVAVKTFDLQ------------------HERAFKSFDTECEV 818
+G G FG V++ + N ++ F ++ A F E ++
Sbjct: 13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKI 72
Query: 819 MKSIRHRNLTKIISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQR---------- 868
+ ++ N+ +++ C +ED +I EYM NG L + L S +++ D +
Sbjct: 73 LSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFL-SSHHLDDKEENGNDAVPPAHC 131
Query: 869 ---------LNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL 919
L++ + +AS ++YL S +H DL N L+ +N+ ++DFG+++ L
Sbjct: 132 LPAISYSSLLHVALQIASGMKYLS---SLNFVHRDLATRNCLVGENLTIKIADFGMSRNL 188
Query: 920 IGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFT--RRKP----TDE 973
D Q + + + +MA E G+ +T DV++FG+ L E + +P TDE
Sbjct: 189 YAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDE 248
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 3e-11
Identities = 49/197 (24%), Positives = 91/197 (46%), Gaps = 17/197 (8%)
Query: 776 LIGRGSFGSVYIARLQ----NGIEVAVKTF-DLQHERAFKSFDTECEVMKSIRHRNLTKI 830
++G G FG + L+ + VA+ T ++ + F E + H N+ ++
Sbjct: 12 ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71
Query: 831 ISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYL-HFGYSAP 889
+ + ++ EYM NG+L+ L L Q + ++ +AS ++YL GY
Sbjct: 72 EGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGY--- 128
Query: 890 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTL---ATLGYMAPEYGREG 946
+H L VL++ ++V +S F + ED+S T+ + + + APE +
Sbjct: 129 -VHKGLAAHKVLVNSDLVCKISGFRRLQ----EDKSEAIYTTMSGKSPVLWAAPEAIQYH 183
Query: 947 RVSTKGDVYSFGILLME 963
S+ DV+SFGI++ E
Sbjct: 184 HFSSASDVWSFGIVMWE 200
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 4e-11
Identities = 61/219 (27%), Positives = 96/219 (43%), Gaps = 42/219 (19%)
Query: 776 LIGRGSFGSVYIARLQNG--------IEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNL 827
++G G++G V++ R +G ++V K +Q + + TE +V++ IR
Sbjct: 7 VLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 66
Query: 828 TKIISSCSNEDFKA-LILEYMRNGSL-------------EKCLYSGNYILDIFQRLNIMI 873
+ D K LIL+Y+ G L E +YSG +L
Sbjct: 67 LVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVL---------- 116
Query: 874 DVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLA 933
ALE+LH +I+ D+K N+LLD N L+DFG++K ED+
Sbjct: 117 ----ALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFH-EDEVERAYSFCG 168
Query: 934 TLGYMAPEY--GREGRVSTKGDVYSFGILLMETFTRRKP 970
T+ YMAP+ G +G D +S G+L+ E T P
Sbjct: 169 TIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 4e-11
Identities = 73/271 (26%), Positives = 120/271 (44%), Gaps = 36/271 (13%)
Query: 776 LIGRGSFGSV-YIARLQNGIEVAVKTFDLQ------HERAFKSFDT--ECEVMKSIR-HR 825
++G G+ G+V R+ +G AVK D++ RA C+ ++ H
Sbjct: 39 VLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHE 98
Query: 826 NLTKIISSCSNED---FKALILEYMRNGSLEKCLYSGNYILDIFQRLN---IMIDVASAL 879
+ K N + AL+L+Y G L + + S F+ + I V A+
Sbjct: 99 DFAK--KDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAV 156
Query: 880 EYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL---IGEDQSMTQTQTLATLG 936
++H S +IH D+K +N+LL N + L DFG +K+ + +D T T
Sbjct: 157 HHVH---SKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRT---FCGTPY 210
Query: 937 YMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDF--LPISM- 993
Y+APE R S K D++S G+LL E T ++P D E+ K + LP S+
Sbjct: 211 YVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLPPSIS 270
Query: 994 --MKIIDANLLITEDKHFAAKEQCASSVFNL 1022
M+ I LL ++ K + +S + N+
Sbjct: 271 PEMQEIVTALLSSDPK----RRPSSSKLLNM 297
|
Length = 496 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 4e-11
Identities = 71/242 (29%), Positives = 111/242 (45%), Gaps = 42/242 (17%)
Query: 765 FQATNGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQHERAFKSFDT--------- 814
F+ TN + + +G G+FG V AR Q G VA+K + K F T
Sbjct: 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIK-------KIMKPFSTPVLAKRTYR 58
Query: 815 ECEVMKSIRHRN---LTKIISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNI 871
E +++K +RH N L+ I S + + + E + L + L S Q
Sbjct: 59 ELKLLKHLRHENIISLSDIFISPLEDIY--FVTELLGT-DLHRLLTSRPLEKQFIQYF-- 113
Query: 872 MIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQT 931
+ + L+Y+H SA V+H DLKPSN+L+++N + DFG+A++ +D M T
Sbjct: 114 LYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARI---QDPQM--TGY 165
Query: 932 LATLGYMAPEYGRE-GRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLP 990
++T Y APE + + D++S G + E KP +F G K VN F
Sbjct: 166 VSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEML-EGKP---LFPG----KDHVNQFSI 217
Query: 991 IS 992
I+
Sbjct: 218 IT 219
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 5e-11
Identities = 57/201 (28%), Positives = 93/201 (46%), Gaps = 14/201 (6%)
Query: 776 LIGRGSFGSVYIARLQ-NGIEVAVKTFDLQHERAFKSFD-----TECEVMKSIRHRNLTK 829
L+G+G+FG V + R + +G A+K L+ E + TE V+K+ RH LT
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKI--LKKEVIIAKDEVAHTLTESRVLKNTRHPFLTS 59
Query: 830 IISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAP 889
+ S +D ++EY+ G L L + R ++ SAL+YLH S
Sbjct: 60 LKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRF-YGAEIVSALDYLH---SGK 115
Query: 890 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVS 949
+++ DLK N++LD + ++DFG+ K G + T T Y+APE +
Sbjct: 116 IVYRDLKLENLMLDKDGHIKITDFGLCKE--GITDAATMKTFCGTPEYLAPEVLEDNDYG 173
Query: 950 TKGDVYSFGILLMETFTRRKP 970
D + G+++ E R P
Sbjct: 174 RAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 5e-11
Identities = 56/234 (23%), Positives = 93/234 (39%), Gaps = 40/234 (17%)
Query: 774 NNLIGRGSFGSVYIAR-LQNGIEVAVKTFDLQHERAFKSFDT--------------ECEV 818
+G G++G V A G VA+K + + D E ++
Sbjct: 14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKI 73
Query: 819 MKSIRHRNLTKIISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASA 878
M I+H N+ ++ DF L+++ M L+K + L Q I++ + +
Sbjct: 74 MNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKK-VVDRKIRLTESQVKCILLQILNG 131
Query: 879 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK-----LLIGE--DQSMTQ--- 928
L LH Y +H DL P+N+ ++ + ++DFG+A+ Q
Sbjct: 132 LNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRRE 188
Query: 929 --TQTLATLGYMAPE--YGREGRVSTKGDVYSFGILLMETFTRRKP----TDEI 974
T + TL Y APE G E + D++S G + E T KP +EI
Sbjct: 189 EMTSKVVTLWYRAPELLMGAE-KYHFAVDMWSVGCIFAELLT-GKPLFPGENEI 240
|
Length = 335 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 9e-11
Identities = 76/244 (31%), Positives = 115/244 (47%), Gaps = 13/244 (5%)
Query: 311 NVSTLKLIELSNNTFFGSLP-SSTDVQLPNLEELYLWGNNFSGTLPSFIFNASNLSKLSL 369
++S L ++L + + SL S + L L L L N S + +NL+ L L
Sbjct: 65 SLSRLLSLDLLSPSGISSLDGSENLLNLLPLPSLDLNLNRLRS-NISELLELTNLTSLDL 123
Query: 370 GDNSFSGLIPNTFGNLRNLKRLRLYNNYLTSPELSFLSSLSNCKYLEIIALSGNPLNGII 429
+N+ + + P NLK L L +N + S S L N L+ + LS N L+ +
Sbjct: 124 DNNNITDIPPLIGLLKSNLKELDLSDNKIE----SLPSPLRNLPNLKNLDLSFNDLS-DL 178
Query: 430 PMSAGNLSHSLEELFMPDCNVSGRIPKEIGNLANLVTLDLGGNKFNGSIPIALGKLQKLQ 489
P NLS +L L + +S +P EI L+ L LDL N + +L L+ L
Sbjct: 179 PKLLSNLS-NLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLS 235
Query: 490 LLNLDDNKLEGSIPDDICGLVELYKLALGDNKLSGQIPACFGNLASLRELWLGPNELISF 549
L L +NKLE +P+ I L L L L +N++S + G+L +LREL L N L +
Sbjct: 236 GLELSNNKLE-DLPESIGNLSNLETLDLSNNQIS--SISSLGSLTNLRELDLSGNSLSNA 292
Query: 550 IPST 553
+P
Sbjct: 293 LPLI 296
|
Length = 394 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 1e-10
Identities = 61/193 (31%), Positives = 91/193 (47%), Gaps = 11/193 (5%)
Query: 776 LIGRGSFGSVYIA-RLQNGIEVAVKTFD---LQHERAFKSFDTECEVM-KSIRHRNLTKI 830
+IG+GSFG V +A R +G AVK + + + K E V+ K+++H L +
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 831 ISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPV 890
S + +L+++ G L L + R ++ASAL YLH S +
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAA-EIASALGYLH---SINI 117
Query: 891 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVST 950
++ DLKP N+LLD L+DFG+ K G QS T T T Y+APE R+
Sbjct: 118 VYRDLKPENILLDSQGHVVLTDFGLCKE--GIAQSDTTTTFCGTPEYLAPEVIRKQPYDN 175
Query: 951 KGDVYSFGILLME 963
D + G +L E
Sbjct: 176 TVDWWCLGAVLYE 188
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 1e-10
Identities = 56/218 (25%), Positives = 96/218 (44%), Gaps = 49/218 (22%)
Query: 775 NLIGRGSFGSVYIARLQ-NGIEVAVKT-----FDLQH-ERAFKSFDTECEVMKSIRHRNL 827
+ +G G++G V A G +VA+K H +R ++ E ++K + H N
Sbjct: 21 SPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYR----ELRLLKHMDHEN- 75
Query: 828 TKIIS-------SCSNEDFKA--LILEYMRNGSLEKCLYSGNYILDIFQRLN------IM 872
+I + S EDF+ L+ M L + Q+L+ ++
Sbjct: 76 --VIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKC--------QKLSDDHIQFLV 124
Query: 873 IDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTL 932
+ L+Y+H SA +IH DLKPSN+ ++++ + DFG+A+ D M T +
Sbjct: 125 YQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHT---DDEM--TGYV 176
Query: 933 ATLGYMAPE--YGREGRVSTKGDVYSFGILLMETFTRR 968
AT Y APE + D++S G ++ E T +
Sbjct: 177 ATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 2e-10
Identities = 31/79 (39%), Positives = 49/79 (62%)
Query: 231 GGISSTLSNCKHLRILDLSFNDLWGDIPKEIGNLTKLKELFLDFNILQGEIPHTVGNLHN 290
G I + +S +HL+ ++LS N + G+IP +G++T L+ L L +N G IP ++G L +
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTS 491
Query: 291 LEYLSLVNNELVGTVPATI 309
L L+L N L G VPA +
Sbjct: 492 LRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 2e-10
Identities = 56/208 (26%), Positives = 91/208 (43%), Gaps = 30/208 (14%)
Query: 776 LIGRGSFGSVYIAR-LQNGIEVAVKTFDLQHERAFKSFDTECEVMKSI-RHRNLTKII-- 831
+IG G++G VY AR + G VA+K D+ + + E +++ H N+
Sbjct: 13 VIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEE-EEIKEEYNILRKYSNHPNIATFYGA 71
Query: 832 ----SSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLN------IMIDVASALEY 881
+ N+D L++E GS+ + + +RL I+ + L Y
Sbjct: 72 FIKKNPPGNDDQLWLVMELCGGGSVTDLV---KGLRKKGKRLKEEWIAYILRETLRGLAY 128
Query: 882 LHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQT-LATLGYMAP 940
LH VIH D+K N+LL N L DFG++ L D ++ + T + T +MAP
Sbjct: 129 LH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQL---DSTLGRRNTFIGTPYWMAP 182
Query: 941 E-----YGREGRVSTKGDVYSFGILLME 963
E + + DV+S GI +E
Sbjct: 183 EVIACDEQPDASYDARSDVWSLGITAIE 210
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 3e-10
Identities = 55/243 (22%), Positives = 90/243 (37%), Gaps = 35/243 (14%)
Query: 337 LPNLEELYLWGNNFSGTLPSFIFNA----SNLSKLSLGDN------SFSGLIPNTFGNLR 386
L L+ L L GN + +A +L +L L N +
Sbjct: 22 LLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC 81
Query: 387 NLKRLRLYNNYLTSPELSFLSSLSNCKYLEIIALSGNPL-NGIIPMSAGNL---SHSLEE 442
L+ L L +N L L SL L+ + L+ N L + + + A L +LE+
Sbjct: 82 GLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEK 141
Query: 443 LFMPDCNVSGRIPKEIGNLA----NLVTLDLGGNKFNGSIPIALGK----LQKLQLLNLD 494
L + + G + + +L L+L N + AL + L++L+L+
Sbjct: 142 LVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLN 201
Query: 495 DNKL--EGSIPDDICGLVE----LYKLALGDNKLSGQI-----PACFGNLASLRELWLGP 543
+N L EG+ + + L L LGDN L+ A SL L L
Sbjct: 202 NNGLTDEGAS--ALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSC 259
Query: 544 NEL 546
N++
Sbjct: 260 NDI 262
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 3e-10
Identities = 55/211 (26%), Positives = 101/211 (47%), Gaps = 11/211 (5%)
Query: 776 LIGRGSFGSVYIA-RLQNG----IEVAVKTF-DLQHERAFKSFDTECEVMKSIRHRNLTK 829
++G G+FG+VY + G I VA+K + +A F E +M S+ H +L +
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 830 IISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAP 889
++ C + + L+ + M +G L ++ + LN + +A + YL
Sbjct: 74 LLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE---ERR 129
Query: 890 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVS 949
++H DL NVL+ ++DFG+A+LL G+++ + +MA E + +
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFT 189
Query: 950 TKGDVYSFGILLMETFT-RRKPTDEIFSGEM 979
+ DV+S+G+ + E T KP D I + E+
Sbjct: 190 HQSDVWSYGVTIWELMTFGGKPYDGIPTREI 220
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 3e-10
Identities = 64/225 (28%), Positives = 103/225 (45%), Gaps = 50/225 (22%)
Query: 777 IGRGSFGSVYIAR-LQNGIEVAVK----TFD--LQHERAFKSFDTECEVMKSIRHRNLTK 829
IGRG++G V A+ + +VA+K FD + +R + E ++++ + H N+
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLR----EIKLLRHLDHENVIA 68
Query: 830 ---IISSCSNEDFKALILEY-MRNGSLEKCLYSGNYILD------IFQRLNIMIDVASAL 879
I+ E F + + Y + + L + + S + D ++Q L L
Sbjct: 69 IKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLR-------GL 121
Query: 880 EYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMA 939
+Y+H SA V+H DLKPSN+LL+ N + DFG+A+ + M T+ + T Y A
Sbjct: 122 KYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFM--TEYVVTRWYRA 176
Query: 940 PE-------YGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSG 977
PE Y T DV+S G + E RKP +F G
Sbjct: 177 PELLLNCSEYT------TAIDVWSVGCIFAELLG-RKP---LFPG 211
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 56/201 (27%), Positives = 91/201 (45%), Gaps = 14/201 (6%)
Query: 776 LIGRGSFGSVYIARLQ-NGIEVAVKTFDLQHERAFKSFD-----TECEVMKSIRHRNLTK 829
L+G+G+FG V + R + G A+K L+ E + TE V+++ RH LT
Sbjct: 2 LLGKGTFGKVILVREKATGRYYAMKI--LRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 59
Query: 830 IISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAP 889
+ + D ++EY G L L + R ++ SALEYLH S
Sbjct: 60 LKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYLH---SRD 115
Query: 890 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVS 949
V++ D+K N++LD + ++DFG+ K I + +M T Y+APE +
Sbjct: 116 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KTFCGTPEYLAPEVLEDNDYG 173
Query: 950 TKGDVYSFGILLMETFTRRKP 970
D + G+++ E R P
Sbjct: 174 RAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 4e-10
Identities = 63/219 (28%), Positives = 100/219 (45%), Gaps = 35/219 (15%)
Query: 777 IGRGSFGSVYIAR-LQNGIEVAVKTFDLQHER------AFKSFDTECEVMKSIRHRNLTK 829
IG G++G VY AR G VA+K L+ E A + E ++K + H N+ +
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIR----EISLLKELNHPNIVR 62
Query: 830 IISSCSNEDFKALILEYMRNGSLEKCLYS-GNYILDIFQRLNIMIDVASALEYLHFGYSA 888
++ +E+ L+ E++ + L+K + S LD + + + + Y H S
Sbjct: 63 LLDVVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH---SH 118
Query: 889 PVIHCDLKPSNVLLDDNMVAHLSDFGIAK-----LLIGEDQSMTQTQTLATLGYMAPEYG 943
V+H DLKP N+L+D L+DFG+A+ + T T + TL Y APE
Sbjct: 119 RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV-------RTYTHEVVTLWYRAPEIL 171
Query: 944 REGR-VSTKGDVYSFGILLMETFTRR------KPTDEIF 975
R ST D++S G + E RR D++F
Sbjct: 172 LGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLF 210
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 4e-10
Identities = 55/221 (24%), Positives = 92/221 (41%), Gaps = 39/221 (17%)
Query: 776 LIGRGSFGSVYIAR-LQNGIEVAVKT---FDLQHERAFKSFD-TECEVMKSIRHRNLTKI 830
+IGRG+FG V++ R G A+K D+ +R + E +++ + K+
Sbjct: 8 VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDM-IKRNQIAHVRAERDILADADSPWIVKL 66
Query: 831 ISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLH-FGYSAP 889
S +E+ L++EYM G L L + + R I ++ AL+ +H G+
Sbjct: 67 YYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIA-ELVLALDSVHKLGF--- 122
Query: 890 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQ------------------- 930
IH D+KP N+L+D + L+DFG+ K +
Sbjct: 123 -IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHK 181
Query: 931 --------TLATLGYMAPEYGREGRVSTKGDVYSFGILLME 963
T+ T Y+APE R + D +S G++L E
Sbjct: 182 QRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYE 222
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 4e-10
Identities = 63/195 (32%), Positives = 92/195 (47%), Gaps = 15/195 (7%)
Query: 776 LIGRGSFGSVYIA-RLQNGIEVAVKTFDLQHERAFKSFD-----TECEVM-KSIRHRNLT 828
+IG+GSFG V +A R +G AVK LQ + K + E V+ K+++H L
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKV--LQKKTILKKKEQNHIMAERNVLLKNLKHPFLV 59
Query: 829 KIISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSA 888
+ S + +L+Y+ G L L L+ R +VASA+ YLH S
Sbjct: 60 GLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARF-YAAEVASAIGYLH---SL 115
Query: 889 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRV 948
+I+ DLKP N+LLD L+DFG+ K G + T + T Y+APE R+
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKE--GVEPEETTSTFCGTPEYLAPEVLRKEPY 173
Query: 949 STKGDVYSFGILLME 963
D + G +L E
Sbjct: 174 DRTVDWWCLGAVLYE 188
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 4e-10
Identities = 57/213 (26%), Positives = 105/213 (49%), Gaps = 22/213 (10%)
Query: 776 LIGRGSFGSVYIARLQNGIE-VAVKTFDLQHERAFKSFDTECEVMK----SIRHRN--LT 828
++G+GSFG V +A L+ E AVK L+ + D EC +++ ++ N LT
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKA--LKKDVVLIDDDVECTMVEKRVLALAWENPFLT 59
Query: 829 KIISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSA 888
+ + ++ ++E++ G L + D+++ ++ L++LH S
Sbjct: 60 HLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGR-FDLYRATFYAAEIVCGLQFLH---SK 115
Query: 889 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKL-LIGEDQSMTQTQTLATLGYMAPEYGREGR 947
+I+ DLK NV+LD + ++DFG+ K + G++++ T T Y+APE + +
Sbjct: 116 GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST---FCGTPDYIAPEILQGLK 172
Query: 948 VSTKGDVYSFGILLMETFTRRKP-----TDEIF 975
+ D +SFG+LL E + P DE+F
Sbjct: 173 YTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELF 205
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 4e-10
Identities = 58/223 (26%), Positives = 102/223 (45%), Gaps = 23/223 (10%)
Query: 771 FSENNLIGRGSFGSVY----IARLQN-GIEVAVKTF-DLQHERAFKSFDTECEVMKSIRH 824
F + ++G G+FG+VY I + I VA+K + +A K E VM S+ +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 825 RNLTKIISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQR------LNIMIDVASA 878
++ +++ C + LI + M G CL +Y+ + LN + +A
Sbjct: 69 PHVCRLLGICLTSTVQ-LITQLMPFG----CLL--DYVREHKDNIGSQYLLNWCVQIAKG 121
Query: 879 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYM 938
+ YL ++H DL NVL+ ++DFG+AKLL +++ + +M
Sbjct: 122 MNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWM 178
Query: 939 APEYGREGRVSTKGDVYSFGILLMETFT-RRKPTDEIFSGEMT 980
A E + + DV+S+G+ + E T KP D I + E++
Sbjct: 179 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 221
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 5e-10
Identities = 67/279 (24%), Positives = 124/279 (44%), Gaps = 43/279 (15%)
Query: 777 IGRGSFGSVYI-----ARLQNGIEV--AVKTFDLQHERAFKSFDTECEVMKSIRHRNLTK 829
+G+GSFG+VY+ A + ++V + +L ++ + E +++ + H + K
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQA-NQEAQLLSKLDHPAIVK 66
Query: 830 IISSCSNEDFKALILEYMRNGSL----EKCLYSGNYILDIFQRLNIMIDVASALEYLHFG 885
+S D +I EY L E+ ++G L Q I + + Y+H
Sbjct: 67 FHASFLERDAFCIITEYCEGRDLDCKLEELKHTGK-TLSENQVCEWFIQLLLGVHYMH-- 123
Query: 886 YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGE-DQSMTQTQTLATLGYMAPEYGR 944
++H DLK N+ L +N++ + DFG+++LL+G D + T T T YM+PE +
Sbjct: 124 -QRRILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMGSCDLATTFT---GTPYYMSPEALK 178
Query: 945 EGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLIT 1004
+K D++S G +L E F G+ +FL + +++I++
Sbjct: 179 HQGYDSKSDIWSLGCILYEMCC----LAHAFEGQ--------NFLSV-VLRIVEGPT--- 222
Query: 1005 EDKHFAAKEQCASSVFNLAMECTVE-SPDERITAKEIVR 1042
+ + S N M+ + P R +A EI+R
Sbjct: 223 -----PSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 5e-10
Identities = 54/203 (26%), Positives = 101/203 (49%), Gaps = 17/203 (8%)
Query: 776 LIGRGSFGSVYIARLQ-NGIEVAVKTFDLQHERAFKSFDTECEVMK------SIRHRNLT 828
++G+GSFG V++A L+ A+K L+ + D EC +++ + H LT
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKA--LKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 59
Query: 829 KIISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSA 888
+ + ++ ++EY+ G L + S + D+ + ++ L++LH S
Sbjct: 60 HLYCTFQTKENLFFVMEYLNGGDLMFHIQSC-HKFDLPRATFYAAEIICGLQFLH---SK 115
Query: 889 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKL-LIGEDQSMTQTQTLATLGYMAPEYGREGR 947
+++ DLK N+LLD + ++DFG+ K ++G+ ++ T T Y+APE +
Sbjct: 116 GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCT---FCGTPDYIAPEILLGQK 172
Query: 948 VSTKGDVYSFGILLMETFTRRKP 970
+T D +SFG+LL E + P
Sbjct: 173 YNTSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 5e-10
Identities = 57/211 (27%), Positives = 99/211 (46%), Gaps = 21/211 (9%)
Query: 776 LIGRGSFGSVYIARLQNGIEV-AVKTFDLQHERAFKSFDTECEVMK------SIRHRNLT 828
++G+GSFG V +A L+ E A+K L+ + + D EC +++ + H LT
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKA--LKKDVVLEDDDVECTMVERRVLALAWEHPFLT 59
Query: 829 KIISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSA 888
+ + ++ ++EY+ G L + S D + ++ L++LH
Sbjct: 60 HLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGR-FDEARARFYAAEIICGLQFLH---KK 115
Query: 889 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTL-ATLGYMAPEYGREGR 947
+I+ DLK NVLLD + ++DFG+ K + + + T T Y+APE + +
Sbjct: 116 GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE---GKASTFCGTPDYIAPEILKGQK 172
Query: 948 VSTKGDVYSFGILLMETFTRRKPTDEIFSGE 978
+ D +SFG+LL E + P F GE
Sbjct: 173 YNESVDWWSFGVLLYEMLIGQSP----FHGE 199
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 6e-10
Identities = 61/209 (29%), Positives = 92/209 (44%), Gaps = 11/209 (5%)
Query: 776 LIGRGSFGSVYIARLQN-----GIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKI 830
+IG+GSFG V +AR + ++V K L+ + ++K+++H L +
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 831 ISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPV 890
S D +L+Y+ G L L L+ R ++ASAL YLH S +
Sbjct: 62 HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-YAAEIASALGYLH---SLNI 117
Query: 891 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVST 950
++ DLKP N+LLD L+DFG+ K I E T T T Y+APE +
Sbjct: 118 VYRDLKPENILLDSQGHIVLTDFGLCKENI-EHNGTTST-FCGTPEYLAPEVLHKQPYDR 175
Query: 951 KGDVYSFGILLMETFTRRKPTDEIFSGEM 979
D + G +L E P + EM
Sbjct: 176 TVDWWCLGAVLYEMLYGLPPFYSRNTAEM 204
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 6e-10
Identities = 57/221 (25%), Positives = 94/221 (42%), Gaps = 18/221 (8%)
Query: 775 NLIGRGSFGSVYIARLQNGI-----EVAVKTF-DLQHERAFKSFDTECEVMKSIRHRNLT 828
+L+ G+FG ++ L + EV VKT D E E ++ + H+N+
Sbjct: 12 DLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNIL 71
Query: 829 KIISSCSNEDFKALILE-YMRNGSLEKCLYSGNYI-------LDIFQRLNIMIDVASALE 880
I+ C + +L YM G+L+ L L Q +++ I +A +
Sbjct: 72 PILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMS 131
Query: 881 YLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAP 940
YLH VIH D+ N ++D+ + ++D +++ L D + +MA
Sbjct: 132 YLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMAL 188
Query: 941 EYGREGRVSTKGDVYSFGILLMETFTRRK-PTDEIFSGEMT 980
E S+ DV+SFG+LL E T + P EI EM
Sbjct: 189 ESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMA 229
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 6e-10
Identities = 57/218 (26%), Positives = 100/218 (45%), Gaps = 35/218 (16%)
Query: 777 IGRGSFGSVYIAR-LQNGIEVAVKTFDLQHER------AFKSFDTECEVMKSIRHRNLTK 829
+G G+FG VY AR ++ G VA+K + +E+ A + E +++K ++H N+
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR----EIKILKKLKHPNVVP 71
Query: 830 II------SSCSNEDFKA--LILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEY 881
+I S + ++ YM + L L + + L Q M+ + + Y
Sbjct: 72 LIDMAVERPDKSKRKRGSVYMVTPYM-DHDLSGLLENPSVKLTESQIKCYMLQLLEGINY 130
Query: 882 LHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQ---------TQTL 932
LH ++H D+K +N+L+D+ + ++DFG+A+ G + T +
Sbjct: 131 LH---ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLV 187
Query: 933 ATLGYMAPEY--GREGRVSTKGDVYSFGILLMETFTRR 968
T Y PE G E R +T D++ G + E FTRR
Sbjct: 188 VTRWYRPPELLLG-ERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 6e-10
Identities = 51/177 (28%), Positives = 76/177 (42%), Gaps = 27/177 (15%)
Query: 777 IGRGSFGSVYIAR-LQNGIEVAVKTF-----DLQ-HERAFKSFDTECEVMKSIRHRNLTK 829
IG GS+G V+ R + G VA+K F D + A + E ++K ++H NL
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALR----EIRMLKQLKHPNLVN 64
Query: 830 IISSCSNEDFKA-----LILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHF 884
+I E F+ L+ EY + L + L + I+ A+ + H
Sbjct: 65 LI-----EVFRRKRKLHLVFEYCDHTVLNE-LEKNPRGVPEHLIKKIIWQTLQAVNFCH- 117
Query: 885 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPE 941
IH D+KP N+L+ L DFG A++L G T +AT Y APE
Sbjct: 118 --KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDY--TDYVATRWYRAPE 170
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 7e-10
Identities = 32/86 (37%), Positives = 42/86 (48%)
Query: 467 LDLGGNKFNGSIPIALGKLQKLQLLNLDDNKLEGSIPDDICGLVELYKLALGDNKLSGQI 526
L L G IP + KL+ LQ +NL N + G+IP + + L L L N +G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 527 PACFGNLASLRELWLGPNELISFIPS 552
P G L SLR L L N L +P+
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPA 508
|
Length = 623 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 8e-10
Identities = 40/127 (31%), Positives = 64/127 (50%), Gaps = 7/127 (5%)
Query: 844 LEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLD 903
+E+M GSL++ L I + I I V L YL + ++H D+KPSN+L++
Sbjct: 78 MEHMDGGSLDQVLKKAGRIPENILG-KISIAVLRGLTYLREKHK--IMHRDVKPSNILVN 134
Query: 904 DNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLME 963
L DFG++ LI SM + + T YM+PE + + + D++S G+ L+E
Sbjct: 135 SRGEIKLCDFGVSGQLI---DSMANS-FVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVE 190
Query: 964 TFTRRKP 970
R P
Sbjct: 191 MAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 59.9 bits (146), Expect = 2e-09
Identities = 58/213 (27%), Positives = 105/213 (49%), Gaps = 22/213 (10%)
Query: 775 NLIGRGSFGSVYIAR-LQNGIEVAVKTFDLQHERAFKSFDT----ECEVMKSIRHRNLTK 829
N I G++G VY AR + G VA+K ++ E+ + F E ++ ++H N+
Sbjct: 11 NRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK--EGFPITSLREINILLKLQHPNIVT 68
Query: 830 I--ISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYS 887
+ + SN D +++EY+ + L+ + + + +M+ + S + +LH +
Sbjct: 69 VKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW- 126
Query: 888 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPE--YGRE 945
++H DLK SN+LL++ + + DFG+A+ + TQ + TL Y APE G
Sbjct: 127 --ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPY--TQLVVTLWYRAPELLLG-A 181
Query: 946 GRVSTKGDVYSFGILLMETFTRRKPTDEIFSGE 978
ST D++S G + E +KP +F G+
Sbjct: 182 KEYSTAIDMWSVGCIFAE-LLTKKP---LFPGK 210
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 2e-09
Identities = 60/216 (27%), Positives = 95/216 (43%), Gaps = 28/216 (12%)
Query: 776 LIGRGSFGSVYIARLQNGIEV-AVKTFDLQHERAFKSFDTECEVMK------SIRHRNLT 828
++G+GSFG V +ARL+ + AVK L+ + + D EC + + + H LT
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKV--LKKDVILQDDDVECTMTEKRILSLARNHPFLT 59
Query: 829 KIISSCSNEDFKALILEYMRNGSL----EKCLYSGNYILDIFQRLNIMIDVASALEYLHF 884
++ D ++E++ G L +K D + ++ SAL +LH
Sbjct: 60 QLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRR-----FDEARARFYAAEITSALMFLH- 113
Query: 885 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGR 944
+I+ DLK NVLLD L+DFG+ K I T + T Y+APE +
Sbjct: 114 --DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN--GKTTSTFCGTPDYIAPEILQ 169
Query: 945 EGRVSTKGDVYSFGILLMETFTRRKP-----TDEIF 975
E D ++ G+LL E P D++F
Sbjct: 170 EMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLF 205
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 2e-09
Identities = 58/216 (26%), Positives = 101/216 (46%), Gaps = 23/216 (10%)
Query: 777 IGRGSFGSVYIARLQ-NGIEVAVKTFDLQHERA-FKSFDTECEVMKSIRHRNLTKIISSC 834
+G+G++GSVY + G+ +A+K L+ + + F E +++ + +
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68
Query: 835 SNEDFKALILEYMRNGSLEKCLYSGNYILDIF---QRLNIMIDVASALEYLHFGYSAPVI 891
E + +EYM GSL+K LY+G + I V L++L ++ +I
Sbjct: 69 FIEGAVYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--II 125
Query: 892 HCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTK 951
H D+KP+NVL++ N L DFG++ L+ S+ +T + YMAPE + G +
Sbjct: 126 HRDVKPTNVLVNGNGQVKLCDFGVSGNLV---ASLAKTN-IGCQSYMAPERIKSGGPNQN 181
Query: 952 G------DVYSFGILLMETFTRRKP-----TDEIFS 976
DV+S G+ ++E R P IF+
Sbjct: 182 PTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFA 217
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 2e-09
Identities = 33/92 (35%), Positives = 51/92 (55%), Gaps = 3/92 (3%)
Query: 875 VASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLAT 934
VA +E+L S IH DL N+LL +N V + DFG+A+ + + + +
Sbjct: 182 VARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238
Query: 935 LGYMAPEYGREGRVSTKGDVYSFGILLMETFT 966
L +MAPE + +T+ DV+SFG+LL E F+
Sbjct: 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 2e-09
Identities = 62/228 (27%), Positives = 95/228 (41%), Gaps = 39/228 (17%)
Query: 776 LIGRGSFGSVYIAR-LQNGIEVAVKTF--DL-QHERAFKSFDTECEVMKSIRHRNLTKII 831
LIG+G G VY+A VA+K DL ++ K F E ++ + H + +
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 832 SSCSNED-------------FKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASA 878
S CS+ D K+L+ + SL K L + L+I + +
Sbjct: 69 SICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAF---LSIFHKICAT 125
Query: 879 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ-------------- 924
+EY+H S V+H DLKP N+LL + D+G A E++
Sbjct: 126 IEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICY 182
Query: 925 -SMTQT-QTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKP 970
SMT + + T YMAPE S D+Y+ G++L + T P
Sbjct: 183 SSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230
|
Length = 932 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 3e-09
Identities = 98/337 (29%), Positives = 145/337 (43%), Gaps = 66/337 (19%)
Query: 163 NLGNLSSLQLLDLSDNQLSGSIPSFIFKISSLQALHFGNNRLSGELPANICDNLPFLNFF 222
NL NL L LDL+ N+L +I S + ++++L +L NN NI D P +
Sbjct: 88 NLLNLLPLPSLDLNLNRLRSNI-SELLELTNLTSLDLDNN--------NITDIPPLIGLL 138
Query: 223 SVYKNMFYGGISSTLSNCKHLRILDLSFNDLWGDIPKEIGNLTKLKELFLDFNILQGEIP 282
+L+ LDLS N + +P + NL LK L L FN L ++P
Sbjct: 139 K-----------------SNLKELDLSDNKI-ESLPSPLRNLPNLKNLDLSFNDLS-DLP 179
Query: 283 HTVGNLHNLEYLSLVNNELVGTVPATIFNVSTLKLIELSNNTFFGSLPSSTDVQLPNLEE 342
+ NL NL L L N++ +P I +S L+ ++LSNN+
Sbjct: 180 KLLSNLSNLNNLDLSGNKI-SDLPPEIELLSALEELDLSNNSII---------------- 222
Query: 343 LYLWGNNFSGTLPSFIFNASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNYLTSPE 402
L S + N NLS L L +N +P + GNL NL+ L L NN ++S
Sbjct: 223 ----------ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQISS-- 269
Query: 403 LSFLSSLSNCKYLEIIALSGNPLNGIIPMSAGNLSHSLEELFMPDCNVSGRIPKEIGNLA 462
+SSL + L + LSGN L+ +P+ A L L + E+ +
Sbjct: 270 ---ISSLGSLTNLRELDLSGNSLSNALPLIALLLLLLELLLNLLLTL----KALELKLNS 322
Query: 463 NLVTLDLGGNKFNGSIPIALGKLQKLQLLNLDDNKLE 499
L+ ++ N S P AL L+ L L DN L+
Sbjct: 323 ILLNNNILSNGE-TSSPEALSILESLNNLWTLDNALD 358
|
Length = 394 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 3e-09
Identities = 56/207 (27%), Positives = 98/207 (47%), Gaps = 15/207 (7%)
Query: 771 FSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQHERAFKSFD-----TECEVMKSIRH 824
F ++G+G FG V +++ G A K L+ +R K E ++++ +
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKK--LEKKRIKKRKGEAMALNEKQILEKVNS 59
Query: 825 RNLTKIISSCSNEDFKALILEYMRNGSLEKCLYS-GNYILDIFQRLNIMIDVASALEYLH 883
R + + + +D L+L M G L+ +Y+ GN D + + ++ LE LH
Sbjct: 60 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH 119
Query: 884 FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYG 943
+++ DLKP N+LLDD +SD G+A + I E +++ + T+GYMAPE
Sbjct: 120 ---RERIVYRDLKPENILLDDYGHIRISDLGLA-VEIPEGETI--RGRVGTVGYMAPEVV 173
Query: 944 REGRVSTKGDVYSFGILLMETFTRRKP 970
+ R + D + G L+ E + P
Sbjct: 174 KNERYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 3e-09
Identities = 51/186 (27%), Positives = 85/186 (45%), Gaps = 22/186 (11%)
Query: 765 FQATNGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQHERA--FKSFDTECEVMKS 821
F + + + +G GS+ +VY + + NG VA+K LQ E F + E ++K
Sbjct: 1 FGKADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAI-REASLLKG 59
Query: 822 IRHRNLTKIISSCSNEDFKALILEYMRNGSLEKC------LYSGNYILDIFQRLNIMIDV 875
++H N+ + ++ L+ EY+ + L+ N L +FQ L
Sbjct: 60 LKHANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLR----- 114
Query: 876 ASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATL 935
L Y+H Y ++H DLKP N+L+ D L+DFG+A+ S T + + TL
Sbjct: 115 --GLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLAR--AKSVPSHTYSNEVVTL 167
Query: 936 GYMAPE 941
Y P+
Sbjct: 168 WYRPPD 173
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 3e-09
Identities = 55/207 (26%), Positives = 94/207 (45%), Gaps = 15/207 (7%)
Query: 771 FSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQHERAFKSFD-----TECEVMKSIRH 824
F ++G+G FG V +++ G A K L+ +R K E +++ +
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKK--LEKKRIKKRKGEAMALNEKRILEKVNS 59
Query: 825 RNLTKIISSCSNEDFKALILEYMRNGSLEKCLYS-GNYILDIFQRLNIMIDVASALEYLH 883
R + + + +D L+L M G L+ +Y+ GN D + + ++ LE L
Sbjct: 60 RFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ 119
Query: 884 FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYG 943
+++ DLKP N+LLDD +SD G+A + I E + T + T+GYMAPE
Sbjct: 120 ---RERIVYRDLKPENILLDDRGHIRISDLGLA-VQIPEGE--TVRGRVGTVGYMAPEVI 173
Query: 944 REGRVSTKGDVYSFGILLMETFTRRKP 970
+ + D + G L+ E + P
Sbjct: 174 NNEKYTFSPDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 3e-09
Identities = 48/205 (23%), Positives = 83/205 (40%), Gaps = 32/205 (15%)
Query: 776 LIGRGSFG--SVYIARLQ-NGIEVAVKTFDL--QHERAFKSFDTECEVMKSIRHRNLTKI 830
LIG+ V++A+ + VAVK +L + K E + ++H N+
Sbjct: 5 LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPY 64
Query: 831 ISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRL---NIMIDVASALEYLHFGYS 887
++S + ++ M GS E L + + L I+ DV +AL+Y+H S
Sbjct: 65 VTSFIVDSELYVVSPLMAYGSCEDLL--KTHFPEGLPELAIAFILKDVLNALDYIH---S 119
Query: 888 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQ-----TQTLATLGYMAPE- 941
IH +K S++LL + LS + +I + ++ L +++PE
Sbjct: 120 KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEV 179
Query: 942 -------YGREGRVSTKGDVYSFGI 959
Y K D+YS GI
Sbjct: 180 LQQNLQGYN------EKSDIYSVGI 198
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 3e-09
Identities = 59/218 (27%), Positives = 99/218 (45%), Gaps = 40/218 (18%)
Query: 777 IGRGSFGSVYIA-RLQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKII---- 831
+G GS G V+ A VAVK L ++ K E ++++ + H N+ K+
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 832 --SSCSNEDFKAL--------ILEYM----RNGSLEKCLYSGNYI-LDIFQRLNIMIDVA 876
S ED +L + EYM N LE+ S + L ++Q L
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYMETDLAN-VLEQGPLSEEHARLFMYQLLR------ 125
Query: 877 SALEYLHFGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLIGEDQSMTQ----TQT 931
L+Y+H SA V+H DLKP+NV ++ +++V + DFG+A+++ D + ++
Sbjct: 126 -GLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIV---DPHYSHKGYLSEG 178
Query: 932 LATLGYMAPEYGREGRVSTKG-DVYSFGILLMETFTRR 968
L T Y +P TK D+++ G + E T +
Sbjct: 179 LVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 3e-09
Identities = 67/228 (29%), Positives = 105/228 (46%), Gaps = 48/228 (21%)
Query: 777 IGRGSFGSVYIAR---LQNGIEVAVK----TFD--LQHERAFKSFDTECEVMKSIR-HRN 826
+G+G++G V AR VA+K F + +RA + E ++++ R H+N
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALR----ELKLLRHFRGHKN 63
Query: 827 LTKII------SSCSNEDFKALILEYMRNGSLEKCLYSGNYILD------IFQRLNIMID 874
+T + NE + L E M L + + SG + D I+Q L
Sbjct: 64 ITCLYDMDIVFPGNFNELY--LYEELM-EADLHQIIRSGQPLTDAHFQSFIYQIL----- 115
Query: 875 VASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQ---TQT 931
L+Y+H SA V+H DLKP N+L++ + + DFG+A+ E+ T+
Sbjct: 116 --CGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLAR-GFSENPGENAGFMTEY 169
Query: 932 LATLGYMAPEYGREGRVSTKG-DVYSFGILLMETFTRRKPTDEIFSGE 978
+AT Y APE + TK DV+S G +L E RKP +F G+
Sbjct: 170 VATRWYRAPEIMLSFQSYTKAIDVWSVGCILAE-LLGRKP---VFKGK 213
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 3e-09
Identities = 58/202 (28%), Positives = 96/202 (47%), Gaps = 20/202 (9%)
Query: 777 IGRGSFGSVYIARLQNGIE-VAVKTFDLQHE------RAFKSFDTECEVMKSIRHRNLTK 829
IG G++G VY AR + E +A+K L+ E A + E ++K ++H N+ +
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIR----EISLLKEMQHGNIVR 65
Query: 830 IISSCSNEDFKALILEYMRNGSLEKCLYSG-NYILDIFQRLNIMIDVASALEYLHFGYSA 888
+ +E L+ EY+ + L+K + S ++ + + + + Y H S
Sbjct: 66 LQDVVHSEKRLYLVFEYL-DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH---SH 121
Query: 889 PVIHCDLKPSNVLLDDNMVA-HLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGR 947
V+H DLKP N+L+D A L+DFG+A+ T T + TL Y APE R
Sbjct: 122 RVLHRDLKPQNLLIDRRTNALKLADFGLARAF--GIPVRTFTHEVVTLWYRAPEILLGSR 179
Query: 948 -VSTKGDVYSFGILLMETFTRR 968
ST D++S G + E ++
Sbjct: 180 HYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 3e-09
Identities = 56/209 (26%), Positives = 85/209 (40%), Gaps = 26/209 (12%)
Query: 776 LIGRGSFGSVYIA-RLQNGIEVAVKTF-DLQHERAFKSFDTECEVMKSIRHRNLTKIISS 833
L+GR + ++A R + E V F L ER +E + + H + K
Sbjct: 74 LVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDD 133
Query: 834 CSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLN------------IMIDVASALEY 881
++D LI+EY G L K I QRL + + AL+
Sbjct: 134 FKSDDKLLLIMEYGSGGDLNK---------QIKQRLKEHLPFQEYEVGLLFYQIVLALDE 184
Query: 882 LHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPE 941
+H S ++H DLK +N+ L + L DFG +K + T Y+APE
Sbjct: 185 VH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPE 241
Query: 942 YGREGRVSTKGDVYSFGILLMETFTRRKP 970
R S K D++S G++L E T +P
Sbjct: 242 LWERKRYSKKADMWSLGVILYELLTLHRP 270
|
Length = 478 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 3e-09
Identities = 56/207 (27%), Positives = 100/207 (48%), Gaps = 27/207 (13%)
Query: 777 IGRGSFGSVY-IARLQNGIEVAVK----TFD--LQHERAFKSFDTECEVMKSIRHRNLTK 829
IG G+FG V+ + ++G VA+K F + +R F+ E +++ +H N+
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFR----ELKMLCFFKHDNVLS 63
Query: 830 IIS-------SCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYL 882
+ E + ++ E M++ L K + S + ++ + + L+YL
Sbjct: 64 ALDILQPPHIDPFEEIY--VVTELMQS-DLHKIIVSPQPLSSDHVKV-FLYQILRGLKYL 119
Query: 883 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEY 942
H SA ++H D+KP N+L++ N V + DFG+A++ D+S TQ + T Y APE
Sbjct: 120 H---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVE-EPDESKHMTQEVVTQYYRAPEI 175
Query: 943 GREGR-VSTKGDVYSFGILLMETFTRR 968
R ++ D++S G + E RR
Sbjct: 176 LMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 4e-09
Identities = 27/87 (31%), Positives = 52/87 (59%)
Query: 246 LDLSFNDLWGDIPKEIGNLTKLKELFLDFNILQGEIPHTVGNLHNLEYLSLVNNELVGTV 305
L L L G IP +I L L+ + L N ++G IP ++G++ +LE L L N G++
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 306 PATIFNVSTLKLIELSNNTFFGSLPSS 332
P ++ +++L+++ L+ N+ G +P++
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAA 509
|
Length = 623 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 4e-09
Identities = 66/288 (22%), Positives = 121/288 (42%), Gaps = 52/288 (18%)
Query: 777 IGRGSFGSVYIARLQN---------GIEVAVKTFDL-QHERAFKSFDTECEVMKSIRHRN 826
+G+G+F ++Y L+ G EV+V L R +F +M + H++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 827 LTKIISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGY 886
L K+ C D ++ EY++ G L+ L+ + + +L++ +ASAL YL
Sbjct: 63 LVKLYGVCV-RDENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLE--- 118
Query: 887 SAPVIHCDLKPSNVLL---DDNM----VAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMA 939
++H ++ N+L+ N LSD GI + +++ + + + ++A
Sbjct: 119 DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITV------LSREERVERIPWIA 172
Query: 940 PEYGREGRVSTK--GDVYSFGILLMETFTR-RKPTDEIFSGEMTLKHWVNDFLPISMMKI 996
PE R G+ S D +SFG L+E + +P + S E +
Sbjct: 173 PECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFY------------- 219
Query: 997 IDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRL 1044
+D+H CA + NL +C P +R + + I+R L
Sbjct: 220 --------QDQHRLPMPDCAE-LANLINQCWTYDPTKRPSFRAILRDL 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 5e-09
Identities = 45/172 (26%), Positives = 72/172 (41%), Gaps = 25/172 (14%)
Query: 875 VASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLAT 934
VA +E+L S IH DL N+LL +N V + DFG+A+ + + + +
Sbjct: 188 VAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244
Query: 935 LGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMM 994
L +MAPE + + + DV+SFG+LL E F+ P +
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS-------------------PYPGV 285
Query: 995 KIIDANLL--ITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRL 1044
KI D + E A + ++ ++C P +R T E+V L
Sbjct: 286 KI-DEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 6e-09
Identities = 41/131 (31%), Positives = 69/131 (52%), Gaps = 9/131 (6%)
Query: 841 ALILEYMRNGSLEKCLYSGNYILD-IFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSN 899
++ +E+M GSL++ L I + I +++I V L YL + ++H D+KPSN
Sbjct: 79 SICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYLREKHK--IMHRDVKPSN 134
Query: 900 VLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGI 959
+L++ L DFG++ LI SM + + T YM+PE + S + D++S G+
Sbjct: 135 ILVNSRGEIKLCDFGVSGQLI---DSMANS-FVGTRSYMSPERLQGTHYSVQSDIWSMGL 190
Query: 960 LLMETFTRRKP 970
L+E R P
Sbjct: 191 SLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 6e-09
Identities = 50/205 (24%), Positives = 96/205 (46%), Gaps = 31/205 (15%)
Query: 777 IGRGSFGSVYIAR-LQNGIEVAVKTFDL------QHERAFKSFDTECEVMKSIRHRNLTK 829
IG GSFG + + ++G + +K ++ + E + K E V+ +++H N+ +
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRK----EVAVLSNMKHPNIVQ 63
Query: 830 IISSCSNEDFKALILEYMRNGSLEK-------CLYSGNYILDIFQRLNIMIDVASALEYL 882
S ++++Y G L K L+ + ILD F + + AL+++
Sbjct: 64 YQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWF------VQICLALKHV 117
Query: 883 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQT-LATLGYMAPE 941
H ++H D+K N+ L + L DFGIA++L + ++ +T + T Y++PE
Sbjct: 118 H---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVL---NSTVELARTCIGTPYYLSPE 171
Query: 942 YGREGRVSTKGDVYSFGILLMETFT 966
+ K D+++ G +L E T
Sbjct: 172 ICENRPYNNKSDIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 6e-09
Identities = 52/201 (25%), Positives = 89/201 (44%), Gaps = 12/201 (5%)
Query: 777 IGRGSFGSVYIARLQ-NGIEVAVKTFD---LQHERAFKSFDTECEVMKSIRHRNLTKIIS 832
+G+G FG V +++ G A K + L+ + ++ E ++ + R + +
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 833 SCSNEDFKALILEYMRNGSLEKCLYS---GNYILDIFQRLNIMIDVASALEYLHFGYSAP 889
+ + L++ M G L +Y+ N + + S LE+LH
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRR 117
Query: 890 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVS 949
+I+ DLKP NVLLD++ +SD G+A L + QS T+ T G+MAPE +
Sbjct: 118 IIYRDLKPENVLLDNDGNVRISDLGLAVELK-DGQSKTKGYA-GTPGFMAPELLQGEEYD 175
Query: 950 TKGDVYSFGILLMETFTRRKP 970
D ++ G+ L E R P
Sbjct: 176 FSVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 6e-09
Identities = 59/213 (27%), Positives = 90/213 (42%), Gaps = 42/213 (19%)
Query: 777 IGRGSFGSVYIARLQNG--IEVAVKTFDLQHERAFKSFD---TECEVMKSIRHRNLTKII 831
+G GSFG V +A +N VA+K F+ K D +E +++ I H +
Sbjct: 38 LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLY 97
Query: 832 SSCSNEDFKALILEYMRNGSLEK-------------CLYSGNYILDIFQRLNIMIDVASA 878
S +E + L+LE++ G C Y+ +L IF
Sbjct: 98 GSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVL-IF------------ 144
Query: 879 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTL-ATLGY 937
EYL S +++ DLKP N+LLD + ++DFG AK++ T+T TL T Y
Sbjct: 145 -EYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV------DTRTYTLCGTPEY 194
Query: 938 MAPEYGREGRVSTKGDVYSFGILLMETFTRRKP 970
+APE D ++ GI + E P
Sbjct: 195 IAPEILLNVGHGKAADWWTLGIFIYEILVGCPP 227
|
Length = 340 |
| >gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain | Back alignment and domain information |
|---|
Score = 51.9 bits (125), Expect = 7e-09
Identities = 19/40 (47%), Positives = 27/40 (67%), Gaps = 1/40 (2%)
Query: 28 DQDALLALKDHITYDPTNFFAKNWLTNSTMVCNWTGVTCD 67
D+DALLA K + DP+ + +W +S+ C+WTGVTCD
Sbjct: 4 DRDALLAFKSSLNGDPSGALS-SWNPSSSDPCSWTGVTCD 42
|
Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 8e-09
Identities = 56/197 (28%), Positives = 93/197 (47%), Gaps = 11/197 (5%)
Query: 777 IGRGSFGSVYIARLQ-NGIEVAVKTFDLQHERAFKSFDT-ECEVMKSIRHRNLTKIISSC 834
+G G++ +VY R + G VA+K L E S E +MK ++H N+ ++
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67
Query: 835 SNEDFKALILEYMRNGSLEKCL--YSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIH 892
E+ L+ EYM + L+K + + LD + + + + H V+H
Sbjct: 68 HTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH---ENRVLH 123
Query: 893 CDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRV-STK 951
DLKP N+L++ L+DFG+A+ G + T + + TL Y AP+ R ST
Sbjct: 124 RDLKPQNLLINKRGELKLADFGLAR-AFGIPVN-TFSNEVVTLWYRAPDVLLGSRTYSTS 181
Query: 952 GDVYSFGILLMETFTRR 968
D++S G ++ E T R
Sbjct: 182 IDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 58.2 bits (140), Expect = 9e-09
Identities = 54/209 (25%), Positives = 102/209 (48%), Gaps = 23/209 (11%)
Query: 776 LIGRGSFGSVYIARLQNGIEV-AVKTFDLQHERAFKSFDTEC-----EVMKSIRHRNLTK 829
+IGRG+FG V + +L+N +V A+K L K +T C +V+ + ++ +T
Sbjct: 8 VIGRGAFGEVAVVKLKNADKVFAMKI--LNKWEMLKRAETACFREERDVLVNGDNQWITT 65
Query: 830 IISSCSNEDFKALILEYMRNGSLEKCL--YSGNYILDIFQ-RLNIMIDVASALEYLHFGY 886
+ + +E+ L+++Y G L L + D+ + L M+ ++ LH+
Sbjct: 66 LHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHY-- 123
Query: 887 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGR-- 944
+H D+KP N+L+D N L+DFG + L + ED ++ + + T Y++PE +
Sbjct: 124 ----VHRDIKPDNILMDMNGHIRLADFG-SCLKLMEDGTVQSSVAVGTPDYISPEILQAM 178
Query: 945 ---EGRVSTKGDVYSFGILLMETFTRRKP 970
+G+ + D +S G+ + E P
Sbjct: 179 EDGKGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 1e-08
Identities = 41/143 (28%), Positives = 67/143 (46%), Gaps = 28/143 (19%)
Query: 270 LFLDFNILQGEIPHTVGNLHNLEYLSLVNNELVGTVPATIFNVSTLKLIELSNNTFFGSL 329
L LD L+G IP+ + L +L+ ++L N + G +P ++ ++++L++++LS N+F GS+
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 330 PSSTDVQLPNLEELYLWGNNFSGTLPSFIFNASNLSKLSLGDNSFSGLIPNTFGNLRNLK 389
P S G L S L L+L NS SG +P G R L
Sbjct: 483 PESL------------------GQLTS-------LRILNLNGNSLSGRVPAALGG-RLLH 516
Query: 390 RLRLYNNYLTSPELSFLSSLSNC 412
R N+ + L + L C
Sbjct: 517 RASF--NFTDNAGLCGIPGLRAC 537
|
Length = 623 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 1e-08
Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 3/92 (3%)
Query: 875 VASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLAT 934
VA+ +E+L S +H DL NVL+ + + + DFG+A+ ++ + +++ T
Sbjct: 248 VANGMEFLA---SKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLP 304
Query: 935 LGYMAPEYGREGRVSTKGDVYSFGILLMETFT 966
L +MAPE +T DV+SFGILL E FT
Sbjct: 305 LKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-08
Identities = 33/92 (35%), Positives = 51/92 (55%), Gaps = 3/92 (3%)
Query: 875 VASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLAT 934
VA +E+L S IH DL N+LL +N V + DFG+A+ + + + +
Sbjct: 183 VARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239
Query: 935 LGYMAPEYGREGRVSTKGDVYSFGILLMETFT 966
L +MAPE + +T+ DV+SFG+LL E F+
Sbjct: 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 1e-08
Identities = 41/131 (31%), Positives = 69/131 (52%), Gaps = 9/131 (6%)
Query: 841 ALILEYMRNGSLEKCLYSGNYI-LDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSN 899
++ +E+M GSL++ L I +I +++I V L YL + ++H D+KPSN
Sbjct: 79 SICMEHMDGGSLDQVLKEAKRIPEEILGKVSIA--VLRGLAYLREKHQ--IMHRDVKPSN 134
Query: 900 VLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGI 959
+L++ L DFG++ LI SM + + T YM+PE + S + D++S G+
Sbjct: 135 ILVNSRGEIKLCDFGVSGQLI---DSMANS-FVGTRSYMSPERLQGTHYSVQSDIWSMGL 190
Query: 960 LLMETFTRRKP 970
L+E R P
Sbjct: 191 SLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 2e-08
Identities = 33/104 (31%), Positives = 54/104 (51%), Gaps = 3/104 (2%)
Query: 863 LDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGE 922
L L+ VA +E+L S +H DL NVLL + + DFG+A+ ++ +
Sbjct: 234 LTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHD 290
Query: 923 DQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFT 966
+++ T + +MAPE + +T DV+S+GILL E F+
Sbjct: 291 SNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-08
Identities = 64/232 (27%), Positives = 105/232 (45%), Gaps = 24/232 (10%)
Query: 776 LIGRGSFGSVYIARLQNGIEV-AVKTFDLQHERAFKSFDTECEVMK------SIRHRNLT 828
++G+GSFG V +A + E+ A+K L+ + + D EC +++ S + LT
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKI--LKKDVVIQDDDVECTMVEKRVLALSGKPPFLT 64
Query: 829 KIISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSA 888
++ S D ++EY+ G L +Y + F+ + + A L F +S
Sbjct: 65 QLHSCFQTMDRLYFVMEYVNGGDL---MYQIQQV-GRFKEPHAVFYAAEIAIGLFFLHSK 120
Query: 889 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRV 948
+I+ DLK NV+LD ++DFG+ K + + +T T Y+APE
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD--GVTTKTFCGTPDYIAPEIIAYQPY 178
Query: 949 STKGDVYSFGILLMETFTRRKP-----TDEIFSGEMTLKHWVNDFLPISMMK 995
D ++FG+LL E + P DE+F M +H V P SM K
Sbjct: 179 GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM--EHNVA--YPKSMSK 226
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 2e-08
Identities = 64/214 (29%), Positives = 102/214 (47%), Gaps = 40/214 (18%)
Query: 771 FSENNLIGRGSFGSVYIARLQNGIEV-AVK---TFDL--QHERAFKSFDTECEVMKSIRH 824
F +IGRG+FG V + R ++ +V A+K F++ + + AF F E ++M H
Sbjct: 45 FDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAF--FWEERDIMA---H 99
Query: 825 RNLTKIIS-SCSNEDFKAL--ILEYMRNGSLEKCLYSGNY-ILDIFQRLNIMIDVASALE 880
N I+ + +D K L ++EYM G L + NY I + + R +V AL+
Sbjct: 100 ANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLM--SNYDIPEKWARFYTA-EVVLALD 156
Query: 881 YLH-FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMA 939
+H G+ IH D+KP N+LLD + L+DFG + + + + + T Y++
Sbjct: 157 AIHSMGF----IHRDVKPDNMLLDKSGHLKLADFGTC-MKMDANGMVRCDTAVGTPDYIS 211
Query: 940 PE----------YGREGRVSTKGDVYSFGILLME 963
PE YGRE D +S G+ L E
Sbjct: 212 PEVLKSQGGDGYYGRE------CDWWSVGVFLYE 239
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 2e-08
Identities = 54/204 (26%), Positives = 87/204 (42%), Gaps = 11/204 (5%)
Query: 776 LIGRGSFGSVYIARLQNGIEV----AVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKII 831
+IGRGS+ V + RL+ ++ VK + + TE V + +
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61
Query: 832 SSCSNEDFKA-LILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPV 890
SC + L++EY+ G L + + + R ++ AL +LH +
Sbjct: 62 HSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARF-YAAEICIALNFLH---ERGI 117
Query: 891 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVST 950
I+ DLK NVLLD + L+D+G+ K +G T + T Y+APE R
Sbjct: 118 IYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD--TTSTFCGTPNYIAPEILRGEEYGF 175
Query: 951 KGDVYSFGILLMETFTRRKPTDEI 974
D ++ G+L+ E R P D I
Sbjct: 176 SVDWWALGVLMFEMMAGRSPFDII 199
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 2e-08
Identities = 55/206 (26%), Positives = 99/206 (48%), Gaps = 20/206 (9%)
Query: 776 LIGRGSFGSVYIARLQNGIEV-AVK---TFDLQHERAFKSFDTECEVMKSIRHRNLTKII 831
+IGRG+FG V + R ++ +V A+K F++ F E ++M + ++
Sbjct: 50 VIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 109
Query: 832 SSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLN--IMIDVASALEYLHFGYSAP 889
+ ++ + +++EYM G L + NY D+ ++ +V AL+ +H S
Sbjct: 110 CAFQDDKYLYMVMEYMPGGDLVNLM--SNY--DVPEKWAKFYTAEVVLALDAIH---SMG 162
Query: 890 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQT-LATLGYMAPEY----GR 944
+IH D+KP N+LLD + L+DFG + ++ M + T + T Y++PE G
Sbjct: 163 LIHRDVKPDNMLLDKHGHLKLADFGTCMKM--DETGMVRCDTAVGTPDYISPEVLKSQGG 220
Query: 945 EGRVSTKGDVYSFGILLMETFTRRKP 970
+G + D +S G+ L E P
Sbjct: 221 DGYYGRECDWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 4e-08
Identities = 56/205 (27%), Positives = 87/205 (42%), Gaps = 21/205 (10%)
Query: 776 LIGRGSFGSV----------YIARLQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHR 825
L+G+G+FG V Y A EV V ++ H TE V+++ RH
Sbjct: 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTL------TENRVLQNSRHP 55
Query: 826 NLTKIISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFG 885
LT + S D ++EY G L L + R ++ SAL+YLH
Sbjct: 56 FLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALDYLH-- 112
Query: 886 YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGRE 945
V++ DLK N++LD + ++DFG+ K I + +M T Y+APE +
Sbjct: 113 SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM--KTFCGTPEYLAPEVLED 170
Query: 946 GRVSTKGDVYSFGILLMETFTRRKP 970
D + G+++ E R P
Sbjct: 171 NDYGRAVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 4e-08
Identities = 66/236 (27%), Positives = 103/236 (43%), Gaps = 38/236 (16%)
Query: 776 LIGRGSFGSVYIAR-LQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISS- 833
+IGRG FG VY R G A+K D + + K +T ++ R + ++S+
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIK-MKQGET-----LALNERIMLSLVSTG 54
Query: 834 ------CSNEDFKA-----LILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYL 882
C F IL+ M G L L + R ++ LE++
Sbjct: 55 DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRF-YATEIILGLEHM 113
Query: 883 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQ-TLATLGYMAPE 941
H + V++ DLKP+N+LLD++ +SD G+A D S + ++ T GYMAPE
Sbjct: 114 HNRF---VVYRDLKPANILLDEHGHVRISDLGLAC-----DFSKKKPHASVGTHGYMAPE 165
Query: 942 YGREGRV-STKGDVYSFGILLME------TFTRRKPTDEIFSGEMTLKHWVNDFLP 990
++G + D +S G +L + F + K D+ MTL VN LP
Sbjct: 166 VLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT--VNVELP 219
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 4e-08
Identities = 67/322 (20%), Positives = 118/322 (36%), Gaps = 65/322 (20%)
Query: 770 GFSENNLIGRGSFGSVYIARLQNGI---EVAVKTFDLQHERAFKSFDTEC-EVM--KSIR 823
+ IGRG++G VY A+ +NG E A+K F E+ + C E+ + ++
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK 60
Query: 824 HRNLTKIISSCSNEDFKA--LILEYMRNGSLEKCLYSGNYILDIFQRL---NIMIDVASA 878
H N+ ++ K+ L+ +Y + + + +++ + +
Sbjct: 61 HENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNG 120
Query: 879 LEYLHFGYSAPVIHCDLKPSNVLL----DDNMVAHLSDFGIA-------KLLIGEDQSMT 927
+ YLH S V+H DLKP+N+L+ + V + D G+A K L D
Sbjct: 121 VHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLD---- 173
Query: 928 QTQTLATLGYMAPEYGREGRVSTKG-DVYSFGILLMETFTRR------------------ 968
+ T+ Y APE R TK D+++ G + E T
Sbjct: 174 --PVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQR 231
Query: 969 -----------KPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHFAAKEQCAS 1017
PT++ + + + +L +KH Q
Sbjct: 232 DQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQG-- 289
Query: 1018 SVFNLAMECTVESPDERITAKE 1039
F+L + P +RITA+E
Sbjct: 290 --FDLLRKLLEYDPTKRITAEE 309
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 50.2 bits (121), Expect = 5e-08
Identities = 24/59 (40%), Positives = 32/59 (54%)
Query: 584 LTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQGSIPDSVGDLISLKSLNLSNNNL 642
L +LD S N L+ + GL L+ L L N L P++ L SL+SL+LS NNL
Sbjct: 2 LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 5e-08
Identities = 57/208 (27%), Positives = 90/208 (43%), Gaps = 28/208 (13%)
Query: 776 LIGRGSFGSVYIARLQNG-----IEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKI 830
L+G+G+FG V + R + +++ K + + + TE V+++ RH LT +
Sbjct: 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTL-TESRVLQNTRHPFLTAL 60
Query: 831 ISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPV 890
S D ++EY G L L + R ++ SAL YLH S V
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALGYLH---SCDV 116
Query: 891 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTL--ATLGYMAPE------Y 942
++ DLK N++LD + ++DFG+ K E S T T Y+APE Y
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCK----EGISDGATMKTFCGTPEYLAPEVLEDNDY 172
Query: 943 GREGRVSTKGDVYSFGILLMETFTRRKP 970
GR D + G+++ E R P
Sbjct: 173 GR------AVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 5e-08
Identities = 35/117 (29%), Positives = 60/117 (51%), Gaps = 3/117 (2%)
Query: 850 GSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAH 909
S ++ ++ LD+ L VA +++L S IH D+ NVLL D VA
Sbjct: 196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAK 252
Query: 910 LSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFT 966
+ DFG+A+ ++ + + + + +MAPE + + + DV+S+GILL E F+
Sbjct: 253 ICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 309
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 6e-08
Identities = 55/208 (26%), Positives = 87/208 (41%), Gaps = 11/208 (5%)
Query: 776 LIGRGSFGSVYIARLQNGIEV----AVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKII 831
+IGRGS+ V + RL+ + VK + + TE V + + +
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 832 SSC-SNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPV 890
SC E ++EY+ G L + + + R +++ AL YLH +
Sbjct: 62 HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF-YSAEISLALNYLH---ERGI 117
Query: 891 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVST 950
I+ DLK NVLLD L+D+G+ K G T + T Y+APE R
Sbjct: 118 IYRDLKLDNVLLDSEGHIKLTDYGMCKE--GLRPGDTTSTFCGTPNYIAPEILRGEDYGF 175
Query: 951 KGDVYSFGILLMETFTRRKPTDEIFSGE 978
D ++ G+L+ E R P D + S +
Sbjct: 176 SVDWWALGVLMFEMMAGRSPFDIVGSSD 203
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 6e-08
Identities = 56/208 (26%), Positives = 101/208 (48%), Gaps = 21/208 (10%)
Query: 776 LIGRGSFGSVYIARLQNGIEV-AVKTFDLQHERAFKSFDTEC-----EVMKSIRHRNLTK 829
+IGRG+FG V + +++N +V A+K L K +T C +V+ + R +T
Sbjct: 8 VIGRGAFGEVAVVKMKNTGQVYAMKI--LNKWEMLKRAETACFREERDVLVNGDRRWITN 65
Query: 830 IISSCSNEDFKALILEYMRNGSLEKCLYS-GNYILDIFQRLNIMIDVASALEYLH-FGYS 887
+ + +E+ L+++Y G L L + + + R + ++ A++ +H GY
Sbjct: 66 LHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLA-EMVLAIDSVHQLGY- 123
Query: 888 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGR--- 944
+H D+KP NVLLD N L+DFG + L + D ++ + T Y++PE +
Sbjct: 124 ---VHRDIKPDNVLLDKNGHIRLADFG-SCLRLLADGTVQSNVAVGTPDYISPEILQAME 179
Query: 945 --EGRVSTKGDVYSFGILLMETFTRRKP 970
+GR + D +S G+ + E P
Sbjct: 180 DGKGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 6e-08
Identities = 54/199 (27%), Positives = 94/199 (47%), Gaps = 17/199 (8%)
Query: 777 IGRGSFGSVYIAR--LQNGIEVAVKTFDLQHER-AFKSFDTECEVMKSIRHRNLTKIISS 833
+G G++ +VY R L + + VA+K L+HE A + E ++K ++H N+ +
Sbjct: 14 LGEGTYATVYKGRSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 834 CSNEDFKALILEYMRNG---SLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPV 890
E L+ EY+ L+ C GN I N+ + + L L++ + V
Sbjct: 73 IHTEKSLTLVFEYLDKDLKQYLDDC---GNSI----NMHNVKLFLFQLLRGLNYCHRRKV 125
Query: 891 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPE-YGREGRVS 949
+H DLKP N+L+++ L+DFG+A+ + T + + TL Y P+ S
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLAR--AKSIPTKTYSNEVVTLWYRPPDILLGSTDYS 183
Query: 950 TKGDVYSFGILLMETFTRR 968
T+ D++ G + E T R
Sbjct: 184 TQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 7e-08
Identities = 65/268 (24%), Positives = 114/268 (42%), Gaps = 16/268 (5%)
Query: 74 TALNISYLSLTGN----IPRQLGNLSSLEILDLNFNRLSGEIPWELGNLAKLEKLLLHNN 129
N+ L L+ N +P L NL +L+ LDL+FN LS ++P L NL+ L L L N
Sbjct: 138 LKSNLKELDLSDNKIESLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGN 196
Query: 130 FLTGTIPFSIFKLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQLSGSIPSFIF 189
+P I LS+L +L LS+N++ + S L NL +L L+LS+N+L +P I
Sbjct: 197 -KISDLPPEIELLSALEELDLSNNSIIELLSS--LSNLKNLSGLELSNNKLE-DLPESIG 252
Query: 190 KISSLQALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGGISSTLSNCKHLRILDLS 249
+S+L+ L NN++S + + +L L + N ++ L L L+
Sbjct: 253 NLSNLETLDLSNNQIS-SISSLG--SLTNLRELDLSGNSLS-NALPLIALLLLLLELLLN 308
Query: 250 FNDLWGDIPKEIGNLTKLKELFLDFNILQGEIPHTVGNLHNLEYLSLVNNELVGTVPATI 309
+ ++ ++ + + + P + L +L L ++N L +
Sbjct: 309 LLLTLKALELKLNSILLNNNI---LSNGETSSPEALSILESLNNLWTLDNALDESNLNRY 365
Query: 310 FNVSTLKLIELSNNTFFGSLPSSTDVQL 337
+ + L + V
Sbjct: 366 IVKNPNAIGSLLDLVKKHVNQLLEKVNY 393
|
Length = 394 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 7e-08
Identities = 64/246 (26%), Positives = 102/246 (41%), Gaps = 53/246 (21%)
Query: 776 LIGRGSFGSVYIARLQNGIEVAVKTFDLQHERAFKSFDTECEVMK-----SIRHRNLTKI 830
+IGRG FG VY R D A K D + MK ++ R + +
Sbjct: 1 IIGRGGFGEVYGCR----------KADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSL 50
Query: 831 ISS-------CSNEDFK-----ALILEYMRNGSLEKCLYSGNYILDIFQRLNIMI---DV 875
+S+ C + F + IL+ M G L L +F + ++
Sbjct: 51 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG----VFSEAEMRFYAAEI 106
Query: 876 ASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQ-TLAT 934
LE++H + V++ DLKP+N+LLD++ +SD G+A D S + ++ T
Sbjct: 107 ILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLAC-----DFSKKKPHASVGT 158
Query: 935 LGYMAPEYGREGRV-STKGDVYSFGILLME------TFTRRKPTDEIFSGEMTLK---HW 984
GYMAPE ++G + D +S G +L + F + K D+ MTL
Sbjct: 159 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVEL 218
Query: 985 VNDFLP 990
+ F P
Sbjct: 219 PDSFSP 224
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 7e-08
Identities = 54/204 (26%), Positives = 97/204 (47%), Gaps = 24/204 (11%)
Query: 776 LIGRGSFGSVYIAR-LQNGIEVAVKTFDLQHERAFKSFDTECEVMKSI-RHRNLTKII-- 831
++G G++G VY R ++ G A+K D+ + + E ++K HRN+
Sbjct: 23 VVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE-EEIKLEINMLKKYSHHRNIATYYGA 81
Query: 832 ----SSCSNEDFKALILEYMRNGSLEKCLYS--GNYILDIFQRLNIMIDVASALEYLHFG 885
S ++D L++E+ GS+ + + GN + + + I ++ L +LH
Sbjct: 82 FIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY-ICREILRGLAHLH-- 138
Query: 886 YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQT-LATLGYMAPEY-- 942
+ VIH D+K NVLL +N L DFG++ L D+++ + T + T +MAPE
Sbjct: 139 -AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL---DRTVGRRNTFIGTPYWMAPEVIA 194
Query: 943 ---GREGRVSTKGDVYSFGILLME 963
+ + D++S GI +E
Sbjct: 195 CDENPDATYDYRSDIWSLGITAIE 218
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 9e-08
Identities = 59/241 (24%), Positives = 107/241 (44%), Gaps = 19/241 (7%)
Query: 769 NGFSENNLIGRGSFGSVYIARLQNGIE-VAVKTF--DLQHERAFKSFDTECEVMKSIRHR 825
N F ++G G++G V R + E VA+K F ++E ++ E +++++++
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 826 NLTKIISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFG 885
N+ ++ + L+ EY+ LE N + R I ++ +H+
Sbjct: 61 NIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIY----QLIKAIHWC 116
Query: 886 YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGRE 945
+ ++H D+KP N+L+ N V L DFG A+ L E + T+ +AT Y +PE
Sbjct: 117 HKNDIVHRDIKPENLLISHNDVLKLCDFGFARNL-SEGSNANYTEYVATRWYRSPELLLG 175
Query: 946 GRVSTKGDVYSFGILLME------TFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDA 999
D++S G +L E F D++F+ + L LP MK+ +
Sbjct: 176 APYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGP-----LPAEQMKLFYS 230
Query: 1000 N 1000
N
Sbjct: 231 N 231
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 1e-07
Identities = 85/334 (25%), Positives = 139/334 (41%), Gaps = 16/334 (4%)
Query: 70 QRRVTALNISYLSLTGNI-PRQLGNLSSLEILDLNFNRLSGEIPWELGNLAKLEKLLLHN 128
V L ++ S T + P L L SL++L + E L N
Sbjct: 44 SVAVNRLALNLSSNTLLLLPSSLSRLLSLDLLSPSGISSLDGS--ENLLNLLPLPSLDLN 101
Query: 129 NFLTGTIPFSIFKLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQLSGSIPSFI 188
+ + +L++L L L +NN+T IP S+L+ LDLSDN++ S+PS +
Sbjct: 102 LNRLRSNISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPL 159
Query: 189 FKISSLQALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGGISSTLSNCKHLRILDL 248
+ +L+ L N LS +LP + NL LN + N + + L LDL
Sbjct: 160 RNLPNLKNLDLSFNDLS-DLPKLLS-NLSNLNNLDLSGNKI-SDLPPEIELLSALEELDL 216
Query: 249 SFNDLWGDIPKEIGNLTKLKELFLDFNILQGEIPHTVGNLHNLEYLSLVNNELVGTVPAT 308
S N ++ + NL L L L N ++P ++GNL NLE L L NN++ + ++
Sbjct: 217 SNNS-IIELLSSLSNLKNLSGLELSNN-KLEDLPESIGNLSNLETLDLSNNQI--SSISS 272
Query: 309 IFNVSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSGTLPSFIFNASN----L 364
+ +++ L+ ++LS N+ +LP + L L L + L +N
Sbjct: 273 LGSLTNLRELDLSGNSLSNALPLIALLLLLLELLLNLLLTLKALELKLNSILLNNNILSN 332
Query: 365 SKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNYL 398
+ S + N L N N Y+
Sbjct: 333 GETSSPEALSILESLNNLWTLDNALDESNLNRYI 366
|
Length = 394 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 1e-07
Identities = 54/215 (25%), Positives = 89/215 (41%), Gaps = 14/215 (6%)
Query: 769 NGFSENNLIGRGSFGSVYIAR-LQNGIEVAVKTFD---LQHERAFKSFDTECEVMKSIRH 824
F +L+GRG FG V + R G A+K L + F+ E +++
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 825 RNLTKIISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHF 884
+ ++ + ++D L++EY G L L N D F +A + +H
Sbjct: 61 PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLL---NRYEDQFDEDMAQFYLAELVLAIHS 117
Query: 885 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEY-- 942
+ +H D+KP NVL+D L+DFG A L ++ + + T Y+APE
Sbjct: 118 VHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARL-TANKMVNSKLPVGTPDYIAPEVLT 176
Query: 943 ----GREGRVSTKGDVYSFGILLMETFTRRKPTDE 973
+G + D +S G++ E R P E
Sbjct: 177 TMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHE 211
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 1e-07
Identities = 52/201 (25%), Positives = 92/201 (45%), Gaps = 21/201 (10%)
Query: 777 IGRGSFGSVYIARLQ-NGIEVAVKTFDLQHER-AFKSFDTECEVMKSIRHRNLTKIISSC 834
+G G++ +V+ R + VA+K L+HE A + E ++K+++H N+ +
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72
Query: 835 SNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 894
E L+ EY+ + + GN + N+ I + L L + + ++H D
Sbjct: 73 HTERCLTLVFEYLDSDLKQYLDNCGN----LMSMHNVKIFMFQLLRGLSYCHKRKILHRD 128
Query: 895 LKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAP-------EYGREGR 947
LKP N+L+++ L+DFG+A+ + T + + TL Y P EY
Sbjct: 129 LKPQNLLINEKGELKLADFGLAR--AKSVPTKTYSNEVVTLWYRPPDVLLGSTEY----- 181
Query: 948 VSTKGDVYSFGILLMETFTRR 968
ST D++ G +L E T R
Sbjct: 182 -STPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 1e-07
Identities = 60/282 (21%), Positives = 110/282 (39%), Gaps = 45/282 (15%)
Query: 772 SENNLIGRGSFGSVYIARLQNGIEVAVKTF---DLQHERAFKSFDTECEVMKSIRHRNLT 828
++ N I +G F N EV ++TF H+ + E + ++ I N+
Sbjct: 31 NDQNSIYKGIF---------NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNIL 81
Query: 829 KI----ISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHF 884
KI I + +LILEY G L + L L +L++ ID L L+
Sbjct: 82 KIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDK-EKDLSFKTKLDMAIDCCKGLYNLYK 140
Query: 885 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGR 944
+ P + +L + L+ +N + G+ K+L S + + + Y + +
Sbjct: 141 YTNKP--YKNLTSVSFLVTENYKLKIICHGLEKIL-----SSPPFKNVNFMVYFSYKMLN 193
Query: 945 E--GRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLL 1002
+ + K D+YS G++L E FT + P + + + E+ +L+
Sbjct: 194 DIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIY-------------------DLI 234
Query: 1003 ITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRL 1044
I ++ C + + CT +R KEI+ L
Sbjct: 235 INKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNL 276
|
Length = 283 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 1e-07
Identities = 58/205 (28%), Positives = 96/205 (46%), Gaps = 27/205 (13%)
Query: 777 IGRGSFGSVYIA-RLQNGIEVAVKTFDLQHERAFKSF------DTECEVMKSIRHRNLTK 829
+G G++GSV A + G+ VAVK R F+S E ++K ++H N+
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKL----SRPFQSIIHAKRTYRELRLLKHMKHENVIG 80
Query: 830 IIS----SCSNEDFKALIL-EYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHF 884
++ + S E+F + L ++ L + D Q L + + L+Y+H
Sbjct: 81 LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH- 137
Query: 885 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGR 944
SA +IH DLKPSN+ ++++ + DFG+A+ D M T +AT Y APE
Sbjct: 138 --SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEM--TGYVATRWYRAPEIML 190
Query: 945 EG-RVSTKGDVYSFGILLMETFTRR 968
+ D++S G ++ E T R
Sbjct: 191 NWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 1e-07
Identities = 55/184 (29%), Positives = 89/184 (48%), Gaps = 40/184 (21%)
Query: 777 IGRGSFGSV---YIARLQNGIEVAVKTFDLQHERAFKSF------DTECEVMKSIRHRNL 827
+G G++GSV Y RL+ +VAVK R F+S E ++K ++H N+
Sbjct: 23 VGSGAYGSVCSAYDTRLRQ--KVAVKKL----SRPFQSLIHARRTYRELRLLKHMKHENV 76
Query: 828 TKIIS----SCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLN------IMIDVAS 877
++ + S E+F + L G+ N I+ Q+L+ ++ +
Sbjct: 77 IGLLDVFTPATSIENFNEVYLVTNLMGA------DLNNIVK-CQKLSDEHVQFLIYQLLR 129
Query: 878 ALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGY 937
L+Y+H SA +IH DLKPSNV ++++ + DFG+A+ D M T +AT Y
Sbjct: 130 GLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLAR---QADDEM--TGYVATRWY 181
Query: 938 MAPE 941
APE
Sbjct: 182 RAPE 185
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.2 bits (131), Expect = 1e-07
Identities = 61/226 (26%), Positives = 96/226 (42%), Gaps = 47/226 (20%)
Query: 776 LIGRGSFGSVYIARLQNGIEV-AVKTFD---LQHERAFKSFDTECEVMKSIRHRNLTKII 831
L+G+G G V++ RL+ ++ A+K D + K TE E++ ++ H L +
Sbjct: 8 LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLY 67
Query: 832 SSCSNEDFKALILEYMRNGSLEKCL--YSGNYILDIFQRLNIMIDVASALEYLH-FGYSA 888
+S E + L+++Y G L + L G + + R +V ALEYLH G
Sbjct: 68 ASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAA-EVLLALEYLHLLGI-- 124
Query: 889 PVIHCDLKPSNVLLDDNMVAHLSDFGIAK------------LLIGEDQSMTQTQTLATLG 936
++ DLKP N+LL ++ LSDF ++K L G +S + T
Sbjct: 125 --VYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFS 182
Query: 937 ---------------YMAPE----YGREGRVSTKGDVYSFGILLME 963
Y+APE G V D ++ GILL E
Sbjct: 183 EEPSFRSNSFVGTEEYIAPEVISGDGHGSAV----DWWTLGILLYE 224
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 53.6 bits (128), Expect = 2e-07
Identities = 55/204 (26%), Positives = 95/204 (46%), Gaps = 24/204 (11%)
Query: 776 LIGRGSFGSVYIAR-LQNGIEVAVKTFDLQHERAFKSFDTECEVMKSI-RHRNLTKIISS 833
L+G G++G VY R ++ G A+K D+ + + E ++K HRN+ +
Sbjct: 13 LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE-EEIKQEINMLKKYSHHRNIATYYGA 71
Query: 834 C------SNEDFKALILEYMRNGSLEKCLYS--GNYILDIFQRLNIMIDVASALEYLHFG 885
+D L++E+ GS+ + + GN + + + I ++ L +LH
Sbjct: 72 FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY-ICREILRGLSHLH-- 128
Query: 886 YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQT-LATLGYMAPEY-- 942
VIH D+K NVLL +N L DFG++ L D+++ + T + T +MAPE
Sbjct: 129 -QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL---DRTVGRRNTFIGTPYWMAPEVIA 184
Query: 943 ---GREGRVSTKGDVYSFGILLME 963
+ K D++S GI +E
Sbjct: 185 CDENPDATYDFKSDLWSLGITAIE 208
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 2e-07
Identities = 53/203 (26%), Positives = 96/203 (47%), Gaps = 14/203 (6%)
Query: 776 LIGRGSFGSVYIARLQNGIEV-AVK---TFDLQHERAFKSFDTECEVMKSIRHRNLTKII 831
+IGRG+FG V + R ++ +V A+K F++ F E ++M + ++
Sbjct: 50 VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 109
Query: 832 SSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVI 891
+ ++ + +++EYM G L L S + + + R +V AL+ +H S I
Sbjct: 110 YAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARF-YTAEVVLALDAIH---SMGFI 164
Query: 892 HCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEY----GREGR 947
H D+KP N+LLD + L+DFG + + ++ + + T Y++PE G +G
Sbjct: 165 HRDVKPDNMLLDKSGHLKLADFGTC-MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGY 223
Query: 948 VSTKGDVYSFGILLMETFTRRKP 970
+ D +S G+ L E P
Sbjct: 224 YGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 2e-07
Identities = 66/245 (26%), Positives = 108/245 (44%), Gaps = 50/245 (20%)
Query: 776 LIGRGSFGSVYIARLQNGIEV-AVKTFDLQHERAFKSFDTECEVMK------SIRHRNLT 828
++G+GSFG V +A + E+ A+K L+ + + D EC +++ + LT
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKI--LKKDVIIQDDDVECTMVEKRVLALPGKPPFLT 64
Query: 829 KIISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLN------IMIDVASALEYL 882
++ S D ++EY+ G L Y + + ++A L +L
Sbjct: 65 QLHSCFQTMDRLYFVMEYVNGGDLM-------YHIQQVGKFKEPHAVFYAAEIAIGLFFL 117
Query: 883 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTL-ATLGYMAPE 941
H S +I+ DLK NV+LD ++DFG+ K I ++ T+T T Y+APE
Sbjct: 118 H---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT---TRTFCGTPDYIAPE 171
Query: 942 ------YGREGRVSTKGDVYSFGILLMETFTRRKP-----TDEIFSGEMTLKHWVNDFLP 990
YG+ D ++FG+LL E + P DE+F M +H N P
Sbjct: 172 IIAYQPYGKS------VDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIM--EH--NVSYP 221
Query: 991 ISMMK 995
S+ K
Sbjct: 222 KSLSK 226
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 43/144 (29%), Positives = 74/144 (51%), Gaps = 7/144 (4%)
Query: 777 IGRGSFGSVYIARLQNGIE-VAVK--TFDLQHERAFKSFDTECEVMKSIRHRNLTKIISS 833
IG G++G+V+ A+ + E VA+K D E S E ++K ++H+N+ ++
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 834 CSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHC 893
++ L+ EY + L+K S N +D + M + L + H S V+H
Sbjct: 68 LHSDKKLTLVFEYC-DQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH---SHNVLHR 123
Query: 894 DLKPSNVLLDDNMVAHLSDFGIAK 917
DLKP N+L++ N L+DFG+A+
Sbjct: 124 DLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 67/285 (23%), Positives = 113/285 (39%), Gaps = 37/285 (12%)
Query: 777 IGRGSFGSVYIARLQNGIEVA-VKTFDLQHERAFK---SFDTECEVMKSIRHRNLTKIIS 832
IG G FG V ++ + VA V +L+ + K F + + + ++H N+ + +
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 833 SCSNEDFKALILEYMRNGSLEKCLYS-----GNYILDIFQRLNIMIDVASALEYLHFGYS 887
C L+ EY G L+ L N L + QR+ ++A+ + ++H
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRM--ACEIAAGVTHMH---K 117
Query: 888 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEY--GRE 945
+H DL N L ++ + D+GI ED T+ L ++APE
Sbjct: 118 HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFH 177
Query: 946 GRVSTK-----GDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDAN 1000
G + T +V++ G+ L E F S L H + D +K+
Sbjct: 178 GGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKD----QQVKLFKPQ 233
Query: 1001 LLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLL 1045
L E S + ++ SP++R TA+E V RLL
Sbjct: 234 L-----------ELPYSERWYEVLQFCWLSPEKRATAEE-VHRLL 266
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 3e-07
Identities = 59/211 (27%), Positives = 102/211 (48%), Gaps = 42/211 (19%)
Query: 776 LIGRGSFGSVYIA-RLQNGIEVAVKTFD--LQHE----RAFKSFDTECEVMKSIRHRN-- 826
+G G++GSV A + G +VA+K Q E RA++ E ++K ++H N
Sbjct: 22 QVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYR----ELTLLKHMQHENVI 77
Query: 827 --LTKIISSCSNEDFKA--LILEYMRNGSLEKCLYSGNYILD------IFQRLNIMIDVA 876
L S+ S ++F+ L++ YM+ L+K + G+ + + ++Q L
Sbjct: 78 GLLDVFTSAVSGDEFQDFYLVMPYMQT-DLQKIM--GHPLSEDKVQYLVYQML------- 127
Query: 877 SALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLG 936
L+Y+H SA +IH DLKP N+ ++++ + DFG+A+ D M T + T
Sbjct: 128 CGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLAR---HADAEM--TGYVVTRW 179
Query: 937 YMAPEYGREGRVSTKG-DVYSFGILLMETFT 966
Y APE + D++S G ++ E T
Sbjct: 180 YRAPEVILNWMHYNQTVDIWSVGCIMAEMLT 210
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 4e-07
Identities = 33/96 (34%), Positives = 49/96 (51%), Gaps = 4/96 (4%)
Query: 364 LSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNYLTSPELSFLSSLSNCKYLEIIALSGN 423
+ L L + G IPN LR+L+ + L N + + SL + LE++ LS N
Sbjct: 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSI---RGNIPPSLGSITSLEVLDLSYN 476
Query: 424 PLNGIIPMSAGNLSHSLEELFMPDCNVSGRIPKEIG 459
NG IP S G L+ SL L + ++SGR+P +G
Sbjct: 477 SFNGSIPESLGQLT-SLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 4e-07
Identities = 50/185 (27%), Positives = 89/185 (48%), Gaps = 15/185 (8%)
Query: 777 IGRGSFGSVYIARLQN-----GIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKII 831
I RG+FG VY+ R +N ++V VK D+ ++ E + + + + +
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKV-VKKADMINKNMVHQVQAERDALALSKSPFIVHLY 70
Query: 832 SSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVI 891
S + + L++EY+ G ++ L+ Y D + + +VA AL+YLH +I
Sbjct: 71 YSLQSANNVYLVMEYLIGGDVKSLLHIYGY-FDEEMAVKYISEVALALDYLH---RHGII 126
Query: 892 HCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTK 951
H DLKP N+L+ + L+DFG++K+ + + +M T ++ +Y R T
Sbjct: 127 HRDLKPDNMLISNEGHIKLTDFGLSKVTLNRELNMMDILTTPSMAKPKNDYSR-----TP 181
Query: 952 GDVYS 956
G V S
Sbjct: 182 GQVLS 186
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 4e-07
Identities = 65/282 (23%), Positives = 117/282 (41%), Gaps = 32/282 (11%)
Query: 776 LIGRGSFGSVY----IARLQN-GIEVAVKTF-DLQHERAFKSFDTECEVMKSIRHRNLTK 829
++G G+FG+VY I +N I VA+K + +A K E VM + + +
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 830 IISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAP 889
++ C + L+ + M G L + + LN + +A + YL
Sbjct: 74 LLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE---EVR 129
Query: 890 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVS 949
++H DL NVL+ ++DFG+A+LL ++ + +MA E R +
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFT 189
Query: 950 TKGDVYSFGILLMETFT-RRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKH 1008
+ DV+S+G+ + E T KP D I + E I D L+ + +
Sbjct: 190 HQSDVWSYGVTVWELMTFGAKPYDGIPARE-----------------IPD---LLEKGER 229
Query: 1009 FAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKI-RD 1049
C V+ + ++C + + R +E+V ++ RD
Sbjct: 230 LPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD 271
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 4e-07
Identities = 49/196 (25%), Positives = 94/196 (47%), Gaps = 11/196 (5%)
Query: 777 IGRGSFGSVYIAR--LQNGIEVAVKTFDLQHER-AFKSFDTECEVMKSIRHRNLTKIISS 833
+G G++ +V+ R L + VA+K L+HE A + E ++K ++H N+ +
Sbjct: 14 LGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 834 CSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHC 893
+ L+ EY+ + L++ + I+ + N+ I + L L + + V+H
Sbjct: 73 VHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMH---NVKIFLYQILRGLAYCHRRKVLHR 128
Query: 894 DLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGR-EGRVSTKG 952
DLKP N+L+++ L+DFG+A+ + T + + TL Y P+ ST+
Sbjct: 129 DLKPQNLLINERGELKLADFGLAR--AKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQI 186
Query: 953 DVYSFGILLMETFTRR 968
D++ G + E + R
Sbjct: 187 DMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 4e-07
Identities = 52/209 (24%), Positives = 99/209 (47%), Gaps = 23/209 (11%)
Query: 776 LIGRGSFGSVYIARLQNGIEV-AVKTFDLQHERAFKSFDTEC-----EVMKSIRHRNLTK 829
+IGRG+FG V + ++++ + A+K L K +T C V+ + + +T
Sbjct: 8 VIGRGAFGEVAVVKMKHTERIYAMKI--LNKWEMLKRAETACFREERNVLVNGDCQWITT 65
Query: 830 IISSCSNEDFKALILEYMRNGSLEKCLYS-GNYILDIFQRLNI--MIDVASALEYLHFGY 886
+ + +E++ L+++Y G L L + + + R I M+ ++ LH+
Sbjct: 66 LHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHY-- 123
Query: 887 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGRE- 945
+H D+KP NVLLD N L+DFG + L + +D ++ + + T Y++PE +
Sbjct: 124 ----VHRDIKPDNVLLDMNGHIRLADFG-SCLKMNQDGTVQSSVAVGTPDYISPEILQAM 178
Query: 946 ----GRVSTKGDVYSFGILLMETFTRRKP 970
G+ + D +S G+ + E P
Sbjct: 179 EDGMGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 5e-07
Identities = 55/218 (25%), Positives = 94/218 (43%), Gaps = 37/218 (16%)
Query: 765 FQATNGFSENNLIGRGSFGSVY--IARLQNGIEVAVKTFDLQHERA--FKSFDTECEVMK 820
F A + +G GS+ +VY I+R+ NG VA+K ++ E F + E ++K
Sbjct: 1 FGAATSYLNLEKLGEGSYATVYKGISRI-NGQLVALKVISMKTEEGVPFTAI-REASLLK 58
Query: 821 SIRHRNLTKIISSCSNEDFKALILEYMRNGSLEKC------LYSGNYILDIFQRLNIMID 874
++H N+ + ++ + EYM + L+ N L +FQ L
Sbjct: 59 GLKHANIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLR---- 114
Query: 875 VASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLAT 934
L Y+H + ++H DLKP N+L+ L+DFG+A+ S T + + T
Sbjct: 115 ---GLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLAR--AKSIPSQTYSSEVVT 166
Query: 935 LGYMAP-------EYGREGRVSTKGDVYSFGILLMETF 965
L Y P +Y S+ D++ G + +E
Sbjct: 167 LWYRPPDVLLGATDY------SSALDIWGAGCIFIEML 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 8e-07
Identities = 62/240 (25%), Positives = 111/240 (46%), Gaps = 40/240 (16%)
Query: 776 LIGRGSFGSVYIARLQNGIEV-AVKTFDLQHERAFKSFDTECEVMK----SIRHRN--LT 828
++G+GSFG V +A + E+ A+K L+ + + D EC +++ +++ + LT
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKI--LKKDVVIQDDDVECTMVEKRVLALQDKPPFLT 64
Query: 829 KIISSCSNEDFKALILEYMRNGSLEKCLYSGNYI--LDIFQRLNIMIDVASALEYLHFGY 886
++ S D ++EY+ G L +Y + Q + +++ L +LH
Sbjct: 65 QLHSCFQTVDRLYFVMEYVNGGDL---MYHIQQVGKFKEPQAVFYAAEISVGLFFLH--- 118
Query: 887 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPE----- 941
+I+ DLK NV+LD ++DFG+ K + + +T T Y+APE
Sbjct: 119 RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD--GVTTRTFCGTPDYIAPEIIAYQ 176
Query: 942 -YGREGRVSTKGDVYSFGILLMETFTRRKP-----TDEIFSGEMTLKHWVNDFLPISMMK 995
YG+ D +++G+LL E + P DE+F M +H V+ P S+ K
Sbjct: 177 PYGKS------VDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIM--EHNVS--YPKSLSK 226
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 9e-07
Identities = 23/44 (52%), Positives = 30/44 (68%)
Query: 73 VTALNISYLSLTGNIPRQLGNLSSLEILDLNFNRLSGEIPWELG 116
+ L++SY S G+IP LG L+SL IL+LN N LSG +P LG
Sbjct: 468 LEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 9e-07
Identities = 57/204 (27%), Positives = 92/204 (45%), Gaps = 32/204 (15%)
Query: 777 IGRGSFGSVYIARLQNGIEV-AVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCS 835
IG+G+FG VY R ++ + A+K + K + EV +I RN+ + +
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVL------SKKEIVAKKEVAHTIGERNIL-VRTLLD 53
Query: 836 NEDFKA-------------LILEYMRNGSLEKCLYSGNYILDIFQRLNIMI-DVASALEY 881
F L+ +YM G L L + R I ++ ALE+
Sbjct: 54 ESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSE--DRAKFYIAELVLALEH 111
Query: 882 LHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTL-ATLGYMAP 940
LH +++ DLKP N+LLD L DFG++K + ++++ T T T Y+AP
Sbjct: 112 LH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT---TNTFCGTTEYLAP 165
Query: 941 EYGREGRVSTKG-DVYSFGILLME 963
E + + TK D +S G+L+ E
Sbjct: 166 EVLLDEKGYTKHVDFWSLGVLVFE 189
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 46.0 bits (110), Expect = 1e-06
Identities = 26/61 (42%), Positives = 31/61 (50%), Gaps = 1/61 (1%)
Query: 120 KLEKLLLHNNFLTGTIPFSIFKLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQ 179
L+ L L NN LT + L +L L LS NNLT +I L SL+ LDLS N
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLT-SISPEAFSGLPSLRSLDLSGNN 59
Query: 180 L 180
L
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 46.0 bits (110), Expect = 1e-06
Identities = 23/60 (38%), Positives = 32/60 (53%)
Query: 607 GLQYLFLGHNRLQGSIPDSVGDLISLKSLNLSNNNLSGPIPTSLEKLSDLKELNLSFNKL 666
L+ L L +NRL + L +LK L+LS NNL+ P + L L+ L+LS N L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 1e-06
Identities = 57/222 (25%), Positives = 97/222 (43%), Gaps = 35/222 (15%)
Query: 776 LIGRGSFGSVYIARLQNGI----EVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKII 831
LIG G FG VY + + + K +L++E + E V +I + +
Sbjct: 19 LIGCGGFGCVYETQCASDHCINNQAVAKIENLENE----TIVMETLVYNNIYDIDKIALW 74
Query: 832 SSCSNEDFKALILEYMRNGSLEKCLYSGNYIL---------DIFQRL---------NIMI 873
+ N D I +Y GS ++C +IL +IF+R+ NIM
Sbjct: 75 KNIHNIDHLG-IPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNKKLIKNIMK 133
Query: 874 DVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLI--GEDQSMTQTQT 931
D+ + LEY+H + H D+KP N+++D N ++ D+GIA I G+ ++ Q
Sbjct: 134 DMLTTLEYIH---EHGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQK 190
Query: 932 ---LATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKP 970
TL Y + V+ +GD+ S G +++ + P
Sbjct: 191 DLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLP 232
|
Length = 294 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 1e-06
Identities = 31/104 (29%), Positives = 50/104 (48%), Gaps = 3/104 (2%)
Query: 863 LDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGE 922
LD L+ VA + +L S IH DL N+LL + + DFG+A+ + +
Sbjct: 211 LDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRND 267
Query: 923 DQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFT 966
+ + + +MAPE + + DV+S+GILL E F+
Sbjct: 268 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 1e-06
Identities = 48/211 (22%), Positives = 85/211 (40%), Gaps = 34/211 (16%)
Query: 776 LIGRGSFGSVYIARLQNG--------IEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNL 827
++G GSFG + + N I + + ++ R E ++ ++H N+
Sbjct: 7 VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSR------KEAVLLAKMKHPNI 60
Query: 828 TKIISSCSNEDFKALILEYMRNGSLEKC-------LYSGNYILDIFQRLNIMIDVASALE 880
S + +++EY G L + L+ + IL F + + ++
Sbjct: 61 VAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWF------VQMCLGVQ 114
Query: 881 YLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQT-LATLGYMA 939
++H V+H D+K N+ L N L DFG A+LL T + T Y+
Sbjct: 115 HIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLL---TSPGAYACTYVGTPYYVP 168
Query: 940 PEYGREGRVSTKGDVYSFGILLMETFTRRKP 970
PE + K D++S G +L E T + P
Sbjct: 169 PEIWENMPYNNKSDIWSLGCILYELCTLKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 2e-06
Identities = 51/200 (25%), Positives = 92/200 (46%), Gaps = 22/200 (11%)
Query: 793 GIEVAVKTFD--LQHERAFKSFDTECEVMKSIRHRNLTKIIS----SCSNEDFKA--LIL 844
GI VAVK Q++ K E ++K + H+N+ +++ S E+F+ L++
Sbjct: 46 GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVM 105
Query: 845 EYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDD 904
E M + +L + ++ LD + ++ + +++LH SA +IH DLKPSN+++
Sbjct: 106 ELM-DANLCQVIHME---LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKS 158
Query: 905 NMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMET 964
+ + DFG+A+ + T + T Y APE D++S G ++ E
Sbjct: 159 DCTLKILDFGLART---ACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEL 215
Query: 965 FTRRKPTDEIFSGEMTLKHW 984
IF G + W
Sbjct: 216 VK----GSVIFQGTDHIDQW 231
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 2e-06
Identities = 55/216 (25%), Positives = 89/216 (41%), Gaps = 29/216 (13%)
Query: 777 IGRGSFGSVYIARLQN-----GIEVAVKTFDLQHERAFKSFDTE---CEVMKSIRHRNLT 828
+GRG FG V +A + I+ K + + +S E E S RH L
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEV-ESLMCEKRIFETANSERHPFLV 65
Query: 829 KIISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVAS---ALEYLHFG 885
+ + ED ++EY G L +++ D+F + A L+YLH
Sbjct: 66 NLFACFQTEDHVCFVMEYAAGGDLMMHIHT-----DVFSEPRAVFYAACVVLGLQYLH-- 118
Query: 886 YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTL-ATLGYMAPEYGR 944
+++ DLK N+LLD ++DFG+ K +G +T T T ++APE
Sbjct: 119 -ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGD---RTSTFCGTPEFLAPEVLT 174
Query: 945 EGRVSTKGDVYSFGILLMETFTRRKP-----TDEIF 975
E + D + G+L+ E P +E+F
Sbjct: 175 ETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVF 210
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 3e-06
Identities = 55/256 (21%), Positives = 97/256 (37%), Gaps = 67/256 (26%)
Query: 777 IGRGSFGSVYIAR-LQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCS 835
IG G++G VY AR G VA+K + D E ++R +L +++S
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALK-------KTRLEMDEEGIPPTALREISLLQMLSES- 60
Query: 836 NEDFKALILEYMRNGSLEKCLYSGNYILDIFQRL-------------------------N 870
+ L +E++ + + LY +F+ L +
Sbjct: 61 IYIVRLLDVEHVEEKNGKPSLYL------VFEYLDSDLKKFMDSNGRGPGRPLPAKTIKS 114
Query: 871 IMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDN-MVAHLSDFGIAKLLIGEDQSMTQT 929
M + + + H V+H DLKP N+L+D + ++D G+ + +S T
Sbjct: 115 FMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSY--T 169
Query: 930 QTLATLGYMAPEYGREGR-VSTKGDVYSFGILLMETFTRR-------------------- 968
+ TL Y APE ST D++S G + E ++
Sbjct: 170 HEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLG 229
Query: 969 KPTDEIFSGEMTLKHW 984
PT++++ G L+ W
Sbjct: 230 TPTEQVWPGVSKLRDW 245
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 3e-06
Identities = 65/227 (28%), Positives = 107/227 (47%), Gaps = 33/227 (14%)
Query: 775 NLIGRGSFGSVYIAR-LQNGIEVAVKTF--DLQHERAFKSFDTECEVMKSIRHRNLTKII 831
N+IG GSFG VY A + +VA+K D Q++ + E +MK++ H N+ +
Sbjct: 72 NIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYK------NRELLIMKNLNHINIIFLK 125
Query: 832 SSCSNEDFKA--------LILEYMRNGSLEKCL--YS-GNYILDIFQRLNIMIDVASALE 880
E FK +++E++ ++ K + Y+ N+ L +F + AL
Sbjct: 126 DYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALA 184
Query: 881 YLHFGYSAPVIHCDLKPSNVLLDDNM-VAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMA 939
Y+H S + H DLKP N+L+D N L DFG AK L+ +S++ + + Y A
Sbjct: 185 YIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSY---ICSRFYRA 238
Query: 940 PEYGR-EGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWV 985
PE +T D++S G ++ E IFSG+ ++ V
Sbjct: 239 PELMLGATNYTTHIDLWSLGCIIAEMILGYP----IFSGQSSVDQLV 281
|
Length = 440 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 3e-06
Identities = 67/285 (23%), Positives = 119/285 (41%), Gaps = 47/285 (16%)
Query: 777 IGRGSFGSVY--IARLQ------NGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLT 828
+G+G+F ++ I R + EV +K D H +SF +M + H++L
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 829 KIISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSA 888
C D ++ EY++ GSL+ L +++I +L + +A AL +L
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLE---DK 119
Query: 889 PVIHCDLKPSNVLL---DDNMVAH-----LSDFGIAKLLIGEDQSMTQTQTLATLGYMAP 940
+ H ++ NVLL +D + LSD GI+ ++ ++ L + ++ P
Sbjct: 120 GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKE------ILLERIPWVPP 173
Query: 941 EYGREGR-VSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDA 999
E + +S D +SFG L E F+ G+ P+S +
Sbjct: 174 ECIENPQNLSLAADKWSFGTTLWEIFS---------GGDK----------PLSALD-SQK 213
Query: 1000 NLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRL 1044
L ED+H + + + NL +C PD R + + I+R L
Sbjct: 214 KLQFYEDRHQLPAPKW-TELANLINQCMDYEPDFRPSFRAIIRDL 257
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 5e-06
Identities = 38/176 (21%), Positives = 74/176 (42%), Gaps = 16/176 (9%)
Query: 815 ECEVMKSIRHRNLTKIISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMID 874
E +++++ H ++ ++ + + ++L + + L L + L I Q L I
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSS-DLYTYLTKRSRPLPIDQALIIEKQ 165
Query: 875 VASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLAT 934
+ L YLH + +IH D+K N+ ++D + D G A+ + + T+ T
Sbjct: 166 ILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVET 222
Query: 935 LGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRK---------PTDEIFSGEMTL 981
APE + ++K D++S GI+L E P + + S L
Sbjct: 223 ---NAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHL 275
|
Length = 357 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 5e-06
Identities = 55/217 (25%), Positives = 99/217 (45%), Gaps = 23/217 (10%)
Query: 777 IGRGSFGSV---YIARLQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISS 833
IG G+ G V Y A L + + + Q++ K E +MK + H+N+ +++
Sbjct: 25 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 84
Query: 834 CSN----EDFKA--LILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYS 887
+ E+F+ L++E M + +L + + LD + ++ + +++LH S
Sbjct: 85 FTPQKSLEEFQDVYLVMELM-DANLCQVI---QMELDHERMSYLLYQMLCGIKHLH---S 137
Query: 888 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGR 947
A +IH DLKPSN+++ + + DFG+A+ S T + T Y APE
Sbjct: 138 AGIIHRDLKPSNIVVKSDCTLKILDFGLART---AGTSFMMTPYVVTRYYRAPEVILGMG 194
Query: 948 VSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHW 984
D++S G ++ E R K +F G + W
Sbjct: 195 YKENVDIWSVGCIMGE-MVRHKI---LFPGRDYIDQW 227
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 6e-06
Identities = 69/281 (24%), Positives = 117/281 (41%), Gaps = 58/281 (20%)
Query: 777 IGRGSFGSVYIARLQNGIEV----AVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIIS 832
IG G FG V++ + + E A+ L+ ER E VM+ ++H+N+ + I
Sbjct: 21 IGNGRFGEVFLVKHKRTQEFFCWKAISYRGLK-EREKSQLVIEVNVMRELKHKNIVRYID 79
Query: 833 SCSNEDFKAL--ILEYMRNGSL----EKCL-----YSGNYILDIFQRLNIMIDVASALEY 881
N+ + L ++E+ G L +KC + I+DI ++L AL Y
Sbjct: 80 RFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQL------LHALAY 133
Query: 882 LHFGYSAP----VIHCDLKPSNVLLDDNM-----------------VAHLSDFGIAKLLI 920
H P V+H DLKP N+ L + +A + DFG++K +
Sbjct: 134 CHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIG 193
Query: 921 GEDQSMTQTQTLATLGYMAPE--YGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGE 978
E SM + + T Y +PE K D+++ G ++ E + + P F
Sbjct: 194 IE--SMAHS-CVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP----FHKA 246
Query: 979 MTLKHWVNDF-----LPISMMKIIDANLLITEDKHFAAKEQ 1014
+++ LPI K + N+LI + +AKE+
Sbjct: 247 NNFSQLISELKRGPDLPIK-GKSKELNILIKNLLNLSAKER 286
|
Length = 1021 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 6e-06
Identities = 52/206 (25%), Positives = 96/206 (46%), Gaps = 29/206 (14%)
Query: 777 IGRGSFGSV-YIARLQNGIEVAVKTF------DLQHERAFKSFDTECEVMKSIRHRNLTK 829
+G G++G+V + G +VA+K +L +RA++ E ++K ++H N+
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYR----ELRLLKHMKHENVIG 78
Query: 830 II----SSCSNEDFKA--LILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLH 883
++ S + F L++ +M L K + D Q L + + L+Y+H
Sbjct: 79 LLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKHEKLSEDRIQFL--VYQMLKGLKYIH 135
Query: 884 FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYG 943
+A +IH DLKP N+ ++++ + DFG+A+ D M T + T Y APE
Sbjct: 136 ---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR---QTDSEM--TGYVVTRWYRAPEVI 187
Query: 944 REG-RVSTKGDVYSFGILLMETFTRR 968
+ D++S G ++ E T +
Sbjct: 188 LNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 44.1 bits (105), Expect = 7e-06
Identities = 18/60 (30%), Positives = 25/60 (41%)
Query: 339 NLEELYLWGNNFSGTLPSFIFNASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNYL 398
NL+ L L N + NL L L N+ + + P F L +L+ L L N L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 9e-06
Identities = 46/143 (32%), Positives = 67/143 (46%), Gaps = 14/143 (9%)
Query: 530 FGNLASLRELWLGPNELISFI----PSTFWNIKDIMYVNFSSNFLTGPLPLEIENLKA-L 584
NL L L L N L S I T D+ N + +P I LK+ L
Sbjct: 89 LLNLLPLPSLDLNLNRLRSNISELLELTNLTSLDLDNNNITD------IPPLIGLLKSNL 142
Query: 585 TTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQGSIPDSVGDLISLKSLNLSNNNLSG 644
LD S N + +P+ + L L+ L L N L +P + +L +L +L+LS N +S
Sbjct: 143 KELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS- 199
Query: 645 PIPTSLEKLSDLKELNLSFNKLE 667
+P +E LS L+EL+LS N +
Sbjct: 200 DLPPEIELLSALEELDLSNNSII 222
|
Length = 394 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 9e-06
Identities = 56/205 (27%), Positives = 96/205 (46%), Gaps = 27/205 (13%)
Query: 777 IGRGSFGSVY-IARLQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIR-HRNLTKIISSC 834
IG+G++G V+ + +NG + AVK D H+ + + E ++K++ H N+ K
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID-EEIEAEYNILKALSDHPNVVKFYGMY 84
Query: 835 SNEDFKA-----LILEYMRNGSLEKCLYSGNYILDIFQRLN------IMIDVASALEYLH 883
+D K L+LE GS+ L G L +R+ I+ + L++LH
Sbjct: 85 YKKDVKNGDQLWLVLELCNGGSVTD-LVKG--FLKRGERMEEPIIAYILHEALMGLQHLH 141
Query: 884 FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEY- 942
IH D+K +N+LL L DFG++ L + + ++ T +MAPE
Sbjct: 142 ---VNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLT--STRLRRNTSVGTPFWMAPEVI 196
Query: 943 GREGRVST----KGDVYSFGILLME 963
E ++ + + DV+S GI +E
Sbjct: 197 ACEQQLDSTYDARCDVWSLGITAIE 221
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 9e-06
Identities = 45/167 (26%), Positives = 72/167 (43%), Gaps = 17/167 (10%)
Query: 810 KSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEYMRNGSLEKC-LYSGNYI-----L 863
K+ E +++K+I HR + +I + K+ + M KC L++ Y+ L
Sbjct: 131 KTPGREIDILKTISHRAIINLIHAYRW---KSTVCMVMPK---YKCDLFT--YVDRSGPL 182
Query: 864 DIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGED 923
+ Q + I + AL YLH +IH D+K N+ LD+ A L DFG A L
Sbjct: 183 PLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP 239
Query: 924 QSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKP 970
+ TL +PE K D++S G++L E +
Sbjct: 240 DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVT 286
|
Length = 392 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 1e-05
Identities = 52/215 (24%), Positives = 80/215 (37%), Gaps = 37/215 (17%)
Query: 776 LIGRGSFGSVYIARLQNGIEV----AVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKII 831
+IGRGS+ V + L+ + +K + + TE V ++ + +
Sbjct: 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGL 61
Query: 832 SSC-SNEDFKALILEYMRNGSL-------------EKCLYSGNYILDIFQRLNIMIDVAS 877
SC E ++E++ G L YS L
Sbjct: 62 HSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISL-------------- 107
Query: 878 ALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGY 937
AL +LH +I+ DLK NVLLD L+D+G+ K I T + T Y
Sbjct: 108 ALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD--TTSTFCGTPNY 162
Query: 938 MAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTD 972
+APE R D ++ G+L+ E R P D
Sbjct: 163 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 1e-05
Identities = 61/201 (30%), Positives = 91/201 (45%), Gaps = 16/201 (7%)
Query: 777 IGRGSFGSVYIARLQNGIEV-AVKTFDLQHERAFKSFD---TECEVMKSIRHRNLTKIIS 832
IG+GSFG V R ++ + A+KT H + E V+ + + +
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 833 SCSNEDFKALILEYMRNGSLEKCLY-SGNYILDIFQRLNIMIDVASALEYLHFGYSAPVI 891
S + + L+L ++ G L L G + D+ + ++ ALE LH VI
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRF--DLSRARFYTAELLCALENLH---KFNVI 115
Query: 892 HCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTL-ATLGYMAPEYGREGRVST 950
+ DLKP N+LLD L DFG+ KL + +D +T T T Y+APE G T
Sbjct: 116 YRDLKPENILLDYQGHIALCDFGLCKLNMKDDD---KTNTFCGTPEYLAPEL-LLGHGYT 171
Query: 951 KG-DVYSFGILLMETFTRRKP 970
K D ++ G+LL E T P
Sbjct: 172 KAVDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 48.0 bits (115), Expect = 1e-05
Identities = 48/200 (24%), Positives = 93/200 (46%), Gaps = 22/200 (11%)
Query: 777 IGRGSFGSVYIAR-LQNGIEVAVKTFDLQHERAFKSFD-----TECEVMKSIR-HRNLTK 829
IG G+F V A+ + G A+K ++ FKS + E + ++ + H N+ +
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCM----KKHFKSLEQVNNLREIQALRRLSPHPNILR 62
Query: 830 IISSCSNEDFK--ALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYS 887
+I + AL+ E M + +L + + L + + M + +L+++H
Sbjct: 63 LIEVLFDRKTGRLALVFELM-DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH---R 118
Query: 888 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPE-YGREG 946
+ H D+KP N+L+ D+++ L+DFG + G T+ ++T Y APE +G
Sbjct: 119 NGIFHRDIKPENILIKDDIL-KLADFGSCR---GIYSKPPYTEYISTRWYRAPECLLTDG 174
Query: 947 RVSTKGDVYSFGILLMETFT 966
K D+++ G + E +
Sbjct: 175 YYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 1e-05
Identities = 54/210 (25%), Positives = 98/210 (46%), Gaps = 28/210 (13%)
Query: 776 LIGRGSFGSVYIAR-LQNGIEVAVKTFD--LQHERAFKSFDTECEVMKSIRHRNLTK--- 829
+IG+GS+G V A G +VA+K + +H E ++++ +RH ++ +
Sbjct: 7 VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKH 66
Query: 830 IISSCSNEDFKAL--ILEYMRNGSLEKC------LYSGNYILDIFQRLNIMIDVASALEY 881
I+ S +FK + + E M + L + L ++ ++Q L AL+Y
Sbjct: 67 IMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHHQFFLYQLLR-------ALKY 118
Query: 882 LHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMT-QTQTLATLGYMAP 940
+H +A V H DLKP N+L + + + DFG+A++ + + T +AT Y AP
Sbjct: 119 IH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAP 175
Query: 941 EYGRE--GRVSTKGDVYSFGILLMETFTRR 968
E + + D++S G + E T +
Sbjct: 176 ELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 1e-05
Identities = 65/252 (25%), Positives = 114/252 (45%), Gaps = 44/252 (17%)
Query: 777 IGRGSFGSVYIA-RLQNGIEVAVKTF-----DLQH-ERAFKSFDTECEVMKSIRHRNLTK 829
IG G+ G V A G VA+K ++ H +RA++ +MK + H+N+
Sbjct: 24 IGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYREL----VLMKLVNHKNIIG 79
Query: 830 IIS----SCSNEDFKA--LILEYMRNGSLEKCLYSGNYILDIFQRLNIMI-DVASALEYL 882
+++ S E+F+ L++E M + +L + + LD +R++ ++ + +++L
Sbjct: 80 LLNVFTPQKSLEEFQDVYLVMELM-DANLCQVI---QMDLD-HERMSYLLYQMLCGIKHL 134
Query: 883 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEY 942
H SA +IH DLKPSN+++ + + DFG+A+ G M T + T Y APE
Sbjct: 135 H---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMM--TPYVVTRYYRAPEV 188
Query: 943 GREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLL 1002
D++S G ++ E +F G + W KII+ L
Sbjct: 189 ILGMGYKENVDIWSVGCIMGEMIRGTV----LFPGTDHIDQW---------NKIIE--QL 233
Query: 1003 ITEDKHFAAKEQ 1014
T F ++ Q
Sbjct: 234 GTPSDEFMSRLQ 245
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 2e-05
Identities = 59/213 (27%), Positives = 90/213 (42%), Gaps = 43/213 (20%)
Query: 777 IGRGSFGSVY-IARLQNGIEVAVKTFDLQHERAFKSFDTECEVMKSI-----RHRNLTKI 830
IG+G++G VY + ++G AVK D D E E +I H N+ K
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVKILD-----PISDVDEEIEAEYNILQSLPNHPNVVKF 84
Query: 831 ISSCSNEDFKA-----LILEYMRNGSLEKCLYSGNYILDIFQRLN------IMIDVASAL 879
D L+LE GS+ + L G +L QRL+ I+ L
Sbjct: 85 YGMFYKADKLVGGQLWLVLELCNGGSVTE-LVKG--LLICGQRLDEAMISYILYGALLGL 141
Query: 880 EYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMA 939
++LH + +IH D+K +N+LL L DFG++ L + + ++ T +MA
Sbjct: 142 QHLH---NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLT--STRLRRNTSVGTPFWMA 196
Query: 940 PE---------YGREGRVSTKGDVYSFGILLME 963
PE Y + R DV+S GI +E
Sbjct: 197 PEVIACEQQYDYSYDARC----DVWSLGITAIE 225
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|215633 PLN03210, PLN03210, Resistant to P | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 2e-05
Identities = 68/267 (25%), Positives = 115/267 (43%), Gaps = 25/267 (9%)
Query: 237 LSNCKHLRILDLSFNDLWGDIPKEIGNLTKLKELFLDFNILQGEIPHTVGNLHNLEYLSL 296
LS +L L LS ++P I L KL++L + +P + NL +L L+L
Sbjct: 653 LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSLYRLNL 711
Query: 297 VNNELVGTVPATIFNVSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYL--------WGN 348
+ + P N+S L L E + F PS +++L NL+EL L W
Sbjct: 712 SGCSRLKSFPDISTNISWLDLDETAIEEF----PS--NLRLENLDELILCEMKSEKLWER 765
Query: 349 NFSGTLPSFIFNASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNYLTSPELSFLSS 408
T P + +L++L L D +P++ NL L+ L + N L L +
Sbjct: 766 VQPLT-PLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIEN----CINLETLPT 820
Query: 409 LSNCKYLEIIALSGNPLNGIIPMSAGNLSHSLEELFMPDCNVSGRIPKEIGNLANLVTLD 468
N + LE + LSG P ++S ++ +L + + +P I +NL LD
Sbjct: 821 GINLESLESLDLSGCSRLRTFP----DISTNISDLNLSRTGIE-EVPWWIEKFSNLSFLD 875
Query: 469 LGGNKFNGSIPIALGKLQKLQLLNLDD 495
+ G + + + KL+ L+ ++ D
Sbjct: 876 MNGCNNLQRVSLNISKLKHLETVDFSD 902
|
syringae 6; Provisional. Length = 1153 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 2e-05
Identities = 59/208 (28%), Positives = 90/208 (43%), Gaps = 35/208 (16%)
Query: 777 IGRGSFGSVYIARLQ-NGIEVAVKTFDLQHERA--FKSFDTECEVMKSIRHRNLTKIISS 833
+G GS+ +VY R + G VA+K L+HE F + E ++K ++H N+ +
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAI-REASLLKDLKHANIVTLHDI 71
Query: 834 CSNEDFKALILEYMRNG---SLEKC---LYSGNYILDIFQRLNIMIDVASALEYLHFGYS 887
+ L+ EY+ ++ C L N L +FQ L L Y H
Sbjct: 72 IHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLR-------GLAYCH---Q 121
Query: 888 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAP------- 940
V+H DLKP N+L+ + L+DFG+A+ S T + + TL Y P
Sbjct: 122 RRVLHRDLKPQNLLISERGELKLADFGLAR--AKSVPSKTYSNEVVTLWYRPPDVLLGST 179
Query: 941 EYGREGRVSTKGDVYSFGILLMETFTRR 968
EY ST D++ G + E T R
Sbjct: 180 EY------STSLDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 2e-05
Identities = 53/217 (24%), Positives = 98/217 (45%), Gaps = 23/217 (10%)
Query: 777 IGRGSFGSV---YIARLQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIIS- 832
IG G+ G V Y A L+ + + + Q++ K E +MK + H+N+ +++
Sbjct: 32 IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 833 ---SCSNEDFKAL--ILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYS 887
S E+F+ + ++E M + +L + + LD + ++ + +++LH S
Sbjct: 92 FTPQKSLEEFQDVYIVMELM-DANLCQVI---QMELDHERMSYLLYQMLCGIKHLH---S 144
Query: 888 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGR 947
A +IH DLKPSN+++ + + DFG+A+ S T + T Y APE
Sbjct: 145 AGIIHRDLKPSNIVVKSDCTLKILDFGLART---AGTSFMMTPYVVTRYYRAPEVILGMG 201
Query: 948 VSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHW 984
D++S G ++ E +F G + W
Sbjct: 202 YKENVDIWSVGCIMGEMIKGGV----LFPGTDHIDQW 234
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|215633 PLN03210, PLN03210, Resistant to P | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 6e-05
Identities = 78/293 (26%), Positives = 116/293 (39%), Gaps = 43/293 (14%)
Query: 94 LSSLEILDLNFNRLSGEIPWELGNLAKLEKLLLHNNFLTGTIPFSIFKLSSLLDLKLSDN 153
L+ L +DL ++ EIP +L LE L L + +P SI L+ L DL +S
Sbjct: 633 LTGLRNIDLRGSKNLKEIP-DLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRC 691
Query: 154 NLTGTIPSHNLGNLSSLQLLDLSDNQLSGSIPSFIFKISSLQALHFGNNRLSGELPANIC 213
+P+ NL SL L+LS S P IS L L
Sbjct: 692 ENLEILPTGI--NLKSLYRLNLSGCSRLKSFPDISTNISWLD--------LDETAIEEFP 741
Query: 214 DNLPFLNFFSVYKNMFYGGISSTLSNCKHLRILDLSFNDLWGDIPKEIGNLT----KLKE 269
NL L N L + ++ LW + +T L
Sbjct: 742 SNLR-------------------LENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTR 782
Query: 270 LFLDFNILQGEIPHTVGNLHNLEYLSLVNNELVGTVPATIFNVSTLKLIELSNNTFFGSL 329
LFL E+P ++ NLH LE+L + N + T+P I N+ +L+ ++LS + +
Sbjct: 783 LFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTF 841
Query: 330 PS-STDVQLPNLEELYLWGNNFSGTLPSFIFNASNLSKLSL-GDNSFSGLIPN 380
P ST N+ +L L +P +I SNLS L + G N+ + N
Sbjct: 842 PDIST-----NISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQRVSLN 888
|
syringae 6; Provisional. Length = 1153 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 7e-05
Identities = 47/215 (21%), Positives = 93/215 (43%), Gaps = 37/215 (17%)
Query: 777 IGRGSFGSVYIARLQNGIEVAVKTFDLQHERAFKSFD---------TECEVMKSIRHRN- 826
+GRG++G VY A+ ++G + + E A K + E +++ ++H N
Sbjct: 9 VGRGTYGHVYKAKRKDGKD--------EKEYALKQIEGTGISMSACREIALLRELKHPNV 60
Query: 827 --LTKIISSCSNEDFKALILEYMRNG-----SLEKCLYSGNYILDIFQRL--NIMIDVAS 877
L K+ S S+ L+ +Y + + + + + + + +++ +
Sbjct: 61 IALQKVFLSHSDRKV-WLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILD 119
Query: 878 ALEYLHFGYSAPVIHCDLKPSNVLL----DDNMVAHLSDFGIAKLLIGEDQSMTQTQ-TL 932
+ YLH + V+H DLKP+N+L+ + ++D G A+L + + +
Sbjct: 120 GIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 176
Query: 933 ATLGYMAPEYGREGRVSTKG-DVYSFGILLMETFT 966
T Y APE R TK D+++ G + E T
Sbjct: 177 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 1e-04
Identities = 71/263 (26%), Positives = 96/263 (36%), Gaps = 52/263 (19%)
Query: 143 SSLLDLKLSDNNLTGTIPS------HNLGNLSSLQLLDLSDNQLS----GSIPSFIFKIS 192
SL +L LS N TG IP L LQ LDLSDN L G + S + + S
Sbjct: 51 PSLKELCLSLNE-TGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLL-RSS 108
Query: 193 SLQALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGGISSTLSNCKHLRILDLSFND 252
SLQ L NN L + L L L L N
Sbjct: 109 SLQELKLNNNGLGDRGLRLLAKGLK--------------------DLPPALEKLVLGRNR 148
Query: 253 LWGDIPKEIGNL----TKLKELFLDFNILQGE-IPHTVGNL---HNLEYLSLVNNEL--- 301
L G + + LKEL L N + I L NLE L L NN L
Sbjct: 149 LEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDE 208
Query: 302 -VGTVPATIFNVSTLKLIELSNN--TFFG--SLPSSTDVQLPNLEELYLWGNNF----SG 352
+ T+ ++ +L+++ L +N T G +L S+ +L L L N+ +
Sbjct: 209 GASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAK 268
Query: 353 TLPSFIFNASNLSKLSLGDNSFS 375
L + +L +L L N F
Sbjct: 269 DLAEVLAEKESLLELDLRGNKFG 291
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 1e-04
Identities = 43/156 (27%), Positives = 72/156 (46%), Gaps = 28/156 (17%)
Query: 776 LIGRGSFGSVYIARLQN-GIEVAVKTFD---------LQHERAFKSFDTECEVMKSIRHR 825
+IGRG+FG V + + ++ G A+K + H RA E +++ +
Sbjct: 8 VIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRA------ERDILAEADNP 61
Query: 826 NLTKIISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIF---QRLNIMIDVASALEYL 882
+ K+ S +E++ LI+EY+ G + L D F + + + A++ +
Sbjct: 62 WVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMK----KDTFTEEETRFYIAETILAIDSI 117
Query: 883 H-FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK 917
H GY IH D+KP N+LLD LSDFG+
Sbjct: 118 HKLGY----IHRDIKPDNLLLDAKGHIKLSDFGLCT 149
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-04
Identities = 41/155 (26%), Positives = 68/155 (43%), Gaps = 10/155 (6%)
Query: 814 TECEVMKSIRHRNLTKIISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMI 873
TE ++++I H ++ ++ + + F LIL + C + + I L I
Sbjct: 132 TEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTDLY--CYLAAKRNIAICDILAIER 189
Query: 874 DVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIA--KLLIGEDQSMTQTQT 931
V A++YLH +IH D+K N+ ++ L DFG A + I ++ T
Sbjct: 190 SVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGT 246
Query: 932 LATLGYMAPEYGREGRVSTKGDVYSFGILLMETFT 966
+AT APE D++S GI+L E T
Sbjct: 247 IAT---NAPELLARDPYGPAVDIWSAGIVLFEMAT 278
|
Length = 391 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 2e-04
Identities = 30/139 (21%), Positives = 63/139 (45%), Gaps = 19/139 (13%)
Query: 785 VYIARLQNGIEVAVKTFDLQHERAFKSFDTECEV--MKSIRHRNLT--KIISSCSNEDFK 840
VY+ ++ + +K + K D E EV ++ + + L K+++S ++ +
Sbjct: 14 VYLLGTKDE-DYVLK----INPSREKGADREREVAILQLLARKGLPVPKVLASGESDGWS 68
Query: 841 ALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPV-IHCDLKPSN 899
L++E++ +L++ + ++ +I +A L LH V H DL P N
Sbjct: 69 YLLMEWIEGETLDE--------VSEEEKEDIAEQLAELLAKLH-QLPLLVLCHGDLHPGN 119
Query: 900 VLLDDNMVAHLSDFGIAKL 918
+L+DD + + D+ A
Sbjct: 120 ILVDDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 3e-04
Identities = 73/306 (23%), Positives = 108/306 (35%), Gaps = 61/306 (19%)
Query: 385 LRNLKRLRLYNNYLTSPELSFLSSLSNCKYLEIIALSGNPLNGIIPMSAGNLSHSLEELF 444
L L+ LRL N L L+S AL P S L SL E
Sbjct: 22 LLCLQVLRLEGNTLGEEAAKALAS----------ALRPQP-------SLKELCLSLNETG 64
Query: 445 MPDCNVSGRIPKEIGNLANLVTLDLGGNKFNGSIP---IALGKLQKLQLLNLDDNKLEGS 501
+ + + + L LDL N +L + LQ L L++N L
Sbjct: 65 RIPRGL-QSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDR 123
Query: 502 IPDDIC-GLVE----LYKLALGDNKLSGQIPACFGNLA----SLRELWLGPNELISF-IP 551
+ GL + L KL LG N+L G L+EL L N + I
Sbjct: 124 GLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIR 183
Query: 552 STFWNIKD---IMYVNFSSNFLT----GPLPLEIENLKALTTLDFSMNNLSGVIPTTIGG 604
+ +K + ++ ++N LT L + +LK+L L+ NNL
Sbjct: 184 ALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNL---------T 234
Query: 605 LKGLQYLFLGHNRLQGSIPDSVGDLISLKSLNLSNNNL----SGPIPTSLEKLSDLKELN 660
G L + ISL +L+LS N++ + + L + L EL+
Sbjct: 235 DAGAAALASA----------LLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELD 284
Query: 661 LSFNKL 666
L NK
Sbjct: 285 LRGNKF 290
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 39.4 bits (93), Expect = 3e-04
Identities = 20/59 (33%), Positives = 28/59 (47%)
Query: 560 IMYVNFSSNFLTGPLPLEIENLKALTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRL 618
+ ++ S+N LT + L L LD S NNL+ + P GL L+ L L N L
Sbjct: 2 LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 3e-04
Identities = 57/264 (21%), Positives = 105/264 (39%), Gaps = 48/264 (18%)
Query: 794 IEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEYMRNGSLE 853
+ V +K D H +F +M + H +L + C ++ E++ +G L+
Sbjct: 45 LRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLD 104
Query: 854 KCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAH---- 909
CL + + ++ + +ASAL YL ++H ++ N+LL +A
Sbjct: 105 VCLRKEKGRVPVAWKITVAQQLASALSYLE---DKNLVHGNVCAKNILLARLGLAEGTSP 161
Query: 910 ---LSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREG-RVSTKGDVYSFGILLMETF 965
LSD G++ ++++ + + + ++APE G +ST D +SFG L+E
Sbjct: 162 FIKLSDPGVSF------TALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEI- 214
Query: 966 TRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHFAAK-----EQCASSVF 1020
F GE+ LK +E + F K E +
Sbjct: 215 --------CFDGEVPLKERTP-----------------SEKERFYEKKHRLPEPSCKELA 249
Query: 1021 NLAMECTVESPDERITAKEIVRRL 1044
L +C P +R + + I+R L
Sbjct: 250 TLISQCLTYEPTQRPSFRTILRDL 273
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 39.1 bits (92), Expect = 4e-04
Identities = 23/61 (37%), Positives = 32/61 (52%), Gaps = 1/61 (1%)
Query: 144 SLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQLSGSIPSFIFKISSLQALHFGNNR 203
+L L LS+N LT IP L +L++LDLS N L+ P + SL++L N
Sbjct: 1 NLKSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59
Query: 204 L 204
L
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 5e-04
Identities = 47/227 (20%), Positives = 95/227 (41%), Gaps = 39/227 (17%)
Query: 777 IGRGSFGSVYIARL-------------QNGIEVAVKTFDLQHERAFKSFDTECEVMKSIR 823
+GRG+ +Y L + I+V +K D H +F +M+ +
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 824 HRNLTKIISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLH 883
H+++ + C + ++ E++ G L+ ++ + +L + + +ASAL YL
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLE 122
Query: 884 FGYSAPVIHCDLKPSNVLL-------DDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLG 936
++H ++ N+LL + LSD GI + +++ + + +
Sbjct: 123 ---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITV------LSRQECVERIP 173
Query: 937 YMAPEYGREGRV-STKGDVYSFGILLMETFTRRKPTDEIFSGEMTLK 982
++APE + + S D +SFG L E ++GE+ LK
Sbjct: 174 WIAPECVEDSKNLSIAADKWSFGTTLWEI---------CYNGEIPLK 211
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 5e-04
Identities = 61/223 (27%), Positives = 95/223 (42%), Gaps = 24/223 (10%)
Query: 777 IGRG--SFGSVYIAR-LQNGIEVAVKTFDLQH--ERAFKSFDTECEVMKSIRHRNLTKII 831
IGRG + SVY+AR G V V+ DL++ E K+ E + RH N+
Sbjct: 6 IGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSW 65
Query: 832 SSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRL---NIMIDVASALEYLH-FGYS 887
+ + + +I +M GS L Y + NI+ L YLH GY
Sbjct: 66 TVFTTGSWLWVISPFMAYGSANSLL--KTYFPEGMSEALIGNILFGALRGLNYLHQNGY- 122
Query: 888 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ------SMTQTQTLATLGYMAPE 941
IH ++K S++L+ + + LS L+ Q Q T + L +++PE
Sbjct: 123 ---IHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFST-SVLPWLSPE 178
Query: 942 YGREGR--VSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLK 982
R+ + K D+YS GI E T R P ++ +M L+
Sbjct: 179 LLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQ 221
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 6e-04
Identities = 33/105 (31%), Positives = 50/105 (47%), Gaps = 28/105 (26%)
Query: 878 ALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLI---------GEDQSMTQ 928
ALEYLH + ++H DLKP N+L+ L+DFG++K+ + G + T+
Sbjct: 113 ALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTR 169
Query: 929 ----TQTLATLGYMAPE------YGREGRVSTKGDVYSFGILLME 963
Q T Y+APE YG+ D ++ GI+L E
Sbjct: 170 EFLDKQVCGTPEYIAPEVILRQGYGK------PVDWWAMGIILYE 208
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 38.3 bits (90), Expect = 8e-04
Identities = 23/61 (37%), Positives = 26/61 (42%), Gaps = 2/61 (3%)
Query: 242 HLRILDLSFNDLWGDIPKEI-GNLTKLKELFLDFNILQGEIPHTVGNLHNLEYLSLVNNE 300
+L+ LDLS N L IP L LK L L N L P L +L L L N
Sbjct: 1 NLKSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59
Query: 301 L 301
L
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 8e-04
Identities = 42/159 (26%), Positives = 69/159 (43%), Gaps = 22/159 (13%)
Query: 769 NGFSENNLIGRGSFGSV-YIARLQNGIEVAVKTF---------DLQHERAFKSFDTECEV 818
F +IG+G+FG V + + G A+KT L H +A E +V
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKA------ERDV 54
Query: 819 MKSIRHRNLTKIISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASA 878
+ + + S + + LI+E++ G L L + + R M + A
Sbjct: 55 LAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRF-YMAECVLA 113
Query: 879 LEYLH-FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIA 916
+E +H G+ IH D+KP N+L+D LSDFG++
Sbjct: 114 IEAVHKLGF----IHRDIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.9 bits (89), Expect = 0.001
Identities = 21/60 (35%), Positives = 27/60 (45%)
Query: 463 NLVTLDLGGNKFNGSIPIALGKLQKLQLLNLDDNKLEGSIPDDICGLVELYKLALGDNKL 522
NL +LDL N+ A L L++L+L N L P+ GL L L L N L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.5 bits (88), Expect = 0.002
Identities = 26/61 (42%), Positives = 32/61 (52%), Gaps = 2/61 (3%)
Query: 96 SLEILDLNFNRLSGEIPWE-LGNLAKLEKLLLHNNFLTGTIPFSIFKLSSLLDLKLSDNN 154
+L+ LDL+ NRL+ IP L L+ L L N LT P + L SL L LS NN
Sbjct: 1 NLKSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59
Query: 155 L 155
L
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.002
Identities = 44/208 (21%), Positives = 93/208 (44%), Gaps = 23/208 (11%)
Query: 777 IGRGSFGSVYIARLQNGIEVAVKTFDLQHERAFKSFDTECE---VMKSIRHRNLTKIISS 833
+GRG++G VY A+ ++G + + + L+ + C +++ ++H N+ +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDD--RDYALKQIEGTGISMSACREIALLRELKHPNVISLQKV 66
Query: 834 -CSNEDFKA-LILEYMRNG-----SLEKCLYSGNYILDIFQRL--NIMIDVASALEYLHF 884
S+ D K L+ +Y + + + + + + + +++ + + YLH
Sbjct: 67 FLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA 126
Query: 885 GYSAPVIHCDLKPSNVLL----DDNMVAHLSDFGIAKLLIGEDQSMTQTQ-TLATLGYMA 939
+ V+H DLKP+N+L+ + ++D G A+L + + + T Y A
Sbjct: 127 NW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 940 PEYGREGRVSTKG-DVYSFGILLMETFT 966
PE R TK D+++ G + E T
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.002
Identities = 36/150 (24%), Positives = 70/150 (46%), Gaps = 10/150 (6%)
Query: 771 FSENNLIGRGSFGSVYIAR-LQNGIEVAVKTF---DLQHERAFKSFDTECEVMKSIRHRN 826
F + +G G+FG V +A + A+KT D+ + E +++ +
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62
Query: 827 LTKIISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLH-FG 885
+ K+ S ++D +++Y+ G + L ++ R I ++ A+E +H G
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIA-ELTLAIESVHKMG 121
Query: 886 YSAPVIHCDLKPSNVLLDDNMVAHLSDFGI 915
+ IH D+KP N+L+D + L+DFG+
Sbjct: 122 F----IHRDIKPDNILIDLDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 0.002
Identities = 49/229 (21%), Positives = 83/229 (36%), Gaps = 64/229 (27%)
Query: 780 GSFGSVYIARLQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDF 839
G+FG ++I L+ E A + K +CE + + R + ++ NE
Sbjct: 159 GAFGKIFICALRASTEEAEARRGVNSTNQGKP---KCERLIAKRVKAGSRAAIQLENE-- 213
Query: 840 KALILEYMRNGSLEKC--------------------LYSGNYILD--------IFQRLNI 871
L L + + ++ K LYS Y + Q I
Sbjct: 214 -ILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAI 272
Query: 872 MIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQT 931
M + A+EY+H +IH D+K N+ L+ + L DFG A E +
Sbjct: 273 MKQLLCAVEYIH---DKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKERE------- 322
Query: 932 LATLGYMAPEYGREGRVSTKG-------------DVYSFGILLMETFTR 967
A +YG G V+T D++S G++L++ +
Sbjct: 323 -------AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSH 364
|
Length = 501 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.002
Identities = 38/150 (25%), Positives = 70/150 (46%), Gaps = 10/150 (6%)
Query: 771 FSENNLIGRGSFGSVYIARLQN-GIEVAVKTF---DLQHERAFKSFDTECEVMKSIRHRN 826
F +IGRG+FG V + + ++ G A+K D+ + E +++
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLW 62
Query: 827 LTKIISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLH-FG 885
+ K+ S ++ LI+E++ G + L + + + + I + A++ +H G
Sbjct: 63 VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIA-ETVLAIDSIHQLG 121
Query: 886 YSAPVIHCDLKPSNVLLDDNMVAHLSDFGI 915
+ IH D+KP N+LLD LSDFG+
Sbjct: 122 F----IHRDIKPDNLLLDSKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 0.003
Identities = 46/179 (25%), Positives = 69/179 (38%), Gaps = 44/179 (24%)
Query: 95 SSLEILDLNFNRLSGEIPWELG-----NLAKLEKLLLHNNFLTGTIPFSIFKL----SSL 145
SSL+ L LN N L L LEKL+L N L G ++ K L
Sbjct: 108 SSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDL 167
Query: 146 LDLKLSDNNLTGT-IPS--HNLGNLSSLQLLDLSDN--------QLSGSIPSFIFKISSL 194
+L L++N + I + L +L++LDL++N L+ ++ S SL
Sbjct: 168 KELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLK----SL 223
Query: 195 QALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGGISSTLSNCKHLRILDLSFNDL 253
+ L+ G+N L+ A + L N L L LS ND+
Sbjct: 224 EVLNLGDNNLTDAGAAALASALLSPN--------------------ISLLTLSLSCNDI 262
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 36.4 bits (85), Expect = 0.004
Identities = 17/57 (29%), Positives = 26/57 (45%)
Query: 512 LYKLALGDNKLSGQIPACFGNLASLRELWLGPNELISFIPSTFWNIKDIMYVNFSSN 568
L L L +N+L+ F L +L+ L L N L S P F + + ++ S N
Sbjct: 2 LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGN 58
|
Length = 60 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.004
Identities = 38/150 (25%), Positives = 70/150 (46%), Gaps = 10/150 (6%)
Query: 771 FSENNLIGRGSFGSVYIARLQN-GIEVAVKTF---DLQHERAFKSFDTECEVMKSIRHRN 826
F +IGRG+FG V + + ++ G A+K D+ + E +++
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAW 62
Query: 827 LTKIISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLH-FG 885
+ K+ S ++ LI+E++ G + L + + + + I + A++ +H G
Sbjct: 63 VVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIA-ETVLAIDAIHQLG 121
Query: 886 YSAPVIHCDLKPSNVLLDDNMVAHLSDFGI 915
+ IH D+KP N+LLD LSDFG+
Sbjct: 122 F----IHRDIKPDNLLLDAKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1057 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.98 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.98 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.98 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.98 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.98 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.98 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.98 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.98 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.98 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.98 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.94 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.94 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.93 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.93 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.93 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.91 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.9 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.89 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.88 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.88 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.88 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.87 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.87 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.85 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.85 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.83 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.83 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.82 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.81 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.8 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.79 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.79 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.79 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.78 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.76 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.76 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.75 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.75 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.75 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.74 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.73 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.72 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.7 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.68 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.68 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.67 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.66 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.66 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.63 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.58 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.58 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.57 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.54 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.53 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.51 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.46 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.4 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.38 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.37 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.31 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.3 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.28 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.28 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.25 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.24 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.21 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.19 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.13 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.13 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.12 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.12 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.1 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.09 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.08 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.06 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.05 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.03 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.02 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.02 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.99 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.97 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.95 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.92 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.88 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.86 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.82 | |
| PF08263 | 43 | LRRNT_2: Leucine rich repeat N-terminal domain; In | 98.8 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.76 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.75 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.73 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.7 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.64 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.59 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.57 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.55 | |
| KOG2120 | 419 | consensus SCF ubiquitin ligase, Skp2 component [Po | 98.51 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.5 | |
| COG5238 | 388 | RNA1 Ran GTPase-activating protein (RanGAP) involv | 98.48 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-115 Score=1122.89 Aligned_cols=917 Identities=33% Similarity=0.552 Sum_probs=691.2
Q ss_pred CcchHHHHHHHHHhcccCCCCcccCCCCCCCCCCcccceeEecCCCCceeEEeeecccCcccccccccCCCCCcEEeCCC
Q 001544 25 IDIDQDALLALKDHITYDPTNFFAKNWLTNSTMVCNWTGVTCDINQRRVTALNISYLSLTGNIPRQLGNLSSLEILDLNF 104 (1057)
Q Consensus 25 ~~~d~~~l~~~k~~~~~~~~~~~~~~w~~~~~~~c~w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~ 104 (1057)
.+.|++||++||+++. ||.+.+ .+|.. +.+||.|.||+|+. ..+|+.|+|++++++|.+|+.+..+++|++|+|++
T Consensus 27 ~~~~~~~l~~~~~~~~-~~~~~~-~~w~~-~~~~c~w~gv~c~~-~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~ 102 (968)
T PLN00113 27 HAEELELLLSFKSSIN-DPLKYL-SNWNS-SADVCLWQGITCNN-SSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSN 102 (968)
T ss_pred CHHHHHHHHHHHHhCC-CCcccC-CCCCC-CCCCCcCcceecCC-CCcEEEEEecCCCccccCChHHhCCCCCCEEECCC
Confidence 3578999999999995 777666 58954 57899999999985 46899999999999999999999999999999999
Q ss_pred CCccccCCcccc-cccccceeecccccccCCCCccccccCCCCeEeccCCCCCCCCCcccccCCCCCceeEccCCccccc
Q 001544 105 NRLSGEIPWELG-NLAKLEKLLLHNNFLTGTIPFSIFKLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQLSGS 183 (1057)
Q Consensus 105 n~l~~~~p~~l~-~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~l~~l~~L~~L~Ls~n~l~~~ 183 (1057)
|+++|.+|..+. .+++|++|+|++|++++.+|. +.+++|++|+|++|.+++.+|. .++++++|++|+|++|.+.+.
T Consensus 103 n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~~~p~-~~~~l~~L~~L~L~~n~l~~~ 179 (968)
T PLN00113 103 NQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPN-DIGSFSSLKVLDLGGNVLVGK 179 (968)
T ss_pred CccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEECcCCcccccCCh-HHhcCCCCCEEECccCccccc
Confidence 999999998765 899999999999999988886 5688999999999999888886 488999999999999999888
Q ss_pred CchhhhccccCCeeEeeccCCccccCccccCCCCcccEEEeeccccccCccccccCCCCCcEEEccCCCCcCCccccccC
Q 001544 184 IPSFIFKISSLQALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGGISSTLSNCKHLRILDLSFNDLWGDIPKEIGN 263 (1057)
Q Consensus 184 ~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~l~~n~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~ 263 (1057)
+|..++++++|++|+|++|++++.+|. .++++++|++|+|++|.+++.+|..+++
T Consensus 180 ~p~~~~~l~~L~~L~L~~n~l~~~~p~-------------------------~l~~l~~L~~L~L~~n~l~~~~p~~l~~ 234 (968)
T PLN00113 180 IPNSLTNLTSLEFLTLASNQLVGQIPR-------------------------ELGQMKSLKWIYLGYNNLSGEIPYEIGG 234 (968)
T ss_pred CChhhhhCcCCCeeeccCCCCcCcCCh-------------------------HHcCcCCccEEECcCCccCCcCChhHhc
Confidence 999999999999999999988776664 3466778888888888887778888888
Q ss_pred cCCCcEEeeeccccccccCccccccccccEEEeecCccccccCccccccccccEEEecCCccccCCCCCcccCCCCCceE
Q 001544 264 LTKLKELFLDFNILQGEIPHTVGNLHNLEYLSLVNNELVGTVPATIFNVSTLKLIELSNNTFFGSLPSSTDVQLPNLEEL 343 (1057)
Q Consensus 264 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L 343 (1057)
+++|++|++++|.+++.+|..|+++++|++|+|++|++.+.+|..+.++++|+.|++++|.+.+.+|..+ ..+++|+.|
T Consensus 235 l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~-~~l~~L~~L 313 (968)
T PLN00113 235 LTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELV-IQLQNLEIL 313 (968)
T ss_pred CCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhH-cCCCCCcEE
Confidence 8888888888888887778888888888888888888877777777777777777777777766655443 356667777
Q ss_pred EecCccccccCCccccccccccccccccccccccccchhcccccccEEeccCcccCCCccccccccCCCcchhhhhccCC
Q 001544 344 YLWGNNFSGTLPSFIFNASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNYLTSPELSFLSSLSNCKYLEIIALSGN 423 (1057)
Q Consensus 344 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~l~~L~~L~Ls~N 423 (1057)
++++|.+++..|..+..+++|+.|++++|.+++.+|..++.+++|+.|++++|.++
T Consensus 314 ~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~------------------------ 369 (968)
T PLN00113 314 HLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLT------------------------ 369 (968)
T ss_pred ECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeE------------------------
Confidence 77777776666666666666777777766666666666665555555555555443
Q ss_pred CcccccccccccccccccEEEcCCCcccccccccccCccCCcEEEccCCcCCCCCCcccccccccceeecccccCcccCC
Q 001544 424 PLNGIIPMSAGNLSHSLEELFMPDCNVSGRIPKEIGNLANLVTLDLGGNKFNGSIPIALGKLQKLQLLNLDDNKLEGSIP 503 (1057)
Q Consensus 424 ~l~~~~~~~~~~l~~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~~ 503 (1057)
+.+|..+..+++|+.|++++|++.+.+|..+..+++|+.|++++|++++..|
T Consensus 370 ----------------------------~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p 421 (968)
T PLN00113 370 ----------------------------GEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELP 421 (968)
T ss_pred ----------------------------eeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECC
Confidence 2334444445555555555555555555555555555555555555555555
Q ss_pred cccccccccceEEecCeeeeecCCccccCcccccccccCCccccccccccccccccccEEEeccccccCCCchhhccccc
Q 001544 504 DDICGLVELYKLALGDNKLSGQIPACFGNLASLRELWLGPNELISFIPSTFWNIKDIMYVNFSSNFLTGPLPLEIENLKA 583 (1057)
Q Consensus 504 ~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 583 (1057)
..|..++.|+.|++++|++++.+|..+..+++|+.|++++|++.+..|..+ ..++|+.|++++|++++..|..+..+++
T Consensus 422 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~-~~~~L~~L~ls~n~l~~~~~~~~~~l~~ 500 (968)
T PLN00113 422 SEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSF-GSKRLENLDLSRNQFSGAVPRKLGSLSE 500 (968)
T ss_pred hhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCccc-ccccceEEECcCCccCCccChhhhhhhc
Confidence 555555555555555555555555555555666666666666555555443 3467888999999999999999999999
Q ss_pred cceeccccccccccccccccCccccceecccccccccccCccccccCccceecccCccccCCCcccccCcccccccccCC
Q 001544 584 LTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQGSIPDSVGDLISLKSLNLSNNNLSGPIPTSLEKLSDLKELNLSF 663 (1057)
Q Consensus 584 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~ 663 (1057)
|+.|+|++|++++.+|..++.+++|+.|+|++|+++|.+|..|..+++|+.|||++|+++|.+|..+..+++|+.|++++
T Consensus 501 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~ 580 (968)
T PLN00113 501 LMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISH 580 (968)
T ss_pred cCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CcccCcCCCCCCCcccCcccccCCcccCCCCC-CCCCCCccccccccccchhhhhhccchhhhHhHHHHHhhhhhcccCC
Q 001544 664 NKLEGEIPRGGPFVNFSAKSFMGNNLLCGSPN-LQVPPCRASIDHISKKNALLLGIILPFSTIFVIVIILLISRYQTRGE 742 (1057)
Q Consensus 664 N~l~~~~p~~~~~~~~~~~~~~~n~~~cg~~~-~~~~~c~~~~~~~~~~~~~~~~i~~~~~~i~l~v~~~~~~~~~~~~~ 742 (1057)
|+++|.+|..++|.++...++.||+.+||.+. ...++|..... ......++.++++++.++++++++++++|++++.+
T Consensus 581 N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 659 (968)
T PLN00113 581 NHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRK-TPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLE 659 (968)
T ss_pred CcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCccccc-cceeeeehhHHHHHHHHHHHHHHHHHHHHhhhccc
Confidence 99999999999999999999999999999653 23557754321 11111111111111111112222222222222111
Q ss_pred --CCCCC---CCCccc--cccccCCHHHHHHHhCCCCCCceeccccCeEEEEEEe-cCCcEEEEEEeeccchhHHHHHHH
Q 001544 743 --NVPNE---VNVPLE--ATWRRFSYLELFQATNGFSENNLIGRGSFGSVYIARL-QNGIEVAVKTFDLQHERAFKSFDT 814 (1057)
Q Consensus 743 --~~~~~---~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~ 814 (1057)
+...+ .+.... ...+.++++++ ...|+..++||+|+||.||+|.. .++..||||+++..... ..+
T Consensus 660 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~ 732 (968)
T PLN00113 660 LKRVENEDGTWELQFFDSKVSKSITINDI---LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSS 732 (968)
T ss_pred ccccccccccccccccccccchhhhHHHH---HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHH
Confidence 11110 000000 00122333333 34677889999999999999986 57899999998643321 234
Q ss_pred HHHHHHhcCCCCceeEeeeeccCCeeEEEEEEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcc
Q 001544 815 ECEVMKSIRHRNLTKIISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 894 (1057)
Q Consensus 815 E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~D 894 (1057)
|++.+++++||||++++++|.+++..++||||+++|+|.++++. ++|.++.+|+.|+|+|++|||..++++|+|||
T Consensus 733 ~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~d 808 (968)
T PLN00113 733 EIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGN 808 (968)
T ss_pred HHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCC
Confidence 68899999999999999999999999999999999999999963 88999999999999999999977778999999
Q ss_pred CCCCCeeeCCCCcEEEEcccccccccCCCCccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcc
Q 001544 895 LKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEI 974 (1057)
Q Consensus 895 lkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~ 974 (1057)
|||+||+++.++.+++. ||.+.... ......++++|+|||+..+..++.++|||||||++|||+||+.||+..
T Consensus 809 lkp~Nil~~~~~~~~~~-~~~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~ 881 (968)
T PLN00113 809 LSPEKIIIDGKDEPHLR-LSLPGLLC------TDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAE 881 (968)
T ss_pred CCHHhEEECCCCceEEE-eccccccc------cCCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcc
Confidence 99999999999988876 66554321 112236789999999999999999999999999999999999999765
Q ss_pred cccccchhhhhhhccchh-HHHhhhcccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHHHhHHH
Q 001544 975 FSGEMTLKHWVNDFLPIS-MMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKIRDF 1050 (1057)
Q Consensus 975 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~ 1050 (1057)
.........|........ ....+|+..... .........++.+++.+||+.||++||+|+|++++|+++.+.
T Consensus 882 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~ 954 (968)
T PLN00113 882 FGVHGSIVEWARYCYSDCHLDMWIDPSIRGD----VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS 954 (968)
T ss_pred cCCCCcHHHHHHHhcCccchhheeCccccCC----CCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence 554555566654433221 222333322111 111223456788999999999999999999999999998764
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-61 Score=621.91 Aligned_cols=518 Identities=39% Similarity=0.594 Sum_probs=451.7
Q ss_pred CCCcEEeCCCCCccccCCcccccccccceeecccccccCCCCcccc-ccCCCCeEeccCCCCCCCCCcccccCCCCCcee
Q 001544 95 SSLEILDLNFNRLSGEIPWELGNLAKLEKLLLHNNFLTGTIPFSIF-KLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLL 173 (1057)
Q Consensus 95 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~-~l~~L~~L~Ls~n~l~~~~p~~~l~~l~~L~~L 173 (1057)
.+++.|||++|+++|.+|..+..+++|++|+|++|+++|.+|..+. .+++|++|+|++|+++|.+|. +.+++|++|
T Consensus 69 ~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~---~~l~~L~~L 145 (968)
T PLN00113 69 SRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR---GSIPNLETL 145 (968)
T ss_pred CcEEEEEecCCCccccCChHHhCCCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCc---cccCCCCEE
Confidence 4689999999999999999999999999999999999999998876 999999999999999998885 568999999
Q ss_pred EccCCcccccCchhhhccccCCeeEeeccCCccccCccccCCCCcccEEEeeccccccCccccccCCCCCcEEEccCCCC
Q 001544 174 DLSDNQLSGSIPSFIFKISSLQALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGGISSTLSNCKHLRILDLSFNDL 253 (1057)
Q Consensus 174 ~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~l~~n~~~~~~~~~l~~l~~L~~L~Ls~N~l 253 (1057)
+|++|.+++.+|..++.+++|++|+|++|.+++.+|. .++++++|++|+|++|.+
T Consensus 146 ~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~-------------------------~~~~l~~L~~L~L~~n~l 200 (968)
T PLN00113 146 DLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPN-------------------------SLTNLTSLEFLTLASNQL 200 (968)
T ss_pred ECcCCcccccCChHHhcCCCCCEEECccCcccccCCh-------------------------hhhhCcCCCeeeccCCCC
Confidence 9999999999999999999999999999988766554 457788999999999999
Q ss_pred cCCccccccCcCCCcEEeeeccccccccCccccccccccEEEeecCccccccCccccccccccEEEecCCccccCCCCCc
Q 001544 254 WGDIPKEIGNLTKLKELFLDFNILQGEIPHTVGNLHNLEYLSLVNNELVGTVPATIFNVSTLKLIELSNNTFFGSLPSST 333 (1057)
Q Consensus 254 ~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 333 (1057)
++.+|..++++++|++|+|++|.+++.+|..++++++|++|++++|++++.+|..+.++++|+.|+|++|.+.+.+|..+
T Consensus 201 ~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l 280 (968)
T PLN00113 201 VGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSI 280 (968)
T ss_pred cCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhH
Confidence 98899999999999999999999998999999999999999999999988888888888888888888887776666554
Q ss_pred ccCCCCCceEEecCccccccCCccccccccccccccccccccccccchhcccccccEEeccCcccCCCccccccccCCCc
Q 001544 334 DVQLPNLEELYLWGNNFSGTLPSFIFNASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNYLTSPELSFLSSLSNCK 413 (1057)
Q Consensus 334 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~l~ 413 (1057)
. .+++|++|+|++|++.+.+|..+..+++|+.|++++|.+.+..|..+..+++|+.|++++|.
T Consensus 281 ~-~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~---------------- 343 (968)
T PLN00113 281 F-SLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNK---------------- 343 (968)
T ss_pred h-hccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCC----------------
Confidence 3 56677777777777776666666666667777777666666666666655555555555444
Q ss_pred chhhhhccCCCcccccccccccccccccEEEcCCCcccccccccccCccCCcEEEccCCcCCCCCCcccccccccceeec
Q 001544 414 YLEIIALSGNPLNGIIPMSAGNLSHSLEELFMPDCNVSGRIPKEIGNLANLVTLDLGGNKFNGSIPIALGKLQKLQLLNL 493 (1057)
Q Consensus 414 ~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L 493 (1057)
+.+.+|..++.+++|+.|+|++|++++.+|.++..+++|+.|++
T Consensus 344 ------------------------------------l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l 387 (968)
T PLN00113 344 ------------------------------------FSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLIL 387 (968)
T ss_pred ------------------------------------CcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEEC
Confidence 33456777888899999999999999999999999999999999
Q ss_pred ccccCcccCCcccccccccceEEecCeeeeecCCccccCcccccccccCCccccccccccccccccccEEEeccccccCC
Q 001544 494 DDNKLEGSIPDDICGLVELYKLALGDNKLSGQIPACFGNLASLRELWLGPNELISFIPSTFWNIKDIMYVNFSSNFLTGP 573 (1057)
Q Consensus 494 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 573 (1057)
++|++.+.+|..+..+++|+.|++++|++++..|..|..+++|+.|++++|.+.+..+..++.+++|+.|++++|.+.+.
T Consensus 388 ~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~ 467 (968)
T PLN00113 388 FSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGG 467 (968)
T ss_pred cCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeee
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999998
Q ss_pred CchhhccccccceeccccccccccccccccCccccceecccccccccccCccccccCccceecccCccccCCCcccccCc
Q 001544 574 LPLEIENLKALTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQGSIPDSVGDLISLKSLNLSNNNLSGPIPTSLEKL 653 (1057)
Q Consensus 574 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l 653 (1057)
.|..+ ..++|+.|+|++|++++.+|..|..+++|+.|+|++|++++.+|..+.++++|++|+|++|+++|.+|..+..+
T Consensus 468 ~p~~~-~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 546 (968)
T PLN00113 468 LPDSF-GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEM 546 (968)
T ss_pred cCccc-ccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCc
Confidence 88766 45899999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCcccCcCCCC-CCCcccCcccccCCcccCCCC
Q 001544 654 SDLKELNLSFNKLEGEIPRG-GPFVNFSAKSFMGNNLLCGSP 694 (1057)
Q Consensus 654 ~~L~~l~ls~N~l~~~~p~~-~~~~~~~~~~~~~n~~~cg~~ 694 (1057)
++|+.|+|++|+++|.+|.. ..+..+......+|+..+.-|
T Consensus 547 ~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p 588 (968)
T PLN00113 547 PVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLP 588 (968)
T ss_pred ccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCC
Confidence 99999999999999999973 234444555566776554333
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-49 Score=440.62 Aligned_cols=289 Identities=41% Similarity=0.661 Sum_probs=244.9
Q ss_pred ccccCCHHHHHHHhCCCCCCceeccccCeEEEEEEecCCcEEEEEEeeccchhHHHHHHHHHHHHHhcCCCCceeEeeee
Q 001544 755 TWRRFSYLELFQATNGFSENNLIGRGSFGSVYIARLQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSC 834 (1057)
Q Consensus 755 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 834 (1057)
..+.|++.++..+|++|...++||+|+||.||+|..++|+.||||++.........+|.+|++++++++|||+|+++|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 56789999999999999999999999999999999999999999988654432145699999999999999999999999
Q ss_pred ccCC-eeEEEEEEccCCChhHHHhcCCc-cCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEc
Q 001544 835 SNED-FKALILEYMRNGSLEKCLYSGNY-ILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSD 912 (1057)
Q Consensus 835 ~~~~-~~~lV~E~~~~gsL~~~l~~~~~-~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D 912 (1057)
.+.+ +.++|||||++|+|+++++.... +++|.+|++||.++|+||+|||+.+.++||||||||+|||+|+++++||+|
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD 220 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD 220 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence 9988 59999999999999999998776 899999999999999999999998888999999999999999999999999
Q ss_pred ccccccccCCCCccccccc-cccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCccc-ccccchhhhhhhccc
Q 001544 913 FGIAKLLIGEDQSMTQTQT-LATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIF-SGEMTLKHWVNDFLP 990 (1057)
Q Consensus 913 fg~a~~~~~~~~~~~~~~~-~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~-~~~~~~~~~~~~~~~ 990 (1057)
||+|+..... ....... .||.+|+|||+...+..+.|+|||||||+++|++||+.|.+... .++..+..|......
T Consensus 221 FGLa~~~~~~--~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~ 298 (361)
T KOG1187|consen 221 FGLAKLGPEG--DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLE 298 (361)
T ss_pred ccCcccCCcc--ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHH
Confidence 9999654221 1111122 79999999999999999999999999999999999999887644 344557888755543
Q ss_pred h-hHHHhhhcccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHHHhHH
Q 001544 991 I-SMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKIRD 1049 (1057)
Q Consensus 991 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~ 1049 (1057)
. ...+++|+.+.... ... ......+..++.+|++.+|++||+|.||++.|+.+..
T Consensus 299 ~~~~~eiiD~~l~~~~---~~~-~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 299 EGKLREIVDPRLKEGE---YPD-EKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS 354 (361)
T ss_pred CcchhheeCCCccCCC---CCh-HHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence 3 57777777654211 110 1345668999999999999999999999999976654
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=381.93 Aligned_cols=253 Identities=24% Similarity=0.326 Sum_probs=210.1
Q ss_pred CCCCceeccccCeEEEEEEec-CCcEEEEEEeeccc-hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCC-eeEEEEEEc
Q 001544 771 FSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQH-ERAFKSFDTECEVMKSIRHRNLTKIISSCSNED-FKALILEYM 847 (1057)
Q Consensus 771 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lV~E~~ 847 (1057)
.+..+.||+|..|+|||++.+ +++-+|+|++.... +...+++.+|++++++.+||+||+++|+|.... ..+++||||
T Consensus 81 le~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYM 160 (364)
T KOG0581|consen 81 LERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYM 160 (364)
T ss_pred hhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhc
Confidence 445688999999999999865 78999999995543 455688999999999999999999999999888 599999999
Q ss_pred cCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCccc
Q 001544 848 RNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMT 927 (1057)
Q Consensus 848 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 927 (1057)
++|+|++++...+ .+++....+|+.+|++||.|||+ +++||||||||+|||++..|++||||||.++.+.. ..
T Consensus 161 DgGSLd~~~k~~g-~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvn----S~ 233 (364)
T KOG0581|consen 161 DGGSLDDILKRVG-RIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVN----SI 233 (364)
T ss_pred CCCCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHHhhh----hh
Confidence 9999999887653 59999999999999999999994 49999999999999999999999999999987632 24
Q ss_pred cccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhcccccccch
Q 001544 928 QTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDK 1007 (1057)
Q Consensus 928 ~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1057)
....+||..|||||-+.+..|+.++||||||++++|+++|+.||....+. ...| .+.++..... +.+
T Consensus 234 a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~---~~~~---------~~Ll~~Iv~~-ppP 300 (364)
T KOG0581|consen 234 ANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPP---YLDI---------FELLCAIVDE-PPP 300 (364)
T ss_pred cccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCC---CCCH---------HHHHHHHhcC-CCC
Confidence 55678999999999999999999999999999999999999998764111 1111 1222221111 111
Q ss_pred hhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHH
Q 001544 1008 HFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRL 1044 (1057)
Q Consensus 1008 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 1044 (1057)
..+. ..+++++.+++..|+++||.+||++.|+++|=
T Consensus 301 ~lP~-~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hp 336 (364)
T KOG0581|consen 301 RLPE-GEFSPEFRSFVSCCLRKDPSERPSAKQLLQHP 336 (364)
T ss_pred CCCc-ccCCHHHHHHHHHHhcCCcccCCCHHHHhcCH
Confidence 1111 14889999999999999999999999999874
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-45 Score=400.13 Aligned_cols=257 Identities=30% Similarity=0.477 Sum_probs=213.9
Q ss_pred CCCceeccccCeEEEEEEecCCcEEEEEEeeccch--hHHHHHHHHHHHHHhcCCCCceeEeeeeccCC-eeEEEEEEcc
Q 001544 772 SENNLIGRGSFGSVYIARLQNGIEVAVKTFDLQHE--RAFKSFDTECEVMKSIRHRNLTKIISSCSNED-FKALILEYMR 848 (1057)
Q Consensus 772 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lV~E~~~ 848 (1057)
...+.+|+|+||+||+|.+.....||||++..... ...++|.+|+.+|++++|||||+++|+|.+.. ..++|||||+
T Consensus 44 ~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~ 123 (362)
T KOG0192|consen 44 PIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMP 123 (362)
T ss_pred hhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCC
Confidence 34456999999999999998444499999965432 22579999999999999999999999999887 7899999999
Q ss_pred CCChhHHHhc-CCccCCHHHHHHHHHHHHHHHHHHHhCCCCC-eEEccCCCCCeeeCCCC-cEEEEcccccccccCCCCc
Q 001544 849 NGSLEKCLYS-GNYILDIFQRLNIMIDVASALEYLHFGYSAP-VIHCDLKPSNVLLDDNM-VAHLSDFGIAKLLIGEDQS 925 (1057)
Q Consensus 849 ~gsL~~~l~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~-ivH~Dlkp~Nill~~~~-~~kl~Dfg~a~~~~~~~~~ 925 (1057)
+|+|.++++. ....+++..+++|+.|||+|+.||| +.+ ||||||||+|||++.++ ++||+|||+++......
T Consensus 124 ~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH---~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-- 198 (362)
T KOG0192|consen 124 GGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLH---SEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-- 198 (362)
T ss_pred CCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh---cCCCeeecccChhhEEEcCCCCEEEECCCccceeecccc--
Confidence 9999999988 3677999999999999999999999 777 99999999999999998 99999999998753211
Q ss_pred cccccccccccccCccccC--CCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhccccc
Q 001544 926 MTQTQTLATLGYMAPEYGR--EGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLI 1003 (1057)
Q Consensus 926 ~~~~~~~~t~~y~aPE~~~--~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1003 (1057)
...+...||+.|||||++. ...++.|+||||||+++|||+||+.||........ . ..+.
T Consensus 199 ~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~--~-----------~~v~------ 259 (362)
T KOG0192|consen 199 TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQV--A-----------SAVV------ 259 (362)
T ss_pred ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHH--H-----------HHHH------
Confidence 3444478999999999999 56899999999999999999999999987433111 0 0111
Q ss_pred ccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHHHhHHHHh
Q 001544 1004 TEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKIRDFLL 1052 (1057)
Q Consensus 1004 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~~ 1052 (1057)
....+...+..+++.+..++.+||+.||++||++.|++..|+.+...+.
T Consensus 260 ~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~ 308 (362)
T KOG0192|consen 260 VGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHIS 308 (362)
T ss_pred hcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence 0111222234488899999999999999999999999999999987654
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-44 Score=394.78 Aligned_cols=248 Identities=24% Similarity=0.364 Sum_probs=214.4
Q ss_pred CCCCCCceeccccCeEEEEEEe-cCCcEEEEEEeecc---chhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEE
Q 001544 769 NGFSENNLIGRGSFGSVYIARL-QNGIEVAVKTFDLQ---HERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALIL 844 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 844 (1057)
.+|...+.||+|||+.||.++. .+|+.||+|++.+. .....+.+.+||++.++++|||||+++++|++.++.|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5688899999999999999987 88999999999643 4556788899999999999999999999999999999999
Q ss_pred EEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCC
Q 001544 845 EYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ 924 (1057)
Q Consensus 845 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 924 (1057)
|+|++++|.+++. .++++++.+++.+++||+.|+.||| +.+|+|||||..|+|++++.++||+|||+|..+...+
T Consensus 98 ELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH---~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~- 172 (592)
T KOG0575|consen 98 ELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLH---SLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG- 172 (592)
T ss_pred EecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHH---hcCceecccchhheeecCcCcEEecccceeeeecCcc-
Confidence 9999999999877 6678999999999999999999999 9999999999999999999999999999999885432
Q ss_pred ccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhcccccc
Q 001544 925 SMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLIT 1004 (1057)
Q Consensus 925 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1057)
......+||+.|+|||++....++..+||||+|||+|-|++|++||+... +.+.++....
T Consensus 173 -Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~-----------------vkety~~Ik~-- 232 (592)
T KOG0575|consen 173 -ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT-----------------VKETYNKIKL-- 232 (592)
T ss_pred -cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch-----------------HHHHHHHHHh--
Confidence 33445689999999999999999999999999999999999999997621 1111111111
Q ss_pred cchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 1005 EDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 1005 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
.....+...+.+..++|.++++++|.+|||+.+|+.|
T Consensus 233 --~~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 233 --NEYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred --cCcccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 1122234677889999999999999999999999986
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=394.39 Aligned_cols=254 Identities=31% Similarity=0.521 Sum_probs=218.2
Q ss_pred CCCCceeccccCeEEEEEEecCCcEEEEEEeeccchhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEEccCC
Q 001544 771 FSENNLIGRGSFGSVYIARLQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEYMRNG 850 (1057)
Q Consensus 771 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g 850 (1057)
++..+.||+|.||+||.|.++....||||.++.. ....++|.+|+++|++++|++||+++|+|..++..|||||||+.|
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~G 286 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKG 286 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccC
Confidence 3445789999999999999998889999999654 333478889999999999999999999999989999999999999
Q ss_pred ChhHHHhc-CCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCccccc
Q 001544 851 SLEKCLYS-GNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQT 929 (1057)
Q Consensus 851 sL~~~l~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 929 (1057)
+|.++++. .+..+...+.+.++.|||+|++||+ ++++|||||.++|||++++..+||+|||+|+.. .++.+....
T Consensus 287 sLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLe---s~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~-~d~~Y~~~~ 362 (468)
T KOG0197|consen 287 SLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLE---SKNYIHRDLAARNILVDEDLVVKISDFGLARLI-GDDEYTASE 362 (468)
T ss_pred cHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHH---hCCccchhhhhhheeeccCceEEEccccccccc-CCCceeecC
Confidence 99999987 5567999999999999999999999 999999999999999999999999999999943 344444444
Q ss_pred cccccccccCccccCCCCCCccchHHHHHHHHHHHhh-CCCCCCcccccccchhhhhhhccchhHHHhhhcccccccchh
Q 001544 930 QTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFT-RRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKH 1008 (1057)
Q Consensus 930 ~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1008 (1057)
...-...|.|||.+..++++.|||||||||++|||+| |+.||...... +.....+.+.+
T Consensus 363 ~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~--------------------ev~~~le~GyR 422 (468)
T KOG0197|consen 363 GGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNE--------------------EVLELLERGYR 422 (468)
T ss_pred CCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHH--------------------HHHHHHhccCc
Confidence 4455678999999999999999999999999999999 77776652211 11122345567
Q ss_pred hHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHHHhHH
Q 001544 1009 FAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKIRD 1049 (1057)
Q Consensus 1009 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~ 1049 (1057)
.+.++.||.++.++|..||+.+|++|||+..+...++++..
T Consensus 423 lp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 423 LPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred CCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence 77778899999999999999999999999999888888754
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-44 Score=374.37 Aligned_cols=253 Identities=24% Similarity=0.362 Sum_probs=206.2
Q ss_pred CCCCCCceeccccCeEEEEEE-ecCCcEEEEEEeeccch-------hHHHHHHHHHHHHHhcCCCCceeEeeeeccCCee
Q 001544 769 NGFSENNLIGRGSFGSVYIAR-LQNGIEVAVKTFDLQHE-------RAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFK 840 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 840 (1057)
+.|.+.+.+|+|+||.|-+|. .++|+.||||++++..- ......++|+++|++++|||||+++++|++.+..
T Consensus 172 d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~ 251 (475)
T KOG0615|consen 172 DYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSS 251 (475)
T ss_pred ceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCce
Confidence 356778999999999999996 45799999999965421 1123467999999999999999999999999999
Q ss_pred EEEEEEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCC---CcEEEEcccccc
Q 001544 841 ALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDN---MVAHLSDFGIAK 917 (1057)
Q Consensus 841 ~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~---~~~kl~Dfg~a~ 917 (1057)
|+||||++||+|.+.+-..+. +.+..-..+++|++.|+.||| +.||+||||||+|||+..+ ..+||+|||+|+
T Consensus 252 YmVlE~v~GGeLfd~vv~nk~-l~ed~~K~~f~Qll~avkYLH---~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK 327 (475)
T KOG0615|consen 252 YMVLEYVEGGELFDKVVANKY-LREDLGKLLFKQLLTAVKYLH---SQGIIHRDIKPENILLSNDAEDCLLKITDFGLAK 327 (475)
T ss_pred EEEEEEecCccHHHHHHhccc-cccchhHHHHHHHHHHHHHHH---HcCcccccCCcceEEeccCCcceEEEecccchhh
Confidence 999999999999998876553 777778899999999999999 9999999999999999765 889999999999
Q ss_pred cccCCCCccccccccccccccCccccCCCC---CCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHH
Q 001544 918 LLIGEDQSMTQTQTLATLGYMAPEYGREGR---VSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMM 994 (1057)
Q Consensus 918 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~---~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 994 (1057)
... ........+||+.|.|||++.... +..|+|+||+||++|-+++|.+||.+...... +.
T Consensus 328 ~~g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s-------------l~ 391 (475)
T KOG0615|consen 328 VSG---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS-------------LK 391 (475)
T ss_pred ccc---cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc-------------HH
Confidence 753 334455678999999999987654 33488999999999999999999987433221 11
Q ss_pred HhhhcccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHH
Q 001544 995 KIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRL 1044 (1057)
Q Consensus 995 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 1044 (1057)
+-+-... .....+.+..++.+..++|.+|+..||++|||+.|+++|=
T Consensus 392 eQI~~G~---y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hp 438 (475)
T KOG0615|consen 392 EQILKGR---YAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHP 438 (475)
T ss_pred HHHhcCc---ccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcCh
Confidence 1111111 1122345567888999999999999999999999999873
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-43 Score=365.79 Aligned_cols=199 Identities=30% Similarity=0.523 Sum_probs=180.6
Q ss_pred hCCCCCCceeccccCeEEEEEEec-CCcEEEEEEeecc--chhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEE
Q 001544 768 TNGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQ--HERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALIL 844 (1057)
Q Consensus 768 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 844 (1057)
..+|...+.||+|+||+||+|+.. ++..||||.+... ..+..+.+..|+++++.++|||||++++++..++..|+||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 457888888999999999999854 6899999999655 4566677899999999999999999999999999999999
Q ss_pred EEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCC------CcEEEEccccccc
Q 001544 845 EYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDN------MVAHLSDFGIAKL 918 (1057)
Q Consensus 845 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~------~~~kl~Dfg~a~~ 918 (1057)
|||+||+|.++++..+ .+++.+++.++.|+|.|+++|| +++||||||||.|||++.. -.+||+|||+|+.
T Consensus 89 EyC~gGDLs~yi~~~~-~l~e~t~r~Fm~QLA~alq~L~---~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~ 164 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRG-RLPEATARHFMQQLASALQFLH---ENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF 164 (429)
T ss_pred EeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence 9999999999998876 4999999999999999999999 9999999999999999864 4689999999998
Q ss_pred ccCCCCccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCc
Q 001544 919 LIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDE 973 (1057)
Q Consensus 919 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~ 973 (1057)
+. ........+|++-|||||++..++|+.|+|+||+|+++|||++|+.||+.
T Consensus 165 L~---~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a 216 (429)
T KOG0595|consen 165 LQ---PGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA 216 (429)
T ss_pred CC---chhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc
Confidence 74 33445567899999999999999999999999999999999999999985
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=356.06 Aligned_cols=255 Identities=25% Similarity=0.382 Sum_probs=206.4
Q ss_pred CCCCCCceeccccCeEEEEEE-ecCCcEEEEEEeecc--chhHHHHHHHHHHHHHhcCCCCceeEee-eeccCC-eeEEE
Q 001544 769 NGFSENNLIGRGSFGSVYIAR-LQNGIEVAVKTFDLQ--HERAFKSFDTECEVMKSIRHRNLTKIIS-SCSNED-FKALI 843 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~-~~~~~~-~~~lV 843 (1057)
.+|++.++||+|+||+|||+. ..+|..||.|.+.-. +.+..++...|+.++++++|||||++++ .+.++. ..++|
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 357788999999999999996 668999999988533 4566788999999999999999999998 455544 48999
Q ss_pred EEEccCCChhHHHhc---CCccCCHHHHHHHHHHHHHHHHHHHhCCCCC-eEEccCCCCCeeeCCCCcEEEEcccccccc
Q 001544 844 LEYMRNGSLEKCLYS---GNYILDIFQRLNIMIDVASALEYLHFGYSAP-VIHCDLKPSNVLLDDNMVAHLSDFGIAKLL 919 (1057)
Q Consensus 844 ~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~-ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~ 919 (1057)
|||+++|+|.+.++. .+..+++..+++++.|+++||.++|....++ |+||||||.||+++.+|.+|++|||+++.+
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 999999999988753 4467999999999999999999999432232 889999999999999999999999999987
Q ss_pred cCCCCccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhc
Q 001544 920 IGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDA 999 (1057)
Q Consensus 920 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 999 (1057)
.. ........+|||.||+||.+.+..|++|+||||+||++|||+.-++||.+. .+. +..+-+..
T Consensus 179 ~s--~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~-----n~~---------~L~~KI~q 242 (375)
T KOG0591|consen 179 SS--KTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD-----NLL---------SLCKKIEQ 242 (375)
T ss_pred cc--hhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc-----cHH---------HHHHHHHc
Confidence 43 334455678999999999999999999999999999999999999998762 111 11122211
Q ss_pred ccccccchhhHHH-HHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHH
Q 001544 1000 NLLITEDKHFAAK-EQCASSVFNLAMECTVESPDERITAKEIVRRLL 1045 (1057)
Q Consensus 1000 ~~~~~~~~~~~~~-~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 1045 (1057)
. ...+.+ +.++.++.+++..|+.+||+.||+...+++.++
T Consensus 243 g------d~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 243 G------DYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred C------CCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 1 111122 567889999999999999999998655555443
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-43 Score=350.83 Aligned_cols=267 Identities=22% Similarity=0.310 Sum_probs=209.2
Q ss_pred CCCCCCceeccccCeEEEEEEec-CCcEEEEEEeecc--chhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEE
Q 001544 769 NGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQ--HERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILE 845 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 845 (1057)
+.|+...++|+|+||+|||++.+ +|+.||||+|... ++...+-..+|++++++++|+|+|.++++|......++|||
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 46778899999999999999866 6999999999433 34456778899999999999999999999999999999999
Q ss_pred EccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCc
Q 001544 846 YMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS 925 (1057)
Q Consensus 846 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 925 (1057)
|++..-|++ +.....-.+...+.++++|+++|+.|+| +++++||||||+|||++.+|.+|+||||+|+.+.. ..
T Consensus 82 ~~dhTvL~e-Le~~p~G~~~~~vk~~l~Q~l~ai~~cH---k~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~--pg 155 (396)
T KOG0593|consen 82 YCDHTVLHE-LERYPNGVPSELVKKYLYQLLKAIHFCH---KNNCIHRDIKPENILITQNGVVKLCDFGFARTLSA--PG 155 (396)
T ss_pred ecchHHHHH-HHhccCCCCHHHHHHHHHHHHHHhhhhh---hcCeecccCChhheEEecCCcEEeccchhhHhhcC--Cc
Confidence 999855544 5555556899999999999999999999 99999999999999999999999999999998853 44
Q ss_pred cccccccccccccCccccCC-CCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhc---cchhHHHhhhcc-
Q 001544 926 MTQTQTLATLGYMAPEYGRE-GRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDF---LPISMMKIIDAN- 1000 (1057)
Q Consensus 926 ~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~- 1000 (1057)
..++.++.|.+|+|||.+.+ ..|+..+||||+||++.||++|.+-|.+. .+.+.-..+... .......++...
T Consensus 156 d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~--SDiDQLy~I~ktLG~L~prhq~iF~~N~ 233 (396)
T KOG0593|consen 156 DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGR--SDIDQLYLIRKTLGNLIPRHQSIFSSNP 233 (396)
T ss_pred chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCc--chHHHHHHHHHHHcccCHHHHHHhccCC
Confidence 56778889999999998877 67999999999999999999999877542 222211111111 111222222211
Q ss_pred -----cccccchhhH---HHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 1001 -----LLITEDKHFA---AKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 1001 -----~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
.........+ ..+..+..+.+++..|++.||++|++.+|++.|
T Consensus 234 ~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 234 FFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred ceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 1111111111 112345678999999999999999999999876
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-46 Score=385.95 Aligned_cols=493 Identities=29% Similarity=0.432 Sum_probs=341.7
Q ss_pred eeEEeeecccCcccccccccCCCCCcEEeCCCCCccccCCcccccccccceeecccccccCCCCccccccCCCCeEeccC
Q 001544 73 VTALNISYLSLTGNIPRQLGNLSSLEILDLNFNRLSGEIPWELGNLAKLEKLLLHNNFLTGTIPFSIFKLSSLLDLKLSD 152 (1057)
Q Consensus 73 v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~ 152 (1057)
...+.+++|.+. .+.+.+.+|..|.+|++++|+++ +.|++++.+..++.|+.++|+++ .+|.+++.+.+|++|++++
T Consensus 47 l~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~ 123 (565)
T KOG0472|consen 47 LQKLILSHNDLE-VLREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSS 123 (565)
T ss_pred hhhhhhccCchh-hccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhccc
Confidence 667788888887 66777888999999999999988 78889999999999999999998 8888999999999999999
Q ss_pred CCCCCCCCcccccCCCCCceeEccCCcccccCchhhhccccCCeeEeeccCCccccCccccCCCCcccEEEeeccccccC
Q 001544 153 NNLTGTIPSHNLGNLSSLQLLDLSDNQLSGSIPSFIFKISSLQALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGG 232 (1057)
Q Consensus 153 n~l~~~~p~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~l~~n~~~~~ 232 (1057)
|.+. .+|+ .++.+-.|..|+..+|+++ ..|..++.+.+|..|++.+|+++ +.|+..
T Consensus 124 n~~~-el~~-~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~-~l~~~~-------------------- 179 (565)
T KOG0472|consen 124 NELK-ELPD-SIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLK-ALPENH-------------------- 179 (565)
T ss_pred ccee-ecCc-hHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchh-hCCHHH--------------------
Confidence 9887 5554 3788888888888888887 67777777777777777777776 333321
Q ss_pred ccccccCCCCCcEEEccCCCCcCCccccccCcCCCcEEeeeccccccccCccccccccccEEEeecCccccccCcccccc
Q 001544 233 ISSTLSNCKHLRILDLSFNDLWGDIPKEIGNLTKLKELFLDFNILQGEIPHTVGNLHNLEYLSLVNNELVGTVPATIFNV 312 (1057)
Q Consensus 233 ~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 312 (1057)
-+++.|++||...|.++ .+|+.++.+.+|.-|||..|+|. ..| +|.++..|.+|.++.|+|.
T Consensus 180 -----i~m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~---------- 241 (565)
T KOG0472|consen 180 -----IAMKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIE---------- 241 (565)
T ss_pred -----HHHHHHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHH----------
Confidence 22666777777777664 56666666666666666666666 444 5555555665555555554
Q ss_pred ccccEEEecCCccccCCCCCcccCCCCCceEEecCccccccCCccccccccccccccccccccccccchhcccccccEEe
Q 001544 313 STLKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSGTLPSFIFNASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLR 392 (1057)
Q Consensus 313 ~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 392 (1057)
.+|......++++..|||.+|+++ +.|+.++-+.+|++||+|+|.|++. |..++++ .|+.|-
T Consensus 242 ---------------~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is~L-p~sLgnl-hL~~L~ 303 (565)
T KOG0472|consen 242 ---------------MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDISSL-PYSLGNL-HLKFLA 303 (565)
T ss_pred ---------------hhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCccccC-Ccccccc-eeeehh
Confidence 445555556777777777777777 7888888889999999999999875 6778888 899999
Q ss_pred ccCcccCCCccccccc--cCCCcchhhhhccCCCcccccccccccccccccEEEcCCCcccccccccccCccCCcEEEcc
Q 001544 393 LYNNYLTSPELSFLSS--LSNCKYLEIIALSGNPLNGIIPMSAGNLSHSLEELFMPDCNVSGRIPKEIGNLANLVTLDLG 470 (1057)
Q Consensus 393 L~~N~l~~~~~~~~~~--l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~Ls 470 (1057)
+.+|++.++....++. -.-+++|+. ....-.++.. .+- ..+.-............+.+.+.|+++
T Consensus 304 leGNPlrTiRr~ii~~gT~~vLKyLrs-~~~~dglS~s--e~~----------~e~~~t~~~~~~~~~~~~i~tkiL~~s 370 (565)
T KOG0472|consen 304 LEGNPLRTIRREIISKGTQEVLKYLRS-KIKDDGLSQS--EGG----------TETAMTLPSESFPDIYAIITTKILDVS 370 (565)
T ss_pred hcCCchHHHHHHHHcccHHHHHHHHHH-hhccCCCCCC--ccc----------ccccCCCCCCcccchhhhhhhhhhccc
Confidence 9999988765544431 112334432 0000011000 000 000000000011112233455566666
Q ss_pred CCcCCCCCCcccccccc---cceeecccccCcccCCcccccccccceEEecCeeeeecCCccccCcccccccccCCcccc
Q 001544 471 GNKFNGSIPIALGKLQK---LQLLNLDDNKLEGSIPDDICGLVELYKLALGDNKLSGQIPACFGNLASLRELWLGPNELI 547 (1057)
Q Consensus 471 ~N~i~~~~p~~~~~l~~---L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~ 547 (1057)
.-+++ .+|.....--+ .+..+++.|++. + +|..+..+..+...-+..|+..
T Consensus 371 ~~qlt-~VPdEVfea~~~~~Vt~VnfskNqL~-e------------------------lPk~L~~lkelvT~l~lsnn~i 424 (565)
T KOG0472|consen 371 DKQLT-LVPDEVFEAAKSEIVTSVNFSKNQLC-E------------------------LPKRLVELKELVTDLVLSNNKI 424 (565)
T ss_pred ccccc-cCCHHHHHHhhhcceEEEecccchHh-h------------------------hhhhhHHHHHHHHHHHhhcCcc
Confidence 66665 33433222112 445555555554 3 4444444444433333333344
Q ss_pred ccccccccccccccEEEeccccccCCCchhhccccccceeccccccccccccccccCccccceecccccccccccCcccc
Q 001544 548 SFIPSTFWNIKDIMYVNFSSNFLTGPLPLEIENLKALTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQGSIPDSVG 627 (1057)
Q Consensus 548 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 627 (1057)
++.|..+..+++|.+|+|++|.+. .+|.+++.+..|+.||+|.|+|. ..|+.+..+..|+.+-.++|++....|+.+.
T Consensus 425 sfv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~ 502 (565)
T KOG0472|consen 425 SFVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLK 502 (565)
T ss_pred ccchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccChHHhh
Confidence 455556666667777888777777 47888888889999999999997 7899988888899888888999977777799
Q ss_pred ccCccceecccCccccCCCcccccCcccccccccCCCcccCcCCC
Q 001544 628 DLISLKSLNLSNNNLSGPIPTSLEKLSDLKELNLSFNKLEGEIPR 672 (1057)
Q Consensus 628 ~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~ 672 (1057)
+|.+|.+|||.+|.+. .+|+.++++++|+.|+++||+|. .|+
T Consensus 503 nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr--~Pr 544 (565)
T KOG0472|consen 503 NMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR--QPR 544 (565)
T ss_pred hhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC--CCH
Confidence 9999999999999998 89999999999999999999998 554
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=391.61 Aligned_cols=259 Identities=30% Similarity=0.526 Sum_probs=222.5
Q ss_pred CCCCCCceeccccCeEEEEEEec------CCcEEEEEEeeccchh-HHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeE
Q 001544 769 NGFSENNLIGRGSFGSVYIARLQ------NGIEVAVKTFDLQHER-AFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKA 841 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 841 (1057)
.+....+.||+|+||+||+|+.. +.+.||||.++...+. ..++|++|+++++.++|||||+++|.|.+++..+
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~ 565 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC 565 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence 34455688999999999999743 3567999999876655 7899999999999999999999999999999999
Q ss_pred EEEEEccCCChhHHHhcCC-------------ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcE
Q 001544 842 LILEYMRNGSLEKCLYSGN-------------YILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVA 908 (1057)
Q Consensus 842 lV~E~~~~gsL~~~l~~~~-------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~ 908 (1057)
+|+|||..|||.+++.... .+++..+.+.||.|||.|++||- ++.+|||||..+|+||.++..|
T Consensus 566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs---~~~FVHRDLATRNCLVge~l~V 642 (774)
T KOG1026|consen 566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS---SHHFVHRDLATRNCLVGENLVV 642 (774)
T ss_pred EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCcccccchhhhhceeccceEE
Confidence 9999999999999986422 23888999999999999999999 9999999999999999999999
Q ss_pred EEEcccccccccCCCCccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhh-CCCCCCcccccccchhhhhhh
Q 001544 909 HLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFT-RRKPTDEIFSGEMTLKHWVND 987 (1057)
Q Consensus 909 kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~ 987 (1057)
||+|||+++.+...+.+.......-..+|||||.+..++++.+||||||||++||+++ |+.||.+....+
T Consensus 643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E--------- 713 (774)
T KOG1026|consen 643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE--------- 713 (774)
T ss_pred EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH---------
Confidence 9999999998877777766656677889999999999999999999999999999999 788876632221
Q ss_pred ccchhHHHhhhcccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHHHhHHH
Q 001544 988 FLPISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKIRDF 1050 (1057)
Q Consensus 988 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~ 1050 (1057)
+.+.+. .+..++.++.||.++++||..||+..|++||+++||-..|+...+.
T Consensus 714 -----VIe~i~------~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~ 765 (774)
T KOG1026|consen 714 -----VIECIR------AGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA 765 (774)
T ss_pred -----HHHHHH------cCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence 222221 1223556688999999999999999999999999999999887654
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-42 Score=372.69 Aligned_cols=262 Identities=26% Similarity=0.411 Sum_probs=213.9
Q ss_pred hCCCCCCceeccccCeEEEEEEecCCcEEEEEEeeccc--hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEE
Q 001544 768 TNGFSENNLIGRGSFGSVYIARLQNGIEVAVKTFDLQH--ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILE 845 (1057)
Q Consensus 768 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 845 (1057)
.+.+.+.+.||+|.||+||+|++. -.||||+++... +...+.|+.|+.++++-||.||+=+.|||..+.. .||+.
T Consensus 391 ~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTq 467 (678)
T KOG0193|consen 391 PEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQ 467 (678)
T ss_pred HHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeeh
Confidence 344567789999999999999987 369999997553 4578899999999999999999999999998888 99999
Q ss_pred EccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCc
Q 001544 846 YMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS 925 (1057)
Q Consensus 846 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 925 (1057)
+|+|.+|+.++|-.+..++..+.+.||+|||+|+.||| .++|||||+|..|||+.+++.|||+|||++..-......
T Consensus 468 wCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLH---AK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~ 544 (678)
T KOG0193|consen 468 WCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLH---AKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGE 544 (678)
T ss_pred hccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhh---hhhhhhhhccccceEEccCCcEEEecccceeeeeeeccc
Confidence 99999999999998888999999999999999999999 999999999999999999999999999999754332223
Q ss_pred cccccccccccccCccccCCC---CCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhcccc
Q 001544 926 MTQTQTLATLGYMAPEYGREG---RVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLL 1002 (1057)
Q Consensus 926 ~~~~~~~~t~~y~aPE~~~~~---~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1002 (1057)
.......|...|||||+++.+ .|++.+||||||+|+|||++|..||.. ...+.. -|.- ... ..
T Consensus 545 ~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi-~~~dqI--ifmV--GrG--------~l- 610 (678)
T KOG0193|consen 545 QQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSI-QNRDQI--IFMV--GRG--------YL- 610 (678)
T ss_pred cccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCC-CChhhe--EEEe--ccc--------cc-
Confidence 334445677789999998754 589999999999999999999999873 111110 0100 000 00
Q ss_pred cccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHHHhHHHH
Q 001544 1003 ITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKIRDFL 1051 (1057)
Q Consensus 1003 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~ 1051 (1057)
..........|+.++++|+..||..++++||.+.+++..|+++..+.
T Consensus 611 --~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~ 657 (678)
T KOG0193|consen 611 --MPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSL 657 (678)
T ss_pred --CccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcc
Confidence 00111223467889999999999999999999999999998887643
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=351.47 Aligned_cols=250 Identities=28% Similarity=0.363 Sum_probs=205.8
Q ss_pred HhCCCCCCceeccccCeEEEEEEe-cCCcEEEEEEeeccc---hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEE
Q 001544 767 ATNGFSENNLIGRGSFGSVYIARL-QNGIEVAVKTFDLQH---ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKAL 842 (1057)
Q Consensus 767 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 842 (1057)
..++|++.++||+|+||+||+++. ++++.+|+|++++.. ....+...+|..++.+++||+||+++-.|++.+..|+
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence 356899999999999999999975 468999999996542 3456778899999999999999999999999999999
Q ss_pred EEEEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCC
Q 001544 843 ILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGE 922 (1057)
Q Consensus 843 V~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~ 922 (1057)
|+||+.||.|..++++.+. +++..+.-++.+|+.||.||| +++|||||+||+|||+|++|+++|+|||+++....
T Consensus 103 Vld~~~GGeLf~hL~~eg~-F~E~~arfYlaEi~lAL~~LH---~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~- 177 (357)
T KOG0598|consen 103 VLDYLNGGELFYHLQREGR-FSEDRARFYLAEIVLALGYLH---SKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK- 177 (357)
T ss_pred EEeccCCccHHHHHHhcCC-cchhHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHeeecCCCcEEEeccccchhccc-
Confidence 9999999999999987664 889999999999999999999 99999999999999999999999999999985422
Q ss_pred CCccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhcccc
Q 001544 923 DQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLL 1002 (1057)
Q Consensus 923 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1002 (1057)
........+||+.|||||++.+..++..+|.||+|+++|||++|.+||...... ++++....
T Consensus 178 -~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~-----------------~~~~~I~~ 239 (357)
T KOG0598|consen 178 -DGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVK-----------------KMYDKILK 239 (357)
T ss_pred -CCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHH-----------------HHHHHHhc
Confidence 222333468999999999999999999999999999999999999998762111 11111111
Q ss_pred cccchhhHHHHHHHHHHHHHHhHcccCCCCCCC----CHHHHHH
Q 001544 1003 ITEDKHFAAKEQCASSVFNLAMECTVESPDERI----TAKEIVR 1042 (1057)
Q Consensus 1003 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp----s~~evl~ 1042 (1057)
.. ....+...+.+..+++.+.+..||++|. .+.++.+
T Consensus 240 ~k---~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~ 280 (357)
T KOG0598|consen 240 GK---LPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKR 280 (357)
T ss_pred Cc---CCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhc
Confidence 00 0111123567889999999999999996 4555443
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=330.10 Aligned_cols=265 Identities=23% Similarity=0.355 Sum_probs=207.1
Q ss_pred CCCCCCceeccccCeEEEEEE-ecCCcEEEEEEeeccch--hHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEE
Q 001544 769 NGFSENNLIGRGSFGSVYIAR-LQNGIEVAVKTFDLQHE--RAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILE 845 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 845 (1057)
.+|...+++|+|.||.||+|+ .++|+.||||+++.... .......+|++.++.++|+||+.++++|...+...+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 367778999999999999997 45799999999975432 233566889999999999999999999999999999999
Q ss_pred EccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCc
Q 001544 846 YMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS 925 (1057)
Q Consensus 846 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 925 (1057)
||+. +|+..++.....++..++..++.++++|++||| .+.|+||||||.|+|++++|.+||+|||+|+.+......
T Consensus 82 fm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H---~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~ 157 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCH---SKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI 157 (318)
T ss_pred eccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHH---hhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence 9976 999999999989999999999999999999999 999999999999999999999999999999988554433
Q ss_pred cccccccccccccCccccCCC-CCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhh---cc---chh---HHH
Q 001544 926 MTQTQTLATLGYMAPEYGREG-RVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVND---FL---PIS---MMK 995 (1057)
Q Consensus 926 ~~~~~~~~t~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~---~~---~~~---~~~ 995 (1057)
.+..+.|.+|+|||.+.+. .|+..+|+||.||++.||+-|.+-|.+ +.++.+.... .. +.. +..
T Consensus 158 --~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG----~sDidQL~~If~~LGTP~~~~WP~~~~ 231 (318)
T KOG0659|consen 158 --QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPG----DSDIDQLSKIFRALGTPTPDQWPEMTS 231 (318)
T ss_pred --cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCC----CchHHHHHHHHHHcCCCCcccCccccc
Confidence 3333789999999988875 489999999999999999999875543 2222211100 00 000 111
Q ss_pred hhhccc--ccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 996 IIDANL--LITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 996 ~~~~~~--~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
.-|... ..........-..++.+..+++.+|+.++|.+|++++|+++|
T Consensus 232 lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 232 LPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred cccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 111000 000000001123456778999999999999999999999876
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=360.04 Aligned_cols=267 Identities=28% Similarity=0.355 Sum_probs=210.8
Q ss_pred CCCCCCceeccccCeEEEEEE-ecCCcEEEEEEeeccc--hhHHHHHHHHHHHHHhcCCCCceeEeeeeccC--CeeEEE
Q 001544 769 NGFSENNLIGRGSFGSVYIAR-LQNGIEVAVKTFDLQH--ERAFKSFDTECEVMKSIRHRNLTKIISSCSNE--DFKALI 843 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lV 843 (1057)
+.|+..++||+|.||.||+|+ ..+|+.||+|+++... +....-..+||.+|+++.||||+++.+...+. ...|+|
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 356667899999999999997 5689999999997654 44456678999999999999999999988765 789999
Q ss_pred EEEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCC
Q 001544 844 LEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGED 923 (1057)
Q Consensus 844 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~ 923 (1057)
||||+. +|.-++...+..+++.++..++.|++.||+|+| +++|+|||||.+|||+|.+|.+||+|||+|+++....
T Consensus 197 FeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~ 272 (560)
T KOG0600|consen 197 FEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCH---SRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSG 272 (560)
T ss_pred Eecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHh---hcCeeeccccccceEEcCCCCEEeccccceeeccCCC
Confidence 999988 999999888878999999999999999999999 9999999999999999999999999999999875433
Q ss_pred CccccccccccccccCccccCCC-CCCccchHHHHHHHHHHHhhCCCCCCcccccc-----------cchhhhhhhccch
Q 001544 924 QSMTQTQTLATLGYMAPEYGREG-RVSTKGDVYSFGILLMETFTRRKPTDEIFSGE-----------MTLKHWVNDFLPI 991 (1057)
Q Consensus 924 ~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~-----------~~~~~~~~~~~~~ 991 (1057)
....+..+.|.+|+|||++.+. .|+.++|+||.|||+.||++|++.|....+-+ .....|.....+
T Consensus 273 -~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP- 350 (560)
T KOG0600|consen 273 -SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLP- 350 (560)
T ss_pred -CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCC-
Confidence 3457778899999999988765 68999999999999999999999876522111 111123211111
Q ss_pred hHHHhhhcccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 992 SMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 992 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
....+.+....... -.+.....+....+|+..+|..||++|.||.+++++
T Consensus 351 -~~~~~kp~~~y~r~-l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 351 -HATIFKPQQPYKRR-LRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred -cccccCCCCcccch-HHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 00111111100000 111234567889999999999999999999999864
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=366.98 Aligned_cols=250 Identities=26% Similarity=0.401 Sum_probs=215.6
Q ss_pred CCCCCCceeccccCeEEEEEE-ecCCcEEEEEEeeccchhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEEc
Q 001544 769 NGFSENNLIGRGSFGSVYIAR-LQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEYM 847 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 847 (1057)
..|+...+||+|+.|.||.|. ..+++.||||++........+-+.+|+.+|+..+|+|||.+++.|..++..++|||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 357777899999999999996 5578999999998887777788999999999999999999999998899999999999
Q ss_pred cCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCccc
Q 001544 848 RNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMT 927 (1057)
Q Consensus 848 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 927 (1057)
+||+|.+.+.... +++.++..|++++++||+||| .++|+|||||.+|||++.+|.+||+|||++..+..... .
T Consensus 353 ~ggsLTDvVt~~~--~~E~qIA~Icre~l~aL~fLH---~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~--K 425 (550)
T KOG0578|consen 353 EGGSLTDVVTKTR--MTEGQIAAICREILQGLKFLH---ARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS--K 425 (550)
T ss_pred CCCchhhhhhccc--ccHHHHHHHHHHHHHHHHHHH---hcceeeeccccceeEeccCCcEEEeeeeeeeccccccC--c
Confidence 9999999887655 899999999999999999999 99999999999999999999999999999988754332 4
Q ss_pred cccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhcccccccch
Q 001544 928 QTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDK 1007 (1057)
Q Consensus 928 ~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1057)
....+||+.|||||+.....|++|+||||+|++++||+-|.+||-. +..-.+-| -+. .....
T Consensus 426 R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYln---E~PlrAly----------LIa-----~ng~P 487 (550)
T KOG0578|consen 426 RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLN---ENPLRALY----------LIA-----TNGTP 487 (550)
T ss_pred cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccC---CChHHHHH----------HHh-----hcCCC
Confidence 5567899999999999999999999999999999999999999743 11111111 111 11223
Q ss_pred hhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 1008 HFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 1008 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
....++.+++++.+|+.+||..||++|++|+|+++|
T Consensus 488 ~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 488 KLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred CcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 344556789999999999999999999999999987
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-42 Score=362.28 Aligned_cols=267 Identities=22% Similarity=0.326 Sum_probs=210.0
Q ss_pred hCCCCCCceeccccCeEEEEEE-ecCCcEEEEEEeeccchhH-HHHHHHHHHHHHhcC-CCCceeEeeeeccCC-eeEEE
Q 001544 768 TNGFSENNLIGRGSFGSVYIAR-LQNGIEVAVKTFDLQHERA-FKSFDTECEVMKSIR-HRNLTKIISSCSNED-FKALI 843 (1057)
Q Consensus 768 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~-~~~lV 843 (1057)
.++|...++||.|.||.||+|+ ..+|..||||+++..-..+ ...=.+|++.++++. ||||+++.+.+.+.+ ..|+|
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV 88 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV 88 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence 4578888999999999999997 4579999999986543322 223457999999998 999999999998888 99999
Q ss_pred EEEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCC
Q 001544 844 LEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGED 923 (1057)
Q Consensus 844 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~ 923 (1057)
||||+. +|.+.+..+++.+++.++..|+.||++||+|+| .+|+.|||+||+|||+.....+||+|||+||-+.
T Consensus 89 fE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiH---k~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~--- 161 (538)
T KOG0661|consen 89 FEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIH---KHGFFHRDLKPENILISGNDVIKIADFGLAREVR--- 161 (538)
T ss_pred HHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHH---hcCcccccCChhheEecccceeEecccccccccc---
Confidence 999977 999999998999999999999999999999999 9999999999999999999999999999999763
Q ss_pred CccccccccccccccCcccc-CCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccc-----------hhhhhhhccch
Q 001544 924 QSMTQTQTLATLGYMAPEYG-REGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMT-----------LKHWVNDFLPI 991 (1057)
Q Consensus 924 ~~~~~~~~~~t~~y~aPE~~-~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~-----------~~~~~~~~~~~ 991 (1057)
....++.++.|.+|+|||++ +.+.|+.+.|+||+|||++|+.+-++-|.+..+-+.- ...|... .
T Consensus 162 SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg---~ 238 (538)
T KOG0661|consen 162 SKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEG---Y 238 (538)
T ss_pred cCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhH---H
Confidence 45567888999999999975 5677899999999999999999999877653221111 1111110 0
Q ss_pred hHHHhhhcccccccchhh-HHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHH
Q 001544 992 SMMKIIDANLLITEDKHF-AAKEQCASSVFNLAMECTVESPDERITAKEIVRRL 1044 (1057)
Q Consensus 992 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 1044 (1057)
.....+.-......+... .....++.++.+++.+|+++||++||||.|+++|-
T Consensus 239 ~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p 292 (538)
T KOG0661|consen 239 NLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHP 292 (538)
T ss_pred HHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence 011111111111111111 11234678899999999999999999999999873
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-41 Score=356.20 Aligned_cols=258 Identities=29% Similarity=0.458 Sum_probs=207.4
Q ss_pred CCCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccchhHHHHHHHHHHHHHhcCCCCceeEeeeeccCC--eeEEEEE
Q 001544 769 NGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCSNED--FKALILE 845 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lV~E 845 (1057)
.+|...+.||+|+||+||++... +|+..|||.+........+.+++|++++++++|||||+++|.....+ ..++.||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 35667799999999999999865 49999999987654333677899999999999999999999854444 6899999
Q ss_pred EccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCC-CCcEEEEcccccccccC-CC
Q 001544 846 YMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDD-NMVAHLSDFGIAKLLIG-ED 923 (1057)
Q Consensus 846 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~-~~~~kl~Dfg~a~~~~~-~~ 923 (1057)
|+++|+|.+++...+..+++..+..+++||++||+||| +++||||||||+|||++. ++.+||+|||+++.... ..
T Consensus 97 y~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylH---s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~ 173 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLH---SKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGT 173 (313)
T ss_pred ccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCcccceEEEeCCCCeEEeccCccccccccccc
Confidence 99999999999876656999999999999999999999 999999999999999999 79999999999987643 11
Q ss_pred CccccccccccccccCccccCCC-CCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhcccc
Q 001544 924 QSMTQTQTLATLGYMAPEYGREG-RVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLL 1002 (1057)
Q Consensus 924 ~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1002 (1057)
.........||+.|||||++..+ ...+++||||+||++.||+||++||..... ...+ ...+....
T Consensus 174 ~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~----~~~~--------~~~ig~~~-- 239 (313)
T KOG0198|consen 174 KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFE----EAEA--------LLLIGRED-- 239 (313)
T ss_pred cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcc----hHHH--------HHHHhccC--
Confidence 22334456799999999999854 344699999999999999999999876300 0000 00110000
Q ss_pred cccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHHHh
Q 001544 1003 ITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKI 1047 (1057)
Q Consensus 1003 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i 1047 (1057)
.....+..++.+..+++.+|+..+|++||||.|+++|..-.
T Consensus 240 ----~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~ 280 (313)
T KOG0198|consen 240 ----SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLK 280 (313)
T ss_pred ----CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhh
Confidence 01122345778899999999999999999999999987543
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=358.42 Aligned_cols=254 Identities=27% Similarity=0.434 Sum_probs=211.8
Q ss_pred HHhCCCCCCceeccccCeEEEEEEe-cCCcEEEEEEeeccc---hhHHHHHHHHHHHHHhc-CCCCceeEeeeeccCCee
Q 001544 766 QATNGFSENNLIGRGSFGSVYIARL-QNGIEVAVKTFDLQH---ERAFKSFDTECEVMKSI-RHRNLTKIISSCSNEDFK 840 (1057)
Q Consensus 766 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 840 (1057)
...++|...+.||+|+|++||+|+. .+++.||||++.+.. +...+-+.+|-++|.++ .||.|++++..|.++...
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL 149 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL 149 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence 4567899999999999999999974 479999999986542 23335567788999999 899999999999999999
Q ss_pred EEEEEEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEccccccccc
Q 001544 841 ALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLI 920 (1057)
Q Consensus 841 ~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~ 920 (1057)
|+|+||+++|+|.+++++.+ .+++...+-++.+|+.||+||| ++|||||||||+|||+|+||++||+|||.|+.+.
T Consensus 150 YFvLe~A~nGdll~~i~K~G-sfde~caR~YAAeIldAleylH---~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~ 225 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIKKYG-SFDETCARFYAAEILDALEYLH---SNGIIHRDLKPENILLDKDGHIKITDFGSAKILS 225 (604)
T ss_pred EEEEEecCCCcHHHHHHHhC-cchHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeEcCCCcEEEeeccccccCC
Confidence 99999999999999998876 4999999999999999999999 9999999999999999999999999999999875
Q ss_pred CCCCc---------cc--cccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhcc
Q 001544 921 GEDQS---------MT--QTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFL 989 (1057)
Q Consensus 921 ~~~~~---------~~--~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 989 (1057)
+.... .. ....+||..|.+||++..+..++.+|+|+|||++|+|+.|++||.+..+ |.
T Consensus 226 ~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne-------yl---- 294 (604)
T KOG0592|consen 226 PSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE-------YL---- 294 (604)
T ss_pred hhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH-------HH----
Confidence 43211 11 1346899999999999999999999999999999999999999976211 10
Q ss_pred chhHHHhhhcccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHH
Q 001544 990 PISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRL 1044 (1057)
Q Consensus 990 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 1044 (1057)
-..++++.. +..++..++.+.+|+.+.+..||.+|+|..++.+|-
T Consensus 295 --iFqkI~~l~--------y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp 339 (604)
T KOG0592|consen 295 --IFQKIQALD--------YEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHP 339 (604)
T ss_pred --HHHHHHHhc--------ccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCc
Confidence 012222221 222345567889999999999999999999988874
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=376.10 Aligned_cols=271 Identities=25% Similarity=0.452 Sum_probs=226.5
Q ss_pred cccCCHHHHHHHhCC---------CCCCceeccccCeEEEEEEec----CCcEEEEEEeeccc-hhHHHHHHHHHHHHHh
Q 001544 756 WRRFSYLELFQATNG---------FSENNLIGRGSFGSVYIARLQ----NGIEVAVKTFDLQH-ERAFKSFDTECEVMKS 821 (1057)
Q Consensus 756 ~~~~~~~~~~~~~~~---------~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~ 821 (1057)
.+.++|+|-.++... ..+.++||.|.||.||+|+++ ....||||.++... +++..+|..|+.+|.+
T Consensus 607 iDP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQ 686 (996)
T KOG0196|consen 607 IDPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQ 686 (996)
T ss_pred cCCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhccc
Confidence 445666665444443 346789999999999999876 24579999997653 5678899999999999
Q ss_pred cCCCCceeEeeeeccCCeeEEEEEEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCee
Q 001544 822 IRHRNLTKIISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVL 901 (1057)
Q Consensus 822 l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nil 901 (1057)
+.||||+++.|........+||+|||++|+|+.+++..+..+.+.+...+.++||.|+.||. +.++|||||.++|||
T Consensus 687 FdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLs---dm~YVHRDLAARNIL 763 (996)
T KOG0196|consen 687 FDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLS---DMNYVHRDLAARNIL 763 (996)
T ss_pred CCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHh---hcCchhhhhhhhhee
Confidence 99999999999999999999999999999999999999988999999999999999999999 999999999999999
Q ss_pred eCCCCcEEEEcccccccccCCCC-ccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhh-CCCCCCccccccc
Q 001544 902 LDDNMVAHLSDFGIAKLLIGEDQ-SMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFT-RRKPTDEIFSGEM 979 (1057)
Q Consensus 902 l~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~ 979 (1057)
++.+-.+|++|||+++.+..+.. ........-..+|.|||.+...+++.++|||||||+|||.++ |..||.+....
T Consensus 764 VNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQ-- 841 (996)
T KOG0196|consen 764 VNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ-- 841 (996)
T ss_pred eccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchH--
Confidence 99999999999999997643321 111122223568999999999999999999999999999887 88898763221
Q ss_pred chhhhhhhccchhHHHhhhcccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHHHhHH
Q 001544 980 TLKHWVNDFLPISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKIRD 1049 (1057)
Q Consensus 980 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~ 1049 (1057)
++.+ ..+.+.+.+.+.+||..+.+||..||++|-.+||++.+++.+|.++.+
T Consensus 842 ------------dVIk------aIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIr 893 (996)
T KOG0196|consen 842 ------------DVIK------AIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIR 893 (996)
T ss_pred ------------HHHH------HHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhc
Confidence 1112 223455667778999999999999999999999999999999987644
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=342.62 Aligned_cols=262 Identities=25% Similarity=0.367 Sum_probs=211.1
Q ss_pred hCCCCCCceeccccCeEEEEEE-ecCCcEEEEEEeeccc-hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEE
Q 001544 768 TNGFSENNLIGRGSFGSVYIAR-LQNGIEVAVKTFDLQH-ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILE 845 (1057)
Q Consensus 768 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 845 (1057)
.+.|+..++||.|..++||+|+ .+.++.||||++..+. ....+.+.+|+..|+.++||||++++..|..+...++||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 4578889999999999999997 5678999999997654 3346889999999999999999999999999999999999
Q ss_pred EccCCChhHHHhcCC-ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCC
Q 001544 846 YMRNGSLEKCLYSGN-YILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ 924 (1057)
Q Consensus 846 ~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 924 (1057)
||.+|++.+.+...- .-+++..+..|.+++++||.||| .+|.||||||+.|||++.+|.+||+|||.+..+...+.
T Consensus 105 fMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH---~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~ 181 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLH---QNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGD 181 (516)
T ss_pred hhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHH---hcCceecccccccEEEcCCCcEEEcCceeeeeecccCc
Confidence 999999999886532 34899999999999999999999 99999999999999999999999999999877654432
Q ss_pred cccc--ccccccccccCccccCC--CCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhcc
Q 001544 925 SMTQ--TQTLATLGYMAPEYGRE--GRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDAN 1000 (1057)
Q Consensus 925 ~~~~--~~~~~t~~y~aPE~~~~--~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1000 (1057)
.... ...+||+.|||||++.. ..|+.|+||||||++..|+.+|..||.....-++-+...-+.. |...
T Consensus 182 R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~p-p~~~------- 253 (516)
T KOG0582|consen 182 RQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDP-PTLL------- 253 (516)
T ss_pred eeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCC-CCcc-------
Confidence 2211 34579999999999543 3589999999999999999999999987443322211111110 0000
Q ss_pred cccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 1001 LLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 1001 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
............+..+.+++..|+..||++|||++++++|
T Consensus 254 ---t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 254 ---TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred ---cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 0111223334556689999999999999999999999876
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=356.52 Aligned_cols=242 Identities=26% Similarity=0.428 Sum_probs=206.6
Q ss_pred CceeccccCeEEEEEEecCCcEEEEEEeeccchhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEEccCCChh
Q 001544 774 NNLIGRGSFGSVYIARLQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEYMRNGSLE 853 (1057)
Q Consensus 774 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL~ 853 (1057)
.+-+|+|+.|.||.|+++ ++.||||+++.. -+.+|+-|++++||||+.+.|+|...-.+|||||||..|.|.
T Consensus 129 LeWlGSGaQGAVF~Grl~-netVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~ 200 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRLH-NETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLY 200 (904)
T ss_pred hhhhccCcccceeeeecc-CceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHH
Confidence 477999999999999998 688999987532 245788999999999999999999999999999999999999
Q ss_pred HHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCccccccccc
Q 001544 854 KCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLA 933 (1057)
Q Consensus 854 ~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~ 933 (1057)
..++.++. +.....+.|..+||.|+.||| .++|||||||.-||||..+..+||+|||-++..... .......|
T Consensus 201 ~VLka~~~-itp~llv~Wsk~IA~GM~YLH---~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STkMSFaG 273 (904)
T KOG4721|consen 201 EVLKAGRP-ITPSLLVDWSKGIAGGMNYLH---LHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK---STKMSFAG 273 (904)
T ss_pred HHHhccCc-cCHHHHHHHHHHhhhhhHHHH---HhhHhhhccCCCceEeeccceEEeccccchHhhhhh---hhhhhhhh
Confidence 99987764 777788999999999999999 999999999999999999999999999999865322 33445689
Q ss_pred cccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhcccccccchhhHHHH
Q 001544 934 TLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHFAAKE 1013 (1057)
Q Consensus 934 t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1013 (1057)
|..|||||+++....++|+||||||||+|||+||..||.+......-+. ........+.+.
T Consensus 274 TVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwG-------------------VGsNsL~LpvPs 334 (904)
T KOG4721|consen 274 TVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWG-------------------VGSNSLHLPVPS 334 (904)
T ss_pred hHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEe-------------------ccCCcccccCcc
Confidence 9999999999999999999999999999999999999877433221111 111122445667
Q ss_pred HHHHHHHHHHhHcccCCCCCCCCHHHHHHHHHHhHH
Q 001544 1014 QCASSVFNLAMECTVESPDERITAKEIVRRLLKIRD 1049 (1057)
Q Consensus 1014 ~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~ 1049 (1057)
.|+..|+-++++||+..|..||++++++.|++-...
T Consensus 335 tcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~p 370 (904)
T KOG4721|consen 335 TCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASP 370 (904)
T ss_pred cCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCH
Confidence 899999999999999999999999999999976543
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=362.92 Aligned_cols=365 Identities=24% Similarity=0.252 Sum_probs=239.1
Q ss_pred CCcEEEccCCCCcCCccccccCcCCCcEEeeeccccccccCccccccccccEEEeecCccccccCccccccccccEEEec
Q 001544 242 HLRILDLSFNDLWGDIPKEIGNLTKLKELFLDFNILQGEIPHTVGNLHNLEYLSLVNNELVGTVPATIFNVSTLKLIELS 321 (1057)
Q Consensus 242 ~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls 321 (1057)
.-+.||+|+|++...-+..|.++++|++++|.+|.++ .+|.......+|+.|+|.+|.|+..-...+..++.|+.||||
T Consensus 79 ~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLS 157 (873)
T KOG4194|consen 79 QTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLS 157 (873)
T ss_pred ceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhh
Confidence 4567999999998777888899999999999999998 788766666779999999999987777888888999999999
Q ss_pred CCccccCCCCCcccCCCCCceEEecCccccccCCccccccccccccccccccccccccchhcccccccEEeccCcccCCC
Q 001544 322 NNTFFGSLPSSTDVQLPNLEELYLWGNNFSGTLPSFIFNASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNYLTSP 401 (1057)
Q Consensus 322 ~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 401 (1057)
.|.++ .+|...|..-+++++|+|++|+|+..-...|..+.+|..|.|++|+++.+.+..|.++++|+.|+|..|+|...
T Consensus 158 rN~is-~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~iriv 236 (873)
T KOG4194|consen 158 RNLIS-EIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIV 236 (873)
T ss_pred hchhh-cccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeee
Confidence 99887 77777777778899999999999988888888888999999999999988888888899999999988888764
Q ss_pred ccccccccCCCcchhhhhccCCCcccccccccccccccccEEEcCCCcccccccccccCccCCcEEEccCCcCCCCCCcc
Q 001544 402 ELSFLSSLSNCKYLEIIALSGNPLNGIIPMSAGNLSHSLEELFMPDCNVSGRIPKEIGNLANLVTLDLGGNKFNGSIPIA 481 (1057)
Q Consensus 402 ~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~ 481 (1057)
+.. .+..+++|+.|.|..|.+. ..--..|..+.++++|+|+.|+++..-.+|
T Consensus 237 e~l---tFqgL~Sl~nlklqrN~I~-------------------------kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~ 288 (873)
T KOG4194|consen 237 EGL---TFQGLPSLQNLKLQRNDIS-------------------------KLDDGAFYGLEKMEHLNLETNRLQAVNEGW 288 (873)
T ss_pred hhh---hhcCchhhhhhhhhhcCcc-------------------------cccCcceeeecccceeecccchhhhhhccc
Confidence 332 2223333333333333332 222234455555555555555555544555
Q ss_pred cccccccceeecccccCcccCCcccccccccceEEecCeeeeecCCccccCcccccccccCCcccccccccccccccccc
Q 001544 482 LGKLQKLQLLNLDDNKLEGSIPDDICGLVELYKLALGDNKLSGQIPACFGNLASLRELWLGPNELISFIPSTFWNIKDIM 561 (1057)
Q Consensus 482 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 561 (1057)
+.+|+.|+.|+||+|.|..+.++...-.++|+.|+|++|+|+...+.+|..+..|++|.|++|++..+-...|.++.+|+
T Consensus 289 lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~ 368 (873)
T KOG4194|consen 289 LFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLH 368 (873)
T ss_pred ccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhh
Confidence 55555555555555555555555555555555555555555555555555555555555555555555555555555555
Q ss_pred EEEeccccccCCCch---hhccccccceeccccccccccccccccCccccceecccccccccccCccccccCccceecc
Q 001544 562 YVNFSSNFLTGPLPL---EIENLKALTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQGSIPDSVGDLISLKSLNL 637 (1057)
Q Consensus 562 ~L~Ls~N~l~~~~p~---~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 637 (1057)
.|||++|.++..+.+ .|.++++|+.|+|.+|+|..+...+|.++.+|+.|||.+|.|..+-|++|..+ .|+.|-+
T Consensus 369 ~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~ 446 (873)
T KOG4194|consen 369 KLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVM 446 (873)
T ss_pred hhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeecccccccc-hhhhhhh
Confidence 555555555433322 23444455555555555544444445555555555555555544444444444 4444443
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=349.52 Aligned_cols=248 Identities=28% Similarity=0.421 Sum_probs=211.2
Q ss_pred CCCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccc--hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEE
Q 001544 769 NGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQH--ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILE 845 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 845 (1057)
++|.+.+.||+|+||.||||+.+ +.+.||+|.+.+.. ++..+.+.+|++++++++||||+.++++|+...+.++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 46778889999999999999755 68999999996543 4557789999999999999999999999999999999999
Q ss_pred EccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCc
Q 001544 846 YMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS 925 (1057)
Q Consensus 846 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 925 (1057)
|+.| +|..++...+. +++.++..|+.+++.||.||| +.+|.|||+||.||+++..|.+|+||||+|+.+.. ..
T Consensus 82 ~a~g-~L~~il~~d~~-lpEe~v~~~a~~LVsaL~yLh---s~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~--~t 154 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDGK-LPEEQVRAIAYDLVSALYYLH---SNRILHRDMKPQNILLEKGGTLKLCDFGLARAMST--NT 154 (808)
T ss_pred hhhh-hHHHHHHhccC-CCHHHHHHHHHHHHHHHHHHH---hcCcccccCCcceeeecCCCceeechhhhhhhccc--Cc
Confidence 9987 99999987664 999999999999999999999 99999999999999999999999999999998733 34
Q ss_pred cccccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhccccccc
Q 001544 926 MTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITE 1005 (1057)
Q Consensus 926 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1057)
...+...||+-|||||+..++.|+..+|.||+||++||+++|++||... ++...+..... .
T Consensus 155 ~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~-----------------si~~Lv~~I~~--d 215 (808)
T KOG0597|consen 155 SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR-----------------SITQLVKSILK--D 215 (808)
T ss_pred eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH-----------------HHHHHHHHHhc--C
Confidence 5566778999999999999999999999999999999999999998541 11111111111 1
Q ss_pred chhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHH
Q 001544 1006 DKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRL 1044 (1057)
Q Consensus 1006 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 1044 (1057)
...+ +...+..+..++...+.+||.+|.+-.+++.|=
T Consensus 216 ~v~~--p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~Hp 252 (808)
T KOG0597|consen 216 PVKP--PSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHP 252 (808)
T ss_pred CCCC--cccccHHHHHHHHHHhhcChhhcccHHHHhcCh
Confidence 1111 125678899999999999999999999998874
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=358.86 Aligned_cols=395 Identities=26% Similarity=0.264 Sum_probs=313.2
Q ss_pred CcEEEccCCCCcCCccccccCc--CCCcEEeeeccccccccCccccccccccEEEeecCccccccCccccccccccEEEe
Q 001544 243 LRILDLSFNDLWGDIPKEIGNL--TKLKELFLDFNILQGEIPHTVGNLHNLEYLSLVNNELVGTVPATIFNVSTLKLIEL 320 (1057)
Q Consensus 243 L~~L~Ls~N~l~~~~p~~l~~l--~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 320 (1057)
-..||++.+.+...-...+.+. +.-+.|++++|++....+..|.++++|+++++..|.++ .+|........|+.|+|
T Consensus 54 ~~lldcs~~~lea~~~~~l~g~lp~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L 132 (873)
T KOG4194|consen 54 TRLLDCSDRELEAIDKSRLKGFLPSQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDL 132 (873)
T ss_pred ceeeecCccccccccccccCCcCccceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEee
Confidence 3467888888754322222222 34556889999988888888888899999999998887 77776666667888888
Q ss_pred cCCccccCCCCCcccCCCCCceEEecCccccccCCccccccccccccccccccccccccchhcccccccEEeccCcccCC
Q 001544 321 SNNTFFGSLPSSTDVQLPNLEELYLWGNNFSGTLPSFIFNASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNYLTS 400 (1057)
Q Consensus 321 s~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 400 (1057)
.+|.|+ ++.......++.|+.|||+.|.|+...-..|..-.++++|+|++|+|+.+..+.|..+.+|..|.|++|+|+.
T Consensus 133 ~~N~I~-sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNritt 211 (873)
T KOG4194|consen 133 RHNLIS-SVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITT 211 (873)
T ss_pred eccccc-cccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccc
Confidence 888886 5555555667888888888888885555556666778888888888888877888888888888888888888
Q ss_pred CccccccccCCCcchhhhhccCCCcccccccccccccccccEEEcCCCcccccccccccCccCCcEEEccCCcCCCCCCc
Q 001544 401 PELSFLSSLSNCKYLEIIALSGNPLNGIIPMSAGNLSHSLEELFMPDCNVSGRIPKEIGNLANLVTLDLGGNKFNGSIPI 480 (1057)
Q Consensus 401 ~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~ 480 (1057)
++... +.++++|+.|+|..|.+.- .---.|..+++|+.|.|..|.|.....+
T Consensus 212 Lp~r~---Fk~L~~L~~LdLnrN~iri-------------------------ve~ltFqgL~Sl~nlklqrN~I~kL~DG 263 (873)
T KOG4194|consen 212 LPQRS---FKRLPKLESLDLNRNRIRI-------------------------VEGLTFQGLPSLQNLKLQRNDISKLDDG 263 (873)
T ss_pred cCHHH---hhhcchhhhhhccccceee-------------------------ehhhhhcCchhhhhhhhhhcCcccccCc
Confidence 76543 3456667777777776641 1123577788888999999998877788
Q ss_pred ccccccccceeecccccCcccCCcccccccccceEEecCeeeeecCCccccCcccccccccCCccccccccccccccccc
Q 001544 481 ALGKLQKLQLLNLDDNKLEGSIPDDICGLVELYKLALGDNKLSGQIPACFGNLASLRELWLGPNELISFIPSTFWNIKDI 560 (1057)
Q Consensus 481 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 560 (1057)
.|..+.++++|+|+.|+++.+-.+++.+|+.|+.|+||+|.|..+-+++....++|++|+|+.|+|..+.++.|..+..|
T Consensus 264 ~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~L 343 (873)
T KOG4194|consen 264 AFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQL 343 (873)
T ss_pred ceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHh
Confidence 88889999999999999988888888899999999999999888888888888889999999999999988899999999
Q ss_pred cEEEeccccccCCCchhhccccccceeccccccccccccc---cccCccccceecccccccccccCccccccCccceecc
Q 001544 561 MYVNFSSNFLTGPLPLEIENLKALTTLDFSMNNLSGVIPT---TIGGLKGLQYLFLGHNRLQGSIPDSVGDLISLKSLNL 637 (1057)
Q Consensus 561 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~---~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 637 (1057)
+.|+|+.|.+..+-...|..+++|+.|||++|.|++.+.+ .|.+|++|+.|.|.+|+|..+...+|.++..|+.|||
T Consensus 344 e~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL 423 (873)
T KOG4194|consen 344 EELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDL 423 (873)
T ss_pred hhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecC
Confidence 9999999998887788888888999999999988876643 5778889999999999998666677888999999999
Q ss_pred cCccccCCCcccccCcccccccccCCCcccC
Q 001544 638 SNNNLSGPIPTSLEKLSDLKELNLSFNKLEG 668 (1057)
Q Consensus 638 s~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~ 668 (1057)
.+|.|....|+.|..+ .|+.|-+..-.+-+
T Consensus 424 ~~NaiaSIq~nAFe~m-~Lk~Lv~nSssflC 453 (873)
T KOG4194|consen 424 GDNAIASIQPNAFEPM-ELKELVMNSSSFLC 453 (873)
T ss_pred CCCcceeecccccccc-hhhhhhhcccceEE
Confidence 9999888888888888 88888776555544
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=385.09 Aligned_cols=262 Identities=28% Similarity=0.488 Sum_probs=222.4
Q ss_pred CCCCCceeccccCeEEEEEEecC--Cc----EEEEEEeecc-chhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEE
Q 001544 770 GFSENNLIGRGSFGSVYIARLQN--GI----EVAVKTFDLQ-HERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKAL 842 (1057)
Q Consensus 770 ~~~~~~~lg~G~~g~Vy~~~~~~--~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 842 (1057)
..+..+.||+|.||.||.|...+ |. .||||.++.. +.+...+|.+|..+|+.++|||||+++|.|-+....++
T Consensus 693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i 772 (1025)
T KOG1095|consen 693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLI 772 (1025)
T ss_pred heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEE
Confidence 34566889999999999998553 43 4899998654 45567899999999999999999999999999999999
Q ss_pred EEEEccCCChhHHHhcC------CccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEccccc
Q 001544 843 ILEYMRNGSLEKCLYSG------NYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIA 916 (1057)
Q Consensus 843 V~E~~~~gsL~~~l~~~------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a 916 (1057)
++|||++|+|..++++. ...++....+.++.|||+|+.||+ ++++|||||.++|+|+++...+||+|||+|
T Consensus 773 ~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe---~~~fvHRDLAaRNCLL~~~r~VKIaDFGlA 849 (1025)
T KOG1095|consen 773 LLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE---SKHFVHRDLAARNCLLDERRVVKIADFGLA 849 (1025)
T ss_pred EehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH---hCCCcCcchhhhheeecccCcEEEcccchh
Confidence 99999999999999987 567999999999999999999999 999999999999999999999999999999
Q ss_pred ccccCCCCccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhh-CCCCCCcccccccchhhhhhhccchhHHH
Q 001544 917 KLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFT-RRKPTDEIFSGEMTLKHWVNDFLPISMMK 995 (1057)
Q Consensus 917 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 995 (1057)
+.+...+.+.......-...|||||.+.++.++.|+|||||||++||++| |..||......+ +..
T Consensus 850 rDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~--------------v~~ 915 (1025)
T KOG1095|consen 850 RDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFE--------------VLL 915 (1025)
T ss_pred HhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHH--------------HHH
Confidence 97766665555555455679999999999999999999999999999999 778876522111 111
Q ss_pred hhhcccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHHHhHHHHhhh
Q 001544 996 IIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKIRDFLLRN 1054 (1057)
Q Consensus 996 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~~~~ 1054 (1057)
....+.+.+.+..|+..++++|.+||+.+|++||++..+++.+..+.......
T Consensus 916 ------~~~~ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~ 968 (1025)
T KOG1095|consen 916 ------DVLEGGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALGT 968 (1025)
T ss_pred ------HHHhCCccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhccC
Confidence 11122356667789999999999999999999999999999998887766544
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-39 Score=361.97 Aligned_cols=260 Identities=26% Similarity=0.419 Sum_probs=205.1
Q ss_pred hCCCCCCceeccccCeEEEEEEe------cCCcEEEEEEeeccc-hhHHHHHHHHHHHHHhc-CCCCceeEeeeeccC-C
Q 001544 768 TNGFSENNLIGRGSFGSVYIARL------QNGIEVAVKTFDLQH-ERAFKSFDTECEVMKSI-RHRNLTKIISSCSNE-D 838 (1057)
Q Consensus 768 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~ 838 (1057)
.++|++.++||+|+||.||+|.. .+++.||||+++... ....+.+.+|+++++++ +||||++++++|... +
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 45788999999999999999963 235789999986432 33456789999999999 899999999988654 4
Q ss_pred eeEEEEEEccCCChhHHHhcCC----------------------------------------------------------
Q 001544 839 FKALILEYMRNGSLEKCLYSGN---------------------------------------------------------- 860 (1057)
Q Consensus 839 ~~~lV~E~~~~gsL~~~l~~~~---------------------------------------------------------- 860 (1057)
..++||||+++|+|.+++....
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 6789999999999999886532
Q ss_pred ---ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCccccccccccccc
Q 001544 861 ---YILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGY 937 (1057)
Q Consensus 861 ---~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y 937 (1057)
.++++.++..++.||++||+||| +++|+||||||+||+++.++.+||+|||+++...............++..|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 24778888999999999999999 999999999999999999999999999999865332222222333456789
Q ss_pred cCccccCCCCCCccchHHHHHHHHHHHhh-CCCCCCcccccccchhhhhhhccchhHHHhhhcccccccchhhHHHHHHH
Q 001544 938 MAPEYGREGRVSTKGDVYSFGILLMETFT-RRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHFAAKEQCA 1016 (1057)
Q Consensus 938 ~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1016 (1057)
+|||++.+..++.++|||||||++|||++ |..||......+. .. ....+.. ....+..++
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~-~~-----------~~~~~~~-------~~~~~~~~~ 303 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE-FC-----------QRLKDGT-------RMRAPENAT 303 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH-HH-----------HHHhcCC-------CCCCCCCCC
Confidence 99999988899999999999999999997 9999865321110 00 0000000 011123456
Q ss_pred HHHHHHHhHcccCCCCCCCCHHHHHHHHHHhHH
Q 001544 1017 SSVFNLAMECTVESPDERITAKEIVRRLLKIRD 1049 (1057)
Q Consensus 1017 ~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~ 1049 (1057)
+++.+++.+||+.||++|||+.|+++.|+++.+
T Consensus 304 ~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 304 PEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 778999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-39 Score=356.39 Aligned_cols=250 Identities=25% Similarity=0.378 Sum_probs=207.3
Q ss_pred HhCCCCCCceeccccCeEEEEEEe-cCCcEEEEEEeecc----ch-hHHHHHHHHHHHHHhcC-CCCceeEeeeeccCCe
Q 001544 767 ATNGFSENNLIGRGSFGSVYIARL-QNGIEVAVKTFDLQ----HE-RAFKSFDTECEVMKSIR-HRNLTKIISSCSNEDF 839 (1057)
Q Consensus 767 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~ 839 (1057)
....|...+.||+|+||+|+.|.. .+++.||||+++.. .. ...+.+.+|+.++++++ ||||+++++++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 456889999999999999999964 47899999977543 11 23456778999999998 9999999999999999
Q ss_pred eEEEEEEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCC-CcEEEEccccccc
Q 001544 840 KALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDN-MVAHLSDFGIAKL 918 (1057)
Q Consensus 840 ~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~-~~~kl~Dfg~a~~ 918 (1057)
.|+||||+.||+|.+++.. ..++.+..+..+++|++.|++||| +++|+||||||+||+++.+ +.+||+|||++..
T Consensus 95 ~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H---~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~ 170 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCH---SRGIVHRDLKPENILLDGNEGNLKLSDFGLSAI 170 (370)
T ss_pred EEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEecCCCCCEEEeccccccc
Confidence 9999999999999999998 556888999999999999999999 9999999999999999999 9999999999987
Q ss_pred ccCCCCccccccccccccccCccccCCCC-C-CccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHh
Q 001544 919 LIGEDQSMTQTQTLATLGYMAPEYGREGR-V-STKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKI 996 (1057)
Q Consensus 919 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~-~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 996 (1057)
.. ..........||+.|+|||++.+.. | +.++||||+||++|-|++|+.||++..... +...
T Consensus 171 ~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~--------------l~~k 234 (370)
T KOG0583|consen 171 SP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPN--------------LYRK 234 (370)
T ss_pred cC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHH--------------HHHH
Confidence 63 2233445568999999999998866 6 489999999999999999999998721110 0111
Q ss_pred hhcccccccchhhHHHHHH-HHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 997 IDANLLITEDKHFAAKEQC-ASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 997 ~~~~~~~~~~~~~~~~~~~-~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
+.. ..+..+..+ ++++..++.+|+..+|.+|+++.|+++|
T Consensus 235 i~~-------~~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h 275 (370)
T KOG0583|consen 235 IRK-------GEFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEH 275 (370)
T ss_pred Hhc-------CCccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhC
Confidence 111 112222334 7788999999999999999999999854
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=355.27 Aligned_cols=248 Identities=25% Similarity=0.371 Sum_probs=210.9
Q ss_pred CCCCCCceeccccCeEEEEEE-ecCCcEEEEEEeeccc---hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEE
Q 001544 769 NGFSENNLIGRGSFGSVYIAR-LQNGIEVAVKTFDLQH---ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALIL 844 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 844 (1057)
.-|+..+.||.|+.|.|..|+ ..+|+.+|||++.+.. +.....+++|+-+|+-+.|||++++++.|++..+.|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 456778899999999999997 5689999999996542 234567899999999999999999999999999999999
Q ss_pred EEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCC
Q 001544 845 EYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ 924 (1057)
Q Consensus 845 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 924 (1057)
||+++|.|.+++-.++. +++.++.+++.||+.|+.|+| ..+|||||+||+|+|+|..+.+||+|||+|..-. .
T Consensus 92 Eyv~gGELFdylv~kG~-l~e~eaa~ff~QIi~gv~yCH---~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~---~ 164 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRKGP-LPEREAAHFFRQILDGVSYCH---AFNICHRDLKPENLLLDVKNNIKIADFGMASLEV---P 164 (786)
T ss_pred EecCCchhHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHh---hhcceeccCCchhhhhhcccCEeeeccceeeccc---C
Confidence 99999999999887664 889999999999999999999 9999999999999999999999999999998632 2
Q ss_pred ccccccccccccccCccccCCCCC-CccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhccccc
Q 001544 925 SMTQTQTLATLGYMAPEYGREGRV-STKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLI 1003 (1057)
Q Consensus 925 ~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1003 (1057)
.......+|.+.|.|||++.+..| +.++||||.|||+|.++||+.||++ ..+..... +
T Consensus 165 gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD-----dNir~LLl--------K-------- 223 (786)
T KOG0588|consen 165 GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD-----DNIRVLLL--------K-------- 223 (786)
T ss_pred CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC-----ccHHHHHH--------H--------
Confidence 334455689999999999999887 6899999999999999999999985 22221111 1
Q ss_pred ccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHH
Q 001544 1004 TEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRL 1044 (1057)
Q Consensus 1004 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 1044 (1057)
-....+..+..+++++.+|+.+|+..||++|.|++||++|-
T Consensus 224 V~~G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP 264 (786)
T KOG0588|consen 224 VQRGVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHP 264 (786)
T ss_pred HHcCcccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCc
Confidence 11223444467788999999999999999999999999985
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=316.00 Aligned_cols=249 Identities=27% Similarity=0.361 Sum_probs=211.2
Q ss_pred hCCCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccc---hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEE
Q 001544 768 TNGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQH---ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALI 843 (1057)
Q Consensus 768 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 843 (1057)
.++|++.+.||+|.||.||.|+.+ ++-.||+|++.++. ....+++.+|+++-+.++||||.+++++|.+....|++
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 357899999999999999999854 68899999985442 34457899999999999999999999999999999999
Q ss_pred EEEccCCChhHHHhcCC-ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCC
Q 001544 844 LEYMRNGSLEKCLYSGN-YILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGE 922 (1057)
Q Consensus 844 ~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~ 922 (1057)
+||..+|++...+..++ ..+++.....+..|+|.|+.|+| .++|+||||||+|+|++.++.+|++|||.+..-
T Consensus 101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~--- 174 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCH---LKRVIHRDIKPENLLLGSAGELKIADFGWSVHA--- 174 (281)
T ss_pred EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhc---cCCcccCCCCHHHhccCCCCCeeccCCCceeec---
Confidence 99999999999998655 45899999999999999999999 999999999999999999999999999999753
Q ss_pred CCccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhcccc
Q 001544 923 DQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLL 1002 (1057)
Q Consensus 923 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1002 (1057)
........+||.-|.|||...+..++..+|+|++|++.||++.|.+||+....+ ..+.. +...
T Consensus 175 -p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~-etYkr------------I~k~--- 237 (281)
T KOG0580|consen 175 -PSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHS-ETYKR------------IRKV--- 237 (281)
T ss_pred -CCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhH-HHHHH------------HHHc---
Confidence 133444568999999999999999999999999999999999999999863321 11111 1111
Q ss_pred cccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHH
Q 001544 1003 ITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRL 1044 (1057)
Q Consensus 1003 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 1044 (1057)
+...+..++.++.++|.+|+..+|.+|.+..|+++|-
T Consensus 238 -----~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hp 274 (281)
T KOG0580|consen 238 -----DLKFPSTISGGAADLISRLLVKNPIERLALTEVMDHP 274 (281)
T ss_pred -----cccCCcccChhHHHHHHHHhccCccccccHHHHhhhH
Confidence 1122245678899999999999999999999999874
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=332.54 Aligned_cols=272 Identities=25% Similarity=0.281 Sum_probs=210.1
Q ss_pred HHhCCCCCCceeccccCeEEEEEEec-CCcEEEEEEee--ccchhHHHHHHHHHHHHHhcCCCCceeEeeeecc-----C
Q 001544 766 QATNGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFD--LQHERAFKSFDTECEVMKSIRHRNLTKIISSCSN-----E 837 (1057)
Q Consensus 766 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~ 837 (1057)
.....|...+.||+|+||.|..|... +|+.||||++. .......++..+|+++++.++|+||+.+.+.+.. -
T Consensus 19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f 98 (359)
T KOG0660|consen 19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF 98 (359)
T ss_pred eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence 34556766799999999999999754 79999999986 4455667888999999999999999999998754 4
Q ss_pred CeeEEEEEEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccc
Q 001544 838 DFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK 917 (1057)
Q Consensus 838 ~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~ 917 (1057)
...|+|+|+|+ .+|.+.++.++ .++...+.-+++|+++||.|+| +.+|+|||+||+|++++.++.+||+|||+|+
T Consensus 99 ~DvYiV~elMe-tDL~~iik~~~-~L~d~H~q~f~YQiLrgLKyiH---SAnViHRDLKPsNll~n~~c~lKI~DFGLAR 173 (359)
T KOG0660|consen 99 NDVYLVFELME-TDLHQIIKSQQ-DLTDDHAQYFLYQILRGLKYIH---SANVIHRDLKPSNLLLNADCDLKICDFGLAR 173 (359)
T ss_pred ceeEEehhHHh-hHHHHHHHcCc-cccHHHHHHHHHHHHHhcchhh---cccccccccchhheeeccCCCEEecccccee
Confidence 57899999994 49999887765 4889999999999999999999 9999999999999999999999999999999
Q ss_pred cccCCCCccccccccccccccCcccc-CCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhh--hccchh--
Q 001544 918 LLIGEDQSMTQTQTLATLGYMAPEYG-REGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVN--DFLPIS-- 992 (1057)
Q Consensus 918 ~~~~~~~~~~~~~~~~t~~y~aPE~~-~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~--~~~~~~-- 992 (1057)
...........+.++.|.+|+|||++ ....|+.+.||||.||++.||++|++-|.+...-. .+..... ...++.
T Consensus 174 ~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~-Ql~lI~~~lGtP~~e~l 252 (359)
T KOG0660|consen 174 YLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVH-QLQLILELLGTPSEEDL 252 (359)
T ss_pred eccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHH-HHHHHHHhcCCCCHHHH
Confidence 87544334556788899999999975 45679999999999999999999998775421110 0000000 001111
Q ss_pred -------HHHhhhcccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 993 -------MMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 993 -------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
....+.......+.......+.+.+...+++.+|+..||.+|+|++|+++|
T Consensus 253 ~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 253 QKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 111111111111111112223567889999999999999999999999987
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=358.03 Aligned_cols=259 Identities=27% Similarity=0.420 Sum_probs=211.9
Q ss_pred hCCCCCCceeccccCeEEEEEEecC--C---cEEEEEEeecc---chhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCe
Q 001544 768 TNGFSENNLIGRGSFGSVYIARLQN--G---IEVAVKTFDLQ---HERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDF 839 (1057)
Q Consensus 768 ~~~~~~~~~lg~G~~g~Vy~~~~~~--~---~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 839 (1057)
.++....++||+|+||.||+|++.. + ..||||..+.. ......+|.+|+++|++++|||||+++|++..+..
T Consensus 156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~P 235 (474)
T KOG0194|consen 156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEP 235 (474)
T ss_pred ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc
Confidence 3445556899999999999997652 2 23899998753 35678899999999999999999999999999999
Q ss_pred eEEEEEEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccc
Q 001544 840 KALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL 919 (1057)
Q Consensus 840 ~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~ 919 (1057)
.|+|||+|.||+|++++.+.+..++..++..++.++|.||+||| +++++||||.++|+|++.++.+||+|||+++.-
T Consensus 236 l~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh---~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~ 312 (474)
T KOG0194|consen 236 LMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLH---SKNCIHRDIAARNCLYSKKGVVKISDFGLSRAG 312 (474)
T ss_pred cEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHH---HCCCcchhHhHHHheecCCCeEEeCccccccCC
Confidence 99999999999999999998878999999999999999999999 999999999999999999999999999998753
Q ss_pred cCCCCccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhh-CCCCCCcccccccchhhhhhhccchhHHHhhh
Q 001544 920 IGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFT-RRKPTDEIFSGEMTLKHWVNDFLPISMMKIID 998 (1057)
Q Consensus 920 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 998 (1057)
. ..........-...|+|||.+..+.+++++|||||||++||+++ |..||...... ....++ .
T Consensus 313 ~--~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~--~v~~kI------------~ 376 (474)
T KOG0194|consen 313 S--QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY--EVKAKI------------V 376 (474)
T ss_pred c--ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH--HHHHHH------------H
Confidence 1 11111112234578999999999999999999999999999999 78887652211 111111 0
Q ss_pred cccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHHHhHHH
Q 001544 999 ANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKIRDF 1050 (1057)
Q Consensus 999 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~ 1050 (1057)
....+.+.+...+.++..++.+||..+|++||+|.++.+.++.+.+.
T Consensus 377 -----~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~ 423 (474)
T KOG0194|consen 377 -----KNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKK 423 (474)
T ss_pred -----hcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhc
Confidence 11112222335677889999999999999999999999999998765
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=344.34 Aligned_cols=250 Identities=30% Similarity=0.435 Sum_probs=209.9
Q ss_pred hCCCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccc-hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEE
Q 001544 768 TNGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQH-ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILE 845 (1057)
Q Consensus 768 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 845 (1057)
...|+..+.||+|+||.||+|.+. +++.||+|++.... .....++++|+.++.+++++||.++++.+..+...+++||
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe 91 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME 91 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence 345777799999999999999754 78999999997654 3456889999999999999999999999999999999999
Q ss_pred EccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCc
Q 001544 846 YMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS 925 (1057)
Q Consensus 846 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 925 (1057)
|+.||++.+.+..+. .+++..+..|++++..|+.|+| ..+.+|||||+.||++..+|.+|++|||.+..+.....
T Consensus 92 y~~gGsv~~lL~~~~-~~~E~~i~~ilre~l~~l~ylH---~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~- 166 (467)
T KOG0201|consen 92 YCGGGSVLDLLKSGN-ILDEFEIAVILREVLKGLDYLH---SEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK- 166 (467)
T ss_pred HhcCcchhhhhccCC-CCccceeeeehHHHHHHhhhhh---hcceecccccccceeEeccCcEEEEecceeeeeechhh-
Confidence 999999999887665 3588888999999999999999 99999999999999999999999999999987743332
Q ss_pred cccccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhccccccc
Q 001544 926 MTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITE 1005 (1057)
Q Consensus 926 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1057)
.....+||+.|||||++....|+.|+||||+|++.+||++|.+|+.+..+...-+ .+ ..
T Consensus 167 -rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlf--------------lI------pk 225 (467)
T KOG0201|consen 167 -RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLF--------------LI------PK 225 (467)
T ss_pred -ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEE--------------ec------cC
Confidence 2256789999999999998899999999999999999999999987743311100 00 00
Q ss_pred chhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 1006 DKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 1006 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
.........+++.+++++..|+..+|+.||+|.++++|
T Consensus 226 ~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 226 SAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred CCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 00111112567889999999999999999999999886
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=324.09 Aligned_cols=267 Identities=24% Similarity=0.298 Sum_probs=205.6
Q ss_pred hCCCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccchhH--HHHHHHHHHHHHhcCCCCceeEeeeecc--CCeeEE
Q 001544 768 TNGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQHERA--FKSFDTECEVMKSIRHRNLTKIISSCSN--EDFKAL 842 (1057)
Q Consensus 768 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l 842 (1057)
.+.|+.++.|++|+||.||+|+++ +++.||+|+++...+.. --...+||.++.+.+|||||.+-+.... -+..|+
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 345778899999999999999865 68999999997654321 2345789999999999999999887754 467999
Q ss_pred EEEEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCC
Q 001544 843 ILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGE 922 (1057)
Q Consensus 843 V~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~ 922 (1057)
|||||+. +|...+..-+.++...++..++.|+++|++||| ...|+|||+|++|+|+...|.+||+|||+|+.+.
T Consensus 155 VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH---~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg-- 228 (419)
T KOG0663|consen 155 VMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLH---DNWILHRDLKTSNLLLSHKGILKIADFGLAREYG-- 228 (419)
T ss_pred eHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHh---hceeEecccchhheeeccCCcEEecccchhhhhc--
Confidence 9999988 999999888888999999999999999999999 9999999999999999999999999999999873
Q ss_pred CCccccccccccccccCccccCCC-CCCccchHHHHHHHHHHHhhCCCCCCcccccccchh-------------hhhhhc
Q 001544 923 DQSMTQTQTLATLGYMAPEYGREG-RVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLK-------------HWVNDF 988 (1057)
Q Consensus 923 ~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~-------------~~~~~~ 988 (1057)
......+..+.|.+|+|||.+.+. .|+.+.|+||+|||+.||+++++-|.+.. +.+.. .|-...
T Consensus 229 sp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~s--E~dQl~~If~llGtPte~iwpg~~ 306 (419)
T KOG0663|consen 229 SPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKS--EIDQLDKIFKLLGTPSEAIWPGYS 306 (419)
T ss_pred CCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCc--hHHHHHHHHHHhCCCccccCCCcc
Confidence 334567778899999999987765 58999999999999999999998776521 11111 111110
Q ss_pred cchhHHHh-hhcccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 989 LPISMMKI-IDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 989 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
....+... +.......-...+... ..+..-++++..++.+||.+|.||.|.++|
T Consensus 307 ~lp~~k~~~f~~~pyn~lr~kF~~~-~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 307 ELPAVKKMTFSEHPYNNLRKKFGAL-SLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred ccchhhccccCCCCchhhhhhcccc-ccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 00000000 0000000011111111 145778899999999999999999999876
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=344.88 Aligned_cols=247 Identities=23% Similarity=0.316 Sum_probs=200.8
Q ss_pred CceeccccCeEEEEEEecCCcEEEEEEeeccch---hHHHHHHHHHHHHHhcCCCCceeEeeeecc----CCeeEEEEEE
Q 001544 774 NNLIGRGSFGSVYIARLQNGIEVAVKTFDLQHE---RAFKSFDTECEVMKSIRHRNLTKIISSCSN----EDFKALILEY 846 (1057)
Q Consensus 774 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lV~E~ 846 (1057)
...||+|++|.||+|.. +|+.||||+++.... ...+.+.+|++++++++||||++++|++.+ ....++||||
T Consensus 25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 36899999999999998 489999999965432 235778899999999999999999999866 3467899999
Q ss_pred ccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCC-CCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCc
Q 001544 847 MRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYS-APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS 925 (1057)
Q Consensus 847 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~-~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 925 (1057)
+++|+|.+++...+ .+++.++.+++.|++.|++||| + .+++||||||+||++++++.+||+|||+++.+...
T Consensus 104 ~~~g~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lH---~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~--- 176 (283)
T PHA02988 104 CTRGYLREVLDKEK-DLSFKTKLDMAIDCCKGLYNLY---KYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP--- 176 (283)
T ss_pred CCCCcHHHHHhhCC-CCChhHHHHHHHHHHHHHHHHH---hcCCCCCCcCChhhEEECCCCcEEEcccchHhhhccc---
Confidence 99999999997654 5889999999999999999999 6 48889999999999999999999999999865321
Q ss_pred cccccccccccccCccccCC--CCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhccccc
Q 001544 926 MTQTQTLATLGYMAPEYGRE--GRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLI 1003 (1057)
Q Consensus 926 ~~~~~~~~t~~y~aPE~~~~--~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1003 (1057)
.....++..|+|||++.+ ..++.++|||||||++|||++|+.||...... ++.. .+...
T Consensus 177 --~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~-----~~~~--------~i~~~---- 237 (283)
T PHA02988 177 --PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK-----EIYD--------LIINK---- 237 (283)
T ss_pred --cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH-----HHHH--------HHHhc----
Confidence 123457889999999876 67899999999999999999999999753211 1000 01000
Q ss_pred ccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHHHhHH
Q 001544 1004 TEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKIRD 1049 (1057)
Q Consensus 1004 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~ 1049 (1057)
..+...+..+++++.+++.+||+.||++|||+.|+++.|+.++.
T Consensus 238 --~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 238 --NNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred --CCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 00111122467789999999999999999999999999998764
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=330.92 Aligned_cols=275 Identities=25% Similarity=0.306 Sum_probs=204.9
Q ss_pred CCCCCceeccccCeEEEEEEecCCcEEEEEEeeccchhHHHHHHHHHHHHHh--cCCCCceeEeeeeccCC----eeEEE
Q 001544 770 GFSENNLIGRGSFGSVYIARLQNGIEVAVKTFDLQHERAFKSFDTECEVMKS--IRHRNLTKIISSCSNED----FKALI 843 (1057)
Q Consensus 770 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~----~~~lV 843 (1057)
..+..++||+|.||.||||.++ ++.||||++... ..+.|++|-++++- ++|+||++++++-.... .+.+|
T Consensus 211 pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLV 286 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLV 286 (534)
T ss_pred chhhHHHhhcCccceeehhhcc-CceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEE
Confidence 4455688999999999999988 599999999643 34667777777764 58999999999876555 78999
Q ss_pred EEEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhC------CCCCeEEccCCCCCeeeCCCCcEEEEcccccc
Q 001544 844 LEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFG------YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK 917 (1057)
Q Consensus 844 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~------~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~ 917 (1057)
+||.+.|+|.+++... .++|....+|+..+++||+|||++ .+++|+|||||++|||+..|+++.|+|||+|.
T Consensus 287 t~fh~kGsL~dyL~~n--tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl 364 (534)
T KOG3653|consen 287 TEFHPKGSLCDYLKAN--TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLAL 364 (534)
T ss_pred eeeccCCcHHHHHHhc--cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeE
Confidence 9999999999999865 499999999999999999999953 35789999999999999999999999999999
Q ss_pred cccCCCCccccccccccccccCccccCCCCC------CccchHHHHHHHHHHHhhCCCCCCcccccc--cchhhhhhhcc
Q 001544 918 LLIGEDQSMTQTQTLATLGYMAPEYGREGRV------STKGDVYSFGILLMETFTRRKPTDEIFSGE--MTLKHWVNDFL 989 (1057)
Q Consensus 918 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~------~~~~Dv~s~G~il~elltg~~p~~~~~~~~--~~~~~~~~~~~ 989 (1057)
++.+..........+||.+|||||++.+..- -.+.||||+|.|+|||+++..-+.....++ ..++.=+....
T Consensus 365 ~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hP 444 (534)
T KOG3653|consen 365 RLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHP 444 (534)
T ss_pred EecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCC
Confidence 9876665555566899999999999876432 236899999999999999865442111111 11111111111
Q ss_pred c-hhHHHhhhcccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHHHhHHH
Q 001544 990 P-ISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKIRDF 1050 (1057)
Q Consensus 990 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~ 1050 (1057)
. +++.+.+-.......-...-....-...+.+.+..||..||+.|.|+.=|-+.+.++...
T Consensus 445 t~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~ 506 (534)
T KOG3653|consen 445 TLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMML 506 (534)
T ss_pred CHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhcc
Confidence 1 112222221111111111111123456789999999999999999999999999888654
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=341.83 Aligned_cols=255 Identities=24% Similarity=0.362 Sum_probs=205.6
Q ss_pred HhCCCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccc---hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEE
Q 001544 767 ATNGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQH---ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKAL 842 (1057)
Q Consensus 767 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 842 (1057)
..++|+.+.+||+|+||.||.|+.+ +|..+|+|++++.. ..+.+.+..|-.+|....+|.||+++-.|.+.+..||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 4578999999999999999999754 69999999997653 3456778889999999999999999999999999999
Q ss_pred EEEEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCC
Q 001544 843 ILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGE 922 (1057)
Q Consensus 843 V~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~ 922 (1057)
||||++||++..+|...+ .+++..+..++.+.+-|++.+| +.|+|||||||+|+|||..|++|++|||++.-+...
T Consensus 219 iMEylPGGD~mTLL~~~~-~L~e~~arfYiaE~vlAI~~iH---~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~ 294 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRKD-TLTEDWARFYIAETVLAIESIH---QLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKK 294 (550)
T ss_pred EEEecCCccHHHHHHhcC-cCchHHHHHHHHHHHHHHHHHH---HcCcccccCChhheeecCCCCEeeccccccchhhhh
Confidence 999999999999998766 5899999999999999999999 999999999999999999999999999998533110
Q ss_pred ----------------------CCc----cccc-------------------cccccccccCccccCCCCCCccchHHHH
Q 001544 923 ----------------------DQS----MTQT-------------------QTLATLGYMAPEYGREGRVSTKGDVYSF 957 (1057)
Q Consensus 923 ----------------------~~~----~~~~-------------------~~~~t~~y~aPE~~~~~~~~~~~Dv~s~ 957 (1057)
+.. ...+ ..+|||-|||||++.+..|+..+|.||+
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSL 374 (550)
T KOG0605|consen 295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSL 374 (550)
T ss_pred hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHH
Confidence 000 0000 2369999999999999999999999999
Q ss_pred HHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhcccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCC-
Q 001544 958 GILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERIT- 1036 (1057)
Q Consensus 958 G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps- 1036 (1057)
|||+|||+.|.+||...... +.|. +++.-. ..-.++....++.+..++|.+|+. ||++|..
T Consensus 375 G~ImyEmLvGyPPF~s~tp~----~T~r---------kI~nwr----~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~ 436 (550)
T KOG0605|consen 375 GCIMYEMLVGYPPFCSETPQ----ETYR---------KIVNWR----ETLKFPEEVDLSDEAKDLITRLLC-DPENRLGS 436 (550)
T ss_pred HHHHHHHHhCCCCCCCCCHH----HHHH---------HHHHHh----hhccCCCcCcccHHHHHHHHHHhc-CHHHhcCc
Confidence 99999999999998762221 1111 111111 011222234556889999999999 9999985
Q ss_pred --HHHHHHH
Q 001544 1037 --AKEIVRR 1043 (1057)
Q Consensus 1037 --~~evl~~ 1043 (1057)
+.||.+|
T Consensus 437 ~G~~EIK~H 445 (550)
T KOG0605|consen 437 KGAEEIKKH 445 (550)
T ss_pred ccHHHHhcC
Confidence 6666554
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=356.30 Aligned_cols=481 Identities=28% Similarity=0.371 Sum_probs=345.9
Q ss_pred ceeEEeeecccCcccccccccCCCCCcEEeCCCCCccccCCcccccccccceeecccccccCCCCccccccCCCCeEecc
Q 001544 72 RVTALNISYLSLTGNIPRQLGNLSSLEILDLNFNRLSGEIPWELGNLAKLEKLLLHNNFLTGTIPFSIFKLSSLLDLKLS 151 (1057)
Q Consensus 72 ~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls 151 (1057)
-.+.+++.++.++ ++|++++.+..++.|+.++|+++ ++|+.++++.+|.+|+.++|.+. .+|++++.+..|..|+..
T Consensus 69 ~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~n~~~-el~~~i~~~~~l~dl~~~ 145 (565)
T KOG0472|consen 69 CLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSSNELK-ELPDSIGRLLDLEDLDAT 145 (565)
T ss_pred ceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhcccccee-ecCchHHHHhhhhhhhcc
Confidence 3788899999998 89999999999999999999998 99999999999999999999999 899999999999999999
Q ss_pred CCCCCCCCCcccccCCCCCceeEccCCcccccCchhhhccccCCeeEeeccCCccccCccccCCCCcccEEEeecccccc
Q 001544 152 DNNLTGTIPSHNLGNLSSLQLLDLSDNQLSGSIPSFIFKISSLQALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYG 231 (1057)
Q Consensus 152 ~n~l~~~~p~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~l~~n~~~~ 231 (1057)
+|+++ ..|. .+.++.+|..|++.+|++....|. .-.++.|++||...|-++ .+|..
T Consensus 146 ~N~i~-slp~-~~~~~~~l~~l~~~~n~l~~l~~~-~i~m~~L~~ld~~~N~L~-tlP~~-------------------- 201 (565)
T KOG0472|consen 146 NNQIS-SLPE-DMVNLSKLSKLDLEGNKLKALPEN-HIAMKRLKHLDCNSNLLE-TLPPE-------------------- 201 (565)
T ss_pred ccccc-cCch-HHHHHHHHHHhhccccchhhCCHH-HHHHHHHHhcccchhhhh-cCChh--------------------
Confidence 99998 6665 489999999999999999955444 445999999999999886 56654
Q ss_pred CccccccCCCCCcEEEccCCCCcCCccccccCcCCCcEEeeeccccccccCcc-ccccccccEEEeecCccccccCcccc
Q 001544 232 GISSTLSNCKHLRILDLSFNDLWGDIPKEIGNLTKLKELFLDFNILQGEIPHT-VGNLHNLEYLSLVNNELVGTVPATIF 310 (1057)
Q Consensus 232 ~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~-~~~l~~L~~L~L~~N~l~~~~~~~~~ 310 (1057)
++.+.+|..|+|..|+|. .+| +|+++..|.+|++..|+|. .+|.. ..++++|..|||..|+++ ..|..+.
T Consensus 202 -----lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~c 272 (565)
T KOG0472|consen 202 -----LGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEIC 272 (565)
T ss_pred -----hcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCchHHH
Confidence 578899999999999996 566 8999999999999999999 56655 458999999999999998 7888888
Q ss_pred ccccccEEEecCCccccCCCCCcccCCCCCceEEecCccccccCCccccccc---cccccccccccccccccchhccccc
Q 001544 311 NVSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSGTLPSFIFNAS---NLSKLSLGDNSFSGLIPNTFGNLRN 387 (1057)
Q Consensus 311 ~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~---~L~~L~L~~N~l~~~~~~~~~~l~~ 387 (1057)
-+.+|+.||+|+|.++ .+|.... ++ .|+.|-+.+|.+.. +-..+-+.. -|++|.= .+...
T Consensus 273 lLrsL~rLDlSNN~is-~Lp~sLg-nl-hL~~L~leGNPlrT-iRr~ii~~gT~~vLKyLrs---~~~~d---------- 335 (565)
T KOG0472|consen 273 LLRSLERLDLSNNDIS-SLPYSLG-NL-HLKFLALEGNPLRT-IRREIISKGTQEVLKYLRS---KIKDD---------- 335 (565)
T ss_pred HhhhhhhhcccCCccc-cCCcccc-cc-eeeehhhcCCchHH-HHHHHHcccHHHHHHHHHH---hhccC----------
Confidence 8888888888888776 3443332 33 45555555555542 111111110 0111110 00000
Q ss_pred ccEEeccCc---ccCCC--ccccccccCCCcchhhhhccCCCcccccccccccccccccEEEcCCCcccccccccccCcc
Q 001544 388 LKRLRLYNN---YLTSP--ELSFLSSLSNCKYLEIIALSGNPLNGIIPMSAGNLSHSLEELFMPDCNVSGRIPKEIGNLA 462 (1057)
Q Consensus 388 L~~L~L~~N---~l~~~--~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~l~~n~~~~~~p~~~~~l~ 462 (1057)
.++.- .-++. +...++...... +.+.|++++-+++ .+|+....-.
T Consensus 336 ----glS~se~~~e~~~t~~~~~~~~~~~~i-------------------------~tkiL~~s~~qlt-~VPdEVfea~ 385 (565)
T KOG0472|consen 336 ----GLSQSEGGTETAMTLPSESFPDIYAII-------------------------TTKILDVSDKQLT-LVPDEVFEAA 385 (565)
T ss_pred ----CCCCCcccccccCCCCCCcccchhhhh-------------------------hhhhhcccccccc-cCCHHHHHHh
Confidence 00000 00000 000111112222 3444455554444 2344333332
Q ss_pred ---CCcEEEccCCcCCCCCCcccccccccceeecccccCcccCCcccccccccceEEecCeeeeecCCccccCccccccc
Q 001544 463 ---NLVTLDLGGNKFNGSIPIALGKLQKLQLLNLDDNKLEGSIPDDICGLVELYKLALGDNKLSGQIPACFGNLASLREL 539 (1057)
Q Consensus 463 ---~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L 539 (1057)
-.+..+++.|++. .+|..+..+..+++.-+..|+..+.+|..++.+++|..|+|++|-+. .+|..++.+..|+.|
T Consensus 386 ~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~isfv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~L 463 (565)
T KOG0472|consen 386 KSEIVTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNKISFVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTL 463 (565)
T ss_pred hhcceEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCccccchHHHHhhhcceeeecccchhh-hcchhhhhhhhhhee
Confidence 2778888888888 68888877777666544444444478888888888888888888776 567777776666665
Q ss_pred ccCCccccccccccccccccccEEEeccccccCCCchhhccccccceeccccccccccccccccCccccceecccccccc
Q 001544 540 WLGPNELISFIPSTFWNIKDIMYVNFSSNFLTGPLPLEIENLKALTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQ 619 (1057)
Q Consensus 540 ~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 619 (1057)
+++.|+ +. ..|..+..+..++.+-.++|++..+.|..+.+|.+|..|||.+|.+.
T Consensus 464 nlS~Nr------------------------Fr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq 518 (565)
T KOG0472|consen 464 NLSFNR------------------------FR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ 518 (565)
T ss_pred cccccc------------------------cc-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchh
Confidence 555554 43 35666666677777777888888776777889999999999999998
Q ss_pred cccCccccccCccceecccCccccCCCcccccCcccccccccCCC
Q 001544 620 GSIPDSVGDLISLKSLNLSNNNLSGPIPTSLEKLSDLKELNLSFN 664 (1057)
Q Consensus 620 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N 664 (1057)
.+|..+++|++|++|+|++|.|+ ..+...-.-+....|..-++
T Consensus 519 -~IPp~LgnmtnL~hLeL~gNpfr-~Pr~~iLmkgT~aiL~ylrd 561 (565)
T KOG0472|consen 519 -QIPPILGNMTNLRHLELDGNPFR-QPRHQILMKGTAAILSYLRD 561 (565)
T ss_pred -hCChhhccccceeEEEecCCccC-CCHHHHhccChHHHHHHhcc
Confidence 78888999999999999999998 44444433333444443333
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-40 Score=317.46 Aligned_cols=253 Identities=22% Similarity=0.351 Sum_probs=207.2
Q ss_pred hCCCCCCceeccccCeEEEEEE-ecCCcEEEEEEeecc--chhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEE
Q 001544 768 TNGFSENNLIGRGSFGSVYIAR-LQNGIEVAVKTFDLQ--HERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALIL 844 (1057)
Q Consensus 768 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 844 (1057)
.+.|++.++||+|.|+.||++. ..+|+.+|+|++... .....+.+++|+++-+.++||||+++.+.+.+....|+|+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 3467778899999999999985 557999999988533 2346788999999999999999999999999999999999
Q ss_pred EEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeC---CCCcEEEEcccccccccC
Q 001544 845 EYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLD---DNMVAHLSDFGIAKLLIG 921 (1057)
Q Consensus 845 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~---~~~~~kl~Dfg~a~~~~~ 921 (1057)
|+|+|++|..-+-.. ..+++..+-..++||+++++|+| .++|||||+||+|+++- ...-+|++|||+|..+.
T Consensus 90 e~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH---~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~- 164 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCH---SNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN- 164 (355)
T ss_pred ecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeeeeccCCCceeecccceEEEeC-
Confidence 999999996544332 45788888899999999999999 99999999999999995 34579999999999874
Q ss_pred CCCccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhccc
Q 001544 922 EDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANL 1001 (1057)
Q Consensus 922 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1001 (1057)
........+||++|||||+.+..+++..+|||+.||++|-++.|++||.+.... .+++...
T Consensus 165 --~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~-----------------rlye~I~ 225 (355)
T KOG0033|consen 165 --DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH-----------------RLYEQIK 225 (355)
T ss_pred --CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH-----------------HHHHHHh
Confidence 344566778999999999999999999999999999999999999998762211 1111111
Q ss_pred ccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHH
Q 001544 1002 LITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRL 1044 (1057)
Q Consensus 1002 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 1044 (1057)
........+.+..++++.++++++|+..||.+|.|+.|+++|=
T Consensus 226 ~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~Hp 268 (355)
T KOG0033|consen 226 AGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHP 268 (355)
T ss_pred ccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCc
Confidence 1111122233456778899999999999999999999998764
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=313.42 Aligned_cols=236 Identities=27% Similarity=0.367 Sum_probs=201.1
Q ss_pred CCCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccc---hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEE
Q 001544 769 NGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQH---ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALIL 844 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 844 (1057)
++|+..+.+|.|+||.|..++.+ +|..+|+|++++.. -++.+...+|..+++++.||+++++++.|.+.+..|+||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 46888899999999999999855 68999999997653 345567788999999999999999999999999999999
Q ss_pred EEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCC
Q 001544 845 EYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ 924 (1057)
Q Consensus 845 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 924 (1057)
||++||.|..++++.+. +++..++-+|.||+.|++||| +.+|++||+||+|||+|++|.+||+|||+|+++.+.
T Consensus 124 eyv~GGElFS~Lrk~~r-F~e~~arFYAAeivlAleylH---~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r-- 197 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKSGR-FSEPHARFYAAEIVLALEYLH---SLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR-- 197 (355)
T ss_pred eccCCccHHHHHHhcCC-CCchhHHHHHHHHHHHHHHHH---hcCeeeccCChHHeeeccCCcEEEEeccceEEecCc--
Confidence 99999999999988664 999999999999999999999 999999999999999999999999999999987321
Q ss_pred ccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhH-HHhhhccccc
Q 001544 925 SMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISM-MKIIDANLLI 1003 (1057)
Q Consensus 925 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 1003 (1057)
.-..+||+.|+|||++....+..++|-|||||++|||+.|.+||..... ..+ .++....
T Consensus 198 ---T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~--------------~~iY~KI~~~~--- 257 (355)
T KOG0616|consen 198 ---TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP--------------IQIYEKILEGK--- 257 (355)
T ss_pred ---EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh--------------HHHHHHHHhCc---
Confidence 3345799999999999999999999999999999999999999976211 011 1122111
Q ss_pred ccchhhHHHHHHHHHHHHHHhHcccCCCCCCC
Q 001544 1004 TEDKHFAAKEQCASSVFNLAMECTVESPDERI 1035 (1057)
Q Consensus 1004 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp 1035 (1057)
...+...+.++.+++...++.|-.+|.
T Consensus 258 -----v~fP~~fs~~~kdLl~~LL~vD~t~R~ 284 (355)
T KOG0616|consen 258 -----VKFPSYFSSDAKDLLKKLLQVDLTKRF 284 (355)
T ss_pred -----ccCCcccCHHHHHHHHHHHhhhhHhhh
Confidence 122345677899999999999999983
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=347.11 Aligned_cols=262 Identities=24% Similarity=0.415 Sum_probs=202.7
Q ss_pred CCCCCCceeccccCeEEEEEEecC-----------------CcEEEEEEeeccc-hhHHHHHHHHHHHHHhcCCCCceeE
Q 001544 769 NGFSENNLIGRGSFGSVYIARLQN-----------------GIEVAVKTFDLQH-ERAFKSFDTECEVMKSIRHRNLTKI 830 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l 830 (1057)
.+|++.++||+|+||.||+|.+++ +..||||++.... .....++.+|++++++++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 468888999999999999997532 3479999987543 3345679999999999999999999
Q ss_pred eeeeccCCeeEEEEEEccCCChhHHHhcCC------------------ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEE
Q 001544 831 ISSCSNEDFKALILEYMRNGSLEKCLYSGN------------------YILDIFQRLNIMIDVASALEYLHFGYSAPVIH 892 (1057)
Q Consensus 831 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~------------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH 892 (1057)
++++.+.+..++||||+++|+|.+++.... ..+++.++.+++.||+.||+||| +.+|+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNFVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH---HCCccc
Confidence 999999999999999999999999885432 24678889999999999999999 899999
Q ss_pred ccCCCCCeeeCCCCcEEEEcccccccccCCCCccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhh--CCCC
Q 001544 893 CDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFT--RRKP 970 (1057)
Q Consensus 893 ~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt--g~~p 970 (1057)
|||||+||++++++.+||+|||+++.+.............++..|+|||++..+.++.++||||||+++|||++ +..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 99999999999999999999999986543332222233445778999999988889999999999999999987 4566
Q ss_pred CCcccccccchhhhhhhccchhHHHhhhcccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHHH
Q 001544 971 TDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLK 1046 (1057)
Q Consensus 971 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 1046 (1057)
|......+ ..... .+....... ......+..++..+.+++.+||+.||++|||+.|+.+.|++
T Consensus 242 ~~~~~~~~--~~~~~--------~~~~~~~~~---~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 242 YGELTDEQ--VIENA--------GEFFRDQGR---QVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCcCCHHH--HHHHH--------HHHhhhccc---cccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 65421111 00000 000000000 00001112456789999999999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=332.35 Aligned_cols=257 Identities=26% Similarity=0.394 Sum_probs=203.4
Q ss_pred HHhCCCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccch---------h-----HHHHHHHHHHHHHhcCCCCceeE
Q 001544 766 QATNGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQHE---------R-----AFKSFDTECEVMKSIRHRNLTKI 830 (1057)
Q Consensus 766 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---------~-----~~~~~~~E~~~l~~l~h~niv~l 830 (1057)
+.-++|++.+.||+|.||.|-+|+.. +++.||||++.+... . ..+...+||.+|++++|||||++
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 45678999999999999999999854 799999999954321 1 13578899999999999999999
Q ss_pred eeeecc--CCeeEEEEEEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcE
Q 001544 831 ISSCSN--EDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVA 908 (1057)
Q Consensus 831 ~~~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~ 908 (1057)
+++..+ .+..|+|+|||..|.+...= .....++..++++++.++..||+||| ..+||||||||+|+|++++|++
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p-~d~~els~~~Ar~ylrDvv~GLEYLH---~QgiiHRDIKPsNLLl~~~g~V 249 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCP-PDKPELSEQQARKYLRDVVLGLEYLH---YQGIIHRDIKPSNLLLSSDGTV 249 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCC-CCcccccHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEEcCCCcE
Confidence 999866 57899999999999886532 11223899999999999999999999 9999999999999999999999
Q ss_pred EEEcccccccccCC---CCccccccccccccccCccccCCCC----CCccchHHHHHHHHHHHhhCCCCCCcccccccch
Q 001544 909 HLSDFGIAKLLIGE---DQSMTQTQTLATLGYMAPEYGREGR----VSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTL 981 (1057)
Q Consensus 909 kl~Dfg~a~~~~~~---~~~~~~~~~~~t~~y~aPE~~~~~~----~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~ 981 (1057)
||+|||.+...... +........+||+.|+|||...++. .+.+.||||+||++|.|+.|+.||-+.+. +
T Consensus 250 KIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~----~ 325 (576)
T KOG0585|consen 250 KISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE----L 325 (576)
T ss_pred EeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH----H
Confidence 99999998765211 1222334478999999999877633 46788999999999999999999865211 0
Q ss_pred hhhhhhccchhHHHhhhcccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHH
Q 001544 982 KHWVNDFLPISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLL 1045 (1057)
Q Consensus 982 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 1045 (1057)
+ -..+++... ..++..++..+++.+++.+|+.+||++|.+..+|..|..
T Consensus 326 ~---------l~~KIvn~p------L~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpw 374 (576)
T KOG0585|consen 326 E---------LFDKIVNDP------LEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPW 374 (576)
T ss_pred H---------HHHHHhcCc------ccCCCcccccHHHHHHHHHHhhcChhheeehhhheecce
Confidence 0 011222111 123333456788999999999999999999999988764
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=308.04 Aligned_cols=263 Identities=22% Similarity=0.310 Sum_probs=211.2
Q ss_pred HhCCCCCCceeccccCeEEEEEE-ecCCcEEEEEEeeccchhHHHHHHHHHHHHHhcCCCCceeEeeeeccC-----Cee
Q 001544 767 ATNGFSENNLIGRGSFGSVYIAR-LQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCSNE-----DFK 840 (1057)
Q Consensus 767 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~ 840 (1057)
..++|++.+.+|+|||+.||.++ ..++..||+|++.....+..+...+|++..++++|||+++++++...+ ...
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 34689999999999999999997 667899999999777667778899999999999999999999987443 358
Q ss_pred EEEEEEccCCChhHHHhc---CCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccc
Q 001544 841 ALILEYMRNGSLEKCLYS---GNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK 917 (1057)
Q Consensus 841 ~lV~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~ 917 (1057)
|++++|...|+|.+.+.. ++..+++.++++|+.+|++||++||. ...+++||||||.||++.+++.+++.|||.++
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~-~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHE-KEPPYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhc-cCCcccccCCCcceeEecCCCceEEEeccCcc
Confidence 999999999999998764 33579999999999999999999992 13349999999999999999999999999997
Q ss_pred cccCCCCc-------cccccccccccccCccccC---CCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhh
Q 001544 918 LLIGEDQS-------MTQTQTLATLGYMAPEYGR---EGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVND 987 (1057)
Q Consensus 918 ~~~~~~~~-------~~~~~~~~t~~y~aPE~~~---~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~ 987 (1057)
...-.-.. ........|..|+|||.+. +...++++||||+||++|+|+.|..||+...+...++.--+.
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~- 256 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQ- 256 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeee-
Confidence 65321111 1122345788999999874 455789999999999999999999999876554333321110
Q ss_pred ccchhHHHhhhcccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHHHh
Q 001544 988 FLPISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKI 1047 (1057)
Q Consensus 988 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i 1047 (1057)
.....++....+++.+.+++++|+++||.+||++.|++.++..+
T Consensus 257 ----------------n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 257 ----------------NAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred ----------------ccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 01111222223678899999999999999999999999998765
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=355.47 Aligned_cols=258 Identities=26% Similarity=0.388 Sum_probs=204.2
Q ss_pred hCCCCCCceeccccCeEEEEEEe------cCCcEEEEEEeeccc-hhHHHHHHHHHHHHHhc-CCCCceeEeeeeccCCe
Q 001544 768 TNGFSENNLIGRGSFGSVYIARL------QNGIEVAVKTFDLQH-ERAFKSFDTECEVMKSI-RHRNLTKIISSCSNEDF 839 (1057)
Q Consensus 768 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 839 (1057)
.++|++.+.||+|+||.||+|+. +++..||||+++... ....+.+.+|+++++++ +||||++++++|.+.+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 34688899999999999999963 246689999986443 33456788999999999 89999999999999999
Q ss_pred eEEEEEEccCCChhHHHhcCC-----------------------------------------------------------
Q 001544 840 KALILEYMRNGSLEKCLYSGN----------------------------------------------------------- 860 (1057)
Q Consensus 840 ~~lV~E~~~~gsL~~~l~~~~----------------------------------------------------------- 860 (1057)
.++||||+++|+|.+++....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 999999999999999886432
Q ss_pred ---------------ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCc
Q 001544 861 ---------------YILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS 925 (1057)
Q Consensus 861 ---------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 925 (1057)
..+++..+.+++.||++||+||| +++|+||||||+||+++.++.+||+|||+++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 24788899999999999999999 999999999999999999999999999999865332222
Q ss_pred cccccccccccccCccccCCCCCCccchHHHHHHHHHHHhh-CCCCCCcccccccchhhhhhhccchhHHHhhhcccccc
Q 001544 926 MTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFT-RRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLIT 1004 (1057)
Q Consensus 926 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1057)
.......++..|+|||++.+..++.++|||||||++|||++ |..||....... .. .+.+....
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~-~~------------~~~~~~~~--- 334 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS-KF------------YKMIKEGY--- 334 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH-HH------------HHHHHhCc---
Confidence 22222334667999999999999999999999999999998 888876532111 11 11111110
Q ss_pred cchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHHHh
Q 001544 1005 EDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKI 1047 (1057)
Q Consensus 1005 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i 1047 (1057)
+...+...+.++.+++.+||+.||++||++.|+++.|++.
T Consensus 335 ---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 335 ---RMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred ---cCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 0001122456789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=341.00 Aligned_cols=263 Identities=24% Similarity=0.432 Sum_probs=219.9
Q ss_pred CCCCCCceeccccCeEEEEEEecCCcEEEEEEeeccchh-HHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEEc
Q 001544 769 NGFSENNLIGRGSFGSVYIARLQNGIEVAVKTFDLQHER-AFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEYM 847 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 847 (1057)
....+.++||+|.||.|..+....+..||||.++..... ...+|.+|+++|.+++||||++++|.|..++..++|+|||
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm 617 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM 617 (807)
T ss_pred hheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence 356678999999999999999988899999999876544 4589999999999999999999999999999999999999
Q ss_pred cCCChhHHHhcCCcc-CCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCcc
Q 001544 848 RNGSLEKCLYSGNYI-LDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSM 926 (1057)
Q Consensus 848 ~~gsL~~~l~~~~~~-l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 926 (1057)
++|+|.+++.....+ .......+|+.|||.|++||. +..+||||+.++|+|++.++++||+|||+++-+...+.+.
T Consensus 618 EnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~ 694 (807)
T KOG1094|consen 618 ENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYR 694 (807)
T ss_pred hcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcccEEecCcccccccccCCcee
Confidence 999999999877543 366777889999999999999 9999999999999999999999999999999877777777
Q ss_pred ccccccccccccCccccCCCCCCccchHHHHHHHHHHHhh--CCCCCCcccccccchhhhhhhccchhHHHhhhcccccc
Q 001544 927 TQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFT--RRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLIT 1004 (1057)
Q Consensus 927 ~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1057)
.....+-..+|||||.+..++++.++|||+||+++||+++ ...||.+..++.. . +...++.+.. .
T Consensus 695 vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~v-v---------en~~~~~~~~---~ 761 (807)
T KOG1094|consen 695 VQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQV-V---------ENAGEFFRDQ---G 761 (807)
T ss_pred eecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHH-H---------HhhhhhcCCC---C
Confidence 7777777889999999999999999999999999999876 5678766332211 0 0011111110 0
Q ss_pred cchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHHHh
Q 001544 1005 EDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKI 1047 (1057)
Q Consensus 1005 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i 1047 (1057)
.......+..|+.+++++|.+||.+|-++||+++++..+|++.
T Consensus 762 ~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 762 RQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred cceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 1112233457899999999999999999999999999998764
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=338.21 Aligned_cols=255 Identities=22% Similarity=0.359 Sum_probs=206.1
Q ss_pred CCCCCCceeccccCeEEEEEEec----CCcEEEEEEeeccc-hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEE
Q 001544 769 NGFSENNLIGRGSFGSVYIARLQ----NGIEVAVKTFDLQH-ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALI 843 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 843 (1057)
++|++.+.||+|+||.||+|.+. .+..||+|+++... ......+.+|++++++++||||+++++++..++..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 46888899999999999999753 36789999987553 33446789999999999999999999999999999999
Q ss_pred EEEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCC
Q 001544 844 LEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGED 923 (1057)
Q Consensus 844 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~ 923 (1057)
|||+++|+|.+++......+++.+++.++.|++.|++||| +.+++||||||+||+++.++.+|++|||.+.......
T Consensus 85 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~ 161 (266)
T cd05064 85 TEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLS---EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEA 161 (266)
T ss_pred EEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeeccccHhhEEEcCCCcEEECCCcccccccccc
Confidence 9999999999999876667899999999999999999999 9999999999999999999999999999876532111
Q ss_pred CccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhh-CCCCCCcccccccchhhhhhhccchhHHHhhhcccc
Q 001544 924 QSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFT-RRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLL 1002 (1057)
Q Consensus 924 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1002 (1057)
........++..|+|||...+..++.++|||||||++||+++ |+.||...... ...+.+...
T Consensus 162 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~--------------~~~~~~~~~-- 224 (266)
T cd05064 162 -IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ--------------DVIKAVEDG-- 224 (266)
T ss_pred -hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--------------HHHHHHHCC--
Confidence 111112234578999999988999999999999999999775 99998652111 011111110
Q ss_pred cccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHHHh
Q 001544 1003 ITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKI 1047 (1057)
Q Consensus 1003 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i 1047 (1057)
...+.+..++..+.+++.+||+.+|++||++.|+.+.|+++
T Consensus 225 ----~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 225 ----FRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred ----CCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 01112245677899999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=355.49 Aligned_cols=259 Identities=25% Similarity=0.422 Sum_probs=205.1
Q ss_pred hCCCCCCceeccccCeEEEEEEec------CCcEEEEEEeeccc-hhHHHHHHHHHHHHHhc-CCCCceeEeeeeccCCe
Q 001544 768 TNGFSENNLIGRGSFGSVYIARLQ------NGIEVAVKTFDLQH-ERAFKSFDTECEVMKSI-RHRNLTKIISSCSNEDF 839 (1057)
Q Consensus 768 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 839 (1057)
.++|++.+.||+|+||.||+|... ++..||||+++... ......+.+|+++++++ +||||++++++|.+.+.
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 346888999999999999998742 34579999996543 33456788999999999 89999999999999999
Q ss_pred eEEEEEEccCCChhHHHhcCC-----------------------------------------------------------
Q 001544 840 KALILEYMRNGSLEKCLYSGN----------------------------------------------------------- 860 (1057)
Q Consensus 840 ~~lV~E~~~~gsL~~~l~~~~----------------------------------------------------------- 860 (1057)
.++||||+++|+|.++++...
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 999999999999999885421
Q ss_pred ----------ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCcccccc
Q 001544 861 ----------YILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQ 930 (1057)
Q Consensus 861 ----------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 930 (1057)
..+++.++.+++.||++||+||| +++|+||||||+||++++++.+||+|||+++.+...........
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 24788889999999999999999 99999999999999999999999999999986533222112222
Q ss_pred ccccccccCccccCCCCCCccchHHHHHHHHHHHhh-CCCCCCcccccccchhhhhhhccchhHHHhhhcccccccchhh
Q 001544 931 TLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFT-RRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHF 1009 (1057)
Q Consensus 931 ~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1057)
..++..|+|||++.+..++.++|||||||++|||++ |+.||........ ......... ..
T Consensus 274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~-------------~~~~~~~~~------~~ 334 (374)
T cd05106 274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK-------------FYKMVKRGY------QM 334 (374)
T ss_pred CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH-------------HHHHHHccc------Cc
Confidence 335568999999988899999999999999999997 9999865322111 011111000 00
Q ss_pred HHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHHHhH
Q 001544 1010 AAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKIR 1048 (1057)
Q Consensus 1010 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~ 1048 (1057)
..+...++++.+++.+||+.||++||++.|+++.|+++.
T Consensus 335 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 335 SRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred cCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 011124577899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=341.42 Aligned_cols=250 Identities=21% Similarity=0.324 Sum_probs=201.8
Q ss_pred CCCCceeccccCeEEEEEEe-cCCcEEEEEEeeccc---hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEE
Q 001544 771 FSENNLIGRGSFGSVYIARL-QNGIEVAVKTFDLQH---ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEY 846 (1057)
Q Consensus 771 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 846 (1057)
|+..+.||+|+||+||+|.. .+|+.||||.+.... ......+.+|++++++++|++|+++++++.+++..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 67789999999999999975 479999999986432 22335678899999999999999999999999999999999
Q ss_pred ccCCChhHHHhcCC-ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCc
Q 001544 847 MRNGSLEKCLYSGN-YILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS 925 (1057)
Q Consensus 847 ~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 925 (1057)
+++|+|.+++.... ..+++.++..++.|++.|++||| +.+|+||||||+||++++++.+||+|||+++.....
T Consensus 82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~--- 155 (285)
T cd05631 82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG--- 155 (285)
T ss_pred cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC---
Confidence 99999998876433 45899999999999999999999 999999999999999999999999999999865221
Q ss_pred cccccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhccccccc
Q 001544 926 MTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITE 1005 (1057)
Q Consensus 926 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1057)
.......|+..|+|||++.+..++.++||||+||++|||++|+.||........ ... ....+..
T Consensus 156 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~-~~~---------~~~~~~~------ 219 (285)
T cd05631 156 ETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK-REE---------VDRRVKE------ 219 (285)
T ss_pred CeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh-HHH---------HHHHhhc------
Confidence 122345689999999999999999999999999999999999999875322110 000 0000000
Q ss_pred chhhHHHHHHHHHHHHHHhHcccCCCCCCCC-----HHHHHHH
Q 001544 1006 DKHFAAKEQCASSVFNLAMECTVESPDERIT-----AKEIVRR 1043 (1057)
Q Consensus 1006 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~evl~~ 1043 (1057)
........++.++.+++.+||+.||++||+ ++|+++|
T Consensus 220 -~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 220 -DQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred -ccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 001112245678899999999999999997 8999886
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=340.07 Aligned_cols=269 Identities=20% Similarity=0.255 Sum_probs=204.5
Q ss_pred CCCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccc--hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEE
Q 001544 769 NGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQH--ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILE 845 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 845 (1057)
++|++.+.||+|+||+||+|+.. +++.||||+++... ....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 46889999999999999999875 68899999986542 2345678899999999999999999999999999999999
Q ss_pred EccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCc
Q 001544 846 YMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS 925 (1057)
Q Consensus 846 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 925 (1057)
|++++.+..+.. ....+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++...... .
T Consensus 81 ~~~~~~l~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~ 155 (287)
T cd07848 81 YVEKNMLELLEE-MPNGVPPEKVRSYIYQLIKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS-N 155 (287)
T ss_pred cCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccc-c
Confidence 999987765543 3446899999999999999999999 9999999999999999999999999999998753221 2
Q ss_pred cccccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccc--hhhhhhhccchhHHHhhhc----
Q 001544 926 MTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMT--LKHWVNDFLPISMMKIIDA---- 999 (1057)
Q Consensus 926 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~---- 999 (1057)
.......++..|+|||++.+..++.++||||+||++|||++|+.||......+.. ....... .+....+....
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 234 (287)
T cd07848 156 ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGP-LPAEQMKLFYSNPRF 234 (287)
T ss_pred ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCC-CCHHHHHhhhccchh
Confidence 2223456889999999998888999999999999999999999998753221110 0000000 01110100000
Q ss_pred ------ccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 1000 ------NLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 1000 ------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
...............++.++.+++.+|++.||++|||++|+++|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 235 HGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred cccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00000000011122357789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=327.93 Aligned_cols=262 Identities=26% Similarity=0.370 Sum_probs=197.6
Q ss_pred CCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccchhHHHHHHHHHHHHHhcCCCCceeEeeeeccC---C--eeEEE
Q 001544 770 GFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCSNE---D--FKALI 843 (1057)
Q Consensus 770 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---~--~~~lV 843 (1057)
.|...+++|+|+||.||+|... +++.||||++-...+- -.+|+++|+.++|||||++.-+|... + ...+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 4666799999999999999855 5799999998433321 13699999999999999999888442 2 33589
Q ss_pred EEEccCCChhHHHhc---CCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCC-CcEEEEcccccccc
Q 001544 844 LEYMRNGSLEKCLYS---GNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDN-MVAHLSDFGIAKLL 919 (1057)
Q Consensus 844 ~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~-~~~kl~Dfg~a~~~ 919 (1057)
||||+. +|.+.++. .+..++...+.-+++||++|++||| +.+||||||||.|+|+|.+ |.+||||||.|+.+
T Consensus 101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh---~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLH---SHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHH---hcCcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 999987 99888874 2345788888899999999999999 9999999999999999965 99999999999987
Q ss_pred cCCCCccccccccccccccCccccCCC-CCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHh--
Q 001544 920 IGEDQSMTQTQTLATLGYMAPEYGREG-RVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKI-- 996 (1057)
Q Consensus 920 ~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-- 996 (1057)
..... ...+..|..|+|||.+.+. .|+.+.||||.|||+.||+-|++-|.+ .++...+...++........++
T Consensus 177 ~~~ep---niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG-~s~~dQL~eIik~lG~Pt~e~I~~ 252 (364)
T KOG0658|consen 177 VKGEP---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPG-DSSVDQLVEIIKVLGTPTREDIKS 252 (364)
T ss_pred ccCCC---ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCC-CCHHHHHHHHHHHhCCCCHHHHhh
Confidence 54433 3556788999999988775 589999999999999999999998765 2222333444433322211111
Q ss_pred hhccc------ccccchhh-HHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 997 IDANL------LITEDKHF-AAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 997 ~~~~~------~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
..+.. ........ -.....+++..+++.+++.++|.+|.++.|+++|
T Consensus 253 mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 253 MNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred cCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 11110 00000000 1223567889999999999999999999999876
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=339.79 Aligned_cols=269 Identities=22% Similarity=0.304 Sum_probs=203.3
Q ss_pred hCCCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccch-hHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEE
Q 001544 768 TNGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQHE-RAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILE 845 (1057)
Q Consensus 768 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 845 (1057)
.++|+..++||+|+||+||+|... +++.||+|+++.... .....+.+|++++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE 83 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence 356888999999999999999865 689999999865432 234567789999999999999999999999999999999
Q ss_pred EccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCc
Q 001544 846 YMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS 925 (1057)
Q Consensus 846 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 925 (1057)
|+++ +|.+++......+++..+..++.||+.||+||| +.+|+||||||+||++++++.+||+|||+++..... .
T Consensus 84 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~--~ 157 (288)
T cd07871 84 YLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVP--T 157 (288)
T ss_pred CCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEECcCcceeeccCC--C
Confidence 9975 999988776666899999999999999999999 999999999999999999999999999999754221 1
Q ss_pred cccccccccccccCccccCC-CCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhc--cchhH-HHhhh---
Q 001544 926 MTQTQTLATLGYMAPEYGRE-GRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDF--LPISM-MKIID--- 998 (1057)
Q Consensus 926 ~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~--~~~~~-~~~~~--- 998 (1057)
.......+++.|+|||++.+ ..++.++||||+||++|||++|+.||......+. ........ .+... ....+
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07871 158 KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEE-LHLIFRLLGTPTEETWPGITSNEE 236 (288)
T ss_pred ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCChHHhhccccchh
Confidence 22234567899999998765 5689999999999999999999999865322111 11000000 00000 00000
Q ss_pred --cccccc--cchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 999 --ANLLIT--EDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 999 --~~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
...... ..........++.++.+++.+|+..||.+|||++|+++|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 237 FRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred hhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000000 000011112346778999999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=343.54 Aligned_cols=246 Identities=24% Similarity=0.319 Sum_probs=202.8
Q ss_pred CCCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccc---hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEE
Q 001544 769 NGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQH---ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALIL 844 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 844 (1057)
++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36888999999999999999865 68999999986432 234567889999999999999999999999999999999
Q ss_pred EEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCC
Q 001544 845 EYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ 924 (1057)
Q Consensus 845 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 924 (1057)
||+++|+|.+++...+ .+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~-- 154 (291)
T cd05612 81 EYVPGGELFSYLRNSG-RFSNSTGLFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR-- 154 (291)
T ss_pred eCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC--
Confidence 9999999999987654 5889999999999999999999 999999999999999999999999999999865321
Q ss_pred ccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhcccccc
Q 001544 925 SMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLIT 1004 (1057)
Q Consensus 925 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1057)
.....|++.|+|||++.+..++.++||||+||++|||++|+.||......+ . ...+....
T Consensus 155 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~-----~--------~~~i~~~~---- 214 (291)
T cd05612 155 ---TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG-----I--------YEKILAGK---- 214 (291)
T ss_pred ---cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----H--------HHHHHhCC----
Confidence 123468899999999988889999999999999999999999986521110 0 00111100
Q ss_pred cchhhHHHHHHHHHHHHHHhHcccCCCCCCCC-----HHHHHHHH
Q 001544 1005 EDKHFAAKEQCASSVFNLAMECTVESPDERIT-----AKEIVRRL 1044 (1057)
Q Consensus 1005 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~evl~~L 1044 (1057)
...+..++..+.+++.+|++.||.+||+ +.|+++|-
T Consensus 215 ----~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~ 255 (291)
T cd05612 215 ----LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHR 255 (291)
T ss_pred ----cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCc
Confidence 0111234567899999999999999995 89988773
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=347.64 Aligned_cols=242 Identities=26% Similarity=0.352 Sum_probs=198.1
Q ss_pred ceeccccCeEEEEEEec-CCcEEEEEEeeccc---hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEEccCC
Q 001544 775 NLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQH---ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEYMRNG 850 (1057)
Q Consensus 775 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g 850 (1057)
+.||+|+||.||+|... +|+.||||+++... ......+.+|++++++++||||+++++++.+.+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999764 68999999997542 234466788999999999999999999999999999999999999
Q ss_pred ChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCcccccc
Q 001544 851 SLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQ 930 (1057)
Q Consensus 851 sL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 930 (1057)
+|.+++...+ .+++.++..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++..... ......
T Consensus 81 ~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~--~~~~~~ 154 (323)
T cd05571 81 ELFFHLSRER-VFSEDRARFYGAEIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD--GATMKT 154 (323)
T ss_pred cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC--CCcccc
Confidence 9999887654 5899999999999999999999 999999999999999999999999999998753211 122334
Q ss_pred ccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhcccccccchhhH
Q 001544 931 TLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHFA 1010 (1057)
Q Consensus 931 ~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1057)
..||+.|+|||++.+..++.++||||+||++|||++|+.||...... .....+... ...
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~--------------~~~~~~~~~-------~~~ 213 (323)
T cd05571 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--------------KLFELILME-------EIR 213 (323)
T ss_pred eecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH--------------HHHHHHHcC-------CCC
Confidence 56899999999999889999999999999999999999998642110 000111000 001
Q ss_pred HHHHHHHHHHHHHhHcccCCCCCCC-----CHHHHHHH
Q 001544 1011 AKEQCASSVFNLAMECTVESPDERI-----TAKEIVRR 1043 (1057)
Q Consensus 1011 ~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~ 1043 (1057)
.+..++.++.+++.+|++.||++|| ++.|+++|
T Consensus 214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 214 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred CCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 1124567789999999999999999 89999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=320.04 Aligned_cols=248 Identities=24% Similarity=0.364 Sum_probs=207.9
Q ss_pred hCCCCCCceeccccCeEEEEEEe-cCCcEEEEEEeecc---chhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEE
Q 001544 768 TNGFSENNLIGRGSFGSVYIARL-QNGIEVAVKTFDLQ---HERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALI 843 (1057)
Q Consensus 768 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 843 (1057)
..+|++.+.||+|.||+|-+|.. ..|+.||||.+++. +++..-.+.+|+++|+.++||||+.+++.|+..+...+|
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 44688889999999999999975 67999999998654 445566789999999999999999999999999999999
Q ss_pred EEEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCC
Q 001544 844 LEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGED 923 (1057)
Q Consensus 844 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~ 923 (1057)
|||..+|.|.+++...+ .+++.++..+++||..|+.|+| .++|+|||+|.+|||+|+++.+||+|||++-++..
T Consensus 132 MEYaS~GeLYDYiSer~-~LsErEaRhfFRQIvSAVhYCH---knrVvHRDLKLENILLD~N~NiKIADFGLSNly~~-- 205 (668)
T KOG0611|consen 132 MEYASGGELYDYISERG-SLSEREARHFFRQIVSAVHYCH---KNRVVHRDLKLENILLDQNNNIKIADFGLSNLYAD-- 205 (668)
T ss_pred EEecCCccHHHHHHHhc-cccHHHHHHHHHHHHHHHHHHh---hccceecccchhheeecCCCCeeeeccchhhhhcc--
Confidence 99999999999998766 4999999999999999999999 99999999999999999999999999999987632
Q ss_pred CccccccccccccccCccccCCCCC-CccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhcccc
Q 001544 924 QSMTQTQTLATLGYMAPEYGREGRV-STKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLL 1002 (1057)
Q Consensus 924 ~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1002 (1057)
....+..+|++-|.+||++.+..| ++.+|.||+||++|-++.|..||++.. ... +..-+.....
T Consensus 206 -~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D-----hk~---------lvrQIs~GaY 270 (668)
T KOG0611|consen 206 -KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD-----HKR---------LVRQISRGAY 270 (668)
T ss_pred -ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch-----HHH---------HHHHhhcccc
Confidence 234455689999999999998887 588999999999999999999998721 111 1111111111
Q ss_pred cccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHH
Q 001544 1003 ITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRL 1044 (1057)
Q Consensus 1003 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 1044 (1057)
.++ .-+....-+|+.|+..+|++|.|..+|..|-
T Consensus 271 rEP--------~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 271 REP--------ETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred cCC--------CCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 111 2245567899999999999999999998774
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=341.23 Aligned_cols=265 Identities=21% Similarity=0.311 Sum_probs=206.4
Q ss_pred hCCCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccc-hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEE
Q 001544 768 TNGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQH-ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILE 845 (1057)
Q Consensus 768 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 845 (1057)
.++|++.+.||+|+||.||+|+.. +|..||+|.+.... ......+.+|++++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 357899999999999999999865 68899999987543 3445779999999999999999999999999999999999
Q ss_pred EccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCC-CeEEccCCCCCeeeCCCCcEEEEcccccccccCCCC
Q 001544 846 YMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSA-PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ 924 (1057)
Q Consensus 846 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~-~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 924 (1057)
|+++|+|.+++.... .+++..+..++.|++.|++||| +. +|+||||||+||+++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 157 (331)
T cd06649 84 HMDGGSLDQVLKEAK-RIPEEILGKVSIAVLRGLAYLR---EKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 157 (331)
T ss_pred cCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHh---hcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc--
Confidence 999999999987654 4889999999999999999999 64 6999999999999999999999999998765221
Q ss_pred ccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhc---------------c
Q 001544 925 SMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDF---------------L 989 (1057)
Q Consensus 925 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~---------------~ 989 (1057)
......|+..|+|||++.+..++.++||||+||++|||++|+.||......+ +....... .
T Consensus 158 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 233 (331)
T cd06649 158 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE--LEAIFGRPVVDGEEGEPHSISPRP 233 (331)
T ss_pred --ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHhcccccccccCCccccCccc
Confidence 2233468899999999998899999999999999999999999996432111 00000000 0
Q ss_pred ----------------chhHHHhhhcccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHH
Q 001544 990 ----------------PISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRL 1044 (1057)
Q Consensus 990 ----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 1044 (1057)
.....+..+....... ... ....++.++.+++.+||+.||++|||+.|+++|-
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~-~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~ 302 (331)
T cd06649 234 RPPGRPVSGHGMDSRPAMAIFELLDYIVNEPP-PKL-PNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT 302 (331)
T ss_pred ccccccccccccccccchhHHHHHHHHHhCCC-cCC-CCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 0000000000000000 000 0113567899999999999999999999999985
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=338.35 Aligned_cols=249 Identities=34% Similarity=0.562 Sum_probs=196.3
Q ss_pred CCceeccccCeEEEEEEec-----CCcEEEEEEeeccc-hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEE
Q 001544 773 ENNLIGRGSFGSVYIARLQ-----NGIEVAVKTFDLQH-ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEY 846 (1057)
Q Consensus 773 ~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 846 (1057)
..+.||+|.||.||+|.+. .+..|+||+++... ....+.+.+|++.+++++||||++++|++...+..++||||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 3478999999999999876 36789999996543 34478899999999999999999999999988889999999
Q ss_pred ccCCChhHHHhcC-CccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCc
Q 001544 847 MRNGSLEKCLYSG-NYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS 925 (1057)
Q Consensus 847 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 925 (1057)
+++|+|.+++... ...+++.++.+|+.||++||+||| +.+++||||+++||++++++.+||+|||++.........
T Consensus 83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh---~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLH---SNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred cccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccccc
Confidence 9999999999887 567999999999999999999999 899999999999999999999999999999876322222
Q ss_pred cccccccccccccCccccCCCCCCccchHHHHHHHHHHHhh-CCCCCCcccccccchhhhhhhccchhHHHhhhcccccc
Q 001544 926 MTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFT-RRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLIT 1004 (1057)
Q Consensus 926 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1057)
...........|+|||.+....++.++||||||+++||+++ |+.||.+.... .+ ...+.+..
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~-----~~--------~~~~~~~~---- 222 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNE-----EI--------IEKLKQGQ---- 222 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHH-----HH--------HHHHHTTE----
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccc-----cc--------cccccccc----
Confidence 33334456778999999988889999999999999999999 67887653111 10 01111111
Q ss_pred cchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHH
Q 001544 1005 EDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRL 1044 (1057)
Q Consensus 1005 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 1044 (1057)
+...+..++..+.+++.+||+.+|++||++.|+++.|
T Consensus 223 ---~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 223 ---RLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ---ETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ---cceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 1112234577789999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=337.32 Aligned_cols=256 Identities=29% Similarity=0.518 Sum_probs=208.3
Q ss_pred CCCCCCceeccccCeEEEEEEecC------CcEEEEEEeeccc-hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeE
Q 001544 769 NGFSENNLIGRGSFGSVYIARLQN------GIEVAVKTFDLQH-ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKA 841 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 841 (1057)
++|++.+.||+|+||.||+|.... ...||+|.++... .....++.+|++++++++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 367888999999999999997542 2579999986443 344567899999999999999999999999999999
Q ss_pred EEEEEccCCChhHHHhcCC---------------ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCC
Q 001544 842 LILEYMRNGSLEKCLYSGN---------------YILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNM 906 (1057)
Q Consensus 842 lV~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~ 906 (1057)
++|||+++|+|.+++.... ..+++.++..++.|++.|++||| +.+++||||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccccceEEEcCCC
Confidence 9999999999999986532 34788899999999999999999 99999999999999999999
Q ss_pred cEEEEcccccccccCCCCccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhh-CCCCCCcccccccchhhhh
Q 001544 907 VAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFT-RRKPTDEIFSGEMTLKHWV 985 (1057)
Q Consensus 907 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~ 985 (1057)
.+||+|||+++...............+++.|+|||...+..++.++|||||||++|||++ |..||......
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~-------- 233 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ-------- 233 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH--------
Confidence 999999999986543333333344456788999999988889999999999999999998 99998652211
Q ss_pred hhccchhHHHhhhcccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHHHh
Q 001544 986 NDFLPISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKI 1047 (1057)
Q Consensus 986 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i 1047 (1057)
.....+.... ....+..++.++.+++.+||+.||++||++.|++++|+.+
T Consensus 234 ------~~~~~i~~~~------~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 234 ------EVIEMIRSRQ------LLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred ------HHHHHHHcCC------cCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 1111111110 1112345778899999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=343.95 Aligned_cols=258 Identities=24% Similarity=0.388 Sum_probs=207.4
Q ss_pred CCCCCCceeccccCeEEEEEEec-CCc----EEEEEEeeccc-hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEE
Q 001544 769 NGFSENNLIGRGSFGSVYIARLQ-NGI----EVAVKTFDLQH-ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKAL 842 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 842 (1057)
.+|+..+.||+|+||.||+|.+. +++ .||||+++... ....+++.+|+.+++.++||||+++++++... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 46889999999999999999853 333 48999986443 34557888999999999999999999998764 5679
Q ss_pred EEEEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCC
Q 001544 843 ILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGE 922 (1057)
Q Consensus 843 V~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~ 922 (1057)
|+||+++|+|.+++......+++..+..++.||+.||+||| +.+|+||||||+||++++++.+||+|||+++.+...
T Consensus 86 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 162 (316)
T cd05108 86 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD 162 (316)
T ss_pred eeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEecCCCcEEEccccccccccCC
Confidence 99999999999999887767899999999999999999999 999999999999999999999999999999876433
Q ss_pred CCccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhh-CCCCCCcccccccchhhhhhhccchhHHHhhhccc
Q 001544 923 DQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFT-RRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANL 1001 (1057)
Q Consensus 923 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1001 (1057)
..........++..|+|||.+.+..++.++|||||||++||+++ |+.||+.....+ .........
T Consensus 163 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~--------------~~~~~~~~~ 228 (316)
T cd05108 163 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--------------ISSILEKGE 228 (316)
T ss_pred CcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH--------------HHHHHhCCC
Confidence 22222223334678999999998999999999999999999998 999986521110 111111110
Q ss_pred ccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHHHhHHH
Q 001544 1002 LITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKIRDF 1050 (1057)
Q Consensus 1002 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~ 1050 (1057)
..+.+..++.++.+++.+||..+|++||++.+++.++.++.+.
T Consensus 229 ------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~ 271 (316)
T cd05108 229 ------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 271 (316)
T ss_pred ------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence 1111223556788999999999999999999999999888654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=338.01 Aligned_cols=261 Identities=28% Similarity=0.485 Sum_probs=211.4
Q ss_pred CCCCCCceeccccCeEEEEEEe------cCCcEEEEEEeeccchhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEE
Q 001544 769 NGFSENNLIGRGSFGSVYIARL------QNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKAL 842 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 842 (1057)
.+|.+.+.||+|+||+||++.. .++..||+|.+........+.+.+|++++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 4678889999999999999974 2356799999976666667789999999999999999999999999999999
Q ss_pred EEEEccCCChhHHHhcCC------------ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEE
Q 001544 843 ILEYMRNGSLEKCLYSGN------------YILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHL 910 (1057)
Q Consensus 843 V~E~~~~gsL~~~l~~~~------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl 910 (1057)
||||+++++|.+++.... ..+++.++..++.|++.||+||| +++++||||||+||++++++.+|+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH---~~~i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCcEEe
Confidence 999999999999986432 24899999999999999999999 999999999999999999999999
Q ss_pred EcccccccccCCCCccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhh-CCCCCCcccccccchhhhhhhcc
Q 001544 911 SDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFT-RRKPTDEIFSGEMTLKHWVNDFL 989 (1057)
Q Consensus 911 ~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 989 (1057)
+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||......+
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~----------- 230 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE----------- 230 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-----------
Confidence 99999986533322222333445778999999988889999999999999999998 888876532111
Q ss_pred chhHHHhhhcccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHHHhHHHHh
Q 001544 990 PISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKIRDFLL 1052 (1057)
Q Consensus 990 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~~ 1052 (1057)
..+.+..... ......++.++.+++.+||+.+|.+|||+.|+.+.|+++.+...
T Consensus 231 ---~~~~i~~~~~------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~~~ 284 (288)
T cd05093 231 ---VIECITQGRV------LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKASP 284 (288)
T ss_pred ---HHHHHHcCCc------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHhcc
Confidence 0001100000 00112345678999999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=349.30 Aligned_cols=259 Identities=24% Similarity=0.410 Sum_probs=206.5
Q ss_pred hCCCCCCceeccccCeEEEEEEec------CCcEEEEEEeeccc-hhHHHHHHHHHHHHHhcC-CCCceeEeeeeccCCe
Q 001544 768 TNGFSENNLIGRGSFGSVYIARLQ------NGIEVAVKTFDLQH-ERAFKSFDTECEVMKSIR-HRNLTKIISSCSNEDF 839 (1057)
Q Consensus 768 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~ 839 (1057)
.++|.+.++||+|+||.||+|+.. .+..||||+++... ....+.+.+|+++++++. ||||++++++|.+.+.
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 457888999999999999999753 23579999996443 334567899999999996 9999999999999999
Q ss_pred eEEEEEEccCCChhHHHhcCC-----------------------------------------------------------
Q 001544 840 KALILEYMRNGSLEKCLYSGN----------------------------------------------------------- 860 (1057)
Q Consensus 840 ~~lV~E~~~~gsL~~~l~~~~----------------------------------------------------------- 860 (1057)
.++||||+++|+|.++++...
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 999999999999999876421
Q ss_pred ------------------------------------ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCC
Q 001544 861 ------------------------------------YILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDD 904 (1057)
Q Consensus 861 ------------------------------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~ 904 (1057)
..+++.++..++.|+++|++||| +.+|+||||||+||++++
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHhEEEeC
Confidence 23678888999999999999999 899999999999999999
Q ss_pred CCcEEEEcccccccccCCCCccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhh-CCCCCCcccccccchhh
Q 001544 905 NMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFT-RRKPTDEIFSGEMTLKH 983 (1057)
Q Consensus 905 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~ 983 (1057)
++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |+.||........
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~---- 348 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST---- 348 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH----
Confidence 99999999999986533222222233446778999999988889999999999999999997 8899865321111
Q ss_pred hhhhccchhHHHhhhcccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHHHhH
Q 001544 984 WVNDFLPISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKIR 1048 (1057)
Q Consensus 984 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~ 1048 (1057)
....+... .....+..++.++.+++.+||+.+|++||++.++.+.|+++.
T Consensus 349 ---------~~~~~~~~------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 349 ---------FYNKIKSG------YRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred ---------HHHHHhcC------CCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 01111110 011122346778999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=336.12 Aligned_cols=255 Identities=25% Similarity=0.415 Sum_probs=219.3
Q ss_pred CCCCCceeccccCeEEEEEEecC---C--cEEEEEEeeccc-hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEE
Q 001544 770 GFSENNLIGRGSFGSVYIARLQN---G--IEVAVKTFDLQH-ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALI 843 (1057)
Q Consensus 770 ~~~~~~~lg~G~~g~Vy~~~~~~---~--~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 843 (1057)
..+..++||+|.||.||+|.+.+ | -.||||.-+... ....+.|..|..+|++++||||++++|.|.+.. .++|
T Consensus 390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~P-~Wiv 468 (974)
T KOG4257|consen 390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQP-MWIV 468 (974)
T ss_pred hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeeccc-eeEE
Confidence 34456789999999999997542 3 358888876643 345788999999999999999999999998655 4799
Q ss_pred EEEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCC
Q 001544 844 LEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGED 923 (1057)
Q Consensus 844 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~ 923 (1057)
||.++-|.|..+++.....++......++.||..||+||| +.++|||||..+|||+.....+|++|||+++++....
T Consensus 469 mEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLe---SkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~ 545 (974)
T KOG4257|consen 469 MELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLE---SKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDA 545 (974)
T ss_pred EecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHH---hhchhhhhhhhhheeecCcceeeecccchhhhccccc
Confidence 9999999999999999988999999999999999999999 9999999999999999999999999999999985443
Q ss_pred CccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhh-CCCCCCcccccccchhhhhhhccchhHHHhhhcccc
Q 001544 924 QSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFT-RRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLL 1002 (1057)
Q Consensus 924 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1002 (1057)
+...+...-...|||||-+.-.+++.++|||.|||++||+++ |..||...... |....
T Consensus 546 -yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNs--------------------DVI~~ 604 (974)
T KOG4257|consen 546 -YYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNS--------------------DVIGH 604 (974)
T ss_pred -hhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccccc--------------------ceEEE
Confidence 334444455678999999999999999999999999999977 88998764333 23334
Q ss_pred cccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHHHhHH
Q 001544 1003 ITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKIRD 1049 (1057)
Q Consensus 1003 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~ 1049 (1057)
.+.+.+.+.++.|++.++.++.+||+++|.+||++.|+...|.++.+
T Consensus 605 iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 605 IENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred ecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 55667788889999999999999999999999999999999998866
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=332.15 Aligned_cols=251 Identities=25% Similarity=0.408 Sum_probs=203.0
Q ss_pred CCCCCCceeccccCeEEEEEEecCCcEEEEEEeeccchhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEEcc
Q 001544 769 NGFSENNLIGRGSFGSVYIARLQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEYMR 848 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 848 (1057)
++|++.+.||+|+||.||+|..+++..+|+|.+.... ...+++.+|++++++++||||+++++++.+.+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 3577889999999999999998888899999886432 234678899999999999999999999999999999999999
Q ss_pred CCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCcccc
Q 001544 849 NGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQ 928 (1057)
Q Consensus 849 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 928 (1057)
+|+|.++++.....+++..+..++.|++.|++||| +.+|+||||||+||+++.++.+|++|||.++...... ....
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~-~~~~ 158 (256)
T cd05114 83 NGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE-YTSS 158 (256)
T ss_pred CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcceEEEcCCCeEEECCCCCccccCCCc-eecc
Confidence 99999999866556899999999999999999999 9999999999999999999999999999988653221 1112
Q ss_pred ccccccccccCccccCCCCCCccchHHHHHHHHHHHhh-CCCCCCcccccccchhhhhhhccchhHHHhhhcccccccch
Q 001544 929 TQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFT-RRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDK 1007 (1057)
Q Consensus 929 ~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1057)
....++..|+|||...+..++.++||||||+++|||++ |+.||...... .... .+.....
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~--~~~~-----------~i~~~~~------ 219 (256)
T cd05114 159 SGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY--EVVE-----------MISRGFR------ 219 (256)
T ss_pred CCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH--HHHH-----------HHHCCCC------
Confidence 22334568999999988889999999999999999999 88898652111 0000 1110000
Q ss_pred hhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHH
Q 001544 1008 HFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRL 1044 (1057)
Q Consensus 1008 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 1044 (1057)
...+...+.++.+++.+||+.+|++||++.|+++.|
T Consensus 220 -~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 220 -LYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred -CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 001122356789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=320.54 Aligned_cols=271 Identities=25% Similarity=0.314 Sum_probs=205.4
Q ss_pred CCCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccch--hHHHHHHHHHHHHHhcCCCC-ceeEeeeeccCC------
Q 001544 769 NGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQHE--RAFKSFDTECEVMKSIRHRN-LTKIISSCSNED------ 838 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~------ 838 (1057)
..|...++||+|+||+||+|+.+ +|+.||+|+++...+ ..-....+|+.++++++|+| |+++++++....
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 34566688999999999999854 789999999976543 34456688999999999999 999999997766
Q ss_pred eeEEEEEEccCCChhHHHhcCC---ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccc
Q 001544 839 FKALILEYMRNGSLEKCLYSGN---YILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGI 915 (1057)
Q Consensus 839 ~~~lV~E~~~~gsL~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 915 (1057)
..++||||++. +|.+++.... ..++...+..++.|+++|++||| +++|+||||||.||+++++|.+||+|||+
T Consensus 91 ~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H---~~~IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLH---SHGILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCcceEEECCCCcEeeeccch
Confidence 88999999976 9999987765 34777899999999999999999 99999999999999999999999999999
Q ss_pred cccccCCCCccccccccccccccCccccCCC-CCCccchHHHHHHHHHHHhhCCCCCCcccccccc-----------hhh
Q 001544 916 AKLLIGEDQSMTQTQTLATLGYMAPEYGREG-RVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMT-----------LKH 983 (1057)
Q Consensus 916 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~-----------~~~ 983 (1057)
|+... -.....+..++|..|+|||++.+. .|+...|+||+||+++||++++.-|....+.+.. ...
T Consensus 167 Ara~~--ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~ 244 (323)
T KOG0594|consen 167 ARAFS--IPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKD 244 (323)
T ss_pred HHHhc--CCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccC
Confidence 98652 123346677899999999998877 6889999999999999999999877653221110 011
Q ss_pred hhhhccchhHHHhhhccc-ccc-cchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH--HHHhHH
Q 001544 984 WVNDFLPISMMKIIDANL-LIT-EDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR--LLKIRD 1049 (1057)
Q Consensus 984 ~~~~~~~~~~~~~~~~~~-~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~--L~~i~~ 1049 (1057)
|-... .....+... ... ........+...+...+++.+|++++|.+|.|++.+++| +.++.+
T Consensus 245 Wp~v~----~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~ 310 (323)
T KOG0594|consen 245 WPGVS----SLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPE 310 (323)
T ss_pred CCCcc----ccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccccc
Confidence 11000 000000000 000 000001111222478899999999999999999999998 665533
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=332.25 Aligned_cols=256 Identities=27% Similarity=0.481 Sum_probs=208.3
Q ss_pred CCCCCCceeccccCeEEEEEEec----CCcEEEEEEeeccc-hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEE
Q 001544 769 NGFSENNLIGRGSFGSVYIARLQ----NGIEVAVKTFDLQH-ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALI 843 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 843 (1057)
++|++.+.||+|+||+||+|.+. +...||||+++... .....++.+|+.++++++||||+++++++.+.+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 56888999999999999999864 24689999986543 34456788999999999999999999999999999999
Q ss_pred EEEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCC
Q 001544 844 LEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGED 923 (1057)
Q Consensus 844 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~ 923 (1057)
|||+++++|.+++......+++.++.+++.|++.|++||| +++|+||||||+||++++++.++++|||+++......
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd05033 84 TEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE 160 (266)
T ss_pred EEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence 9999999999999876667899999999999999999999 8999999999999999999999999999998764222
Q ss_pred CccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhh-CCCCCCcccccccchhhhhhhccchhHHHhhhcccc
Q 001544 924 QSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFT-RRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLL 1002 (1057)
Q Consensus 924 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1002 (1057)
.........++..|+|||...+..++.++||||||+++|||++ |..||......+ ..+.+....
T Consensus 161 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~--------------~~~~~~~~~- 225 (266)
T cd05033 161 ATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD--------------VIKAVEDGY- 225 (266)
T ss_pred cceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH--------------HHHHHHcCC-
Confidence 2222222334678999999988899999999999999999998 998985421110 011111000
Q ss_pred cccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHHHh
Q 001544 1003 ITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKI 1047 (1057)
Q Consensus 1003 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i 1047 (1057)
..+.+..++..+.+++.+|++.+|++||++.|++++|+++
T Consensus 226 -----~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 226 -----RLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred -----CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0011234567789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=339.05 Aligned_cols=251 Identities=25% Similarity=0.386 Sum_probs=213.9
Q ss_pred hCCCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccc--hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCe-eEEE
Q 001544 768 TNGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQH--ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDF-KALI 843 (1057)
Q Consensus 768 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~lV 843 (1057)
.++|...+++|+|+||.++.++.+ +++.|++|.+.... .........|+.++++++|||||.+.+.|.+++. .+||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 357888999999999999998644 67899999986543 3444577889999999999999999999999888 9999
Q ss_pred EEEccCCChhHHHhcCC-ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCC
Q 001544 844 LEYMRNGSLEKCLYSGN-YILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGE 922 (1057)
Q Consensus 844 ~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~ 922 (1057)
|+|++||++.+.+.+.+ ..+++.++..|+.|++.|+.||| +..|+|||||+.|||+++++.+|++|||+|+.+.+.
T Consensus 83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH---~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLH---ENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH---hhhhhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 99999999999987766 77999999999999999999999 999999999999999999999999999999988543
Q ss_pred CCccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhcccc
Q 001544 923 DQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLL 1002 (1057)
Q Consensus 923 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1002 (1057)
. ......+||+.||+||.+.+..|..|+|+||+||++|||++-+++|........ ..++....
T Consensus 160 ~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~L-------------i~ki~~~~-- 222 (426)
T KOG0589|consen 160 D--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSEL-------------ILKINRGL-- 222 (426)
T ss_pred h--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHH-------------HHHHhhcc--
Confidence 3 345567899999999999999999999999999999999999999876322111 12222211
Q ss_pred cccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 1003 ITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 1003 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
..+.+...+.++..++..|+..+|+.||++.+++.+
T Consensus 223 -----~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 223 -----YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred -----CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 123345678889999999999999999999999987
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=345.51 Aligned_cols=251 Identities=22% Similarity=0.345 Sum_probs=204.6
Q ss_pred CCCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccc---hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEE
Q 001544 769 NGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQH---ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALIL 844 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 844 (1057)
++|++.+.||+|+||.||+|+.. +++.||||+++... ......+.+|++++.+++||||+++++++.+++..|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36888999999999999999876 58999999996542 234567888999999999999999999999999999999
Q ss_pred EEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCC
Q 001544 845 EYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ 924 (1057)
Q Consensus 845 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 924 (1057)
||+++|+|.+++.... .+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNLG-VLSEDHARFYMAEMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--- 153 (333)
T ss_pred eCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEEEeCcCCccccc---
Confidence 9999999999987654 5889999999999999999999 99999999999999999999999999999986522
Q ss_pred ccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCccccccc--chhhhhhhccchhHHHhhhcccc
Q 001544 925 SMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEM--TLKHWVNDFLPISMMKIIDANLL 1002 (1057)
Q Consensus 925 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 1002 (1057)
......||+.|+|||++.+..++.++||||+||++|||++|+.||......+. ....|.. ...
T Consensus 154 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~---------~~~---- 218 (333)
T cd05600 154 --YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKE---------TLQ---- 218 (333)
T ss_pred --ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccc---------ccc----
Confidence 22345689999999999988999999999999999999999999865221110 0000100 000
Q ss_pred cccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 1003 ITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 1003 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
..........++.++.+++.+|+..+|++||++.|+++|
T Consensus 219 --~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 219 --RPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred --CCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 000000012356788999999999999999999999987
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=339.22 Aligned_cols=270 Identities=21% Similarity=0.272 Sum_probs=201.9
Q ss_pred hCCCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccch-hHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEE
Q 001544 768 TNGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQHE-RAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILE 845 (1057)
Q Consensus 768 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 845 (1057)
.++|++.+.||+|+||+||+|+.. +++.||||+++.... .....+.+|++++++++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 467999999999999999999865 689999999865432 223467789999999999999999999999999999999
Q ss_pred EccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCc
Q 001544 846 YMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS 925 (1057)
Q Consensus 846 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 925 (1057)
|++ +++.+++......++...+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++..... .
T Consensus 84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~--~ 157 (303)
T cd07869 84 YVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVP--S 157 (303)
T ss_pred CCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECCCCcceeccCC--C
Confidence 996 5888888766666899999999999999999999 999999999999999999999999999998754221 2
Q ss_pred cccccccccccccCccccCC-CCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhcc--chhH----H--Hh
Q 001544 926 MTQTQTLATLGYMAPEYGRE-GRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFL--PISM----M--KI 996 (1057)
Q Consensus 926 ~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~--~~~~----~--~~ 996 (1057)
.......+++.|+|||++.+ ..++.++||||+||++|||++|+.||.................. .... . ..
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (303)
T cd07869 158 HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPH 237 (303)
T ss_pred ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccc
Confidence 22334567899999998765 45788999999999999999999999764221111111100000 0000 0 00
Q ss_pred hhcccc-cccchhhH---HHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 997 IDANLL-ITEDKHFA---AKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 997 ~~~~~~-~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
.+.... ........ .....+..+.+++.+|++.||++|||+.|+++|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h 288 (303)
T cd07869 238 FKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH 288 (303)
T ss_pred cccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence 000000 00000000 001134578899999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=347.16 Aligned_cols=245 Identities=23% Similarity=0.317 Sum_probs=201.9
Q ss_pred CCCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccc---hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEE
Q 001544 769 NGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQH---ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALIL 844 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 844 (1057)
++|++.+.||+|+||.||+|+.. +++.||||+++... ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 46888999999999999999865 68999999986432 234567889999999999999999999999999999999
Q ss_pred EEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCC
Q 001544 845 EYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ 924 (1057)
Q Consensus 845 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 924 (1057)
||+++|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 98 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-- 171 (329)
T PTZ00263 98 EFVVGGELFTHLRKAG-RFPNDVAKFYHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR-- 171 (329)
T ss_pred cCCCCChHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC--
Confidence 9999999999987654 4888899999999999999999 999999999999999999999999999999865321
Q ss_pred ccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhcccccc
Q 001544 925 SMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLIT 1004 (1057)
Q Consensus 925 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1057)
.....||+.|+|||++.+..++.++||||+||++|||++|+.||..... ... ...+....
T Consensus 172 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~----~~~---------~~~i~~~~---- 231 (329)
T PTZ00263 172 ---TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP----FRI---------YEKILAGR---- 231 (329)
T ss_pred ---cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH----HHH---------HHHHhcCC----
Confidence 1234689999999999988899999999999999999999999864211 000 00111100
Q ss_pred cchhhHHHHHHHHHHHHHHhHcccCCCCCCCC-----HHHHHHH
Q 001544 1005 EDKHFAAKEQCASSVFNLAMECTVESPDERIT-----AKEIVRR 1043 (1057)
Q Consensus 1005 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~evl~~ 1043 (1057)
...+..++.++.+++.+||+.||++||+ +.|+++|
T Consensus 232 ----~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 232 ----LKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred ----cCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 0111224567889999999999999996 7888876
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=369.97 Aligned_cols=507 Identities=29% Similarity=0.335 Sum_probs=336.6
Q ss_pred EeeecccCcccccccccCCCCCcEEeCCCCCccccCCcccccccccceeecccccccCCCCccccccCCCCeEeccCCCC
Q 001544 76 LNISYLSLTGNIPRQLGNLSSLEILDLNFNRLSGEIPWELGNLAKLEKLLLHNNFLTGTIPFSIFKLSSLLDLKLSDNNL 155 (1057)
Q Consensus 76 l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l 155 (1057)
+|.++..+. .||..+..-..++.|+++.|-+-...-+.+...-+|+.|++++|+++ ..|..+..+.+|+.|+++.|.+
T Consensus 3 vd~s~~~l~-~ip~~i~~~~~~~~ln~~~N~~l~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i 80 (1081)
T KOG0618|consen 3 VDASDEQLE-LIPEQILNNEALQILNLRRNSLLSRPLEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYI 80 (1081)
T ss_pred cccccccCc-ccchhhccHHHHHhhhccccccccCchHHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchhhH
Confidence 456666666 67777766666888888888665222223444455888888888888 7888888888888888888888
Q ss_pred CCCCCcccccCCCCCceeEccCCcccccCchhhhccccCCeeEeeccCCccccCccccCCCCcccEEEeeccccccCccc
Q 001544 156 TGTIPSHNLGNLSSLQLLDLSDNQLSGSIPSFIFKISSLQALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGGISS 235 (1057)
Q Consensus 156 ~~~~p~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~l~~n~~~~~~~~ 235 (1057)
. .+|. .++++.+|++|.|.+|.+. ..|..+..+.+|+.|+++.|++. .+|.
T Consensus 81 ~-~vp~-s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~N~f~-~~Pl------------------------- 131 (1081)
T KOG0618|consen 81 R-SVPS-SCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSFNHFG-PIPL------------------------- 131 (1081)
T ss_pred h-hCch-hhhhhhcchhheeccchhh-cCchhHHhhhcccccccchhccC-CCch-------------------------
Confidence 7 6664 5888888888888888887 78888888888888888888885 4443
Q ss_pred cccCCCCCcEEEccCCCCcCCccccccCcCCCcEEeeeccccccccCccccccccccEEEeecCccccccCccccccccc
Q 001544 236 TLSNCKHLRILDLSFNDLWGDIPKEIGNLTKLKELFLDFNILQGEIPHTVGNLHNLEYLSLVNNELVGTVPATIFNVSTL 315 (1057)
Q Consensus 236 ~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 315 (1057)
.+..+..++.++.++|.... .++... ++.++|..|.+.+.++..+..++. .|||+.|.+. ...+.++.+|
T Consensus 132 ~i~~lt~~~~~~~s~N~~~~----~lg~~~-ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~---~~dls~~~~l 201 (1081)
T KOG0618|consen 132 VIEVLTAEEELAASNNEKIQ----RLGQTS-IKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEME---VLDLSNLANL 201 (1081)
T ss_pred hHHhhhHHHHHhhhcchhhh----hhcccc-chhhhhhhhhcccchhcchhhhhe--eeecccchhh---hhhhhhccch
Confidence 34556667777777772221 122222 777777777777777777776665 6888888775 2335567777
Q ss_pred cEEEecCCccccCCCCCcccCCCCCceEEecCccccccCCccccccccccccccccccccccccchhcccccccEEeccC
Q 001544 316 KLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSGTLPSFIFNASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYN 395 (1057)
Q Consensus 316 ~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 395 (1057)
+.|....|.+.. .....++|+.|+.++|.++...+. ....+|+++++++|++++. |+++..+.+|+.++..+
T Consensus 202 ~~l~c~rn~ls~-----l~~~g~~l~~L~a~~n~l~~~~~~--p~p~nl~~~dis~n~l~~l-p~wi~~~~nle~l~~n~ 273 (1081)
T KOG0618|consen 202 EVLHCERNQLSE-----LEISGPSLTALYADHNPLTTLDVH--PVPLNLQYLDISHNNLSNL-PEWIGACANLEALNANH 273 (1081)
T ss_pred hhhhhhhcccce-----EEecCcchheeeeccCcceeeccc--cccccceeeecchhhhhcc-hHHHHhcccceEecccc
Confidence 788877777652 112457888899999888843332 2346789999999999876 58899999999999999
Q ss_pred cccCCCccccccccCCCcchhhhhccCCCcccccccccccccccccEEEcCCCcccccccccccCccCCcEEEccCCcCC
Q 001544 396 NYLTSPELSFLSSLSNCKYLEIIALSGNPLNGIIPMSAGNLSHSLEELFMPDCNVSGRIPKEIGNLANLVTLDLGGNKFN 475 (1057)
Q Consensus 396 N~l~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~i~ 475 (1057)
|+++..+... ...++|+.|.+..|.+. -+|.....++.|++|||..|+|.
T Consensus 274 N~l~~lp~ri----~~~~~L~~l~~~~nel~--------------------------yip~~le~~~sL~tLdL~~N~L~ 323 (1081)
T KOG0618|consen 274 NRLVALPLRI----SRITSLVSLSAAYNELE--------------------------YIPPFLEGLKSLRTLDLQSNNLP 323 (1081)
T ss_pred hhHHhhHHHH----hhhhhHHHHHhhhhhhh--------------------------hCCCcccccceeeeeeehhcccc
Confidence 9886654332 33455666666666654 24455566778888888888888
Q ss_pred CCCCcccccccc-cceeecccccCcccCCcccccccccceEEecCeeeeecCCccccCcccccccccCCccccccccccc
Q 001544 476 GSIPIALGKLQK-LQLLNLDDNKLEGSIPDDICGLVELYKLALGDNKLSGQIPACFGNLASLRELWLGPNELISFIPSTF 554 (1057)
Q Consensus 476 ~~~p~~~~~l~~-L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~ 554 (1057)
...+..|..+.. |+.|+.+.|++.....-.=..+..|+.|++.+|.++...-..+.++.+|+.|+|++|++.+++...+
T Consensus 324 ~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~ 403 (1081)
T KOG0618|consen 324 SLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKL 403 (1081)
T ss_pred ccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHH
Confidence 443434444444 7777777777764433333344556666666776665554556666666666666666666666666
Q ss_pred cccccccEEEeccccccCCCchhhccccccceeccccccccccccccccCccccceecccccccccccCccccccCccce
Q 001544 555 WNIKDIMYVNFSSNFLTGPLPLEIENLKALTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQGSIPDSVGDLISLKS 634 (1057)
Q Consensus 555 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 634 (1057)
.++..|+.|+||+|+++. +|..+.++..|++|...+|+|. ..| .+..++.|+.+|+|.|+|+...-..-..-++|++
T Consensus 404 ~kle~LeeL~LSGNkL~~-Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~Lky 480 (1081)
T KOG0618|consen 404 RKLEELEELNLSGNKLTT-LPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKY 480 (1081)
T ss_pred hchHHhHHHhcccchhhh-hhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCCcccce
Confidence 666666666666666663 5566666666666666666665 444 5666666666666666665432222222256666
Q ss_pred ecccCccccCCCcccccCcccccccccCCC
Q 001544 635 LNLSNNNLSGPIPTSLEKLSDLKELNLSFN 664 (1057)
Q Consensus 635 L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N 664 (1057)
|||++|.-....-..|..+.++...++.-|
T Consensus 481 LdlSGN~~l~~d~~~l~~l~~l~~~~i~~~ 510 (1081)
T KOG0618|consen 481 LDLSGNTRLVFDHKTLKVLKSLSQMDITLN 510 (1081)
T ss_pred eeccCCcccccchhhhHHhhhhhheecccC
Confidence 666666532233344445555555555444
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=343.84 Aligned_cols=267 Identities=21% Similarity=0.289 Sum_probs=198.4
Q ss_pred CCCCCceeccccCeEEEEEEec-CCcEEEEEEeecc--chhHHHHHHHHHHHHHhcCCCCceeEeeeeccC-----CeeE
Q 001544 770 GFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQ--HERAFKSFDTECEVMKSIRHRNLTKIISSCSNE-----DFKA 841 (1057)
Q Consensus 770 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~ 841 (1057)
+|++.++||+|+||.||+|... +|+.||||++... ......++.+|++++++++||||+++++++... ...|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4788899999999999999854 6899999998643 223345788999999999999999999987432 3579
Q ss_pred EEEEEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccC
Q 001544 842 LILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIG 921 (1057)
Q Consensus 842 lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~ 921 (1057)
+||||++ ++|.+++.... .+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 81 lv~e~~~-~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 155 (338)
T cd07859 81 VVFELME-SDLHQVIKAND-DLTPEHHQFFLYQLLRALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFN 155 (338)
T ss_pred EEEecCC-CCHHHHHHhcc-cCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEccCcccccccc
Confidence 9999995 68988886554 4899999999999999999999 99999999999999999999999999999986432
Q ss_pred CCC-ccccccccccccccCccccCC--CCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhcc---c-----
Q 001544 922 EDQ-SMTQTQTLATLGYMAPEYGRE--GRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFL---P----- 990 (1057)
Q Consensus 922 ~~~-~~~~~~~~~t~~y~aPE~~~~--~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~---~----- 990 (1057)
... ........+|..|+|||++.+ ..++.++||||+||++|||++|+.||...... ....++.... +
T Consensus 156 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~ 233 (338)
T cd07859 156 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV--HQLDLITDLLGTPSPETIS 233 (338)
T ss_pred ccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChH--HHHHHHHHHhCCCCHHHHH
Confidence 221 122234578999999998765 67899999999999999999999998652211 0000110000 0
Q ss_pred ----hhHHHhhhcccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 991 ----ISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 991 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
.......+..............+.+++++.+++.+||+.||++||+++|+++|
T Consensus 234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 00001111000000000001112345678999999999999999999999987
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=350.33 Aligned_cols=257 Identities=26% Similarity=0.371 Sum_probs=208.6
Q ss_pred CCCCCCceeccccCeEEEEEEecCC-cEEEEEEeeccchhHHHHHHHHHHHHHhcC-CCCceeEeee-ecc------CCe
Q 001544 769 NGFSENNLIGRGSFGSVYIARLQNG-IEVAVKTFDLQHERAFKSFDTECEVMKSIR-HRNLTKIISS-CSN------EDF 839 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~-~~~------~~~ 839 (1057)
.++++.++|.+|||+.||.|.+..+ ..||+|++-..++.+.+.+.+||++|++|+ |+|||.+++. ... ..+
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E 116 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE 116 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence 3566789999999999999987765 999999997778888899999999999997 9999999993 211 246
Q ss_pred eEEEEEEccCCChhHHHhcCC-ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEccccccc
Q 001544 840 KALILEYMRNGSLEKCLYSGN-YILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL 918 (1057)
Q Consensus 840 ~~lV~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~ 918 (1057)
.++.||||.||.|-+++...- ..+++.++++|+.|+++|+++|| .+..+|||||||.+|||++.+|..||||||.|.-
T Consensus 117 vllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH-~~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt 195 (738)
T KOG1989|consen 117 VLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMH-YLKPPIIHRDLKIENVLLSADGNYKLCDFGSATT 195 (738)
T ss_pred EEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHh-cCCCccchhhhhhhheEEcCCCCEEeCccccccc
Confidence 789999999999999987433 34999999999999999999999 4567799999999999999999999999999975
Q ss_pred ccCCCCcc-------ccccccccccccCcccc---CCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhc
Q 001544 919 LIGEDQSM-------TQTQTLATLGYMAPEYG---REGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDF 988 (1057)
Q Consensus 919 ~~~~~~~~-------~~~~~~~t~~y~aPE~~---~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~ 988 (1057)
........ .......|+.|+|||.+ .+..+++|+|||++||++|-++....||++.-. .
T Consensus 196 ~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~--l--------- 264 (738)
T KOG1989|consen 196 KILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK--L--------- 264 (738)
T ss_pred ccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc--e---------
Confidence 32211111 11123468999999965 577899999999999999999999999987211 1
Q ss_pred cchhHHHhhhcccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHHHhHH
Q 001544 989 LPISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKIRD 1049 (1057)
Q Consensus 989 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~ 1049 (1057)
.++ .....++....++..+.+||+.||+++|++||++-+|+.++.++..
T Consensus 265 ------aIl------ng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~ 313 (738)
T KOG1989|consen 265 ------AIL------NGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN 313 (738)
T ss_pred ------eEE------eccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence 111 1111223334678889999999999999999999999999988864
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=330.74 Aligned_cols=255 Identities=25% Similarity=0.432 Sum_probs=206.9
Q ss_pred hCCCCCCceeccccCeEEEEEEecCCcEEEEEEeeccchhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEEc
Q 001544 768 TNGFSENNLIGRGSFGSVYIARLQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEYM 847 (1057)
Q Consensus 768 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 847 (1057)
.++|++.++||+|+||.||+|...+++.||+|.+.... ...+.+.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 34688899999999999999998888899999986543 23578899999999999999999999999999999999999
Q ss_pred cCCChhHHHhcC-CccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCcc
Q 001544 848 RNGSLEKCLYSG-NYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSM 926 (1057)
Q Consensus 848 ~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 926 (1057)
++|+|.+++... ...+++.++..++.|+++|++||| +.+++||||||+||++++++.++++|||.++...... ..
T Consensus 84 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~-~~ 159 (261)
T cd05072 84 AKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE-YT 159 (261)
T ss_pred CCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEecCCCcEEECCCccceecCCCc-ee
Confidence 999999998754 355889999999999999999999 8999999999999999999999999999998653221 11
Q ss_pred ccccccccccccCccccCCCCCCccchHHHHHHHHHHHhh-CCCCCCcccccccchhhhhhhccchhHHHhhhccccccc
Q 001544 927 TQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFT-RRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITE 1005 (1057)
Q Consensus 927 ~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1057)
......++..|+|||+...+.++.++|||||||++|||++ |+.||...... ....+ +....
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--~~~~~------------~~~~~---- 221 (261)
T cd05072 160 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS--DVMSA------------LQRGY---- 221 (261)
T ss_pred ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH--HHHHH------------HHcCC----
Confidence 1222345678999999988889999999999999999998 89998642111 01111 00000
Q ss_pred chhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHHHh
Q 001544 1006 DKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKI 1047 (1057)
Q Consensus 1006 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i 1047 (1057)
..+....++.++.+++.+|++.+|++||++.++.+.|+++
T Consensus 222 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 222 --RMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred --CCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 0111123566789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=342.26 Aligned_cols=242 Identities=25% Similarity=0.350 Sum_probs=197.4
Q ss_pred ceeccccCeEEEEEEec-CCcEEEEEEeeccc---hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEEccCC
Q 001544 775 NLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQH---ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEYMRNG 850 (1057)
Q Consensus 775 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g 850 (1057)
+.||+|+||.||+|... +|+.||+|+++... ......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999864 68999999996542 234566788999999999999999999999999999999999999
Q ss_pred ChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCcccccc
Q 001544 851 SLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQ 930 (1057)
Q Consensus 851 sL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 930 (1057)
+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++..... ......
T Consensus 81 ~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~--~~~~~~ 154 (323)
T cd05595 81 ELFFHLSRER-VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKT 154 (323)
T ss_pred cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEEcCCCCEEecccHHhccccCC--CCcccc
Confidence 9998887654 5899999999999999999999 999999999999999999999999999998753221 122233
Q ss_pred ccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhcccccccchhhH
Q 001544 931 TLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHFA 1010 (1057)
Q Consensus 931 ~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1057)
..||+.|+|||++.+..++.++||||+||++|||++|+.||......+. ......... .
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~-------------~~~~~~~~~--------~ 213 (323)
T cd05595 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL-------------FELILMEEI--------R 213 (323)
T ss_pred ccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHH-------------HHHHhcCCC--------C
Confidence 5689999999999988999999999999999999999999865211100 000100000 0
Q ss_pred HHHHHHHHHHHHHhHcccCCCCCCC-----CHHHHHHH
Q 001544 1011 AKEQCASSVFNLAMECTVESPDERI-----TAKEIVRR 1043 (1057)
Q Consensus 1011 ~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~ 1043 (1057)
.+..+++++.+++.+||+.||++|| ++.++++|
T Consensus 214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 214 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred CCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 1124567789999999999999998 89998876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=341.64 Aligned_cols=259 Identities=27% Similarity=0.442 Sum_probs=204.5
Q ss_pred CCCCCCceeccccCeEEEEEEec------CCcEEEEEEeeccc-hhHHHHHHHHHHHHHhc-CCCCceeEeeeecc-CCe
Q 001544 769 NGFSENNLIGRGSFGSVYIARLQ------NGIEVAVKTFDLQH-ERAFKSFDTECEVMKSI-RHRNLTKIISSCSN-EDF 839 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-~~~ 839 (1057)
++|++.++||+|+||.||+|... +++.||+|+++... ....+.+.+|++++.++ +||||++++++|.. +..
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~ 86 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP 86 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence 46888999999999999999532 35789999986432 33446778899999999 79999999998754 467
Q ss_pred eEEEEEEccCCChhHHHhcCC-----------------------------------------------------------
Q 001544 840 KALILEYMRNGSLEKCLYSGN----------------------------------------------------------- 860 (1057)
Q Consensus 840 ~~lV~E~~~~gsL~~~l~~~~----------------------------------------------------------- 860 (1057)
.++||||+++++|.+++....
T Consensus 87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (337)
T cd05054 87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY 166 (337)
T ss_pred EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence 889999999999999885422
Q ss_pred -ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCccccccccccccccC
Q 001544 861 -YILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMA 939 (1057)
Q Consensus 861 -~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~a 939 (1057)
..+++.++.+++.||++|++||| +.+|+||||||+||++++++.+||+|||+++.+.............++..|+|
T Consensus 167 ~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 243 (337)
T cd05054 167 KEPLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 243 (337)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence 25789999999999999999999 99999999999999999999999999999987643332222333455678999
Q ss_pred ccccCCCCCCccchHHHHHHHHHHHhh-CCCCCCcccccccchhhhhhhccchhHHHhhhcccccccchhhHHHHHHHHH
Q 001544 940 PEYGREGRVSTKGDVYSFGILLMETFT-RRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHFAAKEQCASS 1018 (1057)
Q Consensus 940 PE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1018 (1057)
||++.+..++.++||||+||++|||++ |..||......+ .. .+.+.... ....+..++++
T Consensus 244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~-~~------------~~~~~~~~------~~~~~~~~~~~ 304 (337)
T cd05054 244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE-EF------------CRRLKEGT------RMRAPEYATPE 304 (337)
T ss_pred cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH-HH------------HHHHhccC------CCCCCccCCHH
Confidence 999999999999999999999999998 999986522111 01 01111000 00111234567
Q ss_pred HHHHHhHcccCCCCCCCCHHHHHHHHHHhHH
Q 001544 1019 VFNLAMECTVESPDERITAKEIVRRLLKIRD 1049 (1057)
Q Consensus 1019 l~~li~~cl~~dP~~Rps~~evl~~L~~i~~ 1049 (1057)
+.+++.+||+.+|++||++.|++++|+++.+
T Consensus 305 ~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 305 IYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 8999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=341.57 Aligned_cols=242 Identities=26% Similarity=0.375 Sum_probs=197.9
Q ss_pred ceeccccCeEEEEEEec-CCcEEEEEEeeccc---hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEEccCC
Q 001544 775 NLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQH---ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEYMRNG 850 (1057)
Q Consensus 775 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g 850 (1057)
+.||+|+||.||+|... +|+.||||++.... ......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999854 68999999996532 334567888999999999999999999999999999999999999
Q ss_pred ChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCcccccc
Q 001544 851 SLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQ 930 (1057)
Q Consensus 851 sL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 930 (1057)
+|.+++.... .+++.++..++.||+.||+||| +++|+||||||+||+++.++.+||+|||+++..... ......
T Consensus 81 ~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~--~~~~~~ 154 (328)
T cd05593 81 ELFFHLSRER-VFSEDRTRFYGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD--AATMKT 154 (328)
T ss_pred CHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeEECCCCcEEEecCcCCccCCCc--cccccc
Confidence 9998886654 5899999999999999999999 999999999999999999999999999998753211 122233
Q ss_pred ccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhcccccccchhhH
Q 001544 931 TLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHFA 1010 (1057)
Q Consensus 931 ~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1057)
..||+.|+|||++.+..++.++||||+||++|||++|+.||...... .. .+.+... ...
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~-----~~---------~~~~~~~-------~~~ 213 (328)
T cd05593 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----KL---------FELILME-------DIK 213 (328)
T ss_pred ccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH-----HH---------HHHhccC-------Ccc
Confidence 56899999999999889999999999999999999999998652111 00 0100000 001
Q ss_pred HHHHHHHHHHHHHhHcccCCCCCCC-----CHHHHHHH
Q 001544 1011 AKEQCASSVFNLAMECTVESPDERI-----TAKEIVRR 1043 (1057)
Q Consensus 1011 ~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~ 1043 (1057)
.+..++.++.+++.+|++.||++|| ++.|+++|
T Consensus 214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 214 FPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 1123567789999999999999997 89999877
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=330.92 Aligned_cols=260 Identities=22% Similarity=0.372 Sum_probs=206.2
Q ss_pred CCCCCCceeccccCeEEEEEEec-CCc----EEEEEEeeccc-hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEE
Q 001544 769 NGFSENNLIGRGSFGSVYIARLQ-NGI----EVAVKTFDLQH-ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKAL 842 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 842 (1057)
.+|++.+.||+|+||+||+|.+. +++ .||+|.+.... .....++..|+..+++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 46788899999999999999864 344 47888775332 3345678888999999999999999999864 45678
Q ss_pred EEEEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCC
Q 001544 843 ILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGE 922 (1057)
Q Consensus 843 V~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~ 922 (1057)
|+||+++|+|.+++......+++..+..|+.||+.|++||| +++++||||||+||++++++.+|++|||.++.....
T Consensus 86 i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPD 162 (279)
T ss_pred EEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence 99999999999999877667999999999999999999999 899999999999999999999999999999876433
Q ss_pred CCccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhh-CCCCCCcccccccchhhhhhhccchhHHHhhhccc
Q 001544 923 DQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFT-RRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANL 1001 (1057)
Q Consensus 923 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1001 (1057)
..........++..|+|||...++.++.++||||||+++||+++ |+.||...... ...+.+....
T Consensus 163 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~--------------~~~~~~~~~~ 228 (279)
T cd05111 163 DKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH--------------EVPDLLEKGE 228 (279)
T ss_pred CcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH--------------HHHHHHHCCC
Confidence 32223334456778999999988899999999999999999998 99998652111 0111111111
Q ss_pred ccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHHHhHHHHh
Q 001544 1002 LITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKIRDFLL 1052 (1057)
Q Consensus 1002 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~~ 1052 (1057)
. ...+..++.++.+++.+||..+|++||++.|+++.+..+.+.-+
T Consensus 229 ~------~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~~ 273 (279)
T cd05111 229 R------LAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDPP 273 (279)
T ss_pred c------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCCc
Confidence 0 01112245567889999999999999999999999998876433
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=303.27 Aligned_cols=253 Identities=26% Similarity=0.346 Sum_probs=207.3
Q ss_pred hCCCCCCceeccccCeEEEEEEe-cCCcEEEEEEeeccc--------hhHHHHHHHHHHHHHhc-CCCCceeEeeeeccC
Q 001544 768 TNGFSENNLIGRGSFGSVYIARL-QNGIEVAVKTFDLQH--------ERAFKSFDTECEVMKSI-RHRNLTKIISSCSNE 837 (1057)
Q Consensus 768 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 837 (1057)
-+.|...+.+|.|..++|.++.. .+|..+|+|++.... ....++-.+|+.+++++ .||+|+++.++|+.+
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 34677788999999999998864 478999999985321 12345566799999999 599999999999999
Q ss_pred CeeEEEEEEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccc
Q 001544 838 DFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK 917 (1057)
Q Consensus 838 ~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~ 917 (1057)
...++|+|.|+.|.|.|++.+.- .++++...+|++|+.+|++||| .+.|||||+||+|||++++..+||+|||+|+
T Consensus 96 sF~FlVFdl~prGELFDyLts~V-tlSEK~tR~iMrqlfegVeylH---a~~IVHRDLKpENILlddn~~i~isDFGFa~ 171 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYLTSKV-TLSEKETRRIMRQLFEGVEYLH---ARNIVHRDLKPENILLDDNMNIKISDFGFAC 171 (411)
T ss_pred chhhhhhhhcccchHHHHhhhhe-eecHHHHHHHHHHHHHHHHHHH---HhhhhhcccChhheeeccccceEEeccceee
Confidence 99999999999999999997754 5999999999999999999999 9999999999999999999999999999999
Q ss_pred cccCCCCccccccccccccccCccccCC------CCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccch
Q 001544 918 LLIGEDQSMTQTQTLATLGYMAPEYGRE------GRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPI 991 (1057)
Q Consensus 918 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~------~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 991 (1057)
.+.+ .......+||++|.|||.+.- ..|+..+|.|+.||++|-++.|.+||..-.+ .
T Consensus 172 ~l~~---GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ--------------m 234 (411)
T KOG0599|consen 172 QLEP---GEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ--------------M 234 (411)
T ss_pred ccCC---chhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH--------------H
Confidence 8743 345566789999999998652 3477899999999999999999999854100 0
Q ss_pred hHHHhhhcccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHH
Q 001544 992 SMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRL 1044 (1057)
Q Consensus 992 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 1044 (1057)
-+...+-.. ...-+-+.+.+.+...++++.+|++.||.+|.|++|+++|=
T Consensus 235 lMLR~ImeG---kyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHp 284 (411)
T KOG0599|consen 235 LMLRMIMEG---KYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHP 284 (411)
T ss_pred HHHHHHHhc---ccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcCh
Confidence 111222111 11223345567888999999999999999999999999874
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=356.81 Aligned_cols=251 Identities=22% Similarity=0.292 Sum_probs=204.5
Q ss_pred CCCCCceeccccCeEEEEEEec-C-CcEEEEEEeeccchhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEEc
Q 001544 770 GFSENNLIGRGSFGSVYIARLQ-N-GIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEYM 847 (1057)
Q Consensus 770 ~~~~~~~lg~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 847 (1057)
.|...+.||+|+||.||+|... + ++.||+|.+..........+.+|+++++.++||||+++++++..++..|+||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 4888899999999999999744 3 6789999876655566677888999999999999999999999999999999999
Q ss_pred cCCChhHHHhcC---CccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCC
Q 001544 848 RNGSLEKCLYSG---NYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ 924 (1057)
Q Consensus 848 ~~gsL~~~l~~~---~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 924 (1057)
++|+|.+++... ..++++.++..++.||+.||+||| +++|+||||||+||+++.++.+||+|||+++.+.....
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999999887542 346889999999999999999999 99999999999999999999999999999987643222
Q ss_pred ccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhcccccc
Q 001544 925 SMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLIT 1004 (1057)
Q Consensus 925 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1057)
........||++|+|||++.+..++.++||||+||++|||++|+.||...... .. .........
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~-----~~--------~~~~~~~~~--- 288 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR-----EI--------MQQVLYGKY--- 288 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH-----HH--------HHHHHhCCC---
Confidence 22233456899999999999889999999999999999999999998652111 00 001110000
Q ss_pred cchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 1005 EDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 1005 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
.+.+..++.++.+++.+||..||++||++.+++.+
T Consensus 289 ----~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 289 ----DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred ----CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 01112356778999999999999999999999764
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=338.59 Aligned_cols=242 Identities=22% Similarity=0.323 Sum_probs=201.4
Q ss_pred hCCCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccc---hhHHHHHHHHHHHHHhc-CCCCceeEeeeeccCCeeEE
Q 001544 768 TNGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQH---ERAFKSFDTECEVMKSI-RHRNLTKIISSCSNEDFKAL 842 (1057)
Q Consensus 768 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 842 (1057)
.++|...++||+|+||+|++|..+ +++.+|||++++.. +...+..+.|.+++... +||.+++++.+|...++.|+
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f 446 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF 446 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence 457899999999999999999865 68899999997653 44567778888888877 59999999999999999999
Q ss_pred EEEEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCC
Q 001544 843 ILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGE 922 (1057)
Q Consensus 843 V~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~ 922 (1057)
||||+.||++..+.+. ..+++..+.-++..|+.||+||| +++|||||||.+|||+|.+|++||+|||+++.-..
T Consensus 447 vmey~~Ggdm~~~~~~--~~F~e~rarfyaAev~l~L~fLH---~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~- 520 (694)
T KOG0694|consen 447 VMEYVAGGDLMHHIHT--DVFSEPRARFYAAEVVLGLQFLH---ENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG- 520 (694)
T ss_pred EEEecCCCcEEEEEec--ccccHHHHHHHHHHHHHHHHHHH---hcCceeeecchhheEEcccCcEEecccccccccCC-
Confidence 9999999995544433 45999999999999999999999 99999999999999999999999999999986432
Q ss_pred CCccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhcccc
Q 001544 923 DQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLL 1002 (1057)
Q Consensus 923 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1002 (1057)
.........||+.|||||++.+..|+..+|-|||||++|||+.|+.||.+..+ .+++|....
T Consensus 521 -~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddE-----------------ee~FdsI~~ 582 (694)
T KOG0694|consen 521 -QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDE-----------------EEVFDSIVN 582 (694)
T ss_pred -CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCH-----------------HHHHHHHhc
Confidence 22355567899999999999999999999999999999999999999975211 122222221
Q ss_pred cccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCH
Q 001544 1003 ITEDKHFAAKEQCASSVFNLAMECTVESPDERITA 1037 (1057)
Q Consensus 1003 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~ 1037 (1057)
.+. ..+..++.+..+++++++..+|++|..+
T Consensus 583 d~~----~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 583 DEV----RYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred CCC----CCCCcccHHHHHHHHHHhccCcccccCC
Confidence 111 1224567889999999999999999955
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=325.56 Aligned_cols=248 Identities=27% Similarity=0.447 Sum_probs=199.3
Q ss_pred ceeccccCeEEEEEEec-CCcEEEEEEeeccc-hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEEccCCCh
Q 001544 775 NLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQH-ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEYMRNGSL 852 (1057)
Q Consensus 775 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL 852 (1057)
+.||+|+||.||+|+.. +++.||+|.+.... ......+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46999999999999864 68999999875433 34457789999999999999999999999999999999999999999
Q ss_pred hHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCcccccccc
Q 001544 853 EKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTL 932 (1057)
Q Consensus 853 ~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 932 (1057)
.+++......+++.++..++.|+++||+||| +.+|+||||||+||+++.++.+|++|||++................
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 157 (252)
T cd05084 81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ 157 (252)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence 9999776666899999999999999999999 9999999999999999999999999999987643211111111122
Q ss_pred ccccccCccccCCCCCCccchHHHHHHHHHHHhh-CCCCCCcccccccchhhhhhhccchhHHHhhhcccccccchhhHH
Q 001544 933 ATLGYMAPEYGREGRVSTKGDVYSFGILLMETFT-RRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHFAA 1011 (1057)
Q Consensus 933 ~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1011 (1057)
.+..|+|||.+.++.++.++||||+|+++|||++ |..||...... .....+.... ....
T Consensus 158 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~--------------~~~~~~~~~~------~~~~ 217 (252)
T cd05084 158 IPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ--------------QTREAIEQGV------RLPC 217 (252)
T ss_pred CceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH--------------HHHHHHHcCC------CCCC
Confidence 3457999999988889999999999999999998 88887542111 0111111110 0111
Q ss_pred HHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHH
Q 001544 1012 KEQCASSVFNLAMECTVESPDERITAKEIVRRLL 1045 (1057)
Q Consensus 1012 ~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 1045 (1057)
+..++..+.+++.+|++.+|++||++.|+.+.|+
T Consensus 218 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 218 PELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 2345678899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=340.09 Aligned_cols=240 Identities=25% Similarity=0.305 Sum_probs=195.3
Q ss_pred eccccCeEEEEEEec-CCcEEEEEEeecc---chhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEEccCCCh
Q 001544 777 IGRGSFGSVYIARLQ-NGIEVAVKTFDLQ---HERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEYMRNGSL 852 (1057)
Q Consensus 777 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL 852 (1057)
||+|+||+||+|+.. +++.||+|+++.. .......+.+|++++++++||||+++++++.+++..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999865 5889999998643 233456778899999999999999999999999999999999999999
Q ss_pred hHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCcccccccc
Q 001544 853 EKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTL 932 (1057)
Q Consensus 853 ~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 932 (1057)
.+++.... .+++..+..++.|+++||+||| +++|+||||||+||+++.++.+||+|||+++..... ........
T Consensus 81 ~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~ 154 (312)
T cd05585 81 FHHLQREG-RFDLSRARFYTAELLCALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD--DDKTNTFC 154 (312)
T ss_pred HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHeEECCCCcEEEEECcccccCccC--CCcccccc
Confidence 99987654 4899999999999999999999 999999999999999999999999999998754221 12233456
Q ss_pred ccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhcccccccchhhHHH
Q 001544 933 ATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHFAAK 1012 (1057)
Q Consensus 933 ~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1012 (1057)
||+.|+|||++.+..++.++||||+||++|||++|+.||..... .... ...... ....+
T Consensus 155 gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~-----~~~~--------~~~~~~--------~~~~~ 213 (312)
T cd05585 155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV-----NEMY--------RKILQE--------PLRFP 213 (312)
T ss_pred CCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH-----HHHH--------HHHHcC--------CCCCC
Confidence 89999999999998999999999999999999999999865211 1110 011100 01111
Q ss_pred HHHHHHHHHHHhHcccCCCCCCC---CHHHHHHH
Q 001544 1013 EQCASSVFNLAMECTVESPDERI---TAKEIVRR 1043 (1057)
Q Consensus 1013 ~~~~~~l~~li~~cl~~dP~~Rp---s~~evl~~ 1043 (1057)
..+++++.+++.+||+.||++|| ++.|++.|
T Consensus 214 ~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 214 DGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred CcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 34567789999999999999997 46777765
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=331.15 Aligned_cols=256 Identities=29% Similarity=0.504 Sum_probs=211.3
Q ss_pred HhCCCCCCceeccccCeEEEEEEecCCcEEEEEEeeccchhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEE
Q 001544 767 ATNGFSENNLIGRGSFGSVYIARLQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEY 846 (1057)
Q Consensus 767 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 846 (1057)
...+|+..++||+|+||.||+|...++..||+|++.........++.+|++++++++||||+++++++.+.+..++||||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 34568889999999999999999888999999999776665667899999999999999999999999999999999999
Q ss_pred ccCCChhHHHhcCC-ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCc
Q 001544 847 MRNGSLEKCLYSGN-YILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS 925 (1057)
Q Consensus 847 ~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 925 (1057)
+++++|.+++.... ..+++.++..++.|++.|++||| +.+|+||||||+||++++++.+||+|||.+.......
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~-- 158 (261)
T cd05148 84 MEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV-- 158 (261)
T ss_pred cccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccCcceEEEcCCceEEEccccchhhcCCcc--
Confidence 99999999997643 45899999999999999999999 8999999999999999999999999999997653221
Q ss_pred cccccccccccccCccccCCCCCCccchHHHHHHHHHHHhh-CCCCCCcccccccchhhhhhhccchhHHHhhhcccccc
Q 001544 926 MTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFT-RRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLIT 1004 (1057)
Q Consensus 926 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1057)
.......++..|+|||......++.++||||||+++|+|++ |+.||......+ ....+...
T Consensus 159 ~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~--------------~~~~~~~~---- 220 (261)
T cd05148 159 YLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE--------------VYDQITAG---- 220 (261)
T ss_pred ccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH--------------HHHHHHhC----
Confidence 11223345678999999988889999999999999999998 888986522110 00111100
Q ss_pred cchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHHHh
Q 001544 1005 EDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKI 1047 (1057)
Q Consensus 1005 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i 1047 (1057)
.+.+.+..++.++.+++.+||+.||++|||++++.+.|+.+
T Consensus 221 --~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 221 --YRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred --CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 01112234567889999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=333.26 Aligned_cols=259 Identities=27% Similarity=0.488 Sum_probs=209.8
Q ss_pred CCCCCCceeccccCeEEEEEEec------CCcEEEEEEeeccchhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEE
Q 001544 769 NGFSENNLIGRGSFGSVYIARLQ------NGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKAL 842 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 842 (1057)
.+|...+.||+|+||.||+|... ++..||+|.++.......+.+.+|++++++++||||+++++++.+.+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 35777899999999999999742 356799999876665666789999999999999999999999999999999
Q ss_pred EEEEccCCChhHHHhcCC---------------ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCc
Q 001544 843 ILEYMRNGSLEKCLYSGN---------------YILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMV 907 (1057)
Q Consensus 843 V~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~ 907 (1057)
||||+++++|.+++.... ..+++.+++.++.|++.|++||| +++|+||||||+||+++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCc
Confidence 999999999999986532 34789999999999999999999 999999999999999999999
Q ss_pred EEEEcccccccccCCCCccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhh-CCCCCCcccccccchhhhhh
Q 001544 908 AHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFT-RRKPTDEIFSGEMTLKHWVN 986 (1057)
Q Consensus 908 ~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~ 986 (1057)
++|+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |+.||......+
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-------- 233 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE-------- 233 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--------
Confidence 99999999976533222222334456788999999988899999999999999999999 999976522111
Q ss_pred hccchhHHHhhhcccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHHHhHHH
Q 001544 987 DFLPISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKIRDF 1050 (1057)
Q Consensus 987 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~ 1050 (1057)
..+.+..... ......++..+.+++.+||+.+|++||++.++++.|+++...
T Consensus 234 ------~~~~~~~~~~------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 234 ------VIECITQGRV------LERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred ------HHHHHhCCCC------CCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 0010100000 001123466789999999999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=341.45 Aligned_cols=246 Identities=22% Similarity=0.287 Sum_probs=201.8
Q ss_pred hCCCCCCceeccccCeEEEEEEecC--CcEEEEEEeeccc---hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEE
Q 001544 768 TNGFSENNLIGRGSFGSVYIARLQN--GIEVAVKTFDLQH---ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKAL 842 (1057)
Q Consensus 768 ~~~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 842 (1057)
.++|++.+.||+|+||.||+|...+ +..||+|++.... ....+.+.+|+++++.++||||+++++++.+.+..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 3468889999999999999997543 3689999986432 2345678899999999999999999999999999999
Q ss_pred EEEEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCC
Q 001544 843 ILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGE 922 (1057)
Q Consensus 843 V~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~ 922 (1057)
||||+++|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 109 v~Ey~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~- 183 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRNK-RFPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT- 183 (340)
T ss_pred EEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC-
Confidence 999999999999987654 5899999999999999999999 99999999999999999999999999999986522
Q ss_pred CCccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhcccc
Q 001544 923 DQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLL 1002 (1057)
Q Consensus 923 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1002 (1057)
......||+.|+|||++.+..++.++||||+||++|||++|+.||...... .. ...+.....
T Consensus 184 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~----~~---------~~~i~~~~~- 245 (340)
T PTZ00426 184 ----RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL----LI---------YQKILEGII- 245 (340)
T ss_pred ----CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH----HH---------HHHHhcCCC-
Confidence 122346899999999998888999999999999999999999998652110 00 011111110
Q ss_pred cccchhhHHHHHHHHHHHHHHhHcccCCCCCCC-----CHHHHHHH
Q 001544 1003 ITEDKHFAAKEQCASSVFNLAMECTVESPDERI-----TAKEIVRR 1043 (1057)
Q Consensus 1003 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~ 1043 (1057)
..+...+..+.+++.+|++.||++|+ +++|+++|
T Consensus 246 -------~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 246 -------YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred -------CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 01123456788999999999999995 89999887
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=333.04 Aligned_cols=255 Identities=30% Similarity=0.515 Sum_probs=206.1
Q ss_pred CCCCCCceeccccCeEEEEEEec------CCcEEEEEEeeccchh-HHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeE
Q 001544 769 NGFSENNLIGRGSFGSVYIARLQ------NGIEVAVKTFDLQHER-AFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKA 841 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 841 (1057)
.+|.+.+.||+|+||.||+|... +++.||||.++..... ..+.+.+|++++++++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 45778899999999999999753 3578999999655433 5678999999999999999999999999999999
Q ss_pred EEEEEccCCChhHHHhcCC-------------ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcE
Q 001544 842 LILEYMRNGSLEKCLYSGN-------------YILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVA 908 (1057)
Q Consensus 842 lV~E~~~~gsL~~~l~~~~-------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~ 908 (1057)
+||||+++++|.+++...+ ..+++.++..++.|++.|++||| +.+++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA---SQHFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeeccccccceEEEcCCCeE
Confidence 9999999999999986542 34788899999999999999999 9999999999999999999999
Q ss_pred EEEcccccccccCCCCccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhh-CCCCCCcccccccchhhhhhh
Q 001544 909 HLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFT-RRKPTDEIFSGEMTLKHWVND 987 (1057)
Q Consensus 909 kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~ 987 (1057)
|++|||.++...............++..|+|||++.+..++.++||||+||++|||++ |..||......+
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~--------- 232 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE--------- 232 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH---------
Confidence 9999999976533222222233445778999999999999999999999999999998 999986522111
Q ss_pred ccchhHHHhhhcccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHHH
Q 001544 988 FLPISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLK 1046 (1057)
Q Consensus 988 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 1046 (1057)
..+.+..... ...+..++.++.+++.+||..+|++||++.|+++.|++
T Consensus 233 -----~~~~~~~~~~------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 233 -----VIECITQGRL------LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred -----HHHHHHcCCc------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 0111111000 01112356778999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=328.30 Aligned_cols=252 Identities=24% Similarity=0.415 Sum_probs=203.6
Q ss_pred CCCCCCceeccccCeEEEEEEecCCcEEEEEEeeccchhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEEcc
Q 001544 769 NGFSENNLIGRGSFGSVYIARLQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEYMR 848 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 848 (1057)
++|++.+.||+|+||+||+|+..++..||||.+.... .....+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 3577889999999999999988877789999986433 234678899999999999999999999998889999999999
Q ss_pred CCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCcccc
Q 001544 849 NGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQ 928 (1057)
Q Consensus 849 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 928 (1057)
+|+|.+++......+++.+++.++.||+.|++||| +.+++|+||||+||+++.++.+||+|||.++...... ....
T Consensus 83 ~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~-~~~~ 158 (256)
T cd05113 83 NGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE-YTSS 158 (256)
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCCEEECCCccceecCCCc-eeec
Confidence 99999999876657899999999999999999999 9999999999999999999999999999987653221 1122
Q ss_pred ccccccccccCccccCCCCCCccchHHHHHHHHHHHhh-CCCCCCcccccccchhhhhhhccchhHHHhhhcccccccch
Q 001544 929 TQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFT-RRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDK 1007 (1057)
Q Consensus 929 ~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1057)
....++..|+|||...+..++.++||||||+++|||++ |+.||......+ ..+.+.....
T Consensus 159 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~--------------~~~~~~~~~~----- 219 (256)
T cd05113 159 VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE--------------TVEKVSQGLR----- 219 (256)
T ss_pred CCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH--------------HHHHHhcCCC-----
Confidence 22345678999999988889999999999999999999 999986422110 0011100000
Q ss_pred hhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHH
Q 001544 1008 HFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLL 1045 (1057)
Q Consensus 1008 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 1045 (1057)
...+...+..+.+++.+||+.+|++||++.++++.++
T Consensus 220 -~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 220 -LYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred -CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 0001123567899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=315.10 Aligned_cols=250 Identities=26% Similarity=0.382 Sum_probs=214.1
Q ss_pred CCCCCceeccccCeEEEEEEe-cCCcEEEEEEeeccchhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEEcc
Q 001544 770 GFSENNLIGRGSFGSVYIARL-QNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEYMR 848 (1057)
Q Consensus 770 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 848 (1057)
-|.++++||+|+||+||+|.. .+|+.||||.+.. +...+++.+|+.+|++++.|++|+++|.|-.....++|||||.
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG 111 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG 111 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence 366778999999999999964 4799999999754 3456888999999999999999999998888888899999999
Q ss_pred CCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCcccc
Q 001544 849 NGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQ 928 (1057)
Q Consensus 849 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 928 (1057)
.|+..+.++.+++++++.++..|++.-++||+||| ..+-+|||||+.|||++.+|.+|++|||.|..+.. .-...
T Consensus 112 AGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH---~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD--TMAKR 186 (502)
T KOG0574|consen 112 AGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLH---DLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTD--TMAKR 186 (502)
T ss_pred CCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHH---HHHHHHhhcccccEEEcccchhhhhhccccchhhh--hHHhh
Confidence 99999999999999999999999999999999999 78889999999999999999999999999987632 22234
Q ss_pred ccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhcccccccchh
Q 001544 929 TQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKH 1008 (1057)
Q Consensus 929 ~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1008 (1057)
...+||+.|||||++..-.|..++|+||+|++..||..|++||.+...-.. ++ .....+.+.
T Consensus 187 NTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA----------------IF--MIPT~PPPT 248 (502)
T KOG0574|consen 187 NTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRA----------------IF--MIPTKPPPT 248 (502)
T ss_pred CccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccce----------------eE--eccCCCCCC
Confidence 456899999999999998999999999999999999999999987433211 00 011223334
Q ss_pred hHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHH
Q 001544 1009 FAAKEQCASSVFNLAMECTVESPDERITAKEIVRRL 1044 (1057)
Q Consensus 1009 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 1044 (1057)
+..++..+.++.+++++|+-..|++|.|+.++++|-
T Consensus 249 F~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~ 284 (502)
T KOG0574|consen 249 FKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHT 284 (502)
T ss_pred CCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhh
Confidence 556678889999999999999999999999999874
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=337.47 Aligned_cols=267 Identities=21% Similarity=0.330 Sum_probs=204.1
Q ss_pred hCCCCCCceeccccCeEEEEEEec-CCcEEEEEEeecc-chhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEE
Q 001544 768 TNGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQ-HERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILE 845 (1057)
Q Consensus 768 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 845 (1057)
.++|++.+.||+|+||.||+|... ++..||+|.+... .......+.+|++++++++||||++++++|.+++..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 367999999999999999999865 6889999998654 33445778999999999999999999999999999999999
Q ss_pred EccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCC-CCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCC
Q 001544 846 YMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYS-APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ 924 (1057)
Q Consensus 846 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~-~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 924 (1057)
|+++|+|.+++.... .+++..+..++.|++.|++||| + .+|+||||||+||++++++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH---~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-- 157 (333)
T cd06650 84 HMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 157 (333)
T ss_pred cCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh--
Confidence 999999999987654 4889999999999999999999 6 47999999999999999999999999998754221
Q ss_pred ccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccch-------hhhhhhc---------
Q 001544 925 SMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTL-------KHWVNDF--------- 988 (1057)
Q Consensus 925 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~-------~~~~~~~--------- 988 (1057)
......++..|+|||.+.+..++.++||||+||++|||++|+.||......+... ..+....
T Consensus 158 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (333)
T cd06650 158 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPG 235 (333)
T ss_pred --ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCcc
Confidence 1223468899999999998889999999999999999999999987532211100 0000000
Q ss_pred ------cc-----hhHHHhhhcccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHH
Q 001544 989 ------LP-----ISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRL 1044 (1057)
Q Consensus 989 ------~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 1044 (1057)
.+ .......+..... ...... ....+.++.+++.+||+.||++|||+.|+++|-
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~-~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~ 300 (333)
T cd06650 236 RPLSSYGPDSRPPMAIFELLDYIVNE-PPPKLP-SGVFGAEFQDFVNKCLIKNPAERADLKQLMVHA 300 (333)
T ss_pred chhhhhcccccccccHHHHHHHHhcC-CCccCC-CCCcCHHHHHHHHHhccCCcccCcCHHHHhhCH
Confidence 00 0000000000000 000000 012356789999999999999999999998763
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=330.43 Aligned_cols=255 Identities=26% Similarity=0.476 Sum_probs=204.6
Q ss_pred CCCCCCceeccccCeEEEEEEe-----cCCcEEEEEEeeccc-hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEE
Q 001544 769 NGFSENNLIGRGSFGSVYIARL-----QNGIEVAVKTFDLQH-ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKAL 842 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 842 (1057)
.+|++.+.||+|+||+||+|.. .++..||+|.+.... ......+.+|++++++++||||+++++++..++..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 3577889999999999999974 246889999986433 3445778999999999999999999999999999999
Q ss_pred EEEEccCCChhHHHhcCC----------------ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCC
Q 001544 843 ILEYMRNGSLEKCLYSGN----------------YILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNM 906 (1057)
Q Consensus 843 V~E~~~~gsL~~~l~~~~----------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~ 906 (1057)
||||+++++|.+++.... ..+++.++..++.|++.|++||| +++++||||||+||++++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS---SHFFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hcCeehhccccceEEEcCCC
Confidence 999999999999985321 24788899999999999999999 89999999999999999999
Q ss_pred cEEEEcccccccccCCCCccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhh-CCCCCCcccccccchhhhh
Q 001544 907 VAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFT-RRKPTDEIFSGEMTLKHWV 985 (1057)
Q Consensus 907 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~ 985 (1057)
.+|++|||+++...............++..|+|||+..+..++.++||||||+++|||++ |..||.....
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~--------- 232 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN--------- 232 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH---------
Confidence 999999999986543332222333445678999999988889999999999999999999 8888754211
Q ss_pred hhccchhHHHhhhcccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHHH
Q 001544 986 NDFLPISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLK 1046 (1057)
Q Consensus 986 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 1046 (1057)
....+.++.... .+.+..++.++.+++.+|++.||++||++.++.++++.
T Consensus 233 -----~~~~~~~~~~~~------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 233 -----QEVIEMVRKRQL------LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred -----HHHHHHHHcCCc------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 011111111110 11123456788999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=325.77 Aligned_cols=258 Identities=24% Similarity=0.341 Sum_probs=207.9
Q ss_pred CCCCCCceeccccCeEEEEEEec-CCcEEEEEEeecc---chhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEE
Q 001544 769 NGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQ---HERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALIL 844 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 844 (1057)
++|++.+.||+|+||.||+|+.. +++.||||.++.. ......++.+|++++++++||||+++++++.+.+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 47889999999999999999854 7899999987542 2344567889999999999999999999999999999999
Q ss_pred EEccCCChhHHHhc---CCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccC
Q 001544 845 EYMRNGSLEKCLYS---GNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIG 921 (1057)
Q Consensus 845 E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~ 921 (1057)
||+++|+|.+++.. ....+++.++..++.|+++|++||| +.+++||||||+||+++.++.++++|||.+..+..
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 99999999988753 2345889999999999999999999 99999999999999999999999999999886532
Q ss_pred CCCccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhccc
Q 001544 922 EDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANL 1001 (1057)
Q Consensus 922 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1001 (1057)
.. .......++..|+|||...+..++.++|+||+|+++|||++|+.||...... ...+. ..+....
T Consensus 159 ~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~---~~~~~---------~~~~~~~ 224 (267)
T cd08228 159 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN---LFSLC---------QKIEQCD 224 (267)
T ss_pred hh--HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc---HHHHH---------HHHhcCC
Confidence 21 1222345788999999998888999999999999999999999998542111 11111 1111100
Q ss_pred ccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHHHhH
Q 001544 1002 LITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKIR 1048 (1057)
Q Consensus 1002 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~ 1048 (1057)
. ........+..+.+++.+||..+|++||++.|+++.+++++
T Consensus 225 ~-----~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 225 Y-----PPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred C-----CCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 0 00011245677899999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=327.00 Aligned_cols=255 Identities=29% Similarity=0.479 Sum_probs=206.6
Q ss_pred hCCCCCCceeccccCeEEEEEEecCCcEEEEEEeeccchhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEEc
Q 001544 768 TNGFSENNLIGRGSFGSVYIARLQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEYM 847 (1057)
Q Consensus 768 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 847 (1057)
.++|++.+.||+|++|.||+|...+++.||||.++... ...+.+.+|++++++++||||+++++++...+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 35688889999999999999998778899999986543 23467889999999999999999999999999999999999
Q ss_pred cCCChhHHHhcCC-ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCcc
Q 001544 848 RNGSLEKCLYSGN-YILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSM 926 (1057)
Q Consensus 848 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 926 (1057)
++++|.+++.... ..+++.++..++.|++.|++||| +.+|+||||||+||++++++.+||+|||+++...... ..
T Consensus 84 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~-~~ 159 (261)
T cd05068 84 KYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDI-YE 159 (261)
T ss_pred cCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCc-cc
Confidence 9999999987644 56899999999999999999999 8999999999999999999999999999998763211 11
Q ss_pred ccccccccccccCccccCCCCCCccchHHHHHHHHHHHhh-CCCCCCcccccccchhhhhhhccchhHHHhhhccccccc
Q 001544 927 TQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFT-RRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITE 1005 (1057)
Q Consensus 927 ~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1057)
.......+..|+|||+..+..++.++||||||+++|||++ |+.||...... .....++...
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--------------~~~~~~~~~~---- 221 (261)
T cd05068 160 AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA--------------EVLQQVDQGY---- 221 (261)
T ss_pred ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH--------------HHHHHHHcCC----
Confidence 1111223457999999988899999999999999999999 99888652111 0111111110
Q ss_pred chhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHHHh
Q 001544 1006 DKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKI 1047 (1057)
Q Consensus 1006 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i 1047 (1057)
..+....++..+.+++.+|++.+|++||++.++.+.|+++
T Consensus 222 --~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 222 --RMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred --CCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 0111124567789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=330.03 Aligned_cols=268 Identities=25% Similarity=0.429 Sum_probs=207.2
Q ss_pred CCCCCCceeccccCeEEEEEEe-----cCCcEEEEEEeeccchhHHHHHHHHHHHHHhcCCCCceeEeeeecc--CCeeE
Q 001544 769 NGFSENNLIGRGSFGSVYIARL-----QNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCSN--EDFKA 841 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~ 841 (1057)
.+|++.+.||+|+||+||+|.. .++..||||++........+.+.+|++++++++||||+++++++.. ....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 4688889999999999999974 2578999999977666667889999999999999999999998643 45688
Q ss_pred EEEEEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccC
Q 001544 842 LILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIG 921 (1057)
Q Consensus 842 lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~ 921 (1057)
+||||+++|+|.+++...+..+++..+..++.|++.||+||| +++|+||||||+||++++++.+||+|||+++....
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 160 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ 160 (284)
T ss_pred EEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence 999999999999999876667899999999999999999999 99999999999999999999999999999987633
Q ss_pred CCCcccc-ccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccc-----hhHHH
Q 001544 922 EDQSMTQ-TQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLP-----ISMMK 995 (1057)
Q Consensus 922 ~~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~-----~~~~~ 995 (1057)
....... ....++..|+|||...+..++.++||||+||++|||++|..|+...... .......... ....+
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05081 161 DKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE---FMRMMGNDKQGQMIVYHLIE 237 (284)
T ss_pred CCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh---hhhhcccccccccchHHHHH
Confidence 2221111 1122344699999998888999999999999999999998775432110 0000000000 00111
Q ss_pred hhhcccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHHHhH
Q 001544 996 IIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKIR 1048 (1057)
Q Consensus 996 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~ 1048 (1057)
.... ....+....++.++.+++.+||+.+|++|||+.|+++.|+.++
T Consensus 238 ~~~~------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~~ 284 (284)
T cd05081 238 LLKN------NGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284 (284)
T ss_pred HHhc------CCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhcC
Confidence 1111 1111122345678999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=342.08 Aligned_cols=264 Identities=20% Similarity=0.217 Sum_probs=200.0
Q ss_pred hCCCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccchhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEE
Q 001544 768 TNGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEY 846 (1057)
Q Consensus 768 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 846 (1057)
..+|++.+.||+|+||.||+|... +++.||+|... ...+.+|++++++++||||+++++++......++|+|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 357999999999999999999754 68999999753 23467899999999999999999999999999999999
Q ss_pred ccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCcc
Q 001544 847 MRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSM 926 (1057)
Q Consensus 847 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 926 (1057)
+. ++|.+++.... .+++.+++.++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 165 ~~-~~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~ylH---~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~-~~ 238 (391)
T PHA03212 165 YK-TDLYCYLAAKR-NIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN-AN 238 (391)
T ss_pred CC-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHhEEEcCCCCEEEEeCCccccccccc-cc
Confidence 95 68888876544 4889999999999999999999 8999999999999999999999999999997542211 12
Q ss_pred ccccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCccccc--c----cchhhhhhhcc------ch---
Q 001544 927 TQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSG--E----MTLKHWVNDFL------PI--- 991 (1057)
Q Consensus 927 ~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~--~----~~~~~~~~~~~------~~--- 991 (1057)
......||+.|+|||++.+..++.++||||+||++|||++|+.||-..... . ..+...+.... +.
T Consensus 239 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~ 318 (391)
T PHA03212 239 KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQ 318 (391)
T ss_pred ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchh
Confidence 223457899999999998889999999999999999999999886432111 0 01111100000 00
Q ss_pred -hHHHhh---hcccc--cccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 992 -SMMKII---DANLL--ITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 992 -~~~~~~---~~~~~--~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
.....+ ..... ......+......+.++.+++.+|++.||++|||++|+++|
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 319 ANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 000000 00000 00111122223457789999999999999999999999975
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=331.29 Aligned_cols=257 Identities=24% Similarity=0.403 Sum_probs=203.3
Q ss_pred HhCCCCCCceeccccCeEEEEEEec------CCcEEEEEEeeccc-hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCe
Q 001544 767 ATNGFSENNLIGRGSFGSVYIARLQ------NGIEVAVKTFDLQH-ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDF 839 (1057)
Q Consensus 767 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 839 (1057)
..++|+..+.||+|+||.||+|... .+..||||++.... .....++.+|+.++++++||||+++++++.+...
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 3567899999999999999999743 35679999985432 3345678899999999999999999999999999
Q ss_pred eEEEEEEccCCChhHHHhcCC---------ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEE
Q 001544 840 KALILEYMRNGSLEKCLYSGN---------YILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHL 910 (1057)
Q Consensus 840 ~~lV~E~~~~gsL~~~l~~~~---------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl 910 (1057)
.++||||+++|+|.+++.... ...++.++..++.|+++|++||| +.+++||||||+||++++++.+++
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCcchheEEEcCCCCEEE
Confidence 999999999999999986532 23678889999999999999999 899999999999999999999999
Q ss_pred EcccccccccCCCCccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhh-CCCCCCcccccccchhhhhhhcc
Q 001544 911 SDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFT-RRKPTDEIFSGEMTLKHWVNDFL 989 (1057)
Q Consensus 911 ~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 989 (1057)
+|||+++...............++..|+|||++.++.++.++|||||||++|||++ |..||...... .
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~-----~------ 229 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE-----Q------ 229 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-----H------
Confidence 99999876533222222222345678999999988889999999999999999999 67887542111 1
Q ss_pred chhHHHhhhcccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHHH
Q 001544 990 PISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLK 1046 (1057)
Q Consensus 990 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 1046 (1057)
..+.+..... ...+..++..+.+++.+|++.+|++||++.|+++++++
T Consensus 230 ---~~~~~~~~~~------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 230 ---VLRFVMEGGL------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred ---HHHHHHcCCc------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 0111000000 00112346678999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=344.04 Aligned_cols=253 Identities=23% Similarity=0.330 Sum_probs=204.1
Q ss_pred CCCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccc---hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEE
Q 001544 769 NGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQH---ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALIL 844 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 844 (1057)
++|++.+.||+|+||+||+|... +|+.||||+++... ....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 36888999999999999999865 68999999997542 234567889999999999999999999999999999999
Q ss_pred EEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCC
Q 001544 845 EYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ 924 (1057)
Q Consensus 845 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 924 (1057)
||+++|+|.+++......+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++........
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 157 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVH---QMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM 157 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence 999999999999877667999999999999999999999 99999999999999999999999999999986532221
Q ss_pred ccccccccccccccCccccC------CCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhh
Q 001544 925 SMTQTQTLATLGYMAPEYGR------EGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIID 998 (1057)
Q Consensus 925 ~~~~~~~~~t~~y~aPE~~~------~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 998 (1057)
.......||+.|+|||++. ...++.++||||+||++|||++|+.||......+ . ...+..
T Consensus 158 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~-----~--------~~~i~~ 223 (330)
T cd05601 158 -VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK-----T--------YNNIMN 223 (330)
T ss_pred -eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH-----H--------HHHHHc
Confidence 1223346899999999876 4567899999999999999999999986521110 0 011111
Q ss_pred cccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 999 ANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 999 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
... ....+....++.++.+++.+|+. +|++||++.++++|
T Consensus 224 ~~~----~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 224 FQR----FLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred CCC----ccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 000 00111112356778999999998 99999999999876
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=327.05 Aligned_cols=254 Identities=28% Similarity=0.456 Sum_probs=205.1
Q ss_pred CCCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccchhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEEc
Q 001544 769 NGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEYM 847 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 847 (1057)
.+|++.+.||+|+||.||+|... +++.||+|++.... ...+.+.+|++++++++||||+++++++..++..++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 35777899999999999999865 58899999986443 33567889999999999999999999999999999999999
Q ss_pred cCCChhHHHhcCC-ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCcc
Q 001544 848 RNGSLEKCLYSGN-YILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSM 926 (1057)
Q Consensus 848 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 926 (1057)
++++|.+++.... ..+++..+..++.|+++|++||| +.+++||||||+||++++++.+||+|||.+........ .
T Consensus 85 ~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~-~ 160 (263)
T cd05052 85 TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-T 160 (263)
T ss_pred CCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCcEEeCCCcccccccccee-e
Confidence 9999999987543 45899999999999999999999 89999999999999999999999999999986532211 1
Q ss_pred ccccccccccccCccccCCCCCCccchHHHHHHHHHHHhh-CCCCCCcccccccchhhhhhhccchhHHHhhhccccccc
Q 001544 927 TQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFT-RRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITE 1005 (1057)
Q Consensus 927 ~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1057)
......++.+|+|||...+..++.++|||||||++|||++ |..||..... ..+ .+.+....
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~-----~~~---------~~~~~~~~---- 222 (263)
T cd05052 161 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-----SQV---------YELLEKGY---- 222 (263)
T ss_pred ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH-----HHH---------HHHHHCCC----
Confidence 1112233568999999988899999999999999999998 8888754211 110 11111110
Q ss_pred chhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHHHh
Q 001544 1006 DKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKI 1047 (1057)
Q Consensus 1006 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i 1047 (1057)
....++.++.++.+++.+||+.+|++||++.|+++.|+.+
T Consensus 223 --~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 223 --RMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred --CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 0111234567899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=326.16 Aligned_cols=250 Identities=28% Similarity=0.462 Sum_probs=202.2
Q ss_pred CCCCCceeccccCeEEEEEEecCCcEEEEEEeeccchhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEEccC
Q 001544 770 GFSENNLIGRGSFGSVYIARLQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEYMRN 849 (1057)
Q Consensus 770 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 849 (1057)
+|++.+.||+|+||.||+|..+++..+|+|.+..... ....+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 5778899999999999999988778899999864322 235678899999999999999999999999999999999999
Q ss_pred CChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCccccc
Q 001544 850 GSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQT 929 (1057)
Q Consensus 850 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 929 (1057)
++|.+++......+++..+..++.|+++|++||| +.+++||||||+||++++++.+|++|||.++...... .....
T Consensus 84 ~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~-~~~~~ 159 (256)
T cd05059 84 GCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ-YTSSQ 159 (256)
T ss_pred CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHhhEEECCCCcEEECCcccceeccccc-ccccC
Confidence 9999999876667899999999999999999999 9999999999999999999999999999987653211 11111
Q ss_pred cccccccccCccccCCCCCCccchHHHHHHHHHHHhh-CCCCCCcccccccchhhhhhhccchhHHHhhhcccccccchh
Q 001544 930 QTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFT-RRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKH 1008 (1057)
Q Consensus 930 ~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1008 (1057)
...++..|+|||...+..++.++||||||+++||+++ |+.||......+ ..+.+.... .
T Consensus 160 ~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--------------~~~~~~~~~------~ 219 (256)
T cd05059 160 GTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE--------------VVESVSAGY------R 219 (256)
T ss_pred CCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH--------------HHHHHHcCC------c
Confidence 2223457999999988899999999999999999999 788886421111 001111100 0
Q ss_pred hHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHH
Q 001544 1009 FAAKEQCASSVFNLAMECTVESPDERITAKEIVRRL 1044 (1057)
Q Consensus 1009 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 1044 (1057)
...+..++.++.+++.+||+.+|++||++.|+++.|
T Consensus 220 ~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 220 LYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 011123567899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=346.32 Aligned_cols=253 Identities=23% Similarity=0.347 Sum_probs=201.7
Q ss_pred CCCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccc---hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEE
Q 001544 769 NGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQH---ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALIL 844 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 844 (1057)
++|++.+.||+|+||+||+|+.. +|+.||||+++... ......+.+|+++++.++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 46889999999999999999865 68999999996532 334567888999999999999999999999999999999
Q ss_pred EEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCC
Q 001544 845 EYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ 924 (1057)
Q Consensus 845 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 924 (1057)
||+++|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.+.....
T Consensus 81 E~~~~g~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 156 (364)
T cd05599 81 EYLPGGDMMTLLMKKD-TFTEEETRFYIAETILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHR 156 (364)
T ss_pred CCCCCcHHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEeecccceecccccc
Confidence 9999999999987654 5899999999999999999999 99999999999999999999999999999875422110
Q ss_pred cc------------------------------------ccccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCC
Q 001544 925 SM------------------------------------TQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRR 968 (1057)
Q Consensus 925 ~~------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~ 968 (1057)
.. ......||+.|+|||++....++.++||||+||++|||++|+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~ 236 (364)
T cd05599 157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY 236 (364)
T ss_pred ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCC
Confidence 00 011235899999999998889999999999999999999999
Q ss_pred CCCCcccccccchhhhhhhccchhHHHhhhcccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCC---HHHHHHH
Q 001544 969 KPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERIT---AKEIVRR 1043 (1057)
Q Consensus 969 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps---~~evl~~ 1043 (1057)
.||......+. ...+.... .....+....+++++.+++.+|+. +|.+|++ +.|+++|
T Consensus 237 ~Pf~~~~~~~~-------------~~~i~~~~----~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 237 PPFCSDNPQET-------------YRKIINWK----ETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCCCCHHHH-------------HHHHHcCC----CccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 99865221100 00111000 000001111346678899999996 9999998 9999886
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=328.64 Aligned_cols=266 Identities=25% Similarity=0.387 Sum_probs=204.2
Q ss_pred CCCceeccccCeEEEEEEe-----cCCcEEEEEEeeccc-hhHHHHHHHHHHHHHhcCCCCceeEeeeecc--CCeeEEE
Q 001544 772 SENNLIGRGSFGSVYIARL-----QNGIEVAVKTFDLQH-ERAFKSFDTECEVMKSIRHRNLTKIISSCSN--EDFKALI 843 (1057)
Q Consensus 772 ~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lV 843 (1057)
+..+.||+|+||+||++.. .++..||+|+++... ......+.+|++++++++||||+++++++.. ....++|
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 7889999999999988653 357899999986543 2345678899999999999999999998765 3467899
Q ss_pred EEEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCC
Q 001544 844 LEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGED 923 (1057)
Q Consensus 844 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~ 923 (1057)
|||+++++|.+++.... +++.++..++.|++.|++||| +.+|+||||||+||++++++.+|++|||+++......
T Consensus 87 ~e~~~~~~l~~~~~~~~--l~~~~~~~i~~~l~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 161 (283)
T cd05080 87 MEYVPLGSLRDYLPKHK--LNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH 161 (283)
T ss_pred ecCCCCCCHHHHHHHcC--CCHHHHHHHHHHHHHHHHHHH---HCCeeccccChheEEEcCCCcEEEeecccccccCCcc
Confidence 99999999999987643 899999999999999999999 9999999999999999999999999999998653222
Q ss_pred Ccc-ccccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhc-cchhHHHhhhccc
Q 001544 924 QSM-TQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDF-LPISMMKIIDANL 1001 (1057)
Q Consensus 924 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 1001 (1057)
... ......++..|+|||...+..++.++||||||+++|||++|+.||............+.... ......+..+...
T Consensus 162 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (283)
T cd05080 162 EYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGM 241 (283)
T ss_pred hhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcCC
Confidence 111 11223355679999999888899999999999999999999999865322111111111000 0001111111111
Q ss_pred ccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHHHhH
Q 001544 1002 LITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKIR 1048 (1057)
Q Consensus 1002 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~ 1048 (1057)
..+.+..++.++.+++.+||+.+|++||+++++++.|++++
T Consensus 242 ------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 242 ------RLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred ------CCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 11122345678999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=342.11 Aligned_cols=254 Identities=22% Similarity=0.292 Sum_probs=197.7
Q ss_pred CCCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccc---hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEE
Q 001544 769 NGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQH---ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALIL 844 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 844 (1057)
++|+..+.||+|+||+||+|... +++.||||+++... ......+.+|++++.+++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 46888999999999999999754 68999999996532 233467888999999999999999999999999999999
Q ss_pred EEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCC
Q 001544 845 EYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ 924 (1057)
Q Consensus 845 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 924 (1057)
||+++|+|.+++...+ .+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.+.....
T Consensus 81 E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH---~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~ 156 (363)
T cd05628 81 EFLPGGDMMTLLMKKD-TLTEEETQFYIAETVLAIDSIH---QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHR 156 (363)
T ss_pred cCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCCEEEeeccCccccccccc
Confidence 9999999999987654 5899999999999999999999 99999999999999999999999999999875432110
Q ss_pred c---------------------------------cccccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCC
Q 001544 925 S---------------------------------MTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPT 971 (1057)
Q Consensus 925 ~---------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~ 971 (1057)
. .......||+.|+|||++.+..++.++||||+||++|||++|+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf 236 (363)
T cd05628 157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (363)
T ss_pred ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCC
Confidence 0 0012346899999999999889999999999999999999999998
Q ss_pred CcccccccchhhhhhhccchhHHHhhhcccccccchhhHHHHHHHHHHHHHHhHccc--CCCCCCCCHHHHHHH
Q 001544 972 DEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTV--ESPDERITAKEIVRR 1043 (1057)
Q Consensus 972 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~--~dP~~Rps~~evl~~ 1043 (1057)
......+ . ...+..... ...++....++.++.+++.+++. .++..||++.|+++|
T Consensus 237 ~~~~~~~----~---------~~~i~~~~~----~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 237 CSETPQE----T---------YKKVMNWKE----TLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCCCHHH----H---------HHHHHcCcC----cccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 6521111 0 001110000 00011111245667788887554 233356899999987
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=344.96 Aligned_cols=253 Identities=21% Similarity=0.301 Sum_probs=199.0
Q ss_pred CCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccc---hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEE
Q 001544 770 GFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQH---ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILE 845 (1057)
Q Consensus 770 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 845 (1057)
.|+..+.||+|+||+||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5788899999999999999754 68999999996532 3345678899999999999999999999999999999999
Q ss_pred EccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCC-
Q 001544 846 YMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ- 924 (1057)
Q Consensus 846 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~- 924 (1057)
|+++|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.+.....
T Consensus 82 ~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~~LH---~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~ 157 (381)
T cd05626 82 YIPGGDMMSLLIRME-VFPEVLARFYIAELTLAIESVH---KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNS 157 (381)
T ss_pred cCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccc
Confidence 999999999987654 4889999999999999999999 99999999999999999999999999999754311000
Q ss_pred --------------------------------------------ccccccccccccccCccccCCCCCCccchHHHHHHH
Q 001544 925 --------------------------------------------SMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGIL 960 (1057)
Q Consensus 925 --------------------------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~i 960 (1057)
........||+.|+|||++.+..++.++||||+||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i 237 (381)
T cd05626 158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI 237 (381)
T ss_pred ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence 000112468999999999988889999999999999
Q ss_pred HHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhcccccccchhhHHHHHHHHHHHHHHhH--cccCCCCCCCCHH
Q 001544 961 LMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHFAAKEQCASSVFNLAME--CTVESPDERITAK 1038 (1057)
Q Consensus 961 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~--cl~~dP~~Rps~~ 1038 (1057)
+|||++|+.||......+. ...+...... ...+....+++++.+++.+ |+..+|..||++.
T Consensus 238 l~elltG~~Pf~~~~~~~~-------------~~~i~~~~~~----~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~ 300 (381)
T cd05626 238 LFEMLVGQPPFLAPTPTET-------------QLKVINWENT----LHIPPQVKLSPEAVDLITKLCCSAEERLGRNGAD 300 (381)
T ss_pred HHHHHhCCCCCcCCCHHHH-------------HHHHHccccc----cCCCCCCCCCHHHHHHHHHHccCcccccCCCCHH
Confidence 9999999999975321111 0111110000 0111112346778899988 5556666799999
Q ss_pred HHHHH
Q 001544 1039 EIVRR 1043 (1057)
Q Consensus 1039 evl~~ 1043 (1057)
|+++|
T Consensus 301 ~~l~h 305 (381)
T cd05626 301 DIKAH 305 (381)
T ss_pred HHhcC
Confidence 99987
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=334.38 Aligned_cols=245 Identities=28% Similarity=0.434 Sum_probs=206.5
Q ss_pred ceeccccCeEEEEEEec-CCcEEEEEEeeccchhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEEccCCChh
Q 001544 775 NLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEYMRNGSLE 853 (1057)
Q Consensus 775 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL~ 853 (1057)
-++|+|.||+||-|++. +...+|||.+........+.+.+|+.+.++++|.|||+++|.+.++++.-+.||-++||+|.
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 37999999999999865 56789999997777777788999999999999999999999999999999999999999999
Q ss_pred HHHhcCCccC--CHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeC-CCCcEEEEcccccccccCCCCcccccc
Q 001544 854 KCLYSGNYIL--DIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLIGEDQSMTQTQ 930 (1057)
Q Consensus 854 ~~l~~~~~~l--~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 930 (1057)
+.++..=.++ .+.+.--+.+||++||.||| +..|||||||-+|||++ -.|.+||+|||-++++.+- ......
T Consensus 661 sLLrskWGPlKDNEstm~fYtkQILeGLkYLH---en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi--nP~TET 735 (1226)
T KOG4279|consen 661 SLLRSKWGPLKDNESTMNFYTKQILEGLKYLH---ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI--NPCTET 735 (1226)
T ss_pred HHHHhccCCCccchhHHHHHHHHHHHHhhhhh---hcceeeccccCCcEEEeeccceEEecccccchhhccC--Cccccc
Confidence 9998765556 67778889999999999999 99999999999999997 6899999999999987432 223334
Q ss_pred ccccccccCccccCCCC--CCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhcccccccchh
Q 001544 931 TLATLGYMAPEYGREGR--VSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKH 1008 (1057)
Q Consensus 931 ~~~t~~y~aPE~~~~~~--~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1008 (1057)
..||..|||||++..+. |+.++|||||||++.||.||++||.+.-.+ ...++.... ...+
T Consensus 736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgsp---------------qAAMFkVGm---yKvH 797 (1226)
T KOG4279|consen 736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSP---------------QAAMFKVGM---YKVH 797 (1226)
T ss_pred cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCCh---------------hHhhhhhcc---eecC
Confidence 57999999999997664 788999999999999999999999763222 112222221 2234
Q ss_pred hHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHH
Q 001544 1009 FAAKEQCASSVFNLAMECTVESPDERITAKEIVR 1042 (1057)
Q Consensus 1009 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 1042 (1057)
.+.+++++.+...++.+|+.+||.+||+|+++++
T Consensus 798 P~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 798 PPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred CCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 4566788999999999999999999999999875
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=355.13 Aligned_cols=255 Identities=24% Similarity=0.340 Sum_probs=204.8
Q ss_pred HHhCCCCCCceeccccCeEEEEEEe-cCCcEEEEEEeecc--chhHHHHHHHHHHHHHhcCCCCceeEeeeeccCC----
Q 001544 766 QATNGFSENNLIGRGSFGSVYIARL-QNGIEVAVKTFDLQ--HERAFKSFDTECEVMKSIRHRNLTKIISSCSNED---- 838 (1057)
Q Consensus 766 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---- 838 (1057)
...++|++.+.||+|+||+||+|+. .+|+.||||++... .......+.+|+.++..++|+||+++++.+...+
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 3456899999999999999999975 47999999998644 3345567889999999999999999988764332
Q ss_pred ----eeEEEEEEccCCChhHHHhcC---CccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEE
Q 001544 839 ----FKALILEYMRNGSLEKCLYSG---NYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLS 911 (1057)
Q Consensus 839 ----~~~lV~E~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~ 911 (1057)
..++||||+++|+|.+++... ...+++..+..++.|++.||+|+| +.+|+||||||+||+++.++.+||+
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH---~~~IiHrDLKP~NILl~~~~~vkL~ 185 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVH---SKHMIHRDIKSANILLCSNGLVKLG 185 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEeCCCCEEEE
Confidence 367999999999999988653 246899999999999999999999 9999999999999999999999999
Q ss_pred cccccccccCCCCccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccch
Q 001544 912 DFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPI 991 (1057)
Q Consensus 912 Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 991 (1057)
|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||.... ...+..
T Consensus 186 DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~-----~~~~~~----- 255 (496)
T PTZ00283 186 DFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN-----MEEVMH----- 255 (496)
T ss_pred ecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC-----HHHHHH-----
Confidence 9999986543222222334568999999999999899999999999999999999999986521 111110
Q ss_pred hHHHhhhcccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 992 SMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 992 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
...... ..+.+..+++++.+++.+||+.||++||++.+++++
T Consensus 256 ---~~~~~~-------~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 256 ---KTLAGR-------YDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred ---HHhcCC-------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 111000 001123456789999999999999999999999876
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=326.59 Aligned_cols=254 Identities=25% Similarity=0.356 Sum_probs=203.1
Q ss_pred CCCCCCceeccccCeEEEEEEe-cCCcEEEEEEeeccchhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEEc
Q 001544 769 NGFSENNLIGRGSFGSVYIARL-QNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEYM 847 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 847 (1057)
.+|++.+.||+|+||.||+|+. .+++.||+|++..........+.+|+.++++++||||+++++++..++..++||||+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 4688999999999999999986 468999999997655455567889999999999999999999999999999999999
Q ss_pred cCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCccc
Q 001544 848 RNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMT 927 (1057)
Q Consensus 848 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 927 (1057)
++++|.+++.... .+++.++..++.|+++|++||| +.+|+|||+||+||+++.++.+||+|||++..+.... ..
T Consensus 89 ~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~--~~ 162 (267)
T cd06646 89 GGGSLQDIYHVTG-PLSELQIAYVCRETLQGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI--AK 162 (267)
T ss_pred CCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEECcCccceeecccc--cc
Confidence 9999999887544 5899999999999999999999 8999999999999999999999999999998653211 12
Q ss_pred cccccccccccCccccC---CCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhcccccc
Q 001544 928 QTQTLATLGYMAPEYGR---EGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLIT 1004 (1057)
Q Consensus 928 ~~~~~~t~~y~aPE~~~---~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1057)
.....++..|+|||.+. ...++.++||||+||++|||++|+.||......+.. ..+.. ...
T Consensus 163 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~-~~~~~------------~~~--- 226 (267)
T cd06646 163 RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL-FLMSK------------SNF--- 226 (267)
T ss_pred cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh-eeeec------------CCC---
Confidence 23346788999999874 345788999999999999999999998542211100 00000 000
Q ss_pred cchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHH
Q 001544 1005 EDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRL 1044 (1057)
Q Consensus 1005 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 1044 (1057)
...........+.++.+++.+||..+|++||+++++++++
T Consensus 227 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 227 QPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CCCCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 0001111123456789999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=343.07 Aligned_cols=247 Identities=25% Similarity=0.406 Sum_probs=194.8
Q ss_pred CCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccc-hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEEc
Q 001544 770 GFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQH-ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEYM 847 (1057)
Q Consensus 770 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 847 (1057)
+|+..++||+|+||.||+|+.. +++.||||++.... ......+.+|++++++++|+||+++++++.+.+..++||||+
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 154 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM 154 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence 4566789999999999999865 68999999986543 344577899999999999999999999999999999999999
Q ss_pred cCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCccc
Q 001544 848 RNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMT 927 (1057)
Q Consensus 848 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 927 (1057)
++|+|.+. ...++..+..++.||+.||+||| +.+|+||||||+||++++++.+||+|||+++...... ..
T Consensus 155 ~~~~L~~~-----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~~ 224 (353)
T PLN00034 155 DGGSLEGT-----HIADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM--DP 224 (353)
T ss_pred CCCccccc-----ccCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEcccccceeccccc--cc
Confidence 99998653 23567788899999999999999 9999999999999999999999999999998653211 12
Q ss_pred cccccccccccCccccCC-----CCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhcccc
Q 001544 928 QTQTLATLGYMAPEYGRE-----GRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLL 1002 (1057)
Q Consensus 928 ~~~~~~t~~y~aPE~~~~-----~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1002 (1057)
.....||..|+|||++.. ...+.++|||||||++|||++|+.||...... .|... ..... .
T Consensus 225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~-----~~~~~-----~~~~~----~ 290 (353)
T PLN00034 225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG-----DWASL-----MCAIC----M 290 (353)
T ss_pred ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc-----cHHHH-----HHHHh----c
Confidence 234568999999998743 23456899999999999999999998732111 11110 00000 0
Q ss_pred cccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 1003 ITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 1003 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
.........++.++.+++.+||+.||++||++.|+++|
T Consensus 291 ---~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 291 ---SQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred ---cCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00011112456789999999999999999999999987
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=345.57 Aligned_cols=253 Identities=25% Similarity=0.382 Sum_probs=205.6
Q ss_pred CCCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccc---hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEE
Q 001544 769 NGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQH---ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALIL 844 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 844 (1057)
++|++.+.||+|+||+||+|+.. +|+.||||+++... ......+.+|++++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 36888999999999999999865 68999999996542 234567889999999999999999999999999999999
Q ss_pred EEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCC-
Q 001544 845 EYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGED- 923 (1057)
Q Consensus 845 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~- 923 (1057)
||+++|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++......
T Consensus 81 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 156 (350)
T cd05573 81 EYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVH---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKD 156 (350)
T ss_pred cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCc
Confidence 999999999998776 45899999999999999999999 8999999999999999999999999999998653322
Q ss_pred --------------------------CccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCccccc
Q 001544 924 --------------------------QSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSG 977 (1057)
Q Consensus 924 --------------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~ 977 (1057)
.........||+.|+|||++.+..++.++||||+||++|||++|+.||......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~ 236 (350)
T cd05573 157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ 236 (350)
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHH
Confidence 011223456899999999999999999999999999999999999998753211
Q ss_pred ccchhhhhhhccchhHHHhhhcccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCC-HHHHHHH
Q 001544 978 EMTLKHWVNDFLPISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERIT-AKEIVRR 1043 (1057)
Q Consensus 978 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-~~evl~~ 1043 (1057)
+ . ...+.... .....+....+++++.+++.+|+. ||++||+ +.|+++|
T Consensus 237 ~----~---------~~~i~~~~----~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 237 E----T---------YNKIINWK----ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred H----H---------HHHHhccC----CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 0 0 01111100 000011111256788999999997 9999999 9999987
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=338.16 Aligned_cols=242 Identities=25% Similarity=0.356 Sum_probs=196.3
Q ss_pred ceeccccCeEEEEEEe----cCCcEEEEEEeeccc----hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEE
Q 001544 775 NLIGRGSFGSVYIARL----QNGIEVAVKTFDLQH----ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEY 846 (1057)
Q Consensus 775 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 846 (1057)
+.||+|+||.||+|+. .+++.||||+++... ......+.+|++++++++||||+++++++..++..|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6799999999999975 357899999986432 23345678899999999999999999999999999999999
Q ss_pred ccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCcc
Q 001544 847 MRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSM 926 (1057)
Q Consensus 847 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 926 (1057)
+++|+|.+++.... .+.+..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++...... .
T Consensus 82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~ 155 (323)
T cd05584 82 LSGGELFMHLEREG-IFMEDTACFYLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG--T 155 (323)
T ss_pred CCCchHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC--C
Confidence 99999999887654 4788889999999999999999 9999999999999999999999999999987542211 1
Q ss_pred ccccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhcccccccc
Q 001544 927 TQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITED 1006 (1057)
Q Consensus 927 ~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1006 (1057)
......|++.|+|||++.+..++.++||||+||++|||++|+.||...... . ....+....
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~-----~--------~~~~~~~~~------ 216 (323)
T cd05584 156 VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK-----K--------TIDKILKGK------ 216 (323)
T ss_pred cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH-----H--------HHHHHHcCC------
Confidence 223346899999999998888999999999999999999999998652111 0 011111111
Q ss_pred hhhHHHHHHHHHHHHHHhHcccCCCCCCC-----CHHHHHHH
Q 001544 1007 KHFAAKEQCASSVFNLAMECTVESPDERI-----TAKEIVRR 1043 (1057)
Q Consensus 1007 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~ 1043 (1057)
...+..+++++.+++.+|++.+|++|| ++.++++|
T Consensus 217 --~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 217 --LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred --CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 111123467789999999999999999 88888875
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=345.99 Aligned_cols=253 Identities=24% Similarity=0.318 Sum_probs=198.9
Q ss_pred CCCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccc---hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEE
Q 001544 769 NGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQH---ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALIL 844 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 844 (1057)
++|++.+.||+|+||+||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 46888999999999999999754 78999999986432 234567889999999999999999999999999999999
Q ss_pred EEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCC
Q 001544 845 EYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ 924 (1057)
Q Consensus 845 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 924 (1057)
||+++|+|.+++...+ .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+|++|||+++.+.....
T Consensus 81 E~~~gg~L~~~l~~~~-~~~~~~~~~~~~ql~~aL~~LH---~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 156 (377)
T cd05629 81 EFLPGGDLMTMLIKYD-TFSEDVTRFYMAECVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHD 156 (377)
T ss_pred eCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEEeecccccccccccc
Confidence 9999999999987654 5889999999999999999999 99999999999999999999999999999864321100
Q ss_pred c---------------------------------------------cccccccccccccCccccCCCCCCccchHHHHHH
Q 001544 925 S---------------------------------------------MTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGI 959 (1057)
Q Consensus 925 ~---------------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~ 959 (1057)
. .......||+.|+|||++.+..++.++||||+||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv 236 (377)
T cd05629 157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA 236 (377)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecch
Confidence 0 0001246899999999998889999999999999
Q ss_pred HHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhcccccccchhhHHHHHHHHHHHHHHhHcccCCCCCC---CC
Q 001544 960 LLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDER---IT 1036 (1057)
Q Consensus 960 il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---ps 1036 (1057)
++|||++|+.||......+. . ..+.... ....++....++.++.+++.+|+. +|.+| ++
T Consensus 237 il~elltG~~Pf~~~~~~~~-~------------~~i~~~~----~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~ 298 (377)
T cd05629 237 IMFECLIGWPPFCSENSHET-Y------------RKIINWR----ETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGG 298 (377)
T ss_pred hhhhhhcCCCCCCCCCHHHH-H------------HHHHccC----CccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCC
Confidence 99999999999865221110 0 0010000 000111112345678899999997 67765 59
Q ss_pred HHHHHHH
Q 001544 1037 AKEIVRR 1043 (1057)
Q Consensus 1037 ~~evl~~ 1043 (1057)
+.|+++|
T Consensus 299 ~~~~l~h 305 (377)
T cd05629 299 AHEIKSH 305 (377)
T ss_pred HHHHhcC
Confidence 9999987
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=328.66 Aligned_cols=256 Identities=26% Similarity=0.417 Sum_probs=203.2
Q ss_pred hCCCCCCceeccccCeEEEEEEec------CCcEEEEEEeeccc-hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCee
Q 001544 768 TNGFSENNLIGRGSFGSVYIARLQ------NGIEVAVKTFDLQH-ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFK 840 (1057)
Q Consensus 768 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 840 (1057)
.++|++.+.||+|+||.||+|... .+..||+|.+.... ......+.+|+.++++++|+||+++++++.+.+..
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 456888999999999999999865 35789999886443 33446789999999999999999999999988899
Q ss_pred EEEEEEccCCChhHHHhcCC------ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCC---cEEEE
Q 001544 841 ALILEYMRNGSLEKCLYSGN------YILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNM---VAHLS 911 (1057)
Q Consensus 841 ~lV~E~~~~gsL~~~l~~~~------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~---~~kl~ 911 (1057)
++||||+++++|.+++...+ ..+++.++.+++.||+.|++||| +.+++||||||+||+++.++ .+|++
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchheEEEeccCCCcceEec
Confidence 99999999999999987653 25899999999999999999999 89999999999999998654 69999
Q ss_pred cccccccccCCCCccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhh-CCCCCCcccccccchhhhhhhccc
Q 001544 912 DFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFT-RRKPTDEIFSGEMTLKHWVNDFLP 990 (1057)
Q Consensus 912 Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 990 (1057)
|||+++................+..|+|||++.+..++.++|||||||++|||++ |..||......+
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~------------ 229 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE------------ 229 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH------------
Confidence 9999987632222111222233568999999988899999999999999999997 888886521111
Q ss_pred hhHHHhhhcccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHHH
Q 001544 991 ISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLK 1046 (1057)
Q Consensus 991 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 1046 (1057)
..+.+.... ....+..++..+.+++.+|++.+|++||++.|++++|++
T Consensus 230 --~~~~~~~~~------~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~ 277 (277)
T cd05036 230 --VMEFVTGGG------RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY 277 (277)
T ss_pred --HHHHHHcCC------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence 111111110 011123456778999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=337.80 Aligned_cols=245 Identities=22% Similarity=0.345 Sum_probs=195.6
Q ss_pred CCCCceeccccCeEEEEEEec-CCcEEEEEEeeccc---hhHHHHHHHHHHHH---HhcCCCCceeEeeeeccCCeeEEE
Q 001544 771 FSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQH---ERAFKSFDTECEVM---KSIRHRNLTKIISSCSNEDFKALI 843 (1057)
Q Consensus 771 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~lV 843 (1057)
|++.+.||+|+||.||+|... +++.||||+++... ....+.+.+|++++ ++++||||+++++++..++..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 567899999999999999865 68999999996542 22345566676655 566799999999999999999999
Q ss_pred EEEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCC
Q 001544 844 LEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGED 923 (1057)
Q Consensus 844 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~ 923 (1057)
|||+++|+|...+... .+++.++..++.|++.|++||| +.+|+||||||+||++++++.+||+|||+++.....
T Consensus 81 ~E~~~~~~L~~~~~~~--~l~~~~~~~~~~qi~~al~~lH---~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~- 154 (324)
T cd05589 81 MEYAAGGDLMMHIHTD--VFSEPRAVFYAACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF- 154 (324)
T ss_pred EcCCCCCcHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC-
Confidence 9999999999888653 4899999999999999999999 999999999999999999999999999998753221
Q ss_pred CccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhccccc
Q 001544 924 QSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLI 1003 (1057)
Q Consensus 924 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1003 (1057)
........|++.|+|||.+.+..++.++||||+||++|||++|+.||...... ... ..+.....
T Consensus 155 -~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~-----~~~--------~~i~~~~~-- 218 (324)
T cd05589 155 -GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE-----EVF--------DSIVNDEV-- 218 (324)
T ss_pred -CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH-----HHH--------HHHHhCCC--
Confidence 12223456899999999999889999999999999999999999998652111 000 01111000
Q ss_pred ccchhhHHHHHHHHHHHHHHhHcccCCCCCCC-----CHHHHHHH
Q 001544 1004 TEDKHFAAKEQCASSVFNLAMECTVESPDERI-----TAKEIVRR 1043 (1057)
Q Consensus 1004 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~ 1043 (1057)
..+..++.++.+++.+|++.||++|| ++.++++|
T Consensus 219 ------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 219 ------RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred ------CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 01123567788999999999999999 57777765
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=340.25 Aligned_cols=242 Identities=25% Similarity=0.342 Sum_probs=196.7
Q ss_pred ceeccccCeEEEEEEec-CCcEEEEEEeeccc---hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEEccCC
Q 001544 775 NLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQH---ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEYMRNG 850 (1057)
Q Consensus 775 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g 850 (1057)
+.||+|+||.||+|... +|+.||+|+++... ......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999754 68999999996542 234466788999999999999999999999999999999999999
Q ss_pred ChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCC-CCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCccccc
Q 001544 851 SLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYS-APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQT 929 (1057)
Q Consensus 851 sL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~-~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 929 (1057)
+|.+++.... .+++.++..++.||+.||+||| + .+|+||||||+||+++.++.+||+|||+++..... .....
T Consensus 81 ~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH---~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~--~~~~~ 154 (325)
T cd05594 81 ELFFHLSRER-VFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD--GATMK 154 (325)
T ss_pred cHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCC--Ccccc
Confidence 9998886654 5899999999999999999999 7 79999999999999999999999999998753221 11223
Q ss_pred cccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhcccccccchhh
Q 001544 930 QTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHF 1009 (1057)
Q Consensus 930 ~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1057)
...||+.|+|||++.+..++.++||||+||++|||++|+.||...... ...+.+.... .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~--------------~~~~~i~~~~-------~ 213 (325)
T cd05594 155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--------------KLFELILMEE-------I 213 (325)
T ss_pred cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH--------------HHHHHHhcCC-------C
Confidence 346899999999999889999999999999999999999998652111 0111110000 0
Q ss_pred HHHHHHHHHHHHHHhHcccCCCCCCC-----CHHHHHHH
Q 001544 1010 AAKEQCASSVFNLAMECTVESPDERI-----TAKEIVRR 1043 (1057)
Q Consensus 1010 ~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~ 1043 (1057)
..+..+++++.+++.+|++.||++|+ ++.++++|
T Consensus 214 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 214 RFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 01123466789999999999999997 89999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=328.13 Aligned_cols=260 Identities=22% Similarity=0.363 Sum_probs=207.1
Q ss_pred hCCCCCCceeccccCeEEEEEEec-CCc----EEEEEEeeccc-hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeE
Q 001544 768 TNGFSENNLIGRGSFGSVYIARLQ-NGI----EVAVKTFDLQH-ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKA 841 (1057)
Q Consensus 768 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 841 (1057)
..+|+..++||+|+||+||+|.+. +|+ .||+|+++... ......+.+|+.+++.++||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence 356888899999999999999743 444 58999986443 34457788999999999999999999998754 467
Q ss_pred EEEEEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccC
Q 001544 842 LILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIG 921 (1057)
Q Consensus 842 lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~ 921 (1057)
+++||+++|+|.+++......+++.++..++.|+++||+||| +++|+||||||+||++++++.+||+|||+++....
T Consensus 85 l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~ 161 (279)
T cd05109 85 LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI 161 (279)
T ss_pred EEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence 999999999999999876667999999999999999999999 99999999999999999999999999999987643
Q ss_pred CCCccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhh-CCCCCCcccccccchhhhhhhccchhHHHhhhcc
Q 001544 922 EDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFT-RRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDAN 1000 (1057)
Q Consensus 922 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1000 (1057)
...........++..|+|||...+..++.++|||||||++|||++ |..||+..... ....+ +...
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~------------~~~~ 227 (279)
T cd05109 162 DETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR--EIPDL------------LEKG 227 (279)
T ss_pred ccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHH------------HHCC
Confidence 222222222345678999999988889999999999999999998 88887642111 11111 1111
Q ss_pred cccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHHHhHHHH
Q 001544 1001 LLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKIRDFL 1051 (1057)
Q Consensus 1001 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~ 1051 (1057)
. ..+.+..++.++.+++.+||+.||++||++.|+++.++++.++.
T Consensus 228 ~------~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 228 E------RLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred C------cCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 0 01111235667899999999999999999999999998887654
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=332.75 Aligned_cols=259 Identities=28% Similarity=0.460 Sum_probs=206.9
Q ss_pred HhCCCCCCceeccccCeEEEEEEec------CCcEEEEEEeeccc-hhHHHHHHHHHHHHHhc-CCCCceeEeeeeccCC
Q 001544 767 ATNGFSENNLIGRGSFGSVYIARLQ------NGIEVAVKTFDLQH-ERAFKSFDTECEVMKSI-RHRNLTKIISSCSNED 838 (1057)
Q Consensus 767 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 838 (1057)
..++|+..+.||+|+||.||+|... ....||+|.+.... ......+.+|++++.++ +||||+++++++..++
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 3456888899999999999999754 23689999986542 34456788999999999 7999999999999999
Q ss_pred eeEEEEEEccCCChhHHHhcC---------------CccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeC
Q 001544 839 FKALILEYMRNGSLEKCLYSG---------------NYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLD 903 (1057)
Q Consensus 839 ~~~lV~E~~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~ 903 (1057)
..++||||+++|+|.+++... ...+++..+++++.|++.|++||| +.+|+||||||+||+++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~Nil~~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA---SKKCIHRDLAARNVLVT 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCccccccceeeEEEc
Confidence 999999999999999998642 246889999999999999999999 99999999999999999
Q ss_pred CCCcEEEEcccccccccCCCCccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhh-CCCCCCcccccccchh
Q 001544 904 DNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFT-RRKPTDEIFSGEMTLK 982 (1057)
Q Consensus 904 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~ 982 (1057)
+++.+|++|||.++.+.............++..|+|||+..+..++.++|||||||++||+++ |..||......+
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---- 242 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE---- 242 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH----
Confidence 999999999999987643322222222335678999999988889999999999999999998 888875421110
Q ss_pred hhhhhccchhHHHhhhcccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHHHhH
Q 001544 983 HWVNDFLPISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKIR 1048 (1057)
Q Consensus 983 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~ 1048 (1057)
..+...... ....+..++.++.+++.+|+..+|++|||+.|+++.|+++.
T Consensus 243 ----------~~~~~~~~~------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 243 ----------LFKLLKEGY------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred ----------HHHHHHcCC------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 111111110 01112234667899999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=328.94 Aligned_cols=254 Identities=27% Similarity=0.483 Sum_probs=205.1
Q ss_pred CCCCCceeccccCeEEEEEEec------CCcEEEEEEeeccchhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEE
Q 001544 770 GFSENNLIGRGSFGSVYIARLQ------NGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALI 843 (1057)
Q Consensus 770 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 843 (1057)
+|...++||+|+||.||+|... ++..||+|.+..........+.+|++++++++|+||+++++++.+.+..++|
T Consensus 6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (280)
T cd05092 6 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMV 85 (280)
T ss_pred hceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEE
Confidence 5677899999999999999632 4668999998766666678899999999999999999999999999999999
Q ss_pred EEEccCCChhHHHhcCC--------------ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEE
Q 001544 844 LEYMRNGSLEKCLYSGN--------------YILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAH 909 (1057)
Q Consensus 844 ~E~~~~gsL~~~l~~~~--------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~k 909 (1057)
|||+++|+|.+++.... ..+++.++..++.|++.|++||| +.+++||||||+||++++++.+|
T Consensus 86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~nil~~~~~~~k 162 (280)
T cd05092 86 FEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA---SLHFVHRDLATRNCLVGQGLVVK 162 (280)
T ss_pred EecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH---HCCeecccccHhhEEEcCCCCEE
Confidence 99999999999987543 24789999999999999999999 99999999999999999999999
Q ss_pred EEcccccccccCCCCccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhh-CCCCCCcccccccchhhhhhhc
Q 001544 910 LSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFT-RRKPTDEIFSGEMTLKHWVNDF 988 (1057)
Q Consensus 910 l~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~ 988 (1057)
|+|||+++.+.............+++.|+|||...+..++.++|||||||++|||++ |..||......+.
T Consensus 163 L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~--------- 233 (280)
T cd05092 163 IGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA--------- 233 (280)
T ss_pred ECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH---------
Confidence 999999976533222222223345678999999988899999999999999999998 8888754211110
Q ss_pred cchhHHHhhhcccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHHH
Q 001544 989 LPISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLK 1046 (1057)
Q Consensus 989 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 1046 (1057)
........ ....+..++..+.+++.+||+.||++||++.|+.+.|++
T Consensus 234 ----~~~~~~~~-------~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 234 ----IECITQGR-------ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred ----HHHHHcCc-------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 01111100 011112456778999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=329.04 Aligned_cols=267 Identities=24% Similarity=0.313 Sum_probs=196.6
Q ss_pred CCCCCCceeccccCeEEEEEEec--CCcEEEEEEeeccc--hhHHHHHHHHHHHHHhc---CCCCceeEeeeec-----c
Q 001544 769 NGFSENNLIGRGSFGSVYIARLQ--NGIEVAVKTFDLQH--ERAFKSFDTECEVMKSI---RHRNLTKIISSCS-----N 836 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~-----~ 836 (1057)
.+|++.+.||+|+||+||+|+.. +++.||||+++... ......+.+|+++++++ +||||+++++++. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36888999999999999999753 47889999986432 22234556777777766 6999999999874 3
Q ss_pred CCeeEEEEEEccCCChhHHHhcCC-ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccc
Q 001544 837 EDFKALILEYMRNGSLEKCLYSGN-YILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGI 915 (1057)
Q Consensus 837 ~~~~~lV~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 915 (1057)
....++||||++ ++|.+++.... ..+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEcCCCCEEEccccc
Confidence 456899999996 58988886543 45899999999999999999999 99999999999999999999999999999
Q ss_pred cccccCCCCccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhc---cchh
Q 001544 916 AKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDF---LPIS 992 (1057)
Q Consensus 916 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~---~~~~ 992 (1057)
++..... .......+++.|+|||.+.+..++.++||||+||++|||++|++||......+ ......... .+..
T Consensus 157 ~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~-~~~~i~~~~~~~~~~~ 232 (290)
T cd07862 157 ARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-QLGKILDVIGLPGEED 232 (290)
T ss_pred eEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH-HHHHHHHHhCCCChhh
Confidence 9865322 22334568899999999988889999999999999999999999987632211 111111000 0000
Q ss_pred HHHhh---hcccccccchh-hHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 993 MMKII---DANLLITEDKH-FAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 993 ~~~~~---~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
..... ........... ......++..+.+++.+|++.||++|||+.|+++|
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 233 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred chhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 00000 00000000000 01112456778999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=343.93 Aligned_cols=254 Identities=22% Similarity=0.273 Sum_probs=202.5
Q ss_pred hCCCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccc---hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEE
Q 001544 768 TNGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQH---ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALI 843 (1057)
Q Consensus 768 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 843 (1057)
.++|++.+.||+|+||.||+|+.. +++.||+|+++... ....+.+.+|+++++.++||||+++++++.+++..++|
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv 121 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV 121 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence 457889999999999999999865 68999999996432 23345678899999999999999999999999999999
Q ss_pred EEEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCC
Q 001544 844 LEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGED 923 (1057)
Q Consensus 844 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~ 923 (1057)
|||+++|+|.+++... .+++..+..++.|++.||+||| +++|+||||||+||++++++.+||+|||++.......
T Consensus 122 ~Ey~~gg~L~~~l~~~--~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~ 196 (370)
T cd05596 122 MEYMPGGDLVNLMSNY--DIPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANG 196 (370)
T ss_pred EcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCC
Confidence 9999999999988764 3788889999999999999999 9999999999999999999999999999998653221
Q ss_pred CccccccccccccccCccccCCC----CCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhc
Q 001544 924 QSMTQTQTLATLGYMAPEYGREG----RVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDA 999 (1057)
Q Consensus 924 ~~~~~~~~~~t~~y~aPE~~~~~----~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 999 (1057)
........||+.|+|||++.+. .++.++||||+||++|||++|+.||...... .. ...+.+.
T Consensus 197 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~----~~---------~~~i~~~ 262 (370)
T cd05596 197 -MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV----GT---------YSKIMDH 262 (370)
T ss_pred -cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH----HH---------HHHHHcC
Confidence 1122345689999999987643 4788999999999999999999998652110 00 1111111
Q ss_pred ccccccchhhHHHHHHHHHHHHHHhHcccCCCCC--CCCHHHHHHHH
Q 001544 1000 NLLITEDKHFAAKEQCASSVFNLAMECTVESPDE--RITAKEIVRRL 1044 (1057)
Q Consensus 1000 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--Rps~~evl~~L 1044 (1057)
.. ...++....++.++.+++.+|+..+|++ ||++.|+++|-
T Consensus 263 ~~----~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~ 305 (370)
T cd05596 263 KN----SLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHP 305 (370)
T ss_pred CC----cCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCc
Confidence 00 0111112235678899999999999988 99999998873
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=329.90 Aligned_cols=259 Identities=26% Similarity=0.432 Sum_probs=205.2
Q ss_pred CCCCCCceeccccCeEEEEEEecC-C--cEEEEEEeecc-chhHHHHHHHHHHHHHhc-CCCCceeEeeeeccCCeeEEE
Q 001544 769 NGFSENNLIGRGSFGSVYIARLQN-G--IEVAVKTFDLQ-HERAFKSFDTECEVMKSI-RHRNLTKIISSCSNEDFKALI 843 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~Vy~~~~~~-~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV 843 (1057)
++|++.++||+|+||.||+|..++ + ..+|+|.++.. .....+.+.+|+++++++ +||||+++++++.+.+..++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 478889999999999999998653 3 35788888643 334457789999999999 799999999999999999999
Q ss_pred EEEccCCChhHHHhcCC---------------ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcE
Q 001544 844 LEYMRNGSLEKCLYSGN---------------YILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVA 908 (1057)
Q Consensus 844 ~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~ 908 (1057)
+||+++|+|.+++.... ..+++.++..++.|++.|++||| +++|+||||||+||++++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS---EKQFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCcCCcceEEECCCCeE
Confidence 99999999999986532 24788999999999999999999 9999999999999999999999
Q ss_pred EEEcccccccccCCCCccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhh-CCCCCCcccccccchhhhhhh
Q 001544 909 HLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFT-RRKPTDEIFSGEMTLKHWVND 987 (1057)
Q Consensus 909 kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~ 987 (1057)
||+|||++.... ..........+..|+|||......++.++|||||||++|||++ |..||......+
T Consensus 159 kl~dfg~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~--------- 226 (297)
T cd05089 159 KIADFGLSRGEE---VYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE--------- 226 (297)
T ss_pred EECCcCCCcccc---ceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---------
Confidence 999999986421 1111111223457999999988889999999999999999997 999986521110
Q ss_pred ccchhHHHhhhcccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHHHhHHHHhh
Q 001544 988 FLPISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKIRDFLLR 1053 (1057)
Q Consensus 988 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~~~ 1053 (1057)
......... ....+..++.++.+++.+||+.+|.+||++.++++.|+.+.+....
T Consensus 227 -----~~~~~~~~~------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~ 281 (297)
T cd05089 227 -----LYEKLPQGY------RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKA 281 (297)
T ss_pred -----HHHHHhcCC------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 011111110 1111134567889999999999999999999999999998775443
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=326.45 Aligned_cols=257 Identities=26% Similarity=0.437 Sum_probs=205.6
Q ss_pred CCCCCceeccccCeEEEEEEec------CCcEEEEEEeeccc-hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEE
Q 001544 770 GFSENNLIGRGSFGSVYIARLQ------NGIEVAVKTFDLQH-ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKAL 842 (1057)
Q Consensus 770 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 842 (1057)
+|++.+.||+|+||+||+|... ....||+|.+.... .....++.+|+.++++++||||+++++++...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4677899999999999999753 23579999886543 3345778999999999999999999999999999999
Q ss_pred EEEEccCCChhHHHhcCC-----------------------ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCC
Q 001544 843 ILEYMRNGSLEKCLYSGN-----------------------YILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSN 899 (1057)
Q Consensus 843 V~E~~~~gsL~~~l~~~~-----------------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~N 899 (1057)
|+||+.+|+|.+++.... ..+++.++..++.|++.|++||| +.+++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA---EMKLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH---HCCeehhhhhhhe
Confidence 999999999999876421 34788999999999999999999 9999999999999
Q ss_pred eeeCCCCcEEEEcccccccccCCCCccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhh-CCCCCCcccccc
Q 001544 900 VLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFT-RRKPTDEIFSGE 978 (1057)
Q Consensus 900 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~ 978 (1057)
|++++++.+||+|||+++...............++..|+|||...+..++.++||||||+++|||++ |..||......
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~- 236 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE- 236 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH-
Confidence 9999999999999999986543332222233345678999999888889999999999999999999 99888642111
Q ss_pred cchhhhhhhccchhHHHhhhcccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHHHhHH
Q 001544 979 MTLKHWVNDFLPISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKIRD 1049 (1057)
Q Consensus 979 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~ 1049 (1057)
...+...... ....+..++.++.+++.+|++.+|++||++.|+++.|+++..
T Consensus 237 -------------~~~~~~~~~~------~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 237 -------------RLFNLLKTGY------RMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred -------------HHHHHHhCCC------CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 1111111111 011123456778999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=325.27 Aligned_cols=254 Identities=27% Similarity=0.457 Sum_probs=201.5
Q ss_pred CCCCceeccccCeEEEEEEecC----CcEEEEEEeeccc--hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCe-----
Q 001544 771 FSENNLIGRGSFGSVYIARLQN----GIEVAVKTFDLQH--ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDF----- 839 (1057)
Q Consensus 771 ~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 839 (1057)
|++.+.||+|+||.||+|.... +..||||+++... ......+.+|++.++.++||||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5677899999999999997542 3779999986432 3445678999999999999999999998865543
Q ss_pred -eEEEEEEccCCChhHHHhcC-----CccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcc
Q 001544 840 -KALILEYMRNGSLEKCLYSG-----NYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDF 913 (1057)
Q Consensus 840 -~~lV~E~~~~gsL~~~l~~~-----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 913 (1057)
.++|+||+++|+|.+++... ...+++.++..++.|++.||+||| +.+++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchheEEECCCCeEEECCc
Confidence 78999999999999887543 245899999999999999999999 899999999999999999999999999
Q ss_pred cccccccCCCCccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhh-CCCCCCcccccccchhhhhhhccchh
Q 001544 914 GIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFT-RRKPTDEIFSGEMTLKHWVNDFLPIS 992 (1057)
Q Consensus 914 g~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 992 (1057)
|+++.+..............+..|+|||...+..++.++|||||||++|||++ |..||...... ....+
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~--~~~~~-------- 227 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH--EIYDY-------- 227 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH--HHHHH--------
Confidence 99987643332222222345678999999988889999999999999999999 88887552211 01011
Q ss_pred HHHhhhcccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHHHh
Q 001544 993 MMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKI 1047 (1057)
Q Consensus 993 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i 1047 (1057)
..+.. ....+..++.++.+++.+||+.||++||++.|++++|+++
T Consensus 228 ---~~~~~-------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 228 ---LRHGN-------RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred ---HHcCC-------CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00000 1111234567899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=332.44 Aligned_cols=259 Identities=27% Similarity=0.454 Sum_probs=207.0
Q ss_pred CCCCCCceeccccCeEEEEEEec--------CCcEEEEEEeeccc-hhHHHHHHHHHHHHHhc-CCCCceeEeeeeccCC
Q 001544 769 NGFSENNLIGRGSFGSVYIARLQ--------NGIEVAVKTFDLQH-ERAFKSFDTECEVMKSI-RHRNLTKIISSCSNED 838 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 838 (1057)
++|.+.+.||+|+||.||+|... ++..||+|.++... ......+.+|+++++++ +||||+++++++.+.+
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 46889999999999999999742 23579999997542 34456788899999999 7999999999999999
Q ss_pred eeEEEEEEccCCChhHHHhcCC---------------ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeC
Q 001544 839 FKALILEYMRNGSLEKCLYSGN---------------YILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLD 903 (1057)
Q Consensus 839 ~~~lV~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~ 903 (1057)
..++||||+++|+|.+++.... ..+++.++..++.|++.||+||| +.+++||||||+||+++
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill~ 174 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVT 174 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHHheEEc
Confidence 9999999999999999997642 24888999999999999999999 89999999999999999
Q ss_pred CCCcEEEEcccccccccCCCCccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhh-CCCCCCcccccccchh
Q 001544 904 DNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFT-RRKPTDEIFSGEMTLK 982 (1057)
Q Consensus 904 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~ 982 (1057)
+++.+||+|||.++...............++..|+|||...+..++.++||||+||++|||++ |..||..... .
T Consensus 175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~-----~ 249 (307)
T cd05098 175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV-----E 249 (307)
T ss_pred CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH-----H
Confidence 999999999999876532211111222234568999999988889999999999999999998 7888754211 1
Q ss_pred hhhhhccchhHHHhhhcccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHHHhHHH
Q 001544 983 HWVNDFLPISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKIRDF 1050 (1057)
Q Consensus 983 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~ 1050 (1057)
. ..+.+.... ....+..++.++.+++.+|++.+|++||++.|+++.|+++.+.
T Consensus 250 ~---------~~~~~~~~~------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 250 E---------LFKLLKEGH------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred H---------HHHHHHcCC------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 1 111111110 1112234567889999999999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=328.65 Aligned_cols=251 Identities=22% Similarity=0.347 Sum_probs=201.9
Q ss_pred CCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccc---hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEE
Q 001544 770 GFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQH---ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILE 845 (1057)
Q Consensus 770 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 845 (1057)
.|+..++||+|+||+||+|... +++.||||++.... ......+.+|++++++++||||+++++++.+++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 3778899999999999999864 68999999986432 2223567789999999999999999999999999999999
Q ss_pred EccCCChhHHHhcCC-ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCC
Q 001544 846 YMRNGSLEKCLYSGN-YILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ 924 (1057)
Q Consensus 846 ~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 924 (1057)
|+++|+|.+++.... ..+++..+..++.|++.|++||| +.+++||||||+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-- 155 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG-- 155 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCC--
Confidence 999999998886543 46899999999999999999999 899999999999999999999999999999865221
Q ss_pred ccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhcccccc
Q 001544 925 SMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLIT 1004 (1057)
Q Consensus 925 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1057)
.......|+..|+|||++.+..++.++||||+||++|||++|+.||...... ..... ....+...
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~-~~~~~---------~~~~~~~~---- 220 (285)
T cd05605 156 -ETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEK-VKREE---------VERRVKED---- 220 (285)
T ss_pred -CccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchh-hHHHH---------HHHHhhhc----
Confidence 1222346889999999998888999999999999999999999998652111 10000 01111100
Q ss_pred cchhhHHHHHHHHHHHHHHhHcccCCCCCCC-----CHHHHHHH
Q 001544 1005 EDKHFAAKEQCASSVFNLAMECTVESPDERI-----TAKEIVRR 1043 (1057)
Q Consensus 1005 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~ 1043 (1057)
....+..++..+.+++.+||+.||++|| ++.++++|
T Consensus 221 ---~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 221 ---QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred ---ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 0111133567789999999999999999 88899876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=327.75 Aligned_cols=260 Identities=24% Similarity=0.387 Sum_probs=209.1
Q ss_pred hCCCCCCceeccccCeEEEEEEecC-----CcEEEEEEeecc-chhHHHHHHHHHHHHHhcCCCCceeEeeeecc-CCee
Q 001544 768 TNGFSENNLIGRGSFGSVYIARLQN-----GIEVAVKTFDLQ-HERAFKSFDTECEVMKSIRHRNLTKIISSCSN-EDFK 840 (1057)
Q Consensus 768 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~ 840 (1057)
.++|++.+.||+|+||.||+|...+ +..||+|++... .....+.+.+|+.++++++||||+++++++.. +...
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4578888999999999999998765 688999998643 33456778899999999999999999998765 5788
Q ss_pred EEEEEEccCCChhHHHhcCC-------ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcc
Q 001544 841 ALILEYMRNGSLEKCLYSGN-------YILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDF 913 (1057)
Q Consensus 841 ~lV~E~~~~gsL~~~l~~~~-------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 913 (1057)
++++||+++|+|.+++.... ..+++.++..++.|++.|++||| +.+++||||||+||++++++.+|++||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCHhhEEEcCCCcEEECCC
Confidence 99999999999999986532 45899999999999999999999 999999999999999999999999999
Q ss_pred cccccccCCCCccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhh-CCCCCCcccccccchhhhhhhccchh
Q 001544 914 GIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFT-RRKPTDEIFSGEMTLKHWVNDFLPIS 992 (1057)
Q Consensus 914 g~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 992 (1057)
|+++.+.............++..|+|||++.+..++.++||||+|+++||+++ |+.||..... .....+...
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~~~~~----- 234 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP--FEMAAYLKD----- 234 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH--HHHHHHHHc-----
Confidence 99986543332222223345678999999988889999999999999999999 9999865211 111111110
Q ss_pred HHHhhhcccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHHHhHHH
Q 001544 993 MMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKIRDF 1050 (1057)
Q Consensus 993 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~ 1050 (1057)
.. .......++.++.+++.+||..||++|||+.|+++.|+.+.+.
T Consensus 235 -------~~------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 235 -------GY------RLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred -------CC------CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 00 0111123567789999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=330.92 Aligned_cols=260 Identities=27% Similarity=0.458 Sum_probs=207.7
Q ss_pred hCCCCCCceeccccCeEEEEEEec--------CCcEEEEEEeeccc-hhHHHHHHHHHHHHHhc-CCCCceeEeeeeccC
Q 001544 768 TNGFSENNLIGRGSFGSVYIARLQ--------NGIEVAVKTFDLQH-ERAFKSFDTECEVMKSI-RHRNLTKIISSCSNE 837 (1057)
Q Consensus 768 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 837 (1057)
.++|++.+.||+|+||.||+|+.. ++..||+|.++... .....++.+|+.+++.+ +||||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 456888899999999999999631 34579999986442 34457889999999999 899999999999999
Q ss_pred CeeEEEEEEccCCChhHHHhcCC---------------ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeee
Q 001544 838 DFKALILEYMRNGSLEKCLYSGN---------------YILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLL 902 (1057)
Q Consensus 838 ~~~~lV~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill 902 (1057)
+..++||||+++|+|.+++.... ..+++.++..++.||++|++||| +++|+||||||+||++
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH---HCCeeecccccceEEE
Confidence 99999999999999999987532 34788899999999999999999 9999999999999999
Q ss_pred CCCCcEEEEcccccccccCCCCccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhh-CCCCCCcccccccch
Q 001544 903 DDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFT-RRKPTDEIFSGEMTL 981 (1057)
Q Consensus 903 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~ 981 (1057)
++++.+||+|||.++.+.............++..|+|||+..+..++.++||||||+++||+++ |..||.... .
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~-----~ 245 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-----V 245 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC-----H
Confidence 9999999999999987643322222233345678999999988889999999999999999998 777775421 1
Q ss_pred hhhhhhccchhHHHhhhcccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHHHhHHH
Q 001544 982 KHWVNDFLPISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKIRDF 1050 (1057)
Q Consensus 982 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~ 1050 (1057)
..+. +.+.... ....+..++.++.+++.+||+.+|++||++.|+++.|+++...
T Consensus 246 ~~~~---------~~~~~~~------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 246 EELF---------KLLKEGH------RMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred HHHH---------HHHHcCC------cCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 1111 1111000 0111234567899999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=320.96 Aligned_cols=247 Identities=25% Similarity=0.450 Sum_probs=197.6
Q ss_pred eccccCeEEEEEEec---CCcEEEEEEeeccc-hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEEccCCCh
Q 001544 777 IGRGSFGSVYIARLQ---NGIEVAVKTFDLQH-ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEYMRNGSL 852 (1057)
Q Consensus 777 lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL 852 (1057)
||+|+||.||+|.+. ++..||||++.... ....+.+.+|++++++++||||+++++++. .+..++||||+++|+|
T Consensus 3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~L 81 (257)
T cd05115 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGPL 81 (257)
T ss_pred cCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCCH
Confidence 899999999999754 35679999986543 334567899999999999999999999886 4567899999999999
Q ss_pred hHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCcc-ccccc
Q 001544 853 EKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSM-TQTQT 931 (1057)
Q Consensus 853 ~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~ 931 (1057)
.+++......+++.++.+++.|++.|++||| +++++||||||+||+++.++.+|++|||++.......... .....
T Consensus 82 ~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05115 82 NKFLSGKKDEITVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAG 158 (257)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCC
Confidence 9999876667999999999999999999999 8999999999999999999999999999997653222111 11222
Q ss_pred cccccccCccccCCCCCCccchHHHHHHHHHHHhh-CCCCCCcccccccchhhhhhhccchhHHHhhhcccccccchhhH
Q 001544 932 LATLGYMAPEYGREGRVSTKGDVYSFGILLMETFT-RRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHFA 1010 (1057)
Q Consensus 932 ~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1057)
.++..|+|||......++.++|||||||++||+++ |+.||......+ ....+.... +..
T Consensus 159 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--------------~~~~~~~~~------~~~ 218 (257)
T cd05115 159 KWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE--------------VMSFIEQGK------RLD 218 (257)
T ss_pred CCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH--------------HHHHHHCCC------CCC
Confidence 33568999999888889999999999999999996 999986532111 111111110 111
Q ss_pred HHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHHHh
Q 001544 1011 AKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKI 1047 (1057)
Q Consensus 1011 ~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i 1047 (1057)
.+..+++++.+++.+||..+|++||++.++.+.|+.+
T Consensus 219 ~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 219 CPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 1234567899999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=324.20 Aligned_cols=254 Identities=26% Similarity=0.431 Sum_probs=197.5
Q ss_pred CCCCceeccccCeEEEEEEecC-Cc--EEEEEEeecc--chhHHHHHHHHHHHHHhcCCCCceeEeeeeccC------Ce
Q 001544 771 FSENNLIGRGSFGSVYIARLQN-GI--EVAVKTFDLQ--HERAFKSFDTECEVMKSIRHRNLTKIISSCSNE------DF 839 (1057)
Q Consensus 771 ~~~~~~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~ 839 (1057)
|.+.++||+|+||.||+|.+.+ +. .||||.++.. .....+.+.+|++++++++||||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3456889999999999998654 33 6999988653 344567889999999999999999999986432 25
Q ss_pred eEEEEEEccCCChhHHHhc-----CCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEccc
Q 001544 840 KALILEYMRNGSLEKCLYS-----GNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFG 914 (1057)
Q Consensus 840 ~~lV~E~~~~gsL~~~l~~-----~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 914 (1057)
.++||||+++|+|.+++.. ....+++..+..++.|++.|++||| +++|+||||||+||++++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhheEEcCCCCEEECCCC
Confidence 6899999999999988742 2245899999999999999999999 8999999999999999999999999999
Q ss_pred ccccccCCCCccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhh-CCCCCCcccccccchhhhhhhccchhH
Q 001544 915 IAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFT-RRKPTDEIFSGEMTLKHWVNDFLPISM 993 (1057)
Q Consensus 915 ~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 993 (1057)
+++.+.............+++.|+|||...+..++.++||||||+++|||++ |+.||...... . .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~------------~ 223 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS--E------------I 223 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH--H------------H
Confidence 9987633222112222345678999999988889999999999999999999 78887542111 0 0
Q ss_pred HHhhhcccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHHHh
Q 001544 994 MKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKI 1047 (1057)
Q Consensus 994 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i 1047 (1057)
.+.+.... .......++..+.+++.+||+.+|++|||+.|+++.|+++
T Consensus 224 ~~~~~~~~------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 224 YDYLRQGN------RLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred HHHHHcCC------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11111000 0011123566789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=324.59 Aligned_cols=255 Identities=25% Similarity=0.463 Sum_probs=205.1
Q ss_pred CCCCCceeccccCeEEEEEEec-CC---cEEEEEEeecc-chhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEE
Q 001544 770 GFSENNLIGRGSFGSVYIARLQ-NG---IEVAVKTFDLQ-HERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALIL 844 (1057)
Q Consensus 770 ~~~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 844 (1057)
+|++.+.||+|+||.||+|... ++ ..||||.++.. ......+|..|++++++++||||+++++++.+++..++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 4678899999999999999864 33 36999998654 3445678999999999999999999999999999999999
Q ss_pred EEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCC
Q 001544 845 EYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ 924 (1057)
Q Consensus 845 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 924 (1057)
||+++|+|.+++......+++.+++.++.|++.|++||| +.+++||||||+||+++.++.+|++|||.+........
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH---~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~ 161 (269)
T cd05065 85 EFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 161 (269)
T ss_pred ecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccChheEEEcCCCcEEECCCccccccccCcc
Confidence 999999999999876667899999999999999999999 89999999999999999999999999999876533221
Q ss_pred cccccccc---ccccccCccccCCCCCCccchHHHHHHHHHHHhh-CCCCCCcccccccchhhhhhhccchhHHHhhhcc
Q 001544 925 SMTQTQTL---ATLGYMAPEYGREGRVSTKGDVYSFGILLMETFT-RRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDAN 1000 (1057)
Q Consensus 925 ~~~~~~~~---~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1000 (1057)
........ .+..|+|||...+..++.++||||+||++||+++ |..||...... ....+ +...
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~--~~~~~------------i~~~ 227 (269)
T cd05065 162 DPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ--DVINA------------IEQD 227 (269)
T ss_pred ccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH--HHHHH------------HHcC
Confidence 11111111 2457999999988899999999999999999886 99998652111 11111 1000
Q ss_pred cccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHHHh
Q 001544 1001 LLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKI 1047 (1057)
Q Consensus 1001 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i 1047 (1057)
...+.+..++..+.+++.+||..+|++||++.++++.|+++
T Consensus 228 ------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 228 ------YRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ------CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 01111234567789999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=340.96 Aligned_cols=254 Identities=22% Similarity=0.282 Sum_probs=200.8
Q ss_pred HhCCCCCCceeccccCeEEEEEEec-CCcEEEEEEeecc---chhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEE
Q 001544 767 ATNGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQ---HERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKAL 842 (1057)
Q Consensus 767 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 842 (1057)
..++|++.+.||+|+||.||+|+.. +++.||+|++... .....+.+.+|+++++.++||||+++++++.+++..|+
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l 120 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM 120 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 3467999999999999999999865 5889999998642 22234567889999999999999999999999999999
Q ss_pred EEEEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCC
Q 001544 843 ILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGE 922 (1057)
Q Consensus 843 V~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~ 922 (1057)
||||+++|+|.+++... .+++.++..++.||+.||+||| +++|+||||||+||++++++.+||+|||++......
T Consensus 121 v~Ey~~gg~L~~~l~~~--~~~~~~~~~~~~qil~aL~~LH---~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~ 195 (370)
T cd05621 121 VMEYMPGGDLVNLMSNY--DVPEKWAKFYTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDET 195 (370)
T ss_pred EEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEEecccceecccC
Confidence 99999999999998654 3788999999999999999999 999999999999999999999999999999865322
Q ss_pred CCccccccccccccccCccccCCC----CCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhh
Q 001544 923 DQSMTQTQTLATLGYMAPEYGREG----RVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIID 998 (1057)
Q Consensus 923 ~~~~~~~~~~~t~~y~aPE~~~~~----~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 998 (1057)
. ........||+.|+|||++.+. .++.++||||+||++|||++|+.||...... . ....+.+
T Consensus 196 ~-~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~----~---------~~~~i~~ 261 (370)
T cd05621 196 G-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV----G---------TYSKIMD 261 (370)
T ss_pred C-ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH----H---------HHHHHHh
Confidence 1 1122345689999999988653 3788999999999999999999998652110 0 0111111
Q ss_pred cccccccchhhHHHHHHHHHHHHHHhHcccCCCCC--CCCHHHHHHH
Q 001544 999 ANLLITEDKHFAAKEQCASSVFNLAMECTVESPDE--RITAKEIVRR 1043 (1057)
Q Consensus 999 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--Rps~~evl~~ 1043 (1057)
.... ..++....++..+.+++..|+..+|.+ |+++.|+++|
T Consensus 262 ~~~~----~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 262 HKNS----LNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred CCcc----cCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 1110 111112245677889999999865544 8899999988
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=336.47 Aligned_cols=252 Identities=24% Similarity=0.319 Sum_probs=199.4
Q ss_pred CCCCCceeccccCeEEEEEEe----cCCcEEEEEEeeccc----hhHHHHHHHHHHHHHhc-CCCCceeEeeeeccCCee
Q 001544 770 GFSENNLIGRGSFGSVYIARL----QNGIEVAVKTFDLQH----ERAFKSFDTECEVMKSI-RHRNLTKIISSCSNEDFK 840 (1057)
Q Consensus 770 ~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 840 (1057)
+|++.+.||+|+||+||+|+. .+++.||+|++.... ....+.+.+|+++++++ +||+|+++++++.+.+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 478889999999999999974 358899999986432 23346678899999999 599999999999999999
Q ss_pred EEEEEEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEccccccccc
Q 001544 841 ALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLI 920 (1057)
Q Consensus 841 ~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~ 920 (1057)
++||||+++|+|.+++.... .+++.++..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++.+.
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~ 156 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRD-NFSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHeEECCCCCEEEeeCcCCcccc
Confidence 99999999999999987654 4889999999999999999999 9999999999999999999999999999998653
Q ss_pred CCCCccccccccccccccCccccCCC-CCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhc
Q 001544 921 GEDQSMTQTQTLATLGYMAPEYGREG-RVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDA 999 (1057)
Q Consensus 921 ~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 999 (1057)
.... .......||..|+|||++.+. .++.++||||+||++|||++|+.||........ ..... ..+...
T Consensus 157 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-~~~~~--------~~~~~~ 226 (332)
T cd05614 157 SEEK-ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT-QSEVS--------RRILKC 226 (332)
T ss_pred ccCC-CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC-HHHHH--------HHHhcC
Confidence 2221 122234689999999998765 478899999999999999999999864211110 00000 000000
Q ss_pred ccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCC-----CHHHHHHH
Q 001544 1000 NLLITEDKHFAAKEQCASSVFNLAMECTVESPDERI-----TAKEIVRR 1043 (1057)
Q Consensus 1000 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~ 1043 (1057)
....+..++..+.+++.+|++.||++|| ++.++++|
T Consensus 227 --------~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 227 --------DPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred --------CCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 0011123567789999999999999999 78888876
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=335.85 Aligned_cols=242 Identities=25% Similarity=0.346 Sum_probs=194.9
Q ss_pred ceeccccCeEEEEEEec-CCcEEEEEEeeccc---hhHHHHHHHHHHHHHhc-CCCCceeEeeeeccCCeeEEEEEEccC
Q 001544 775 NLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQH---ERAFKSFDTECEVMKSI-RHRNLTKIISSCSNEDFKALILEYMRN 849 (1057)
Q Consensus 775 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~~ 849 (1057)
+.||+|+||+||+|..+ +++.||||+++... ....+.+..|.+++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999865 68999999986432 23456677888888877 699999999999999999999999999
Q ss_pred CChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCccccc
Q 001544 850 GSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQT 929 (1057)
Q Consensus 850 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 929 (1057)
|+|.+++...+ .+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++..... .....
T Consensus 81 g~L~~~i~~~~-~l~~~~~~~~~~ql~~~L~~lH---~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~--~~~~~ 154 (320)
T cd05590 81 GDLMFHIQKSR-RFDEARARFYAAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN--GKTTS 154 (320)
T ss_pred chHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC--CCccc
Confidence 99999887654 4899999999999999999999 999999999999999999999999999998753211 12223
Q ss_pred cccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhcccccccchhh
Q 001544 930 QTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHF 1009 (1057)
Q Consensus 930 ~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1057)
...||+.|+|||++.+..++.++||||+||++|||++|+.||...... . ..+.+.... .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~-----~---------~~~~i~~~~-------~ 213 (320)
T cd05590 155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED-----D---------LFEAILNDE-------V 213 (320)
T ss_pred ccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH-----H---------HHHHHhcCC-------C
Confidence 456899999999999888999999999999999999999998652111 0 011110000 0
Q ss_pred HHHHHHHHHHHHHHhHcccCCCCCCCCH------HHHHHH
Q 001544 1010 AAKEQCASSVFNLAMECTVESPDERITA------KEIVRR 1043 (1057)
Q Consensus 1010 ~~~~~~~~~l~~li~~cl~~dP~~Rps~------~evl~~ 1043 (1057)
..+..++.++.+++.+|++.||++||++ .++++|
T Consensus 214 ~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h 253 (320)
T cd05590 214 VYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH 253 (320)
T ss_pred CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence 0112346678999999999999999998 666654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=336.60 Aligned_cols=248 Identities=24% Similarity=0.331 Sum_probs=196.2
Q ss_pred ceeccccCeEEEEEEec-CCcEEEEEEeecc---chhHHHHHHHHHHHHHhc-CCCCceeEeeeeccCCeeEEEEEEccC
Q 001544 775 NLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQ---HERAFKSFDTECEVMKSI-RHRNLTKIISSCSNEDFKALILEYMRN 849 (1057)
Q Consensus 775 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~~ 849 (1057)
+.||+|+||+||+|... +++.||+|+++.. .......+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999865 6889999999753 233456678899988877 799999999999999999999999999
Q ss_pred CChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCccccc
Q 001544 850 GSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQT 929 (1057)
Q Consensus 850 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 929 (1057)
|+|..++.... .+++..+..++.|++.|++||| +++|+||||||+||+++.++.+||+|||+++..... .....
T Consensus 81 ~~L~~~~~~~~-~l~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~--~~~~~ 154 (329)
T cd05618 81 GDLMFHMQRQR-KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP--GDTTS 154 (329)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCC--CCccc
Confidence 99998886554 5899999999999999999999 999999999999999999999999999998753221 11223
Q ss_pred cccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCccccccc---chhhhhhhccchhHHHhhhcccccccc
Q 001544 930 QTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEM---TLKHWVNDFLPISMMKIIDANLLITED 1006 (1057)
Q Consensus 930 ~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1006 (1057)
...||+.|+|||++.+..++.++||||+||++|||++|+.||........ ....+. .+.+...
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~--------~~~i~~~------ 220 (329)
T cd05618 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL--------FQVILEK------ 220 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHH--------HHHHhcC------
Confidence 45689999999999999999999999999999999999999964221111 111111 1111000
Q ss_pred hhhHHHHHHHHHHHHHHhHcccCCCCCCCC------HHHHHHH
Q 001544 1007 KHFAAKEQCASSVFNLAMECTVESPDERIT------AKEIVRR 1043 (1057)
Q Consensus 1007 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps------~~evl~~ 1043 (1057)
....+..++.++.+++.+|++.||++||+ +.|+++|
T Consensus 221 -~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 221 -QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred -CCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 01112345677889999999999999998 4677665
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=336.69 Aligned_cols=260 Identities=25% Similarity=0.412 Sum_probs=203.0
Q ss_pred CCCCCCceeccccCeEEEEEEe------cCCcEEEEEEeeccc-hhHHHHHHHHHHHHHhc-CCCCceeEeeeecc-CCe
Q 001544 769 NGFSENNLIGRGSFGSVYIARL------QNGIEVAVKTFDLQH-ERAFKSFDTECEVMKSI-RHRNLTKIISSCSN-EDF 839 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-~~~ 839 (1057)
++|++.+.||+|+||+||+|.. .+++.||||+++... ......+.+|++++.++ +||||+++++++.. +..
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 86 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence 4788999999999999999963 347899999996543 33456788999999999 68999999998765 456
Q ss_pred eEEEEEEccCCChhHHHhcCC-----------------------------------------------------------
Q 001544 840 KALILEYMRNGSLEKCLYSGN----------------------------------------------------------- 860 (1057)
Q Consensus 840 ~~lV~E~~~~gsL~~~l~~~~----------------------------------------------------------- 860 (1057)
.++||||+++|+|.+++....
T Consensus 87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (343)
T cd05103 87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 166 (343)
T ss_pred eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence 789999999999999886432
Q ss_pred -------ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCccccccccc
Q 001544 861 -------YILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLA 933 (1057)
Q Consensus 861 -------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~ 933 (1057)
..+++.++..++.|+++|++||| +++|+||||||+||++++++.+|++|||++................+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd05103 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243 (343)
T ss_pred hhhhhhhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence 23678888999999999999999 99999999999999999999999999999986533222222223345
Q ss_pred cccccCccccCCCCCCccchHHHHHHHHHHHhh-CCCCCCcccccccchhhhhhhccchhHHHhhhcccccccchhhHHH
Q 001544 934 TLGYMAPEYGREGRVSTKGDVYSFGILLMETFT-RRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHFAAK 1012 (1057)
Q Consensus 934 t~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1012 (1057)
+..|+|||...+..++.++||||||+++|||++ |..||......+. ......... ....+
T Consensus 244 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-------------~~~~~~~~~------~~~~~ 304 (343)
T cd05103 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-------------FCRRLKEGT------RMRAP 304 (343)
T ss_pred CcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH-------------HHHHHhccC------CCCCC
Confidence 678999999988889999999999999999997 8888765221110 001110000 00111
Q ss_pred HHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHHHhHHH
Q 001544 1013 EQCASSVFNLAMECTVESPDERITAKEIVRRLLKIRDF 1050 (1057)
Q Consensus 1013 ~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~ 1050 (1057)
...++++.+++.+||+.+|++||++.|++++|+.+.+.
T Consensus 305 ~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 305 DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 22456789999999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=336.33 Aligned_cols=248 Identities=23% Similarity=0.314 Sum_probs=197.1
Q ss_pred ceeccccCeEEEEEEec-CCcEEEEEEeeccc---hhHHHHHHHHHHHHHhc-CCCCceeEeeeeccCCeeEEEEEEccC
Q 001544 775 NLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQH---ERAFKSFDTECEVMKSI-RHRNLTKIISSCSNEDFKALILEYMRN 849 (1057)
Q Consensus 775 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~~ 849 (1057)
++||+|+||+||+|+.. +++.||||+++... ......+.+|..++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999865 68999999997532 23446688899999998 699999999999999999999999999
Q ss_pred CChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCccccc
Q 001544 850 GSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQT 929 (1057)
Q Consensus 850 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 929 (1057)
|+|.+++...+ .+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++..... .....
T Consensus 81 g~L~~~~~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--~~~~~ 154 (329)
T cd05588 81 GDLMFHMQRQR-KLPEEHARFYSAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP--GDTTS 154 (329)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEECcCccccccccC--CCccc
Confidence 99998886554 5899999999999999999999 999999999999999999999999999998743211 12223
Q ss_pred cccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccc---cchhhhhhhccchhHHHhhhcccccccc
Q 001544 930 QTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGE---MTLKHWVNDFLPISMMKIIDANLLITED 1006 (1057)
Q Consensus 930 ~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1006 (1057)
...||+.|+|||++.+..++.++|+||+||++|||++|+.||+.....+ .....+. .+.+....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~--------~~~~~~~~----- 221 (329)
T cd05588 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYL--------FQVILEKQ----- 221 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHH--------HHHHHcCC-----
Confidence 4568999999999999899999999999999999999999996422111 1111111 11110000
Q ss_pred hhhHHHHHHHHHHHHHHhHcccCCCCCCCC------HHHHHHH
Q 001544 1007 KHFAAKEQCASSVFNLAMECTVESPDERIT------AKEIVRR 1043 (1057)
Q Consensus 1007 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps------~~evl~~ 1043 (1057)
...+..++.++.+++.+|++.||.+||+ +.|+++|
T Consensus 222 --~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 222 --IRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred --CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 0111235667899999999999999997 6787765
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=323.25 Aligned_cols=256 Identities=26% Similarity=0.461 Sum_probs=205.7
Q ss_pred CCCCCCceeccccCeEEEEEEec----CCcEEEEEEeeccc-hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEE
Q 001544 769 NGFSENNLIGRGSFGSVYIARLQ----NGIEVAVKTFDLQH-ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALI 843 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 843 (1057)
.+|++.+.||+|+||.||+|... .+..||+|.++... ....+.+.+|+.++++++||||+++++++..++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 46788899999999999999753 23479999986543 34457889999999999999999999999999999999
Q ss_pred EEEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCC
Q 001544 844 LEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGED 923 (1057)
Q Consensus 844 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~ 923 (1057)
|||+++++|.+++......+++.++..++.|++.|++||| +.+++||||||+||+++.++.++++|||++..+....
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd05066 84 TEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 160 (267)
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence 9999999999999877667899999999999999999999 9999999999999999999999999999998763322
Q ss_pred Ccc-ccccccccccccCccccCCCCCCccchHHHHHHHHHHHhh-CCCCCCcccccccchhhhhhhccchhHHHhhhccc
Q 001544 924 QSM-TQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFT-RRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANL 1001 (1057)
Q Consensus 924 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1001 (1057)
... ......++..|+|||.+.+..++.++||||||+++||+++ |..||......+ ... .+.+.
T Consensus 161 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~--~~~-----------~~~~~-- 225 (267)
T cd05066 161 EAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD--VIK-----------AIEEG-- 225 (267)
T ss_pred ceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH--HHH-----------HHhCC--
Confidence 111 1111223567999999988889999999999999999887 999986522110 000 01100
Q ss_pred ccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHHHh
Q 001544 1002 LITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKI 1047 (1057)
Q Consensus 1002 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i 1047 (1057)
.+.+....++..+.+++.+|++.+|++||++.++++.|+++
T Consensus 226 -----~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 226 -----YRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred -----CcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 00111123567789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=330.98 Aligned_cols=268 Identities=21% Similarity=0.294 Sum_probs=202.6
Q ss_pred CCCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccc-hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEE
Q 001544 769 NGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQH-ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEY 846 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 846 (1057)
++|...+.||+|+||+||+|+.+ +++.||+|+++... ......+.+|++++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 57888999999999999999865 68899999986443 22334677899999999999999999999999999999999
Q ss_pred ccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCcc
Q 001544 847 MRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSM 926 (1057)
Q Consensus 847 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 926 (1057)
+++ ++.+++......+++..+..++.|+++||+||| +++|+||||||+||+++.++.+||+|||+++...... .
T Consensus 86 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~ 159 (309)
T cd07872 86 LDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPT--K 159 (309)
T ss_pred CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECccccceecCCCc--c
Confidence 975 888888776666899999999999999999999 9999999999999999999999999999987542221 1
Q ss_pred ccccccccccccCccccCC-CCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhc--cchhHHHhhh-----
Q 001544 927 TQTQTLATLGYMAPEYGRE-GRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDF--LPISMMKIID----- 998 (1057)
Q Consensus 927 ~~~~~~~t~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~----- 998 (1057)
......++..|+|||.+.+ ..++.++||||+||++|||++|+.||......+. ........ ........+.
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (309)
T cd07872 160 TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDE-LHLIFRLLGTPTEETWPGISSNDEF 238 (309)
T ss_pred ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCHHHHhhhcchhhh
Confidence 2233457889999998764 4688999999999999999999999865322111 10000000 0000000000
Q ss_pred --cccc-cccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 999 --ANLL-ITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 999 --~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
.... ............++.++.+++.+|++.||++|||+.|+++|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred hhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 0000 00000111123456788999999999999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=322.22 Aligned_cols=252 Identities=29% Similarity=0.495 Sum_probs=202.7
Q ss_pred CCCCCCceeccccCeEEEEEEecCCcEEEEEEeeccchhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEEcc
Q 001544 769 NGFSENNLIGRGSFGSVYIARLQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEYMR 848 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 848 (1057)
++|++.+.||+|+||.||+|..+++..||+|.++.... ..+++.+|++++++++|++++++++++.+ +..++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~ 83 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEYMS 83 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEecC
Confidence 46888899999999999999988888999999865433 34678999999999999999999998854 55789999999
Q ss_pred CCChhHHHhcCC-ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCccc
Q 001544 849 NGSLEKCLYSGN-YILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMT 927 (1057)
Q Consensus 849 ~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 927 (1057)
+++|.+++.... ..+++.++..++.|++.|++||| +.+++||||||+||++++++.++++|||.+..+.... ...
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~-~~~ 159 (260)
T cd05070 84 KGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE-YTA 159 (260)
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEEeCCceEEeCCceeeeeccCcc-ccc
Confidence 999999987643 45899999999999999999999 8999999999999999999999999999998653221 111
Q ss_pred cccccccccccCccccCCCCCCccchHHHHHHHHHHHhh-CCCCCCcccccccchhhhhhhccchhHHHhhhcccccccc
Q 001544 928 QTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFT-RRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITED 1006 (1057)
Q Consensus 928 ~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1006 (1057)
.....++..|+|||...+..++.++|+||||+++|||++ |..||......+ ..+.+....
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~--------------~~~~~~~~~----- 220 (260)
T cd05070 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE--------------VLEQVERGY----- 220 (260)
T ss_pred ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH--------------HHHHHHcCC-----
Confidence 122234567999999888889999999999999999999 888886521110 011111100
Q ss_pred hhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHHH
Q 001544 1007 KHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLK 1046 (1057)
Q Consensus 1007 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 1046 (1057)
..+.+...+.++.+++.+|+..+|++|||+.++.+.|++
T Consensus 221 -~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 221 -RMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred -CCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 111123456779999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=339.21 Aligned_cols=258 Identities=25% Similarity=0.412 Sum_probs=204.3
Q ss_pred CCCCCCceeccccCeEEEEEEec------CCcEEEEEEeeccc-hhHHHHHHHHHHHHHhcC-CCCceeEeeeeccCCee
Q 001544 769 NGFSENNLIGRGSFGSVYIARLQ------NGIEVAVKTFDLQH-ERAFKSFDTECEVMKSIR-HRNLTKIISSCSNEDFK 840 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~ 840 (1057)
++|.+.+.||+|+||.||+|++. .++.||||+++... ....+.+.+|++++.++. ||||+++++++...+..
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~ 116 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPI 116 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCc
Confidence 45777899999999999999853 34689999996542 333457889999999997 99999999999999999
Q ss_pred EEEEEEccCCChhHHHhcCC------------------------------------------------------------
Q 001544 841 ALILEYMRNGSLEKCLYSGN------------------------------------------------------------ 860 (1057)
Q Consensus 841 ~lV~E~~~~gsL~~~l~~~~------------------------------------------------------------ 860 (1057)
++||||+++|+|.++++..+
T Consensus 117 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (401)
T cd05107 117 YIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMK 196 (401)
T ss_pred EEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcch
Confidence 99999999999999986532
Q ss_pred -------------------------------------ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeC
Q 001544 861 -------------------------------------YILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLD 903 (1057)
Q Consensus 861 -------------------------------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~ 903 (1057)
..+++..+..++.|++.||+||| +.+|+||||||+||+++
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrdlkp~NiLl~ 273 (401)
T cd05107 197 GTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAARNVLIC 273 (401)
T ss_pred hhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCcCcccCCcceEEEe
Confidence 13577788999999999999999 99999999999999999
Q ss_pred CCCcEEEEcccccccccCCCCccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhh-CCCCCCcccccccchh
Q 001544 904 DNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFT-RRKPTDEIFSGEMTLK 982 (1057)
Q Consensus 904 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~ 982 (1057)
+++.+|++|||+++...............++..|+|||.+....++.++|||||||++|||++ |+.||......+.
T Consensus 274 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~--- 350 (401)
T cd05107 274 EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ--- 350 (401)
T ss_pred CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH---
Confidence 999999999999986532222112222346778999999988889999999999999999998 8888865321111
Q ss_pred hhhhhccchhHHHhhhcccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHHHhH
Q 001544 983 HWVNDFLPISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKIR 1048 (1057)
Q Consensus 983 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~ 1048 (1057)
..+.+.... +...+..++.++.+++.+||..+|++||+++|+++.|+++.
T Consensus 351 ----------~~~~~~~~~------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 351 ----------FYNAIKRGY------RMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred ----------HHHHHHcCC------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 011111110 01112235678999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=321.48 Aligned_cols=253 Identities=28% Similarity=0.474 Sum_probs=203.4
Q ss_pred CCCCCCceeccccCeEEEEEEecCCcEEEEEEeeccchhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEEcc
Q 001544 769 NGFSENNLIGRGSFGSVYIARLQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEYMR 848 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 848 (1057)
++|++.++||+|+||.||+|+..++..||+|+++.... ..+.+.+|++++++++||||+++++++.+ +..++||||++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~ 83 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 83 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCC
Confidence 46889999999999999999887777899999875332 34678899999999999999999998754 55789999999
Q ss_pred CCChhHHHhcCC-ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCccc
Q 001544 849 NGSLEKCLYSGN-YILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMT 927 (1057)
Q Consensus 849 ~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 927 (1057)
+|+|.+++.... ..+++.++..++.|+++||+|+| +.+++||||||+||++++++.+||+|||.++.+..... ..
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~-~~ 159 (262)
T cd05071 84 KGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TA 159 (262)
T ss_pred CCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcccEEEcCCCcEEeccCCceeecccccc-cc
Confidence 999999997633 45899999999999999999999 99999999999999999999999999999976532221 12
Q ss_pred cccccccccccCccccCCCCCCccchHHHHHHHHHHHhh-CCCCCCcccccccchhhhhhhccchhHHHhhhcccccccc
Q 001544 928 QTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFT-RRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITED 1006 (1057)
Q Consensus 928 ~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1006 (1057)
.....++..|+|||+..+..++.++||||||+++|||++ |..||......+ ....+....
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~--------------~~~~~~~~~----- 220 (262)
T cd05071 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--------------VLDQVERGY----- 220 (262)
T ss_pred ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH--------------HHHHHhcCC-----
Confidence 223345678999999988889999999999999999999 777876521110 111111100
Q ss_pred hhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHHHh
Q 001544 1007 KHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKI 1047 (1057)
Q Consensus 1007 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i 1047 (1057)
..+....++..+.+++.+|++.+|++||++.++++.|++.
T Consensus 221 -~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 221 -RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred -CCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 0111234567889999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=327.91 Aligned_cols=262 Identities=26% Similarity=0.417 Sum_probs=201.4
Q ss_pred CCCCCCceeccccCeEEEEEEecC---------------CcEEEEEEeeccc-hhHHHHHHHHHHHHHhcCCCCceeEee
Q 001544 769 NGFSENNLIGRGSFGSVYIARLQN---------------GIEVAVKTFDLQH-ERAFKSFDTECEVMKSIRHRNLTKIIS 832 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~Vy~~~~~~---------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~ 832 (1057)
.+|++.+.||+|+||.||+|.... ...||||.++... ......+.+|++++++++|||++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 478889999999999999986532 2358999986542 334567899999999999999999999
Q ss_pred eeccCCeeEEEEEEccCCChhHHHhcCC-----------ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCee
Q 001544 833 SCSNEDFKALILEYMRNGSLEKCLYSGN-----------YILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVL 901 (1057)
Q Consensus 833 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~-----------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nil 901 (1057)
++...+..++||||+++++|.+++.... ..+++.++..++.|+++|++||| +.+++||||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH---hcCeeccccChhhEE
Confidence 9999999999999999999999886532 23688899999999999999999 999999999999999
Q ss_pred eCCCCcEEEEcccccccccCCCCccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhh--CCCCCCccccccc
Q 001544 902 LDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFT--RRKPTDEIFSGEM 979 (1057)
Q Consensus 902 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt--g~~p~~~~~~~~~ 979 (1057)
+++++.+|++|||++................++..|+|||...++.++.++|||||||++|||++ |..||......+
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~- 240 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ- 240 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH-
Confidence 99999999999999976533222222223345678999999988889999999999999999998 556665421111
Q ss_pred chhhhhhhccchhHHHhhhcccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHHH
Q 001544 980 TLKHWVNDFLPISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLK 1046 (1057)
Q Consensus 980 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 1046 (1057)
..... .+..+..... ........++..+.+++.+|++.+|++||++.++++.|++
T Consensus 241 ~~~~~---------~~~~~~~~~~---~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 241 VIENT---------GEFFRNQGRQ---IYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred HHHHH---------HHhhhhcccc---ccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 00000 0000000000 0001112346789999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=328.93 Aligned_cols=254 Identities=25% Similarity=0.401 Sum_probs=202.5
Q ss_pred CCCCCceeccccCeEEEEEEec------CCcEEEEEEeeccch-hHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEE
Q 001544 770 GFSENNLIGRGSFGSVYIARLQ------NGIEVAVKTFDLQHE-RAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKAL 842 (1057)
Q Consensus 770 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 842 (1057)
+|++.+.||+|+||+||+|... ++..||||+++.... .....+.+|+.++++++||||+++++++.+.+..++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 4666788999999999999753 257899999975433 335678899999999999999999999999999999
Q ss_pred EEEEccCCChhHHHhcC---------------CccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCc
Q 001544 843 ILEYMRNGSLEKCLYSG---------------NYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMV 907 (1057)
Q Consensus 843 V~E~~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~ 907 (1057)
++||+.+++|.+++... ...+++..+..++.|++.||+|+| +++|+||||||+||++++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HcCccccccchhheEecCCCc
Confidence 99999999999988532 134788889999999999999999 999999999999999999999
Q ss_pred EEEEcccccccccCCCCccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhh-CCCCCCcccccccchhhhhh
Q 001544 908 AHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFT-RRKPTDEIFSGEMTLKHWVN 986 (1057)
Q Consensus 908 ~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~ 986 (1057)
+||+|||+++...............+++.|+|||.+.++.++.++||||+||++|||++ |..||...... ++..
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-----~~~~ 237 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ-----DVIE 237 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH-----HHHH
Confidence 99999999886533322222233445778999999988889999999999999999998 77787542111 1110
Q ss_pred hccchhHHHhhhcccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHHH
Q 001544 987 DFLPISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLK 1046 (1057)
Q Consensus 987 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 1046 (1057)
.+.+.. ..+.+..++..+.+++.+||+.+|++||++.|+++.|+.
T Consensus 238 --------~i~~~~-------~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 238 --------MIRNRQ-------VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred --------HHHcCC-------cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 111100 011123567789999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=329.68 Aligned_cols=251 Identities=25% Similarity=0.354 Sum_probs=211.5
Q ss_pred hCCCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccch---hHHHHHHHHHHHHHhcC-CCCceeEeeeeccCCeeEE
Q 001544 768 TNGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQHE---RAFKSFDTECEVMKSIR-HRNLTKIISSCSNEDFKAL 842 (1057)
Q Consensus 768 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l 842 (1057)
...|+..+.||+|.||.||+++.+ +|+.+|+|++.+... .....+.+|+++|+++. |||||.+.+.|++.+..++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 456888899999999999999866 599999999965543 24578999999999998 9999999999999999999
Q ss_pred EEEEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCC----CCcEEEEccccccc
Q 001544 843 ILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDD----NMVAHLSDFGIAKL 918 (1057)
Q Consensus 843 V~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~----~~~~kl~Dfg~a~~ 918 (1057)
|||+++||.|.+.+... . +++..+..++.|++.+++||| +.+|+|||+||+|+|+.. ++.+|++|||++.+
T Consensus 114 vmEL~~GGeLfd~i~~~-~-~sE~da~~~~~~il~av~~lH---~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~ 188 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK-H-YSERDAAGIIRQILEAVKYLH---SLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKF 188 (382)
T ss_pred EEEecCCchHHHHHHHc-c-CCHHHHHHHHHHHHHHHHHHH---hCCceeccCCHHHeeeccccCCCCcEEEeeCCCceE
Confidence 99999999999998776 3 999999999999999999999 999999999999999963 35799999999998
Q ss_pred ccCCCCccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhh
Q 001544 919 LIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIID 998 (1057)
Q Consensus 919 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 998 (1057)
..+ .......+||+.|+|||++....++.++||||+||++|.|++|.+||......+... .+..
T Consensus 189 ~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-------------~i~~ 252 (382)
T KOG0032|consen 189 IKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-------------AILR 252 (382)
T ss_pred ccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-------------HHHc
Confidence 743 445566789999999999999999999999999999999999999997632221111 1111
Q ss_pred cccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 999 ANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 999 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
... ....+.+..++..+.+++..|+..||.+|+|+.++++|
T Consensus 253 ~~~----~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 253 GDF----DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred CCC----CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 111 11222334567889999999999999999999999997
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=333.61 Aligned_cols=242 Identities=22% Similarity=0.325 Sum_probs=191.7
Q ss_pred ceeccccCeEEEEEEec-CCcEEEEEEeeccc---hhHHHHHHHHHHHHHhc-CCCCceeEeeeeccCCeeEEEEEEccC
Q 001544 775 NLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQH---ERAFKSFDTECEVMKSI-RHRNLTKIISSCSNEDFKALILEYMRN 849 (1057)
Q Consensus 775 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~~ 849 (1057)
++||+|+||+||+|+.. +++.||||+++... ....+.+..|.+++... +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999865 58899999997542 22344556677777654 899999999999999999999999999
Q ss_pred CChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCccccc
Q 001544 850 GSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQT 929 (1057)
Q Consensus 850 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 929 (1057)
|+|.+++.... .+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++...... ....
T Consensus 81 g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~~ 154 (316)
T cd05592 81 GDLMFHIQSSG-RFDEARARFYAAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKAS 154 (316)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Cccc
Confidence 99999887654 5899999999999999999999 8999999999999999999999999999997542221 2233
Q ss_pred cccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhcccccccchhh
Q 001544 930 QTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHF 1009 (1057)
Q Consensus 930 ~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1057)
...||+.|+|||++.+..++.++||||+||++|||++|+.||...... . ....+.... .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~-----~---------~~~~i~~~~-------~ 213 (316)
T cd05592 155 TFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED-----E---------LFDSILNDR-------P 213 (316)
T ss_pred cccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH-----H---------HHHHHHcCC-------C
Confidence 456899999999999888999999999999999999999998652111 0 000000000 0
Q ss_pred HHHHHHHHHHHHHHhHcccCCCCCCCCHH-HHHHH
Q 001544 1010 AAKEQCASSVFNLAMECTVESPDERITAK-EIVRR 1043 (1057)
Q Consensus 1010 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~-evl~~ 1043 (1057)
..+..++.++.+++.+||+.+|++||++. ++++|
T Consensus 214 ~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h 248 (316)
T cd05592 214 HFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQH 248 (316)
T ss_pred CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence 01123456788999999999999999875 55543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=334.75 Aligned_cols=247 Identities=23% Similarity=0.304 Sum_probs=197.6
Q ss_pred CCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccc---hhHHHHHHHHHHHHHhcCC-CCceeEeeeeccCCeeEEEE
Q 001544 770 GFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQH---ERAFKSFDTECEVMKSIRH-RNLTKIISSCSNEDFKALIL 844 (1057)
Q Consensus 770 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lV~ 844 (1057)
+|++.+.||+|+||.||+|... +++.||||+++... ....+.+..|++++..++| ++|+++++++.+.+..|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4788899999999999999865 57899999996532 3345677889999999976 56888999999999999999
Q ss_pred EEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCC
Q 001544 845 EYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ 924 (1057)
Q Consensus 845 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 924 (1057)
||+++|+|.+++.... .+++.++..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~-- 154 (324)
T cd05587 81 EYVNGGDLMYHIQQVG-KFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG-- 154 (324)
T ss_pred cCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCC--
Confidence 9999999999887654 4889999999999999999999 999999999999999999999999999998743211
Q ss_pred ccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhcccccc
Q 001544 925 SMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLIT 1004 (1057)
Q Consensus 925 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1057)
........||+.|+|||++.+..++.++||||+||++|||++|+.||......+. ...+....
T Consensus 155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~-------------~~~i~~~~---- 217 (324)
T cd05587 155 GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL-------------FQSIMEHN---- 217 (324)
T ss_pred CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH-------------HHHHHcCC----
Confidence 1122345689999999999998999999999999999999999999865211100 01111100
Q ss_pred cchhhHHHHHHHHHHHHHHhHcccCCCCCCCCH-----HHHHHH
Q 001544 1005 EDKHFAAKEQCASSVFNLAMECTVESPDERITA-----KEIVRR 1043 (1057)
Q Consensus 1005 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~-----~evl~~ 1043 (1057)
...+..++.++.+++.+|+..||.+|++. .++.+|
T Consensus 218 ----~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 218 ----VSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred ----CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 01112356678899999999999999976 666655
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=326.61 Aligned_cols=255 Identities=28% Similarity=0.444 Sum_probs=215.4
Q ss_pred CCCCCCceeccccCeEEEEEEecC-CcEEEEEEeeccchhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEEc
Q 001544 769 NGFSENNLIGRGSFGSVYIARLQN-GIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEYM 847 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 847 (1057)
.+..+.++||-|.||.||.|.|+. .-.||||.++. +....++|.+|+.+|+.++|||+|+++|.|..+-..|||+|||
T Consensus 267 tdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKE-DtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM 345 (1157)
T KOG4278|consen 267 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFM 345 (1157)
T ss_pred hheeeeeccCCCcccceeeeeeeccceeeehhhhhh-cchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecc
Confidence 355677899999999999999874 56799999863 4455689999999999999999999999999999999999999
Q ss_pred cCCChhHHHhcCC-ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCcc
Q 001544 848 RNGSLEKCLYSGN-YILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSM 926 (1057)
Q Consensus 848 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 926 (1057)
..|+|.+++++.. ..++.--.+.++.||+.|++||. .+.+|||||.++|.|+.++..+||+|||+++.+.++. +.
T Consensus 346 ~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLE---kknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDT-YT 421 (1157)
T KOG4278|consen 346 CYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDT-YT 421 (1157)
T ss_pred cCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHH---HhhhhhhhhhhhhccccccceEEeeccchhhhhcCCc-ee
Confidence 9999999998765 44666677899999999999999 9999999999999999999999999999999985443 33
Q ss_pred ccccccccccccCccccCCCCCCccchHHHHHHHHHHHhh-CCCCCCcccccccchhhhhhhccchhHHHhhhccccccc
Q 001544 927 TQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFT-RRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITE 1005 (1057)
Q Consensus 927 ~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1057)
.+........|.|||-+....++.|+|||+|||++||+.| |..||....-. .+.+.. +.
T Consensus 422 AHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlS--------------qVY~LL------Ek 481 (1157)
T KOG4278|consen 422 AHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--------------QVYGLL------EK 481 (1157)
T ss_pred cccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHH--------------HHHHHH------hc
Confidence 3333445678999999999999999999999999999999 66676542111 122222 33
Q ss_pred chhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHHHhH
Q 001544 1006 DKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKIR 1048 (1057)
Q Consensus 1006 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~ 1048 (1057)
+.+...++.|++.++++|+.||+..|.+||+++|+-+.++.+.
T Consensus 482 gyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf 524 (1157)
T KOG4278|consen 482 GYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF 524 (1157)
T ss_pred cccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence 4456667889999999999999999999999999999998874
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=353.18 Aligned_cols=259 Identities=25% Similarity=0.328 Sum_probs=203.6
Q ss_pred CCCCCCceeccccCeEEEEEEec-CCcEEEEEEeecc---chhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEE
Q 001544 769 NGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQ---HERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALIL 844 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 844 (1057)
++|++.++||+|+||.||+|... +|+.||||+++.. .....+++.+|++++++++||||+++++++.+++..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 47889999999999999999865 6899999998643 2334567899999999999999999999999999999999
Q ss_pred EEccCCChhHHHhcC----------CccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEccc
Q 001544 845 EYMRNGSLEKCLYSG----------NYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFG 914 (1057)
Q Consensus 845 E~~~~gsL~~~l~~~----------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 914 (1057)
||++||+|.+++... ....++.++++++.||++||+||| +.+|+||||||+||+++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH---s~GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH---HCCccccCCchheEEEcCCCCEEEEecC
Confidence 999999999988642 123567788999999999999999 8999999999999999999999999999
Q ss_pred ccccccCCCC----------------ccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccc
Q 001544 915 IAKLLIGEDQ----------------SMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGE 978 (1057)
Q Consensus 915 ~a~~~~~~~~----------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~ 978 (1057)
+++....... ........||+.|+|||.+.+..++.++||||+||++|||+||+.||......+
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9986521110 001112468999999999999999999999999999999999999986521111
Q ss_pred cchhhhhhhccchhHHHhhhcccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCC-CHHHHHHHHHHhH
Q 001544 979 MTLKHWVNDFLPISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERI-TAKEIVRRLLKIR 1048 (1057)
Q Consensus 979 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-s~~evl~~L~~i~ 1048 (1057)
...... ..+ .........+++.+.+++.+|++.||++|| ++.++.+.|+...
T Consensus 239 i~~~~~-----------i~~-------P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~l 291 (932)
T PRK13184 239 ISYRDV-----------ILS-------PIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHL 291 (932)
T ss_pred hhhhhh-----------ccC-------hhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 100000 000 000011124567789999999999999997 5666777776653
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=324.85 Aligned_cols=245 Identities=21% Similarity=0.321 Sum_probs=195.7
Q ss_pred eccccCeEEEEEEec-CCcEEEEEEeeccch---hHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEEccCCCh
Q 001544 777 IGRGSFGSVYIARLQ-NGIEVAVKTFDLQHE---RAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEYMRNGSL 852 (1057)
Q Consensus 777 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL 852 (1057)
||+|+||+||+|... +++.||||.+..... ...+.+..|++++++++||||+++.+++..+...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999765 689999999864322 2345678899999999999999999999999999999999999999
Q ss_pred hHHHhc---CCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCccccc
Q 001544 853 EKCLYS---GNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQT 929 (1057)
Q Consensus 853 ~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 929 (1057)
.+.+.. ....+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||.+....... ....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~--~~~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ--SKTK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCC--cccc
Confidence 987753 2346899999999999999999999 9999999999999999999999999999997653221 1223
Q ss_pred cccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhcccccccchhh
Q 001544 930 QTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHF 1009 (1057)
Q Consensus 930 ~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1057)
...|++.|+|||++.+..++.++||||+||++|||++|+.||....... ...... ...... ..
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~-~~~~~~--------~~~~~~--------~~ 218 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV-ENKELK--------QRILND--------SV 218 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcch-hHHHHH--------Hhhccc--------CC
Confidence 3468899999999999999999999999999999999999986521110 000000 000000 01
Q ss_pred HHHHHHHHHHHHHHhHcccCCCCCCC-----CHHHHHHH
Q 001544 1010 AAKEQCASSVFNLAMECTVESPDERI-----TAKEIVRR 1043 (1057)
Q Consensus 1010 ~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~ 1043 (1057)
..+..++.++.+++.+|++.||++|| ++.|+++|
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 219 TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred CCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 11234567889999999999999999 77888876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=335.30 Aligned_cols=242 Identities=24% Similarity=0.333 Sum_probs=195.4
Q ss_pred ceeccccCeEEEEEEec-CCcEEEEEEeeccc---hhHHHHHHHHHHHHHhc-CCCCceeEeeeeccCCeeEEEEEEccC
Q 001544 775 NLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQH---ERAFKSFDTECEVMKSI-RHRNLTKIISSCSNEDFKALILEYMRN 849 (1057)
Q Consensus 775 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~~ 849 (1057)
++||+|+||.||+|+.. +++.||||+++... ....+.+..|.+++..+ +||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999865 58899999996532 23445677888998866 799999999999999999999999999
Q ss_pred CChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCccccc
Q 001544 850 GSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQT 929 (1057)
Q Consensus 850 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 929 (1057)
|+|..++.... .+++..+..++.|++.||+||| +.+|+||||||+||++++++.+||+|||+++..... .....
T Consensus 81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~--~~~~~ 154 (321)
T cd05591 81 GDLMFQIQRSR-KFDEPRSRFYAAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILN--GVTTT 154 (321)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeecccceecccC--Ccccc
Confidence 99999887654 4889999999999999999999 999999999999999999999999999998754221 12223
Q ss_pred cccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhcccccccchhh
Q 001544 930 QTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHF 1009 (1057)
Q Consensus 930 ~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1057)
...||+.|+|||++.+..++.++||||+||++|||++|+.||......+ . ...+.....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~-----~--------~~~i~~~~~-------- 213 (321)
T cd05591 155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD-----L--------FESILHDDV-------- 213 (321)
T ss_pred ccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH-----H--------HHHHHcCCC--------
Confidence 4568999999999998899999999999999999999999986521110 0 001110000
Q ss_pred HHHHHHHHHHHHHHhHcccCCCCCCC-------CHHHHHHH
Q 001544 1010 AAKEQCASSVFNLAMECTVESPDERI-------TAKEIVRR 1043 (1057)
Q Consensus 1010 ~~~~~~~~~l~~li~~cl~~dP~~Rp-------s~~evl~~ 1043 (1057)
..+..++.++.+++.+|++.||++|| ++.++++|
T Consensus 214 ~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 214 LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 01122456788999999999999999 88888876
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=320.31 Aligned_cols=258 Identities=24% Similarity=0.369 Sum_probs=208.8
Q ss_pred CCCCCCceeccccCeEEEEEEec-CCcEEEEEEeecc---chhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEE
Q 001544 769 NGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQ---HERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALIL 844 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 844 (1057)
++|++.+.||+|+||.||+|... +|+.||+|.++.. .....+.+.+|++++++++|+|++++++++.+.+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57888999999999999999876 7999999988532 2334678899999999999999999999999999999999
Q ss_pred EEccCCChhHHHhc---CCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccC
Q 001544 845 EYMRNGSLEKCLYS---GNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIG 921 (1057)
Q Consensus 845 E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~ 921 (1057)
||+++|+|.+++.. ....+++.++..++.|+++|++||| +.+|+||||+|+||+++.++.++++|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 99999999998864 2345899999999999999999999 99999999999999999999999999999876532
Q ss_pred CCCccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhccc
Q 001544 922 EDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANL 1001 (1057)
Q Consensus 922 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1001 (1057)
.. .......++..|+|||...+..++.++||||+||++|||++|+.||.... .....+. +......
T Consensus 159 ~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~---------~~~~~~~ 224 (267)
T cd08224 159 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK---MNLYSLC---------KKIEKCD 224 (267)
T ss_pred CC--cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC---ccHHHHH---------hhhhcCC
Confidence 21 12223457888999999988889999999999999999999999985421 1111110 0010000
Q ss_pred ccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHHHhH
Q 001544 1002 LITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKIR 1048 (1057)
Q Consensus 1002 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~ 1048 (1057)
. . .. ..+.++..+.+++.+||..+|++||++.++++.+++++
T Consensus 225 ~---~-~~-~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 225 Y---P-PL-PADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred C---C-CC-ChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 0 0 00 01245667899999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=327.08 Aligned_cols=263 Identities=25% Similarity=0.426 Sum_probs=205.2
Q ss_pred hCCCCCCceeccccCeEEEEEEecC-----------------CcEEEEEEeeccc-hhHHHHHHHHHHHHHhcCCCCcee
Q 001544 768 TNGFSENNLIGRGSFGSVYIARLQN-----------------GIEVAVKTFDLQH-ERAFKSFDTECEVMKSIRHRNLTK 829 (1057)
Q Consensus 768 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~ 829 (1057)
..+|++.+.||+|+||.||+|.... +..||+|.+.... ....+.+.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3578889999999999999997542 2468999986543 345678899999999999999999
Q ss_pred EeeeeccCCeeEEEEEEccCCChhHHHhcCC----------ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCC
Q 001544 830 IISSCSNEDFKALILEYMRNGSLEKCLYSGN----------YILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSN 899 (1057)
Q Consensus 830 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~----------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~N 899 (1057)
+++++..++..++||||+++++|.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH---~~~i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH---HcCccccccchhc
Confidence 9999999999999999999999999987644 25899999999999999999999 8999999999999
Q ss_pred eeeCCCCcEEEEcccccccccCCCCccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhh--CCCCCCccccc
Q 001544 900 VLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFT--RRKPTDEIFSG 977 (1057)
Q Consensus 900 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt--g~~p~~~~~~~ 977 (1057)
|+++.++.++++|||+++...............++..|+|||...+..++.++|||||||++|||++ |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 9999999999999999976533322222334456778999999988889999999999999999998 66776542111
Q ss_pred ccchhhhhhhccchhHHHhhhcccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHHH
Q 001544 978 EMTLKHWVNDFLPISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLK 1046 (1057)
Q Consensus 978 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 1046 (1057)
+ .+ .... ...... ......+.+..++.++.+++.+|++.||++||++.|+++.|++
T Consensus 241 ~-~~-~~~~--------~~~~~~---~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 241 Q-VI-ENAG--------HFFRDD---GRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred H-HH-HHHH--------hccccc---cccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 0 00 0000 000000 0000011122345789999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=342.64 Aligned_cols=252 Identities=22% Similarity=0.327 Sum_probs=197.8
Q ss_pred CCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccc---hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEE
Q 001544 770 GFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQH---ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILE 845 (1057)
Q Consensus 770 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 845 (1057)
.|+..++||+|+||+||+|+.. +++.||||++.... ......+.+|++++++++||||+++++++.+++..|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5788999999999999999854 68899999986532 3345678899999999999999999999999999999999
Q ss_pred EccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCC-
Q 001544 846 YMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ- 924 (1057)
Q Consensus 846 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~- 924 (1057)
|+++|+|.+++...+ .+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 82 ~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~al~~lH---~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~ 157 (382)
T cd05625 82 YIPGGDMMSLLIRMG-IFPEDLARFYIAELTCAVESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (382)
T ss_pred CCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccc
Confidence 999999999987654 5788899999999999999999 99999999999999999999999999999753210000
Q ss_pred --------------------------------------------ccccccccccccccCccccCCCCCCccchHHHHHHH
Q 001544 925 --------------------------------------------SMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGIL 960 (1057)
Q Consensus 925 --------------------------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~i 960 (1057)
........||+.|+|||++.+..++.++||||+||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvi 237 (382)
T cd05625 158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 237 (382)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHH
Confidence 000112368999999999998899999999999999
Q ss_pred HHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhcccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCC---H
Q 001544 961 LMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERIT---A 1037 (1057)
Q Consensus 961 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps---~ 1037 (1057)
+|||++|+.||......+. ...+.... .....+.....++++.+++.+|+ .+|++|++ +
T Consensus 238 l~elltG~~Pf~~~~~~~~-------------~~~i~~~~----~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~ 299 (382)
T cd05625 238 LYEMLVGQPPFLAQTPLET-------------QMKVINWQ----TSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGA 299 (382)
T ss_pred HHHHHhCCCCCCCCCHHHH-------------HHHHHccC----CCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCH
Confidence 9999999999865211110 01111000 00011111234567788888876 59999997 8
Q ss_pred HHHHHH
Q 001544 1038 KEIVRR 1043 (1057)
Q Consensus 1038 ~evl~~ 1043 (1057)
.|+++|
T Consensus 300 ~ei~~h 305 (382)
T cd05625 300 DEIKAH 305 (382)
T ss_pred HHHhcC
Confidence 888876
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=320.13 Aligned_cols=252 Identities=25% Similarity=0.377 Sum_probs=203.3
Q ss_pred CCCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccc-----hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEE
Q 001544 769 NGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQH-----ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKAL 842 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 842 (1057)
++|+..+.||+|++|.||+|... ++++||+|++.... ....+.+.+|++++++++||||+++++++.+++..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 46888999999999999999854 68999999986432 1234678899999999999999999999999999999
Q ss_pred EEEEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCC
Q 001544 843 ILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGE 922 (1057)
Q Consensus 843 V~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~ 922 (1057)
|+||+++++|.+++.... .+++..+..++.|++.|++||| +.+++||||+|+||++++++.++|+|||.++.....
T Consensus 82 v~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~ 157 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYG-ALTETVTRKYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 157 (263)
T ss_pred EEEECCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecccc
Confidence 999999999999887654 4888999999999999999999 999999999999999999999999999999765322
Q ss_pred CCcc-ccccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhccc
Q 001544 923 DQSM-TQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANL 1001 (1057)
Q Consensus 923 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1001 (1057)
.... ......++..|+|||...+..++.++||||+|+++|||++|+.||......+. .......
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-------------~~~~~~~-- 222 (263)
T cd06625 158 CSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAA-------------IFKIATQ-- 222 (263)
T ss_pred ccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHH-------------HHHHhcc--
Confidence 1111 11234577899999999988899999999999999999999999865211100 0000000
Q ss_pred ccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 1002 LITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 1002 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
......+..++.++.+++.+||..+|++||++.|++++
T Consensus 223 ----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 223 ----PTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred ----CCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 00111223456778999999999999999999999876
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=322.39 Aligned_cols=256 Identities=26% Similarity=0.476 Sum_probs=205.7
Q ss_pred CCCCCCceeccccCeEEEEEEec-CC---cEEEEEEeecc-chhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEE
Q 001544 769 NGFSENNLIGRGSFGSVYIARLQ-NG---IEVAVKTFDLQ-HERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALI 843 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 843 (1057)
++|+..+.||+|+||.||+|... ++ ..||+|.++.. .....+.+..|++++++++|||++++.+++...+..++|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 46778899999999999999865 33 37999998654 234457789999999999999999999999999999999
Q ss_pred EEEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCC
Q 001544 844 LEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGED 923 (1057)
Q Consensus 844 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~ 923 (1057)
|||+++++|.+++......+++.++..++.|++.|++||| +.+++||||||+||++++++.+|++|||++.......
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~ 161 (268)
T cd05063 85 TEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLS---DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDP 161 (268)
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEEcCCCcEEECCCccceeccccc
Confidence 9999999999999876667899999999999999999999 8999999999999999999999999999997653222
Q ss_pred Cccc-cccccccccccCccccCCCCCCccchHHHHHHHHHHHhh-CCCCCCcccccccchhhhhhhccchhHHHhhhccc
Q 001544 924 QSMT-QTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFT-RRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANL 1001 (1057)
Q Consensus 924 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1001 (1057)
.... ......+..|+|||++....++.++|||||||++||+++ |+.||...... . ....+...
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~-----~---------~~~~i~~~- 226 (268)
T cd05063 162 EGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH-----E---------VMKAINDG- 226 (268)
T ss_pred ccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH-----H---------HHHHHhcC-
Confidence 1111 111223457999999988889999999999999999998 99998542111 1 11111110
Q ss_pred ccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHHHh
Q 001544 1002 LITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKI 1047 (1057)
Q Consensus 1002 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i 1047 (1057)
...+....++.++.+++.+||+.+|++||++.++++.|+++
T Consensus 227 -----~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 227 -----FRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred -----CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 01111234567889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=328.82 Aligned_cols=257 Identities=26% Similarity=0.402 Sum_probs=205.5
Q ss_pred CCCCCCceeccccCeEEEEEEec------CCcEEEEEEeeccc-hhHHHHHHHHHHHHHhc-CCCCceeEeeeeccCCee
Q 001544 769 NGFSENNLIGRGSFGSVYIARLQ------NGIEVAVKTFDLQH-ERAFKSFDTECEVMKSI-RHRNLTKIISSCSNEDFK 840 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 840 (1057)
++|...+.||+|+||.||+|... ++..||||+++... ....+.+.+|+++++++ +||||+++++++...+..
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 114 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI 114 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence 46888999999999999999642 35689999986543 34456789999999999 799999999999999999
Q ss_pred EEEEEEccCCChhHHHhcCC-ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccc
Q 001544 841 ALILEYMRNGSLEKCLYSGN-YILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL 919 (1057)
Q Consensus 841 ~lV~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~ 919 (1057)
++||||+.+|+|.+++.... ..+++.++..++.|++.|++||| +.+|+||||||+||+++.++.++++|||+++..
T Consensus 115 ~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~ 191 (302)
T cd05055 115 LVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNVLLTHGKIVKICDFGLARDI 191 (302)
T ss_pred EEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeehhhhccceEEEcCCCeEEECCCcccccc
Confidence 99999999999999997644 34899999999999999999999 899999999999999999999999999999865
Q ss_pred cCCCCccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhh-CCCCCCcccccccchhhhhhhccchhHHHhhh
Q 001544 920 IGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFT-RRKPTDEIFSGEMTLKHWVNDFLPISMMKIID 998 (1057)
Q Consensus 920 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 998 (1057)
.............++..|+|||.+.+..++.++||||+||++|||++ |..||......+ ...+..+
T Consensus 192 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~-------------~~~~~~~ 258 (302)
T cd05055 192 MNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS-------------KFYKLIK 258 (302)
T ss_pred cCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH-------------HHHHHHH
Confidence 33222112222345678999999988889999999999999999998 899986532111 0111111
Q ss_pred cccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHHHh
Q 001544 999 ANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKI 1047 (1057)
Q Consensus 999 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i 1047 (1057)
.... ...+...+.++.+++.+|++.+|++||++.|+++.|++.
T Consensus 259 ~~~~------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 259 EGYR------MAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred cCCc------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 1100 001123456789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=344.39 Aligned_cols=253 Identities=22% Similarity=0.318 Sum_probs=199.4
Q ss_pred CCCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccc---hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEE
Q 001544 769 NGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQH---ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALIL 844 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 844 (1057)
.+|++.+.||+|+||.||+|+.. +++.||||++.... ......+.+|++++++++||||+++++.+.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 36889999999999999999854 68999999986432 233467889999999999999999999999999999999
Q ss_pred EEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCC-
Q 001544 845 EYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGED- 923 (1057)
Q Consensus 845 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~- 923 (1057)
||+++|+|.+++...+ .+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+|..+....
T Consensus 81 E~~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~ 156 (376)
T cd05598 81 DYIPGGDMMSLLIRLG-IFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (376)
T ss_pred eCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccc
Confidence 9999999999987654 4888889999999999999999 9999999999999999999999999999975321000
Q ss_pred ----------------------------------------CccccccccccccccCccccCCCCCCccchHHHHHHHHHH
Q 001544 924 ----------------------------------------QSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLME 963 (1057)
Q Consensus 924 ----------------------------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~e 963 (1057)
.........||+.|+|||++.+..++.++||||+||++||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilye 236 (376)
T cd05598 157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236 (376)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeee
Confidence 0000112468999999999999899999999999999999
Q ss_pred HhhCCCCCCcccccccchhhhhhhccchhHHHhhhcccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCC---CHHHH
Q 001544 964 TFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERI---TAKEI 1040 (1057)
Q Consensus 964 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp---s~~ev 1040 (1057)
|++|+.||......+.. ..+.... .....+....+++++.+++.+|+ .+|.+|+ ++.|+
T Consensus 237 ll~G~~Pf~~~~~~~~~-------------~~i~~~~----~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~el 298 (376)
T cd05598 237 MLVGQPPFLADTPAETQ-------------LKVINWE----TTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEI 298 (376)
T ss_pred hhhCCCCCCCCCHHHHH-------------HHHhccC----ccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHH
Confidence 99999999753211110 0000000 00001111234667788898876 5999999 89999
Q ss_pred HHH
Q 001544 1041 VRR 1043 (1057)
Q Consensus 1041 l~~ 1043 (1057)
++|
T Consensus 299 l~h 301 (376)
T cd05598 299 KAH 301 (376)
T ss_pred hCC
Confidence 887
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=318.49 Aligned_cols=247 Identities=27% Similarity=0.441 Sum_probs=199.8
Q ss_pred ceeccccCeEEEEEEecCCcEEEEEEeeccc-hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEEccCCChh
Q 001544 775 NLIGRGSFGSVYIARLQNGIEVAVKTFDLQH-ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEYMRNGSLE 853 (1057)
Q Consensus 775 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL~ 853 (1057)
++||+|+||.||+|...+++.||+|.++... ......+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 4699999999999998889999999986543 334457889999999999999999999999999999999999999999
Q ss_pred HHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCccccccccc
Q 001544 854 KCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLA 933 (1057)
Q Consensus 854 ~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~ 933 (1057)
+++......+++.++..++.|++.|+.|+| +++++||||||+||++++++.+|++|||++....... ........+
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~ 156 (250)
T cd05085 81 SFLRKKKDELKTKQLVKFALDAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGI-YSSSGLKQI 156 (250)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccChheEEEcCCCeEEECCCccceeccccc-cccCCCCCC
Confidence 998776666899999999999999999999 9999999999999999999999999999987542211 111112234
Q ss_pred cccccCccccCCCCCCccchHHHHHHHHHHHhh-CCCCCCcccccccchhhhhhhccchhHHHhhhcccccccchhhHHH
Q 001544 934 TLGYMAPEYGREGRVSTKGDVYSFGILLMETFT-RRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHFAAK 1012 (1057)
Q Consensus 934 t~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1012 (1057)
+..|+|||+..+..++.++||||||+++||+++ |..||....... ....+.... +...+
T Consensus 157 ~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~--------------~~~~~~~~~------~~~~~ 216 (250)
T cd05085 157 PIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ--------------AREQVEKGY------RMSCP 216 (250)
T ss_pred cccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH--------------HHHHHHcCC------CCCCC
Confidence 567999999988889999999999999999998 888986521110 001111000 00111
Q ss_pred HHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHH
Q 001544 1013 EQCASSVFNLAMECTVESPDERITAKEIVRRLL 1045 (1057)
Q Consensus 1013 ~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 1045 (1057)
..++..+.+++.+|++.+|++||++.|+++.|.
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 217 QKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 235678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=310.35 Aligned_cols=265 Identities=27% Similarity=0.437 Sum_probs=203.7
Q ss_pred CCCCCCceeccccCeEEEEEEecCCcEEEEEEeeccchhHHHHHHHHHHHHHh--cCCCCceeEeeeeccC----CeeEE
Q 001544 769 NGFSENNLIGRGSFGSVYIARLQNGIEVAVKTFDLQHERAFKSFDTECEVMKS--IRHRNLTKIISSCSNE----DFKAL 842 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~----~~~~l 842 (1057)
.+....+.||+|.||.||+|++. |+.||||+|...++. .+.+|.++++. ++|+||..+++.-..+ .+.++
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srdE~---SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwL 286 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRDER---SWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWL 286 (513)
T ss_pred heeEEEEEecCccccceeecccc-CCceEEEEecccchh---hhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEE
Confidence 35567789999999999999998 899999999766554 44567777765 4999999999875433 36789
Q ss_pred EEEEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHh-----CCCCCeEEccCCCCCeeeCCCCcEEEEcccccc
Q 001544 843 ILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHF-----GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK 917 (1057)
Q Consensus 843 V~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~-----~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~ 917 (1057)
|++|.+.|||.|++.. ..++....++++..+|.||+|||. +..+.|.|||||+.|||+.+++.+.|+|+|+|.
T Consensus 287 vTdYHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv 364 (513)
T KOG2052|consen 287 VTDYHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 364 (513)
T ss_pred eeecccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeE
Confidence 9999999999999987 458999999999999999999993 346789999999999999999999999999998
Q ss_pred cccCCCC--ccccccccccccccCccccCCCC----C--CccchHHHHHHHHHHHhhC----------CCCCCccccccc
Q 001544 918 LLIGEDQ--SMTQTQTLATLGYMAPEYGREGR----V--STKGDVYSFGILLMETFTR----------RKPTDEIFSGEM 979 (1057)
Q Consensus 918 ~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~----~--~~~~Dv~s~G~il~elltg----------~~p~~~~~~~~~ 979 (1057)
.+..... .......+||-+|||||++.+.- + -..+||||||.|+||++-. +.||.+..+.+.
T Consensus 365 ~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DP 444 (513)
T KOG2052|consen 365 RHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDP 444 (513)
T ss_pred EecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCC
Confidence 8754322 33445678999999999886532 1 2368999999999999864 356655444443
Q ss_pred chhhhhhhccchhHHHhhhcccc-cccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHHHhHH
Q 001544 980 TLKHWVNDFLPISMMKIIDANLL-ITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKIRD 1049 (1057)
Q Consensus 980 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~ 1049 (1057)
..++. .+++-.... .....++.. .++...+.++|+.||..+|..|.|+--+.+.+.++.+
T Consensus 445 s~eeM---------rkVVCv~~~RP~ipnrW~s-~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 445 SFEEM---------RKVVCVQKLRPNIPNRWKS-DPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CHHHH---------hcceeecccCCCCCccccc-CHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 33322 222211111 112222322 3456789999999999999999999999999988763
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=324.38 Aligned_cols=269 Identities=22% Similarity=0.410 Sum_probs=205.6
Q ss_pred CCCCCceeccccCeEEEEEEe-----cCCcEEEEEEeeccc-hhHHHHHHHHHHHHHhcCCCCceeEeeeeccC--CeeE
Q 001544 770 GFSENNLIGRGSFGSVYIARL-----QNGIEVAVKTFDLQH-ERAFKSFDTECEVMKSIRHRNLTKIISSCSNE--DFKA 841 (1057)
Q Consensus 770 ~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 841 (1057)
-|++.+.||+|+||.||+|.. .++..||+|.++... ......+.+|++++++++|||++++++++.+. ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 467889999999999999974 357899999986543 34457899999999999999999999998764 5688
Q ss_pred EEEEEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccC
Q 001544 842 LILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIG 921 (1057)
Q Consensus 842 lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~ 921 (1057)
+||||+++++|.+++.+....+++.++..++.|++.||+||| +++|+||||||+||+++.++.++|+|||+++....
T Consensus 85 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 161 (284)
T ss_pred EEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccchheEEEcCCCCEEECCCcccccccc
Confidence 999999999999999776666899999999999999999999 99999999999999999999999999999986643
Q ss_pred CCCc-cccccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchh-hhhhhccchhHHHhhhc
Q 001544 922 EDQS-MTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLK-HWVNDFLPISMMKIIDA 999 (1057)
Q Consensus 922 ~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 999 (1057)
.... .......++..|+|||+..+..++.++||||||+++|||++++.|+........... .+..........+....
T Consensus 162 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (284)
T cd05079 162 DKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEE 241 (284)
T ss_pred CccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHc
Confidence 2221 111233456679999998888899999999999999999998876543211100000 00000000000111100
Q ss_pred ccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHHHh
Q 001544 1000 NLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKI 1047 (1057)
Q Consensus 1000 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i 1047 (1057)
..+.+.+..++.++.+++.+|++.+|++||++.++++.++++
T Consensus 242 ------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 242 ------GKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred ------CccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 011112234677899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=319.16 Aligned_cols=249 Identities=26% Similarity=0.380 Sum_probs=204.7
Q ss_pred CCCCCceeccccCeEEEEEEec-CCcEEEEEEeecc--chhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEE
Q 001544 770 GFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQ--HERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEY 846 (1057)
Q Consensus 770 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 846 (1057)
+|+..+.||+|++|.||+|..+ +++.||+|.+... .......+.+|++++++++|||++++++++.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4777899999999999999865 6899999998643 344567889999999999999999999999999999999999
Q ss_pred ccCCChhHHHhcC-CccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCc
Q 001544 847 MRNGSLEKCLYSG-NYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS 925 (1057)
Q Consensus 847 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 925 (1057)
+++++|.+++... ...+++.++..++.|++.|++||| +.+++||||||+||+++.++.++++|||+++......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~-- 155 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT-- 155 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEeCCCCEEEcccccceeccCcc--
Confidence 9999999999775 456899999999999999999999 8999999999999999999999999999988653221
Q ss_pred cccccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhccccccc
Q 001544 926 MTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITE 1005 (1057)
Q Consensus 926 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1057)
.......++..|+|||+..+..++.++|+||||+++|||++|+.||......+ . ........
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~-----------~~~~~~~~----- 217 (256)
T cd08529 156 NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA--L-----------ILKIIRGV----- 217 (256)
T ss_pred chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH--H-----------HHHHHcCC-----
Confidence 12233457889999999998889999999999999999999999986532110 0 00111000
Q ss_pred chhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 1006 DKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 1006 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
.......++.++.+++.+||+.+|++||++.|++++
T Consensus 218 --~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 218 --FPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred --CCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 001112456778999999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=326.77 Aligned_cols=250 Identities=26% Similarity=0.353 Sum_probs=204.7
Q ss_pred CCCCCCceeccccCeEEEEEEe-cCCcEEEEEEeeccchhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEEc
Q 001544 769 NGFSENNLIGRGSFGSVYIARL-QNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEYM 847 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 847 (1057)
.+|+..+.||+|+||.||+|.. .+++.||+|.+..........+.+|++++++++|||++++++++..++..++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 4788889999999999999985 468999999997665555678889999999999999999999999999999999999
Q ss_pred cCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCccc
Q 001544 848 RNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMT 927 (1057)
Q Consensus 848 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 927 (1057)
++++|.+++... .+++.++..++.|++.|++||| +.+|+||||||+||+++.++.+||+|||.+....... ..
T Consensus 100 ~~~~L~~~~~~~--~~~~~~~~~i~~ql~~aL~~LH---~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~--~~ 172 (296)
T cd06654 100 AGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SK 172 (296)
T ss_pred CCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEECccccchhccccc--cc
Confidence 999999998654 4789999999999999999999 9999999999999999999999999999987653221 12
Q ss_pred cccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhcccccccch
Q 001544 928 QTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDK 1007 (1057)
Q Consensus 928 ~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1057)
.....+++.|+|||...+..++.++|||||||++|||++|+.||......+. ...+. ... ..
T Consensus 173 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~-~~~~~-----------~~~------~~ 234 (296)
T cd06654 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-LYLIA-----------TNG------TP 234 (296)
T ss_pred cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh-HHHHh-----------cCC------CC
Confidence 2334678899999999888889999999999999999999999865221110 00000 000 00
Q ss_pred hhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 1008 HFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 1008 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
....+...+..+.+++.+||..+|++||++.|++++
T Consensus 235 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 235 ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred CCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 011123456678899999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=310.68 Aligned_cols=252 Identities=26% Similarity=0.373 Sum_probs=205.6
Q ss_pred CCCCCceeccccCeEEEEEEecC-CcEEEEEEeeccc---hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEE
Q 001544 770 GFSENNLIGRGSFGSVYIARLQN-GIEVAVKTFDLQH---ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILE 845 (1057)
Q Consensus 770 ~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 845 (1057)
.|+..+.||+|.-|+||+++..+ +..+|+|++.+.. .....+.+.|.+||+.+.||.++.+|+.|+.++..|+|||
T Consensus 78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~me 157 (459)
T KOG0610|consen 78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVME 157 (459)
T ss_pred HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEe
Confidence 45667899999999999999764 5899999996543 3456778899999999999999999999999999999999
Q ss_pred EccCCChhHHHhcCC-ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCC--
Q 001544 846 YMRNGSLEKCLYSGN-YILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGE-- 922 (1057)
Q Consensus 846 ~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~-- 922 (1057)
||+||+|....+++. +.+++..++-++.+|+-||+||| -.|||+|||||+|||+.++|++.++||.++......
T Consensus 158 yCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt 234 (459)
T KOG0610|consen 158 YCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPT 234 (459)
T ss_pred cCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcEEeeeccccccCCCCCe
Confidence 999999999887655 67999999999999999999999 999999999999999999999999999987543110
Q ss_pred -----C------------------------C-c----------------------cccccccccccccCccccCCCCCCc
Q 001544 923 -----D------------------------Q-S----------------------MTQTQTLATLGYMAPEYGREGRVST 950 (1057)
Q Consensus 923 -----~------------------------~-~----------------------~~~~~~~~t~~y~aPE~~~~~~~~~ 950 (1057)
. . . ......+||-.|.|||++.+..++.
T Consensus 235 ~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgs 314 (459)
T KOG0610|consen 235 LVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGS 314 (459)
T ss_pred eeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCc
Confidence 0 0 0 0001125777899999999999999
Q ss_pred cchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhcccccccchhhHHHHHHHHHHHHHHhHcccCC
Q 001544 951 KGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVES 1030 (1057)
Q Consensus 951 ~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 1030 (1057)
++|.|+|||++|||+.|..||.+.... .++.. ++- ....++..+..+..++|||++.+.+|
T Consensus 315 AVDWWtfGIflYEmLyG~TPFKG~~~~-~Tl~N------------Iv~------~~l~Fp~~~~vs~~akDLIr~LLvKd 375 (459)
T KOG0610|consen 315 AVDWWTFGIFLYEMLYGTTPFKGSNNK-ETLRN------------IVG------QPLKFPEEPEVSSAAKDLIRKLLVKD 375 (459)
T ss_pred hhhHHHHHHHHHHHHhCCCCcCCCCch-hhHHH------------Hhc------CCCcCCCCCcchhHHHHHHHHHhccC
Confidence 999999999999999999999763222 22221 111 11123333466788999999999999
Q ss_pred CCCCCC----HHHHHHH
Q 001544 1031 PDERIT----AKEIVRR 1043 (1057)
Q Consensus 1031 P~~Rps----~~evl~~ 1043 (1057)
|.+|.. |.||.+|
T Consensus 376 P~kRlg~~rGA~eIK~H 392 (459)
T KOG0610|consen 376 PSKRLGSKRGAAEIKRH 392 (459)
T ss_pred hhhhhccccchHHhhcC
Confidence 999997 8888776
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=318.18 Aligned_cols=254 Identities=25% Similarity=0.376 Sum_probs=207.1
Q ss_pred CCCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccchhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEEc
Q 001544 769 NGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEYM 847 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 847 (1057)
++|+..+.||+|+||.||+|... +++.+|+|++........+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 57888999999999999999864 57899999997665556788999999999999999999999999999999999999
Q ss_pred cCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCccc
Q 001544 848 RNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMT 927 (1057)
Q Consensus 848 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 927 (1057)
++++|.+++......+++.++..++.|++.|++||| +.+++||||+|+||++++++.+||+|||.+....... ..
T Consensus 83 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~~ 157 (262)
T cd06613 83 GGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI--AK 157 (262)
T ss_pred CCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCChhhEEECCCCCEEECccccchhhhhhh--hc
Confidence 999999998876567999999999999999999999 8999999999999999999999999999987653211 12
Q ss_pred cccccccccccCccccCCC---CCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhcccccc
Q 001544 928 QTQTLATLGYMAPEYGREG---RVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLIT 1004 (1057)
Q Consensus 928 ~~~~~~t~~y~aPE~~~~~---~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1057)
.....++..|+|||..... .++.++||||+|+++|||++|+.||......+... .. .....
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~-------------~~-~~~~~-- 221 (262)
T cd06613 158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALF-------------LI-SKSNF-- 221 (262)
T ss_pred cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH-------------HH-HhccC--
Confidence 2334678889999998776 78999999999999999999999986532111100 00 00000
Q ss_pred cchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 1005 EDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 1005 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
...........+.++.+++.+||..+|.+||++.+++.+
T Consensus 222 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 222 PPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred CCccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000111123456778999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=321.05 Aligned_cols=255 Identities=26% Similarity=0.405 Sum_probs=203.3
Q ss_pred HHhCCCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccchhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEE
Q 001544 766 QATNGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALIL 844 (1057)
Q Consensus 766 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 844 (1057)
.+++.+.....||+|+||.||+|... +++.||+|.+........+.+.+|++++++++|+||+++++++..++..++|+
T Consensus 5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 84 (268)
T cd06624 5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFM 84 (268)
T ss_pred cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEE
Confidence 45556666789999999999999854 67899999987666666788999999999999999999999999999999999
Q ss_pred EEccCCChhHHHhcCCccC--CHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCC-CCcEEEEcccccccccC
Q 001544 845 EYMRNGSLEKCLYSGNYIL--DIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDD-NMVAHLSDFGIAKLLIG 921 (1057)
Q Consensus 845 E~~~~gsL~~~l~~~~~~l--~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~-~~~~kl~Dfg~a~~~~~ 921 (1057)
||+++++|.+++......+ ++..+..++.|+++|++||| +.+|+||||||+||+++. ++.++|+|||.+.....
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~ 161 (268)
T cd06624 85 EQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG 161 (268)
T ss_pred ecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCeEEEecchhheeccc
Confidence 9999999999998654445 88889999999999999999 999999999999999986 67999999999876532
Q ss_pred CCCccccccccccccccCccccCCCC--CCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhc
Q 001544 922 EDQSMTQTQTLATLGYMAPEYGREGR--VSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDA 999 (1057)
Q Consensus 922 ~~~~~~~~~~~~t~~y~aPE~~~~~~--~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 999 (1057)
.. .......++..|+|||+..... ++.++||||+|+++|||++|+.||........ ..|..
T Consensus 162 ~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~--~~~~~------------- 224 (268)
T cd06624 162 IN--PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA--AMFKV------------- 224 (268)
T ss_pred CC--CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh--hHhhh-------------
Confidence 21 1222335788999999876543 78899999999999999999999865211110 00000
Q ss_pred ccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 1000 NLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 1000 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
... ......+..+++++.+++.+||+.+|++||++.|+++|
T Consensus 225 ~~~---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 225 GMF---KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred hhh---ccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 000 00011123456778999999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=326.02 Aligned_cols=258 Identities=24% Similarity=0.386 Sum_probs=203.5
Q ss_pred HhCCCCCCceeccccCeEEEEEEec------CCcEEEEEEeeccc-hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCe
Q 001544 767 ATNGFSENNLIGRGSFGSVYIARLQ------NGIEVAVKTFDLQH-ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDF 839 (1057)
Q Consensus 767 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 839 (1057)
..++|++.++||+|+||.||+|... .+..||+|.++... ......+.+|+.++++++||||+++++++.+.+.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 3567899999999999999999643 24589999886443 2334567889999999999999999999999999
Q ss_pred eEEEEEEccCCChhHHHhcCC---------ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEE
Q 001544 840 KALILEYMRNGSLEKCLYSGN---------YILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHL 910 (1057)
Q Consensus 840 ~~lV~E~~~~gsL~~~l~~~~---------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl 910 (1057)
.++||||+++|+|.+++.... ...++..+..++.|++.|++||| +++|+||||||+||++++++.+++
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCCChheEEEcCCCcEEE
Confidence 999999999999999986522 34567788999999999999999 999999999999999999999999
Q ss_pred EcccccccccCCCCccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhh-CCCCCCcccccccchhhhhhhcc
Q 001544 911 SDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFT-RRKPTDEIFSGEMTLKHWVNDFL 989 (1057)
Q Consensus 911 ~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 989 (1057)
+|||+++...............++..|+|||...++.++.++|||||||++|||++ |..||...... .+..
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~-----~~~~--- 232 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE-----QVLK--- 232 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH-----HHHH---
Confidence 99999986533222222222345678999999988889999999999999999999 67787542111 1110
Q ss_pred chhHHHhhhcccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHHHh
Q 001544 990 PISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKI 1047 (1057)
Q Consensus 990 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i 1047 (1057)
...+... ...++.++..+.+++.+|++.+|++||++.|+++.+++.
T Consensus 233 -----~~~~~~~-------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 233 -----FVMDGGY-------LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred -----HHHcCCC-------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 0111100 011123467899999999999999999999999988875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=322.06 Aligned_cols=254 Identities=20% Similarity=0.312 Sum_probs=207.1
Q ss_pred hCCCCCCceeccccCeEEEEEEecCCcEEEEEEee--ccchhHHHHHHHHHHHHHhcC-CCCceeEeeeeccCCeeEEEE
Q 001544 768 TNGFSENNLIGRGSFGSVYIARLQNGIEVAVKTFD--LQHERAFKSFDTECEVMKSIR-HRNLTKIISSCSNEDFKALIL 844 (1057)
Q Consensus 768 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~ 844 (1057)
...|++.+.||+||.++||++...+.+.||+|++. ..+......|..|+..|.+++ |.+||++++|-..++..|+||
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm 439 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM 439 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence 34688899999999999999998888889988763 335566788999999999995 999999999999999999999
Q ss_pred EEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCC
Q 001544 845 EYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ 924 (1057)
Q Consensus 845 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 924 (1057)
||-+ .+|.+++.++....+...++.+..|++.|+.++| .+||||.||||.|+++- +|.+||+|||.|..+.....
T Consensus 440 E~Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH---~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DTT 514 (677)
T KOG0596|consen 440 ECGD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIH---QHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDTT 514 (677)
T ss_pred eccc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHH---HhceeecCCCcccEEEE-eeeEEeeeechhcccCcccc
Confidence 9864 4999999887765664588999999999999999 99999999999999985 47999999999999877777
Q ss_pred ccccccccccccccCccccCCC-----------CCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhH
Q 001544 925 SMTQTQTLATLGYMAPEYGREG-----------RVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISM 993 (1057)
Q Consensus 925 ~~~~~~~~~t~~y~aPE~~~~~-----------~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 993 (1057)
.......+||+.||+||.+... +.+.++||||+||++|+|+.|+.||+..... | ..+
T Consensus 515 sI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~------~------aKl 582 (677)
T KOG0596|consen 515 SIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQ------I------AKL 582 (677)
T ss_pred ceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHH------H------HHH
Confidence 7777788999999999976432 2567999999999999999999999763211 1 113
Q ss_pred HHhhhcccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 994 MKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 994 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
..+.++.-..+...... ..++.++|+.|+..||++||+..|+++|
T Consensus 583 ~aI~~P~~~Iefp~~~~-----~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 583 HAITDPNHEIEFPDIPE-----NDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred HhhcCCCccccccCCCC-----chHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 33444322211111111 1238899999999999999999999986
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=322.99 Aligned_cols=245 Identities=23% Similarity=0.358 Sum_probs=193.4
Q ss_pred eccccCeEEEEEEec-CCcEEEEEEeeccc---hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEEccCCCh
Q 001544 777 IGRGSFGSVYIARLQ-NGIEVAVKTFDLQH---ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEYMRNGSL 852 (1057)
Q Consensus 777 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL 852 (1057)
||+|+||.||+++.+ +|+.||+|++.... ......+..|++++++++||||+++++++.++...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999865 68999999985432 12234556799999999999999999999999999999999999999
Q ss_pred hHHHhcCC-ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCccccccc
Q 001544 853 EKCLYSGN-YILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQT 931 (1057)
Q Consensus 853 ~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 931 (1057)
.+++.... ..+++..+..++.|++.|++||| +.+|+||||||+||+++.++.++|+|||++...... ......
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~---~~~~~~ 154 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG---KTITQR 154 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCC---ceeecc
Confidence 98876543 45899999999999999999999 999999999999999999999999999998765321 122334
Q ss_pred cccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhcccccccchhhHH
Q 001544 932 LATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHFAA 1011 (1057)
Q Consensus 932 ~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1011 (1057)
.++..|+|||++.+..++.++||||+||++|||++|+.||...... ....... ........ .. .
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~-~~~~~~~--------~~~~~~~~------~~-~ 218 (277)
T cd05607 155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEK-VAKEELK--------RRTLEDEV------KF-E 218 (277)
T ss_pred CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcch-hhHHHHH--------HHhhcccc------cc-c
Confidence 6889999999998888999999999999999999999998652211 1100100 00010000 00 0
Q ss_pred HHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 1012 KEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 1012 ~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
...++.++.+++.+||+.||++||+++|+++.
T Consensus 219 ~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ 250 (277)
T cd05607 219 HQNFTEESKDICRLFLAKKPEDRLGSREKNDD 250 (277)
T ss_pred cccCCHHHHHHHHHHhccCHhhCCCCccchhh
Confidence 12356778999999999999999999776543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=320.68 Aligned_cols=253 Identities=25% Similarity=0.457 Sum_probs=204.1
Q ss_pred hCCCCCCceeccccCeEEEEEEecCCcEEEEEEeeccchhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEEc
Q 001544 768 TNGFSENNLIGRGSFGSVYIARLQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEYM 847 (1057)
Q Consensus 768 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 847 (1057)
.++|++.++||+|+||.||+|..++++.||+|.+..... ...++.+|++++++++||||+++++++. .+..++||||+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM 82 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence 356888999999999999999988899999999865433 3467889999999999999999999874 45689999999
Q ss_pred cCCChhHHHhcCC-ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCcc
Q 001544 848 RNGSLEKCLYSGN-YILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSM 926 (1057)
Q Consensus 848 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 926 (1057)
++++|.+++.... ..+++.++..++.|++.||+||| +.+++||||||+||++++++.++++|||.+....... ..
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-~~ 158 (260)
T cd05067 83 ENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNE-YT 158 (260)
T ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHHhEEEcCCCCEEEccCcceeecCCCC-cc
Confidence 9999999886533 46899999999999999999999 9999999999999999999999999999997653211 11
Q ss_pred ccccccccccccCccccCCCCCCccchHHHHHHHHHHHhh-CCCCCCcccccccchhhhhhhccchhHHHhhhccccccc
Q 001544 927 TQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFT-RRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITE 1005 (1057)
Q Consensus 927 ~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1057)
......++..|+|||+.....++.++||||||+++||+++ |+.||......+ ..+......
T Consensus 159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--------------~~~~~~~~~---- 220 (260)
T cd05067 159 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE--------------VIQNLERGY---- 220 (260)
T ss_pred cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH--------------HHHHHHcCC----
Confidence 2223345678999999988889999999999999999999 999986522111 011111100
Q ss_pred chhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHHH
Q 001544 1006 DKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLK 1046 (1057)
Q Consensus 1006 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 1046 (1057)
..+.+..++.++.+++.+|++.+|++||+++++.+.|+.
T Consensus 221 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 221 --RMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred --CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 011112345679999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=323.76 Aligned_cols=251 Identities=25% Similarity=0.375 Sum_probs=202.8
Q ss_pred CCCCceeccccCeEEEEEEec-CCcEEEEEEeeccchhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEEccC
Q 001544 771 FSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEYMRN 849 (1057)
Q Consensus 771 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 849 (1057)
|++.+.||+|+||.||+|... ++..+|+|.+........+.+.+|+++++.++|||++++++++..++..++||||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 566788999999999999865 5788999998766666677889999999999999999999999999999999999999
Q ss_pred CChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCccccc
Q 001544 850 GSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQT 929 (1057)
Q Consensus 850 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 929 (1057)
++|.+++......+++..+..++.|+++||+||| +.+++||||||+||+++.++.+|++|||++...... .....
T Consensus 87 ~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~--~~~~~ 161 (282)
T cd06643 87 GAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--IQRRD 161 (282)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEccCCCEEEcccccccccccc--ccccc
Confidence 9999988766667999999999999999999999 999999999999999999999999999998764221 12223
Q ss_pred cccccccccCccccC-----CCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhcccccc
Q 001544 930 QTLATLGYMAPEYGR-----EGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLIT 1004 (1057)
Q Consensus 930 ~~~~t~~y~aPE~~~-----~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1057)
...++..|+|||++. +..++.++||||+||++|||++|+.||......+. . ........
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~-~------------~~~~~~~~--- 225 (282)
T cd06643 162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRV-L------------LKIAKSEP--- 225 (282)
T ss_pred cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHH-H------------HHHhhcCC---
Confidence 346888999999873 44578899999999999999999999865221110 0 00000000
Q ss_pred cchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHH
Q 001544 1005 EDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRL 1044 (1057)
Q Consensus 1005 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 1044 (1057)
.....+..++.++.+++.+||+.+|++||++.+++++-
T Consensus 226 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 263 (282)
T cd06643 226 --PTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHP 263 (282)
T ss_pred --CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCC
Confidence 00111223566789999999999999999999998763
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=318.45 Aligned_cols=250 Identities=32% Similarity=0.517 Sum_probs=206.1
Q ss_pred hCCCCCCceeccccCeEEEEEEecCCcEEEEEEeeccchhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEEc
Q 001544 768 TNGFSENNLIGRGSFGSVYIARLQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEYM 847 (1057)
Q Consensus 768 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 847 (1057)
.++|++.+.||+|+||.||+|... |+.||||.++.... ..+++.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 346888899999999999999876 78999999976544 4678899999999999999999999999899999999999
Q ss_pred cCCChhHHHhcCC-ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCcc
Q 001544 848 RNGSLEKCLYSGN-YILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSM 926 (1057)
Q Consensus 848 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 926 (1057)
++++|.+++.... ..+++.++..++.|++.|++||| +.+++||||||+||+++.++.+||+|||.++......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~--- 156 (256)
T cd05039 83 AKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ--- 156 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccchhcccceEEEeCCCCEEEccccccccccccc---
Confidence 9999999987654 36899999999999999999999 9999999999999999999999999999998652111
Q ss_pred ccccccccccccCccccCCCCCCccchHHHHHHHHHHHhh-CCCCCCcccccccchhhhhhhccchhHHHhhhccccccc
Q 001544 927 TQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFT-RRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITE 1005 (1057)
Q Consensus 927 ~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1057)
.....+..|+|||....+.++.++||||+|+++||+++ |+.||......+ ....+....
T Consensus 157 --~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--------------~~~~~~~~~---- 216 (256)
T cd05039 157 --DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--------------VVPHVEKGY---- 216 (256)
T ss_pred --ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH--------------HHHHHhcCC----
Confidence 12234567999999988889999999999999999997 999986421110 111111100
Q ss_pred chhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHHHh
Q 001544 1006 DKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKI 1047 (1057)
Q Consensus 1006 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i 1047 (1057)
....+..+++++.+++.+|+..+|++||++.|++++|+.+
T Consensus 217 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 217 --RMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred --CCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 1111234567899999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=337.50 Aligned_cols=267 Identities=24% Similarity=0.291 Sum_probs=199.3
Q ss_pred CCCCCceeccccCeEEEEEEec-CCcEEEEEEeecc--chhHHHHHHHHHHHHHhcCCCCceeEeeeeccCC-----eeE
Q 001544 770 GFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQ--HERAFKSFDTECEVMKSIRHRNLTKIISSCSNED-----FKA 841 (1057)
Q Consensus 770 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 841 (1057)
+|+..+.||+|+||+||+|... +|+.||||++... .....+++.+|+++++.++||||+++++++...+ ..|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4778899999999999999864 7899999998543 2334567889999999999999999999998766 789
Q ss_pred EEEEEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccC
Q 001544 842 LILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIG 921 (1057)
Q Consensus 842 lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~ 921 (1057)
+|+||+. ++|.+.+.... .+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++....
T Consensus 81 lv~e~~~-~~l~~~~~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~ 155 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSPQ-PLSSDHVKVFLYQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEP 155 (372)
T ss_pred EEeeccc-cCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence 9999997 57888776543 5899999999999999999999 99999999999999999999999999999986532
Q ss_pred CCCccccccccccccccCccccCCC-CCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccc---hhH----
Q 001544 922 EDQSMTQTQTLATLGYMAPEYGREG-RVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLP---ISM---- 993 (1057)
Q Consensus 922 ~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~---~~~---- 993 (1057)
. .........++..|+|||.+.+. .++.++||||+||++|||++|+.||......+ .+......... ...
T Consensus 156 ~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~~~g~~~~~~~~~~~ 233 (372)
T cd07853 156 D-ESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQ-QLDLITDLLGTPSLEAMRSAC 233 (372)
T ss_pred C-ccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHH-HHHHHHHHcCCCCHHHHHHhh
Confidence 2 12223344678899999988764 47899999999999999999999997532111 01110000000 000
Q ss_pred ---HHhhhcccccccc--hhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 994 ---MKIIDANLLITED--KHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 994 ---~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
...+......... .........++++.+++.+|++.||++|||+.|+++|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 234 EGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 0000000000000 0000112346778999999999999999999999986
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=331.28 Aligned_cols=242 Identities=23% Similarity=0.352 Sum_probs=192.7
Q ss_pred ceeccccCeEEEEEEec-CCcEEEEEEeeccc---hhHHHHHHHHHHHHHhc-CCCCceeEeeeeccCCeeEEEEEEccC
Q 001544 775 NLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQH---ERAFKSFDTECEVMKSI-RHRNLTKIISSCSNEDFKALILEYMRN 849 (1057)
Q Consensus 775 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~~ 849 (1057)
+.||+|+||+||+|... +++.||||+++... ......+..|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999865 57899999997542 23345566788888764 899999999999999999999999999
Q ss_pred CChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCccccc
Q 001544 850 GSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQT 929 (1057)
Q Consensus 850 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 929 (1057)
|+|.+++.... .+++.++..++.|++.||+||| +.+|+||||||+||++++++.+||+|||+++..... .....
T Consensus 81 g~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~ 154 (316)
T cd05619 81 GDLMFHIQSCH-KFDLPRATFYAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLG--DAKTC 154 (316)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCC--CCcee
Confidence 99999887643 5889999999999999999999 999999999999999999999999999998753211 11223
Q ss_pred cccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhcccccccchhh
Q 001544 930 QTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHF 1009 (1057)
Q Consensus 930 ~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1057)
...||..|+|||++.+..++.++||||+||++|||++|+.||...... . ....+.....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~-----~---------~~~~i~~~~~------- 213 (316)
T cd05619 155 TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE-----E---------LFQSIRMDNP------- 213 (316)
T ss_pred eecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH-----H---------HHHHHHhCCC-------
Confidence 446899999999999889999999999999999999999998652111 0 0111110000
Q ss_pred HHHHHHHHHHHHHHhHcccCCCCCCCCHH-HHHHH
Q 001544 1010 AAKEQCASSVFNLAMECTVESPDERITAK-EIVRR 1043 (1057)
Q Consensus 1010 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~-evl~~ 1043 (1057)
..+..++.++.+++.+|++.||++||++. ++.+|
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h 248 (316)
T cd05619 214 CYPRWLTREAKDILVKLFVREPERRLGVKGDIRQH 248 (316)
T ss_pred CCCccCCHHHHHHHHHHhccCHhhcCCChHHHHcC
Confidence 01123456788999999999999999997 66553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=319.99 Aligned_cols=248 Identities=32% Similarity=0.545 Sum_probs=205.0
Q ss_pred ceeccccCeEEEEEEecC----CcEEEEEEeeccchh-HHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEEccC
Q 001544 775 NLIGRGSFGSVYIARLQN----GIEVAVKTFDLQHER-AFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEYMRN 849 (1057)
Q Consensus 775 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 849 (1057)
+.||+|+||.||+|.... +..||+|++...... ..+.+.+|++.+++++|+|++++++++...+..++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999998653 789999999765433 367899999999999999999999999999999999999999
Q ss_pred CChhHHHhcC--------CccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccC
Q 001544 850 GSLEKCLYSG--------NYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIG 921 (1057)
Q Consensus 850 gsL~~~l~~~--------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~ 921 (1057)
++|.+++... ...+++.++..++.|+++|++||| +++++||||||+||++++++.+|++|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH---cCCcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999876 467999999999999999999999 99999999999999999999999999999987644
Q ss_pred CCCccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhh-CCCCCCcccccccchhhhhhhccchhHHHhhhcc
Q 001544 922 EDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFT-RRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDAN 1000 (1057)
Q Consensus 922 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1000 (1057)
...........++..|+|||......++.++||||+|+++|||++ |..||...... .. .....+
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-----~~--------~~~~~~-- 222 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE-----EV--------LEYLRK-- 222 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH-----HH--------HHHHHc--
Confidence 332233344557889999999988889999999999999999999 58888763111 00 001111
Q ss_pred cccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHH
Q 001544 1001 LLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLL 1045 (1057)
Q Consensus 1001 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 1045 (1057)
......+..++.++.+++.+|+..+|++||++.|++++|+
T Consensus 223 -----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 223 -----GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred -----CCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 0111222345778999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=332.39 Aligned_cols=242 Identities=24% Similarity=0.324 Sum_probs=195.8
Q ss_pred ceeccccCeEEEEEEec-CCcEEEEEEeeccc---hhHHHHHHHHHHHHHhc-CCCCceeEeeeeccCCeeEEEEEEccC
Q 001544 775 NLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQH---ERAFKSFDTECEVMKSI-RHRNLTKIISSCSNEDFKALILEYMRN 849 (1057)
Q Consensus 775 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~~ 849 (1057)
+.||+|+||+||+|... +++.||||+++... ......+..|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999865 58899999997542 23456677888999888 699999999999999999999999999
Q ss_pred CChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCccccc
Q 001544 850 GSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQT 929 (1057)
Q Consensus 850 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 929 (1057)
|+|.+++.... .+++.++..++.|++.||+||| +.+|+||||||+||++++++.+||+|||+++..... .....
T Consensus 81 ~~L~~~~~~~~-~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~--~~~~~ 154 (318)
T cd05570 81 GDLMFHIQRSG-RFDEPRARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG--GVTTS 154 (318)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEccCCCHHHeEECCCCcEEecccCCCeecCcC--CCccc
Confidence 99999887654 5899999999999999999999 999999999999999999999999999998753211 11223
Q ss_pred cccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhcccccccchhh
Q 001544 930 QTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHF 1009 (1057)
Q Consensus 930 ~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1057)
...|++.|+|||++.+..++.++||||+||++|||++|+.||...... ... ..+.... .
T Consensus 155 ~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~-----~~~--------~~i~~~~--------~ 213 (318)
T cd05570 155 TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED-----ELF--------QSILEDE--------V 213 (318)
T ss_pred ceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH-----HHH--------HHHHcCC--------C
Confidence 346889999999999999999999999999999999999998652111 000 0011000 0
Q ss_pred HHHHHHHHHHHHHHhHcccCCCCCCCCH-----HHHHHH
Q 001544 1010 AAKEQCASSVFNLAMECTVESPDERITA-----KEIVRR 1043 (1057)
Q Consensus 1010 ~~~~~~~~~l~~li~~cl~~dP~~Rps~-----~evl~~ 1043 (1057)
..+..++.++.+++.+||+.||++||++ .+++++
T Consensus 214 ~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 214 RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 1112356778999999999999999999 888765
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=327.81 Aligned_cols=257 Identities=26% Similarity=0.448 Sum_probs=202.3
Q ss_pred hCCCCCCceeccccCeEEEEEEec-CCc--EEEEEEeecc-chhHHHHHHHHHHHHHhc-CCCCceeEeeeeccCCeeEE
Q 001544 768 TNGFSENNLIGRGSFGSVYIARLQ-NGI--EVAVKTFDLQ-HERAFKSFDTECEVMKSI-RHRNLTKIISSCSNEDFKAL 842 (1057)
Q Consensus 768 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 842 (1057)
.++|++.+.||+|+||.||+|..+ ++. .+|+|.++.. .......+.+|++++.++ +||||+++++++.+++..++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 356888899999999999999864 454 4677777543 234456788999999999 89999999999999999999
Q ss_pred EEEEccCCChhHHHhcCC---------------ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCc
Q 001544 843 ILEYMRNGSLEKCLYSGN---------------YILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMV 907 (1057)
Q Consensus 843 V~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~ 907 (1057)
||||+++|+|.++++... ..+++.+++.++.|++.|++||| +++|+||||||+||++++++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEecCCCc
Confidence 999999999999987542 25789999999999999999999 999999999999999999999
Q ss_pred EEEEcccccccccCCCCccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhh-CCCCCCcccccccchhhhhh
Q 001544 908 AHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFT-RRKPTDEIFSGEMTLKHWVN 986 (1057)
Q Consensus 908 ~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~ 986 (1057)
+||+|||++.... .........++..|+|||+..+..++.++|||||||++|||+| |..||...... .
T Consensus 163 ~kl~dfg~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-----~--- 231 (303)
T cd05088 163 AKIADFGLSRGQE---VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-----E--- 231 (303)
T ss_pred EEeCccccCcccc---hhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH-----H---
Confidence 9999999986321 1111112234567999999888889999999999999999998 99998542111 0
Q ss_pred hccchhHHHhhhcccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHHHhHHH
Q 001544 987 DFLPISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKIRDF 1050 (1057)
Q Consensus 987 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~ 1050 (1057)
..+...... ....+..++.++.+++.+||+.+|++||++.+++++++++...
T Consensus 232 ------~~~~~~~~~------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~ 283 (303)
T cd05088 232 ------LYEKLPQGY------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 283 (303)
T ss_pred ------HHHHHhcCC------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 001010000 0011123456789999999999999999999999999887543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=321.26 Aligned_cols=257 Identities=25% Similarity=0.397 Sum_probs=206.7
Q ss_pred CCCCCCceeccccCeEEEEEEecC----CcEEEEEEeeccc-hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEE
Q 001544 769 NGFSENNLIGRGSFGSVYIARLQN----GIEVAVKTFDLQH-ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALI 843 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 843 (1057)
++|+..+.||+|+||.||+|...+ ...||||...... ....+.+.+|++++++++||||+++++++.+ +..++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 457788999999999999997543 3579999886554 4456789999999999999999999999875 456899
Q ss_pred EEEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCC
Q 001544 844 LEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGED 923 (1057)
Q Consensus 844 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~ 923 (1057)
|||+++|+|.+++......+++.++..++.|++.|++||| +.+++||||||+||+++.++.+|++|||+++......
T Consensus 85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 161 (270)
T cd05056 85 MELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES 161 (270)
T ss_pred EEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccChheEEEecCCCeEEccCceeeeccccc
Confidence 9999999999999876666899999999999999999999 8999999999999999999999999999998653322
Q ss_pred CccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhh-CCCCCCcccccccchhhhhhhccchhHHHhhhcccc
Q 001544 924 QSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFT-RRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLL 1002 (1057)
Q Consensus 924 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1002 (1057)
. .......++..|+|||.+....++.++||||||+++||+++ |..||......+. ..+ . ..
T Consensus 162 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~--~~~-----------~-~~--- 223 (270)
T cd05056 162 Y-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV--IGR-----------I-EN--- 223 (270)
T ss_pred c-eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH--HHH-----------H-Hc---
Confidence 1 12222334567999999888889999999999999999986 9999865322111 000 0 00
Q ss_pred cccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHHHhHHH
Q 001544 1003 ITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKIRDF 1050 (1057)
Q Consensus 1003 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~ 1050 (1057)
..+...+..++..+.+++.+|+..+|++|||+.|+++.|+++++.
T Consensus 224 ---~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 224 ---GERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred ---CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 001111234567899999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=320.75 Aligned_cols=258 Identities=24% Similarity=0.355 Sum_probs=207.5
Q ss_pred CCCCCCceeccccCeEEEEEEe-cCCcEEEEEEeecc---chhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEE
Q 001544 769 NGFSENNLIGRGSFGSVYIARL-QNGIEVAVKTFDLQ---HERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALIL 844 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 844 (1057)
++|++.+.||+|+||.||+|.. .+++.||||.+... ......++.+|++++++++||||+++++++.+++..++||
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 3677889999999999999985 47899999988543 2334568889999999999999999999999999999999
Q ss_pred EEccCCChhHHHhc---CCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccC
Q 001544 845 EYMRNGSLEKCLYS---GNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIG 921 (1057)
Q Consensus 845 E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~ 921 (1057)
||+++++|.+++.. ....+++.++..++.|++.|++||| +.+++|+||||+||+++.++.++++|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 99999999998864 2345899999999999999999999 99999999999999999999999999999876532
Q ss_pred CCCccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhccc
Q 001544 922 EDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANL 1001 (1057)
Q Consensus 922 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1001 (1057)
.. .......++..|+|||...+..++.++|+||||+++|||++|..||...... ...+. +.+....
T Consensus 159 ~~--~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~---------~~~~~~~ 224 (267)
T cd08229 159 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN---LYSLC---------KKIEQCD 224 (267)
T ss_pred CC--cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch---HHHHh---------hhhhcCC
Confidence 22 1122345788999999998888999999999999999999999998542111 11110 0110000
Q ss_pred ccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHHHhH
Q 001544 1002 LITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKIR 1048 (1057)
Q Consensus 1002 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~ 1048 (1057)
. .......++.++.+++.+||+.+|++|||+.+|++.++++.
T Consensus 225 ~-----~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 225 Y-----PPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred C-----CCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 0 00011235678999999999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=337.55 Aligned_cols=258 Identities=22% Similarity=0.294 Sum_probs=202.5
Q ss_pred HHHHhCCCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccc---hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCe
Q 001544 764 LFQATNGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQH---ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDF 839 (1057)
Q Consensus 764 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 839 (1057)
.....++|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+++.
T Consensus 38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (371)
T cd05622 38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 117 (371)
T ss_pred cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence 3445678999999999999999999865 68899999986422 2334567889999999999999999999999999
Q ss_pred eEEEEEEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccc
Q 001544 840 KALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL 919 (1057)
Q Consensus 840 ~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~ 919 (1057)
.++||||+++|+|.+++.... +++..+..++.||+.||+||| +++|+||||||+||+++.++.+||+|||+++..
T Consensus 118 ~~lv~Ey~~gg~L~~~~~~~~--~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~ 192 (371)
T cd05622 118 LYMVMEYMPGGDLVNLMSNYD--VPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (371)
T ss_pred EEEEEcCCCCCcHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHEEECCCCCEEEEeCCceeEc
Confidence 999999999999999987543 788889999999999999999 999999999999999999999999999999865
Q ss_pred cCCCCccccccccccccccCccccCCC----CCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHH
Q 001544 920 IGEDQSMTQTQTLATLGYMAPEYGREG----RVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMK 995 (1057)
Q Consensus 920 ~~~~~~~~~~~~~~t~~y~aPE~~~~~----~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 995 (1057)
.... ........||+.|+|||++... .++.++||||+||++|||++|+.||...... .. ...
T Consensus 193 ~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~----~~---------~~~ 258 (371)
T cd05622 193 NKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV----GT---------YSK 258 (371)
T ss_pred CcCC-cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH----HH---------HHH
Confidence 3221 1122345689999999987653 3788999999999999999999998652110 00 011
Q ss_pred hhhcccccccchhhHHHHHHHHHHHHHHhHcccCCCCC--CCCHHHHHHHH
Q 001544 996 IIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDE--RITAKEIVRRL 1044 (1057)
Q Consensus 996 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--Rps~~evl~~L 1044 (1057)
+.... ....++....++..+.+++.+|+...|.+ ||++.|+++|.
T Consensus 259 i~~~~----~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 259 IMNHK----NSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred HHcCC----CcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 11100 00111222346777899999999844433 78999999875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=332.41 Aligned_cols=242 Identities=22% Similarity=0.321 Sum_probs=192.5
Q ss_pred ceeccccCeEEEEEEec-CCcEEEEEEeeccc---hhHHHHHHHHHHHHHhc-CCCCceeEeeeeccCCeeEEEEEEccC
Q 001544 775 NLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQH---ERAFKSFDTECEVMKSI-RHRNLTKIISSCSNEDFKALILEYMRN 849 (1057)
Q Consensus 775 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~~ 849 (1057)
++||+|+||.||+|+.. +|+.||||+++... ......+..|.+++... +||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999865 68999999996542 22345567788888765 899999999999999999999999999
Q ss_pred CChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCccccc
Q 001544 850 GSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQT 929 (1057)
Q Consensus 850 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 929 (1057)
|+|.+++.... .+++.++..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||+++..... .....
T Consensus 81 g~L~~~i~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~ 154 (316)
T cd05620 81 GDLMFHIQDKG-RFDLYRATFYAAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG--DNRAS 154 (316)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEeCccCCCeecccC--CCcee
Confidence 99999887653 4889999999999999999999 999999999999999999999999999998743211 12233
Q ss_pred cccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhcccccccchhh
Q 001544 930 QTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHF 1009 (1057)
Q Consensus 930 ~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1057)
...||+.|+|||++.+..++.++||||+||++|||++|+.||...... . ..+.+.... .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~-----~---------~~~~~~~~~-------~ 213 (316)
T cd05620 155 TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED-----E---------LFESIRVDT-------P 213 (316)
T ss_pred ccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH-----H---------HHHHHHhCC-------C
Confidence 456899999999999999999999999999999999999998652110 0 011110000 0
Q ss_pred HHHHHHHHHHHHHHhHcccCCCCCCCCHH-HHHHH
Q 001544 1010 AAKEQCASSVFNLAMECTVESPDERITAK-EIVRR 1043 (1057)
Q Consensus 1010 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~-evl~~ 1043 (1057)
..+..++.++.+++.+|++.||++||++. ++.+|
T Consensus 214 ~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h 248 (316)
T cd05620 214 HYPRWITKESKDILEKLFERDPTRRLGVVGNIRGH 248 (316)
T ss_pred CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence 01112456788999999999999999985 56543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=317.87 Aligned_cols=250 Identities=26% Similarity=0.395 Sum_probs=207.2
Q ss_pred CCCCCCceeccccCeEEEEEEecC-CcEEEEEEeeccchhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEEc
Q 001544 769 NGFSENNLIGRGSFGSVYIARLQN-GIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEYM 847 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 847 (1057)
++|+..+.||+|+||.||+|...+ ++.||+|.++.... .+++.+|++++++++||||+++++++.+++..++|+||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 578889999999999999998764 88999999865433 678999999999999999999999999999999999999
Q ss_pred cCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCccc
Q 001544 848 RNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMT 927 (1057)
Q Consensus 848 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 927 (1057)
++++|.+++......+++..+..++.|+++|++||| +.+++||||+|+||+++.++.++|+|||++....... ..
T Consensus 81 ~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~--~~ 155 (256)
T cd06612 81 GAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM--AK 155 (256)
T ss_pred CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEECCCCcEEEcccccchhcccCc--cc
Confidence 999999999876777999999999999999999999 8999999999999999999999999999998653221 12
Q ss_pred cccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhcccccccch
Q 001544 928 QTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDK 1007 (1057)
Q Consensus 928 ~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1057)
.....++..|+|||+..+..++.++||||||+++|||++|+.||......+... .... ....
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~--------------~~~~----~~~~ 217 (256)
T cd06612 156 RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIF--------------MIPN----KPPP 217 (256)
T ss_pred cccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhh--------------hhcc----CCCC
Confidence 233457889999999988889999999999999999999999987532211100 0000 0001
Q ss_pred hhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 1008 HFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 1008 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
.......++.++.+++.+||+.+|++||++.|++++
T Consensus 218 ~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 218 TLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred CCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 111223456778999999999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=318.70 Aligned_cols=247 Identities=25% Similarity=0.403 Sum_probs=197.3
Q ss_pred eeccccCeEEEEEEec---CCcEEEEEEeeccc--hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEEccCC
Q 001544 776 LIGRGSFGSVYIARLQ---NGIEVAVKTFDLQH--ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEYMRNG 850 (1057)
Q Consensus 776 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g 850 (1057)
.||+|+||+||+|.++ ++..||+|+++... ....+.+.+|+.++++++||||+++++++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 5899999999999643 57899999986443 334578899999999999999999999885 45678999999999
Q ss_pred ChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCcc-ccc
Q 001544 851 SLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSM-TQT 929 (1057)
Q Consensus 851 sL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-~~~ 929 (1057)
+|.+++.... .+++..+..++.|++.|++||| +++|+||||||.||++++++.+||+|||.++.+....... ...
T Consensus 81 ~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05116 81 PLNKFLQKNK-HVTEKNITELVHQVSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKT 156 (257)
T ss_pred cHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecC
Confidence 9999987544 5899999999999999999999 9999999999999999999999999999998653322211 112
Q ss_pred cccccccccCccccCCCCCCccchHHHHHHHHHHHhh-CCCCCCcccccccchhhhhhhccchhHHHhhhcccccccchh
Q 001544 930 QTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFT-RRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKH 1008 (1057)
Q Consensus 930 ~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1008 (1057)
...++..|+|||......++.++|+|||||++|||++ |+.||...... . ..+.++... .
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-----~---------~~~~i~~~~------~ 216 (257)
T cd05116 157 HGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN-----E---------VTQMIESGE------R 216 (257)
T ss_pred CCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-----H---------HHHHHHCCC------C
Confidence 2234578999999888889999999999999999998 99998652111 1 111111111 1
Q ss_pred hHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHHHh
Q 001544 1009 FAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKI 1047 (1057)
Q Consensus 1009 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i 1047 (1057)
.+.+..+++++.+++.+||+.||++||++.+|.+.|++.
T Consensus 217 ~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 217 MECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 111234677899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=325.18 Aligned_cols=262 Identities=24% Similarity=0.417 Sum_probs=202.7
Q ss_pred CCCCCCceeccccCeEEEEEEec-----------------CCcEEEEEEeeccc-hhHHHHHHHHHHHHHhcCCCCceeE
Q 001544 769 NGFSENNLIGRGSFGSVYIARLQ-----------------NGIEVAVKTFDLQH-ERAFKSFDTECEVMKSIRHRNLTKI 830 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l 830 (1057)
++|++.+.||+|+||.||+|... ++..||+|+++... .....++.+|++++++++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 46889999999999999998532 24469999986543 3445788999999999999999999
Q ss_pred eeeeccCCeeEEEEEEccCCChhHHHhcCC----------ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCe
Q 001544 831 ISSCSNEDFKALILEYMRNGSLEKCLYSGN----------YILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNV 900 (1057)
Q Consensus 831 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~----------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Ni 900 (1057)
++++..++..++||||+++|+|.+++.... ..+++.++..++.|++.|++||| +.+++||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCeecccCChheE
Confidence 999999999999999999999999987543 24678899999999999999999 99999999999999
Q ss_pred eeCCCCcEEEEcccccccccCCCCccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhh--CCCCCCcccccc
Q 001544 901 LLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFT--RRKPTDEIFSGE 978 (1057)
Q Consensus 901 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt--g~~p~~~~~~~~ 978 (1057)
++++++.++++|||+++.+.............++..|+|||....+.++.++|||||||++|||++ |..||......+
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence 999999999999999986533222222222334678999998888889999999999999999998 667775422111
Q ss_pred cchhhhhhhccchhHHHhhhcccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHHH
Q 001544 979 MTLKHWVNDFLPISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLK 1046 (1057)
Q Consensus 979 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 1046 (1057)
++.. .......... ....+.+..++..+.+++.+||+.||++||++.|+++.|++
T Consensus 242 -----~~~~-----~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 242 -----VIEN-----TGEFFRDQGR---QVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred -----HHHH-----HHHHHhhccc---cccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 1100 0011100000 00011122356788999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=332.94 Aligned_cols=247 Identities=23% Similarity=0.315 Sum_probs=197.4
Q ss_pred CCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccc---hhHHHHHHHHHHHHHhc-CCCCceeEeeeeccCCeeEEEE
Q 001544 770 GFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQH---ERAFKSFDTECEVMKSI-RHRNLTKIISSCSNEDFKALIL 844 (1057)
Q Consensus 770 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~ 844 (1057)
+|++.+.||+|+||+||+|... +++.||||+++... ......+..|.+++... +|++|+++++++.+.+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4778899999999999999865 57899999986542 22345567788888777 5899999999999999999999
Q ss_pred EEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCC
Q 001544 845 EYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ 924 (1057)
Q Consensus 845 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 924 (1057)
||+++|+|.+++.... .+++.++..++.|++.||+||| +.+|+||||||+||++++++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~-- 154 (323)
T cd05616 81 EYVNGGDLMYQIQQVG-RFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD-- 154 (323)
T ss_pred cCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEecCCCHHHeEECCCCcEEEccCCCceecCCC--
Confidence 9999999999887654 4889999999999999999999 999999999999999999999999999998753211
Q ss_pred ccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhcccccc
Q 001544 925 SMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLIT 1004 (1057)
Q Consensus 925 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1057)
........||+.|+|||++.+..++.++||||+||++|||++|+.||...... .. ...+.+...
T Consensus 155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~--~~-----------~~~i~~~~~--- 218 (323)
T cd05616 155 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED--EL-----------FQSIMEHNV--- 218 (323)
T ss_pred CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH--HH-----------HHHHHhCCC---
Confidence 12233456899999999999999999999999999999999999998652111 00 011111100
Q ss_pred cchhhHHHHHHHHHHHHHHhHcccCCCCCCCCH-----HHHHHH
Q 001544 1005 EDKHFAAKEQCASSVFNLAMECTVESPDERITA-----KEIVRR 1043 (1057)
Q Consensus 1005 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~-----~evl~~ 1043 (1057)
..+...+.++.+++.+|++.||++|+++ .++.+|
T Consensus 219 -----~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05616 219 -----AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 257 (323)
T ss_pred -----CCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence 1112356778999999999999999974 666554
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=316.77 Aligned_cols=248 Identities=30% Similarity=0.491 Sum_probs=200.7
Q ss_pred ceeccccCeEEEEEEecCCcEEEEEEeeccchh-HHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEEccCCChh
Q 001544 775 NLIGRGSFGSVYIARLQNGIEVAVKTFDLQHER-AFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEYMRNGSLE 853 (1057)
Q Consensus 775 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL~ 853 (1057)
++||+|+||.||+|...+++.||+|.++..... ....+.+|++++++++||||+++++++.+....++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 469999999999998777999999998655433 5678899999999999999999999999999999999999999999
Q ss_pred HHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCccccccccc
Q 001544 854 KCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLA 933 (1057)
Q Consensus 854 ~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~ 933 (1057)
+++......+++..+..++.+++.|++||| +.+++||||||+||+++.++.+||+|||.+.................
T Consensus 81 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (251)
T cd05041 81 TFLRKKKNRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI 157 (251)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence 999776666899999999999999999999 99999999999999999999999999999976532111111112223
Q ss_pred cccccCccccCCCCCCccchHHHHHHHHHHHhh-CCCCCCcccccccchhhhhhhccchhHHHhhhcccccccchhhHHH
Q 001544 934 TLGYMAPEYGREGRVSTKGDVYSFGILLMETFT-RRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHFAAK 1012 (1057)
Q Consensus 934 t~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1012 (1057)
+..|+|||.+.++.++.++|+||+|+++|||+| |..||....... ....+.... ....+
T Consensus 158 ~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~--------------~~~~~~~~~------~~~~~ 217 (251)
T cd05041 158 PIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ--------------TRERIESGY------RMPAP 217 (251)
T ss_pred eeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH--------------HHHHHhcCC------CCCCC
Confidence 567999999988889999999999999999999 788875521110 111111100 01112
Q ss_pred HHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHH
Q 001544 1013 EQCASSVFNLAMECTVESPDERITAKEIVRRLL 1045 (1057)
Q Consensus 1013 ~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 1045 (1057)
..++.++.+++.+|+..+|++||++.|+++.|+
T Consensus 218 ~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 218 QLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred ccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 345678999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=325.30 Aligned_cols=256 Identities=27% Similarity=0.448 Sum_probs=204.1
Q ss_pred hCCCCCCceeccccCeEEEEEEec------CCcEEEEEEeeccc-hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCee
Q 001544 768 TNGFSENNLIGRGSFGSVYIARLQ------NGIEVAVKTFDLQH-ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFK 840 (1057)
Q Consensus 768 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 840 (1057)
.++|+..+.||+|+||.||+|... ++..||+|++.... ......+.+|++++++++||||+++++++.+++..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 457888999999999999999753 46889999986543 33456788999999999999999999999999999
Q ss_pred EEEEEEccCCChhHHHhcCC---------------------ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCC
Q 001544 841 ALILEYMRNGSLEKCLYSGN---------------------YILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSN 899 (1057)
Q Consensus 841 ~lV~E~~~~gsL~~~l~~~~---------------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~N 899 (1057)
++||||+++|+|.+++.... ..+++.+++.++.|++.||+||| +.+++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH---~~~i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS---ERKFVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCeecccccHhh
Confidence 99999999999999986422 24788889999999999999999 8999999999999
Q ss_pred eeeCCCCcEEEEcccccccccCCCCccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhh-CCCCCCcccccc
Q 001544 900 VLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFT-RRKPTDEIFSGE 978 (1057)
Q Consensus 900 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~ 978 (1057)
|++++++.++++|||.+..+..............+..|+|||...+..++.++|||||||++|||++ |..||......
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~- 239 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE- 239 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-
Confidence 9999999999999999876533222222223344667999999988899999999999999999998 77787542111
Q ss_pred cchhhhhhhccchhHHHhhhcccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHHH
Q 001544 979 MTLKHWVNDFLPISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLK 1046 (1057)
Q Consensus 979 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 1046 (1057)
++. ....+... ...+..++.++.+++.+|++.+|++||++.|+++.|++
T Consensus 240 ----~~~--------~~~~~~~~-------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 240 ----EVI--------YYVRDGNV-------LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred ----HHH--------HHHhcCCC-------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 111 11111100 01112356789999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=328.03 Aligned_cols=260 Identities=28% Similarity=0.439 Sum_probs=206.0
Q ss_pred CCCCCCceeccccCeEEEEEEec--------CCcEEEEEEeeccc-hhHHHHHHHHHHHHHhc-CCCCceeEeeeeccCC
Q 001544 769 NGFSENNLIGRGSFGSVYIARLQ--------NGIEVAVKTFDLQH-ERAFKSFDTECEVMKSI-RHRNLTKIISSCSNED 838 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 838 (1057)
++|.+.+.||+|+||.||+|+.. .+..||+|.++... ......+.+|+++++++ +||||+++++++.+.+
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 46788899999999999999642 24579999986543 34456788999999999 6999999999999989
Q ss_pred eeEEEEEEccCCChhHHHhcCC---------------ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeC
Q 001544 839 FKALILEYMRNGSLEKCLYSGN---------------YILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLD 903 (1057)
Q Consensus 839 ~~~lV~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~ 903 (1057)
..++||||+++|+|.+++.... ..+++.++.+++.|++.|++||| +++++||||||+||+++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill~ 168 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNVLVT 168 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeeccccceeEEEc
Confidence 9999999999999999986532 34889999999999999999999 99999999999999999
Q ss_pred CCCcEEEEcccccccccCCCCccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhh-CCCCCCcccccccchh
Q 001544 904 DNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFT-RRKPTDEIFSGEMTLK 982 (1057)
Q Consensus 904 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~ 982 (1057)
+++.+|++|||.++...............++..|+|||.+.+..++.++||||||+++|||++ |..||......
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~----- 243 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE----- 243 (314)
T ss_pred CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH-----
Confidence 999999999999986532222111222234467999999988889999999999999999999 88887542110
Q ss_pred hhhhhccchhHHHhhhcccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHHHhHHHH
Q 001544 983 HWVNDFLPISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKIRDFL 1051 (1057)
Q Consensus 983 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~ 1051 (1057)
...+...... ....+..++.++.+++.+|++.+|++||++.|+++.|+++....
T Consensus 244 ---------~~~~~~~~~~------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 297 (314)
T cd05099 244 ---------ELFKLLREGH------RMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAV 297 (314)
T ss_pred ---------HHHHHHHcCC------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHh
Confidence 0111111100 01112345667889999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=323.07 Aligned_cols=252 Identities=23% Similarity=0.345 Sum_probs=204.3
Q ss_pred CCCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccchhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEEc
Q 001544 769 NGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEYM 847 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 847 (1057)
+.|++.++||+|+||.||+|... +++.||+|++........+.+.+|++++++++||||+++++++..+...++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 46888999999999999999865 58999999997766666788999999999999999999999999999999999999
Q ss_pred cCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCccc
Q 001544 848 RNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMT 927 (1057)
Q Consensus 848 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 927 (1057)
++++|..++.+....+++..+..++.|+++|++||| +.+++||||||+||+++.++.+||+|||.+..... ....
T Consensus 92 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~--~~~~ 166 (292)
T cd06644 92 PGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK--TLQR 166 (292)
T ss_pred CCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---cCCeeecCCCcceEEEcCCCCEEEccCccceeccc--cccc
Confidence 999999888766667899999999999999999999 99999999999999999999999999999875421 1122
Q ss_pred cccccccccccCccccC-----CCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhcccc
Q 001544 928 QTQTLATLGYMAPEYGR-----EGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLL 1002 (1057)
Q Consensus 928 ~~~~~~t~~y~aPE~~~-----~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1002 (1057)
.....++..|+|||++. ...++.++|||||||++|||++|+.||...... ... .......
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-~~~------------~~~~~~~-- 231 (292)
T cd06644 167 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM-RVL------------LKIAKSE-- 231 (292)
T ss_pred cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH-HHH------------HHHhcCC--
Confidence 23445788999999874 345688999999999999999999998652111 000 0010000
Q ss_pred cccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 1003 ITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 1003 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
......+..++.++.+++.+||+.+|++||++.|++++
T Consensus 232 ---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 232 ---PPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred ---CccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 00111122445678999999999999999999999875
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=318.19 Aligned_cols=252 Identities=29% Similarity=0.481 Sum_probs=202.1
Q ss_pred CCCCCCceeccccCeEEEEEEecCCcEEEEEEeeccchhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEEcc
Q 001544 769 NGFSENNLIGRGSFGSVYIARLQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEYMR 848 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 848 (1057)
++|.+.+.||+|++|.||+|..+.+..||+|.+.... ...+.+.+|++++++++|||++++++++.+ +..++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcCC
Confidence 4578889999999999999998877789999886433 234678899999999999999999998854 56789999999
Q ss_pred CCChhHHHhcCC-ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCccc
Q 001544 849 NGSLEKCLYSGN-YILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMT 927 (1057)
Q Consensus 849 ~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 927 (1057)
+|+|.++++... ..+++..+..++.|++.||+||| +.+++||||||+||++++++.++|+|||.++...... ...
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~-~~~ 159 (260)
T cd05069 84 KGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE-YTA 159 (260)
T ss_pred CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCeEEECCCccceEccCCc-ccc
Confidence 999999997643 45889999999999999999999 8999999999999999999999999999997653221 112
Q ss_pred cccccccccccCccccCCCCCCccchHHHHHHHHHHHhh-CCCCCCcccccccchhhhhhhccchhHHHhhhcccccccc
Q 001544 928 QTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFT-RRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITED 1006 (1057)
Q Consensus 928 ~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1006 (1057)
.....++..|+|||...+..++.++||||+|+++|||++ |..||......+ ...+ +....
T Consensus 160 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~~------------~~~~~----- 220 (260)
T cd05069 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE--VLEQ------------VERGY----- 220 (260)
T ss_pred cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHH------------HHcCC-----
Confidence 222345678999999988889999999999999999999 888886522111 0011 10000
Q ss_pred hhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHHH
Q 001544 1007 KHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLK 1046 (1057)
Q Consensus 1007 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 1046 (1057)
..+.+...+..+.+++.+||+.+|++||++.++++.|++
T Consensus 221 -~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 221 -RMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred -CCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 001113456779999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=323.95 Aligned_cols=252 Identities=27% Similarity=0.407 Sum_probs=206.6
Q ss_pred CCCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccchhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEEc
Q 001544 769 NGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEYM 847 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 847 (1057)
++|++.+.||+|+||.||+|... ++..||+|+++.......+.+.+|++++++++||||+++++++..+...++||||+
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC 84 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence 46888899999999999999864 68999999998766666788999999999999999999999999999999999999
Q ss_pred cCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCccc
Q 001544 848 RNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMT 927 (1057)
Q Consensus 848 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 927 (1057)
++++|.+++...+..+++.++..++.|++.|++||| +.+|+||||||+||+++.++.++|+|||.+...... ...
T Consensus 85 ~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~--~~~ 159 (280)
T cd06611 85 DGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST--LQK 159 (280)
T ss_pred CCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEECCCCCEEEccCccchhhccc--ccc
Confidence 999999999876667999999999999999999999 999999999999999999999999999998754221 122
Q ss_pred cccccccccccCccccC-----CCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhcccc
Q 001544 928 QTQTLATLGYMAPEYGR-----EGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLL 1002 (1057)
Q Consensus 928 ~~~~~~t~~y~aPE~~~-----~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1002 (1057)
.....++..|+|||.+. ...++.++|+||+|+++|||++|+.||......+ .. ......
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~-~~------------~~~~~~--- 223 (280)
T cd06611 160 RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR-VL------------LKILKS--- 223 (280)
T ss_pred cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH-HH------------HHHhcC---
Confidence 23446788999999864 3456789999999999999999999986531110 00 011000
Q ss_pred cccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 1003 ITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 1003 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
.......+..++.++.+++.+||+.+|++||++.+++++
T Consensus 224 --~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 224 --EPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred --CCCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 000111123456778999999999999999999999987
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=315.27 Aligned_cols=239 Identities=21% Similarity=0.377 Sum_probs=191.0
Q ss_pred ceeccccCeEEEEEEecC-------------CcEEEEEEeeccchhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeE
Q 001544 775 NLIGRGSFGSVYIARLQN-------------GIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKA 841 (1057)
Q Consensus 775 ~~lg~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 841 (1057)
+.||+|+||.||+|...+ ...||+|++..........+.+|+.++++++||||+++++++..+...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999997532 2358999887665566678889999999999999999999999988999
Q ss_pred EEEEEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCc-------EEEEccc
Q 001544 842 LILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMV-------AHLSDFG 914 (1057)
Q Consensus 842 lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~-------~kl~Dfg 914 (1057)
+||||+++|+|+.++......+++..+..++.||++|++||| +++|+||||||+||+++.++. ++++|||
T Consensus 81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhh---hCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 999999999999998776667999999999999999999999 999999999999999987664 8999999
Q ss_pred ccccccCCCCccccccccccccccCccccC-CCCCCccchHHHHHHHHHHHh-hCCCCCCcccccccchhhhhhhccchh
Q 001544 915 IAKLLIGEDQSMTQTQTLATLGYMAPEYGR-EGRVSTKGDVYSFGILLMETF-TRRKPTDEIFSGEMTLKHWVNDFLPIS 992 (1057)
Q Consensus 915 ~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~Dv~s~G~il~ell-tg~~p~~~~~~~~~~~~~~~~~~~~~~ 992 (1057)
.+..... .....++..|+|||.+. +..++.++|||||||++|||+ +|..||......+
T Consensus 158 ~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-------------- 217 (262)
T cd05077 158 IPITVLS------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE-------------- 217 (262)
T ss_pred CCccccC------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH--------------
Confidence 9875421 12345678899999876 466899999999999999998 5777765421110
Q ss_pred HHHhhhcccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHH
Q 001544 993 MMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRL 1044 (1057)
Q Consensus 993 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 1044 (1057)
.......... .....+.++.+++.+||+.||++||++.++++++
T Consensus 218 ~~~~~~~~~~--------~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 218 KERFYEGQCM--------LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred HHHHHhcCcc--------CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 0000000000 0011245688999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=322.92 Aligned_cols=255 Identities=25% Similarity=0.408 Sum_probs=204.3
Q ss_pred hCCCCCCceeccccCeEEEEEEec------CCcEEEEEEeeccc-hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCee
Q 001544 768 TNGFSENNLIGRGSFGSVYIARLQ------NGIEVAVKTFDLQH-ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFK 840 (1057)
Q Consensus 768 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 840 (1057)
.++|++.+.||+|+||.||+|... .+..||+|.+.... ......+.+|++++++++||||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 357888899999999999999754 24689999986443 34456788999999999999999999999999999
Q ss_pred EEEEEEccCCChhHHHhcCC---------ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEE
Q 001544 841 ALILEYMRNGSLEKCLYSGN---------YILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLS 911 (1057)
Q Consensus 841 ~lV~E~~~~gsL~~~l~~~~---------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~ 911 (1057)
++||||+++|+|.+++.... ..+++..+..++.|++.|++||| +.+|+||||||+||++++++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccChheEEEcCCCCEEEC
Confidence 99999999999999986432 24688899999999999999999 9999999999999999999999999
Q ss_pred cccccccccCCCCccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhh-CCCCCCcccccccchhhhhhhccc
Q 001544 912 DFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFT-RRKPTDEIFSGEMTLKHWVNDFLP 990 (1057)
Q Consensus 912 Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 990 (1057)
|||+++.+.............++..|+|||...++.++.++|||||||++||+++ |..||......
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~------------- 228 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE------------- 228 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHH-------------
Confidence 9999986543322222233446778999999988889999999999999999998 88887542111
Q ss_pred hhHHHhhhcccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHH
Q 001544 991 ISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLL 1045 (1057)
Q Consensus 991 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 1045 (1057)
...+...... ....+..++.++.+++.+||+.+|++|||+.|+++.|+
T Consensus 229 -~~~~~~~~~~------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 229 -EVLKFVIDGG------HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred -HHHHHHhcCC------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 0111111000 11111234678899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=333.70 Aligned_cols=267 Identities=22% Similarity=0.263 Sum_probs=198.3
Q ss_pred HhCCCCCCceeccccCeEEEEEEec-CCcEEEEEEeecc--chhHHHHHHHHHHHHHhcCCCCceeEeeeeccC------
Q 001544 767 ATNGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQ--HERAFKSFDTECEVMKSIRHRNLTKIISSCSNE------ 837 (1057)
Q Consensus 767 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 837 (1057)
..++|++.+.||+|+||.||+|... +|+.||||++... .......+.+|+.++++++||||+++++++...
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 4578999999999999999999864 6899999998643 234456788999999999999999999988543
Q ss_pred CeeEEEEEEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccc
Q 001544 838 DFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK 917 (1057)
Q Consensus 838 ~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~ 917 (1057)
...|+||||+++ ++.+.+.. .+++..+..++.|+++||+||| +++|+||||||+||+++.++.+||+|||+++
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~~L~~LH---~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~ 171 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIHM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 171 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHhc---cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEecCCCcc
Confidence 357999999976 56655542 3788899999999999999999 9999999999999999999999999999997
Q ss_pred cccCCCCccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccc--hh---
Q 001544 918 LLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLP--IS--- 992 (1057)
Q Consensus 918 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~--~~--- 992 (1057)
.... ........+|..|+|||.+.+..++.++||||+||++|||++|+.||......+ .+......... ..
T Consensus 172 ~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~ 247 (359)
T cd07876 172 TACT---NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHID-QWNKVIEQLGTPSAEFMN 247 (359)
T ss_pred cccc---CccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCcHHHHH
Confidence 5422 122334568899999999999899999999999999999999999997532110 01100000000 00
Q ss_pred -----HHHhhhccccccc------------chhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHH
Q 001544 993 -----MMKIIDANLLITE------------DKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRL 1044 (1057)
Q Consensus 993 -----~~~~~~~~~~~~~------------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 1044 (1057)
............. ..........+.++.+++.+|++.||++|||+.|+++|-
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 316 (359)
T cd07876 248 RLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHP 316 (359)
T ss_pred HHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCc
Confidence 0000000000000 000000112356789999999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=322.02 Aligned_cols=260 Identities=24% Similarity=0.370 Sum_probs=208.5
Q ss_pred CCCCCCceeccccCeEEEEEEec-CCc----EEEEEEeeccc-hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEE
Q 001544 769 NGFSENNLIGRGSFGSVYIARLQ-NGI----EVAVKTFDLQH-ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKAL 842 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 842 (1057)
.+|++.+.||+|+||.||+|..+ +|. .||+|...... ......+.+|++++++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 46788899999999999999854 333 68999886543 3445788899999999999999999999887 78899
Q ss_pred EEEEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCC
Q 001544 843 ILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGE 922 (1057)
Q Consensus 843 V~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~ 922 (1057)
||||+++|+|.+++......+++..+..++.|++.|++||| +.+++||||||+||+++.++.+||+|||.++.....
T Consensus 86 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~ 162 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD 162 (279)
T ss_pred EEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecccCcceEEEcCCCeEEECCCcccccccCc
Confidence 99999999999999887767999999999999999999999 899999999999999999999999999999876433
Q ss_pred CCccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhh-CCCCCCcccccccchhhhhhhccchhHHHhhhccc
Q 001544 923 DQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFT-RRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANL 1001 (1057)
Q Consensus 923 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1001 (1057)
..........++..|+|||......++.++|+||||+++||+++ |+.||...... + ....+....
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-----~---------~~~~~~~~~ 228 (279)
T cd05057 163 EKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV-----E---------IPDLLEKGE 228 (279)
T ss_pred ccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH-----H---------HHHHHhCCC
Confidence 22222222234568999999888889999999999999999998 99998652111 1 111111100
Q ss_pred ccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHHHhHHHHh
Q 001544 1002 LITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKIRDFLL 1052 (1057)
Q Consensus 1002 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~~ 1052 (1057)
..+.+..++..+.+++.+||..+|.+||++.++++.++++.+...
T Consensus 229 ------~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~~ 273 (279)
T cd05057 229 ------RLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARDPQ 273 (279)
T ss_pred ------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhCCc
Confidence 111112345678899999999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=329.71 Aligned_cols=255 Identities=22% Similarity=0.294 Sum_probs=199.4
Q ss_pred CCCCCCceeccccCeEEEEEEec-CCcEEEEEEeecc---chhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEE
Q 001544 769 NGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQ---HERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALIL 844 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 844 (1057)
++|++.+.||+|+||+||+|+.. +++.||||++... .....+.+.+|+.++..++|+||+++++++.+++..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 46889999999999999999865 6899999999642 2234466888999999999999999999999999999999
Q ss_pred EEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCC
Q 001544 845 EYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ 924 (1057)
Q Consensus 845 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 924 (1057)
||+++|+|.+++.+....+++..+..++.||+.||+||| +++|+||||||+||+++.++.+||+|||++.......
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~- 156 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVH---QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG- 156 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCC-
Confidence 999999999999776666899999999999999999999 9999999999999999999999999999987653222
Q ss_pred ccccccccccccccCccccCC-----CCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhc
Q 001544 925 SMTQTQTLATLGYMAPEYGRE-----GRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDA 999 (1057)
Q Consensus 925 ~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 999 (1057)
........||+.|+|||++.. ..++.++||||+||++|||++|+.||...... +. ...+...
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~-----~~--------~~~i~~~ 223 (331)
T cd05597 157 TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV-----ET--------YGKIMNH 223 (331)
T ss_pred CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHH-----HH--------HHHHHcC
Confidence 122233468999999998763 45788999999999999999999998652111 00 0011100
Q ss_pred ccccccchhhHHHHHHHHHHHHHHhHcccCCCCC--CCCHHHHHHH
Q 001544 1000 NLLITEDKHFAAKEQCASSVFNLAMECTVESPDE--RITAKEIVRR 1043 (1057)
Q Consensus 1000 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--Rps~~evl~~ 1043 (1057)
..... .......++.++.+++.+|+..++++ ||++.++++|
T Consensus 224 ~~~~~---~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 224 KEHFQ---FPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred CCccc---CCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 00000 00011235677889999987654443 8899999988
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=358.54 Aligned_cols=483 Identities=31% Similarity=0.341 Sum_probs=331.3
Q ss_pred eecccccccCCCCccccccCCCCeEeccCCCCCCCCCcccccCCCCCceeEccCCcccccCchhhhccccCCeeEeeccC
Q 001544 124 LLLHNNFLTGTIPFSIFKLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQLSGSIPSFIFKISSLQALHFGNNR 203 (1057)
Q Consensus 124 L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~ 203 (1057)
+|++..++. .||..+..-..|+.|++++|-+. ..|-....+.-+|+.||+++|+++ ..|..+..+.+|+.|.++.|-
T Consensus 3 vd~s~~~l~-~ip~~i~~~~~~~~ln~~~N~~l-~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~ 79 (1081)
T KOG0618|consen 3 VDASDEQLE-LIPEQILNNEALQILNLRRNSLL-SRPLEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNY 79 (1081)
T ss_pred cccccccCc-ccchhhccHHHHHhhhccccccc-cCchHHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchhh
Confidence 556666666 56666655555777777777665 333223333444777777777666 566666666677777776666
Q ss_pred CccccCccccCCCCcccEEEeeccccccCccccccCCCCCcEEEccCCCCcCCccccccCcCCCcEEeeeccccccccCc
Q 001544 204 LSGELPANICDNLPFLNFFSVYKNMFYGGISSTLSNCKHLRILDLSFNDLWGDIPKEIGNLTKLKELFLDFNILQGEIPH 283 (1057)
Q Consensus 204 l~~~~p~~~~~~l~~L~~L~l~~n~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~ 283 (1057)
+. .+| ...+++++|++|.|.+|.+. ..|..+..+.+|++|++++|++. .+|.
T Consensus 80 i~-~vp-------------------------~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~N~f~-~~Pl 131 (1081)
T KOG0618|consen 80 IR-SVP-------------------------SSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSFNHFG-PIPL 131 (1081)
T ss_pred Hh-hCc-------------------------hhhhhhhcchhheeccchhh-cCchhHHhhhcccccccchhccC-CCch
Confidence 65 333 23466777777777777775 56777777777777777777776 6677
Q ss_pred cccccccccEEEeecCccccccCccccccccccEEEecCCccccCCCCCcccCCCCCce-EEecCccccccCCccccccc
Q 001544 284 TVGNLHNLEYLSLVNNELVGTVPATIFNVSTLKLIELSNNTFFGSLPSSTDVQLPNLEE-LYLWGNNFSGTLPSFIFNAS 362 (1057)
Q Consensus 284 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~-L~L~~N~l~~~~~~~~~~l~ 362 (1057)
.+..++.++.+..++|......+.. .++.+++..|.+.+.++... ..|++ |+|++|.+. -..+.++.
T Consensus 132 ~i~~lt~~~~~~~s~N~~~~~lg~~-----~ik~~~l~~n~l~~~~~~~i----~~l~~~ldLr~N~~~---~~dls~~~ 199 (1081)
T KOG0618|consen 132 VIEVLTAEEELAASNNEKIQRLGQT-----SIKKLDLRLNVLGGSFLIDI----YNLTHQLDLRYNEME---VLDLSNLA 199 (1081)
T ss_pred hHHhhhHHHHHhhhcchhhhhhccc-----cchhhhhhhhhcccchhcch----hhhheeeecccchhh---hhhhhhcc
Confidence 7777777777777777222222221 16666777776666555443 23333 777777765 12345566
Q ss_pred cccccccccccccccccchhcccccccEEeccCcccCCCccccccccCCCcchhhhhccCCCcccccccccccccccccE
Q 001544 363 NLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNYLTSPELSFLSSLSNCKYLEIIALSGNPLNGIIPMSAGNLSHSLEE 442 (1057)
Q Consensus 363 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~ 442 (1057)
+|+.|....|+++... -..++|+.|+.+.|.+++... ...-.+|+.+|+|.|++++.. ..++.. .+|+.
T Consensus 200 ~l~~l~c~rn~ls~l~----~~g~~l~~L~a~~n~l~~~~~-----~p~p~nl~~~dis~n~l~~lp-~wi~~~-~nle~ 268 (1081)
T KOG0618|consen 200 NLEVLHCERNQLSELE----ISGPSLTALYADHNPLTTLDV-----HPVPLNLQYLDISHNNLSNLP-EWIGAC-ANLEA 268 (1081)
T ss_pred chhhhhhhhcccceEE----ecCcchheeeeccCcceeecc-----ccccccceeeecchhhhhcch-HHHHhc-ccceE
Confidence 7777777777776432 234567777777777764322 122345666777777776543 333333 45777
Q ss_pred EEcCCCcccccccccccCccCCcEEEccCCcCCCCCCcccccccccceeecccccCcccCCcccccccc-cceEEecCee
Q 001544 443 LFMPDCNVSGRIPKEIGNLANLVTLDLGGNKFNGSIPIALGKLQKLQLLNLDDNKLEGSIPDDICGLVE-LYKLALGDNK 521 (1057)
Q Consensus 443 L~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~-L~~L~L~~N~ 521 (1057)
+...+|++ ..+|..+...++|+.|++..|.+. -+|....+++.|++|+|..|+|...++..|.-+.. |..|..+.|+
T Consensus 269 l~~n~N~l-~~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~ 346 (1081)
T KOG0618|consen 269 LNANHNRL-VALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNK 346 (1081)
T ss_pred ecccchhH-HhhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhcc
Confidence 77777766 356666666677777777777766 45666666777777777777776433333333333 5666666666
Q ss_pred eeecCCccccCcccccccccCCccccccccccccccccccEEEeccccccCCCchhhccccccceecccccccccccccc
Q 001544 522 LSGQIPACFGNLASLRELWLGPNELISFIPSTFWNIKDIMYVNFSSNFLTGPLPLEIENLKALTTLDFSMNNLSGVIPTT 601 (1057)
Q Consensus 522 i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 601 (1057)
+.......-..++.|+.|++.+|.++.-.-..+.+..+|+.|+|++|++.......+.++..|+.|+||+|+|+ .+|..
T Consensus 347 l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~t 425 (1081)
T KOG0618|consen 347 LSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDT 425 (1081)
T ss_pred ccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHH
Confidence 66433222345678999999999999988888999999999999999999766677889999999999999998 78899
Q ss_pred ccCccccceecccccccccccCccccccCccceecccCccccCC-CcccccCcccccccccCCCcc
Q 001544 602 IGGLKGLQYLFLGHNRLQGSIPDSVGDLISLKSLNLSNNNLSGP-IPTSLEKLSDLKELNLSFNKL 666 (1057)
Q Consensus 602 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~l~~l~~L~~l~ls~N~l 666 (1057)
+..++.|++|...+|+|. ..| .+..+++|+.+|+|.|+|+.. +|..+ .-++|++|||+||..
T Consensus 426 va~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~-p~p~LkyLdlSGN~~ 488 (1081)
T KOG0618|consen 426 VANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEAL-PSPNLKYLDLSGNTR 488 (1081)
T ss_pred HHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhC-CCcccceeeccCCcc
Confidence 999999999999999999 778 799999999999999999854 34443 338999999999985
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=334.89 Aligned_cols=238 Identities=27% Similarity=0.365 Sum_probs=192.7
Q ss_pred ceeccccCeEEEEEEe----cCCcEEEEEEeeccch--hHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEEcc
Q 001544 775 NLIGRGSFGSVYIARL----QNGIEVAVKTFDLQHE--RAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEYMR 848 (1057)
Q Consensus 775 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 848 (1057)
+.||+|+||.||+++. .+|+.||+|+++.... .....+.+|++++++++||||+++++++.+.+..|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 6799999999999864 3589999999965432 234567789999999999999999999999999999999999
Q ss_pred CCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCcccc
Q 001544 849 NGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQ 928 (1057)
Q Consensus 849 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 928 (1057)
+|+|.+++.... .+++..+..++.||++||+||| +.+|+||||||+||+++.++.+||+|||+++..... ....
T Consensus 82 ~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~--~~~~ 155 (318)
T cd05582 82 GGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH--EKKA 155 (318)
T ss_pred CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCC--CCce
Confidence 999999986644 5899999999999999999999 999999999999999999999999999998764322 1122
Q ss_pred ccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhcccccccchh
Q 001544 929 TQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKH 1008 (1057)
Q Consensus 929 ~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1008 (1057)
....|++.|+|||.+.+..++.++|||||||++|||++|+.||...... .. ...+....
T Consensus 156 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~-----~~--------~~~i~~~~-------- 214 (318)
T cd05582 156 YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK-----ET--------MTMILKAK-------- 214 (318)
T ss_pred ecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH-----HH--------HHHHHcCC--------
Confidence 3356899999999998888999999999999999999999998652111 00 00111100
Q ss_pred hHHHHHHHHHHHHHHhHcccCCCCCCCCHHH
Q 001544 1009 FAAKEQCASSVFNLAMECTVESPDERITAKE 1039 (1057)
Q Consensus 1009 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e 1039 (1057)
...+..++.++.+++.+||+.||++||++.+
T Consensus 215 ~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 215 LGMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 0111235677889999999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=317.51 Aligned_cols=248 Identities=31% Similarity=0.469 Sum_probs=200.3
Q ss_pred CCCCCCceeccccCeEEEEEEecCCcEEEEEEeeccchhHHHHHHHHHHHHHhcCCCCceeEeeee-ccCCeeEEEEEEc
Q 001544 769 NGFSENNLIGRGSFGSVYIARLQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSC-SNEDFKALILEYM 847 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lV~E~~ 847 (1057)
.+|++.+.||+|+||.||+|... |..||+|.++... ..+.+.+|+.++++++|+|++++++++ .++...++||||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 46888899999999999999766 7889999986433 346788999999999999999999975 4556789999999
Q ss_pred cCCChhHHHhcCC-ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCcc
Q 001544 848 RNGSLEKCLYSGN-YILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSM 926 (1057)
Q Consensus 848 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 926 (1057)
++++|.+++.... ..+++..+..++.|++.|++||| +.+++||||||+||++++++.+|++|||++.......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--- 156 (256)
T cd05082 83 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--- 156 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccccchheEEEcCCCcEEecCCccceeccccC---
Confidence 9999999987654 35889999999999999999999 9999999999999999999999999999987542211
Q ss_pred ccccccccccccCccccCCCCCCccchHHHHHHHHHHHhh-CCCCCCcccccccchhhhhhhccchhHHHhhhccccccc
Q 001544 927 TQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFT-RRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITE 1005 (1057)
Q Consensus 927 ~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1057)
....++..|+|||+..+..++.++||||+||++|||++ |+.||.... .... ...+....
T Consensus 157 --~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~-----~~~~---------~~~~~~~~---- 216 (256)
T cd05082 157 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-----LKDV---------VPRVEKGY---- 216 (256)
T ss_pred --CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC-----HHHH---------HHHHhcCC----
Confidence 22234568999999988889999999999999999998 888875421 1111 01111100
Q ss_pred chhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHHHh
Q 001544 1006 DKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKI 1047 (1057)
Q Consensus 1006 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i 1047 (1057)
.......++..+.+++.+|++.+|++|||+.+++++|+++
T Consensus 217 --~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 217 --KMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred --CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 0011124567889999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=316.17 Aligned_cols=248 Identities=26% Similarity=0.415 Sum_probs=200.6
Q ss_pred ceeccccCeEEEEEEecC--C--cEEEEEEeeccch-hHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEEccC
Q 001544 775 NLIGRGSFGSVYIARLQN--G--IEVAVKTFDLQHE-RAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEYMRN 849 (1057)
Q Consensus 775 ~~lg~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 849 (1057)
++||+|++|.||+|.+.+ + ..||||.++.... ...+++.+|++++++++||||+++++++.+ ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998643 3 3699999976655 567889999999999999999999999988 888999999999
Q ss_pred CChhHHHhcCC-ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCc-cc
Q 001544 850 GSLEKCLYSGN-YILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS-MT 927 (1057)
Q Consensus 850 gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~ 927 (1057)
++|.+++.... ..+++..+..++.|++.||+||| +.+++||||||+||+++.++.+||+|||+++........ ..
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHH---hCCccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 99999997765 56899999999999999999999 999999999999999999999999999999876432221 11
Q ss_pred cccccccccccCccccCCCCCCccchHHHHHHHHHHHhh-CCCCCCcccccccchhhhhhhccchhHHHhhhcccccccc
Q 001544 928 QTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFT-RRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITED 1006 (1057)
Q Consensus 928 ~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1006 (1057)
.....++..|+|||...+..++.++|||||||++|||++ |+.||......+ ..+.+....
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--------------~~~~~~~~~----- 217 (257)
T cd05040 157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ--------------ILKKIDKEG----- 217 (257)
T ss_pred ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH--------------HHHHHHhcC-----
Confidence 223456778999999988889999999999999999999 999986421111 001111000
Q ss_pred hhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHH
Q 001544 1007 KHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLL 1045 (1057)
Q Consensus 1007 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 1045 (1057)
.....+..++..+.+++.+|++.+|++||++.|+++.|.
T Consensus 218 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 218 ERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 011112235677899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=326.08 Aligned_cols=246 Identities=29% Similarity=0.394 Sum_probs=202.0
Q ss_pred CCCCCceeccccCeEEEEEEec-CCcEEEEEEeecc---chhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEE
Q 001544 770 GFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQ---HERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILE 845 (1057)
Q Consensus 770 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 845 (1057)
.|...+.||.|+||.||.|++. +.+.||||++.-. ....++++..|++++.+++|||++.+.|+|-.+...++|||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 3556688999999999999854 6889999998543 34567899999999999999999999999999999999999
Q ss_pred EccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCc
Q 001544 846 YMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS 925 (1057)
Q Consensus 846 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 925 (1057)
||-| +-.|.+.-.++++-+.++..|+.+.++||+||| +.+.||||||+.|||+++.|.||++|||.|..+.
T Consensus 107 YClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLH---S~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~----- 177 (948)
T KOG0577|consen 107 YCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNRIHRDIKAGNILLSEPGLVKLADFGSASIMA----- 177 (948)
T ss_pred HHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHH---HhhHHhhhccccceEecCCCeeeeccccchhhcC-----
Confidence 9955 888887777778999999999999999999999 9999999999999999999999999999998763
Q ss_pred cccccccccccccCcccc---CCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhcccc
Q 001544 926 MTQTQTLATLGYMAPEYG---REGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLL 1002 (1057)
Q Consensus 926 ~~~~~~~~t~~y~aPE~~---~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1002 (1057)
+....+|||.|||||++ ..+.|+-|+||||+|+++.|+...++|.-.+ .....+.+ +.....
T Consensus 178 -PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnM-NAMSALYH------------IAQNes- 242 (948)
T KOG0577|consen 178 -PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-NAMSALYH------------IAQNES- 242 (948)
T ss_pred -chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCc-hHHHHHHH------------HHhcCC-
Confidence 33456899999999976 4678999999999999999999999995321 00001111 110000
Q ss_pred cccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHH
Q 001544 1003 ITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRL 1044 (1057)
Q Consensus 1003 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 1044 (1057)
..-...+.+..|..|+..|++.-|.+|||..++++|-
T Consensus 243 -----PtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~ 279 (948)
T KOG0577|consen 243 -----PTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKHR 279 (948)
T ss_pred -----CCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhcc
Confidence 0011235577899999999999999999999999874
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=337.98 Aligned_cols=266 Identities=19% Similarity=0.197 Sum_probs=199.9
Q ss_pred hCCCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccchhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEE
Q 001544 768 TNGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEY 846 (1057)
Q Consensus 768 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 846 (1057)
..+|.+.+.||+|+||.||+|... .++.||||... ...+.+|++++++++|+||+++++++..++..++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 457899999999999999999865 57899999642 23456899999999999999999999999999999999
Q ss_pred ccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCcc
Q 001544 847 MRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSM 926 (1057)
Q Consensus 847 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 926 (1057)
+. ++|.+++......+++.++..|+.|+++||+||| +++|+||||||+||+++.++.+||+|||+++.........
T Consensus 242 ~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~ 317 (461)
T PHA03211 242 YR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP 317 (461)
T ss_pred cC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccc
Confidence 95 6888888766667999999999999999999999 9999999999999999999999999999998654322222
Q ss_pred ccccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccc--c----chhhhhhhc-------cc---
Q 001544 927 TQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGE--M----TLKHWVNDF-------LP--- 990 (1057)
Q Consensus 927 ~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~--~----~~~~~~~~~-------~~--- 990 (1057)
......||..|+|||++.+..++.++|||||||++|||++|..|+-...... . .+...+... ..
T Consensus 318 ~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~ 397 (461)
T PHA03211 318 FHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAG 397 (461)
T ss_pred cccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcc
Confidence 2234568999999999999999999999999999999999887643211110 0 011111000 00
Q ss_pred hhHHHhhhcc-----cccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 991 ISMMKIIDAN-----LLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 991 ~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
......+... ........+........++.+++.+||+.||++|||+.|+++|
T Consensus 398 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 398 SRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred hHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0000000000 0000001111112344578899999999999999999999987
|
|
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=317.42 Aligned_cols=249 Identities=21% Similarity=0.332 Sum_probs=202.5
Q ss_pred CCCCCceeccccCeEEEEEEec-CCcEEEEEEeecc-chhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEEc
Q 001544 770 GFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQ-HERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEYM 847 (1057)
Q Consensus 770 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 847 (1057)
+|++.+.||+|+||.||++... +++.||+|.++.. .....+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4778899999999999999865 6899999998643 3345677889999999999999999999999999999999999
Q ss_pred cCCChhHHHhcC-CccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCcc
Q 001544 848 RNGSLEKCLYSG-NYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSM 926 (1057)
Q Consensus 848 ~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 926 (1057)
++|+|.+++... ...+++..+..++.|++.|++||| +.+|+|+||||+||++++++.++++|||.+....... .
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~--~ 155 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG--A 155 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEECCCCcEEEcccCcceeecccc--c
Confidence 999999988653 345889999999999999999999 9999999999999999999999999999997653221 1
Q ss_pred ccccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhcccccccc
Q 001544 927 TQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITED 1006 (1057)
Q Consensus 927 ~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1006 (1057)
......++..|+|||+..+..++.++|+||+|+++|+|++|+.||..... .... .......
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~-----~~~~--------~~~~~~~------ 216 (255)
T cd08219 156 YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW-----KNLI--------LKVCQGS------ 216 (255)
T ss_pred ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH-----HHHH--------HHHhcCC------
Confidence 22335678899999999888899999999999999999999999865211 0000 0000000
Q ss_pred hhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 1007 KHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 1007 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
..+.+..++..+.+++.+||+.||++||++.|++..
T Consensus 217 -~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 217 -YKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred -CCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 001112345678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=327.95 Aligned_cols=249 Identities=25% Similarity=0.412 Sum_probs=207.7
Q ss_pred CCceeccccCeEEEEEEec--CC--cEEEEEEeeccchh-HHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEEc
Q 001544 773 ENNLIGRGSFGSVYIARLQ--NG--IEVAVKTFDLQHER-AFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEYM 847 (1057)
Q Consensus 773 ~~~~lg~G~~g~Vy~~~~~--~~--~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 847 (1057)
..++||+|+||+|++|.|. +| ..||||.++..... ...+|.+|+.+|-+++|||++++||...+ ....+|||.+
T Consensus 114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELa 192 (1039)
T KOG0199|consen 114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELA 192 (1039)
T ss_pred HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhc
Confidence 4478999999999999876 34 46899999765543 67899999999999999999999999987 6668999999
Q ss_pred cCCChhHHHhc-CCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCcc
Q 001544 848 RNGSLEKCLYS-GNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSM 926 (1057)
Q Consensus 848 ~~gsL~~~l~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 926 (1057)
+.|+|.+.+++ .+..+-......++.|||.|+.||. +++.||||+..+|+++-....+||+|||+.+-+...+..+
T Consensus 193 plGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Y 269 (1039)
T KOG0199|consen 193 PLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMY 269 (1039)
T ss_pred ccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhhhheecccceeeeecccceeccCCCCcce
Confidence 99999999998 4467888889999999999999999 9999999999999999999999999999999876544433
Q ss_pred cc-ccccccccccCccccCCCCCCccchHHHHHHHHHHHhh-CCCCCCcccccccchhhhhhhccchhHHHhhhcccccc
Q 001544 927 TQ-TQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFT-RRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLIT 1004 (1057)
Q Consensus 927 ~~-~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1057)
.. ....-.+.|+|||.+....++.++|||+|||++|||+| |..||-. .....+.+.+|
T Consensus 270 vm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G--------------~~g~qIL~~iD------ 329 (1039)
T KOG0199|consen 270 VMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVG--------------CRGIQILKNID------ 329 (1039)
T ss_pred EecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCC--------------CCHHHHHHhcc------
Confidence 32 33344668999999999999999999999999999999 5567644 11223344444
Q ss_pred cchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHH
Q 001544 1005 EDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLL 1045 (1057)
Q Consensus 1005 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 1045 (1057)
.+.+.+.++.|+++++++++.||...|++|||+..+.+.+-
T Consensus 330 ~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~ 370 (1039)
T KOG0199|consen 330 AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLV 370 (1039)
T ss_pred ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHH
Confidence 22345556789999999999999999999999999985553
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=320.13 Aligned_cols=253 Identities=29% Similarity=0.459 Sum_probs=200.4
Q ss_pred CCCCceeccccCeEEEEEEec-CCcEEEEEEeeccchhHH--HHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEEc
Q 001544 771 FSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQHERAF--KSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEYM 847 (1057)
Q Consensus 771 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~--~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 847 (1057)
|+..+.||+|+||+||+|... +++.||+|++........ ....+|+.++++++||||+++++++.+.+..++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 556789999999999999866 567899999976654322 23456999999999999999999999999999999999
Q ss_pred cCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCccc
Q 001544 848 RNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMT 927 (1057)
Q Consensus 848 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 927 (1057)
++++|.+++... ..+++.++..++.|+++||+||| +.+|+||||||+||++++++.++|+|||.+..+ ......
T Consensus 81 ~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~Lh---~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~--~~~~~~ 154 (260)
T PF00069_consen 81 PGGSLQDYLQKN-KPLSEEEILKIAYQILEALAYLH---SKGIVHRDIKPENILLDENGEVKLIDFGSSVKL--SENNEN 154 (260)
T ss_dssp TTEBHHHHHHHH-SSBBHHHHHHHHHHHHHHHHHHH---HTTEEESSBSGGGEEESTTSEEEESSGTTTEES--TSTTSE
T ss_pred cccccccccccc-ccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc--cccccc
Confidence 999999999832 34899999999999999999999 899999999999999999999999999999754 122334
Q ss_pred cccccccccccCccccC-CCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhcccccccc
Q 001544 928 QTQTLATLGYMAPEYGR-EGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITED 1006 (1057)
Q Consensus 928 ~~~~~~t~~y~aPE~~~-~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1006 (1057)
.....++..|+|||+.. +..++.++||||+|+++|+|++|..||...... .. ...+.........
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~--~~------------~~~~~~~~~~~~~ 220 (260)
T PF00069_consen 155 FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSD--DQ------------LEIIEKILKRPLP 220 (260)
T ss_dssp BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHH--HH------------HHHHHHHHHTHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccch--hh------------hhhhhhccccccc
Confidence 45567889999999988 888999999999999999999999998763100 00 0000000000000
Q ss_pred hhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 1007 KHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 1007 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
...........++.+++.+|++.||++||++.+++++
T Consensus 221 ~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 221 SSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp HHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred ccccccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000011123789999999999999999999999875
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=340.21 Aligned_cols=264 Identities=24% Similarity=0.310 Sum_probs=192.7
Q ss_pred hCCCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccchhHHHHHHHHHHHHHhcCCCCceeEeeeeccC--------C
Q 001544 768 TNGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCSNE--------D 838 (1057)
Q Consensus 768 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------~ 838 (1057)
..+|++.++||+|+||+||+|... +++.||||++.... ....+|+.++++++||||+++++++... .
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 457999999999999999999864 68999999885432 2335799999999999999998876321 2
Q ss_pred eeEEEEEEccCCChhHHHhc---CCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCC-cEEEEccc
Q 001544 839 FKALILEYMRNGSLEKCLYS---GNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNM-VAHLSDFG 914 (1057)
Q Consensus 839 ~~~lV~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~-~~kl~Dfg 914 (1057)
..++||||+++ ++.+++.. ....+++..+..++.||+.||+||| +.+|+||||||+||+++.++ .+||+|||
T Consensus 141 ~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH---~~~IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 141 FLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred EEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCcCHHHEEEcCCCCceeeeccc
Confidence 46789999975 67666542 3356899999999999999999999 99999999999999999664 79999999
Q ss_pred ccccccCCCCccccccccccccccCccccCC-CCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhcc--ch
Q 001544 915 IAKLLIGEDQSMTQTQTLATLGYMAPEYGRE-GRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFL--PI 991 (1057)
Q Consensus 915 ~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~--~~ 991 (1057)
+|+.+.... ......+|+.|+|||++.+ ..++.++||||+||++|||++|++||......+ .+........ ..
T Consensus 217 la~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~-~~~~i~~~~~~p~~ 292 (440)
T PTZ00036 217 SAKNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD-QLVRIIQVLGTPTE 292 (440)
T ss_pred cchhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCCH
Confidence 998653222 2234567899999998765 468999999999999999999999986532111 1111111000 00
Q ss_pred hHHHhhhccc-----c--cccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 992 SMMKIIDANL-----L--ITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 992 ~~~~~~~~~~-----~--~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
.......... . .........+...+.++.+++.+||.+||.+|||+.|+++|
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred HHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 0000000000 0 00000111122346789999999999999999999999976
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=319.92 Aligned_cols=253 Identities=25% Similarity=0.357 Sum_probs=201.6
Q ss_pred CCCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccchhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEEc
Q 001544 769 NGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEYM 847 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 847 (1057)
++|++.+.||+|+||.||+|... +++.||+|+++.........+.+|+.+++.++||||+++++++.+++..++||||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 46777899999999999999754 68999999997665555667889999999999999999999999999999999999
Q ss_pred cCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCccc
Q 001544 848 RNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMT 927 (1057)
Q Consensus 848 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 927 (1057)
++++|.+++...+ .+++.++..++.|++.|++||| +.+++||||||+||+++.++.++|+|||.+...... ...
T Consensus 89 ~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~--~~~ 162 (267)
T cd06645 89 GGGSLQDIYHVTG-PLSESQIAYVSRETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITAT--IAK 162 (267)
T ss_pred CCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECcceeeeEccCc--ccc
Confidence 9999999886554 5899999999999999999999 899999999999999999999999999998765321 122
Q ss_pred cccccccccccCccccC---CCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhcccccc
Q 001544 928 QTQTLATLGYMAPEYGR---EGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLIT 1004 (1057)
Q Consensus 928 ~~~~~~t~~y~aPE~~~---~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1057)
.....|+..|+|||++. ...++.++||||+||++|||++|+.||........... .......
T Consensus 163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~-------------~~~~~~~-- 227 (267)
T cd06645 163 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFL-------------MTKSNFQ-- 227 (267)
T ss_pred cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHh-------------hhccCCC--
Confidence 23456889999999874 45578899999999999999999999754221110000 0000000
Q ss_pred cchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 1005 EDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 1005 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
.........++..+.+++.+|++.+|++||++.++++|
T Consensus 228 -~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 228 -PPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred -CCcccccCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 00001111245568899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=330.94 Aligned_cols=248 Identities=25% Similarity=0.338 Sum_probs=196.1
Q ss_pred ceeccccCeEEEEEEec-CCcEEEEEEeeccc---hhHHHHHHHHHHHHHhc-CCCCceeEeeeeccCCeeEEEEEEccC
Q 001544 775 NLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQH---ERAFKSFDTECEVMKSI-RHRNLTKIISSCSNEDFKALILEYMRN 849 (1057)
Q Consensus 775 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~~ 849 (1057)
++||+|+||+||+|... +++.||||+++... ....+.+.+|+.++.++ +||+|+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999865 67899999997542 23456688899999888 699999999999999999999999999
Q ss_pred CChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCccccc
Q 001544 850 GSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQT 929 (1057)
Q Consensus 850 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 929 (1057)
|+|.+++...+ .+++..+..++.|++.|++||| +++|+||||||+||+++.++.+||+|||+++..... .....
T Consensus 81 ~~L~~~~~~~~-~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~--~~~~~ 154 (327)
T cd05617 81 GDLMFHMQRQR-KLPEEHARFYAAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP--GDTTS 154 (327)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEeCCCCEEEeccccceeccCC--CCcee
Confidence 99998886544 5899999999999999999999 999999999999999999999999999998753211 11223
Q ss_pred cccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccc-cchhhhhhhccchhHHHhhhcccccccchh
Q 001544 930 QTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGE-MTLKHWVNDFLPISMMKIIDANLLITEDKH 1008 (1057)
Q Consensus 930 ~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1008 (1057)
...||+.|+|||++.+..++.++||||+||++|||++|+.||....... .....+. ...+... .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~--------~~~~~~~-------~ 219 (327)
T cd05617 155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYL--------FQVILEK-------P 219 (327)
T ss_pred cccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHH--------HHHHHhC-------C
Confidence 4568999999999999999999999999999999999999996432211 1111111 1111000 0
Q ss_pred hHHHHHHHHHHHHHHhHcccCCCCCCCCH------HHHHHH
Q 001544 1009 FAAKEQCASSVFNLAMECTVESPDERITA------KEIVRR 1043 (1057)
Q Consensus 1009 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~------~evl~~ 1043 (1057)
...+...+..+.+++.+|++.||++|+++ .++++|
T Consensus 220 ~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 220 IRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence 01122345678899999999999999984 566655
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=318.13 Aligned_cols=254 Identities=30% Similarity=0.516 Sum_probs=205.7
Q ss_pred hCCCCCCceeccccCeEEEEEEecCCcEEEEEEeeccchhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEEc
Q 001544 768 TNGFSENNLIGRGSFGSVYIARLQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEYM 847 (1057)
Q Consensus 768 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 847 (1057)
.++|++.++||+|+||.||+|..++++.||||.+..... ..+++.+|++++++++||||+++++++......++||||+
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM 83 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence 457888999999999999999988888999999865432 3467899999999999999999999999889999999999
Q ss_pred cCCChhHHHhcCC-ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCcc
Q 001544 848 RNGSLEKCLYSGN-YILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSM 926 (1057)
Q Consensus 848 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 926 (1057)
++++|.+++.... ..+++.++..++.|++.|++||| +.+++||||||+||++++++.+|++|||.++..... ...
T Consensus 84 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~-~~~ 159 (261)
T cd05034 84 SKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDD-EYT 159 (261)
T ss_pred CCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcchheEEEcCCCCEEECccccceeccch-hhh
Confidence 9999999997654 46899999999999999999999 899999999999999999999999999998765321 111
Q ss_pred ccccccccccccCccccCCCCCCccchHHHHHHHHHHHhh-CCCCCCcccccccchhhhhhhccchhHHHhhhccccccc
Q 001544 927 TQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFT-RRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITE 1005 (1057)
Q Consensus 927 ~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1057)
.......+..|+|||...+..++.++|+||+|+++||+++ |+.||...... .... .. ....
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~-~~~~------------~~-~~~~---- 221 (261)
T cd05034 160 AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR-EVLE------------QV-ERGY---- 221 (261)
T ss_pred hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-HHHH------------HH-HcCC----
Confidence 1122234568999999988889999999999999999999 89998542111 0000 11 0000
Q ss_pred chhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHHH
Q 001544 1006 DKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLK 1046 (1057)
Q Consensus 1006 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 1046 (1057)
..+.+..++.++.+++.+|+..+|++||+++|+.+.|+.
T Consensus 222 --~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 222 --RMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred --CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 011112346678999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=317.35 Aligned_cols=251 Identities=28% Similarity=0.467 Sum_probs=195.3
Q ss_pred ceeccccCeEEEEEEec----CCcEEEEEEeecc-chhHHHHHHHHHHHHHhcCCCCceeEeeeec-cCCeeEEEEEEcc
Q 001544 775 NLIGRGSFGSVYIARLQ----NGIEVAVKTFDLQ-HERAFKSFDTECEVMKSIRHRNLTKIISSCS-NEDFKALILEYMR 848 (1057)
Q Consensus 775 ~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lV~E~~~ 848 (1057)
+.||+|+||.||+|... ++..||+|.+... .....+.+.+|+.+++.++||||+++++++. .++..++||||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999753 2467999998543 3345678889999999999999999999764 4566889999999
Q ss_pred CCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCc--c
Q 001544 849 NGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS--M 926 (1057)
Q Consensus 849 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~--~ 926 (1057)
+|+|.+++.......++..+..++.|+++|++||| +.+++||||||+||++++++.+|++|||+++.+...... .
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 157 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH 157 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence 99999999876656788888999999999999999 899999999999999999999999999999765322111 1
Q ss_pred ccccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCC-CCCCcccccccchhhhhhhccchhHHHhhhccccccc
Q 001544 927 TQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRR-KPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITE 1005 (1057)
Q Consensus 927 ~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1057)
......++..|+|||...+..++.++|||||||++|||++|+ +||...... ... ......
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~--~~~------------~~~~~~----- 218 (262)
T cd05058 158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSF--DIT------------VYLLQG----- 218 (262)
T ss_pred ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHH--HHH------------HHHhcC-----
Confidence 112334567899999998888999999999999999999965 455431110 000 000000
Q ss_pred chhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHHHhH
Q 001544 1006 DKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKIR 1048 (1057)
Q Consensus 1006 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~ 1048 (1057)
.....+..++..+.+++.+||..+|++||++.|+++.++++.
T Consensus 219 -~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 219 -RRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred -CCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 011111234567899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=319.68 Aligned_cols=251 Identities=25% Similarity=0.363 Sum_probs=200.0
Q ss_pred CCCCCCceeccccCeEEEEEEe-cCCcEEEEEEeeccc-hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEE
Q 001544 769 NGFSENNLIGRGSFGSVYIARL-QNGIEVAVKTFDLQH-ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEY 846 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 846 (1057)
++|+..++||+|+||.||+|.. .+++.||+|++.... ......+.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 3577889999999999999975 478999999986542 33456788999999999999999999999999999999999
Q ss_pred ccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCcc
Q 001544 847 MRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSM 926 (1057)
Q Consensus 847 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 926 (1057)
+++++|..+. .+++..+..++.|++.|++||| +.+|+||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~---- 148 (279)
T cd06619 81 MDGGSLDVYR-----KIPEHVLGRIAVAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---- 148 (279)
T ss_pred CCCCChHHhh-----cCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc----
Confidence 9999997642 3678889999999999999999 999999999999999999999999999999765221
Q ss_pred ccccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHH-hhhccccccc
Q 001544 927 TQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMK-IIDANLLITE 1005 (1057)
Q Consensus 927 ~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 1005 (1057)
......++..|+|||++.+..++.++||||+|+++|||++|+.||......+.... +..... ..+....
T Consensus 149 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~-------~~~~~~~~~~~~~~--- 218 (279)
T cd06619 149 IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLM-------PLQLLQCIVDEDPP--- 218 (279)
T ss_pred cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccc-------hHHHHHHHhccCCC---
Confidence 22334688899999999988899999999999999999999999875332211110 000001 0100000
Q ss_pred chhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHH
Q 001544 1006 DKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRL 1044 (1057)
Q Consensus 1006 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 1044 (1057)
.. .....++++.+++.+|++.+|++||++.|++++-
T Consensus 219 --~~-~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~ 254 (279)
T cd06619 219 --VL-PVGQFSEKFVHFITQCMRKQPKERPAPENLMDHP 254 (279)
T ss_pred --CC-CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCc
Confidence 00 0112456789999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=323.23 Aligned_cols=250 Identities=26% Similarity=0.367 Sum_probs=205.3
Q ss_pred CCCCCCceeccccCeEEEEEEe-cCCcEEEEEEeeccchhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEEc
Q 001544 769 NGFSENNLIGRGSFGSVYIARL-QNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEYM 847 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 847 (1057)
.+|+..+.||.|+||.||+|.. .+++.||+|.+........+.+.+|++++++++|||++++++++.+++..++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 4688889999999999999975 478999999997665555678899999999999999999999999999999999999
Q ss_pred cCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCccc
Q 001544 848 RNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMT 927 (1057)
Q Consensus 848 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 927 (1057)
++++|.+++... .+++.++..++.|++.|++||| +.+++||||||+||+++.++.+||+|||++........ .
T Consensus 99 ~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH---~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~--~ 171 (296)
T cd06655 99 AGGSLTDVVTET--CMDEAQIAAVCRECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS--K 171 (296)
T ss_pred CCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccchhcccccc--c
Confidence 999999988654 4899999999999999999999 99999999999999999999999999999876532221 1
Q ss_pred cccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhcccccccch
Q 001544 928 QTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDK 1007 (1057)
Q Consensus 928 ~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1057)
.....++..|+|||.+.+..++.++|||||||++|||++|+.||......+. .. ..... ...
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~-~~------------~~~~~-----~~~ 233 (296)
T cd06655 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-LY------------LIATN-----GTP 233 (296)
T ss_pred CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HH------------HHHhc-----CCc
Confidence 2234578899999999888899999999999999999999999865322110 00 00000 000
Q ss_pred hhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 1008 HFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 1008 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
....+..+++.+.+++.+||..||++||++.+++++
T Consensus 234 ~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 234 ELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred ccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 111223456778999999999999999999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=331.65 Aligned_cols=237 Identities=29% Similarity=0.351 Sum_probs=188.4
Q ss_pred ceeccccCeEEEEEEec-CCcEEEEEEeeccc---hhHHHHHHHHHH-HHHhcCCCCceeEeeeeccCCeeEEEEEEccC
Q 001544 775 NLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQH---ERAFKSFDTECE-VMKSIRHRNLTKIISSCSNEDFKALILEYMRN 849 (1057)
Q Consensus 775 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 849 (1057)
+.||+|+||+||+|+.. +|+.||||++.... ......+.+|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999865 68999999996432 122334445544 56789999999999999999999999999999
Q ss_pred CChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCccccc
Q 001544 850 GSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQT 929 (1057)
Q Consensus 850 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 929 (1057)
|+|.+++.... .+++..+..++.||++||+||| +.+|+||||||+||+++.++.+||+|||+++.... ......
T Consensus 81 g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~--~~~~~~ 154 (323)
T cd05575 81 GELFFHLQRER-SFPEPRARFYAAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIE--HSKTTS 154 (323)
T ss_pred CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeccCCCccccc--CCCccc
Confidence 99999887654 5889999999999999999999 99999999999999999999999999999875321 112233
Q ss_pred cccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhcccccccchhh
Q 001544 930 QTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHF 1009 (1057)
Q Consensus 930 ~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1057)
...||+.|+|||++.+..++.++||||+||++|||++|+.||..... ... ...+.....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~-----~~~--------~~~i~~~~~-------- 213 (323)
T cd05575 155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT-----AEM--------YDNILNKPL-------- 213 (323)
T ss_pred cccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH-----HHH--------HHHHHcCCC--------
Confidence 45689999999999998999999999999999999999999865211 010 011111100
Q ss_pred HHHHHHHHHHHHHHhHcccCCCCCCCCHH
Q 001544 1010 AAKEQCASSVFNLAMECTVESPDERITAK 1038 (1057)
Q Consensus 1010 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~ 1038 (1057)
......+.++.+++.+|++.||++||++.
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 214 RLKPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 01123467789999999999999999885
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=322.74 Aligned_cols=264 Identities=21% Similarity=0.310 Sum_probs=204.1
Q ss_pred CCCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccc-hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEE
Q 001544 769 NGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQH-ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEY 846 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 846 (1057)
++|++.+.||+|+||.||+|... ++..||+|.+.... .....++.+|++++++++||||+++++++.+++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 36888999999999999999754 68889999986542 33456788999999999999999999999999999999999
Q ss_pred ccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCC-CCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCc
Q 001544 847 MRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYS-APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS 925 (1057)
Q Consensus 847 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~-~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 925 (1057)
+++++|.+++... ..+++..+..++.|+++||+||| + .+++||||||+||+++.++.+|++|||++......
T Consensus 81 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--- 153 (308)
T cd06615 81 MDGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 153 (308)
T ss_pred cCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hhCCEEECCCChHHEEEecCCcEEEccCCCccccccc---
Confidence 9999999999765 35889999999999999999999 6 58999999999999999999999999998754221
Q ss_pred cccccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccc---------------
Q 001544 926 MTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLP--------------- 990 (1057)
Q Consensus 926 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~--------------- 990 (1057)
......++..|+|||...+..++.++|+||||+++|||++|+.||..... .....+......
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (308)
T cd06615 154 -MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDA--KELEAMFGRPVSEGEAKESHRPVSGHP 230 (308)
T ss_pred -ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcch--hhHHHhhcCccccccccCCcccccCCC
Confidence 12234678899999998888899999999999999999999999864221 111111110000
Q ss_pred ------hhHHHhhhcccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHH
Q 001544 991 ------ISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRL 1044 (1057)
Q Consensus 991 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 1044 (1057)
....+..+.... ......+ ...++.++.+++.+|+..+|++||++.|++++-
T Consensus 231 ~~~~~~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 288 (308)
T cd06615 231 PDSPRPMAIFELLDYIVN-EPPPKLP-SGAFSDEFQDFVDKCLKKNPKERADLKELTKHP 288 (308)
T ss_pred CCccchhhHHHHHHHHhc-CCCccCc-CcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 000011110000 0000000 012466799999999999999999999999884
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=323.21 Aligned_cols=266 Identities=24% Similarity=0.440 Sum_probs=209.1
Q ss_pred CCCCCceeccccCeEEEEEEec-----CCcEEEEEEeeccchh-HHHHHHHHHHHHHhcCCCCceeEeeeecc--CCeeE
Q 001544 770 GFSENNLIGRGSFGSVYIARLQ-----NGIEVAVKTFDLQHER-AFKSFDTECEVMKSIRHRNLTKIISSCSN--EDFKA 841 (1057)
Q Consensus 770 ~~~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~ 841 (1057)
.|+..+.||+|+||.||+|+.. ++..||||+++..... ..+.+.+|++++++++||||+++++++.. ....+
T Consensus 5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05038 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR 84 (284)
T ss_pred hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence 5677799999999999999753 3789999999755443 56789999999999999999999999877 56789
Q ss_pred EEEEEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccC
Q 001544 842 LILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIG 921 (1057)
Q Consensus 842 lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~ 921 (1057)
+||||+++++|.+++......+++.++..++.|++.||+||| +.+++||||||+||+++.++.++++|||.+.....
T Consensus 85 lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05038 85 LIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPE 161 (284)
T ss_pred EEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEccccccccccc
Confidence 999999999999999877667999999999999999999999 89999999999999999999999999999987642
Q ss_pred CCCcc-ccccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccc----hhHHHh
Q 001544 922 EDQSM-TQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLP----ISMMKI 996 (1057)
Q Consensus 922 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~ 996 (1057)
..... ......++..|+|||...+..++.++||||||+++|||++|+.|+......... +...... ....+.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~ 238 (284)
T cd05038 162 DKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR---MIGIAQGQMIVTRLLEL 238 (284)
T ss_pred CCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcc---ccccccccccHHHHHHH
Confidence 22211 111223456799999998888999999999999999999999997653221111 0000000 001111
Q ss_pred hhcccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHHHh
Q 001544 997 IDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKI 1047 (1057)
Q Consensus 997 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i 1047 (1057)
.... .+.+.+..++.++.+++.+||+.+|++||++.|++++|+++
T Consensus 239 ~~~~------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 239 LKEG------ERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHcC------CcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 1111 11122234567899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=329.42 Aligned_cols=259 Identities=27% Similarity=0.453 Sum_probs=205.5
Q ss_pred CCCCCCceeccccCeEEEEEEec--------CCcEEEEEEeeccc-hhHHHHHHHHHHHHHhc-CCCCceeEeeeeccCC
Q 001544 769 NGFSENNLIGRGSFGSVYIARLQ--------NGIEVAVKTFDLQH-ERAFKSFDTECEVMKSI-RHRNLTKIISSCSNED 838 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 838 (1057)
.+|++.+.||+|+||.||+|... .+..||+|.++... ....+++.+|+++++++ +||||+++++++..++
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 36888999999999999999642 12469999886443 34467889999999999 7999999999999999
Q ss_pred eeEEEEEEccCCChhHHHhcCC---------------ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeC
Q 001544 839 FKALILEYMRNGSLEKCLYSGN---------------YILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLD 903 (1057)
Q Consensus 839 ~~~lV~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~ 903 (1057)
..++||||+++|+|.+++.... ..+++.++..++.|+++|++||| +++++||||||+||+++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA---SQKCIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEc
Confidence 9999999999999999986532 34788999999999999999999 99999999999999999
Q ss_pred CCCcEEEEcccccccccCCCCccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhh-CCCCCCcccccccchh
Q 001544 904 DNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFT-RRKPTDEIFSGEMTLK 982 (1057)
Q Consensus 904 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~ 982 (1057)
+++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||.... ..
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~-----~~ 243 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP-----VE 243 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC-----HH
Confidence 999999999999986533222222222334567999999988899999999999999999998 788875421 11
Q ss_pred hhhhhccchhHHHhhhcccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHHHhHHH
Q 001544 983 HWVNDFLPISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKIRDF 1050 (1057)
Q Consensus 983 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~ 1050 (1057)
.+. ..+.... ....+..++.++.+++.+||+.+|++||++.|++++|+++...
T Consensus 244 ~~~---------~~~~~~~------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~ 296 (334)
T cd05100 244 ELF---------KLLKEGH------RMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTV 296 (334)
T ss_pred HHH---------HHHHcCC------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhh
Confidence 111 1111000 0111123466789999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=323.18 Aligned_cols=251 Identities=26% Similarity=0.344 Sum_probs=205.7
Q ss_pred hCCCCCCceeccccCeEEEEEEe-cCCcEEEEEEeeccchhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEE
Q 001544 768 TNGFSENNLIGRGSFGSVYIARL-QNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEY 846 (1057)
Q Consensus 768 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 846 (1057)
..+|++.+.||+|+||.||+|.. .+++.||+|.+........+.+.+|+.++++++||||+++++++..++..++||||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 35788999999999999999985 47999999999765555567788999999999999999999999999999999999
Q ss_pred ccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCcc
Q 001544 847 MRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSM 926 (1057)
Q Consensus 847 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 926 (1057)
+++++|.+++.+. .+++.++..++.|++.|++||| +.+++||||||+||+++.++.++|+|||.+....... .
T Consensus 98 ~~~~~L~~~~~~~--~~~~~~~~~~~~~l~~~L~~LH---~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~--~ 170 (297)
T cd06656 98 LAGGSLTDVVTET--CMDEGQIAAVCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--S 170 (297)
T ss_pred cCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEECcCccceEccCCc--c
Confidence 9999999998654 4788999999999999999999 8999999999999999999999999999987653222 1
Q ss_pred ccccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhcccccccc
Q 001544 927 TQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITED 1006 (1057)
Q Consensus 927 ~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1006 (1057)
......+++.|+|||...+..++.++|+||+||++|++++|+.||............+.. ..
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~------------------~~ 232 (297)
T cd06656 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN------------------GT 232 (297)
T ss_pred CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccC------------------CC
Confidence 223346788999999998888999999999999999999999998652221110000000 00
Q ss_pred hhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 1007 KHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 1007 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
.....+...+..+.+++.+||..+|++||++.|++++
T Consensus 233 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 233 PELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0011123456678899999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=336.73 Aligned_cols=253 Identities=22% Similarity=0.322 Sum_probs=198.9
Q ss_pred CCCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccc---hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEE
Q 001544 769 NGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQH---ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALIL 844 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 844 (1057)
++|+..+.||+|+||+||+|... +++.||||+++... ......+.+|++++.+++||+|+++++++.+++..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36888999999999999999865 68999999996432 334567888999999999999999999999999999999
Q ss_pred EEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCC
Q 001544 845 EYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ 924 (1057)
Q Consensus 845 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 924 (1057)
||+++|+|.+++...+ .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus 81 E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~~L~~lH---~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~ 156 (360)
T cd05627 81 EFLPGGDMMTLLMKKD-TLSEEATQFYIAETVLAIDAIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHR 156 (360)
T ss_pred eCCCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccc
Confidence 9999999999987654 4899999999999999999999 99999999999999999999999999999875422110
Q ss_pred c---------------------------------cccccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCC
Q 001544 925 S---------------------------------MTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPT 971 (1057)
Q Consensus 925 ~---------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~ 971 (1057)
. .......||+.|+|||++.+..++.++||||+||++|||++|+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf 236 (360)
T cd05627 157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (360)
T ss_pred cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCC
Confidence 0 0011246899999999999999999999999999999999999998
Q ss_pred CcccccccchhhhhhhccchhHHHhhhcccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCC---HHHHHHH
Q 001544 972 DEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERIT---AKEIVRR 1043 (1057)
Q Consensus 972 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps---~~evl~~ 1043 (1057)
......+. ...+..... ...++.....+.++.+++.+|+ .||++|++ +.|+++|
T Consensus 237 ~~~~~~~~-------------~~~i~~~~~----~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 237 CSETPQET-------------YRKVMNWKE----TLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSH 293 (360)
T ss_pred CCCCHHHH-------------HHHHHcCCC----ceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcC
Confidence 65221110 001111000 0001111124567888898876 49999984 6787776
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=325.15 Aligned_cols=268 Identities=22% Similarity=0.289 Sum_probs=202.2
Q ss_pred CCCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccc-hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEE
Q 001544 769 NGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQH-ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEY 846 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 846 (1057)
++|+..+.||+|+||.||+|... +++.||+|.++... ......+.+|++++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 56888999999999999999865 68899999986443 23345677899999999999999999999999999999999
Q ss_pred ccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCcc
Q 001544 847 MRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSM 926 (1057)
Q Consensus 847 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 926 (1057)
++ ++|.+++......+++..+..++.|+++||+||| +.+|+||||||+||++++++.+||+|||++...... ..
T Consensus 86 ~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~--~~ 159 (301)
T cd07873 86 LD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIP--TK 159 (301)
T ss_pred cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCC--CC
Confidence 97 5899888776667899999999999999999999 999999999999999999999999999998754221 11
Q ss_pred ccccccccccccCccccCC-CCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhh---hhhhccchhHHHhhhcccc
Q 001544 927 TQTQTLATLGYMAPEYGRE-GRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKH---WVNDFLPISMMKIIDANLL 1002 (1057)
Q Consensus 927 ~~~~~~~t~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 1002 (1057)
......++..|+|||.+.+ ..++.++||||+||++|||++|+.||......+. ... ......+.......+....
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (301)
T cd07873 160 TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQ-LHFIFRILGTPTEETWPGILSNEEF 238 (301)
T ss_pred cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHcCCCChhhchhhhccccc
Confidence 2233456889999998765 4578899999999999999999999865321110 000 0000000001111100000
Q ss_pred c---cc----chhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 1003 I---TE----DKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 1003 ~---~~----~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
. .+ .........+++.+.+++.+|++.||.+|||+.|+++|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 239 KSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred cccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0 00 00011112456788999999999999999999999984
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=320.31 Aligned_cols=250 Identities=22% Similarity=0.332 Sum_probs=200.0
Q ss_pred CCCCceeccccCeEEEEEEec-CCcEEEEEEeeccc---hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEE
Q 001544 771 FSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQH---ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEY 846 (1057)
Q Consensus 771 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 846 (1057)
|+..++||+|+||+||+|... +++.||+|.+.... ......+.+|++++++++|++|+++.+++..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 667789999999999999864 68999999986432 22345678899999999999999999999999999999999
Q ss_pred ccCCChhHHHhcCC-ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCc
Q 001544 847 MRNGSLEKCLYSGN-YILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS 925 (1057)
Q Consensus 847 ~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 925 (1057)
+++++|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+||++++++.+||+|||++......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~--- 155 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG--- 155 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEECCCCCEEEecCCcceecCCC---
Confidence 99999998886543 46999999999999999999999 999999999999999999999999999998764221
Q ss_pred cccccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhccccccc
Q 001544 926 MTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITE 1005 (1057)
Q Consensus 926 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1057)
.......|+..|+|||++.+..++.++|+||+||++|||++|+.||....... ....+ .......
T Consensus 156 ~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~-~~~~~-------------~~~~~~~- 220 (285)
T cd05632 156 ESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKV-KREEV-------------DRRVLET- 220 (285)
T ss_pred CcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHH-HHHHH-------------HHhhhcc-
Confidence 12233468899999999988889999999999999999999999986521110 00100 0000000
Q ss_pred chhhHHHHHHHHHHHHHHhHcccCCCCCCCC-----HHHHHHH
Q 001544 1006 DKHFAAKEQCASSVFNLAMECTVESPDERIT-----AKEIVRR 1043 (1057)
Q Consensus 1006 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~evl~~ 1043 (1057)
.......++.++.+++.+|++.||++||+ +.|+++|
T Consensus 221 --~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 221 --EEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred --ccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 00111235667889999999999999999 7777776
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=317.14 Aligned_cols=238 Identities=23% Similarity=0.387 Sum_probs=189.5
Q ss_pred eeccccCeEEEEEEecC-------------------------CcEEEEEEeeccchhHHHHHHHHHHHHHhcCCCCceeE
Q 001544 776 LIGRGSFGSVYIARLQN-------------------------GIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKI 830 (1057)
Q Consensus 776 ~lg~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 830 (1057)
+||+|+||.||+|.... ...||+|++..........+.+|++++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999997421 24589999876555556778899999999999999999
Q ss_pred eeeeccCCeeEEEEEEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCC----
Q 001544 831 ISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNM---- 906 (1057)
Q Consensus 831 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~---- 906 (1057)
++++.+....++||||+++|+|+.++......+++..+..++.|+++||+||| +++|+||||||+||++++.+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLE---DKNLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---cCCccCCCCCcccEEEeccCcccC
Confidence 99999999999999999999999999776667899999999999999999999 99999999999999997643
Q ss_pred ---cEEEEcccccccccCCCCccccccccccccccCccccCC-CCCCccchHHHHHHHHHHHh-hCCCCCCcccccccch
Q 001544 907 ---VAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGRE-GRVSTKGDVYSFGILLMETF-TRRKPTDEIFSGEMTL 981 (1057)
Q Consensus 907 ---~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dv~s~G~il~ell-tg~~p~~~~~~~~~~~ 981 (1057)
.+|++|||.+..... .....++..|+|||.+.+ ..++.++||||||+++||++ +|+.||......+.
T Consensus 159 ~~~~~kl~d~g~~~~~~~------~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~-- 230 (274)
T cd05076 159 TSPFIKLSDPGVSFTALS------REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK-- 230 (274)
T ss_pred ccceeeecCCcccccccc------ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH--
Confidence 489999998864321 122346778999998765 56899999999999999995 68888865321110
Q ss_pred hhhhhhccchhHHHhhhcccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHH
Q 001544 982 KHWVNDFLPISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRL 1044 (1057)
Q Consensus 982 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 1044 (1057)
......... .++...+++.+++.+||+.+|++||++.++++.|
T Consensus 231 ------------~~~~~~~~~--------~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 231 ------------ERFYEKKHR--------LPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred ------------HHHHHhccC--------CCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 011110000 0011234688999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=316.49 Aligned_cols=251 Identities=27% Similarity=0.457 Sum_probs=202.7
Q ss_pred CCCCCCceeccccCeEEEEEEecCCcEEEEEEeeccchhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEEcc
Q 001544 769 NGFSENNLIGRGSFGSVYIARLQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEYMR 848 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 848 (1057)
.+|++.+.||+|+||.||+|.+.+++.+|+|.++.... ...++.+|++++++++|||++++++++......++||||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 46778899999999999999887788999998864322 23578899999999999999999999999999999999999
Q ss_pred CCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCcccc
Q 001544 849 NGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQ 928 (1057)
Q Consensus 849 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 928 (1057)
+++|.+++......+++..+..++.|++.|++||| +.+++||||||+||+++.++.+||+|||.++...... ....
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~~~ 158 (256)
T cd05112 83 HGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ-YTSS 158 (256)
T ss_pred CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccccceEEEcCCCeEEECCCcceeecccCc-cccc
Confidence 99999999876666899999999999999999999 8999999999999999999999999999987652211 1112
Q ss_pred ccccccccccCccccCCCCCCccchHHHHHHHHHHHhh-CCCCCCcccccccchhhhhhhccchhHHHhhhcccccccch
Q 001544 929 TQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFT-RRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDK 1007 (1057)
Q Consensus 929 ~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1057)
....++.+|+|||...++.++.++||||+|+++|||++ |+.||...... ... +.+......
T Consensus 159 ~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-----~~~---------~~~~~~~~~---- 220 (256)
T cd05112 159 TGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS-----EVV---------ETINAGFRL---- 220 (256)
T ss_pred CCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH-----HHH---------HHHhCCCCC----
Confidence 22334578999999988889999999999999999998 89998652211 111 000000000
Q ss_pred hhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHH
Q 001544 1008 HFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRL 1044 (1057)
Q Consensus 1008 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 1044 (1057)
..+...+.++.+++.+||+.+|++||++.|++++|
T Consensus 221 --~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 221 --YKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred --CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 00112356789999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=330.85 Aligned_cols=260 Identities=25% Similarity=0.404 Sum_probs=219.8
Q ss_pred CCCCceeccccCeEEEEEEe-cCC----cEEEEEEeecc-chhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEE
Q 001544 771 FSENNLIGRGSFGSVYIARL-QNG----IEVAVKTFDLQ-HERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALIL 844 (1057)
Q Consensus 771 ~~~~~~lg~G~~g~Vy~~~~-~~~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 844 (1057)
.+..++||+|+||+||+|.+ ..| .+||+|++... ..++..++.+|+..|.+++|||+++++|+|.... ..||+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 34468999999999999974 333 57899998533 3455688999999999999999999999998766 78999
Q ss_pred EEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCC
Q 001544 845 EYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ 924 (1057)
Q Consensus 845 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 924 (1057)
+||+.|+|.++++..+..+-.+..+.|.+|||+|+.||| ++++|||||..+|||+.+-..+||.|||+++.....+.
T Consensus 777 q~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe---~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ 853 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLE---EQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK 853 (1177)
T ss_pred HhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH---hcchhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence 999999999999998888999999999999999999999 99999999999999999999999999999998866655
Q ss_pred ccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhh-CCCCCCcccccccchhhhhhhccchhHHHhhhccccc
Q 001544 925 SMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFT-RRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLI 1003 (1057)
Q Consensus 925 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1003 (1057)
........-.+.|||-|.+....++.++|||||||++||++| |..|++.....+ +.+.+
T Consensus 854 ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e--------------I~dll------ 913 (1177)
T KOG1025|consen 854 EYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE--------------IPDLL------ 913 (1177)
T ss_pred cccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH--------------hhHHH------
Confidence 555555555678999999999999999999999999999999 888987632221 11222
Q ss_pred ccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHHHhHHHHhhh
Q 001544 1004 TEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKIRDFLLRN 1054 (1057)
Q Consensus 1004 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~~~~ 1054 (1057)
+.+.+.++++-|+.++..++.+||..|++.||+++++...+.++.+.-.|.
T Consensus 914 e~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardpqry 964 (1177)
T KOG1025|consen 914 EKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDPQRY 964 (1177)
T ss_pred hccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCcceE
Confidence 223356677789999999999999999999999999999998887654443
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=325.09 Aligned_cols=258 Identities=23% Similarity=0.401 Sum_probs=204.4
Q ss_pred CCCCCCceeccccCeEEEEEEec-CCc----EEEEEEeeccc-hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEE
Q 001544 769 NGFSENNLIGRGSFGSVYIARLQ-NGI----EVAVKTFDLQH-ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKAL 842 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 842 (1057)
++|+..+.||+|+||.||+|.+. +|. .||+|.+.... ......+.+|+.++++++||||+++++++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 46778899999999999999753 444 57889886543 23345788999999999999999999998654 4679
Q ss_pred EEEEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCC
Q 001544 843 ILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGE 922 (1057)
Q Consensus 843 V~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~ 922 (1057)
|+||+++|+|.+++......+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++.....
T Consensus 86 v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~ 162 (303)
T cd05110 86 VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGD 162 (303)
T ss_pred eehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHh---hcCeeccccccceeeecCCCceEEccccccccccCc
Confidence 99999999999999876667899999999999999999999 999999999999999999999999999999876433
Q ss_pred CCccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhh-CCCCCCcccccccchhhhhhhccchhHHHhhhccc
Q 001544 923 DQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFT-RRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANL 1001 (1057)
Q Consensus 923 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1001 (1057)
..........++..|+|||...+..++.++||||||+++||+++ |+.||...... ....+ .....
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~--~~~~~------------~~~~~ 228 (303)
T cd05110 163 EKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR--EIPDL------------LEKGE 228 (303)
T ss_pred ccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHH------------HHCCC
Confidence 22222223345678999999988889999999999999999998 88888652111 11111 11100
Q ss_pred ccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHHHhHHH
Q 001544 1002 LITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKIRDF 1050 (1057)
Q Consensus 1002 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~ 1050 (1057)
..+.+..++..+.+++.+||..+|++||++.|+++.++++.+.
T Consensus 229 ------~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 229 ------RLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred ------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 0111123456788999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=316.34 Aligned_cols=247 Identities=28% Similarity=0.417 Sum_probs=203.9
Q ss_pred CCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccc-hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEEc
Q 001544 770 GFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQH-ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEYM 847 (1057)
Q Consensus 770 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 847 (1057)
.|+..+.||+|+||.||+|... +++.||+|++.... ......+.+|++++++++||||+++++++.++...++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 4677789999999999999865 58899999987543 445678899999999999999999999999999999999999
Q ss_pred cCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCccc
Q 001544 848 RNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMT 927 (1057)
Q Consensus 848 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 927 (1057)
++|+|.+++... .+++.++..++.|++.|++|+| +.+++|+||+|+||+++.++.++++|||++....... ..
T Consensus 85 ~~~~L~~~i~~~--~l~~~~~~~~~~~l~~~l~~lh---~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~ 157 (277)
T cd06640 85 GGGSALDLLRAG--PFDEFQIATMLKEILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--IK 157 (277)
T ss_pred CCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCccCcCCChhhEEEcCCCCEEEcccccceeccCCc--cc
Confidence 999999988754 4888999999999999999999 9999999999999999999999999999997653222 12
Q ss_pred cccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhcccccccch
Q 001544 928 QTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDK 1007 (1057)
Q Consensus 928 ~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1057)
.....++..|+|||+..+..++.++|+|||||++|||++|..||......+. ....... .
T Consensus 158 ~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--------------~~~~~~~------~ 217 (277)
T cd06640 158 RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV--------------LFLIPKN------N 217 (277)
T ss_pred cccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhH--------------hhhhhcC------C
Confidence 2234578889999999888899999999999999999999999865321110 0000000 0
Q ss_pred hhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 1008 HFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 1008 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
.......++..+.+++.+||+.+|++||++.|++++
T Consensus 218 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 218 PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 111223467788999999999999999999999888
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=321.10 Aligned_cols=252 Identities=23% Similarity=0.336 Sum_probs=198.7
Q ss_pred HhCCCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccchhHHHHHHHHHHHHHhc-CCCCceeEeeeecc------CC
Q 001544 767 ATNGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQHERAFKSFDTECEVMKSI-RHRNLTKIISSCSN------ED 838 (1057)
Q Consensus 767 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~------~~ 838 (1057)
+.+.|+..+.||+|+||.||+|... +++.||+|++..... ....+..|+++++++ +||||+++++++.. ..
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc-cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 4567888899999999999999865 688999999865432 335778899999998 69999999999864 24
Q ss_pred eeEEEEEEccCCChhHHHhcCC-ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccc
Q 001544 839 FKALILEYMRNGSLEKCLYSGN-YILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK 917 (1057)
Q Consensus 839 ~~~lV~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~ 917 (1057)
..++||||+++++|.+++.... ..+++..+..++.|++.|++||| +++|+||||||+||++++++.++|+|||+++
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~ 159 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSA 159 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHEEECCCCCEEEccCCCce
Confidence 6889999999999999987643 46899999999999999999999 8999999999999999999999999999987
Q ss_pred cccCCCCccccccccccccccCccccC-----CCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchh
Q 001544 918 LLIGEDQSMTQTQTLATLGYMAPEYGR-----EGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPIS 992 (1057)
Q Consensus 918 ~~~~~~~~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 992 (1057)
..... ........|+..|+|||++. +..++.++||||+||++|||++|+.||....... .+.
T Consensus 160 ~~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~----~~~------- 226 (272)
T cd06637 160 QLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR----ALF------- 226 (272)
T ss_pred ecccc--cccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHH----HHH-------
Confidence 65221 12223456888999999875 3457889999999999999999999986522110 000
Q ss_pred HHHhhhcccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 993 MMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 993 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
...... ........++.++.+++.+||..+|.+|||+.|+++|
T Consensus 227 --~~~~~~------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 227 --LIPRNP------APRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred --HHhcCC------CCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 000000 0000112345678999999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=328.70 Aligned_cols=247 Identities=23% Similarity=0.316 Sum_probs=196.3
Q ss_pred CCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccc---hhHHHHHHHHHHHHHhcC-CCCceeEeeeeccCCeeEEEE
Q 001544 770 GFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQH---ERAFKSFDTECEVMKSIR-HRNLTKIISSCSNEDFKALIL 844 (1057)
Q Consensus 770 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~ 844 (1057)
+|+..+.||+|+||+||+|... +|+.||||+++... ....+.+..|.++++.+. |++|+++++++.+.+..|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 3677899999999999999855 68999999986432 233456778888988885 678888999999999999999
Q ss_pred EEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCC
Q 001544 845 EYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ 924 (1057)
Q Consensus 845 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 924 (1057)
||+++|+|.+++.... .+++.++..++.|++.||+||| +++|+||||||+||++++++.+||+|||+++......
T Consensus 81 Ey~~~g~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~lH---~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~- 155 (323)
T cd05615 81 EYVNGGDLMYHIQQVG-KFKEPQAVFYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG- 155 (323)
T ss_pred cCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeccccccccCCCC-
Confidence 9999999999887654 4899999999999999999999 9999999999999999999999999999987532211
Q ss_pred ccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhcccccc
Q 001544 925 SMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLIT 1004 (1057)
Q Consensus 925 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1057)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||....... . ...+.....
T Consensus 156 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~--~-----------~~~i~~~~~--- 218 (323)
T cd05615 156 -VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE--L-----------FQSIMEHNV--- 218 (323)
T ss_pred -ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH--H-----------HHHHHhCCC---
Confidence 12233458999999999988889999999999999999999999987521110 0 011111100
Q ss_pred cchhhHHHHHHHHHHHHHHhHcccCCCCCCCCH-----HHHHHH
Q 001544 1005 EDKHFAAKEQCASSVFNLAMECTVESPDERITA-----KEIVRR 1043 (1057)
Q Consensus 1005 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~-----~evl~~ 1043 (1057)
..+..++.++.+++.+|++.+|.+|++. .++.+|
T Consensus 219 -----~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05615 219 -----SYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREH 257 (323)
T ss_pred -----CCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcC
Confidence 1112346678899999999999999974 455544
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=315.12 Aligned_cols=249 Identities=28% Similarity=0.434 Sum_probs=198.2
Q ss_pred ceeccccCeEEEEEEecC----CcEEEEEEeeccch-hHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEEccC
Q 001544 775 NLIGRGSFGSVYIARLQN----GIEVAVKTFDLQHE-RAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEYMRN 849 (1057)
Q Consensus 775 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 849 (1057)
+.||+|+||.||+|.+.. +..||+|.+..... ...+++.+|+++++++.||||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 469999999999997532 36899999865443 34577899999999999999999999876 4567999999999
Q ss_pred CChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCccc-c
Q 001544 850 GSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMT-Q 928 (1057)
Q Consensus 850 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~-~ 928 (1057)
|+|.+++.... .+++..+..++.|++.|++||| +.+++||||||+||+++.++.+|++|||.++.......... .
T Consensus 80 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~ 155 (257)
T cd05060 80 GPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT 155 (257)
T ss_pred CcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHh---hcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccc
Confidence 99999998765 5899999999999999999999 89999999999999999999999999999987643222111 1
Q ss_pred ccccccccccCccccCCCCCCccchHHHHHHHHHHHhh-CCCCCCcccccccchhhhhhhccchhHHHhhhcccccccch
Q 001544 929 TQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFT-RRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDK 1007 (1057)
Q Consensus 929 ~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1057)
....++..|+|||......++.++||||||+++|||++ |+.||...... ....++ ....
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~--~~~~~~------------~~~~------ 215 (257)
T cd05060 156 TAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA--EVIAML------------ESGE------ 215 (257)
T ss_pred cCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH--HHHHHH------------HcCC------
Confidence 11223467999999988889999999999999999998 99998653211 111111 1100
Q ss_pred hhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHHHhH
Q 001544 1008 HFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKIR 1048 (1057)
Q Consensus 1008 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~ 1048 (1057)
....+..++..+.+++.+|+..+|++||++.++++.|+++.
T Consensus 216 ~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 216 RLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 01112345678899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=336.14 Aligned_cols=267 Identities=21% Similarity=0.219 Sum_probs=200.8
Q ss_pred hCCCCCCceeccccCeEEEEEEec---CCcEEEEEEeeccchhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEE
Q 001544 768 TNGFSENNLIGRGSFGSVYIARLQ---NGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALIL 844 (1057)
Q Consensus 768 ~~~~~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 844 (1057)
..+|++.+.||+|+||.||+|... .+..||||.+... ....+|++++++++||||+++++++......++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 347899999999999999999743 4678999988543 23467999999999999999999999999999999
Q ss_pred EEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCC
Q 001544 845 EYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ 924 (1057)
Q Consensus 845 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 924 (1057)
||+. ++|.+++.. ...+++.+++.++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus 166 e~~~-~~l~~~l~~-~~~l~~~~~~~i~~ql~~aL~~LH---~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~ 240 (392)
T PHA03207 166 PKYK-CDLFTYVDR-SGPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD 240 (392)
T ss_pred hhcC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEccCccccccCcccc
Confidence 9996 588888843 346899999999999999999999 99999999999999999999999999999986643333
Q ss_pred ccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccc--cchhhhhhhcc------ch----h
Q 001544 925 SMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGE--MTLKHWVNDFL------PI----S 992 (1057)
Q Consensus 925 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~--~~~~~~~~~~~------~~----~ 992 (1057)
........||+.|+|||++.+..++.++||||+||++|||++|+.||....... ..+........ +. .
T Consensus 241 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~ 320 (392)
T PHA03207 241 TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTN 320 (392)
T ss_pred cccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchh
Confidence 333334578999999999998899999999999999999999999986532211 00111000000 00 0
Q ss_pred HHHhhhcccc-cccchh---hHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHH
Q 001544 993 MMKIIDANLL-ITEDKH---FAAKEQCASSVFNLAMECTVESPDERITAKEIVRRL 1044 (1057)
Q Consensus 993 ~~~~~~~~~~-~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 1044 (1057)
..+.+..... ...... ......++.++.+++.+|+..||++||++.|+++|=
T Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p 376 (392)
T PHA03207 321 LCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLP 376 (392)
T ss_pred HHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCc
Confidence 0000000000 000000 000112356788999999999999999999999873
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=315.43 Aligned_cols=252 Identities=23% Similarity=0.355 Sum_probs=191.2
Q ss_pred ceeccccCeEEEEEEecC---CcEEEEEEeeccch-hHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEEccCC
Q 001544 775 NLIGRGSFGSVYIARLQN---GIEVAVKTFDLQHE-RAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEYMRNG 850 (1057)
Q Consensus 775 ~~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g 850 (1057)
+.||+|+||.||+|...+ +..+|+|.++.... .....+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 358999999999997643 46799998865432 33457888999999999999999999999999999999999999
Q ss_pred ChhHHHhcCC----ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCcc
Q 001544 851 SLEKCLYSGN----YILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSM 926 (1057)
Q Consensus 851 sL~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 926 (1057)
+|.+++.... ...++..+..++.|++.|++||| +.+++||||||+||+++.++.+|++|||.++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 9999987533 34677788899999999999999 9999999999999999999999999999987543222222
Q ss_pred ccccccccccccCccccCCC-------CCCccchHHHHHHHHHHHhh-CCCCCCcccccccchhhhhhhccchhHHHhhh
Q 001544 927 TQTQTLATLGYMAPEYGREG-------RVSTKGDVYSFGILLMETFT-RRKPTDEIFSGEMTLKHWVNDFLPISMMKIID 998 (1057)
Q Consensus 927 ~~~~~~~t~~y~aPE~~~~~-------~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 998 (1057)
......++..|+|||++... .++.++|+||||+++|||++ |+.||......+.. .+ .+.
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~--~~-----------~~~ 224 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVL--TY-----------TVR 224 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHH--HH-----------Hhh
Confidence 22334567889999987532 35789999999999999996 99998653221110 00 000
Q ss_pred cccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHH
Q 001544 999 ANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLL 1045 (1057)
Q Consensus 999 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 1045 (1057)
....... ........+..+.+++..|| .+|++|||+.|+++.|+
T Consensus 225 ~~~~~~~--~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 225 EQQLKLP--KPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred cccCCCC--CCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 0000000 00001123556888999999 68999999999998764
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=328.45 Aligned_cols=268 Identities=22% Similarity=0.254 Sum_probs=198.7
Q ss_pred HHHHhCCCCCCceeccccCeEEEEEEe-cCCcEEEEEEeeccc--hhHHHHHHHHHHHHHhcCCCCceeEeeeeccC---
Q 001544 764 LFQATNGFSENNLIGRGSFGSVYIARL-QNGIEVAVKTFDLQH--ERAFKSFDTECEVMKSIRHRNLTKIISSCSNE--- 837 (1057)
Q Consensus 764 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--- 837 (1057)
.....++|++.+.||+|+||+||+|.. .+++.||||++.... ......+.+|++++++++||||+++++++...
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07878 10 VWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSI 89 (343)
T ss_pred HhhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccc
Confidence 344567899999999999999999975 468899999986432 22345677899999999999999999987533
Q ss_pred ---CeeEEEEEEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEccc
Q 001544 838 ---DFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFG 914 (1057)
Q Consensus 838 ---~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 914 (1057)
...|+++|++ +++|.+++... .+++..+..++.|+++||+||| +.+|+||||||+||++++++.+||+|||
T Consensus 90 ~~~~~~~~~~~~~-~~~l~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg 163 (343)
T cd07878 90 ENFNEVYLVTNLM-GADLNNIVKCQ--KLSDEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFG 163 (343)
T ss_pred cccCcEEEEeecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhhEEECCCCCEEEcCCc
Confidence 4568999988 77998877643 4899999999999999999999 9999999999999999999999999999
Q ss_pred ccccccCCCCccccccccccccccCccccCC-CCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhcc--ch
Q 001544 915 IAKLLIGEDQSMTQTQTLATLGYMAPEYGRE-GRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFL--PI 991 (1057)
Q Consensus 915 ~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~--~~ 991 (1057)
+++.... ......+|..|+|||++.+ ..++.++||||+||++|||++|+.||...... .....+..... ..
T Consensus 164 ~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~~~~~~~~~~~ 237 (343)
T cd07878 164 LARQADD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYI-DQLKRIMEVVGTPSP 237 (343)
T ss_pred cceecCC-----CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHHhCCCCH
Confidence 9986532 1233468899999998876 56889999999999999999999998652211 11111111000 00
Q ss_pred hHH---------HhhhcccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 992 SMM---------KIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 992 ~~~---------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
... ......................+.+.+++.+|++.||++|||+.|+++|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 238 EVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000 0000000000000000011234568899999999999999999999987
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=319.66 Aligned_cols=250 Identities=23% Similarity=0.365 Sum_probs=200.6
Q ss_pred CCCCceeccccCeEEEEEEec-CCcEEEEEEeeccc---hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEE
Q 001544 771 FSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQH---ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEY 846 (1057)
Q Consensus 771 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 846 (1057)
|+..++||+|+||.||+|... +++.||||.+.... ......+.+|+.++++++|++++.+++.+.+.+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 667789999999999999765 68999999986432 22335677899999999999999999999999999999999
Q ss_pred ccCCChhHHHhcCC-ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCc
Q 001544 847 MRNGSLEKCLYSGN-YILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS 925 (1057)
Q Consensus 847 ~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 925 (1057)
+++++|.+++.... ..+++.++..++.|++.|++||| +.+|+||||||+||++++++.++++|||++.......
T Consensus 82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-- 156 (285)
T cd05630 82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-- 156 (285)
T ss_pred cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc--
Confidence 99999999886533 45899999999999999999999 9999999999999999999999999999987642211
Q ss_pred cccccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhccccccc
Q 001544 926 MTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITE 1005 (1057)
Q Consensus 926 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1057)
......|+..|+|||++.+..++.++||||+||++|||++|+.||....... .... .....+..
T Consensus 157 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~-~~~~---------~~~~~~~~----- 220 (285)
T cd05630 157 -TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI-KREE---------VERLVKEV----- 220 (285)
T ss_pred -cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccc-hHHH---------HHhhhhhh-----
Confidence 2223468999999999998899999999999999999999999987532110 0000 00000000
Q ss_pred chhhHHHHHHHHHHHHHHhHcccCCCCCCCC-----HHHHHHH
Q 001544 1006 DKHFAAKEQCASSVFNLAMECTVESPDERIT-----AKEIVRR 1043 (1057)
Q Consensus 1006 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~evl~~ 1043 (1057)
.......+++++.+++.+||+.||++||| +.|+++|
T Consensus 221 --~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 221 --QEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred --hhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 00111235667899999999999999999 8899885
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=316.65 Aligned_cols=248 Identities=27% Similarity=0.468 Sum_probs=195.8
Q ss_pred ceeccccCeEEEEEEec-CCc--EEEEEEeeccc-hhHHHHHHHHHHHHHhc-CCCCceeEeeeeccCCeeEEEEEEccC
Q 001544 775 NLIGRGSFGSVYIARLQ-NGI--EVAVKTFDLQH-ERAFKSFDTECEVMKSI-RHRNLTKIISSCSNEDFKALILEYMRN 849 (1057)
Q Consensus 775 ~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~~ 849 (1057)
++||+|+||.||+|..+ ++. .+|+|.++... ....+.+.+|+++++++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 36899999999999875 343 57888886432 34456888999999999 799999999999999999999999999
Q ss_pred CChhHHHhcCC---------------ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEccc
Q 001544 850 GSLEKCLYSGN---------------YILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFG 914 (1057)
Q Consensus 850 gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 914 (1057)
|+|.+++.... ..+++.++..++.|++.|++||| +.+++||||||+||++++++.+|++|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccccceEEEcCCCeEEECCCC
Confidence 99999987532 24789999999999999999999 8999999999999999999999999999
Q ss_pred ccccccCCCCccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhh-CCCCCCcccccccchhhhhhhccchhH
Q 001544 915 IAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFT-RRKPTDEIFSGEMTLKHWVNDFLPISM 993 (1057)
Q Consensus 915 ~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 993 (1057)
++.... ..........+..|+|||+.....++.++|||||||++|||++ |+.||...... . .
T Consensus 158 l~~~~~---~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~-----~---------~ 220 (270)
T cd05047 158 LSRGQE---VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-----E---------L 220 (270)
T ss_pred Cccccc---hhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH-----H---------H
Confidence 986321 1111112233567999999988889999999999999999997 99998542111 0 0
Q ss_pred HHhhhcccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHHHhH
Q 001544 994 MKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKIR 1048 (1057)
Q Consensus 994 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~ 1048 (1057)
...+.... ....+..++.++.+++.+||+.+|.+||++.|+++.|+++.
T Consensus 221 ~~~~~~~~------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 221 YEKLPQGY------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred HHHHhCCC------CCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 11111100 00111234567889999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=327.77 Aligned_cols=255 Identities=20% Similarity=0.276 Sum_probs=200.0
Q ss_pred CCCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccc---hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEE
Q 001544 769 NGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQH---ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALIL 844 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 844 (1057)
++|++.++||+|+||+||++..+ +++.||+|++.... ......+.+|+.++..++|++|+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 46888999999999999999865 57889999985421 223455788999999999999999999999999999999
Q ss_pred EEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCC
Q 001544 845 EYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ 924 (1057)
Q Consensus 845 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 924 (1057)
||+++|+|.+++.+....+++..+..++.|++.|++||| +.+|+||||||+||+++.++.+||+|||++.......
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH---~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~- 156 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG- 156 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEeecchheecccCC-
Confidence 999999999999876667899999999999999999999 9999999999999999999999999999987543221
Q ss_pred ccccccccccccccCccccC-----CCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhc
Q 001544 925 SMTQTQTLATLGYMAPEYGR-----EGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDA 999 (1057)
Q Consensus 925 ~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 999 (1057)
........||+.|+|||++. ...++.++|||||||++|||++|+.||...... .. ...+...
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~-----~~--------~~~i~~~ 223 (332)
T cd05623 157 TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV-----ET--------YGKIMNH 223 (332)
T ss_pred cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHH-----HH--------HHHHhCC
Confidence 22223356899999999875 345788999999999999999999998652111 00 0111110
Q ss_pred ccccccchhhHHHHHHHHHHHHHHhHcccCCCCC--CCCHHHHHHH
Q 001544 1000 NLLITEDKHFAAKEQCASSVFNLAMECTVESPDE--RITAKEIVRR 1043 (1057)
Q Consensus 1000 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--Rps~~evl~~ 1043 (1057)
.... ........++.++.+++.+|+..+|++ |+++.|+++|
T Consensus 224 ~~~~---~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 224 KERF---QFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred Cccc---cCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 0000 001111345678899999988665554 7899999988
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=311.08 Aligned_cols=247 Identities=25% Similarity=0.366 Sum_probs=209.2
Q ss_pred CCCCCceeccccCeEEEEEE-ecCCcEEEEEEeecc--chhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEE
Q 001544 770 GFSENNLIGRGSFGSVYIAR-LQNGIEVAVKTFDLQ--HERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEY 846 (1057)
Q Consensus 770 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 846 (1057)
-|...+.||+|.|++|-.|+ .-+|..||||++.+. ++.....+.+|++.|+-++|||||++|+....+...|+|.|.
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL 98 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL 98 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence 46677889999999999996 447999999999654 344567788899999999999999999999999999999999
Q ss_pred ccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeee-CCCCcEEEEcccccccccCCCCc
Q 001544 847 MRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLL-DDNMVAHLSDFGIAKLLIGEDQS 925 (1057)
Q Consensus 847 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill-~~~~~~kl~Dfg~a~~~~~~~~~ 925 (1057)
-++|+|.+++.+.+.-+.+.-+.+++.||+.|+.|+| ...|||||+||+||.+ .+-|-+|+.|||++-.+.+ .
T Consensus 99 GD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCH---qLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P---G 172 (864)
T KOG4717|consen 99 GDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCH---QLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP---G 172 (864)
T ss_pred cCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHh---hhhhhcccCCcceeEEeeecCceEeeeccccccCCC---c
Confidence 9999999999988888999999999999999999999 8999999999999765 5679999999999977643 3
Q ss_pred cccccccccccccCccccCCCCCC-ccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhcccccc
Q 001544 926 MTQTQTLATLGYMAPEYGREGRVS-TKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLIT 1004 (1057)
Q Consensus 926 ~~~~~~~~t~~y~aPE~~~~~~~~-~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1057)
......+|+..|-|||++.+..|+ +++||||+||++|-+++|++||....+.+. +..++|-
T Consensus 173 ~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET-------------LTmImDC----- 234 (864)
T KOG4717|consen 173 KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET-------------LTMIMDC----- 234 (864)
T ss_pred chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh-------------hhhhhcc-----
Confidence 344556799999999999988876 678999999999999999999987433321 1222221
Q ss_pred cchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 1005 EDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 1005 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
.+..+..++.++.++|..|+..||++|.+.+|++.+
T Consensus 235 ---KYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 235 ---KYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred ---cccCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 223445678899999999999999999999998754
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=314.28 Aligned_cols=253 Identities=27% Similarity=0.455 Sum_probs=203.8
Q ss_pred hCCCCCCceeccccCeEEEEEEecCCcEEEEEEeeccchhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEEc
Q 001544 768 TNGFSENNLIGRGSFGSVYIARLQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEYM 847 (1057)
Q Consensus 768 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 847 (1057)
.++|+..+.||+|+||.||+|...++..||+|.+... ....+.+.+|++++++++|+||+++++++.+ ...++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 3578889999999999999999877888999988643 3345678899999999999999999999887 7789999999
Q ss_pred cCCChhHHHhcC-CccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCcc
Q 001544 848 RNGSLEKCLYSG-NYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSM 926 (1057)
Q Consensus 848 ~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 926 (1057)
++++|.+++... ....++.++..++.|++.|++||| +.+++||||||+||+++.++.+|++|||.+...... ...
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~-~~~ 158 (260)
T cd05073 83 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN-EYT 158 (260)
T ss_pred CCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCCcceeeccCC-Ccc
Confidence 999999998764 345888999999999999999999 899999999999999999999999999999765321 111
Q ss_pred ccccccccccccCccccCCCCCCccchHHHHHHHHHHHhh-CCCCCCcccccccchhhhhhhccchhHHHhhhccccccc
Q 001544 927 TQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFT-RRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITE 1005 (1057)
Q Consensus 927 ~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1057)
......++..|+|||++....++.++|+|||||++||+++ |+.||...... ....+ +....
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--~~~~~------------~~~~~---- 220 (260)
T cd05073 159 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP--EVIRA------------LERGY---- 220 (260)
T ss_pred cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH--HHHHH------------HhCCC----
Confidence 2222345567999999988889999999999999999999 88888652111 11111 11100
Q ss_pred chhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHHH
Q 001544 1006 DKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLK 1046 (1057)
Q Consensus 1006 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 1046 (1057)
..+.....+.++.+++.+|++.+|++||++.++.+.|+.
T Consensus 221 --~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 221 --RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred --CCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 001112345678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=330.20 Aligned_cols=240 Identities=28% Similarity=0.326 Sum_probs=188.8
Q ss_pred ceeccccCeEEEEEEec-CCcEEEEEEeeccc---hhHHHHHHHHH-HHHHhcCCCCceeEeeeeccCCeeEEEEEEccC
Q 001544 775 NLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQH---ERAFKSFDTEC-EVMKSIRHRNLTKIISSCSNEDFKALILEYMRN 849 (1057)
Q Consensus 775 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~-~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 849 (1057)
+.||+|+||+||+|+.. +++.||+|++.... ......+..|. .+++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999865 57889999986432 12223344444 456788999999999999999999999999999
Q ss_pred CChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCccccc
Q 001544 850 GSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQT 929 (1057)
Q Consensus 850 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 929 (1057)
|+|.+++.... .+++.++..++.||++||+||| +.+|+||||||+||+++.++.+||+|||+++..... .....
T Consensus 81 ~~L~~~~~~~~-~~~~~~~~~~~~qi~~~L~~lH---~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~--~~~~~ 154 (325)
T cd05602 81 GELFYHLQRER-CFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH--NGTTS 154 (325)
T ss_pred CcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEEccCCCCcccccC--CCCcc
Confidence 99999887654 4778888899999999999999 999999999999999999999999999998754221 12233
Q ss_pred cccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhcccccccchhh
Q 001544 930 QTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHF 1009 (1057)
Q Consensus 930 ~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1057)
...||+.|+|||++.+..++.++||||+||++|||++|+.||......+ .. ..+.....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-----~~--------~~i~~~~~-------- 213 (325)
T cd05602 155 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE-----MY--------DNILNKPL-------- 213 (325)
T ss_pred cccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH-----HH--------HHHHhCCc--------
Confidence 4568999999999999899999999999999999999999986521110 00 01111000
Q ss_pred HHHHHHHHHHHHHHhHcccCCCCCCCCHHHHH
Q 001544 1010 AAKEQCASSVFNLAMECTVESPDERITAKEIV 1041 (1057)
Q Consensus 1010 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl 1041 (1057)
.....++..+.+++.+|++.||.+||++.+.+
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 214 QLKPNITNSARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence 11123567789999999999999999887443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=294.90 Aligned_cols=272 Identities=21% Similarity=0.308 Sum_probs=215.1
Q ss_pred CHHHHHHHhCCCCCCceeccccCeEEEEEE-ecCCcEEEEEEeeccchhHHHHHHHHHHHHHhcC-CCCceeEeeeeccC
Q 001544 760 SYLELFQATNGFSENNLIGRGSFGSVYIAR-LQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIR-HRNLTKIISSCSNE 837 (1057)
Q Consensus 760 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~ 837 (1057)
.+.|+++.++ ++||+|+|++|.-+. +.+|.+||||++.+.......++.+|++++.+.+ |+||++++++|+++
T Consensus 74 ~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd 148 (463)
T KOG0607|consen 74 KFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD 148 (463)
T ss_pred hHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence 3567777664 789999999999886 7789999999998887788899999999999995 99999999999999
Q ss_pred CeeEEEEEEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCC---cEEEEccc
Q 001544 838 DFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNM---VAHLSDFG 914 (1057)
Q Consensus 838 ~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~---~~kl~Dfg 914 (1057)
+..|+|||-|.||+|..++++.. .+++.++.++.++||.||.||| .+||.|||+||+|||-.... -+|||||.
T Consensus 149 ~~FYLVfEKm~GGplLshI~~~~-~F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPENiLC~~pn~vsPvKiCDfD 224 (463)
T KOG0607|consen 149 TRFYLVFEKMRGGPLLSHIQKRK-HFNEREASRVVKDIASALDFLH---TKGIAHRDLKPENILCESPNKVSPVKICDFD 224 (463)
T ss_pred ceEEEEEecccCchHHHHHHHhh-hccHHHHHHHHHHHHHHHHHHh---hcCcccccCCccceeecCCCCcCceeeeccc
Confidence 99999999999999999998766 4899999999999999999999 99999999999999997544 58999999
Q ss_pred ccccccCCC-----CccccccccccccccCccccC-----CCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhh
Q 001544 915 IAKLLIGED-----QSMTQTQTLATLGYMAPEYGR-----EGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHW 984 (1057)
Q Consensus 915 ~a~~~~~~~-----~~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~ 984 (1057)
+..-+.-.. .......++|+..|||||+.. ...|+.+.|.||+|||+|-|++|.+||.+....+-.|.
T Consensus 225 LgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWd-- 302 (463)
T KOG0607|consen 225 LGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWD-- 302 (463)
T ss_pred cccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCcc--
Confidence 875432111 112223456778899999642 23578899999999999999999999987655433221
Q ss_pred hhhcc-chhHHHhhhcccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 985 VNDFL-PISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 985 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
.... +.-..+.++........-....+..++.+..+++...+..||.+|.++.++++|
T Consensus 303 -rGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnh 361 (463)
T KOG0607|consen 303 -RGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNH 361 (463)
T ss_pred -CCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCC
Confidence 1111 111223333222222222334566788999999999999999999999999874
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=315.27 Aligned_cols=252 Identities=24% Similarity=0.387 Sum_probs=202.4
Q ss_pred CCCCCceeccccCeEEEEEEecCCcEEEEEEeeccc------hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEE
Q 001544 770 GFSENNLIGRGSFGSVYIARLQNGIEVAVKTFDLQH------ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALI 843 (1057)
Q Consensus 770 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 843 (1057)
+|+..+.||+|+||+||+|...+++.+|||.++... ......+.+|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 477889999999999999988889999999886432 23346788999999999999999999999999999999
Q ss_pred EEEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCC
Q 001544 844 LEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGED 923 (1057)
Q Consensus 844 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~ 923 (1057)
|||+++++|.+++.+.. .+++..+..++.|++.|++||| +.+|+|+||+|+||++++++.++++|||.+.......
T Consensus 81 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 156 (265)
T cd06631 81 MEFVPGGSISSILNRFG-PLPEPVFCKYTKQILDGVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG 156 (265)
T ss_pred EecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcc
Confidence 99999999999987654 4789999999999999999999 8999999999999999999999999999987642211
Q ss_pred C----ccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhc
Q 001544 924 Q----SMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDA 999 (1057)
Q Consensus 924 ~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 999 (1057)
. ........++..|+|||+..+..++.++||||+|+++|||++|+.||......+ .. ......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~----~~---------~~~~~~ 223 (265)
T cd06631 157 LHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA----AM---------FYIGAH 223 (265)
T ss_pred ccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH----HH---------HHhhhc
Confidence 1 111223457889999999988889999999999999999999999986521110 00 000000
Q ss_pred ccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 1000 NLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 1000 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
... ....+..++.++.+++.+||+.+|++||++.|++++
T Consensus 224 ~~~-----~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 224 RGL-----MPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRH 262 (265)
T ss_pred cCC-----CCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 000 001112356778999999999999999999999864
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=327.34 Aligned_cols=255 Identities=20% Similarity=0.273 Sum_probs=199.9
Q ss_pred CCCCCCceeccccCeEEEEEEec-CCcEEEEEEeecc---chhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEE
Q 001544 769 NGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQ---HERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALIL 844 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 844 (1057)
++|++.+.||+|+||+||+|+.. +++.||+|++... .......+.+|+.++..++|++|+++++++.+++..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47889999999999999999865 6889999998642 2233456788999999999999999999999999999999
Q ss_pred EEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCC
Q 001544 845 EYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ 924 (1057)
Q Consensus 845 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 924 (1057)
||+++|+|.+++......+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+++......
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH---~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~- 156 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG- 156 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCC-
Confidence 999999999999876567899999999999999999999 9999999999999999999999999999997653222
Q ss_pred ccccccccccccccCccccCC-----CCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhc
Q 001544 925 SMTQTQTLATLGYMAPEYGRE-----GRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDA 999 (1057)
Q Consensus 925 ~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 999 (1057)
........|+++|+|||++.+ +.++.++||||+||++|||++|+.||......+ . ...+...
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~----~---------~~~i~~~ 223 (331)
T cd05624 157 TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE----T---------YGKIMNH 223 (331)
T ss_pred ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHH----H---------HHHHHcC
Confidence 122233568999999998765 467889999999999999999999986421110 0 0111110
Q ss_pred ccccccchhhHHHHHHHHHHHHHHhHcccCCCCC--CCCHHHHHHH
Q 001544 1000 NLLITEDKHFAAKEQCASSVFNLAMECTVESPDE--RITAKEIVRR 1043 (1057)
Q Consensus 1000 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--Rps~~evl~~ 1043 (1057)
..... .......++.++.+++.+|+..++++ |+++.++++|
T Consensus 224 ~~~~~---~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 224 EERFQ---FPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred CCccc---CCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 00000 00111234677889999999876654 5688988876
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=317.98 Aligned_cols=268 Identities=24% Similarity=0.298 Sum_probs=199.4
Q ss_pred CCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccc--hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEE
Q 001544 770 GFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQH--ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEY 846 (1057)
Q Consensus 770 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 846 (1057)
+|++.+.||+|++|.||+|+.. +++.||||+++... ......+.+|++++++++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4778899999999999999865 68999999986432 22346788899999999999999999999999999999999
Q ss_pred ccCCChhHHHhcCC--ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCC
Q 001544 847 MRNGSLEKCLYSGN--YILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ 924 (1057)
Q Consensus 847 ~~~gsL~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 924 (1057)
++ ++|.+++.... ..+++.++..++.|+++||+||| +.+++||||||+||+++.++.+||+|||++......
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-- 154 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP-- 154 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEEcCCCcEEECcccceeecCCC--
Confidence 97 58888876533 56899999999999999999999 999999999999999999999999999998754221
Q ss_pred ccccccccccccccCccccCCC-CCCccchHHHHHHHHHHHhhCCCCCCcccccccchhh--hhhhccchh-----HHHh
Q 001544 925 SMTQTQTLATLGYMAPEYGREG-RVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKH--WVNDFLPIS-----MMKI 996 (1057)
Q Consensus 925 ~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~--~~~~~~~~~-----~~~~ 996 (1057)
........+++.|+|||.+.+. .++.++||||+||++|||++|+.||......+..... ......... ....
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
T cd07861 155 VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD 234 (285)
T ss_pred cccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHH
Confidence 1222334568899999987654 4788999999999999999999998753221110000 000000000 0000
Q ss_pred hhccccc-ccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 997 IDANLLI-TEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 997 ~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
....... ...........+++++.+++.+||..||++|||+.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 235 YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred HHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 0000000 0000001112356788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=317.25 Aligned_cols=249 Identities=30% Similarity=0.516 Sum_probs=198.5
Q ss_pred ceeccccCeEEEEEEecC-------CcEEEEEEeeccc-hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEE
Q 001544 775 NLIGRGSFGSVYIARLQN-------GIEVAVKTFDLQH-ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEY 846 (1057)
Q Consensus 775 ~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 846 (1057)
+.||+|+||.||+|+..+ ++.||||.+.... ......+.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999997542 2579999885433 34467889999999999999999999999999999999999
Q ss_pred ccCCChhHHHhcC------CccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCC-----cEEEEcccc
Q 001544 847 MRNGSLEKCLYSG------NYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNM-----VAHLSDFGI 915 (1057)
Q Consensus 847 ~~~gsL~~~l~~~------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~-----~~kl~Dfg~ 915 (1057)
+++++|.+++... ...+++.++..++.|++.|++||| +.+++|+||||+||+++.++ .++++|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH---hCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 9999999998652 234788999999999999999999 89999999999999999877 899999999
Q ss_pred cccccCCCCccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhh-CCCCCCcccccccchhhhhhhccchhHH
Q 001544 916 AKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFT-RRKPTDEIFSGEMTLKHWVNDFLPISMM 994 (1057)
Q Consensus 916 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 994 (1057)
++...............++..|+|||++.++.++.++|||||||++|||++ |+.||......+ . .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~--~------------~ 223 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE--V------------L 223 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH--H------------H
Confidence 976543322222223345678999999999999999999999999999998 999986421110 0 1
Q ss_pred HhhhcccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHHH
Q 001544 995 KIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLK 1046 (1057)
Q Consensus 995 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 1046 (1057)
..+... .....+..++..+.+++.+||..+|++||++.++++.|++
T Consensus 224 ~~~~~~------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 224 QHVTAG------GRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred HHHhcC------CccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 111110 0111123456788999999999999999999999998863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=324.14 Aligned_cols=250 Identities=24% Similarity=0.384 Sum_probs=208.4
Q ss_pred CCCCceeccccCeEEEEEEecC-CcEEEEEEeeccchhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEEccC
Q 001544 771 FSENNLIGRGSFGSVYIARLQN-GIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEYMRN 849 (1057)
Q Consensus 771 ~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 849 (1057)
|.+...||.|+||.||+|..++ +-..|.|++........++|.-|+++++.+.||+||++++.|..+...++..|||.|
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~G 113 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGG 113 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCC
Confidence 5566789999999999998663 556788999888888889999999999999999999999999999999999999999
Q ss_pred CChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCccccc
Q 001544 850 GSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQT 929 (1057)
Q Consensus 850 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 929 (1057)
|-.+..+-.-+..+.+.++.-+++|++.||.||| +..|||||+|+.|||++-+|.++++|||.+... ........
T Consensus 114 GAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LH---s~~iIHRDLKAGNiL~TldGdirLADFGVSAKn--~~t~qkRD 188 (1187)
T KOG0579|consen 114 GAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLH---SQNIIHRDLKAGNILLTLDGDIRLADFGVSAKN--KSTRQKRD 188 (1187)
T ss_pred chHhHHHHHhccccchHHHHHHHHHHHHHHHHHh---hcchhhhhccccceEEEecCcEeeecccccccc--hhHHhhhc
Confidence 9999998887788999999999999999999999 999999999999999999999999999998643 12233445
Q ss_pred cccccccccCcccc-----CCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhcccccc
Q 001544 930 QTLATLGYMAPEYG-----REGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLIT 1004 (1057)
Q Consensus 930 ~~~~t~~y~aPE~~-----~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1057)
..+||+.|||||+. ....|++++||||||+++.||..+.+|..+...-.. +.++ ...
T Consensus 189 sFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRV-------------llKi-----aKS 250 (1187)
T KOG0579|consen 189 SFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV-------------LLKI-----AKS 250 (1187)
T ss_pred cccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHH-------------HHHH-----hhc
Confidence 56899999999964 467899999999999999999999999655211000 0111 111
Q ss_pred cchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 1005 EDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 1005 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
..+....+...+..|.+++.+|+..+|+.||+++++++|
T Consensus 251 ePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 251 EPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred CCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 112223345667889999999999999999999999986
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=331.11 Aligned_cols=267 Identities=21% Similarity=0.245 Sum_probs=198.2
Q ss_pred HHhCCCCCCceeccccCeEEEEEEec-CCcEEEEEEeecc--chhHHHHHHHHHHHHHhcCCCCceeEeeeeccC-----
Q 001544 766 QATNGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQ--HERAFKSFDTECEVMKSIRHRNLTKIISSCSNE----- 837 (1057)
Q Consensus 766 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----- 837 (1057)
...++|+..+.||+|+||.||+|... .++.||||++... .......+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 34578999999999999999999754 6899999998643 233456778899999999999999999987543
Q ss_pred -CeeEEEEEEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEccccc
Q 001544 838 -DFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIA 916 (1057)
Q Consensus 838 -~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a 916 (1057)
...++||||+++ ++.+.+.. .+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||++
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH---~~givHrDikp~Nill~~~~~~kl~Dfg~~ 166 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHhh---cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEECCCCCEEEeeCccc
Confidence 357999999976 66665543 3788899999999999999999 999999999999999999999999999999
Q ss_pred ccccCCCCccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhcc---c---
Q 001544 917 KLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFL---P--- 990 (1057)
Q Consensus 917 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~---~--- 990 (1057)
+.... ........+|..|+|||++.+..++.++||||+||++|||++|+.||......+. +...+.... +
T Consensus 167 ~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~ 242 (355)
T cd07874 167 RTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ-WNKVIEQLGTPCPEFM 242 (355)
T ss_pred ccCCC---ccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCCHHHH
Confidence 86422 2223345688999999999888899999999999999999999999865221110 000000000 0
Q ss_pred ----hhHHHhhhcccccc------------cchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 991 ----ISMMKIIDANLLIT------------EDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 991 ----~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
.......+...... ...........+.++.+++.+|++.||++|||+.|+++|
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 00001110000000 000000111234678999999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=339.48 Aligned_cols=269 Identities=19% Similarity=0.213 Sum_probs=194.9
Q ss_pred HHHHhCCCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccchhHHHHHHHHHHHHHhcCC------CCceeEeeeecc
Q 001544 764 LFQATNGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQHERAFKSFDTECEVMKSIRH------RNLTKIISSCSN 836 (1057)
Q Consensus 764 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~l~~~~~~ 836 (1057)
+.....+|++.++||+|+||+||+|... +++.||||+++... .....+..|+++++.++| .+++++++++..
T Consensus 124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~ 202 (467)
T PTZ00284 124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN 202 (467)
T ss_pred cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence 3345678999999999999999999764 68899999996432 223456678888877765 458889998865
Q ss_pred C-CeeEEEEEEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCC-CCeEEccCCCCCeeeCCCC--------
Q 001544 837 E-DFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYS-APVIHCDLKPSNVLLDDNM-------- 906 (1057)
Q Consensus 837 ~-~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~-~~ivH~Dlkp~Nill~~~~-------- 906 (1057)
+ .+.++|||++ +++|.+++.+.+ .+++.++..|+.||+.||+||| + .+||||||||+|||++.++
T Consensus 203 ~~~~~~iv~~~~-g~~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~yLH---~~~gIiHrDlKP~NILl~~~~~~~~~~~~ 277 (467)
T PTZ00284 203 ETGHMCIVMPKY-GPCLLDWIMKHG-PFSHRHLAQIIFQTGVALDYFH---TELHLMHTDLKPENILMETSDTVVDPVTN 277 (467)
T ss_pred CCceEEEEEecc-CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hcCCeecCCCCHHHEEEecCCcccccccc
Confidence 4 5788999988 678888887654 5899999999999999999999 7 5999999999999998765
Q ss_pred --------cEEEEcccccccccCCCCccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccc
Q 001544 907 --------VAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGE 978 (1057)
Q Consensus 907 --------~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~ 978 (1057)
.+||+|||.+... ........||+.|+|||++.+..++.++|||||||++|||++|+.||+.....+
T Consensus 278 ~~~~~~~~~vkl~DfG~~~~~-----~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~ 352 (467)
T PTZ00284 278 RALPPDPCRVRICDLGGCCDE-----RHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLE 352 (467)
T ss_pred cccCCCCceEEECCCCccccC-----ccccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 4999999987642 122334578999999999999999999999999999999999999997532211
Q ss_pred cc----------hhhhhhhccchhHHHhhhcccccccchh-----------hHHHHHHHHHHHHHHhHcccCCCCCCCCH
Q 001544 979 MT----------LKHWVNDFLPISMMKIIDANLLITEDKH-----------FAAKEQCASSVFNLAMECTVESPDERITA 1037 (1057)
Q Consensus 979 ~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~l~~li~~cl~~dP~~Rps~ 1037 (1057)
.. ...|..........+.++.......... ........+.+.+|+.+||+.||++|||+
T Consensus 353 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta 432 (467)
T PTZ00284 353 HLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNA 432 (467)
T ss_pred HHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCH
Confidence 00 0111111000001111111000000000 00001124568899999999999999999
Q ss_pred HHHHHH
Q 001544 1038 KEIVRR 1043 (1057)
Q Consensus 1038 ~evl~~ 1043 (1057)
+|+++|
T Consensus 433 ~e~L~H 438 (467)
T PTZ00284 433 RQMTTH 438 (467)
T ss_pred HHHhcC
Confidence 999986
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=334.08 Aligned_cols=371 Identities=29% Similarity=0.406 Sum_probs=248.5
Q ss_pred cCCCCCcEEeCCCCCccc-cCCcccccccccceeecccccccCCCCccccccCCCCeEeccCCCCCCCCCcccccCCCCC
Q 001544 92 GNLSSLEILDLNFNRLSG-EIPWELGNLAKLEKLLLHNNFLTGTIPFSIFKLSSLLDLKLSDNNLTGTIPSHNLGNLSSL 170 (1057)
Q Consensus 92 ~~l~~L~~L~L~~n~l~~-~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~l~~l~~L 170 (1057)
+-|+..+-.|+++|.|+| ..|.....+++++.|.|...++. .+|.+++.+.+|++|.+++|+++.... .++.|
T Consensus 4 gVLpFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~~vhG--ELs~L--- 77 (1255)
T KOG0444|consen 4 GVLPFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLISVHG--ELSDL--- 77 (1255)
T ss_pred cccceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhHhhhh--hhccc---
Confidence 446777889999999994 58999999999999999999988 788888888888888888888862211 13333
Q ss_pred ceeEccCCcccccCchhhhccccCCeeEeeccCCccccCccccCCCCcccEEEeeccccccCccccccCCCCCcEEEccC
Q 001544 171 QLLDLSDNQLSGSIPSFIFKISSLQALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGGISSTLSNCKHLRILDLSF 250 (1057)
Q Consensus 171 ~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~l~~n~~~~~~~~~l~~l~~L~~L~Ls~ 250 (1057)
+.|+.+.+..|++..
T Consensus 78 ---------------------p~LRsv~~R~N~LKn-------------------------------------------- 92 (1255)
T KOG0444|consen 78 ---------------------PRLRSVIVRDNNLKN-------------------------------------------- 92 (1255)
T ss_pred ---------------------hhhHHHhhhcccccc--------------------------------------------
Confidence 444444444444431
Q ss_pred CCCcCCccccccCcCCCcEEeeeccccccccCccccccccccEEEeecCccccccCccccccccccEEEecCCccccCCC
Q 001544 251 NDLWGDIPKEIGNLTKLKELFLDFNILQGEIPHTVGNLHNLEYLSLVNNELVGTVPATIFNVSTLKLIELSNNTFFGSLP 330 (1057)
Q Consensus 251 N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 330 (1057)
+-+|..+..+..|+.|+||+|+++ +.|..+...+++-.|+||+|+|. +||
T Consensus 93 ----sGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie-------------------------tIP 142 (1255)
T KOG0444|consen 93 ----SGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIE-------------------------TIP 142 (1255)
T ss_pred ----CCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccc-------------------------cCC
Confidence 123333334444444444444444 44555555556666666666654 333
Q ss_pred CCcccCCCCCceEEecCccccccCCccccccccccccccccccccccccchhcccccccEEeccCcccCCCccccccccC
Q 001544 331 SSTDVQLPNLEELYLWGNNFSGTLPSFIFNASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNYLTSPELSFLSSLS 410 (1057)
Q Consensus 331 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 410 (1057)
...+.++..|-.|||++|++. .+|..+..+.+|++|+|++|.+...- +..++
T Consensus 143 n~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQ---------------------------LrQLP 194 (1255)
T KOG0444|consen 143 NSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQ---------------------------LRQLP 194 (1255)
T ss_pred chHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCChhhHHH---------------------------HhcCc
Confidence 333334444444444444444 44555555666666666666654321 22233
Q ss_pred CCcchhhhhccCCCcccccccccccccccccEEEcCCCcccccccccccCccCCcEEEccCCcCCCCCCcccccccccce
Q 001544 411 NCKYLEIIALSGNPLNGIIPMSAGNLSHSLEELFMPDCNVSGRIPKEIGNLANLVTLDLGGNKFNGSIPIALGKLQKLQL 490 (1057)
Q Consensus 411 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~ 490 (1057)
.+++|++|.+|+.+=+ ...+|.++..+.+|..+|+|.|.+. .+|..+.++++|+.
T Consensus 195 smtsL~vLhms~TqRT------------------------l~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~Lrr 249 (1255)
T KOG0444|consen 195 SMTSLSVLHMSNTQRT------------------------LDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRR 249 (1255)
T ss_pred cchhhhhhhcccccch------------------------hhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhhe
Confidence 3444555555443321 1246777888889999999999998 78999999999999
Q ss_pred eecccccCcccCCcccccccccceEEecCeeeeecCCccccCcccccccccCCccccccccccccccccccEEEeccccc
Q 001544 491 LNLDDNKLEGSIPDDICGLVELYKLALGDNKLSGQIPACFGNLASLRELWLGPNELISFIPSTFWNIKDIMYVNFSSNFL 570 (1057)
Q Consensus 491 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 570 (1057)
|+||+|+|+ +.......-.+|++|+||.|+++ .+|+++..++.|+.|++.+|++.-
T Consensus 250 LNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~F---------------------- 305 (1255)
T KOG0444|consen 250 LNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTF---------------------- 305 (1255)
T ss_pred eccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccc----------------------
Confidence 999999998 44445555667777788888777 677777777777777777776421
Q ss_pred cCCCchhhccccccceeccccccccccccccccCccccceecccccccccccCccccccCccceecccCcccc
Q 001544 571 TGPLPLEIENLKALTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQGSIPDSVGDLISLKSLNLSNNNLS 643 (1057)
Q Consensus 571 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 643 (1057)
.| +|..++.+.+|+.+..++|++. .+|+.++.+..|+.|.|++|++- .+|+.+.-|+.|+.|||..|.--
T Consensus 306 eG-iPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpnL 375 (1255)
T KOG0444|consen 306 EG-IPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPNL 375 (1255)
T ss_pred cC-CccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCcCc
Confidence 22 5677778888888888888886 77888888888888888888877 67888888888888888887543
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=330.24 Aligned_cols=238 Identities=28% Similarity=0.355 Sum_probs=188.5
Q ss_pred ceeccccCeEEEEEEec-CCcEEEEEEeeccc---hhHHHHHHHHHH-HHHhcCCCCceeEeeeeccCCeeEEEEEEccC
Q 001544 775 NLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQH---ERAFKSFDTECE-VMKSIRHRNLTKIISSCSNEDFKALILEYMRN 849 (1057)
Q Consensus 775 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 849 (1057)
+.||+|+||+||+|+.. +|+.||||++.... ......+..|.. +++.++||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999854 68999999996542 223344555554 46778999999999999999999999999999
Q ss_pred CChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCccccc
Q 001544 850 GSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQT 929 (1057)
Q Consensus 850 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 929 (1057)
|+|..++.... .+++.++..++.||++||+||| +.+|+||||||+||++++++.+||+|||+++..... .....
T Consensus 81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH---~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~--~~~~~ 154 (325)
T cd05604 81 GELFFHLQRER-SFPEPRARFYAAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ--SDTTT 154 (325)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCC--CCCcc
Confidence 99998887544 5899999999999999999999 999999999999999999999999999998753211 12223
Q ss_pred cccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhcccccccchhh
Q 001544 930 QTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHF 1009 (1057)
Q Consensus 930 ~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1057)
...||+.|+|||++.+..++.++||||+||++|||++|+.||......+ . ..........
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~-----~--------~~~~~~~~~~------- 214 (325)
T cd05604 155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE-----M--------YDNILHKPLV------- 214 (325)
T ss_pred cccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH-----H--------HHHHHcCCcc-------
Confidence 4568999999999999999999999999999999999999986521110 0 0111111110
Q ss_pred HHHHHHHHHHHHHHhHcccCCCCCCCCHHH
Q 001544 1010 AAKEQCASSVFNLAMECTVESPDERITAKE 1039 (1057)
Q Consensus 1010 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~e 1039 (1057)
..+..+.++.+++.+|++.+|.+||++++
T Consensus 215 -~~~~~~~~~~~ll~~ll~~~p~~R~~~~~ 243 (325)
T cd05604 215 -LRPGASLTAWSILEELLEKDRQRRLGAKE 243 (325)
T ss_pred -CCCCCCHHHHHHHHHHhccCHHhcCCCCC
Confidence 01124567889999999999999998763
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=317.13 Aligned_cols=249 Identities=28% Similarity=0.395 Sum_probs=204.0
Q ss_pred CCCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccc-hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEE
Q 001544 769 NGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQH-ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEY 846 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 846 (1057)
++|+..+.||+|++|.||+|... +++.||+|++.... ......+.+|++++++++||||+++++++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 36788899999999999999865 68999999986543 34456788999999999999999999999999999999999
Q ss_pred ccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCcc
Q 001544 847 MRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSM 926 (1057)
Q Consensus 847 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 926 (1057)
+++++|.+++... .+++.++..++.|++.|++||| +.+++||||+|+||++++++.++++|||.++...... .
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~ 153 (274)
T cd06609 81 CGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM--S 153 (274)
T ss_pred eCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEcccccceeecccc--c
Confidence 9999999998765 5899999999999999999999 9999999999999999999999999999998763221 2
Q ss_pred ccccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhcccccccc
Q 001544 927 TQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITED 1006 (1057)
Q Consensus 927 ~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1006 (1057)
......++..|+|||+..+..++.++||||||+++|||++|+.||......+. ...+.....
T Consensus 154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~--------------~~~~~~~~~---- 215 (274)
T cd06609 154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRV--------------LFLIPKNNP---- 215 (274)
T ss_pred ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHH--------------HHHhhhcCC----
Confidence 22344678899999999888899999999999999999999999865321110 000000000
Q ss_pred hhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 1007 KHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 1007 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
..... ..++.++.+++.+|+..+|++||++++++++
T Consensus 216 ~~~~~-~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 216 PSLEG-NKFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred CCCcc-cccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 00000 1156678999999999999999999999875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=319.72 Aligned_cols=266 Identities=24% Similarity=0.313 Sum_probs=195.0
Q ss_pred CCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccc--hhHHHHHHHHHHHHHhc---CCCCceeEeeeecc-----CC
Q 001544 770 GFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQH--ERAFKSFDTECEVMKSI---RHRNLTKIISSCSN-----ED 838 (1057)
Q Consensus 770 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~-----~~ 838 (1057)
+|++.+.||+|+||+||+|... +++.||+|.++... ......+.+|+++++++ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4788899999999999999765 68999999986432 12223456677777665 69999999998754 34
Q ss_pred eeEEEEEEccCCChhHHHhcCC-ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccc
Q 001544 839 FKALILEYMRNGSLEKCLYSGN-YILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK 917 (1057)
Q Consensus 839 ~~~lV~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~ 917 (1057)
..++||||+++ +|.+++.... ..+++.++..++.|++.||+||| +.+|+||||||+||++++++.+||+|||+++
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccCccc
Confidence 67899999975 8888886543 45899999999999999999999 9999999999999999999999999999998
Q ss_pred cccCCCCccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhcc---chhHH
Q 001544 918 LLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFL---PISMM 994 (1057)
Q Consensus 918 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~---~~~~~ 994 (1057)
..... .......++..|+|||++.+..++.++||||+||++|||++|++||......+ .......... .....
T Consensus 157 ~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~-~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07863 157 IYSCQ---MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD-QLGKIFDLIGLPPEDDWP 232 (288)
T ss_pred cccCc---ccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHH-HHHHHHHHhCCCChhhCc
Confidence 65321 12233467889999999988889999999999999999999999986532211 1111110000 00000
Q ss_pred Hhhh---cccc-cccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 995 KIID---ANLL-ITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 995 ~~~~---~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
.... .... ..........+.++.++.+++.+|++.||++|||+.|+++|
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 233 RDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred ccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0000 0000 00000011112456778999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=315.13 Aligned_cols=250 Identities=26% Similarity=0.414 Sum_probs=201.1
Q ss_pred CCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccch---------hHHHHHHHHHHHHHhcCCCCceeEeeeeccCCe
Q 001544 770 GFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQHE---------RAFKSFDTECEVMKSIRHRNLTKIISSCSNEDF 839 (1057)
Q Consensus 770 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 839 (1057)
+|.+.+.||+|++|.||+|... +++.||+|.+..... ...+.+.+|++++++++||||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4677899999999999999764 689999998854321 234678899999999999999999999999999
Q ss_pred eEEEEEEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccc
Q 001544 840 KALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL 919 (1057)
Q Consensus 840 ~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~ 919 (1057)
.++||||+++++|.+++.... .+++..+..++.|++.|++||| +.+++||||+|+||++++++.++|+|||.++..
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~~l~~~l~~lH---~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~ 156 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYG-AFEETLVRNFVRQILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKL 156 (267)
T ss_pred cEEEEEecCCCCHHHHHHhcc-CccHHHHHHHHHHHHHHHHHHH---hcCcccccCCHHHEEEcCCCCEEecccCCCccc
Confidence 999999999999999997653 5888999999999999999999 899999999999999999999999999999876
Q ss_pred cCCCCc----cccccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHH
Q 001544 920 IGEDQS----MTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMK 995 (1057)
Q Consensus 920 ~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 995 (1057)
...... .......++..|+|||...+..++.++|+||+||++|||++|+.||........ ...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-------------~~~ 223 (267)
T cd06628 157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQA-------------IFK 223 (267)
T ss_pred ccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHH-------------HHH
Confidence 422111 111223477889999999888899999999999999999999999875211100 001
Q ss_pred hhhcccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 996 IIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 996 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
.... .....+..++..+.+++.+||+.||++||++.|++++
T Consensus 224 ~~~~-------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 224 IGEN-------ASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred Hhcc-------CCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 0000 0011112456778999999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=318.78 Aligned_cols=253 Identities=23% Similarity=0.371 Sum_probs=201.3
Q ss_pred CCCCCCceeccccCeEEEEEEec-CCcEEEEEEeecc-chhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEE
Q 001544 769 NGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQ-HERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEY 846 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 846 (1057)
++|++.+.||+|+||.||+|... +++.||+|.++.. .+.....+.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 36788899999999999999876 7899999998654 334457888999999999999999999999999999999999
Q ss_pred ccCCChhHHHhcCC--ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCC
Q 001544 847 MRNGSLEKCLYSGN--YILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ 924 (1057)
Q Consensus 847 ~~~gsL~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 924 (1057)
+++++|.+++.... ..+++..+..++.|+++|+.|||+ +.+|+||||||+||+++.++.+|++|||.+..+...
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-- 156 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS-- 156 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC--
Confidence 99999999887642 368999999999999999999992 259999999999999999999999999998765221
Q ss_pred ccccccccccccccCccccCCCC------CCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhh
Q 001544 925 SMTQTQTLATLGYMAPEYGREGR------VSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIID 998 (1057)
Q Consensus 925 ~~~~~~~~~t~~y~aPE~~~~~~------~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 998 (1057)
......++..|+|||.+.+.. ++.++|+||+||++|||++|+.||....... +.. ......+
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-----~~~-----~~~~~~~ 224 (286)
T cd06622 157 --LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN-----IFA-----QLSAIVD 224 (286)
T ss_pred --ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh-----HHH-----HHHHHhh
Confidence 122345778999999875443 4789999999999999999999986421110 000 0011111
Q ss_pred cccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHH
Q 001544 999 ANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRL 1044 (1057)
Q Consensus 999 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 1044 (1057)
.. ....+..++.++.+++.+|+..+|++||++.+++++-
T Consensus 225 ~~-------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~ 263 (286)
T cd06622 225 GD-------PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHP 263 (286)
T ss_pred cC-------CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcCh
Confidence 00 0111234677889999999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=328.18 Aligned_cols=237 Identities=26% Similarity=0.324 Sum_probs=186.8
Q ss_pred ceeccccCeEEEEEEec-CCcEEEEEEeeccc---hhHHHHHHHHHH-HHHhcCCCCceeEeeeeccCCeeEEEEEEccC
Q 001544 775 NLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQH---ERAFKSFDTECE-VMKSIRHRNLTKIISSCSNEDFKALILEYMRN 849 (1057)
Q Consensus 775 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 849 (1057)
++||+|+||.||+|+.. +++.||+|++.... ......+.+|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999865 68999999986432 222344555554 67889999999999999999999999999999
Q ss_pred CChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCccccc
Q 001544 850 GSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQT 929 (1057)
Q Consensus 850 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 929 (1057)
|+|.+++.... .+++.++..++.||++||+||| +.+|+||||||+||+++.++.+||+|||+++..... .....
T Consensus 81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~~~ 154 (321)
T cd05603 81 GELFFHLQRER-CFLEPRARFYAAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP--EETTS 154 (321)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCC--CCccc
Confidence 99998886543 5888889999999999999999 999999999999999999999999999998753211 12233
Q ss_pred cccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhcccccccchhh
Q 001544 930 QTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHF 1009 (1057)
Q Consensus 930 ~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1057)
...||+.|+|||.+.+..++.++||||+||++|||++|+.||..... .... ..+.....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----~~~~--------~~i~~~~~-------- 213 (321)
T cd05603 155 TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV-----SQMY--------DNILHKPL-------- 213 (321)
T ss_pred cccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH-----HHHH--------HHHhcCCC--------
Confidence 45689999999999888899999999999999999999999865211 1100 01111000
Q ss_pred HHHHHHHHHHHHHHhHcccCCCCCCCCHH
Q 001544 1010 AAKEQCASSVFNLAMECTVESPDERITAK 1038 (1057)
Q Consensus 1010 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~ 1038 (1057)
..+...+.++.+++.+|++.||.+||++.
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 214 QLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 11122356788999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=324.62 Aligned_cols=194 Identities=25% Similarity=0.358 Sum_probs=169.6
Q ss_pred CCCCCceeccccCeEEEEEEe-cCCcEEEEEEeeccchhHHHHHHHHHHHHHhcC-C-----CCceeEeeeeccCCeeEE
Q 001544 770 GFSENNLIGRGSFGSVYIARL-QNGIEVAVKTFDLQHERAFKSFDTECEVMKSIR-H-----RNLTKIISSCSNEDFKAL 842 (1057)
Q Consensus 770 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~~~~~~~~~~~l 842 (1057)
+|++.++||+|+||.|-+|.+ ++++.||||+++... .-..+...|+.+|..++ | -|+|+++++|.-..+.||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 788999999999999999975 479999999997543 33466678999999996 4 389999999999999999
Q ss_pred EEEEccCCChhHHHhcCC-ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCC--CCcEEEEcccccccc
Q 001544 843 ILEYMRNGSLEKCLYSGN-YILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDD--NMVAHLSDFGIAKLL 919 (1057)
Q Consensus 843 V~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~--~~~~kl~Dfg~a~~~ 919 (1057)
|+|.++. +|.+++.... ..++...++.|+.||+.||.+|| +.+|||+||||+|||+.+ ...+||+|||.|+..
T Consensus 266 VfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~---~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 266 VFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLH---ELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred eehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence 9999966 9999998766 56899999999999999999999 999999999999999974 348999999999875
Q ss_pred cCCCCccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCc
Q 001544 920 IGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDE 973 (1057)
Q Consensus 920 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~ 973 (1057)
. .... .++.+..|+|||++.+.+|+.+.||||||||++||++|.+-|.+
T Consensus 342 ~----q~vy-tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG 390 (586)
T KOG0667|consen 342 S----QRVY-TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPG 390 (586)
T ss_pred C----Ccce-eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCC
Confidence 2 1222 56678899999999999999999999999999999999876654
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=324.21 Aligned_cols=272 Identities=20% Similarity=0.296 Sum_probs=199.1
Q ss_pred CCceeccc--cCeEEEEEEe-cCCcEEEEEEeeccc--hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEEc
Q 001544 773 ENNLIGRG--SFGSVYIARL-QNGIEVAVKTFDLQH--ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEYM 847 (1057)
Q Consensus 773 ~~~~lg~G--~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 847 (1057)
+.++||+| +|++||++.. .+|+.||||+++... ......+++|+++++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45789999 7889999975 478999999996542 334567888999999999999999999999999999999999
Q ss_pred cCCChhHHHhcC-CccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCcc
Q 001544 848 RNGSLEKCLYSG-NYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSM 926 (1057)
Q Consensus 848 ~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 926 (1057)
++|+|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+||+++.++.++++||+.+..........
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~ 158 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL 158 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence 999999998653 245899999999999999999999 9999999999999999999999999998754432111110
Q ss_pred -----ccccccccccccCccccCC--CCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccch-------h
Q 001544 927 -----TQTQTLATLGYMAPEYGRE--GRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPI-------S 992 (1057)
Q Consensus 927 -----~~~~~~~t~~y~aPE~~~~--~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~-------~ 992 (1057)
......++..|+|||++.+ ..++.++||||+||++|||++|+.||.............. ...+. .
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 237 (327)
T cd08227 159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLN-GTVPCLLDTTTIP 237 (327)
T ss_pred cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhc-CCccccccccchh
Confidence 1112345678999999865 4588999999999999999999999975322111111000 00000 0
Q ss_pred HHHh--------hhc-----------ccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH--HHHhH
Q 001544 993 MMKI--------IDA-----------NLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR--LLKIR 1048 (1057)
Q Consensus 993 ~~~~--------~~~-----------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~--L~~i~ 1048 (1057)
..+. .+. ..........+....+++++.+++.+||+.||++|||+.|+++| +++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~ 314 (327)
T cd08227 238 AEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK 314 (327)
T ss_pred hhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhcc
Confidence 0000 000 00000000011223456789999999999999999999999985 45544
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=312.26 Aligned_cols=251 Identities=23% Similarity=0.363 Sum_probs=197.6
Q ss_pred CCCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccc-----hhHHHHHHHHHHHHHhcCCCCceeEeeeecc--CCee
Q 001544 769 NGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQH-----ERAFKSFDTECEVMKSIRHRNLTKIISSCSN--EDFK 840 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~ 840 (1057)
.+|+..+.||+|+||.||+|... ++..||+|++.... ......+.+|++++++++||||+++++++.+ ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 46888999999999999999764 68999999885432 2345678899999999999999999998865 4677
Q ss_pred EEEEEEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEccccccccc
Q 001544 841 ALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLI 920 (1057)
Q Consensus 841 ~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~ 920 (1057)
++|+||+++++|.+++.... .+++..+..++.|++.|++||| +.+|+||||||+||+++.++.+||+|||+++...
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~LH---~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~ 157 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYG-ALTESVTRKYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ 157 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCCCccccc
Confidence 89999999999999987654 4889999999999999999999 9999999999999999999999999999987653
Q ss_pred CCCC-ccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhc
Q 001544 921 GEDQ-SMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDA 999 (1057)
Q Consensus 921 ~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 999 (1057)
.... ........++.+|+|||.+.+..++.++||||+||++||+++|+.||......+ ........
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~-------------~~~~~~~~ 224 (266)
T cd06651 158 TICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA-------------AIFKIATQ 224 (266)
T ss_pred cccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHH-------------HHHHHhcC
Confidence 2111 111223457889999999998889999999999999999999999986521110 00000000
Q ss_pred ccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 1000 NLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 1000 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
. .....+..+...+.+++ +||..+|++||+++|+++|
T Consensus 225 ~------~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 225 P------TNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred C------CCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 0 01111233456677777 6888999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=318.25 Aligned_cols=248 Identities=28% Similarity=0.387 Sum_probs=201.1
Q ss_pred CCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccc-hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEEc
Q 001544 770 GFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQH-ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEYM 847 (1057)
Q Consensus 770 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 847 (1057)
.|+..+.||+|+||.||+|... +++.||+|.++... ....+.+.+|++++++++||||+++++++..+...++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 3555688999999999999764 58899999986443 345578899999999999999999999999999999999999
Q ss_pred cCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCccc
Q 001544 848 RNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMT 927 (1057)
Q Consensus 848 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 927 (1057)
++++|.+++... .+++..+..++.|+++|++||| +.+++|+||+|+||++++++.++++|||++...... ...
T Consensus 85 ~~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH---~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~--~~~ 157 (277)
T cd06642 85 GGGSALDLLKPG--PLEETYIATILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT--QIK 157 (277)
T ss_pred CCCcHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHh---cCCeeccCCChheEEEeCCCCEEEccccccccccCc--chh
Confidence 999999988653 4889999999999999999999 899999999999999999999999999999765322 112
Q ss_pred cccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhcccccccch
Q 001544 928 QTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDK 1007 (1057)
Q Consensus 928 ~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1057)
.....++..|+|||++.+..++.++|||||||++|||++|+.||........ ..+ .....
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~~~------------~~~~~------ 217 (277)
T cd06642 158 RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV--LFL------------IPKNS------ 217 (277)
T ss_pred hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH--Hhh------------hhcCC------
Confidence 2234578899999999888899999999999999999999999865321110 000 00000
Q ss_pred hhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHH
Q 001544 1008 HFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRL 1044 (1057)
Q Consensus 1008 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 1044 (1057)
.......++.++.+++.+||+.+|++||++.|+++|-
T Consensus 218 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 254 (277)
T cd06642 218 PPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHK 254 (277)
T ss_pred CCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhH
Confidence 0001123456788999999999999999999999863
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=311.02 Aligned_cols=250 Identities=23% Similarity=0.373 Sum_probs=204.8
Q ss_pred CCCCCceeccccCeEEEEEEe-cCCcEEEEEEeecc--chhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEE
Q 001544 770 GFSENNLIGRGSFGSVYIARL-QNGIEVAVKTFDLQ--HERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEY 846 (1057)
Q Consensus 770 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 846 (1057)
+|+..++||+|+||.||.++. .+++.|++|.+... ......++.+|++++++++|+||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 478889999999999999974 46899999998644 244567788999999999999999999999999999999999
Q ss_pred ccCCChhHHHhcC-CccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCc
Q 001544 847 MRNGSLEKCLYSG-NYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS 925 (1057)
Q Consensus 847 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 925 (1057)
+++++|.+++... ...+++.++..++.|+++|++||| +.+++||||+|+||++++++.+||+|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~- 156 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS- 156 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence 9999999998765 356899999999999999999999 89999999999999999999999999999986532221
Q ss_pred cccccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhccccccc
Q 001544 926 MTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITE 1005 (1057)
Q Consensus 926 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1057)
......++..|+|||...+..++.++||||+|+++|||++|+.||...... .. .........
T Consensus 157 -~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~-----~~--------~~~~~~~~~---- 218 (256)
T cd08221 157 -MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL-----NL--------VVKIVQGNY---- 218 (256)
T ss_pred -cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH-----HH--------HHHHHcCCC----
Confidence 223456789999999998888899999999999999999999998642111 00 111110000
Q ss_pred chhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHH
Q 001544 1006 DKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRL 1044 (1057)
Q Consensus 1006 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 1044 (1057)
.+....++.++.+++.+||..+|++||++.|++++.
T Consensus 219 ---~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 219 ---TPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred ---CCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 011134567789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=312.36 Aligned_cols=251 Identities=24% Similarity=0.350 Sum_probs=189.4
Q ss_pred eeccccCeEEEEEEecC---CcEEEEEEeeccc-hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEEccCCC
Q 001544 776 LIGRGSFGSVYIARLQN---GIEVAVKTFDLQH-ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEYMRNGS 851 (1057)
Q Consensus 776 ~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gs 851 (1057)
.||+|+||+||+|...+ ...+|+|.+.... ......+.+|+++++.++||||+++++++...+..++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999997543 4578888875443 3345678899999999999999999999999999999999999999
Q ss_pred hhHHHhcCC----ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCccc
Q 001544 852 LEKCLYSGN----YILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMT 927 (1057)
Q Consensus 852 L~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 927 (1057)
|.+++.... ...++.....++.|++.|++||| +.+|+||||||+||++++++.+||+|||++...........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH---hcCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 999987644 23467788999999999999999 99999999999999999999999999999875432222222
Q ss_pred cccccccccccCccccC-------CCCCCccchHHHHHHHHHHHhh-CCCCCCcccccccchhhhhhhccchhHHHhhhc
Q 001544 928 QTQTLATLGYMAPEYGR-------EGRVSTKGDVYSFGILLMETFT-RRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDA 999 (1057)
Q Consensus 928 ~~~~~~t~~y~aPE~~~-------~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 999 (1057)
.....++..|+|||+.. ...++.++||||+||++|||++ |..||......+ ... .....
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-~~~------------~~~~~ 225 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ-VLK------------QVVRE 225 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH-HHH------------HHhhc
Confidence 23334567899999864 3456889999999999999999 777876522111 000 00000
Q ss_pred ccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHH
Q 001544 1000 NLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLL 1045 (1057)
Q Consensus 1000 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 1045 (1057)
...... .......++..+.+++..|| .||++||+++||++.+.
T Consensus 226 ~~~~~~--~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 226 QDIKLP--KPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred cCccCC--CCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 000000 00112245677788999998 59999999999998763
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=318.59 Aligned_cols=259 Identities=23% Similarity=0.331 Sum_probs=201.3
Q ss_pred HHHHHHhCCCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccchhHHHHHHHHHHHHHhc-CCCCceeEeeeec----
Q 001544 762 LELFQATNGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQHERAFKSFDTECEVMKSI-RHRNLTKIISSCS---- 835 (1057)
Q Consensus 762 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~---- 835 (1057)
+++..+.++|++.+.||+|+||.||+|... +++.||+|+++.... ....+.+|+.+++++ +||||+++++++.
T Consensus 11 ~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 89 (286)
T cd06638 11 DSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD-IDEEIEAEYNILKALSDHPNVVKFYGMYYKKDV 89 (286)
T ss_pred ecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc-hHHHHHHHHHHHHHHhcCCCeeeeeeeeeeccc
Confidence 344457789999999999999999999764 688999998864322 235678899999999 6999999999873
Q ss_pred -cCCeeEEEEEEccCCChhHHHhc---CCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEE
Q 001544 836 -NEDFKALILEYMRNGSLEKCLYS---GNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLS 911 (1057)
Q Consensus 836 -~~~~~~lV~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~ 911 (1057)
.++..++||||+++++|.+++.. ....+++..+..++.|+++|+.||| +.+++||||||+||++++++.+|++
T Consensus 90 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~kl~ 166 (286)
T cd06638 90 KNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH---VNKTIHRDVKGNNILLTTEGGVKLV 166 (286)
T ss_pred CCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHH---hCCccccCCCHHhEEECCCCCEEEc
Confidence 45678999999999999988753 2345889999999999999999999 9999999999999999999999999
Q ss_pred cccccccccCCCCccccccccccccccCccccCC-----CCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhh
Q 001544 912 DFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGRE-----GRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVN 986 (1057)
Q Consensus 912 Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~ 986 (1057)
|||+++.+... ........++..|+|||++.. ..++.++||||+||++|||++|+.||......+ .+.
T Consensus 167 dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~----~~~- 239 (286)
T cd06638 167 DFGVSAQLTST--RLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR----ALF- 239 (286)
T ss_pred cCCceeecccC--CCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH----HHh-
Confidence 99998865322 122233468899999998753 447889999999999999999999986521110 000
Q ss_pred hccchhHHHhhhcccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHH
Q 001544 987 DFLPISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRL 1044 (1057)
Q Consensus 987 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 1044 (1057)
.. ... .......+..++.++.+++.+||+.||++||++.|++++.
T Consensus 240 --------~~-~~~----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 240 --------KI-PRN----PPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred --------hc-ccc----CCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 00 000 0000011122355788999999999999999999999874
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=319.22 Aligned_cols=268 Identities=24% Similarity=0.275 Sum_probs=199.8
Q ss_pred CCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccc--hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEE
Q 001544 770 GFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQH--ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEY 846 (1057)
Q Consensus 770 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 846 (1057)
+|+..+.||+|+||.||+|+.. +|+.||+|+++... ......+.+|++++++++||||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4778899999999999999865 68999999986432 22335677899999999999999999999999999999999
Q ss_pred ccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCcc
Q 001544 847 MRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSM 926 (1057)
Q Consensus 847 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 926 (1057)
+++ +|.+++......+++..+..++.||++||+||| +.+++||||||+||+++.++.+||+|||+++..... ..
T Consensus 81 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~--~~ 154 (284)
T cd07839 81 CDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP--VR 154 (284)
T ss_pred CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEcCCCcEEECccchhhccCCC--CC
Confidence 975 888887765566999999999999999999999 899999999999999999999999999999764221 12
Q ss_pred ccccccccccccCccccCCC-CCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhcc--chh-H---HHhhhc
Q 001544 927 TQTQTLATLGYMAPEYGREG-RVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFL--PIS-M---MKIIDA 999 (1057)
Q Consensus 927 ~~~~~~~t~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~--~~~-~---~~~~~~ 999 (1057)
......++..|+|||.+.+. .++.++||||+||++|||++|+.|+......+..+........ +.. . ....+.
T Consensus 155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07839 155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDY 234 (284)
T ss_pred CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccc
Confidence 22334578899999987664 4689999999999999999999886432221111111000000 000 0 000000
Q ss_pred cccccc---chhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 1000 NLLITE---DKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 1000 ~~~~~~---~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
...... .........++.++.+++.+||+.||++|||++|+++|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 235 KPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred cccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 000000 00011112356788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=325.36 Aligned_cols=264 Identities=20% Similarity=0.236 Sum_probs=196.5
Q ss_pred HhCCCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccchhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEE
Q 001544 767 ATNGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILE 845 (1057)
Q Consensus 767 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 845 (1057)
...+|++.+.||+|+||.||+|... +++.||+|+.... ....|+.++++++||||+++++++..++..++|+|
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 4567999999999999999999865 5788999975322 23468999999999999999999999999999999
Q ss_pred EccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCc
Q 001544 846 YMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS 925 (1057)
Q Consensus 846 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 925 (1057)
|+. ++|.+++......+++.++..|+.||+.||+||| +++|+||||||+||+++.++.+||+|||.++.... .
T Consensus 138 ~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~---~ 210 (357)
T PHA03209 138 HYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV---A 210 (357)
T ss_pred ccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEecCcccccccc---C
Confidence 995 5888888776677999999999999999999999 99999999999999999999999999999975321 1
Q ss_pred cccccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCC-Ccccccccc--------hhhhhhhcc--chh--
Q 001544 926 MTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPT-DEIFSGEMT--------LKHWVNDFL--PIS-- 992 (1057)
Q Consensus 926 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~-~~~~~~~~~--------~~~~~~~~~--~~~-- 992 (1057)
.......||..|+|||++.+..++.++|||||||++|||+++..|+ ......... +...+.... +..
T Consensus 211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 290 (357)
T PHA03209 211 PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFP 290 (357)
T ss_pred cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcC
Confidence 1223456899999999999989999999999999999999966553 332111000 000000000 000
Q ss_pred -------HHHhhhcccc-cccchhh--HHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 993 -------MMKIIDANLL-ITEDKHF--AAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 993 -------~~~~~~~~~~-~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
....++.... ..+.... .....++.++.+++.+||+.||++||||.|+++|
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h 351 (357)
T PHA03209 291 RDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY 351 (357)
T ss_pred CCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence 0000000000 0000000 0111345567789999999999999999999986
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=311.81 Aligned_cols=249 Identities=21% Similarity=0.373 Sum_probs=203.1
Q ss_pred CCCCCceeccccCeEEEEEEec-CCcEEEEEEeecc--chhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEE
Q 001544 770 GFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQ--HERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEY 846 (1057)
Q Consensus 770 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 846 (1057)
+|++.+.||+|+||.||++... +|+.||+|++... .....+++.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4788899999999999999754 6899999998643 233456789999999999999999999999999999999999
Q ss_pred ccCCChhHHHhcCC-ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCc
Q 001544 847 MRNGSLEKCLYSGN-YILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS 925 (1057)
Q Consensus 847 ~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 925 (1057)
+++++|.+++.... ..+++.++..++.|++.|++||| +.+++|+||+|+||+++.++.++++|||.+.......
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~-- 155 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV-- 155 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcch--
Confidence 99999999887643 35789999999999999999999 8999999999999999999999999999997653221
Q ss_pred cccccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhccccccc
Q 001544 926 MTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITE 1005 (1057)
Q Consensus 926 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1057)
.......++..|+|||+..+..++.++|+|||||++|||++|+.||..... ... ........
T Consensus 156 ~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~-----~~~--------~~~~~~~~----- 217 (256)
T cd08218 156 ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM-----KNL--------VLKIIRGS----- 217 (256)
T ss_pred hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH-----HHH--------HHHHhcCC-----
Confidence 122234578889999999888899999999999999999999999864211 000 01111000
Q ss_pred chhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 1006 DKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 1006 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
....+..++.++.+++.+||+.+|++||++.|+++|
T Consensus 218 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 218 --YPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred --CCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 011123456778999999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=319.81 Aligned_cols=194 Identities=21% Similarity=0.310 Sum_probs=159.2
Q ss_pred CceeccccCeEEEEEEec---CCcEEEEEEeeccchhHHHHHHHHHHHHHhcCCCCceeEeeeecc--CCeeEEEEEEcc
Q 001544 774 NNLIGRGSFGSVYIARLQ---NGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCSN--EDFKALILEYMR 848 (1057)
Q Consensus 774 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lV~E~~~ 848 (1057)
.++||+|+||+||+|+.. +++.||+|.+..... ...+.+|++++++++||||+++++++.. +...++||||++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 368999999999999854 468899999864332 2456789999999999999999998843 567889999986
Q ss_pred CCChhHHHhcC--------CccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeee----CCCCcEEEEccccc
Q 001544 849 NGSLEKCLYSG--------NYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLL----DDNMVAHLSDFGIA 916 (1057)
Q Consensus 849 ~gsL~~~l~~~--------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill----~~~~~~kl~Dfg~a 916 (1057)
+ +|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+||++ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 5 887776432 135889999999999999999999 9999999999999999 46689999999999
Q ss_pred ccccCCCC-ccccccccccccccCccccCC-CCCCccchHHHHHHHHHHHhhCCCCCCc
Q 001544 917 KLLIGEDQ-SMTQTQTLATLGYMAPEYGRE-GRVSTKGDVYSFGILLMETFTRRKPTDE 973 (1057)
Q Consensus 917 ~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~ 973 (1057)
+.+..... ........+|+.|+|||++.+ ..++.++||||+||++|||++|++||..
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~ 218 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence 86532211 122234578999999998876 4588999999999999999999999964
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=310.56 Aligned_cols=249 Identities=24% Similarity=0.403 Sum_probs=200.7
Q ss_pred CCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccc--hhHHHHHHHHHHHHHhcCCCCceeEeeeecc-CCeeEEEEE
Q 001544 770 GFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQH--ERAFKSFDTECEVMKSIRHRNLTKIISSCSN-EDFKALILE 845 (1057)
Q Consensus 770 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lV~E 845 (1057)
+|++.+.||+|++|.||+|... +++.||+|.+.... ....+.+.+|++++++++|||++++++.+.. ....++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4788999999999999999865 57899999986432 3445678899999999999999999998764 446789999
Q ss_pred EccCCChhHHHhcC-CccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCC
Q 001544 846 YMRNGSLEKCLYSG-NYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ 924 (1057)
Q Consensus 846 ~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 924 (1057)
|+++++|.+++... ...+++.++..++.|++.|++||| +.+++||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH---~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~- 156 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC- 156 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCchhEEEecCCcEEEecccceEEecccC-
Confidence 99999999998764 345899999999999999999999 9999999999999999999999999999998653221
Q ss_pred ccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhcccccc
Q 001544 925 SMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLIT 1004 (1057)
Q Consensus 925 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1057)
.......+++.|+|||+..+..++.++||||+|+++|||++|+.||..... ..+. ........
T Consensus 157 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~-----~~~~--------~~~~~~~~--- 219 (257)
T cd08223 157 -DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM-----NSLV--------YRIIEGKL--- 219 (257)
T ss_pred -CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH-----HHHH--------HHHHhcCC---
Confidence 222334578899999999988999999999999999999999999864211 1110 00100000
Q ss_pred cchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 1005 EDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 1005 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
...+...+.++.+++.+|++.+|++||++.|++++
T Consensus 220 ----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 220 ----PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred ----CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 01112456778999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=329.27 Aligned_cols=266 Identities=21% Similarity=0.234 Sum_probs=198.0
Q ss_pred HhCCCCCCceeccccCeEEEEEEec-CCcEEEEEEeecc--chhHHHHHHHHHHHHHhcCCCCceeEeeeeccC------
Q 001544 767 ATNGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQ--HERAFKSFDTECEVMKSIRHRNLTKIISSCSNE------ 837 (1057)
Q Consensus 767 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 837 (1057)
..++|+..+.||+|+||.||+|... .++.||||++... .......+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 4568999999999999999999854 6889999998643 233456788899999999999999999987543
Q ss_pred CeeEEEEEEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccc
Q 001544 838 DFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK 917 (1057)
Q Consensus 838 ~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~ 917 (1057)
...|+||||+++ ++.+.+.. .+++.++..++.|+++||+||| +++|+||||||+||+++.++.+||+|||+++
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 174 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 174 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh---cCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEECCCCcEEEEeCCCcc
Confidence 357999999976 67766643 3788899999999999999999 9999999999999999999999999999998
Q ss_pred cccCCCCccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccc--hhHHH
Q 001544 918 LLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLP--ISMMK 995 (1057)
Q Consensus 918 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~--~~~~~ 995 (1057)
.... ........+|..|+|||++.+..++.++||||+||++|||++|+.||......+ .+...+..... ....+
T Consensus 175 ~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~ 250 (364)
T cd07875 175 TAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID-QWNKVIEQLGTPCPEFMK 250 (364)
T ss_pred ccCC---CCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCCHHHHH
Confidence 6422 222234568899999999999899999999999999999999999996532111 11111110000 00000
Q ss_pred --------hhhcccccc------------cchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 996 --------IIDANLLIT------------EDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 996 --------~~~~~~~~~------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
..+...... .............++.+++.+|++.||++|||+.|+++|
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 251 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred hhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000000000 000000011124578899999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=315.79 Aligned_cols=268 Identities=23% Similarity=0.330 Sum_probs=202.5
Q ss_pred CCCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccc--hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEE
Q 001544 769 NGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQH--ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILE 845 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 845 (1057)
++|+..+.||+|+||.||+|... +|+.||+|++.... ....+.+.+|++++++++|||++++++++..+...++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 36888899999999999999876 68999999985432 2234567899999999999999999999999999999999
Q ss_pred EccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCc
Q 001544 846 YMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS 925 (1057)
Q Consensus 846 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 925 (1057)
|++++++..+..... .+++.++..++.|++.||+||| +.+++||||||+||++++++.++|+|||++........
T Consensus 81 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~ql~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~- 155 (286)
T cd07847 81 YCDHTVLNELEKNPR-GVPEHLIKKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD- 155 (286)
T ss_pred ccCccHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCChhhEEEcCCCcEEECccccceecCCCcc-
Confidence 999998888765443 5899999999999999999999 89999999999999999999999999999987633221
Q ss_pred cccccccccccccCccccCC-CCCCccchHHHHHHHHHHHhhCCCCCCcccccccch--hhhhhhccchhHHHhhhccc-
Q 001544 926 MTQTQTLATLGYMAPEYGRE-GRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTL--KHWVNDFLPISMMKIIDANL- 1001 (1057)
Q Consensus 926 ~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~- 1001 (1057)
......++..|+|||.+.+ ..++.++||||+|+++|||++|+.||......+... ........+ ......+...
T Consensus 156 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 233 (286)
T cd07847 156 -DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIP-RHQQIFSTNQF 233 (286)
T ss_pred -cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh-HHhhhcccccc
Confidence 2223457788999998765 557899999999999999999999997533221110 000001000 0000100000
Q ss_pred -----ccccc---hhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 1002 -----LITED---KHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 1002 -----~~~~~---~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
..... .........+..+.+++.+||+.+|++||++.|++.|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 234 FKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred cccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 00000 0001112346788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=314.72 Aligned_cols=254 Identities=26% Similarity=0.451 Sum_probs=203.6
Q ss_pred CCCCCCceeccccCeEEEEEEec------CCcEEEEEEeeccchh-HHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeE
Q 001544 769 NGFSENNLIGRGSFGSVYIARLQ------NGIEVAVKTFDLQHER-AFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKA 841 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 841 (1057)
++|+..+.||+|+||+||+|+.+ +.+.||+|.+...... ..+.+.+|++++++++||||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 46888899999999999999854 3467999988654433 5678999999999999999999999999999999
Q ss_pred EEEEEccCCChhHHHhcCC--------ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcc
Q 001544 842 LILEYMRNGSLEKCLYSGN--------YILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDF 913 (1057)
Q Consensus 842 lV~E~~~~gsL~~~l~~~~--------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 913 (1057)
+||||+++|+|.+++.... ..+++.++..++.|++.||+||| +.+|+||||||+||+++.++.++++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh---hcCcccCcCccceEEEeCCCcEEEccc
Confidence 9999999999999987544 15899999999999999999999 999999999999999999999999999
Q ss_pred cccccccCCCCccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhh-CCCCCCcccccccchhhhhhhccchh
Q 001544 914 GIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFT-RRKPTDEIFSGEMTLKHWVNDFLPIS 992 (1057)
Q Consensus 914 g~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 992 (1057)
|++...... .........++..|+|||...+..++.++||||+|+++||+++ |..||....... ....
T Consensus 162 ~~~~~~~~~-~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~--~~~~-------- 230 (275)
T cd05046 162 SLSKDVYNS-EYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE--VLNR-------- 230 (275)
T ss_pred ccccccCcc-cccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH--HHHH--------
Confidence 998754222 1222233356778999999888888999999999999999999 777875421111 0000
Q ss_pred HHHhhhcccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHH
Q 001544 993 MMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLL 1045 (1057)
Q Consensus 993 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 1045 (1057)
...... .+.....++..+.+++.+|++.+|++||++.|++++|.
T Consensus 231 ---~~~~~~------~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 231 ---LQAGKL------ELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred ---HHcCCc------CCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 000000 01111245678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=318.55 Aligned_cols=265 Identities=22% Similarity=0.321 Sum_probs=206.6
Q ss_pred CCCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccc-hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEE
Q 001544 769 NGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQH-ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEY 846 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 846 (1057)
++|++.+.||+|+||+||+|... +|+.||+|++.... ....+.+.+|+++++.++||||+++++++......++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 46778899999999999999855 68999999886543 34467889999999999999999999999999999999999
Q ss_pred ccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCcc
Q 001544 847 MRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSM 926 (1057)
Q Consensus 847 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 926 (1057)
+++++|.+++...+ .+++..+..++.+++.|+.|||+ ..+++||||||+||++++++.++|+|||++......
T Consensus 85 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~---- 157 (284)
T cd06620 85 MDCGSLDRIYKKGG-PIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS---- 157 (284)
T ss_pred CCCCCHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh----
Confidence 99999999887644 58999999999999999999993 258999999999999999999999999998754211
Q ss_pred ccccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhcccccccc
Q 001544 927 TQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITED 1006 (1057)
Q Consensus 927 ~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1006 (1057)
......++..|+|||++.+..++.++|+|||||++||+++|+.||......+... ..+....+........ ..
T Consensus 158 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~------~~~~~~~~~~~~~~~~-~~ 230 (284)
T cd06620 158 IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQ------DDPMGILDLLQQIVQE-PP 230 (284)
T ss_pred ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhh------hhhhHHHHHHHHHhhc-cC
Confidence 1123468899999999888889999999999999999999999997643221100 0000111111111000 00
Q ss_pred hhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHHHhH
Q 001544 1007 KHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKIR 1048 (1057)
Q Consensus 1007 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~ 1048 (1057)
...+ ...++.++.+++.+|++.||++||++.|++++..-++
T Consensus 231 ~~~~-~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~ 271 (284)
T cd06620 231 PRLP-SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ 271 (284)
T ss_pred CCCC-chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 0111 1235677899999999999999999999999854443
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=348.28 Aligned_cols=255 Identities=21% Similarity=0.309 Sum_probs=197.5
Q ss_pred HHhCCCCCCceeccccCeEEEEEEec-CCcEEEEEEeecc--chhHHHHHHHHHHHHHhcCCCCceeEeeeecc--CCee
Q 001544 766 QATNGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQ--HERAFKSFDTECEVMKSIRHRNLTKIISSCSN--EDFK 840 (1057)
Q Consensus 766 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~ 840 (1057)
...++|++.+.||+|+||+||+|... ++..||+|++... .......+..|+.++++++||||++++++|.+ .+..
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 34568999999999999999999865 5788999998643 33445778999999999999999999998844 4678
Q ss_pred EEEEEEccCCChhHHHhcC---CccCCHHHHHHHHHHHHHHHHHHHhCC----CCCeEEccCCCCCeeeCC---------
Q 001544 841 ALILEYMRNGSLEKCLYSG---NYILDIFQRLNIMIDVASALEYLHFGY----SAPVIHCDLKPSNVLLDD--------- 904 (1057)
Q Consensus 841 ~lV~E~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~i~~~L~~LH~~~----~~~ivH~Dlkp~Nill~~--------- 904 (1057)
|+||||+++|+|.+++... ...+++..++.|+.||+.||+|||... ..+||||||||+|||++.
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 9999999999999988653 245899999999999999999999321 145999999999999964
Q ss_pred --------CCcEEEEcccccccccCCCCccccccccccccccCccccCC--CCCCccchHHHHHHHHHHHhhCCCCCCcc
Q 001544 905 --------NMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGRE--GRVSTKGDVYSFGILLMETFTRRKPTDEI 974 (1057)
Q Consensus 905 --------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~Dv~s~G~il~elltg~~p~~~~ 974 (1057)
.+.+||+|||++..+... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~---s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~ 246 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIE---SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246 (1021)
T ss_pred ccccccCCCCceEEccCCcccccccc---ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence 335899999999865221 12234568999999998754 45889999999999999999999998642
Q ss_pred cccccchhhhhhhccchhHHHhhhcccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 975 FSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 975 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
.. ...++ ..+.... ..+ ....+.++.+|+..||..+|++||++.|++++
T Consensus 247 ~~----~~qli---------~~lk~~p------~lp-i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h 295 (1021)
T PTZ00266 247 NN----FSQLI---------SELKRGP------DLP-IKGKSKELNILIKNLLNLSAKERPSALQCLGY 295 (1021)
T ss_pred Cc----HHHHH---------HHHhcCC------CCC-cCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence 11 11111 1110000 000 01235678999999999999999999999864
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=316.19 Aligned_cols=239 Identities=25% Similarity=0.377 Sum_probs=190.7
Q ss_pred ceeccccCeEEEEEEecC--------CcEEEEEEeeccchhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEE
Q 001544 775 NLIGRGSFGSVYIARLQN--------GIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEY 846 (1057)
Q Consensus 775 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 846 (1057)
+.||+|+||+||+|.... ...||+|.+........+.+.+|+.++++++|||++++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999997532 335889988665555567889999999999999999999999998999999999
Q ss_pred ccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCc--------EEEEccccccc
Q 001544 847 MRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMV--------AHLSDFGIAKL 918 (1057)
Q Consensus 847 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~--------~kl~Dfg~a~~ 918 (1057)
+++|+|.+++...+..+++..+..++.||+.|++||| +++|+||||||+||+++.++. ++++|||.+..
T Consensus 81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 9999999999877667899999999999999999999 999999999999999987765 69999998865
Q ss_pred ccCCCCccccccccccccccCccccCCC-CCCccchHHHHHHHHHHHhhCC-CCCCcccccccchhhhhhhccchhHHHh
Q 001544 919 LIGEDQSMTQTQTLATLGYMAPEYGREG-RVSTKGDVYSFGILLMETFTRR-KPTDEIFSGEMTLKHWVNDFLPISMMKI 996 (1057)
Q Consensus 919 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 996 (1057)
... .....++..|+|||++.+. .++.++||||+|+++|||++|. .|+...... .....
T Consensus 158 ~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~--------------~~~~~ 217 (258)
T cd05078 158 VLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ--------------KKLQF 217 (258)
T ss_pred cCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHH--------------HHHHH
Confidence 422 1224577889999998764 5789999999999999999995 454331110 00001
Q ss_pred hhcccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHH
Q 001544 997 IDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRL 1044 (1057)
Q Consensus 997 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 1044 (1057)
..... ..+.....++.+++.+||+.+|++|||++|+++.|
T Consensus 218 ~~~~~--------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 218 YEDRH--------QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred HHccc--------cCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 10000 01112345688999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=309.98 Aligned_cols=250 Identities=30% Similarity=0.586 Sum_probs=201.6
Q ss_pred CCCCceeccccCeEEEEEEecC-----CcEEEEEEeeccchh-HHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEE
Q 001544 771 FSENNLIGRGSFGSVYIARLQN-----GIEVAVKTFDLQHER-AFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALIL 844 (1057)
Q Consensus 771 ~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 844 (1057)
|++.+.||+|+||.||+|...+ +..||+|+++..... ..+.+..|++++++++|+||+++++++.+.+..++||
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3566899999999999998653 388999999655433 5678999999999999999999999999999999999
Q ss_pred EEccCCChhHHHhcCCcc-CCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCC
Q 001544 845 EYMRNGSLEKCLYSGNYI-LDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGED 923 (1057)
Q Consensus 845 E~~~~gsL~~~l~~~~~~-l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~ 923 (1057)
||+++++|.+++...... +++.++..++.|++.|++||| +.+++||||||+||+++.++.++++|||.++......
T Consensus 81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh---~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHh---cCCeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 999999999998765544 899999999999999999999 9999999999999999999999999999998764332
Q ss_pred CccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhh-CCCCCCcccccccchhhhhhhccchhHHHhhhcccc
Q 001544 924 QSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFT-RRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLL 1002 (1057)
Q Consensus 924 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1002 (1057)
.... ....++..|+|||...+..++.++||||+|+++|||++ |+.||..... .. .........
T Consensus 158 ~~~~-~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~-----~~---------~~~~~~~~~- 221 (258)
T smart00219 158 YYKK-KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN-----EE---------VLEYLKKGY- 221 (258)
T ss_pred cccc-ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH-----HH---------HHHHHhcCC-
Confidence 2111 12336789999999988889999999999999999998 7787754111 00 011111100
Q ss_pred cccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHH
Q 001544 1003 ITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRL 1044 (1057)
Q Consensus 1003 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 1044 (1057)
.......++.++.+++.+|+..+|++|||+.|+++.|
T Consensus 222 -----~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 222 -----RLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred -----CCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 0111123577899999999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=310.20 Aligned_cols=248 Identities=26% Similarity=0.369 Sum_probs=201.8
Q ss_pred CCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccc-----hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEE
Q 001544 770 GFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQH-----ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALI 843 (1057)
Q Consensus 770 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 843 (1057)
+|+..+.||+|+||+||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++.+++..++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4677899999999999999876 78999999986533 23557889999999999999999999999999999999
Q ss_pred EEEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCC
Q 001544 844 LEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGED 923 (1057)
Q Consensus 844 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~ 923 (1057)
+||+++++|.+++.... .+++..+..++.|+++|++||| +.+++||||+|+||+++.++.+||+|||.+.......
T Consensus 81 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~ 156 (258)
T cd06632 81 LELVPGGSLAKLLKKYG-SFPEPVIRLYTRQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS 156 (258)
T ss_pred EEecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccceeccccc
Confidence 99999999999987654 4889999999999999999999 9999999999999999999999999999987653222
Q ss_pred CccccccccccccccCccccCCCC-CCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhcccc
Q 001544 924 QSMTQTQTLATLGYMAPEYGREGR-VSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLL 1002 (1057)
Q Consensus 924 ~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1002 (1057)
......++..|+|||...... ++.++|+||+|+++||+++|+.||......+.. .......
T Consensus 157 ---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~-------------~~~~~~~-- 218 (258)
T cd06632 157 ---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAV-------------FKIGRSK-- 218 (258)
T ss_pred ---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHH-------------HHHHhcc--
Confidence 223445788999999887666 899999999999999999999998763211000 0000000
Q ss_pred cccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 1003 ITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 1003 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
.....+..++.++.+++.+||+.+|++||++.|++++
T Consensus 219 ----~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 219 ----ELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred ----cCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 0001112346778899999999999999999999875
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=310.75 Aligned_cols=255 Identities=26% Similarity=0.407 Sum_probs=199.8
Q ss_pred CCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccc----------hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCC
Q 001544 770 GFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQH----------ERAFKSFDTECEVMKSIRHRNLTKIISSCSNED 838 (1057)
Q Consensus 770 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 838 (1057)
+|...+.||+|+||.||+|... +|+.||||.++... ....+.+.+|++++++++|||++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4667889999999999999754 68999999885321 112356788999999999999999999999999
Q ss_pred eeEEEEEEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEccccccc
Q 001544 839 FKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL 918 (1057)
Q Consensus 839 ~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~ 918 (1057)
..++||||+++++|.+++.... .+++..+..++.|++.|+.||| +.+++||||+|+||+++.++.++++|||.++.
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~ 157 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYG-RFEEQLVRFFTEQVLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKK 157 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHh---hCCeeecCCChhhEEEcCCCeEEEeecccccc
Confidence 9999999999999999987764 5899999999999999999999 89999999999999999999999999999976
Q ss_pred ccCCCCccccccccccccccCccccCCCC--CCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHh
Q 001544 919 LIGEDQSMTQTQTLATLGYMAPEYGREGR--VSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKI 996 (1057)
Q Consensus 919 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~--~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 996 (1057)
..............++..|+|||...... ++.++||||+|+++||+++|..||...... ..+ .+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~----~~~---------~~~ 224 (272)
T cd06629 158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI----AAM---------FKL 224 (272)
T ss_pred ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH----HHH---------HHh
Confidence 43221112223345788999999877654 789999999999999999999998542111 100 000
Q ss_pred hhcccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 997 IDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 997 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
......... .......++.++.+++.+|+.++|++||++.|+++|
T Consensus 225 ~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 225 GNKRSAPPI--PPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred hccccCCcC--CccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 000000000 001112456789999999999999999999999876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=308.85 Aligned_cols=251 Identities=23% Similarity=0.327 Sum_probs=198.1
Q ss_pred CCCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccc-----hhHHHHHHHHHHHHHhcCCCCceeEeeeeccC--Cee
Q 001544 769 NGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQH-----ERAFKSFDTECEVMKSIRHRNLTKIISSCSNE--DFK 840 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 840 (1057)
++|++.+.||+|+||.||+|... +++.||||.+.... ....+.+.+|++++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 47888999999999999999865 58999999885321 23456888999999999999999999998663 567
Q ss_pred EEEEEEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEccccccccc
Q 001544 841 ALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLI 920 (1057)
Q Consensus 841 ~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~ 920 (1057)
++||||+++++|.+++.... .+++..+.+++.|++.||+||| +.+++||||||+||+++.++.++|+|||.++...
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~ 157 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYG-ALTENVTRKYTRQILEGVSYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQ 157 (265)
T ss_pred EEEEEecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEecCCCCEEECcCccccccc
Confidence 89999999999999987654 4788899999999999999999 9999999999999999999999999999987653
Q ss_pred CCCC-ccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhc
Q 001544 921 GEDQ-SMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDA 999 (1057)
Q Consensus 921 ~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 999 (1057)
.... ........++..|+|||...+..++.++|||||||++|||++|+.||....... . ..+....
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~----~---------~~~~~~~ 224 (265)
T cd06652 158 TICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA----A---------IFKIATQ 224 (265)
T ss_pred cccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHH----H---------HHHHhcC
Confidence 2111 111223457889999999988889999999999999999999999986521110 0 0000000
Q ss_pred ccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 1000 NLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 1000 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
......+...+..+.+++.+|+. +|++||+++|++++
T Consensus 225 ------~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 225 ------PTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred ------CCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 00111123455678899999995 99999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=313.57 Aligned_cols=268 Identities=21% Similarity=0.274 Sum_probs=204.0
Q ss_pred CCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccc--hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEE
Q 001544 770 GFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQH--ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEY 846 (1057)
Q Consensus 770 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 846 (1057)
+|++.+.||+|+||.||+|... +|+.||||++.... ......+.+|++++++++||||+++++++..+...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4778899999999999999864 68999999986543 33457889999999999999999999999999999999999
Q ss_pred ccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCcc
Q 001544 847 MRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSM 926 (1057)
Q Consensus 847 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 926 (1057)
+ +++|.+++......+++.++..++.||++||+||| +.+++|+||||+||+++.++.++++|||.+........ .
T Consensus 81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~ 155 (286)
T cd07832 81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-R 155 (286)
T ss_pred c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-C
Confidence 9 99999998776677999999999999999999999 99999999999999999999999999999986533221 2
Q ss_pred ccccccccccccCccccCCC-CCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhcc---chhHHHhhh----
Q 001544 927 TQTQTLATLGYMAPEYGREG-RVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFL---PISMMKIID---- 998 (1057)
Q Consensus 927 ~~~~~~~t~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~---- 998 (1057)
......++..|+|||.+.+. .++.++||||+|+++|||++|++||...... ..+........ +....+..+
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07832 156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI-EQLAIVFRTLGTPNEETWPGLTSLPDY 234 (286)
T ss_pred ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH-HHHHHHHHHcCCCChHHHhhccCcchh
Confidence 23345688899999987654 4689999999999999999998877542211 11110000000 000000000
Q ss_pred -cccc-cccchhh-HHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 999 -ANLL-ITEDKHF-AAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 999 -~~~~-~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
.... ....... ...+..+.++.+++.+|+..+|++||+++++++|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 235 NKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred hcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000 0000000 1112346789999999999999999999999876
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=315.27 Aligned_cols=250 Identities=26% Similarity=0.346 Sum_probs=205.0
Q ss_pred CCCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccchhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEEc
Q 001544 769 NGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEYM 847 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 847 (1057)
.+|++.+.||+|+||.||+|... ++..||+|.+........+.+.+|+.++++++|||++++++++...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 57888999999999999999754 68899999987655555678899999999999999999999999999999999999
Q ss_pred cCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCccc
Q 001544 848 RNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMT 927 (1057)
Q Consensus 848 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 927 (1057)
++++|.+++.+. .+++.++..++.|++.|++||| +.+++||||||+||+++.++.++|+|||++........ .
T Consensus 99 ~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH---~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~--~ 171 (293)
T cd06647 99 AGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--K 171 (293)
T ss_pred CCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---hCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc--c
Confidence 999999998754 3788999999999999999999 99999999999999999999999999999876533221 2
Q ss_pred cccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhcccccccch
Q 001544 928 QTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDK 1007 (1057)
Q Consensus 928 ~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1057)
.....+++.|+|||......++.++||||||+++||+++|+.||......+.....+. ....
T Consensus 172 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~------------------~~~~ 233 (293)
T cd06647 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT------------------NGTP 233 (293)
T ss_pred cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhc------------------CCCC
Confidence 2334678899999999888899999999999999999999999865322111000000 0001
Q ss_pred hhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 1008 HFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 1008 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
........+..+.+++.+||..+|++||++.+++.|
T Consensus 234 ~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 234 ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111223356678899999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=314.38 Aligned_cols=259 Identities=22% Similarity=0.317 Sum_probs=202.9
Q ss_pred CHHHHHHHhCCCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccchhHHHHHHHHHHHHHhc-CCCCceeEeeeecc-
Q 001544 760 SYLELFQATNGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQHERAFKSFDTECEVMKSI-RHRNLTKIISSCSN- 836 (1057)
Q Consensus 760 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~- 836 (1057)
++.++......|++.+.||+|+||.||+|... +++.||+|++..... ....+..|+.++.++ +||||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED-EEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChH-HHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 44555566778999999999999999999864 689999999865433 346688899999998 69999999999842
Q ss_pred -----CCeeEEEEEEccCCChhHHHhcCC-ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEE
Q 001544 837 -----EDFKALILEYMRNGSLEKCLYSGN-YILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHL 910 (1057)
Q Consensus 837 -----~~~~~lV~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl 910 (1057)
.+..++||||+++|+|.+++.... ..+++..+..++.|++.|++||| +.+++||||||+||++++++.++|
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dl~~~nili~~~~~~~l 162 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVKL 162 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEE
Confidence 467899999999999999887643 45888889999999999999999 999999999999999999999999
Q ss_pred EcccccccccCCCCccccccccccccccCccccC-----CCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhh
Q 001544 911 SDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGR-----EGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWV 985 (1057)
Q Consensus 911 ~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~ 985 (1057)
+|||++...... ........++..|+|||.+. ...++.++||||+||++|||++|+.||......+..
T Consensus 163 ~dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~----- 235 (282)
T cd06636 163 VDFGVSAQLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL----- 235 (282)
T ss_pred eeCcchhhhhcc--ccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhh-----
Confidence 999998754211 11223346788999999875 345788999999999999999999998652211100
Q ss_pred hhccchhHHHhhhcccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 986 NDFLPISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 986 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
...... . ........++.++.+++.+||+.||.+||++.|++++
T Consensus 236 --------~~~~~~-~-----~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 236 --------FLIPRN-P-----PPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred --------hhHhhC-C-----CCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 000000 0 0001112456789999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=315.82 Aligned_cols=259 Identities=22% Similarity=0.304 Sum_probs=201.5
Q ss_pred HHHHHHHhCCCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccchhHHHHHHHHHHHHHhc-CCCCceeEeeeeccC-
Q 001544 761 YLELFQATNGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQHERAFKSFDTECEVMKSI-RHRNLTKIISSCSNE- 837 (1057)
Q Consensus 761 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~- 837 (1057)
..++..+.++|++.+.||+|+||.||+|... +++.||+|++.... .....+.+|+.+++++ +|||++++++++...
T Consensus 14 ~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~ 92 (291)
T cd06639 14 LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKAD 92 (291)
T ss_pred cccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecc
Confidence 3445556788999999999999999999864 68999999986432 2235677899999999 799999999998643
Q ss_pred ----CeeEEEEEEccCCChhHHHhc---CCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEE
Q 001544 838 ----DFKALILEYMRNGSLEKCLYS---GNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHL 910 (1057)
Q Consensus 838 ----~~~~lV~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl 910 (1057)
+..++||||+++++|.++++. ....+++..+..++.|++.|++||| +.+++||||||+||++++++.+||
T Consensus 93 ~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~nili~~~~~~kl 169 (291)
T cd06639 93 KLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGVKL 169 (291)
T ss_pred ccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEE
Confidence 368999999999999998753 3346899999999999999999999 899999999999999999999999
Q ss_pred EcccccccccCCCCccccccccccccccCccccCCC-----CCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhh
Q 001544 911 SDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREG-----RVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWV 985 (1057)
Q Consensus 911 ~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-----~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~ 985 (1057)
+|||.+....... .......++..|+|||.+... .++.++||||+||++|||++|+.||......+. ...+.
T Consensus 170 ~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~-~~~~~ 246 (291)
T cd06639 170 VDFGVSAQLTSTR--LRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT-LFKIP 246 (291)
T ss_pred eecccchhccccc--ccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH-HHHHh
Confidence 9999988653221 122234678899999987543 368899999999999999999999865321110 11100
Q ss_pred hhccchhHHHhhhcccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 986 NDFLPISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 986 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
.. ........+.....+.+++.+||+.+|++||++.|+++|
T Consensus 247 ~~-----------------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 247 RN-----------------PPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred cC-----------------CCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 00 000011112345678999999999999999999999876
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=321.35 Aligned_cols=246 Identities=26% Similarity=0.421 Sum_probs=196.0
Q ss_pred CCCceeccccCeEEEEEEec-CCcEEEEEEeec----cchhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCe--eEEEE
Q 001544 772 SENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDL----QHERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDF--KALIL 844 (1057)
Q Consensus 772 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~----~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--~~lV~ 844 (1057)
+...+||+|+|-+||||.+. +|..||.-.++. ......++|..|+++|+.++||||++++.+|.+... ..+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 34578999999999999765 688888755532 234556899999999999999999999999987655 66899
Q ss_pred EEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeC-CCCcEEEEcccccccccCCC
Q 001544 845 EYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLIGED 923 (1057)
Q Consensus 845 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~-~~~~~kl~Dfg~a~~~~~~~ 923 (1057)
|.+..|+|..+..+.+. .+....+.|++||++||.|||.. .++|+|||||.+|||++ ..|.|||+|.|+|+.+.
T Consensus 123 EL~TSGtLr~Y~kk~~~-vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r--- 197 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKHRR-VNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR--- 197 (632)
T ss_pred ecccCCcHHHHHHHhcc-CCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhh---
Confidence 99999999999887664 88889999999999999999954 68999999999999997 67999999999999863
Q ss_pred CccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhccccc
Q 001544 924 QSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLI 1003 (1057)
Q Consensus 924 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1003 (1057)
.......+|||.|||||... ..|++.+||||||++++||+|+.+||.+=.....-+..-.....|....++
T Consensus 198 -~s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV------- 268 (632)
T KOG0584|consen 198 -KSHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKV------- 268 (632)
T ss_pred -ccccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhcc-------
Confidence 22333478999999999876 789999999999999999999999986521111111111111111111111
Q ss_pred ccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 1004 TEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 1004 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
-.+++++||.+|+.. ..+|||+.|++++
T Consensus 269 -----------~dPevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 269 -----------KDPEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred -----------CCHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 135788999999999 8999999999875
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=317.70 Aligned_cols=248 Identities=27% Similarity=0.356 Sum_probs=200.0
Q ss_pred CCCCceeccccCeEEEEEEec-CCcEEEEEEeeccchhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEEccC
Q 001544 771 FSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEYMRN 849 (1057)
Q Consensus 771 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 849 (1057)
|.....||+|+||.||+|... ++..||||.+........+.+.+|+.++++++||||+++++++..++..++||||+++
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~ 103 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG 103 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence 333467999999999999864 6899999998766556667889999999999999999999999999999999999999
Q ss_pred CChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCccccc
Q 001544 850 GSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQT 929 (1057)
Q Consensus 850 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 929 (1057)
++|.+++... .+++.++..++.||+.|++||| +.+|+||||||+||++++++.++|+|||++....... ....
T Consensus 104 ~~L~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~--~~~~ 176 (292)
T cd06658 104 GALTDIVTHT--RMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV--PKRK 176 (292)
T ss_pred CcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEccCcchhhccccc--ccCc
Confidence 9999988654 4889999999999999999999 8999999999999999999999999999987543221 1223
Q ss_pred cccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhcccccccchhh
Q 001544 930 QTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHF 1009 (1057)
Q Consensus 930 ~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1057)
...++..|+|||...+..++.++||||+|+++|||++|+.||...... . ....+..... ...
T Consensus 177 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~----~----------~~~~~~~~~~----~~~ 238 (292)
T cd06658 177 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL----Q----------AMRRIRDNLP----PRV 238 (292)
T ss_pred eeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----H----------HHHHHHhcCC----Ccc
Confidence 346788999999998888999999999999999999999998642110 0 0000000000 001
Q ss_pred HHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 1010 AAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 1010 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
......+..+.+++.+|+..||.+|||+.|++++
T Consensus 239 ~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 239 KDSHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred ccccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 1112345678899999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=310.25 Aligned_cols=246 Identities=28% Similarity=0.489 Sum_probs=198.2
Q ss_pred CCCCCCceeccccCeEEEEEEecCCcEEEEEEeeccchhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEEcc
Q 001544 769 NGFSENNLIGRGSFGSVYIARLQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEYMR 848 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 848 (1057)
++|++.+.||+|+||.||+|.. +++.||+|.++... ....+.+|+.++++++|||++++++++... ..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 3588889999999999999975 57889999986543 236788999999999999999999998654 4689999999
Q ss_pred CCChhHHHhcCC-ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCccc
Q 001544 849 NGSLEKCLYSGN-YILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMT 927 (1057)
Q Consensus 849 ~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 927 (1057)
+++|.+++.... ..+++.++..++.|+++|++||| +.+++||||||+||+++.++.+||+|||.+......
T Consensus 82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~----- 153 (254)
T cd05083 82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG----- 153 (254)
T ss_pred CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCcEEECCCccceecccc-----
Confidence 999999987654 45889999999999999999999 999999999999999999999999999998754211
Q ss_pred cccccccccccCccccCCCCCCccchHHHHHHHHHHHhh-CCCCCCcccccccchhhhhhhccchhHHHhhhcccccccc
Q 001544 928 QTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFT-RRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITED 1006 (1057)
Q Consensus 928 ~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1006 (1057)
......+..|+|||.+.++.++.++|+||+|+++|||++ |+.||...... . ..+.+....
T Consensus 154 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-----~---------~~~~~~~~~----- 214 (254)
T cd05083 154 VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK-----E---------VKECVEKGY----- 214 (254)
T ss_pred CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH-----H---------HHHHHhCCC-----
Confidence 112234567999999988899999999999999999998 89888652111 1 111111111
Q ss_pred hhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHHH
Q 001544 1007 KHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLK 1046 (1057)
Q Consensus 1007 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 1046 (1057)
.......++.++.+++.+||+.+|++||++.++++.+++
T Consensus 215 -~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 215 -RMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred -CCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 011113456778999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=316.42 Aligned_cols=268 Identities=24% Similarity=0.328 Sum_probs=202.2
Q ss_pred CCCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccc--hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEE
Q 001544 769 NGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQH--ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILE 845 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 845 (1057)
++|+..++||+|+||.||+|..+ +++.||+|++.... ....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 36888899999999999999875 58999999885432 2234678889999999999999999999999999999999
Q ss_pred EccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCc
Q 001544 846 YMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS 925 (1057)
Q Consensus 846 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 925 (1057)
|++++++.++..... .+++.++..++.|+++|++||| +.+++||||+|+||++++++.++++|||++.......
T Consensus 81 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~LH---~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~-- 154 (286)
T cd07846 81 FVDHTVLDDLEKYPN-GLDESRVRKYLFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-- 154 (286)
T ss_pred cCCccHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc--
Confidence 999999988765543 4899999999999999999999 8999999999999999999999999999988653322
Q ss_pred cccccccccccccCccccCC-CCCCccchHHHHHHHHHHHhhCCCCCCccccccc--chhhhhhhccchhHHHhhh----
Q 001544 926 MTQTQTLATLGYMAPEYGRE-GRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEM--TLKHWVNDFLPISMMKIID---- 998 (1057)
Q Consensus 926 ~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~---- 998 (1057)
.......++..|+|||+..+ ..++.++||||||+++|||++|+.||......+. ....+..... ....+..+
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 233 (286)
T cd07846 155 EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLI-PRHQEIFQKNPL 233 (286)
T ss_pred cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCc-hhhHHHhccchH
Confidence 22233457889999998765 4578899999999999999999998864221110 0000111100 00111110
Q ss_pred --cccccc---cchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 999 --ANLLIT---EDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 999 --~~~~~~---~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
...... ........+.++..+.+++.+||+.+|++||++.|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 234 FAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred hhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 000000 000111123456789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=310.60 Aligned_cols=253 Identities=25% Similarity=0.335 Sum_probs=204.8
Q ss_pred CCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccc-hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEEc
Q 001544 770 GFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQH-ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEYM 847 (1057)
Q Consensus 770 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 847 (1057)
+|+..+.||+|+||.||+|... +++.||+|++.... ....+++.+|++++++++||||+++++++..+...++|+||+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 5777899999999999999876 68999999986553 345577889999999999999999999999999999999999
Q ss_pred cCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCC-CCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCcc
Q 001544 848 RNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYS-APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSM 926 (1057)
Q Consensus 848 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~-~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 926 (1057)
++++|.+++......+++..+..++.|++.|++|+| + .+++||||||+||++++++.++|+|||.+.......
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~--- 155 (265)
T cd06605 82 DGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLH---EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL--- 155 (265)
T ss_pred CCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHc---CCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHH---
Confidence 999999999876567899999999999999999999 8 999999999999999999999999999987652211
Q ss_pred ccccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhcccccccc
Q 001544 927 TQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITED 1006 (1057)
Q Consensus 927 ~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1006 (1057)
.....++..|+|||...+..++.++||||+|+++|+|++|+.||.............. ....... .
T Consensus 156 -~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~--------~~~~~~~----~- 221 (265)
T cd06605 156 -AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELL--------QYIVNEP----P- 221 (265)
T ss_pred -hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHH--------HHHhcCC----C-
Confidence 1115678899999999888999999999999999999999999865322111111110 0111100 0
Q ss_pred hhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 1007 KHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 1007 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
...+ ...++.++.+++.+||..+|++||++.|++++
T Consensus 222 ~~~~-~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 222 PRLP-SGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred CCCC-hhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 0000 01156779999999999999999999999876
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=309.85 Aligned_cols=251 Identities=22% Similarity=0.379 Sum_probs=200.4
Q ss_pred CCCCCceeccccCeEEEEEEecC--CcEEEEEEeecc----------chhHHHHHHHHHHHHHh-cCCCCceeEeeeecc
Q 001544 770 GFSENNLIGRGSFGSVYIARLQN--GIEVAVKTFDLQ----------HERAFKSFDTECEVMKS-IRHRNLTKIISSCSN 836 (1057)
Q Consensus 770 ~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~----------~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~ 836 (1057)
+|++.+.||+|+||.||+|.... ++.+|||.+... ......++.+|++++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47788999999999999998764 788999988532 22344567788888865 799999999999999
Q ss_pred CCeeEEEEEEccCCChhHHHhc---CCccCCHHHHHHHHHHHHHHHHHHHhCCC-CCeEEccCCCCCeeeCCCCcEEEEc
Q 001544 837 EDFKALILEYMRNGSLEKCLYS---GNYILDIFQRLNIMIDVASALEYLHFGYS-APVIHCDLKPSNVLLDDNMVAHLSD 912 (1057)
Q Consensus 837 ~~~~~lV~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~-~~ivH~Dlkp~Nill~~~~~~kl~D 912 (1057)
++..++||||+++++|.+++.. ....+++..+++++.|++.|++||| + .+++||||+|+||+++.++.+|++|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~~i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLH---KEKRIVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhc---cCCceeecCCCHHHEEECCCCcEEEec
Confidence 9999999999999999988743 3456899999999999999999999 5 6799999999999999999999999
Q ss_pred ccccccccCCCCccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchh
Q 001544 913 FGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPIS 992 (1057)
Q Consensus 913 fg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 992 (1057)
||.+....... ......++..|+|||...+..++.++||||||+++|||++|+.||...... ..
T Consensus 158 fg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~-----~~-------- 221 (269)
T cd08528 158 FGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML-----SL-------- 221 (269)
T ss_pred ccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH-----HH--------
Confidence 99998653222 334456788999999998888999999999999999999999998642111 00
Q ss_pred HHHhhhcccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHH
Q 001544 993 MMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLL 1045 (1057)
Q Consensus 993 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 1045 (1057)
.....+..... .....++.++.+++.+||+.||++||++.|+.++++
T Consensus 222 ~~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 222 ATKIVEAVYEP------LPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred HHHHhhccCCc------CCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 00111110000 001134567899999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=309.02 Aligned_cols=257 Identities=26% Similarity=0.352 Sum_probs=205.7
Q ss_pred CCCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccc-hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEE
Q 001544 769 NGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQH-ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEY 846 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 846 (1057)
++|++.+.||+|+||+||+|... ++..||+|++.... ....+.+.+|+++++.++|+|++++++.+..++..++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 46888999999999999999854 68899999986433 33567899999999999999999999999999999999999
Q ss_pred ccCCChhHHHhcCC--ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCC
Q 001544 847 MRNGSLEKCLYSGN--YILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ 924 (1057)
Q Consensus 847 ~~~gsL~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 924 (1057)
+++++|.+++.... ..+++..+..++.|++.|++||| +.+++||||+|+||++++++.++++|||++..+.....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh---~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 99999999987642 46899999999999999999999 99999999999999999999999999999977643322
Q ss_pred cc--ccccccccccccCccccCCC-CCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhccc
Q 001544 925 SM--TQTQTLATLGYMAPEYGREG-RVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANL 1001 (1057)
Q Consensus 925 ~~--~~~~~~~t~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1001 (1057)
.. ......++..|+|||.+... .++.++|+|||||++|||++|+.||......+. ...+.. ...
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~-~~~~~~------------~~~ 224 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV-LMLTLQ------------NDP 224 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh-HHHHhc------------CCC
Confidence 21 22334578899999988766 789999999999999999999999875322111 111100 000
Q ss_pred ccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 1002 LITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 1002 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
. ..........+++++.+++.+|+..||++||++.|+++|
T Consensus 225 ~--~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 225 P--SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred C--CcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 0 000000113456788999999999999999999999875
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=308.63 Aligned_cols=237 Identities=24% Similarity=0.438 Sum_probs=189.4
Q ss_pred ceeccccCeEEEEEEecC-C----------cEEEEEEeeccchhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEE
Q 001544 775 NLIGRGSFGSVYIARLQN-G----------IEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALI 843 (1057)
Q Consensus 775 ~~lg~G~~g~Vy~~~~~~-~----------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 843 (1057)
+.||+|+||.||+|...+ + ..|++|++...... ...+.+|+.++++++||||+++++++.. +..++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 469999999999998764 3 25788887654433 6788999999999999999999999887 778999
Q ss_pred EEEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCC-------cEEEEccccc
Q 001544 844 LEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNM-------VAHLSDFGIA 916 (1057)
Q Consensus 844 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~-------~~kl~Dfg~a 916 (1057)
|||+++|+|.+++......+++..+..++.|++.||+||| +.+|+||||||+||+++.++ .+|++|||++
T Consensus 79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh---hCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 9999999999999876657899999999999999999999 99999999999999999888 7999999999
Q ss_pred ccccCCCCccccccccccccccCccccCCC--CCCccchHHHHHHHHHHHhh-CCCCCCcccccccchhhhhhhccchhH
Q 001544 917 KLLIGEDQSMTQTQTLATLGYMAPEYGREG--RVSTKGDVYSFGILLMETFT-RRKPTDEIFSGEMTLKHWVNDFLPISM 993 (1057)
Q Consensus 917 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 993 (1057)
..... .....++..|+|||++... .++.++||||+|+++||+++ |..||...... ....+..
T Consensus 156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~--~~~~~~~------- 220 (259)
T cd05037 156 ITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS--EKERFYQ------- 220 (259)
T ss_pred ccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch--hHHHHHh-------
Confidence 86532 2233456789999998776 78999999999999999999 46676553211 0000000
Q ss_pred HHhhhcccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHH
Q 001544 994 MKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRL 1044 (1057)
Q Consensus 994 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 1044 (1057)
..... .. .....+.+++.+||..+|++||++.|+++.|
T Consensus 221 ----~~~~~--~~-------~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 221 ----DQHRL--PM-------PDCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred ----cCCCC--CC-------CCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 00000 00 0015788999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=311.68 Aligned_cols=254 Identities=27% Similarity=0.459 Sum_probs=197.9
Q ss_pred CCCCceeccccCeEEEEEEec----CCcEEEEEEeecc--chhHHHHHHHHHHHHHhcCCCCceeEeeeeccCC------
Q 001544 771 FSENNLIGRGSFGSVYIARLQ----NGIEVAVKTFDLQ--HERAFKSFDTECEVMKSIRHRNLTKIISSCSNED------ 838 (1057)
Q Consensus 771 ~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 838 (1057)
|++.++||+|+||+||+|... +++.||||++... .....+++.+|++++++++||||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 566789999999999999753 4689999998644 3345677889999999999999999999875432
Q ss_pred eeEEEEEEccCCChhHHHhcC-----CccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcc
Q 001544 839 FKALILEYMRNGSLEKCLYSG-----NYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDF 913 (1057)
Q Consensus 839 ~~~lV~E~~~~gsL~~~l~~~-----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 913 (1057)
..++++||+++|+|.+++... ...+++..+.+++.|++.|++||| +.+|+||||||+||+++.++.+|++||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccchhhEEEcCCCCEEECcc
Confidence 347899999999998887432 134788999999999999999999 899999999999999999999999999
Q ss_pred cccccccCCCCccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhh-CCCCCCcccccccchhhhhhhccchh
Q 001544 914 GIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFT-RRKPTDEIFSGEMTLKHWVNDFLPIS 992 (1057)
Q Consensus 914 g~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 992 (1057)
|.++...............++..|++||......++.++||||||+++|||++ |+.||...... ....+..
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~--~~~~~~~------ 229 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS--EIYNYLI------ 229 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH--HHHHHHH------
Confidence 99986533222222223345568999999988889999999999999999999 88887642111 1111110
Q ss_pred HHHhhhcccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHHHh
Q 001544 993 MMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKI 1047 (1057)
Q Consensus 993 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i 1047 (1057)
.... ......++..+.+++.+|++.+|++||++.|+++.|+++
T Consensus 230 -----~~~~-------~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 230 -----KGNR-------LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred -----cCCc-------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0000 001123456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=316.97 Aligned_cols=246 Identities=26% Similarity=0.348 Sum_probs=198.8
Q ss_pred CCceeccccCeEEEEEEec-CCcEEEEEEeeccchhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEEccCCC
Q 001544 773 ENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEYMRNGS 851 (1057)
Q Consensus 773 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gs 851 (1057)
....||+|+||.||+|... +++.||+|++........+.+.+|+.+++.++|||++++++++..++..++|+||+++++
T Consensus 25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~ 104 (297)
T cd06659 25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104 (297)
T ss_pred hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCC
Confidence 3457999999999999864 689999999865544455678899999999999999999999999999999999999999
Q ss_pred hhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCccccccc
Q 001544 852 LEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQT 931 (1057)
Q Consensus 852 L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 931 (1057)
|.+++... .+++.++..++.|++.|++||| +.+++||||||+||+++.++.+||+|||++....... ......
T Consensus 105 L~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~--~~~~~~ 177 (297)
T cd06659 105 LTDIVSQT--RLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV--PKRKSL 177 (297)
T ss_pred HHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHeEEccCCcEEEeechhHhhccccc--ccccce
Confidence 99877553 4889999999999999999999 9999999999999999999999999999987542221 122335
Q ss_pred cccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhcccccccchhhHH
Q 001544 932 LATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHFAA 1011 (1057)
Q Consensus 932 ~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1011 (1057)
.++..|+|||++.+..++.++|||||||++|||++|+.||......+ .. ..+.... ......
T Consensus 178 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-~~-------------~~~~~~~----~~~~~~ 239 (297)
T cd06659 178 VGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ-AM-------------KRLRDSP----PPKLKN 239 (297)
T ss_pred ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HH-------------HHHhccC----CCCccc
Confidence 68889999999988889999999999999999999999986421110 00 0000000 000111
Q ss_pred HHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 1012 KEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 1012 ~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
....+.++.+++.+|++.+|++||++.|++++
T Consensus 240 ~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 240 AHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred cCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 12345678899999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=313.74 Aligned_cols=271 Identities=21% Similarity=0.307 Sum_probs=199.5
Q ss_pred HhCCCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccc-hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEE
Q 001544 767 ATNGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQH-ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALIL 844 (1057)
Q Consensus 767 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 844 (1057)
++++|.+.+.||+|+||.||+|... +|+.||+|++.... ......+.+|++++++++|+||+++++++.+++..++||
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 4578999999999999999999754 68999999986543 222346778999999999999999999999999999999
Q ss_pred EEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCC
Q 001544 845 EYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ 924 (1057)
Q Consensus 845 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 924 (1057)
||+. +++.+++......+++.++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++......
T Consensus 83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 157 (291)
T cd07870 83 EYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPS- 157 (291)
T ss_pred eccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEEcCCCcEEEeccccccccCCCC-
Confidence 9996 6777777655556788889999999999999999 8999999999999999999999999999987542211
Q ss_pred ccccccccccccccCccccCCC-CCCccchHHHHHHHHHHHhhCCCCCCcccccccchhh-hhhhccchh-HHH-h----
Q 001544 925 SMTQTQTLATLGYMAPEYGREG-RVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKH-WVNDFLPIS-MMK-I---- 996 (1057)
Q Consensus 925 ~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~-~~~~~~~~~-~~~-~---- 996 (1057)
.......++..|+|||.+.+. .++.++||||+||++|||++|+.||.........+.. |.....+.. ... .
T Consensus 158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (291)
T cd07870 158 -QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLP 236 (291)
T ss_pred -CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcc
Confidence 122334568899999988654 5788999999999999999999999753322111111 110000000 000 0
Q ss_pred --hhcccccccchhhHH---HHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 997 --IDANLLITEDKHFAA---KEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 997 --~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
............... ....+.++.+++.+|+..||++|||+.|++.|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 237 NYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred cccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 000000000000000 00124678899999999999999999999865
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=314.34 Aligned_cols=267 Identities=22% Similarity=0.301 Sum_probs=200.6
Q ss_pred CCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccch-----hHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEE
Q 001544 770 GFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQHE-----RAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALI 843 (1057)
Q Consensus 770 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 843 (1057)
+|+..+.||+|+||.||+|... +|+.||||+++.... .....+..|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4777889999999999999865 689999999965432 2345677899999999999999999999999999999
Q ss_pred EEEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCC
Q 001544 844 LEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGED 923 (1057)
Q Consensus 844 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~ 923 (1057)
|||+ +|+|.+++......+++..+..++.||++||+||| +.+|+||||||+||+++.++.++|+|||+++......
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 156 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN 156 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC
Confidence 9999 88999999776556999999999999999999999 9999999999999999999999999999998653321
Q ss_pred CccccccccccccccCccccCC-CCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhcc---chhHHHhh--
Q 001544 924 QSMTQTQTLATLGYMAPEYGRE-GRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFL---PISMMKII-- 997 (1057)
Q Consensus 924 ~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~-- 997 (1057)
.......++..|+|||.+.+ ..++.++|||||||++|||++|.+||......+ .......... +.......
T Consensus 157 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 233 (298)
T cd07841 157 --RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID-QLGKIFEALGTPTEENWPGVTSL 233 (298)
T ss_pred --ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHH-HHHHHHHHcCCCchhhhhhcccc
Confidence 12233356778999998754 457899999999999999999987775422111 1111100000 00000000
Q ss_pred -hccc--ccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 998 -DANL--LITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 998 -~~~~--~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
+... ..............+.++.+++.+||+.+|++|||+.|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 234 PDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0000 000000011112346788999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=315.81 Aligned_cols=193 Identities=22% Similarity=0.316 Sum_probs=158.4
Q ss_pred ceeccccCeEEEEEEec---CCcEEEEEEeeccchhHHHHHHHHHHHHHhcCCCCceeEeeeec--cCCeeEEEEEEccC
Q 001544 775 NLIGRGSFGSVYIARLQ---NGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCS--NEDFKALILEYMRN 849 (1057)
Q Consensus 775 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~lV~E~~~~ 849 (1057)
.+||+|+||+||+|+.. ++..||+|.++.... ...+.+|++++++++||||+++++++. .+...++||||+++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 68999999999999864 457899999864432 245778999999999999999999884 45678999999875
Q ss_pred CChhHHHhcC--------CccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeee----CCCCcEEEEcccccc
Q 001544 850 GSLEKCLYSG--------NYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLL----DDNMVAHLSDFGIAK 917 (1057)
Q Consensus 850 gsL~~~l~~~--------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill----~~~~~~kl~Dfg~a~ 917 (1057)
+|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+||++ +.++.+||+|||+++
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 777766421 135888999999999999999999 9999999999999999 567899999999998
Q ss_pred cccCCCC-ccccccccccccccCccccCC-CCCCccchHHHHHHHHHHHhhCCCCCCc
Q 001544 918 LLIGEDQ-SMTQTQTLATLGYMAPEYGRE-GRVSTKGDVYSFGILLMETFTRRKPTDE 973 (1057)
Q Consensus 918 ~~~~~~~-~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~ 973 (1057)
....... ........+|+.|+|||++.+ ..++.++||||+||++|||+||++||..
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 6533221 112234567899999998876 4578999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=326.66 Aligned_cols=241 Identities=23% Similarity=0.296 Sum_probs=187.2
Q ss_pred eccccCeEEEEEEec-CCcEEEEEEeeccc---hhHHHHHHHHHHHHHhc---CCCCceeEeeeeccCCeeEEEEEEccC
Q 001544 777 IGRGSFGSVYIARLQ-NGIEVAVKTFDLQH---ERAFKSFDTECEVMKSI---RHRNLTKIISSCSNEDFKALILEYMRN 849 (1057)
Q Consensus 777 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~lV~E~~~~ 849 (1057)
||+|+||+||+|+.. +++.||||++.... ......+..|..++.+. +||||+++++++.+.+..|+||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999865 68999999986432 12234455566776655 699999999999999999999999999
Q ss_pred CChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCccccc
Q 001544 850 GSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQT 929 (1057)
Q Consensus 850 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 929 (1057)
|+|.+++.... .+++..+..++.||++||+||| +.+|+||||||+||+++.++.+||+|||+++..... .....
T Consensus 81 g~L~~~l~~~~-~~~~~~~~~~~~qil~al~~LH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~--~~~~~ 154 (330)
T cd05586 81 GELFWHLQKEG-RFSEDRAKFYIAELVLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTD--NKTTN 154 (330)
T ss_pred ChHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCC--CCCcc
Confidence 99999887654 5899999999999999999999 999999999999999999999999999998753221 12223
Q ss_pred cccccccccCccccCCC-CCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhcccccccchh
Q 001544 930 QTLATLGYMAPEYGREG-RVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKH 1008 (1057)
Q Consensus 930 ~~~~t~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1008 (1057)
...||..|+|||++.+. .++.++||||+||++|||++|+.||...... . ....+..... .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~-----~---------~~~~i~~~~~-----~ 215 (330)
T cd05586 155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ-----Q---------MYRNIAFGKV-----R 215 (330)
T ss_pred CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH-----H---------HHHHHHcCCC-----C
Confidence 45689999999988654 4789999999999999999999998652111 0 0000000000 0
Q ss_pred hHHHHHHHHHHHHHHhHcccCCCCCCC----CHHHHHHH
Q 001544 1009 FAAKEQCASSVFNLAMECTVESPDERI----TAKEIVRR 1043 (1057)
Q Consensus 1009 ~~~~~~~~~~l~~li~~cl~~dP~~Rp----s~~evl~~ 1043 (1057)
.+ ...++.++.+++.+||+.||++|| ++.|+++|
T Consensus 216 ~~-~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h 253 (330)
T cd05586 216 FP-KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEH 253 (330)
T ss_pred CC-CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence 00 012456788999999999999998 56777664
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=314.53 Aligned_cols=270 Identities=22% Similarity=0.291 Sum_probs=199.3
Q ss_pred hCCCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccch-hHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEE
Q 001544 768 TNGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQHE-RAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILE 845 (1057)
Q Consensus 768 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 845 (1057)
.++|+..+.||+|++|.||+|... +++.||||.+..... .....+.+|++++++++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 357888999999999999999865 689999999864432 223456789999999999999999999999999999999
Q ss_pred EccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCc
Q 001544 846 YMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS 925 (1057)
Q Consensus 846 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 925 (1057)
|+++ +|.+++......+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||+++......
T Consensus 84 ~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~-- 157 (291)
T cd07844 84 YLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPS-- 157 (291)
T ss_pred cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCHHHEEEcCCCCEEECccccccccCCCC--
Confidence 9985 999988776667899999999999999999999 9999999999999999999999999999987542111
Q ss_pred cccccccccccccCccccCC-CCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhc--c-chhHHHhhhcc-
Q 001544 926 MTQTQTLATLGYMAPEYGRE-GRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDF--L-PISMMKIIDAN- 1000 (1057)
Q Consensus 926 ~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~--~-~~~~~~~~~~~- 1000 (1057)
.......++..|+|||+..+ ..++.++||||+|+++|||++|+.||................. . +.......+..
T Consensus 158 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (291)
T cd07844 158 KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPE 237 (291)
T ss_pred ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccc
Confidence 11222346788999998765 4578999999999999999999999865331111111000000 0 00000000000
Q ss_pred --cc----cccchhhHHHHHHH--HHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 1001 --LL----ITEDKHFAAKEQCA--SSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 1001 --~~----~~~~~~~~~~~~~~--~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
.. .............. .++.+++.+|++.+|++||++.|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 238 FKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred cccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 00 00000000001122 677899999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=307.48 Aligned_cols=248 Identities=23% Similarity=0.415 Sum_probs=201.0
Q ss_pred CCCCCceeccccCeEEEEEEec-CCcEEEEEEeecc--chhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEE
Q 001544 770 GFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQ--HERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEY 846 (1057)
Q Consensus 770 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 846 (1057)
+|+..+.||+|+||.||+|... +++.||||++... .......+.+|++++++++|||++++++.+..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4778899999999999999754 6899999998654 234467889999999999999999999999999999999999
Q ss_pred ccCCChhHHHhcCC-ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCC-CcEEEEcccccccccCCCC
Q 001544 847 MRNGSLEKCLYSGN-YILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDN-MVAHLSDFGIAKLLIGEDQ 924 (1057)
Q Consensus 847 ~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~-~~~kl~Dfg~a~~~~~~~~ 924 (1057)
+++++|.+++.... ..+++..+.+++.|+++|++||| +.+++||||+|+||+++++ +.+|++|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~- 156 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS- 156 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc-
Confidence 99999999997653 45899999999999999999999 9999999999999999854 568999999998653221
Q ss_pred ccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhcccccc
Q 001544 925 SMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLIT 1004 (1057)
Q Consensus 925 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1057)
......++..|+|||...+..++.++||||||+++|+|++|+.||...... .. .........
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~-----~~--------~~~~~~~~~--- 218 (256)
T cd08220 157 --KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP-----AL--------VLKIMSGTF--- 218 (256)
T ss_pred --cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH-----HH--------HHHHHhcCC---
Confidence 222345788999999998888899999999999999999999998652111 00 001110000
Q ss_pred cchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 1005 EDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 1005 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
.+.+..++.++.+++.+||+.+|++|||+.|++++
T Consensus 219 ----~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 219 ----APISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred ----CCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 00112356778999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=308.87 Aligned_cols=254 Identities=24% Similarity=0.405 Sum_probs=202.2
Q ss_pred CCCCCceeccccCeEEEEEEe-cCCcEEEEEEeeccc------hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEE
Q 001544 770 GFSENNLIGRGSFGSVYIARL-QNGIEVAVKTFDLQH------ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKAL 842 (1057)
Q Consensus 770 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 842 (1057)
+|+..+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|++++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477889999999999999975 578999999986432 2245788999999999999999999999999999999
Q ss_pred EEEEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCC-cEEEEcccccccccC
Q 001544 843 ILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNM-VAHLSDFGIAKLLIG 921 (1057)
Q Consensus 843 V~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~-~~kl~Dfg~a~~~~~ 921 (1057)
||||+++++|.+++...+ .+++..+..++.|++.|++||| +.+++||||+|+||+++.++ .+||+|||.+..+..
T Consensus 81 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~ql~~al~~LH---~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~ 156 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYG-AFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAA 156 (268)
T ss_pred EEeccCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccccccccccc
Confidence 999999999999987644 5889999999999999999999 99999999999999998776 699999999977643
Q ss_pred CCC--ccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhc
Q 001544 922 EDQ--SMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDA 999 (1057)
Q Consensus 922 ~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 999 (1057)
... ........++..|+|||...+..++.++||||+|+++||+++|..||........ ... .......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~--~~~--------~~~~~~~ 226 (268)
T cd06630 157 KGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH--LAL--------IFKIASA 226 (268)
T ss_pred ccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch--HHH--------HHHHhcc
Confidence 211 1112234578899999999888899999999999999999999999864211100 000 0000000
Q ss_pred ccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 1000 NLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 1000 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
......+...++++.+++.+|+..+|++||++.|++++
T Consensus 227 ------~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 227 ------TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred ------CCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 00111223456788999999999999999999999865
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=311.40 Aligned_cols=267 Identities=25% Similarity=0.313 Sum_probs=199.1
Q ss_pred CCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccc--hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEE
Q 001544 770 GFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQH--ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEY 846 (1057)
Q Consensus 770 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 846 (1057)
+|+..+.||+|++|.||+|+.. +|+.||||+++... ......+.+|++++++++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4778899999999999999865 68999999986443 22346788999999999999999999999999999999999
Q ss_pred ccCCChhHHHhcCC-ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCc
Q 001544 847 MRNGSLEKCLYSGN-YILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS 925 (1057)
Q Consensus 847 ~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 925 (1057)
+. ++|.+++.... ..+++.++..++.|+++|++||| +.+++||||+|+||+++.++.+|++|||++...... .
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh---~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~--~ 154 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP--V 154 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEeeccchhhcccC--c
Confidence 96 58888886543 46899999999999999999999 899999999999999999999999999998765221 1
Q ss_pred cccccccccccccCccccCCCC-CCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhcc-c-hhHHHhhh----
Q 001544 926 MTQTQTLATLGYMAPEYGREGR-VSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFL-P-ISMMKIID---- 998 (1057)
Q Consensus 926 ~~~~~~~~t~~y~aPE~~~~~~-~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~-~-~~~~~~~~---- 998 (1057)
.......++..|+|||...+.. ++.++||||||+++|||+||+.||......+ .......... + ........
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07860 155 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID-QLFRIFRTLGTPDEVVWPGVTSLPD 233 (284)
T ss_pred cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHHhCCCChhhhhhhhHHHH
Confidence 1223345678899999876644 5889999999999999999999986522111 1111111000 0 00000000
Q ss_pred ---cccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 999 ---ANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 999 ---~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
..............+.++.++.+++.+|++.||++||+++|+++|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 234 YKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 000000000001112345778899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=309.29 Aligned_cols=247 Identities=29% Similarity=0.409 Sum_probs=201.3
Q ss_pred CCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccc-hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEEc
Q 001544 770 GFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQH-ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEYM 847 (1057)
Q Consensus 770 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 847 (1057)
-|+..+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 3667789999999999999764 68999999986433 344567889999999999999999999999999999999999
Q ss_pred cCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCccc
Q 001544 848 RNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMT 927 (1057)
Q Consensus 848 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 927 (1057)
++++|.+++... .+++..+..++.|++.|++||| +.+++|+||+|+||+++.++.++++|||++....... ..
T Consensus 85 ~~~~l~~~i~~~--~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~--~~ 157 (277)
T cd06641 85 GGGSALDLLEPG--PLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--IK 157 (277)
T ss_pred CCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHc---cCCeecCCCCHHhEEECCCCCEEEeecccceecccch--hh
Confidence 999999988654 4889999999999999999999 9999999999999999999999999999987653221 12
Q ss_pred cccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhcccccccch
Q 001544 928 QTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDK 1007 (1057)
Q Consensus 928 ~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1057)
.....++..|+|||...+..++.++|+||+||++|||++|..||...... .+. ..+....
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-----~~~---------~~~~~~~------ 217 (277)
T cd06641 158 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM-----KVL---------FLIPKNN------ 217 (277)
T ss_pred hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH-----HHH---------HHHhcCC------
Confidence 22345788999999998888999999999999999999999998652111 000 0000000
Q ss_pred hhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 1008 HFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 1008 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
.......++.++.+++.+|++.+|++||++.++++|
T Consensus 218 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 218 PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 001112356778899999999999999999999996
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=305.56 Aligned_cols=253 Identities=29% Similarity=0.449 Sum_probs=203.4
Q ss_pred CCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccch--hHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEE
Q 001544 770 GFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQHE--RAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEY 846 (1057)
Q Consensus 770 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 846 (1057)
+|+..+.||+|+||.||+|... +++.||+|+++.... ...+.+.+|++++++++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4778899999999999999854 689999999875543 3678899999999999999999999999999999999999
Q ss_pred ccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCcc
Q 001544 847 MRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSM 926 (1057)
Q Consensus 847 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 926 (1057)
+++++|.+++.... .+++..+..++.|+++|++||| +.+|+||||+|+||++++++.+||+|||.+..........
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~ 156 (264)
T cd06626 81 CSGGTLEELLEHGR-ILDEHVIRVYTLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM 156 (264)
T ss_pred CCCCcHHHHHhhcC-CCChHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc
Confidence 99999999987654 4788999999999999999999 9999999999999999999999999999998764332211
Q ss_pred c--cccccccccccCccccCCCC---CCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhccc
Q 001544 927 T--QTQTLATLGYMAPEYGREGR---VSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANL 1001 (1057)
Q Consensus 927 ~--~~~~~~t~~y~aPE~~~~~~---~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1001 (1057)
. .....++..|+|||++.+.. .+.++||||||+++||+++|+.||...... .........
T Consensus 157 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~-~~~~~~~~~-------------- 221 (264)
T cd06626 157 GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE-FQIMFHVGA-------------- 221 (264)
T ss_pred cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch-HHHHHHHhc--------------
Confidence 1 11345778999999987766 889999999999999999999998652211 000000000
Q ss_pred ccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 1002 LITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 1002 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
......+....++..+.+++.+|++.+|++||++.|++.+
T Consensus 222 --~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 222 --GHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQH 261 (264)
T ss_pred --CCCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000111122346678899999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=308.93 Aligned_cols=256 Identities=25% Similarity=0.314 Sum_probs=200.3
Q ss_pred CCCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccch-hHHHHHHHHHHHHHhcCCCCceeEeeeecc--CCeeEEEE
Q 001544 769 NGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQHE-RAFKSFDTECEVMKSIRHRNLTKIISSCSN--EDFKALIL 844 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lV~ 844 (1057)
++|+..+.||.|++|.||+|... +++.||+|.+..... ....++.+|++++++++||||++++++|.+ .+..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 36778899999999999999875 689999999865432 345778999999999999999999998854 34789999
Q ss_pred EEccCCChhHHHhc---CCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccC
Q 001544 845 EYMRNGSLEKCLYS---GNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIG 921 (1057)
Q Consensus 845 E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~ 921 (1057)
||+++++|.+++.. ....+++..+..++.|+++||+||| +.+++||||+|+||+++.++.++++|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 99999999887653 3345889999999999999999999 99999999999999999999999999999875422
Q ss_pred CCCccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccc---cchhhhhhhccchhHHHhhh
Q 001544 922 EDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGE---MTLKHWVNDFLPISMMKIID 998 (1057)
Q Consensus 922 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 998 (1057)
. ......++..|+|||...+..++.++||||+|+++|||++|+.||....... .....|........
T Consensus 158 ~----~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~------ 227 (287)
T cd06621 158 S----LAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPE------ 227 (287)
T ss_pred c----ccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchh------
Confidence 1 1123356788999999988899999999999999999999999987642211 11111111100000
Q ss_pred cccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 999 ANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 999 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
. ..........++++.+++.+||+.+|++|||+.|++++
T Consensus 228 --~----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 228 --L----KDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred --h----ccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 0 00000001235678999999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=313.08 Aligned_cols=248 Identities=27% Similarity=0.373 Sum_probs=198.5
Q ss_pred hCCCCCCceeccccCeEEEEEEec-CCcEEEEEEeecc---chhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEE
Q 001544 768 TNGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQ---HERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALI 843 (1057)
Q Consensus 768 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 843 (1057)
...|+..+.||+|+||+||+|... +++.||+|++... .....+++.+|+++++.++||||+++++++.+++..++|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 345888899999999999999865 6899999998533 233456788999999999999999999999999999999
Q ss_pred EEEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCC
Q 001544 844 LEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGED 923 (1057)
Q Consensus 844 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~ 923 (1057)
|||++ |++.+.+......+++.++..++.|++.|+.||| +.+|+||||+|+||++++++.++|+|||++......
T Consensus 94 ~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH---~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~- 168 (307)
T cd06607 94 MEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA- 168 (307)
T ss_pred HHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEECCCCCEEEeecCcceecCCC-
Confidence 99997 5777777655556999999999999999999999 999999999999999999999999999998754221
Q ss_pred CccccccccccccccCccccC---CCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhcc
Q 001544 924 QSMTQTQTLATLGYMAPEYGR---EGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDAN 1000 (1057)
Q Consensus 924 ~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1000 (1057)
....++..|+|||++. ...++.++||||||+++|||++|+.||........ ........
T Consensus 169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~-------------~~~~~~~~ 230 (307)
T cd06607 169 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-------------LYHIAQND 230 (307)
T ss_pred -----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH-------------HHHHhcCC
Confidence 2345778899999874 45688999999999999999999999864211100 00000000
Q ss_pred cccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHH
Q 001544 1001 LLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRL 1044 (1057)
Q Consensus 1001 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 1044 (1057)
. .......++.++.+++.+||+.+|++||++.+++++.
T Consensus 231 ~------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 268 (307)
T cd06607 231 S------PTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR 268 (307)
T ss_pred C------CCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 0 0001123566799999999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=309.97 Aligned_cols=248 Identities=27% Similarity=0.348 Sum_probs=200.5
Q ss_pred CCCCceeccccCeEEEEEEe-cCCcEEEEEEeeccchhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEEccC
Q 001544 771 FSENNLIGRGSFGSVYIARL-QNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEYMRN 849 (1057)
Q Consensus 771 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 849 (1057)
|...+.||+|++|.||+|.. .+++.||+|+++.......+.+.+|+.++++++|||++++++++...+..++|+||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 44568999999999999985 46899999998765555566788999999999999999999999999999999999999
Q ss_pred CChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCccccc
Q 001544 850 GSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQT 929 (1057)
Q Consensus 850 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 929 (1057)
++|.+++.. ..+++.++..++.|++.|++||| +.+++||||+|+||+++.++.++++|||.+....... ....
T Consensus 101 ~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~--~~~~ 173 (285)
T cd06648 101 GALTDIVTH--TRMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV--PRRK 173 (285)
T ss_pred CCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChhhEEEcCCCcEEEcccccchhhccCC--cccc
Confidence 999999877 34899999999999999999999 9999999999999999999999999999887542211 1222
Q ss_pred cccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhcccccccchhh
Q 001544 930 QTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHF 1009 (1057)
Q Consensus 930 ~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1057)
...++..|+|||...+..++.++||||+|+++|||++|+.||..... .... ..+.... ....
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~-----~~~~---------~~~~~~~----~~~~ 235 (285)
T cd06648 174 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP-----LQAM---------KRIRDNL----PPKL 235 (285)
T ss_pred cccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH-----HHHH---------HHHHhcC----CCCC
Confidence 34578899999999888899999999999999999999999854111 0000 0000000 0001
Q ss_pred HHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 1010 AAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 1010 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
.....++..+.+++.+||+.+|++||++.|++++
T Consensus 236 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 236 KNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred cccccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 1112256779999999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=310.26 Aligned_cols=254 Identities=28% Similarity=0.367 Sum_probs=207.3
Q ss_pred HhCCCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccchhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEE
Q 001544 767 ATNGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILE 845 (1057)
Q Consensus 767 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 845 (1057)
..+.|+..+.||+|++|.||+|..+ ++..||+|++..... ..+.+.+|++.+++++|+|++++++++...+..++|+|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 4556888899999999999999876 689999999976554 45778899999999999999999999999999999999
Q ss_pred EccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCc
Q 001544 846 YMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS 925 (1057)
Q Consensus 846 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 925 (1057)
|+++++|.+++......+++.++..++.|++.|++||| +.+++|+||+|+||+++.++.++|+|||.+.......
T Consensus 96 ~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~-- 170 (286)
T cd06614 96 YMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK-- 170 (286)
T ss_pred ccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCChhhEEEcCCCCEEECccchhhhhccch--
Confidence 99999999999876556999999999999999999999 8999999999999999999999999999987653221
Q ss_pred cccccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhccccccc
Q 001544 926 MTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITE 1005 (1057)
Q Consensus 926 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1057)
.......++..|+|||...+..++.++||||||+++|||++|+.||....... ... ......
T Consensus 171 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~-~~~------------~~~~~~----- 232 (286)
T cd06614 171 SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR-ALF------------LITTKG----- 232 (286)
T ss_pred hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH-HHH------------HHHhcC-----
Confidence 12223346789999999988889999999999999999999999986421110 000 000000
Q ss_pred chhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHH
Q 001544 1006 DKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRL 1044 (1057)
Q Consensus 1006 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 1044 (1057)
.........++.++.+++.+|++.+|.+||++.+++++-
T Consensus 233 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~ 271 (286)
T cd06614 233 IPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHP 271 (286)
T ss_pred CCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhCh
Confidence 001111233567899999999999999999999998754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=309.35 Aligned_cols=253 Identities=25% Similarity=0.357 Sum_probs=200.8
Q ss_pred HhCCCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccchhHHHHHHHHHHHHHhc-CCCCceeEeeeeccC------C
Q 001544 767 ATNGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQHERAFKSFDTECEVMKSI-RHRNLTKIISSCSNE------D 838 (1057)
Q Consensus 767 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~------~ 838 (1057)
.+++|++.+.||+|++|.||+|... +++.||+|++..... ..+++.+|+++++++ +|+||+++++++.+. +
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 4678999999999999999999875 678999999875543 346789999999999 699999999998653 4
Q ss_pred eeEEEEEEccCCChhHHHhcC---CccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccc
Q 001544 839 FKALILEYMRNGSLEKCLYSG---NYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGI 915 (1057)
Q Consensus 839 ~~~lV~E~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 915 (1057)
..++||||+++++|.+++... +..+++..+..++.|+++|++||| +.+++||||+|+||++++++.+|++|||.
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEEccCCeEEECCCcc
Confidence 589999999999999987653 356899999999999999999999 99999999999999999999999999999
Q ss_pred cccccCCCCccccccccccccccCccccCC-----CCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccc
Q 001544 916 AKLLIGEDQSMTQTQTLATLGYMAPEYGRE-----GRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLP 990 (1057)
Q Consensus 916 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 990 (1057)
+...... ........++..|+|||++.. ..++.++||||+|+++|||++|+.||......+ ...
T Consensus 160 ~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~-------- 228 (275)
T cd06608 160 SAQLDST--LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR-ALF-------- 228 (275)
T ss_pred ceecccc--hhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH-HHH--------
Confidence 8765321 122233457889999998643 346789999999999999999999986421111 011
Q ss_pred hhHHHhhhcccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 991 ISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 991 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
..... ..........++.++.+++.+||..||++|||+.|++++
T Consensus 229 ----~~~~~-----~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 229 ----KIPRN-----PPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred ----Hhhcc-----CCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 11000 000111123356788999999999999999999999874
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=289.40 Aligned_cols=274 Identities=22% Similarity=0.288 Sum_probs=199.8
Q ss_pred HhCCCCCCceeccccCeEEEEEEec---C--CcEEEEEEeeccch--hHHHHHHHHHHHHHhcCCCCceeEeeeecc-CC
Q 001544 767 ATNGFSENNLIGRGSFGSVYIARLQ---N--GIEVAVKTFDLQHE--RAFKSFDTECEVMKSIRHRNLTKIISSCSN-ED 838 (1057)
Q Consensus 767 ~~~~~~~~~~lg~G~~g~Vy~~~~~---~--~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~ 838 (1057)
....|+....||+|.||.||+|.-. + ...+|+|.++.+.+ ......-+|+.+++.++|||++.+...+-. +.
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~ 101 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDK 101 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence 3456888999999999999999532 2 23799999976532 334556789999999999999999999877 78
Q ss_pred eeEEEEEEccCCChhHHHhcCC----ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCC----CcEEE
Q 001544 839 FKALILEYMRNGSLEKCLYSGN----YILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDN----MVAHL 910 (1057)
Q Consensus 839 ~~~lV~E~~~~gsL~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~----~~~kl 910 (1057)
..++++||++. +|.+.++-.+ +.++...+..|+.||+.|+.||| +.-|+|||+||.||++..+ |.+||
T Consensus 102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH---~NWvlHRDLKPaNIlvmgdgperG~VKI 177 (438)
T KOG0666|consen 102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLH---SNWVLHRDLKPANILVMGDGPERGRVKI 177 (438)
T ss_pred eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHh---hhheeeccCCcceEEEeccCCccCeeEe
Confidence 88999999988 8888876433 56888999999999999999999 8999999999999999877 99999
Q ss_pred EcccccccccCCCCc-cccccccccccccCccccCCCC-CCccchHHHHHHHHHHHhhCCCCCCccccc-----------
Q 001544 911 SDFGIAKLLIGEDQS-MTQTQTLATLGYMAPEYGREGR-VSTKGDVYSFGILLMETFTRRKPTDEIFSG----------- 977 (1057)
Q Consensus 911 ~Dfg~a~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~-~~~~~Dv~s~G~il~elltg~~p~~~~~~~----------- 977 (1057)
+|||+++.+...-.. ......+.|.+|+|||.+.+.+ ||++.|||+.||++.||+|-.+-|......
T Consensus 178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQ 257 (438)
T KOG0666|consen 178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQ 257 (438)
T ss_pred ecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHH
Confidence 999999987543222 2445567899999999988764 789999999999999999988766431100
Q ss_pred ---------ccchhhhhhhcc-ch--hHHHhhhcccccc--cchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 978 ---------EMTLKHWVNDFL-PI--SMMKIIDANLLIT--EDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 978 ---------~~~~~~~~~~~~-~~--~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
..+...|-.... |+ .....+....... -.........-++...+++.+++.+||.+|.|+++++++
T Consensus 258 l~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh 337 (438)
T KOG0666|consen 258 LDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH 337 (438)
T ss_pred HHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence 000111211100 00 0001111000000 000111111123447899999999999999999999987
Q ss_pred H
Q 001544 1044 L 1044 (1057)
Q Consensus 1044 L 1044 (1057)
.
T Consensus 338 ~ 338 (438)
T KOG0666|consen 338 P 338 (438)
T ss_pred c
Confidence 5
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=306.23 Aligned_cols=252 Identities=25% Similarity=0.346 Sum_probs=206.7
Q ss_pred CCCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccch-hHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEE
Q 001544 769 NGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQHE-RAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEY 846 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 846 (1057)
++|++.+.||+|++|.||+|+.. +++.||||++..... .....+.+|++.+++++|+|++++++++..++..++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 36788899999999999999876 599999999876543 4567899999999999999999999999999999999999
Q ss_pred ccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCC-CCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCc
Q 001544 847 MRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYS-APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS 925 (1057)
Q Consensus 847 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~-~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 925 (1057)
+++++|.+++... ..+++..+..++.|+++|++||| + .+++||||+|+||+++.++.++++|||.+........
T Consensus 81 ~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh---~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~- 155 (264)
T cd06623 81 MDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLH---TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD- 155 (264)
T ss_pred cCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHh---ccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCC-
Confidence 9999999998765 45899999999999999999999 8 9999999999999999999999999999986632221
Q ss_pred cccccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhccccccc
Q 001544 926 MTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITE 1005 (1057)
Q Consensus 926 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1057)
......++..|+|||...+..++.++|+||||+++|||++|+.||...... ...+. ...+.....
T Consensus 156 -~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~--~~~~~--------~~~~~~~~~---- 220 (264)
T cd06623 156 -QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQP--SFFEL--------MQAICDGPP---- 220 (264)
T ss_pred -cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccccc--CHHHH--------HHHHhcCCC----
Confidence 112345788999999998888999999999999999999999998764321 00000 001110000
Q ss_pred chhhHHHHH-HHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 1006 DKHFAAKEQ-CASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 1006 ~~~~~~~~~-~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
...... ++..+.+++.+|++.+|++||++.|++++
T Consensus 221 ---~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 221 ---PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred ---CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 011122 56789999999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=306.24 Aligned_cols=252 Identities=23% Similarity=0.331 Sum_probs=202.2
Q ss_pred CCCCCceeccccCeEEEEEEe-cCCcEEEEEEeecc--chhHHHHHHHHHHHHHhcCCCCceeEeeeecc--CCeeEEEE
Q 001544 770 GFSENNLIGRGSFGSVYIARL-QNGIEVAVKTFDLQ--HERAFKSFDTECEVMKSIRHRNLTKIISSCSN--EDFKALIL 844 (1057)
Q Consensus 770 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lV~ 844 (1057)
+|++.+.||+|+||.||+|.. .+++.||+|++... .....+++..|++++++++||||+++++++.. +...++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 477889999999999999975 46889999998643 33445778899999999999999999997753 45678999
Q ss_pred EEccCCChhHHHhcC---CccCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEEccCCCCCeeeCCCCcEEEEcccccccc
Q 001544 845 EYMRNGSLEKCLYSG---NYILDIFQRLNIMIDVASALEYLHFGY--SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL 919 (1057)
Q Consensus 845 E~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~i~~~L~~LH~~~--~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~ 919 (1057)
||+++++|.+++... ...+++.+++.++.|+++|++|||..+ +.+++||||||+||+++.++.+|++|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999998653 356899999999999999999999543 678999999999999999999999999999875
Q ss_pred cCCCCccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhc
Q 001544 920 IGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDA 999 (1057)
Q Consensus 920 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 999 (1057)
.... .......++..|+|||.+....++.++|+||+|+++|+|++|+.||...... ... +.+..
T Consensus 161 ~~~~--~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~------------~~~~~ 224 (265)
T cd08217 161 GHDS--SFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL--QLA------------SKIKE 224 (265)
T ss_pred cCCc--ccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH--HHH------------HHHhc
Confidence 3222 1123346788999999998888999999999999999999999998753211 111 11111
Q ss_pred ccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 1000 NLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 1000 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
... ...+...+.++.+++.+|++.+|++||++.|++++
T Consensus 225 ~~~------~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 225 GKF------RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred CCC------CCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 000 01123456788999999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=301.92 Aligned_cols=250 Identities=29% Similarity=0.433 Sum_probs=205.9
Q ss_pred CCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccchhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEEcc
Q 001544 770 GFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEYMR 848 (1057)
Q Consensus 770 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 848 (1057)
+|+..+.||+|++|.||+|... +++.|++|++........+.+.+|++.+++++||+++++++++......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4777899999999999999875 689999999976655566889999999999999999999999999999999999999
Q ss_pred CCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCcccc
Q 001544 849 NGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQ 928 (1057)
Q Consensus 849 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 928 (1057)
+++|.+++......+++..+..++.|+++|++||| +.+++||||+|+||++++++.++|+|||.+........ .
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~ 154 (253)
T cd05122 81 GGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---R 154 (253)
T ss_pred CCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhh---cCCEecCCCCHHHEEEccCCeEEEeecccccccccccc---c
Confidence 99999998876567999999999999999999999 89999999999999999999999999999986533221 2
Q ss_pred ccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhcccccccchh
Q 001544 929 TQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKH 1008 (1057)
Q Consensus 929 ~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1008 (1057)
....++..|+|||......++.++||||+|+++|+|++|+.||........ ... .... ....
T Consensus 155 ~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-------------~~~-~~~~----~~~~ 216 (253)
T cd05122 155 NTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKA-------------LFK-IATN----GPPG 216 (253)
T ss_pred cceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHH-------------HHH-HHhc----CCCC
Confidence 345678899999999888899999999999999999999999865211000 000 0000 0000
Q ss_pred hHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 1009 FAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 1009 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
......++..+.+++.+|+..||++|||+.|+++|
T Consensus 217 ~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 217 LRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred cCcccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11112235678999999999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=306.50 Aligned_cols=251 Identities=22% Similarity=0.376 Sum_probs=186.4
Q ss_pred eeccccCeEEEEEEecCC---cEEEEEEeeccc-hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEEccCCC
Q 001544 776 LIGRGSFGSVYIARLQNG---IEVAVKTFDLQH-ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEYMRNGS 851 (1057)
Q Consensus 776 ~lg~G~~g~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gs 851 (1057)
.||+|+||+||+|...++ ..+++|.++... ....+.+.+|+.+++.++||||+++++++.+....++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 599999999999975433 356677765433 3445788999999999999999999999999999999999999999
Q ss_pred hhHHHhcCC---ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCcccc
Q 001544 852 LEKCLYSGN---YILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQ 928 (1057)
Q Consensus 852 L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 928 (1057)
|.+++.+.. ...++..+..++.||++||+||| +.+++||||||+||+++.++.+||+|||++............
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 999987643 34667778899999999999999 899999999999999999999999999998643222111222
Q ss_pred ccccccccccCccccCC-------CCCCccchHHHHHHHHHHHhhC-CCCCCcccccccchhhhhhhccchhHHHhhhcc
Q 001544 929 TQTLATLGYMAPEYGRE-------GRVSTKGDVYSFGILLMETFTR-RKPTDEIFSGEMTLKHWVNDFLPISMMKIIDAN 1000 (1057)
Q Consensus 929 ~~~~~t~~y~aPE~~~~-------~~~~~~~Dv~s~G~il~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1000 (1057)
....++..|+|||+... ..++.++|||||||++|||+++ ..||......+ ....... .......+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-~~~~~~~----~~~~~~~~-- 231 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDRE-VLNHVIK----DQQVKLFK-- 231 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHHh----hcccccCC--
Confidence 33457789999998743 2457899999999999999975 56765421110 0110000 00000000
Q ss_pred cccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHH
Q 001544 1001 LLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLL 1045 (1057)
Q Consensus 1001 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 1045 (1057)
.......+..+.+++..|| .+|++||+++|+++.|.
T Consensus 232 --------~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 232 --------PQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred --------CccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 0011124567888999999 67999999999998774
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=313.34 Aligned_cols=254 Identities=21% Similarity=0.306 Sum_probs=197.7
Q ss_pred CCCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccc---hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEE
Q 001544 769 NGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQH---ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALIL 844 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 844 (1057)
++|+..+.||+|+||.||+|... +++.||+|.+.... ......+.+|+++++.++||||+++++++..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36888899999999999999865 57899999986543 234567889999999999999999999999999999999
Q ss_pred EEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCC
Q 001544 845 EYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ 924 (1057)
Q Consensus 845 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 924 (1057)
||+++++|.+++...+ .+++..+..++.|++.|++||| +.+++||||||+||+++.++.+|++|||.++.......
T Consensus 81 e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~ 156 (305)
T cd05609 81 EYVEGGDCATLLKNIG-ALPVDMARMYFAETVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT 156 (305)
T ss_pred ecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcc
Confidence 9999999999997654 5899999999999999999999 89999999999999999999999999999864211000
Q ss_pred -------------ccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccch
Q 001544 925 -------------SMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPI 991 (1057)
Q Consensus 925 -------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 991 (1057)
........++..|+|||.+....++.++|+||||+++|||++|+.||..... ..+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~-----~~~~~----- 226 (305)
T cd05609 157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP-----EELFG----- 226 (305)
T ss_pred ccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHH-----
Confidence 0011123467789999999888899999999999999999999999854211 11100
Q ss_pred hHHHhhhcccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHH
Q 001544 992 SMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRL 1044 (1057)
Q Consensus 992 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 1044 (1057)
........ .......++.++.+++.+||+.+|++||++.++.+.+
T Consensus 227 ---~~~~~~~~-----~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll 271 (305)
T cd05609 227 ---QVISDDIE-----WPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVK 271 (305)
T ss_pred ---HHHhcccC-----CCCccccCCHHHHHHHHHHhccChhhccCccCHHHHH
Confidence 00000000 0001113567789999999999999999854444333
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=312.33 Aligned_cols=245 Identities=25% Similarity=0.323 Sum_probs=201.8
Q ss_pred CCCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccc---hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEE
Q 001544 769 NGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQH---ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALIL 844 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 844 (1057)
++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 36888899999999999999865 68999999986432 234567889999999999999999999999999999999
Q ss_pred EEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCC
Q 001544 845 EYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ 924 (1057)
Q Consensus 845 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 924 (1057)
||+++++|.+++.... .+++..+..++.|+++||+||| +.+++||||+|+||+++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~~-~l~~~~~~~~~~qil~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-- 154 (290)
T cd05580 81 EYVPGGELFSHLRKSG-RFPEPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-- 154 (290)
T ss_pred ecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--
Confidence 9999999999987764 5899999999999999999999 899999999999999999999999999999865322
Q ss_pred ccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhcccccc
Q 001544 925 SMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLIT 1004 (1057)
Q Consensus 925 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1057)
.....+++.|+|||...+...+.++||||+|+++|||++|+.||...... .. .......
T Consensus 155 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~---------~~~~~~~----- 213 (290)
T cd05580 155 ---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI----QI---------YEKILEG----- 213 (290)
T ss_pred ---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH----HH---------HHHHhcC-----
Confidence 23345788999999998888899999999999999999999998652210 00 0011100
Q ss_pred cchhhHHHHHHHHHHHHHHhHcccCCCCCCC-----CHHHHHHH
Q 001544 1005 EDKHFAAKEQCASSVFNLAMECTVESPDERI-----TAKEIVRR 1043 (1057)
Q Consensus 1005 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~ 1043 (1057)
....+...+..+.+++.+||..+|++|| +++|+++|
T Consensus 214 ---~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 214 ---KVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred ---CccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 0111123466788999999999999999 78888765
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=309.41 Aligned_cols=250 Identities=27% Similarity=0.355 Sum_probs=193.1
Q ss_pred CCCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccc-hhHHHHHHHHHHH-HHhcCCCCceeEeeeeccCCeeEEEEE
Q 001544 769 NGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQH-ERAFKSFDTECEV-MKSIRHRNLTKIISSCSNEDFKALILE 845 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lV~E 845 (1057)
++|++.+.||+|+||.||+|... +|+.||+|+++... ......+..|+.. ++..+||||+++++++..++..++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 36888999999999999999865 69999999986543 2223445556665 566789999999999999999999999
Q ss_pred EccCCChhHHHhc---CCccCCHHHHHHHHHHHHHHHHHHHhCCCC-CeEEccCCCCCeeeCCCCcEEEEcccccccccC
Q 001544 846 YMRNGSLEKCLYS---GNYILDIFQRLNIMIDVASALEYLHFGYSA-PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIG 921 (1057)
Q Consensus 846 ~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~-~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~ 921 (1057)
|++ |+|.+++.. ....+++..+..++.|++.|++||| ++ +++||||||+||+++.++.+||+|||.++....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH---SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 997 588777654 2346899999999999999999999 76 999999999999999999999999999986532
Q ss_pred CCCccccccccccccccCccccCC----CCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhh
Q 001544 922 EDQSMTQTQTLATLGYMAPEYGRE----GRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKII 997 (1057)
Q Consensus 922 ~~~~~~~~~~~~t~~y~aPE~~~~----~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 997 (1057)
. .......++..|+|||.+.+ ..++.++|+||+||++|||++|+.||.......... ....
T Consensus 157 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~------------~~~~ 221 (283)
T cd06617 157 S---VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQL------------KQVV 221 (283)
T ss_pred c---cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHH------------HHHH
Confidence 1 12233457888999998764 446889999999999999999999986422111111 1111
Q ss_pred hcccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 998 DANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 998 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
..... ..+ ...++.++.+++.+||..+|++||++.+++++
T Consensus 222 ~~~~~-----~~~-~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 222 EEPSP-----QLP-AEKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred hcCCC-----CCC-ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 10000 000 12356778999999999999999999999974
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=308.98 Aligned_cols=266 Identities=26% Similarity=0.316 Sum_probs=199.0
Q ss_pred CCCCceeccccCeEEEEEEec-CCcEEEEEEeeccc--hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEEc
Q 001544 771 FSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQH--ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEYM 847 (1057)
Q Consensus 771 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 847 (1057)
|++.+.||+|++|.||+|... +|+.||||++.... ......+.+|++++++++|||++++++++.+++..++||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 567789999999999999864 79999999986543 223456888999999999999999999999999999999999
Q ss_pred cCCChhHHHhcCC-ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCcc
Q 001544 848 RNGSLEKCLYSGN-YILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSM 926 (1057)
Q Consensus 848 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 926 (1057)
+ ++|.+++.... ..+++.++..++.|+++||+||| +.+++||||+|+||++++++.++++|||.+...... ..
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH---~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~--~~ 154 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVP--VR 154 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCC--cc
Confidence 5 68999887654 45899999999999999999999 899999999999999999999999999999764221 11
Q ss_pred ccccccccccccCccccCCC-CCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhcc-ch-hHH-------Hh
Q 001544 927 TQTQTLATLGYMAPEYGREG-RVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFL-PI-SMM-------KI 996 (1057)
Q Consensus 927 ~~~~~~~t~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~-~~-~~~-------~~ 996 (1057)
......++..|+|||++.+. .++.++|+||+|+++|||++|+.||......+. ......... +. ... +.
T Consensus 155 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07835 155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ-LFRIFRTLGTPDEDVWPGVTSLPDY 233 (283)
T ss_pred ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCChHHhhhhhhchhh
Confidence 22233567899999987654 468899999999999999999999865322111 111110000 00 000 00
Q ss_pred hhcccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 997 IDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 997 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
................+..+.++.+++.+|++.+|++||+++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 234 KPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00000000000111123345788999999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=308.59 Aligned_cols=248 Identities=24% Similarity=0.339 Sum_probs=202.9
Q ss_pred CCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccc---hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEE
Q 001544 770 GFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQH---ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILE 845 (1057)
Q Consensus 770 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 845 (1057)
+|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+++..++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4778899999999999999865 68999999996432 2446788999999999999999999999999999999999
Q ss_pred EccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCc
Q 001544 846 YMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS 925 (1057)
Q Consensus 846 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 925 (1057)
|+++++|.+++... ..+++.++..++.|+++|++||| +.+++|+||+|+||++++++.++++|||.+.......
T Consensus 81 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-- 154 (258)
T cd05578 81 LLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-- 154 (258)
T ss_pred CCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc--
Confidence 99999999998766 46899999999999999999999 8999999999999999999999999999987653221
Q ss_pred cccccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhccccccc
Q 001544 926 MTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITE 1005 (1057)
Q Consensus 926 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1057)
......++..|+|||...+..++.++|+||+|+++|+|++|+.||...... ..... ......
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~---------~~~~~~------ 216 (258)
T cd05578 155 -LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT--IRDQI---------RAKQET------ 216 (258)
T ss_pred -cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc--HHHHH---------HHHhcc------
Confidence 223445788899999998888999999999999999999999998753221 01110 111110
Q ss_pred chhhHHHHHHHHHHHHHHhHcccCCCCCCCCH--HHHHH
Q 001544 1006 DKHFAAKEQCASSVFNLAMECTVESPDERITA--KEIVR 1042 (1057)
Q Consensus 1006 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~--~evl~ 1042 (1057)
.....++..+.++.+++.+||+.||++||++ +|+++
T Consensus 217 -~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 217 -ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred -ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence 0111223456788999999999999999999 66654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=311.29 Aligned_cols=269 Identities=24% Similarity=0.328 Sum_probs=203.1
Q ss_pred CCCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccc--hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEE
Q 001544 769 NGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQH--ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILE 845 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 845 (1057)
++|+..+.||+|+||.||+|..+ +++.||||+++... ....+.+.+|++++++++|+||+++++++..++..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36888999999999999999865 58899999986432 3345778999999999999999999999999999999999
Q ss_pred EccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCc
Q 001544 846 YMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS 925 (1057)
Q Consensus 846 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 925 (1057)
|++++.+..+... ...+++.++..++.|++.|++||| +.+++|||++|+||++++++.+||+|||.+........
T Consensus 81 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~- 155 (288)
T cd07833 81 YVERTLLELLEAS-PGGLPPDAVRSYIWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA- 155 (288)
T ss_pred cCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc-
Confidence 9998777665544 345899999999999999999999 89999999999999999999999999999987643322
Q ss_pred cccccccccccccCccccCCC-CCCccchHHHHHHHHHHHhhCCCCCCcccccccch--hhhhhhccchhHHHhhhcccc
Q 001544 926 MTQTQTLATLGYMAPEYGREG-RVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTL--KHWVNDFLPISMMKIIDANLL 1002 (1057)
Q Consensus 926 ~~~~~~~~t~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 1002 (1057)
.......++..|+|||+..+. .++.++||||+|+++|||++|+.||......+... ..+... .+............
T Consensus 156 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 234 (288)
T cd07833 156 SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGP-LPPSHQELFSSNPR 234 (288)
T ss_pred ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC-CCHHHhhhcccCcc
Confidence 122345678889999998887 78999999999999999999999986532111100 000000 00011111000000
Q ss_pred c------ccchh----hHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 1003 I------TEDKH----FAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 1003 ~------~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
. ..... ...+..++.++.+++.+||..+|++||++++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 235 FAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred ccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 0 00000 00112347889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=314.11 Aligned_cols=253 Identities=28% Similarity=0.391 Sum_probs=202.9
Q ss_pred CCCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccch---hHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEE
Q 001544 769 NGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQHE---RAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALIL 844 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 844 (1057)
++|+..+.||+|+||+||+|... +++.||+|.+..... ...+.+.+|++++++++||||+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36888899999999999999865 589999999965432 34567889999999999999999999999999999999
Q ss_pred EEccCCChhHHHhcCC-ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCC
Q 001544 845 EYMRNGSLEKCLYSGN-YILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGED 923 (1057)
Q Consensus 845 E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~ 923 (1057)
||+.+++|.+++.... ..+++..+..++.|+++||+||| +.+++||||||+||+++.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence 9999999999987543 56899999999999999999999 9999999999999999999999999999987542211
Q ss_pred Cc---------------------------cccccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccc
Q 001544 924 QS---------------------------MTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFS 976 (1057)
Q Consensus 924 ~~---------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~ 976 (1057)
.. .......|+..|+|||+..+..++.++||||||+++|||++|+.||.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 10 011123578889999999888899999999999999999999999865221
Q ss_pred cccchhhhhhhccchhHHHhhhcccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCC----HHHHHHH
Q 001544 977 GEMTLKHWVNDFLPISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERIT----AKEIVRR 1043 (1057)
Q Consensus 977 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps----~~evl~~ 1043 (1057)
.+ ......+... ..+.....+.++.+++.+|++.+|++||+ +.|++++
T Consensus 238 ~~-------------~~~~~~~~~~------~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 238 DE-------------TFSNILKKEV------TFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred HH-------------HHHHHhcCCc------cCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 10 0111111111 11111125678999999999999999999 7777775
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=307.43 Aligned_cols=248 Identities=28% Similarity=0.428 Sum_probs=199.6
Q ss_pred CCCCCceeccccCeEEEEEEe-cCCcEEEEEEeeccc-hhHHHHHHHHHHHHHhcC---CCCceeEeeeeccCCeeEEEE
Q 001544 770 GFSENNLIGRGSFGSVYIARL-QNGIEVAVKTFDLQH-ERAFKSFDTECEVMKSIR---HRNLTKIISSCSNEDFKALIL 844 (1057)
Q Consensus 770 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lV~ 844 (1057)
.|+..+.||+|+||.||+|.. .+++.||+|.++... ....+++.+|++++++++ |||++++++++.++...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 467788999999999999985 478999999986542 344567889999999997 999999999999999999999
Q ss_pred EEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCC
Q 001544 845 EYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ 924 (1057)
Q Consensus 845 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 924 (1057)
||+++++|.+++... .+++..+..++.|++.|++||| +.+++||||+|+||+++.++.++++|||.+..+....
T Consensus 82 e~~~~~~L~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~- 155 (277)
T cd06917 82 EYAEGGSVRTLMKAG--PIAEKYISVIIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS- 155 (277)
T ss_pred ecCCCCcHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc-
Confidence 999999999988664 5899999999999999999999 9999999999999999999999999999998764322
Q ss_pred ccccccccccccccCccccCCC-CCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhccccc
Q 001544 925 SMTQTQTLATLGYMAPEYGREG-RVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLI 1003 (1057)
Q Consensus 925 ~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1003 (1057)
.......|+..|+|||...++ .++.++|||||||++|||++|+.||...... .+... ....
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~-----~~~~~---------~~~~--- 217 (277)
T cd06917 156 -SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF-----RAMML---------IPKS--- 217 (277)
T ss_pred -cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChh-----hhhhc---------cccC---
Confidence 222334688899999987654 4688999999999999999999998653211 11000 0000
Q ss_pred ccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 1004 TEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 1004 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
...... ....+.++.+++.+||+.||++||++.|++++
T Consensus 218 -~~~~~~-~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 218 -KPPRLE-DNGYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred -CCCCCC-cccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 000000 01145678999999999999999999999875
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=309.92 Aligned_cols=268 Identities=22% Similarity=0.254 Sum_probs=199.5
Q ss_pred CCCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccc--hhHHHHHHHHHHHHHhcCCCCceeEeeeeccC--CeeEEE
Q 001544 769 NGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQH--ERAFKSFDTECEVMKSIRHRNLTKIISSCSNE--DFKALI 843 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lV 843 (1057)
++|+..+.||+|+||.||+|... +++.||+|.++... ......+.+|++++++++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46888899999999999999876 58899999986443 22234567899999999999999999998776 899999
Q ss_pred EEEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCC
Q 001544 844 LEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGED 923 (1057)
Q Consensus 844 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~ 923 (1057)
|||+++ +|.+++......+++.++..++.|+++||+||| +.+++||||||+||+++.++.+||+|||.+.......
T Consensus 85 ~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 85 MEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL 160 (293)
T ss_pred ehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence 999975 999988776667999999999999999999999 8999999999999999999999999999998653321
Q ss_pred CccccccccccccccCccccCCC-CCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhc---cchhHHHhhhc
Q 001544 924 QSMTQTQTLATLGYMAPEYGREG-RVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDF---LPISMMKIIDA 999 (1057)
Q Consensus 924 ~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 999 (1057)
.......++..|+|||.+.+. .++.++|+||+|+++|||++|+.||......+ ......... .+.......+.
T Consensus 161 --~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 237 (293)
T cd07843 161 --KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEID-QLNKIFKLLGTPTEKIWPGFSEL 237 (293)
T ss_pred --cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCchHHHHHhhcc
Confidence 222334578889999987654 46889999999999999999999987532111 000000000 00000000000
Q ss_pred cccc-----ccch---hhHHHHH-HHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 1000 NLLI-----TEDK---HFAAKEQ-CASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 1000 ~~~~-----~~~~---~~~~~~~-~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
.... .... ....+.. ++..+.+++.+||+.+|++|||+.|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 238 PGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred chhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0000 0000 0000011 36678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=301.50 Aligned_cols=252 Identities=29% Similarity=0.422 Sum_probs=206.5
Q ss_pred CCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccc--hhHHHHHHHHHHHHHhcCCCCceeEeeeeccC--CeeEEEE
Q 001544 770 GFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQH--ERAFKSFDTECEVMKSIRHRNLTKIISSCSNE--DFKALIL 844 (1057)
Q Consensus 770 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lV~ 844 (1057)
+|+..+.||+|++|.||+|... +++.|++|++.... ....+.+.+|++++++++||||+++++.+.+. +..++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4677899999999999999876 78999999986554 24567899999999999999999999999888 8999999
Q ss_pred EEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCC
Q 001544 845 EYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ 924 (1057)
Q Consensus 845 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 924 (1057)
||+++++|.+++.... .+++.++..++.|+++|++||| +.+++||||+|+||+++.++.++|+|||.+........
T Consensus 81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh---~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 156 (260)
T cd06606 81 EYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET 156 (260)
T ss_pred EecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEcccccEEecccccc
Confidence 9999999999988765 6899999999999999999999 89999999999999999999999999999987643322
Q ss_pred ccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhcccccc
Q 001544 925 SMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLIT 1004 (1057)
Q Consensus 925 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1057)
........++..|+|||...+...+.++||||+|+++|+|++|+.||...... ... ......
T Consensus 157 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~---------~~~~~~------ 218 (260)
T cd06606 157 GEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNP---MAA---------LYKIGS------ 218 (260)
T ss_pred cccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch---HHH---------HHhccc------
Confidence 11233456788999999998888999999999999999999999998763210 000 001100
Q ss_pred cchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 1005 EDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 1005 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
.......+...+.++.+++.+|++.+|++||++.|++++
T Consensus 219 ~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 219 SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 000111123346789999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=310.67 Aligned_cols=246 Identities=27% Similarity=0.373 Sum_probs=197.8
Q ss_pred CCCCceeccccCeEEEEEEec-CCcEEEEEEeecc---chhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEE
Q 001544 771 FSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQ---HERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEY 846 (1057)
Q Consensus 771 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 846 (1057)
|+..+.||+|+||.||+|+.. ++..||+|++... .......+.+|++++++++|||++++++++.+++..++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 666789999999999999854 6899999998643 233456788999999999999999999999999999999999
Q ss_pred ccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCcc
Q 001544 847 MRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSM 926 (1057)
Q Consensus 847 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 926 (1057)
+.+ ++.+.+......+++.++..++.|++.|+.||| +.+|+||||+|+||+++.++.++|+|||++.....
T Consensus 107 ~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~----- 177 (317)
T cd06635 107 CLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP----- 177 (317)
T ss_pred CCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcccEEECCCCCEEEecCCCccccCC-----
Confidence 975 788877665667999999999999999999999 99999999999999999999999999999875421
Q ss_pred ccccccccccccCccccC---CCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhccccc
Q 001544 927 TQTQTLATLGYMAPEYGR---EGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLI 1003 (1057)
Q Consensus 927 ~~~~~~~t~~y~aPE~~~---~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1003 (1057)
.....++..|+|||++. .+.++.++|||||||++|||++|+.||...... .....+ .....
T Consensus 178 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-~~~~~~------------~~~~~-- 241 (317)
T cd06635 178 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-SALYHI------------AQNES-- 241 (317)
T ss_pred -cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH-HHHHHH------------HhccC--
Confidence 12345788999999863 456889999999999999999999998652111 001111 10000
Q ss_pred ccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHH
Q 001544 1004 TEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLL 1045 (1057)
Q Consensus 1004 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 1045 (1057)
.......++..+.+++.+|++.+|++||++.|++++..
T Consensus 242 ----~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~ 279 (317)
T cd06635 242 ----PTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMF 279 (317)
T ss_pred ----CCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChh
Confidence 00111234567899999999999999999999999753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=344.42 Aligned_cols=254 Identities=28% Similarity=0.438 Sum_probs=207.3
Q ss_pred HhCCCCCCceeccccCeEEEEEE-ecCCcEEEEEEeeccc--hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEE
Q 001544 767 ATNGFSENNLIGRGSFGSVYIAR-LQNGIEVAVKTFDLQH--ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALI 843 (1057)
Q Consensus 767 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 843 (1057)
.+-+|.....||.|.||.||-|. .++|...|||.++... ....+.+.+|+.++..++|||+|+++|.-...+..+|-
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence 34467778899999999999997 5579999999886543 34557788999999999999999999999989999999
Q ss_pred EEEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCC
Q 001544 844 LEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGED 923 (1057)
Q Consensus 844 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~ 923 (1057)
||||++|+|.+.+..++ ..++.-...+..|++.|++||| +.|||||||||.||+++.+|-+|++|||.|+.+.+..
T Consensus 1313 MEyC~~GsLa~ll~~gr-i~dE~vt~vyt~qll~gla~LH---~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~ 1388 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLEHGR-IEDEMVTRVYTKQLLEGLAYLH---EHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNA 1388 (1509)
T ss_pred HHHhccCcHHHHHHhcc-hhhhhHHHHHHHHHHHHHHHHH---hcCceecCCCccceeeecCCcEEeecccceeEecCch
Confidence 99999999999887765 3666666778899999999999 9999999999999999999999999999999876542
Q ss_pred C--ccccccccccccccCccccCCCC---CCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhh
Q 001544 924 Q--SMTQTQTLATLGYMAPEYGREGR---VSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIID 998 (1057)
Q Consensus 924 ~--~~~~~~~~~t~~y~aPE~~~~~~---~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 998 (1057)
. .......+||+.|||||++.+.. ...++||||+|||+.||+||+.||...... |. -++.
T Consensus 1389 ~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne------~a---------IMy~ 1453 (1509)
T KOG4645|consen 1389 QTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE------WA---------IMYH 1453 (1509)
T ss_pred hcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch------hH---------HHhH
Confidence 1 22334568999999999987543 567899999999999999999998763221 11 1111
Q ss_pred cccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 999 ANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 999 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
+..+...+.++.++++-.+++..|+..||++|.++.|++++
T Consensus 1454 ----V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1454 ----VAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred ----HhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 11111223345588899999999999999999999988876
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=306.10 Aligned_cols=263 Identities=22% Similarity=0.281 Sum_probs=195.9
Q ss_pred CCCCceeccccCeEEEEEEec-CCcEEEEEEeeccc-hhHHHHHHHHHHHHHhcC-CCCceeEeeeeccC--CeeEEEEE
Q 001544 771 FSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQH-ERAFKSFDTECEVMKSIR-HRNLTKIISSCSNE--DFKALILE 845 (1057)
Q Consensus 771 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lV~E 845 (1057)
|++.+.||+|+||.||+|... +++.||+|+++... ........+|+.++.++. |||++++++++.++ +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 567789999999999999854 68999999986532 222234457888999885 99999999999877 88999999
Q ss_pred EccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCc
Q 001544 846 YMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS 925 (1057)
Q Consensus 846 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 925 (1057)
|++ |++.+.+......+++.++..++.|++.||+||| +.+++||||+|+||+++. +.+||+|||.++......
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~-- 153 (282)
T cd07831 81 LMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH---RNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP-- 153 (282)
T ss_pred cCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEcC-CCeEEEecccccccccCC--
Confidence 997 4888888766567899999999999999999999 899999999999999999 999999999998653221
Q ss_pred cccccccccccccCccccC-CCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhcc---chhHHHhhhccc
Q 001544 926 MTQTQTLATLGYMAPEYGR-EGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFL---PISMMKIIDANL 1001 (1057)
Q Consensus 926 ~~~~~~~~t~~y~aPE~~~-~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~ 1001 (1057)
......++..|+|||... ++.++.++||||+||++|||++|..||......+ ...+..... +..+........
T Consensus 154 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
T cd07831 154 -PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD--QIAKIHDVLGTPDAEVLKKFRKSR 230 (282)
T ss_pred -CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH--HHHHHHHHcCCCCHHHHHhhcccc
Confidence 122345788999999754 4567889999999999999999999986532111 111111111 011111111000
Q ss_pred ccc-------cchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 1002 LIT-------EDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 1002 ~~~-------~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
... ...-......++.++.+++.+|++++|++||++.|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 231 HMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred cccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 000 000011123457889999999999999999999999875
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=331.34 Aligned_cols=253 Identities=25% Similarity=0.401 Sum_probs=189.1
Q ss_pred hCCCCCCceeccccCeEEEEEEec-CCcEEEEEEeecc-chhHHHHHHHHHHHHHhcCCCCceeEeeeeccC--------
Q 001544 768 TNGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQ-HERAFKSFDTECEVMKSIRHRNLTKIISSCSNE-------- 837 (1057)
Q Consensus 768 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-------- 837 (1057)
..+|+..++||+||||.||+++.+ ||+.||||++... .......+.+|+.++++++|||||+++..|.+.
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e 557 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE 557 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence 346778899999999999999977 8999999999544 445567889999999999999999997322100
Q ss_pred --------------------------------------------------------------------------------
Q 001544 838 -------------------------------------------------------------------------------- 837 (1057)
Q Consensus 838 -------------------------------------------------------------------------------- 837 (1057)
T Consensus 558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e 637 (1351)
T KOG1035|consen 558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE 637 (1351)
T ss_pred ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence
Q ss_pred -------------------------------CeeEEEEEEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCC
Q 001544 838 -------------------------------DFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGY 886 (1057)
Q Consensus 838 -------------------------------~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~ 886 (1057)
...||-||||+..++.++++.+...-.....++++++|++||+|+|
T Consensus 638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH--- 714 (1351)
T KOG1035|consen 638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIH--- 714 (1351)
T ss_pred CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHH---
Confidence 1257889999998888877765532246678999999999999999
Q ss_pred CCCeEEccCCCCCeeeCCCCcEEEEccccccccc----------------CCCCccccccccccccccCccccCCC---C
Q 001544 887 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLI----------------GEDQSMTQTQTLATLGYMAPEYGREG---R 947 (1057)
Q Consensus 887 ~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~----------------~~~~~~~~~~~~~t~~y~aPE~~~~~---~ 947 (1057)
+.|||||||||.||++++++.|||+|||+|+... ........+..+||.-|+|||++.+. .
T Consensus 715 ~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~ 794 (1351)
T KOG1035|consen 715 DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNK 794 (1351)
T ss_pred hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccc
Confidence 9999999999999999999999999999998721 01122245667899999999987654 4
Q ss_pred CCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhcccccccchhhHHHHHHHHHHHHHHhHcc
Q 001544 948 VSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECT 1027 (1057)
Q Consensus 948 ~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 1027 (1057)
|+.|+|+||+|||++||+. ||....+.-..+.. .-+.... .+ ..+. ....+.-..+|.+|+
T Consensus 795 Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~------------LR~g~iP-~~-~~f~--~~~~~~e~slI~~Ll 855 (1351)
T KOG1035|consen 795 YNSKIDMYSLGIVLFEMLY---PFGTSMERASILTN------------LRKGSIP-EP-ADFF--DPEHPEEASLIRWLL 855 (1351)
T ss_pred ccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHh------------cccCCCC-CC-cccc--cccchHHHHHHHHHh
Confidence 9999999999999999996 56542111111111 1001010 00 0000 111233457999999
Q ss_pred cCCCCCCCCHHHHHH
Q 001544 1028 VESPDERITAKEIVR 1042 (1057)
Q Consensus 1028 ~~dP~~Rps~~evl~ 1042 (1057)
++||.+||||.|+++
T Consensus 856 ~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 856 SHDPSKRPTATELLN 870 (1351)
T ss_pred cCCCccCCCHHHHhh
Confidence 999999999999986
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=305.85 Aligned_cols=267 Identities=23% Similarity=0.287 Sum_probs=200.4
Q ss_pred CCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccch-hHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEEc
Q 001544 770 GFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQHE-RAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEYM 847 (1057)
Q Consensus 770 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 847 (1057)
+|+..+.||+|++|.||+|+.. +|+.||||+++.... ...+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4788899999999999999875 689999999865432 23456778999999999999999999999999999999999
Q ss_pred cCCChhHHHhcCC--ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCc
Q 001544 848 RNGSLEKCLYSGN--YILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS 925 (1057)
Q Consensus 848 ~~gsL~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 925 (1057)
++ +|.+++.... ..+++.++..++.|++.|++||| +.+++||||||+||++++++.++++|||+++..... .
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~--~ 154 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIP--V 154 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCC--c
Confidence 85 8888876544 46899999999999999999999 899999999999999999999999999999754221 1
Q ss_pred cccccccccccccCccccCC-CCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhh---ccchhHHHhhh---
Q 001544 926 MTQTQTLATLGYMAPEYGRE-GRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVND---FLPISMMKIID--- 998 (1057)
Q Consensus 926 ~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~--- 998 (1057)
.......++..|+|||.+.+ ..++.++||||+|+++|||++|+.||......+. ....... ...........
T Consensus 155 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07836 155 NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQ-LLKIFRIMGTPTESTWPGISQLPE 233 (284)
T ss_pred cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHHHhCCCChhhHHHHhcCch
Confidence 12233456889999998765 3568899999999999999999999875322111 1100000 00000000000
Q ss_pred --cccccc-cchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 999 --ANLLIT-EDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 999 --~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
...... ........+.++.++.+++.+|++.||++||++.|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 000000 000011123456789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-33 Score=301.50 Aligned_cols=250 Identities=23% Similarity=0.279 Sum_probs=195.8
Q ss_pred HHHHHHhCCCCCCcee--ccccCeEEEEEEec-CCcEEEEEEeeccchhHHHHHHHHHHHHHhc-CCCCceeEeeeeccC
Q 001544 762 LELFQATNGFSENNLI--GRGSFGSVYIARLQ-NGIEVAVKTFDLQHERAFKSFDTECEVMKSI-RHRNLTKIISSCSNE 837 (1057)
Q Consensus 762 ~~~~~~~~~~~~~~~l--g~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 837 (1057)
.+.....++|++.+.+ |+|+||.||++..+ ++..+|+|++....... .|+.....+ +||||+++++++...
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~~ 81 (267)
T PHA03390 7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTTL 81 (267)
T ss_pred HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEecC
Confidence 3444455677777776 99999999999854 68899999986542211 122222222 699999999999999
Q ss_pred CeeEEEEEEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCC-cEEEEccccc
Q 001544 838 DFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNM-VAHLSDFGIA 916 (1057)
Q Consensus 838 ~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~-~~kl~Dfg~a 916 (1057)
+..++||||+++++|.+++.... .+++.++..++.|+++|++||| +.+++||||||+||+++.++ .++++|||.+
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~ 157 (267)
T PHA03390 82 KGHVLIMDYIKDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLC 157 (267)
T ss_pred CeeEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEeCCCCeEEEecCccc
Confidence 99999999999999999997765 6899999999999999999999 99999999999999999988 9999999998
Q ss_pred ccccCCCCccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHh
Q 001544 917 KLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKI 996 (1057)
Q Consensus 917 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 996 (1057)
+..... ....++..|+|||++.+..++.++||||+|+++|||++|+.||......+.....|....
T Consensus 158 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-------- 223 (267)
T PHA03390 158 KIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-------- 223 (267)
T ss_pred eecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh--------
Confidence 765211 123578899999999888899999999999999999999999975433332222222111
Q ss_pred hhcccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCC-HHHHHHH
Q 001544 997 IDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERIT-AKEIVRR 1043 (1057)
Q Consensus 997 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-~~evl~~ 1043 (1057)
. .........++.+.+++.+|++.+|++||+ ++|+++|
T Consensus 224 -~--------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 224 -Q--------KKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred -c--------ccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence 0 011111246778999999999999999996 6998864
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=311.58 Aligned_cols=269 Identities=25% Similarity=0.276 Sum_probs=199.0
Q ss_pred hCCCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccch--hHHHHHHHHHHHHHhcCCCCceeEeeeeccC--CeeEE
Q 001544 768 TNGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQHE--RAFKSFDTECEVMKSIRHRNLTKIISSCSNE--DFKAL 842 (1057)
Q Consensus 768 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 842 (1057)
.++|++.+.||+|+||.||+|... +|+.||+|+++.... .....+.+|++++++++|+||+++++++.+. +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 457899999999999999999865 689999999864432 2233566799999999999999999998654 56899
Q ss_pred EEEEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCC
Q 001544 843 ILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGE 922 (1057)
Q Consensus 843 V~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~ 922 (1057)
||||+++ +|.+++......+++.++..++.|+++|++||| +.+++||||||+||++++++.+||+|||.+......
T Consensus 86 v~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~ 161 (309)
T cd07845 86 VMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP 161 (309)
T ss_pred EEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence 9999975 888888766567999999999999999999999 999999999999999999999999999999876332
Q ss_pred CCccccccccccccccCccccCC-CCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhcc--chhHHHhhhc
Q 001544 923 DQSMTQTQTLATLGYMAPEYGRE-GRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFL--PISMMKIIDA 999 (1057)
Q Consensus 923 ~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 999 (1057)
. .......++..|+|||.+.+ ..++.++||||+||++|||++|+.||......+ .+........ ........+.
T Consensus 162 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 238 (309)
T cd07845 162 A--KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIE-QLDLIIQLLGTPNESIWPGFSD 238 (309)
T ss_pred c--CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCChhhchhhhc
Confidence 2 12233345778999998765 457899999999999999999999986532111 1110000000 0000000000
Q ss_pred ----ccccccch---hh-HHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 1000 ----NLLITEDK---HF-AAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 1000 ----~~~~~~~~---~~-~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
........ .. ......++++.+++.+|++.||++|||+.|+++|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 239 LPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred ccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00000000 00 0011246778899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=281.55 Aligned_cols=250 Identities=23% Similarity=0.302 Sum_probs=199.7
Q ss_pred CCCCceeccccCeEEEEEEec-CCcEEEEEEeeccc-hhHHHHHHHHHHHHHhcC-CCCceeEeeeeccCCeeEEEEEEc
Q 001544 771 FSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQH-ERAFKSFDTECEVMKSIR-HRNLTKIISSCSNEDFKALILEYM 847 (1057)
Q Consensus 771 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~E~~ 847 (1057)
.+....||.|+.|.||+++.. +|...|||.+.... ....+++...++++..-. .|.||+.+|||..+....+.||.|
T Consensus 94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM 173 (391)
T KOG0983|consen 94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM 173 (391)
T ss_pred hhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH
Confidence 345577999999999999865 58999999996543 445677888888877764 899999999999888888999988
Q ss_pred cCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCccc
Q 001544 848 RNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMT 927 (1057)
Q Consensus 848 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 927 (1057)
.. -+++++..-..++++.-+-++...++.||.||.+ .++|+|||+||+|||+|+.|.+|+||||.+.++. ....
T Consensus 174 s~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlv---dSkA 247 (391)
T KOG0983|consen 174 ST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLV---DSKA 247 (391)
T ss_pred HH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceee---cccc
Confidence 54 6677777666779998888999999999999986 7899999999999999999999999999998763 3344
Q ss_pred cccccccccccCccccCC---CCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhcccccc
Q 001544 928 QTQTLATLGYMAPEYGRE---GRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLIT 1004 (1057)
Q Consensus 928 ~~~~~~t~~y~aPE~~~~---~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1057)
.+...|-+.|||||-+.- ..|+-++||||||+.++|++||+.||..-..+-.. +.++.+.
T Consensus 248 htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~------------ltkvln~----- 310 (391)
T KOG0983|consen 248 HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEV------------LTKVLNE----- 310 (391)
T ss_pred cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHH------------HHHHHhc-----
Confidence 556678889999997753 46888999999999999999999998762222111 1122221
Q ss_pred cchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 1005 EDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 1005 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
..+..+....+++.+.+++..|+..|+.+||...++++|
T Consensus 311 ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 311 EPPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred CCCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 112222223378889999999999999999999999886
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=314.22 Aligned_cols=269 Identities=23% Similarity=0.295 Sum_probs=198.5
Q ss_pred hCCCCCCceeccccCeEEEEEEe-cCCcEEEEEEeecc-chhHHHHHHHHHHHHHhcCCCCceeEeeeeccC-----Cee
Q 001544 768 TNGFSENNLIGRGSFGSVYIARL-QNGIEVAVKTFDLQ-HERAFKSFDTECEVMKSIRHRNLTKIISSCSNE-----DFK 840 (1057)
Q Consensus 768 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~ 840 (1057)
.++|++.+.||+|+||.||+|.. .+|+.||||+++.. .......+.+|++++++++||||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 46899999999999999999975 46899999998643 233456788899999999999999999876543 357
Q ss_pred EEEEEEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEccccccccc
Q 001544 841 ALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLI 920 (1057)
Q Consensus 841 ~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~ 920 (1057)
++|+||+++ ++.+.+... .+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||++....
T Consensus 84 ~lv~e~~~~-~l~~~~~~~--~l~~~~~~~i~~ql~~aL~~LH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~ 157 (336)
T cd07849 84 YIVQELMET-DLYKLIKTQ--HLSNDHIQYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIAD 157 (336)
T ss_pred EEEehhccc-CHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEECcccceeecc
Confidence 999999975 888777543 4899999999999999999999 9999999999999999999999999999997653
Q ss_pred CCCC-ccccccccccccccCccccCC-CCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhc---cchhHHH
Q 001544 921 GEDQ-SMTQTQTLATLGYMAPEYGRE-GRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDF---LPISMMK 995 (1057)
Q Consensus 921 ~~~~-~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~---~~~~~~~ 995 (1057)
.... ........++..|+|||.+.+ ..++.++||||+||++|||++|+.||...... .....+.... .+.....
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~-~~~~~~~~~~~~~~~~~~~~ 236 (336)
T cd07849 158 PEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYL-HQLNLILGVLGTPSQEDLNC 236 (336)
T ss_pred ccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHcCCCCHHHHHH
Confidence 2221 112233467889999998654 56889999999999999999999998652111 0111111000 0011111
Q ss_pred hhhccc-------ccccchhh-HHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 996 IIDANL-------LITEDKHF-AAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 996 ~~~~~~-------~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
+.+... ........ ...+..+.++.+++.+||+.+|++|||+.|+++|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 237 IISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred hhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 111000 00000000 1112346779999999999999999999999987
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-33 Score=310.07 Aligned_cols=270 Identities=21% Similarity=0.289 Sum_probs=197.2
Q ss_pred CCCCCceeccccCeEEEEEEec---CCcEEEEEEeeccc---hhHHHHHHHHHHHHHhcCCCCceeEeeeeccC--CeeE
Q 001544 770 GFSENNLIGRGSFGSVYIARLQ---NGIEVAVKTFDLQH---ERAFKSFDTECEVMKSIRHRNLTKIISSCSNE--DFKA 841 (1057)
Q Consensus 770 ~~~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 841 (1057)
+|++.+.||+|+||.||+|... +++.||+|.+.... ......+.+|++++++++||||+++++++.+. +..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4778899999999999999864 47999999997632 33446678899999999999999999999887 8899
Q ss_pred EEEEEccCCChhHHHhcC----CccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCC----CCcEEEEcc
Q 001544 842 LILEYMRNGSLEKCLYSG----NYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDD----NMVAHLSDF 913 (1057)
Q Consensus 842 lV~E~~~~gsL~~~l~~~----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~----~~~~kl~Df 913 (1057)
+||||+++ ++.+.+... ...+++..+..++.|++.|++||| +.+|+||||||+||+++. ++.+|++||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999976 666655322 136889999999999999999999 999999999999999999 999999999
Q ss_pred cccccccCCCC-ccccccccccccccCccccCCC-CCCccchHHHHHHHHHHHhhCCCCCCccccccc--------chhh
Q 001544 914 GIAKLLIGEDQ-SMTQTQTLATLGYMAPEYGREG-RVSTKGDVYSFGILLMETFTRRKPTDEIFSGEM--------TLKH 983 (1057)
Q Consensus 914 g~a~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~--------~~~~ 983 (1057)
|+++....... ........++..|+|||...+. .++.++||||+||++|||++|+.||........ ....
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99986532221 1222334678899999987654 578999999999999999999999975432210 0000
Q ss_pred hhhhccc--h----------hHHH---hhhcccccccch--hhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 984 WVNDFLP--I----------SMMK---IIDANLLITEDK--HFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 984 ~~~~~~~--~----------~~~~---~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
++..... . .... ............ ........+.++.+++.+|++.||++|||+.|+++|
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0000000 0 0000 000000000000 000001345678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=321.16 Aligned_cols=364 Identities=28% Similarity=0.398 Sum_probs=254.4
Q ss_pred ceeEEeeecccCcc-cccccccCCCCCcEEeCCCCCccccCCcccccccccceeecccccccCCCCccccccCCCCeEec
Q 001544 72 RVTALNISYLSLTG-NIPRQLGNLSSLEILDLNFNRLSGEIPWELGNLAKLEKLLLHNNFLTGTIPFSIFKLSSLLDLKL 150 (1057)
Q Consensus 72 ~v~~l~l~~~~l~g-~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L 150 (1057)
-|..+|+++|.++| ..|.....+++++.|.|...++. .+|++++.|.+|++|.+++|++. .+-.+++.|+.|+.+++
T Consensus 8 FVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~~ 85 (1255)
T KOG0444|consen 8 FVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVIV 85 (1255)
T ss_pred eeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHhh
Confidence 47889999999995 78999999999999999999998 89999999999999999999999 77889999999999999
Q ss_pred cCCCCCCC-CCcccccCCCCCceeEccCCcccccCchhhhccccCCeeEeeccCCccccCccccCCCCcccEEEeecccc
Q 001544 151 SDNNLTGT-IPSHNLGNLSSLQLLDLSDNQLSGSIPSFIFKISSLQALHFGNNRLSGELPANICDNLPFLNFFSVYKNMF 229 (1057)
Q Consensus 151 s~n~l~~~-~p~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~l~~n~~ 229 (1057)
.+|++... ||. .+-.+..|+.||||+|++. ..|..+..-+++-.|+||+|+|. .||..+|-+
T Consensus 86 R~N~LKnsGiP~-diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfin-------------- 148 (1255)
T KOG0444|consen 86 RDNNLKNSGIPT-DIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFIN-------------- 148 (1255)
T ss_pred hccccccCCCCc-hhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccc-cCCchHHHh--------------
Confidence 99998643 565 4778999999999999998 78999999999999999999996 788776554
Q ss_pred ccCccccccCCCCCcEEEccCCCCcCCccccccCcCCCcEEeeeccccccccCccccccccccEEEeecCccc-cccCcc
Q 001544 230 YGGISSTLSNCKHLRILDLSFNDLWGDIPKEIGNLTKLKELFLDFNILQGEIPHTVGNLHNLEYLSLVNNELV-GTVPAT 308 (1057)
Q Consensus 230 ~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-~~~~~~ 308 (1057)
+..|-.||||+|++. .+|+.+..+..|++|.|++|.+....-..+..+++|+.|.+++.+-+ ..+|.+
T Consensus 149 ----------LtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Pts 217 (1255)
T KOG0444|consen 149 ----------LTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTS 217 (1255)
T ss_pred ----------hHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCc
Confidence 455555666666664 44555556666666666666555333333444555555666655433 245555
Q ss_pred ccccccccEEEecCCccccCCCCCcccCCCCCceEEecCccccccCCccccccccccccccccccccccccchhcccccc
Q 001544 309 IFNVSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSGTLPSFIFNASNLSKLSLGDNSFSGLIPNTFGNLRNL 388 (1057)
Q Consensus 309 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 388 (1057)
+..+.+|..+|+|.|.+. .+|...+ .+++|+.|+|++|+|+ .+........+|++|+||.|+++. .|+++..++.|
T Consensus 218 ld~l~NL~dvDlS~N~Lp-~vPecly-~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt~-LP~avcKL~kL 293 (1255)
T KOG0444|consen 218 LDDLHNLRDVDLSENNLP-IVPECLY-KLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLTV-LPDAVCKLTKL 293 (1255)
T ss_pred hhhhhhhhhccccccCCC-cchHHHh-hhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhcc-chHHHhhhHHH
Confidence 556666666666666554 4444443 4556666666666665 333444455566666666666663 36666666666
Q ss_pred cEEeccCcccCCCccccccccCCCcchhhhhccCCCcccccccccccccccccEEEcCCCcccccccccccCccCCcEEE
Q 001544 389 KRLRLYNNYLTSPELSFLSSLSNCKYLEIIALSGNPLNGIIPMSAGNLSHSLEELFMPDCNVSGRIPKEIGNLANLVTLD 468 (1057)
Q Consensus 389 ~~L~L~~N~l~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~ 468 (1057)
+.|.+.+|+++-.+ ..++..++..|+++..++|.+. .+|+.++.+..|+.|.
T Consensus 294 ~kLy~n~NkL~FeG--iPSGIGKL~~Levf~aanN~LE--------------------------lVPEglcRC~kL~kL~ 345 (1255)
T KOG0444|consen 294 TKLYANNNKLTFEG--IPSGIGKLIQLEVFHAANNKLE--------------------------LVPEGLCRCVKLQKLK 345 (1255)
T ss_pred HHHHhccCcccccC--CccchhhhhhhHHHHhhccccc--------------------------cCchhhhhhHHHHHhc
Confidence 66666666665322 2345555555666555555543 4566666666677777
Q ss_pred ccCCcCCCCCCcccccccccceeecccccC
Q 001544 469 LGGNKFNGSIPIALGKLQKLQLLNLDDNKL 498 (1057)
Q Consensus 469 Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~l 498 (1057)
|+.|++. .+|.++.-|+.|+.|||..|.=
T Consensus 346 L~~NrLi-TLPeaIHlL~~l~vLDlreNpn 374 (1255)
T KOG0444|consen 346 LDHNRLI-TLPEAIHLLPDLKVLDLRENPN 374 (1255)
T ss_pred cccccee-echhhhhhcCCcceeeccCCcC
Confidence 7777666 5666666667777777766643
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-34 Score=292.61 Aligned_cols=270 Identities=24% Similarity=0.310 Sum_probs=227.2
Q ss_pred HHHHHhCCCCCCceeccccCeEEEEEEec------CCcEEEEEEeecc-chhHHHHHHHHHHHHHhcCCCCceeEeeeec
Q 001544 763 ELFQATNGFSENNLIGRGSFGSVYIARLQ------NGIEVAVKTFDLQ-HERAFKSFDTECEVMKSIRHRNLTKIISSCS 835 (1057)
Q Consensus 763 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 835 (1057)
++.....+++...++-+|.||.||+|.+. +.+.|-||.++.. .+.+...+..|.-.+....|||+..+.+.+.
T Consensus 278 ~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~i 357 (563)
T KOG1024|consen 278 ELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSI 357 (563)
T ss_pred hhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEe
Confidence 34444456777788999999999999543 4566888877533 3455678888988999999999999999875
Q ss_pred c-CCeeEEEEEEccCCChhHHHhcC-------CccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCc
Q 001544 836 N-EDFKALILEYMRNGSLEKCLYSG-------NYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMV 907 (1057)
Q Consensus 836 ~-~~~~~lV~E~~~~gsL~~~l~~~-------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~ 907 (1057)
+ .+..+.+|.++.-|+|..++... ...++..+...++.|++.|++||| .++|||.||..+|.++|+.-+
T Consensus 358 e~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh---~~~ViHkDiAaRNCvIdd~Lq 434 (563)
T KOG1024|consen 358 EDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH---NHGVIHKDIAARNCVIDDQLQ 434 (563)
T ss_pred eccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH---hcCcccchhhhhcceehhhee
Confidence 4 56788999999999999998722 245778888999999999999999 999999999999999999999
Q ss_pred EEEEcccccccccCCCCccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhh-CCCCCCcccccccchhhhhh
Q 001544 908 AHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFT-RRKPTDEIFSGEMTLKHWVN 986 (1057)
Q Consensus 908 ~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~ 986 (1057)
+|++|=.+++.+.+.+...-.........||+||.+....++.++|||||||++|||+| |+.|+.+..+.|
T Consensus 435 VkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfE-------- 506 (563)
T KOG1024|consen 435 VKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFE-------- 506 (563)
T ss_pred EEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHH--------
Confidence 99999999999998888877777778889999999999999999999999999999999 888987632221
Q ss_pred hccchhHHHhhhcccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHHHhHHHHhhhh
Q 001544 987 DFLPISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKIRDFLLRNV 1055 (1057)
Q Consensus 987 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~~~~~~ 1055 (1057)
+.. ....+.+..++..||.+++.+|.-||..+|++||++++++..|.++..++.+.|
T Consensus 507 ------m~~------ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~qlt~YV 563 (563)
T KOG1024|consen 507 ------MEH------YLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQLTRYV 563 (563)
T ss_pred ------HHH------HHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHHhhcC
Confidence 111 223455667778899999999999999999999999999999999999888764
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=313.67 Aligned_cols=270 Identities=24% Similarity=0.303 Sum_probs=200.6
Q ss_pred HhCCCCCCceeccccCeEEEEEEec-CCcEEEEEEeecc--chhHHHHHHHHHHHHHhc-CCCCceeEeeeeccC--Cee
Q 001544 767 ATNGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQ--HERAFKSFDTECEVMKSI-RHRNLTKIISSCSNE--DFK 840 (1057)
Q Consensus 767 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~--~~~ 840 (1057)
..++|++.+.||+|+||.||+|... +++.||||++... .......+.+|+.+++++ +||||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 3457888899999999999999865 6889999988532 233445677899999999 999999999988643 468
Q ss_pred EEEEEEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEccccccccc
Q 001544 841 ALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLI 920 (1057)
Q Consensus 841 ~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~ 920 (1057)
++||||++ ++|..++... .+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||.++...
T Consensus 85 ~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH---~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~ 158 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLS 158 (337)
T ss_pred EEEecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccchhccc
Confidence 99999997 5999888765 5889999999999999999999 8999999999999999999999999999998664
Q ss_pred CCCCc---cccccccccccccCccccCC-CCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhh--ccc----
Q 001544 921 GEDQS---MTQTQTLATLGYMAPEYGRE-GRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVND--FLP---- 990 (1057)
Q Consensus 921 ~~~~~---~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~--~~~---- 990 (1057)
..... .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+. ....... ...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~ 237 (337)
T cd07852 159 ELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQ-LEKIIEVIGPPSAEDI 237 (337)
T ss_pred cccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCHHHH
Confidence 33221 12233467889999997654 5578899999999999999999999865322211 0000000 000
Q ss_pred -----hhHHHhhhcccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 991 -----ISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 991 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
.......+..............+.++.++.+++.+||+.+|++|||+.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 238 ESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 00011111000000000111112357789999999999999999999999986
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=302.86 Aligned_cols=249 Identities=24% Similarity=0.392 Sum_probs=200.2
Q ss_pred CCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccc--hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEE
Q 001544 770 GFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQH--ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEY 846 (1057)
Q Consensus 770 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 846 (1057)
+|+..+.||+|+||.||+|... +|..||+|.+.... ....+.+.+|++++++++|+||+++++++...+..++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4778899999999999999865 58899999986532 23346788999999999999999999999999999999999
Q ss_pred ccCCChhHHHhcCC-ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCC-cEEEEcccccccccCCCC
Q 001544 847 MRNGSLEKCLYSGN-YILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNM-VAHLSDFGIAKLLIGEDQ 924 (1057)
Q Consensus 847 ~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~-~~kl~Dfg~a~~~~~~~~ 924 (1057)
+++++|.+++.... ..+++..+..++.|+++|++||| +.+++|+||||+||++++++ .+|++|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~- 156 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM- 156 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEcCCCCeEEecccccchhccCCc-
Confidence 99999999987643 35799999999999999999999 89999999999999999875 56999999997653221
Q ss_pred ccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhcccccc
Q 001544 925 SMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLIT 1004 (1057)
Q Consensus 925 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1057)
.......+++.|+|||+..+..++.++||||||+++|||++|+.||.... ...+.. ........
T Consensus 157 -~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~--------~~~~~~~~-- 220 (257)
T cd08225 157 -ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN-----LHQLVL--------KICQGYFA-- 220 (257)
T ss_pred -ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-----HHHHHH--------HHhcccCC--
Confidence 11223457889999999888889999999999999999999999986421 111111 11110000
Q ss_pred cchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 1005 EDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 1005 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
+.....+.++.+++.+|+..+|++|||+.|++++
T Consensus 221 -----~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 221 -----PISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred -----CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 0112345678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=307.30 Aligned_cols=245 Identities=27% Similarity=0.352 Sum_probs=198.1
Q ss_pred CceeccccCeEEEEEEec-CCcEEEEEEeeccchhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEEccCCCh
Q 001544 774 NNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEYMRNGSL 852 (1057)
Q Consensus 774 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL 852 (1057)
..+||+|+||.||+|..+ +++.||||++..........+.+|+.++++++|+|++++++++...+..++||||+++++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 367999999999999864 7899999998655555567789999999999999999999999999999999999999999
Q ss_pred hHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCcccccccc
Q 001544 853 EKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTL 932 (1057)
Q Consensus 853 ~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 932 (1057)
.+++... .+++..+..++.|++.|++||| +.+++||||+|+||++++++.++++|||.+....... .......
T Consensus 105 ~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH---~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~--~~~~~~~ 177 (292)
T cd06657 105 TDIVTHT--RMNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRKSLV 177 (292)
T ss_pred HHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEcccccceeccccc--ccccccc
Confidence 9987544 4789999999999999999999 8999999999999999999999999999987553221 1223346
Q ss_pred ccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhcccccccchhhHHH
Q 001544 933 ATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHFAAK 1012 (1057)
Q Consensus 933 ~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1012 (1057)
++.+|+|||...+..++.++|+||+|+++|||++|+.||...... .. ......... ......
T Consensus 178 ~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~--~~------------~~~~~~~~~----~~~~~~ 239 (292)
T cd06657 178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL--KA------------MKMIRDNLP----PKLKNL 239 (292)
T ss_pred cCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HH------------HHHHHhhCC----cccCCc
Confidence 788999999988888899999999999999999999998641110 00 001100000 001111
Q ss_pred HHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 1013 EQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 1013 ~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
..++..+.+++.+||..+|.+||++.|++++
T Consensus 240 ~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 240 HKVSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred ccCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 2345678899999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=313.80 Aligned_cols=271 Identities=23% Similarity=0.258 Sum_probs=200.9
Q ss_pred hCCCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccc--hhHHHHHHHHHHHHHhcCCCCceeEeeeecc----CCee
Q 001544 768 TNGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQH--ERAFKSFDTECEVMKSIRHRNLTKIISSCSN----EDFK 840 (1057)
Q Consensus 768 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~ 840 (1057)
..+|++.+.||+|+||.||+|... +|+.||+|++.... ....+.+.+|+.++++++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 467889999999999999999854 69999999986542 2345677889999999999999999998753 3568
Q ss_pred EEEEEEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEccccccccc
Q 001544 841 ALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLI 920 (1057)
Q Consensus 841 ~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~ 920 (1057)
++||||+. |+|.+++.... .+++..+..++.|+++||+||| +.+|+||||||+||++++++.+||+|||++....
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 158 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQ-PLTEEHIRYFLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLS 158 (334)
T ss_pred EEEEehhh-hhHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEecccccceeec
Confidence 99999996 58998886654 4899999999999999999999 8999999999999999999999999999997653
Q ss_pred CCCCc--cccccccccccccCccccCC-CCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhh--ccc-----
Q 001544 921 GEDQS--MTQTQTLATLGYMAPEYGRE-GRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVND--FLP----- 990 (1057)
Q Consensus 921 ~~~~~--~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~--~~~----- 990 (1057)
..... .......++..|+|||.+.. ..++.++||||+||++|||++|+.||....... ........ ..+
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~-~~~~~~~~~g~~~~~~~~ 237 (334)
T cd07855 159 SSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVH-QLKLILSVLGSPSEEVLN 237 (334)
T ss_pred ccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHH-HHHHHHHHhCCChhHhhh
Confidence 22211 11233467889999998755 458899999999999999999999986532111 00000000 000
Q ss_pred ----hhHHHhhhcccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHH
Q 001544 991 ----ISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRL 1044 (1057)
Q Consensus 991 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 1044 (1057)
.......+..............+..+.++.+++.+|++.+|++||++.+++++-
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~ 295 (334)
T cd07855 238 RIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHP 295 (334)
T ss_pred hhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhCh
Confidence 001111110000000000111133578899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=304.87 Aligned_cols=266 Identities=24% Similarity=0.321 Sum_probs=200.1
Q ss_pred CCCCceeccccCeEEEEEEec-CCcEEEEEEeeccc--hhHHHHHHHHHHHHHhcCCCCceeEeeeeccC--CeeEEEEE
Q 001544 771 FSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQH--ERAFKSFDTECEVMKSIRHRNLTKIISSCSNE--DFKALILE 845 (1057)
Q Consensus 771 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lV~E 845 (1057)
|++.+.||+|+||.||+|+.. +++.||+|++.... ......+.+|++++++++|||++++++++.+. +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 567889999999999999866 58999999997653 33456788999999999999999999999887 89999999
Q ss_pred EccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCc
Q 001544 846 YMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS 925 (1057)
Q Consensus 846 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 925 (1057)
|+++ +|.+++......+++.++..++.|+++|++||| +.+++|+||+|+||++++++.+|++|||.+........
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH---~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~- 155 (287)
T cd07840 81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS- 155 (287)
T ss_pred cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc-
Confidence 9975 899888776567999999999999999999999 89999999999999999999999999999987643221
Q ss_pred cccccccccccccCccccCC-CCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhh---hccchhHH-------
Q 001544 926 MTQTQTLATLGYMAPEYGRE-GRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVN---DFLPISMM------- 994 (1057)
Q Consensus 926 ~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~---~~~~~~~~------- 994 (1057)
.......++..|+|||.+.+ ..++.++||||||+++|||++|+.||....... ....... ........
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07840 156 ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELE-QLEKIFELCGSPTDENWPGVSKLPW 234 (287)
T ss_pred ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCchhhccccccchh
Confidence 12233456788999997654 457899999999999999999999986532111 0110000 00000000
Q ss_pred -HhhhcccccccchhhHHHHH-HHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 995 -KIIDANLLITEDKHFAAKEQ-CASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 995 -~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
........... ........ ++.++.+++.+|+..+|++||++++++++
T Consensus 235 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 235 FENLKPKKPYKR-RLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred hhhccccccchh-HHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 00000000000 00011112 36789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-33 Score=303.69 Aligned_cols=242 Identities=22% Similarity=0.304 Sum_probs=187.7
Q ss_pred eeccccCeEEEEEEec-CCcEEEEEEeeccc---hhHHHHHHHHHHHH---HhcCCCCceeEeeeeccCCeeEEEEEEcc
Q 001544 776 LIGRGSFGSVYIARLQ-NGIEVAVKTFDLQH---ERAFKSFDTECEVM---KSIRHRNLTKIISSCSNEDFKALILEYMR 848 (1057)
Q Consensus 776 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 848 (1057)
+||+|+||.||+|... +++.||+|.+.... ......+.+|..++ ...+||+|+.+++++..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999864 68999999885432 12223334444433 33479999999999999999999999999
Q ss_pred CCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCcccc
Q 001544 849 NGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQ 928 (1057)
Q Consensus 849 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 928 (1057)
+|+|.+++.... .+++.++..++.|++.|++||| +.+|+||||||+||++++++.++++|||++...... ..
T Consensus 81 ~~~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~----~~ 152 (279)
T cd05633 81 GGDLHYHLSQHG-VFSEKEMRFYATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----KP 152 (279)
T ss_pred CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc----Cc
Confidence 999999887654 4899999999999999999999 999999999999999999999999999998754221 12
Q ss_pred ccccccccccCccccCC-CCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhcccccccch
Q 001544 929 TQTLATLGYMAPEYGRE-GRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDK 1007 (1057)
Q Consensus 929 ~~~~~t~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1057)
....++..|+|||...+ ..++.++||||+||++|||++|..||........ .. ...... ..
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~---------~~~~~~-------~~ 214 (279)
T cd05633 153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--HE---------IDRMTL-------TV 214 (279)
T ss_pred cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH--HH---------HHHHhh-------cC
Confidence 23468899999998764 5578999999999999999999999875322111 00 000000 00
Q ss_pred hhHHHHHHHHHHHHHHhHcccCCCCCCC-----CHHHHHHH
Q 001544 1008 HFAAKEQCASSVFNLAMECTVESPDERI-----TAKEIVRR 1043 (1057)
Q Consensus 1008 ~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~ 1043 (1057)
....+..++.++.+++.+|+..||++|| +++|+++|
T Consensus 215 ~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 215 NVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred CcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 1111234567889999999999999999 69999987
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=281.01 Aligned_cols=255 Identities=22% Similarity=0.263 Sum_probs=203.3
Q ss_pred HHHhCCCCCC-ceeccccCeEEEEEEec-CCcEEEEEEeeccchhHHHHHHHHHHHHHhc-CCCCceeEeeeecc----C
Q 001544 765 FQATNGFSEN-NLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQHERAFKSFDTECEVMKSI-RHRNLTKIISSCSN----E 837 (1057)
Q Consensus 765 ~~~~~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~ 837 (1057)
...+++|++. ++||-|-.|.|..+..+ +|+.+|+|++... ....+|++..-+. .|||||.+++.|+. .
T Consensus 57 ~~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~r 131 (400)
T KOG0604|consen 57 YSITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGR 131 (400)
T ss_pred ccchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCc
Confidence 3456777654 68999999999998644 7999999998532 2345788876555 69999999998754 4
Q ss_pred CeeEEEEEEccCCChhHHHhcCC-ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeC---CCCcEEEEcc
Q 001544 838 DFKALILEYMRNGSLEKCLYSGN-YILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLD---DNMVAHLSDF 913 (1057)
Q Consensus 838 ~~~~lV~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~---~~~~~kl~Df 913 (1057)
+...+|||.|+||.|...+++.+ ..+++.++..|+.||+.|+.||| +..|.||||||+|+|.. .+..+|++||
T Consensus 132 kcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH---~~nIAHRDlKpENLLyt~t~~na~lKLtDf 208 (400)
T KOG0604|consen 132 KCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLH---SMNIAHRDLKPENLLYTTTSPNAPLKLTDF 208 (400)
T ss_pred eeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHH---hcchhhccCChhheeeecCCCCcceEeccc
Confidence 56779999999999999998766 56999999999999999999999 99999999999999996 4568999999
Q ss_pred cccccccCCCCccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhH
Q 001544 914 GIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISM 993 (1057)
Q Consensus 914 g~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 993 (1057)
|+|+.-. ..........|+.|.|||++...+++...|+||+||++|-|+.|.+||....... .+..+
T Consensus 209 GFAK~t~---~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a----------ispgM 275 (400)
T KOG0604|consen 209 GFAKETQ---EPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA----------ISPGM 275 (400)
T ss_pred ccccccC---CCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc----------CChhH
Confidence 9998632 2334455678999999999999999999999999999999999999997632211 12223
Q ss_pred HHhhhcccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 994 MKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 994 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
...+.......+ .+.+..++++.+++|+.++..+|.+|.|..|++.|
T Consensus 276 k~rI~~gqy~FP---~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 276 KRRIRTGQYEFP---EPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred HhHhhccCccCC---ChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 333322222222 23455778899999999999999999999999876
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=305.92 Aligned_cols=268 Identities=22% Similarity=0.268 Sum_probs=196.0
Q ss_pred CCCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccch--hHHHHHHHHHHHHHhcC-CCCceeEeeeeccCCe-----
Q 001544 769 NGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQHE--RAFKSFDTECEVMKSIR-HRNLTKIISSCSNEDF----- 839 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~----- 839 (1057)
++|+..+.||+|+||.||+|... +++.||||+++.... .....+.+|++++++++ ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 36888899999999999999865 689999999865432 23456788999999995 6999999999876655
Q ss_pred eEEEEEEccCCChhHHHhcCC----ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCC-CCcEEEEccc
Q 001544 840 KALILEYMRNGSLEKCLYSGN----YILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDD-NMVAHLSDFG 914 (1057)
Q Consensus 840 ~~lV~E~~~~gsL~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~-~~~~kl~Dfg 914 (1057)
.|+||||+++ ++.+++.... ..+++.++..++.||++||+||| +++|+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999986 7888876432 35899999999999999999999 999999999999999998 8999999999
Q ss_pred ccccccCCCCccccccccccccccCccccCC-CCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhc--cch
Q 001544 915 IAKLLIGEDQSMTQTQTLATLGYMAPEYGRE-GRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDF--LPI 991 (1057)
Q Consensus 915 ~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~--~~~ 991 (1057)
.++.+... ........+++.|+|||++.+ ..++.++||||||+++|||++|..||......+... ...... ...
T Consensus 157 ~~~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~-~~~~~~~~~~~ 233 (295)
T cd07837 157 LGRAFSIP--VKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLL-HIFKLLGTPTE 233 (295)
T ss_pred cceecCCC--ccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHH-HHHHHhCCCCh
Confidence 98765322 112223356788999998765 457899999999999999999999986422111100 000000 000
Q ss_pred h----HHHhhhccccc--ccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 992 S----MMKIIDANLLI--TEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 992 ~----~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
. .....+..... .........+.++.++.+++.+||.++|++||++.|+++|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 234 QVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred hhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0 00000000000 0000001113457789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=302.34 Aligned_cols=267 Identities=24% Similarity=0.283 Sum_probs=202.9
Q ss_pred CCCCceeccccCeEEEEEEec-CCcEEEEEEeeccch--hHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEEc
Q 001544 771 FSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQHE--RAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEYM 847 (1057)
Q Consensus 771 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 847 (1057)
|+..+.||+|++|.||+|... +++.+|+|+++.... .....+.+|++++++++|+||+++++++..++..++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 566789999999999999865 689999999865432 34567888999999999999999999999999999999999
Q ss_pred cCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCccc
Q 001544 848 RNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMT 927 (1057)
Q Consensus 848 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 927 (1057)
++ ++.+++......+++.++..++.|+++|++||| +.+|+||||||+||++++++.++|+|||.+....... ..
T Consensus 81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~~ 154 (283)
T cd05118 81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--RP 154 (283)
T ss_pred CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHH---HCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--cc
Confidence 75 888888776567999999999999999999999 9999999999999999999999999999997663322 12
Q ss_pred cccccccccccCccccCCC-CCCccchHHHHHHHHHHHhhCCCCCCcccccccch--hhhhhhccchhHHHhhh---cc-
Q 001544 928 QTQTLATLGYMAPEYGREG-RVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTL--KHWVNDFLPISMMKIID---AN- 1000 (1057)
Q Consensus 928 ~~~~~~t~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~---~~- 1000 (1057)
.....++..|+|||...+. .++.++|+||+|+++|+|++|+.||......+... ........+.......+ ..
T Consensus 155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd05118 155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYK 234 (283)
T ss_pred ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhh
Confidence 2334577889999988766 78999999999999999999999986532211000 00000000000000000 00
Q ss_pred --c-ccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 1001 --L-LITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 1001 --~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
. ...........+.++.++.+++.+||++||.+||++.|++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 235 FSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 0 000000112234567889999999999999999999999875
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-33 Score=306.54 Aligned_cols=253 Identities=26% Similarity=0.348 Sum_probs=193.5
Q ss_pred CCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccc-hhHHHHHHHHHHHHHhcC-CCCceeEeeeeccCCeeEEEEEE
Q 001544 770 GFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQH-ERAFKSFDTECEVMKSIR-HRNLTKIISSCSNEDFKALILEY 846 (1057)
Q Consensus 770 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~E~ 846 (1057)
+|+..+.||+|+||.||++... +++.||+|.+.... ......+.+|+.++.++. ||||+++++++..++..++||||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 4555688999999999999864 68999999986432 344567889999999996 99999999999888899999999
Q ss_pred ccCCChhHH---Hhc-CCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCC
Q 001544 847 MRNGSLEKC---LYS-GNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGE 922 (1057)
Q Consensus 847 ~~~gsL~~~---l~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~ 922 (1057)
+.. ++.++ +.. ....+++..+..++.|+++|++|||+ ..+++||||||+||+++.++.+||+|||+++.....
T Consensus 85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 864 55443 222 23568999999999999999999992 259999999999999999999999999999765321
Q ss_pred CCccccccccccccccCccccCCC---CCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhc
Q 001544 923 DQSMTQTQTLATLGYMAPEYGREG---RVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDA 999 (1057)
Q Consensus 923 ~~~~~~~~~~~t~~y~aPE~~~~~---~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 999 (1057)
.......++..|+|||.+.+. .++.++||||+||++|||++|+.||..... ... ...+....
T Consensus 162 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---~~~---------~~~~~~~~ 226 (288)
T cd06616 162 ---IAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS---VFD---------QLTQVVKG 226 (288)
T ss_pred ---CccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch---HHH---------HHhhhcCC
Confidence 122233578899999998766 688999999999999999999999865210 000 00011000
Q ss_pred ccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 1000 NLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 1000 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
.. ..........++.++.+++.+||+.+|++|||+.|++++
T Consensus 227 ~~---~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 227 DP---PILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CC---CcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 000011112456789999999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=307.83 Aligned_cols=276 Identities=23% Similarity=0.338 Sum_probs=200.2
Q ss_pred ceeccc--cCeEEEEEEec-CCcEEEEEEeeccc--hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEEccC
Q 001544 775 NLIGRG--SFGSVYIARLQ-NGIEVAVKTFDLQH--ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEYMRN 849 (1057)
Q Consensus 775 ~~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 849 (1057)
..||+| +||+||+|... +|+.||||++.... ....+.+.+|+.+++.++||||++++++|..++..++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456666 99999999864 79999999986432 34457889999999999999999999999999999999999999
Q ss_pred CChhHHHhcCC-ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCccc-
Q 001544 850 GSLEKCLYSGN-YILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMT- 927 (1057)
Q Consensus 850 gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~- 927 (1057)
+++.+++.... ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.++++||+.+...........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 99999887643 35889999999999999999999 99999999999999999999999999986643321111110
Q ss_pred ----cccccccccccCccccCCC--CCCccchHHHHHHHHHHHhhCCCCCCcccccccchhh--------hhhhccchhH
Q 001544 928 ----QTQTLATLGYMAPEYGREG--RVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKH--------WVNDFLPISM 993 (1057)
Q Consensus 928 ----~~~~~~t~~y~aPE~~~~~--~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~--------~~~~~~~~~~ 993 (1057)
.....++..|+|||++.+. .++.++||||+||++|||++|+.||............ |.....+...
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEE 240 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhh
Confidence 0112245579999998763 4789999999999999999999999764322111000 0000000000
Q ss_pred HHhhhc-----------c-------cccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH--HHHhHHHHhh
Q 001544 994 MKIIDA-----------N-------LLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR--LLKIRDFLLR 1053 (1057)
Q Consensus 994 ~~~~~~-----------~-------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~--L~~i~~~~~~ 1053 (1057)
....+. . .........+....++..+.+++.+||+.||++|||+.|+++| ++.++....+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~~~~~ 320 (328)
T cd08226 241 SRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKEQTQG 320 (328)
T ss_pred hhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHHhccc
Confidence 000000 0 0000111222334577889999999999999999999999865 4555554333
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=304.88 Aligned_cols=269 Identities=23% Similarity=0.290 Sum_probs=196.5
Q ss_pred CCCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccc--hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEE
Q 001544 769 NGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQH--ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILE 845 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 845 (1057)
++|+..+.||+|++|+||+|..+ +|+.||+|.+.... ......+.+|++++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46888999999999999999865 68999999985432 2334678889999999999999999999999999999999
Q ss_pred EccCCChhHHHhcCC-ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCC-CCcEEEEcccccccccCCC
Q 001544 846 YMRNGSLEKCLYSGN-YILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDD-NMVAHLSDFGIAKLLIGED 923 (1057)
Q Consensus 846 ~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~-~~~~kl~Dfg~a~~~~~~~ 923 (1057)
|+++ ++.+++.... ...++..+..++.||+.||+||| +++++||||+|+||++++ ++.+|++|||++......
T Consensus 82 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~- 156 (294)
T PLN00009 82 YLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP- 156 (294)
T ss_pred cccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCcceEEEECCCCEEEEcccccccccCCC-
Confidence 9964 7877765433 34688888999999999999999 899999999999999985 567999999999754221
Q ss_pred CccccccccccccccCccccCCC-CCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhh--hhccchhHHH---hh
Q 001544 924 QSMTQTQTLATLGYMAPEYGREG-RVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWV--NDFLPISMMK---II 997 (1057)
Q Consensus 924 ~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~--~~~~~~~~~~---~~ 997 (1057)
........++..|+|||++.+. .++.++||||+|+++|||+||+.||......+....... .......+.. ..
T Consensus 157 -~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (294)
T PLN00009 157 -VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLP 235 (294)
T ss_pred -ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccch
Confidence 1122334568899999987654 578999999999999999999999865322111100000 0000000000 00
Q ss_pred h---cccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 998 D---ANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 998 ~---~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
+ ..............+..+.++.+++.+|++.+|++||++.+++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 236 DYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred hhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 000000000001112346778999999999999999999999975
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=298.89 Aligned_cols=249 Identities=27% Similarity=0.429 Sum_probs=204.3
Q ss_pred CCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccc--hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEE
Q 001544 770 GFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQH--ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEY 846 (1057)
Q Consensus 770 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 846 (1057)
+|+..+.||+|+||.||+|... ++..||+|++.... ......+.+|++++++++|||++++++.+..++..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4778899999999999999865 68999999996543 25567789999999999999999999999999999999999
Q ss_pred ccCCChhHHHhcC---CccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCC
Q 001544 847 MRNGSLEKCLYSG---NYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGED 923 (1057)
Q Consensus 847 ~~~gsL~~~l~~~---~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~ 923 (1057)
+++++|.+++... ...+++.++..++.++++|++||| +.+++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 9999999998765 367999999999999999999999 8999999999999999999999999999997653222
Q ss_pred CccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhccccc
Q 001544 924 QSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLI 1003 (1057)
Q Consensus 924 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1003 (1057)
.......+++.|+|||...+..++.++|+||+|+++|+|++|+.||...... ... ........
T Consensus 158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~-----~~~--------~~~~~~~~-- 220 (258)
T cd08215 158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL-----ELA--------LKILKGQY-- 220 (258)
T ss_pred --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH-----HHH--------HHHhcCCC--
Confidence 1223346788999999988888999999999999999999999998652111 000 00110000
Q ss_pred ccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 1004 TEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 1004 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
.+.+..++.++.+++.+||..+|++||++.|++++
T Consensus 221 -----~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 221 -----PPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred -----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00112456778999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=298.53 Aligned_cols=251 Identities=23% Similarity=0.335 Sum_probs=199.1
Q ss_pred CCCCCCceeccccCeEEEEEEec-CCcEEEEEEeecc-----chhHHHHHHHHHHHHHhcCCCCceeEeeeeccC--Cee
Q 001544 769 NGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQ-----HERAFKSFDTECEVMKSIRHRNLTKIISSCSNE--DFK 840 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 840 (1057)
.+|++.+.||+|+||.||+|... ++..||+|++... .......+.+|++++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 46888999999999999999864 6899999987432 223456889999999999999999999998653 567
Q ss_pred EEEEEEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEccccccccc
Q 001544 841 ALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLI 920 (1057)
Q Consensus 841 ~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~ 920 (1057)
++|+||+++++|.+++.... .+++..+..++.|++.|++||| +.+++||||||+||+++.++.++|+|||.++...
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 157 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYG-ALTENVTRRYTRQILQGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQ 157 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECccccccccc
Confidence 89999999999999987654 4889999999999999999999 9999999999999999999999999999997653
Q ss_pred CCCC-ccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhc
Q 001544 921 GEDQ-SMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDA 999 (1057)
Q Consensus 921 ~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 999 (1057)
.... ........++..|+|||...+..++.++|+|||||++||+++|+.||......+ ...+...
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------------~~~~~~~- 223 (264)
T cd06653 158 TICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA-------------AIFKIAT- 223 (264)
T ss_pred cccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH-------------HHHHHHc-
Confidence 2111 111223457889999999988889999999999999999999999986521110 0011110
Q ss_pred ccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 1000 NLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 1000 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
. ......+..+++++.+++.+|+. +|.+||++.+++.|
T Consensus 224 --~---~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 224 --Q---PTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred --C---CCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 0 00111223456789999999999 57999999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=331.83 Aligned_cols=256 Identities=29% Similarity=0.468 Sum_probs=210.7
Q ss_pred CCCCCceeccccCeEEEEEEec--------CCcEEEEEEeeccc-hhHHHHHHHHHHHHHhc-CCCCceeEeeeeccCCe
Q 001544 770 GFSENNLIGRGSFGSVYIARLQ--------NGIEVAVKTFDLQH-ERAFKSFDTECEVMKSI-RHRNLTKIISSCSNEDF 839 (1057)
Q Consensus 770 ~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 839 (1057)
+..+.+.+|+|.||.||+|... ....||||.++... ..+.+++..|+++|+.+ +|+||+.++|+|...+.
T Consensus 297 ~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~ 376 (609)
T KOG0200|consen 297 NLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGP 376 (609)
T ss_pred hccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCc
Confidence 3455569999999999999743 14679999986443 35678999999999999 69999999999999999
Q ss_pred eEEEEEEccCCChhHHHhcCC---------------ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCC
Q 001544 840 KALILEYMRNGSLEKCLYSGN---------------YILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDD 904 (1057)
Q Consensus 840 ~~lV~E~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~ 904 (1057)
.++|+||++.|+|.++++..+ ..++....+.++.|||.|++||+ +.++||||+.++|||+.+
T Consensus 377 ~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~---~~~~vHRDLAaRNVLi~~ 453 (609)
T KOG0200|consen 377 LYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA---SVPCVHRDLAARNVLITK 453 (609)
T ss_pred eEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh---hCCccchhhhhhhEEecC
Confidence 999999999999999998877 45888999999999999999999 999999999999999999
Q ss_pred CCcEEEEcccccccccCCCCcccc-ccccccccccCccccCCCCCCccchHHHHHHHHHHHhh-CCCCCCcccccccchh
Q 001544 905 NMVAHLSDFGIAKLLIGEDQSMTQ-TQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFT-RRKPTDEIFSGEMTLK 982 (1057)
Q Consensus 905 ~~~~kl~Dfg~a~~~~~~~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~ 982 (1057)
+..+||+|||+|+.....+.+... +...-...|||||.+....++.|+|||||||++||++| |..||.+....
T Consensus 454 ~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~----- 528 (609)
T KOG0200|consen 454 NKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT----- 528 (609)
T ss_pred CCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcH-----
Confidence 999999999999976444433322 11113457999999999999999999999999999999 67787552111
Q ss_pred hhhhhccchhHHHhhhcccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHHHh
Q 001544 983 HWVNDFLPISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKI 1047 (1057)
Q Consensus 983 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i 1047 (1057)
....+ ....+.+...+..|+.+++++|+.||+.+|++||++.|+++.++..
T Consensus 529 --------~~l~~------~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 529 --------EELLE------FLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred --------HHHHH------HHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 01111 1223345556678899999999999999999999999999999884
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=307.69 Aligned_cols=271 Identities=22% Similarity=0.311 Sum_probs=195.9
Q ss_pred hCCCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccc--hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCC------
Q 001544 768 TNGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQH--ERAFKSFDTECEVMKSIRHRNLTKIISSCSNED------ 838 (1057)
Q Consensus 768 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 838 (1057)
.++|+..+.||+|+||.||+|... +++.||||.+.... ......+.+|++++++++||||+++++++...+
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 457889999999999999999865 68999999985432 222345678999999999999999999886543
Q ss_pred --eeEEEEEEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEccccc
Q 001544 839 --FKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIA 916 (1057)
Q Consensus 839 --~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a 916 (1057)
..++||||+.+ ++.+.+......+++.++..++.|++.|++||| +.+++||||||+||+++.++.+||+|||.+
T Consensus 91 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~ 166 (310)
T cd07865 91 KGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLA 166 (310)
T ss_pred CceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEECCCCcEEECcCCCc
Confidence 45999999965 888888766656899999999999999999999 899999999999999999999999999999
Q ss_pred ccccCCCCc--cccccccccccccCccccCCC-CCCccchHHHHHHHHHHHhhCCCCCCccccccc-chhhhhhhccchh
Q 001544 917 KLLIGEDQS--MTQTQTLATLGYMAPEYGREG-RVSTKGDVYSFGILLMETFTRRKPTDEIFSGEM-TLKHWVNDFLPIS 992 (1057)
Q Consensus 917 ~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~ 992 (1057)
..+...... .......++..|+|||.+.+. .++.++||||||+++|||++|+.||........ ..........+..
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (310)
T cd07865 167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPE 246 (310)
T ss_pred ccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 765322211 112234567889999987654 368899999999999999999999864221100 0000000000000
Q ss_pred HH------HhhhcccccccchhhHHHH-----HHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 993 MM------KIIDANLLITEDKHFAAKE-----QCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 993 ~~------~~~~~~~~~~~~~~~~~~~-----~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
.. +..+..... ......... .....+.+++.+|+..||++|||+.|+++|
T Consensus 247 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 247 VWPGVDKLELFKKMELP-QGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred hcccccchhhhhhccCC-CccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 00 000000000 000000000 123567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=306.03 Aligned_cols=253 Identities=25% Similarity=0.318 Sum_probs=196.8
Q ss_pred hCCCCCCceeccccCeEEEEEEecC-CcEEEEEEeeccc-hhHHHHHHHHHHHHHhcC-CCCceeEeeeeccCCeeEEEE
Q 001544 768 TNGFSENNLIGRGSFGSVYIARLQN-GIEVAVKTFDLQH-ERAFKSFDTECEVMKSIR-HRNLTKIISSCSNEDFKALIL 844 (1057)
Q Consensus 768 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~ 844 (1057)
.++|++.+.||+|+||.||+|..++ ++.||||+++... ......+.+|++++.+.. ||||+++++++.++...++||
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 3568888999999999999998764 8999999996543 233456677887777775 999999999999999999999
Q ss_pred EEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCC-CCeEEccCCCCCeeeCCCCcEEEEcccccccccCCC
Q 001544 845 EYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYS-APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGED 923 (1057)
Q Consensus 845 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~-~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~ 923 (1057)
||+.+ ++.++.......+++..+..++.|+++|++||| + .+|+||||+|+||++++++.+||+|||.+..+....
T Consensus 94 e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~ 169 (296)
T cd06618 94 ELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLK---EKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK 169 (296)
T ss_pred eccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCC
Confidence 99854 787777665557899999999999999999999 6 589999999999999999999999999987653221
Q ss_pred CccccccccccccccCccccCCCC----CCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhc
Q 001544 924 QSMTQTQTLATLGYMAPEYGREGR----VSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDA 999 (1057)
Q Consensus 924 ~~~~~~~~~~t~~y~aPE~~~~~~----~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 999 (1057)
......++..|+|||.+.+.. ++.++||||||+++|||++|+.||........... .....
T Consensus 170 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~------------~~~~~ 234 (296)
T cd06618 170 ---AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLT------------KILQE 234 (296)
T ss_pred ---cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHH------------HHhcC
Confidence 122335678899999886554 78899999999999999999999864211111111 11111
Q ss_pred ccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHH
Q 001544 1000 NLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRL 1044 (1057)
Q Consensus 1000 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 1044 (1057)
... ..+....++.++.+++.+||+.||++||++.+++++-
T Consensus 235 ~~~-----~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~ 274 (296)
T cd06618 235 EPP-----SLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP 274 (296)
T ss_pred CCC-----CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence 000 0011113466789999999999999999999998874
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=297.20 Aligned_cols=248 Identities=31% Similarity=0.454 Sum_probs=203.4
Q ss_pred CCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccch--hHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEE
Q 001544 770 GFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQHE--RAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEY 846 (1057)
Q Consensus 770 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 846 (1057)
+|+..+.||+|++|.||+|... +++.||+|.+..... .....+.+|++++++++|||++++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4778899999999999999765 688999999965543 4567899999999999999999999999999999999999
Q ss_pred ccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCcc
Q 001544 847 MRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSM 926 (1057)
Q Consensus 847 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 926 (1057)
+++++|.+++... ..+++..+..++.|++.|++||| +.+++||||+|+||+++.++.++|+|||.+........
T Consensus 81 ~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 154 (254)
T cd06627 81 AENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK-- 154 (254)
T ss_pred CCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcc--
Confidence 9999999988765 45899999999999999999999 99999999999999999999999999999987643222
Q ss_pred ccccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhcccccccc
Q 001544 927 TQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITED 1006 (1057)
Q Consensus 927 ~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1006 (1057)
......++..|+|||...+..++.++|||++|+++|+|++|+.||..... .... ..... .
T Consensus 155 ~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~----~~~~---------~~~~~-------~ 214 (254)
T cd06627 155 DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP----MAAL---------FRIVQ-------D 214 (254)
T ss_pred cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH----HHHH---------HHHhc-------c
Confidence 12334578899999998887789999999999999999999999865221 0000 00000 0
Q ss_pred hhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 1007 KHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 1007 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
.....+..++.++.+++.+|+..+|++||++.|++.+
T Consensus 215 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 251 (254)
T cd06627 215 DHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKH 251 (254)
T ss_pred CCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence 0111122346778999999999999999999999864
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=312.14 Aligned_cols=266 Identities=21% Similarity=0.243 Sum_probs=198.0
Q ss_pred HhCCCCCCceeccccCeEEEEEEec-CCcEEEEEEeecc--chhHHHHHHHHHHHHHhcCCCCceeEeeeeccC------
Q 001544 767 ATNGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQ--HERAFKSFDTECEVMKSIRHRNLTKIISSCSNE------ 837 (1057)
Q Consensus 767 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 837 (1057)
..++|+..+.||+|+||.||+|... +++.||||++... .......+.+|++++++++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4578999999999999999999854 7899999998542 233446677899999999999999999987543
Q ss_pred CeeEEEEEEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccc
Q 001544 838 DFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK 917 (1057)
Q Consensus 838 ~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~ 917 (1057)
...|+||||+++ +|.+.+... ++..++..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||.++
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 166 (353)
T cd07850 94 QDVYLVMELMDA-NLCQVIQMD---LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 166 (353)
T ss_pred CcEEEEEeccCC-CHHHHHhhc---CCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCccce
Confidence 357999999965 888877543 888999999999999999999 8999999999999999999999999999998
Q ss_pred cccCCCCccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhcc--chhHHH
Q 001544 918 LLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFL--PISMMK 995 (1057)
Q Consensus 918 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~--~~~~~~ 995 (1057)
..... .......++..|+|||.+.+..++.++||||+||++|+|++|+.||...... ..+........ +.....
T Consensus 167 ~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~ 242 (353)
T cd07850 167 TAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHI-DQWNKIIEQLGTPSDEFMS 242 (353)
T ss_pred eCCCC---CCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHhcCCCCHHHHH
Confidence 65321 1223345788999999999889999999999999999999999998642111 00100000000 000111
Q ss_pred hhh--------ccccccc-------------chhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 996 IID--------ANLLITE-------------DKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 996 ~~~--------~~~~~~~-------------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
..+ ....... ..........+.++.+++.+|++.||++|||+.|++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 243 RLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000 0000000 00000011345678999999999999999999999976
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=298.75 Aligned_cols=247 Identities=24% Similarity=0.339 Sum_probs=202.7
Q ss_pred CCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccc--hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEE
Q 001544 770 GFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQH--ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEY 846 (1057)
Q Consensus 770 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 846 (1057)
+|++.+.||+|+||.||+|... +++.+|+|.+.... ......+.+|++++++++||||+++++++.+....++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4778899999999999999754 68899999986532 34456778899999999999999999999999999999999
Q ss_pred ccCCChhHHHhcC---CccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCC
Q 001544 847 MRNGSLEKCLYSG---NYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGED 923 (1057)
Q Consensus 847 ~~~gsL~~~l~~~---~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~ 923 (1057)
+++++|.+++... ...+++..+..++.|+++|++||| +.+++||||+|+||+++.++.+|++|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh---~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 9999999988662 245899999999999999999999 999999999999999999999999999999876332
Q ss_pred CccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhccccc
Q 001544 924 QSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLI 1003 (1057)
Q Consensus 924 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1003 (1057)
......++..|+|||...+..++.++|+||+|+++|||++|+.||......+ . ...+....
T Consensus 157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~--~------------~~~~~~~~-- 217 (256)
T cd08530 157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD--L------------RYKVQRGK-- 217 (256)
T ss_pred ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--H------------HHHHhcCC--
Confidence 2223457889999999988889999999999999999999999986522110 0 00110000
Q ss_pred ccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 1004 TEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 1004 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
..+....++.++.+++.+|++.+|++||++.|++++
T Consensus 218 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 218 ----YPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred ----CCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 011122456779999999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=302.57 Aligned_cols=244 Identities=23% Similarity=0.332 Sum_probs=194.1
Q ss_pred eccccCeEEEEEEec-CCcEEEEEEeeccc---hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEEccCCCh
Q 001544 777 IGRGSFGSVYIARLQ-NGIEVAVKTFDLQH---ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEYMRNGSL 852 (1057)
Q Consensus 777 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL 852 (1057)
||+|+||+||+|... +|+.||+|.+.... ......+.+|++++++++||||+++++++...+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999754 68999999986432 22345667899999999999999999999999999999999999999
Q ss_pred hHHHhcCC-ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCccccccc
Q 001544 853 EKCLYSGN-YILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQT 931 (1057)
Q Consensus 853 ~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 931 (1057)
.+++.... ..+++.++..++.|++.|+.||| +.+++||||+|+||++++++.++++|||.+..... .......
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~---~~~~~~~ 154 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG---GKKIKGR 154 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEccCcchhhhcc---CCccccc
Confidence 99987654 35899999999999999999999 99999999999999999999999999999876532 1222334
Q ss_pred cccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhcccccccchhhHH
Q 001544 932 LATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHFAA 1011 (1057)
Q Consensus 932 ~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1011 (1057)
.++..|+|||...+..++.++||||+|+++|||++|+.||....... ... ++...... .....
T Consensus 155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~------------~~~~~~~~----~~~~~ 217 (277)
T cd05577 155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKV-EKE------------ELKRRTLE----MAVEY 217 (277)
T ss_pred cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccc-cHH------------HHHhcccc----ccccC
Confidence 57789999999888889999999999999999999999986532210 000 00000000 01111
Q ss_pred HHHHHHHHHHHHhHcccCCCCCCC-----CHHHHHHH
Q 001544 1012 KEQCASSVFNLAMECTVESPDERI-----TAKEIVRR 1043 (1057)
Q Consensus 1012 ~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~ 1043 (1057)
+...++.+.+++.+||+.+|++|| ++.++++|
T Consensus 218 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h 254 (277)
T cd05577 218 PDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREH 254 (277)
T ss_pred CccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhC
Confidence 223467789999999999999999 77777664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=304.67 Aligned_cols=271 Identities=25% Similarity=0.320 Sum_probs=200.9
Q ss_pred HHhCCCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccc--hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCC----
Q 001544 766 QATNGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQH--ERAFKSFDTECEVMKSIRHRNLTKIISSCSNED---- 838 (1057)
Q Consensus 766 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---- 838 (1057)
...++|++.+.||+|+||.||+|..+ +|+.||||+++... ......+.+|++++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 35568999999999999999999875 58999999996543 223456778999999999999999999886654
Q ss_pred ------eeEEEEEEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEc
Q 001544 839 ------FKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSD 912 (1057)
Q Consensus 839 ------~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D 912 (1057)
..++|+||+++ ++.+.+......+++.++..++.|++.||+||| +.+|+||||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~kl~d 159 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLAD 159 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCcEEeCc
Confidence 78999999986 777777665556899999999999999999999 89999999999999999999999999
Q ss_pred ccccccccCCCCccccccccccccccCccccCC-CCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhh---hc
Q 001544 913 FGIAKLLIGEDQSMTQTQTLATLGYMAPEYGRE-GRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVN---DF 988 (1057)
Q Consensus 913 fg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~---~~ 988 (1057)
||.+........ .......++..|+|||...+ ..++.++||||+||++|||++|+.||...... ........ ..
T Consensus 160 fg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~-~~~~~~~~~~~~~ 237 (302)
T cd07864 160 FGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQEL-AQLELISRLCGSP 237 (302)
T ss_pred ccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCC
Confidence 999986533221 22223345778999997754 45789999999999999999999998652211 11111100 00
Q ss_pred cchhHHHhh--------hcccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 989 LPISMMKII--------DANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 989 ~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
.+....... +....... ........++..+.+++.+||+.+|++||++.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 238 CPAVWPDVIKLPYFNTMKPKKQYRR-RLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred Chhhccccccccccccccccccccc-chhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 000000000 00000000 0001112356789999999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=310.81 Aligned_cols=273 Identities=23% Similarity=0.271 Sum_probs=202.5
Q ss_pred hCCCCCCceeccccCeEEEEEEec-CCcEEEEEEeecc--chhHHHHHHHHHHHHHhcCCCCceeEeeeeccC-----Ce
Q 001544 768 TNGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQ--HERAFKSFDTECEVMKSIRHRNLTKIISSCSNE-----DF 839 (1057)
Q Consensus 768 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 839 (1057)
..+|.+.+.||+|+||+||+|+.. +++.||||.++.. .......+.+|+++++.++||||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 457889999999999999999754 6899999998643 233345677899999999999999999987543 35
Q ss_pred eEEEEEEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccc
Q 001544 840 KALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL 919 (1057)
Q Consensus 840 ~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~ 919 (1057)
.++|+||+. ++|.+++.... .+++..+..++.|++.|++||| +++++||||||+||+++.++.+||+|||+++..
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 158 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSSQ-TLSDDHCQYFLYQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTT 158 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcCcccccc
Confidence 799999996 68988886554 5899999999999999999999 999999999999999999999999999999865
Q ss_pred cCCCCccccccccccccccCccccCC-CCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhh---hh--------
Q 001544 920 IGEDQSMTQTQTLATLGYMAPEYGRE-GRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWV---ND-------- 987 (1057)
Q Consensus 920 ~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~---~~-------- 987 (1057)
.... .......++..|+|||.+.. ..++.++|||||||++|||++|+.||......+ ...... ..
T Consensus 159 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~ 235 (337)
T cd07858 159 SEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVH-QLKLITELLGSPSEEDLGF 235 (337)
T ss_pred CCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHH-HHHHHHHHhCCCChHHhhh
Confidence 3221 12233457889999998754 468899999999999999999999986532110 000000 00
Q ss_pred ccchhHHHhhhcccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH--HHHhH
Q 001544 988 FLPISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR--LLKIR 1048 (1057)
Q Consensus 988 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~--L~~i~ 1048 (1057)
.......+.................+.++.++.+++.+|++.+|++|||++|+++| ++.+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~ 298 (337)
T cd07858 236 IRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLH 298 (337)
T ss_pred cCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhc
Confidence 00000111111000000000111123467889999999999999999999999998 55543
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=282.56 Aligned_cols=250 Identities=25% Similarity=0.327 Sum_probs=204.2
Q ss_pred HhCCCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccc---hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEE
Q 001544 767 ATNGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQH---ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKAL 842 (1057)
Q Consensus 767 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 842 (1057)
..++|...++||+|.||+|..++-+ +|+.+|+|++++.. ....+.-..|-++++..+||.+..+.-.|...+..|+
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence 3467888999999999999999855 79999999997653 2334555678999999999999999888999999999
Q ss_pred EEEEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCC
Q 001544 843 ILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGE 922 (1057)
Q Consensus 843 V~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~ 922 (1057)
||||+.||.|.-++...+ .+++....-+-..|+.||.||| +++||.||+|.+|.++|++|++||+|||+++.- .
T Consensus 246 VMeyanGGeLf~HLsrer-~FsE~RtRFYGaEIvsAL~YLH---s~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~--I 319 (516)
T KOG0690|consen 246 VMEYANGGELFFHLSRER-VFSEDRTRFYGAEIVSALGYLH---SRNIVYRDLKLENLLLDKDGHIKITDFGLCKEE--I 319 (516)
T ss_pred EEEEccCceEeeehhhhh-cccchhhhhhhHHHHHHhhhhh---hCCeeeeechhhhheeccCCceEeeecccchhc--c
Confidence 999999999998887654 4788888888999999999999 999999999999999999999999999999742 2
Q ss_pred CCccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhcccc
Q 001544 923 DQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLL 1002 (1057)
Q Consensus 923 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1002 (1057)
.........+||+.|.|||++....|+.++|-|.+||++|||++|+.||..... ....+.+-..
T Consensus 320 ~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh--------------~kLFeLIl~e-- 383 (516)
T KOG0690|consen 320 KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH--------------EKLFELILME-- 383 (516)
T ss_pred cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccch--------------hHHHHHHHhh--
Confidence 233445567899999999999999999999999999999999999999865211 1111111110
Q ss_pred cccchhhHHHHHHHHHHHHHHhHcccCCCCCCC-----CHHHHHHH
Q 001544 1003 ITEDKHFAAKEQCASSVFNLAMECTVESPDERI-----TAKEIVRR 1043 (1057)
Q Consensus 1003 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~ 1043 (1057)
....+...+++...++...+..||.+|. .++||.+|
T Consensus 384 -----d~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h 424 (516)
T KOG0690|consen 384 -----DLKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH 424 (516)
T ss_pred -----hccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence 1112235677889999999999999998 56666655
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=310.01 Aligned_cols=269 Identities=22% Similarity=0.291 Sum_probs=198.0
Q ss_pred hCCCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccc--hhHHHHHHHHHHHHHhcCCCCceeEeeeeccC------C
Q 001544 768 TNGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQH--ERAFKSFDTECEVMKSIRHRNLTKIISSCSNE------D 838 (1057)
Q Consensus 768 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 838 (1057)
..+|...+.||+|+||.||+|... +|+.||||++.... ......+.+|++++++++||||+++++++... .
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 478999999999999999999854 68999999986432 22345678999999999999999999988654 3
Q ss_pred eeEEEEEEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEccccccc
Q 001544 839 FKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL 918 (1057)
Q Consensus 839 ~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~ 918 (1057)
..++|+||+.. ++.++.. ..+++..+..++.|+++|++||| +.+++||||||+||+++.++.+|++|||+++.
T Consensus 94 ~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~ 166 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMG---HPLSEDKVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLARH 166 (342)
T ss_pred eEEEEeccccc-CHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCCCCcC
Confidence 46899999964 7776542 34889999999999999999999 89999999999999999999999999999875
Q ss_pred ccCCCCccccccccccccccCccccCC-CCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhh--hccchhHHH
Q 001544 919 LIGEDQSMTQTQTLATLGYMAPEYGRE-GRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVN--DFLPISMMK 995 (1057)
Q Consensus 919 ~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~--~~~~~~~~~ 995 (1057)
... ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||....... ....... ........+
T Consensus 167 ~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~ 240 (342)
T cd07879 167 ADA-----EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQILKVTGVPGPEFVQ 240 (342)
T ss_pred CCC-----CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCCHHHHH
Confidence 421 1223457888999998766 468899999999999999999999987522111 0100000 000111111
Q ss_pred hhhcc--------cccccchh-hHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH--HHHhHH
Q 001544 996 IIDAN--------LLITEDKH-FAAKEQCASSVFNLAMECTVESPDERITAKEIVRR--LLKIRD 1049 (1057)
Q Consensus 996 ~~~~~--------~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~--L~~i~~ 1049 (1057)
..+.. ........ ....+..+.++.+++.+||+.||++||++.|+++| ++..++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 241 KLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred HhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 11000 00000000 01112345678999999999999999999999977 666543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=297.26 Aligned_cols=243 Identities=27% Similarity=0.380 Sum_probs=196.4
Q ss_pred eccccCeEEEEEEec-CCcEEEEEEeeccc---hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEEccCCCh
Q 001544 777 IGRGSFGSVYIARLQ-NGIEVAVKTFDLQH---ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEYMRNGSL 852 (1057)
Q Consensus 777 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL 852 (1057)
||+|++|.||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++.++...++|+||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999865 58999999986432 23457799999999999999999999999999999999999999999
Q ss_pred hHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCcccccccc
Q 001544 853 EKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTL 932 (1057)
Q Consensus 853 ~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 932 (1057)
.+++.+.. .+++.++..++.|+++|++|+| +.+++|+||+|+||+++.++.++++|||.+....... ......
T Consensus 81 ~~~l~~~~-~l~~~~~~~~~~~i~~~l~~lH---~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~~ 153 (262)
T cd05572 81 WTILRDRG-LFDEYTARFYIACVVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFC 153 (262)
T ss_pred HHHHhhcC-CCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cccccc
Confidence 99997654 4889999999999999999999 9999999999999999999999999999998663221 222345
Q ss_pred ccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhcccccccchhhHHH
Q 001544 933 ATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHFAAK 1012 (1057)
Q Consensus 933 ~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1012 (1057)
++..|+|||...+..++.++|+||+|+++|||++|..||........ .. .....+.. .....+
T Consensus 154 ~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~--------~~~~~~~~------~~~~~~ 216 (262)
T cd05572 154 GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPM---EI--------YNDILKGN------GKLEFP 216 (262)
T ss_pred CCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHH---HH--------HHHHhccC------CCCCCC
Confidence 78899999998888899999999999999999999999876322100 00 11111000 011111
Q ss_pred HHHHHHHHHHHhHcccCCCCCCCC-----HHHHHHH
Q 001544 1013 EQCASSVFNLAMECTVESPDERIT-----AKEIVRR 1043 (1057)
Q Consensus 1013 ~~~~~~l~~li~~cl~~dP~~Rps-----~~evl~~ 1043 (1057)
..++.++.+++.+||+.+|++||+ ++|+++|
T Consensus 217 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~ 252 (262)
T cd05572 217 NYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKH 252 (262)
T ss_pred cccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcC
Confidence 233678999999999999999999 7777764
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=295.43 Aligned_cols=253 Identities=23% Similarity=0.331 Sum_probs=205.3
Q ss_pred hCCCCCCceeccccCeEEEEEEec-CCcEEEEEEeecc---chhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEE
Q 001544 768 TNGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQ---HERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALI 843 (1057)
Q Consensus 768 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 843 (1057)
.+.|+.-++||+|+||.||-++.. +|+.+|.|.+.+. ..........|-.+++++..+.||.+--+|+..+..++|
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 346778899999999999999754 6999999988543 233445677899999999999999998889999999999
Q ss_pred EEEccCCChhHHHhcCC-ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCC
Q 001544 844 LEYMRNGSLEKCLYSGN-YILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGE 922 (1057)
Q Consensus 844 ~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~ 922 (1057)
+..|.||+|.-++...+ ..+++..++-++.+|+.||++|| ..+||+||+||+|||+|+.|+++|+|.|+|..+..
T Consensus 264 LtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH---~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~- 339 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLH---RRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPE- 339 (591)
T ss_pred EEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHH---hcceeeccCChhheeeccCCCeEeeccceEEecCC-
Confidence 99999999988887654 56999999999999999999999 99999999999999999999999999999997733
Q ss_pred CCccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhcccc
Q 001544 923 DQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLL 1002 (1057)
Q Consensus 923 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1002 (1057)
.......+||.||||||++.++.|+...|-||+||++|||+.|+.||....... -.+-+|....
T Consensus 340 --g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKv--------------k~eEvdrr~~ 403 (591)
T KOG0986|consen 340 --GKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKV--------------KREEVDRRTL 403 (591)
T ss_pred --CCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhh--------------hHHHHHHHHh
Confidence 233445589999999999999999999999999999999999999987622110 1111222211
Q ss_pred cccchhhHHHHHHHHHHHHHHhHcccCCCCCCC-----CHHHHHHH
Q 001544 1003 ITEDKHFAAKEQCASSVFNLAMECTVESPDERI-----TAKEIVRR 1043 (1057)
Q Consensus 1003 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~ 1043 (1057)
.. ....++..+++..++.+..+..||++|. .+.||.+|
T Consensus 404 ~~---~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~H 446 (591)
T KOG0986|consen 404 ED---PEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEH 446 (591)
T ss_pred cc---hhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhC
Confidence 11 1122345678899999999999999998 44555544
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=306.71 Aligned_cols=269 Identities=24% Similarity=0.303 Sum_probs=200.2
Q ss_pred HHHHhCCCCCCceeccccCeEEEEEEec-CCcEEEEEEeecc--chhHHHHHHHHHHHHHhcCCCCceeEeeeecc-CCe
Q 001544 764 LFQATNGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQ--HERAFKSFDTECEVMKSIRHRNLTKIISSCSN-EDF 839 (1057)
Q Consensus 764 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~ 839 (1057)
+...+++|++.+.||+|+||.||+|... +++.||||++... .....+.+.+|++++++++||||+++.+++.. ...
T Consensus 5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 84 (328)
T cd07856 5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED 84 (328)
T ss_pred eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence 3456788999999999999999999755 7999999988542 22345678889999999999999999998865 567
Q ss_pred eEEEEEEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccc
Q 001544 840 KALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL 919 (1057)
Q Consensus 840 ~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~ 919 (1057)
.++|+||+ +++|.+++... .+++..+..++.|+++|++||| +.+|+||||+|+||++++++.++++|||.+...
T Consensus 85 ~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~ql~~aL~~LH---~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~ 158 (328)
T cd07856 85 IYFVTELL-GTDLHRLLTSR--PLEKQFIQYFLYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARIQ 158 (328)
T ss_pred EEEEeehh-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEeECCCCCEEeCcccccccc
Confidence 89999998 56898887643 3788888999999999999999 999999999999999999999999999998754
Q ss_pred cCCCCccccccccccccccCccccCC-CCCCccchHHHHHHHHHHHhhCCCCCCccccccc--ch--------hhhhhhc
Q 001544 920 IGEDQSMTQTQTLATLGYMAPEYGRE-GRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEM--TL--------KHWVNDF 988 (1057)
Q Consensus 920 ~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~--~~--------~~~~~~~ 988 (1057)
.. ......++..|+|||.+.+ ..++.++||||+|+++|||++|+.||........ .. .+|....
T Consensus 159 ~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (328)
T cd07856 159 DP-----QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTI 233 (328)
T ss_pred CC-----CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 21 1123356788999998765 5689999999999999999999999865321100 00 1111111
Q ss_pred cchhHHHhhhcccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 989 LPISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 989 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
......+.................+.++.++.+++.+|++.+|++||++.|++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 234 CSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred cchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 1111111111000000000001112356789999999999999999999999877
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-32 Score=303.25 Aligned_cols=244 Identities=27% Similarity=0.354 Sum_probs=194.8
Q ss_pred CCCCceeccccCeEEEEEEec-CCcEEEEEEeecc---chhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEE
Q 001544 771 FSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQ---HERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEY 846 (1057)
Q Consensus 771 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 846 (1057)
|...+.||+|+||+||+|+.. +++.||+|++... .......+.+|++++++++|||++++++++.+++..++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 555678999999999999864 6899999998643 233456788899999999999999999999999999999999
Q ss_pred ccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCcc
Q 001544 847 MRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSM 926 (1057)
Q Consensus 847 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 926 (1057)
+. |++.+++......+++.++..++.|++.|++||| +.+++||||+|+||+++.++.+||+|||++....
T Consensus 103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~------ 172 (313)
T cd06633 103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS------ 172 (313)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChhhEEECCCCCEEEeecCCCcccC------
Confidence 96 5788877766667999999999999999999999 8999999999999999999999999999986431
Q ss_pred ccccccccccccCccccC---CCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhccccc
Q 001544 927 TQTQTLATLGYMAPEYGR---EGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLI 1003 (1057)
Q Consensus 927 ~~~~~~~t~~y~aPE~~~---~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1003 (1057)
......++..|+|||++. .+.++.++|||||||++|||++|+.||....... .. .........
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~--~~-----------~~~~~~~~~- 238 (313)
T cd06633 173 PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--AL-----------YHIAQNDSP- 238 (313)
T ss_pred CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH--HH-----------HHHHhcCCC-
Confidence 122346788999999874 4568889999999999999999999976521110 00 000000000
Q ss_pred ccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 1004 TEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 1004 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
......++..+.+++.+|++.+|++||++.+++++
T Consensus 239 -----~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 239 -----TLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred -----CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00012234568899999999999999999999986
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-32 Score=307.57 Aligned_cols=269 Identities=20% Similarity=0.279 Sum_probs=199.4
Q ss_pred HHHHhCCCCCCceeccccCeEEEEEEe-cCCcEEEEEEeecc--chhHHHHHHHHHHHHHhcCCCCceeEeeeeccCC--
Q 001544 764 LFQATNGFSENNLIGRGSFGSVYIARL-QNGIEVAVKTFDLQ--HERAFKSFDTECEVMKSIRHRNLTKIISSCSNED-- 838 (1057)
Q Consensus 764 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-- 838 (1057)
+....++|++.+.||+|+||.||+|.. .+|+.||||++... .......+.+|++++++++||||+++++++..+.
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 344567899999999999999999975 47899999998543 2334467889999999999999999999886543
Q ss_pred ----eeEEEEEEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEccc
Q 001544 839 ----FKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFG 914 (1057)
Q Consensus 839 ----~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 914 (1057)
..++||||+ +++|.+++... .+++..+..++.|+++|++||| +.+|+||||||+||+++.++.++++|||
T Consensus 90 ~~~~~~~lv~e~~-~~~l~~~~~~~--~l~~~~~~~i~~qi~~al~~LH---~~gi~H~dlkp~Nill~~~~~~kl~dfg 163 (343)
T cd07880 90 DRFHDFYLVMPFM-GTDLGKLMKHE--KLSEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFG 163 (343)
T ss_pred cccceEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecc
Confidence 458999999 67998887643 4899999999999999999999 9999999999999999999999999999
Q ss_pred ccccccCCCCccccccccccccccCccccCC-CCCCccchHHHHHHHHHHHhhCCCCCCcccccccch----------hh
Q 001544 915 IAKLLIGEDQSMTQTQTLATLGYMAPEYGRE-GRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTL----------KH 983 (1057)
Q Consensus 915 ~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~----------~~ 983 (1057)
++..... ......++..|+|||.+.+ ..++.++|+||+|+++|++++|+.||.......... ..
T Consensus 164 ~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 238 (343)
T cd07880 164 LARQTDS-----EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKE 238 (343)
T ss_pred ccccccc-----CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence 9976422 1223456889999998765 458899999999999999999999987532110000 00
Q ss_pred hhhhccchhHHHhhhcccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 984 WVNDFLPISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 984 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
|............................+.++.++.+++.+|++.||++|||+.+++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~ 298 (343)
T cd07880 239 FVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH 298 (343)
T ss_pred HHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 111100000000000000000000011123456778999999999999999999999854
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-32 Score=298.26 Aligned_cols=265 Identities=25% Similarity=0.303 Sum_probs=196.8
Q ss_pred CCCCceeccccCeEEEEEEec-CCcEEEEEEeeccc--hhHHHHHHHHHHHHHhc---CCCCceeEeeeeccCCe-----
Q 001544 771 FSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQH--ERAFKSFDTECEVMKSI---RHRNLTKIISSCSNEDF----- 839 (1057)
Q Consensus 771 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~----- 839 (1057)
|++.+.||+|+||.||+|+.+ +++.||+|+++... ......+.+|+++++++ +|||++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 567789999999999999876 48999999996432 22334566788777766 59999999999987766
Q ss_pred eEEEEEEccCCChhHHHhcCC-ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEccccccc
Q 001544 840 KALILEYMRNGSLEKCLYSGN-YILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL 918 (1057)
Q Consensus 840 ~~lV~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~ 918 (1057)
.+++|||+.+ +|.+++.... ..+++.++..++.|+++||+||| +.+++|+||+|+||++++++.+||+|||.+..
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH---~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhEEEccCCCEEEeccCccee
Confidence 8999999975 8988886643 35899999999999999999999 89999999999999999999999999999876
Q ss_pred ccCCCCccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhh-
Q 001544 919 LIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKII- 997 (1057)
Q Consensus 919 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~- 997 (1057)
..... ......++..|+|||...+..++.++|+|||||++|||++|+.||...... .....+.............
T Consensus 157 ~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07838 157 YSFEM---ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEA-DQLDKIFDVIGLPSEEEWPR 232 (287)
T ss_pred ccCCc---ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChH-HHHHHHHHHcCCCChHhcCC
Confidence 53221 122334678899999998888999999999999999999999988653221 1111111110000000000
Q ss_pred h----cc--cccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 998 D----AN--LLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 998 ~----~~--~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
. .. ...............+..+.+++.+||+.||++||++.|+++|
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 233 NVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred CcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 0 00 0000000111123456788999999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=305.05 Aligned_cols=266 Identities=19% Similarity=0.233 Sum_probs=193.2
Q ss_pred ceeccccCeEEEEEEecCCcEEEEEEeecc--chhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEEccCCCh
Q 001544 775 NLIGRGSFGSVYIARLQNGIEVAVKTFDLQ--HERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEYMRNGSL 852 (1057)
Q Consensus 775 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL 852 (1057)
+.+|.|+++.||++.. +++.||||+++.. .....+.+.+|++++++++||||+++++++.+.+..+++|||+++|+|
T Consensus 8 ~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l 86 (314)
T cd08216 8 KCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC 86 (314)
T ss_pred HhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCH
Confidence 3444555555555544 6899999998654 345567899999999999999999999999999999999999999999
Q ss_pred hHHHhcC-CccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCc-----c
Q 001544 853 EKCLYSG-NYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS-----M 926 (1057)
Q Consensus 853 ~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~-----~ 926 (1057)
.+++... ...+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+|++|||.+..+...... .
T Consensus 87 ~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH---~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~ 163 (314)
T cd08216 87 EDLLKTHFPEGLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHD 163 (314)
T ss_pred HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCcceEEEecCCceEEecCccceeecccccccccccc
Confidence 9998754 345889999999999999999999 999999999999999999999999999998765322211 1
Q ss_pred ccccccccccccCccccCC--CCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhh--------ccchhHHHh
Q 001544 927 TQTQTLATLGYMAPEYGRE--GRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVND--------FLPISMMKI 996 (1057)
Q Consensus 927 ~~~~~~~t~~y~aPE~~~~--~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~--------~~~~~~~~~ 996 (1057)
......++..|+|||++.. ..++.++||||+||++|||++|+.||................ ..+......
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (314)
T cd08216 164 FPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSM 243 (314)
T ss_pred ccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCc
Confidence 1123346778999998865 357889999999999999999999997532221111110000 000000000
Q ss_pred hh-----cccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHH
Q 001544 997 ID-----ANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRL 1044 (1057)
Q Consensus 997 ~~-----~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 1044 (1057)
.. .................+.++.+++.+||..+|++|||+.|+++|-
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p 296 (314)
T cd08216 244 SQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHS 296 (314)
T ss_pred CcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCc
Confidence 00 0000000011122234567899999999999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=301.47 Aligned_cols=259 Identities=19% Similarity=0.233 Sum_probs=185.3
Q ss_pred hCCCCCCceeccccCeEEEEEEecC----CcEEEEEEeeccchhH-----------HHHHHHHHHHHHhcCCCCceeEee
Q 001544 768 TNGFSENNLIGRGSFGSVYIARLQN----GIEVAVKTFDLQHERA-----------FKSFDTECEVMKSIRHRNLTKIIS 832 (1057)
Q Consensus 768 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~h~niv~l~~ 832 (1057)
.++|.+.++||+|+||+||+|...+ +..+|+|+........ ......+...+..+.|++++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 3578999999999999999998653 4567777643322111 011223334456678999999998
Q ss_pred eeccCC----eeEEEEEEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcE
Q 001544 833 SCSNED----FKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVA 908 (1057)
Q Consensus 833 ~~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~ 908 (1057)
++.... ..++++|++.. ++.+.+... ...++..+..|+.|+++|++||| +.+|+||||||+||+++.++.+
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~iiHrDiKp~Nill~~~~~~ 165 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKRI-KCKNKKLIKNIMKDMLTTLEYIH---EHGISHGDIKPENIMVDGNNRG 165 (294)
T ss_pred eeeEecCCceEEEEEEehhcc-CHHHHHHhh-ccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCcE
Confidence 765443 44678887644 666655443 23578888999999999999999 9999999999999999999999
Q ss_pred EEEcccccccccCCCCc-----cccccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhh
Q 001544 909 HLSDFGIAKLLIGEDQS-----MTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKH 983 (1057)
Q Consensus 909 kl~Dfg~a~~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~ 983 (1057)
+|+|||+|+.+...... .......||+.|+|||+..+..++.++||||+||++|||++|+.||............
T Consensus 166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~ 245 (294)
T PHA02882 166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHA 245 (294)
T ss_pred EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHH
Confidence 99999999876322211 1122346899999999999999999999999999999999999999764221110000
Q ss_pred hhhhccchhHHHhhhcccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHH
Q 001544 984 WVNDFLPISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRL 1044 (1057)
Q Consensus 984 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 1044 (1057)
. ..+.+..... . ......++..+.+++..|+..+|++||++.++++.+
T Consensus 246 ~--------~~~~~~~~~~--~---~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 246 A--------KCDFIKRLHE--G---KIKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred h--------HHHHHHHhhh--h---hhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 0 0001100000 0 001134567899999999999999999999999865
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=304.86 Aligned_cols=247 Identities=28% Similarity=0.374 Sum_probs=197.1
Q ss_pred CCCCCceeccccCeEEEEEEec-CCcEEEEEEeecc---chhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEE
Q 001544 770 GFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQ---HERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILE 845 (1057)
Q Consensus 770 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 845 (1057)
.|+..+.||+|+||.||+|+.. ++..||+|.+... ......++.+|+++++.++|+|++++++++..++..++|||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 4666788999999999999865 6889999998642 23345678889999999999999999999999999999999
Q ss_pred EccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCc
Q 001544 846 YMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS 925 (1057)
Q Consensus 846 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 925 (1057)
|+. |++.+.+......+++.++..++.|++.|++||| +.+++||||+|+||+++.++.++++|||++.....
T Consensus 96 ~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~---- 167 (308)
T cd06634 96 YCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---- 167 (308)
T ss_pred ccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHhEEECCCCcEEECCcccceeecC----
Confidence 996 5888877665566899999999999999999999 89999999999999999999999999999876422
Q ss_pred cccccccccccccCccccC---CCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhcccc
Q 001544 926 MTQTQTLATLGYMAPEYGR---EGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLL 1002 (1057)
Q Consensus 926 ~~~~~~~~t~~y~aPE~~~---~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1002 (1057)
.....++..|+|||.+. ...++.++||||+||++|||++|+.||......+ ....+ .....
T Consensus 168 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~~------------~~~~~- 231 (308)
T cd06634 168 --ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHI------------AQNES- 231 (308)
T ss_pred --cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH-HHHHH------------hhcCC-
Confidence 12345788999999864 3567889999999999999999999975521110 00000 00000
Q ss_pred cccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHH
Q 001544 1003 ITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLL 1045 (1057)
Q Consensus 1003 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 1045 (1057)
.......++..+.+++.+||+.+|++||++.+++++-.
T Consensus 232 -----~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 232 -----PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred -----CCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence 00011235667899999999999999999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-32 Score=307.68 Aligned_cols=273 Identities=23% Similarity=0.291 Sum_probs=201.4
Q ss_pred CHHHHHHHhCCCCCCceeccccCeEEEEEEe-cCCcEEEEEEeeccc--hhHHHHHHHHHHHHHhcCCCCceeEeeeecc
Q 001544 760 SYLELFQATNGFSENNLIGRGSFGSVYIARL-QNGIEVAVKTFDLQH--ERAFKSFDTECEVMKSIRHRNLTKIISSCSN 836 (1057)
Q Consensus 760 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 836 (1057)
...++...+++|++.+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|++++++++||||+++++++..
T Consensus 8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~ 87 (345)
T cd07877 8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 87 (345)
T ss_pred HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence 3456677889999999999999999999975 478999999986432 2234667889999999999999999998753
Q ss_pred C------CeeEEEEEEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEE
Q 001544 837 E------DFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHL 910 (1057)
Q Consensus 837 ~------~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl 910 (1057)
. ...++|+|++ +++|.+++... .+++..+..++.|+++|++||| +.+|+||||||+||++++++.+||
T Consensus 88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl 161 (345)
T cd07877 88 ARSLEEFNDVYLVTHLM-GADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKI 161 (345)
T ss_pred cccccccccEEEEehhc-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEcCCCCEEE
Confidence 2 3467888887 77998887654 4899999999999999999999 999999999999999999999999
Q ss_pred EcccccccccCCCCccccccccccccccCccccCC-CCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhh--h
Q 001544 911 SDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGRE-GRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVN--D 987 (1057)
Q Consensus 911 ~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~--~ 987 (1057)
+|||+++.... ......++..|+|||...+ ..++.++||||+||++|||++|+.||....... ....... .
T Consensus 162 ~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~ 235 (345)
T cd07877 162 LDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID-QLKLILRLVG 235 (345)
T ss_pred ecccccccccc-----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhC
Confidence 99999875421 2233467889999998765 567889999999999999999999986422111 1111000 0
Q ss_pred ccchhHHHhhhcc--------cccccchhhH-HHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHH
Q 001544 988 FLPISMMKIIDAN--------LLITEDKHFA-AKEQCASSVFNLAMECTVESPDERITAKEIVRRL 1044 (1057)
Q Consensus 988 ~~~~~~~~~~~~~--------~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 1044 (1057)
..+......+... ........+. .....+.++.+++.+|++.||++||++.|+++|=
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~ 301 (345)
T cd07877 236 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 301 (345)
T ss_pred CCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcCh
Confidence 0000111000000 0000000000 0112456789999999999999999999999873
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=307.95 Aligned_cols=274 Identities=24% Similarity=0.286 Sum_probs=206.5
Q ss_pred CCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccc--hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCC-----eeE
Q 001544 770 GFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQH--ERAFKSFDTECEVMKSIRHRNLTKIISSCSNED-----FKA 841 (1057)
Q Consensus 770 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 841 (1057)
+|++.+.||+|++|.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++...+ ..|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4788899999999999999865 58999999986543 344578899999999999999999999987765 789
Q ss_pred EEEEEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccC
Q 001544 842 LILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIG 921 (1057)
Q Consensus 842 lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~ 921 (1057)
+||||+++ +|.+++.... .+++..+..++.|+++|++||| +.+|+||||||.||+++.++.++|+|||.+.....
T Consensus 81 lv~e~~~~-~l~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH---~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~ 155 (330)
T cd07834 81 IVTELMET-DLHKVIKSPQ-PLTDDHIQYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDP 155 (330)
T ss_pred EEecchhh-hHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccCceEeecc
Confidence 99999984 8988887655 6999999999999999999999 99999999999999999999999999999987643
Q ss_pred CCC-ccccccccccccccCccccCCC-CCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhh---h--------c
Q 001544 922 EDQ-SMTQTQTLATLGYMAPEYGREG-RVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVN---D--------F 988 (1057)
Q Consensus 922 ~~~-~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~---~--------~ 988 (1057)
... ........++..|+|||.+.+. .++.++|+||+|+++|+|++|+.||......+. ...... . .
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~ 234 (330)
T cd07834 156 DEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQ-LNLIVEVLGTPSEEDLKFI 234 (330)
T ss_pred cccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHH-HHHHHHhcCCCChhHhhhc
Confidence 221 1123344678899999998877 789999999999999999999999865322110 000000 0 0
Q ss_pred cchhHHHhhhcccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH--HHHhHH
Q 001544 989 LPISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR--LLKIRD 1049 (1057)
Q Consensus 989 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~--L~~i~~ 1049 (1057)
........+..................+.++.+++.+||+.+|++||++.+++++ ++.+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 235 TSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred cccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 0000111111100000000111112356789999999999999999999999986 555543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=300.00 Aligned_cols=244 Identities=26% Similarity=0.374 Sum_probs=194.6
Q ss_pred eccccCeEEEEEEec-CCcEEEEEEeeccch---hHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEEccCCCh
Q 001544 777 IGRGSFGSVYIARLQ-NGIEVAVKTFDLQHE---RAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEYMRNGSL 852 (1057)
Q Consensus 777 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL 852 (1057)
||+|+||.||+|... +|+.||+|++..... ...+.+.+|++++++++||||+++++.+..++..|+||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999876 499999999865432 4567889999999999999999999999999999999999999999
Q ss_pred hHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCC------cc
Q 001544 853 EKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ------SM 926 (1057)
Q Consensus 853 ~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~------~~ 926 (1057)
.+++...+ .+++..+..++.|+++||+||| +.+++||||+|+||++++++.++++|||++........ ..
T Consensus 81 ~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 156 (265)
T cd05579 81 ASLLENVG-SLDEDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEK 156 (265)
T ss_pred HHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccc
Confidence 99987655 5899999999999999999999 99999999999999999999999999999875432211 11
Q ss_pred ccccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhcccccccc
Q 001544 927 TQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITED 1006 (1057)
Q Consensus 927 ~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1006 (1057)
......++..|+|||.......+.++||||+|+++||+++|..||...... .+. .......
T Consensus 157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~-----~~~--------~~~~~~~------ 217 (265)
T cd05579 157 EDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE-----EIF--------QNILNGK------ 217 (265)
T ss_pred cccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH-----HHH--------HHHhcCC------
Confidence 223345778899999988888999999999999999999999998652211 000 0000000
Q ss_pred hhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 1007 KHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 1007 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
..++.....+..+.+++.+|++.+|++|||+.++.+.
T Consensus 218 ~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~ 254 (265)
T cd05579 218 IEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEI 254 (265)
T ss_pred cCCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHH
Confidence 0111111136788999999999999999999444433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-32 Score=295.39 Aligned_cols=240 Identities=23% Similarity=0.313 Sum_probs=186.4
Q ss_pred ceeccccCeEEEEEEec-CCcEEEEEEeeccch---hHHHHHHHHHHHH-HhcCCCCceeEeeeeccCCeeEEEEEEccC
Q 001544 775 NLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQHE---RAFKSFDTECEVM-KSIRHRNLTKIISSCSNEDFKALILEYMRN 849 (1057)
Q Consensus 775 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 849 (1057)
+.||+|+||.||+|... +|+.||||+++.... .....+..|..++ .+.+|+|++++++++.+.+..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 56999999999999864 689999999864321 2223344555444 455899999999999999999999999999
Q ss_pred CChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCccccc
Q 001544 850 GSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQT 929 (1057)
Q Consensus 850 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 929 (1057)
++|.+++.... .+++..+..++.|++.||.||| +.+++||||+|+||++++++.++++|||+++.... ..
T Consensus 82 ~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~~ 151 (260)
T cd05611 82 GDCASLIKTLG-GLPEDWAKQYIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------NK 151 (260)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEeecccceeccc------cc
Confidence 99999987654 4889999999999999999999 89999999999999999999999999999875321 22
Q ss_pred cccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhcccccccchhh
Q 001544 930 QTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHF 1009 (1057)
Q Consensus 930 ~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1057)
...++..|+|||...+..++.++||||+|+++|||++|..||...... ... ........ ....
T Consensus 152 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~~---------~~~~~~~~---~~~~ 214 (260)
T cd05611 152 KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD-----AVF---------DNILSRRI---NWPE 214 (260)
T ss_pred cCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH-----HHH---------HHHHhccc---CCCC
Confidence 345778899999988888899999999999999999999998642111 000 00000000 0001
Q ss_pred HHHHHHHHHHHHHHhHcccCCCCCCCCHHHHH
Q 001544 1010 AAKEQCASSVFNLAMECTVESPDERITAKEIV 1041 (1057)
Q Consensus 1010 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl 1041 (1057)
.....++..+.+++.+||+.+|++||++.++.
T Consensus 215 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~ 246 (260)
T cd05611 215 EVKEFCSPEAVDLINRLLCMDPAKRLGANGYQ 246 (260)
T ss_pred cccccCCHHHHHHHHHHccCCHHHccCCCcHH
Confidence 11124577899999999999999999765443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=322.40 Aligned_cols=271 Identities=19% Similarity=0.206 Sum_probs=190.2
Q ss_pred hCCCCCCceeccccCeEEEEEEecC--CcEEEEEEee-----------------ccchhHHHHHHHHHHHHHhcCCCCce
Q 001544 768 TNGFSENNLIGRGSFGSVYIARLQN--GIEVAVKTFD-----------------LQHERAFKSFDTECEVMKSIRHRNLT 828 (1057)
Q Consensus 768 ~~~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~-----------------~~~~~~~~~~~~E~~~l~~l~h~niv 828 (1057)
.++|++.+.||+|+||+||+|..+. +..+++|.+. .........+.+|++++++++||||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 4689999999999999999986542 2222222110 01122345688999999999999999
Q ss_pred eEeeeeccCCeeEEEEEEccCCChhHHHhcCC----ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCC
Q 001544 829 KIISSCSNEDFKALILEYMRNGSLEKCLYSGN----YILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDD 904 (1057)
Q Consensus 829 ~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~ 904 (1057)
++++++...+..|+|+|++.+ ++.+++.... ......++..|+.|++.||+||| +++|+||||||+|||++.
T Consensus 227 ~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH---~~gIiHrDLKP~NILl~~ 302 (501)
T PHA03210 227 KIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH---DKKLIHRDIKLENIFLNC 302 (501)
T ss_pred cEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECC
Confidence 999999999999999999854 7777665432 22345677889999999999999 999999999999999999
Q ss_pred CCcEEEEcccccccccCCCCccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCC-CCcccccc-cchh
Q 001544 905 NMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKP-TDEIFSGE-MTLK 982 (1057)
Q Consensus 905 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p-~~~~~~~~-~~~~ 982 (1057)
++.+||+|||+++.+..... .......||..|+|||++.+..++.++|||||||++|||++|..+ +....... ..+.
T Consensus 303 ~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~ 381 (501)
T PHA03210 303 DGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL 381 (501)
T ss_pred CCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHH
Confidence 99999999999987632221 122235689999999999998999999999999999999998754 43211110 1111
Q ss_pred hhhhhc------cch---hHHHhhhcccccccchh---hHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 983 HWVNDF------LPI---SMMKIIDANLLITEDKH---FAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 983 ~~~~~~------~~~---~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
..+... .+. ...+.++.......... .......+.++.+++.+|++.||++|||+.|+++|
T Consensus 382 ~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 382 KIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 111100 000 01111111110000000 00111245678889999999999999999999986
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-32 Score=302.45 Aligned_cols=250 Identities=26% Similarity=0.364 Sum_probs=207.1
Q ss_pred HhCCCCCCceeccccCeEEEEEEe-cCCcEEEEEEeeccc--hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEE
Q 001544 767 ATNGFSENNLIGRGSFGSVYIARL-QNGIEVAVKTFDLQH--ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALI 843 (1057)
Q Consensus 767 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 843 (1057)
....|.+...||+|.|++|..|+. .++..||||.+++.. ....+.+.+|+++|..+.|||||+++.+...+...|+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 345788999999999999999974 479999999996553 23345588999999999999999999999999999999
Q ss_pred EEEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCC
Q 001544 844 LEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGED 923 (1057)
Q Consensus 844 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~ 923 (1057)
|||+.+|.+++++.+.+. ..+..+..++.|+.+|++||| ++.|||||||++||+++.+..+||+|||++..+.
T Consensus 134 ~eya~~ge~~~yl~~~gr-~~e~~ar~~F~q~vsaveYcH---~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~--- 206 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKHGR-MKEKEARAKFRQIVSAVEYCH---SKNIVHRDLKAENILLDENMNIKIADFGFSTFFD--- 206 (596)
T ss_pred EEeccCchhHHHHHhccc-chhhhhhhhhHHHHHHHHHHh---hcceeccccchhhcccccccceeeeccccceeec---
Confidence 999999999999988775 444888999999999999999 9999999999999999999999999999999874
Q ss_pred CccccccccccccccCccccCCCCC-CccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhcccc
Q 001544 924 QSMTQTQTLATLGYMAPEYGREGRV-STKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLL 1002 (1057)
Q Consensus 924 ~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1002 (1057)
.........|++-|.|||++.+..+ ++++|+||+|+++|-++.|..||++..-.+. -++.+.
T Consensus 207 ~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~L-----------------r~rvl~ 269 (596)
T KOG0586|consen 207 YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKEL-----------------RPRVLR 269 (596)
T ss_pred ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccc-----------------cchhee
Confidence 3344555689999999999988765 6899999999999999999999986211110 001111
Q ss_pred cccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHH
Q 001544 1003 ITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRL 1044 (1057)
Q Consensus 1003 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 1044 (1057)
..+..+.-++.+..+++++++..+|.+|++..++.++-
T Consensus 270 ----gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~ 307 (596)
T KOG0586|consen 270 ----GKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDR 307 (596)
T ss_pred ----eeecccceeechhHHHHHHhhccCccccCCHHHhhhhc
Confidence 01112233566788999999999999999999998764
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=3e-32 Score=308.85 Aligned_cols=266 Identities=23% Similarity=0.286 Sum_probs=199.0
Q ss_pred HHhCCCCCCceeccccCeEEEEEEec-CCcEEEEEEeecc--chhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCe---
Q 001544 766 QATNGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQ--HERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDF--- 839 (1057)
Q Consensus 766 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--- 839 (1057)
...++|++.+.||+|++|.||+|... +++.||||++... .....+.+.+|+.++++++|||++++++++...+.
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 34678999999999999999999865 6889999998643 22334667789999999999999999998766554
Q ss_pred ---eEEEEEEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEccccc
Q 001544 840 ---KALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIA 916 (1057)
Q Consensus 840 ---~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a 916 (1057)
.++|+||+ +++|.+++... .+++.++..++.|+++|++||| +.+|+||||||+||++++++.+||+|||++
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nill~~~~~~kL~dfg~~ 165 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKCQ--KLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLA 165 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEcccccc
Confidence 89999999 56999988753 4899999999999999999999 899999999999999999999999999999
Q ss_pred ccccCCCCccccccccccccccCccccCC-CCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhh-----------h
Q 001544 917 KLLIGEDQSMTQTQTLATLGYMAPEYGRE-GRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKH-----------W 984 (1057)
Q Consensus 917 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~-----------~ 984 (1057)
...... .....++..|+|||...+ ..++.++||||+||++||+++|+.||......+ .+.. +
T Consensus 166 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~-~~~~i~~~~~~~~~~~ 239 (343)
T cd07851 166 RHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHID-QLKRIMNLVGTPDEEL 239 (343)
T ss_pred cccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHhcCCCCHHH
Confidence 865221 233457788999998755 367899999999999999999999986432111 0111 1
Q ss_pred hhhccchhHHHhhhcccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 985 VNDFLPISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 985 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
...............................+.++.+++.+|++.+|++|||+.|+++|
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 240 LQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred HhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 11110000011100000000000011112346789999999999999999999999875
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.2e-32 Score=295.60 Aligned_cols=242 Identities=22% Similarity=0.305 Sum_probs=187.0
Q ss_pred eeccccCeEEEEEEec-CCcEEEEEEeeccc---hhHHHHHHHHH---HHHHhcCCCCceeEeeeeccCCeeEEEEEEcc
Q 001544 776 LIGRGSFGSVYIARLQ-NGIEVAVKTFDLQH---ERAFKSFDTEC---EVMKSIRHRNLTKIISSCSNEDFKALILEYMR 848 (1057)
Q Consensus 776 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~---~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 848 (1057)
+||+|+||.||+|... +++.||+|.+.... ......+..|. +.++...||+|+++++++.+.+..++||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999754 68999999986432 11112233343 34445579999999999999999999999999
Q ss_pred CCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCcccc
Q 001544 849 NGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQ 928 (1057)
Q Consensus 849 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 928 (1057)
+|+|.+++... ..+++.++..++.|+++|++||| +.+|+||||||+||+++.++.+||+|||++...... ..
T Consensus 81 g~~L~~~l~~~-~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~----~~ 152 (278)
T cd05606 81 GGDLHYHLSQH-GVFSEAEMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----KP 152 (278)
T ss_pred CCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc----CC
Confidence 99999988654 35899999999999999999999 899999999999999999999999999998755221 12
Q ss_pred ccccccccccCccccCCC-CCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhcccccccch
Q 001544 929 TQTLATLGYMAPEYGREG-RVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDK 1007 (1057)
Q Consensus 929 ~~~~~t~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1057)
....|+..|+|||...++ .++.++||||+||++|||++|+.||.......... ....... .
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~-----------~~~~~~~-------~ 214 (278)
T cd05606 153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-----------IDRMTLT-------M 214 (278)
T ss_pred cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHH-----------HHHHhhc-------c
Confidence 234688999999998754 68899999999999999999999987632211100 0000000 0
Q ss_pred hhHHHHHHHHHHHHHHhHcccCCCCCCC-----CHHHHHHH
Q 001544 1008 HFAAKEQCASSVFNLAMECTVESPDERI-----TAKEIVRR 1043 (1057)
Q Consensus 1008 ~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~ 1043 (1057)
....+..++.++.+++.+|+..+|.+|| ++.|++++
T Consensus 215 ~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 215 AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred CCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 0111123467889999999999999999 99999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-32 Score=300.98 Aligned_cols=250 Identities=27% Similarity=0.418 Sum_probs=203.3
Q ss_pred CCCCCCceeccccCeEEEEEEec-CCcEEEEEEeecc---chhHHHHHHHHHHHHHhcC-CCCceeEeeeeccCCeeEEE
Q 001544 769 NGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQ---HERAFKSFDTECEVMKSIR-HRNLTKIISSCSNEDFKALI 843 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV 843 (1057)
++|.+.+.||+|+||.||+|... +|+.||+|++... .....+.+.+|++++++++ ||||+++++++..++..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46888999999999999999865 6999999998643 2334567889999999998 99999999999999999999
Q ss_pred EEEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCC
Q 001544 844 LEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGED 923 (1057)
Q Consensus 844 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~ 923 (1057)
|||+++++|.+++...+ .+++.++..|+.|++.|++||| +.+++|+||+|+||+++.++.++++|||++.......
T Consensus 81 ~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~Lh---~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~ 156 (280)
T cd05581 81 LEYAPNGELLQYIRKYG-SLDEKCTRFYAAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNS 156 (280)
T ss_pred EcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEecCCccccccCCcc
Confidence 99999999999987664 5999999999999999999999 9999999999999999999999999999998653322
Q ss_pred Cc------------------cccccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhh
Q 001544 924 QS------------------MTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWV 985 (1057)
Q Consensus 924 ~~------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~ 985 (1057)
.. .......++..|+|||......++.++|+||+|++++++++|+.||.......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------- 229 (280)
T cd05581 157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL------- 229 (280)
T ss_pred ccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH-------
Confidence 11 12223356789999999888889999999999999999999999987532100
Q ss_pred hhccchhHHHhhhcccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCH----HHHHHH
Q 001544 986 NDFLPISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITA----KEIVRR 1043 (1057)
Q Consensus 986 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~----~evl~~ 1043 (1057)
......+. ....+...++.+.+++.+||+.+|++||++ .++++|
T Consensus 230 ------~~~~~~~~--------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 230 ------TFQKILKL--------EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred ------HHHHHHhc--------CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 00111110 011112346678999999999999999999 888765
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-32 Score=307.43 Aligned_cols=276 Identities=26% Similarity=0.350 Sum_probs=206.2
Q ss_pred CCCCceeccccCeEEEEEE-ecCCcEEEEEEeeccc-hhHHHHHHHHHHHHHhcCCCCceeEeeeeccC------CeeEE
Q 001544 771 FSENNLIGRGSFGSVYIAR-LQNGIEVAVKTFDLQH-ERAFKSFDTECEVMKSIRHRNLTKIISSCSNE------DFKAL 842 (1057)
Q Consensus 771 ~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~l 842 (1057)
|...+.||+|+||.||+|+ ..+|+.||||.++... ....++.-+|++++++++|||||++++.-++. +...+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 4556889999999999998 5579999999996532 33456778899999999999999999876543 46789
Q ss_pred EEEEccCCChhHHHhcCC--ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeC--CCC--cEEEEccccc
Q 001544 843 ILEYMRNGSLEKCLYSGN--YILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLD--DNM--VAHLSDFGIA 916 (1057)
Q Consensus 843 V~E~~~~gsL~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~--~~~--~~kl~Dfg~a 916 (1057)
|||||.+|+|...+.+.. .-+++.+.+.+..+++.|+.||| +++||||||||.||++- ++| .-||+|||.|
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~Lr---En~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLR---ENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHH---HcCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 999999999999998755 45999999999999999999999 99999999999999984 334 4799999999
Q ss_pred ccccCCCCccccccccccccccCccccCC-CCCCccchHHHHHHHHHHHhhCCCCCCcccccccchh-hhhhhccchh-H
Q 001544 917 KLLIGEDQSMTQTQTLATLGYMAPEYGRE-GRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLK-HWVNDFLPIS-M 993 (1057)
Q Consensus 917 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~-~~~~~~~~~~-~ 993 (1057)
+-+. .........||..|.+||.... +.++.-+|.|||||++||++||..||........... .|.......+ .
T Consensus 172 rel~---d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v 248 (732)
T KOG4250|consen 172 RELD---DNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGV 248 (732)
T ss_pred ccCC---CCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCce
Confidence 9763 3336677889999999999884 8889999999999999999999999976444322111 1221111111 1
Q ss_pred HHhhhc--ccccccchhhHHH----HHHHHHHHHHHhHcccCCCCCCC--CHHHHHHHHHHhHHHHh
Q 001544 994 MKIIDA--NLLITEDKHFAAK----EQCASSVFNLAMECTVESPDERI--TAKEIVRRLLKIRDFLL 1052 (1057)
Q Consensus 994 ~~~~~~--~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~Rp--s~~evl~~L~~i~~~~~ 1052 (1057)
.-..+. .........++.+ ......+-.++..++..+|++|- .+.+....+.+|.+.-.
T Consensus 249 ~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~~v 315 (732)
T KOG4250|consen 249 AIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNLKV 315 (732)
T ss_pred eEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhhhe
Confidence 000000 0011111111211 12234566778888999999999 88888888877766443
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.9e-32 Score=306.93 Aligned_cols=269 Identities=21% Similarity=0.268 Sum_probs=196.8
Q ss_pred hCCCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccchhHHHHHHHHHHHHHhcCCCCceeEeeeeccC---------
Q 001544 768 TNGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCSNE--------- 837 (1057)
Q Consensus 768 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------- 837 (1057)
..+|+..+.||+|+||.||+|... +|+.||+|++........+.+.+|++++++++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 357889999999999999999864 6899999999766556667888999999999999999999876543
Q ss_pred -----CeeEEEEEEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeC-CCCcEEEE
Q 001544 838 -----DFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLD-DNMVAHLS 911 (1057)
Q Consensus 838 -----~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~-~~~~~kl~ 911 (1057)
...++||||++ ++|.+++... .+++..+..++.||++|++||| +.+|+||||||+||+++ +++.+|++
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH---~~givH~dikp~Nili~~~~~~~kl~ 157 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQG--PLSEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANVFINTEDLVLKIG 157 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCceEEEC
Confidence 35789999997 5898887643 4889999999999999999999 89999999999999998 45678999
Q ss_pred cccccccccCCCCc-cccccccccccccCccccCC-CCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhcc
Q 001544 912 DFGIAKLLIGEDQS-MTQTQTLATLGYMAPEYGRE-GRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFL 989 (1057)
Q Consensus 912 Dfg~a~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 989 (1057)
|||.++........ .......++..|+|||.+.. ..++.++||||+||++|||++|+.||......+. .........
T Consensus 158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~-~~~~~~~~~ 236 (342)
T cd07854 158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQ-MQLILESVP 236 (342)
T ss_pred CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcC
Confidence 99999765322111 11123357888999997644 5678899999999999999999999965322111 000000000
Q ss_pred --ch-hHHHh---hhcc----cccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 990 --PI-SMMKI---IDAN----LLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 990 --~~-~~~~~---~~~~----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
.. ..... .... ............+..+.++.+++.+|+..||++|||+.|+++|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 237 VVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred CCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 00 00000 0000 0000000011112356788999999999999999999999865
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=296.53 Aligned_cols=266 Identities=21% Similarity=0.262 Sum_probs=196.8
Q ss_pred CCCCceeccccCeEEEEEEec-CCcEEEEEEeeccch-hHHHHHHHHHHHHHhcC-CCCceeEeeeeccCCeeEEEEEEc
Q 001544 771 FSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQHE-RAFKSFDTECEVMKSIR-HRNLTKIISSCSNEDFKALILEYM 847 (1057)
Q Consensus 771 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~E~~ 847 (1057)
|++.+.||+|++|+||+|... +++.||||++..... .......+|++.+++++ |||++++++++.+++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 567789999999999999875 578999999864432 22334567899999998 999999999999999999999999
Q ss_pred cCCChhHHHhcCC-ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCcc
Q 001544 848 RNGSLEKCLYSGN-YILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSM 926 (1057)
Q Consensus 848 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 926 (1057)
+|++.+++.... ..+++.++..++.|++.|++||| +.+++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~--- 153 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP--- 153 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCCEEEeecccceeccCCC---
Confidence 789998887654 46899999999999999999999 8999999999999999999999999999998653221
Q ss_pred ccccccccccccCccccC-CCCCCccchHHHHHHHHHHHhhCCCCCCcccccccch--hhhhhhccchhHHH------hh
Q 001544 927 TQTQTLATLGYMAPEYGR-EGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTL--KHWVNDFLPISMMK------II 997 (1057)
Q Consensus 927 ~~~~~~~t~~y~aPE~~~-~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~--~~~~~~~~~~~~~~------~~ 997 (1057)
......++..|+|||... ...++.++|+||||++++||++|+.||......+... ..+..........+ ..
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07830 154 PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKL 233 (283)
T ss_pred CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccc
Confidence 223345788999999774 4557899999999999999999999986532111100 00000000000000 00
Q ss_pred hccccccc-chhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 998 DANLLITE-DKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 998 ~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
+....... .......+..+.++.+++.+||+.+|++||+++|++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 234 GFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred cccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 00000000 00001111225679999999999999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=8e-32 Score=301.77 Aligned_cols=271 Identities=22% Similarity=0.291 Sum_probs=196.4
Q ss_pred hCCCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccch--hHHHHHHHHHHHHHhcCCCCceeEeeeeccC-------
Q 001544 768 TNGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQHE--RAFKSFDTECEVMKSIRHRNLTKIISSCSNE------- 837 (1057)
Q Consensus 768 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------- 837 (1057)
.++|++.++||+|+||.||+|... +++.||||++..... .....+.+|++++++++||||+++++++.+.
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 468999999999999999999865 689999999854322 2234667899999999999999999987443
Q ss_pred -CeeEEEEEEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEccccc
Q 001544 838 -DFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIA 916 (1057)
Q Consensus 838 -~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a 916 (1057)
...++|+||+++ ++...+......+++.++..++.|+++||+||| +.+|+||||||+||++++++.++++|||++
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~ 162 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLA 162 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECcCccc
Confidence 346999999975 777777665567999999999999999999999 999999999999999999999999999999
Q ss_pred ccccCCCCc---------cccccccccccccCccccCC-CCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhh
Q 001544 917 KLLIGEDQS---------MTQTQTLATLGYMAPEYGRE-GRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVN 986 (1057)
Q Consensus 917 ~~~~~~~~~---------~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~ 986 (1057)
+........ .......++..|+|||...+ ..++.++||||+||++|||++|++||........ ......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~-~~~~~~ 241 (311)
T cd07866 163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQ-LHLIFK 241 (311)
T ss_pred hhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHH
Confidence 765322211 11123356788999998765 4578999999999999999999999865322110 000000
Q ss_pred ---hccchhHH--Hhhhc----cccc-ccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 987 ---DFLPISMM--KIIDA----NLLI-TEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 987 ---~~~~~~~~--~~~~~----~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
...+.... ..... .... .............+.+.+++.+|+..+|++|||+.|++.|
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred HhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 00000000 00000 0000 0000001112334678999999999999999999999865
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=303.93 Aligned_cols=269 Identities=21% Similarity=0.256 Sum_probs=195.9
Q ss_pred CCCC-CCceeccccCeEEEEEEec-CCcEEEEEEeeccchhH--------------HHHHHHHHHHHHhcCCCCceeEee
Q 001544 769 NGFS-ENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQHERA--------------FKSFDTECEVMKSIRHRNLTKIIS 832 (1057)
Q Consensus 769 ~~~~-~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~h~niv~l~~ 832 (1057)
++|. ..+.||+|+||+||+|... +++.||||+++...... ...+.+|++++++++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 4564 3477999999999999865 68999999985432211 124778999999999999999999
Q ss_pred eeccCCeeEEEEEEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEc
Q 001544 833 SCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSD 912 (1057)
Q Consensus 833 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D 912 (1057)
++..++..++||||++ |+|.+++... ..+++.....++.|++.|++||| +.+++||||+|+||+++.++.++++|
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH---~~~i~H~dl~~~nill~~~~~~kl~d 162 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRK-IRLTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIAD 162 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHeEECCCCCEEECC
Confidence 9999999999999997 5898888654 35899999999999999999999 99999999999999999999999999
Q ss_pred ccccccccCCC------------CccccccccccccccCccccCCC-CCCccchHHHHHHHHHHHhhCCCCCCccccccc
Q 001544 913 FGIAKLLIGED------------QSMTQTQTLATLGYMAPEYGREG-RVSTKGDVYSFGILLMETFTRRKPTDEIFSGEM 979 (1057)
Q Consensus 913 fg~a~~~~~~~------------~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~ 979 (1057)
||.+....... .........++..|+|||.+.+. .++.++||||+||++|||++|+.||......+.
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~ 242 (335)
T PTZ00024 163 FGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQ 242 (335)
T ss_pred ccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 99997653110 01112223467789999988764 468999999999999999999999865322111
Q ss_pred chhhhhhhc---cchhHHHh-----hhcccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 980 TLKHWVNDF---LPISMMKI-----IDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 980 ~~~~~~~~~---~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
........ .+...... ..................++.++.+++.+|++.+|++||++.|++.+
T Consensus 243 -~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 243 -LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred -HHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 10000000 00000000 00000000000111112346778999999999999999999999875
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.1e-32 Score=297.94 Aligned_cols=252 Identities=24% Similarity=0.317 Sum_probs=197.0
Q ss_pred CCCCCceeccccCeEEEEEEe----cCCcEEEEEEeeccc----hhHHHHHHHHHHHHHhc-CCCCceeEeeeeccCCee
Q 001544 770 GFSENNLIGRGSFGSVYIARL----QNGIEVAVKTFDLQH----ERAFKSFDTECEVMKSI-RHRNLTKIISSCSNEDFK 840 (1057)
Q Consensus 770 ~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 840 (1057)
+|++.+.||+|+||.||+|.. .+|+.||+|+++... ....+.+.+|+++++++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 477889999999999999975 368999999986432 22346778899999999 599999999999999999
Q ss_pred EEEEEEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEccccccccc
Q 001544 841 ALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLI 920 (1057)
Q Consensus 841 ~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~ 920 (1057)
++||||+++++|.+++.... .+++..+..++.|+++||+||| +.+++||||+|+||++++++.+||+|||++....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 156 (290)
T cd05613 81 HLILDYINGGELFTHLSQRE-RFKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFH 156 (290)
T ss_pred EEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEECCCCCEEEeeCccceecc
Confidence 99999999999999987654 5888999999999999999999 9999999999999999999999999999997653
Q ss_pred CCCCccccccccccccccCccccCCC--CCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhh
Q 001544 921 GEDQSMTQTQTLATLGYMAPEYGREG--RVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIID 998 (1057)
Q Consensus 921 ~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 998 (1057)
... ........++..|+|||..... .++.++||||+|+++|+|++|+.||..... ......+.. ..
T Consensus 157 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~-~~~~~~~~~---------~~- 224 (290)
T cd05613 157 EDE-VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE-KNSQAEISR---------RI- 224 (290)
T ss_pred ccc-ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCc-cccHHHHHH---------Hh-
Confidence 221 1122234578899999987653 467899999999999999999999863111 111111110 00
Q ss_pred cccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCC-----CHHHHHHH
Q 001544 999 ANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERI-----TAKEIVRR 1043 (1057)
Q Consensus 999 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~evl~~ 1043 (1057)
.... .+.+..+++.+.+++.+|++.+|++|| ++.+++.+
T Consensus 225 --~~~~----~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 225 --LKSE----PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred --hccC----CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 0000 011123567789999999999999997 77888765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=6e-32 Score=299.08 Aligned_cols=255 Identities=23% Similarity=0.321 Sum_probs=198.5
Q ss_pred CCCCCceeccccCeEEEEEEe----cCCcEEEEEEeeccc----hhHHHHHHHHHHHHHhc-CCCCceeEeeeeccCCee
Q 001544 770 GFSENNLIGRGSFGSVYIARL----QNGIEVAVKTFDLQH----ERAFKSFDTECEVMKSI-RHRNLTKIISSCSNEDFK 840 (1057)
Q Consensus 770 ~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 840 (1057)
+|++.+.||+|+||.||+|+. .+++.||||+++... ....+.+.+|+++++++ +||||+++++.+..++..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 367789999999999999974 357899999986432 23346788999999999 599999999999999999
Q ss_pred EEEEEEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEccccccccc
Q 001544 841 ALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLI 920 (1057)
Q Consensus 841 ~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~ 920 (1057)
++||||+++|+|.+++.... .+++..+..++.|+++||+||| +.+++||||||+||+++.++.++++|||+++...
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lH---~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 156 (288)
T cd05583 81 HLILDYVNGGELFTHLYQRE-HFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (288)
T ss_pred EEEEecCCCCcHHHHHhhcC-CcCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEEECccccccc
Confidence 99999999999999887643 5889999999999999999999 8999999999999999999999999999987653
Q ss_pred CCCCccccccccccccccCccccCCCC--CCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhh
Q 001544 921 GEDQSMTQTQTLATLGYMAPEYGREGR--VSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIID 998 (1057)
Q Consensus 921 ~~~~~~~~~~~~~t~~y~aPE~~~~~~--~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 998 (1057)
.... .......++..|+|||...+.. .+.++||||+|+++|||++|..||..... ......+. .....
T Consensus 157 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~-~~~~~~~~--------~~~~~ 226 (288)
T cd05583 157 AEEE-ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGE-QNSQSEIS--------RRILK 226 (288)
T ss_pred cccc-cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcc-cchHHHHH--------HHHHc
Confidence 3221 1122345788999999887655 78899999999999999999999853111 00011110 00100
Q ss_pred cccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHHH
Q 001544 999 ANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLK 1046 (1057)
Q Consensus 999 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 1046 (1057)
. ..+.+..++..+.+++.+||+.+|++|||++++.+.++.
T Consensus 227 ~--------~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 227 S--------KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred c--------CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 0 011122355678999999999999999998877665543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=295.48 Aligned_cols=267 Identities=26% Similarity=0.296 Sum_probs=200.3
Q ss_pred CCCCceeccccCeEEEEEEec-CCcEEEEEEeeccc--hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEEc
Q 001544 771 FSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQH--ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEYM 847 (1057)
Q Consensus 771 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 847 (1057)
|+..+.||+|++|.||+|+.. +++.||+|++.... ....+.+..|++++++++|+|++++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 556788999999999999865 59999999997543 333467788999999999999999999999999999999999
Q ss_pred cCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCccc
Q 001544 848 RNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMT 927 (1057)
Q Consensus 848 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 927 (1057)
+ ++|.+++......+++.++..++.|+++|++||| +.+|+||||+|+||++++++.++|+|||.++...... ..
T Consensus 81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~--~~ 154 (282)
T cd07829 81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPL--RT 154 (282)
T ss_pred C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChheEEEcCCCCEEEecCCcccccCCCc--cc
Confidence 8 5899999876556999999999999999999999 8999999999999999999999999999987653221 12
Q ss_pred cccccccccccCccccCCC-CCCccchHHHHHHHHHHHhhCCCCCCcccccccc--hhhhhhhccchhHHHhhhc-----
Q 001544 928 QTQTLATLGYMAPEYGREG-RVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMT--LKHWVNDFLPISMMKIIDA----- 999 (1057)
Q Consensus 928 ~~~~~~t~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~----- 999 (1057)
.....++..|+|||...+. .++.++||||+|+++||+++|+.||......+.. .........+.......+.
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
T cd07829 155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKP 234 (282)
T ss_pred cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccc
Confidence 2334456789999988766 7899999999999999999999998652211100 0000000000000000000
Q ss_pred ccccccch-hhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 1000 NLLITEDK-HFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 1000 ~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
........ .....+..+..+.+++.+|+..+|++||++.+++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 235 TFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred cccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 00000000 001112236789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-32 Score=251.78 Aligned_cols=267 Identities=25% Similarity=0.287 Sum_probs=200.5
Q ss_pred CCCCCceeccccCeEEEEEEe-cCCcEEEEEEeeccc--hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEE
Q 001544 770 GFSENNLIGRGSFGSVYIARL-QNGIEVAVKTFDLQH--ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEY 846 (1057)
Q Consensus 770 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 846 (1057)
.|...++||+|.||+||+|+. ++++.||+|+++..+ +..-....+|+-+++.++|+|||++++....+....+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 455568899999999999985 468999999986543 34456678999999999999999999999989999999999
Q ss_pred ccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCcc
Q 001544 847 MRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSM 926 (1057)
Q Consensus 847 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 926 (1057)
|+. +|.++..+-...++...+..++.|+++|+.++| ++.+.|||+||.|.+++.+|++|++|||+++.+. -...
T Consensus 83 cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fch---shnvlhrdlkpqnllin~ngelkladfglarafg--ipvr 156 (292)
T KOG0662|consen 83 CDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCH---SHNVLHRDLKPQNLLINRNGELKLADFGLARAFG--IPVR 156 (292)
T ss_pred hhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhh---hhhhhhccCCcceEEeccCCcEEecccchhhhcC--CceE
Confidence 976 899888877777999999999999999999999 9999999999999999999999999999998652 2223
Q ss_pred ccccccccccccCccccCCCC-CCccchHHHHHHHHHHHhhCCCC-CCcccccccchhhhhh--hccch----hHHHhhh
Q 001544 927 TQTQTLATLGYMAPEYGREGR-VSTKGDVYSFGILLMETFTRRKP-TDEIFSGEMTLKHWVN--DFLPI----SMMKIID 998 (1057)
Q Consensus 927 ~~~~~~~t~~y~aPE~~~~~~-~~~~~Dv~s~G~il~elltg~~p-~~~~~~~~~~~~~~~~--~~~~~----~~~~~~~ 998 (1057)
-.+..+.|..|++|.++.+.+ |+...|+||.||++.|+.....| |..... +..+..... ....+ ++.+.-|
T Consensus 157 cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dv-ddqlkrif~~lg~p~ed~wps~t~lpd 235 (292)
T KOG0662|consen 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV-DDQLKRIFRLLGTPTEDQWPSMTKLPD 235 (292)
T ss_pred eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcH-HHHHHHHHHHhCCCccccCCccccCCC
Confidence 445567899999999988866 78889999999999999985555 432111 111111100 00000 0111111
Q ss_pred cccccccc--h-hhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 999 ANLLITED--K-HFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 999 ~~~~~~~~--~-~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
........ . .....+.....-.+++.+.+.-+|.+|.++.++++|
T Consensus 236 yk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 236 YKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred CcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 11111000 0 111123344556788999999999999999999876
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.2e-32 Score=292.84 Aligned_cols=248 Identities=23% Similarity=0.344 Sum_probs=194.3
Q ss_pred CCCCCceeccccCeEEEEEEec-CCcEEEEEEeecc-----chhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEE
Q 001544 770 GFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQ-----HERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALI 843 (1057)
Q Consensus 770 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 843 (1057)
+|.+.++||+|+||.||+|... .+..+++|+++.. ......++.+|+.++++++||||+++++++.+.+..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 4778899999999999999765 3455666665421 122334567899999999999999999999999999999
Q ss_pred EEEccCCChhHHHhc---CCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEccccccccc
Q 001544 844 LEYMRNGSLEKCLYS---GNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLI 920 (1057)
Q Consensus 844 ~E~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~ 920 (1057)
|||+++++|.+++.. ....+++.++..++.|+++|++||| +.+++|+||+|+||+++. +.++++|||.+....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH---QRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH---HcCccccCCChhheEeec-CCEeecccCceeecC
Confidence 999999999998864 3356899999999999999999999 999999999999999975 579999999987653
Q ss_pred CCCCccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhcc
Q 001544 921 GEDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDAN 1000 (1057)
Q Consensus 921 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1000 (1057)
.... ......++..|+|||...+..++.++|+||+|+++|+|++|..||...... .. ........
T Consensus 157 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~-----~~--------~~~~~~~~ 221 (260)
T cd08222 157 GSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFL-----SV--------VLRIVEGP 221 (260)
T ss_pred CCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH-----HH--------HHHHHcCC
Confidence 3221 222345788999999988888899999999999999999999998542110 00 00111000
Q ss_pred cccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 1001 LLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 1001 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
....+..++.++.+++.+|+..+|++||++.|++++
T Consensus 222 -------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 222 -------TPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred -------CCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 011123456788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=300.22 Aligned_cols=268 Identities=22% Similarity=0.246 Sum_probs=193.4
Q ss_pred CCCCCceeccccCeEEEEEEec-C--CcEEEEEEeeccc--hhHHHHHHHHHHHHHhc-CCCCceeEeeeecc----CCe
Q 001544 770 GFSENNLIGRGSFGSVYIARLQ-N--GIEVAVKTFDLQH--ERAFKSFDTECEVMKSI-RHRNLTKIISSCSN----EDF 839 (1057)
Q Consensus 770 ~~~~~~~lg~G~~g~Vy~~~~~-~--~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~ 839 (1057)
+|++.+.||+|+||.||+|+.. + +..||||++.... ....+.+.+|+++++++ .||||+++++++.. ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4778899999999999999865 4 7899999986432 22346778899999999 59999999987532 346
Q ss_pred eEEEEEEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccc
Q 001544 840 KALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL 919 (1057)
Q Consensus 840 ~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~ 919 (1057)
.++++||++ ++|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+||++++++.+||+|||.++..
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~ 155 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSGQ-PLTDAHFQSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGF 155 (332)
T ss_pred EEEEEeccc-CCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence 788999986 58998886544 5899999999999999999999 999999999999999999999999999999865
Q ss_pred cCCCC--ccccccccccccccCccccCC-CCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhh-----------hh
Q 001544 920 IGEDQ--SMTQTQTLATLGYMAPEYGRE-GRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKH-----------WV 985 (1057)
Q Consensus 920 ~~~~~--~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~-----------~~ 985 (1057)
..... ........|+..|+|||...+ ..++.++|+||+||++|+|++|+.||....... .... +.
T Consensus 156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~ 234 (332)
T cd07857 156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVD-QLNQILQVLGTPDEETL 234 (332)
T ss_pred ccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHH-HHHHHHHHhCCCCHHHH
Confidence 32211 111223467889999998765 468899999999999999999999986522110 0000 00
Q ss_pred hhccchhHHHhhhcccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 986 NDFLPISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 986 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
...........................+..+..+.+++.+|++.+|++|||+.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 235 SRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred HhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000000000000000000000001112245679999999999999999999999865
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-32 Score=294.07 Aligned_cols=246 Identities=22% Similarity=0.332 Sum_probs=199.7
Q ss_pred CceeccccCeEEEEEE-ecCCcEEEEEEeeccc--hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEEccCC
Q 001544 774 NNLIGRGSFGSVYIAR-LQNGIEVAVKTFDLQH--ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEYMRNG 850 (1057)
Q Consensus 774 ~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g 850 (1057)
.++||+|.||+||-|. .++|+.||||++++.. ++...++.+|+.++++++||.||.+-..|+..+..+.|||-+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 4789999999999996 4589999999996542 344578899999999999999999999999999999999999764
Q ss_pred ChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCC---CcEEEEcccccccccCCCCccc
Q 001544 851 SLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDN---MVAHLSDFGIAKLLIGEDQSMT 927 (1057)
Q Consensus 851 sL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~---~~~kl~Dfg~a~~~~~~~~~~~ 927 (1057)
-|+-.+......+++....-...||+.||.||| .++|||+|+||+|||+... -++|+||||+|+++.. ...
T Consensus 649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH---~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE---ksF 722 (888)
T KOG4236|consen 649 MLEMILSSEKGRLPERITKFLVTQILVALRYLH---FKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE---KSF 722 (888)
T ss_pred HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhh---hcceeeccCCchheeeccCCCCCceeeccccceeecch---hhh
Confidence 455455555567888888889999999999999 8999999999999999643 3799999999998732 233
Q ss_pred cccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhcccccccch
Q 001544 928 QTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDK 1007 (1057)
Q Consensus 928 ~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1057)
....+||+.|.|||++....|...-|+||.||++|--++|..||.+..+ +. +-+.... .-.
T Consensus 723 RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd----In------------dQIQNAa---FMy 783 (888)
T KOG4236|consen 723 RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED----IN------------DQIQNAA---FMY 783 (888)
T ss_pred hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc----hh------------HHhhccc---ccc
Confidence 4457899999999999999999999999999999999999999876211 11 1111111 111
Q ss_pred hhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHH
Q 001544 1008 HFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRL 1044 (1057)
Q Consensus 1008 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 1044 (1057)
....+.+++++..++|...++..-.+|.+..+.+.|-
T Consensus 784 Pp~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~ 820 (888)
T KOG4236|consen 784 PPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHP 820 (888)
T ss_pred CCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccch
Confidence 2223456788899999999999999999998877653
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-32 Score=318.94 Aligned_cols=258 Identities=22% Similarity=0.319 Sum_probs=209.4
Q ss_pred HHHHhCCCCCCceeccccCeEEEEEEec-CCcEEEEEEeec---cchhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCe
Q 001544 764 LFQATNGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDL---QHERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDF 839 (1057)
Q Consensus 764 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 839 (1057)
+.-..++|.+.++||+|+||.|..++.+ +++.||+|++++ -......-|..|-.+|.--..+=|++++-+|.+..+
T Consensus 70 lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~ 149 (1317)
T KOG0612|consen 70 LRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERY 149 (1317)
T ss_pred HhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccc
Confidence 3344578999999999999999999865 688999999865 233445778899999998889999999999999999
Q ss_pred eEEEEEEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccc
Q 001544 840 KALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL 919 (1057)
Q Consensus 840 ~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~ 919 (1057)
.|+|||||+||+|-..+.+.+ ++++..+.-++..|+-||+-+| +.|+|||||||+|||+|..|++|++|||.+-.+
T Consensus 150 LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH---~mgyVHRDiKPDNvLld~~GHikLADFGsClkm 225 (1317)
T KOG0612|consen 150 LYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLH---SMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKM 225 (1317)
T ss_pred eEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHH---hccceeccCCcceeEecccCcEeeccchhHHhc
Confidence 999999999999999998877 7999999999999999999999 999999999999999999999999999999877
Q ss_pred cCCCCccccccccccccccCccccC----C-CCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHH
Q 001544 920 IGEDQSMTQTQTLATLGYMAPEYGR----E-GRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMM 994 (1057)
Q Consensus 920 ~~~~~~~~~~~~~~t~~y~aPE~~~----~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 994 (1057)
... ........+|||-|++||++. + +.|++.+|.||+||++|||+.|..||.... ....| .
T Consensus 226 ~~d-G~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads----lveTY---------~ 291 (1317)
T KOG0612|consen 226 DAD-GTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS----LVETY---------G 291 (1317)
T ss_pred CCC-CcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH----HHHHH---------H
Confidence 433 344556678999999999864 3 678999999999999999999999986511 01111 1
Q ss_pred HhhhcccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCC---HHHHHHHH
Q 001544 995 KIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERIT---AKEIVRRL 1044 (1057)
Q Consensus 995 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps---~~evl~~L 1044 (1057)
++.+.. ....+|....++.+..++|.+.+. +|+.|.. +.++..|-
T Consensus 292 KIm~hk----~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~Hp 339 (1317)
T KOG0612|consen 292 KIMNHK----ESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHP 339 (1317)
T ss_pred HHhchh----hhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCc
Confidence 222211 111223334578889999998876 6777776 88887764
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-32 Score=285.95 Aligned_cols=256 Identities=28% Similarity=0.430 Sum_probs=200.7
Q ss_pred CCCCCCceeccccCeEEEEEE-ecCCcEEEEEEeeccc-------hhHHHHHHHHHHHHHhcCCCCceeEeeeec-cCCe
Q 001544 769 NGFSENNLIGRGSFGSVYIAR-LQNGIEVAVKTFDLQH-------ERAFKSFDTECEVMKSIRHRNLTKIISSCS-NEDF 839 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~-------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~ 839 (1057)
++|-...+||+|||+.||+|. +...+.||||+-.... ....+...+|.++.+.+.||.||++++||. +.+.
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 456677899999999999996 5568999999863321 123355678999999999999999999995 5678
Q ss_pred eEEEEEEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeC---CCCcEEEEccccc
Q 001544 840 KALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLD---DNMVAHLSDFGIA 916 (1057)
Q Consensus 840 ~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~---~~~~~kl~Dfg~a 916 (1057)
.|-|.|||+|.+|+-++...+ .++++++..|+.||+.||.||.+ .+.+|||-|+||.|||+. .-|.+||.|||++
T Consensus 543 FCTVLEYceGNDLDFYLKQhk-lmSEKEARSIiMQiVnAL~YLNE-ikpPIIHYDLKPgNILLv~GtacGeIKITDFGLS 620 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLKQHK-LMSEKEARSIIMQIVNALKYLNE-IKPPIIHYDLKPGNILLVNGTACGEIKITDFGLS 620 (775)
T ss_pred ceeeeeecCCCchhHHHHhhh-hhhHHHHHHHHHHHHHHHHHHhc-cCCCeeeeccCCccEEEecCcccceeEeeecchh
Confidence 899999999999998887765 48999999999999999999994 478999999999999995 4589999999999
Q ss_pred ccccCCCCcc-----ccccccccccccCccccCCC----CCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhh
Q 001544 917 KLLIGEDQSM-----TQTQTLATLGYMAPEYGREG----RVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVND 987 (1057)
Q Consensus 917 ~~~~~~~~~~-----~~~~~~~t~~y~aPE~~~~~----~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~ 987 (1057)
+.+.+..... ..+...||.+|++||.+.-+ +.+.|+||||+||++|+++.|+.||+.....
T Consensus 621 KIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ---------- 690 (775)
T KOG1151|consen 621 KIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ---------- 690 (775)
T ss_pred hhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH----------
Confidence 9986554332 22345799999999976533 4688999999999999999999999762211
Q ss_pred ccchhHHHhhhcc-cccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHH
Q 001544 988 FLPISMMKIIDAN-LLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVR 1042 (1057)
Q Consensus 988 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 1042 (1057)
.++.... +....+..++..+.++.+..++|++|+++.-++|..+.++..
T Consensus 691 ------QdILqeNTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 691 ------QDILQENTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred ------HHHHhhhchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 1111111 111112233444567788999999999999999998887754
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-33 Score=270.86 Aligned_cols=272 Identities=21% Similarity=0.327 Sum_probs=200.1
Q ss_pred CCCCCCceeccccCeEEEEEEec-CCcEEEEEEeec--cchhHHHHHHHHHHHHHhcCCCCceeEeeeecc--------C
Q 001544 769 NGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDL--QHERAFKSFDTECEVMKSIRHRNLTKIISSCSN--------E 837 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------~ 837 (1057)
..|+...+||+|.||.||+|+.+ +|+.||+|++-. +....-....+|++++..++|+|++.+++.|.. .
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 45666789999999999999754 588899987632 233333556789999999999999999998743 2
Q ss_pred CeeEEEEEEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccc
Q 001544 838 DFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK 917 (1057)
Q Consensus 838 ~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~ 917 (1057)
...|+||++++. +|.-.+......++..++.+++.++..||.|+| ...|+|||+||.|+|++.+|.+||+|||+++
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iH---r~kilHRDmKaaNvLIt~dgilklADFGlar 172 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIH---RNKILHRDMKAANVLITKDGILKLADFGLAR 172 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHH---HhhHHhhcccHhhEEEcCCceEEeecccccc
Confidence 357999999987 888888777677999999999999999999999 9999999999999999999999999999997
Q ss_pred cccCCC--CccccccccccccccCccccCC-CCCCccchHHHHHHHHHHHhhCCCCCCccccc-----------ccchhh
Q 001544 918 LLIGED--QSMTQTQTLATLGYMAPEYGRE-GRVSTKGDVYSFGILLMETFTRRKPTDEIFSG-----------EMTLKH 983 (1057)
Q Consensus 918 ~~~~~~--~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~-----------~~~~~~ 983 (1057)
.+.... ....++..+.|..|++||.+.+ ..++++.|+|+.||++.||+||.+-+....+. ..+..-
T Consensus 173 ~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkev 252 (376)
T KOG0669|consen 173 AFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEV 252 (376)
T ss_pred ceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCccc
Confidence 653222 2334556677999999998765 56899999999999999999998876542110 011111
Q ss_pred hhhhccchhHHHhhhcccccccchhhHHHHHH------HHHHHHHHhHcccCCCCCCCCHHHHHHHHHHh
Q 001544 984 WVNDFLPISMMKIIDANLLITEDKHFAAKEQC------ASSVFNLAMECTVESPDERITAKEIVRRLLKI 1047 (1057)
Q Consensus 984 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i 1047 (1057)
|-.- ...+.++.++..-..+.. ....++. .++..+++.+++..||.+|+++.+++.|----
T Consensus 253 WP~~-d~lpL~~sie~ePl~~~~--~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~ 319 (376)
T KOG0669|consen 253 WPNV-DNLPLYQSIELEPLPKGQ--KRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFW 319 (376)
T ss_pred CCCc-ccchHHHhccCCCCCcch--hhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhh
Confidence 2110 011122222111111111 1111111 24678999999999999999999999886433
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-32 Score=281.88 Aligned_cols=266 Identities=22% Similarity=0.255 Sum_probs=199.9
Q ss_pred hCCCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccchhHHHHHHHHHHHHHhcC--CC----CceeEeeeeccCCee
Q 001544 768 TNGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQHERAFKSFDTECEVMKSIR--HR----NLTKIISSCSNEDFK 840 (1057)
Q Consensus 768 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~----niv~l~~~~~~~~~~ 840 (1057)
+++|.+...+|+|.||.|-++.+. .+..||||+++. .....++..-|+++++++. .| -++.+.++|.-.++.
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~-V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi 166 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKN-VDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI 166 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHH-HHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence 678999999999999999999654 479999999864 3455567788999999993 23 377888899999999
Q ss_pred EEEEEEccCCChhHHHhcCC-ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCC---------------
Q 001544 841 ALILEYMRNGSLEKCLYSGN-YILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDD--------------- 904 (1057)
Q Consensus 841 ~lV~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~--------------- 904 (1057)
|+|+|.+ |-++.+++..+. .+++..++..|++|++++++||| +.+++|.|+||+||++.+
T Consensus 167 Civfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh---~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~ 242 (415)
T KOG0671|consen 167 CIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLH---DLKLTHTDLKPENILFVSSEYFKTYNPKKKVCF 242 (415)
T ss_pred EEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHH---hcceeecCCChheEEEeccceEEEeccCCccce
Confidence 9999988 558999998755 67999999999999999999999 999999999999999832
Q ss_pred -----CCcEEEEcccccccccCCCCccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCccccccc
Q 001544 905 -----NMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEM 979 (1057)
Q Consensus 905 -----~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~ 979 (1057)
+..+|++|||.|++- ....+..+.|..|+|||++.+-.++.++||||+|||++|+.||..-|......|.
T Consensus 243 ~r~~ks~~I~vIDFGsAtf~-----~e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EH 317 (415)
T KOG0671|consen 243 IRPLKSTAIKVIDFGSATFD-----HEHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEH 317 (415)
T ss_pred eccCCCcceEEEecCCccee-----ccCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHH
Confidence 336899999999864 2233556789999999999999999999999999999999999987765432210
Q ss_pred c-hhhhhhhccchhHHHhh------hcccc--------------cccchhh----HHHHHHHHHHHHHHhHcccCCCCCC
Q 001544 980 T-LKHWVNDFLPISMMKII------DANLL--------------ITEDKHF----AAKEQCASSVFNLAMECTVESPDER 1034 (1057)
Q Consensus 980 ~-~~~~~~~~~~~~~~~~~------~~~~~--------------~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~R 1034 (1057)
- .-+-+-...|..+.... ..... ....... ........++++++++|+..||.+|
T Consensus 318 LaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~R 397 (415)
T KOG0671|consen 318 LAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARR 397 (415)
T ss_pred HHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcccc
Confidence 0 00000011111111111 00000 0000000 0011234579999999999999999
Q ss_pred CCHHHHHHH
Q 001544 1035 ITAKEIVRR 1043 (1057)
Q Consensus 1035 ps~~evl~~ 1043 (1057)
+|++|++.|
T Consensus 398 iTl~EAL~H 406 (415)
T KOG0671|consen 398 ITLREALSH 406 (415)
T ss_pred ccHHHHhcC
Confidence 999999986
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-31 Score=320.64 Aligned_cols=146 Identities=28% Similarity=0.433 Sum_probs=131.7
Q ss_pred hCCCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccc---hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEE
Q 001544 768 TNGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQH---ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALI 843 (1057)
Q Consensus 768 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 843 (1057)
.++|.+.++||+|+||+||+|... +++.||||+++... ......+.+|+.+++.++||||+++++++...+..|+|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 357889999999999999999866 68999999986432 33457788999999999999999999999999999999
Q ss_pred EEEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccc
Q 001544 844 LEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK 917 (1057)
Q Consensus 844 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~ 917 (1057)
|||+.+++|.+++.... .+++..++.|+.||+.||+||| ..+|+||||||+|||++.++.+||+|||+++
T Consensus 83 mEy~~g~~L~~li~~~~-~l~~~~~~~i~~qil~aL~yLH---~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIYG-YFDEEMAVKYISEVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999987654 4888999999999999999999 8999999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-31 Score=284.44 Aligned_cols=239 Identities=29% Similarity=0.361 Sum_probs=194.4
Q ss_pred eccccCeEEEEEEec-CCcEEEEEEeeccch---hHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEEccCCCh
Q 001544 777 IGRGSFGSVYIARLQ-NGIEVAVKTFDLQHE---RAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEYMRNGSL 852 (1057)
Q Consensus 777 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL 852 (1057)
||+|+||.||+|... +++.||+|++..... .....+..|++++++++||||+++++.+..++..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999865 589999999865432 2456888999999999999999999999999999999999999999
Q ss_pred hHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCcccccccc
Q 001544 853 EKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTL 932 (1057)
Q Consensus 853 ~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 932 (1057)
.+++.... .+++..+..++.|+++|+.|+| +.+++|+||+|+||+++.++.++++|||.+....... .......
T Consensus 81 ~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lh---~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~ 154 (250)
T cd05123 81 FSHLSKEG-RFSEERARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTFC 154 (250)
T ss_pred HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccCCc
Confidence 99987664 4899999999999999999999 8999999999999999999999999999997653221 1233456
Q ss_pred ccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhcccccccchhhHHH
Q 001544 933 ATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHFAAK 1012 (1057)
Q Consensus 933 ~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1012 (1057)
++..|+|||...+...+.++|+||+|+++||+++|+.||..... ... ...... .....+
T Consensus 155 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-----~~~--------~~~~~~--------~~~~~~ 213 (250)
T cd05123 155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR-----KEI--------YEKILK--------DPLRFP 213 (250)
T ss_pred CCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-----HHH--------HHHHhc--------CCCCCC
Confidence 78899999999888889999999999999999999999865221 000 001110 011112
Q ss_pred HHHHHHHHHHHhHcccCCCCCCCCH---HHHHH
Q 001544 1013 EQCASSVFNLAMECTVESPDERITA---KEIVR 1042 (1057)
Q Consensus 1013 ~~~~~~l~~li~~cl~~dP~~Rps~---~evl~ 1042 (1057)
...+.++.+++.+||..||++||++ .++.+
T Consensus 214 ~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~ 246 (250)
T cd05123 214 EFLSPEARDLISGLLQKDPTKRLGSGGAEEIKA 246 (250)
T ss_pred CCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHh
Confidence 2336678899999999999999999 55544
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=295.46 Aligned_cols=241 Identities=25% Similarity=0.263 Sum_probs=195.6
Q ss_pred hCCCCCCceeccccCeEEEEEE-ecCCcEEEEEEeeccchhHHHHHHHHHHHHHhc-CCCCceeEeeeeccCCeeEEEEE
Q 001544 768 TNGFSENNLIGRGSFGSVYIAR-LQNGIEVAVKTFDLQHERAFKSFDTECEVMKSI-RHRNLTKIISSCSNEDFKALILE 845 (1057)
Q Consensus 768 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E 845 (1057)
++.|+....+|.|+|+.|-++. ..+++..+||++.... .+-.+|+.++... .||||+++.+.+.++.+.|+|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 3456666779999999999886 4468999999996552 2335677777666 69999999999999999999999
Q ss_pred EccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeee-CCCCcEEEEcccccccccCCCC
Q 001544 846 YMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLL-DDNMVAHLSDFGIAKLLIGEDQ 924 (1057)
Q Consensus 846 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill-~~~~~~kl~Dfg~a~~~~~~~~ 924 (1057)
.+.|+-+.+.+...+. ...++..|+.+|+.|+.||| ++||||||+||+|||+ ++.++++|+|||.++.....
T Consensus 397 ~l~g~ell~ri~~~~~--~~~e~~~w~~~lv~Av~~LH---~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-- 469 (612)
T KOG0603|consen 397 LLDGGELLRRIRSKPE--FCSEASQWAAELVSAVDYLH---EQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-- 469 (612)
T ss_pred hccccHHHHHHHhcch--hHHHHHHHHHHHHHHHHHHH---hcCeeecCCChhheeecCCCCcEEEEEechhhhCchh--
Confidence 9999988887776553 22778889999999999999 9999999999999999 69999999999999875322
Q ss_pred ccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhcccccc
Q 001544 925 SMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLIT 1004 (1057)
Q Consensus 925 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1057)
....+-|..|.|||+.....+++++|+||+|+++|+|++|+.||.....+.. ....+ .
T Consensus 470 ---~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~e-------------i~~~i---~--- 527 (612)
T KOG0603|consen 470 ---CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIE-------------IHTRI---Q--- 527 (612)
T ss_pred ---hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHH-------------HHHhh---c---
Confidence 3344568899999999999999999999999999999999999876433310 11111 0
Q ss_pred cchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHH
Q 001544 1005 EDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRL 1044 (1057)
Q Consensus 1005 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 1044 (1057)
..+..+.++.++++++.+|++.||.+||+|.++..|=
T Consensus 528 ---~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~ 564 (612)
T KOG0603|consen 528 ---MPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAHP 564 (612)
T ss_pred ---CCccccccCHHHHHHHHHhccCChhhCcChhhhccCc
Confidence 0011156788899999999999999999999998763
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.1e-31 Score=280.37 Aligned_cols=219 Identities=20% Similarity=0.172 Sum_probs=176.1
Q ss_pred ccCeEEEEEEec-CCcEEEEEEeeccchhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEEccCCChhHHHhc
Q 001544 780 GSFGSVYIARLQ-NGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEYMRNGSLEKCLYS 858 (1057)
Q Consensus 780 G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~ 858 (1057)
|.+|+||+|... +++.||+|++.... .+.+|...+....||||+++++++.+.+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 899999999864 68999999986542 233455555566799999999999999999999999999999998876
Q ss_pred CCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCcccccccccccccc
Q 001544 859 GNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYM 938 (1057)
Q Consensus 859 ~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~ 938 (1057)
.. .+++..+..++.|+++|++||| +.+|+||||||+||+++.++.++++|||.+...... .....++..|+
T Consensus 79 ~~-~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~y~ 149 (237)
T cd05576 79 FL-NIPEECVKRWAAEMVVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVENMYC 149 (237)
T ss_pred hc-CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCcccc
Confidence 54 4899999999999999999999 999999999999999999999999999987654221 12234567799
Q ss_pred CccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhcccccccchhhHHHHHHHHH
Q 001544 939 APEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHFAAKEQCASS 1018 (1057)
Q Consensus 939 aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1018 (1057)
|||...+..++.++||||+|+++|||++|+.|+........ .. .....+..++..
T Consensus 150 aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~---------------~~----------~~~~~~~~~~~~ 204 (237)
T cd05576 150 APEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN---------------TH----------TTLNIPEWVSEE 204 (237)
T ss_pred CCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc---------------cc----------cccCCcccCCHH
Confidence 99999888889999999999999999999987643211000 00 000111234567
Q ss_pred HHHHHhHcccCCCCCCCCH
Q 001544 1019 VFNLAMECTVESPDERITA 1037 (1057)
Q Consensus 1019 l~~li~~cl~~dP~~Rps~ 1037 (1057)
+.+++.+|++.||++||++
T Consensus 205 ~~~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 205 ARSLLQQLLQFNPTERLGA 223 (237)
T ss_pred HHHHHHHHccCCHHHhcCC
Confidence 8899999999999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.8e-31 Score=297.70 Aligned_cols=254 Identities=22% Similarity=0.348 Sum_probs=207.8
Q ss_pred HHhCCCCCCceeccccCeEEEEEE-ecCCcEEEEEEeeccchhHHHHHHHHHHHHHhc-CCCCceeEeeeec-----cCC
Q 001544 766 QATNGFSENNLIGRGSFGSVYIAR-LQNGIEVAVKTFDLQHERAFKSFDTECEVMKSI-RHRNLTKIISSCS-----NED 838 (1057)
Q Consensus 766 ~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~-----~~~ 838 (1057)
..++.|++.++||.|.+|.||+++ .++|+.+|||+.....+.. ++++.|.++++.. .|||++.++|+|. .++
T Consensus 16 dp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~d-eEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~D 94 (953)
T KOG0587|consen 16 DPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEE-EEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGD 94 (953)
T ss_pred CCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcccc-HHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCC
Confidence 346678999999999999999997 5579999999987655443 6678899999888 6999999999984 367
Q ss_pred eeEEEEEEccCCChhHHHhcC-CccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccc
Q 001544 839 FKALILEYMRNGSLEKCLYSG-NYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK 917 (1057)
Q Consensus 839 ~~~lV~E~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~ 917 (1057)
..++|||||.+|+..|++..- +..+.|..+..|++.++.|+.+|| ...++|||||-.|||++.++.+|++|||.+.
T Consensus 95 qLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH---~nkviHRDikG~NiLLT~e~~VKLvDFGvSa 171 (953)
T KOG0587|consen 95 QLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLH---NNKVIHRDIKGQNVLLTENAEVKLVDFGVSA 171 (953)
T ss_pred eEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHh---hcceeeecccCceEEEeccCcEEEeeeeeee
Confidence 899999999999999987643 356899999999999999999999 9999999999999999999999999999998
Q ss_pred cccCCCCccccccccccccccCccccCC-----CCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchh
Q 001544 918 LLIGEDQSMTQTQTLATLGYMAPEYGRE-----GRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPIS 992 (1057)
Q Consensus 918 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 992 (1057)
.+.. ........+||+.|||||++.. ..|+.++|+||+|++..||.-|.+|+.++..-..
T Consensus 172 Qlds--T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmra------------- 236 (953)
T KOG0587|consen 172 QLDS--TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRA------------- 236 (953)
T ss_pred eeec--ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhh-------------
Confidence 7632 2233445689999999998753 3467899999999999999999999877433211
Q ss_pred HHHhhhcccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 993 MMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 993 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
++. +...+......++....++.++|..|+..|.++||++.++++|
T Consensus 237 ---LF~--IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 237 ---LFL--IPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred ---hcc--CCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 110 1122333334455667899999999999999999999999876
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=276.55 Aligned_cols=263 Identities=23% Similarity=0.310 Sum_probs=203.6
Q ss_pred CCCCCCccccccccCCHHHHHHHhCCCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccc---hhHHHHHHHHHHHHH
Q 001544 745 PNEVNVPLEATWRRFSYLELFQATNGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQH---ERAFKSFDTECEVMK 820 (1057)
Q Consensus 745 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~ 820 (1057)
++....+........+-.+..+ ..+|....+||+|+||+|-.|.-+ +.+.+|||++++.. +...+--+.|-++++
T Consensus 326 p~~~~~~~~~~~~~~~~~d~i~-~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLA 404 (683)
T KOG0696|consen 326 PEKKTMPTDSKFHNSSKRDRIK-ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLA 404 (683)
T ss_pred CCCCCCCCcccCCCCCccccee-ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhhee
Confidence 3333344444444555555333 347999999999999999999755 56789999987552 222333445667776
Q ss_pred hc-CCCCceeEeeeeccCCeeEEEEEEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCC
Q 001544 821 SI-RHRNLTKIISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSN 899 (1057)
Q Consensus 821 ~l-~h~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~N 899 (1057)
-. +-|.+++++.+|..-+..|+||||+.||+|--.+++-++ +.+..++-+|.+||-||-+|| +++|+.||+|.+|
T Consensus 405 L~~kppFL~qlHScFQTmDRLyFVMEyvnGGDLMyhiQQ~Gk-FKEp~AvFYAaEiaigLFFLh---~kgIiYRDLKLDN 480 (683)
T KOG0696|consen 405 LPGKPPFLVQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGK-FKEPVAVFYAAEIAIGLFFLH---SKGIIYRDLKLDN 480 (683)
T ss_pred cCCCCchHHHHHHHhhhhhheeeEEEEecCchhhhHHHHhcc-cCCchhhhhhHHHHHHhhhhh---cCCeeeeeccccc
Confidence 65 578999999999999999999999999999888876554 777888999999999999999 9999999999999
Q ss_pred eeeCCCCcEEEEcccccccccCCCCccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCccccccc
Q 001544 900 VLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEM 979 (1057)
Q Consensus 900 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~ 979 (1057)
|++|.+|++||+|||+++.-. -.........||+.|+|||++....|+..+|-|||||++|||+.|++||+...+.+
T Consensus 481 vmLd~eGHiKi~DFGmcKEni--~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e- 557 (683)
T KOG0696|consen 481 VMLDSEGHIKIADFGMCKENI--FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE- 557 (683)
T ss_pred eEeccCCceEeeecccccccc--cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHH-
Confidence 999999999999999997421 12233345679999999999999999999999999999999999999998732211
Q ss_pred chhhhhhhccchhHHHhhhcccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCC
Q 001544 980 TLKHWVNDFLPISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERI 1035 (1057)
Q Consensus 980 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp 1035 (1057)
+ ...+.+.. ...+..++.+..++....+...|.+|.
T Consensus 558 -l-----------F~aI~ehn--------vsyPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 558 -L-----------FQAIMEHN--------VSYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred -H-----------HHHHHHcc--------CcCcccccHHHHHHHHHHhhcCCcccc
Confidence 1 11222211 122345677888999999999999997
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-32 Score=267.04 Aligned_cols=248 Identities=27% Similarity=0.354 Sum_probs=188.6
Q ss_pred CceeccccCeEEEEEEe-cCCcEEEEEEeeccc-hhHHHHHHHHHHHHHh-cCCCCceeEeeeeccCCeeEEEEEEccCC
Q 001544 774 NNLIGRGSFGSVYIARL-QNGIEVAVKTFDLQH-ERAFKSFDTECEVMKS-IRHRNLTKIISSCSNEDFKALILEYMRNG 850 (1057)
Q Consensus 774 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~lV~E~~~~g 850 (1057)
...||.|+||+|+|-.. +.|+..|||+++... ....+++..|.++..+ -+.||||+++|.+-.++..++.||.|+-
T Consensus 69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd~- 147 (361)
T KOG1006|consen 69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMDI- 147 (361)
T ss_pred HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHhh-
Confidence 46799999999999864 479999999997554 3556778888877544 4799999999988777777899999965
Q ss_pred ChhHHHh---c-CCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCcc
Q 001544 851 SLEKCLY---S-GNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSM 926 (1057)
Q Consensus 851 sL~~~l~---~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 926 (1057)
+++.+.. . ....+++.-.-.|..-.+.||.||-+ ...|+|||+||+|||++..|.+|+||||.+..+. .+.
T Consensus 148 SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv---~Si 222 (361)
T KOG1006|consen 148 SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLV---DSI 222 (361)
T ss_pred hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhHH---HHH
Confidence 7766432 1 23458888888899999999999986 6789999999999999999999999999998763 234
Q ss_pred ccccccccccccCccccCCC--CCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhh--hcccc
Q 001544 927 TQTQTLATLGYMAPEYGREG--RVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKII--DANLL 1002 (1057)
Q Consensus 927 ~~~~~~~t~~y~aPE~~~~~--~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~ 1002 (1057)
..+..+|-..|||||-+... .++-++||||+|+++||+.||..|+.. |-..+. .+..++ |+...
T Consensus 223 AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~----------w~svfe--ql~~Vv~gdpp~l 290 (361)
T KOG1006|consen 223 AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRK----------WDSVFE--QLCQVVIGDPPIL 290 (361)
T ss_pred HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcch----------HHHHHH--HHHHHHcCCCCee
Confidence 45556777889999987543 478899999999999999999999765 211100 011111 01000
Q ss_pred cccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 1003 ITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 1003 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
... ....+.+..+..++..|+..|-..||.+.++.++
T Consensus 291 ~~~----~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 291 LFD----KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred cCc----ccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 000 0112467789999999999999999999998764
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-30 Score=295.02 Aligned_cols=265 Identities=18% Similarity=0.252 Sum_probs=183.8
Q ss_pred HhCCCCCCceeccccCeEEEEEEe-----------------cCCcEEEEEEeeccchhHHHH--------------HHHH
Q 001544 767 ATNGFSENNLIGRGSFGSVYIARL-----------------QNGIEVAVKTFDLQHERAFKS--------------FDTE 815 (1057)
Q Consensus 767 ~~~~~~~~~~lg~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~~--------------~~~E 815 (1057)
..++|++.++||+|+||+||+|.. .+++.||||++........++ ...|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 356899999999999999999963 235789999986543322222 3346
Q ss_pred HHHHHhcCCCCc-----eeEeeeecc--------CCeeEEEEEEccCCChhHHHhcCC----------------------
Q 001544 816 CEVMKSIRHRNL-----TKIISSCSN--------EDFKALILEYMRNGSLEKCLYSGN---------------------- 860 (1057)
Q Consensus 816 ~~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lV~E~~~~gsL~~~l~~~~---------------------- 860 (1057)
+.++.+++|.++ ++++++|.. ++..++||||+++++|.++++...
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777766554 677777643 356799999999999999886421
Q ss_pred -ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCccccccccccccccC
Q 001544 861 -YILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMA 939 (1057)
Q Consensus 861 -~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~a 939 (1057)
...++..+..++.|+++|++|+| +.+|+||||||+||+++.++.+||+|||+++.+.... ........+++.|+|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH---~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~-~~~~~~g~~tp~Y~a 378 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGI-NFNPLYGMLDPRYSP 378 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCC-ccCccccCCCcceeC
Confidence 12467788899999999999999 8999999999999999999999999999997653221 112222345789999
Q ss_pred ccccCCCCC----------------------CccchHHHHHHHHHHHhhCCC-CCCcccccccchhhhhhhccchhHHHh
Q 001544 940 PEYGREGRV----------------------STKGDVYSFGILLMETFTRRK-PTDEIFSGEMTLKHWVNDFLPISMMKI 996 (1057)
Q Consensus 940 PE~~~~~~~----------------------~~~~Dv~s~G~il~elltg~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~ 996 (1057)
||.+..... ..+.||||+||++|||++|.. ||.....-......+-.... ....
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~---~~r~ 455 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLN---RWRM 455 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHH---HHHh
Confidence 998653321 134799999999999999975 66432111111111000000 0000
Q ss_pred hhcccccccchhhHHHHHHHHHHHHHHhHcccCCC---CCCCCHHHHHHH
Q 001544 997 IDANLLITEDKHFAAKEQCASSVFNLAMECTVESP---DERITAKEIVRR 1043 (1057)
Q Consensus 997 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP---~~Rps~~evl~~ 1043 (1057)
+ ......+......+....+++.+|+..+| .+|+|++|+++|
T Consensus 456 ~-----~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 456 Y-----KGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred h-----cccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 0 00111222233456788999999999866 689999999987
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-30 Score=304.13 Aligned_cols=260 Identities=20% Similarity=0.249 Sum_probs=170.9
Q ss_pred HhCCCCCCceeccccCeEEEEEEec-C----CcEEEEEEeeccchhHHHHHHHHHHHHHhcCCCCceeEeee------ec
Q 001544 767 ATNGFSENNLIGRGSFGSVYIARLQ-N----GIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISS------CS 835 (1057)
Q Consensus 767 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~------~~ 835 (1057)
..++|+..+.||+|+||.||+|+.. + +..||||++...... +....| .+....+.++..++.. ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 4678999999999999999999865 4 689999987543221 111111 1111122222222211 24
Q ss_pred cCCeeEEEEEEccCCChhHHHhcCCccC-------------------CHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCC
Q 001544 836 NEDFKALILEYMRNGSLEKCLYSGNYIL-------------------DIFQRLNIMIDVASALEYLHFGYSAPVIHCDLK 896 (1057)
Q Consensus 836 ~~~~~~lV~E~~~~gsL~~~l~~~~~~l-------------------~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk 896 (1057)
.++..++||||+++++|.+++....... ....+..++.|++.||+||| +++|+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH---~~gIiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH---STGIVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH---HCCEEeCcCC
Confidence 5678899999999999999887543211 12345679999999999999 8999999999
Q ss_pred CCCeeeCC-CCcEEEEcccccccccCCCCccccccccccccccCccccCCC----------------------CCCccch
Q 001544 897 PSNVLLDD-NMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREG----------------------RVSTKGD 953 (1057)
Q Consensus 897 p~Nill~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~----------------------~~~~~~D 953 (1057)
|+|||++. ++.+||+|||+|+.+.... ........++++|+|||.+... .++.++|
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~-~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGI-NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCcccccccc-ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 99999985 6899999999998653222 2233445788999999954322 2344679
Q ss_pred HHHHHHHHHHHhhCCCCCCccc--------ccccchhhhhhhccchhHHHhhhcccccccchhhHHHHHHHHHHHHHHhH
Q 001544 954 VYSFGILLMETFTRRKPTDEIF--------SGEMTLKHWVNDFLPISMMKIIDANLLITEDKHFAAKEQCASSVFNLAME 1025 (1057)
Q Consensus 954 v~s~G~il~elltg~~p~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 1025 (1057)
|||+||++|||+++..|++... ..+.....|... ............+........+..+|+.+
T Consensus 362 VwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~d~~~~~~~dLi~~ 432 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKL---------VEPRASPDLRRGFEVLDLDGGAGWELLKS 432 (566)
T ss_pred cHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHh---------hccccchhhhhhhhhccccchHHHHHHHH
Confidence 9999999999999877654310 001111222111 11100000000000001112345689999
Q ss_pred cccCCCCCCCCHHHHHHH
Q 001544 1026 CTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 1026 cl~~dP~~Rps~~evl~~ 1043 (1057)
|++.||++|||+.|+++|
T Consensus 433 mL~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 433 MMRFKGRQRISAKAALAH 450 (566)
T ss_pred HccCCcccCCCHHHHhCC
Confidence 999999999999999987
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=298.69 Aligned_cols=245 Identities=26% Similarity=0.395 Sum_probs=191.7
Q ss_pred CCCCceeccccCeE-EEEEEecCCcEEEEEEeeccchhHHHHHHHHHHHHHhc-CCCCceeEeeeeccCCeeEEEEEEcc
Q 001544 771 FSENNLIGRGSFGS-VYIARLQNGIEVAVKTFDLQHERAFKSFDTECEVMKSI-RHRNLTKIISSCSNEDFKALILEYMR 848 (1057)
Q Consensus 771 ~~~~~~lg~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~ 848 (1057)
|...+++|.|+-|+ ||+|..+ |+.||||++-.. .....++|+..++.- +|||||++++.-.+....|++.|.|.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~ 586 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA 586 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC-CceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence 34457799999985 6999987 889999998432 335667899999888 69999999999999999999999997
Q ss_pred CCChhHHHhcCCc---cCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCC---C--CcEEEEccccccccc
Q 001544 849 NGSLEKCLYSGNY---ILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDD---N--MVAHLSDFGIAKLLI 920 (1057)
Q Consensus 849 ~gsL~~~l~~~~~---~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~---~--~~~kl~Dfg~a~~~~ 920 (1057)
. +|++++..... .......+.+..|++.|+++|| +.+||||||||.||||+. + ..++|+|||+++.+.
T Consensus 587 ~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 587 C-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLH---SLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred h-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHH---hcccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 6 99999987421 1111345788999999999999 999999999999999975 3 479999999999886
Q ss_pred CCCC-ccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhhC-CCCCCcccccccchhhhhhhccchhHHHhhh
Q 001544 921 GEDQ-SMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTR-RKPTDEIFSGEMTLKHWVNDFLPISMMKIID 998 (1057)
Q Consensus 921 ~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 998 (1057)
.... ........||.||+|||.+....-+.++|+||+||++|+.++| .+||++....+..+..-...
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~~~~----------- 731 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTGNYT----------- 731 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcCccc-----------
Confidence 5443 2334567899999999999998889999999999999999997 88998754332222110000
Q ss_pred cccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 999 ANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 999 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
. .. .....++ +..++|.+|++++|..||+|.+|+.|
T Consensus 732 L-~~------L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 732 L-VH------LEPLPDC--EAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred e-ee------eccCchH--HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 0 00 0001122 67899999999999999999999875
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.7e-30 Score=245.83 Aligned_cols=265 Identities=19% Similarity=0.296 Sum_probs=196.5
Q ss_pred HhCCCCCCceeccccCeEEEEEE-ecCCcEEEEEEeeccchhHHHHHHHHHHHHHhcC-CCCceeEeeeeccC--CeeEE
Q 001544 767 ATNGFSENNLIGRGSFGSVYIAR-LQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIR-HRNLTKIISSCSNE--DFKAL 842 (1057)
Q Consensus 767 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~l 842 (1057)
..++|++.+++|+|.|+.||.|. ..+.++++||++++.. .+.+.+|+.++..++ ||||+++++...++ ....+
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL 112 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL 112 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence 45688999999999999999996 5578999999997543 467889999999997 99999999998764 56679
Q ss_pred EEEEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCC-CCcEEEEcccccccccC
Q 001544 843 ILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDD-NMVAHLSDFGIAKLLIG 921 (1057)
Q Consensus 843 V~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~-~~~~kl~Dfg~a~~~~~ 921 (1057)
|+||+++.+...... .++...+...+.+++.||.|+| +.||+|||+||.|+++|. .-.++++|+|+|.++.+
T Consensus 113 iFE~v~n~Dfk~ly~----tl~d~dIryY~~elLkALdyCH---S~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp 185 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLYP----TLTDYDIRYYIYELLKALDYCH---SMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185 (338)
T ss_pred HhhhhccccHHHHhh----hhchhhHHHHHHHHHHHHhHHH---hcCcccccCCcceeeechhhceeeeeecchHhhcCC
Confidence 999999988876543 3777788999999999999999 999999999999999994 56899999999998754
Q ss_pred CCCccccccccccccccCccccCC-CCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhcc
Q 001544 922 EDQSMTQTQTLATLGYMAPEYGRE-GRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDAN 1000 (1057)
Q Consensus 922 ~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1000 (1057)
... ..-.+.+..|.-||.+.. ..++..-|+|||||++..|+..+.||-...+....+...+.-........-+...
T Consensus 186 ~~e---YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY 262 (338)
T KOG0668|consen 186 GKE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKY 262 (338)
T ss_pred Cce---eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHH
Confidence 432 233345567788997654 5678899999999999999999999743222222222222111111111111110
Q ss_pred cc-----------cccchhhHH------HHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHH
Q 001544 1001 LL-----------ITEDKHFAA------KEQCASSVFNLAMECTVESPDERITAKEIVRRL 1044 (1057)
Q Consensus 1001 ~~-----------~~~~~~~~~------~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 1044 (1057)
.. .-...++.. ..-.+++..+++.+.+.+|.++||||+|+++|-
T Consensus 263 ~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~Hp 323 (338)
T KOG0668|consen 263 QIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHP 323 (338)
T ss_pred ccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCc
Confidence 00 000001110 112358899999999999999999999999873
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-29 Score=268.35 Aligned_cols=239 Identities=30% Similarity=0.384 Sum_probs=193.4
Q ss_pred cCeEEEEEEec-CCcEEEEEEeeccchhH-HHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEEccCCChhHHHhc
Q 001544 781 SFGSVYIARLQ-NGIEVAVKTFDLQHERA-FKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEYMRNGSLEKCLYS 858 (1057)
Q Consensus 781 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~ 858 (1057)
+||.||+|... +|+.||+|++....... .+.+.+|++.+++++|+|++++++++......++|+||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999876 58999999997654433 68899999999999999999999999998999999999999999999876
Q ss_pred CCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCcccccccccccccc
Q 001544 859 GNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYM 938 (1057)
Q Consensus 859 ~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~ 938 (1057)
... +++.++..++.+++++++||| +.+++|+||+|+||+++.++.++++|||.+....... ......++..|+
T Consensus 81 ~~~-~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~ 153 (244)
T smart00220 81 RGR-LSEDEARFYARQILSALEYLH---SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEYM 153 (244)
T ss_pred ccC-CCHHHHHHHHHHHHHHHHHHH---HcCeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCCC
Confidence 544 889999999999999999999 8999999999999999999999999999998763321 233455788999
Q ss_pred CccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhcccccccchhhHHHHHHHHH
Q 001544 939 APEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHFAAKEQCASS 1018 (1057)
Q Consensus 939 aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1018 (1057)
|||......++.++|||++|++++++++|..||......+. ..+......... ......++.+
T Consensus 154 ~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~-------------~~~~~~~~~~~~----~~~~~~~~~~ 216 (244)
T smart00220 154 APEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLE-------------LFKKIGKPKPPF----PPPEWKISPE 216 (244)
T ss_pred CHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHH-------------HHHHHhccCCCC----ccccccCCHH
Confidence 99999888889999999999999999999999865211110 111111000000 0000115677
Q ss_pred HHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 1019 VFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 1019 l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
+.+++.+|+..+|++||++.+++++
T Consensus 217 ~~~~i~~~l~~~p~~Rp~~~~~~~~ 241 (244)
T smart00220 217 AKDLIRKLLVKDPEKRLTAEEALQH 241 (244)
T ss_pred HHHHHHHHccCCchhccCHHHHhhC
Confidence 8999999999999999999999873
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=256.28 Aligned_cols=247 Identities=23% Similarity=0.327 Sum_probs=198.7
Q ss_pred hCCCCCCceeccccCeEEEEEEec-CCcEEEEEEeecc---chhHHHHHHHHHHHHHhc-CCCCceeEeeeeccCCeeEE
Q 001544 768 TNGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQ---HERAFKSFDTECEVMKSI-RHRNLTKIISSCSNEDFKAL 842 (1057)
Q Consensus 768 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 842 (1057)
..+|...++||+|+|++|..++.. +.+.+|+|+++++ .++...-.+.|-.+..+. +||.+|.+..+|..+...++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 457889999999999999999854 6788999998754 344556677888888777 69999999999999999999
Q ss_pred EEEEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCC
Q 001544 843 ILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGE 922 (1057)
Q Consensus 843 V~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~ 922 (1057)
|.||++||+|--++++.++ ++++.+.-+..+|.-||.||| ++||+.||+|..|||+|..|++|+.|+|+++.-.
T Consensus 329 vieyv~ggdlmfhmqrqrk-lpeeharfys~ei~lal~flh---~rgiiyrdlkldnvlldaeghikltdygmcke~l-- 402 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQRK-LPEEHARFYSAEICLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL-- 402 (593)
T ss_pred EEEEecCcceeeehhhhhc-CcHHHhhhhhHHHHHHHHHHh---hcCeeeeeccccceEEccCCceeecccchhhcCC--
Confidence 9999999999777766654 889999999999999999999 9999999999999999999999999999997532
Q ss_pred CCccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCccc--ccccchhhhhhhccchhHHHhhhcc
Q 001544 923 DQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIF--SGEMTLKHWVNDFLPISMMKIIDAN 1000 (1057)
Q Consensus 923 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 1000 (1057)
......+...||+.|+|||++++..|...+|.|++||+++||+.|+.||+-.- .++..-++|... -+.+..
T Consensus 403 ~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfq-------vilekq 475 (593)
T KOG0695|consen 403 GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQ-------VILEKQ 475 (593)
T ss_pred CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHH-------HHhhhc
Confidence 22334456789999999999999999999999999999999999999998532 223332332221 111111
Q ss_pred cccccchhhHHHHHHHHHHHHHHhHcccCCCCCCC
Q 001544 1001 LLITEDKHFAAKEQCASSVFNLAMECTVESPDERI 1035 (1057)
Q Consensus 1001 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp 1035 (1057)
. ..+..++.....+++.-++.||.+|.
T Consensus 476 i--------riprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 476 I--------RIPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred c--------cccceeehhhHHHHHHhhcCCcHHhc
Confidence 1 11223455566788999999999986
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-30 Score=276.49 Aligned_cols=249 Identities=23% Similarity=0.320 Sum_probs=202.4
Q ss_pred CCCCCceeccccCeEEEEEEecCCc-EEEEEEeecc---chhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEE
Q 001544 770 GFSENNLIGRGSFGSVYIARLQNGI-EVAVKTFDLQ---HERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILE 845 (1057)
Q Consensus 770 ~~~~~~~lg~G~~g~Vy~~~~~~~~-~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 845 (1057)
+++....||-|+||.|-.+..+... .+|+|.+++. ++.+.+.+..|-.+|...+.|.||++|-.|.+++..|+.||
T Consensus 421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmE 500 (732)
T KOG0614|consen 421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLME 500 (732)
T ss_pred hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHH
Confidence 4555667999999999999876433 4888887543 45566778889999999999999999999999999999999
Q ss_pred EccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCc
Q 001544 846 YMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS 925 (1057)
Q Consensus 846 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 925 (1057)
-|-||.++..++..+. ++..+..-++..+.+|++||| .++||+||+||+|.+++.+|.+|+.|||+|+.+.. .
T Consensus 501 aClGGElWTiLrdRg~-Fdd~tarF~~acv~EAfeYLH---~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~---g 573 (732)
T KOG0614|consen 501 ACLGGELWTILRDRGS-FDDYTARFYVACVLEAFEYLH---RKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS---G 573 (732)
T ss_pred hhcCchhhhhhhhcCC-cccchhhhhHHHHHHHHHHHH---hcCceeccCChhheeeccCCceEEeehhhHHHhcc---C
Confidence 9999999999987664 888899999999999999999 99999999999999999999999999999998732 2
Q ss_pred cccccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhccccccc
Q 001544 926 MTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITE 1005 (1057)
Q Consensus 926 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1057)
...-..+||+.|.|||++.+..++.++|.||+|+++||+++|.+||....+-. ++.. +.+-+|
T Consensus 574 ~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmk-tYn~---------ILkGid------- 636 (732)
T KOG0614|consen 574 RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMK-TYNL---------ILKGID------- 636 (732)
T ss_pred CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHH-HHHH---------HHhhhh-------
Confidence 33344689999999999999999999999999999999999999997632110 0000 011111
Q ss_pred chhhHHHHHHHHHHHHHHhHcccCCCCCCCC-----HHHHHHHH
Q 001544 1006 DKHFAAKEQCASSVFNLAMECTVESPDERIT-----AKEIVRRL 1044 (1057)
Q Consensus 1006 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~evl~~L 1044 (1057)
.+..+..++....+++++.+...|.+|.. ..|+.+|-
T Consensus 637 --~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~ 678 (732)
T KOG0614|consen 637 --KIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHR 678 (732)
T ss_pred --hhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhh
Confidence 12223455667789999999999999985 66666553
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.3e-31 Score=258.01 Aligned_cols=266 Identities=23% Similarity=0.344 Sum_probs=195.0
Q ss_pred CCCceeccccCeEEEEEEec-CCcEEEEEEeeccc--hhHHHHHHHHHHHHHhcCCCCceeEeeeeccC-----CeeEEE
Q 001544 772 SENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQH--ERAFKSFDTECEVMKSIRHRNLTKIISSCSNE-----DFKALI 843 (1057)
Q Consensus 772 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~lV 843 (1057)
+..+.||.|+||.||-+++. +|+.||.|++...- -.+.+++.+|+++++..+|.|+...++..... ++.|.|
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 34588999999999999865 79999999884332 24568899999999999999999888765432 356788
Q ss_pred EEEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCC
Q 001544 844 LEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGED 923 (1057)
Q Consensus 844 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~ 923 (1057)
+|.|. .+|.+.+-+.. .++...+.-+.+||++||.||| +.+|.||||||.|.+++.+..+||||||+++.. ..+
T Consensus 136 TELmQ-SDLHKIIVSPQ-~Ls~DHvKVFlYQILRGLKYLH---sA~ILHRDIKPGNLLVNSNCvLKICDFGLARve-e~d 209 (449)
T KOG0664|consen 136 TELMQ-SDLHKIIVSPQ-ALTPDHVKVFVYQILRGLKYLH---TANILHRDIKPGNLLVNSNCILKICDFGLARTW-DQR 209 (449)
T ss_pred HHHHH-hhhhheeccCC-CCCcchhhhhHHHHHhhhHHHh---hcchhhccCCCccEEeccCceEEeccccccccc-chh
Confidence 89884 48888776544 4788888999999999999999 999999999999999999999999999999865 334
Q ss_pred CccccccccccccccCccccCCC-CCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHH-------
Q 001544 924 QSMTQTQTLATLGYMAPEYGREG-RVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMK------- 995 (1057)
Q Consensus 924 ~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~------- 995 (1057)
.....+..+.|..|+|||++.+. .|+.+.||||.||++.|++..+.-|..... ....+.+.+...-...+
T Consensus 210 ~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~P--iqQL~lItdLLGTPs~EaMr~ACE 287 (449)
T KOG0664|consen 210 DRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGP--IEQLQMIIDLLGTPSQEAMKYACE 287 (449)
T ss_pred hhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccCh--HHHHHHHHHHhCCCcHHHHHHHhh
Confidence 45566777889999999998876 478999999999999999998877654211 11111111111111111
Q ss_pred -----hhhcccccccc---hhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHH
Q 001544 996 -----IIDANLLITED---KHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLL 1045 (1057)
Q Consensus 996 -----~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~ 1045 (1057)
+.......... .....+.....+...+...++..||++|.+..+++.+.-
T Consensus 288 GAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 288 GAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred hhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 11000000000 000111122346678899999999999999999988764
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-28 Score=260.08 Aligned_cols=266 Identities=22% Similarity=0.264 Sum_probs=195.2
Q ss_pred CCCCCCceeccccCeEEEEEE-ecCCcEEEEEEeeccchhHHHHHHHHHHHHHhcC-----C---CCceeEeeeec----
Q 001544 769 NGFSENNLIGRGSFGSVYIAR-LQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIR-----H---RNLTKIISSCS---- 835 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~l~~~~~---- 835 (1057)
.+|.+.++||-|.|++||+|. .++.+.||+|+.+.. +...+....||+++++++ | ..||++++.|.
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 578899999999999999996 457899999998643 344566788999999985 2 36999999984
Q ss_pred cCCeeEEEEEEccCCChhHHHhcCC-ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCC---------
Q 001544 836 NEDFKALILEYMRNGSLEKCLYSGN-YILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDN--------- 905 (1057)
Q Consensus 836 ~~~~~~lV~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~--------- 905 (1057)
.+.+.|+|+|++ |.+|..++.... .-++...+.+|++||+.||.|||. ..+|||.||||+|||+..+
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~--ecgIIHTDlKPENvLl~~~e~~~~~~~~ 233 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHR--ECGIIHTDLKPENVLLCSTEIDPAKDAR 233 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHH--hcCccccCCCcceeeeeccccchhhhhh
Confidence 467999999999 558888887655 458999999999999999999997 4599999999999998210
Q ss_pred --------------------------------------------------------------------------------
Q 001544 906 -------------------------------------------------------------------------------- 905 (1057)
Q Consensus 906 -------------------------------------------------------------------------------- 905 (1057)
T Consensus 234 ~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~~ 313 (590)
T KOG1290|consen 234 EAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGNE 313 (590)
T ss_pred hhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCccc
Confidence
Q ss_pred -----------------------------------------------------------------------------CcE
Q 001544 906 -----------------------------------------------------------------------------MVA 908 (1057)
Q Consensus 906 -----------------------------------------------------------------------------~~~ 908 (1057)
-.+
T Consensus 314 ~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~v 393 (590)
T KOG1290|consen 314 STVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIRV 393 (590)
T ss_pred cchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccceeE
Confidence 014
Q ss_pred EEEcccccccccCCCCccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccc-----cccchhh
Q 001544 909 HLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFS-----GEMTLKH 983 (1057)
Q Consensus 909 kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~-----~~~~~~~ 983 (1057)
||+|||-|.++ ....+..+.|..|+|||++.+..|++.+|+||++|++||++||..-|+.... ++..++.
T Consensus 394 KIaDlGNACW~-----~khFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~ 468 (590)
T KOG1290|consen 394 KIADLGNACWV-----HKHFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIAL 468 (590)
T ss_pred EEeeccchhhh-----hhhhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHH
Confidence 55555555543 2333445667889999999999999999999999999999999988874322 2222332
Q ss_pred hhhhcc--chh-------HHHhhhccccccc---ch----------hhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHH
Q 001544 984 WVNDFL--PIS-------MMKIIDANLLITE---DK----------HFAAKEQCASSVFNLAMECTVESPDERITAKEIV 1041 (1057)
Q Consensus 984 ~~~~~~--~~~-------~~~~~~~~~~~~~---~~----------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl 1041 (1057)
.+.... |.. ..+.+++...... -+ .+...++-..++.+++.-|++.+|++||||.+++
T Consensus 469 i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl 548 (590)
T KOG1290|consen 469 IMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCL 548 (590)
T ss_pred HHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHh
Confidence 221110 100 1122222111000 00 1122345578899999999999999999999999
Q ss_pred HH
Q 001544 1042 RR 1043 (1057)
Q Consensus 1042 ~~ 1043 (1057)
+|
T Consensus 549 ~h 550 (590)
T KOG1290|consen 549 KH 550 (590)
T ss_pred cC
Confidence 76
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.6e-29 Score=269.64 Aligned_cols=206 Identities=23% Similarity=0.352 Sum_probs=174.3
Q ss_pred CCCCCceeccccCeEEEEEE-ecCCcEEEEEEeeccc---hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEE
Q 001544 770 GFSENNLIGRGSFGSVYIAR-LQNGIEVAVKTFDLQH---ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILE 845 (1057)
Q Consensus 770 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 845 (1057)
-|...+.||-|+||+|.+++ .++...||+|.+++.+ ..+....+.|-.||..-..+=||+++-.|.+++..|+|||
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd 709 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 709 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence 46778899999999999996 4557789999986553 3456778889999999999999999999999999999999
Q ss_pred EccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccc------
Q 001544 846 YMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL------ 919 (1057)
Q Consensus 846 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~------ 919 (1057)
|++||++-.++-+.+ .+++.-++-++.++..|+++.| ..|+|||||||+|||||.+|++|+.|||+++-+
T Consensus 710 YIPGGDmMSLLIrmg-IFeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHds 785 (1034)
T KOG0608|consen 710 YIPGGDMMSLLIRMG-IFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 785 (1034)
T ss_pred ccCCccHHHHHHHhc-cCHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEEccCCceeeeeccccccceecccc
Confidence 999999998877655 4788888889999999999999 999999999999999999999999999998533
Q ss_pred ---cCCCCcc-------------------------------ccccccccccccCccccCCCCCCccchHHHHHHHHHHHh
Q 001544 920 ---IGEDQSM-------------------------------TQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETF 965 (1057)
Q Consensus 920 ---~~~~~~~-------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~ell 965 (1057)
...+..+ .....+||+.|+|||++....++.-+|.||.|||+|||+
T Consensus 786 kYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~ 865 (1034)
T KOG0608|consen 786 KYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEML 865 (1034)
T ss_pred ccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHh
Confidence 1111000 001235899999999999999999999999999999999
Q ss_pred hCCCCCCccccccc
Q 001544 966 TRRKPTDEIFSGEM 979 (1057)
Q Consensus 966 tg~~p~~~~~~~~~ 979 (1057)
.|++||.+...++.
T Consensus 866 ~g~~pf~~~tp~~t 879 (1034)
T KOG0608|consen 866 VGQPPFLADTPGET 879 (1034)
T ss_pred hCCCCccCCCCCcc
Confidence 99999987655543
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.4e-29 Score=235.12 Aligned_cols=199 Identities=28% Similarity=0.351 Sum_probs=162.4
Q ss_pred CCCCceeccccCeEEEEEE-ecCCcEEEEEEeeccc-hhHHHHHHHHHHHHHhc-CCCCceeEeeeeccCCeeEEEEEEc
Q 001544 771 FSENNLIGRGSFGSVYIAR-LQNGIEVAVKTFDLQH-ERAFKSFDTECEVMKSI-RHRNLTKIISSCSNEDFKALILEYM 847 (1057)
Q Consensus 771 ~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~ 847 (1057)
......||+|++|.|-+.+ .++|+..|||++.... .+..++...|+.+..+. .+|.+|+++|.+......++.||.|
T Consensus 48 L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M 127 (282)
T KOG0984|consen 48 LVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM 127 (282)
T ss_pred hhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh
Confidence 3445679999999998886 5589999999996543 33446677788876555 6999999999988888889999999
Q ss_pred cCCChhHHHh---cCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCC
Q 001544 848 RNGSLEKCLY---SGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ 924 (1057)
Q Consensus 848 ~~gsL~~~l~---~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 924 (1057)
+. +|+.+-. +.+..+++.-.-+|+..+.+|+.|||+ ...|+|||+||+|||++.+|++|+||||.+.++. .
T Consensus 128 ~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~---d 201 (282)
T KOG0984|consen 128 DT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYLV---D 201 (282)
T ss_pred hh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccceeeh---h
Confidence 65 8876543 345668999999999999999999995 5689999999999999999999999999998763 2
Q ss_pred ccccccccccccccCccccCC----CCCCccchHHHHHHHHHHHhhCCCCCCccc
Q 001544 925 SMTQTQTLATLGYMAPEYGRE----GRVSTKGDVYSFGILLMETFTRRKPTDEIF 975 (1057)
Q Consensus 925 ~~~~~~~~~t~~y~aPE~~~~----~~~~~~~Dv~s~G~il~elltg~~p~~~~~ 975 (1057)
+...+...|--.|||||.+.. ..|+-|+||||+|+.+.||.+++.||+...
T Consensus 202 SiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~ 256 (282)
T KOG0984|consen 202 SIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG 256 (282)
T ss_pred hhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence 333344556667999997653 368889999999999999999999987633
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-28 Score=247.89 Aligned_cols=261 Identities=25% Similarity=0.314 Sum_probs=197.9
Q ss_pred hCCCCCCceeccccCeEEEEEEec-CCcEEEEEEeecc--chhHHHHHHHHHHHHHhcCCCCceeEeeeeccC------C
Q 001544 768 TNGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQ--HERAFKSFDTECEVMKSIRHRNLTKIISSCSNE------D 838 (1057)
Q Consensus 768 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 838 (1057)
..+|...+.+|.|.- .|..|.+. .+++||+|..... .....++..+|..++..+.|+||++++.+|... .
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 456777889999998 66666433 5899999987433 234457788999999999999999999998543 4
Q ss_pred eeEEEEEEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEccccccc
Q 001544 839 FKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL 918 (1057)
Q Consensus 839 ~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~ 918 (1057)
..|+|||||+. +|...++ ..++-.+...|..|++.|+.||| +.+|+||||||+||++..++.+||.|||+|+.
T Consensus 95 e~y~v~e~m~~-nl~~vi~---~elDH~tis~i~yq~~~~ik~lh---s~~IihRdLkPsnivv~~~~~lKi~dfg~ar~ 167 (369)
T KOG0665|consen 95 EVYLVMELMDA-NLCQVIL---MELDHETISYILYQMLCGIKHLH---SAGIIHRDLKPSNIVVNSDCTLKILDFGLART 167 (369)
T ss_pred hHHHHHHhhhh-HHHHHHH---HhcchHHHHHHHHHHHHHHHHHH---hcceeecccCcccceecchhheeeccchhhcc
Confidence 67999999965 8888776 23677888999999999999999 99999999999999999999999999999985
Q ss_pred ccCCCCccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhcc-----chhH
Q 001544 919 LIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFL-----PISM 993 (1057)
Q Consensus 919 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~-----~~~~ 993 (1057)
- +.....+.++.|..|+|||++.+..+.+.+||||.||++.||++|+.-|. ++..+.+|.+... ..+.
T Consensus 168 e---~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~----g~d~idQ~~ki~~~lgtpd~~F 240 (369)
T KOG0665|consen 168 E---DTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFP----GKDHIDQWNKIIEQLGTPDPSF 240 (369)
T ss_pred c---CcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEec----CchHHHHHHHHHHHhcCCCHHH
Confidence 3 33356778889999999999988889999999999999999999998653 5555666654221 1111
Q ss_pred HH-hhhc----------ccccccchhhHH---------HHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 994 MK-IIDA----------NLLITEDKHFAA---------KEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 994 ~~-~~~~----------~~~~~~~~~~~~---------~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
.+ ..+. .........++. .+--...+.+++.+|+..+|++|.++.++++|
T Consensus 241 ~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 241 MKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 11 0000 000000000000 00112457899999999999999999999986
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-26 Score=242.26 Aligned_cols=211 Identities=35% Similarity=0.571 Sum_probs=184.2
Q ss_pred eccccCeEEEEEEecC-CcEEEEEEeeccchh-HHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEEccCCChhH
Q 001544 777 IGRGSFGSVYIARLQN-GIEVAVKTFDLQHER-AFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEYMRNGSLEK 854 (1057)
Q Consensus 777 lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL~~ 854 (1057)
||+|++|.||++...+ ++.++||++...... ..+.+.+|++.++.++|++++++++++......++|+||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999998764 899999999755432 45788999999999999999999999999899999999999999999
Q ss_pred HHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCC-CCcEEEEcccccccccCCCCccccccccc
Q 001544 855 CLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDD-NMVAHLSDFGIAKLLIGEDQSMTQTQTLA 933 (1057)
Q Consensus 855 ~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~ 933 (1057)
++......+++..+..++.+++++++||| +.+++|+||+|.||+++. ++.++++|||.+........ ......+
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~ 155 (215)
T cd00180 81 LLKENEGKLSEDEILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVG 155 (215)
T ss_pred HHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcccC
Confidence 98876446899999999999999999999 899999999999999999 89999999999986532211 2333457
Q ss_pred cccccCccccCCC-CCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhcccccccchhhHHH
Q 001544 934 TLGYMAPEYGREG-RVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHFAAK 1012 (1057)
Q Consensus 934 t~~y~aPE~~~~~-~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1012 (1057)
...|++||..... ..+.++|+|++|++++++
T Consensus 156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------------ 187 (215)
T cd00180 156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------------ 187 (215)
T ss_pred CCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------------------
Confidence 7889999998777 788999999999999998
Q ss_pred HHHHHHHHHHHhHcccCCCCCCCCHHHHHHHH
Q 001544 1013 EQCASSVFNLAMECTVESPDERITAKEIVRRL 1044 (1057)
Q Consensus 1013 ~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 1044 (1057)
.++.+++.+|++.+|++||++.++++++
T Consensus 188 ----~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 ----PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred ----HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 3467899999999999999999998763
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-28 Score=271.21 Aligned_cols=254 Identities=24% Similarity=0.379 Sum_probs=205.1
Q ss_pred hCCCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccchhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEE
Q 001544 768 TNGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEY 846 (1057)
Q Consensus 768 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 846 (1057)
.++|+....+|+|.||.||||++. +++..|||+++......++-++.|+-+++..+||||+.++|.+...+..+++|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 457888999999999999999855 6999999999988888888899999999999999999999999999999999999
Q ss_pred ccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCcc
Q 001544 847 MRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSM 926 (1057)
Q Consensus 847 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 926 (1057)
+.+|+|++.-+-. .++++.++..+++...+|++||| +.+-+|||||-.||++++.|.+|++|||.+..+.. .-.
T Consensus 94 cgggslQdiy~~T-gplselqiayvcRetl~gl~ylh---s~gk~hRdiKGanilltd~gDvklaDfgvsaqita--ti~ 167 (829)
T KOG0576|consen 94 CGGGSLQDIYHVT-GPLSELQIAYVCRETLQGLKYLH---SQGKIHRDIKGANILLTDEGDVKLADFGVSAQITA--TIA 167 (829)
T ss_pred cCCCcccceeeec-ccchhHHHHHHHhhhhccchhhh---cCCcccccccccceeecccCceeecccCchhhhhh--hhh
Confidence 9999999965543 46999999999999999999999 99999999999999999999999999999876632 222
Q ss_pred ccccccccccccCcccc---CCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhccccc
Q 001544 927 TQTQTLATLGYMAPEYG---REGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLI 1003 (1057)
Q Consensus 927 ~~~~~~~t~~y~aPE~~---~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1003 (1057)
......||+.|||||+. +.+.|..++|||+.|+...|+-.-++|.-+.. +.....+.-.. .
T Consensus 168 KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlh--------------pmr~l~LmTkS--~ 231 (829)
T KOG0576|consen 168 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLH--------------PMRALFLMTKS--G 231 (829)
T ss_pred hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccc--------------hHHHHHHhhcc--C
Confidence 33456899999999964 45668899999999999999988887732211 11111111100 0
Q ss_pred ccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 1004 TEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 1004 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
.............+.+.++++.|+..+|++||++..+++|
T Consensus 232 ~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~h 271 (829)
T KOG0576|consen 232 FQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQH 271 (829)
T ss_pred CCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhheec
Confidence 1111122223345678899999999999999999988774
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.4e-28 Score=260.88 Aligned_cols=198 Identities=23% Similarity=0.346 Sum_probs=169.4
Q ss_pred HhCCCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccc---hhH-----HHHHHHHHHHHHhcC---CCCceeEeeee
Q 001544 767 ATNGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQH---ERA-----FKSFDTECEVMKSIR---HRNLTKIISSC 834 (1057)
Q Consensus 767 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~-----~~~~~~E~~~l~~l~---h~niv~l~~~~ 834 (1057)
...+|+..+.+|+|+||.|+.|..+ +...|+||.+.++. +.+ .-.+-.|+++|..++ |+||++++++|
T Consensus 559 k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF 638 (772)
T KOG1152|consen 559 KFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF 638 (772)
T ss_pred ccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee
Confidence 3457999999999999999999866 56789999986542 111 123456999999997 99999999999
Q ss_pred ccCCeeEEEEEEc-cCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcc
Q 001544 835 SNEDFKALILEYM-RNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDF 913 (1057)
Q Consensus 835 ~~~~~~~lV~E~~-~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 913 (1057)
++++.+|++||-. ++.+|.+++..+. .+++.++.-|++||+.|+++|| +.+|||||||-+||.++.+|.+|++||
T Consensus 639 Eddd~yyl~te~hg~gIDLFd~IE~kp-~m~E~eAk~IFkQV~agi~hlh---~~~ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 639 EDDDYYYLETEVHGEGIDLFDFIEFKP-RMDEPEAKLIFKQVVAGIKHLH---DQGIVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred ecCCeeEEEecCCCCCcchhhhhhccC-ccchHHHHHHHHHHHhcccccc---ccCceecccccccEEEecCCeEEEeec
Confidence 9999999999985 4558899887655 4999999999999999999999 999999999999999999999999999
Q ss_pred cccccccCCCCccccccccccccccCccccCCCCC-CccchHHHHHHHHHHHhhCCCCCC
Q 001544 914 GIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRV-STKGDVYSFGILLMETFTRRKPTD 972 (1057)
Q Consensus 914 g~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Dv~s~G~il~elltg~~p~~ 972 (1057)
|.|.+.. ..+....+||.+|.|||++.+..| +..-|||++|+++|-++...-||.
T Consensus 715 gsaa~~k----sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 715 GSAAYTK----SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred cchhhhc----CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 9998752 334456689999999999998877 567899999999999998888874
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-27 Score=251.07 Aligned_cols=272 Identities=25% Similarity=0.317 Sum_probs=204.3
Q ss_pred HHHHhCCCCCCceeccccCeEEEEEEec----CCcEEEEEEeeccchhHHHHHHHHHHHHHhcC-CCCceeEeeeeccCC
Q 001544 764 LFQATNGFSENNLIGRGSFGSVYIARLQ----NGIEVAVKTFDLQHERAFKSFDTECEVMKSIR-HRNLTKIISSCSNED 838 (1057)
Q Consensus 764 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~ 838 (1057)
.....+.|..+++||+|.|++||+|.+. ..+.||+|.+...... .++.+|++++..+. +.||+++.+++...+
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p--~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP--SRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc--hHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 3445677899999999999999999743 4688999998654433 56889999999994 999999999999999
Q ss_pred eeEEEEEEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeC-CCCcEEEEcccccc
Q 001544 839 FKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFGIAK 917 (1057)
Q Consensus 839 ~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~-~~~~~kl~Dfg~a~ 917 (1057)
...+|+||++.....++... ++..++..+++.+..||+++| ..|||||||||+|++.+ ..+.-.|.|||+|.
T Consensus 109 ~v~ivlp~~~H~~f~~l~~~----l~~~~i~~Yl~~ll~Al~~~h---~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~ 181 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYRS----LSLAEIRWYLRNLLKALAHLH---KNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQ 181 (418)
T ss_pred eeEEEecccCccCHHHHHhc----CCHHHHHHHHHHHHHHhhhhh---ccCccccCCCccccccccccCCceEEechhHH
Confidence 99999999999999888764 678889999999999999999 99999999999999998 56788999999997
Q ss_pred cccCCC------------------------------------------CccccccccccccccCccccC-CCCCCccchH
Q 001544 918 LLIGED------------------------------------------QSMTQTQTLATLGYMAPEYGR-EGRVSTKGDV 954 (1057)
Q Consensus 918 ~~~~~~------------------------------------------~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~Dv 954 (1057)
.+.... .....-...||+||+|||++. .+..+.++||
T Consensus 182 ~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDi 261 (418)
T KOG1167|consen 182 RYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDI 261 (418)
T ss_pred HHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccce
Confidence 321100 000011235899999999765 4667899999
Q ss_pred HHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhh---hc---------------------c----ccc-cc
Q 001544 955 YSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKII---DA---------------------N----LLI-TE 1005 (1057)
Q Consensus 955 ~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~---------------------~----~~~-~~ 1005 (1057)
||.||+++-+++++.||-....+-..+.+.+..+.+..+.+.- +. . ... ..
T Consensus 262 ws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q 341 (418)
T KOG1167|consen 262 WSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQ 341 (418)
T ss_pred eeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccc
Confidence 9999999999999999866544444444443333222222110 00 0 000 00
Q ss_pred --chhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHH
Q 001544 1006 --DKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRL 1044 (1057)
Q Consensus 1006 --~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L 1044 (1057)
..........+..+.+++.+|++.+|.+|.|++|+++|-
T Consensus 342 ~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHp 382 (418)
T KOG1167|consen 342 PNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHP 382 (418)
T ss_pred cceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCc
Confidence 001111122345789999999999999999999999874
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.4e-29 Score=258.21 Aligned_cols=409 Identities=26% Similarity=0.261 Sum_probs=289.8
Q ss_pred EEEccCCCCcCCccccccCcCCCcEEeeeccccccccCccccccccccEEEeecCccccccCccccccccccEEEecC-C
Q 001544 245 ILDLSFNDLWGDIPKEIGNLTKLKELFLDFNILQGEIPHTVGNLHNLEYLSLVNNELVGTVPATIFNVSTLKLIELSN-N 323 (1057)
Q Consensus 245 ~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~-N 323 (1057)
..|-++-.++ .+|..+. +.-.+++|..|+|+...|.+|+.+++|+.||||+|.|+.+.|.+|.++.+|..|.+-+ |
T Consensus 50 ~VdCr~~GL~-eVP~~LP--~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~N 126 (498)
T KOG4237|consen 50 IVDCRGKGLT-EVPANLP--PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNN 126 (498)
T ss_pred eEEccCCCcc-cCcccCC--CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCC
Confidence 4555666665 5665554 4667889999999987788899999999999999999999999999998888776655 8
Q ss_pred ccccCCCCCcccCCCCCceEEecCccccccCCccccccccccccccccccccccccchhcccccccEEeccCcccCCC-c
Q 001544 324 TFFGSLPSSTDVQLPNLEELYLWGNNFSGTLPSFIFNASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNYLTSP-E 402 (1057)
Q Consensus 324 ~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-~ 402 (1057)
+|+ .+|...|.++..|+.|.+.-|++.-...+.|..+++|..|.+.+|.+..+.-.+|..+.+++.+++..|.+... .
T Consensus 127 kI~-~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCn 205 (498)
T KOG4237|consen 127 KIT-DLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCN 205 (498)
T ss_pred chh-hhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccc
Confidence 886 88999999999999999999999988888899999999999999999876556899999999999999884321 0
Q ss_pred ccc--------ccccCCCcchhhhhccCCCcccccccccccccccccEEEcCCCccccccc-ccccCccCCcEEEccCCc
Q 001544 403 LSF--------LSSLSNCKYLEIIALSGNPLNGIIPMSAGNLSHSLEELFMPDCNVSGRIP-KEIGNLANLVTLDLGGNK 473 (1057)
Q Consensus 403 ~~~--------~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~l~~n~~~~~~p-~~~~~l~~L~~L~Ls~N~ 473 (1057)
..+ ...+....-..-..+.++.+..+.+..+.....++..-..+.+...+..| ..|..+++|+.|+|++|+
T Consensus 206 L~wla~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~ 285 (498)
T KOG4237|consen 206 LPWLADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNK 285 (498)
T ss_pred cchhhhHHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCc
Confidence 000 00111112222223333444333333332222222222334444444444 568899999999999999
Q ss_pred CCCCCCcccccccccceeecccccCcccCCcccccccccceEEecCeeeeecCCccccCcccccccccCCcccccccc--
Q 001544 474 FNGSIPIALGKLQKLQLLNLDDNKLEGSIPDDICGLVELYKLALGDNKLSGQIPACFGNLASLRELWLGPNELISFIP-- 551 (1057)
Q Consensus 474 i~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-- 551 (1057)
|+++-+.+|.++..++.|+|..|+|..+....|.++..|+.|+|++|+|+...|.+|..+.+|.+|.|-.|.+.---.
T Consensus 286 i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~ 365 (498)
T KOG4237|consen 286 ITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLA 365 (498)
T ss_pred cchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccchH
Confidence 999999999999999999999999998888999999999999999999999999999999999999998886532100
Q ss_pred ---ccc-----------cccccccEEEeccccccCC---Cchhhc---------cccccce-eccccccccccccccccC
Q 001544 552 ---STF-----------WNIKDIMYVNFSSNFLTGP---LPLEIE---------NLKALTT-LDFSMNNLSGVIPTTIGG 604 (1057)
Q Consensus 552 ---~~~-----------~~l~~L~~L~Ls~N~l~~~---~p~~~~---------~l~~L~~-L~Ls~N~l~~~~p~~~~~ 604 (1057)
+|+ ..-..++.+.++.+.+... .|++.. ..+-+.+ ...|++.++ .+|..+.
T Consensus 366 wl~~Wlr~~~~~~~~~Cq~p~~~~~~~~~dv~~~~~~c~~~ee~~~~~s~~cP~~c~c~~tVvRcSnk~lk-~lp~~iP- 443 (498)
T KOG4237|consen 366 WLGEWLRKKSVVGNPRCQSPGFVRQIPISDVAFGDFRCGGPEELGCLTSSPCPPPCTCLDTVVRCSNKLLK-LLPRGIP- 443 (498)
T ss_pred HHHHHHhhCCCCCCCCCCCCchhccccchhccccccccCCccccCCCCCCCCCCCcchhhhhHhhcccchh-hcCCCCC-
Confidence 000 0112233444444433311 111111 1122222 233444443 4554443
Q ss_pred ccccceecccccccccccCccccccCccceecccCccccCCCcccccCcccccccccCCC
Q 001544 605 LKGLQYLFLGHNRLQGSIPDSVGDLISLKSLNLSNNNLSGPIPTSLEKLSDLKELNLSFN 664 (1057)
Q Consensus 605 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N 664 (1057)
..-..|++.+|.++ .+|++ .+.+| .+|||+|+++..--..|.+++.|.+|-||+|
T Consensus 444 -~d~telyl~gn~~~-~vp~~--~~~~l-~~dls~n~i~~Lsn~tf~n~tql~tlilsyn 498 (498)
T KOG4237|consen 444 -VDVTELYLDGNAIT-SVPDE--LLRSL-LLDLSNNRISSLSNYTFSNMTQLSTLILSYN 498 (498)
T ss_pred -chhHHHhcccchhc-ccCHH--HHhhh-hcccccCceehhhcccccchhhhheeEEecC
Confidence 45667888999988 77776 66778 8899999988666677888888888888876
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-25 Score=237.01 Aligned_cols=199 Identities=29% Similarity=0.434 Sum_probs=172.8
Q ss_pred CCCCceeccccCeEEEEEEecC-CcEEEEEEeeccchh-HHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEEcc
Q 001544 771 FSENNLIGRGSFGSVYIARLQN-GIEVAVKTFDLQHER-AFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEYMR 848 (1057)
Q Consensus 771 ~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 848 (1057)
|+..+.||+|++|.||+|...+ ++.+|+|.+...... ..+.+.+|++.+++++|+|++++++++...+..++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4567899999999999998764 899999999765544 56889999999999999999999999998899999999999
Q ss_pred CCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCcccc
Q 001544 849 NGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQ 928 (1057)
Q Consensus 849 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 928 (1057)
+++|.+++......+++..+..++.++++++.||| +.+++|+|++|.||+++.++.++++|||.+........ ...
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-~~~ 156 (225)
T smart00221 81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLH---SLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA-ALL 156 (225)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-ccc
Confidence 99999998775543789999999999999999999 88999999999999999999999999999987643221 122
Q ss_pred ccccccccccCcccc-CCCCCCccchHHHHHHHHHHHhhCCCCCCc
Q 001544 929 TQTLATLGYMAPEYG-REGRVSTKGDVYSFGILLMETFTRRKPTDE 973 (1057)
Q Consensus 929 ~~~~~t~~y~aPE~~-~~~~~~~~~Dv~s~G~il~elltg~~p~~~ 973 (1057)
....++..|++||.. ....++.++|||++|++++||++|+.||..
T Consensus 157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 157 KTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 334567789999988 666778899999999999999999999854
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.1e-28 Score=252.23 Aligned_cols=417 Identities=21% Similarity=0.248 Sum_probs=289.8
Q ss_pred EeeecccCcccccccccCCCCCcEEeCCCCCccccCCcccccccccceeecccccccCCCCccccccCCCCeEeccC-CC
Q 001544 76 LNISYLSLTGNIPRQLGNLSSLEILDLNFNRLSGEIPWELGNLAKLEKLLLHNNFLTGTIPFSIFKLSSLLDLKLSD-NN 154 (1057)
Q Consensus 76 l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~-n~ 154 (1057)
++-++-+|+ .+|..+- +.-.+++|..|+|+...|..|+.+++|++||||+|+|+.+-|.+|.++.+|..|-+-+ |+
T Consensus 51 VdCr~~GL~-eVP~~LP--~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~Nk 127 (498)
T KOG4237|consen 51 VDCRGKGLT-EVPANLP--PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNK 127 (498)
T ss_pred EEccCCCcc-cCcccCC--CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCc
Confidence 345555666 5555432 3457899999999977777899999999999999999999999999999988876655 89
Q ss_pred CCCCCCcccccCCCCCceeEccCCcccccCchhhhccccCCeeEeeccCCccccCccccCCCCcccEEEeeccccc----
Q 001544 155 LTGTIPSHNLGNLSSLQLLDLSDNQLSGSIPSFIFKISSLQALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFY---- 230 (1057)
Q Consensus 155 l~~~~p~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~l~~n~~~---- 230 (1057)
|+ .+|...|++|..|+.|.+.-|++.-...++|..+++|..|.+.+|.+. .+++..+..+..++.+.+..|.+.
T Consensus 128 I~-~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q-~i~~~tf~~l~~i~tlhlA~np~icdCn 205 (498)
T KOG4237|consen 128 IT-DLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQ-SICKGTFQGLAAIKTLHLAQNPFICDCN 205 (498)
T ss_pred hh-hhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhh-hhccccccchhccchHhhhcCccccccc
Confidence 98 889999999999999999999999888899999999999999999997 788878888888999988888732
Q ss_pred --------cCccccccCCCCCcEEEccCCCCcCCccccccC-cCCCcEEeeeccccccccC-ccccccccccEEEeecCc
Q 001544 231 --------GGISSTLSNCKHLRILDLSFNDLWGDIPKEIGN-LTKLKELFLDFNILQGEIP-HTVGNLHNLEYLSLVNNE 300 (1057)
Q Consensus 231 --------~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~-l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~ 300 (1057)
...+..++..+...-..+.++++...-+..|.. +..+..=..+.+..-+..| ..|.+|++|+.|+|++|+
T Consensus 206 L~wla~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~ 285 (498)
T KOG4237|consen 206 LPWLADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNK 285 (498)
T ss_pred cchhhhHHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCc
Confidence 234455566666666666666665443433332 1222222223333333444 468899999999999999
Q ss_pred cccccCccccccccccEEEecCCccccCCCCCcccCCCCCceEEecCccccccCCcccccccccccccccccccccc---
Q 001544 301 LVGTVPATIFNVSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSGTLPSFIFNASNLSKLSLGDNSFSGL--- 377 (1057)
Q Consensus 301 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~--- 377 (1057)
|+++-+.+|.++..+++|.|..|++. .+....|.++.+|+.|+|.+|+|+..-|.+|..+..|.+|+|-.|.+.--
T Consensus 286 i~~i~~~aFe~~a~l~eL~L~~N~l~-~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l 364 (498)
T KOG4237|consen 286 ITRIEDGAFEGAAELQELYLTRNKLE-FVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRL 364 (498)
T ss_pred cchhhhhhhcchhhhhhhhcCcchHH-HHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccch
Confidence 99988999999999999999999986 67777888899999999999999988899998899999999887766421
Q ss_pred --ccchhcc-----------cccccEEeccCcccCCCccccccccCCCcchhhhhccCCCcccccccccccccccccEEE
Q 001544 378 --IPNTFGN-----------LRNLKRLRLYNNYLTSPELSFLSSLSNCKYLEIIALSGNPLNGIIPMSAGNLSHSLEELF 444 (1057)
Q Consensus 378 --~~~~~~~-----------l~~L~~L~L~~N~l~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~ 444 (1057)
..+++.+ -..++.+.++.+.+.+.......... +.-.+.-|..- +-+....
T Consensus 365 ~wl~~Wlr~~~~~~~~~Cq~p~~~~~~~~~dv~~~~~~c~~~ee~~------------~~~s~~cP~~c----~c~~tVv 428 (498)
T KOG4237|consen 365 AWLGEWLRKKSVVGNPRCQSPGFVRQIPISDVAFGDFRCGGPEELG------------CLTSSPCPPPC----TCLDTVV 428 (498)
T ss_pred HHHHHHHhhCCCCCCCCCCCCchhccccchhccccccccCCccccC------------CCCCCCCCCCc----chhhhhH
Confidence 1112111 11233333433333322111000000 00000000000 0111111
Q ss_pred cCCCcccccccccccCccCCcEEEccCCcCCCCCCcccccccccceeecccccCcccCCcccccccccceEEecCe
Q 001544 445 MPDCNVSGRIPKEIGNLANLVTLDLGGNKFNGSIPIALGKLQKLQLLNLDDNKLEGSIPDDICGLVELYKLALGDN 520 (1057)
Q Consensus 445 l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 520 (1057)
=-.|.....+|..+. ...++|++.+|.++ .+|.. .+..| .+++++|++.......|.++++|.+|-|++|
T Consensus 429 RcSnk~lk~lp~~iP--~d~telyl~gn~~~-~vp~~--~~~~l-~~dls~n~i~~Lsn~tf~n~tql~tlilsyn 498 (498)
T KOG4237|consen 429 RCSNKLLKLLPRGIP--VDVTELYLDGNAIT-SVPDE--LLRSL-LLDLSNNRISSLSNYTFSNMTQLSTLILSYN 498 (498)
T ss_pred hhcccchhhcCCCCC--chhHHHhcccchhc-ccCHH--HHhhh-hcccccCceehhhcccccchhhhheeEEecC
Confidence 111222223444332 35677888888888 56666 56677 8889999888777788888999988888876
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.4e-26 Score=245.95 Aligned_cols=198 Identities=25% Similarity=0.287 Sum_probs=166.6
Q ss_pred HhCCCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccchhHHHHHHHHHHHHHhcCC------CCceeEeeeeccCCe
Q 001544 767 ATNGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQHERAFKSFDTECEVMKSIRH------RNLTKIISSCSNEDF 839 (1057)
Q Consensus 767 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~l~~~~~~~~~ 839 (1057)
.-.+|.+....|+|-|++|.+|... .|..||||++..... ..+.=.+|+++|+++.. -|+++++-.|....+
T Consensus 430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~-M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknH 508 (752)
T KOG0670|consen 430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV-MHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNH 508 (752)
T ss_pred hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH-HhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcce
Confidence 4568888889999999999999865 488999999975532 23444679999999952 488999999999999
Q ss_pred eEEEEEEccCCChhHHHhcCC--ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCC-CcEEEEccccc
Q 001544 840 KALILEYMRNGSLEKCLYSGN--YILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDN-MVAHLSDFGIA 916 (1057)
Q Consensus 840 ~~lV~E~~~~gsL~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~-~~~kl~Dfg~a 916 (1057)
.|+|||-+.- +|.+++.+-+ .-+....+..++.|+.-||..|- ..+|+|.||||.|||+++. ..+||||||.|
T Consensus 509 LClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK---~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA 584 (752)
T KOG0670|consen 509 LCLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLK---KCGVLHADIKPDNILVNESKNILKLCDFGSA 584 (752)
T ss_pred eEEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHH---hcCeeecccCccceEeccCcceeeeccCccc
Confidence 9999998854 8999887654 34778889999999999999999 9999999999999999865 57899999999
Q ss_pred ccccCCCCccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCc
Q 001544 917 KLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDE 973 (1057)
Q Consensus 917 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~ 973 (1057)
..... ...+.+..+..|.|||++.+-.|+...|+||.||++||+.||+.-|.+
T Consensus 585 ~~~~e----neitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG 637 (752)
T KOG0670|consen 585 SFASE----NEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPG 637 (752)
T ss_pred ccccc----ccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCC
Confidence 86522 233445556789999999999999999999999999999999987754
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3e-26 Score=226.80 Aligned_cols=250 Identities=18% Similarity=0.266 Sum_probs=184.7
Q ss_pred CCCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccchhHHHHHHHHHHHHHhc-CCCCceeEee-eeccCCeeEEEEE
Q 001544 769 NGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQHERAFKSFDTECEVMKSI-RHRNLTKIIS-SCSNEDFKALILE 845 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~-~~~~~~~~~lV~E 845 (1057)
+.|.+.+.+|+|.||.+-.+..+ +.+.+++|.+..... ..++|.+|...--.+ .|.||+.-++ .|+..+.+++++|
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t-t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE 102 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT-TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE 102 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh-hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence 46888899999999999999754 678899999865433 358899998876666 5999998776 4677888899999
Q ss_pred EccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeC--CCCcEEEEcccccccccCCC
Q 001544 846 YMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLD--DNMVAHLSDFGIAKLLIGED 923 (1057)
Q Consensus 846 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~--~~~~~kl~Dfg~a~~~~~~~ 923 (1057)
|++.|+|..-+...+ +.+....+++.|++.|+.||| ++.+||||||.+|||+- +...+|+||||..+....
T Consensus 103 ~aP~gdL~snv~~~G--igE~~~K~v~~ql~SAi~fMH---sknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~-- 175 (378)
T KOG1345|consen 103 FAPRGDLRSNVEAAG--IGEANTKKVFAQLLSAIEFMH---SKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT-- 175 (378)
T ss_pred cCccchhhhhcCccc--ccHHHHHHHHHHHHHHHHHhh---ccchhhcccccceEEEecCCccEEEeeecccccccCc--
Confidence 999999998876654 778888999999999999999 99999999999999984 345899999999875421
Q ss_pred CccccccccccccccCccccCCC-----CCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhh
Q 001544 924 QSMTQTQTLATLGYMAPEYGREG-----RVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIID 998 (1057)
Q Consensus 924 ~~~~~~~~~~t~~y~aPE~~~~~-----~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 998 (1057)
.......+..|.|||..... ...+.+|+|.||+++|.++||+.||......+..+..|..-. .
T Consensus 176 ---tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~---------~ 243 (378)
T KOG1345|consen 176 ---TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWL---------K 243 (378)
T ss_pred ---eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHh---------c
Confidence 11122245579999965432 246789999999999999999999986443333333332211 1
Q ss_pred cccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHH
Q 001544 999 ANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVR 1042 (1057)
Q Consensus 999 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 1042 (1057)
+.... ....-...++.+..+.++-+.++|++|=...++.+
T Consensus 244 rk~~~----~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk 283 (378)
T KOG1345|consen 244 RKNPA----LPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKK 283 (378)
T ss_pred ccCcc----CchhhcccCHHHHHHHHHhcCCcccccchhHHHHH
Confidence 11000 00111234566778889999999999944444433
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.8e-24 Score=215.89 Aligned_cols=170 Identities=22% Similarity=0.217 Sum_probs=130.2
Q ss_pred CChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCccccc
Q 001544 850 GSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQT 929 (1057)
Q Consensus 850 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 929 (1057)
|+|.+++...+..+++.+++.|+.|+++||+||| +.+ ||+||+++.++.+|+ ||.++.....
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~------- 62 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELH---RQA------KSGNILLTWDGLLKL--DGSVAFKTPE------- 62 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---hcC------CcccEeEcCccceee--ccceEeeccc-------
Confidence 6899999876667999999999999999999999 665 999999999999999 9998865321
Q ss_pred cccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhcccccccchhh
Q 001544 930 QTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHF 1009 (1057)
Q Consensus 930 ~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1057)
...||+.|+|||++.+..++.++|||||||++|||++|+.||............+.... .......+
T Consensus 63 ~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~------------~~~~~~~~- 129 (176)
T smart00750 63 QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGM------------PADDPRDR- 129 (176)
T ss_pred cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHh------------ccCCcccc-
Confidence 12578999999999999999999999999999999999999865322221122111110 00000000
Q ss_pred HHHHHHHH--HHHHHHhHcccCCCCCCCCHHHHHHHHHHhHHH
Q 001544 1010 AAKEQCAS--SVFNLAMECTVESPDERITAKEIVRRLLKIRDF 1050 (1057)
Q Consensus 1010 ~~~~~~~~--~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~ 1050 (1057)
........ ++.+++.+||..+|++||++.|+++++..+...
T Consensus 130 ~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~ 172 (176)
T smart00750 130 SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAE 172 (176)
T ss_pred ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHH
Confidence 11122233 689999999999999999999999999887654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.3e-24 Score=270.08 Aligned_cols=198 Identities=18% Similarity=0.243 Sum_probs=140.6
Q ss_pred hcCC-CCceeEeeee-------ccCCeeEEEEEEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEE
Q 001544 821 SIRH-RNLTKIISSC-------SNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIH 892 (1057)
Q Consensus 821 ~l~h-~niv~l~~~~-------~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH 892 (1057)
.++| +||++++++| .+.+..+.++||+ +++|.+++......+++.+++.++.||++||+||| +++|+|
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~gIvH 103 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAH---SQGIVV 103 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHH---hCCeee
Confidence 4445 5777788877 2234667889987 55999999876667999999999999999999999 999999
Q ss_pred ccCCCCCeeeCC-------------------CCcEEEEcccccccccCCCC--------------ccccccccccccccC
Q 001544 893 CDLKPSNVLLDD-------------------NMVAHLSDFGIAKLLIGEDQ--------------SMTQTQTLATLGYMA 939 (1057)
Q Consensus 893 ~Dlkp~Nill~~-------------------~~~~kl~Dfg~a~~~~~~~~--------------~~~~~~~~~t~~y~a 939 (1057)
|||||+|||++. ++.+|++|||+++....... ........||+.|||
T Consensus 104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 183 (793)
T PLN00181 104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS 183 (793)
T ss_pred ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence 999999999965 44556666666653211000 001112357888999
Q ss_pred ccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhcccccccchhhHHHHHHHHHH
Q 001544 940 PEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHFAAKEQCASSV 1019 (1057)
Q Consensus 940 PE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 1019 (1057)
||++.+..++.++|||||||++|||++|..|+..... ....+ . .... + +......++.
T Consensus 184 PE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~---~~~~~------------~-~~~~--~----~~~~~~~~~~ 241 (793)
T PLN00181 184 PEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR---TMSSL------------R-HRVL--P----PQILLNWPKE 241 (793)
T ss_pred hhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH---HHHHH------------H-Hhhc--C----hhhhhcCHHH
Confidence 9999999999999999999999999999887543100 00000 0 0000 0 0000112345
Q ss_pred HHHHhHcccCCCCCCCCHHHHHHHH
Q 001544 1020 FNLAMECTVESPDERITAKEIVRRL 1044 (1057)
Q Consensus 1020 ~~li~~cl~~dP~~Rps~~evl~~L 1044 (1057)
.+++.+||+++|.+||++.|+++|-
T Consensus 242 ~~~~~~~L~~~P~~Rps~~eil~h~ 266 (793)
T PLN00181 242 ASFCLWLLHPEPSCRPSMSELLQSE 266 (793)
T ss_pred HHHHHHhCCCChhhCcChHHHhhch
Confidence 6788999999999999999998763
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.89 E-value=1e-22 Score=262.63 Aligned_cols=125 Identities=19% Similarity=0.273 Sum_probs=63.3
Q ss_pred cccceEEecCeeeeecCCccccCcccccccccCCccccccccccccccccccEEEeccccccCCCchhhccccccceecc
Q 001544 510 VELYKLALGDNKLSGQIPACFGNLASLRELWLGPNELISFIPSTFWNIKDIMYVNFSSNFLTGPLPLEIENLKALTTLDF 589 (1057)
Q Consensus 510 ~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 589 (1057)
++|+.|++++|...+.+|..++++++|+.|++++|...+..|... ++++|+.|++++|.....+|.. ..+|+.|+|
T Consensus 778 ~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~L 853 (1153)
T PLN03210 778 PSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNL 853 (1153)
T ss_pred ccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeEC
Confidence 345555555554444455555555555555555443222222222 3445555555554332223321 245566666
Q ss_pred ccccccccccccccCccccceeccccc-ccccccCccccccCccceecccCc
Q 001544 590 SMNNLSGVIPTTIGGLKGLQYLFLGHN-RLQGSIPDSVGDLISLKSLNLSNN 640 (1057)
Q Consensus 590 s~N~l~~~~p~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~N 640 (1057)
++|.++ .+|..+..+++|+.|+|++| ++. .+|..+..+++|+.|++++|
T Consensus 854 s~n~i~-~iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~~L~~L~l~~C 903 (1153)
T PLN03210 854 SRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLKHLETVDFSDC 903 (1153)
T ss_pred CCCCCc-cChHHHhcCCCCCEEECCCCCCcC-ccCcccccccCCCeeecCCC
Confidence 666665 45556666666666666653 343 45555566666666666655
|
syringae 6; Provisional |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.5e-22 Score=223.76 Aligned_cols=166 Identities=20% Similarity=0.209 Sum_probs=130.3
Q ss_pred HHhCCCCCCceeccccCeEEEEEEec--CCcEEEEEEeecc-----chhHHHHHHHHHHHHHhcCCCCcee-EeeeeccC
Q 001544 766 QATNGFSENNLIGRGSFGSVYIARLQ--NGIEVAVKTFDLQ-----HERAFKSFDTECEVMKSIRHRNLTK-IISSCSNE 837 (1057)
Q Consensus 766 ~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~-l~~~~~~~ 837 (1057)
....+|+..+.||+|+||+||+|... +++.||||++... .....+.+.+|++++++++|+|++. ++++
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---- 90 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---- 90 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----
Confidence 35678999999999999999999764 5788899987532 2234567999999999999999985 4432
Q ss_pred CeeEEEEEEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccC-CCCCeeeCCCCcEEEEccccc
Q 001544 838 DFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDL-KPSNVLLDDNMVAHLSDFGIA 916 (1057)
Q Consensus 838 ~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dl-kp~Nill~~~~~~kl~Dfg~a 916 (1057)
+..|+||||++|++|.. .... . ...++.|+++||+||| +++|+|||| ||+||+++.++.+||+|||+|
T Consensus 91 ~~~~LVmE~~~G~~L~~-~~~~----~---~~~~~~~i~~aL~~lH---~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA 159 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHL-ARPH----G---DPAWFRSAHRALRDLH---RAGITHNDLAKPQNWLMGPDGEAAVIDFQLA 159 (365)
T ss_pred CCcEEEEEccCCCCHHH-hCcc----c---hHHHHHHHHHHHHHHH---HCCCeeCCCCCcceEEEcCCCCEEEEECccc
Confidence 45799999999999973 2111 1 2467899999999999 999999999 999999999999999999999
Q ss_pred ccccCCCCccc------cccccccccccCccccCCC
Q 001544 917 KLLIGEDQSMT------QTQTLATLGYMAPEYGREG 946 (1057)
Q Consensus 917 ~~~~~~~~~~~------~~~~~~t~~y~aPE~~~~~ 946 (1057)
+.+........ .....+++.|+|||++...
T Consensus 160 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 160 SVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred eecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 97654332111 1344678889999987643
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.3e-22 Score=254.15 Aligned_cols=293 Identities=24% Similarity=0.316 Sum_probs=162.5
Q ss_pred CCCCcEEEccCCCCcCCccccccCcCCCcEEeeeccccccccCccccccccccEEEeecCccccccCccccccccccEEE
Q 001544 240 CKHLRILDLSFNDLWGDIPKEIGNLTKLKELFLDFNILQGEIPHTVGNLHNLEYLSLVNNELVGTVPATIFNVSTLKLIE 319 (1057)
Q Consensus 240 l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 319 (1057)
..+|+.|+|++|++. .++..+..+++|+.|+|++|...+.+|. ++.+++|++|+|++|.....+|..+.++++|+.|+
T Consensus 610 ~~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~ 687 (1153)
T PLN03210 610 PENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLD 687 (1153)
T ss_pred ccCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEe
Confidence 466777777777765 4566666777777777776654445553 66677777777777765556777777777777777
Q ss_pred ecCCccccCCCCCcccCCCCCceEEecCccccccCCccccccccccccccccccccccccchhcccccccEEeccCcccC
Q 001544 320 LSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSGTLPSFIFNASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNYLT 399 (1057)
Q Consensus 320 Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 399 (1057)
+++|...+.+|... .+++|+.|++++|.....+|.. ..+|+.|++++|.+... |..+ .+++|++|++.++...
T Consensus 688 L~~c~~L~~Lp~~i--~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~~l-P~~~-~l~~L~~L~l~~~~~~ 760 (1153)
T PLN03210 688 MSRCENLEILPTGI--NLKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIEEF-PSNL-RLENLDELILCEMKSE 760 (1153)
T ss_pred CCCCCCcCccCCcC--CCCCCCEEeCCCCCCccccccc---cCCcCeeecCCCccccc-cccc-cccccccccccccchh
Confidence 77765545666544 4667777777777554444432 34566677777766543 3333 4556666666543321
Q ss_pred CCccccccccCCCcchhhhhccCCCcccccccccccccccccEEEcCCCcccccccccccCccCCcEEEccCCcCCCCCC
Q 001544 400 SPELSFLSSLSNCKYLEIIALSGNPLNGIIPMSAGNLSHSLEELFMPDCNVSGRIPKEIGNLANLVTLDLGGNKFNGSIP 479 (1057)
Q Consensus 400 ~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p 479 (1057)
.... .+... +......+++|+.|++++|...+.+|.+++++++|+.|+|++|..-+.+|
T Consensus 761 ~l~~--------------------~~~~l-~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP 819 (1153)
T PLN03210 761 KLWE--------------------RVQPL-TPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLP 819 (1153)
T ss_pred hccc--------------------ccccc-chhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeC
Confidence 1100 00000 00111123456666666665555566666666666666666653333455
Q ss_pred cccccccccceeecccccCcccCCcccccccccceEEecCeeeeecCCccccCcccccccccCCcccccccccccccccc
Q 001544 480 IALGKLQKLQLLNLDDNKLEGSIPDDICGLVELYKLALGDNKLSGQIPACFGNLASLRELWLGPNELISFIPSTFWNIKD 559 (1057)
Q Consensus 480 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 559 (1057)
..+ ++++|+.|+|++|.....+|.. ..+|+.|+|++|.|+ .+|.++..+ ++
T Consensus 820 ~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~i~-~iP~si~~l------------------------~~ 870 (1153)
T PLN03210 820 TGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLSRTGIE-EVPWWIEKF------------------------SN 870 (1153)
T ss_pred CCC-CccccCEEECCCCCcccccccc---ccccCEeECCCCCCc-cChHHHhcC------------------------CC
Confidence 444 4556666666655433233322 134444555555544 334444444 44
Q ss_pred ccEEEeccc-cccCCCchhhccccccceeccccc
Q 001544 560 IMYVNFSSN-FLTGPLPLEIENLKALTTLDFSMN 592 (1057)
Q Consensus 560 L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~N 592 (1057)
|++|++++| +++. +|..+..++.|+.+++++|
T Consensus 871 L~~L~L~~C~~L~~-l~~~~~~L~~L~~L~l~~C 903 (1153)
T PLN03210 871 LSFLDMNGCNNLQR-VSLNISKLKHLETVDFSDC 903 (1153)
T ss_pred CCEEECCCCCCcCc-cCcccccccCCCeeecCCC
Confidence 445555542 3332 4444555666666666666
|
syringae 6; Provisional |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.2e-23 Score=207.90 Aligned_cols=248 Identities=23% Similarity=0.346 Sum_probs=191.8
Q ss_pred CCceeccccCeEEEEEEecCCcEEEEEEeeccc--hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEEccCC
Q 001544 773 ENNLIGRGSFGSVYIARLQNGIEVAVKTFDLQH--ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEYMRNG 850 (1057)
Q Consensus 773 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g 850 (1057)
...+|.+...|..|+|+++ |..+++|++.... .....+|.+|.-.++-..||||..++|.|....+..++..||+.|
T Consensus 194 l~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~g 272 (448)
T KOG0195|consen 194 LITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFG 272 (448)
T ss_pred hhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccch
Confidence 3456889999999999998 6778888875443 234468999999999999999999999999999999999999999
Q ss_pred ChhHHHhcCC-ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCccccc
Q 001544 851 SLEKCLYSGN-YILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQT 929 (1057)
Q Consensus 851 sL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 929 (1057)
+|...++++. ...+..++.+++.++|+|++|||. .++-|.---+.+..|++|++.+++|+- +-+++ +.+..
T Consensus 273 slynvlhe~t~vvvd~sqav~faldiargmaflhs-lep~ipr~~lns~hvmidedltarism-ad~kf------sfqe~ 344 (448)
T KOG0195|consen 273 SLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHS-LEPMIPRFYLNSKHVMIDEDLTARISM-ADTKF------SFQEV 344 (448)
T ss_pred HHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhh-cchhhhhhhcccceEEecchhhhheec-cccee------eeecc
Confidence 9999999876 457888999999999999999993 233344446889999999999888752 11111 12223
Q ss_pred cccccccccCccccCCCCC---CccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhcccccccc
Q 001544 930 QTLATLGYMAPEYGREGRV---STKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITED 1006 (1057)
Q Consensus 930 ~~~~t~~y~aPE~~~~~~~---~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1006 (1057)
...-.+.||+||.+....- -.++|+|||++++||+.|...||.+...-+-.. ++. .++
T Consensus 345 gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgm-------------kia------leg 405 (448)
T KOG0195|consen 345 GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGM-------------KIA------LEG 405 (448)
T ss_pred ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhh-------------hhh------hcc
Confidence 3445688999998876543 357899999999999999999998743322111 111 112
Q ss_pred hhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHHHhH
Q 001544 1007 KHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKIR 1048 (1057)
Q Consensus 1007 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~ 1048 (1057)
.+...++..++.+.+++.-|+..||.+||.+..++-.|+++.
T Consensus 406 lrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 406 LRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred ccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 233344556778899999999999999999999999998864
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=4e-22 Score=194.43 Aligned_cols=264 Identities=20% Similarity=0.210 Sum_probs=203.8
Q ss_pred HhCCCCCCceeccccCeEEEEEE-ecCCcEEEEEEeeccchhHHHHHHHHHHHHHhcCC-CCceeEeeeeccCCeeEEEE
Q 001544 767 ATNGFSENNLIGRGSFGSVYIAR-LQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRH-RNLTKIISSCSNEDFKALIL 844 (1057)
Q Consensus 767 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lV~ 844 (1057)
....|..+++||+|+||.+|.|. ..+|..||||+-+..... .++..|.++.+.+++ ..|..+.-|..+.+.-.+||
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h--pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH--PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC--cchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 34679999999999999999996 678999999987544322 456678899999974 78888888999999999999
Q ss_pred EEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeC---CCCcEEEEcccccccccC
Q 001544 845 EYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLD---DNMVAHLSDFGIAKLLIG 921 (1057)
Q Consensus 845 E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~---~~~~~kl~Dfg~a~~~~~ 921 (1057)
|.+ |.+|++.+.-....++.++++-.+-|++.-++|+| .++++||||||+|+|.. ....+.++|||+|+.+..
T Consensus 91 dLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH---~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d 166 (341)
T KOG1163|consen 91 DLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVH---LRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRD 166 (341)
T ss_pred ecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHH---hhccccccCCccceeeccccccceEEEEeccchhhhcc
Confidence 988 77999998877778999999999999999999999 99999999999999996 345789999999988754
Q ss_pred CCC-----ccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHh
Q 001544 922 EDQ-----SMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKI 996 (1057)
Q Consensus 922 ~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 996 (1057)
... ........||.+|.+-....+.+.+.+.|+-|+|.++.++--|..||.+........ .-.++
T Consensus 167 ~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~Q----------KyEkI 236 (341)
T KOG1163|consen 167 IRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQ----------KYEKI 236 (341)
T ss_pred ccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHH----------HHHHH
Confidence 322 222334578999999888877888899999999999999999999998743221100 01111
Q ss_pred hhcccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHHHhHH
Q 001544 997 IDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKIRD 1049 (1057)
Q Consensus 997 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~ 1049 (1057)
.+.... .. .....+..|.++.-.+..|=..--++-|...-+-+.++-+.+
T Consensus 237 ~EkK~s-~~--ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr 286 (341)
T KOG1163|consen 237 SEKKMS-TP--IEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFR 286 (341)
T ss_pred HHhhcC-CC--HHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHh
Confidence 111111 00 112234567888889999988888888988777666655544
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.6e-21 Score=217.62 Aligned_cols=261 Identities=21% Similarity=0.237 Sum_probs=197.2
Q ss_pred CCCCCceeccccCeEEEEEEecCC--cEEEEEEeeccchhHHHHHHHHHHHHHhcCC----CCceeEeeee-ccCCeeEE
Q 001544 770 GFSENNLIGRGSFGSVYIARLQNG--IEVAVKTFDLQHERAFKSFDTECEVMKSIRH----RNLTKIISSC-SNEDFKAL 842 (1057)
Q Consensus 770 ~~~~~~~lg~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~l~~~~-~~~~~~~l 842 (1057)
+|.+.++||+|+||.||.|...+. ..+|+|............+..|+.++..+.. +++..+++.. ..++..++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 799999999999999999986643 5799998765433322367789999988863 6899999998 57888999
Q ss_pred EEEEccCCChhHHHhcCC-ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCC-----CcEEEEccccc
Q 001544 843 ILEYMRNGSLEKCLYSGN-YILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDN-----MVAHLSDFGIA 916 (1057)
Q Consensus 843 V~E~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~-----~~~kl~Dfg~a 916 (1057)
||+.+ |.+|.++..... ..++..++..|+.|++.+|.++| +.|++||||||.|+.+... ..+.+.|||++
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH---~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLH---SKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHH---hcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99977 779999775444 67999999999999999999999 9999999999999999854 46999999999
Q ss_pred c--cccCCCCc--c---c-cccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhc
Q 001544 917 K--LLIGEDQS--M---T-QTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDF 988 (1057)
Q Consensus 917 ~--~~~~~~~~--~---~-~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~ 988 (1057)
+ .+...... . . .....||..|+++....+...+.+.|+||++.++.|+..|..||........ ...
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~-~~~----- 248 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL-KSK----- 248 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch-HHH-----
Confidence 8 33222211 1 1 2234599999999999999999999999999999999999999865332211 000
Q ss_pred cchhHHHhhhcccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHHHhHHH
Q 001544 989 LPISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKIRDF 1050 (1057)
Q Consensus 989 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~~ 1050 (1057)
..+......... .....+.++.++...+-..+..++|....+...+++....
T Consensus 249 ----~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~ 300 (322)
T KOG1164|consen 249 ----FEKDPRKLLTDR------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS 300 (322)
T ss_pred ----HHHHhhhhcccc------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence 000000000000 1122345677777777779999999999999998776554
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.9e-22 Score=237.51 Aligned_cols=256 Identities=32% Similarity=0.386 Sum_probs=161.9
Q ss_pred EEeeecccCcccccccccCCCCCcEEeCCCCCccccCCcccccccccceeecccccccCCCCccccccCCCCeEeccCCC
Q 001544 75 ALNISYLSLTGNIPRQLGNLSSLEILDLNFNRLSGEIPWELGNLAKLEKLLLHNNFLTGTIPFSIFKLSSLLDLKLSDNN 154 (1057)
Q Consensus 75 ~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~ 154 (1057)
.|+++.++|+ .+|+.+. ++|+.|++++|+|+ .+|.. +++|++|+|++|+|+ .+|.. .++|++|+|++|.
T Consensus 205 ~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt-~LP~l---p~~Lk~LdLs~N~Lt-sLP~l---p~sL~~L~Ls~N~ 273 (788)
T PRK15387 205 VLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPAL---PPELRTLEVSGNQLT-SLPVL---PPGLLELSIFSNP 273 (788)
T ss_pred EEEcCCCCCC-cCCcchh--cCCCEEEccCCcCC-CCCCC---CCCCcEEEecCCccC-cccCc---ccccceeeccCCc
Confidence 4566666666 5666554 35666666666666 35532 356666666666666 34432 3456666666666
Q ss_pred CCCCCCcccccCCCCCceeEccCCcccccCchhhhccccCCeeEeeccCCccccCccccCCCCcccEEEeeccccccCcc
Q 001544 155 LTGTIPSHNLGNLSSLQLLDLSDNQLSGSIPSFIFKISSLQALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGGIS 234 (1057)
Q Consensus 155 l~~~~p~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~l~~n~~~~~~~ 234 (1057)
++ .+|. ..++|+.|+|++|+++ .+|.. +++|+.|+|++|++++ +|.
T Consensus 274 L~-~Lp~----lp~~L~~L~Ls~N~Lt-~LP~~---p~~L~~LdLS~N~L~~-Lp~------------------------ 319 (788)
T PRK15387 274 LT-HLPA----LPSGLCKLWIFGNQLT-SLPVL---PPGLQELSVSDNQLAS-LPA------------------------ 319 (788)
T ss_pred hh-hhhh----chhhcCEEECcCCccc-ccccc---ccccceeECCCCcccc-CCC------------------------
Confidence 65 3443 1245666666666665 33431 3456666666666652 332
Q ss_pred ccccCCCCCcEEEccCCCCcCCccccccCcCCCcEEeeeccccccccCccccccccccEEEeecCccccccCcccccccc
Q 001544 235 STLSNCKHLRILDLSFNDLWGDIPKEIGNLTKLKELFLDFNILQGEIPHTVGNLHNLEYLSLVNNELVGTVPATIFNVST 314 (1057)
Q Consensus 235 ~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 314 (1057)
. ..+|+.|++++|.+++ +|.. ..+|++|+|++|+|++ +|.. .++|+.|++++|+|+ .+|.. .++
T Consensus 320 -l---p~~L~~L~Ls~N~L~~-LP~l---p~~Lq~LdLS~N~Ls~-LP~l---p~~L~~L~Ls~N~L~-~LP~l---~~~ 383 (788)
T PRK15387 320 -L---PSELCKLWAYNNQLTS-LPTL---PSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLT-SLPAL---PSG 383 (788)
T ss_pred -C---cccccccccccCcccc-cccc---ccccceEecCCCccCC-CCCC---Ccccceehhhccccc-cCccc---ccc
Confidence 1 1346667777777753 4431 2467778888887773 4442 246777788888877 35543 346
Q ss_pred ccEEEecCCccccCCCCCcccCCCCCceEEecCccccccCCccccccccccccccccccccccccchhcccccccEEecc
Q 001544 315 LKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSGTLPSFIFNASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLY 394 (1057)
Q Consensus 315 L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 394 (1057)
|+.|++++|.++ .+|.. .++|+.|++++|++++ +|.. ..+|+.|++++|+|+. +|..+.++++|+.|+|+
T Consensus 384 L~~LdLs~N~Lt-~LP~l----~s~L~~LdLS~N~Lss-IP~l---~~~L~~L~Ls~NqLt~-LP~sl~~L~~L~~LdLs 453 (788)
T PRK15387 384 LKELIVSGNRLT-SLPVL----PSELKELMVSGNRLTS-LPML---PSGLLSLSVYRNQLTR-LPESLIHLSSETTVNLE 453 (788)
T ss_pred cceEEecCCccc-CCCCc----ccCCCEEEccCCcCCC-CCcc---hhhhhhhhhccCcccc-cChHHhhccCCCeEECC
Confidence 788888888876 35532 3578888888888874 5653 3467888899999884 57788888899999999
Q ss_pred CcccCCC
Q 001544 395 NNYLTSP 401 (1057)
Q Consensus 395 ~N~l~~~ 401 (1057)
+|+++..
T Consensus 454 ~N~Ls~~ 460 (788)
T PRK15387 454 GNPLSER 460 (788)
T ss_pred CCCCCch
Confidence 9988763
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.6e-22 Score=239.04 Aligned_cols=261 Identities=27% Similarity=0.383 Sum_probs=131.7
Q ss_pred ccEEEecCCccccCCCCCcccCCCCCceEEecCccccccCCccccccccccccccccccccccccchhcccccccEEecc
Q 001544 315 LKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSGTLPSFIFNASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLY 394 (1057)
Q Consensus 315 L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 394 (1057)
-..|+|++|.++ .+|..+. ++|+.|++++|+++. +|.. +++|++|++++|+|+.+ |.. .++|+.|+++
T Consensus 203 ~~~LdLs~~~Lt-sLP~~l~---~~L~~L~L~~N~Lt~-LP~l---p~~Lk~LdLs~N~LtsL-P~l---p~sL~~L~Ls 270 (788)
T PRK15387 203 NAVLNVGESGLT-TLPDCLP---AHITTLVIPDNNLTS-LPAL---PPELRTLEVSGNQLTSL-PVL---PPGLLELSIF 270 (788)
T ss_pred CcEEEcCCCCCC-cCCcchh---cCCCEEEccCCcCCC-CCCC---CCCCcEEEecCCccCcc-cCc---ccccceeecc
Confidence 456677777665 5665442 356666666666663 3432 34555555555555543 221 2345555555
Q ss_pred CcccCCCccccccccCCCcchhhhhccCCCcccccccccccccccccEEEcCCCcccccccccccCccCCcEEEccCCcC
Q 001544 395 NNYLTSPELSFLSSLSNCKYLEIIALSGNPLNGIIPMSAGNLSHSLEELFMPDCNVSGRIPKEIGNLANLVTLDLGGNKF 474 (1057)
Q Consensus 395 ~N~l~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~i 474 (1057)
+|.++.++. ++.+|+.|++++|+++. +|. .+++|+.|+|++|+|
T Consensus 271 ~N~L~~Lp~--------------------------------lp~~L~~L~Ls~N~Lt~-LP~---~p~~L~~LdLS~N~L 314 (788)
T PRK15387 271 SNPLTHLPA--------------------------------LPSGLCKLWIFGNQLTS-LPV---LPPGLQELSVSDNQL 314 (788)
T ss_pred CCchhhhhh--------------------------------chhhcCEEECcCCcccc-ccc---cccccceeECCCCcc
Confidence 554443211 11234444444444442 222 124566666666666
Q ss_pred CCCCCcccccccccceeecccccCcccCCcccccccccceEEecCeeeeecCCccccCcccccccccCCccccccccccc
Q 001544 475 NGSIPIALGKLQKLQLLNLDDNKLEGSIPDDICGLVELYKLALGDNKLSGQIPACFGNLASLRELWLGPNELISFIPSTF 554 (1057)
Q Consensus 475 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~ 554 (1057)
++ +|... .+|+.|++++|+|++ +|.. ..+|+.|+|++|+|++ +|... .+|+.|++++|+|..+
T Consensus 315 ~~-Lp~lp---~~L~~L~Ls~N~L~~-LP~l---p~~Lq~LdLS~N~Ls~-LP~lp---~~L~~L~Ls~N~L~~L----- 377 (788)
T PRK15387 315 AS-LPALP---SELCKLWAYNNQLTS-LPTL---PSGLQELSVSDNQLAS-LPTLP---SELYKLWAYNNRLTSL----- 377 (788)
T ss_pred cc-CCCCc---ccccccccccCcccc-cccc---ccccceEecCCCccCC-CCCCC---cccceehhhccccccC-----
Confidence 53 33321 235555566666553 3321 1245555555555553 23211 2344444444444432
Q ss_pred cccccccEEEeccccccCCCchhhccccccceeccccccccccccccccCccccceecccccccccccCccccccCccce
Q 001544 555 WNIKDIMYVNFSSNFLTGPLPLEIENLKALTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQGSIPDSVGDLISLKS 634 (1057)
Q Consensus 555 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 634 (1057)
|.. ..+|+.|+|++|+|++ +|.. .++|+.|++++|+|+ .+|..+ .+|+.
T Consensus 378 --------------------P~l---~~~L~~LdLs~N~Lt~-LP~l---~s~L~~LdLS~N~Ls-sIP~l~---~~L~~ 426 (788)
T PRK15387 378 --------------------PAL---PSGLKELIVSGNRLTS-LPVL---PSELKELMVSGNRLT-SLPMLP---SGLLS 426 (788)
T ss_pred --------------------ccc---ccccceEEecCCcccC-CCCc---ccCCCEEEccCCcCC-CCCcch---hhhhh
Confidence 221 1345556666666653 3322 245666666666666 345432 34566
Q ss_pred ecccCccccCCCcccccCcccccccccCCCcccCcCCC
Q 001544 635 LNLSNNNLSGPIPTSLEKLSDLKELNLSFNKLEGEIPR 672 (1057)
Q Consensus 635 L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~ 672 (1057)
|+|++|+|+ .+|..+.++++|+.|+|++|+|+|.+|.
T Consensus 427 L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~ 463 (788)
T PRK15387 427 LSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQ 463 (788)
T ss_pred hhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHH
Confidence 666666666 5666666666666666666666666553
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.4e-21 Score=195.12 Aligned_cols=262 Identities=18% Similarity=0.195 Sum_probs=202.5
Q ss_pred CCCCCCceeccccCeEEEEEE-ecCCcEEEEEEeeccchhHHHHHHHHHHHHHhc-CCCCceeEeeeeccCCeeEEEEEE
Q 001544 769 NGFSENNLIGRGSFGSVYIAR-LQNGIEVAVKTFDLQHERAFKSFDTECEVMKSI-RHRNLTKIISSCSNEDFKALILEY 846 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~ 846 (1057)
-.|.+.++||+|+||+.+.|+ +-++++||||.-.... ...++..|.+..+.+ ..++|..++-|..++.+-.+|+|.
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL 105 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL 105 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence 468889999999999999997 4578999999653222 235667788888888 479999999888889999999998
Q ss_pred ccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCC-----CcEEEEcccccccccC
Q 001544 847 MRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDN-----MVAHLSDFGIAKLLIG 921 (1057)
Q Consensus 847 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~-----~~~kl~Dfg~a~~~~~ 921 (1057)
+ |.+|+|++.-.+..++.+++..||.|++.-++|+| ++..|.|||||+|+||... ..+.++|||+|+.+..
T Consensus 106 L-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH---~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD 181 (449)
T KOG1165|consen 106 L-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVH---EKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD 181 (449)
T ss_pred h-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHH---hcceeecccCccceeecCCCCCCCceEEEEeccchhhhcC
Confidence 8 77999999888888999999999999999999999 9999999999999999743 4689999999998754
Q ss_pred CCC-----ccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHh
Q 001544 922 EDQ-----SMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKI 996 (1057)
Q Consensus 922 ~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 996 (1057)
... +.......||.+||+-....+.+.+.+.|.-|+|-++++.+-|..||........-. . -.++
T Consensus 182 p~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~-k---------YeKI 251 (449)
T KOG1165|consen 182 PKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKE-K---------YEKI 251 (449)
T ss_pred ccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHH-H---------HHHh
Confidence 432 223334569999999999999999999999999999999999999998754332111 0 1111
Q ss_pred hhcccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHHHhHH
Q 001544 997 IDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKIRD 1049 (1057)
Q Consensus 997 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~ 1049 (1057)
-+... ........+.+|.++..-+...=..+-++-|...-+..-+..+.+
T Consensus 252 Ge~Kr---~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvld 301 (449)
T KOG1165|consen 252 GETKR---STPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLD 301 (449)
T ss_pred ccccc---cCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHH
Confidence 11111 011112234567777777777777788888888776666655544
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=9.4e-21 Score=227.70 Aligned_cols=246 Identities=26% Similarity=0.394 Sum_probs=124.1
Q ss_pred ccceeecccccccCCCCccccccCCCCeEeccCCCCCCCCCcccccCCCCCceeEccCCcccccCchhhhccccCCeeEe
Q 001544 120 KLEKLLLHNNFLTGTIPFSIFKLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQLSGSIPSFIFKISSLQALHF 199 (1057)
Q Consensus 120 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L 199 (1057)
+.+.|++++++++ .+|..+. ++|+.|+|++|+++ .+|.. + .++|++|++++|+++ .+|..+. .+|+.|+|
T Consensus 179 ~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~-l--~~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~L 248 (754)
T PRK15370 179 NKTELRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPEN-L--QGNIKTLYANSNQLT-SIPATLP--DTIQEMEL 248 (754)
T ss_pred CceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChh-h--ccCCCEEECCCCccc-cCChhhh--ccccEEEC
Confidence 3455555555555 3454432 35556666666555 34432 1 135566666666655 3444332 24566666
Q ss_pred eccCCccccCccccCCCCcccEEEeeccccccCccccccCCCCCcEEEccCCCCcCCccccccCcCCCcEEeeecccccc
Q 001544 200 GNNRLSGELPANICDNLPFLNFFSVYKNMFYGGISSTLSNCKHLRILDLSFNDLWGDIPKEIGNLTKLKELFLDFNILQG 279 (1057)
Q Consensus 200 ~~N~l~~~~p~~~~~~l~~L~~L~l~~n~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~ 279 (1057)
++|+++ .+|..+. ++|+.|++++|.+.. +|..+. ++|+.|++++|++++ +|..+. ++|+.|++++|.++.
T Consensus 249 s~N~L~-~LP~~l~---s~L~~L~Ls~N~L~~-LP~~l~--~sL~~L~Ls~N~Lt~-LP~~lp--~sL~~L~Ls~N~Lt~ 318 (754)
T PRK15370 249 SINRIT-ELPERLP---SALQSLDLFHNKISC-LPENLP--EELRYLSVYDNSIRT-LPAHLP--SGITHLNVQSNSLTA 318 (754)
T ss_pred cCCccC-cCChhHh---CCCCEEECcCCccCc-cccccC--CCCcEEECCCCcccc-Ccccch--hhHHHHHhcCCcccc
Confidence 666655 4444332 123333333333332 122221 356666666666653 343332 356666666666663
Q ss_pred ccCccccccccccEEEeecCccccccCccccccccccEEEecCCccccCCCCCcccCCCCCceEEecCccccccCCcccc
Q 001544 280 EIPHTVGNLHNLEYLSLVNNELVGTVPATIFNVSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSGTLPSFIF 359 (1057)
Q Consensus 280 ~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 359 (1057)
+|..+. ++|++|++++|.+++ +|..+. ++|+.|++++|+++ .+|... .++|+.|+|++|+++ .+|..+.
T Consensus 319 -LP~~l~--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~-~LP~~l---p~~L~~LdLs~N~Lt-~LP~~l~ 387 (754)
T PRK15370 319 -LPETLP--PGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQIT-VLPETL---PPTITTLDVSRNALT-NLPENLP 387 (754)
T ss_pred -CCcccc--ccceeccccCCcccc-CChhhc--CcccEEECCCCCCC-cCChhh---cCCcCEEECCCCcCC-CCCHhHH
Confidence 343332 456666666666653 444332 45666666666664 344432 245666666666666 3444332
Q ss_pred ccccccccccccccccccccch----hcccccccEEeccCcccC
Q 001544 360 NASNLSKLSLGDNSFSGLIPNT----FGNLRNLKRLRLYNNYLT 399 (1057)
Q Consensus 360 ~l~~L~~L~L~~N~l~~~~~~~----~~~l~~L~~L~L~~N~l~ 399 (1057)
..|+.|++++|+++.+ |.. +..++++..|++.+|+++
T Consensus 388 --~sL~~LdLs~N~L~~L-P~sl~~~~~~~~~l~~L~L~~Npls 428 (754)
T PRK15370 388 --AALQIMQASRNNLVRL-PESLPHFRGEGPQPTRIIVEYNPFS 428 (754)
T ss_pred --HHHHHHhhccCCcccC-chhHHHHhhcCCCccEEEeeCCCcc
Confidence 2466666666666532 322 233355555555555554
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.85 E-value=8.5e-22 Score=232.59 Aligned_cols=253 Identities=21% Similarity=0.236 Sum_probs=192.8
Q ss_pred CCceeccccCeEEEEEEec-CCcEEEEEEee-----ccchhH-HHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEE
Q 001544 773 ENNLIGRGSFGSVYIARLQ-NGIEVAVKTFD-----LQHERA-FKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILE 845 (1057)
Q Consensus 773 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~-----~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 845 (1057)
..+++|.|++|.|+.+... .....+.|.++ ...... ...+..|+-+-..++|||++..+..+.+.+..+-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 4578999999988877533 34445555443 111111 2226678888888999999988888877776666799
Q ss_pred EccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCc
Q 001544 846 YMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS 925 (1057)
Q Consensus 846 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 925 (1057)
|+++ +|...+.... .+...++-.++.|+..|++|+| +.||.|||+|++|+++..+|.+||+|||.+.........
T Consensus 402 ~~~~-Dlf~~~~~~~-~~~~~e~~c~fKqL~~Gv~y~h---~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~ 476 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSNG-KLTPLEADCFFKQLLRGVKYLH---SMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEK 476 (601)
T ss_pred cccH-HHHHHHhccc-ccchhhhhHHHHHHHHHHHHHH---hcCceeccCccccEEEecCCceEEeecCcceeeccCcch
Confidence 9999 9999887653 4788889999999999999999 999999999999999999999999999999876544443
Q ss_pred --cccccccccccccCccccCCCCCCc-cchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhcccc
Q 001544 926 --MTQTQTLATLGYMAPEYGREGRVST-KGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLL 1002 (1057)
Q Consensus 926 --~~~~~~~~t~~y~aPE~~~~~~~~~-~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1002 (1057)
.......|+..|+|||++.+..|.+ ..||||.|++++.|.+|+.||......+..+. ........
T Consensus 477 ~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~------------~~~~~~~~ 544 (601)
T KOG0590|consen 477 NIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFK------------TNNYSDQR 544 (601)
T ss_pred hhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchh------------hhcccccc
Confidence 5556678899999999999988865 57999999999999999999976544433210 00000001
Q ss_pred cccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHH
Q 001544 1003 ITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVR 1042 (1057)
Q Consensus 1003 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 1042 (1057)
.............+.+...++.+|++.+|.+|.|+.+|++
T Consensus 545 ~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 545 NIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred ccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 1112233344567888899999999999999999999975
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.3e-19 Score=205.30 Aligned_cols=258 Identities=31% Similarity=0.423 Sum_probs=197.8
Q ss_pred CCCCceeccccCeEEEEEEecCCcEEEEEEeeccchh---HHHHHHHHHHHHHhcCCC-CceeEeeeeccCCeeEEEEEE
Q 001544 771 FSENNLIGRGSFGSVYIARLQNGIEVAVKTFDLQHER---AFKSFDTECEVMKSIRHR-NLTKIISSCSNEDFKALILEY 846 (1057)
Q Consensus 771 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lV~E~ 846 (1057)
|...+.||.|+||.||++... ..+|+|.+...... ....+.+|+.+++.+.|+ +++++.+++......++++||
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 567789999999999999877 88999998654332 467899999999999988 799999999777778999999
Q ss_pred ccCCChhHHHhcCC--ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCC-cEEEEcccccccccCCC
Q 001544 847 MRNGSLEKCLYSGN--YILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNM-VAHLSDFGIAKLLIGED 923 (1057)
Q Consensus 847 ~~~gsL~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~-~~kl~Dfg~a~~~~~~~ 923 (1057)
+.++++.+++.... ..+.......++.|++.++.|+| +.+++|||+||+||+++..+ .++++|||.++......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H---~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 99999997776554 26889999999999999999999 89999999999999999988 79999999998654333
Q ss_pred Ccc----ccccccccccccCccccCC---CCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHh
Q 001544 924 QSM----TQTQTLATLGYMAPEYGRE---GRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKI 996 (1057)
Q Consensus 924 ~~~----~~~~~~~t~~y~aPE~~~~---~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 996 (1057)
... ......++..|+|||...+ .......|+|++|++++++++|..||......... ....+.
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~----------~~~~~~ 226 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSAT----------SQTLKI 226 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccH----------HHHHHH
Confidence 221 3456689999999999887 57889999999999999999999996553221000 001111
Q ss_pred hhccccc--ccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 997 IDANLLI--TEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 997 ~~~~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
+...... ...............+.+++..|+..+|..|.++.+...+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 227 ILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred HHhcCCcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 1110000 0000000002223567899999999999999999887765
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=8.7e-21 Score=228.00 Aligned_cols=283 Identities=24% Similarity=0.371 Sum_probs=199.4
Q ss_pred CCCCeEeccCCCCCCCCCcccccCCCCCceeEccCCcccccCchhhhccccCCeeEeeccCCccccCccccCCCCcccEE
Q 001544 143 SSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQLSGSIPSFIFKISSLQALHFGNNRLSGELPANICDNLPFLNFF 222 (1057)
Q Consensus 143 ~~L~~L~Ls~n~l~~~~p~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L 222 (1057)
.+...|+++++.++ .+|.. + .++|+.|+|++|+++ .+|..+. ++|+.|++++|+++ .+|..+.
T Consensus 178 ~~~~~L~L~~~~Lt-sLP~~-I--p~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--------- 240 (754)
T PRK15370 178 NNKTELRLKILGLT-TIPAC-I--PEQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--------- 240 (754)
T ss_pred cCceEEEeCCCCcC-cCCcc-c--ccCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh---------
Confidence 46789999999998 67753 3 368999999999999 5677664 58999999999998 5665321
Q ss_pred EeeccccccCccccccCCCCCcEEEccCCCCcCCccccccCcCCCcEEeeeccccccccCccccccccccEEEeecCccc
Q 001544 223 SVYKNMFYGGISSTLSNCKHLRILDLSFNDLWGDIPKEIGNLTKLKELFLDFNILQGEIPHTVGNLHNLEYLSLVNNELV 302 (1057)
Q Consensus 223 ~l~~n~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 302 (1057)
.+|+.|+|++|.+. .+|..+. ++|+.|++++|+++ .+|..+. ++|++|+|++|+++
T Consensus 241 ------------------~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt 296 (754)
T PRK15370 241 ------------------DTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIR 296 (754)
T ss_pred ------------------ccccEEECcCCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCccc
Confidence 35777888888876 5666554 47888888888887 4666554 47888888888887
Q ss_pred cccCccccccccccEEEecCCccccCCCCCcccCCCCCceEEecCccccccCCccccccccccccccccccccccccchh
Q 001544 303 GTVPATIFNVSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSGTLPSFIFNASNLSKLSLGDNSFSGLIPNTF 382 (1057)
Q Consensus 303 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~ 382 (1057)
.+|..+. ++|+.|++++|.++ .+|... .++|+.|++++|.+++ +|..+. ++|+.|++++|+|+. +|..+
T Consensus 297 -~LP~~lp--~sL~~L~Ls~N~Lt-~LP~~l---~~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~~-LP~~l 365 (754)
T PRK15370 297 -TLPAHLP--SGITHLNVQSNSLT-ALPETL---PPGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQITV-LPETL 365 (754)
T ss_pred -cCcccch--hhHHHHHhcCCccc-cCCccc---cccceeccccCCcccc-CChhhc--CcccEEECCCCCCCc-CChhh
Confidence 3554432 46888888888887 455443 3678889999998884 666553 689999999999885 45554
Q ss_pred cccccccEEeccCcccCCCccccccccCCCcchhhhhccCCCcccccccccccccccccEEEcCCCcccccccccccCcc
Q 001544 383 GNLRNLKRLRLYNNYLTSPELSFLSSLSNCKYLEIIALSGNPLNGIIPMSAGNLSHSLEELFMPDCNVSGRIPKEIGNLA 462 (1057)
Q Consensus 383 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~l~~n~~~~~~p~~~~~l~ 462 (1057)
.++|++|+|++|.++.++.... +.|+.|++++|++.+. |. .+|..+..++
T Consensus 366 --p~~L~~LdLs~N~Lt~LP~~l~------~sL~~LdLs~N~L~~L-P~---------------------sl~~~~~~~~ 415 (754)
T PRK15370 366 --PPTITTLDVSRNALTNLPENLP------AALQIMQASRNNLVRL-PE---------------------SLPHFRGEGP 415 (754)
T ss_pred --cCCcCEEECCCCcCCCCCHhHH------HHHHHHhhccCCcccC-ch---------------------hHHHHhhcCC
Confidence 3689999999999987654332 3688899999988732 32 2333445567
Q ss_pred CCcEEEccCCcCCCCCCcccccccccceeecccccCcc-cCCcccccccccce
Q 001544 463 NLVTLDLGGNKFNGSIPIALGKLQKLQLLNLDDNKLEG-SIPDDICGLVELYK 514 (1057)
Q Consensus 463 ~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~ 514 (1057)
.+..|+|.+|.|+. ..+.+|+.| ++.+.+.| .++...+.+.+++.
T Consensus 416 ~l~~L~L~~Npls~------~tl~~L~~L-l~s~~~~gp~i~~~~~~~~~l~~ 461 (754)
T PRK15370 416 QPTRIIVEYNPFSE------RTIQNMQRL-MSSVGYQGPRVLFAMGDFSIVRV 461 (754)
T ss_pred CccEEEeeCCCccH------HHHHHHHHh-hhcccccCCcccccccccccccc
Confidence 88899999998872 345566666 44454433 33444444444443
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.1e-20 Score=191.62 Aligned_cols=171 Identities=13% Similarity=0.164 Sum_probs=132.4
Q ss_pred HhCCCCCCceeccccCeEEEEEEecCCcEEEEEEeeccchhH---HHH------HHHHHHHHHhcCCCCceeEeeeeccC
Q 001544 767 ATNGFSENNLIGRGSFGSVYIARLQNGIEVAVKTFDLQHERA---FKS------FDTECEVMKSIRHRNLTKIISSCSNE 837 (1057)
Q Consensus 767 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~------~~~E~~~l~~l~h~niv~l~~~~~~~ 837 (1057)
..++|+..+++|.|+||.||.+.. ++..+|||+++...... ... +++|++.+.+++||+|..+..++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 467899999999999999999766 47789999996543222 222 68999999999999999998886532
Q ss_pred --------CeeEEEEEEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEE
Q 001544 838 --------DFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAH 909 (1057)
Q Consensus 838 --------~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~k 909 (1057)
...++||||++|.+|.++.. .+. ....+++.++..+| ..+++|||+||+||+++.+| ++
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH---~~gi~H~Dikp~Nili~~~g-i~ 174 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLH---QHGMVSGDPHKGNFIVSKNG-LR 174 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHH---HcCCccCCCChHHEEEeCCC-EE
Confidence 35789999999999988632 222 34669999999999 99999999999999999988 99
Q ss_pred EEcccccccccCCCCccccccccccccccCccccCCCCCCccchHHHHHHHHHHHh
Q 001544 910 LSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETF 965 (1057)
Q Consensus 910 l~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~ell 965 (1057)
++|||......... .. ..+.....+..++|+|++|+.+....
T Consensus 175 liDfg~~~~~~e~~---a~-----------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 175 IIDLSGKRCTAQRK---AK-----------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEECCCcccccchh---hH-----------HHHHHHhHhcccccccceeEeehHHH
Confidence 99999886541110 00 01333445667899999999876554
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=7.7e-20 Score=186.35 Aligned_cols=139 Identities=17% Similarity=0.179 Sum_probs=108.9
Q ss_pred CceeccccCeEEEEEEecCCcEEEEEEeeccchh--H------------------------HHHHHHHHHHHHhcCCCCc
Q 001544 774 NNLIGRGSFGSVYIARLQNGIEVAVKTFDLQHER--A------------------------FKSFDTECEVMKSIRHRNL 827 (1057)
Q Consensus 774 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~------------------------~~~~~~E~~~l~~l~h~ni 827 (1057)
...||+|+||.||+|...+|+.||||+++..... . ......|++.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 3679999999999999888999999999654211 0 1123459999999988776
Q ss_pred eeEeeeeccCCeeEEEEEEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHH-HhCCCCCeEEccCCCCCeeeCCCC
Q 001544 828 TKIISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYL-HFGYSAPVIHCDLKPSNVLLDDNM 906 (1057)
Q Consensus 828 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~L-H~~~~~~ivH~Dlkp~Nill~~~~ 906 (1057)
.....+.. ...++||||++++++...... ...++..+...++.|++.+++|+ | +.+|+||||||+||+++ ++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~l~H---~~giiHrDlkP~NIli~-~~ 154 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLK-DAPLSESKARELYLQVIQIMRILYQ---DCRLVHADLSEYNLLYH-DG 154 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhh-cCCCCHHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEE-CC
Confidence 44333222 223899999999877654332 23588999999999999999999 7 88999999999999998 57
Q ss_pred cEEEEcccccccc
Q 001544 907 VAHLSDFGIAKLL 919 (1057)
Q Consensus 907 ~~kl~Dfg~a~~~ 919 (1057)
.++++|||+|...
T Consensus 155 ~v~LiDFG~a~~~ 167 (190)
T cd05147 155 KLYIIDVSQSVEH 167 (190)
T ss_pred cEEEEEccccccC
Confidence 8999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.6e-20 Score=218.54 Aligned_cols=248 Identities=21% Similarity=0.235 Sum_probs=179.4
Q ss_pred CCCCCceeccccCeEEEEEEecCCcEEEEEEeeccc-hhHH---HHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEE
Q 001544 770 GFSENNLIGRGSFGSVYIARLQNGIEVAVKTFDLQH-ERAF---KSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILE 845 (1057)
Q Consensus 770 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~---~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 845 (1057)
+|...+.+|++.|=+|.+|+.+.|. |+||++-+.. .-.. .+..+|++ ...++|||++.+.-.-..++..|+|-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 5677789999999999999998887 9999995544 2223 33334444 556689999999888777888899999
Q ss_pred EccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccc-cCCCC
Q 001544 846 YMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL-IGEDQ 924 (1057)
Q Consensus 846 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~-~~~~~ 924 (1057)
|+.. +|.|.+..+. .+...+.+.|+.|++.|+..+| ..||+|||||.+|||++.-..+.++||..-+.. -+.+.
T Consensus 102 yvkh-nLyDRlSTRP-FL~~iEKkWiaFQLL~al~qcH---~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN 176 (1431)
T KOG1240|consen 102 YVKH-NLYDRLSTRP-FLVLIEKKWIAFQLLKALSQCH---KLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN 176 (1431)
T ss_pred HHhh-hhhhhhccch-HHHHHHHHHHHHHHHHHHHHHH---HcCccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence 9966 8988886544 5777788899999999999999 999999999999999999999999999764321 12222
Q ss_pred cccccc----ccccccccCccccCCC-----------CCCccchHHHHHHHHHHHhh-CCCCCCcccccccchhhhhhh-
Q 001544 925 SMTQTQ----TLATLGYMAPEYGREG-----------RVSTKGDVYSFGILLMETFT-RRKPTDEIFSGEMTLKHWVND- 987 (1057)
Q Consensus 925 ~~~~~~----~~~t~~y~aPE~~~~~-----------~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~- 987 (1057)
....+. ...-..|.|||-+... ..+++.||||.||+++|+++ |++||... .+-.|...
T Consensus 177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS-----QL~aYr~~~ 251 (1431)
T KOG1240|consen 177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS-----QLLAYRSGN 251 (1431)
T ss_pred cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH-----HHHhHhccC
Confidence 222221 2233479999965321 14678999999999999988 68877641 00000000
Q ss_pred -ccchhHHHhhhcccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHHH
Q 001544 988 -FLPISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLK 1046 (1057)
Q Consensus 988 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 1046 (1057)
..++...+. --...+++++..|++.||++|.+|.+.++.-+.
T Consensus 252 ~~~~e~~Le~-----------------Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG 294 (1431)
T KOG1240|consen 252 ADDPEQLLEK-----------------IEDVSLRNLILSMIQRDPSKRLSAEDYLQKYRG 294 (1431)
T ss_pred ccCHHHHHHh-----------------CcCccHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence 000011110 012357889999999999999999999987544
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=8.7e-19 Score=179.69 Aligned_cols=138 Identities=22% Similarity=0.237 Sum_probs=110.8
Q ss_pred CceeccccCeEEEEEEecCCcEEEEEEeeccchh--------------------------HHHHHHHHHHHHHhcCCCCc
Q 001544 774 NNLIGRGSFGSVYIARLQNGIEVAVKTFDLQHER--------------------------AFKSFDTECEVMKSIRHRNL 827 (1057)
Q Consensus 774 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~E~~~l~~l~h~ni 827 (1057)
...||+|++|.||+|...+|+.||||+++..... ....+.+|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4689999999999998778999999998654210 01234678999999999987
Q ss_pred eeEeeeeccCCeeEEEEEEccCCChhHH-HhcCCccCCHHHHHHHHHHHHHHHHHHHhCCC-CCeEEccCCCCCeeeCCC
Q 001544 828 TKIISSCSNEDFKALILEYMRNGSLEKC-LYSGNYILDIFQRLNIMIDVASALEYLHFGYS-APVIHCDLKPSNVLLDDN 905 (1057)
Q Consensus 828 v~l~~~~~~~~~~~lV~E~~~~gsL~~~-l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~-~~ivH~Dlkp~Nill~~~ 905 (1057)
.....+... ..++||||++++++... +.. ..++..+..+++.|++.++.++| + .+|+||||||+||+++ +
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~--~~~~~~~~~~i~~~l~~~l~~lH---~~~givHrDlkP~NIll~-~ 153 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD--VPLEEEEAEELYEQVVEQMRRLY---QEAGLVHGDLSEYNILYH-D 153 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhh--ccCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCChhhEEEE-C
Confidence 544443332 24899999998865433 332 34778889999999999999999 7 9999999999999999 8
Q ss_pred CcEEEEcccccccc
Q 001544 906 MVAHLSDFGIAKLL 919 (1057)
Q Consensus 906 ~~~kl~Dfg~a~~~ 919 (1057)
+.++++|||+++.+
T Consensus 154 ~~~~liDFG~a~~~ 167 (190)
T cd05145 154 GKPYIIDVSQAVEL 167 (190)
T ss_pred CCEEEEEcccceec
Confidence 99999999999865
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=1e-18 Score=174.71 Aligned_cols=186 Identities=18% Similarity=0.167 Sum_probs=139.1
Q ss_pred CCCceeccccCeEEEEEEecCCcEEEEEEeeccch----hHHHHHHHHHHHHHhcC-CCCceeEeeeeccCCeeEEEEEE
Q 001544 772 SENNLIGRGSFGSVYIARLQNGIEVAVKTFDLQHE----RAFKSFDTECEVMKSIR-HRNLTKIISSCSNEDFKALILEY 846 (1057)
Q Consensus 772 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~E~ 846 (1057)
.....|++|+||+||.+.. .+.+++.+.+..... .....+.+|+++|+++. |+++++++++ +..++||||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 3467899999999998766 578888887754432 22346889999999995 5889999886 346899999
Q ss_pred ccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccC-CCCCeeeCCCCcEEEEcccccccccCCCCc
Q 001544 847 MRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDL-KPSNVLLDDNMVAHLSDFGIAKLLIGEDQS 925 (1057)
Q Consensus 847 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dl-kp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 925 (1057)
++|.+|.+.... ....++.|++++++++| ..||+|||| ||.||+++.++.++|+|||+|.........
T Consensus 80 I~G~~L~~~~~~--------~~~~~~~qi~~~L~~lH---~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~ 148 (218)
T PRK12274 80 LAGAAMYQRPPR--------GDLAYFRAARRLLQQLH---RCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARW 148 (218)
T ss_pred ecCccHHhhhhh--------hhHHHHHHHHHHHHHHH---HCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchH
Confidence 999998764321 12457889999999999 999999999 799999999999999999999864322210
Q ss_pred c---c--------cccccccccccCccccCCC-CCC-ccchHHHHHHHHHHHhhCCCCCCc
Q 001544 926 M---T--------QTQTLATLGYMAPEYGREG-RVS-TKGDVYSFGILLMETFTRRKPTDE 973 (1057)
Q Consensus 926 ~---~--------~~~~~~t~~y~aPE~~~~~-~~~-~~~Dv~s~G~il~elltg~~p~~~ 973 (1057)
. . ......++.|++|+...-- ..+ ...+-++-|+-+|.++|++.|+..
T Consensus 149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 0 0 0112356677777643221 222 456888999999999999988644
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.79 E-value=6.4e-19 Score=186.12 Aligned_cols=229 Identities=21% Similarity=0.288 Sum_probs=146.4
Q ss_pred CCCceeccccCeEEEEEEec-CCcEEEEEEeeccc---hhHHHHHHHHHHHHHhcCC----------CCceeEeee----
Q 001544 772 SENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQH---ERAFKSFDTECEVMKSIRH----------RNLTKIISS---- 833 (1057)
Q Consensus 772 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h----------~niv~l~~~---- 833 (1057)
...+.||.|+++.||.+++. +|+++|||++.... ...++.+++|.-....+.+ -.++.-++.
T Consensus 15 ~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~ 94 (288)
T PF14531_consen 15 VRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIP 94 (288)
T ss_dssp EEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEET
T ss_pred EEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEc
Confidence 44688999999999999876 58999999984332 2346677777655544322 111111111
Q ss_pred -----eccC---C-----eeEEEEEEccCCChhHHHh---cCC---ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcc
Q 001544 834 -----CSNE---D-----FKALILEYMRNGSLEKCLY---SGN---YILDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 894 (1057)
Q Consensus 834 -----~~~~---~-----~~~lV~E~~~~gsL~~~l~---~~~---~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~D 894 (1057)
+... . ..+++|+-+. ++|.+++. ... .......+..+..|+++.+++|| ..|+||+|
T Consensus 95 ~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh---~~GlVHgd 170 (288)
T PF14531_consen 95 GKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH---SYGLVHGD 170 (288)
T ss_dssp TS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEEEST
T ss_pred CCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh---hcceEecc
Confidence 1111 1 2357888774 48877643 222 22445556778899999999999 99999999
Q ss_pred CCCCCeeeCCCCcEEEEcccccccccCCCCccccccccccccccCccccCC--------CCCCccchHHHHHHHHHHHhh
Q 001544 895 LKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGRE--------GRVSTKGDVYSFGILLMETFT 966 (1057)
Q Consensus 895 lkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~Dv~s~G~il~ellt 966 (1057)
|+|+|++++++|.++++||+...... . .......+..|.|||.... ..++++.|.|++|+++|.+++
T Consensus 171 i~~~nfll~~~G~v~Lg~F~~~~r~g---~--~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC 245 (288)
T PF14531_consen 171 IKPENFLLDQDGGVFLGDFSSLVRAG---T--RYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC 245 (288)
T ss_dssp -SGGGEEE-TTS-EEE--GGGEEETT---E--EEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred cceeeEEEcCCCCEEEcChHHHeecC---c--eeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence 99999999999999999999887541 1 1111345578999996533 247889999999999999999
Q ss_pred CCCCCCcccccccchhhhhhhccchhHHHhhhcccccccchhhHHHHHHHHHHHHHHhHcccCCCCCC
Q 001544 967 RRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDER 1034 (1057)
Q Consensus 967 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 1034 (1057)
|+.||+........ .| .+....++++.+.++|..+++++|++|
T Consensus 246 ~~lPf~~~~~~~~~--~~-----------------------~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 246 GRLPFGLSSPEADP--EW-----------------------DFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp SS-STCCCGGGSTS--GG-----------------------GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred ccCCCCCCCccccc--cc-----------------------cchhcCCcCHHHHHHHHHHccCCcccC
Confidence 99999864222111 11 111122567889999999999999988
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=9.3e-19 Score=196.43 Aligned_cols=218 Identities=29% Similarity=0.428 Sum_probs=164.1
Q ss_pred HHhcCCCCceeEeeeeccCCeeEEEEEEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCe-EEccCCC
Q 001544 819 MKSIRHRNLTKIISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPV-IHCDLKP 897 (1057)
Q Consensus 819 l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~i-vH~Dlkp 897 (1057)
|+.+.|.|+.+++|.+.++...+.|.+|+..|+|.+.+......+++.....+.++|+.|++|+| ..+| +|+.+++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh---~s~i~~hg~l~s 77 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLH---NSPIGYHGALKS 77 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHh---cCcceeeeeecc
Confidence 35688999999999999999999999999999999999987878999999999999999999999 5554 8999999
Q ss_pred CCeeeCCCCcEEEEcccccccccCCCCccccccccccccccCccccCCCC-------CCccchHHHHHHHHHHHhhCCCC
Q 001544 898 SNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGR-------VSTKGDVYSFGILLMETFTRRKP 970 (1057)
Q Consensus 898 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-------~~~~~Dv~s~G~il~elltg~~p 970 (1057)
.|.++|..+.+|++|||+.................-..-|.|||.+.... .+.+.||||||++++|+++.+.|
T Consensus 78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~ 157 (484)
T KOG1023|consen 78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP 157 (484)
T ss_pred ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence 99999999999999999987653211112222223445699999887631 46789999999999999999999
Q ss_pred CCcccccccchhhhhhhccchhHHHhhhcccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHHHhHH
Q 001544 971 TDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKIRD 1049 (1057)
Q Consensus 971 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~ 1049 (1057)
|+.....+.. .+.+. .+.+ .......+......+.++++..++.+||..+|++||++..+-..++.+..
T Consensus 158 ~~~~~~~~~~-~eii~--------~~~~-~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 158 FDLRNLVEDP-DEIIL--------RVKK-GGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred cccccccCCh-HHHHH--------HHHh-cCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 9874333221 11111 1111 00000001111111455678999999999999999999999888876643
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=9.9e-19 Score=182.45 Aligned_cols=197 Identities=23% Similarity=0.301 Sum_probs=142.6
Q ss_pred CCCCceeEeeeecc---------------------------CCeeEEEEEEccCCChhHHHhcCCccCCHHHHHHHHHHH
Q 001544 823 RHRNLTKIISSCSN---------------------------EDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDV 875 (1057)
Q Consensus 823 ~h~niv~l~~~~~~---------------------------~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i 875 (1057)
+|||||++.++|.+ ....|+||...+. +|.+++.... .+...+.-|..|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~--~s~r~~~~~laQl 350 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH--RSYRTGRVILAQL 350 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC--CchHHHHHHHHHH
Confidence 59999999887633 2367899988865 8998887654 5666778899999
Q ss_pred HHHHHHHHhCCCCCeEEccCCCCCeeeC--CCC--cEEEEcccccccccCCC----CccccccccccccccCccccCCCC
Q 001544 876 ASALEYLHFGYSAPVIHCDLKPSNVLLD--DNM--VAHLSDFGIAKLLIGED----QSMTQTQTLATLGYMAPEYGREGR 947 (1057)
Q Consensus 876 ~~~L~~LH~~~~~~ivH~Dlkp~Nill~--~~~--~~kl~Dfg~a~~~~~~~----~~~~~~~~~~t~~y~aPE~~~~~~ 947 (1057)
++|+.||| .+||.|||+|++|||+. +|+ .+.|+|||.+---...+ .........|...-||||+.....
T Consensus 351 LEav~hL~---~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P 427 (598)
T KOG4158|consen 351 LEAVTHLH---KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP 427 (598)
T ss_pred HHHHHHHH---HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence 99999999 99999999999999984 444 57899999874321111 111222334666789999875432
Q ss_pred ------CCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhcccccccchhhHHHHHHHHHHHH
Q 001544 948 ------VSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHFAAKEQCASSVFN 1021 (1057)
Q Consensus 948 ------~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 1021 (1057)
...|+|.|+.|.+.||+++..-||.. .++..+..-. ..+..-.+.+..+++.+.+
T Consensus 428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~--rGem~L~~r~-----------------Yqe~qLPalp~~vpp~~rq 488 (598)
T KOG4158|consen 428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYK--RGEMLLDTRT-----------------YQESQLPALPSRVPPVARQ 488 (598)
T ss_pred CCceeeccchhhhhhhhhhHHHHhccCCcccc--cchheechhh-----------------hhhhhCCCCcccCChHHHH
Confidence 24589999999999999999999876 3443322100 0111122334567888999
Q ss_pred HHhHcccCCCCCCCCHHHHHHHH
Q 001544 1022 LAMECTVESPDERITAKEIVRRL 1044 (1057)
Q Consensus 1022 li~~cl~~dP~~Rps~~evl~~L 1044 (1057)
++...+++||.+|+++.-+...+
T Consensus 489 lV~~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 489 LVFDLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred HHHHHhcCCccccCCccHHHhHH
Confidence 99999999999999887665554
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=2e-20 Score=173.12 Aligned_cols=182 Identities=31% Similarity=0.531 Sum_probs=147.7
Q ss_pred ccCccCCcEEEccCCcCCCCCCcccccccccceeecccccCcccCCcccccccccceEEecCeeeeecCCccccCccccc
Q 001544 458 IGNLANLVTLDLGGNKFNGSIPIALGKLQKLQLLNLDDNKLEGSIPDDICGLVELYKLALGDNKLSGQIPACFGNLASLR 537 (1057)
Q Consensus 458 ~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~ 537 (1057)
+.++++++.|.||+|+++ .+|..+..+.+|+.|++++|+|+ ..|..++.+++|+.|+++-|++. ..|..|+.++.|+
T Consensus 29 Lf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~le 105 (264)
T KOG0617|consen 29 LFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALE 105 (264)
T ss_pred ccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhh
Confidence 456778899999999999 78888999999999999999998 78889999999999999999888 7888888888888
Q ss_pred ccccCCccccccccccccccccccEEEeccccccCCCchhhccccccceeccccccccccccccccCccccceecccccc
Q 001544 538 ELWLGPNELISFIPSTFWNIKDIMYVNFSSNFLTGPLPLEIENLKALTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNR 617 (1057)
Q Consensus 538 ~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 617 (1057)
.|+|..|.+.+ ..+|+.|..++.|+.|+|++|.+. .+|..++++++||.|.+..|.
T Consensus 106 vldltynnl~e-----------------------~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdnd 161 (264)
T KOG0617|consen 106 VLDLTYNNLNE-----------------------NSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDND 161 (264)
T ss_pred hhhcccccccc-----------------------ccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCc
Confidence 87777776543 245666777788888888888887 778888888888888888888
Q ss_pred cccccCccccccCccceecccCccccCCCcccccCcccc---cccccCCCcccC
Q 001544 618 LQGSIPDSVGDLISLKSLNLSNNNLSGPIPTSLEKLSDL---KELNLSFNKLEG 668 (1057)
Q Consensus 618 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L---~~l~ls~N~l~~ 668 (1057)
+- .+|..++.+++|+.|.+.+|+++ .+|+.++++.-+ +.+.+.+|+|-.
T Consensus 162 ll-~lpkeig~lt~lrelhiqgnrl~-vlppel~~l~l~~~k~v~r~E~NPwv~ 213 (264)
T KOG0617|consen 162 LL-SLPKEIGDLTRLRELHIQGNRLT-VLPPELANLDLVGNKQVMRMEENPWVN 213 (264)
T ss_pred hh-hCcHHHHHHHHHHHHhcccceee-ecChhhhhhhhhhhHHHHhhhhCCCCC
Confidence 87 78888888888888888888888 677776665332 345566666643
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.75 E-value=5.7e-18 Score=202.93 Aligned_cols=196 Identities=23% Similarity=0.270 Sum_probs=162.5
Q ss_pred HhCCCCCCceeccccCeEEEEEEecCCcEEEEEEeeccchhHHHHHHHHHHHHHhcC---CCCceeEeeeeccCCeeEEE
Q 001544 767 ATNGFSENNLIGRGSFGSVYIARLQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIR---HRNLTKIISSCSNEDFKALI 843 (1057)
Q Consensus 767 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lV 843 (1057)
..+.|.+.+.||+|+||+||+|...+|+.||+|+-+.... .+|.--.+++.|++ -+.|..+..++.-.+.-++|
T Consensus 696 ~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~---WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv 772 (974)
T KOG1166|consen 696 GGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNP---WEFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLV 772 (974)
T ss_pred cceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCc---eeeeehHHHHHhhchhhhcchHHHHHHHccCCcceee
Confidence 4457888899999999999999988899999998754432 23333445556665 24455566666667888899
Q ss_pred EEEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeC-------CCCcEEEEccccc
Q 001544 844 LEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLD-------DNMVAHLSDFGIA 916 (1057)
Q Consensus 844 ~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~-------~~~~~kl~Dfg~a 916 (1057)
+||.+.|+|.+++.. .+.+++.-++.+..|+++.+++|| ..+||||||||+|.++. ....++|+|||.+
T Consensus 773 ~ey~~~Gtlld~~N~-~~~m~e~lv~~~~~qml~ive~lH---~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~s 848 (974)
T KOG1166|consen 773 SEYSPYGTLLDLINT-NKVMDEYLVMFFSCQMLRIVEHLH---AMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRS 848 (974)
T ss_pred eeccccccHHHhhcc-CCCCCchhhhHHHHHHHHHHHHHH---hcceecccCCcceeEeecccCCCCcccceEEEecccc
Confidence 999999999999884 456999999999999999999999 99999999999999995 2346899999999
Q ss_pred ccccCCCCccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCC
Q 001544 917 KLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRK 969 (1057)
Q Consensus 917 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~ 969 (1057)
..+.-..........++|-++-.+|...+..|++.+|-|.++.+++-|+.|++
T Consensus 849 iDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 849 IDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred eeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 88765545556667788999999999999999999999999999999999975
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.75 E-value=4.1e-20 Score=207.69 Aligned_cols=181 Identities=30% Similarity=0.246 Sum_probs=83.8
Q ss_pred EeCCCCCccc-cCCcccccccccceeecccccccCC----CCccccccCCCCeEeccCCCCCC------CCCcccccCCC
Q 001544 100 LDLNFNRLSG-EIPWELGNLAKLEKLLLHNNFLTGT----IPFSIFKLSSLLDLKLSDNNLTG------TIPSHNLGNLS 168 (1057)
Q Consensus 100 L~L~~n~l~~-~~p~~l~~l~~L~~L~L~~n~l~~~----~p~~~~~l~~L~~L~Ls~n~l~~------~~p~~~l~~l~ 168 (1057)
|+|..+.+++ ..+..+..+..|+.|+++++.++.. ++..+...++|++|+++++.+.+ .++ ..+..++
T Consensus 3 l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~-~~l~~~~ 81 (319)
T cd00116 3 LSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLL-QGLTKGC 81 (319)
T ss_pred cccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHH-HHHHhcC
Confidence 3444444442 2333344444455555555544321 33333444445555555554431 011 1244455
Q ss_pred CCceeEccCCcccccCchhhhcccc---CCeeEeeccCCccccCccccCCCCcccEEEeeccccccCccccccCC-CCCc
Q 001544 169 SLQLLDLSDNQLSGSIPSFIFKISS---LQALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGGISSTLSNC-KHLR 244 (1057)
Q Consensus 169 ~L~~L~Ls~n~l~~~~p~~l~~l~~---L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~l~~n~~~~~~~~~l~~l-~~L~ 244 (1057)
+|+.|++++|.+.+..+..+..+.+ |++|++++|++++.....+ ...+..+ ++|+
T Consensus 82 ~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l---------------------~~~l~~~~~~L~ 140 (319)
T cd00116 82 GLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLL---------------------AKGLKDLPPALE 140 (319)
T ss_pred ceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHH---------------------HHHHHhCCCCce
Confidence 6666666666665545555554444 6666666666553111111 1122333 4555
Q ss_pred EEEccCCCCcCC----ccccccCcCCCcEEeeeccccccc----cCccccccccccEEEeecCccc
Q 001544 245 ILDLSFNDLWGD----IPKEIGNLTKLKELFLDFNILQGE----IPHTVGNLHNLEYLSLVNNELV 302 (1057)
Q Consensus 245 ~L~Ls~N~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~ 302 (1057)
.|++++|.+++. ++..+..+++|++|++++|.+++. ++..+..+++|++|++++|.++
T Consensus 141 ~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~ 206 (319)
T cd00116 141 KLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLT 206 (319)
T ss_pred EEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccC
Confidence 555555555422 222344445555555555555521 2223333445666666665554
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.75 E-value=4.1e-20 Score=207.69 Aligned_cols=206 Identities=28% Similarity=0.304 Sum_probs=141.0
Q ss_pred EeeecccCc-ccccccccCCCCCcEEeCCCCCcccc----CCcccccccccceeecccccccC------CCCccccccCC
Q 001544 76 LNISYLSLT-GNIPRQLGNLSSLEILDLNFNRLSGE----IPWELGNLAKLEKLLLHNNFLTG------TIPFSIFKLSS 144 (1057)
Q Consensus 76 l~l~~~~l~-g~~~~~l~~l~~L~~L~L~~n~l~~~----~p~~l~~l~~L~~L~L~~n~l~~------~~p~~~~~l~~ 144 (1057)
|+|.++.++ +.....+..++.|++|+++++.+++. ++..+...++|++|+++++.+.+ .++..+..+++
T Consensus 3 l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~ 82 (319)
T cd00116 3 LSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCG 82 (319)
T ss_pred cccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCc
Confidence 566666666 33445566677788888888887543 56667777788888888887762 34456777888
Q ss_pred CCeEeccCCCCCCCCCcccccCCCC---CceeEccCCcccc----cCchhhhcc-ccCCeeEeeccCCccccCccccCCC
Q 001544 145 LLDLKLSDNNLTGTIPSHNLGNLSS---LQLLDLSDNQLSG----SIPSFIFKI-SSLQALHFGNNRLSGELPANICDNL 216 (1057)
Q Consensus 145 L~~L~Ls~n~l~~~~p~~~l~~l~~---L~~L~Ls~n~l~~----~~p~~l~~l-~~L~~L~L~~N~l~~~~p~~~~~~l 216 (1057)
|++|++++|.+.+..+. .+..+.+ |++|++++|.+++ .+...+..+ ++|++|++++|.+++..+..+
T Consensus 83 L~~L~l~~~~~~~~~~~-~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~---- 157 (319)
T cd00116 83 LQELDLSDNALGPDGCG-VLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEAL---- 157 (319)
T ss_pred eeEEEccCCCCChhHHH-HHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHH----
Confidence 88899988888754443 3444444 9999999988873 333455666 788889998888875332221
Q ss_pred CcccEEEeeccccccCccccccCCCCCcEEEccCCCCcCC----ccccccCcCCCcEEeeeccccccc----cCcccccc
Q 001544 217 PFLNFFSVYKNMFYGGISSTLSNCKHLRILDLSFNDLWGD----IPKEIGNLTKLKELFLDFNILQGE----IPHTVGNL 288 (1057)
Q Consensus 217 ~~L~~L~l~~n~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~----~p~~~~~l 288 (1057)
...+..+++|++|++++|.+++. ++..+..+++|++|+|++|.+++. ++..+..+
T Consensus 158 -----------------~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~ 220 (319)
T cd00116 158 -----------------AKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASL 220 (319)
T ss_pred -----------------HHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhccc
Confidence 23455667788888888887642 333455566888888888887643 23445667
Q ss_pred ccccEEEeecCcccc
Q 001544 289 HNLEYLSLVNNELVG 303 (1057)
Q Consensus 289 ~~L~~L~L~~N~l~~ 303 (1057)
++|++|++++|++++
T Consensus 221 ~~L~~L~ls~n~l~~ 235 (319)
T cd00116 221 KSLEVLNLGDNNLTD 235 (319)
T ss_pred CCCCEEecCCCcCch
Confidence 778888888888765
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=2e-17 Score=169.79 Aligned_cols=137 Identities=14% Similarity=0.230 Sum_probs=107.8
Q ss_pred CCCCceeccccCeEEEEEEecCCcEEEEEEeeccchhHHHHHHHHHHHHHhc-----CCCCceeEeeeeccCC---e-eE
Q 001544 771 FSENNLIGRGSFGSVYIARLQNGIEVAVKTFDLQHERAFKSFDTECEVMKSI-----RHRNLTKIISSCSNED---F-KA 841 (1057)
Q Consensus 771 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~~---~-~~ 841 (1057)
+...++||+|+||.||. ..+++.. +||++........+.+.+|+++++++ .||||++++|++.++. . ..
T Consensus 4 L~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred cCCcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 34568899999999996 4334444 79998765444557899999999999 5799999999998763 3 33
Q ss_pred EEEEE--ccCCChhHHHhcCCccCCHHHHHHHHHHHHHHH-HHHHhCCCCCeEEccCCCCCeeeCC----CCcEEEEccc
Q 001544 842 LILEY--MRNGSLEKCLYSGNYILDIFQRLNIMIDVASAL-EYLHFGYSAPVIHCDLKPSNVLLDD----NMVAHLSDFG 914 (1057)
Q Consensus 842 lV~E~--~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L-~~LH~~~~~~ivH~Dlkp~Nill~~----~~~~kl~Dfg 914 (1057)
+|+|| +.+|+|.+++.+.. +++. ..++.|++.++ +||| +.+|+||||||+||+++. ++.++|+||+
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~~--~~e~--~~~~~~~L~~l~~yLh---~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQCR--YEED--VAQLRQLLKKLKRYLL---DNRIVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred EEecCCCCcchhHHHHHHccc--ccHh--HHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 78999 55799999997643 5554 35678888887 9999 999999999999999974 3479999954
Q ss_pred cc
Q 001544 915 IA 916 (1057)
Q Consensus 915 ~a 916 (1057)
-+
T Consensus 155 G~ 156 (210)
T PRK10345 155 GE 156 (210)
T ss_pred CC
Confidence 44
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.2e-19 Score=168.06 Aligned_cols=164 Identities=37% Similarity=0.593 Sum_probs=124.9
Q ss_pred ccCCCCCcEEeCCCCCccccCCcccccccccceeecccccccCCCCccccccCCCCeEeccCCCCCCCCCcccccCCCCC
Q 001544 91 LGNLSSLEILDLNFNRLSGEIPWELGNLAKLEKLLLHNNFLTGTIPFSIFKLSSLLDLKLSDNNLTGTIPSHNLGNLSSL 170 (1057)
Q Consensus 91 l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~l~~l~~L 170 (1057)
+.++++++.|-||+|.++ .+|+.+..|.+|+.|++++|+++ .+|.+++.+++|++|+++-|++. .+|. .|+.++.|
T Consensus 29 Lf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lpr-gfgs~p~l 104 (264)
T KOG0617|consen 29 LFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPR-GFGSFPAL 104 (264)
T ss_pred ccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCcc-ccCCCchh
Confidence 557778888888888888 77888888888999999888888 78888888899999999888886 6665 58889999
Q ss_pred ceeEccCCccc-ccCchhhhccccCCeeEeeccCCccccCccccCCCCcccEEEeeccccccCccccccCCCCCcEEEcc
Q 001544 171 QLLDLSDNQLS-GSIPSFIFKISSLQALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGGISSTLSNCKHLRILDLS 249 (1057)
Q Consensus 171 ~~L~Ls~n~l~-~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~l~~n~~~~~~~~~l~~l~~L~~L~Ls 249 (1057)
+.|||.+|+++ ..+|..|+.++.|+.|+|++|.+. .+|. .++++++|+.|.+.
T Consensus 105 evldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~-------------------------dvg~lt~lqil~lr 158 (264)
T KOG0617|consen 105 EVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPP-------------------------DVGKLTNLQILSLR 158 (264)
T ss_pred hhhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCCh-------------------------hhhhhcceeEEeec
Confidence 99999988886 467888888888888888888775 3333 34566667777777
Q ss_pred CCCCcCCccccccCcCCCcEEeeeccccccccCcccc
Q 001544 250 FNDLWGDIPKEIGNLTKLKELFLDFNILQGEIPHTVG 286 (1057)
Q Consensus 250 ~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~ 286 (1057)
.|.+- .+|+.++.++.|++|++.+|+++ .+|..++
T Consensus 159 dndll-~lpkeig~lt~lrelhiqgnrl~-vlppel~ 193 (264)
T KOG0617|consen 159 DNDLL-SLPKEIGDLTRLRELHIQGNRLT-VLPPELA 193 (264)
T ss_pred cCchh-hCcHHHHHHHHHHHHhcccceee-ecChhhh
Confidence 66664 45666666666666666666666 4444433
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=6.9e-19 Score=196.41 Aligned_cols=225 Identities=26% Similarity=0.328 Sum_probs=178.1
Q ss_pred eeccccCeEEEEEE----ecCCcEEEEEEeeccch--hHHHHHHHHHHHHHhcC-CCCceeEeeeeccCCeeEEEEEEcc
Q 001544 776 LIGRGSFGSVYIAR----LQNGIEVAVKTFDLQHE--RAFKSFDTECEVMKSIR-HRNLTKIISSCSNEDFKALILEYMR 848 (1057)
Q Consensus 776 ~lg~G~~g~Vy~~~----~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~E~~~ 848 (1057)
++|+|+||.|+.++ .+.|..+|+|+.+.... ........|..++...+ ||.++++.-.+..+...+++.+|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999999774 23478899998854421 11124556788888886 9999999999999999999999999
Q ss_pred CCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCcccc
Q 001544 849 NGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQ 928 (1057)
Q Consensus 849 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 928 (1057)
+|.+...+.+... ++..........++-+++++| +.+|+|||+|++||+++.+|++++.|||.++......
T Consensus 81 gg~lft~l~~~~~-f~~~~~~~~~aelaLald~lh---~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~----- 151 (612)
T KOG0603|consen 81 GGDLFTRLSKEVM-FDELDVAFYLAELALALDHLH---KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK----- 151 (612)
T ss_pred cchhhhccccCCc-hHHHHHHHHHHHHHHHHhhcc---hhHHHHhcccccceeecccCccccCCchhhhHhHhhh-----
Confidence 9999988776553 666667777888899999999 9999999999999999999999999999998653222
Q ss_pred ccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhhcccccccchh
Q 001544 929 TQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKH 1008 (1057)
Q Consensus 929 ~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1008 (1057)
...||.-|||||++. .+...+|.||||++++||+||..||.. .....+- ...
T Consensus 152 -~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~------------------~~~~~Il-------~~~ 203 (612)
T KOG0603|consen 152 -IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG------------------DTMKRIL-------KAE 203 (612)
T ss_pred -hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch------------------HHHHHHh-------hhc
Confidence 127899999999987 567889999999999999999999865 0111110 112
Q ss_pred hHHHHHHHHHHHHHHhHcccCCCCCCCCH
Q 001544 1009 FAAKEQCASSVFNLAMECTVESPDERITA 1037 (1057)
Q Consensus 1009 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~ 1037 (1057)
...+.+.+..+.+++..+...+|..|.-.
T Consensus 204 ~~~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 204 LEMPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred cCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 23345667788889999999999999855
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.70 E-value=8.5e-17 Score=169.72 Aligned_cols=142 Identities=18% Similarity=0.145 Sum_probs=112.2
Q ss_pred CCCCCCceeccccCeEEEEEE--ecCCcEEEEEEeeccch------------------------hHHHHHHHHHHHHHhc
Q 001544 769 NGFSENNLIGRGSFGSVYIAR--LQNGIEVAVKTFDLQHE------------------------RAFKSFDTECEVMKSI 822 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~Vy~~~--~~~~~~vavK~~~~~~~------------------------~~~~~~~~E~~~l~~l 822 (1057)
..|++.+.||+|+||.||+|. ..+|+.||||+++.... .....+.+|++.+.++
T Consensus 28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L 107 (237)
T smart00090 28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL 107 (237)
T ss_pred chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 357788999999999999998 56899999999864321 0123467899999999
Q ss_pred CCC--CceeEeeeeccCCeeEEEEEEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCC-eEEccCCCCC
Q 001544 823 RHR--NLTKIISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAP-VIHCDLKPSN 899 (1057)
Q Consensus 823 ~h~--niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~-ivH~Dlkp~N 899 (1057)
.+. .+.+++++ ...++||||++++++....... ......+...++.|++.++++|| +.+ |+||||||+|
T Consensus 108 ~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH---~~g~iiH~Dikp~N 179 (237)
T smart00090 108 YEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD-VEPEEEEEFELYDDILEEMRKLY---KEGELVHGDLSEYN 179 (237)
T ss_pred HhcCCCCCeeeEe----cCceEEEEEecCCccccccccc-CCcchHHHHHHHHHHHHHHHHHH---hcCCEEeCCCChhh
Confidence 753 34445543 2348999999998887654332 23566677899999999999999 899 9999999999
Q ss_pred eeeCCCCcEEEEcccccccc
Q 001544 900 VLLDDNMVAHLSDFGIAKLL 919 (1057)
Q Consensus 900 ill~~~~~~kl~Dfg~a~~~ 919 (1057)
|+++ ++.++++|||.+...
T Consensus 180 Ili~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 180 ILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred EEEE-CCCEEEEEChhhhcc
Confidence 9999 889999999998754
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.1e-16 Score=165.76 Aligned_cols=134 Identities=24% Similarity=0.363 Sum_probs=114.1
Q ss_pred ceeccccCeEEEEEEecCCcEEEEEEeeccch--------hHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEE
Q 001544 775 NLIGRGSFGSVYIARLQNGIEVAVKTFDLQHE--------RAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEY 846 (1057)
Q Consensus 775 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 846 (1057)
+.||+|++|.||+|.. +|..|+||+...... .....+.+|++++..++|+++.....++.+.+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 578899998643221 1234678899999999999988777777777788999999
Q ss_pred ccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEccccccc
Q 001544 847 MRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL 918 (1057)
Q Consensus 847 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~ 918 (1057)
++|++|.+++.... . ++..++.+++.+++++| +.+++|||++|.||+++ ++.++++|||.+..
T Consensus 81 ~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH---~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG----M-EELELSREIGRLVGKLH---SAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHH---hCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999886533 2 78899999999999999 99999999999999999 78999999998864
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.68 E-value=3.1e-16 Score=162.34 Aligned_cols=140 Identities=21% Similarity=0.213 Sum_probs=110.9
Q ss_pred HHhCCCCCCceeccccCeEEEEEEecCCcEEEEEEeeccch----------------------hHHHHHHHHHHHHHhcC
Q 001544 766 QATNGFSENNLIGRGSFGSVYIARLQNGIEVAVKTFDLQHE----------------------RAFKSFDTECEVMKSIR 823 (1057)
Q Consensus 766 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~E~~~l~~l~ 823 (1057)
....-|...+.||+|+||.||+|..++|+.||||++..... .....+..|+.++.++.
T Consensus 12 ~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 91 (198)
T cd05144 12 KRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALY 91 (198)
T ss_pred HcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHH
Confidence 33334777899999999999999988899999998754321 01124677899999998
Q ss_pred CCC--ceeEeeeeccCCeeEEEEEEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCee
Q 001544 824 HRN--LTKIISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVL 901 (1057)
Q Consensus 824 h~n--iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nil 901 (1057)
|++ +...++. ...++||||+++++|.+.... .....++.+++.++.++| +.+|+||||||+||+
T Consensus 92 ~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh---~~gi~H~Dl~p~Nil 157 (198)
T cd05144 92 EEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAY---KHGIIHGDLSEFNIL 157 (198)
T ss_pred HcCCCCCceeec----CCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHH---HCCCCcCCCCcccEE
Confidence 774 4444442 345899999999999775321 235678999999999999 899999999999999
Q ss_pred eCCCCcEEEEcccccccc
Q 001544 902 LDDNMVAHLSDFGIAKLL 919 (1057)
Q Consensus 902 l~~~~~~kl~Dfg~a~~~ 919 (1057)
+++++.++|+|||.+...
T Consensus 158 l~~~~~~~liDfg~~~~~ 175 (198)
T cd05144 158 VDDDEKIYIIDWPQMVST 175 (198)
T ss_pred EcCCCcEEEEECCccccC
Confidence 999999999999999654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.67 E-value=5.2e-16 Score=185.32 Aligned_cols=138 Identities=19% Similarity=0.288 Sum_probs=113.4
Q ss_pred HhCCCCCCceeccccCeEEEEEEecCCcEEEEEEeecc--c------hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCC
Q 001544 767 ATNGFSENNLIGRGSFGSVYIARLQNGIEVAVKTFDLQ--H------ERAFKSFDTECEVMKSIRHRNLTKIISSCSNED 838 (1057)
Q Consensus 767 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 838 (1057)
....|...+.||+|+||+||+|.+.. ..+++|+.... . ....+++.+|++++++++|++++....++....
T Consensus 331 ~~~~~~~~~~iG~G~~g~Vy~~~~~~-~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~ 409 (535)
T PRK09605 331 VKRRKIPDHLIGKGAEADIKKGEYLG-RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE 409 (535)
T ss_pred cccccCccceeccCCcEEEEEEeecC-ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC
Confidence 34455678999999999999998764 34555443111 1 122456889999999999999998888877777
Q ss_pred eeEEEEEEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEccccccc
Q 001544 839 FKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL 918 (1057)
Q Consensus 839 ~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~ 918 (1057)
..++||||+++++|.+++. ....++.+++++++||| +.+++|||+||+||++ .++.++|+|||+++.
T Consensus 410 ~~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH---~~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 410 EKTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLH---KAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred CCEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHH---hCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 7899999999999998875 45789999999999999 9999999999999999 678999999999875
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.66 E-value=3.6e-17 Score=179.37 Aligned_cols=243 Identities=24% Similarity=0.265 Sum_probs=159.0
Q ss_pred CCCCceeccccCeEEEEEEecC----CcEEEEEEeeccchhHHHHHHHHHHHHHhcC-CCCceeEe------eee-----
Q 001544 771 FSENNLIGRGSFGSVYIARLQN----GIEVAVKTFDLQHERAFKSFDTECEVMKSIR-HRNLTKII------SSC----- 834 (1057)
Q Consensus 771 ~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~------~~~----- 834 (1057)
..+.+..+..+++.+....... ..-++.|..+...-.......+++..+.-.. |+..+..- ..+
T Consensus 246 ~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d~~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~~~~~v 325 (516)
T KOG1033|consen 246 SSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVDSLCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFESSKRNKV 325 (516)
T ss_pred ccccccccccccCCchhhhhcccchhhhhccchhhhccchhhhhhhhhhhhheeccccCCcccccCCCCchhhhcccccc
Confidence 3444566666666666554322 2334444433332122233334444444443 44332221 011
Q ss_pred ccCCeeEEEEEEccCCChhHHHhcCC--ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEc
Q 001544 835 SNEDFKALILEYMRNGSLEKCLYSGN--YILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSD 912 (1057)
Q Consensus 835 ~~~~~~~lV~E~~~~gsL~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D 912 (1057)
....+.|+.|++++..+|.+|+...+ ...++.....++.|++.|++| ++.+|||+||.||+...+..+||+|
T Consensus 326 ~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgD 399 (516)
T KOG1033|consen 326 GKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGD 399 (516)
T ss_pred ccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhh
Confidence 11235789999999999999996544 567888899999999999998 6889999999999999999999999
Q ss_pred ccccccccCCC----CccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhh-CCCCCCcccccccchhhhhhh
Q 001544 913 FGIAKLLIGED----QSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFT-RRKPTDEIFSGEMTLKHWVND 987 (1057)
Q Consensus 913 fg~a~~~~~~~----~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~ellt-g~~p~~~~~~~~~~~~~~~~~ 987 (1057)
||+...+.... ....++...||..||+||.+.+..++.|+|+||+|++++|++. =..+++. ...
T Consensus 400 Fgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er----~~t------- 468 (516)
T KOG1033|consen 400 FGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER----IAT------- 468 (516)
T ss_pred hhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH----HHh-------
Confidence 99998764333 2445667789999999999999999999999999999999998 2222211 000
Q ss_pred ccchhHHHhhhcccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHH
Q 001544 988 FLPISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVR 1042 (1057)
Q Consensus 988 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 1042 (1057)
..++-|.... .....+. +.-..++.+++.+.|.+||++.++..
T Consensus 469 -----~~d~r~g~ip------~~~~~d~-p~e~~ll~~lls~~p~~RP~~~~~~~ 511 (516)
T KOG1033|consen 469 -----LTDIRDGIIP------PEFLQDY-PEEYTLLQQLLSPSPEERPSAIEVAL 511 (516)
T ss_pred -----hhhhhcCCCC------hHHhhcC-cHHHHHHHHhcCCCcccCchHHHHhh
Confidence 1111111110 0011111 22357899999999999996655543
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.66 E-value=5.2e-16 Score=161.19 Aligned_cols=130 Identities=22% Similarity=0.398 Sum_probs=107.0
Q ss_pred eeccccCeEEEEEEecCCcEEEEEEeeccc--------hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEEc
Q 001544 776 LIGRGSFGSVYIARLQNGIEVAVKTFDLQH--------ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEYM 847 (1057)
Q Consensus 776 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 847 (1057)
.||+|+||.||+|.. +|..|++|+..... .....++.+|++++..++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 389999999999985 47899999864321 112356788999999999887665555555666778999999
Q ss_pred cCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEccccccc
Q 001544 848 RNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL 918 (1057)
Q Consensus 848 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~ 918 (1057)
+|++|.+++..... .++.+++++++++| +.+++|||++|.||+++ ++.++++|||.+..
T Consensus 80 ~g~~l~~~~~~~~~--------~~~~~i~~~l~~lH---~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGND--------ELLREIGRLVGKLH---KAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcHH--------HHHHHHHHHHHHHH---HCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999988754321 78999999999999 99999999999999999 89999999999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.1e-15 Score=184.21 Aligned_cols=150 Identities=31% Similarity=0.516 Sum_probs=115.6
Q ss_pred CCCcchHHHHHHHHHhcccCCCCcccCCCCCCCCCCc----ccceeEecCC--C--CceeEEeeecccCcccccccccCC
Q 001544 23 TSIDIDQDALLALKDHITYDPTNFFAKNWLTNSTMVC----NWTGVTCDIN--Q--RRVTALNISYLSLTGNIPRQLGNL 94 (1057)
Q Consensus 23 ~~~~~d~~~l~~~k~~~~~~~~~~~~~~w~~~~~~~c----~w~gv~c~~~--~--~~v~~l~l~~~~l~g~~~~~l~~l 94 (1057)
++.+.|.+||++||+++. +|.. .+|.. ..|| .|.||+|+.. . .+|+.|+|++++++|.+|+.++++
T Consensus 368 ~t~~~~~~aL~~~k~~~~-~~~~---~~W~g--~~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L 441 (623)
T PLN03150 368 KTLLEEVSALQTLKSSLG-LPLR---FGWNG--DPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKL 441 (623)
T ss_pred ccCchHHHHHHHHHHhcC-Cccc---CCCCC--CCCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHHHhCC
Confidence 455678999999999985 4432 37843 3343 7999999532 1 258888888888888888888888
Q ss_pred CCCcEEeCCCCCccccCCcccccccccceeecccccccCCCCccccccCCCCeEeccCCCCCCCCCcccccC-CCCCcee
Q 001544 95 SSLEILDLNFNRLSGEIPWELGNLAKLEKLLLHNNFLTGTIPFSIFKLSSLLDLKLSDNNLTGTIPSHNLGN-LSSLQLL 173 (1057)
Q Consensus 95 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~l~~-l~~L~~L 173 (1057)
++|++|+|++|.++|.+|..++.+++|+.|+|++|+++|.+|..++++++|++|+|++|+++|.+|.. ++. +.++..+
T Consensus 442 ~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~-l~~~~~~~~~l 520 (623)
T PLN03150 442 RHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAA-LGGRLLHRASF 520 (623)
T ss_pred CCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChH-HhhccccCceE
Confidence 88888888888888888888888888888888888888888888888888888888888888888764 433 2455566
Q ss_pred EccCCc
Q 001544 174 DLSDNQ 179 (1057)
Q Consensus 174 ~Ls~n~ 179 (1057)
++++|.
T Consensus 521 ~~~~N~ 526 (623)
T PLN03150 521 NFTDNA 526 (623)
T ss_pred EecCCc
Confidence 666664
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.2e-14 Score=143.76 Aligned_cols=135 Identities=19% Similarity=0.302 Sum_probs=115.0
Q ss_pred CCceeccccCeEEEEEEecCCcEEEEEEeeccchhHHHHHHHHHHHHHhcCC--CCceeEeeeeccCCeeEEEEEEccCC
Q 001544 773 ENNLIGRGSFGSVYIARLQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRH--RNLTKIISSCSNEDFKALILEYMRNG 850 (1057)
Q Consensus 773 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lV~E~~~~g 850 (1057)
+.+.||+|.++.||++..++ ..++||....... ...+.+|+++++.++| ..+++++++...++..+++|||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 35789999999999999864 7899999865433 4678899999999976 58999999988888899999999988
Q ss_pred ChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEccccccc
Q 001544 851 SLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL 918 (1057)
Q Consensus 851 sL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~ 918 (1057)
.+... +......++.+++++++++|.....+++|||++|+||++++.+.++++|||.++.
T Consensus 79 ~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 77653 5567788999999999999943335799999999999999999999999999874
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.6e-15 Score=177.61 Aligned_cols=212 Identities=24% Similarity=0.295 Sum_probs=143.6
Q ss_pred HhCCCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccchhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEE
Q 001544 767 ATNGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILE 845 (1057)
Q Consensus 767 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 845 (1057)
...+|..++.|..|+||.||.++.+ ..+.+|+|+ .++.- +.+- ++.....|.+|
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~l-----ilRn--ilt~a~npfvv----------------- 135 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNL-----ILRN--ILTFAGNPFVV----------------- 135 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhhcc-cccch-----hhhc--cccccCCccee-----------------
Confidence 4568889999999999999999765 467788853 22111 1110 22222333333
Q ss_pred EccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCC--
Q 001544 846 YMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGED-- 923 (1057)
Q Consensus 846 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~-- 923 (1057)
|+-.+.+...+ +++.. ++.+++|+| +.+|+|||+||+|.+++.-|++|+.|||+++......
T Consensus 136 ----gDc~tllk~~g-~lPvd--------mvla~Eylh---~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at 199 (1205)
T KOG0606|consen 136 ----GDCATLLKNIG-PLPVD--------MVLAVEYLH---SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT 199 (1205)
T ss_pred ----chhhhhcccCC-CCcch--------hhHHhHhhc---cCCeecCCCCCCcceeeecccccccchhhhhhhhhhccc
Confidence 33333333322 23322 277899999 9999999999999999999999999999986531110
Q ss_pred -----------CccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchh
Q 001544 924 -----------QSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPIS 992 (1057)
Q Consensus 924 -----------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 992 (1057)
.........||+.|+|||++....|+..+|.|++|+++||.+.|+.||... ..+.-+...+.+.
T Consensus 200 nl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGd-tpeelfg~visd~---- 274 (1205)
T KOG0606|consen 200 NLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD-TPEELFGQVISDD---- 274 (1205)
T ss_pred hhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCC-CHHHHHhhhhhhh----
Confidence 011223457999999999999999999999999999999999999998762 1112222222111
Q ss_pred HHHhhhcccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCH
Q 001544 993 MMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITA 1037 (1057)
Q Consensus 993 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~ 1037 (1057)
.. ..+..+..+++..+++.+.++.+|..|--.
T Consensus 275 --------i~-----wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt 306 (1205)
T KOG0606|consen 275 --------IE-----WPEEDEALPPEAQDLIEQLLRQNPLCRLGT 306 (1205)
T ss_pred --------cc-----ccccCcCCCHHHHHHHHHHHHhChHhhccc
Confidence 11 111123456788999999999999999833
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.3e-14 Score=149.04 Aligned_cols=135 Identities=22% Similarity=0.257 Sum_probs=98.2
Q ss_pred CceeccccCeEEEEEEecCCcEEEEEEeeccchh--HHHH----------------------HHHHHHHHHhcCCCC--c
Q 001544 774 NNLIGRGSFGSVYIARLQNGIEVAVKTFDLQHER--AFKS----------------------FDTECEVMKSIRHRN--L 827 (1057)
Q Consensus 774 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~----------------------~~~E~~~l~~l~h~n--i 827 (1057)
.+.||+|+||+||+|...+|+.||||+++..... .... ...|.+.+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4679999999999999888999999998653211 1111 134566666664432 4
Q ss_pred eeEeeeeccCCeeEEEEEEccCCChhH-HHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCC-CCeEEccCCCCCeeeCCC
Q 001544 828 TKIISSCSNEDFKALILEYMRNGSLEK-CLYSGNYILDIFQRLNIMIDVASALEYLHFGYS-APVIHCDLKPSNVLLDDN 905 (1057)
Q Consensus 828 v~l~~~~~~~~~~~lV~E~~~~gsL~~-~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~-~~ivH~Dlkp~Nill~~~ 905 (1057)
.+.+++ ...++||||++++.+.. .+.... .. .++..++.+++.++.++| . .+|+||||||+||+++ +
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~lh---~~~~ivH~Dl~p~Nili~-~ 150 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKLY---REAGLVHGDLSEYNILVD-D 150 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHHh---hccCcCcCCCChhhEEEE-C
Confidence 444443 23589999999954321 111111 11 567889999999999999 7 9999999999999999 9
Q ss_pred CcEEEEcccccccc
Q 001544 906 MVAHLSDFGIAKLL 919 (1057)
Q Consensus 906 ~~~kl~Dfg~a~~~ 919 (1057)
+.++++|||.+...
T Consensus 151 ~~~~liDfg~a~~~ 164 (187)
T cd05119 151 GKVYIIDVPQAVEI 164 (187)
T ss_pred CcEEEEECcccccc
Confidence 99999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.54 E-value=5.6e-16 Score=183.44 Aligned_cols=256 Identities=24% Similarity=0.292 Sum_probs=199.8
Q ss_pred CCCCCCceeccccCeEEEEEEec--CCcEEEEEEeeccc--hhHHHHHHHHHHHHHhcC-CCCceeEeeeeccCCeeEEE
Q 001544 769 NGFSENNLIGRGSFGSVYIARLQ--NGIEVAVKTFDLQH--ERAFKSFDTECEVMKSIR-HRNLTKIISSCSNEDFKALI 843 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV 843 (1057)
..|...+.||+|+|+.|-.+... ....+|+|.+.... .........|..+-..+. |+|++++++...+.+..+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 35677788999999999888653 34556777664432 334455666888878886 99999999999999999999
Q ss_pred EEEccCCChhHHH-hcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCC-cEEEEcccccccccC
Q 001544 844 LEYMRNGSLEKCL-YSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNM-VAHLSDFGIAKLLIG 921 (1057)
Q Consensus 844 ~E~~~~gsL~~~l-~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~-~~kl~Dfg~a~~~~~ 921 (1057)
.||.+++++.+-+ +......+......++.|+..++.|+|. ..+++|||+||+|.+++..+ ..+++|||+|..+..
T Consensus 100 ~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred cCcccccccccccccCCccCCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 9999999999888 4443356667778899999999999995 67899999999999999999 999999999988765
Q ss_pred -CCCccccccccc-cccccCccccCC-CCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhh
Q 001544 922 -EDQSMTQTQTLA-TLGYMAPEYGRE-GRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIID 998 (1057)
Q Consensus 922 -~~~~~~~~~~~~-t~~y~aPE~~~~-~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 998 (1057)
.+.........| ++.|+|||...+ ....+..|+||.|+++.-+++|..||+...........|......
T Consensus 178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~-------- 249 (601)
T KOG0590|consen 178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGR-------- 249 (601)
T ss_pred cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccc--------
Confidence 444555555677 999999999877 456788999999999999999999998876665555555433110
Q ss_pred cccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHH
Q 001544 999 ANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVR 1042 (1057)
Q Consensus 999 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~ 1042 (1057)
.....+........++..+++..+|..|.+.+++..
T Consensus 250 --------~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 250 --------FTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred --------cccCccccCChhhhhcccccccCCchhccccccccc
Confidence 011122334556778899999999999999887754
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.53 E-value=7.8e-14 Score=147.62 Aligned_cols=135 Identities=18% Similarity=0.246 Sum_probs=106.4
Q ss_pred Cceec-cccCeEEEEEEecCCcEEEEEEeeccc-------------hhHHHHHHHHHHHHHhcCCCCc--eeEeeeeccC
Q 001544 774 NNLIG-RGSFGSVYIARLQNGIEVAVKTFDLQH-------------ERAFKSFDTECEVMKSIRHRNL--TKIISSCSNE 837 (1057)
Q Consensus 774 ~~~lg-~G~~g~Vy~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~ 837 (1057)
..+|| .|+.|+||++... +..++||++.... ......+.+|++++.+++|+++ ++.+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 36788 8999999999876 7789999884311 1223567889999999998875 6677764332
Q ss_pred -C---eeEEEEEEccC-CChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEc
Q 001544 838 -D---FKALILEYMRN-GSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSD 912 (1057)
Q Consensus 838 -~---~~~lV~E~~~~-gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D 912 (1057)
. ..++||||++| .+|.+++... .++.. .+.++++++++|| +.||+||||||.|||++.++.++++|
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~--~l~~~----~~~~i~~~l~~lH---~~GI~HrDlkp~NILv~~~~~v~LID 185 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA--PLSEE----QWQAIGQLIARFH---DAGVYHADLNAHNILLDPDGKFWLID 185 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC--CCCHH----HHHHHHHHHHHHH---HCCCCCCCCCchhEEEcCCCCEEEEE
Confidence 2 23599999997 6999887653 24443 3678999999999 99999999999999999999999999
Q ss_pred cccccc
Q 001544 913 FGIAKL 918 (1057)
Q Consensus 913 fg~a~~ 918 (1057)
||.++.
T Consensus 186 fg~~~~ 191 (239)
T PRK01723 186 FDRGEL 191 (239)
T ss_pred CCCccc
Confidence 999875
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.51 E-value=8.5e-15 Score=176.42 Aligned_cols=119 Identities=37% Similarity=0.645 Sum_probs=95.5
Q ss_pred ccceeccccccccccccccccCccccceecccccccccccCccccccCccceecccCccccCCCcccccCcccccccccC
Q 001544 583 ALTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQGSIPDSVGDLISLKSLNLSNNNLSGPIPTSLEKLSDLKELNLS 662 (1057)
Q Consensus 583 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls 662 (1057)
.++.|+|++|.++|.+|..++.+++|+.|+|++|+++|.+|..++.+++|+.|||++|+++|.+|..+.++++|+.|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 46778888888888888888888888888888888888888888888888888888888888888888888888888888
Q ss_pred CCcccCcCCCC--CCCcccCcccccCCcccCCCCCCCCCCCcc
Q 001544 663 FNKLEGEIPRG--GPFVNFSAKSFMGNNLLCGSPNLQVPPCRA 703 (1057)
Q Consensus 663 ~N~l~~~~p~~--~~~~~~~~~~~~~n~~~cg~~~~~~~~c~~ 703 (1057)
+|+++|.+|.. ..+.+.....+.+|+.+||.|. ..+|..
T Consensus 499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~--l~~C~~ 539 (623)
T PLN03150 499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPG--LRACGP 539 (623)
T ss_pred CCcccccCChHHhhccccCceEEecCCccccCCCC--CCCCcc
Confidence 88888888863 2223344556889999999875 346753
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.46 E-value=1.3e-12 Score=150.38 Aligned_cols=140 Identities=21% Similarity=0.240 Sum_probs=101.5
Q ss_pred CceeccccCeEEEEEEecCCcEEEEEEeeccchhHH----------------------------------------HHHH
Q 001544 774 NNLIGRGSFGSVYIARLQNGIEVAVKTFDLQHERAF----------------------------------------KSFD 813 (1057)
Q Consensus 774 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~----------------------------------------~~~~ 813 (1057)
.+.||+|++|.||+|++++|+.||||+.++...... -+|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 378999999999999999999999999865421100 0244
Q ss_pred HHHHHHHhcC----CCCceeEeeee-ccCCeeEEEEEEccCCChhHHHhcCCccCCHHHHHHHHHHHHH-HHHHHHhCCC
Q 001544 814 TECEVMKSIR----HRNLTKIISSC-SNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVAS-ALEYLHFGYS 887 (1057)
Q Consensus 814 ~E~~~l~~l~----h~niv~l~~~~-~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~-~L~~LH~~~~ 887 (1057)
+|++.+.+++ |.+-+.+-..+ ......++||||++|+++.++........ .+.+++.++++ .+.++| .
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~---~ 275 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVL---R 275 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHH---h
Confidence 5666555552 33333333333 23455789999999999988765322112 24456776666 467889 8
Q ss_pred CCeEEccCCCCCeeeCCCCcEEEEcccccccc
Q 001544 888 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL 919 (1057)
Q Consensus 888 ~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~ 919 (1057)
.|++|+|++|.||+++.++.++++|||++..+
T Consensus 276 ~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l 307 (437)
T TIGR01982 276 DGFFHADLHPGNIFVLKDGKIIALDFGIVGRL 307 (437)
T ss_pred CCceeCCCCcccEEECCCCcEEEEeCCCeeEC
Confidence 99999999999999999999999999998765
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.40 E-value=1.9e-14 Score=157.67 Aligned_cols=165 Identities=31% Similarity=0.486 Sum_probs=94.2
Q ss_pred cccccccCccCCcEEEccCCcCCCCCCcccccccccceeecccccCcccCCcccccccccceEEecCeeeeecCCccccC
Q 001544 453 RIPKEIGNLANLVTLDLGGNKFNGSIPIALGKLQKLQLLNLDDNKLEGSIPDDICGLVELYKLALGDNKLSGQIPACFGN 532 (1057)
Q Consensus 453 ~~p~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~ 532 (1057)
++|..+..+..|+.+.|.+|.|. .+|..+.++..|++|||+.|+++ ..|..+|.++ |+.|-+++|+++ .+|..++.
T Consensus 89 elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig~ 164 (722)
T KOG0532|consen 89 ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSNNKLT-SLPEEIGL 164 (722)
T ss_pred cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEEecCccc-cCCccccc
Confidence 45556666666666777777766 56666777777777777777776 5566666554 566666666666 55555665
Q ss_pred cccccccccCCccccccccccccccccccEEEeccccccCCCchhhccccccceeccccccccccccccccCccccceec
Q 001544 533 LASLRELWLGPNELISFIPSTFWNIKDIMYVNFSSNFLTGPLPLEIENLKALTTLDFSMNNLSGVIPTTIGGLKGLQYLF 612 (1057)
Q Consensus 533 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 612 (1057)
+..|.+|+.+.|++.+ +|..+.++.+|+.|.+..|++. .+|+.+.. -.|..||
T Consensus 165 ~~tl~~ld~s~nei~s-------------------------lpsql~~l~slr~l~vrRn~l~-~lp~El~~-LpLi~lD 217 (722)
T KOG0532|consen 165 LPTLAHLDVSKNEIQS-------------------------LPSQLGYLTSLRDLNVRRNHLE-DLPEELCS-LPLIRLD 217 (722)
T ss_pred chhHHHhhhhhhhhhh-------------------------chHHhhhHHHHHHHHHhhhhhh-hCCHHHhC-Cceeeee
Confidence 5666665555555444 3444445555555555555554 23334442 2355555
Q ss_pred ccccccccccCccccccCccceecccCccccCCCcccc
Q 001544 613 LGHNRLQGSIPDSVGDLISLKSLNLSNNNLSGPIPTSL 650 (1057)
Q Consensus 613 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l 650 (1057)
+|.|+++ .+|-.|.+|+.|++|-|.+|.|. ..|+++
T Consensus 218 fScNkis-~iPv~fr~m~~Lq~l~LenNPLq-SPPAqI 253 (722)
T KOG0532|consen 218 FSCNKIS-YLPVDFRKMRHLQVLQLENNPLQ-SPPAQI 253 (722)
T ss_pred cccCcee-ecchhhhhhhhheeeeeccCCCC-CChHHH
Confidence 5555555 45555555555555555555555 344443
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.38 E-value=5e-13 Score=137.24 Aligned_cols=204 Identities=21% Similarity=0.303 Sum_probs=142.9
Q ss_pred HHhcCCCCceeEeeeeccCC-----eeEEEEEEccCCChhHHHhcC---CccCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 001544 819 MKSIRHRNLTKIISSCSNED-----FKALILEYMRNGSLEKCLYSG---NYILDIFQRLNIMIDVASALEYLHFGYSAPV 890 (1057)
Q Consensus 819 l~~l~h~niv~l~~~~~~~~-----~~~lV~E~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~i 890 (1057)
+-++-|.|+++++.||.+.+ ...++.|||+.|++..++++. ...+......+|+.||..||.||| .|+++|
T Consensus 121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLh-s~~Ppi 199 (458)
T KOG1266|consen 121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLH-SCDPPI 199 (458)
T ss_pred HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhh-ccCCcc
Confidence 44557999999999986543 467899999999999998653 356788888999999999999999 678999
Q ss_pred EEccCCCCCeeeCCCCcEEEEcccccccc--cCCCCccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCC
Q 001544 891 IHCDLKPSNVLLDDNMVAHLSDFGIAKLL--IGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRR 968 (1057)
Q Consensus 891 vH~Dlkp~Nill~~~~~~kl~Dfg~a~~~--~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~ 968 (1057)
+|+++..+-|++..+|-+|++--.-.... .............+-++|.|||.......+.++|||+||+...||..+.
T Consensus 200 ihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailE 279 (458)
T KOG1266|consen 200 IHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILE 279 (458)
T ss_pred ccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHhe
Confidence 99999999999999998888532211111 0001111222334677999999988888888999999999999999886
Q ss_pred CCCCcccccccchhhhhhhccchhHHHhhhcccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHHH
Q 001544 969 KPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLK 1046 (1057)
Q Consensus 969 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~ 1046 (1057)
.--.. ++.... ..+.+......... ..-.+++.+|++..|..||+|++++.|.-.
T Consensus 280 iq~tn---seS~~~----------~ee~ia~~i~~len----------~lqr~~i~kcl~~eP~~rp~ar~llfHpll 334 (458)
T KOG1266|consen 280 IQSTN---SESKVE----------VEENIANVIIGLEN----------GLQRGSITKCLEGEPNGRPDARLLLFHPLL 334 (458)
T ss_pred eccCC---Ccceee----------hhhhhhhheeeccC----------ccccCcCcccccCCCCCCcchhhhhcCcee
Confidence 53111 100000 00000000010000 011356889999999999999999988643
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.37 E-value=3.3e-14 Score=155.84 Aligned_cols=175 Identities=33% Similarity=0.505 Sum_probs=132.2
Q ss_pred cCCcEEEccCCcCCCCCCcccccccccceeecccccCcccCCcccccccccceEEecCeeeeecCCccccCccccccccc
Q 001544 462 ANLVTLDLGGNKFNGSIPIALGKLQKLQLLNLDDNKLEGSIPDDICGLVELYKLALGDNKLSGQIPACFGNLASLRELWL 541 (1057)
Q Consensus 462 ~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L 541 (1057)
..-...||+.|++. .+|..+..+..|+.+.|..|.+. .+|..++++..|+.|+|+.|+++ ..|..++.++
T Consensus 75 tdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp------- 144 (722)
T KOG0532|consen 75 TDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP------- 144 (722)
T ss_pred cchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-------
Confidence 33445566666665 45666655666666666666665 45555555555555555555555 3444444433
Q ss_pred CCccccccccccccccccccEEEeccccccCCCchhhccccccceeccccccccccccccccCccccceecccccccccc
Q 001544 542 GPNELISFIPSTFWNIKDIMYVNFSSNFLTGPLPLEIENLKALTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQGS 621 (1057)
Q Consensus 542 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 621 (1057)
|+.|-+++|+++ .+|..++.+..|..||.+.|.+. .+|..++++.+|+.|++..|++. .
T Consensus 145 ------------------Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~ 203 (722)
T KOG0532|consen 145 ------------------LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-D 203 (722)
T ss_pred ------------------ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-h
Confidence 455667777777 47778888899999999999998 67889999999999999999999 6
Q ss_pred cCccccccCccceecccCccccCCCcccccCcccccccccCCCcccCc
Q 001544 622 IPDSVGDLISLKSLNLSNNNLSGPIPTSLEKLSDLKELNLSFNKLEGE 669 (1057)
Q Consensus 622 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~ 669 (1057)
+|..+..| .|..||+|.|+++ .+|-.|.++..|++|-|.+|+|+.+
T Consensus 204 lp~El~~L-pLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLqSP 249 (722)
T KOG0532|consen 204 LPEELCSL-PLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQSP 249 (722)
T ss_pred CCHHHhCC-ceeeeecccCcee-ecchhhhhhhhheeeeeccCCCCCC
Confidence 78788865 5999999999999 8999999999999999999999975
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.31 E-value=7.4e-11 Score=137.07 Aligned_cols=144 Identities=18% Similarity=0.194 Sum_probs=94.0
Q ss_pred CCCCCCceeccccCeEEEEEEecC-CcEEEEEEeeccchhH----------------------------------HH---
Q 001544 769 NGFSENNLIGRGSFGSVYIARLQN-GIEVAVKTFDLQHERA----------------------------------FK--- 810 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~----------------------------------~~--- 810 (1057)
..|+. +.||+|++|.||+|+.++ |+.||||+.++..... .+
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 35665 799999999999999887 9999999996542110 11
Q ss_pred ---HHHHHHHHHHhcC----CCCceeEeeeecc-CCeeEEEEEEccCCChhHHHhcCCccCCHHHHHHHHHHHHHH-HHH
Q 001544 811 ---SFDTECEVMKSIR----HRNLTKIISSCSN-EDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASA-LEY 881 (1057)
Q Consensus 811 ---~~~~E~~~l~~l~----h~niv~l~~~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~-L~~ 881 (1057)
++.+|+..+.+++ +...+.+-..+.+ ....++||||++|+.+.+...-.....+.. .++...++. +..
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~---~la~~~v~~~~~Q 275 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMK---LLAERGVEVFFTQ 275 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHH---HHHHHHHHHHHHH
Confidence 2344554444442 4443444333322 456789999999999987422111112221 122222221 223
Q ss_pred HHhCCCCCeEEccCCCCCeeeCCCC----cEEEEcccccccc
Q 001544 882 LHFGYSAPVIHCDLKPSNVLLDDNM----VAHLSDFGIAKLL 919 (1057)
Q Consensus 882 LH~~~~~~ivH~Dlkp~Nill~~~~----~~kl~Dfg~a~~~ 919 (1057)
++ ..|++|+|+||.||+++.++ .++++|||++..+
T Consensus 276 if---~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l 314 (537)
T PRK04750 276 VF---RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL 314 (537)
T ss_pred HH---hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence 34 68999999999999999888 9999999998765
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.30 E-value=2.6e-12 Score=148.66 Aligned_cols=195 Identities=39% Similarity=0.564 Sum_probs=99.9
Q ss_pred EEeCCCCCccccCCcccccccccceeecccccccCCCCccccccC-CCCeEeccCCCCCCCCCcccccCCCCCceeEccC
Q 001544 99 ILDLNFNRLSGEIPWELGNLAKLEKLLLHNNFLTGTIPFSIFKLS-SLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSD 177 (1057)
Q Consensus 99 ~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~-~L~~L~Ls~n~l~~~~p~~~l~~l~~L~~L~Ls~ 177 (1057)
.|+++.|.+... +..+..++.++.|++.+|.++ .+|...+.+. +|+.|++++|++. .+|. .++.+++|+.|++++
T Consensus 97 ~l~~~~~~~~~~-~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~-~~~~l~~L~~L~l~~ 172 (394)
T COG4886 97 SLDLNLNRLRSN-ISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPS-PLRNLPNLKNLDLSF 172 (394)
T ss_pred eeeccccccccC-chhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhh-hhhccccccccccCC
Confidence 455555555322 223444455666666666666 5555555553 6666666666665 3432 255666666666666
Q ss_pred CcccccCchhhhccccCCeeEeeccCCccccCccccCCCCcccEEEeeccccccCccccccCCCCCcEEEccCCCCcCCc
Q 001544 178 NQLSGSIPSFIFKISSLQALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGGISSTLSNCKHLRILDLSFNDLWGDI 257 (1057)
Q Consensus 178 n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~l~~n~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~ 257 (1057)
|+++ .+|...+.+++|+.|++++|+++ .+|..+ .....|++|++++|.+. ..
T Consensus 173 N~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~-------------------------~~~~~L~~l~~~~N~~~-~~ 224 (394)
T COG4886 173 NDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEI-------------------------ELLSALEELDLSNNSII-EL 224 (394)
T ss_pred chhh-hhhhhhhhhhhhhheeccCCccc-cCchhh-------------------------hhhhhhhhhhhcCCcce-ec
Confidence 6666 34444445566666666666665 333321 22233555555555322 33
Q ss_pred cccccCcCCCcEEeeeccccccccCccccccccccEEEeecCccccccCccccccccccEEEecCCccccC
Q 001544 258 PKEIGNLTKLKELFLDFNILQGEIPHTVGNLHNLEYLSLVNNELVGTVPATIFNVSTLKLIELSNNTFFGS 328 (1057)
Q Consensus 258 p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 328 (1057)
+..+.++.++..|.+++|++. ..+..++.++++++|++++|+++. ++. +..+.+++.|++++|.+...
T Consensus 225 ~~~~~~~~~l~~l~l~~n~~~-~~~~~~~~l~~l~~L~~s~n~i~~-i~~-~~~~~~l~~L~~s~n~~~~~ 292 (394)
T COG4886 225 LSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQISS-ISS-LGSLTNLRELDLSGNSLSNA 292 (394)
T ss_pred chhhhhcccccccccCCceee-eccchhccccccceeccccccccc-ccc-ccccCccCEEeccCcccccc
Confidence 344455555555555555554 224445555555555555555542 222 44455555555555555433
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.28 E-value=3.7e-12 Score=147.37 Aligned_cols=198 Identities=37% Similarity=0.537 Sum_probs=128.3
Q ss_pred EEEccCCcCCCCCCcccccccccceeecccccCcccCCccccccc-ccceEEecCeeeeecCCccccCcccccccccCCc
Q 001544 466 TLDLGGNKFNGSIPIALGKLQKLQLLNLDDNKLEGSIPDDICGLV-ELYKLALGDNKLSGQIPACFGNLASLRELWLGPN 544 (1057)
Q Consensus 466 ~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N 544 (1057)
.++++.|.+. ..+..+..++.++.|++.+|+++ .++.....+. +|+.|++++|++. .+|..++.+++|+.|++++|
T Consensus 97 ~l~~~~~~~~-~~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N 173 (394)
T COG4886 97 SLDLNLNRLR-SNISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN 173 (394)
T ss_pred eeeccccccc-cCchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence 4555555553 22333444455666666666665 3444444443 6666666666665 34445666666666666666
Q ss_pred cccccccccccccccccEEEeccccccCCCchhhccccccceeccccccccccccccccCccccceecccccccccccCc
Q 001544 545 ELISFIPSTFWNIKDIMYVNFSSNFLTGPLPLEIENLKALTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQGSIPD 624 (1057)
Q Consensus 545 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 624 (1057)
++..+.+.. ...+.|+.|++++|+++. +|........|++|++++|++. ..+..+..+.++..|.+++|++. ..+.
T Consensus 174 ~l~~l~~~~-~~~~~L~~L~ls~N~i~~-l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~~~ 249 (394)
T COG4886 174 DLSDLPKLL-SNLSNLNNLDLSGNKISD-LPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPE 249 (394)
T ss_pred hhhhhhhhh-hhhhhhhheeccCCcccc-CchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceee-eccc
Confidence 666653322 255666677777777774 4444445566888888888544 45667778888888888888887 4467
Q ss_pred cccccCccceecccCccccCCCcccccCcccccccccCCCcccCcCCC
Q 001544 625 SVGDLISLKSLNLSNNNLSGPIPTSLEKLSDLKELNLSFNKLEGEIPR 672 (1057)
Q Consensus 625 ~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~ 672 (1057)
.++.+.++++|++++|+++. ++. +..+.+++.|++++|.+....|.
T Consensus 250 ~~~~l~~l~~L~~s~n~i~~-i~~-~~~~~~l~~L~~s~n~~~~~~~~ 295 (394)
T COG4886 250 SIGNLSNLETLDLSNNQISS-ISS-LGSLTNLRELDLSGNSLSNALPL 295 (394)
T ss_pred hhccccccceeccccccccc-ccc-ccccCccCEEeccCccccccchh
Confidence 77888888888888888873 333 77888888888888888876664
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.28 E-value=3.6e-12 Score=143.52 Aligned_cols=249 Identities=22% Similarity=0.215 Sum_probs=182.8
Q ss_pred CCCCCceecc--ccCeEEEEEEe---cCCcEEEEEEeecc--chhHHHHHHHHHHHHHhcC-CCCceeEeeeeccCCeeE
Q 001544 770 GFSENNLIGR--GSFGSVYIARL---QNGIEVAVKTFDLQ--HERAFKSFDTECEVMKSIR-HRNLTKIISSCSNEDFKA 841 (1057)
Q Consensus 770 ~~~~~~~lg~--G~~g~Vy~~~~---~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~ 841 (1057)
.|.+.+.+|+ |.+|.||.+.. .++..+|+|+-+.. ......+=.+|+.....++ |++.++.+..+.+.+..+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 4556688999 99999999976 36889999984322 2222333456777777774 999999999999999999
Q ss_pred EEEEEccCCChhHHHhcCCccCCHHHHHHHHHHHHH----HHHHHHhCCCCCeEEccCCCCCeeeCCC-CcEEEEccccc
Q 001544 842 LILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVAS----ALEYLHFGYSAPVIHCDLKPSNVLLDDN-MVAHLSDFGIA 916 (1057)
Q Consensus 842 lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~----~L~~LH~~~~~~ivH~Dlkp~Nill~~~-~~~kl~Dfg~a 916 (1057)
+-+|++. .++.++.+.....++....+.+..+..+ |+.++| +..++|-|+||.||+...+ ...+++|||+.
T Consensus 195 iqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~~~~kp~~i~~~~~~~s~~~~df~~v 270 (524)
T KOG0601|consen 195 IQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLH---SNNIVHDDLKPANIFTTSDWTSCKLTDFGLV 270 (524)
T ss_pred eeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccC---CCcccccccchhheecccccceeecCCccee
Confidence 9999985 6888887776666888888888888888 999999 9999999999999999999 88999999999
Q ss_pred ccccCCCCccc---cccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhH
Q 001544 917 KLLIGEDQSMT---QTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISM 993 (1057)
Q Consensus 917 ~~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 993 (1057)
..+........ .....+...|++||... +.++.++|+|++|.+..+..++..+...- ....|.....
T Consensus 271 ~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g-----~~~~W~~~r~---- 340 (524)
T KOG0601|consen 271 SKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVG-----KNSSWSQLRQ---- 340 (524)
T ss_pred EEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCC-----CCCCcccccc----
Confidence 88754432111 12225677899999874 56788999999999999999987754321 0111211100
Q ss_pred HHhhhcccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHH
Q 001544 994 MKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 994 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~ 1043 (1057)
.+.+ .+.......++...+..|++.+|..|++++++..+
T Consensus 341 --~~ip---------~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l 379 (524)
T KOG0601|consen 341 --GYIP---------LEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL 379 (524)
T ss_pred --ccCc---------hhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence 0000 00111223445558889999999999998887653
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.25 E-value=1.7e-11 Score=123.69 Aligned_cols=128 Identities=23% Similarity=0.263 Sum_probs=97.1
Q ss_pred CceeccccCeEEEEEEecCCcEEEEEEeeccchhHHHHHHHHHHHHHhcCCCCc-eeEeeeeccCCeeEEEEEEccCCCh
Q 001544 774 NNLIGRGSFGSVYIARLQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNL-TKIISSCSNEDFKALILEYMRNGSL 852 (1057)
Q Consensus 774 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~E~~~~gsL 852 (1057)
.+.++.|.++.||+++.. +..|++|+...... ....+.+|+++++.+.+.++ .+++.+.. +..++||||++|.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCcc
Confidence 367899999999999876 78899998754432 22456789999999865544 45555433 345799999999887
Q ss_pred hHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCC-----eEEccCCCCCeeeCCCCcEEEEccccccc
Q 001544 853 EKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAP-----VIHCDLKPSNVLLDDNMVAHLSDFGIAKL 918 (1057)
Q Consensus 853 ~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~-----ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~ 918 (1057)
.+. . .....++.+++++++.|| ..+ ++|||++|.||+++ ++.++++|||.+..
T Consensus 79 ~~~----~-----~~~~~~~~~l~~~l~~LH---~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 79 LTE----D-----FSDPENLEKIAKLLKKLH---SSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ccc----c-----ccCHHHHHHHHHHHHHHh---CCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 653 0 112346789999999999 666 59999999999999 67899999998764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.24 E-value=4.5e-13 Score=139.39 Aligned_cols=114 Identities=20% Similarity=0.260 Sum_probs=50.3
Q ss_pred ccCCCCCcEEEccCCCCcCC----ccccccCcCCCcEEeeecccccc----ccCccccccccccEEEeecCccccccCcc
Q 001544 237 LSNCKHLRILDLSFNDLWGD----IPKEIGNLTKLKELFLDFNILQG----EIPHTVGNLHNLEYLSLVNNELVGTVPAT 308 (1057)
Q Consensus 237 l~~l~~L~~L~Ls~N~l~~~----~p~~l~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~~~~ 308 (1057)
|...+.|+.+.++.|.|... +...+..+++|+.|||.+|.++. .+...++.+++|+.|++++|.+.......
T Consensus 181 ~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~~Ga~a 260 (382)
T KOG1909|consen 181 FQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLENEGAIA 260 (382)
T ss_pred HHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccccccccccHHH
Confidence 33344444444444444211 12233444444555554444442 12223344445555555555544322222
Q ss_pred cc-----ccccccEEEecCCccccC---CCCCcccCCCCCceEEecCccc
Q 001544 309 IF-----NVSTLKLIELSNNTFFGS---LPSSTDVQLPNLEELYLWGNNF 350 (1057)
Q Consensus 309 ~~-----~l~~L~~L~Ls~N~l~~~---~~~~~~~~l~~L~~L~L~~N~l 350 (1057)
|. ..++|+.|.+.+|.++.. .-.......|.|+.|+|++|.+
T Consensus 261 ~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l 310 (382)
T KOG1909|consen 261 FVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRL 310 (382)
T ss_pred HHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCcccc
Confidence 21 234555555555555311 0001111356777777777777
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.21 E-value=1.6e-10 Score=131.22 Aligned_cols=167 Identities=17% Similarity=0.223 Sum_probs=129.3
Q ss_pred ecCCcEEEEEEeeccchhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEEccCCChhHHHhcCCccCCHHHHH
Q 001544 790 LQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRL 869 (1057)
Q Consensus 790 ~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~ 869 (1057)
..++.+|.|++.+...........+.++-++.+|||+|++++..++.++..|+|+|-+. .|..++.. +......
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~----l~~~~v~ 107 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE----LGKEEVC 107 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH----hHHHHHH
Confidence 44688999998876655556677888999999999999999999999999999999875 46666654 2355666
Q ss_pred HHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccCCCCccccccccccccccCccccCCCCCC
Q 001544 870 NIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVS 949 (1057)
Q Consensus 870 ~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~ 949 (1057)
-.+.||+.||.|||+ +.+++|++|.-.-|++++.|+.||++|.++....+... ......--..|..|+.+....
T Consensus 108 ~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~-- 181 (690)
T KOG1243|consen 108 LGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE-- 181 (690)
T ss_pred HHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc--
Confidence 788999999999985 67899999999999999999999999998865432221 111112223466776543332
Q ss_pred ccchHHHHHHHHHHHhhCC
Q 001544 950 TKGDVYSFGILLMETFTRR 968 (1057)
Q Consensus 950 ~~~Dv~s~G~il~elltg~ 968 (1057)
-..|.|.||++++|++.|.
T Consensus 182 ~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 182 WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred cchhhhhHHHHHHHHhCcc
Confidence 2469999999999999993
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.19 E-value=2.6e-10 Score=114.84 Aligned_cols=136 Identities=18% Similarity=0.185 Sum_probs=100.3
Q ss_pred CceeccccCeEEEEEEecC-------CcEEEEEEeeccc----------------------hhHHHHHH----HHHHHHH
Q 001544 774 NNLIGRGSFGSVYIARLQN-------GIEVAVKTFDLQH----------------------ERAFKSFD----TECEVMK 820 (1057)
Q Consensus 774 ~~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~----------------------~~~~~~~~----~E~~~l~ 820 (1057)
...||.|.-+.||.|...+ +..+|||+.+... ....+.+. +|++.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3579999999999997543 5799999874320 01122333 8999999
Q ss_pred hcCC--CCceeEeeeeccCCeeEEEEEEccCCChhH-HHhcCCccCCHHHHHHHHHHHHHHHHHH-HhCCCCCeEEccCC
Q 001544 821 SIRH--RNLTKIISSCSNEDFKALILEYMRNGSLEK-CLYSGNYILDIFQRLNIMIDVASALEYL-HFGYSAPVIHCDLK 896 (1057)
Q Consensus 821 ~l~h--~niv~l~~~~~~~~~~~lV~E~~~~gsL~~-~l~~~~~~l~~~~~~~i~~~i~~~L~~L-H~~~~~~ivH~Dlk 896 (1057)
++.. -++.+++++ ...++||||+.++.+.. .+.. ..++..+...+..+++.++.++ | ..++||||++
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd--~~~~~~~~~~i~~~i~~~l~~l~H---~~glVHGDLs 152 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD--AKLNDEEMKNAYYQVLSMMKQLYK---ECNLVHADLS 152 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc--cccCHHHHHHHHHHHHHHHHHHHH---hCCeecCCCC
Confidence 9853 456666654 45679999998754422 2222 2345566778889999999999 8 8899999999
Q ss_pred CCCeeeCCCCcEEEEcccccccc
Q 001544 897 PSNVLLDDNMVAHLSDFGIAKLL 919 (1057)
Q Consensus 897 p~Nill~~~~~~kl~Dfg~a~~~ 919 (1057)
+.||+++ ++.++++|||.+...
T Consensus 153 ~~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 153 EYNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred HHHEEEE-CCcEEEEECCCceeC
Confidence 9999997 468999999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.13 E-value=2.8e-11 Score=136.48 Aligned_cols=250 Identities=20% Similarity=0.143 Sum_probs=177.6
Q ss_pred HhCCCCCCceeccccCeEEEEEEec--CCcEEEEEEeeccchhHHHH--HHHHHHHHHhc-CCCCceeEeeeeccCCeeE
Q 001544 767 ATNGFSENNLIGRGSFGSVYIARLQ--NGIEVAVKTFDLQHERAFKS--FDTECEVMKSI-RHRNLTKIISSCSNEDFKA 841 (1057)
Q Consensus 767 ~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~--~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 841 (1057)
...+|..+..||.|.|+.|++...+ ++..|++|...........+ -..|+.+...+ .|.++++....|...+..|
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ 342 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY 342 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence 3457888999999999999998643 67889999875433222121 12355555555 5899999888888888889
Q ss_pred EEEEEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCC-CcEEEEccccccccc
Q 001544 842 LILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDN-MVAHLSDFGIAKLLI 920 (1057)
Q Consensus 842 lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~-~~~kl~Dfg~a~~~~ 920 (1057)
+--||+++++......- ...++...++++..|++.++.++| ++.++|+|+||+||++..+ +..+++|||.++.+.
T Consensus 343 ip~e~~~~~s~~l~~~~-~~~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~ 418 (524)
T KOG0601|consen 343 IPLEFCEGGSSSLRSVT-SQMLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLA 418 (524)
T ss_pred CchhhhcCcchhhhhHH-HHhcCcchhhhhHHHHHhcccccc---chhhhcccccccceeeccchhhhhccccccccccc
Confidence 99999999988766522 234777788999999999999999 9999999999999999886 888999999987431
Q ss_pred CCCCcccccccccccccc--CccccCCCCCCccchHHHHHHHHHHHhhCCCCCCcccccccchhhhhhhccchhHHHhhh
Q 001544 921 GEDQSMTQTQTLATLGYM--APEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIID 998 (1057)
Q Consensus 921 ~~~~~~~~~~~~~t~~y~--aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 998 (1057)
- .........+++ +|+......+..+.|+|+||..+.|.++|..--.. ..+|... .
T Consensus 419 ~-----~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~-------~~~~~~i---------~- 476 (524)
T KOG0601|consen 419 F-----SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSES-------GVQSLTI---------R- 476 (524)
T ss_pred e-----ecccccccccccccchhhccccccccccccccccccccccccCcccCcc-------cccceee---------e-
Confidence 1 111112233444 55566667788999999999999999998752111 0111110 0
Q ss_pred cccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHHHHHHHHHHhHH
Q 001544 999 ANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKIRD 1049 (1057)
Q Consensus 999 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~evl~~L~~i~~ 1049 (1057)
.. ..+........+..+.+.+..+++..||.+.+...+.+..++
T Consensus 477 ~~-------~~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~~ 520 (524)
T KOG0601|consen 477 SG-------DTPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYRD 520 (524)
T ss_pred cc-------cccCCCchHHhhhhhhhhhcCCccccchhhhhhcccchhhhh
Confidence 00 001111122556678888999999999999998887766544
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.13 E-value=1.3e-12 Score=136.12 Aligned_cols=256 Identities=24% Similarity=0.245 Sum_probs=149.7
Q ss_pred ccccCCCCCcEEeCCCCCcccc----CCcccccccccceeecccc---cccCCCCccccccCCCCeEeccCCCCCCCCCc
Q 001544 89 RQLGNLSSLEILDLNFNRLSGE----IPWELGNLAKLEKLLLHNN---FLTGTIPFSIFKLSSLLDLKLSDNNLTGTIPS 161 (1057)
Q Consensus 89 ~~l~~l~~L~~L~L~~n~l~~~----~p~~l~~l~~L~~L~L~~n---~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~ 161 (1057)
+.+..+..++.|+||+|.|..+ +...+.+.++|+..++|+= ++...+|..+..+.
T Consensus 24 ~~~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~------------------ 85 (382)
T KOG1909|consen 24 EELEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLS------------------ 85 (382)
T ss_pred HHhcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHH------------------
Confidence 4456678889999999988643 5566777888888888762 33344555443320
Q ss_pred ccccCCCCCceeEccCCcccccCchh----hhccccCCeeEeeccCCccccCccccCCCCcccEEEeeccccccCccccc
Q 001544 162 HNLGNLSSLQLLDLSDNQLSGSIPSF----IFKISSLQALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGGISSTL 237 (1057)
Q Consensus 162 ~~l~~l~~L~~L~Ls~n~l~~~~p~~----l~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~l~~n~~~~~~~~~l 237 (1057)
.++-..++|++||||+|.+....+.. +.++.+|++|+|.+|.+.-.-...+...|..|. .....
T Consensus 86 ~aL~~~~~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~------------~~kk~ 153 (382)
T KOG1909|consen 86 KALLGCPKLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELA------------VNKKA 153 (382)
T ss_pred HHHhcCCceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHH------------HHhcc
Confidence 13445556777777777666444433 345677888888888775322222222221111 01123
Q ss_pred cCCCCCcEEEccCCCCcCC----ccccccCcCCCcEEeeeccccccc----cCccccccccccEEEeecCcccccc----
Q 001544 238 SNCKHLRILDLSFNDLWGD----IPKEIGNLTKLKELFLDFNILQGE----IPHTVGNLHNLEYLSLVNNELVGTV---- 305 (1057)
Q Consensus 238 ~~l~~L~~L~Ls~N~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~---- 305 (1057)
++-+.|+++..++|++... +...|...+.|+.+.++.|.|... +...|..+++|+.|||..|-++...
T Consensus 154 ~~~~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~L 233 (382)
T KOG1909|consen 154 ASKPKLRVFICGRNRLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVAL 233 (382)
T ss_pred CCCcceEEEEeeccccccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHH
Confidence 4556788888888888643 334455667788888888877521 2234566677777777777665221
Q ss_pred CccccccccccEEEecCCccccCCCCCcccCCCCCceEEecCccccccCCcccc-----cccccccccccccccccc---
Q 001544 306 PATIFNVSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSGTLPSFIF-----NASNLSKLSLGDNSFSGL--- 377 (1057)
Q Consensus 306 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~-----~l~~L~~L~L~~N~l~~~--- 377 (1057)
...+.. +++|++|++++|.+......++. ..++|+.|.+.+|.|+..
T Consensus 234 akaL~s-------------------------~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~ 288 (382)
T KOG1909|consen 234 AKALSS-------------------------WPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAAL 288 (382)
T ss_pred HHHhcc-------------------------cchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHH
Confidence 122223 34555555555555543333332 245666777777766532
Q ss_pred -ccchhcccccccEEeccCcccC
Q 001544 378 -IPNTFGNLRNLKRLRLYNNYLT 399 (1057)
Q Consensus 378 -~~~~~~~l~~L~~L~L~~N~l~ 399 (1057)
+..++...+.|..|+|++|.+.
T Consensus 289 ~la~~~~ek~dL~kLnLngN~l~ 311 (382)
T KOG1909|consen 289 ALAACMAEKPDLEKLNLNGNRLG 311 (382)
T ss_pred HHHHHHhcchhhHHhcCCccccc
Confidence 2233455677777777777774
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.12 E-value=1.1e-11 Score=143.51 Aligned_cols=201 Identities=27% Similarity=0.281 Sum_probs=107.8
Q ss_pred ccCccCCcEEEccCCcCCCCCCcccccccccceeecccccCcccCCcccccccccceEEecCeeeeecCC-ccccCcccc
Q 001544 458 IGNLANLVTLDLGGNKFNGSIPIALGKLQKLQLLNLDDNKLEGSIPDDICGLVELYKLALGDNKLSGQIP-ACFGNLASL 536 (1057)
Q Consensus 458 ~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~-~~~~~l~~L 536 (1057)
+..+++|++|+|++|.|+.+. .+..++.|+.|++++|.|+. ...+..+..|+.+++++|++...-+ . ...+.++
T Consensus 114 l~~~~~L~~L~ls~N~I~~i~--~l~~l~~L~~L~l~~N~i~~--~~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l 188 (414)
T KOG0531|consen 114 LSSLVNLQVLDLSFNKITKLE--GLSTLTLLKELNLSGNLISD--ISGLESLKSLKLLDLSYNRIVDIENDE-LSELISL 188 (414)
T ss_pred hhhhhcchheecccccccccc--chhhccchhhheeccCcchh--ccCCccchhhhcccCCcchhhhhhhhh-hhhccch
Confidence 445666777777777776433 24455567777777777753 2344446677777777777764433 2 4566777
Q ss_pred cccccCCccccccccccccccccccEEEeccccccCCCchhhcccc--ccceeccccccccccccccccCccccceeccc
Q 001544 537 RELWLGPNELISFIPSTFWNIKDIMYVNFSSNFLTGPLPLEIENLK--ALTTLDFSMNNLSGVIPTTIGGLKGLQYLFLG 614 (1057)
Q Consensus 537 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~--~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 614 (1057)
+.+++++|.+..+. .+..+..+..+++..|.++...+ +..+. .|+.+++++|++. ..+..+..+..+..|+++
T Consensus 189 ~~l~l~~n~i~~i~--~~~~~~~l~~~~l~~n~i~~~~~--l~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~ 263 (414)
T KOG0531|consen 189 EELDLGGNSIREIE--GLDLLKKLVLLSLLDNKISKLEG--LNELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLS 263 (414)
T ss_pred HHHhccCCchhccc--chHHHHHHHHhhcccccceeccC--cccchhHHHHHHhcccCccc-cccccccccccccccchh
Confidence 77777777766542 22223333334555555553221 11112 2566666666665 333445555666666666
Q ss_pred ccccccccCccccccCccceecccCccccC---CCccc-ccCcccccccccCCCcccCcC
Q 001544 615 HNRLQGSIPDSVGDLISLKSLNLSNNNLSG---PIPTS-LEKLSDLKELNLSFNKLEGEI 670 (1057)
Q Consensus 615 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~---~~p~~-l~~l~~L~~l~ls~N~l~~~~ 670 (1057)
+|++... ..+.....+..+.++.|++.. ..... ....+.+..+++.+|+.....
T Consensus 264 ~n~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (414)
T KOG0531|consen 264 SNRISNL--EGLERLPKLSELWLNDNKLALSEAISQEYITSAAPTLVTLTLELNPIRKIS 321 (414)
T ss_pred hcccccc--ccccccchHHHhccCcchhcchhhhhccccccccccccccccccCcccccc
Confidence 6665522 123444555555566665542 11111 344455555555555555443
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.12 E-value=1.1e-11 Score=132.64 Aligned_cols=211 Identities=23% Similarity=0.245 Sum_probs=100.9
Q ss_pred ccCCCCeEeccCCCCCCCCC-cccccCCCCCceeEccCCcccc--cCchhhhccccCCeeEeeccCCccccCccccCCCC
Q 001544 141 KLSSLLDLKLSDNNLTGTIP-SHNLGNLSSLQLLDLSDNQLSG--SIPSFIFKISSLQALHFGNNRLSGELPANICDNLP 217 (1057)
Q Consensus 141 ~l~~L~~L~Ls~n~l~~~~p-~~~l~~l~~L~~L~Ls~n~l~~--~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~l~ 217 (1057)
++++|++..|.++... ..+ ......+++++.||||.|-+.. .+......+++|+.|+|+.|++.-......-.
T Consensus 119 n~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~--- 194 (505)
T KOG3207|consen 119 NLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTL--- 194 (505)
T ss_pred hHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchh---
Confidence 3455555555555443 111 1234455666666666665542 22233445666666666666654221111111
Q ss_pred cccEEEeeccccccCccccccCCCCCcEEEccCCCCcC-CccccccCcCCCcEEeeeccccccccCccccccccccEEEe
Q 001544 218 FLNFFSVYKNMFYGGISSTLSNCKHLRILDLSFNDLWG-DIPKEIGNLTKLKELFLDFNILQGEIPHTVGNLHNLEYLSL 296 (1057)
Q Consensus 218 ~L~~L~l~~n~~~~~~~~~l~~l~~L~~L~Ls~N~l~~-~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 296 (1057)
.+++|+.|.|+.|.++- .+-..+..+|+|+.|+|..|...........-+..|+.|||
T Consensus 195 ---------------------~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdL 253 (505)
T KOG3207|consen 195 ---------------------LLSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDL 253 (505)
T ss_pred ---------------------hhhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccc
Confidence 23344444444444431 12222333445555555554322222223333445555555
Q ss_pred ecCccccccC--ccccccccccEEEecCCccccC-CCCC----cccCCCCCceEEecCccccc-cCCccccccccccccc
Q 001544 297 VNNELVGTVP--ATIFNVSTLKLIELSNNTFFGS-LPSS----TDVQLPNLEELYLWGNNFSG-TLPSFIFNASNLSKLS 368 (1057)
Q Consensus 297 ~~N~l~~~~~--~~~~~l~~L~~L~Ls~N~l~~~-~~~~----~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~ 368 (1057)
++|++-. .+ .....++.|+.|+++.+.+... .|+. ....+++|++|+++.|+|.. ..-..+..+++|+.|.
T Consensus 254 s~N~li~-~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~ 332 (505)
T KOG3207|consen 254 SNNNLID-FDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLR 332 (505)
T ss_pred cCCcccc-cccccccccccchhhhhccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhh
Confidence 5555431 11 2233445555555555544311 1111 11356788888888888752 1223445567788888
Q ss_pred ccccccccc
Q 001544 369 LGDNSFSGL 377 (1057)
Q Consensus 369 L~~N~l~~~ 377 (1057)
...|.++..
T Consensus 333 ~~~n~ln~e 341 (505)
T KOG3207|consen 333 ITLNYLNKE 341 (505)
T ss_pred ccccccccc
Confidence 888888754
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.10 E-value=9e-12 Score=133.16 Aligned_cols=185 Identities=28% Similarity=0.267 Sum_probs=124.2
Q ss_pred ccccccceeecccccccCCCC--ccccccCCCCeEeccCCCCCCCCCc-ccccCCCCCceeEccCCcccccCchhh-hcc
Q 001544 116 GNLAKLEKLLLHNNFLTGTIP--FSIFKLSSLLDLKLSDNNLTGTIPS-HNLGNLSSLQLLDLSDNQLSGSIPSFI-FKI 191 (1057)
Q Consensus 116 ~~l~~L~~L~L~~n~l~~~~p--~~~~~l~~L~~L~Ls~n~l~~~~p~-~~l~~l~~L~~L~Ls~n~l~~~~p~~l-~~l 191 (1057)
.++++|+...|.+..+.. .+ .....+++++.||||+|-+....|- .....||+|+.|+|+.|.+.-...+.. ..+
T Consensus 118 sn~kkL~~IsLdn~~V~~-~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l 196 (505)
T KOG3207|consen 118 SNLKKLREISLDNYRVED-AGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLL 196 (505)
T ss_pred hhHHhhhheeecCccccc-cchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhh
Confidence 568899999999988873 33 3667889999999999988754332 235689999999999998873322222 256
Q ss_pred ccCCeeEeeccCCccccCccccCCCCcccEEEeeccccccCccccccCCCCCcEEEccCCCCcCCcc--ccccCcCCCcE
Q 001544 192 SSLQALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGGISSTLSNCKHLRILDLSFNDLWGDIP--KEIGNLTKLKE 269 (1057)
Q Consensus 192 ~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~l~~n~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p--~~l~~l~~L~~ 269 (1057)
+.|+.|.|+.|.++..--..+...+|+|+.|++..|...+.......-+..|+.|||++|++.. .+ ...+.++.|+.
T Consensus 197 ~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~-~~~~~~~~~l~~L~~ 275 (505)
T KOG3207|consen 197 SHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLID-FDQGYKVGTLPGLNQ 275 (505)
T ss_pred hhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccc-cccccccccccchhh
Confidence 7899999999999865555556667777777777775444444455566677777777777642 22 34556667777
Q ss_pred Eeeeccccccc-cCcc-----ccccccccEEEeecCccc
Q 001544 270 LFLDFNILQGE-IPHT-----VGNLHNLEYLSLVNNELV 302 (1057)
Q Consensus 270 L~L~~N~l~~~-~p~~-----~~~l~~L~~L~L~~N~l~ 302 (1057)
|+++.+.++.. +|+. ...+++|++|+++.|+|.
T Consensus 276 Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~ 314 (505)
T KOG3207|consen 276 LNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIR 314 (505)
T ss_pred hhccccCcchhcCCCccchhhhcccccceeeecccCccc
Confidence 77777666532 1222 234456666666666653
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.09 E-value=7.6e-10 Score=117.11 Aligned_cols=142 Identities=18% Similarity=0.235 Sum_probs=111.9
Q ss_pred ceeccccCeEEEEEEecCCcEEEEEEeeccch-hHHHHHHHHHHHHHhcCC--CCceeEeeeeccC---CeeEEEEEEcc
Q 001544 775 NLIGRGSFGSVYIARLQNGIEVAVKTFDLQHE-RAFKSFDTECEVMKSIRH--RNLTKIISSCSNE---DFKALILEYMR 848 (1057)
Q Consensus 775 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~---~~~~lV~E~~~ 848 (1057)
+.++.|..+.||++...+|+.+++|....... .....+.+|+++++.+++ ..+.+++.+..+. +..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 67899999999999887778999998754332 134678899999999975 3457777777654 36689999999
Q ss_pred CCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhC-------------------------------------------
Q 001544 849 NGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFG------------------------------------------- 885 (1057)
Q Consensus 849 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~------------------------------------------- 885 (1057)
|.++.+.+.. ..++..++..++.++++++++||..
T Consensus 84 G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (223)
T cd05154 84 GRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLL 161 (223)
T ss_pred CEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHH
Confidence 9988775532 2467778888999999999999831
Q ss_pred ----------CCCCeEEccCCCCCeeeCC--CCcEEEEccccccc
Q 001544 886 ----------YSAPVIHCDLKPSNVLLDD--NMVAHLSDFGIAKL 918 (1057)
Q Consensus 886 ----------~~~~ivH~Dlkp~Nill~~--~~~~kl~Dfg~a~~ 918 (1057)
....++|+|++|.||+++. ++.+.++||+.+..
T Consensus 162 ~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 162 RWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 1245799999999999998 67789999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.08 E-value=4.2e-11 Score=121.40 Aligned_cols=134 Identities=25% Similarity=0.377 Sum_probs=100.7
Q ss_pred ccccccEEEeecCccccccCccccccccccEEEecCCccccCCCCCcccCCCCCceEEecCccccccCCccccccccccc
Q 001544 287 NLHNLEYLSLVNNELVGTVPATIFNVSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSGTLPSFIFNASNLSK 366 (1057)
Q Consensus 287 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 366 (1057)
..+.|++||||+|.|+ .+..+..-.+.++.|++|+|.+. .+.. ...+++|++|||++|.++ .+..+-..+.+.+.
T Consensus 282 TWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~v~n--La~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKt 356 (490)
T KOG1259|consen 282 TWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIR-TVQN--LAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKT 356 (490)
T ss_pred hHhhhhhccccccchh-hhhhhhhhccceeEEecccccee-eehh--hhhcccceEeecccchhH-hhhhhHhhhcCEee
Confidence 3467788888888887 56666666788888888888876 3333 335788888888888887 45555566788888
Q ss_pred cccccccccccccchhcccccccEEeccCcccCCCccccccccCCCcchhhhhccCCCccccc
Q 001544 367 LSLGDNSFSGLIPNTFGNLRNLKRLRLYNNYLTSPELSFLSSLSNCKYLEIIALSGNPLNGII 429 (1057)
Q Consensus 367 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~ 429 (1057)
|.|+.|.|... ..++.+-+|..|++++|+|...+. ..+..+++-|+++.|.+|++.++.
T Consensus 357 L~La~N~iE~L--SGL~KLYSLvnLDl~~N~Ie~lde--V~~IG~LPCLE~l~L~~NPl~~~v 415 (490)
T KOG1259|consen 357 LKLAQNKIETL--SGLRKLYSLVNLDLSSNQIEELDE--VNHIGNLPCLETLRLTGNPLAGSV 415 (490)
T ss_pred eehhhhhHhhh--hhhHhhhhheeccccccchhhHHH--hcccccccHHHHHhhcCCCccccc
Confidence 88888888754 557778888888888888877543 457778888888888888887653
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.06 E-value=1.5e-09 Score=104.64 Aligned_cols=131 Identities=22% Similarity=0.375 Sum_probs=103.1
Q ss_pred ceeccccCeEEEEEEecCCcEEEEEEeeccc--------hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEEEE
Q 001544 775 NLIGRGSFGSVYIARLQNGIEVAVKTFDLQH--------ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEY 846 (1057)
Q Consensus 775 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 846 (1057)
..+++|+-+.+|.+.+. |.++++|.=.++. .-...+-.+|++++++++--.|...+-+..+.+...++|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 35789999999999775 5557777532211 11245677899999999876776666667778888899999
Q ss_pred ccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEccccccc
Q 001544 847 MRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL 918 (1057)
Q Consensus 847 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~ 918 (1057)
++|..|.+.+... +..++..+=.-+.-|| ..+|||+|+.++||.+..++ +.++|||++.+
T Consensus 81 I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH---~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA--------RPDLLREVGRLVGKLH---KAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc--------chHHHHHHHHHHHHHH---hcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999999888665 2456777778888999 99999999999999998765 99999999874
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.05 E-value=3.7e-11 Score=139.00 Aligned_cols=244 Identities=31% Similarity=0.353 Sum_probs=129.7
Q ss_pred CceEEecCccccccCCccccccccccccccccccccccccchhcccccccEEeccCcccCCCccccccccCCCcchhhhh
Q 001544 340 LEELYLWGNNFSGTLPSFIFNASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNYLTSPELSFLSSLSNCKYLEIIA 419 (1057)
Q Consensus 340 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~l~~L~~L~ 419 (1057)
++.+.+..|.+.. +-..+..+.+|..|++.+|+|..+ ...+..+++|++|++++|.|+++ ..+..++.|+.|+
T Consensus 74 l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~i-~~~l~~~~~L~~L~ls~N~I~~i-----~~l~~l~~L~~L~ 146 (414)
T KOG0531|consen 74 LKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEKI-ENLLSSLVNLQVLDLSFNKITKL-----EGLSTLTLLKELN 146 (414)
T ss_pred HHhhccchhhhhh-hhcccccccceeeeeccccchhhc-ccchhhhhcchheeccccccccc-----cchhhccchhhhe
Confidence 3333344444431 222344455555555555555543 11145556666666666666552 2344444455555
Q ss_pred ccCCCcccccccccccccccccEEEcCCCcccccccccccCccCCcEEEccCCcCCCCCC-cccccccccceeecccccC
Q 001544 420 LSGNPLNGIIPMSAGNLSHSLEELFMPDCNVSGRIPKEIGNLANLVTLDLGGNKFNGSIP-IALGKLQKLQLLNLDDNKL 498 (1057)
Q Consensus 420 Ls~N~l~~~~~~~~~~l~~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~i~~~~p-~~~~~l~~L~~L~L~~N~l 498 (1057)
+++|.+..+ ..+..+++|+.+++++|++...-+ . ...+.+|+.+++.+|.+
T Consensus 147 l~~N~i~~~---------------------------~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i 198 (414)
T KOG0531|consen 147 LSGNLISDI---------------------------SGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSI 198 (414)
T ss_pred eccCcchhc---------------------------cCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCch
Confidence 555555422 122335566666666666664333 1 35566666666666666
Q ss_pred cccCCcccccccccceEEecCeeeeecCCccccCcc--cccccccCCccccccccccccccccccEEEeccccccCCCch
Q 001544 499 EGSIPDDICGLVELYKLALGDNKLSGQIPACFGNLA--SLRELWLGPNELISFIPSTFWNIKDIMYVNFSSNFLTGPLPL 576 (1057)
Q Consensus 499 ~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~--~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~ 576 (1057)
.. ...+..+..+..+++..|.++..-+ +..+. +|+.+++++|++..+ +.
T Consensus 199 ~~--i~~~~~~~~l~~~~l~~n~i~~~~~--l~~~~~~~L~~l~l~~n~i~~~-------------------------~~ 249 (414)
T KOG0531|consen 199 RE--IEGLDLLKKLVLLSLLDNKISKLEG--LNELVMLHLRELYLSGNRISRS-------------------------PE 249 (414)
T ss_pred hc--ccchHHHHHHHHhhcccccceeccC--cccchhHHHHHHhcccCccccc-------------------------cc
Confidence 42 2333334444444566666553222 11222 256655555555432 13
Q ss_pred hhccccccceeccccccccccccccccCccccceecccccccccc---cCcc-ccccCccceecccCccccCCCccc
Q 001544 577 EIENLKALTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQGS---IPDS-VGDLISLKSLNLSNNNLSGPIPTS 649 (1057)
Q Consensus 577 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~---~p~~-~~~l~~L~~L~Ls~N~l~~~~p~~ 649 (1057)
.+..+..+..|++.+|+++.. ..+.....+..+.++.|.+... .... ......++...+..|.+....+..
T Consensus 250 ~~~~~~~l~~l~~~~n~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (414)
T KOG0531|consen 250 GLENLKNLPVLDLSSNRISNL--EGLERLPKLSELWLNDNKLALSEAISQEYITSAAPTLVTLTLELNPIRKISSLD 324 (414)
T ss_pred cccccccccccchhhcccccc--ccccccchHHHhccCcchhcchhhhhccccccccccccccccccCccccccccc
Confidence 445566777777777777644 3455566777777777776522 2222 456678888888888887665544
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.03 E-value=7.9e-09 Score=110.44 Aligned_cols=266 Identities=15% Similarity=0.124 Sum_probs=168.2
Q ss_pred CCceeccccCeEEEEEEecCCcEEEEEEeeccchhHHHHHHHHHHHHHhc-CCCCceeEeee------e-ccCCeeEEEE
Q 001544 773 ENNLIGRGSFGSVYIARLQNGIEVAVKTFDLQHERAFKSFDTECEVMKSI-RHRNLTKIISS------C-SNEDFKALIL 844 (1057)
Q Consensus 773 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~------~-~~~~~~~lV~ 844 (1057)
..+.||+|+-+.+|-.- .-...+.|+.......... +.++.|... .||-+-.-+.+ . ..+....+.|
T Consensus 15 ~gr~LgqGgea~ly~l~--e~~d~VAKIYh~Pppa~~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 15 PGRPLGQGGEADLYTLG--EVRDQVAKIYHAPPPAAQA---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CCccccCCccceeeecc--hhhchhheeecCCCchHHH---HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 35789999999999642 1122345666544332211 233444444 45543221111 1 1223356778
Q ss_pred EEccCCChhHHHhcCC------ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEccccccc
Q 001544 845 EYMRNGSLEKCLYSGN------YILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL 918 (1057)
Q Consensus 845 E~~~~gsL~~~l~~~~------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~ 918 (1057)
..+.+..=-..+.+.+ ...+|...+++++.+|.+.+.|| ..|.+-||+.++|+|+++++.+.+.|-..-..
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH---~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLH---EHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHH---hcCCcccccCccceeeecCceEEEEcccceee
Confidence 8776642222222211 45889999999999999999999 99999999999999999999999998554322
Q ss_pred ccCCCCccccccccccccccCccccC-----CCCCCccchHHHHHHHHHHHhhC-CCCCCccccccc---chh-hhhhhc
Q 001544 919 LIGEDQSMTQTQTLATLGYMAPEYGR-----EGRVSTKGDVYSFGILLMETFTR-RKPTDEIFSGEM---TLK-HWVNDF 988 (1057)
Q Consensus 919 ~~~~~~~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~Dv~s~G~il~elltg-~~p~~~~~~~~~---~~~-~~~~~~ 988 (1057)
. .........+|...|.+||.-. +...+...|.|.+|+++++++.| ++||........ ..+ ......
T Consensus 167 ~---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~ 243 (637)
T COG4248 167 N---ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGR 243 (637)
T ss_pred c---cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcce
Confidence 1 3344555678889999999643 34457789999999999999887 899987532211 111 111100
Q ss_pred cchhHHHhhhcccccccchhhHHHHHHHHHHHHHHhHcccCC--CCCCCCHHHHHHHHHHhHHHHhh
Q 001544 989 LPISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVES--PDERITAKEIVRRLLKIRDFLLR 1053 (1057)
Q Consensus 989 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d--P~~Rps~~evl~~L~~i~~~~~~ 1053 (1057)
.-.. -+...-.............++++..+..+|+... |.-||+++-.+..|..+++++..
T Consensus 244 f~ya----~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~ 306 (637)
T COG4248 244 FAYA----SDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKK 306 (637)
T ss_pred eeec----hhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhh
Confidence 0000 0111111111122223456788888899998764 56799999999999999988754
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.02 E-value=7.9e-11 Score=119.45 Aligned_cols=138 Identities=23% Similarity=0.205 Sum_probs=108.8
Q ss_pred ccccCcccccccccCCccccccccccccccccccEEEeccccccCCCchhhccccccceeccccccccccccccccCccc
Q 001544 528 ACFGNLASLRELWLGPNELISFIPSTFWNIKDIMYVNFSSNFLTGPLPLEIENLKALTTLDFSMNNLSGVIPTTIGGLKG 607 (1057)
Q Consensus 528 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 607 (1057)
..+..+..|++++|++|.|+.+.. ...-++.++.|++|+|.++.+ +.+..+++|+.||||+|.++ .+..+=.++.+
T Consensus 278 ~~~dTWq~LtelDLS~N~I~~iDE-SvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGN 353 (490)
T KOG1259|consen 278 VSADTWQELTELDLSGNLITQIDE-SVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGN 353 (490)
T ss_pred EecchHhhhhhccccccchhhhhh-hhhhccceeEEeccccceeee--hhhhhcccceEeecccchhH-hhhhhHhhhcC
Confidence 344556678889999998887653 445578889999999998853 34778899999999999998 44455557889
Q ss_pred cceecccccccccccCccccccCccceecccCccccCCC-cccccCcccccccccCCCcccCcCC
Q 001544 608 LQYLFLGHNRLQGSIPDSVGDLISLKSLNLSNNNLSGPI-PTSLEKLSDLKELNLSFNKLEGEIP 671 (1057)
Q Consensus 608 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~l~~l~~L~~l~ls~N~l~~~~p 671 (1057)
++.|.|+.|.|.. -..++.+-+|..||+++|+|.... -..++++|-|+.+.|.+|++.+.+-
T Consensus 354 IKtL~La~N~iE~--LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~vd 416 (490)
T KOG1259|consen 354 IKTLKLAQNKIET--LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSVD 416 (490)
T ss_pred EeeeehhhhhHhh--hhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccch
Confidence 9999999999872 345788889999999999997432 3567899999999999999997644
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.02 E-value=2.3e-10 Score=112.87 Aligned_cols=128 Identities=33% Similarity=0.348 Sum_probs=41.4
Q ss_pred ccccccceeecccccccCCCCcccc-ccCCCCeEeccCCCCCCCCCcccccCCCCCceeEccCCcccccCchhh-hcccc
Q 001544 116 GNLAKLEKLLLHNNFLTGTIPFSIF-KLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQLSGSIPSFI-FKISS 193 (1057)
Q Consensus 116 ~~l~~L~~L~L~~n~l~~~~p~~~~-~l~~L~~L~Ls~n~l~~~~p~~~l~~l~~L~~L~Ls~n~l~~~~p~~l-~~l~~ 193 (1057)
.+..++++|+|++|.|+. + ..++ .+.+|+.|+|++|.++ .++ .+..+++|++|++++|.|+. +...+ ..+++
T Consensus 16 ~n~~~~~~L~L~~n~I~~-I-e~L~~~l~~L~~L~Ls~N~I~-~l~--~l~~L~~L~~L~L~~N~I~~-i~~~l~~~lp~ 89 (175)
T PF14580_consen 16 NNPVKLRELNLRGNQIST-I-ENLGATLDKLEVLDLSNNQIT-KLE--GLPGLPRLKTLDLSNNRISS-ISEGLDKNLPN 89 (175)
T ss_dssp ----------------------S--TT-TT--EEE-TTS--S---T--T----TT--EEE--SS---S--CHHHHHH-TT
T ss_pred cccccccccccccccccc-c-cchhhhhcCCCEEECCCCCCc-ccc--CccChhhhhhcccCCCCCCc-cccchHHhCCc
Confidence 334455666666666663 2 2344 4566666777777666 343 26667777777777777774 33334 35777
Q ss_pred CCeeEeeccCCccccCccccCCCCcccEEEeeccccccCccccccCCCCCcEEEccCCCCcCCc---cccccCcCCCcEE
Q 001544 194 LQALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGGISSTLSNCKHLRILDLSFNDLWGDI---PKEIGNLTKLKEL 270 (1057)
Q Consensus 194 L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~l~~n~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~---p~~l~~l~~L~~L 270 (1057)
|++|+|++|+|... .. -..++.+++|++|+|.+|.++..- ...+..+|+|+.|
T Consensus 90 L~~L~L~~N~I~~l-~~-----------------------l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~L 145 (175)
T PF14580_consen 90 LQELYLSNNKISDL-NE-----------------------LEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVL 145 (175)
T ss_dssp --EEE-TTS---SC-CC-----------------------CGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEE
T ss_pred CCEEECcCCcCCCh-HH-----------------------hHHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhhee
Confidence 77777777777521 10 124566777777777777776331 1235567777776
Q ss_pred eee
Q 001544 271 FLD 273 (1057)
Q Consensus 271 ~L~ 273 (1057)
|-.
T Consensus 146 D~~ 148 (175)
T PF14580_consen 146 DGQ 148 (175)
T ss_dssp TTE
T ss_pred CCE
Confidence 643
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.99 E-value=4.8e-09 Score=100.34 Aligned_cols=142 Identities=18% Similarity=0.201 Sum_probs=107.4
Q ss_pred CCceeccccCeEEEEEEecCCcEEEEEEe-ecc-------chhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEEEE
Q 001544 773 ENNLIGRGSFGSVYIARLQNGIEVAVKTF-DLQ-------HERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALIL 844 (1057)
Q Consensus 773 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~-~~~-------~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 844 (1057)
...++-+|+-+.|+++.++ |+.+.||.- .+. ..-..++..+|++.+.+++--.|....-++.+...-.++|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 5678999999999999987 787777743 221 1123567788999999987666665555666666667999
Q ss_pred EEccC-CChhHHHhcCCccCCH-HHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCC---cEEEEccccccc
Q 001544 845 EYMRN-GSLEKCLYSGNYILDI-FQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNM---VAHLSDFGIAKL 918 (1057)
Q Consensus 845 E~~~~-gsL~~~l~~~~~~l~~-~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~---~~kl~Dfg~a~~ 918 (1057)
||++| .++.+++...-..-.. ......+..|-+.+.-|| ..+|||||+..+||++..++ .+.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH---~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLH---DNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhh---hCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 99987 4777777654422223 333788999999999999 99999999999999997554 458999999864
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.97 E-value=5.1e-10 Score=137.68 Aligned_cols=270 Identities=26% Similarity=0.267 Sum_probs=134.2
Q ss_pred CCcEEeCCCCC--ccccCCcccccccccceeecccccccCCCCccccccCCCCeEeccCCCCCCCCCcccccCCCCCcee
Q 001544 96 SLEILDLNFNR--LSGEIPWELGNLAKLEKLLLHNNFLTGTIPFSIFKLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLL 173 (1057)
Q Consensus 96 ~L~~L~L~~n~--l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~l~~l~~L~~L 173 (1057)
.|++|-+.+|. +....++.|..++.|+.|||++|.=-+.+|..++.|-+|++|+|++..++ .+|. .+++|+.|.+|
T Consensus 546 ~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~-~l~~Lk~L~~L 623 (889)
T KOG4658|consen 546 KLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPS-GLGNLKKLIYL 623 (889)
T ss_pred ccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccch-HHHHHHhhhee
Confidence 45555555554 33222223555666666666655544556666666666666666666655 5554 35666666666
Q ss_pred EccCCcccccCchhhhccccCCeeEeeccCCccccCccccCCCCcccEEEeeccccccCccccccCCCCCcEEEccCCCC
Q 001544 174 DLSDNQLSGSIPSFIFKISSLQALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGGISSTLSNCKHLRILDLSFNDL 253 (1057)
Q Consensus 174 ~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~l~~n~~~~~~~~~l~~l~~L~~L~Ls~N~l 253 (1057)
|+..+.-...+|..+..|++|++|.+..-... ........+.++.+|+.+.......
T Consensus 624 nl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~-----------------------~~~~~l~el~~Le~L~~ls~~~~s~ 680 (889)
T KOG4658|consen 624 NLEVTGRLESIPGILLELQSLRVLRLPRSALS-----------------------NDKLLLKELENLEHLENLSITISSV 680 (889)
T ss_pred ccccccccccccchhhhcccccEEEeeccccc-----------------------cchhhHHhhhcccchhhheeecchh
Confidence 66655544444555555666666655433211 0111122334455555555433322
Q ss_pred cCCccccccCcCCCc----EEeeeccccccccCccccccccccEEEeecCccccccCcccccc------ccccEEEecCC
Q 001544 254 WGDIPKEIGNLTKLK----ELFLDFNILQGEIPHTVGNLHNLEYLSLVNNELVGTVPATIFNV------STLKLIELSNN 323 (1057)
Q Consensus 254 ~~~~p~~l~~l~~L~----~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l------~~L~~L~Ls~N 323 (1057)
.+-..+..++.|. .+.+..+... ..+..+..+.+|+.|.+.++.+......+.... +++..+...++
T Consensus 681 --~~~e~l~~~~~L~~~~~~l~~~~~~~~-~~~~~~~~l~~L~~L~i~~~~~~e~~~~~~~~~~~~~~f~~l~~~~~~~~ 757 (889)
T KOG4658|consen 681 --LLLEDLLGMTRLRSLLQSLSIEGCSKR-TLISSLGSLGNLEELSILDCGISEIVIEWEESLIVLLCFPNLSKVSILNC 757 (889)
T ss_pred --HhHhhhhhhHHHHHHhHhhhhcccccc-eeecccccccCcceEEEEcCCCchhhcccccccchhhhHHHHHHHHhhcc
Confidence 1111222233322 2332222222 344566777788888888777754333221111 11111111111
Q ss_pred ccccCCCCCcccCCCCCceEEecCccccccCCcccccccccccccccccccccc-ccchhcccccccEEeccC
Q 001544 324 TFFGSLPSSTDVQLPNLEELYLWGNNFSGTLPSFIFNASNLSKLSLGDNSFSGL-IPNTFGNLRNLKRLRLYN 395 (1057)
Q Consensus 324 ~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L~~ 395 (1057)
..- ..+. ...-.|+|+.|++.++.....+.+....+..+..+-+..+.+.+. .-...++++++..+.+.+
T Consensus 758 ~~~-r~l~-~~~f~~~L~~l~l~~~~~~e~~i~~~k~~~~l~~~i~~f~~~~~l~~~~~l~~l~~i~~~~l~~ 828 (889)
T KOG4658|consen 758 HML-RDLT-WLLFAPHLTSLSLVSCRLLEDIIPKLKALLELKELILPFNKLEGLRMLCSLGGLPQLYWLPLSF 828 (889)
T ss_pred ccc-cccc-hhhccCcccEEEEecccccccCCCHHHHhhhcccEEecccccccceeeecCCCCceeEecccCc
Confidence 110 0111 112357888888888877766666666666666666667776665 344455566655555544
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.95 E-value=2.2e-10 Score=112.99 Aligned_cols=110 Identities=35% Similarity=0.447 Sum_probs=26.6
Q ss_pred ccCcCCCcEEeeeccccccccCcccc-ccccccEEEeecCccccccCccccccccccEEEecCCccccCCCCCcccCCCC
Q 001544 261 IGNLTKLKELFLDFNILQGEIPHTVG-NLHNLEYLSLVNNELVGTVPATIFNVSTLKLIELSNNTFFGSLPSSTDVQLPN 339 (1057)
Q Consensus 261 l~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~ 339 (1057)
+.+..++++|+|++|.|+. + +.++ .+.+|+.|+|++|+|+. ++ .+..++.|+.|++++|.++ .++......+|+
T Consensus 15 ~~n~~~~~~L~L~~n~I~~-I-e~L~~~l~~L~~L~Ls~N~I~~-l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~ 89 (175)
T PF14580_consen 15 YNNPVKLRELNLRGNQIST-I-ENLGATLDKLEVLDLSNNQITK-LE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPN 89 (175)
T ss_dssp -----------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-TT
T ss_pred ccccccccccccccccccc-c-cchhhhhcCCCEEECCCCCCcc-cc-CccChhhhhhcccCCCCCC-ccccchHHhCCc
Confidence 3444567777777777773 2 2344 46677777777777763 22 3555666666666666665 333222223556
Q ss_pred CceEEecCccccccC-Ccccccccccccccccccccc
Q 001544 340 LEELYLWGNNFSGTL-PSFIFNASNLSKLSLGDNSFS 375 (1057)
Q Consensus 340 L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~L~~N~l~ 375 (1057)
|++|+|++|+|...- -..+..+++|+.|+|.+|.++
T Consensus 90 L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~ 126 (175)
T PF14580_consen 90 LQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVC 126 (175)
T ss_dssp --EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred CCEEECcCCcCCChHHhHHHHcCCCcceeeccCCccc
Confidence 666666666654321 122333444444444444444
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.92 E-value=2.2e-09 Score=132.18 Aligned_cols=276 Identities=22% Similarity=0.292 Sum_probs=158.3
Q ss_pred cCCeeEeeccCCccccCccccCCCCcccEEEeeccc--cccCccccccCCCCCcEEEccCCCCcCCccccccCcCCCcEE
Q 001544 193 SLQALHFGNNRLSGELPANICDNLPFLNFFSVYKNM--FYGGISSTLSNCKHLRILDLSFNDLWGDIPKEIGNLTKLKEL 270 (1057)
Q Consensus 193 ~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~l~~n~--~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L 270 (1057)
..+...+-+|++. .++... ..+.|..|-+..|. +....+..|..++.|++||||+|.=-+.+|..++.|-+|++|
T Consensus 524 ~~rr~s~~~~~~~-~~~~~~--~~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL 600 (889)
T KOG4658|consen 524 SVRRMSLMNNKIE-HIAGSS--ENPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYL 600 (889)
T ss_pred heeEEEEeccchh-hccCCC--CCCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcc
Confidence 4455555555443 222211 12245555555554 444445567888889999999887667888889989999999
Q ss_pred eeeccccccccCccccccccccEEEeecCccccccCccccccccccEEEecCCccc-cCCCCCcccCCCCCceEEecCcc
Q 001544 271 FLDFNILQGEIPHTVGNLHNLEYLSLVNNELVGTVPATIFNVSTLKLIELSNNTFF-GSLPSSTDVQLPNLEELYLWGNN 349 (1057)
Q Consensus 271 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~~~l~~L~~L~L~~N~ 349 (1057)
+|++..++ .+|..+++|+.|.+||+..+.-...+|.....+++|++|.+-..... +..-......+..|+.+......
T Consensus 601 ~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~~~~s 679 (889)
T KOG4658|consen 601 DLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSITISS 679 (889)
T ss_pred cccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhheeecch
Confidence 99998888 78888899999999999888866566666777888888888765421 11111111234444444443322
Q ss_pred ccccCCcccccccccc----ccccccccccccccchhcccccccEEeccCcccCCCccccccccCCCc---chhhhhccC
Q 001544 350 FSGTLPSFIFNASNLS----KLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNYLTSPELSFLSSLSNCK---YLEIIALSG 422 (1057)
Q Consensus 350 l~~~~~~~~~~l~~L~----~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~l~---~L~~L~Ls~ 422 (1057)
. .+-..+..+..|. .+.+.++... ..+..+..+.+|+.|.+.++.+.+...........+. .+..+...+
T Consensus 680 ~--~~~e~l~~~~~L~~~~~~l~~~~~~~~-~~~~~~~~l~~L~~L~i~~~~~~e~~~~~~~~~~~~~~f~~l~~~~~~~ 756 (889)
T KOG4658|consen 680 V--LLLEDLLGMTRLRSLLQSLSIEGCSKR-TLISSLGSLGNLEELSILDCGISEIVIEWEESLIVLLCFPNLSKVSILN 756 (889)
T ss_pred h--HhHhhhhhhHHHHHHhHhhhhcccccc-eeecccccccCcceEEEEcCCCchhhcccccccchhhhHHHHHHHHhhc
Confidence 2 1111222333333 3443333333 2355678889999999999888765443333222222 232222222
Q ss_pred CCcccccccccccccccccEEEcCCCcccccccccccCccCCcEEEccCCcCCCC
Q 001544 423 NPLNGIIPMSAGNLSHSLEELFMPDCNVSGRIPKEIGNLANLVTLDLGGNKFNGS 477 (1057)
Q Consensus 423 N~l~~~~~~~~~~l~~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~Ls~N~i~~~ 477 (1057)
... .-.......+++|+.|++..|.....+.+....+..+..+.+..+.+.+.
T Consensus 757 ~~~--~r~l~~~~f~~~L~~l~l~~~~~~e~~i~~~k~~~~l~~~i~~f~~~~~l 809 (889)
T KOG4658|consen 757 CHM--LRDLTWLLFAPHLTSLSLVSCRLLEDIIPKLKALLELKELILPFNKLEGL 809 (889)
T ss_pred ccc--ccccchhhccCcccEEEEecccccccCCCHHHHhhhcccEEecccccccc
Confidence 211 11112223455666676666666655555555555555555555555543
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.88 E-value=3.6e-10 Score=133.57 Aligned_cols=250 Identities=22% Similarity=0.285 Sum_probs=169.0
Q ss_pred HhCCCCCCceeccccCeEEEEEEec-CCcEEEEEEeeccc---hhHHHHHHHHHHHHHhcCCCCceeEeeeeccCCeeEE
Q 001544 767 ATNGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQH---ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKAL 842 (1057)
Q Consensus 767 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 842 (1057)
..+++.+.+.+.+|.++.++-+.-. .|...+.|+..... ....+....+-.+.-..++|-+++..-.+.-....++
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 4556777788999999999987533 34445555442221 1112222222223223345666655555555677899
Q ss_pred EEEEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccC-
Q 001544 843 ILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIG- 921 (1057)
Q Consensus 843 V~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~- 921 (1057)
|++|+.+++|...++... ..+..........+.++.+||| ...+.|||++|.|.+...++..+++|||......-
T Consensus 882 ~~~~~~~~~~~Skl~~~~-~~saepaRs~i~~~vqs~e~L~---s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~ 957 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNSG-CLSAEPARSPILERVQSLESLH---SSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLI 957 (1205)
T ss_pred hhHHhccCCchhhhhcCC-CcccccccchhHHHHhhhhccc---cchhhcccccccchhhcccCCcccCccccccccccc
Confidence 999999999999888766 3444445556667888999999 88899999999999999999999999984322100
Q ss_pred -----C-----------------------CCccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCCCCCc
Q 001544 922 -----E-----------------------DQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDE 973 (1057)
Q Consensus 922 -----~-----------------------~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~p~~~ 973 (1057)
. +.........+|+.|.+||...+......+|.|+.|++++|.++|.+||..
T Consensus 958 ~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na 1037 (1205)
T KOG0606|consen 958 PPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNA 1037 (1205)
T ss_pred cCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCC
Confidence 0 000112334689999999999999999999999999999999999999876
Q ss_pred ccccccchhhhhhhccchhHHHhhhcccccccchhhHHHHHHHHHHHHHHhHcccCCCCCCCCHH
Q 001544 974 IFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAK 1038 (1057)
Q Consensus 974 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ 1038 (1057)
...... +.. +... .......++..+.+..+++...+..+|.+|..|.
T Consensus 1038 ~tpq~~-f~n------------i~~~-----~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1038 ETPQQI-FEN------------ILNR-----DIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred cchhhh-hhc------------cccC-----CCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 322211 110 0000 0111222345566778889999999999998766
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.86 E-value=1.9e-08 Score=101.22 Aligned_cols=125 Identities=24% Similarity=0.273 Sum_probs=84.8
Q ss_pred EEEEEEecCCcEEEEEEeeccc--------------------------hhHHHHHHHHHHHHHhcCCC--CceeEeeeec
Q 001544 784 SVYIARLQNGIEVAVKTFDLQH--------------------------ERAFKSFDTECEVMKSIRHR--NLTKIISSCS 835 (1057)
Q Consensus 784 ~Vy~~~~~~~~~vavK~~~~~~--------------------------~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~ 835 (1057)
.||.|...+|..+|||+.+... .......++|++.|.++... ++.+++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 4899999889999999874320 01234677899999999765 466666553
Q ss_pred cCCeeEEEEEEcc--CCChhHHHhcCCccCCHHHHHHHHHHHHHHHHH-HHhCCCCCeEEccCCCCCeeeCCCCcEEEEc
Q 001544 836 NEDFKALILEYMR--NGSLEKCLYSGNYILDIFQRLNIMIDVASALEY-LHFGYSAPVIHCDLKPSNVLLDDNMVAHLSD 912 (1057)
Q Consensus 836 ~~~~~~lV~E~~~--~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~-LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D 912 (1057)
..++||||++ |..+..+... . ++......++.+++..+.. +| ..|++|||+.+.||+++++ .+.++|
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~-~--~~~~~~~~~~~~il~~~~~~~~---~~givHGDLs~~NIlv~~~-~~~iID 149 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDV-D--LSPEEPKELLEEILEEIIKMLH---KAGIVHGDLSEYNILVDDG-KVYIID 149 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHC-G--GGGSTHHHHHHHHHHHHHHHHH---CTTEEESS-STTSEEEETT-CEEE--
T ss_pred ---CCEEEEEecCCCccchhhHHhc-c--ccchhHHHHHHHHHHHHHHHHH---hcCceecCCChhhEEeecc-eEEEEe
Confidence 3479999998 6555543322 1 1133456778888885555 57 8999999999999999987 999999
Q ss_pred ccccccc
Q 001544 913 FGIAKLL 919 (1057)
Q Consensus 913 fg~a~~~ 919 (1057)
||.+...
T Consensus 150 f~qav~~ 156 (188)
T PF01163_consen 150 FGQAVDS 156 (188)
T ss_dssp GTTEEET
T ss_pred cCcceec
Confidence 9998754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.82 E-value=4.7e-08 Score=104.52 Aligned_cols=140 Identities=16% Similarity=0.070 Sum_probs=101.3
Q ss_pred ceeccccCeEEEEEEecCCcEEEEEEeeccchh-HH----------HHHHHHHHHHHhcCCCCc--eeEeeeecc-----
Q 001544 775 NLIGRGSFGSVYIARLQNGIEVAVKTFDLQHER-AF----------KSFDTECEVMKSIRHRNL--TKIISSCSN----- 836 (1057)
Q Consensus 775 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~----------~~~~~E~~~l~~l~h~ni--v~l~~~~~~----- 836 (1057)
+.+-+.....|+++... |+.|.||+....... .. ..+.+|.+.+.++...+| +..+++...
T Consensus 28 e~v~~~~~rrvvr~~~~-g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFELA-GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEEC-CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 44554455557777664 789999987433211 11 147789999988854333 344555432
Q ss_pred CCeeEEEEEEccCC-ChhHHHhcC-CccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCC-------CCc
Q 001544 837 EDFKALILEYMRNG-SLEKCLYSG-NYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDD-------NMV 907 (1057)
Q Consensus 837 ~~~~~lV~E~~~~g-sL~~~l~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~-------~~~ 907 (1057)
....++|+|++++. +|.+++... ....+...+..++.++++.++-|| ..||+|+|++++|||++. ++.
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH---~~Gi~HgDL~~~NiLl~~~~~~~~~~~~ 183 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMH---AAGINHRDCYICHFLLHLPFPGREEDLK 183 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---HCcCccCCCChhhEEEeccccCCCCCce
Confidence 23568999999986 898887532 233566777899999999999999 999999999999999975 568
Q ss_pred EEEEccccccc
Q 001544 908 AHLSDFGIAKL 918 (1057)
Q Consensus 908 ~kl~Dfg~a~~ 918 (1057)
+.++||+.+..
T Consensus 184 ~~LIDl~r~~~ 194 (268)
T PRK15123 184 LSVIDLHRAQI 194 (268)
T ss_pred EEEEECCcccc
Confidence 99999998753
|
|
| >PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=98.80 E-value=3.4e-09 Score=78.39 Aligned_cols=41 Identities=41% Similarity=0.917 Sum_probs=29.7
Q ss_pred cchHHHHHHHHHhcccCCCCcccCCCCCCC-CCCcccceeEec
Q 001544 26 DIDQDALLALKDHITYDPTNFFAKNWLTNS-TMVCNWTGVTCD 67 (1057)
Q Consensus 26 ~~d~~~l~~~k~~~~~~~~~~~~~~w~~~~-~~~c~w~gv~c~ 67 (1057)
+.|++||++||+++..+|.+.+ .+|..++ ++||.|.||+|+
T Consensus 2 ~~d~~aLl~~k~~l~~~~~~~l-~~W~~~~~~~~C~W~GV~Cd 43 (43)
T PF08263_consen 2 NQDRQALLAFKKSLNNDPSGVL-SSWNPSSDSDPCSWSGVTCD 43 (43)
T ss_dssp HHHHHHHHHHHHCTT-SC-CCC-TT--TT--S-CCCSTTEEE-
T ss_pred cHHHHHHHHHHHhcccccCccc-ccCCCcCCCCCeeeccEEeC
Confidence 5689999999999986776666 5997754 799999999996
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A. |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.76 E-value=5e-09 Score=84.94 Aligned_cols=60 Identities=40% Similarity=0.580 Sum_probs=34.6
Q ss_pred ccceeccccccccccccccccCccccceecccccccccccCccccccCccceecccCccc
Q 001544 583 ALTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQGSIPDSVGDLISLKSLNLSNNNL 642 (1057)
Q Consensus 583 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 642 (1057)
+|++|++++|+|+...+..|.++++|++|++++|+++...|..|.++++|++|++++|+|
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 455556666666555445555556666666666665555555555566666666655553
|
... |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.75 E-value=4.2e-07 Score=100.32 Aligned_cols=166 Identities=17% Similarity=0.200 Sum_probs=125.3
Q ss_pred CeEEEEEEe-cCCcEEEEEEeeccchhHHHHHHHHHHHHHhcCCCCceeEeeeecc----CCeeEEEEEEccC-CChhHH
Q 001544 782 FGSVYIARL-QNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCSN----EDFKALILEYMRN-GSLEKC 855 (1057)
Q Consensus 782 ~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lV~E~~~~-gsL~~~ 855 (1057)
-.+.||+.- -||..|++|+++............-++.++++.|+|+|++.+.+.. +-..++||+|.++ ++|.+.
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 457899964 4899999999955433322223456788999999999999998752 4467899999876 467664
Q ss_pred HhcC--------------CccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCcEEEEcccccccccC
Q 001544 856 LYSG--------------NYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIG 921 (1057)
Q Consensus 856 l~~~--------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~ 921 (1057)
.... ....++...+.++.|+..||.++| +.|..-+-+.+.+|+++.+.+++|+.-|....+..
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH---ssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIH---SSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHH---hcCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 3221 134677889999999999999999 99999999999999999999999998887765532
Q ss_pred CCCccccccccccccccCccccCCCCCCccchHHHHHHHHHHHhhCCC
Q 001544 922 EDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRK 969 (1057)
Q Consensus 922 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dv~s~G~il~elltg~~ 969 (1057)
+.. |.+. --.+-|.=.+|.+++.+.||..
T Consensus 446 d~~----------------~~le---~~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 446 DPT----------------EPLE---SQQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred CCC----------------cchh---HHhhhhHHHHHHHHHHHhhccc
Confidence 220 1111 1235688999999999999965
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.73 E-value=8.2e-08 Score=98.45 Aligned_cols=134 Identities=22% Similarity=0.252 Sum_probs=100.2
Q ss_pred CCCceeccccCeEEEEEEecCCcEEEEEEeeccc----------------------hhHHHHHHHHHHHHHhcCCC--Cc
Q 001544 772 SENNLIGRGSFGSVYIARLQNGIEVAVKTFDLQH----------------------ERAFKSFDTECEVMKSIRHR--NL 827 (1057)
Q Consensus 772 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~----------------------~~~~~~~~~E~~~l~~l~h~--ni 827 (1057)
.+...||.|.-+.||.|..+.|.++|||.=+... ..+....++|.++|.++... .+
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 4568899999999999999999999999632110 11234678899999999644 56
Q ss_pred eeEeeeeccCCeeEEEEEEccCCChhHHHhcCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCc
Q 001544 828 TKIISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMV 907 (1057)
Q Consensus 828 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~ 907 (1057)
.+.+++ +...+||||++|-.|... +++......|+..|++-+.-.- ..||||||+.+-||+++++|.
T Consensus 174 P~P~~~----nRHaVvMe~ieG~eL~~~------r~~~en~~~il~~il~~~~~~~---~~GiVHGDlSefNIlV~~dg~ 240 (304)
T COG0478 174 PKPIAW----NRHAVVMEYIEGVELYRL------RLDVENPDEILDKILEEVRKAY---RRGIVHGDLSEFNILVTEDGD 240 (304)
T ss_pred CCcccc----ccceeeeehcccceeecc------cCcccCHHHHHHHHHHHHHHHH---HcCccccCCchheEEEecCCC
Confidence 665554 345799999999666542 1234445556666666666555 688999999999999999999
Q ss_pred EEEEccccccc
Q 001544 908 AHLSDFGIAKL 918 (1057)
Q Consensus 908 ~kl~Dfg~a~~ 918 (1057)
+.++||-.+..
T Consensus 241 ~~vIDwPQ~v~ 251 (304)
T COG0478 241 IVVIDWPQAVP 251 (304)
T ss_pred EEEEeCccccc
Confidence 99999976653
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.70 E-value=9.6e-09 Score=83.28 Aligned_cols=59 Identities=36% Similarity=0.517 Sum_probs=28.6
Q ss_pred CCcEEEccCCcCCCCCCcccccccccceeecccccCcccCCcccccccccceEEecCee
Q 001544 463 NLVTLDLGGNKFNGSIPIALGKLQKLQLLNLDDNKLEGSIPDDICGLVELYKLALGDNK 521 (1057)
Q Consensus 463 ~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 521 (1057)
+|++|++++|+|+...+.+|.++++|++|++++|+++...|..|.++++|++|++++|+
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence 34455555555554444445555555555555555544444444444444444444443
|
... |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.64 E-value=1.6e-07 Score=108.71 Aligned_cols=140 Identities=21% Similarity=0.180 Sum_probs=96.4
Q ss_pred ceeccccCeEEEEEEecCCcEEEEEEeeccchhH----------------------------------------HHHHHH
Q 001544 775 NLIGRGSFGSVYIARLQNGIEVAVKTFDLQHERA----------------------------------------FKSFDT 814 (1057)
Q Consensus 775 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~----------------------------------------~~~~~~ 814 (1057)
+.|+.++-|.||+|++++|+.||||+.++..... .-++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 7899999999999999999999999986442110 013444
Q ss_pred HHHHHHhcC-----CCCceeEeeeeccCCeeEEEEEEccCCChhHHHhcCCccCCHHHHHHHHHHHHHH-HHHHHhCCCC
Q 001544 815 ECEVMKSIR-----HRNLTKIISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASA-LEYLHFGYSA 888 (1057)
Q Consensus 815 E~~~l~~l~-----h~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~-L~~LH~~~~~ 888 (1057)
|..-+.+++ .|.+.--.=|++-.....++|||++|..+.+...-.....+.+ .++..++++ +..+= ..
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k---~ia~~~~~~f~~q~~---~d 284 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRK---ELAELLVRAFLRQLL---RD 284 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHH---HHHHHHHHHHHHHHH---hc
Confidence 555555553 3333322233444567789999999999988743333335533 333333333 22222 56
Q ss_pred CeEEccCCCCCeeeCCCCcEEEEccccccccc
Q 001544 889 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLI 920 (1057)
Q Consensus 889 ~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~ 920 (1057)
|+.|.|..|.||+++.+|.+.+.|||+...+.
T Consensus 285 gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 285 GFFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred CccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 89999999999999999999999999998764
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.59 E-value=4.7e-07 Score=91.30 Aligned_cols=137 Identities=18% Similarity=0.099 Sum_probs=104.2
Q ss_pred eccccCeEEEEEEecCCcEEEEEEeeccc------hhHHHHHHHHHHHHHhcCCC--CceeEeeeecc-----CCeeEEE
Q 001544 777 IGRGSFGSVYIARLQNGIEVAVKTFDLQH------ERAFKSFDTECEVMKSIRHR--NLTKIISSCSN-----EDFKALI 843 (1057)
Q Consensus 777 lg~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~-----~~~~~lV 843 (1057)
-|+||.+.|++...+ |..+-+|+-.... +-....|.+|+..+.++... .+.+.+ ++.. ....+||
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 477999999998776 4578899864211 22456899999999998532 244444 3321 2345799
Q ss_pred EEEccC-CChhHHHhcCC-ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEccCCCCCeeeCCCCc--EEEEccccccc
Q 001544 844 LEYMRN-GSLEKCLYSGN-YILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMV--AHLSDFGIAKL 918 (1057)
Q Consensus 844 ~E~~~~-gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~--~kl~Dfg~a~~ 918 (1057)
+|-+++ -+|.+++.... .+.+..++..+..++++.++-|| +.|+.|+|+.+.||+++.++. ++++||.-++.
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH---~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMH---SVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 998764 48988886543 35678888999999999999999 999999999999999986666 99999987764
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.57 E-value=2.1e-09 Score=121.50 Aligned_cols=128 Identities=31% Similarity=0.283 Sum_probs=95.5
Q ss_pred cccccccCCccccccccccccccccccEEEeccccccCCCchhhccccccceeccccccccccccccccCccccceeccc
Q 001544 535 SLRELWLGPNELISFIPSTFWNIKDIMYVNFSSNFLTGPLPLEIENLKALTTLDFSMNNLSGVIPTTIGGLKGLQYLFLG 614 (1057)
Q Consensus 535 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 614 (1057)
.|...+.+.|++... ...+.-++.++.|||++|+++.. +.+..++.|++|||+.|.++.+.--...+++ |+.|+++
T Consensus 165 ~L~~a~fsyN~L~~m-D~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~lr 240 (1096)
T KOG1859|consen 165 KLATASFSYNRLVLM-DESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNLR 240 (1096)
T ss_pred hHhhhhcchhhHHhH-HHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhccccccchhhhh-heeeeec
Confidence 455566666666543 23455567777888888888753 3677889999999999999855444445555 9999999
Q ss_pred ccccccccCccccccCccceecccCccccCCCc-ccccCcccccccccCCCcccC
Q 001544 615 HNRLQGSIPDSVGDLISLKSLNLSNNNLSGPIP-TSLEKLSDLKELNLSFNKLEG 668 (1057)
Q Consensus 615 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~l~~l~~L~~l~ls~N~l~~ 668 (1057)
+|.++ .+ ..+.+|++|+.||||+|-|++.-. ..+..|..|+.|+|.||++.+
T Consensus 241 nN~l~-tL-~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c 293 (1096)
T KOG1859|consen 241 NNALT-TL-RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCC 293 (1096)
T ss_pred ccHHH-hh-hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCcccc
Confidence 99998 33 347899999999999999986432 235678889999999999976
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.55 E-value=8.5e-09 Score=93.24 Aligned_cols=115 Identities=22% Similarity=0.213 Sum_probs=80.0
Q ss_pred ccccccEEEeccccccCCCchhhccccccceeccccccccccccccccCccccceecccccccccccCccccccCcccee
Q 001544 556 NIKDIMYVNFSSNFLTGPLPLEIENLKALTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQGSIPDSVGDLISLKSL 635 (1057)
Q Consensus 556 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 635 (1057)
....|+.++|++|.+....+..-...+.+++|+|++|.|+ .+|+.+..++.|+.|+++.|.+. ..|..+..|.+|-.|
T Consensus 51 ~~~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~L 128 (177)
T KOG4579|consen 51 KGYELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDML 128 (177)
T ss_pred CCceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHh
Confidence 3445666777777777543333344557788888888887 56777888888888888888887 677777778888888
Q ss_pred cccCccccCCCcccccCcccccccccCCCcccCcCCCC
Q 001544 636 NLSNNNLSGPIPTSLEKLSDLKELNLSFNKLEGEIPRG 673 (1057)
Q Consensus 636 ~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~ 673 (1057)
|..+|.+- ++|-.+-.-+.....++.+|+|.+.-|.+
T Consensus 129 ds~~na~~-eid~dl~~s~~~al~~lgnepl~~~~~~k 165 (177)
T KOG4579|consen 129 DSPENARA-EIDVDLFYSSLPALIKLGNEPLGDETKKK 165 (177)
T ss_pred cCCCCccc-cCcHHHhccccHHHHHhcCCcccccCccc
Confidence 88888876 55544444444455666777777776654
|
|
| >KOG2120 consensus SCF ubiquitin ligase, Skp2 component [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.51 E-value=3.3e-09 Score=108.10 Aligned_cols=179 Identities=27% Similarity=0.237 Sum_probs=97.7
Q ss_pred CCcEEeCCCCCcccc-CCcccccccccceeecccccccCCCCccccccCCCCeEeccCC-CCCCCCCcccccCCCCCcee
Q 001544 96 SLEILDLNFNRLSGE-IPWELGNLAKLEKLLLHNNFLTGTIPFSIFKLSSLLDLKLSDN-NLTGTIPSHNLGNLSSLQLL 173 (1057)
Q Consensus 96 ~L~~L~L~~n~l~~~-~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n-~l~~~~p~~~l~~l~~L~~L 173 (1057)
.|++||||...|+.. +-.-+..+.+|+.|.|.++++...+-..+++-.+|+.|+|+.+ .++..-..-.+.+++.|..|
T Consensus 186 Rlq~lDLS~s~it~stl~~iLs~C~kLk~lSlEg~~LdD~I~~~iAkN~~L~~lnlsm~sG~t~n~~~ll~~scs~L~~L 265 (419)
T KOG2120|consen 186 RLQHLDLSNSVITVSTLHGILSQCSKLKNLSLEGLRLDDPIVNTIAKNSNLVRLNLSMCSGFTENALQLLLSSCSRLDEL 265 (419)
T ss_pred hhHHhhcchhheeHHHHHHHHHHHHhhhhccccccccCcHHHHHHhccccceeeccccccccchhHHHHHHHhhhhHhhc
Confidence 477778777777532 3444666777777788888777777777777777777777765 33321112235667777777
Q ss_pred EccCCcccccCchhh-hcc-ccCCeeEeeccCCccccCccccCCCCcccEEEeeccccccCccccccCCCCCcEEEccCC
Q 001544 174 DLSDNQLSGSIPSFI-FKI-SSLQALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGGISSTLSNCKHLRILDLSFN 251 (1057)
Q Consensus 174 ~Ls~n~l~~~~p~~l-~~l-~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~l~~n~~~~~~~~~l~~l~~L~~L~Ls~N 251 (1057)
+|+.|.+....-..+ ... ++|+.|+|++.+= |-....+..-.+.+++|..||||.|
T Consensus 266 NlsWc~l~~~~Vtv~V~hise~l~~LNlsG~rr----------------------nl~~sh~~tL~~rcp~l~~LDLSD~ 323 (419)
T KOG2120|consen 266 NLSWCFLFTEKVTVAVAHISETLTQLNLSGYRR----------------------NLQKSHLSTLVRRCPNLVHLDLSDS 323 (419)
T ss_pred CchHhhccchhhhHHHhhhchhhhhhhhhhhHh----------------------hhhhhHHHHHHHhCCceeeeccccc
Confidence 777776653322221 111 2455555554431 1111112223356667777777765
Q ss_pred C-CcCCccccccCcCCCcEEeeeccccccccCc---cccccccccEEEeec
Q 001544 252 D-LWGDIPKEIGNLTKLKELFLDFNILQGEIPH---TVGNLHNLEYLSLVN 298 (1057)
Q Consensus 252 ~-l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~---~~~~l~~L~~L~L~~ 298 (1057)
. ++......|..++.|++|.|+.|.. .+|. .+...+.|.+||+-+
T Consensus 324 v~l~~~~~~~~~kf~~L~~lSlsRCY~--i~p~~~~~l~s~psl~yLdv~g 372 (419)
T KOG2120|consen 324 VMLKNDCFQEFFKFNYLQHLSLSRCYD--IIPETLLELNSKPSLVYLDVFG 372 (419)
T ss_pred cccCchHHHHHHhcchheeeehhhhcC--CChHHeeeeccCcceEEEEecc
Confidence 3 3333333444555556555555543 2333 233445555555443
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.50 E-value=4.9e-09 Score=118.59 Aligned_cols=127 Identities=27% Similarity=0.238 Sum_probs=68.4
Q ss_pred CCcEEeeeccccccccCccccccccccEEEeecCccccccCccccccccccEEEecCCccccCCCCCcccCCCCCceEEe
Q 001544 266 KLKELFLDFNILQGEIPHTVGNLHNLEYLSLVNNELVGTVPATIFNVSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYL 345 (1057)
Q Consensus 266 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L 345 (1057)
+|...+.++|.++ .+..++.-++.|+.|||++|+++... .+..++.|++|||++|.+. .+|...-.+.. |..|.+
T Consensus 165 ~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L~l 239 (1096)
T KOG1859|consen 165 KLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLLNL 239 (1096)
T ss_pred hHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhc-cccccchhhhh-heeeee
Confidence 4555566666665 44455555666666666666665322 4555666666666666664 34432222222 566666
Q ss_pred cCccccccCCccccccccccccccccccccccc-cchhcccccccEEeccCcccC
Q 001544 346 WGNNFSGTLPSFIFNASNLSKLSLGDNSFSGLI-PNTFGNLRNLKRLRLYNNYLT 399 (1057)
Q Consensus 346 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~L~~N~l~ 399 (1057)
++|.++.. ..+.++.+|+.||+++|-|.+-- -..++.+..|+.|+|.+|++-
T Consensus 240 rnN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 240 RNNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred cccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 66665532 33455566666666666555321 122445555666666666554
|
|
| >COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.48 E-value=8.6e-09 Score=103.71 Aligned_cols=256 Identities=21% Similarity=0.167 Sum_probs=118.7
Q ss_pred ccCCCCCcEEeCCCCCcccc----CCcccccccccceeecccccc---cCCCCccccccCCCCeEeccCCCCCCCCCccc
Q 001544 91 LGNLSSLEILDLNFNRLSGE----IPWELGNLAKLEKLLLHNNFL---TGTIPFSIFKLSSLLDLKLSDNNLTGTIPSHN 163 (1057)
Q Consensus 91 l~~l~~L~~L~L~~n~l~~~----~p~~l~~l~~L~~L~L~~n~l---~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~ 163 (1057)
+..+..++.+|||+|.|..+ +...+.+-.+|+..+++.-.. ...+|+++.-| .| +
T Consensus 26 l~~~d~~~evdLSGNtigtEA~e~l~~~ia~~~~L~vvnfsd~ftgr~kde~~~~L~~L----------------l~--a 87 (388)
T COG5238 26 LEMMDELVEVDLSGNTIGTEAMEELCNVIANVRNLRVVNFSDAFTGRDKDELYSNLVML----------------LK--A 87 (388)
T ss_pred HHhhcceeEEeccCCcccHHHHHHHHHHHhhhcceeEeehhhhhhcccHHHHHHHHHHH----------------HH--H
Confidence 44567778888888888644 445556667777777766322 12223222111 11 3
Q ss_pred ccCCCCCceeEccCCcccccCchh----hhccccCCeeEeeccCCccccCccccCCCCcccEEEeeccccccCccccccC
Q 001544 164 LGNLSSLQLLDLSDNQLSGSIPSF----IFKISSLQALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGGISSTLSN 239 (1057)
Q Consensus 164 l~~l~~L~~L~Ls~n~l~~~~p~~----l~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~l~~n~~~~~~~~~l~~ 239 (1057)
+-++|+|+..+||.|.+....|.. +++-+.|++|.|++|.+...-...+...|.+|-+ ..-.++
T Consensus 88 Llkcp~l~~v~LSDNAfg~~~~e~L~d~is~~t~l~HL~l~NnGlGp~aG~rigkal~~la~------------nKKaa~ 155 (388)
T COG5238 88 LLKCPRLQKVDLSDNAFGSEFPEELGDLISSSTDLVHLKLNNNGLGPIAGGRIGKALFHLAY------------NKKAAD 155 (388)
T ss_pred HhcCCcceeeeccccccCcccchHHHHHHhcCCCceeEEeecCCCCccchhHHHHHHHHHHH------------Hhhhcc
Confidence 455666666666666665544433 3445667777777776642212222211111000 001122
Q ss_pred CCCCcEEEccCCCCcCCcc----ccccCcCCCcEEeeeccccccccC-----ccccccccccEEEeecCccccc----cC
Q 001544 240 CKHLRILDLSFNDLWGDIP----KEIGNLTKLKELFLDFNILQGEIP-----HTVGNLHNLEYLSLVNNELVGT----VP 306 (1057)
Q Consensus 240 l~~L~~L~Ls~N~l~~~~p----~~l~~l~~L~~L~L~~N~l~~~~p-----~~~~~l~~L~~L~L~~N~l~~~----~~ 306 (1057)
-+.|++.....|++..-.. ..+..-..|+++.+..|.|....- ..+..+++|+.|||..|-++-. +.
T Consensus 156 kp~Le~vicgrNRlengs~~~~a~~l~sh~~lk~vki~qNgIrpegv~~L~~~gl~y~~~LevLDlqDNtft~~gS~~La 235 (388)
T COG5238 156 KPKLEVVICGRNRLENGSKELSAALLESHENLKEVKIQQNGIRPEGVTMLAFLGLFYSHSLEVLDLQDNTFTLEGSRYLA 235 (388)
T ss_pred CCCceEEEeccchhccCcHHHHHHHHHhhcCceeEEeeecCcCcchhHHHHHHHHHHhCcceeeeccccchhhhhHHHHH
Confidence 3344444444444431110 111112344444444444431100 0112234555555555554421 11
Q ss_pred ccccccccccEEEecCCccccCCCCCcc-----cCCCCCceEEecCccccccCCcc-------ccccccccccccccccc
Q 001544 307 ATIFNVSTLKLIELSNNTFFGSLPSSTD-----VQLPNLEELYLWGNNFSGTLPSF-------IFNASNLSKLSLGDNSF 374 (1057)
Q Consensus 307 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~-----~~l~~L~~L~L~~N~l~~~~~~~-------~~~l~~L~~L~L~~N~l 374 (1057)
..+..++.|+.|.+.+|-++..-...++ ...|+|..|-..+|.+.+.+-.. -..++-|..|.+.+|+|
T Consensus 236 ~al~~W~~lrEL~lnDClls~~G~~~v~~~f~e~~~p~l~~L~~~Yne~~~~~i~~~~l~~~e~~~~p~L~~le~ngNr~ 315 (388)
T COG5238 236 DALCEWNLLRELRLNDCLLSNEGVKSVLRRFNEKFVPNLMPLPGDYNERRGGIILDISLNEFEQDAVPLLVDLERNGNRI 315 (388)
T ss_pred HHhcccchhhhccccchhhccccHHHHHHHhhhhcCCCccccccchhhhcCceeeeechhhhhhcccHHHHHHHHccCcc
Confidence 2233344455555555544321111110 12466666666666655322111 12467788888888888
Q ss_pred cc
Q 001544 375 SG 376 (1057)
Q Consensus 375 ~~ 376 (1057)
..
T Consensus 316 ~E 317 (388)
T COG5238 316 KE 317 (388)
T ss_pred hh
Confidence 74
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 1057 | ||||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 1e-42 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 3e-11 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 2e-42 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 4e-11 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 8e-37 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-35 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 4e-33 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-32 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-26 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-26 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-25 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-23 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-23 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 5e-23 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 6e-22 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-21 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-21 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-21 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-21 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-21 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-21 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-21 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-21 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-21 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-21 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-21 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 4e-21 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 4e-21 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-21 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 4e-21 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 5e-21 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 7e-21 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-20 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-20 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-20 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-20 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-20 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-20 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-20 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-20 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-20 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-20 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-20 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-20 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-20 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-20 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-20 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-20 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 4e-20 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 4e-20 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 4e-20 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 5e-20 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 5e-20 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 6e-20 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 6e-20 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 8e-20 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 8e-20 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 9e-20 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 9e-20 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-19 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-19 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-19 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-19 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-19 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-19 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-19 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-19 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-19 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-19 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-19 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-19 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-19 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-19 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-19 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-19 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-19 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-19 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-19 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-19 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-19 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-19 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-19 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-19 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 2e-19 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 4e-11 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-19 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-19 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-19 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-19 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-19 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-19 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-19 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-19 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-19 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-19 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-19 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-19 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 4e-19 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 4e-19 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 6e-19 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 6e-19 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 6e-19 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 7e-19 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-19 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-19 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 7e-19 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-19 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-19 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 9e-19 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-18 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-18 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-18 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-18 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-18 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-18 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 6e-18 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 6e-18 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 6e-18 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 6e-18 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 6e-18 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 6e-18 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 6e-18 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 6e-18 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 6e-18 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 6e-18 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 6e-18 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 6e-18 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 6e-18 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-18 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 9e-18 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 9e-18 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-17 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-17 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-17 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-17 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-17 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-17 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-17 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-17 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-17 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-17 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-17 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-17 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-17 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-17 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-17 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-17 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-17 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-17 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-17 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-17 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-17 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-17 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-17 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-17 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 5e-17 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 6e-17 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 7e-17 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 7e-17 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 7e-17 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 8e-17 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 8e-17 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 8e-17 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-16 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-16 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-16 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-16 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-16 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-16 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-16 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-16 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-16 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-16 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-16 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-16 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-16 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-16 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-16 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-16 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-16 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-16 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-16 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-16 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-16 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-16 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-16 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-16 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 4e-16 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 4e-16 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-16 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 4e-16 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 4e-16 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 4e-16 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-16 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 4e-16 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 4e-16 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 4e-16 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 4e-16 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-16 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 4e-16 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 4e-16 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 4e-16 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 4e-16 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 5e-16 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 6e-16 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 6e-16 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-16 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 7e-16 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 9e-16 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-16 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-15 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-15 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-15 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-15 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-15 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 4e-15 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 4e-15 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 5e-15 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 5e-15 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 5e-15 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-15 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 6e-15 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 6e-15 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 8e-15 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 8e-15 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 8e-15 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 8e-15 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-15 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 8e-15 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 9e-15 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 9e-15 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-14 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-14 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-14 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-14 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-14 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-14 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 4e-14 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 4e-14 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 4e-14 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 4e-14 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-14 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 6e-14 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 6e-14 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 7e-14 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 7e-14 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 9e-14 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-13 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-13 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-13 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-13 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-13 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-13 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-13 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-13 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-13 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-13 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-13 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-13 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-13 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-13 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-13 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-13 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 4e-13 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 4e-13 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 4e-13 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 4e-13 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 4e-13 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 6e-13 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 7e-13 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 7e-13 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 9e-13 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 9e-13 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 9e-13 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-12 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-12 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-12 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-12 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-12 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-12 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-12 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-12 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-12 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-12 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-12 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-12 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-12 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-12 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-12 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-12 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-12 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-12 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-12 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-12 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-12 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-12 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-12 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-12 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-12 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-12 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-12 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-12 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-12 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-12 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-12 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-12 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-12 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-12 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-12 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-12 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-12 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-12 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-12 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-12 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-12 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-12 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-12 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-12 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 3e-12 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 3e-12 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-12 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-12 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-12 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-12 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 4e-12 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-12 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 4e-12 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 4e-12 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 4e-12 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 4e-12 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-12 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 4e-12 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 4e-12 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 5e-12 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 5e-12 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 5e-12 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 5e-12 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 5e-12 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 5e-12 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 5e-12 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 5e-12 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 6e-12 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 6e-12 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 6e-12 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 6e-12 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-12 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-12 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 7e-12 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 8e-12 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 8e-12 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 8e-12 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 8e-12 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-12 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 8e-12 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 8e-12 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 9e-12 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 9e-12 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 9e-12 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 9e-12 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 9e-12 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-11 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-11 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-11 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-11 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-11 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-11 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-11 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-11 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-11 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-11 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-11 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-11 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-11 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-11 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-11 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-11 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-11 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-11 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-11 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-11 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-11 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-11 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-11 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-11 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-11 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-11 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-11 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-11 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-11 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-11 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-11 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-11 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-11 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-11 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-11 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-11 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-11 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-11 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-11 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-11 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-11 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-11 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-11 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-11 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-11 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-11 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-11 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-11 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-11 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-11 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-11 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-11 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-11 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-11 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 4e-11 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 4e-11 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-11 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 4e-11 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-11 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-11 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 4e-11 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 5e-11 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 5e-11 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 5e-11 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 5e-11 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 5e-11 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 5e-11 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 6e-11 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 6e-11 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-11 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 6e-11 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-11 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 6e-11 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 7e-11 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 7e-11 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 7e-11 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 7e-11 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 7e-11 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 7e-11 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-11 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 7e-11 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 7e-11 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 8e-11 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 8e-11 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 8e-11 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 8e-11 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 8e-11 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 8e-11 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 8e-11 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 8e-11 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 8e-11 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 8e-11 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 8e-11 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 8e-11 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 8e-11 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 8e-11 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 8e-11 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 9e-11 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 9e-11 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 9e-11 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 9e-11 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 9e-11 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 9e-11 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-10 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-10 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-10 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-10 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-10 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-10 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-10 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-10 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-10 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-10 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-10 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-10 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-10 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-10 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-10 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-10 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-10 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-10 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-10 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-10 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-10 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-10 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-10 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-10 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-10 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-10 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-10 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-10 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-10 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-10 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-10 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-10 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-10 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-10 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-10 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-10 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-10 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-10 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-10 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-10 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-10 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-10 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-10 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 4e-10 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 4e-10 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 4e-10 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 4e-10 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 4e-10 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 4e-10 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-10 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 4e-10 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-10 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 5e-10 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 5e-10 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 5e-10 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 5e-10 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 5e-10 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 5e-10 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 5e-10 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 5e-10 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 6e-10 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 6e-10 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 6e-10 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 6e-10 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 6e-10 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 6e-10 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 6e-10 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 6e-10 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 6e-10 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 6e-10 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 6e-10 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 6e-10 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 6e-10 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 6e-10 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 7e-10 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-10 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 7e-10 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 7e-10 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 7e-10 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-10 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 8e-10 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 8e-10 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 8e-10 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 9e-10 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-09 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-09 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-09 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-09 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-09 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-09 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-09 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-09 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-09 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-09 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-09 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-09 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-09 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-09 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-09 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-09 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-09 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-09 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-09 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-09 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-09 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-09 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-09 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-09 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-09 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-09 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-09 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-09 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-09 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 3e-09 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-09 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-09 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 3e-09 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-09 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 4e-09 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 4e-09 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-09 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 4e-09 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 4e-09 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 4e-09 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 4e-09 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 4e-09 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 4e-09 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-09 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 4e-09 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 4e-09 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 4e-09 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 4e-09 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 4e-09 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 4e-09 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 4e-09 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 4e-09 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 4e-09 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 5e-09 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 5e-09 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-09 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 5e-09 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-09 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 6e-09 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-09 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-09 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 6e-09 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 6e-09 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 6e-09 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 6e-09 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 6e-09 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 6e-09 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 6e-09 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 6e-09 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 6e-09 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 6e-09 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-09 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-09 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 6e-09 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 7e-09 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 7e-09 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-09 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 7e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 8e-09 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 9e-09 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 9e-09 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 9e-09 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-09 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-08 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-08 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-08 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-08 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-08 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-08 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-08 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-08 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-08 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-08 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-08 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-08 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-08 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-08 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-08 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-08 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-08 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-08 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-08 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-08 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-08 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-08 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-08 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-08 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-08 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-08 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-08 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-08 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-08 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-08 | ||
| 2omu_A | 462 | Crystal Structure Of Inla G194s+s Y369s/hec1 Comple | 2e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-08 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-08 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-08 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-08 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-08 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-08 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-08 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-08 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-08 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-08 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-08 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-08 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-08 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-08 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-08 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-08 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 3e-08 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-08 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-08 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-08 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-08 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-08 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-08 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-08 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-08 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-08 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-08 | ||
| 2omv_A | 461 | Crystal Structure Of Inla S192n Y369s/hec1 Complex | 3e-08 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-08 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-08 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-08 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-08 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-08 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 4e-08 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-08 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 4e-08 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-08 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 4e-08 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 4e-08 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 4e-08 | ||
| 2omt_A | 462 | Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt | 4e-08 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 4e-08 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-08 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-08 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-08 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 5e-08 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 5e-08 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 5e-08 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 5e-08 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 5e-08 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 5e-08 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 5e-08 | ||
| 2omz_A | 466 | Crystal Structure Of Inla Y369a/hec1 Complex Length | 5e-08 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 5e-08 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 5e-08 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 5e-08 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 5e-08 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-08 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 6e-08 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 6e-08 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 6e-08 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 6e-08 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 6e-08 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 6e-08 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 6e-08 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 6e-08 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 6e-08 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 6e-08 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 7e-08 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 7e-08 | ||
| 2omx_A | 462 | Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX | 7e-08 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 7e-08 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 7e-08 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 7e-08 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 7e-08 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 7e-08 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 7e-08 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 7e-08 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 7e-08 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 7e-08 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 7e-08 | ||
| 2omy_A | 461 | Crystal Structure Of Inla S192n/hec1 Complex Length | 7e-08 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 8e-08 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 8e-08 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 8e-08 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 8e-08 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-08 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 8e-08 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 8e-08 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 8e-08 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 8e-08 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 8e-08 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 8e-08 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 8e-08 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 8e-08 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 8e-08 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-08 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 8e-08 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 8e-08 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 8e-08 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 8e-08 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 8e-08 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 8e-08 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 8e-08 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 8e-08 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 8e-08 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 8e-08 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 8e-08 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 8e-08 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 8e-08 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 8e-08 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 8e-08 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 8e-08 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 9e-08 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 9e-08 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 9e-08 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 9e-08 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 9e-08 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 9e-08 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 9e-08 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 9e-08 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 9e-08 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 9e-08 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 9e-08 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 9e-08 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 9e-08 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 9e-08 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 9e-08 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 9e-08 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 9e-08 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 9e-08 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-07 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-07 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-07 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-07 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-07 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-07 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-07 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-07 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-07 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-07 | ||
| 1o6s_A | 466 | Internalin (Listeria Monocytogenes) E-Cadherin (Hum | 1e-07 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-07 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-07 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-07 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-07 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-07 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-07 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-07 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-07 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-07 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-07 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-07 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-07 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-07 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-07 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-07 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-07 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-07 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-07 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-07 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-07 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-07 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 3e-07 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-07 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-07 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 3e-07 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 4e-07 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 4e-07 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 4e-07 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 4e-07 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 4e-07 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-07 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 4e-07 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-07 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 4e-07 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 4e-07 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-07 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 5e-07 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 5e-07 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 5e-07 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 5e-07 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 5e-07 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 5e-07 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 6e-07 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 6e-07 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 6e-07 | ||
| 3v47_A | 455 | Crystal Structure Of The N-Tetminal Fragment Of Zeb | 6e-07 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 8e-07 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 8e-07 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 8e-07 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 8e-07 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 9e-07 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 9e-07 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 9e-07 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 9e-07 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-07 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-06 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-06 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-06 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-06 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-06 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-06 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-06 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 1e-06 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-06 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-06 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-06 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-06 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-06 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 2e-06 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-06 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-06 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-06 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-06 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-06 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-06 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-06 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-06 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-06 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-06 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 3e-06 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 4e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 4e-06 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 5e-06 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 5e-06 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 6e-06 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 6e-06 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 6e-06 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 6e-06 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 6e-06 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 6e-06 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 6e-06 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 7e-06 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 7e-06 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 7e-06 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 7e-06 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 7e-06 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 8e-06 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 8e-06 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 8e-06 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 8e-06 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 8e-06 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 8e-06 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 8e-06 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 8e-06 | ||
| 2o6q_A | 270 | Structural Diversity Of The Hagfish Variable Lympho | 9e-06 | ||
| 2o6q_A | 270 | Structural Diversity Of The Hagfish Variable Lympho | 2e-04 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 9e-06 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-05 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-05 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-05 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-05 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-05 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-05 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-05 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-05 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-05 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-05 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-05 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-05 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-05 | ||
| 4fho_A | 231 | Crystal Structure Of An Internalin C2 (Inlc2) From | 2e-05 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-05 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-05 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-05 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-05 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-05 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-05 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-05 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-05 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-05 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-05 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-05 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-05 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-05 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-05 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-05 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 3e-05 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 3e-05 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-05 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-05 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-05 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 3e-05 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-05 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-05 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 3e-05 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-05 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-05 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-05 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-05 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 4e-05 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 4e-05 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 4e-05 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 4e-05 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 4e-05 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 4e-05 | ||
| 3rfs_A | 272 | Design Of A Binding Scaffold Based On Variable Lymp | 5e-05 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-05 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-05 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 5e-05 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 6e-05 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 7e-05 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 7e-05 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 7e-05 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 7e-05 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 8e-05 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 9e-05 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 1e-04 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-04 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-04 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-04 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-04 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-04 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 3e-04 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 3e-04 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 3e-04 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 3e-04 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 3e-04 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 3e-04 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 3e-04 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 3e-04 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 3e-04 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 3e-04 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 4e-04 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 4e-04 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 4e-04 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 5e-04 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 5e-04 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 5e-04 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 6e-04 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 6e-04 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 6e-04 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 6e-04 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 6e-04 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 6e-04 |
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2OMV|A Chain A, Crystal Structure Of Inla S192n Y369s/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2OMZ|A Chain A, Crystal Structure Of Inla Y369a/hec1 Complex Length = 466 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2OMY|A Chain A, Crystal Structure Of Inla S192n/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1O6S|A Chain A, Internalin (Listeria Monocytogenes) E-Cadherin (Human) Recognition Complex Length = 466 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3V47|A Chain A, Crystal Structure Of The N-Tetminal Fragment Of Zebrafish Tlr5 In Complex With Salmonella Flagellin Length = 455 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270 | Back alignment and structure |
|
| >pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4FHO|A Chain A, Crystal Structure Of An Internalin C2 (Inlc2) From Listeria Monocytogenes Str. 4b F2365 At 1.90 A Resolution Length = 231 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3RFS|A Chain A, Design Of A Binding Scaffold Based On Variable Lymphocyte Receptors Of Jawless Vertebrates By Module Engineering Length = 272 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 581 bits (1500), Expect = 0.0
Identities = 215/636 (33%), Positives = 310/636 (48%), Gaps = 28/636 (4%)
Query: 76 LNISYLSLTGNIPRQLG-NLSSLEILDLNFNRLSGEIPWEL---GNLAKLEKLLLHNNFL 131
LN+S +L G L+SLE+LDL+ N +SG +L+ L + N +
Sbjct: 131 LNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKI 190
Query: 132 TGTIPFSIFKLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQLSGSIPSFIFKI 191
+G + S + +L L +S NN + IP LG+ S+LQ LD+S N+LSG I
Sbjct: 191 SGDVDVS--RCVNLEFLDVSSNNFSTGIPF--LGDCSALQHLDISGNKLSGDFSRAISTC 246
Query: 192 SSLQALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGGISSTLS-NCKHLRILDLSF 250
+ L+ L+ +N+ G +P +L +L+ + +N F G I LS C L LDLS
Sbjct: 247 TELKLLNISSNQFVGPIPPLPLKSLQYLS---LAENKFTGEIPDFLSGACDTLTGLDLSG 303
Query: 251 NDLWGDIPKEIGNLTKLKELFLDFNILQGEIP-HTVGNLHNLEYLSLVNNELVGTVPATI 309
N +G +P G+ + L+ L L N GE+P T+ + L+ L L NE G +P ++
Sbjct: 304 NHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESL 363
Query: 310 FNVST-LKLIELSNNTFFGSLPSS-TDVQLPNLEELYLWGNNFSGTLPSFIFNASNLSKL 367
N+S L ++LS+N F G + + L+ELYL N F+G +P + N S L L
Sbjct: 364 TNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSL 423
Query: 368 SLGDNSFSGLIPNTFGNLRNLKRLRLYNNYLTSPELSFLSSLSNCKYLEIIALSGNPLNG 427
L N SG IP++ G+L L+ L+L+ N L L K LE + L N L G
Sbjct: 424 HLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEG---EIPQELMYVKTLETLILDFNDLTG 480
Query: 428 IIPMSAGNLSHSLEELFMPDCNVSGRIPKEIGNLANLVTLDLGGNKFNGSIPIALGKLQK 487
IP N + +L + + + ++G IPK IG L NL L L N F+G+IP LG +
Sbjct: 481 EIPSGLSNCT-NLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRS 539
Query: 488 LQLLNLDDNKLEGSIPDDICGLVELYKLALGDNKLSGQIPACFGNLASLRELWLGPN--E 545
L L+L+ N G+IP + + N ++G+ N +E N E
Sbjct: 540 LIWLDLNTNLFNGTIPAAMFKQ----SGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLE 595
Query: 546 LISFIPSTFWNIKDIMYVNFSSNFLTGPLPLEIENLKALTTLDFSMNNLSGVIPTTIGGL 605
+ N +S G +N ++ LD S N LSG IP IG +
Sbjct: 596 FQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSM 655
Query: 606 KGLQYLFLGHNRLQGSIPDSVGDLISLKSLNLSNNNLSGPIPTSLEKLSDLKELNLSFNK 665
L L LGHN + GSIPD VGDL L L+LS+N L G IP ++ L+ L E++LS N
Sbjct: 656 PYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNN 715
Query: 666 LEGEIPRGGPFVNFSAKSFMGNNLLCGSPNLQVPPC 701
L G IP G F F F+ N LCG P +P C
Sbjct: 716 LSGPIPEMGQFETFPPAKFLNNPGLCGYP---LPRC 748
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 520 bits (1342), Expect = e-171
Identities = 180/669 (26%), Positives = 301/669 (44%), Gaps = 57/669 (8%)
Query: 17 IAASANTSIDIDQDALLALKDHITYDPTNFFAKNWLTNSTMVCNWTGVTCDINQRRVTAL 76
AS + S+ + L++ KD + D +W +++ C + GVTC +VT++
Sbjct: 2 FQASPSQSLYREIHQLISFKDVLP-DKN--LLPDW-SSNKNPCTFDGVTCR--DDKVTSI 55
Query: 77 NISYLSLT---GNIPRQLGNLSSLEILDLNFNRLSGEIPWELGNLAKLEKLLLHNNFLTG 133
++S L + L +L+ LE L L+ + ++G + A L L L N L+G
Sbjct: 56 DLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLSRNSLSG 114
Query: 134 TIP--FSIFKLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQLSGSIPSFIF-- 189
+ S+ S L L +S N L L+SL++LDLS N +SG+
Sbjct: 115 PVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLS 174
Query: 190 -KISSLQALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGGISSTLSNCKHLRILDL 248
L+ L N++SG++ +S C +L LD+
Sbjct: 175 DGCGELKHLAISGNKISGDVD---------------------------VSRCVNLEFLDV 207
Query: 249 SFNDLWGDIPKEIGNLTKLKELFLDFNILQGEIPHTVGNLHNLEYLSLVNNELVGTVPAT 308
S N+ IP +G+ + L+ L + N L G+ + L+ L++ +N+ VG +P
Sbjct: 208 SSNNFSTGIP-FLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPP- 265
Query: 309 IFNVSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSGTLPSFIFNASNLSKLS 368
+ +L+ + L+ N F G +P L L L GN+F G +P F + S L L+
Sbjct: 266 -LPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLA 324
Query: 369 LGDNSFSGLIP-NTFGNLRNLKRLRLYNNYLTSPELSFLSSLSNCKY-LEIIALSGNPLN 426
L N+FSG +P +T +R LK L L N + SL+N L + LS N +
Sbjct: 325 LSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGE---LPESLTNLSASLLTLDLSSNNFS 381
Query: 427 GIIPMSAGNLS-HSLEELFMPDCNVSGRIPKEIGNLANLVTLDLGGNKFNGSIPIALGKL 485
G I + ++L+EL++ + +G+IP + N + LV+L L N +G+IP +LG L
Sbjct: 382 GPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSL 441
Query: 486 QKLQLLNLDDNKLEGSIPDDICGLVELYKLALGDNKLSGQIPACFGNLASLRELWLGPNE 545
KL+ L L N LEG IP ++ + L L L N L+G+IP+ N +L + L N
Sbjct: 442 SKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNR 501
Query: 546 LISFIPSTFWNIKDIMYVNFSSNFLTGPLPLEIENLKALTTLDFSMNNLSGVIPTTIGGL 605
L IP ++++ + S+N +G +P E+ + ++L LD + N +G IP +
Sbjct: 502 LTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQ 561
Query: 606 KGLQYLFLGHNRLQGSIPDSVGDLISLKSLNLSNN--NLSGPIPTSLEKLSDLKELNLSF 663
G + N + G + + K + + N G L +LS N++
Sbjct: 562 SGK----IAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITS 617
Query: 664 NKLEGEIPR 672
G
Sbjct: 618 RVYGGHTSP 626
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 275 bits (705), Expect = 2e-79
Identities = 114/439 (25%), Positives = 165/439 (37%), Gaps = 105/439 (23%)
Query: 66 CDINQRRVTALNISYLSLTGNIPRQLGNLSSLEILDLNFNRLSGEIPWELGNLAKLEKLL 125
C + + L + TG IP L N S L L L+FN LSG IP LG+L+KL L
Sbjct: 389 CQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLK 448
Query: 126 LHNNFLTGTIPFSIFKLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQLSGSIP 185
L N L G IP + + +L L L N+LTG IPS L N ++L + LS+N+L+G IP
Sbjct: 449 LWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPS-GLSNCTNLNWISLSNNRLTGEIP 507
Query: 186 SFIFKISSLQALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGGISSTLSNCKHLRI 245
+I ++ +L L NN SG +PA + +C+ L
Sbjct: 508 KWIGRLENLAILKLSNNSFSGNIPAELG-------------------------DCRSLIW 542
Query: 246 LDLSFNDLWGDIPKEIGNLTKLKELFLDFNILQGEIPHTVGNLHNLEYLSLVNNELVGTV 305
LDL+ N G IP + + + N + G+ + N + N
Sbjct: 543 LDLNTNLFNGTIPAAMFKQSGK----IAANFIAGKRYVYIKNDGMKKECHGAGN------ 592
Query: 306 PATIFNVSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSGTLPSFIFNASNLS 365
F G + +L + + G N ++
Sbjct: 593 ----------------LLEFQGIRSEQLN-RLSTRNPCNITSRVYGGHTSPTFDNNGSMM 635
Query: 366 KLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNYLTSPELSFLSSLSNCKYLEIIALSGNPL 425
L + N SG IP G++ L L L +N +
Sbjct: 636 FLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDI--------------------------- 668
Query: 426 NGIIPMSAGNLSHSLEELFMPDCNVSGRIPKEIGNLANLVTLDLGGNKFNGSIPIALGKL 485
SG IP E+G+L L LDL NK +G IP A+ L
Sbjct: 669 -------------------------SGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSAL 703
Query: 486 QKLQLLNLDDNKLEGSIPD 504
L ++L +N L G IP+
Sbjct: 704 TMLTEIDLSNNNLSGPIPE 722
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 369 bits (949), Expect = e-115
Identities = 138/658 (20%), Positives = 242/658 (36%), Gaps = 62/658 (9%)
Query: 71 RRVTALNISYLSLTGNIPRQLGNLSSLEILDLNFNRLSGEIPWELGNLAKLEKLLLHNNF 130
+T LN+++ L S L LD+ FN +S P L L+ L L +N
Sbjct: 25 TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNE 84
Query: 131 LTGTIPFSIFKLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQLSGSIPSFIFK 190
L+ + ++L +L L N++ I ++ +L LDLS N LS + +
Sbjct: 85 LSQLSDKTFAFCTNLTELHLMSNSIQK-IKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQ 143
Query: 191 ISSLQALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGGISSTLSNCKHLRILDLSF 250
+ +LQ L NN++ + + L+ L+LS
Sbjct: 144 LENLQELLLSNNKIQALKSEEL-----------------------DIFANSSLKKLELSS 180
Query: 251 NDLWGDIPKEIGNLTKLKELFLDFNILQGEIPHTVG---NLHNLEYLSLVNNELVGTVPA 307
N + P + +L LFL+ L + + ++ LSL N++L T
Sbjct: 181 NQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNT 240
Query: 308 TIFN--VSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSGTLPSFIFNASNLS 365
T + L +++LS N + + + LP LE +L NN + N+
Sbjct: 241 TFLGLKWTNLTMLDLSYN-NLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVR 299
Query: 366 KLSLGDN---------SFSGLIPNTFGNLRNLKRLRLYNNYLTSPELSFLSSLSNCKYLE 416
L+L + S + +F L+ L+ L + +N + + + + L N KYL
Sbjct: 300 YLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLS 359
Query: 417 IIALSGNPLNGIIPMS---AGNLSHSLEELFMPDCNVSGRIPKEIGNLANLVTLDLGGNK 473
LS + + + L L + +S L +L LDLG N+
Sbjct: 360 ---LSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNE 416
Query: 474 FNGSIPI-ALGKLQKLQLLNLDDNKLEGSIPDDICGLVELYKLALGDNKLSG--QIPACF 530
+ L+ + + L NK + + L +L L L P+ F
Sbjct: 417 IGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPF 476
Query: 531 GNLASLRELWLGPNELISFIPSTFWNIKDIMYVNFSSNFLT--------GPLPLEIENLK 582
L +L L L N + + ++ + ++ N L G ++ L
Sbjct: 477 QPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLS 536
Query: 583 ALTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQGSIPDSVGDLISLKSLNLSNNNL 642
L L+ N + L L+ + LG N L + +SLKSLNL N +
Sbjct: 537 HLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLI 596
Query: 643 SGPIPTSLEK-LSDLKELNLSFNKLEGEIPRGGPFVNFSAKS-----FMGNNLLCGSP 694
+ +L EL++ FN + FVN+ ++ + ++ LC +P
Sbjct: 597 TSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHYLCNTP 654
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 291 bits (746), Expect = 6e-86
Identities = 111/523 (21%), Positives = 178/523 (34%), Gaps = 48/523 (9%)
Query: 169 SLQLLDLSDNQLSGSIPSFIFKISSLQALHFGNNRLSGELPANICDNLPFLNFFSVYKNM 228
S ++ D S +L+ +P + +++ L+ +N+L AN L V N
Sbjct: 5 SHEVADCSHLKLT-QVPDDLP--TNITVLNLTHNQLRRLPAANF-TRYSQLTSLDVGFNT 60
Query: 229 FYGGISSTLSNCKHLRILDLSFNDLWGDIPKEIGNLTKLKELFLDFNILQGEIPHTVGNL 288
L++L+L N+L K T L EL L N +Q +
Sbjct: 61 ISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQ 120
Query: 289 HNLEYLSLVNNELVGTVPATIFNVSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGN 348
NL L L +N L T T L NL+EL L N
Sbjct: 121 KNLITLDLSHNGLSSTKLGTQVQ-------------------------LENLQELLLSNN 155
Query: 349 NFSGTLPSFI--FNASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNYLTSPELSFL 406
+ F S+L KL L N P F + L L L N L L
Sbjct: 156 KIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKL 215
Query: 407 SSLSNCKYLEIIALSGNPLNGIIPMSAGNLSH-SLEELFMPDCNVSGRIPKEIGNLANLV 465
+ ++LS + L+ + L +L L + N++ L L
Sbjct: 216 CLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLE 275
Query: 466 TLDLGGNKFNGSIPIALGKLQKLQLLNLDDN---------KLEGSIPDDICGLVELYKLA 516
L N +L L ++ LNL + L L L L
Sbjct: 276 YFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLN 335
Query: 517 LGDNKLSGQIPACFGNLASLRELWLGPN--ELISFIPSTFWNI--KDIMYVNFSSNFLTG 572
+ DN + G F L +L+ L L + L + TF ++ + +N + N ++
Sbjct: 336 MEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISK 395
Query: 573 PLPLEIENLKALTTLDFSMNNLSGVIP-TTIGGLKGLQYLFLGHNRLQGSIPDSVGDLIS 631
L L LD +N + + GL+ + ++L +N+ +S + S
Sbjct: 396 IESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPS 455
Query: 632 LKSLNLSNNNLSG--PIPTSLEKLSDLKELNLSFNKLEGEIPR 672
L+ L L L P+ + L +L L+LS N +
Sbjct: 456 LQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDD 498
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 175 bits (447), Expect = 5e-46
Identities = 63/301 (20%), Positives = 98/301 (32%), Gaps = 13/301 (4%)
Query: 69 NQRRVTALNISYLSLTGNIPRQLGNLSSLEILDLNFNRLSGE--IPWELGNLA--KLEKL 124
+ + LN+ + G L +L+ L L+ + S +LA L L
Sbjct: 327 WLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHIL 386
Query: 125 LLHNNFLTGTIPFSIFKLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQLSGSI 184
L N ++ + L L L L N + + L ++ + LS N+
Sbjct: 387 NLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLT 446
Query: 185 PSFIFKISSLQALHFGNNRLSG-ELPANICDNLPFLNFFSVYKNMFYGGISSTLSNCKHL 243
+ + SLQ L L + + L L + N L + L
Sbjct: 447 RNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKL 506
Query: 244 RILDLSFNDL--------WGDIPKEIGNLTKLKELFLDFNILQGEIPHTVGNLHNLEYLS 295
ILDL N+L G + L+ L L L+ N +L L+ +
Sbjct: 507 EILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIID 566
Query: 296 LVNNELVGTVPATIFNVSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSGTLP 355
L N L + N +LK + L N NL EL + N F T
Sbjct: 567 LGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCE 626
Query: 356 S 356
S
Sbjct: 627 S 627
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 322 bits (828), Expect = 5e-98
Identities = 86/668 (12%), Positives = 183/668 (27%), Gaps = 152/668 (22%)
Query: 50 NWLTNSTMVCNWT---GVTCDINQRRVTALNISYLSLTGNIP------------------ 88
NW + + W GV+ + + RVT L++ +G +P
Sbjct: 59 NW-NFNKELDMWGAQPGVSLN-SNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHG 116
Query: 89 ----------RQLGNLSSLEILDLNFNRLSGEIPWELGNLA--KLEKLLLHNNFLTGTIP 136
+ + S E L K ++++ +I
Sbjct: 117 EKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIK 176
Query: 137 FSIFKLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQLSGSIPSFIFKISSLQA 196
S + NN+T + + L+ L+ + ++ ++ + +
Sbjct: 177 KSSRITLKDTQIGQLSNNITF-VSK-AVMRLTKLRQFYMGNSPFVAENICEAWENENSE- 233
Query: 197 LHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGGISSTLSNCKHLRILDLSFNDLWGD 256
+ N K L +++
Sbjct: 234 ----YAQQYKTED-------------------------LKWDNLKDLTDVEVYNCPNLTK 264
Query: 257 IPKEIGNLTKLKELFLDFN--------ILQGEIPHTVGNLHNLEYLSLVNNEL-VGTVPA 307
+P + L +++ + + N + ++ + + N L V
Sbjct: 265 LPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVET 324
Query: 308 TIFNVSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSGTLPSFIFNASNLSKL 367
++ + L L N G LP+F + L+ L
Sbjct: 325 SLQK-------------------------MKKLGMLECLYNQLEGKLPAF-GSEIKLASL 358
Query: 368 SLGDNSFSGLIPNTFGNLRNLKRLRLYNNYLTS-PELSFLSSLSNCKYLEIIALSGNPLN 426
+L N + + N G ++ L +N L P + S+S + I S N +
Sbjct: 359 NLAYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSV---MSAIDFSYNEIG 415
Query: 427 GIIPMSAGNLSHSLEELFMPDCNVSGRIPKEIGNLANLVTLDLGGNKFNGSIPIALGKLQ 486
+ + N+ +++L N+ +
Sbjct: 416 SVDG------------------KNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGS 457
Query: 487 KLQLLNLDDNKLEGSIPDDICGLVELYKLALGDNKLSGQIPACFGNLASLRELWLGPNEL 546
L +NL N L IP + F N L + L N+L
Sbjct: 458 PLSSINLMGNMLTE-IPKNSLKD----------------ENENFKNTYLLTSIDLRFNKL 500
Query: 547 ISFIPS-TFWNIKDIMYVNFSSNFLTGPLPLEIENLKALTTL------DFSMNNLSGVIP 599
+ ++ ++ S N + P + N L D N P
Sbjct: 501 TKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWP 559
Query: 600 TTIGGLKGLQYLFLGHNRLQGSIPDSVGDLISLKSLNLSNNNLSGPIPTSLEKLSDLKEL 659
I L L +G N ++ + + + ++ L++ +N + + +
Sbjct: 560 EGITLCPSLTQLQIGSNDIR-KVNEKI--TPNISVLDIKDNPNISIDLSYVCPYIEAGMY 616
Query: 660 NLSFNKLE 667
L ++K +
Sbjct: 617 MLFYDKTQ 624
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 4e-53
Identities = 67/362 (18%), Positives = 123/362 (33%), Gaps = 53/362 (14%)
Query: 74 TALNISYLSL-TGNIPRQLGNLSSLEILDLNFNRLSGEIPWELGNLAKLEKLLLHNNFLT 132
+ I Y +L T + L + L +L+ +N+L G++P G+ KL L L N +T
Sbjct: 308 QIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQIT 366
Query: 133 GTIPFSIF-KLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQLSG-------SI 184
IP + + +L + N L + ++S + +D S N++ +
Sbjct: 367 E-IPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPL 425
Query: 185 PSFIFKISSLQALHFGNNRLSGELPANICDNLPFLNFFSVYKNMF-------YGGISSTL 237
FK ++ +++ NN++S P + L+ ++ NM +
Sbjct: 426 DPTPFKGINVSSINLSNNQISK-FPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENF 484
Query: 238 SNCKHLRILDLSFNDLWGDIPKEI--GNLTKLKELFLDFNILQGEIPHTVGNLHNLEYLS 295
N L +DL FN L + + L L + L +N P N L+
Sbjct: 485 KNTYLLTSIDLRFNKL-TKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFG 542
Query: 296 LVNNELVGTVPATIFNVSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSGTLP 355
+ N N P P+L +L + N+ +
Sbjct: 543 IRNQRD------------------AQGNRTLREWPEGIT-LCPSLTQLQIGSNDIR-KVN 582
Query: 356 SFIFNASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNYLTSPELSFLSSLSNCKYL 415
I N+S L + DN + + L+ + + C L
Sbjct: 583 EKIT--PNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQ--------DIRGCDAL 632
Query: 416 EI 417
+I
Sbjct: 633 DI 634
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 305 bits (782), Expect = 8e-92
Identities = 115/613 (18%), Positives = 193/613 (31%), Gaps = 96/613 (15%)
Query: 73 VTALNISYLSLTGNIPRQLGNLSSLEILDLNFNRLSGEIPWELGNLAKLEKLLLHNNFLT 132
L++S+ L + L++LDL+ + +L+ L L+L N +
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89
Query: 133 GTIPFSIFKLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQLSGSIPSFIFKIS 192
+ LSSL L + NL +G+L +L+ L+++ N +
Sbjct: 90 SLALGAFSGLSSLQKLVAVETNLASLENFP-IGHLKTLKELNVAHNLIQS---------- 138
Query: 193 SLQALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGGISSTLSNCKHLRILDLSFND 252
+ SN +L LDLS N
Sbjct: 139 --------------------------------------FKLPEYFSNLTNLEHLDLSSNK 160
Query: 253 LWGDIPKEIGNLTKLKELFLDFNILQGEIPHTVGNLHNLEYLSLVNNELVGTVPATIFNV 312
+ ++ L ++ L L L L N + + F
Sbjct: 161 IQSIYCTDLRVLHQMPLLNL--------------------SLDLSLNPMNF-IQPGAFKE 199
Query: 313 STLKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSGT--LPSFIFNA-SNLSKLSL 369
L + L NN ++ + L LE L F L F +A L L++
Sbjct: 200 IRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTI 259
Query: 370 GDNSFSGL------IPNTFGNLRNLKRLRLYNNYLTSPELSFLSSLSNCKYLEIIALSGN 423
+ + L I + F L N+ L + + + S + + L
Sbjct: 260 EEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER-----VKDFSYNFGWQHLELVNC 314
Query: 424 PLNGIIPMSAGNLSHSLEELFMPDCNVSGRIPKEIGNLANLVTLDLGGNKFN--GSIPIA 481
+ +L L + G +L +L LDL N + G +
Sbjct: 315 KFGQFPTLKLKSLK-RLTFT-----SNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQS 368
Query: 482 LGKLQKLQLLNLDDNKLEGSIPDDICGLVELYKLALGDNKLSGQIPA-CFGNLASLRELW 540
L+ L+L N + + + GL +L L + L F +L +L L
Sbjct: 369 DFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLD 427
Query: 541 LGPNELISFIPSTFWNIKDIMYVNFSSNFLTGPLPLEI-ENLKALTTLDFSMNNLSGVIP 599
+ F + + + + N +I L+ LT LD S L + P
Sbjct: 428 ISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSP 487
Query: 600 TTIGGLKGLQYLFLGHNRLQGSIPDSVGDLISLKSLNLSNNNLSGPIPTSLEKL-SDLKE 658
T L LQ L + HN L SL+ L+ S N++ L+ S L
Sbjct: 488 TAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAF 547
Query: 659 LNLSFNKLEGEIP 671
LNL+ N
Sbjct: 548 LNLTQNDFACTCE 560
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 267 bits (684), Expect = 4e-78
Identities = 103/503 (20%), Positives = 175/503 (34%), Gaps = 39/503 (7%)
Query: 201 NNRLSGELPANICDNLPFLNFFSVYKNMFYGGISSTLSNCKHLRILDLSFNDLWGDIPKE 260
++P N+ + L+ N S + + L++LDLS ++
Sbjct: 16 ELNFY-KIPDNLPFSTKNLDL---SFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGA 71
Query: 261 IGNLTKLKELFLDFNILQGEIPHTVGNLHNLEYLSLVNNELVGTVPATIFNVSTLKLIEL 320
+L+ L L L N +Q L +L+ L V L I ++ TLK + +
Sbjct: 72 YQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNV 131
Query: 321 SNNTFFGSLPSSTDVQLPNLEELYLWGNNFSGTLPSFIFNASNLS----KLSLGDNSFSG 376
++N L NLE L L N + + + L L N +
Sbjct: 132 AHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF 191
Query: 377 LIPNTFGNLRNLKRLRLYNNYLTSPELS-FLSSLSNCKYLEIIALSGNPLNGIIPMSAGN 435
+ P F + L +L L NN+ + + + L+ + ++ +
Sbjct: 192 IQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSA 250
Query: 436 LSHSLEELFMPDCNVS------GRIPKEIGNLANLVTLDLGGNKFNGSIPIA-LGKLQKL 488
L L L + + ++ I L N+ + L + Q L
Sbjct: 251 LE-GLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHL 309
Query: 489 QLLN----------------LDDNKLEGSIPDDICGLVELYKLALGDNKLS--GQIPACF 530
+L+N L +G L L L L N LS G
Sbjct: 310 ELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSD 369
Query: 531 GNLASLRELWLGPNELISFIPSTFWNIKDIMYVNFSSNFLTGPLPLEI-ENLKALTTLDF 589
SL+ L L N +I+ + S F ++ + +++F + L + +L+ L LD
Sbjct: 370 FGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDI 428
Query: 590 SMNNLSGVIPTTIGGLKGLQYLFLGHNRLQGSI-PDSVGDLISLKSLNLSNNNLSGPIPT 648
S + GL L+ L + N Q + PD +L +L L+LS L PT
Sbjct: 429 SHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPT 488
Query: 649 SLEKLSDLKELNLSFNKLEGEIP 671
+ LS L+ LN+S N
Sbjct: 489 AFNSLSSLQVLNMSHNNFFSLDT 511
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 3e-43
Identities = 58/315 (18%), Positives = 99/315 (31%), Gaps = 53/315 (16%)
Query: 76 LNISYLSLTGNIPRQLGNLSSLEILDLNFNRLS--GEIPWELGNLAKLEKLLLHNNFLTG 133
+++ S G +L SLE LDL+ N LS G L+ L L N +
Sbjct: 328 KRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI- 386
Query: 134 TIPFSIFKLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQLSGSIPSFIFKISS 193
T+ + L L L +NL +L +L LD+S + +SS
Sbjct: 387 TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSS 446
Query: 194 LQALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGGISSTLSNCKHLRILDLSFNDL 253
L+ L N +I + ++L LDLS L
Sbjct: 447 LEVLKMAGNSFQENFLPDI------------------------FTELRNLTFLDLSQCQL 482
Query: 254 WGDIPKEIGNLTKLKELFLDFNILQGEIPHTVGNLHNLEYLSLVNNELVGTVPATIFNVS 313
P +L+ L+ L + N L++L+ L N ++ + + +
Sbjct: 483 EQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHF- 541
Query: 314 TLKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSGTLPS--FIFNASNLSKLSLGD 371
+L L L N+F+ T F+ + +L +
Sbjct: 542 -----------------------PSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEV 578
Query: 372 NSFSGLIPNTFGNLR 386
P+ +
Sbjct: 579 ERMECATPSDKQGMP 593
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 310 bits (795), Expect = 4e-91
Identities = 101/712 (14%), Positives = 202/712 (28%), Gaps = 116/712 (16%)
Query: 13 HSLIIAASANTSIDIDQDALLALKDHITYDPTNFFAKNWLTNSTMVCNWTGVTCDINQRR 72
++ I D AL A+ + + + + N+ NW
Sbjct: 255 ANVPIQLKETAEYIKDYKALKAIWEALD-GKNWRYYSGTINNTIHSLNWN---------- 303
Query: 73 VTALNISYLSLTGNIPRQLGNLSSLEILDLNFNRLSGEIPWELGNLAKLEKLLLHNNFLT 132
N L N + L L G +P +G L +L+ L + T
Sbjct: 304 ---FNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSET 360
Query: 133 GTIPFSIFKLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQLS-----GSIPSF 187
+ + + + + + L L L DL + ++ I
Sbjct: 361 VSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKD 420
Query: 188 IFKISSLQALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGGISSTLSNCKHLRILD 247
+ NR++ + I L L + F + + +
Sbjct: 421 SRISLKDTQIGNLTNRITF-ISKAIQ-RLTKLQIIYFANSPF-----TYDNIAVDWEDAN 473
Query: 248 LSFNDLWGDIPKEIGNLTKLKELFLDFNILQGEIPHTVGNLHNLEYLSLVNNELVG---- 303
+ + + NL L ++ L ++P + +L L+ L++ N +
Sbjct: 474 SDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQL 533
Query: 304 -----TVPATIFNVSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSGTLPSFI 358
+ +++ + N S++ ++ L L N L +F
Sbjct: 534 KADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR-HLEAF- 591
Query: 359 FNASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNYLTS-PELSFLSSLSNCKYLEI 417
L+ L L N + + ++ L +N L P + S+ +
Sbjct: 592 GTNVKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYV---MGS 648
Query: 418 IALSGNPLNGIIPMSAGNLSHSLEELFMPDCNVSGRIPKEIGNLANLVTLDLGGNKFNGS 477
+ S N + N+S S+++ N T+ L N+
Sbjct: 649 VDFSYNKIGSEGR----NISCSMDDY----------------KGINASTVTLSYNEIQKF 688
Query: 478 IPIALGKLQKLQLLNLDDNKLEGSIPDDICGLVELYKLALGDNKLSGQIPACFGNLASLR 537
+ + L +N + SIP++ + N L
Sbjct: 689 PTELFATGSPISTIILSNNLMT-SIPENSLKP----------------KDGNYKNTYLLT 731
Query: 538 ELWLGPNELISFIPSTFWNIKDIMYVNFSSNFLTG-PLPLEIENLKALTTLDFSMNNLSG 596
+ L N LT L L+ +D S N S
Sbjct: 732 TIDL------------------------RFNKLTSLSDDFRATTLPYLSNMDVSYNCFSS 767
Query: 597 VIPTTIGGLKGLQYLFLGH------NRLQGSIPDSVGDLISLKSLNLSNNNLSGPIPTSL 650
PT L+ + H NR+ P + SL L + +N++ + L
Sbjct: 768 -FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRK-VDEKL 825
Query: 651 EKLSDLKELNLSFNKL-EGEIPRGGPFVNFSAKSFMGNN--LLCGSPNLQVP 699
L L+++ N ++ P++ + + + G L +
Sbjct: 826 --TPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQDIRGCDALGIE 875
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 68.4 bits (167), Expect = 8e-12
Identities = 38/252 (15%), Positives = 77/252 (30%), Gaps = 16/252 (6%)
Query: 462 ANLVTLDLGGNKFNGSIPIALGKLQKLQLLNLDDNKLEGSIPDDICGLVELYKLALGDNK 521
AN +D+G + ++ + G Q + + ++ S + V + DNK
Sbjct: 193 ANDKYMDIGVATCDSAVWLPAGTYQVVAYTTYSQSGIKRSELET--QSVRGESFTVIDNK 250
Query: 522 LSGQ--IPACFGNLA-------SLRELW---LGPNELISFIPSTFWNIKDIMYVNFSSNF 569
L+ +P A +L+ +W G N N +
Sbjct: 251 LTKDANVPIQLKETAEYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKELDM 310
Query: 570 LTGPLPLEIENLKALTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQGSIPDSVGDL 629
++++N +T L + G +P IG L L+ L G + S +
Sbjct: 311 WGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEE 370
Query: 630 ISLKSLNLSNNNLSGPI-PTSLEKLSDLKELNLSFNKLEGEIPRGGPFVNFSAKSFMGNN 688
++ + + L+ L +L + + P P S S
Sbjct: 371 LTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAIN-RNPEMKPIKKDSRISLKDTQ 429
Query: 689 LLCGSPNLQVPP 700
+ + +
Sbjct: 430 IGNLTNRITFIS 441
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 289 bits (742), Expect = 8e-90
Identities = 95/341 (27%), Positives = 137/341 (40%), Gaps = 53/341 (15%)
Query: 361 ASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNYLTSPELSFLSSLSNCKYLEIIAL 420
+S L + ++ G++ +T + L L L SSL+N YL + +
Sbjct: 25 SSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNL-PKPYPIPSSLANLPYLNFLYI 83
Query: 421 SGNPLNGIIPMSAGNLSHSLEELFMPDCNVSGRIPKEIGNLANLVTLDLGGNKFNGSIPI 480
G N+ G IP I L L L + +G+IP
Sbjct: 84 GGIN------------------------NLVGPIPPAIAKLTQLHYLYITHTNVSGAIPD 119
Query: 481 ALGKLQKLQLLNLDDNKLEGSIPDDICGLVELYKLALGDNKLSGQIPACFGNLASLRELW 540
L +++ L L+ N L G++P I L L + N++SG IP +G+ + L
Sbjct: 120 FLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFT-- 177
Query: 541 LGPNELISFIPSTFWNIKDIMYVNFSSNFLTGPLPLEIENLKALTTLDFSMNNLSGVIPT 600
+ S N LTG +P NL L +D S N L G
Sbjct: 178 ---------------------SMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASV 215
Query: 601 TIGGLKGLQYLFLGHNRLQGSIPDSVGDLISLKSLNLSNNNLSGPIPTSLEKLSDLKELN 660
G K Q + L N L + VG +L L+L NN + G +P L +L L LN
Sbjct: 216 LFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLN 274
Query: 661 LSFNKLEGEIPRGGPFVNFSAKSFMGNNLLCGSPNLQVPPC 701
+SFN L GEIP+GG F ++ N LCGSP +P C
Sbjct: 275 VSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSP---LPAC 312
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 243 bits (623), Expect = 6e-73
Identities = 84/303 (27%), Positives = 128/303 (42%), Gaps = 39/303 (12%)
Query: 28 DQDALLALKDHITYDPTNFFAKNWLTNSTM-VCNWTGVTCDI--NQRRVTALNISYL--- 81
D+ ALL +K + +PT +WL + W GV CD RV L++S L
Sbjct: 7 DKQALLQIKKDLG-NPTTL--SSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLP 63
Query: 82 ------------------------SLTGNIPRQLGNLSSLEILDLNFNRLSGEIPWELGN 117
+L G IP + L+ L L + +SG IP L
Sbjct: 64 KPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQ 123
Query: 118 LAKLEKLLLHNNFLTGTIPFSIFKLSSLLDLKLSDNNLTGTIPSHNLGNLSSL-QLLDLS 176
+ L L N L+GT+P SI L +L+ + N ++G IP + G+ S L + +S
Sbjct: 124 IKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPD-SYGSFSKLFTSMTIS 182
Query: 177 DNQLSGSIPSFIFKISSLQALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGGISST 236
N+L+G IP + +L + N L G+ + + KN +
Sbjct: 183 RNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFG-SDKNTQKIHLAKNSLAFDLGK- 239
Query: 237 LSNCKHLRILDLSFNDLWGDIPKEIGNLTKLKELFLDFNILQGEIPHTVGNLHNLEYLSL 296
+ K+L LDL N ++G +P+ + L L L + FN L GEIP GNL + +
Sbjct: 240 VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAY 298
Query: 297 VNN 299
NN
Sbjct: 299 ANN 301
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 215 bits (550), Expect = 6e-63
Identities = 74/350 (21%), Positives = 126/350 (36%), Gaps = 60/350 (17%)
Query: 162 HNLGNLSS-LQLLDLSDNQLSGSIPSFIFKISSLQALHFGNNRLSGE--LPANICDNLPF 218
N LSS L D + G + + + L L +P+++ NLP+
Sbjct: 19 GNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLA-NLPY 77
Query: 219 LNFFSVYK-NMFYGGISSTLSNCKHLRILDLSFNDLWGDIPKEIGNLTKLKELFLDFNIL 277
LNF + N G I ++ L L ++ ++ G IP + + L L +N L
Sbjct: 78 LNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNAL 137
Query: 278 QGEIPHTVGNLHNLEYLSLVNNELVGTVPATIFNVSTLKLIELSNNTFFGSLPSSTDVQL 337
G +P ++ +L NL ++ N + G +P + + S L
Sbjct: 138 SGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKL---------------------- 175
Query: 338 PNLEELYLWGNNFSGTLPSFIFNASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNY 397
+ + N +G +P N NL+ + L N G FG+ +N +++ L N
Sbjct: 176 --FTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNS 232
Query: 398 LTSPELSFLSSLSNCKYLEIIALSGNPLNGIIPMSAGNLSHSLEELFMPDCNVSGRIPKE 457
L L + K L + L N + G +P+
Sbjct: 233 LAFD----LGKVGLSKNLNGLDLRNN-------------------------RIYGTLPQG 263
Query: 458 IGNLANLVTLDLGGNKFNGSIPIALGKLQKLQLLNLDDNKLEGSIPDDIC 507
+ L L +L++ N G IP G LQ+ + +NK P C
Sbjct: 264 LTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSPLPAC 312
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 285 bits (732), Expect = 9e-85
Identities = 123/600 (20%), Positives = 209/600 (34%), Gaps = 77/600 (12%)
Query: 73 VTALNISYLSLTGNIPRQLGNLSSLEILDLNFNRLSGEIPWELGNLAKLEKLLLHNNFLT 132
L S+ L L +L LDL ++ + +L+ L+L N L
Sbjct: 35 TECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLI 94
Query: 133 GTIPFSIFKLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQLSGSIPSFIFKIS 192
++ +L L ++ I L N +L+ L L N +S F
Sbjct: 95 FMAETALSGPKALKHLFFIQTGISS-IDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTE 153
Query: 193 SLQALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGGISSTLSNCKHLRILDLSFND 252
L+ L F NN + L +L S L+L+ ND
Sbjct: 154 KLKVLDFQNNAIH-YLSKEDMSSLQQATNLS----------------------LNLNGND 190
Query: 253 LWGDIPKEIGNLTKLKELFLDFNILQGEIPHTVGN--LHNLEYLSLVNNELVGTVPATIF 310
+ G I + + L I + N + +L + + + PA
Sbjct: 191 IAG-IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFE 249
Query: 311 NVSTLKLIELS-NNTFFGSLPSSTDVQLPNLEELYLWGNNFSGTLPSFIFNASNLSKLSL 369
+ + + ++ +F ++ S+T L+EL L + S LPS + S L KL L
Sbjct: 250 GLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVL 308
Query: 370 GDNSFSGLIPNTFGNLRNLKRLRLYNNYLTSPELSFLSSLSNCKYLEIIALSGNPLNGII 429
N F L + N +L L + N + L N + L + LS + +
Sbjct: 309 SANKFENLCQISASNFPSLTHLSIKGNTKRLELGT--GCLENLENLRELDLSHDDIETS- 365
Query: 430 PMSAGNLSHSLEELFMPDCNVSGRIPKEIGNLANLVTLDLGGNKFNGSIPIALGKLQKLQ 489
++ NL++L +L+L N+ A + +L+
Sbjct: 366 ----------------------DCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLE 403
Query: 490 LLNLDDNKLEGSIPDDI-CGLVELYKLALGDNKLSGQIPACFGNLASLRELWLGPNELIS 548
LL+L +L+ L L L L + L F L +L+ L L N
Sbjct: 404 LLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPK 463
Query: 549 FIPSTFWNIKDIMYVNFSSNFLTGPLPLEIENLKALTTLDFSMNNLSGVIPTTIGGLKGL 608
++ L L L S +LS + LK +
Sbjct: 464 GNIQK---------------------TNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMM 502
Query: 609 QYLFLGHNRLQGSIPDSVGDLISLKSLNLSNNNLSGPIPTSLEKLSDLKELNLSFNKLEG 668
++ L HNRL S +++ L + LNL++N++S +P+ L LS + +NL N L+
Sbjct: 503 NHVDLSHNRLTSSSIEALSHLKGIY-LNLASNHISIILPSLLPILSQQRTINLRQNPLDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 272 bits (697), Expect = 7e-80
Identities = 105/509 (20%), Positives = 171/509 (33%), Gaps = 18/509 (3%)
Query: 173 LDLSDNQLSGSIPSFIFKISSLQALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGG 232
+ + L+ IP + +S + L F N L + L L F + + Y
Sbjct: 17 YNCENLGLN-EIPGTLP--NSTECLEFSFNVLP-TIQNTTFSRLINLTFLDLTRCQIYWI 72
Query: 233 ISSTLSNCKHLRILDLSFNDLWGDIPKEIGNLTKLKELFLDFNILQGEIPHTVGNLHNLE 292
T + L L L+ N L + LK LF + + N LE
Sbjct: 73 HEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLE 132
Query: 293 YLSLVNNELVGTVPATIFNVSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYLW-GNNFS 351
L L +N + F LK+++ NN L L L L N
Sbjct: 133 SLYLGSNHISSIKLPKGFPTEKLKVLDFQNN-AIHYLSKEDMSSLQQATNLSLNLNGNDI 191
Query: 352 GTLPSFIFNASNLSKLSLGDNSFSGLIPN--TFGNLRNLKRLRLYNNYLTSPELSFLSSL 409
+ F+++ L+ G +I +++L + + L
Sbjct: 192 AGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGL 251
Query: 410 SNCKYLEIIALSGNPLNGIIPMSAGNLSHSLEELFMPDCNVSGRIPKEIGNLANLVTLDL 469
+E I L + I + S L+EL + ++S +P + L+ L L L
Sbjct: 252 CEM-SVESINLQKHYFFNISSNTFHCFS-GLQELDLTATHLS-ELPSGLVGLSTLKKLVL 308
Query: 470 GGNKFNGSIPIALGKLQKLQLLNLDDNKLEGSIPDD-ICGLVELYKLALGDNKL--SGQI 526
NKF I+ L L++ N + + L L +L L + + S
Sbjct: 309 SANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCC 368
Query: 527 PACFGNLASLRELWLGPNELISFIPSTFWNIKDIMYVNFSSNFLTGPLPLEI-ENLKALT 585
NL+ L+ L L NE +S F + ++ + L +NL L
Sbjct: 369 NLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLK 428
Query: 586 TLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQGSIPDSVG---DLISLKSLNLSNNNL 642
L+ S + L GL LQ+L L N L L+ L LS +L
Sbjct: 429 VLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDL 488
Query: 643 SGPIPTSLEKLSDLKELNLSFNKLEGEIP 671
S + L + ++LS N+L
Sbjct: 489 SSIDQHAFTSLKMMNHVDLSHNRLTSSSI 517
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 259 bits (663), Expect = 3e-75
Identities = 118/583 (20%), Positives = 205/583 (35%), Gaps = 65/583 (11%)
Query: 69 NQRRVTALNISYLSLTGNIPRQLGNLSSLEILDLNFNRLSGEIPWELGNLAKLEKLLLHN 128
+Q R+ L ++ L L +L+ L +S L N LE L L +
Sbjct: 79 SQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGS 138
Query: 129 NFLTGTIPFSIFKLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQL--LDLSDNQLSGSIPS 186
N ++ F L L +N + + ++ +L L+L+ N ++ I
Sbjct: 139 NHISSIKLPKGFPTEKLKVLDFQNNAIH-YLSKEDMSSLQQATNLSLNLNGNDIA-GIEP 196
Query: 187 FIFKISSLQALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGGISSTLSNCKHLRIL 246
F + Q+L+FG + + + +ST+ +
Sbjct: 197 GAFDSAVFQSLNFGGTQNLLVIFKGLK--------------------NSTIQSLWLGTFE 236
Query: 247 DLSFNDLWGDIPKEIGNLTKLKELFLDFNILQGEIPHTVGNLHNLEYLSLVNNELVGTVP 306
D+ D+ + + + ++ ++ + L + +T L+ L L L +P
Sbjct: 237 DMDDEDISPAVFEGLCEMS-VESINLQKHYFFNISSNTFHCFSGLQELDLTATHL-SELP 294
Query: 307 ATIFNVSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSGTLPSFIF-NASNLS 365
+ + +STLK + LS N F +L + P+L L + GN L + N NL
Sbjct: 295 SGLVGLSTLKKLVLSAN-KFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLR 353
Query: 366 KLSLGDN--SFSGLIPNTFGNLRNLKRLRLYNNYLTSPELSFLSSLSNCKYLEIIALSGN 423
+L L + S NL +L+ L L N S + LE++ L+
Sbjct: 354 ELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQ---LELLDLAFT 410
Query: 424 PLNGIIPMSAGNLSHSLEELFMPDCNVSGRIPKEIGNLANLVTLDLGGNKFNGSIPIALG 483
L S NL L L+L + + S
Sbjct: 411 RLKVKDAQSP------------------------FQNLHLLKVLNLSHSLLDISSEQLFD 446
Query: 484 KLQKLQLLNLDDNKLEGSI---PDDICGLVELYKLALGDNKLSGQIPACFGNLASLRELW 540
L LQ LNL N + + L L L L LS F +L + +
Sbjct: 447 GLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVD 506
Query: 541 LGPNELISFIPSTFWNIKDIMYVNFSSNFLTGPLPLEIENLKALTTLDFSMNNLSGVIPT 600
L N L S ++K I Y+N +SN ++ LP + L T++ N L
Sbjct: 507 LSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDC---- 561
Query: 601 TIGGLKGLQYLFLGHNRLQGSIPDSVGDLISLKSLNLSNNNLS 643
T + L++ +L+ + + L+ + LS+ LS
Sbjct: 562 TCSNIYFLEWYKENMQKLEDTEDTLCENPPLLRGVRLSDVTLS 604
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-26
Identities = 44/207 (21%), Positives = 69/207 (33%), Gaps = 5/207 (2%)
Query: 491 LNLDDNKLEGSIPDDICGLVELYKLALGDNKLSGQIPACFGNLASLRELWLGPNELISFI 550
N ++ L IP + L N L F L +L L L ++
Sbjct: 17 YNCENLGLN-EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIH 73
Query: 551 PSTFWNIKDIMYVNFSSNFLTGPLPLEIENLKALTTLDFSMNNLSGVIPTTIGGLKGLQY 610
TF + + + ++N L + KAL L F +S + + K L+
Sbjct: 74 EDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLES 133
Query: 611 LFLGHNRLQGSIPDSVGDLISLKSLNLSNNNLSGPIPTSLEKLSDLK--ELNLSFNKLEG 668
L+LG N + LK L+ NN + + L LNL+ N + G
Sbjct: 134 LYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG 193
Query: 669 EIPRGGPFVNFSAKSFMGNNLLCGSPN 695
P F + +F G L
Sbjct: 194 IEPGAFDSAVFQSLNFGGTQNLLVIFK 220
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 283 bits (725), Expect = 9e-84
Identities = 108/603 (17%), Positives = 188/603 (31%), Gaps = 73/603 (12%)
Query: 76 LNISYLSLTGNIPRQLGNLSSLEILDLNFNRLSGEIPWELGNLAKLEKLLLHNNFLTGTI 135
L+ +P + SS + +DL+FN L + N ++L+ L L +
Sbjct: 16 YQCMDQKLS-KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIE 72
Query: 136 PFSIFKLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQLSGSIPSFIFKISSLQ 195
+ L L +L L+ N + + L+SL+ L + +L+ I ++ +L+
Sbjct: 73 DKAWHGLHHLSNLILTGNPIQS-FSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLK 131
Query: 196 ALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGGISSTLSNCKHLRILDLSFNDLWG 255
L+ +N + + + SN +L +DLS+N +
Sbjct: 132 KLNVAHNFIHS------------------------CKLPAYFSNLTNLVHVDLSYNYIQT 167
Query: 256 DIPKEIGNLTKLKELFLDFNILQGEIPHTVGNLHNLEYLSLVNNELVGTVPATIFNVSTL 315
++ L + L + N + + F L
Sbjct: 168 ITVNDLQFLRENP--------------------QVNLSLDMSLNPI-DFIQDQAFQGIKL 206
Query: 316 KLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSGTLPSFIFNASNLSKL-------- 367
+ L N ++ + L L L F IF S + L
Sbjct: 207 HELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEF 266
Query: 368 SLGDNSFSGLIPNTFGNLRNLKRLRLYNNYLTSPELSFLSSLSNCKYLEIIALSGNPLNG 427
L + F L N+ + L + L + + +++ L
Sbjct: 267 RLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY-----LEDVPKHFKWQSLSIIRCQLKQ 321
Query: 428 IIPMSAGNLSHSLEELFMPDCNVSGRIPKEIGNLANLVTLDLGGNKFNGSIPIAL--GKL 485
+L L+ L + G I + L +L LDL N + S +
Sbjct: 322 F---PTLDLPF-LKSLTLTMNK--GSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGT 375
Query: 486 QKLQLLNLDDNKLEGSIPDDICGLVELYKLALGDNKLSGQIPA-CFGNLASLRELWLGPN 544
L+ L+L N + + GL EL L + L F +L L L +
Sbjct: 376 NSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYT 434
Query: 545 ELISFIPSTFWNIKDIMYVNFSSNFLTGPLPLEI-ENLKALTTLDFSMNNLSGVIPTTIG 603
F + + + + N + N LT LD S L +
Sbjct: 435 NTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFD 494
Query: 604 GLKGLQYLFLGHNRLQGSIPDSVGDLISLKSLNLSNNNLSGPIPTSLEKLSDLKELNLSF 663
L LQ L + HN L L SL +L+ S N + L NL+
Sbjct: 495 TLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTN 554
Query: 664 NKL 666
N +
Sbjct: 555 NSV 557
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 8e-45
Identities = 61/363 (16%), Positives = 118/363 (32%), Gaps = 25/363 (6%)
Query: 76 LNISYLSLTGNIPR-QLGNLSSLEILDLNFNRLSGEIPWE------LGNLAKLEKLLLH- 127
L + + NI + L NL+ L + L E E + L +
Sbjct: 209 LTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRL 268
Query: 128 -NNFLTGTIPFSIFKLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQLSGSIPS 186
L+++ + L+ ++ ++ Q L + QL P+
Sbjct: 269 TYTNDFSDDIVKFHCLANVSAMSLAGVSIKYL---EDVPKHFKWQSLSIIRCQLK-QFPT 324
Query: 187 FIFKISSLQALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGGISSTLSN--CKHLR 244
L++L N+ S +L +L+ +N + S+ LR
Sbjct: 325 LDL--PFLKSLTLTMNKGSISFKKVALPSLSYLDL---SRNALSFSGCCSYSDLGTNSLR 379
Query: 245 ILDLSFNDLWGDIPKEIGNLTKLKELFLDFNILQGEIPHTV-GNLHNLEYLSLVNNELVG 303
LDLSFN + L +L+ L + L+ + +L L YL +
Sbjct: 380 HLDLSFNGA-IIMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKI 438
Query: 304 TVPATIFNVSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSGTLPSFIFNASN 363
+++L ++++ N+F + S+ NL L L
Sbjct: 439 DFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHR 498
Query: 364 LSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNYLTSPELSFLSSLSNCKYLEIIALSGN 423
L L++ N+ L + + L +L L N + + + + L L+ N
Sbjct: 499 LQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKS---LAFFNLTNN 555
Query: 424 PLN 426
+
Sbjct: 556 SVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 1e-19
Identities = 34/157 (21%), Positives = 55/157 (35%), Gaps = 5/157 (3%)
Query: 524 GQIPACFGNLASLRELWLGPNELISFIPSTFWNIKDIMYVNFSSNFLTGPLPLEIENLKA 583
G + C + ++ +L + K ++ S N L N
Sbjct: 2 GSLNPCIEVVPNIT-YQCMDQKLSKVPDDIPSSTK---NIDLSFNPLKILKSYSFSNFSE 57
Query: 584 LTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQGSIPDSVGDLISLKSLNLSNNNLS 643
L LD S + + GL L L L N +Q P S L SL++L L+
Sbjct: 58 LQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLA 117
Query: 644 GPIPTSLEKLSDLKELNLSFNKLEGEIPRGGPFVNFS 680
+ +L LK+LN++ N + F N +
Sbjct: 118 SLESFPIGQLITLKKLNVAHNFIHS-CKLPAYFSNLT 153
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 260 bits (666), Expect = 6e-79
Identities = 99/311 (31%), Positives = 152/311 (48%), Gaps = 14/311 (4%)
Query: 739 TRGENVPNEVNVPLEATWRRFSYLELFQATNGFSENNLIGRGSFGSVYIARLQNGIEVAV 798
T N + + R ++L +ATN F LIG G FG VY L++G +VA+
Sbjct: 9 TNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVAL 68
Query: 799 KTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEYMRNGSLEKCLY- 857
K + + + F+TE E + RH +L +I C + LI +YM NG+L++ LY
Sbjct: 69 KRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYG 128
Query: 858 --SGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGI 915
+ QRL I I A L YLH +IH D+K N+LLD+N V ++DFGI
Sbjct: 129 SDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGI 185
Query: 916 AKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIF 975
+K DQ+ T TLGY+ PEY +GR++ K DVYSFG++L E R +
Sbjct: 186 SKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSL 245
Query: 976 S-GEMTLKHWVNDFLPISM-MKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDE 1033
+ L W + +I+D NL DK + + + A++C S ++
Sbjct: 246 PREMVNLAEWAVESHNNGQLEQIVDPNL---ADKI---RPESLRKFGDTAVKCLALSSED 299
Query: 1034 RITAKEIVRRL 1044
R + +++ +L
Sbjct: 300 RPSMGDVLWKL 310
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 254 bits (651), Expect = 1e-76
Identities = 100/300 (33%), Positives = 149/300 (49%), Gaps = 21/300 (7%)
Query: 756 WRRFSYLELFQATNGFSENNLIGRGSFGSVYIARLQNGIEVAVKTFDLQ----HERAFKS 811
+RFS EL A++ FS N++GRG FG VY RL +G VAVK + E F+
Sbjct: 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQ- 75
Query: 812 FDTECEVMKSIRHRNLTKIISSCSNEDFKALILEYMRNGSLEKCLY---SGNYILDIFQR 868
TE E++ HRNL ++ C + L+ YM NGS+ CL LD +R
Sbjct: 76 --TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKR 133
Query: 869 LNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQ 928
I + A L YLH +IH D+K +N+LLD+ A + DFG+AKL+ +
Sbjct: 134 QRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM-DYKDTHVT 192
Query: 929 TQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGE---MTLKHWV 985
T T+G++APEY G+ S K DV+ +G++L+E T ++ D + L WV
Sbjct: 193 TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 252
Query: 986 NDFLPI-SMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRL 1044
L + ++D +L ++ +E + +A+ CT SP ER E+VR L
Sbjct: 253 KGLLKEKKLEALVDVDL----QGNYKDEE--VEQLIQVALLCTQSSPMERPKMSEVVRML 306
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 230 bits (588), Expect = 3e-68
Identities = 90/302 (29%), Positives = 136/302 (45%), Gaps = 27/302 (8%)
Query: 757 RRFSYLELFQATNGFSE------NNLIGRGSFGSVYIARLQNGIEVAVKTFDLQHERA-- 808
FS+ EL TN F E N +G G FG VY + N VAVK +
Sbjct: 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTE 71
Query: 809 --FKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEYMRNGSLEKCLY--SGNYILD 864
+ FD E +VM +H NL +++ S+ D L+ YM NGSL L G L
Sbjct: 72 ELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLS 131
Query: 865 IFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ 924
R I A+ + +LH IH D+K +N+LLD+ A +SDFG+A+ Q
Sbjct: 132 WHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 188
Query: 925 SMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHW 984
++ ++ + T YMAPE R G ++ K D+YSFG++L+E T DE L
Sbjct: 189 TVMTSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEH-REPQLLLDI 246
Query: 985 VNDFL--PISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVR 1042
+ ++ ID + D + E ++A +C E ++R K++ +
Sbjct: 247 KEEIEDEEKTIEDYIDKKM---NDADSTSVEAMY----SVASQCLHEKKNKRPDIKKVQQ 299
Query: 1043 RL 1044
L
Sbjct: 300 LL 301
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 233 bits (596), Expect = 2e-66
Identities = 109/563 (19%), Positives = 189/563 (33%), Gaps = 42/563 (7%)
Query: 126 LHNNFLTGTIPFSIFKLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQLSGSIP 185
IP ++ S +L LS N L + S++ + LQ+LDLS ++
Sbjct: 14 CMELNFY-KIPDNLP--FSTKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQTIED 69
Query: 186 SFIFKISSLQALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGGISSTLSNCKHLRI 245
+S L L N + L L L + + + + K L+
Sbjct: 70 GAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKE 128
Query: 246 LDLSFNDL-WGDIPKEIGNLTKLKELFLDFNILQGEIPHTVGNLHNLEY----LSLVNNE 300
L+++ N + +P+ NLT L+ L L N +Q + LH + L L N
Sbjct: 129 LNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNP 188
Query: 301 LVGTVPATIFNVSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSGTLPSFIFN 360
+ + F L + L NN ++ + L LE L F
Sbjct: 189 M-NFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEF---------- 237
Query: 361 ASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNYLTSPELSFLSSLSNCKYLEIIAL 420
+ + + L NL YL + + + +L
Sbjct: 238 --------RNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSL 289
Query: 421 SGNPLNGIIPMSAGNLSHSLEELFMPDCNVSGRIPKEIGNLANLVTLDLGGNKFNGSIPI 480
+ + S LE + L +L L NK +
Sbjct: 290 VSVTIERVKDFSYNFGWQHLELVNCKFGQFPT------LKLKSLKRLTFTSNKGGNAF-- 341
Query: 481 ALGKLQKLQLLNLDDNKLE--GSIPDDICGLVELYKLALGDNKLSGQIPACFGNLASLRE 538
+ L L+ L+L N L G G L L L N + + + F L L
Sbjct: 342 SEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEH 400
Query: 539 LWLGPNELISFIP-STFWNIKDIMYVNFSSNFLTGPLPLEIENLKALTTLDFSMNNLSGV 597
L + L S F ++++++Y++ S L +L L + N+
Sbjct: 401 LDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQEN 460
Query: 598 IPTTI-GGLKGLQYLFLGHNRLQGSIPDSVGDLISLKSLNLSNNNLSGPIPTSLEKLSDL 656
I L+ L +L L +L+ P + L SL+ LN+++N L ++L+ L
Sbjct: 461 FLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSL 520
Query: 657 KELNLSFNKLEGEIPRGGPFVNF 679
+++ L N + PR +
Sbjct: 521 QKIWLHTNPWDCSCPRIDYLSRW 543
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 5e-52
Identities = 96/509 (18%), Positives = 169/509 (33%), Gaps = 53/509 (10%)
Query: 174 DLSDNQLSGSIPSFIFKISSLQALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGGI 233
+ IP + S + L N L L +
Sbjct: 13 QCMELNFY-KIPDNLP--FSTKNLDLSFNPLR-HLGSY---------------------- 46
Query: 234 SSTLSNCKHLRILDLSFNDLWGDIPKEIGNLTKLKELFLDFNILQGEIPHTVGNLHNLEY 293
+ + L++LDLS ++ +L+ L L L N +Q L +L+
Sbjct: 47 --SFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQK 104
Query: 294 LSLVNNELVGTVPATIFNVSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSGT 353
L V L I ++ TLK + +++N L NLE L L N
Sbjct: 105 LVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSI 164
Query: 354 LPSFIFNASNLS----KLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNYLTSPELS-FLSS 408
+ + + L L N + + P F + L +L L NN+ + + +
Sbjct: 165 YCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQG 223
Query: 409 LSNCKYLEIIALSGNPLNGIIPMSAGNLSH----SLEELFMPDCNVSGR-IPKEIGNLAN 463
L+ + ++ + L ++EE + + I L N
Sbjct: 224 LAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTN 283
Query: 464 LVTLDLGGNKFNGSIPIA-LGKLQKLQLLNLDDNKLEGSIPDDICGLVELYKLALGDNKL 522
+ + L + Q L+L+N + L L +L NK
Sbjct: 284 VSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPT------LKLKSLKRLTFTSNKG 337
Query: 523 SGQIPACFGNLASLRELWLGPNEL--ISFIPSTFWNIKDIMYVNFSSNFLTGPLPLEIEN 580
+L SL L L N L + + + Y++ S N + +
Sbjct: 338 GNAFS--EVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLG 394
Query: 581 LKALTTLDFSMNNLSGVIPTTI-GGLKGLQYLFLGHNRLQGSIPDSVGDLISLKSLNLSN 639
L+ L LDF +NL + ++ L+ L YL + H + + L SL+ L ++
Sbjct: 395 LEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAG 454
Query: 640 NNLSGPIPT-SLEKLSDLKELNLSFNKLE 667
N+ +L +L L+LS +LE
Sbjct: 455 NSFQENFLPDIFTELRNLTFLDLSQCQLE 483
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 5e-16
Identities = 28/122 (22%), Positives = 43/122 (35%), Gaps = 1/122 (0%)
Query: 559 DIMYVNFSSNFLTGPLPLEIENLKALTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRL 618
++ S N L + L LD S + + L L L L N +
Sbjct: 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI 88
Query: 619 QGSIPDSVGDLISLKSLNLSNNNLSGPIPTSLEKLSDLKELNLSFNKLEGEIPRGGPFVN 678
Q + L SL+ L NL+ + L LKELN++ N ++ F N
Sbjct: 89 QSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ-SFKLPEYFSN 147
Query: 679 FS 680
+
Sbjct: 148 LT 149
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 223 bits (571), Expect = 9e-66
Identities = 66/307 (21%), Positives = 120/307 (39%), Gaps = 22/307 (7%)
Query: 759 FSYLELFQATNGFSENNLIGRGSFGSVYIARLQNGIEVAVKTFDLQHERAFKSFDTECEV 818
L+ + + RG FG V+ A+L VAVK F +Q +++++ + E
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQSWQ-NEYEVYS 71
Query: 819 MKSIRHRNLTKIISSCSNEDFKA----LILEYMRNGSLEKCLYSGNYILDIFQRLNIMID 874
+ ++H N+ + I + LI + GSL L ++ + +I
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK--ANVVSWNELCHIAET 129
Query: 875 VASALEYLH-------FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMT 927
+A L YLH G+ + H D+K NVLL +N+ A ++DFG+A +
Sbjct: 130 MARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGD 189
Query: 928 QTQTLATLGYMAPEYGREG-----RVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLK 982
+ T YMAPE + D+Y+ G++L E +R D M
Sbjct: 190 THGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPF 249
Query: 983 HWVNDFLPI--SMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEI 1040
P M +++ + + K + + EC + R++A +
Sbjct: 250 EEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCV 309
Query: 1041 VRRLLKI 1047
R+ ++
Sbjct: 310 GERITQM 316
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 223 bits (569), Expect = 6e-61
Identities = 136/714 (19%), Positives = 238/714 (33%), Gaps = 112/714 (15%)
Query: 65 TCDINQRRVTALNISYLSLTGNIPRQLGNLSSLEILDLNFNRLSGEIPWELGNLAKLEKL 124
+C + R + +LT +P+ L++ E L L+FN + L +L+ L
Sbjct: 1 SCSFDGRIA---FYRFCNLT-QVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLL 53
Query: 125 LLHNNFLTGTIPFSIFK-LSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQLS-G 182
L + + TI F+ L +L L L + + + L L L L LS
Sbjct: 54 ELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIY-FLHPDAFQGLFHLFELRLYFCGLSDA 112
Query: 183 SIPSFIFK-ISSLQALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGGISSTLSN-- 239
+ F+ + +L L N++ L L N + L
Sbjct: 113 VLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQ 172
Query: 240 CKHLRILDLSFNDLWGDIPKEIGNLTK------LKELFLDFNILQGEIPHTVGN------ 287
K L L+ N L+ + + G L+ L + N +I N
Sbjct: 173 GKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQ 232
Query: 288 ------LHNLEYLSLVNNELVGTVPATIF---NVSTLKLIELSNNTFFGSLPSSTDVQLP 338
H++ + + F S+++ ++LS+ F SL S L
Sbjct: 233 AFSLILAHHIMGAGFGFHNIK-DPDQNTFAGLARSSVRHLDLSHGFVF-SLNSRVFETLK 290
Query: 339 NLEELYLWGNNFSGTLPSFIFNASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNYL 398
+L+ L L N + + NL L+L N L + F L + + L N++
Sbjct: 291 DLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHI 350
Query: 399 TSPELSFLSSLSNCKYLEIIALSGNPLNGIIPMSAGNLSHSLEELFMPDCNVSGRIPKEI 458
+ L + L+ L N L I
Sbjct: 351 AIIQDQTFKFLEKLQTLD---LRDNALT------------------------------TI 377
Query: 459 GNLANLVTLDLGGNKFNGSIPIALGKLQKLQLLNLDDNKLEG-SIPDDICGLVELYKLAL 517
+ ++ + L GNK I L L++L +N+LE I + + L L L
Sbjct: 378 HFIPSIPDIFLSGNKLVTLPKINL----TANLIHLSENRLENLDILYFLLRVPHLQILIL 433
Query: 518 GDNKLSG-QIPACFGNLASLRELWLGPNELISFIPSTFWNIKDIMYVNFSSNFLTGPLPL 576
N+ S SL +L+LG N + T
Sbjct: 434 NQNRFSSCSGDQTPSENPSLEQLFLGEN-------------------MLQLAWETELCWD 474
Query: 577 EIENLKALTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQGSIPDSVGDLISLKSLN 636
E L L L + N L+ + P L L+ L L NRL + + +L+ L+
Sbjct: 475 VFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLT-VLSHND-LPANLEILD 532
Query: 637 LSNNNLSGPIPTSLEKLSDLKELNLSFNKLEGEIPRGGPFVNFSAKSFMG-----NNLLC 691
+S N L P P L L+++ NK E F+N+ + + ++ C
Sbjct: 533 ISRNQLLAPNPDVFVS---LSVLDITHNKFICECEL-STFINWLNHTNVTIAGPPADIYC 588
Query: 692 GSPN-------LQVPPCRASIDHISKKNALLLGIILPFSTIFVIVIILLISRYQ 738
P+ + + + K L I+ + ++ IL +++++
Sbjct: 589 VYPDSFSGVSLFSLSTEGCDEEEVLKSLKFSLFIVCTVTLTLFLMTILTVTKFR 642
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 202 bits (517), Expect = 1e-58
Identities = 75/275 (27%), Positives = 125/275 (45%), Gaps = 27/275 (9%)
Query: 777 IGRGSFGSVYIARLQNGIEVAVKTFDLQ--HERAFKSFDTECEVMKSIRHRNLTKIISSC 834
IG GSFG+V+ A +G +VAVK Q H F E +MK +RH N+ + +
Sbjct: 45 IGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 835 SNEDFKALILEYMRNGSLEKCLYSGN--YILDIFQRLNIMIDVASALEYLHFGYSAPVIH 892
+ +++ EY+ GSL + L+ LD +RL++ DVA + YLH + P++H
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPIVH 162
Query: 893 CDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKG 952
+LK N+L+D + DFG+++L S T +MAPE R+ + K
Sbjct: 163 RNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSS--KSAAGTPEWMAPEVLRDEPSNEKS 220
Query: 953 DVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHFAAK 1012
DVYSFG++L E T ++P + ++ +++ A + + K
Sbjct: 221 DVYSFGVILWELATLQQP----WGN-------------LNPAQVVAA--VGFKCKRLEIP 261
Query: 1013 EQCASSVFNLAMECTVESPDERITAKEIVRRLLKI 1047
V + C P +R + I+ L +
Sbjct: 262 RNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPL 296
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 207 bits (528), Expect = 3e-58
Identities = 106/548 (19%), Positives = 191/548 (34%), Gaps = 93/548 (16%)
Query: 124 LLLHNNFLTGTIPFSIFKLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQLSGS 183
+ + + + L+ + L N+T T+ +L + L +
Sbjct: 7 TITQDTPINQIFTDT--ALAEKMKTVLGKTNVTDTVS---QTDLDQVTTLQADRLGI--K 59
Query: 184 IPSFIFKISSLQALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGGISSTLSNCKHL 243
+ +++L ++F NN+L+ + L N L
Sbjct: 60 SIDGVEYLNNLTQINFSNNQLTD---------------------------ITPLKNLTKL 92
Query: 244 RILDLSFNDLWGDIPKEIGNLTKLKELFLDFNILQGEIPHTVGNLHNLEYLSLVNNELVG 303
+ ++ N + P + NLT L L L N + P + NL NL L L +N +
Sbjct: 93 VDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTI-- 146
Query: 304 TVPATIFNVSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSGTLPSFIFNASN 363
+ + + +++L+ + N P + L LE L + N S S + +N
Sbjct: 147 SDISALSGLTSLQQLSFGNQ-VTDLKPLA---NLTTLERLDISSNKVSD--ISVLAKLTN 200
Query: 364 LSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNYLTSPELSFLSSLSNCKYLEIIALSGN 423
L L +N S + P G L NL L L N L + +L++ L + L+ N
Sbjct: 201 LESLIATNNQISDITP--LGILTNLDELSLNGNQLKD-----IGTLASLTNLTDLDLANN 253
Query: 424 PLNGIIPMSAGNLSHSLEELFMPDCNVSGRIPKEIGNLANLVTLDLGGNKFNGSIPIALG 483
++ + P + L L L LG N+ + P L
Sbjct: 254 QISNLAP---------------------------LSGLTKLTELKLGANQISNISP--LA 284
Query: 484 KLQKLQLLNLDDNKLEGSIPDDICGLVELYKLALGDNKLSGQIPACFGNLASLRELWLGP 543
L L L L++N+LE P I L L L L N +S P +L L+ L+
Sbjct: 285 GLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYN 340
Query: 544 NELISFIPSTFWNIKDIMYVNFSSNFLTGPLPLEIENLKALTTLDFSMNNLSGVIPTTIG 603
N++ S+ N+ +I +++ N ++ P + NL +T L + +
Sbjct: 341 NKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKA 396
Query: 604 GLKGLQYLFLGHNRLQGSIPDSVGDLISLKSLNLSNNNLSGPIPTSLEKLSDLKELNLSF 663
+ + L P ++ D S +++ N S S +
Sbjct: 397 NVSIPNTVKNVTGAL--IAPATISDGGSYTEPDITWNLPSY-TNEVSYTFSQPVTIGKGT 453
Query: 664 NKLEGEIP 671
G +
Sbjct: 454 TTFSGTVT 461
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 199 bits (508), Expect = 2e-55
Identities = 116/557 (20%), Positives = 189/557 (33%), Gaps = 115/557 (20%)
Query: 67 DINQRRVTALNISYLSLTGNIPRQLGNLSSLEILDLNFNRLSGEIPWELGNLAKLEKLLL 126
D + ++T + +L + L + + I + L L ++
Sbjct: 20 DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-SID-GVEYLNNLTQINF 75
Query: 127 HNNFLTGTIPFSIFKLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQLSGSIPS 186
NN LT P L+ L+D+ +++N + P L NL++L L L +NQ++ P
Sbjct: 76 SNNQLTDITPLK--NLTKLVDILMNNNQIADITP---LANLTNLTGLTLFNNQITDIDP- 129
Query: 187 FIFKISSLQALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGGISSTLSNCKHLRIL 246
+ +++L L +N +S S LS L+ L
Sbjct: 130 -LKNLTNLNRLELSSNTISD---------------------------ISALSGLTSLQQL 161
Query: 247 DLSFNDLWGDIPKEIGNLTKLKELFLDFNILQGEIPHTVGNLHNLEYLSLVNNELVGTVP 306
K + NLT L+ L + N + + L NLE L NN++
Sbjct: 162 SFGNQVT---DLKPLANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISD--- 213
Query: 307 ATIFNVSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSGTLPSFIFNASNLSK 366
+ L L NL+EL L GN + + +NL+
Sbjct: 214 ----------ITPLGI--------------LTNLDELSLNGNQLKD--IGTLASLTNLTD 247
Query: 367 LSLGDNSFSGLIPNTFGNLRNLKRLRLYNNYLTSPELSFLSSLSNCKYLEIIALSGNPLN 426
L L +N S L P L L L+L N +++ +S L+ L + L+ N L
Sbjct: 248 LDLANNQISNLAP--LSGLTKLTELKLGANQISN-----ISPLAGLTALTNLELNENQLE 300
Query: 427 GIIPMSAGNLSHSLEELFMPDCNVSGRIPKEIGNLANLVTLDLGGNKFNGSIPIALGKLQ 486
I P I NL NL L L N + P + L
Sbjct: 301 DISP---------------------------ISNLKNLTYLTLYFNNISDISP--VSSLT 331
Query: 487 KLQLLNLDDNKLEGSIPDDICGLVELYKLALGDNKLSGQIPACFGNLASLRELWLGPNEL 546
KLQ L +NK+ + L + L+ G N++S P NL + +L L
Sbjct: 332 KLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAW 387
Query: 547 ISFIPSTFWNIKDIMYVNFSSNFLTGPLPLEIENLKALTTLDFSMNNLSGVIPTTIGGLK 606
+ + N+ V + L P I + + T D + N S
Sbjct: 388 TNAPVNYKANVSIPNTVKNVTGALI--APATISDGGSYTEPDITWNLPSY-TNEVSYTFS 444
Query: 607 GLQYLFLGHNRLQGSIP 623
+ G G++
Sbjct: 445 QPVTIGKGTTTFSGTVT 461
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 5e-53
Identities = 106/456 (23%), Positives = 179/456 (39%), Gaps = 62/456 (13%)
Query: 235 STLSNCKHLRILDLSFNDLWGDIPKEIGNLTKLKELFLDFNILQGEIPHTVGNLHNLEYL 294
T + L ++ + +L ++ L D + V L+NL +
Sbjct: 18 FTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRL--GIKSIDGVEYLNNLTQI 73
Query: 295 SLVNNELVGTVPATIFNVSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSGTL 354
+ NN+L P + N++ L I ++NN P + L NL L L+ N +
Sbjct: 74 NFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLA---NLTNLTGLTLFNNQITD-- 126
Query: 355 PSFIFNASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNYLTSPELSFLSSLSNCKY 414
+ N +NL++L L N+ S + L +L++L N ++ L L+N
Sbjct: 127 IDPLKNLTNLNRLELSSNTISDISA--LSGLTSLQQLSFGNQ------VTDLKPLANLTT 178
Query: 415 LEIIALSGNPLNGIIPMSAGNLSHSLEELFMPDCNVSGRIPKEIGNLANLVTLDLGGNKF 474
LE + +S N ++ I + L NL +L N+
Sbjct: 179 LERLDISSNKVSDISV---------------------------LAKLTNLESLIATNNQI 211
Query: 475 NGSIPIALGKLQKLQLLNLDDNKLEGSIPDDICGLVELYKLALGDNKLSGQIPACFGNLA 534
+ P LG L L L+L+ N+L+ + L L L L +N++S P L
Sbjct: 212 SDITP--LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLT 265
Query: 535 SLRELWLGPNELISFIPSTFWNIKDIMYVNFSSNFLTGPLPLEIENLKALTTLDFSMNNL 594
L EL LG N++ + P + + + + N L P I NLK LT L NN+
Sbjct: 266 KLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNI 321
Query: 595 SGVIPTTIGGLKGLQYLFLGHNRLQGSIPDSVGDLISLKSLNLSNNNLSGPIPTSLEKLS 654
S + P + L LQ LF +N++ S S+ +L ++ L+ +N +S P L L+
Sbjct: 322 SDISP--VSSLTKLQRLFFYNNKV--SDVSSLANLTNINWLSAGHNQISDLTP--LANLT 375
Query: 655 DLKELNLSFNKLEGEIPRGGPFVNFSAKSFMGNNLL 690
+ +L L+ V+ L
Sbjct: 376 RITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGAL 411
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-32
Identities = 63/307 (20%), Positives = 115/307 (37%), Gaps = 51/307 (16%)
Query: 365 SKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNYLTSPELSFLSSLSNCKYLEIIALSGNP 424
S D + + L + L +T S ++ + +
Sbjct: 5 SATITQDTPINQIFT--DTALAEKMKTVLGKTNVTD-----TVSQTDLDQVTTLQADRLG 57
Query: 425 LNGIIPMSAGNLSHSLEELFMPDCNVSGRIPKEIGNLANLVTLDLGGNKFNGSIPIALGK 484
+ I + L++ L ++ + ++ P + NL LV + + N+ P L
Sbjct: 58 IKSIDGV--EYLNN-LTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LAN 110
Query: 485 LQKLQLLNLDDNKLEGSIPDDICGLVELYKLALGDNKLSGQIPACFGNLASLRELWLGPN 544
L L L L +N++ P + L L +L L N +S + L SL++L G N
Sbjct: 111 LTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFG-N 165
Query: 545 ELISFIPSTFWNIKDIMYVNFSSNFLTGPLPLEIENLKALTTLDFSMNNLSGVIPTTIGG 604
++ P + NL L LD S N +S + +
Sbjct: 166 QVTDLKP--------------------------LANLTTLERLDISSNKVSDISV--LAK 197
Query: 605 LKGLQYLFLGHNRLQGSIPDSVGDLISLKSLNLSNNNLSGPIPTSLEKLSDLKELNLSFN 664
L L+ L +N++ P +G L +L L+L+ N L +L L++L +L+L+ N
Sbjct: 198 LTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANN 253
Query: 665 KLEGEIP 671
++ P
Sbjct: 254 QISNLAP 260
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 6e-11
Identities = 26/139 (18%), Positives = 49/139 (35%), Gaps = 9/139 (6%)
Query: 77 NISYLSLTGN---IPRQLGNLSSLEILDLNFNRLSGEIPWELGNLAKLEKLLLHNNFLTG 133
+ L N L NL+++ L N++S P L NL ++ +L L++ T
Sbjct: 332 KLQRLFFYNNKVSDVSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWT- 388
Query: 134 TIPFSIFKLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQLSGSIPSFIFKISS 193
P + S+ + + I + + S D++ N S + S
Sbjct: 389 NAPVNYKANVSIPNTVKNVTGA--LIAPATISDGGSYTEPDITWNLPS-YTNEVSYTFSQ 445
Query: 194 LQALHFGNNRLSGELPANI 212
+ G SG + +
Sbjct: 446 PVTIGKGTTTFSGTVTQPL 464
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 3e-06
Identities = 17/88 (19%), Positives = 33/88 (37%), Gaps = 5/88 (5%)
Query: 584 LTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQGSIPDSVGDLISLKSLNLSNNNLS 643
L + + + I T L LG + ++ + DL + +L +
Sbjct: 3 LGSATITQDTPINQI-FTDTALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK 59
Query: 644 GPIPTSLEKLSDLKELNLSFNKLEGEIP 671
+E L++L ++N S N+L P
Sbjct: 60 --SIDGVEYLNNLTQINFSNNQLTDITP 85
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 201 bits (512), Expect = 4e-58
Identities = 67/289 (23%), Positives = 119/289 (41%), Gaps = 46/289 (15%)
Query: 777 IGRGSFGSVYIARLQ-NGIEVAVKTFDLQHERA-------FKSFDTECEVMKSIRHRNLT 828
IG+G FG V+ RL + VA+K+ L F+ F E +M ++ H N+
Sbjct: 27 IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 829 KIISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSA 888
K+ N +++E++ G L L + + +L +M+D+A +EY+ +
Sbjct: 87 KLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ-NQNP 143
Query: 889 PVIHCDLKPSNVLLD-----DNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPE-- 941
P++H DL+ N+ L + A ++DFG+++ + + L +MAPE
Sbjct: 144 PIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLGNFQWMAPETI 198
Query: 942 YGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDF---LPISMMKIID 998
E + K D YSF ++L T P DE G++ + + + I
Sbjct: 199 GAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIP------ 252
Query: 999 ANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKI 1047
E C + N+ C P +R IV+ L ++
Sbjct: 253 --------------EDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 1e-57
Identities = 75/280 (26%), Positives = 119/280 (42%), Gaps = 35/280 (12%)
Query: 777 IGRGSFGSVYIARLQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCSN 836
+GRG+FG V A+ +VA+K + + ER K+F E + + H N+ K+ +C N
Sbjct: 16 VGRGAFGVVCKAKW-RAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGACLN 72
Query: 837 EDFKALILEYMRNGSLEKCLYSGN--YILDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 894
L++EY GSL L+ ++ + + + YLH +IH D
Sbjct: 73 P--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRD 130
Query: 895 LKPSNVLLDDNM-VAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGD 953
LKP N+LL V + DFG A D T + +MAPE S K D
Sbjct: 131 LKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPEVFEGSNYSEKCD 185
Query: 954 VYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANL--LITEDKHFAA 1011
V+S+GI+L E TRRKP DEI +M + + ++
Sbjct: 186 VFSWGIILWEVITRRKPFDEI------------GGPAFRIMWAVHNGTRPPLIKN----- 228
Query: 1012 KEQCASSVFNLAMECTVESPDERITAKEIVRRLLKIRDFL 1051
+ +L C + P +R + +EIV+ + + +
Sbjct: 229 ---LPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF 265
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 7e-57
Identities = 66/273 (24%), Positives = 119/273 (43%), Gaps = 26/273 (9%)
Query: 777 IGRGSFGSVYIARLQNGIEVAVKTFDLQH--ERAFKSFDTECEVMKSIRHRNLTKIISSC 834
IG GSFG+VY + +VAVK ++ + ++F E V++ RH N+ +
Sbjct: 32 IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 835 SNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 894
+ A++ ++ SL L++ ++ + ++I A ++YLH + +IH D
Sbjct: 90 TAPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRD 145
Query: 895 LKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPE---YGREGRVSTK 951
LK +N+ L ++ + DFG+A S Q ++ +MAPE S +
Sbjct: 146 LKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQ 205
Query: 952 GDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHFAA 1011
DVY+FGI+L E T + P I + + ++ L + K+
Sbjct: 206 SDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKV--------------- 250
Query: 1012 KEQCASSVFNLAMECTVESPDERITAKEIVRRL 1044
+ C + L EC + DER + I+ +
Sbjct: 251 RSNCPKRMKRLMAECLKKKRDERPSFPRILAEI 283
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 204 bits (522), Expect = 1e-56
Identities = 111/550 (20%), Positives = 204/550 (37%), Gaps = 55/550 (10%)
Query: 76 LNISYLSLTGNIPRQLGNLSSLEILDLNFNRLSGEIPWELGNLAKLEKLLLHNNFLTGTI 135
+ S T +IP L ++++ LDL+FN+++ +L A L+ L+L ++ + TI
Sbjct: 10 CDGRSRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRIN-TI 65
Query: 136 PFSIFK-LSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQLSG-SIPSFIFKISS 193
F L SL L LSDN+L+ ++ S G LSSL+ L+L N + S +++
Sbjct: 66 EGDAFYSLGSLEHLDLSDNHLS-SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTN 124
Query: 194 LQALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGGISSTLSNCKHLRILDLSFNDL 253
LQ L GN E+ L LN + S +L + + + L L ++
Sbjct: 125 LQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSES 184
Query: 254 WGDIPKEIGNLTKLKELFLDFNILQGEIPHTVGNLHNLEYLSLVNNELVGTVPATIFNVS 313
+ L+ ++ L L L + + + + + S
Sbjct: 185 AFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGS-----VLTDES 239
Query: 314 TLKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSGTLPSFIFNASNLSKLSLGDNS 373
+L++L S D L L + ++ L + +L +
Sbjct: 240 FNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGK--VETVTIRRLHIPQFY 297
Query: 374 FSGLIPNTFGNLRNLKRLRLYNNYLTSPELSFLSSLSNCKYLEIIALSGNPLNGIIPMSA 433
+ + L +KR+ + N+ + SF L + LE + LS N + ++
Sbjct: 298 LFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKS---LEFLDLSENLMVEEYLKNS 354
Query: 434 GNLS--HSLEELFMPDCNVS--GRIPKEIGNLANLVTLDLGGNKFNGSIPIALGKLQKLQ 489
SL+ L + ++ + + + L NL +LD+ N F+ +P + +K++
Sbjct: 355 ACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMR 413
Query: 490 LLNLDDNKLEGSIPDDICGLVELYKLALGDNKLSGQIPACFGNLASLRELWLGPNELISF 549
LNL + + C L L + +N L L L+EL++ N+L +
Sbjct: 414 FLNLSSTGIR-VVKT--CIPQTLEVLDVSNNNLD-SFSL---FLPRLQELYISRNKLKTL 466
Query: 550 IPSTFWNIKDIMYVNFSSNFLTGPLPLEIENLKALTTLDFSMNNLSGVIPTTIGGLKGLQ 609
++ L + S N L V L LQ
Sbjct: 467 PDASL--------------------------FPVLLVMKISRNQLKSVPDGIFDRLTSLQ 500
Query: 610 YLFLGHNRLQ 619
++L N
Sbjct: 501 KIWLHTNPWD 510
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 1e-47
Identities = 93/458 (20%), Positives = 182/458 (39%), Gaps = 31/458 (6%)
Query: 242 HLRILDLSFNDLWGDIPKEIGNLTKLKELFLDFNILQGEIPHTVGNLHNLEYLSLVNNEL 301
++ LDLSFN + ++ L+ L L + + +L +LE+L L +N L
Sbjct: 27 AMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHL 86
Query: 302 VGTVPATIF-NVSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSGTLPSFIF- 359
++ ++ F +S+LK + L N + +S L NL+ L + + F
Sbjct: 87 S-SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFA 145
Query: 360 NASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNYLTSPELSFLSSLSNCKYLEIIA 419
++L++L + S + ++R++ L L+ + F LS+ +YLE+
Sbjct: 146 GLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRD 205
Query: 420 LSGNPLN------GIIPMSAGNLSHSLEELFMPDCNVSGRIPKEIGNLANLVTLDLGGNK 473
+ + L+ L N ++ + I L+ + D N
Sbjct: 206 TNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNG 265
Query: 474 ---FNGSIPIALGKLQKLQL-----LNLDDNKLEGSIPDDICGLVELYKLALGDNKLSGQ 525
FN S + +L K++ L++ L + L ++ ++ + ++K+
Sbjct: 266 LGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLV 325
Query: 526 IPACFGNLASLRELWLGPNELISFIPST---FWNIKDIMYVNFSSNFLT--GPLPLEIEN 580
+ +L SL L L N ++ + + S N L +
Sbjct: 326 PCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLT 385
Query: 581 LKALTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQGSIPDSVGDLISLKSLNLSNN 640
LK LT+LD S N +P + + +++L L ++ + + +L+ L++SNN
Sbjct: 386 LKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCI--PQTLEVLDVSNN 441
Query: 641 NLSGPIPTSLEKLSDLKELNLSFNKLEGEIPRGGPFVN 678
NL L + L+EL +S NKL+ +P F
Sbjct: 442 NLDS-FSLFLPR---LQELYISRNKLK-TLPDASLFPV 474
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 6e-38
Identities = 63/367 (17%), Positives = 128/367 (34%), Gaps = 27/367 (7%)
Query: 337 LPNLEELYLWGNNFSGTLPSFIFNASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNN 396
++ L L N + + +NL L L + + + + F +L +L+ L L +N
Sbjct: 25 TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDN 84
Query: 397 YLTSPELSFLSSLSNCKYLEIIALSGNPLNGIIPMSAGNLSHSLEELFMPDCNVSGRIPK 456
+L+S S+ LS+ L+ + L GNP + S +L+ L + + I +
Sbjct: 85 HLSSLSSSWFGPLSS---LKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRR 141
Query: 457 E-IGNLANLVTLDLGGNKFNGSIPIALGKLQKLQLLNLDDNKLEGSIPDDICGLVELYKL 515
L +L L++ +L ++ + L L ++ + L + L
Sbjct: 142 IDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYL 201
Query: 516 ALGDNKLSGQIPACFGNLASLRELWLGPNELISFIPSTF----------WNIKDIMYVNF 565
L D L+ + + +F + ++ + +
Sbjct: 202 ELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDC 261
Query: 566 SSNFLTGPLPLEIENLKA--------LTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNR 617
+ N L P E + + + L L + T L+ ++ + + +++
Sbjct: 262 TLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSK 321
Query: 618 LQGSIPDSVGD-LISLKSLNLSNNNLS---GPIPTSLEKLSDLKELNLSFNKLEGEIPRG 673
+ +P S L SL+ L+LS N + L+ L LS N L G
Sbjct: 322 VF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTG 380
Query: 674 GPFVNFS 680
+
Sbjct: 381 EILLTLK 387
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 8e-35
Identities = 64/374 (17%), Positives = 122/374 (32%), Gaps = 35/374 (9%)
Query: 74 TALNISYLSLTGNIPRQLGNLSSLEILDLNFNRLSGEIPWELGNLAKLEKLLLHNNFLTG 133
L I LSL + L ++ + L L+ + + + L+ + L L + L
Sbjct: 151 NELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLAR 210
Query: 134 TIPFSIFKLSSLLDLKLSDNNLTG---------TIPSHNLGNLSSLQLLDLSDNQL---S 181
+ +K + + LS ++ D + N L +
Sbjct: 211 FQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFN 270
Query: 182 GSIPSFIFKISSLQALHFGNNRLSG----ELPANICDNLPFLNFFSVYKNMFYGGISSTL 237
S + ++ ++ + + + + L + +V + + S
Sbjct: 271 PSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFS 330
Query: 238 SNCKHLRILDLSFN---DLWGDIPKEIGNLTKLKELFLDFNILQ--GEIPHTVGNLHNLE 292
+ K L LDLS N + + G L+ L L N L+ + + L NL
Sbjct: 331 QHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLT 390
Query: 293 YLSLVNNELVGTVPATIFNVSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSG 352
L + N +P + ++ + LS+ + LE L + NN
Sbjct: 391 SLDISRNTF-HPMPDSCQWPEKMRFLNLSST----GIRVVKTCIPQTLEVLDVSNNNLD- 444
Query: 353 TLPSFIFNASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNYLTSPELSFLSSLSNC 412
SF L +L + N L + L +++ N L S L++
Sbjct: 445 ---SFSLFLPRLQELYISRNKLKTLPDASL--FPVLLVMKISRNQLKSVPDGIFDRLTS- 498
Query: 413 KYLEIIALSGNPLN 426
L+ I L NP +
Sbjct: 499 --LQKIWLHTNPWD 510
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 5e-24
Identities = 44/235 (18%), Positives = 85/235 (36%), Gaps = 2/235 (0%)
Query: 435 NLSHSLEELFMPDCNVSGRIPKEIGNLANLVTLDLGGNKFNGSIPIALGKLQKLQLLNLD 494
L+ +++ L + ++ ++ ANL L L ++ N A L L+ L+L
Sbjct: 23 GLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLS 82
Query: 495 DNKLEGSIPDDICGLVELYKLALGDNKLSG-QIPACFGNLASLRELWLGPNELISFIP-S 552
DN L L L L L N + + F NL +L+ L +G E S I
Sbjct: 83 DNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRI 142
Query: 553 TFWNIKDIMYVNFSSNFLTGPLPLEIENLKALTTLDFSMNNLSGVIPTTIGGLKGLQYLF 612
F + + + + L +++++ + L ++ + ++ L ++YL
Sbjct: 143 DFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLE 202
Query: 613 LGHNRLQGSIPDSVGDLISLKSLNLSNNNLSGPIPTSLEKLSDLKELNLSFNKLE 667
L L + + S S +L L L +++E
Sbjct: 203 LRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVE 257
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-23
Identities = 47/205 (22%), Positives = 72/205 (35%), Gaps = 5/205 (2%)
Query: 466 TLDLGGNKFNGSIPIALGKLQKLQLLNLDDNKLEGSIPDDICGLVELYKLALGDNKLSGQ 525
D F SIP L ++ L+L NK+ D+ L L L ++++
Sbjct: 9 VCDGRSRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTI 65
Query: 526 IPACFGNLASLRELWLGPNELISFIPSTFWNIKDIMYVNFSSNFLTG-PLPLEIENLKAL 584
F +L SL L L N L S S F + + Y+N N + NL L
Sbjct: 66 EGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNL 125
Query: 585 TTLDFSMNNLSGVIP-TTIGGLKGLQYLFLGHNRLQGSIPDSVGDLISLKSLNLSNNNLS 643
TL I GL L L + L+ S+ + + L L + +
Sbjct: 126 QTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESA 185
Query: 644 GPIPTSLEKLSDLKELNLSFNKLEG 668
+ + LS ++ L L L
Sbjct: 186 FLLEIFADILSSVRYLELRDTNLAR 210
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 3e-20
Identities = 52/336 (15%), Positives = 109/336 (32%), Gaps = 68/336 (20%)
Query: 347 GNNFSGTLPSFIFNASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNYLTSPELSFL 406
+F+ ++PS + + + L L N + + NL+ L L ++ + + E
Sbjct: 14 SRSFT-SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAF 70
Query: 407 SSLSNCKYLEIIALSGNPLNGIIPMSAGNLSHSLEELFMPDCNVSGRIPKEIGNLANLVT 466
SL + LE + LS N L+ + G L++L
Sbjct: 71 YSLGS---LEHLDLSDNHLSSLSSSW-------------------------FGPLSSLKY 102
Query: 467 LDLGGNKFNG-SIPIALGKLQKLQLLNLDDNKLEGSIPDDICGLVELYKLALGDNKLSGQ 525
L+L GN + + L LQ L + + + I
Sbjct: 103 LNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRID------------------- 143
Query: 526 IPACFGNLASLRELWLGPNELISFIPSTFWNIKDIMYVNFSSNFLTGPLPLEIENLKALT 585
F L SL EL + L ++ + +I+DI ++ + L + + L ++
Sbjct: 144 ----FAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVR 199
Query: 586 TLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQGSIPDSVGDLISLKSLNLSNNN---- 641
L+ NL+ + + + + R +S +L+ L L +
Sbjct: 200 YLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFD 259
Query: 642 ---------LSGPIPTSLEKLSDLKELNLSFNKLEG 668
+ + +L ++ + + +
Sbjct: 260 DCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQ 295
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 7e-13
Identities = 33/116 (28%), Positives = 52/116 (44%), Gaps = 4/116 (3%)
Query: 563 VNFSSNFLTGPLPLEIENLKALTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQGSI 622
+ S T +P + A+ +LD S N ++ + + LQ L L +R+
Sbjct: 10 CDGRSRSFTS-IPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIE 66
Query: 623 PDSVGDLISLKSLNLSNNNLSGPIPTSLEKLSDLKELNLSFNKLEGEIPRGGPFVN 678
D+ L SL+ L+LS+N+LS + LS LK LNL N + + F N
Sbjct: 67 GDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQ-TLGVTSLFPN 121
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 3e-56
Identities = 64/281 (22%), Positives = 112/281 (39%), Gaps = 36/281 (12%)
Query: 777 IGRGSFGSVYIARLQNGIEVAVKTFDLQH--ERAFKSFDTECEVMKSIRHRNLTKIISSC 834
+ G ++ R Q G ++ VK ++ R + F+ EC ++ H N+ ++ +C
Sbjct: 18 LNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGAC 76
Query: 835 SNEDFK--ALILEYMRNGSLEKCLYSG-NYILDIFQRLNIMIDVASALEYLHFGYSAPVI 891
+ LI +M GSL L+ G N+++D Q + +D+A + +LH +
Sbjct: 77 QSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH-TLEPLIP 135
Query: 892 HCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPE---YGREGRV 948
L +V++D++M A +S + S + ++APE E
Sbjct: 136 RHALNSRSVMIDEDMTARISMADVKF-------SFQSPGRMYAPAWVAPEALQKKPEDTN 188
Query: 949 STKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKH 1008
D++SF +LL E TR P F+ +S M+I + E
Sbjct: 189 RRSADMWSFAVLLWELVTREVP----FAD-------------LSNMEIGMK--VALEGLR 229
Query: 1009 FAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKIRD 1049
+ V L C E P +R IV L K++D
Sbjct: 230 PTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 1e-55
Identities = 71/320 (22%), Positives = 121/320 (37%), Gaps = 37/320 (11%)
Query: 759 FSYLELFQATNGFSENNLIGRGSFGSVYIARLQNGIEVAVKTFDLQHERAFKSFDTECEV 818
+ E + LIGRG +G+VY L + VAVK F + + +F E +
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQ---NFINEKNI 58
Query: 819 MK--SIRHRNLTKIISSC-----SNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNI 871
+ + H N+ + I L++EY NGSL K L + D +
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS--LHTSDWVSSCRL 116
Query: 872 MIDVASALEYLH------FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS 925
V L YLH Y + H DL NVL+ ++ +SDFG++ L G
Sbjct: 117 AHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLV 176
Query: 926 MTQTQTLA------TLGYMAPEYGRE-------GRVSTKGDVYSFGILLMETFTRRK--- 969
+ A T+ YMAPE + D+Y+ G++ E F R
Sbjct: 177 RPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLF 236
Query: 970 PTDEIFSGEMTLKHWVNDFLPISMMKII--DANLLITEDKHFAAKEQCASSVFNLAMECT 1027
P + + +M + V + M+++ + + S+ +C
Sbjct: 237 PGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCW 296
Query: 1028 VESPDERITAKEIVRRLLKI 1047
+ + R+TA+ R+ ++
Sbjct: 297 DQDAEARLTAQXAEERMAEL 316
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 2e-54
Identities = 73/283 (25%), Positives = 111/283 (39%), Gaps = 38/283 (13%)
Query: 777 IGRGSFGSVYIARLQNGIEVAVKTF----DLQHERAFKSFDTECEVMKSIRHRNLTKIIS 832
IG G FG VY A G EVAVK D + ++ E ++ ++H N+ +
Sbjct: 15 IGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 833 SCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIH 892
C E L++E+ R G L + L + +N + +A + YLH P+IH
Sbjct: 74 VCLKEPNLCLVMEFARGGPLNRVLSGKR--IPPDILVNWAVQIARGMNYLHDEAIVPIIH 131
Query: 893 CDLKPSNVLLD--------DNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGR 944
DLK SN+L+ N + ++DFG+A+ M+ A +MAPE R
Sbjct: 132 RDLKSSNILILQKVENGDLSNKILKITDFGLAR-EWHRTTKMSAAGAYA---WMAPEVIR 187
Query: 945 EGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLIT 1004
S DV+S+G+LL E T P F G I + + +
Sbjct: 188 ASMFSKGSDVWSYGVLLWELLTGEVP----FRG-------------IDGLAVAYG--VAM 228
Query: 1005 EDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKI 1047
C L +C P R + I+ +L I
Sbjct: 229 NKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 190 bits (484), Expect = 3e-54
Identities = 71/294 (24%), Positives = 114/294 (38%), Gaps = 28/294 (9%)
Query: 775 NLIGRGSFGSVYIARLQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSC 834
+G+G +G V+ G VAVK F + E+++ +TE +RH N+ I+S
Sbjct: 14 ECVGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWF-RETELYNTVMLRHENILGFIASD 71
Query: 835 SNEDFKA----LILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLH-----FG 885
+ LI Y GSL L LD L I++ +AS L +LH
Sbjct: 72 MTSRHSSTQLWLITHYHEMGSLYDYLQ--LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQ 129
Query: 886 YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLA--TLGYMAPE-- 941
+ H DLK N+L+ N ++D G+A + + T YMAPE
Sbjct: 130 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVL 189
Query: 942 ----YGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKII 997
+ D+++FG++L E R + + V + M+ +
Sbjct: 190 DETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKV 249
Query: 998 DAN----LLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKI 1047
I + +S+ L EC ++P R+TA I + L KI
Sbjct: 250 VCVDQQRPNIPNRWF---SDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 1e-53
Identities = 70/285 (24%), Positives = 116/285 (40%), Gaps = 34/285 (11%)
Query: 777 IGRGSFGSVYIARL-QNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCS 835
+G+G FG + G + +K E ++F E +VM+ + H N+ K I
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 836 NEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDL 895
+ I EY++ G+L + S + QR++ D+AS + YLH S +IH DL
Sbjct: 78 KDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDL 134
Query: 896 KPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLA------------TLGYMAPEYG 943
N L+ +N ++DFG+A+L++ E ++L +MAPE
Sbjct: 135 NSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMI 194
Query: 944 REGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLI 1003
K DV+SFGI+L E R + M V FL +
Sbjct: 195 NGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFL----------DRYC 244
Query: 1004 TEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKIR 1048
+ C S F + + C P++R + ++ L +R
Sbjct: 245 PPN--------CPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLR 281
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 1e-53
Identities = 71/300 (23%), Positives = 115/300 (38%), Gaps = 36/300 (12%)
Query: 775 NLIGRGSFGSVYIARLQNGIEVAVKTFDLQHERAFKSFDTECEV--MKSIRHRNLTKIIS 832
IG+G +G V++ + G +VAVK F E S+ E E+ +RH N+ I+
Sbjct: 43 KQIGKGRYGEVWMGKW-RGEKVAVKVFFTTEEA---SWFRETEIYQTVLMRHENILGFIA 98
Query: 833 SCSNEDFK----ALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLH----- 883
+ LI +Y NGSL L + LD L + S L +LH
Sbjct: 99 ADIKGTGSWTQLYLITDYHENGSLYDYLK--STTLDAKSMLKLAYSSVSGLCHLHTEIFS 156
Query: 884 FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLA--TLGYMAPE 941
+ H DLK N+L+ N ++D G+A I + + T YM PE
Sbjct: 157 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPE 216
Query: 942 ------YGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMK 995
+ D+YSFG++L E R + ++ V M+
Sbjct: 217 VLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMR 276
Query: 996 IIDANLLITEDKH------FAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKIRD 1049
++ K + ++C + L EC +P R+TA + + L K+ +
Sbjct: 277 -----EIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSE 331
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 2e-53
Identities = 61/287 (21%), Positives = 113/287 (39%), Gaps = 39/287 (13%)
Query: 775 NLIGRGSFGSVYIARLQNGIEVAVKTFDLQH--ERAFKSFDTECEVMKSIRHRNLTKIIS 832
LIG+G FG VY R EVA++ D++ E K+F E + RH N+ +
Sbjct: 39 ELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 833 SCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIH 892
+C + A+I + +L + +LD+ + I ++ + YLH + ++H
Sbjct: 97 ACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGILH 153
Query: 893 CDLKPSNVLLDDNMVAHLSDFGIAKL---LIGEDQSMTQTQTLATLGYMAPE-------- 941
DLK NV D+ V ++DFG+ + L + L ++APE
Sbjct: 154 KDLKSKNVFYDNGKV-VITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPD 212
Query: 942 -YGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDAN 1000
+ S DV++ G + E R P F +++ +
Sbjct: 213 TEEDKLPFSKHSDVFALGTIWYELHAREWP----FKT-QP---------AEAIIWQMGTG 258
Query: 1001 LLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKI 1047
+ K ++ + ++ + C +ER T +++ L K+
Sbjct: 259 M-----KPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKL 300
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 5e-53
Identities = 81/426 (19%), Positives = 159/426 (37%), Gaps = 82/426 (19%)
Query: 74 TALNISYLSLTGNIPRQLGNLSSLEILDLNFNRLSGEIPWELGNLAKLEKLLLHNNFLTG 133
L + P +L+ L ++ + L + KL++ +
Sbjct: 3 ATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVAS 58
Query: 134 TIPFSIFKLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQLSGSIPSFIFKISS 193
L++L L L+ N +T P L NL L L + N++ + S + +++
Sbjct: 59 IQGIE--YLTNLEYLNLNGNQITDISP---LSNLVKLTNLYIGTNKI--TDISALQNLTN 111
Query: 194 LQALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGGISSTLSNCKHLRILDLSFNDL 253
L+ L+ + +S S L+N + L+L N
Sbjct: 112 LRELYLNEDNISD---------------------------ISPLANLTKMYSLNLGANHN 144
Query: 254 WGDIPKEIGNLTKLKELFLDFNILQGEIPHTVGNLHNLEYLSLVNNELVGTVPATIFNVS 313
D+ + N+T L L + + ++ P + NL +L LSL N++
Sbjct: 145 LSDL-SPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIED---------- 191
Query: 314 TLKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSGTLPSFIFNASNLSKLSLGDNS 373
+ L++ L +L + N + + + N + L+ L +G+N
Sbjct: 192 ---ISPLAS--------------LTSLHYFTAYVNQITD--ITPVANMTRLNSLKIGNNK 232
Query: 374 FSGLIPNTFGNLRNLKRLRLYNNYLTSPELSFLSSLSNCKYLEIIALSGNPLNGIIPMSA 433
+ L P NL L L + N ++ ++++ + L+++ + N ++ I ++
Sbjct: 233 ITDLSP--LANLSQLTWLEIGTNQISD-----INAVKDLTKLKMLNVGSNQISDISVLN- 284
Query: 434 GNLSHSLEELFMPDCNVSGRIPKEIGNLANLVTLDLGGNKFNGSIPIALGKLQKLQLLNL 493
NLS L LF+ + + + IG L NL TL L N P L L K+ +
Sbjct: 285 -NLS-QLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADF 340
Query: 494 DDNKLE 499
+ ++
Sbjct: 341 ANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 182 bits (465), Expect = 4e-51
Identities = 77/374 (20%), Positives = 154/374 (41%), Gaps = 32/374 (8%)
Query: 294 LSLVNNELVGTVPATIFNVSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSGT 353
L+ + + P +++ L + + +L ++ +L + G +
Sbjct: 5 LATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVTQE---ELESITKLVVAGEKVAS- 58
Query: 354 LPSFIFNASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNYLTSPELSFLSSLSNCK 413
I +NL L+L N + + P NL L L + N +T +S+L N
Sbjct: 59 -IQGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITD-----ISALQNLT 110
Query: 414 YLEIIALSGNPLNGIIPMSAGNLSHSLEELFMPDCNVSGRIPKEIGNLANLVTLDLGGNK 473
L + L+ + ++ I P+ NL+ + L + + + N+ L L + +K
Sbjct: 111 NLRELYLNEDNISDISPL--ANLT-KMYSLNLGANHNLS-DLSPLSNMTGLNYLTVTESK 166
Query: 474 FNGSIPIALGKLQKLQLLNLDDNKLEGSIPDDICGLVELYKLALGDNKLSGQIPACFGNL 533
PI L L L+L+ N++E P + L L+ N+++ P N+
Sbjct: 167 VKDVTPI--ANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANM 220
Query: 534 ASLRELWLGPNELISFIPSTFWNIKDIMYVNFSSNFLTGPLPLEIENLKALTTLDFSMNN 593
L L +G N++ P N+ + ++ +N ++ ++ +L L L+ N
Sbjct: 221 TRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDINAVK--DLTKLKMLNVGSNQ 276
Query: 594 LSGVIPTTIGGLKGLQYLFLGHNRLQGSIPDSVGDLISLKSLNLSNNNLSGPIPTSLEKL 653
+S + + L L LFL +N+L + +G L +L +L LS N+++ P L L
Sbjct: 277 ISDISV--LNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASL 332
Query: 654 SDLKELNLSFNKLE 667
S + + + ++
Sbjct: 333 SKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 175 bits (447), Expect = 1e-48
Identities = 86/340 (25%), Positives = 145/340 (42%), Gaps = 27/340 (7%)
Query: 332 STDVQLPNLEELYLWGNNFSGTLPSFIFNASNLSKLSLGDNSFSGLIPNTFGNLRNLKRL 391
D L L + + + +++KL + + + L NL+ L
Sbjct: 16 FPDADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVASIQG--IEYLTNLEYL 71
Query: 392 RLYNNYLTSPELSFLSSLSNCKYLEIIALSGNPLNGIIPMSAGNLSHSLEELFMPDCNVS 451
L N +T +S LSN L + + N + I + NL+ +L EL++ + N+S
Sbjct: 72 NLNGNQITD-----ISPLSNLVKLTNLYIGTNKITDISALQ--NLT-NLRELYLNEDNIS 123
Query: 452 GRIPKEIGNLANLVTLDLGGNKFNGSIPIALGKLQKLQLLNLDDNKLEGSIPDDICGLVE 511
P + NL + +L+LG N N S L + L L + ++K++ P I L +
Sbjct: 124 DISP--LANLTKMYSLNLGANH-NLSDLSPLSNMTGLNYLTVTESKVKDVTP--IANLTD 178
Query: 512 LYKLALGDNKLSGQIPACFGNLASLRELWLGPNELISFIPSTFWNIKDIMYVNFSSNFLT 571
LY L+L N++ P +L SL N++ P N+ + + +N +T
Sbjct: 179 LYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKIT 234
Query: 572 GPLPLEIENLKALTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQGSIPDSVGDLIS 631
PL NL LT L+ N +S + + L L+ L +G N++ S + +L
Sbjct: 235 DLSPLA--NLSQLTWLEIGTNQISDINA--VKDLTKLKMLNVGSNQI--SDISVLNNLSQ 288
Query: 632 LKSLNLSNNNLSGPIPTSLEKLSDLKELNLSFNKLEGEIP 671
L SL L+NN L + L++L L LS N + P
Sbjct: 289 LNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP 328
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 7e-45
Identities = 73/402 (18%), Positives = 143/402 (35%), Gaps = 58/402 (14%)
Query: 145 LLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQLSGSIPSFIFKISSLQALHFGNNRL 204
L + P +L L ++ + ++ S+ L ++
Sbjct: 2 AATLATLPAPINQIFPDADLAEG---IRAVLQKASVTDVVT--QEELESITKLVVAGEKV 56
Query: 205 SGELPANICDNLPFLNFFSVYKNMFYGGISSTLSNCKHLRILDLSFNDLWGDIPKEIGNL 264
+ + + +L L+L+ N + P + NL
Sbjct: 57 A-SIQG--------------------------IEYLTNLEYLNLNGNQITDISP--LSNL 87
Query: 265 TKLKELFLDFNILQGEIPHTVGNLHNLEYLSLVNNELVGTVPATIFNVSTLKLIELSNNT 324
KL L++ N + + NL NL L L + + + + + N++ + + L N
Sbjct: 88 VKLTNLYIGTNKI--TDISALQNLTNLRELYLNEDNI--SDISPLANLTKMYSLNLGANH 143
Query: 325 FFGSLPSSTDVQLPNLEELYLWGNNFSGTLPSFIFNASNLSKLSLGDNSFSGLIPNTFGN 384
L + + L L + + + I N ++L LSL N + P +
Sbjct: 144 NLSDLSPLS--NMTGLNYLTVTESKVKD--VTPIANLTDLYSLSLNYNQIEDISP--LAS 197
Query: 385 LRNLKRLRLYNNYLTSPELSFLSSLSNCKYLEIIALSGNPLNGIIPMSAGNLSHSLEELF 444
L +L Y N +T ++ ++N L + + N + + P+ NLS L L
Sbjct: 198 LTSLHYFTAYVNQITD-----ITPVANMTRLNSLKIGNNKITDLSPL--ANLS-QLTWLE 249
Query: 445 MPDCNVSGRIPKEIGNLANLVTLDLGGNKFNGSIPIALGKLQKLQLLNLDDNKLEGSIPD 504
+ +S + +L L L++G N+ + L L +L L L++N+L +
Sbjct: 250 IGTNQISD--INAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDME 305
Query: 505 DICGLVELYKLALGDNKLSGQIPACFGNLASLRELWLGPNEL 546
I GL L L L N ++ P +L+ + +
Sbjct: 306 VIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVI 345
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 9e-51
Identities = 65/296 (21%), Positives = 114/296 (38%), Gaps = 32/296 (10%)
Query: 775 NLIGRGSFGSVYIARLQNGIEVAVKTFDLQHERAFKSFDTECEV--MKSIRHRNLTKIIS 832
IG+G FG V+ + G EVAVK F + ER S+ E E+ +RH N+ I+
Sbjct: 48 ESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER---SWFREAEIYQTVMLRHENILGFIA 103
Query: 833 SCSNEDFKA----LILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLH----- 883
+ + ++ L+ +Y +GSL L Y + + + + + AS L +LH
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVG 161
Query: 884 FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLA--TLGYMAPE 941
+ H DLK N+L+ N ++D G+A ++ T YMAPE
Sbjct: 162 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 221
Query: 942 ------YGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMK 995
+ + D+Y+ G++ E R ++ V + M+
Sbjct: 222 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 281
Query: 996 IIDAN----LLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKI 1047
+ I + + + EC + R+TA I + L ++
Sbjct: 282 KVVCEQKLRPNIPNRWQ---SCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 334
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 1e-50
Identities = 114/532 (21%), Positives = 188/532 (35%), Gaps = 82/532 (15%)
Query: 135 IPFSIFKLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQLSGSIPSFIFKISSL 194
I + L + +NLT +P N+ S + ++ + P + +
Sbjct: 3 INPRNVSNTFLQEPLRHSSNLT-EMPV-EAENVKSKTEYYNAWSEWERNAPPGNGEQREM 60
Query: 195 QALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGGISSTLSNCKHLRILDLSFNDLW 254
L + L + G+SS HL L S N L
Sbjct: 61 AVSR---------LRDCLDRQAHELE---LNNL----GLSSLPELPPHLESLVASCNSL- 103
Query: 255 GDIPKEIGNLTKLKELFLDFNILQGEIPHTVGNLHNLEYLSLVNNELVGTVPATIFNVST 314
++P+ +L L + L P LEYL + NN+L +P + N S
Sbjct: 104 TELPELPQSLKSLLVDNNNLKALSDLPP-------LLEYLGVSNNQLE-KLP-ELQNSSF 154
Query: 315 LKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSGTLPSFIFNASNLSKLSLGDNSF 374
LK+I++ NN LP P+LE + N LP N L+ + +NS
Sbjct: 155 LKIIDVDNN-SLKKLPDL----PPSLEFIAAGNNQLE-ELPELQ-NLPFLTAIYADNNSL 207
Query: 375 SGLIPNTFGNLRNLKRLRLYNNYLTSPELSFLSSLSNCKYLEIIALSGNPLNGIIPMSAG 434
L +L+ + NN L L L N +L I N L +P
Sbjct: 208 KKLPDL----PLSLESIVAGNNILEE-----LPELQNLPFLTTIYADNNLLK-TLPDLPP 257
Query: 435 NLSHSLEELFMPDCNVSGRIPKEIGNLANLVTLDLGGNKFNGSIPIALGKLQKLQLLNLD 494
+L E L + D ++ +P+ +L L + + + P L LN
Sbjct: 258 SL----EALNVRDNYLT-DLPELPQSLTFLDVSENIFSGLSELPP-------NLYYLNAS 305
Query: 495 DNKLEGSIPDDICGLVELYKLALGDNKLSGQIPACFGNLASLRELWLGPNELISFIPSTF 554
N++ S+ D L EL + +NKL ++PA L L N L +P
Sbjct: 306 SNEIR-SLCDLPPSLEELN---VSNNKLI-ELPALPPRL---ERLIASFNHLAE-VPELP 356
Query: 555 WNIKDIMYVNFSSNFLTGPLPLEIENLKALTTLDFSMNNLSGVIPTTIGGLKGLQYLFLG 614
N+K + + N L P E+++ L MN+ +P LK L +
Sbjct: 357 QNLKQL---HVEYNPLRE-FPDIPESVEDLR-----MNSHLAEVPELPQNLK---QLHVE 404
Query: 615 HNRLQGSIPDSVGDLISLKSLNLSNNNLSGPIPTSLEKLSDLKELNLSFNKL 666
N L+ PD S++ L +++ + P + E L++ +
Sbjct: 405 TNPLR-EFPDIPE---SVEDLRMNSERVVDPYEFAHETTDKLEDDVFEHHHH 452
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 3e-46
Identities = 109/556 (19%), Positives = 190/556 (34%), Gaps = 107/556 (19%)
Query: 88 PRQLGNLSSLEILDLNFNRLSGEIPWELGNLAKLEKLLLHNNFLTGTIPFSIFKLSSLLD 147
PR + N L+ + + L+ E+P E N+ + + P + +
Sbjct: 5 PRNVSNTF-LQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAV 62
Query: 148 LKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQLSGSIPSFIFKISSLQALHFGNNRLSGE 207
+L D L+L++ LS S+P L++L N L+ E
Sbjct: 63 SRLRDCLDR------------QAHELELNNLGLS-SLPE---LPPHLESLVASCNSLT-E 105
Query: 208 LPANICDNLPFLNFFSVYKNMFYGGISSTLSNCKHLRILDLSFNDLWGDIPKEIGNLTKL 267
LP +L L + L L +S N L +P E+ N + L
Sbjct: 106 LPELPQ-SLKSLLVDNNNLKALS-------DLPPLLEYLGVSNNQLE-KLP-ELQNSSFL 155
Query: 268 KELFLDFNILQGEIPHTVGNLHNLEYLSLVNNELVGTVPATIFNVSTLKLIELSNNTFFG 327
K + +D N L+ ++P +LE+++ NN+L +L EL N
Sbjct: 156 KIIDVDNNSLK-KLP---DLPPSLEFIAAGNNQLE-------------ELPELQN----- 193
Query: 328 SLPSSTDVQLPNLEELYLWGNNFSGTLPSFIFNASNLSKLSLGDNSFSGLIPNTFGNLRN 387
LP L +Y N+ LP +L + G+N NL
Sbjct: 194 ---------LPFLTAIYADNNSLK-KLPDLP---LSLESIVAGNNILE--ELPELQNLPF 238
Query: 388 LKRLRLYNNYLTSPELSFLSSLSNCKYLEIIALSGNPLNGIIPMSAGNLSHSLEELFMPD 447
L + NN L + + + L + N L + L SL L + +
Sbjct: 239 LTTIYADNNLLKT----LPDLPPSLEALN---VRDNYLTDLP-----ELPQSLTFLDVSE 286
Query: 448 CNVSGRIPKEIGNLANLVTLDLGGNKFNGSIPIALGKLQKLQLLNLDDNKLEGSIPDDIC 507
S + + NL L+ N+ S+ L+ LN+ +NKL +P
Sbjct: 287 NIFS-GLSELPPNL---YYLNASSNEIR-SLC---DLPPSLEELNVSNNKLI-ELPALPP 337
Query: 508 GLVELYKLALGDNKLSGQIPACFGNLASLRELWLGPNELISFIPSTFWNIKDIMYVNFSS 567
L L N L+ ++P NL ++L + N L P +++D+ + +
Sbjct: 338 RLERLI---ASFNHLA-EVPELPQNL---KQLHVEYNPLRE-FPDIPESVEDLRMNSHLA 389
Query: 568 NFLTGPLPLEIENLKALTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQGSIPDSVG 627
+P +NLK L N L P + + L + R+ +
Sbjct: 390 E-----VPELPQNLK---QLHVETNPLR-EFPDIPESV---EDLRMNSERVVDPYEFAHE 437
Query: 628 DLISLKSLNLSNNNLS 643
L+ +++
Sbjct: 438 TTDKLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 6e-41
Identities = 89/440 (20%), Positives = 156/440 (35%), Gaps = 93/440 (21%)
Query: 241 KHLRILDLSFNDLWGDIPKEIGNLTKLKELFLDFNILQGEIPHTVGNLHNLEYLSLVNNE 300
L+ ++L ++P E N+ E + ++ + P G + L +
Sbjct: 11 TFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCL 69
Query: 301 LVGTVPATIFNVSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSGTLPSFIFN 360
+EL+N SLP P+LE L N+ + LP +
Sbjct: 70 D-----------RQAHELELNNL-GLSSLPEL----PPHLESLVASCNSLT-ELPELPQS 112
Query: 361 ASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNYLTSPELSFLSSLSNCKYLEIIAL 420
+L + + S L P L+ L + NN L L L N +L+II +
Sbjct: 113 LKSLLVDNNNLKALSDLPP-------LLEYLGVSNNQLEK-----LPELQNSSFLKIIDV 160
Query: 421 SGNPLNGIIPMSAGNLSHSLEELFMPDCNVSGRIPKEIGNLANLVTLDLGGNKFNGSIPI 480
N L ++P +L + G N+ +P
Sbjct: 161 DNNSLK--------------------------KLPDLPP---SLEFIAAGNNQLE-ELP- 189
Query: 481 ALGKLQKLQLLNLDDNKLEGSIPDDICGLVELYKLALGDNKLSGQIPACFGNLASLRELW 540
L L L + D+N L+ +PD L + G+N L NL L ++
Sbjct: 190 ELQNLPFLTAIYADNNSLK-KLPDLPLSLESIV---AGNNILE--ELPELQNLPFLTTIY 243
Query: 541 LGPNELISFIPSTFWNIKDIMYVNFSSNFLTGPLPLEIENLKALTTLDFSMNNLSGVIP- 599
N L + +P +++ + N N+LT LP ++L L + + LS + P
Sbjct: 244 ADNNLLKT-LPDLPPSLEAL---NVRDNYLTD-LPELPQSLTFLDVSENIFSGLSELPPN 298
Query: 600 ------------TTIGGLKGLQYLFLGHNRLQGSIPDSVGDLISLKSLNLSNNNLSGPIP 647
+ L+ L + +N+L +P L+ L S N+L+ +P
Sbjct: 299 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPP---RLERLIASFNHLAE-VP 353
Query: 648 TSLEKLSDLKELNLSFNKLE 667
+ LK+L++ +N L
Sbjct: 354 ELPQN---LKQLHVEYNPLR 370
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-24
Identities = 54/271 (19%), Positives = 95/271 (35%), Gaps = 54/271 (19%)
Query: 428 IIPMSAGNLSHSLEELFMPDCNVSGRIPKEIGNLANLVTLDLGGNKFNGSIPIALGKL-- 485
I P + N L+E + +P E N+ + +++ + P G+
Sbjct: 3 INPRNVSNTF--LQEPLR-HSSNLTEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQRE 59
Query: 486 -----------QKLQLLNLDDNKLEGSIPDDICGLVELYKLALGDNKLSGQIPACFGNLA 534
++ L L++ L S+P+ L L N L+ ++P +L
Sbjct: 60 MAVSRLRDCLDRQAHELELNNLGLS-SLPELPPHLESLV---ASCNSLT-ELPELPQSLK 114
Query: 535 SLRELWLGPNELISFIPSTFWNIKDIMYVNFSSNFLTGPLPLEIENLKALTTLDFSMNNL 594
SL L P + Y+ S+N L LP E++N L +D N+L
Sbjct: 115 SLLVDNNNLKALSDLPPL-------LEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSL 165
Query: 595 SGVIPT------------------TIGGLKGLQYLFLGHNRLQGSIPDSVGDLISLKSLN 636
+ + L L ++ +N L+ +PD +SL+S+
Sbjct: 166 KKLPDLPPSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSLK-KLPDL---PLSLESIV 221
Query: 637 LSNNNLSGPIPTSLEKLSDLKELNLSFNKLE 667
NN L L+ L L + N L+
Sbjct: 222 AGNNILE--ELPELQNLPFLTTIYADNNLLK 250
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 7e-47
Identities = 82/366 (22%), Positives = 137/366 (37%), Gaps = 44/366 (12%)
Query: 65 TCDINQRRVTALNISYLSLTGNIPRQLGNLSSLEILDLNFNRLSGEIPWELGNLAKLEKL 124
C R V +P + + +LDL NR+ E + LE+L
Sbjct: 8 ECSAQDRAV---LCHRKRFV-AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEEL 61
Query: 125 LLHNNFLTGTIPFSIFK-LSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQLSGS 183
L+ N ++ + F L +L L L N L IP LS+L LD+S+N++
Sbjct: 62 ELNENIVS-AVEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIV-I 118
Query: 184 IPSFIFK-ISSLQALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGGISSTLSNCKH 242
+ ++F+ + +L++L G+N L + S
Sbjct: 119 LLDYMFQDLYNLKSLEVGDNDLV-YISHR------------------------AFSGLNS 153
Query: 243 LRILDLSFNDLWGDIPKEI-GNLTKLKELFLDFNILQGEIPHTVGNLHNLEYLSLVNNEL 301
L L L +L IP E +L L L L + ++ L+ L+ L + +
Sbjct: 154 LEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPY 212
Query: 302 VGTVPATIFNVSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSGTLPSFIF-N 360
+ T+ L + +++ ++P L L L L N S T+ +
Sbjct: 213 LDTMTPNCLYGLNLTSLSITHCN-LTAVPYLAVRHLVYLRFLNLSYNPIS-TIEGSMLHE 270
Query: 361 ASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNYLTSPELSFLSSLSNCKYLEIIAL 420
L ++ L + + P F L L+ L + N LT+ E S S+ N LE + L
Sbjct: 271 LLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGN---LETLIL 327
Query: 421 SGNPLN 426
NPL
Sbjct: 328 DSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 6e-41
Identities = 75/357 (21%), Positives = 141/357 (39%), Gaps = 44/357 (12%)
Query: 124 LLLHNNFLTGTIPFSIFKLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQLSGS 183
+L H +P I + L L N + T+ + L+ L+L++N +S +
Sbjct: 16 VLCHRKRFV-AVPEGIP--TETRLLDLGKNRIK-TLNQDEFASFPHLEELELNENIVS-A 70
Query: 184 IPSFIFK-ISSLQALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGGISSTLSNCKH 242
+ F + +L+ L +NRL +P + L +
Sbjct: 71 VEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLS------------------------N 105
Query: 243 LRILDLSFNDLWGDIPKEI-GNLTKLKELFLDFNILQGEIPHTV-GNLHNLEYLSLVNNE 300
L LD+S N + + + +L LK L + N L I H L++LE L+L
Sbjct: 106 LTKLDISENKI-VILLDYMFQDLYNLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCN 163
Query: 301 LVGTVPATIF-NVSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSGTLPSFIF 359
L ++P ++ L ++ L + ++ + +L L+ L + + T+
Sbjct: 164 LT-SIPTEALSHLHGLIVLRLRHLNI-NAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCL 221
Query: 360 NASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNYLTSPELSFLSSLSNCKYLEIIA 419
NL+ LS+ + + + +L L+ L L N +++ E S L L L+ I
Sbjct: 222 YGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLR---LQEIQ 278
Query: 420 LSGNPLNGIIPMSAGNLSHSLEELFMPDCNVSGRIPKEI-GNLANLVTLDLGGNKFN 475
L G L + P + L+ L L + ++ + + + ++ NL TL L N
Sbjct: 279 LVGGQLAVVEPYAFRGLN-YLRVLNVSGNQLT-TLEESVFHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 8e-39
Identities = 75/354 (21%), Positives = 124/354 (35%), Gaps = 38/354 (10%)
Query: 342 ELYLWGNNFSGTLPSFIFNASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNYLTSP 401
+ F +P I + L LG N L + F + +L+ L L N +++
Sbjct: 15 AVLCHRKRFV-AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAV 71
Query: 402 ELSFLSSLSNCKYLEIIALSGNPLNGIIPMSAGNLSHSLEELFMPDCNVSGRIPKEI-GN 460
E ++L N L + L N L IP +
Sbjct: 72 EPGAFNNLFN---LRTLGLRSNRLK--------------------------LIPLGVFTG 102
Query: 461 LANLVTLDLGGNKFNGSIPIALGKLQKLQLLNLDDNKLEGSIPDDI-CGLVELYKLALGD 519
L+NL LD+ NK + L L+ L + DN L I GL L +L L
Sbjct: 103 LSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEK 161
Query: 520 NKLSGQIPACFGNLASLRELWLGPNELISFIPSTFWNIKDIMYVNFSSNFLTGPLPLEIE 579
L+ +L L L L + + +F + + + S +
Sbjct: 162 CNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCL 221
Query: 580 NLKALTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQGSIPDSVGDLISLKSLNLSN 639
LT+L + NL+ V + L L++L L +N + + +L+ L+ + L
Sbjct: 222 YGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVG 281
Query: 640 NNLSGPIPTSLEKLSDLKELNLSFNKLEGEIPRG--GPFVNFSAKSFMGNNLLC 691
L+ P + L+ L+ LN+S N+L + N N L C
Sbjct: 282 GQLAVVEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHSVGNLETLILDSNPLAC 334
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 4e-46
Identities = 80/441 (18%), Positives = 145/441 (32%), Gaps = 78/441 (17%)
Query: 257 IPKEIGNLTKLKELFLDFNILQGEIPHTVGNLHNLEYLSLVNNELVGTVPATIF-NVSTL 315
I + ++ +D L+N + ++ N+ + +PA + + +
Sbjct: 13 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQV 71
Query: 316 KLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSGTLPSFIF-NASNLSKLSLGDNSF 374
+L+ L++ + + +++LY+ N LP +F N L+ L L N
Sbjct: 72 ELLNLNDL-QIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDL 129
Query: 375 SGLIPNTFGNLRNLKRLRLYNNYLTS-PELSFLSSLSNCKYLEIIALSGNPLNGIIPMSA 433
S L F N L L + NN L + +F L+ + LS N L +
Sbjct: 130 SSLPRGIFHNTPKLTTLSMSNNNLERIEDDTF----QATTSLQNLQLSSNRLTHV----- 180
Query: 434 GNLSHSLEELFMPDCNVSGRIPKEIGNLANLVTLDLGGNKFNGSIPIALGKLQKLQLLNL 493
++ + +L ++ N + L ++ L+
Sbjct: 181 -----------------------DLSLIPSLFHANVSYNLLS-----TLAIPIAVEELDA 212
Query: 494 DDNKLEGSIPDDICGLVELYKLALGDNKLSGQIPACFGNLASLRELWLGPNELISFIPST 553
N + + + VEL L L N L+ N L E+ L NEL +
Sbjct: 213 SHNSIN-VVRGPV--NVELTILKLQHNNLT-DTAW-LLNYPGLVEVDLSYNELEKIMYHP 267
Query: 554 FWNIKDIMYVNFSSNFLTGPLPLEIENLKALTTLDFSMNNLSGVIPTTIGGLKGLQYLFL 613
F ++ L L S N L + + L+ L L
Sbjct: 268 F------------------------VKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDL 302
Query: 614 GHNRLQGSIPDSVGDLISLKSLNLSNNNLSGPIPTSLEKLSDLKELNLSFNKLEGEIPRG 673
HN L + + L++L L +N++ + S LK L LS N +
Sbjct: 303 SHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKLST--HHTLKNLTLSHNDWD-CNSLR 357
Query: 674 GPFVNFSAKSFMGNNLLCGSP 694
F N + + + C
Sbjct: 358 ALFRNVARPAVDDADQHCKID 378
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 4e-42
Identities = 74/353 (20%), Positives = 127/353 (35%), Gaps = 28/353 (7%)
Query: 76 LNISYLSLTGNIPRQLGNLSSLEILDLNFNRLSGEIPWELGNLAKLEKLLLHNNFLTGTI 135
++I + + L++ +I+ + + L + ++E L L++ + I
Sbjct: 26 VHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE-EI 84
Query: 136 PFSIFK-LSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQLSGSIPSFIF-KISS 193
F ++ L + N + +P H N+ L +L L N LS S+P IF
Sbjct: 85 DTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPK 142
Query: 194 LQALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGGISSTLSNCKHLRILDLSFNDL 253
L L NN L + + L + N LS L ++S+N L
Sbjct: 143 LTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRL---THVDLSLIPSLFHANVSYNLL 198
Query: 254 WGDIPKEIGNLTKLKELFLDFNILQGEIPHTVGNLHNLEYLSLVNNELVGTVPATIFNVS 313
+ ++EL N + + L L L +N L T A + N
Sbjct: 199 -----STLAIPIAVEELDASHNSIN-VVRG--PVNVELTILKLQHNNL--TDTAWLLNYP 248
Query: 314 TLKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSGTLPSFIFNASNLSKLSLGDNS 373
L ++LS N + V++ LE LY+ N L + L L L N
Sbjct: 249 GLVEVDLSYNE-LEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNH 306
Query: 374 FSGLIPNTFGNLRNLKRLRLYNNYLTSPELSFLSSLSNCKYLEIIALSGNPLN 426
+ L+ L L +N + + +LS +L N + LS N +
Sbjct: 307 LLH-VERNQPQFDRLENLYLDHNSIVTLKLSTHHTLKN------LTLSHNDWD 352
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 7e-20
Identities = 38/192 (19%), Positives = 68/192 (35%), Gaps = 5/192 (2%)
Query: 477 SIPIALGKLQKLQLLNLDDNKLEGSIPDDICGLVELYKLALGDNKLSGQIPACFGNLASL 536
I L +++D + + L + ++ + A + +
Sbjct: 12 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 71
Query: 537 RELWLGPNELISFIPSTFWNIKDIMYVNFSSNFLTGPLPLEIENLKALTTLDFSMNNLSG 596
L L ++ F I + N + P +N+ LT L N+LS
Sbjct: 72 ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSS 131
Query: 597 VIPTTIGGLKGLQYLFLGHNRLQGSIPDSV-GDLISLKSLNLSNNNLSGPIPTSLEKLSD 655
+ L L + +N L+ I D SL++L LS+N L+ + SL +
Sbjct: 132 LPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLTH-VDLSL--IPS 187
Query: 656 LKELNLSFNKLE 667
L N+S+N L
Sbjct: 188 LFHANVSYNLLS 199
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 1e-12
Identities = 27/122 (22%), Positives = 51/122 (41%), Gaps = 6/122 (4%)
Query: 69 NQRRVTALNISYLSLTGNIPRQLGNLSSLEILDLNFNRLSGEIPWELGNLAKLEKLLLHN 128
N + +++SY L + + LE L ++ NRL + + L+ L L +
Sbjct: 246 NYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSH 304
Query: 129 NFLTGTIPFSIFKLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQLSGSIPSFI 188
N L + + + L +L L N++ T+ L +L+ L LS N + +
Sbjct: 305 NHLL-HVERNQPQFDRLENLYLDHNSIV-TLK---LSTHHTLKNLTLSHNDWDCNSLRAL 359
Query: 189 FK 190
F+
Sbjct: 360 FR 361
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 7e-46
Identities = 59/345 (17%), Positives = 108/345 (31%), Gaps = 48/345 (13%)
Query: 76 LNISYLSLTGNIPRQLGNLSSLEILDLNFNRLSGEIPWELGNLAKLEKLLLHNNFLTGTI 135
L + L D N W N + L
Sbjct: 17 LYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----AWRQANSNNPQIETRTGRALK-AT 71
Query: 136 PFSIFKLSS--LLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQLSGSIPSFIFKISS 193
+ + + L+L L P LS LQ + + L +P + + +
Sbjct: 72 ADLLEDATQPGRVALELRSVPLP-QFPD-QAFRLSHLQHMTIDAAGLM-ELPDTMQQFAG 128
Query: 194 LQALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGGISSTLSNCKHLRILDLSFNDL 253
L+ L N L LPA+I + LR L +
Sbjct: 129 LETLTLARNPLR-ALPASIA-------------------------SLNRLRELSIRACPE 162
Query: 254 WGDIPKEIGN---------LTKLKELFLDFNILQGEIPHTVGNLHNLEYLSLVNNELVGT 304
++P+ + + L L+ L L++ ++ +P ++ NL NL+ L + N+ L
Sbjct: 163 LTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-A 220
Query: 305 VPATIFNVSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSGTLPSFIFNASNL 364
+ I ++ L+ ++L T + P L+ L L + TLP I + L
Sbjct: 221 LGPAIHHLPKLEELDLRGCTALRNYPPIFG-GRAPLKRLILKDCSNLLTLPLDIHRLTQL 279
Query: 365 SKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNYLTSPELSFLSSL 409
KL L +P+ L + + + + +
Sbjct: 280 EKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVAR 324
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 4e-45
Identities = 59/335 (17%), Positives = 113/335 (33%), Gaps = 33/335 (9%)
Query: 336 QLPNLEELYLWGNNFSGTLPSFIFNASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYN 395
E LY G+ + S + D + N N +
Sbjct: 10 HSSGRENLYFQGSTALRPYHDVL---SQWQRHYNADRNRWHSAWR-QANSNNPQIETRTG 65
Query: 396 NYLTSPELSFLSSLSNCKY--LEIIALSGNPLNGIIPMSAGNLSHSLEELFMPDCNVSGR 453
L + L + + L PL P A LSH L+ + + +
Sbjct: 66 RALKA----TADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSH-LQHMTIDAAGLM-E 118
Query: 454 IPKEIGNLANLVTLDLGGNKFNGSIPIALGKLQKLQLLNLDDNKLEGSIPDDICGLVELY 513
+P + A L TL L N ++P ++ L +L+ L++ +P+ +
Sbjct: 119 LPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLAST---- 173
Query: 514 KLALGDNKLSGQIPACFGNLASLRELWLGPNELISFIPSTFWNIKDIMYVNFSSNFLTGP 573
L +L+ L L + S +P++ N++++ + ++ L+
Sbjct: 174 -----------DASGEHQGLVNLQSLRLEWTGIRS-LPASIANLQNLKSLKIRNSPLSA- 220
Query: 574 LPLEIENLKALTTLDFSMNNLSGVIPTTIGGLKGLQYLFL-GHNRLQGSIPDSVGDLISL 632
L I +L L LD P GG L+ L L + L ++P + L L
Sbjct: 221 LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQL 279
Query: 633 KSLNLSNNNLSGPIPTSLEKLSDLKELNLSFNKLE 667
+ L+L +P+ + +L + + +
Sbjct: 280 EKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 4e-43
Identities = 65/386 (16%), Positives = 114/386 (29%), Gaps = 78/386 (20%)
Query: 142 LSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQLSGSIPSFIFKISSLQALHFGN 201
S +L + L D + + ++ Q
Sbjct: 11 SSGRENLYFQGSTALRPYHDV-LSQWQRHYNADRNRWHSAWRQA----NSNNPQIETRTG 65
Query: 202 NRLSGELPANICDNLPFLNFFSVYKNMFYGGISSTLSNCKHLRILDLSFNDLWGDIPKEI 261
L + D + L+L L P +
Sbjct: 66 RALK-ATADLLED-----------------------ATQPGRVALELRSVPL-PQFPDQA 100
Query: 262 GNLTKLKELFLDFNILQGEIPHTVGNLHNLEYLSLVNNELVGTVPATIFNVSTLKLIELS 321
L+ L+ + +D L E+P T+ LE L+L N L +PA+I +++ L+ + +
Sbjct: 101 FRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIR 158
Query: 322 NNTFFGSLPSSTDVQLPNLEELYLWGNNFSGTLPSFIFNASNLSKLSLGDNSFSGLIPNT 381
LP S NL L L L P +
Sbjct: 159 ACPELTELPEPL----------------ASTDASGEHQGLVNLQSLRLEWTGIRSL-PAS 201
Query: 382 FGNLRNLKRLRLYNNYLTSPELSFLSSLSNCKYLEIIALSGNPLNGIIPMSAGNLSHSLE 441
NL+NLK L++ N+ L++ + + +L LE
Sbjct: 202 IANLQNLKSLKIRNSPLSA----------------------------LGPAIHHL-PKLE 232
Query: 442 ELFMPDCNVSGRIPKEIGNLANLVTLDLGGNKFNGSIPIALGKLQKLQLLNLDDNKLEGS 501
EL + C P G A L L L ++P+ + +L +L+ L+L
Sbjct: 233 ELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSR 292
Query: 502 IPDDICGLVELYKLALGDNKLSGQIP 527
+P I L + + + +
Sbjct: 293 LPSLIAQLPANCIILVPPHLQAQLDQ 318
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 7e-41
Identities = 54/347 (15%), Positives = 101/347 (29%), Gaps = 48/347 (13%)
Query: 239 NCKHLRILDLSFNDLWGDIPKEIGNLTKLKELFLDFNILQGEIPHTVGNLHNLEYLSLVN 298
+ L + + + + N +N + +
Sbjct: 10 HSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQA----NSNNPQIETRTG 65
Query: 299 NELVGTVPATIFNVSTLKLIELSNNTFFGSLPSS-TDVQLPNLEELYLWGNNFSGTLPSF 357
L + D P L L P
Sbjct: 66 RALK-------------------------ATADLLEDATQPGRVALELRSVPLP-QFPDQ 99
Query: 358 IFNASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNYLTS-PELSFLSSLSNCKYLE 416
F S+L +++ L P+T L+ L L N L + P S+++ L
Sbjct: 100 AFRLSHLQHMTIDAAGLMEL-PDTMQQFAGLETLTLARNPLRALPA-----SIASLNRLR 153
Query: 417 IIALSGNPLNGIIPMSAGNLS--------HSLEELFMPDCNVSGRIPKEIGNLANLVTLD 468
+++ P +P + +L+ L + + +P I NL NL +L
Sbjct: 154 ELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLK 212
Query: 469 LGGNKFNGSIPIALGKLQKLQLLNLDDNKLEGSIPDDICGLVELYKLALGDNKLSGQIPA 528
+ + + ++ A+ L KL+ L+L + P G L +L L D +P
Sbjct: 213 IRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPL 271
Query: 529 CFGNLASLRELWLGPNELISFIPSTFWNIKDIMYVNFSSNFLTGPLP 575
L L +L L +S +PS + + +
Sbjct: 272 DIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQ 318
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 1e-20
Identities = 33/161 (20%), Positives = 66/161 (40%), Gaps = 6/161 (3%)
Query: 58 VCNWTGVTCDINQRRVTALNISYLSLTGNIPRQLGNLSSLEILDLNFNRLSGEIPWELGN 117
+ + + +L + + + ++P + NL +L+ L + + LS + + +
Sbjct: 170 LASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHH 227
Query: 118 LAKLEKL-LLHNNFLTGTIPFSIFKLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLS 176
L KLE+L L L P + L L L D + T+P ++ L+ L+ LDL
Sbjct: 228 LPKLEELDLRGCTALR-NYPPIFGGRAPLKRLILKDCSNLLTLPL-DIHRLTQLEKLDLR 285
Query: 177 DNQLSGSIPSFIFKISSLQALHFGNNRLSGELPANICDNLP 217
+PS I ++ + + + L +L + P
Sbjct: 286 GCVNLSRLPSLIAQLPANCIILVPPH-LQAQLDQHRPVARP 325
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 1e-10
Identities = 20/96 (20%), Positives = 39/96 (40%), Gaps = 3/96 (3%)
Query: 76 LNISYLSLTGNIPRQLGNLSSLEILDL-NFNRLSGEIPWELGNLAKLEKLLLHNNFLTGT 134
L++ + N P G + L+ L L + + L +P ++ L +LEKL L
Sbjct: 234 LDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCVNLSR 292
Query: 135 IPFSIFKLSSLLDLKLSDNNLTGTIPSHNLGNLSSL 170
+P I +L + + + +L + H +
Sbjct: 293 LPSLIAQLPANCIILVP-PHLQAQLDQHRPVARPAE 327
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 2e-45
Identities = 77/550 (14%), Positives = 154/550 (28%), Gaps = 69/550 (12%)
Query: 87 IPRQLGNLSSLEILDLNFNRLSGEIPWELGNLAKLEKLLLHNNFLTGTIPFSIFKLSSLL 146
I N + +I + + L + + +++L L N L+ + + L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 147 DLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQLSGSIPSFIFKISSLQALHFGNNRLSG 206
L LS N L T+ L +LS+L+ LDL++N + + S++ LH NN +S
Sbjct: 62 LLNLSSNVLYETLD---LESLSTLRTLDLNNNYVQE-----LLVGPSIETLHAANNNIS- 112
Query: 207 ELPANICDNLPFLNFFSVYKNMFYGGISSTLSNCKHLRILDLSFNDLWGDIPKEIGNLTK 266
+ + + + L+ N + + G ++
Sbjct: 113 RVSCSRGQG---------------------------KKNIYLANNKITMLRDLDEGCRSR 145
Query: 267 LKELFLDFNILQG-EIPHTVGNLHNLEYLSLVNNELVGTVPATIFNVSTLKLIELSNNTF 325
++ L L N + + LE+L+L N + V +
Sbjct: 146 VQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVV--------------- 189
Query: 326 FGSLPSSTDVQLPNLEELYLWGNNFSGTLPSFIFNASNLSKLSLGDNSFSGLIPNTFGNL 385
L+ L L N + + +A+ ++ +SL +N I
Sbjct: 190 -----------FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVL-IEKALRFS 236
Query: 386 RNLKRLRLYNNYLTSPEL-SFLSSLSNCKYLEIIALSGNPLNGIIPMSAGNLSHSLEELF 444
+NL+ L N L F S + + + + L H
Sbjct: 237 QNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGH-YGAYC 295
Query: 445 MPDCNVSGRIPKEIGNLANLVTLDLGGNKFNGSIPIALGKLQKLQLLNLDDNKLEGSIPD 504
D L G++ + + + ++ + I
Sbjct: 296 CEDLPAPFADRLIALKRKEHALLSGQGSETE-RLECERENQARQREIDALKEQYRTVIDQ 354
Query: 505 DICGLVELYKLALGDNKLSGQIPACFGNLASLRELWLGPNELISFIPSTFWNIKDIMYVN 564
L L Q+ A L I +T +
Sbjct: 355 VTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHATEEQSPLQLLRA 414
Query: 565 FSSNFLTGPLPLEIENLKALTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQGSIPD 624
+ + + A+ D + + + K L ++ +
Sbjct: 415 IVKRYEEMYVEQQSVQNNAIRDWDMYQHKETQLAEENARLKKLNGEADLALASANATLQE 474
Query: 625 SVGDLISLKS 634
V +L S
Sbjct: 475 LVVREQNLAS 484
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 4e-44
Identities = 75/441 (17%), Positives = 139/441 (31%), Gaps = 26/441 (5%)
Query: 232 GISSTLSNCKHLRILDLSFNDLWGDIPKEIGNLTKLKELFLDFNILQGEIPHTVGNLHNL 291
I N +I ++ + L + + +KEL L N L + L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 292 EYLSLVNNELVGTVPATIFNVSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFS 351
E L+L +N L + ++STL+ ++L+NN + L P++E L+ NN S
Sbjct: 61 ELLNLSSNVL--YETLDLESLSTLRTLDLNNN-YVQELL-----VGPSIETLHAANNNIS 112
Query: 352 GTLPSFIFNASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNYLTSPELSFLSSLSN 411
+ + L +N + L G ++ L L N + + ++F ++
Sbjct: 113 -RVSCSRG--QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDT--VNFAELAAS 167
Query: 412 CKYLEIIALSGNPLNGIIPMSAGNLSHSLEELFMPDCNVSGRIPKEIGNLANLVTLDLGG 471
LE + L N + + + L+ L + ++ + E + A + + L
Sbjct: 168 SDTLEHLNLQYNFIYDV---KGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRN 223
Query: 472 NKFNGSIPIALGKLQKLQLLNLDDNKLE-GSIPDDICGLVELYKLALGDNKLSGQIPACF 530
NK I AL Q L+ +L N G++ D + +A +
Sbjct: 224 NKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAK--QTVKKLTGQNE 280
Query: 531 GNLASLRELWLGPNELISFIPSTFWNIKDIMYVNFSSNFLTG----PLPLEIENLKALTT 586
G + + + G L E EN
Sbjct: 281 EECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQRE 340
Query: 587 LDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQGSIPDSVGDLISLKSLNLSNNNLSGPI 646
+D VI + L L + + L +
Sbjct: 341 IDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIE-L 399
Query: 647 PTSLEKLSDLKELNLSFNKLE 667
+ E+ S L+ L + E
Sbjct: 400 QHATEEQSPLQLLRAIVKRYE 420
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 165 bits (418), Expect = 1e-43
Identities = 70/433 (16%), Positives = 134/433 (30%), Gaps = 47/433 (10%)
Query: 69 NQRRVTALNISYLSLTGNIPRQLGNLSSLEILDLNFNRLSGEIPWELGNLAKLEKLLLHN 128
N R ++ SL + + +++ LDL+ N LS +L KLE L L +
Sbjct: 8 NGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSS 67
Query: 129 NFLTGTIPFSIFKLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQLSGSIPSFI 188
N L T+ LS+L L L++N + L S++ L ++N +S +
Sbjct: 68 NVLYETLDLE--SLSTLRTLDLNNNYVQ------ELLVGPSIETLHAANNNIS-RVSCSR 118
Query: 189 FKISSLQALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGGISSTLSNCKHLRILDL 248
+ ++ NN+++ L ++ LDL
Sbjct: 119 G--QGKKNIYLANNKIT-MLRDL------------------------DEGCRSRVQYLDL 151
Query: 249 SFNDLWG-DIPKEIGNLTKLKELFLDFNILQGEIPHTVGNLHNLEYLSLVNNELVGTVPA 307
N++ + + + L+ L L +N + ++ V L+ L L +N+L +
Sbjct: 152 KLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGP 208
Query: 308 TIFNVSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSGTLPSFIFNASNLSKL 367
+ + + I L NN + + NLE L GN F F + N
Sbjct: 209 EFQSAAGVTWISLRNNK-LVLIEKALR-FSQNLEHFDLRGNGFHCGTLRDFF-SKNQRVQ 265
Query: 368 SLGDNSFSGLIPNTFGNLRNLKRLRLYNNYLTSPELSFLSSLSN--CKYLEIIALSGNPL 425
++ + L F L K +++ G+
Sbjct: 266 TVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSET 325
Query: 426 NGIIPMSAGNLSHSLEELFMPDCNVSGRIPKEIGNLANLVTLDLGGNKFNGSIPIALGKL 485
+ E+ I + +TL+ + +
Sbjct: 326 ERLECERENQA--RQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAH 383
Query: 486 QKLQLLNLDDNKL 498
+L
Sbjct: 384 AELDGTLQQAVGQ 396
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 8e-34
Identities = 53/319 (16%), Positives = 100/319 (31%), Gaps = 65/319 (20%)
Query: 354 LPSFIFNASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNYLTSPELSFLSSLSNCK 413
+ N + + D+S + + + N+K L L N L+ + L+ +
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTK-- 59
Query: 414 YLEIIALSGNPLNGIIPMSAGNLSHSLEELFMPDCNVSGRIPKEIGNLANLVTLDLGGNK 473
LE++ LS N L + + +L+ L TLDL N
Sbjct: 60 -LELLNLSSNVLYETLD---------------------------LESLSTLRTLDLNNNY 91
Query: 474 FNGSIPIALGKLQKLQLLNLDDNKLEGSIPDDICGLVELYKLALGDNKLSGQIPACFGNL 533
L ++ L+ +N + + + L +NK++ G
Sbjct: 92 VQ-----ELLVGPSIETLHAANNNIS-RVSCSR--GQGKKNIYLANNKITMLRDLDEGCR 143
Query: 534 ASLRELWLGPNELISFIPSTFWNIKDIMYVNFSSNFLTGPLPLEIENLKALTTLDFSMNN 593
+ ++ L L NE+ + + + L L+ N
Sbjct: 144 SRVQYLDLKLNEIDTVNFAEL-----------------------AASSDTLEHLNLQYNF 180
Query: 594 LSGVIPTTIGGLKGLQYLFLGHNRLQGSIPDSVGDLISLKSLNLSNNNLSGPIPTSLEKL 653
+ V L+ L L N+L + + ++L NN L I +L
Sbjct: 181 IYDVKGQV--VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVL-IEKALRFS 236
Query: 654 SDLKELNLSFNKLEGEIPR 672
+L+ +L N R
Sbjct: 237 QNLEHFDLRGNGFHCGTLR 255
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 72.6 bits (178), Expect = 3e-13
Identities = 23/96 (23%), Positives = 41/96 (42%), Gaps = 3/96 (3%)
Query: 578 IENLKALTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQGSIPDSVGDLISLKSLNL 637
+N + ++L + + ++ L L N L + L+ LNL
Sbjct: 6 KQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNL 65
Query: 638 SNNNLSGPIPTSLEKLSDLKELNLSFNKLEGEIPRG 673
S+N L + LE LS L+ L+L+ N ++ E+ G
Sbjct: 66 SSNVLYETLD--LESLSTLRTLDLNNNYVQ-ELLVG 98
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 44.8 bits (106), Expect = 1e-04
Identities = 10/52 (19%), Positives = 24/52 (46%)
Query: 621 SIPDSVGDLISLKSLNLSNNNLSGPIPTSLEKLSDLKELNLSFNKLEGEIPR 672
+I + + K +++++L + + + ++KEL+LS N L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAA 52
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 3e-43
Identities = 85/346 (24%), Positives = 137/346 (39%), Gaps = 36/346 (10%)
Query: 707 HISKKNALLLGIILPFSTIFVIVIILLISRYQTRGENVPNEVNVPLEATWRRFSYLELFQ 766
I + L F +I LLI + + + + V L + + L
Sbjct: 60 IIQSLDNLYRLEGEGFPSI-----PLLIDHLLSTQQPLTKKSGVVLHRAVPKDKW-VL-- 111
Query: 767 ATNGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTF-DLQHERAFKSFDTECEVMKSIRH 824
IGRG+FG V+ RL+ + VAVK+ + F E ++K H
Sbjct: 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSH 171
Query: 825 RNLTKIISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHF 884
N+ ++I C+ + +++E ++ G L + L + L ++ D A+ +EYL
Sbjct: 172 PNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE- 230
Query: 885 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGY--MAPEY 942
S IH DL N L+ + V +SDFG+++ D + L + APE
Sbjct: 231 --SKCCIHRDLAARNCLVTEKNVLKISDFGMSREE--ADGVYAASGGLRQVPVKWTAPEA 286
Query: 943 GREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLL 1002
GR S++ DV+SFGILL ETF+ G P +
Sbjct: 287 LNYGRYSSESDVWSFGILLWETFSL---------GAS----------PYPNLSNQQTREF 327
Query: 1003 ITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKIR 1048
+ + E C +VF L +C P +R + I + L IR
Sbjct: 328 VEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 8e-43
Identities = 77/409 (18%), Positives = 137/409 (33%), Gaps = 49/409 (11%)
Query: 59 CNWTGVTCDINQRRVTAL-----NISYLSLTGNI-----PRQLGNLSSLEILDLNFNRLS 108
C+ G R + + +++Y+ L+ N L L+ L +
Sbjct: 8 CSVIGYNAICINRGLHQVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPG 67
Query: 109 GEIPWEL-GNLAKLEKLLLHNNFLTGTIPFSIF-KLSSLLDLKLSDNNLTGT-IPSHNLG 165
I L+ L L L N + F L++L L L+ NL G + +
Sbjct: 68 LVIRNNTFRGLSSLIILKLDYNQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFK 126
Query: 166 NLSSLQLLDLSDNQLSGSIPSFIF-KISSLQALHFGNNRLSGELPANICDNLPFLNF--- 221
L+SL++L L DN + P+ F + L N++ + N +F
Sbjct: 127 PLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVK-SICEEDLLNFQGKHFTLL 185
Query: 222 -------FSVYKNMFYGGISSTLSNCKHLRILDLSFNDLWGDIPKEIGNLTKLKEL---- 270
+ + + LDLS N + K + ++
Sbjct: 186 RLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLI 245
Query: 271 ---------FLDFNILQGEIPHTVGNLH--NLEYLSLVNNELVGTVPATIF-NVSTLKLI 318
+ T L ++ L +++ + ++F + + L+ +
Sbjct: 246 LSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKI-FALLKSVFSHFTDLEQL 304
Query: 319 ELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSGTLPSFIFNA-SNLSKLSLGDNSFSGL 377
L+ N + + L +L +L L N ++ S +F L L L N L
Sbjct: 305 TLAQNE-INKIDDNAFWGLTHLLKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHIRAL 362
Query: 378 IPNTFGNLRNLKRLRLYNNYLTSPELSFLSSLSNCKYLEIIALSGNPLN 426
+F L NLK L L N L S L++ L+ I L NP +
Sbjct: 363 GDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTS---LQKIWLHTNPWD 408
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 2e-38
Identities = 82/461 (17%), Positives = 130/461 (28%), Gaps = 91/461 (19%)
Query: 168 SSLQLLDLSDNQLSGSIPSFIF-KISSLQALHFGNNRLSGELPANICDNLPFLNFFSVYK 226
+ + +DLS N ++ + F ++ LQ L + N L
Sbjct: 30 AHVNYVDLSLNSIA-ELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLS--------- 79
Query: 227 NMFYGGISSTLSNCKHLRILDLSFNDLWGDIPKEI-GNLTKLKELFLDFNILQG-EIPHT 284
L IL L +N + L L+ L L L G +
Sbjct: 80 ---------------SLIILKLDYNQF-LQLETGAFNGLANLEVLTLTQCNLDGAVLSGN 123
Query: 285 V-GNLHNLEYLSLVNNELVGTVPATIF-NVSTLKLIELSNNTFFGSLPSST--DVQLPNL 340
L +LE L L +N + PA+ F N+ +++L+ N S+ + Q +
Sbjct: 124 FFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNK-VKSICEEDLLNFQGKHF 182
Query: 341 EELYLWGNNFSGTLPSFIFNASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNYLTS 400
L L + + ++ L L N
Sbjct: 183 TLLRLSSITL----------------QDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKE 226
Query: 401 PELSFLSSLSNCKYLEIIALSGNPLNGIIPMSAGNLSHSLEELFMPDCNVSGRIPKEIGN 460
++ + LS + N N + G
Sbjct: 227 SMAKRFFDAIAGTKIQSLILSNSY-NMGSSFGHTNFKD------PDNFTFKGL------E 273
Query: 461 LANLVTLDLGGNKFNGSIPI-ALGKLQKLQLLNLDDNKLEGSIPDDIC-GLVELYKLALG 518
+ + T DL +K ++ L+ L L N++ I D+ GL L KL L
Sbjct: 274 ASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLS 331
Query: 519 DNKLSGQIPACFGNLASLRELWLGPNELISFIPSTFWNIKDIMYVNFSSNFLTGPLPLEI 578
N L F NL L L L N + + +F
Sbjct: 332 QNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSF------------------------ 367
Query: 579 ENLKALTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQ 619
L L L N L V L LQ ++L N
Sbjct: 368 LGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWD 408
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 3e-36
Identities = 78/394 (19%), Positives = 142/394 (36%), Gaps = 45/394 (11%)
Query: 290 NLEYLSLVNNELVGTVPATIF-NVSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGN 348
++ Y+ L N + + T F + L+ +++ T + ++T L +L L L N
Sbjct: 31 HVNYVDLSLNSI-AELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89
Query: 349 NFSGTLPSFIFNA-SNLSKLSLGDNSFSGLI--PNTFGNLRNLKRLRLYNNYLTS-PELS 404
F L + FN +NL L+L + G + N F L +L+ L L +N + S
Sbjct: 90 QFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPAS 148
Query: 405 FLSSLSNCKYLEIIALSGNPLNGIIPMSAGNLSHS-LEELFMPDCNVSGRIPKEIGNLAN 463
F ++ ++ L+ N + I N L L++
Sbjct: 149 FFLNMRR---FHVLDLTFNKVKSICEEDLLNFQGKHFTLL----------------RLSS 189
Query: 464 LVTLDLGGNKFNGSIPIALGKLQKLQLLNLDDNKLEGSIPDDICGLVELYKLALGDNKLS 523
+ D+ K + L+L N + S+ +
Sbjct: 190 ITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAG----------- 238
Query: 524 GQIPACFGNLASLRELWLGPNELISFIPSTFWNIK--DIMYVNFSSNFLTGPLPLEI-EN 580
+I + + + G TF ++ + + S + + L + +
Sbjct: 239 TKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFA-LLKSVFSH 297
Query: 581 LKALTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQGSIPDSVGD-LISLKSLNLSN 639
L L + N ++ + GL L L L N L SI + + L L+ L+LS
Sbjct: 298 FTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLG-SIDSRMFENLDKLEVLDLSY 356
Query: 640 NNLSGPIPTSLEKLSDLKELNLSFNKLEGEIPRG 673
N++ S L +LKEL L N+L+ +P G
Sbjct: 357 NHIRALGDQSFLGLPNLKELALDTNQLK-SVPDG 389
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 6e-35
Identities = 78/380 (20%), Positives = 125/380 (32%), Gaps = 63/380 (16%)
Query: 313 STLKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSGTLPSFIF-NASNLSKLSLGD 371
+ + ++LS N+ L ++ +L +L+ L + + + F S+L L L
Sbjct: 30 AHVNYVDLSLNSI-AELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDY 88
Query: 372 NSFSGLIPNTFGNLRNLKRLRLYNNYLTSPELS--FLSSLSNCKYLEIIALSGNPLNGII 429
N F L F L NL+ L L L LS F L++ LE++ L N + I
Sbjct: 89 NQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTS---LEMLVLRDNNIKKIQ 145
Query: 430 PMSAGNLSHSLEELFMPDCNVSGRIPKEIGNLANLVTLDLGGNKFNGSIPIALGKLQKLQ 489
P F+ N+ LDL NK L Q
Sbjct: 146 P----------ASFFL--------------NMRRFHVLDLTFNKVKSICEEDLLNFQGKH 181
Query: 490 LLNLDDNKLEGSIPDDICGLVELYKLALGDNKLSGQIPACFGNLASLRELWLGPNELISF 549
L L + + + L + S+ L L N
Sbjct: 182 FTLLR--------------LSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKES 227
Query: 550 IPSTFW-------------NIKDIMYVNFSSNFLTGPLPLEIENLKA--LTTLDFSMNNL 594
+ F+ + M +F P + L+A + T D S + +
Sbjct: 228 MAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKI 287
Query: 595 SGVIPTTIGGLKGLQYLFLGHNRLQGSIPDSVGD-LISLKSLNLSNNNLSGPIPTSLEKL 653
++ + L+ L L N + I D+ L L LNLS N L E L
Sbjct: 288 FALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENL 346
Query: 654 SDLKELNLSFNKLEGEIPRG 673
L+ L+LS+N + +
Sbjct: 347 DKLEVLDLSYNHIR-ALGDQ 365
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 7e-35
Identities = 88/433 (20%), Positives = 150/433 (34%), Gaps = 68/433 (15%)
Query: 121 LEKLLLHNNFLTGTIPFSIFKLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQL 180
+ + L N + S +L L LK+ I ++ LSSL +L L NQ
Sbjct: 32 VNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQF 91
Query: 181 SGSIPSFIF-KISSLQALHFGNNRL-SGELPANICDNLPFLNFFSVYKN----MFYGGIS 234
+ + F +++L+ L L L N L L + N +
Sbjct: 92 L-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFF 150
Query: 235 STLSNCKHLRILDLSFNDLWGDIPKEIGNLTKLKELFLDFNILQGEIPHTVGNLHNLEYL 294
+ +LDL+FN + +++ N L L ++
Sbjct: 151 LNMRR---FHVLDLTFNKVKSICEEDLLNFQGKHFTLLR--------------LSSITLQ 193
Query: 295 SLVNNELVGTVPATIFNVSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSGTL 354
+ L F +++ ++LS N F S+ + + L +N
Sbjct: 194 DMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMG 253
Query: 355 PSFIFNASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNYLTSPELSFLSSLSNCKY 414
SF N + +F GL + +K L + + + S S ++
Sbjct: 254 SSFGHT--NFKDPD--NFTFKGLEAS------GVKTCDLSKSKIFALLKSVFSHFTD--- 300
Query: 415 LEIIALSGNPLNGIIPMSAGNLSHSLEELFMPDCNVSGRIPKEI-GNLANLVTLDLGGNK 473
LE + L+ N +N +I L +L+ L+L N
Sbjct: 301 LEQLTLAQNEIN--------------------------KIDDNAFWGLTHLLKLNLSQNF 334
Query: 474 FNGSIPI-ALGKLQKLQLLNLDDNKLEGSIPDDI-CGLVELYKLALGDNKLSGQIPACFG 531
GSI L KL++L+L N + ++ D GL L +LAL N+L F
Sbjct: 335 L-GSIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLKSVPDGIFD 392
Query: 532 NLASLRELWLGPN 544
L SL+++WL N
Sbjct: 393 RLTSLQKIWLHTN 405
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 3e-12
Identities = 23/96 (23%), Positives = 43/96 (44%), Gaps = 1/96 (1%)
Query: 584 LTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQGSIPDSVGD-LISLKSLNLSNNNL 642
+ +D S+N+++ + T+ L+ LQ+L + I ++ L SL L L N
Sbjct: 32 VNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQF 91
Query: 643 SGPIPTSLEKLSDLKELNLSFNKLEGEIPRGGPFVN 678
+ L++L+ L L+ L+G + G F
Sbjct: 92 LQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKP 127
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 5e-42
Identities = 80/440 (18%), Positives = 146/440 (33%), Gaps = 76/440 (17%)
Query: 257 IPKEIGNLTKLKELFLDFNILQGEIPHTVGNLHNLEYLSLVNNELVGTVPATIF-NVSTL 315
I + ++ +D L+N + ++ N+ + +PA + + +
Sbjct: 19 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQV 77
Query: 316 KLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSGTLPSFIF-NASNLSKLSLGDNSF 374
+L+ L++ + + +++LY+ N LP +F N L+ L L N
Sbjct: 78 ELLNLNDL-QIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDL 135
Query: 375 SGLIPNTFGNLRNLKRLRLYNNYLTSPELSFLSSLSNCKYLEIIALSGNPLNGIIPMSAG 434
S L F N L L + NN L E + ++ L+ + LS N L +
Sbjct: 136 SSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTS---LQNLQLSSNRLTHV------ 186
Query: 435 NLSHSLEELFMPDCNVSGRIPKEIGNLANLVTLDLGGNKFNGSIPIALGKLQKLQLLNLD 494
++ + +L ++ N + L ++ L+
Sbjct: 187 ----------------------DLSLIPSLFHANVSYNLLS-----TLAIPIAVEELDAS 219
Query: 495 DNKLEGSIPDDICGLVELYKLALGDNKLSGQIPACFGNLASLRELWLGPNELISFIPSTF 554
N + + + VEL L L N L+ N L E+ L NEL + F
Sbjct: 220 HNSIN-VVRGPVN--VELTILKLQHNNLT-DTAW-LLNYPGLVEVDLSYNELEKIMYHPF 274
Query: 555 WNIKDIMYVNFSSNFLTGPLPLEIENLKALTTLDFSMNNLSGVIPTTIGGLKGLQYLFLG 614
++ L L S N L + + L+ L L
Sbjct: 275 ------------------------VKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLS 309
Query: 615 HNRLQGSIPDSVGDLISLKSLNLSNNNLSGPIPTSLEKLSDLKELNLSFNKLEGEIPRGG 674
HN L + + L++L L +N++ + S LK L LS N +
Sbjct: 310 HNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKLST--HHTLKNLTLSHNDWD-CNSLRA 364
Query: 675 PFVNFSAKSFMGNNLLCGSP 694
F N + + + C
Sbjct: 365 LFRNVARPAVDDADQHCKID 384
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 1e-39
Identities = 93/594 (15%), Positives = 182/594 (30%), Gaps = 118/594 (19%)
Query: 76 LNISYLSLTGNIPRQLGNLSSLEILDLNFNRLSGEIPWELGNLAKLEKLLLHNNFLTGTI 135
++I + + L++ +I+ + + L + ++E L L++ + I
Sbjct: 32 VHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE-EI 90
Query: 136 PFSIF-KLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQLSGSIPSFIF-KISS 193
F ++ L + N + +P H N+ L +L L N LS S+P IF
Sbjct: 91 DTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPK 148
Query: 194 LQALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGGISSTLSNCKHLRILDLSFNDL 253
L L NN L + + T L+ L LS N L
Sbjct: 149 LTTLSMSNNNLE-RIEDD------------------------TFQATTSLQNLQLSSNRL 183
Query: 254 WGDIPKEIGNLTKLKELFLDFNILQGEIPHTVGNLHNLEYLSLVNNELVGTVPATIFNVS 313
+ + + L + +N+L T+ +E L +N + V +
Sbjct: 184 -THVD--LSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPVN--- 231
Query: 314 TLKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSGTLPSFIFNASNLSKLSLGDNS 373
L L L NN + + N L ++ L N
Sbjct: 232 ------------------------VELTILKLQHNNLT-DTAWLL-NYPGLVEVDLSYNE 265
Query: 374 FSGLIPNTFGNLRNLKRLRLYNNYLTSPELSFLSSLSNCKYLEIIALSGNPLNGIIPMSA 433
++ + F ++ L+RL + NN L + L L+++ LS N L
Sbjct: 266 LEKIMYHPFVKMQRLERLYISNNRLVALNLYG----QPIPTLKVLDLSHNHLL------- 314
Query: 434 GNLSHSLEELFMPDCNVSGRIPKEIGNLANLVTLDLGGNKFNGSIPIALGKLQKLQLLNL 493
+ + L L L N + L L+ L L
Sbjct: 315 -------------------HVERNQPQFDRLENLYLDHNSIV---TLKLSTHHTLKNLTL 352
Query: 494 DDNKLEGSIPDDICGLVELYKLALGDNKLSGQIPACFGNLASLRELWLGPNELISFIPST 553
N + + + + + A+ D +I + +E
Sbjct: 353 SHNDWDCNSLRAL--FRNVARPAVDDADQHCKIDYQLEHGLCCKE------------SDK 398
Query: 554 FWNIKDIMYVNFSSNFLTGPLPLEIENLKALTTLDFSMNNLSGVIPTTIGGLKGLQYLFL 613
+ + + Y+ +S + + A T++ + + L+G + L
Sbjct: 399 PYLDRLLQYIALTS--VVEKVQRAQGRCSATDTINSVQSLSHYITQQGGVPLQGNEQLEA 456
Query: 614 GHNRLQGSIPDSVGDLISLKSLNLS-NNNLSGPIPTSLEKLSDLKELNLSFNKL 666
N L+ + + I + L + + + L + + NK+
Sbjct: 457 EVNELRAEVQQLTNEQIQQEQLLQGLHAEIDTNLRRYRLPKDGLARSSDNLNKV 510
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 130 bits (327), Expect = 3e-31
Identities = 69/334 (20%), Positives = 120/334 (35%), Gaps = 29/334 (8%)
Query: 348 NNFSGTLPSFIFNASNLSK-LSLGDNSFSGLIPNTFG-----NLRNLKRLRLYNNYLTSP 401
N P + SNL D + + L N K + N+ +
Sbjct: 7 YNVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKL 66
Query: 402 ELSFLSSLSNCKYLEIIALSGNPLNGIIPMSAGNLSHSLEELFMPDCNVSGRIPKEI-GN 460
+ L S +E++ L+ + I + H++++L+M + +P + N
Sbjct: 67 PAALLDSFRQ---VELLNLNDLQIEEIDTYAFAYA-HTIQKLYMGFNAIR-YLPPHVFQN 121
Query: 461 LANLVTLDLGGNKFNGSIPIALGKLQKLQLLNLDDNKLEGSIPDDI-CGLVELYKLALGD 519
+ L L L N + KL L++ +N LE I DD L L L
Sbjct: 122 VPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSS 180
Query: 520 NKLSGQIPACFGNLASLRELWLGPNELISFIPSTFWNIKDIMYVNFSSNFLTGPLPLEIE 579
N+L+ + + SL + N L + + ++ S N + +
Sbjct: 181 NRLT-HVD--LSLIPSLFHANVSYNLLSTLAIPIA-----VEELDASHNSINV---VRGP 229
Query: 580 NLKALTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQGSIPDSVGDLISLKSLNLSN 639
LT L NNL+ + GL + L +N L+ + + L+ L +SN
Sbjct: 230 VNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISN 287
Query: 640 NNLSGPIPTSLEKLSDLKELNLSFNKLEGEIPRG 673
N L + + + LK L+LS N L + R
Sbjct: 288 NRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERN 319
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 70.3 bits (172), Expect = 2e-12
Identities = 28/148 (18%), Positives = 58/148 (39%), Gaps = 8/148 (5%)
Query: 69 NQRRVTALNISYLSLTGNIPRQLGNLSSLEILDLNFNRLSGEIPWELGNLAKLEKLLLHN 128
N + +++SY L + + LE L ++ NRL + + L+ L L +
Sbjct: 252 NYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSH 310
Query: 129 NFLTGTIPFSIFKLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQLSGSIPSFI 188
N L + + + L +L L N++ T+ L +L+ L LS N + +
Sbjct: 311 NHLL-HVERNQPQFDRLENLYLDHNSIV-TLK---LSTHHTLKNLTLSHNDWDCNSLRAL 365
Query: 189 FKISSLQALHFGNNRLSGELPANICDNL 216
F+ ++ + ++ + L
Sbjct: 366 FR--NVARPAVDDADQHCKIDYQLEHGL 391
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 1e-41
Identities = 99/528 (18%), Positives = 174/528 (32%), Gaps = 69/528 (13%)
Query: 150 LSDNNLTGTIPSHNLGNLSSLQLLDLSDNQLSGSIPSFIFKISSLQALHFGNNRLSGELP 209
S N L +P +L++S N +S S I +S L+ L +NR+ L
Sbjct: 7 RSKNGLI-HVPK---DLSQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQ-YLD 61
Query: 210 ANICDNLPFLNFFSVYKNMFYGGISSTLSNCKHLRILDLSFNDLWGDIPKEIGNLTKLKE 269
++ L LDLS N L I LK
Sbjct: 62 ISVFKFNQ------------------------ELEYLDLSHNKLVK-IS--CHPTVNLKH 94
Query: 270 LFLDFNILQGEIPHT--VGNLHNLEYLSLVNNELVGTVPATIFNVS--TLKLIELSNNTF 325
L L FN +P GN+ L++L L L + I +++ + L+
Sbjct: 95 LDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGE 153
Query: 326 FGSLPSSTDVQLPNLEELYLWGNNFSGTLPSFIFNASNLSKLSLGDNSFSGLIPNTFGNL 385
D +L ++ F L + +NL ++ L
Sbjct: 154 KEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSIL 213
Query: 386 RNL------KRLRLYNNYLTSPELSFLSSLSNCKYLEIIALSGNPLNGIIPMSAGNLSHS 439
L L L N T + L + ++S L G + + S +
Sbjct: 214 AKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGT 273
Query: 440 LEELFMPDCNVSGRIPKEIGNLANLVTLDLGGNKFNGSIPIALGKLQKLQLLNLDDNKLE 499
+L L + + F + + N +
Sbjct: 274 --------------------SLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTR 313
Query: 500 GSIPDDICGLVELYKLALGDNKLSGQIPACFGNLASLRELWLGPNEL--ISFIPSTFWNI 557
+ L +N L+ + G+L L L L N+L +S I +
Sbjct: 314 MVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQM 373
Query: 558 KDIMYVNFSSNFLTGPLPLEI-ENLKALTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHN 616
K + ++ S N ++ K+L +L+ S N L+ I + ++ L L N
Sbjct: 374 KSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSN 431
Query: 617 RLQGSIPDSVGDLISLKSLNLSNNNLSGPIPTSLEKLSDLKELNLSFN 664
+++ SIP V L +L+ LN+++N L ++L+ L+++ L N
Sbjct: 432 KIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTN 478
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 160 bits (405), Expect = 1e-41
Identities = 101/491 (20%), Positives = 186/491 (37%), Gaps = 35/491 (7%)
Query: 74 TALNISYLSLTGNIPRQLGNLSSLEILDLNFNRLSGEIPWELGNLAKLEKLLLHNNFLTG 133
++ S L ++P+ L IL+++ N +S ++ +L+KL L++ +N +
Sbjct: 3 FLVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQ- 58
Query: 134 TIPFSIF-KLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQLSGSIPSFIF-KI 191
+ S+F L L LS N L I H N L+ LDLS N F +
Sbjct: 59 YLDISVFKFNQELEYLDLSHNKLV-KISCHPTVN---LKHLDLSFNAFDALPICKEFGNM 114
Query: 192 SSLQALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGGISSTLSNC--KHLRILDLS 249
S L+ L L I + + L + + L I+ +
Sbjct: 115 SQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPT 174
Query: 250 FNDLWGDIPKEIGNLTKLKELFLDFNILQGEIPHTVGNLHNLEY------LSLVNNELVG 303
+ + + + L+ + + + + + L L+ L+L N E
Sbjct: 175 NKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTW 234
Query: 304 TVPATIFNV---STLKLIELSNNTFFGSLPSST-DVQLPNLEELYLW--GNNFSGTLPSF 357
I + +T+ +SN G L D +L+ L + ++ G S+
Sbjct: 235 NSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSY 294
Query: 358 IFNA-SNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNYLTSPELSFLSSLSNCKYLE 416
I+ SN++ + + + + L NN LT L+ + L
Sbjct: 295 IYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLI 354
Query: 417 IIALSGNPLNGIIPMSAGNLSH--SLEELFMPDCNVSGRIPKEI-GNLANLVTLDLGGNK 473
L N L + A + SL++L + +VS K +L++L++ N
Sbjct: 355 ---LQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNI 410
Query: 474 FNGSIPIALGKLQKLQLLNLDDNKLEGSIPDDICGLVELYKLALGDNKLSGQIPACFGNL 533
+I L ++++L+L NK++ SIP + L L +L + N+L F L
Sbjct: 411 LTDTIFRCL--PPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRL 467
Query: 534 ASLRELWLGPN 544
SL+++WL N
Sbjct: 468 TSLQKIWLHTN 478
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 8e-38
Identities = 84/452 (18%), Positives = 159/452 (35%), Gaps = 29/452 (6%)
Query: 241 KHLRILDLSFNDLWGDIPKEIGNLTKLKELFLDFNILQGEIPHTVGNLHNLEYLSLVNNE 300
+ IL++S N + +I +L+KL+ L + N +Q LEYL L +N+
Sbjct: 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNK 80
Query: 301 LVGTVPATIFNVSTLKLIELSNNTFFGSLPSSTD-VQLPNLEELYLWGNNFSGTLPSFIF 359
L + LK ++LS N F +LP + + L+ L L + + I
Sbjct: 81 L-VKISCHPT--VNLKHLDLSFN-AFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIA 136
Query: 360 NASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNYLTSPELSFL--SSLSNCKYLEI 417
+ + L + ++ L++ L+ + T+ E F+ S+ LE+
Sbjct: 137 HLNISKVLLVLGETY--GEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLEL 194
Query: 418 IALSGNPLNGIIPMSAGNLS-----HSLEELFMPDCNVSGRIPKEIGNLANLVTL----- 467
+ + L+ L L + + + I L T+
Sbjct: 195 SNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSI 254
Query: 468 ---DLGGNKFNGSIPIALGKLQKLQLLNLDDNKLEGSIPDDICGLVELYKLALGDNKLSG 524
L G + L+ L + + + + +
Sbjct: 255 SNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRM 314
Query: 525 QIPACFGNLASLRELWLGPNELISFIPSTFWNIKDIMYVNFSSNFLT--GPLPLEIENLK 582
C ++ L N L + ++ ++ + N L + +K
Sbjct: 315 VHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMK 374
Query: 583 ALTTLDFSMNNLSGVIPTTI-GGLKGLQYLFLGHNRLQGSIPDSVGDLISLKSLNLSNNN 641
+L LD S N++S K L L + N L +I + +K L+L +N
Sbjct: 375 SLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNK 432
Query: 642 LSGPIPTSLEKLSDLKELNLSFNKLEGEIPRG 673
+ IP + KL L+ELN++ N+L+ +P G
Sbjct: 433 IKS-IPKQVVKLEALQELNVASNQLK-SVPDG 462
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 4e-25
Identities = 60/365 (16%), Positives = 114/365 (31%), Gaps = 20/365 (5%)
Query: 305 VPATIFNVSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSGTLPSFIFNA-SN 363
VP + ++ +S N L +S + L L L + N L +F
Sbjct: 15 VPKDLS--QKTTILNISQNYIS-ELWTSDILSLSKLRILIISHNRIQ-YLDISVFKFNQE 70
Query: 364 LSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNYLTS-PELSFLSSLSNCKYLEIIALSG 422
L L L N + + NLK L L N + P ++S L+ + LS
Sbjct: 71 LEYLDLSHNKLVKI---SCHPTVNLKHLDLSFNAFDALPICKEFGNMSQ---LKFLGLST 124
Query: 423 NPLNGIIPMSAGNLSHSLEELFMPDCNVSGRIPKEIGNLANLVTLDLGGNKFNGSIPIAL 482
L + +L+ S L + + ++ L + T L +
Sbjct: 125 THLEKSSVLPIAHLNISKVLLVLGETYGE---KEDPEGLQDFNTESLHIVFPTNKEFHFI 181
Query: 483 GKLQKLQLLNLDDNKLEGSIPDDICGLVELYKLALGDNKLSGQIPACFGNLASLRELWLG 542
+ + NL+ + ++ + D+ C L N + L ++ W
Sbjct: 182 LDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNL-----TLNNIETTWNS 236
Query: 543 PNELISFIPSTFWNIKDIMYVNFSSNFLTGPLPLEIENLKALTTLDFSMNNLSGVIPTTI 602
++ + T I V +LKAL+ +
Sbjct: 237 FIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIY 296
Query: 603 GGLKGLQYLFLGHNRLQGSIPDSVGDLISLKSLNLSNNNLSGPIPTSLEKLSDLKELNLS 662
+ + + + L+ SNN L+ + + L++L+ L L
Sbjct: 297 EIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQ 356
Query: 663 FNKLE 667
N+L+
Sbjct: 357 MNQLK 361
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 76.8 bits (189), Expect = 1e-14
Identities = 47/229 (20%), Positives = 82/229 (35%), Gaps = 54/229 (23%)
Query: 73 VTALNISYLSLTGNIPRQLGNLSSLEILDLNFNRLSGEIPWELGNLAKLEKLLLHNNFLT 132
+ N + +S LD + N L+ + G+L +LE L+L N L
Sbjct: 302 MNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK 361
Query: 133 GTIPFSIFKLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQLSGSIPSFIF-KI 191
+ K++ + + SLQ LD+S N +S
Sbjct: 362 -----ELSKIAEMTT------------------QMKSLQQLDISQNSVSYDEKKGDCSWT 398
Query: 192 SSLQALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGGISSTLSNCKHLRILDLSFN 251
SL +L+ +N L+ + F +++LDL N
Sbjct: 399 KSLLSLNMSSNILT---------DTIFRCLPP------------------RIKVLDLHSN 431
Query: 252 DLWGDIPKEIGNLTKLKELFLDFNILQGEIPHTV-GNLHNLEYLSLVNN 299
+ IPK++ L L+EL + N L+ +P + L +L+ + L N
Sbjct: 432 KI-KSIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTN 478
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 66.0 bits (161), Expect = 3e-11
Identities = 44/272 (16%), Positives = 91/272 (33%), Gaps = 9/272 (3%)
Query: 558 KDIMYVNFSSNFLTGPLPLEIENLKALTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNR 617
+ +N S N+++ +I +L L L S N + + + + L+YL L HN+
Sbjct: 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNK 80
Query: 618 LQGSIPDSVGDLISLKSLNLSNNNL-SGPIPTSLEKLSDLKELNLSFNKLEGEIPRGGPF 676
L I ++LK L+LS N + PI +S LK L LS L
Sbjct: 81 LV-KISC--HPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHL-----EKSSV 132
Query: 677 VNFSAKSFMGNNLLCGSPNLQVPPCRASIDHISKKNALLLGIILPFSTIFVIVIILLISR 736
+ + + L+ G + D ++ ++ F I + + + +
Sbjct: 133 LPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANL 192
Query: 737 YQTRGENVPNEVNVPLEATWRRFSYLELFQATNGFSENNLIGRGSFGSVYIARLQNGIEV 796
+ + V + + + + + +
Sbjct: 193 ELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYF 252
Query: 797 AVKTFDLQHERAFKSFDTECEVMKSIRHRNLT 828
++ LQ + F+ FD +K++ +
Sbjct: 253 SISNVKLQGQLDFRDFDYSGTSLKALSIHQVV 284
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 1e-41
Identities = 71/282 (25%), Positives = 128/282 (45%), Gaps = 17/282 (6%)
Query: 777 IGRGSFGSVYIARL-----QNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKII 831
+G+G+FGSV + R G VAVK E + F+ E E++KS++H N+ K
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 832 SSCSNEDFKA--LILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAP 889
C + + LI+EY+ GSL L +D + L + +EYL +
Sbjct: 78 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 134
Query: 890 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATL--GYMAPEYGREGR 947
IH DL N+L+++ + DFG+ K+ + +D+ + + + APE E +
Sbjct: 135 YIHRDLATRNILVENENRVKIGDFGLTKV-LPQDKEFFKVKEPGESPIFWYAPESLTESK 193
Query: 948 VSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDK 1007
S DV+SFG++L E FT + + + M + M + L+ +
Sbjct: 194 FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND----KQGQMIVFHLIELLKNNG 249
Query: 1008 HFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKIRD 1049
+ C ++ + EC + ++R + +++ R+ +IRD
Sbjct: 250 RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 3e-41
Identities = 71/282 (25%), Positives = 128/282 (45%), Gaps = 17/282 (6%)
Query: 777 IGRGSFGSVYIARL-----QNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKII 831
+G+G+FGSV + R G VAVK E + F+ E E++KS++H N+ K
Sbjct: 49 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 832 SSCSNEDFKA--LILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAP 889
C + + LI+EY+ GSL L +D + L + +EYL +
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 165
Query: 890 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATL--GYMAPEYGREGR 947
IH DL N+L+++ + DFG+ K+ + +D+ + + + APE E +
Sbjct: 166 YIHRDLATRNILVENENRVKIGDFGLTKV-LPQDKEYYKVKEPGESPIFWYAPESLTESK 224
Query: 948 VSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDK 1007
S DV+SFG++L E FT + + + M + M + L+ +
Sbjct: 225 FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND----KQGQMIVFHLIELLKNNG 280
Query: 1008 HFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKIRD 1049
+ C ++ + EC + ++R + +++ R+ +IRD
Sbjct: 281 RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 322
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 151 bits (385), Expect = 3e-41
Identities = 71/276 (25%), Positives = 117/276 (42%), Gaps = 34/276 (12%)
Query: 777 IGRGSFGSVYIARLQNGIEVAVKTF--DLQHERAFKSFDTECEVMKSIRHRNLTKIISSC 834
IG G FG V++ N +VA+KT E F E EVM + H L ++ C
Sbjct: 16 IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIE---EAEVMMKLSHPKLVQLYGVC 72
Query: 835 SNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYL---HFGYSAPVI 891
+ L+ E+M +G L L + + L + +DV + YL I
Sbjct: 73 LEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACV------I 126
Query: 892 HCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTK 951
H DL N L+ +N V +SDFG+ + + +DQ + T T + + +PE R S+K
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTRF-VLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 185
Query: 952 GDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHFAA 1011
DV+SFG+L+ E F+ G++ P + I+
Sbjct: 186 SDVWSFGVLMWEVFSE---------GKI----------PYENRSNSEVVEDISTGFRLYK 226
Query: 1012 KEQCASSVFNLAMECTVESPDERITAKEIVRRLLKI 1047
++ V+ + C E P++R ++R+L +I
Sbjct: 227 PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 262
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 5e-41
Identities = 62/283 (21%), Positives = 113/283 (39%), Gaps = 23/283 (8%)
Query: 777 IGRGSFGSVYIARL-----QNGIEVAVKTFDLQH---ERAFKSFDTECEVMKSIRHRNLT 828
+G G FG V + R G +VAVK+ L+ E E+++++ H N+
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKS--LKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 829 KIISSCSNEDFKA--LILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGY 886
K C+ + LI+E++ +GSL++ L +++ Q+L + + ++YL
Sbjct: 87 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG--- 143
Query: 887 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATL--GYMAPEYGR 944
S +H DL NVL++ + DFG+ K I D+ + + APE
Sbjct: 144 SRQYVHRDLAARNVLVESEHQVKIGDFGLTKA-IETDKEYYTVKDDRDSPVFWYAPECLM 202
Query: 945 EGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLIT 1004
+ + DV+SFG+ L E T + + + M + +
Sbjct: 203 QSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIG-----PTHGQMTVTRLVNTLK 257
Query: 1005 EDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKI 1047
E K C V+ L +C P R + + ++ +
Sbjct: 258 EGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 1e-40
Identities = 68/278 (24%), Positives = 117/278 (42%), Gaps = 34/278 (12%)
Query: 777 IGRGSFGSVYIARLQNGIEVAVKTF--DLQHERAFKSFDTECEVMKSIRHRNLTKIISSC 834
+G G FG V + + +VA+K E F E +VM ++ H L ++ C
Sbjct: 32 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIE---EAKVMMNLSHEKLVQLYGVC 88
Query: 835 SNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYL---HFGYSAPVI 891
+ + +I EYM NG L L + Q L + DV A+EYL F +
Sbjct: 89 TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQF------L 142
Query: 892 HCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTK 951
H DL N L++D V +SDFG+++ + +D+ + + + + PE + S+K
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSRY-VLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSK 201
Query: 952 GDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHFAA 1011
D+++FG+L+ E ++ G+M P + I +
Sbjct: 202 SDIWAFGVLMWEIYSL---------GKM----------PYERFTNSETAEHIAQGLRLYR 242
Query: 1012 KEQCASSVFNLAMECTVESPDERITAKEIVRRLLKIRD 1049
+ V+ + C E DER T K ++ +L + D
Sbjct: 243 PHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 280
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 2e-40
Identities = 70/278 (25%), Positives = 122/278 (43%), Gaps = 34/278 (12%)
Query: 777 IGRGSFGSVYIARLQNGIEVAVKTF--DLQHERAFKSFDTECEVMKSIRHRNLTKIISSC 834
+G G FG V + + + +VAVK E F E + M + H L K C
Sbjct: 16 LGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQ---EAQTMMKLSHPKLVKFYGVC 72
Query: 835 SNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYL---HFGYSAPVI 891
S E ++ EY+ NG L L S L+ Q L + DV + +L F I
Sbjct: 73 SKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQF------I 126
Query: 892 HCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTK 951
H DL N L+D ++ +SDFG+ + + +DQ ++ T + + APE + S+K
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMTRY-VLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSK 185
Query: 952 GDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHFAA 1011
DV++FGIL+ E F+ G+M P + + L +++
Sbjct: 186 SDVWAFGILMWEVFSL---------GKM----------PYDLYTNSEVVLKVSQGHRLYR 226
Query: 1012 KEQCASSVFNLAMECTVESPDERITAKEIVRRLLKIRD 1049
+ +++ + C E P++R T ++++ + +R+
Sbjct: 227 PHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 7e-40
Identities = 89/449 (19%), Positives = 163/449 (36%), Gaps = 27/449 (6%)
Query: 242 HLRILDLSFNDLWGDIPKEIGNLTKLKELFLDFNILQGEIPHTV-GNLHNLEYLSLVNNE 300
+ L LS N + +I L++L+ L L N ++ + V +LEYL + +N
Sbjct: 53 RTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHNR 111
Query: 301 LVGTVPATIFNVSTLKLIELSNNTFFGSLPSSTDVQ-LPNLEELYLWGNNF-SGTLPSFI 358
L + ++L+ ++LS N F LP + L L L L F L
Sbjct: 112 LQ-NISCCPM--ASLRHLDLSFN-DFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVA 167
Query: 359 FNASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNYLTSPELSFLSSLSNCKYLEII 418
+ L L G + N L L + + + S++ +L++
Sbjct: 168 HLHLSCILLDLVSYHIKGGETESLQIP-NTTVLHLVFHPNSLFSVQVNMSVNALGHLQLS 226
Query: 419 ALSGNPLNGIIPMS---AGNLSHSLEELFMPDCNVSGRIPKEIGNLA--------NLVTL 467
+ N N M+ +L + + + + ++ N+ L
Sbjct: 227 NIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNL 286
Query: 468 DLGGNKFNGSIPIALGKLQKLQLLNLDDNKLEGSIPDDICGLVELYKLALGDNKLSGQIP 527
+ + L+ L + ++ + S E+ L +
Sbjct: 287 TITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHM 346
Query: 528 ACFGNLASLRELWLGPNELISFIPSTFWNIKDIMYVNFSSNFLT--GPLPLEIENLKALT 585
C + +S L N + +K + + N L + L +N+ +L
Sbjct: 347 VCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLE 406
Query: 586 TLDFSMNNL-SGVIPTTIGGLKGLQYLFLGHNRLQGSIPDSVGDLISLKSLNLSNNNLSG 644
TLD S+N+L S T + + L L N L GS+ + +K L+L NN +
Sbjct: 407 TLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPP--KVKVLDLHNNRIMS 464
Query: 645 PIPTSLEKLSDLKELNLSFNKLEGEIPRG 673
IP + L L+ELN++ N+L+ +P G
Sbjct: 465 -IPKDVTHLQALQELNVASNQLK-SVPDG 491
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 3e-34
Identities = 104/514 (20%), Positives = 172/514 (33%), Gaps = 72/514 (14%)
Query: 143 SSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQLSGSIPSFIF-KISSLQALHFGN 201
L LS N+++ + ++ LS L++L LS N++ S+ +F L+ L +
Sbjct: 52 PRTKALSLSQNSIS-ELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSH 109
Query: 202 NRLSGELPANICDNLPFLNFFSVYKNMFYGGISSTLSNCKHLRILDLSFNDLWGDIP--K 259
NRL N+ LR LDLSFND + +P K
Sbjct: 110 NRLQ---------NISCCPM-------------------ASLRHLDLSFND-FDVLPVCK 140
Query: 260 EIGNLTKLKELFLDFNILQGEIPHTVGNLHNLEY--LSLVNNELVGTVPATIFNVSTLKL 317
E GNLTKL L L + ++ +L L LV+ + G ++ +T L
Sbjct: 141 EFGNLTKLTFLGLSAAKFR-QLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVL 199
Query: 318 -IELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSGTLPSFIFNASNLSKLSLGDNSFSG 376
+ N+ F ++ + L L L +
Sbjct: 200 HLVFHPNSLF---SVQVNMSVNALGHLQLSNIKLN----------------DENCQRLMT 240
Query: 377 LIPNTFGNLRNLKRLRLYNNYLTSPELSFLSSLSNCKYLEIIALSGNPLNGIIPMSAGNL 436
+ L + L + T L + +E + + + I
Sbjct: 241 FLSELTRGPT-LLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTY 299
Query: 437 SH-SLEELFMPDCNVSGRIPKEIG---NLANLVTLDLGGNKFNGSIPIALGKLQKLQLLN 492
S +L+ L + + + A + L + + LN
Sbjct: 300 SETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLN 359
Query: 493 LDDNKLEGSIPDDICGLVELYKLALGDNKLSGQIPACFGNLASLRELWLGPNELISFIPS 552
N S+ L L L L N L ++ L L S
Sbjct: 360 FTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSLNSLNSH 418
Query: 553 TFWNI----KDIMYVNFSSNFLTGPLPLEIENLKALTTLDFSMNNLSGVIPTTIGGLKGL 608
+ + I+ +N SSN LTG + + + LD N + IP + L+ L
Sbjct: 419 AYDRTCAWAESILVLNLSSNMLTGSVFRCL--PPKVKVLDLHNNRIM-SIPKDVTHLQAL 475
Query: 609 QYLFLGHNRLQGSIPDSVGD-LISLKSLNLSNNN 641
Q L + N+L+ S+PD V D L SL+ + L +N
Sbjct: 476 QELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNP 508
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 128 bits (322), Expect = 8e-31
Identities = 98/554 (17%), Positives = 180/554 (32%), Gaps = 91/554 (16%)
Query: 74 TALNISYLSLTGNIPRQLGNLSSLEILDLNFNRLSGEIPWELGNLAKLEKLLLHNNFLTG 133
+ ++ S +LT ++P+ + L L+ N +S ++ L++L L L +N +
Sbjct: 34 SMVDYSNRNLT-HVPK--DLPPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR- 89
Query: 134 TIPFSIF-KLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQLSGSIPSFIF-KI 191
++ F +F L L +S N L I ++SL+ LDLS N F +
Sbjct: 90 SLDFHVFLFNQDLEYLDVSHNRLQ-NISC---CPMASLRHLDLSFNDFDVLPVCKEFGNL 145
Query: 192 SSLQALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGGISSTLSNCKHLRILDLSFN 251
+ L L + L L ++ +LDL
Sbjct: 146 TKLTFLGLSAAKFR---------QLDLLPVAHLHL---------------SCILLDLVSY 181
Query: 252 DLWGDIPKEIGNLTKLKELFLDFNILQGEIPHTVGNLHNLEYLSLVNNELVGTVPATIFN 311
+ G + + L L F+ +++ L +L L N +L +
Sbjct: 182 HIKGGETESLQIP-NTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMT 240
Query: 312 VSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSGTLPSFIFNASNLSKLSLGD 371
+ + +T L + F + L++ +
Sbjct: 241 FLSELTRGPTLLNVTLQHIETTWKCSVKLFQF---------------FWPRPVEYLNIYN 285
Query: 372 NSFSGLIP-----NTFGNLRNLKRLRLYNNYLTSPELSFLSSLSNCKYLEIIALSGNPLN 426
+ + I + L++L + N + + S + + I LS +
Sbjct: 286 LTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAE---MNIKMLSISDTP 342
Query: 427 GIIPMSAGNLSHSLEELFMPDCNVSGRIPKEIGNLANLVTLDLGGNKFNGSIPIA---LG 483
I M S L + + + L L TL L N +
Sbjct: 343 -FIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTK 400
Query: 484 KLQKLQLLNLDDNKLEGSIPDDICGLVE-LYKLALGDNKLSGQIPACFGNLASLRELWLG 542
+ L+ L++ N L D C E + L L N L+G + C ++ L L
Sbjct: 401 NMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCL--PPKVKVLDLH 458
Query: 543 PNELISFIPSTFWNIKDIMYVNFSSNFLTGPLPLEIENLKALTTLDFSMNNLSGVIPTTI 602
N ++S +P ++ +L+AL L+ + N L V
Sbjct: 459 NNRIMS-------------------------IPKDVTHLQALQELNVASNQLKSVPDGVF 493
Query: 603 GGLKGLQYLFLGHN 616
L LQY++L N
Sbjct: 494 DRLTSLQYIWLHDN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-22
Identities = 72/426 (16%), Positives = 131/426 (30%), Gaps = 45/426 (10%)
Query: 77 NISYLSLTGN----IPRQLGNLSSLEILDLNFNRLSGEIPW--ELGNLAKLEKLLLHNNF 130
++ YL ++ N I ++SL LDL+FN +P E GNL KL L L
Sbjct: 101 DLEYLDVSHNRLQNISC--CPMASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAK 157
Query: 131 LTGTIPFSIFKLSSL--LDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQLSGSIPSFI 188
+ L + L L ++ G +++ L N L +
Sbjct: 158 FR-QLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMS 216
Query: 189 FKISSLQALHFGNNRLSG-------ELPANICDNLPFLNFFSVYKNMFYGGISSTLSNCK 241
++L L N +L+ + + LN + +
Sbjct: 217 V--NALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFW 274
Query: 242 HLRILDLSFNDL-------WGDIPKEIGNLTKLKELFLDFNILQGEIPHTVGNLHNLEYL 294
+ L+ +L + L L + + +
Sbjct: 275 PRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIK 334
Query: 295 SLVNNELVGTVPATIFNV-STLKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSGT 353
L ++ + S+ + + N F L L+ L L N
Sbjct: 335 MLSISDT-PFIHMVCPPSPSSFTFLNFTQNVF-TDSVFQGCSTLKRLQTLILQRNGLK-N 391
Query: 354 LPSFIFNASNLSKLSLGDNSFSGLIPNTFGNL----RNLKRLRLYNNYLTSPELSFLSSL 409
N+S L D S + L + + ++ L L +N LT F
Sbjct: 392 FFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTG--SVFRCLP 449
Query: 410 SNCKYLEIIALSGNPLNGIIPMSAGNLSHSLEELFMPDCNVSGRIPKEI-GNLANLVTLD 468
++++ L N + IP +L +L+EL + N +P + L +L +
Sbjct: 450 PK---VKVLDLHNNRIM-SIPKDVTHL-QALQELNV-ASNQLKSVPDGVFDRLTSLQYIW 503
Query: 469 LGGNKF 474
L N +
Sbjct: 504 LHDNPW 509
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 88.8 bits (220), Expect = 3e-18
Identities = 59/307 (19%), Positives = 103/307 (33%), Gaps = 59/307 (19%)
Query: 52 LTNSTMVCNWTGVTCDIN---QRRVTALNISYLSLTGNIPRQLGN-----LSSLEILDLN 103
+T + W R V LNI L++T I R+ L SL I +
Sbjct: 254 VTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVK 313
Query: 104 FNRLSGEIPWELGNLAKLEKLLLHNNFLTGTIPFSIFKLSSLLDLKLSDNNLTGTIPSHN 163
A++ +L + SS L + N T
Sbjct: 314 NQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFT-DSVFQG 372
Query: 164 LGNLSSLQLLDLSDNQLSGSIPSFIFKISSLQALHFGNNRLSGELPANICDNLPFLNFFS 223
L LQ L L N L + ++ +L + L+ L ++ D
Sbjct: 373 CSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSLNS-LNSHAYDRT------- 423
Query: 224 VYKNMFYGGISSTLSNCKHLRILDLSFNDLWGDIPKEIGNLTKLKELFLDFNILQGEIPH 283
+ + + +L+LS N L G + + + K+K L L N + IP
Sbjct: 424 -------------CAWAESILVLNLSSNMLTGSVFRCL--PPKVKVLDLHNNRIM-SIPK 467
Query: 284 TVGNLHNLEYLSLVNNELVGTVPATIFNVSTLKLIELSNNTFFGSLPSSTDVQLPNLEEL 343
V +L L+ L++ +N+L +VP +F+ +L +L+ +
Sbjct: 468 DVTHLQALQELNVASNQLK-SVPDGVFD------------------------RLTSLQYI 502
Query: 344 YLWGNNF 350
+L N +
Sbjct: 503 WLHDNPW 509
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 2e-39
Identities = 63/283 (22%), Positives = 117/283 (41%), Gaps = 21/283 (7%)
Query: 777 IGRGSFGSVYIARLQN-----GIEVAVKTFDLQH-ERAFKSFDTECEVMKSIRHRNLTKI 830
+G G FG V + G VAVK + + E ++++++ H ++ K
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 831 ISSCSNEDFKA--LILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSA 888
C + + L++EY+ GSL L + + + Q L + + YLH +
Sbjct: 99 KGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLH---AQ 153
Query: 889 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATL--GYMAPEYGREG 946
IH DL NVLLD++ + + DFG+AK + E + + + APE +E
Sbjct: 154 HYIHRDLAARNVLLDNDRLVKIGDFGLAKA-VPEGHEYYRVREDGDSPVFWYAPECLKEY 212
Query: 947 RVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITED 1006
+ DV+SFG+ L E T + + + L + M ++ L+
Sbjct: 213 KFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIG-----IAQGQMTVLRLTELLERG 267
Query: 1007 KHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKIRD 1049
+ ++C + V++L C R T + ++ L + +
Sbjct: 268 ERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHE 310
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 2e-39
Identities = 70/286 (24%), Positives = 124/286 (43%), Gaps = 36/286 (12%)
Query: 773 ENNLIGRGSFGSVYIARL----QNGIEVAVKTF-DLQHERAFKSFDTECEVMKSIRHRNL 827
+ +IG+G FG VY QN I+ A+K+ + + ++F E +M+ + H N+
Sbjct: 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84
Query: 828 TKIISSCSNED-FKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYL---H 883
+I + ++L YM +G L + + S + ++ + VA +EYL
Sbjct: 85 LALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK 144
Query: 884 FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATL--GYMAPE 941
F +H DL N +LD++ ++DFG+A+ ++ + Q A L + A E
Sbjct: 145 F------VHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALE 198
Query: 942 YGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANL 1001
+ R +TK DV+SFG+LL E TR G P + D
Sbjct: 199 SLQTYRFTTKSDVWSFGVLLWELLTR---------GAP----------PYRHIDPFDLTH 239
Query: 1002 LITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKI 1047
+ + + E C S++ + +C P R T + +V + +I
Sbjct: 240 FLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQI 285
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 2e-39
Identities = 65/281 (23%), Positives = 113/281 (40%), Gaps = 38/281 (13%)
Query: 777 IGRGSFGSVYIARLQNG---IEVAVKTF--DLQHERAFKSFDTECEVMKSIRHRNLTKII 831
+G G+FG+V Q VAVK + E VM+ + + + ++I
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 832 SSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYL---HFGYSA 888
C E + L++E G L K L + + + ++ V+ ++YL +F
Sbjct: 85 GICEAESWM-LVMEMAELGPLNKYLQQNRH-VKDKNIIELVHQVSMGMKYLEESNF---- 138
Query: 889 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATL--GYMAPEYGREG 946
+H DL NVLL A +SDFG++K + D++ + QT + APE
Sbjct: 139 --VHRDLAARNVLLVTQHYAKISDFGLSKA-LRADENYYKAQTHGKWPVKWYAPECINYY 195
Query: 947 RVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITED 1006
+ S+K DV+SFG+L+ E F+ G+ P MK + ++ +
Sbjct: 196 KFSSKSDVWSFGVLMWEAFSY---------GQK----------PYRGMKGSEVTAMLEKG 236
Query: 1007 KHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKI 1047
+ C +++L C + R + RL
Sbjct: 237 ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 277
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 2e-39
Identities = 71/284 (25%), Positives = 122/284 (42%), Gaps = 36/284 (12%)
Query: 775 NLIGRGSFGSVYIARLQNG----IEVAVKTF-DLQHERAFKSFDTECEVMKSIRHRNLTK 829
+IGRG FG VY L + I AVK+ + F TE +MK H N+
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 830 IISSCSNEDFKAL-ILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYL---HFG 885
++ C + L +L YM++G L + + + + + + VA ++YL F
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKF- 149
Query: 886 YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATL--GYMAPEYG 943
+H DL N +LD+ ++DFG+A+ + ++ +T A L +MA E
Sbjct: 150 -----VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 204
Query: 944 REGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLI 1003
+ + +TK DV+SFG+LL E TR G P + D + +
Sbjct: 205 QTQKFTTKSDVWSFGVLLWELMTR---------GAP----------PYPDVNTFDITVYL 245
Query: 1004 TEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKI 1047
+ + E C ++ + ++C + R + E+V R+ I
Sbjct: 246 LQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 289
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 3e-39
Identities = 68/277 (24%), Positives = 117/277 (42%), Gaps = 18/277 (6%)
Query: 777 IGRGSFGSVYIARL-----QNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKII 831
+G+G+FGSV + R G VAVK + F E +++K++ + K
Sbjct: 31 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 832 SSCSNEDFKA--LILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAP 889
++ L++EY+ +G L L LD + L + +EYL S
Sbjct: 91 GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG---SRR 147
Query: 890 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLL-IGEDQSMTQTQTLATLGYMAPEYGREGRV 948
+H DL N+L++ ++DFG+AKLL + +D + + + + + APE +
Sbjct: 148 CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIF 207
Query: 949 STKGDVYSFGILLMETFTR-RKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDK 1007
S + DV+SFG++L E FT K S + + + L+ E +
Sbjct: 208 SRQSDVWSFGVVLYELFTYCDKS----CSPSAEFLRMMGCERDV--PALSRLLELLEEGQ 261
Query: 1008 HFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRL 1044
A C + V L C SP +R + + +L
Sbjct: 262 RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQL 298
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 4e-39
Identities = 69/291 (23%), Positives = 121/291 (41%), Gaps = 46/291 (15%)
Query: 777 IGRGSFGSVYIARLQNG----IEVAVKT--FDLQHERAFKSFDTECEVMKSIRHRNLTKI 830
+G G FGSV L+ ++VAVKT D +R + F +E MK H N+ ++
Sbjct: 42 LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 831 ISSCSNEDFKA-----LILEYMRNGSL-----EKCLYSGNYILDIFQRLNIMIDVASALE 880
+ C + +IL +M+ G L L +G + + L M+D+A +E
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161
Query: 881 YL---HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGY 937
YL +F +H DL N +L D+M ++DFG++K + D + +
Sbjct: 162 YLSNRNF------LHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKW 215
Query: 938 MAPEYGREGRVSTKGDVYSFGILLMETFTR-RKPTDEIFSGEMTLKHWVNDFLPISMMKI 996
+A E + ++K DV++FG+ + E TR P + G + ++
Sbjct: 216 IAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP----YPG-------------VQNHEM 258
Query: 997 IDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKI 1047
D + E C ++ + C P +R T + +L K+
Sbjct: 259 YD---YLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKL 306
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 6e-39
Identities = 68/294 (23%), Positives = 107/294 (36%), Gaps = 48/294 (16%)
Query: 777 IGRGSFGSVYIARLQ----NGIEVAVKTF---DLQHERAFKSFDTECEVMKSIRHRNLTK 829
+G GSFG V + VAVK L A F E M S+ HRNL +
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 830 IISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYL---HFGY 886
+ K ++ E GSL L + + VA + YL F
Sbjct: 86 LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRF-- 142
Query: 887 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLG------YMAP 940
IH DL N+LL + + DFG+ + L D + + AP
Sbjct: 143 ----IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDD-----HYVMQEHRKVPFAWCAP 193
Query: 941 EYGREGRVSTKGDVYSFGILLMETFTR-RKPTDEIFSGEMTLKHWVNDFLPISMMKIIDA 999
E + S D + FG+ L E FT ++P + G + +I+
Sbjct: 194 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEP----WIG-LNGS------------QILHK 236
Query: 1000 NLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKIRDFLLR 1053
+ E + E C ++N+ ++C P++R T + LL+ + +R
Sbjct: 237 --IDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTDMR 288
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 151 bits (382), Expect = 7e-39
Identities = 71/277 (25%), Positives = 115/277 (41%), Gaps = 30/277 (10%)
Query: 775 NLIGRGSFGSVYIARLQN-GIEVAVKTF--DLQHERAFKSFDTECEVMKSIRHRNLTKII 831
+ +G G +G VY + + VAVKT D F E VMK I+H NL +++
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK---EAAVMKEIKHPNLVQLL 282
Query: 832 SSCSNEDFKALILEYMRNGSLEKCLYSGN-YILDIFQRLNIMIDVASALEYLHFGYSAPV 890
C+ E +I E+M G+L L N + L + ++SA+EYL
Sbjct: 283 GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNF 339
Query: 891 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVST 950
IH +L N L+ +N + ++DFG+++ L+ D + + APE + S
Sbjct: 340 IHRNLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 398
Query: 951 KGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHFA 1010
K DV++FG+LL E T P + + L+ +D
Sbjct: 399 KSDVWAFGVLLWEIATYGM-------------------SPYPGIDLSQVYELLEKDYRME 439
Query: 1011 AKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKI 1047
E C V+ L C +P +R + EI + +
Sbjct: 440 RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 476
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 8e-39
Identities = 85/365 (23%), Positives = 147/365 (40%), Gaps = 49/365 (13%)
Query: 707 HISKKNALLLGIILPFST--IFVIVIILLISRYQTRGENVPNEVNVPLEATWRRFSYL-- 762
H ++ ++ GI++P + + I I +S + N S L
Sbjct: 14 HGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALNP 73
Query: 763 ELFQATNGFSE---------NNLIGRGSFGSVYIARLQNG----IEVAVKTF-DLQHERA 808
EL QA N +IGRG FG VY L + I AVK+ +
Sbjct: 74 ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 133
Query: 809 FKSFDTECEVMKSIRHRNLTKIISSCSNEDFKAL-ILEYMRNGSLEKCLYSGNYILDIFQ 867
F TE +MK H N+ ++ C + L +L YM++G L + + + +
Sbjct: 134 VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD 193
Query: 868 RLNIMIDVASALEYL---HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ 924
+ + VA +++L F +H DL N +LD+ ++DFG+A+ + ++
Sbjct: 194 LIGFGLQVAKGMKFLASKKF------VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 247
Query: 925 SMTQTQTLATL--GYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLK 982
+T A L +MA E + + +TK DV+SFG+LL E TR G
Sbjct: 248 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTR---------GAP--- 295
Query: 983 HWVNDFLPISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVR 1042
P + D + + + + E C ++ + ++C + R + E+V
Sbjct: 296 -------PYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 348
Query: 1043 RLLKI 1047
R+ I
Sbjct: 349 RISAI 353
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 8e-39
Identities = 63/306 (20%), Positives = 116/306 (37%), Gaps = 42/306 (13%)
Query: 751 PLEATWRRFSYLELFQATNGFSENNLIGRGSFGSVYIARLQNG-----IEVAVKTF-DLQ 804
P +A R E + ++G G+FG+VY I VA+K +
Sbjct: 4 PNQALLRILKETEF-------KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT 56
Query: 805 HERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEYMRNGSLEKCLYSGNYILD 864
+A K E VM S+ + ++ +++ C + LI + M G L + +
Sbjct: 57 SPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIG 115
Query: 865 IFQRLNIMIDVASALEYL---HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIG 921
LN + +A + YL +H DL NVL+ ++DFG+AKLL
Sbjct: 116 SQYLLNWCVQIAKGMNYLEDRRL------VHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169
Query: 922 EDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTL 981
E++ + +MA E + + DV+S+G+ + E T G
Sbjct: 170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTF---------GSK-- 218
Query: 982 KHWVNDFLPISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIV 1041
P + + + ++ + + C V+ + +C + D R +E++
Sbjct: 219 --------PYDGIPASEISSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELI 270
Query: 1042 RRLLKI 1047
K+
Sbjct: 271 IEFSKM 276
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 9e-39
Identities = 73/276 (26%), Positives = 123/276 (44%), Gaps = 30/276 (10%)
Query: 775 NLIGRGSFGSVYIARLQNGIEVAVKTF--DLQHERAFKSFDTECEVMKSIRHRNLTKIIS 832
+G+G FG V++ VA+KT AF E +VMK +RH L ++ +
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ---EAQVMKKLRHEKLVQLYA 246
Query: 833 SCSNEDFKALILEYMRNGSLEKCLYSGN-YILDIFQRLNIMIDVASALEYLHFGYSAPVI 891
S E ++ EYM GSL L L + Q +++ +AS + Y+ +
Sbjct: 247 VVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 302
Query: 892 HCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTK 951
H DL+ +N+L+ +N+V ++DFG+A+L I +++ + + + APE GR + K
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 361
Query: 952 GDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHFAA 1011
DV+SFGILL E T+ G + P M + +
Sbjct: 362 SDVWSFGILLTELTTK---------GRV----------PYPGMVNREVLDQVERGYRMPC 402
Query: 1012 KEQCASSVFNLAMECTVESPDERITAKEIVRRLLKI 1047
+C S+ +L +C + P+ER T + + L
Sbjct: 403 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 438
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 1e-38
Identities = 64/290 (22%), Positives = 118/290 (40%), Gaps = 36/290 (12%)
Query: 777 IGRGSFGSVYIARLQNG---IEVAVKTF-DLQHERAFKSFDTECEVMKSIRHRNLTKIIS 832
+G G+FGSV + I+VA+K + + E ++M + + + ++I
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 833 SCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYL---HFGYSAP 889
C E L++E G L K L + + ++ V+ ++YL +F
Sbjct: 78 VCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF----- 131
Query: 890 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATL--GYMAPEYGREGR 947
+H DL NVLL + A +SDFG++K +G D S ++ + APE +
Sbjct: 132 -VHRDLAARNVLLVNRHYAKISDFGLSKA-LGADDSYYTARSAGKWPLKWYAPECINFRK 189
Query: 948 VSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDK 1007
S++ DV+S+G+ + E + G+ P MK + I + K
Sbjct: 190 FSSRSDVWSYGVTMWEALSY---------GQK----------PYKKMKGPEVMAFIEQGK 230
Query: 1008 HFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKIRDFLLRNVES 1057
+C ++ L +C + ++R + +R+ L VE
Sbjct: 231 RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEG 280
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 1e-38
Identities = 65/292 (22%), Positives = 121/292 (41%), Gaps = 47/292 (16%)
Query: 777 IGRGSFGSVYIARLQNG----IEVAVKTF--DLQHERAFKSFDTECEVMKSIRHRNLTKI 830
+G+G FGSV A+L+ ++VAVK D+ + F E MK H ++ K+
Sbjct: 31 LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90
Query: 831 ISSCSNEDFKA------LILEYMRNGSL-----EKCLYSGNYILDIFQRLNIMIDVASAL 879
+ K +IL +M++G L + + L + + M+D+A +
Sbjct: 91 VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGM 150
Query: 880 EYL---HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLG 936
EYL +F IH DL N +L ++M ++DFG+++ + D + +
Sbjct: 151 EYLSSRNF------IHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVK 204
Query: 937 YMAPEYGREGRVSTKGDVYSFGILLMETFTR-RKPTDEIFSGEMTLKHWVNDFLPISMMK 995
++A E + + DV++FG+ + E TR + P ++G I +
Sbjct: 205 WLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP----YAG-------------IENAE 247
Query: 996 IIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKI 1047
I + + +C V++L +C P +R + + L I
Sbjct: 248 IYN---YLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENI 296
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 1e-38
Identities = 73/275 (26%), Positives = 115/275 (41%), Gaps = 30/275 (10%)
Query: 777 IGRGSFGSVYIARLQNG-IEVAVKTF--DLQHERAFKSFDTECEVMKSIRHRNLTKIISS 833
+G G +G VY + + VAVKT D F E VMK I+H NL +++
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK---EAAVMKEIKHPNLVQLLGV 77
Query: 834 CSNEDFKALILEYMRNGSLEKCLYSGN-YILDIFQRLNIMIDVASALEYLHFGYSAPVIH 892
C+ E +I E+M G+L L N + L + ++SA+EYL IH
Sbjct: 78 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIH 134
Query: 893 CDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKG 952
DL N L+ +N + ++DFG+++L + D + + APE + S K
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 193
Query: 953 DVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHFAAK 1012
DV++FG+LL E T G P + + L+ +D
Sbjct: 194 DVWAFGVLLWEIATY---------GMS----------PYPGIDLSQVYELLEKDYRMERP 234
Query: 1013 EQCASSVFNLAMECTVESPDERITAKEIVRRLLKI 1047
E C V+ L C +P +R + EI + +
Sbjct: 235 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 2e-38
Identities = 72/276 (26%), Positives = 120/276 (43%), Gaps = 30/276 (10%)
Query: 775 NLIGRGSFGSVYIARLQNGIEVAVKTF--DLQHERAFKSFDTECEVMKSIRHRNLTKIIS 832
+G G FG V++A +VAVKT AF + E VMK+++H L K+ +
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLA---EANVMKTLQHDKLVKLHA 250
Query: 833 SCSNEDFKALILEYMRNGSLEKCLYS-GNYILDIFQRLNIMIDVASALEYLHFGYSAPVI 891
+ E +I E+M GSL L S + + ++ +A + ++ I
Sbjct: 251 VVTKEPI-YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYI 306
Query: 892 HCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTK 951
H DL+ +N+L+ ++V ++DFG+A++ I +++ + + + APE G + K
Sbjct: 307 HRDLRAANILVSASLVCKIADFGLARV-IEDNEYTAREGAKFPIKWTAPEAINFGSFTIK 365
Query: 952 GDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHFAA 1011
DV+SFGILLME T G + P M + +
Sbjct: 366 SDVWSFGILLMEIVTY---------GRI----------PYPGMSNPEVIRALERGYRMPR 406
Query: 1012 KEQCASSVFNLAMECTVESPDERITAKEIVRRLLKI 1047
E C ++N+ M C P+ER T + I L
Sbjct: 407 PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 442
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 150 bits (379), Expect = 3e-38
Identities = 73/276 (26%), Positives = 123/276 (44%), Gaps = 30/276 (10%)
Query: 775 NLIGRGSFGSVYIARLQNGIEVAVKTF--DLQHERAFKSFDTECEVMKSIRHRNLTKIIS 832
+G+G FG V++ VA+KT AF E +VMK +RH L ++ +
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ---EAQVMKKLRHEKLVQLYA 329
Query: 833 SCSNEDFKALILEYMRNGSLEKCLYSGN-YILDIFQRLNIMIDVASALEYLHFGYSAPVI 891
S E ++ EYM GSL L L + Q +++ +AS + Y+ +
Sbjct: 330 VVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 385
Query: 892 HCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTK 951
H DL+ +N+L+ +N+V ++DFG+A+L I +++ + + + APE GR + K
Sbjct: 386 HRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 444
Query: 952 GDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHFAA 1011
DV+SFGILL E T+ G + P M + +
Sbjct: 445 SDVWSFGILLTELTTK---------GRV----------PYPGMVNREVLDQVERGYRMPC 485
Query: 1012 KEQCASSVFNLAMECTVESPDERITAKEIVRRLLKI 1047
+C S+ +L +C + P+ER T + + L
Sbjct: 486 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 521
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 3e-38
Identities = 69/274 (25%), Positives = 119/274 (43%), Gaps = 30/274 (10%)
Query: 777 IGRGSFGSVYIARLQNGIEVAVKTF--DLQHERAFKSFDTECEVMKSIRHRNLTKIISSC 834
+G G FG V++ +VAVK+ AF + E +MK ++H+ L ++ +
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLA---EANLMKQLQHQRLVRLYAVV 77
Query: 835 SNEDFKALILEYMRNGSLEKCLYSGN-YILDIFQRLNIMIDVASALEYLHFGYSAPVIHC 893
+ E +I EYM NGSL L + + L I + L++ +A + ++ IH
Sbjct: 78 TQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHR 133
Query: 894 DLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGD 953
DL+ +N+L+ D + ++DFG+A+L I +++ + + + APE G + K D
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARL-IEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSD 192
Query: 954 VYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHFAAKE 1013
V+SFGILL E T G + P M + + +
Sbjct: 193 VWSFGILLTEIVTH---------GRI----------PYPGMTNPEVIQNLERGYRMVRPD 233
Query: 1014 QCASSVFNLAMECTVESPDERITAKEIVRRLLKI 1047
C ++ L C E P++R T + L
Sbjct: 234 NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 4e-38
Identities = 55/326 (16%), Positives = 106/326 (32%), Gaps = 66/326 (20%)
Query: 87 IPRQLGNLSSLEILDLNFNRLSGEIPWELGNLAKLEKLLLHNNFLTGTIPFSIFKLSSLL 146
I N + +I + + L + + +++L L N L+ + + L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 147 DLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQLSGSIPSFIFKISSLQALHFGNNRLSG 206
L LS N L L +LS+L+ LDL++N + + S++ LH NN +S
Sbjct: 62 LLNLSSNVLY-ETLD--LESLSTLRTLDLNNNYVQ-ELLVG----PSIETLHAANNNIS- 112
Query: 207 ELPANICDNLPFLNFFSVYKNMFYGGISSTLSNCKHLRILDLSFNDLWGDIPKEIGNLTK 266
+ + + + L+ N + + G ++
Sbjct: 113 RVSCSRGQG---------------------------KKNIYLANNKITMLRDLDEGCRSR 145
Query: 267 LKELFLDFNILQG-EIPHTVGNLHNLEYLSLVNNELVGTVPATIFNVSTLKLIELSNNTF 325
++ L L N + + LE+L+L N + V +
Sbjct: 146 VQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVV--------------- 189
Query: 326 FGSLPSSTDVQLPNLEELYLWGNNFSGTLPSFIFNASNLSKLSLGDNSFSGLIPNTFGNL 385
L+ L L N + + +A+ ++ +SL +N I
Sbjct: 190 -----------FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVL-IEKALRFS 236
Query: 386 RNLKRLRLYNNYLTSPELSFLSSLSN 411
+NL+ L N L S +
Sbjct: 237 QNLEHFDLRGNGFHCGTLRDFFSKNQ 262
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 2e-37
Identities = 62/360 (17%), Positives = 118/360 (32%), Gaps = 45/360 (12%)
Query: 232 GISSTLSNCKHLRILDLSFNDLWGDIPKEIGNLTKLKELFLDFNILQGEIPHTVGNLHNL 291
I N +I ++ + L + + +KEL L N L + L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 292 EYLSLVNNELVGTVPATIFNVSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFS 351
E L+L +N L + ++STL+ ++L+NN + L P++E L+ NN S
Sbjct: 61 ELLNLSSNVL--YETLDLESLSTLRTLDLNNN-YVQELL-----VGPSIETLHAANNNIS 112
Query: 352 GTLPSFIFNASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNYLTSPELSFLSSLSN 411
+ + L +N + L G ++ L L N + + ++F ++
Sbjct: 113 -RVSCSRG--QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDT--VNFAELAAS 167
Query: 412 CKYLEIIALSGNPLNGIIPMSAGNLSHSLEELFMPDCNVSGRIPKEIGNLANLVTLDLGG 471
LE + L N + + ++ A L TLDL
Sbjct: 168 SDTLEHLNLQYNFIY--------------------------DVKGQV-VFAKLKTLDLSS 200
Query: 472 NKFNGSIPIALGKLQKLQLLNLDDNKLEGSIPDDICGLVELYKLALGDNKLS-GQIPACF 530
NK + + ++L +NKL I + L L N G + F
Sbjct: 201 NKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFF 258
Query: 531 GNLASLRELWLGPNELISFIPSTFWNIKDIMYVNFSSNFLTGPLPLEIENLKALTTLDFS 590
++ + + ++ + + + + + L AL
Sbjct: 259 SKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYG--AYCCEDLPAPFADRLIALGHHHHH 316
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 1e-36
Identities = 60/326 (18%), Positives = 117/326 (35%), Gaps = 19/326 (5%)
Query: 69 NQRRVTALNISYLSLTGNIPRQLGNLSSLEILDLNFNRLSGEIPWELGNLAKLEKLLLHN 128
N R ++ SL + + +++ LDL+ N LS +L KLE L L +
Sbjct: 8 NGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSS 67
Query: 129 NFLTGTIPFSIFKLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQLSGSIPSFI 188
N L T+ LS+L L L++N + L S++ L ++N +S +
Sbjct: 68 NVLYETLDLE--SLSTLRTLDLNNNYVQ------ELLVGPSIETLHAANNNIS-RVSCSR 118
Query: 189 FKISSLQALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYG-GISSTLSNCKHLRILD 247
+ + ++ NN+++ L + + + N + ++ L L+
Sbjct: 119 GQ--GKKNIYLANNKIT-MLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLN 175
Query: 248 LSFNDLWGDIPKEIGNLTKLKELFLDFNILQGEIPHTVGNLHNLEYLSLVNNELVGTVPA 307
L +N ++ D+ ++ KLK L L N L + + + ++SL NN+LV +
Sbjct: 176 LQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEK 231
Query: 308 TIFNVSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSGTLPSFIFNASNLSKL 367
+ L+ +L N F + ++ + + +
Sbjct: 232 ALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAK--QTVKKLTGQNEEECTVPTLG 289
Query: 368 SLGDNSFSGLIPNTFGNLRNLKRLRL 393
G L L L
Sbjct: 290 HYGAYCCEDLPAPFADRLIALGHHHH 315
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 3e-36
Identities = 51/314 (16%), Positives = 99/314 (31%), Gaps = 65/314 (20%)
Query: 354 LPSFIFNASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNYLTSPELSFLSSLSNCK 413
+ N + + D+S + + + N+K L L N L+ + L+ +
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTK-- 59
Query: 414 YLEIIALSGNPLNGIIPMSAGNLSHSLEELFMPDCNVSGRIPKEIGNLANLVTLDLGGNK 473
LE++ LS N L + + +L+ L TLDL N
Sbjct: 60 -LELLNLSSNVLYETLD---------------------------LESLSTLRTLDLNNNY 91
Query: 474 FNGSIPIALGKLQKLQLLNLDDNKLEGSIPDDICGLVELYKLALGDNKLSGQIPACFGNL 533
L ++ L+ +N + + + L +NK++ G
Sbjct: 92 VQ-----ELLVGPSIETLHAANNNIS-RVSCSR--GQGKKNIYLANNKITMLRDLDEGCR 143
Query: 534 ASLRELWLGPNELISFIPSTFWNIKDIMYVNFSSNFLTGPLPLEIENLKALTTLDFSMNN 593
+ ++ L L NE+ + + L L+ N
Sbjct: 144 SRVQYLDLKLNEIDTV-----------------------NFAELAASSDTLEHLNLQYNF 180
Query: 594 LSGVIPTTIGGLKGLQYLFLGHNRLQGSIPDSVGDLISLKSLNLSNNNLSGPIPTSLEKL 653
+ + + L+ L L N+L + + ++L NN L I +L
Sbjct: 181 IY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVL-IEKALRFS 236
Query: 654 SDLKELNLSFNKLE 667
+L+ +L N
Sbjct: 237 QNLEHFDLRGNGFH 250
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 7e-14
Identities = 23/100 (23%), Positives = 42/100 (42%), Gaps = 3/100 (3%)
Query: 574 LPLEIENLKALTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQGSIPDSVGDLISLK 633
+ +N + ++L + + ++ L L N L + L+
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 634 SLNLSNNNLSGPIPTSLEKLSDLKELNLSFNKLEGEIPRG 673
LNLS+N L + LE LS L+ L+L+ N ++ E+ G
Sbjct: 62 LLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQ-ELLVG 98
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 5e-05
Identities = 11/53 (20%), Positives = 26/53 (49%), Gaps = 1/53 (1%)
Query: 621 SIPDSVGDLISLKSLNLSNNNLSGPIPTSLEKLSDLKELNLSFNKLEGEIPRG 673
+I + + K +++++L + + + ++KEL+LS N L +I
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLS-QISAA 52
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 9e-38
Identities = 59/281 (20%), Positives = 117/281 (41%), Gaps = 37/281 (13%)
Query: 777 IGRGSFGSVYIARLQ-----NGIEVAVKTF-DLQHERAFKSFDTECEVMKSIRHRNLTKI 830
+G G FG+V+ I V +K D ++F++ + S+ H ++ ++
Sbjct: 21 LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 831 ISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYL---HFGYS 887
+ C + L+ +Y+ GSL + L LN + +A + YL
Sbjct: 81 LGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGM--- 136
Query: 888 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGR 947
+H +L NVLL ++DFG+A LL +D+ + ++ + +MA E G+
Sbjct: 137 ---VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGK 193
Query: 948 VSTKGDVYSFGILLMETFTR-RKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITED 1006
+ + DV+S+G+ + E T +P + E + D L+ +
Sbjct: 194 YTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE-----------------VPD---LLEKG 233
Query: 1007 KHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKI 1047
+ A + C V+ + ++C + + R T KE+ ++
Sbjct: 234 ERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRM 274
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 1e-37
Identities = 65/282 (23%), Positives = 112/282 (39%), Gaps = 39/282 (13%)
Query: 774 NNLIGRGSFGSVYIAR-LQNGIEVAVKTFDLQH--ERAFKSFDTECEVMKSIRHRNLTKI 830
+ IGRGSF +VY + +EVA + + + F E E++K ++H N+ +
Sbjct: 31 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 90
Query: 831 ISSCSNEDFKA----LILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGY 886
S + L+ E M +G+L+ L ++ I + + L++LH
Sbjct: 91 YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLH-TR 148
Query: 887 SAPVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLIGEDQSMTQTQTLA-TLGYMAPEYGR 944
+ P+IH DLK N+ + + D G+A L + + + T +MAPE
Sbjct: 149 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK-----RASFAKAVIGTPEFMAPEMYE 203
Query: 945 EGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLIT 1004
E DVY+FG+ ++E T P E + + + P S K+ +
Sbjct: 204 EK-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEV--- 259
Query: 1005 EDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLK 1046
K C ++ DER + K+ LL
Sbjct: 260 --KEIIEG-------------CIRQNKDERYSIKD----LLN 282
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 2e-37
Identities = 75/291 (25%), Positives = 122/291 (41%), Gaps = 40/291 (13%)
Query: 777 IGRGSFGSVYIARLQ----NGIEVAVKTF-DLQHERAFKSFDTECEVMKSIRHRNLTKII 831
IG G G V RL+ + VA+K ER + F +E +M H N+ ++
Sbjct: 57 IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 832 SSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYL---HFGYSA 888
+ ++ EYM NGSL+ L + + I Q + ++ V + + YL +
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGY---- 172
Query: 889 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGY--MAPEYGREG 946
+H DL NVL+D N+V +SDFG++++ + +D T T + APE
Sbjct: 173 --VHRDLAARNVLVDSNLVCKVSDFGLSRV-LEDDPDAAYTTTGGKIPIRWTAPEAIAFR 229
Query: 947 RVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITED 1006
S+ DV+SFG+++ E GE P M D + E
Sbjct: 230 TFSSASDVWSFGVVMWEVLAY---------GER----------PYWNMTNRDVISSVEEG 270
Query: 1007 KHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKIRDFLLRNVES 1057
A C ++ L ++C + +R +IV L D L+R+ ES
Sbjct: 271 YRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVL----DALIRSPES 317
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 2e-37
Identities = 61/296 (20%), Positives = 113/296 (38%), Gaps = 38/296 (12%)
Query: 777 IGRGSFGSVYIARLQNGIE------VAVKTF-DLQHERAFKSFDTECEVMKSIRHRNLTK 829
+G+GSFG VY + ++ VA+KT + R F E VMK ++ +
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 830 IISSCSNEDFKALILEYMRNGSL---------EKCLYSGNYILDIFQRLNIMIDVASALE 880
++ S +I+E M G L + + + + ++A +
Sbjct: 93 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 881 YLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAP 940
YL+ + +H DL N ++ ++ + DFG+ + + D + L + +M+P
Sbjct: 153 YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 209
Query: 941 EYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDAN 1000
E ++G +T DV+SFG++L E T E P +
Sbjct: 210 ESLKDGVFTTYSDVWSFGVVLWEIATL---------AEQ----------PYQGLSNEQVL 250
Query: 1001 LLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKIRDFLLRNVE 1056
+ E + C +F L C +P R + EI+ + + + R V
Sbjct: 251 RFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVS 306
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 3e-37
Identities = 81/276 (29%), Positives = 124/276 (44%), Gaps = 32/276 (11%)
Query: 775 NLIGRGSFGSVYIARLQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSC 834
IG+G FG V + G +VAVK ++++ ++F E VM +RH NL +++
Sbjct: 27 QTIGKGEFGDVMLGDY-RGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 83
Query: 835 SNEDFKALI-LEYMRNGSLEKCLYS-GNYILDIFQRLNIMIDVASALEYLHFGYSAPVIH 892
E I EYM GSL L S G +L L +DV A+EYL +H
Sbjct: 84 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVH 140
Query: 893 CDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKG 952
DL NVL+ ++ VA +SDFG+ K + S TQ + + APE RE + STK
Sbjct: 141 RDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKS 195
Query: 953 DVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHFAAK 1012
DV+SFGILL E ++ G + P + + D + + A
Sbjct: 196 DVWSFGILLWEIYSF---------GRV----------PYPRIPLKDVVPRVEKGYKMDAP 236
Query: 1013 EQCASSVFNLAMECTVESPDERITAKEIVRRLLKIR 1048
+ C +V+ + C R + ++ +L I+
Sbjct: 237 DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 272
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 3e-37
Identities = 72/292 (24%), Positives = 128/292 (43%), Gaps = 42/292 (14%)
Query: 777 IGRGSFGSVYIARLQNG----IEVAVKTFDLQH---ERAFKSFDTECEVMKSIRHRNLTK 829
+G G FG V RL+ I VA+KT L+ E+ + F E +M H N+ +
Sbjct: 53 VGAGEFGEVCSGRLKLPSKKEISVAIKT--LKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 830 IISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYL---HFGY 886
+ + ++ EYM NGSL+ L + + Q + ++ +AS ++YL +
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY-- 168
Query: 887 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL-IGEDQSMTQTQTLATLGYMAPEYGRE 945
+H DL N+L++ N+V +SDFG+ ++L + + T + + +PE
Sbjct: 169 ----VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY 224
Query: 946 GRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITE 1005
+ ++ DV+S+GI+L E + GE P M D + E
Sbjct: 225 RKFTSASDVWSYGIVLWEVMSY---------GER----------PYWEMSNQDVIKAVDE 265
Query: 1006 DKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKIRDFLLRNVES 1057
C ++++ L ++C + + R ++IV L D L+RN S
Sbjct: 266 GYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL----DKLIRNPGS 313
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 4e-37
Identities = 62/279 (22%), Positives = 107/279 (38%), Gaps = 35/279 (12%)
Query: 777 IGRGSFGSVYIARLQNG----IEVAVKTF-DLQHERAFKSFDTECEVMKSIRHRNLTKII 831
IG G FG V+ + + VA+KT + + + F E M+ H ++ K+I
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 832 SSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYL---HFGYSA 888
+ +I+E G L L Y LD+ + +++AL YL F
Sbjct: 83 GVITENPVW-IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRF---- 137
Query: 889 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRV 948
+H D+ NVL+ N L DFG+++ + + ++ + +MAPE R
Sbjct: 138 --VHRDIAARNVLVSSNDCVKLGDFGLSRY-MEDSTYYKASKGKLPIKWMAPESINFRRF 194
Query: 949 STKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKH 1008
++ DV+ FG+ + E G P +K D I +
Sbjct: 195 TSASDVWMFGVCMWEILMH---------GVK----------PFQGVKNNDVIGRIENGER 235
Query: 1009 FAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKI 1047
C ++++L +C P R E+ +L I
Sbjct: 236 LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 4e-37
Identities = 60/277 (21%), Positives = 114/277 (41%), Gaps = 36/277 (12%)
Query: 777 IGRGSFGSVYIARLQNG---IEVAVKTF-DLQHERAFKSFDTECEVMKSIRHRNLTKIIS 832
+G G+FGSV + I+VA+K + + E ++M + + + ++I
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 833 SCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYL---HFGYSAP 889
C E L++E G L K L + + ++ V+ ++YL +F
Sbjct: 404 VCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF----- 457
Query: 890 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGY--MAPEYGREGR 947
+H +L NVLL + A +SDFG++K +G D S ++ APE +
Sbjct: 458 -VHRNLAARNVLLVNRHYAKISDFGLSKA-LGADDSYYTARSAGKWPLKWYAPECINFRK 515
Query: 948 VSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDK 1007
S++ DV+S+G+ + E + G+ P MK + I + K
Sbjct: 516 FSSRSDVWSYGVTMWEALSY---------GQK----------PYKKMKGPEVMAFIEQGK 556
Query: 1008 HFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRL 1044
+C ++ L +C + ++R + +R+
Sbjct: 557 RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM 593
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 6e-37
Identities = 81/274 (29%), Positives = 125/274 (45%), Gaps = 32/274 (11%)
Query: 777 IGRGSFGSVYIARLQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCSN 836
IG+G FG V + G +VAVK ++++ ++F E VM +RH NL +++
Sbjct: 201 IGKGEFGDVMLGDY-RGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 257
Query: 837 EDFKA-LILEYMRNGSLEKCLYSGN-YILDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 894
E ++ EYM GSL L S +L L +DV A+EYL +H D
Sbjct: 258 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRD 314
Query: 895 LKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGDV 954
L NVL+ ++ VA +SDFG+ K + S TQ + + APE RE + STK DV
Sbjct: 315 LAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKSDV 369
Query: 955 YSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHFAAKEQ 1014
+SFGILL E ++ G + P + + D + + A +
Sbjct: 370 WSFGILLWEIYSF---------GRV----------PYPRIPLKDVVPRVEKGYKMDAPDG 410
Query: 1015 CASSVFNLAMECTVESPDERITAKEIVRRLLKIR 1048
C +V+++ C R T ++ +L IR
Sbjct: 411 CPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIR 444
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 8e-37
Identities = 60/279 (21%), Positives = 107/279 (38%), Gaps = 35/279 (12%)
Query: 777 IGRGSFGSVYIARLQNG----IEVAVKTF-DLQHERAFKSFDTECEVMKSIRHRNLTKII 831
+G G FG VY N I VAVKT + F +E +MK++ H ++ K+I
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 832 SSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYL---HFGYSA 888
E +I+E G L L L + + + + A+ YL +
Sbjct: 80 GIIEEEPTW-IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINC---- 134
Query: 889 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRV 948
+H D+ N+L+ L DFG+++ I ++ + T + +M+PE R
Sbjct: 135 --VHRDIAVRNILVASPECVKLGDFGLSRY-IEDEDYYKASVTRLPIKWMSPESINFRRF 191
Query: 949 STKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKH 1008
+T DV+ F + + E + G+ P ++ D ++ +
Sbjct: 192 TTASDVWMFAVCMWEILSF---------GKQ----------PFFWLENKDVIGVLEKGDR 232
Query: 1009 FAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKI 1047
+ C ++ L C P +R E+V L +
Sbjct: 233 LPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 271
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 146 bits (369), Expect = 2e-36
Identities = 79/381 (20%), Positives = 128/381 (33%), Gaps = 60/381 (15%)
Query: 94 LSSLEILDLNFNRLSGEIPWELGNLAKLEKLLLHNNFLTGTIPFSIFKLSSLLDLKLSDN 153
+ +L++ + L+ +P L + L++ +N LT ++P +L + L++S N
Sbjct: 39 NNGNAVLNVGESGLT-TLPDCLPA--HITTLVIPDNNLT-SLPALPPELRT---LEVSGN 91
Query: 154 NLTGTIPSHNLGNLSSLQLLDLSDNQLSGSIPSFIFKISSLQALHFGNNRLSGELPANIC 213
LT ++P L L + L S L L N+L+ LP
Sbjct: 92 QLT-SLP-VLPPGLLELSIFSNPLTHLPAL-------PSGLCKLWIFGNQLT-SLPVLP- 140
Query: 214 DNLPFLNFFSVYKNMFYGGISSTLSNCKHLRILDLSFNDLWGDIPKEIGNLTKLKELFLD 273
L L+ S L L N L +P L EL +
Sbjct: 141 PGLQELSVSDNQLASLPALPS-------ELCKLWAYNNQL-TSLPMLPSGLQ---ELSVS 189
Query: 274 FNILQGEIPHTVGNLHNLEYLSLVNNELVGTVPATIFNVSTLKLIELSNNTFFGSLPSST 333
N L +P L+ L NN L ++PA LK + +S N SLP
Sbjct: 190 DNQLA-SLPTLPSELYKLWAY---NNRLT-SLPALPSG---LKELIVSGN-RLTSLPVL- 239
Query: 334 DVQLPNLEELYLWGNNFSGTLPSFIFNASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRL 393
L+EL + GN + +LP S L LS+ N + L P + +L + + L
Sbjct: 240 ---PSELKELMVSGNRLT-SLPMLP---SGLLSLSVYRNQLTRL-PESLIHLSSETTVNL 291
Query: 394 YNNYLTSPELSFLSSLSNCKYLEIIALSGNPLNGIIPMSAGNLSHSLEELFMPDCNVSGR 453
N L+ +L + + P+ S +
Sbjct: 292 EGNPLSER------TLQALREITSAPGYSGPII-----RFDMAGASAPRETRALHLAAAD 340
Query: 454 --IPKEIGNLANLVTLDLGGN 472
+P G A + G
Sbjct: 341 WLVPAREGEPAPADRWHMFGQ 361
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 3e-35
Identities = 76/334 (22%), Positives = 129/334 (38%), Gaps = 50/334 (14%)
Query: 339 NLEELYLWGNNFSGTLPSFIFNASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNYL 398
L + + + TLP + +++ L + DN+ + L P LR L + N L
Sbjct: 41 GNAVLNVGESGLT-TLPDCLPA--HITTLVIPDNNLTSL-PALPPELRTL---EVSGNQL 93
Query: 399 TS-PELSFLSSLSNCKYLEIIALSGNPLNGIIPMSAGNLSHSLEELFMPDCNVSGRIPKE 457
TS P L I + L + L +L++ ++ +P
Sbjct: 94 TSLPV-----LPPGLLELSIFSNPLTHLPALPS--------GLCKLWIFGNQLT-SLPVL 139
Query: 458 IGNLANLVTLDLGGNKFNGSIPIALGKLQKLQLLNLDDNKLEGSIPDDICGLVELYKLAL 517
L L + N+ S+P +L KL N N+L S+P GL EL +
Sbjct: 140 PPGLQEL---SVSDNQLA-SLPALPSELCKLWAYN---NQLT-SLPMLPSGLQELS---V 188
Query: 518 GDNKLSGQIPACFGNLASLRELWLGPNELISFIPSTFWNIKDIMYVNFSSNFLTGPLPLE 577
DN+L+ +P L L N ++ +P+ +K++ S N LT LP+
Sbjct: 189 SDNQLA-SLPTLPSELYKLWAY----NNRLTSLPALPSGLKEL---IVSGNRLTS-LPVL 239
Query: 578 IENLKALTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQGSIPDSVGDLISLKSLNL 637
L L S N L+ +P GL L + N+L +P+S+ L S ++NL
Sbjct: 240 PSEL---KELMVSGNRLTS-LPMLPSGL---LSLSVYRNQLT-RLPESLIHLSSETTVNL 291
Query: 638 SNNNLSGPIPTSLEKLSDLKELNLSFNKLEGEIP 671
N LS +L +++ + + +
Sbjct: 292 EGNPLSERTLQALREITSAPGYSGPIIRFDMAGA 325
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 8e-35
Identities = 79/371 (21%), Positives = 130/371 (35%), Gaps = 71/371 (19%)
Query: 73 VTALNISYLSLTGNIPRQLGNLSSLEILDLNFNRLSGEIPWELGNLAKLEKLLLHNNFLT 132
+T L I +LT ++P L +L +++ N+L+ +P L +L L
Sbjct: 63 ITTLVIPDNNLT-SLPALPPELRTL---EVSGNQLT-SLPVLPPGLLELSIFSNPLTHLP 117
Query: 133 GTIPFSIFKLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQLSGSIPSFIFKIS 192
S L L + N LT ++P LQ L +SDNQL+ S+P+ S
Sbjct: 118 AL-------PSGLCKLWIFGNQLT-SLPV----LPPGLQELSVSDNQLA-SLPAL---PS 161
Query: 193 SLQALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGGISSTLSNCKHLRILDLSFND 252
L L NN+L+ LP L+ L +S N
Sbjct: 162 ELCKLWAYNNQLT-SLPMLPS----------------------------GLQELSVSDNQ 192
Query: 253 LWGDIPKEIGNLTKLKELFLDFNILQGEIPHTVGNLHNLEYLSLVNNELVGTVPATIFNV 312
L +P L KL L L+ L + N L ++P
Sbjct: 193 L-ASLPTLPSELYKLWAYNNRLTSLPALPS-------GLKELIVSGNRL-TSLPVLP--- 240
Query: 313 STLKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSGTLPSFIFNASNLSKLSLGDN 372
S LK + +S N SLP L L ++ N + LP + + S+ + ++L N
Sbjct: 241 SELKELMVSGN-RLTSLPML----PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGN 294
Query: 373 SFSGLIPNTFGNLRNLKRLRLYNNYLTSPELSFLSSLSNCKYLEIIALSGNPLNGIIPMS 432
S T LR + Y+ + +++ S+ + L + A +
Sbjct: 295 PLSER---TLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAREGEPA 351
Query: 433 AGNLSHSLEEL 443
+ H +
Sbjct: 352 PADRWHMFGQE 362
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 4e-32
Identities = 79/437 (18%), Positives = 130/437 (29%), Gaps = 124/437 (28%)
Query: 240 CKHLRILDLSFNDLWGDIPKEIGNLTKLKELFLDFNILQGEIPHTVGNLHNLEYLSLVNN 299
+L++ + L +P + + L + N L +P L L + N
Sbjct: 39 NNGNAVLNVGESGL-TTLPDCLP--AHITTLVIPDNNLT-SLP---ALPPELRTLEVSGN 91
Query: 300 ELVGTVPATIFNVSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSGTLPSFIF 359
+L ++P + L + LP+ L +L+++GN + +LP
Sbjct: 92 QLT-SLPVLPPGLLELSIFSNPLT----HLPAL----PSGLCKLWIFGNQLT-SLPVLP- 140
Query: 360 NASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNYLTSPELSFLSSLSNCKYLEIIA 419
L +LS+ DN + L P L L YNN LTS
Sbjct: 141 --PGLQELSVSDNQLASL-PALPSELCKLW---AYNNQLTS------------------- 175
Query: 420 LSGNPLNGIIPMSAGNLSHSLEELFMPDCNVSGRIPKEIGNLANLVTLDLGGNKFNGSIP 479
+P L L + N+ S+P
Sbjct: 176 ----------------------------------LPMLPSGL---QELSVSDNQLA-SLP 197
Query: 480 IALGKLQKLQLLNLDDNKLEGSIPDDICGLVELYKLALGDNKLSGQIPACFGNLASLREL 539
+L KL N N+L S+P GL EL + N+L+ +P L L
Sbjct: 198 TLPSELYKLWAYN---NRLT-SLPALPSGLKELI---VSGNRLT-SLPVLPSELKEL--- 246
Query: 540 WLGPNELISFIPSTFWNIKDIMYVNFSSNFLTGPLPLEIENLKALTTLDFSMNNLSGVIP 599
S N LT LP+ L +L N L+ +P
Sbjct: 247 ------------------------MVSGNRLTS-LPMLPSGL---LSLSVYRNQLT-RLP 277
Query: 600 TTIGGLKGLQYLFLGHNRLQGSIPDSVGDLISLKSLN---LSNNNLSGPIPTSLEKLSDL 656
++ L + L N L ++ ++ S + + + P L
Sbjct: 278 ESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLA 337
Query: 657 KELNLSFNKLEGEIPRG 673
L + P
Sbjct: 338 AADWLVPAREGEPAPAD 354
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 2e-36
Identities = 62/278 (22%), Positives = 97/278 (34%), Gaps = 38/278 (13%)
Query: 775 NLIGRGSFGSVYIAR-LQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISS 833
+GRGSFG V+ + Q G + AVK L+ R E + + + +
Sbjct: 64 PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGA 118
Query: 834 CSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHC 893
+ + +E + GSL + + L + L + LEYLH + ++H
Sbjct: 119 VREGPWVNIFMELLEGGSLGQLIKQMG-CLPEDRALYYLGQALEGLEYLH---TRRILHG 174
Query: 894 DLKPSNVLLDDN-MVAHLSDFGIAKLLIGEDQSMTQTQTLATLG---YMAPEYGREGRVS 949
D+K NVLL + A L DFG A L + + G +MAPE
Sbjct: 175 DVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCD 234
Query: 950 TKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDK-H 1008
K D++S +++ P W F +KI +E
Sbjct: 235 AKVDIWSSCCMMLHMLNGCHP-------------WTQYFRGPLCLKI------ASEPPPI 275
Query: 1009 FAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLK 1046
CA E + P R +A E L +
Sbjct: 276 REIPPSCAPLTAQAIQEGLRKEPVHRASAME----LRR 309
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 2e-36
Identities = 72/280 (25%), Positives = 119/280 (42%), Gaps = 39/280 (13%)
Query: 776 LIGRGSFGSVYIAR-LQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSC 834
++G+G++G VY R L N + +A+K + R + E + K ++H+N+ + + S
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 835 SNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRL--NIMIDVASALEYLHFGYSAPVIH 892
S F + +E + GSL L S L ++ + L+YLH ++H
Sbjct: 89 SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVH 145
Query: 893 CDLKPSNVLLD-DNMVAHLSDFGIAKLLIGEDQSMTQTQTLA-TLGYMAPE---YGREGR 947
D+K NVL++ + V +SDFG +K L G T+T TL YMAPE G G
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKRLAG---INPCTETFTGTLQYMAPEIIDKGPRGY 202
Query: 948 VSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPIS-MMKIIDANLLITED 1006
D++S G ++E T + P + P + M K+
Sbjct: 203 -GKAADIWSLGCTIIEMATGKPP-------------FYELGEPQAAMFKV------GMFK 242
Query: 1007 KHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLK 1046
H E ++ ++C PD+R A + LL
Sbjct: 243 VHPEIPESMSAEAKAFILKCFEPDPDKRACAND----LLV 278
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-36
Identities = 71/283 (25%), Positives = 125/283 (44%), Gaps = 39/283 (13%)
Query: 777 IGRGSFGSVYIARLQNG-----IEVAVKTFDLQH---ERAFKSFDTECEVMKSIRHRNLT 828
IG G FG VY L+ + VA+KT L+ E+ F E +M H N+
Sbjct: 52 IGAGEFGEVYKGMLKTSSGKKEVPVAIKT--LKAGYTEKQRVDFLGEAGIMGQFSHHNII 109
Query: 829 KIISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYL---HFG 885
++ S +I EYM NG+L+K L + + Q + ++ +A+ ++YL ++
Sbjct: 110 RLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNY- 168
Query: 886 YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQ-TLATLGYMAPEYGR 944
+H DL N+L++ N+V +SDFG++++L + ++ T + + APE
Sbjct: 169 -----VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAIS 223
Query: 945 EGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLIT 1004
+ ++ DV+SFGI++ E T GE P + + I
Sbjct: 224 YRKFTSASDVWSFGIVMWEVMTY---------GER----------PYWELSNHEVMKAIN 264
Query: 1005 EDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKI 1047
+ C S+++ L M+C + R +IV L K+
Sbjct: 265 DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 307
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-36
Identities = 59/280 (21%), Positives = 110/280 (39%), Gaps = 35/280 (12%)
Query: 777 IGRGSFGSVYIARLQNG-----IEVAVKTF-DLQHERAFKSFDTECEVMKSIRHRNLTKI 830
+G G+FG+VY I VA+K + +A K E VM S+ + ++ ++
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 831 ISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYL---HFGYS 887
+ C + LI + M G L + + LN + +A + YL
Sbjct: 83 LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRL--- 138
Query: 888 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGR 947
+H DL NVL+ ++DFG+AKLL E++ + +MA E
Sbjct: 139 ---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 195
Query: 948 VSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDK 1007
+ + DV+S+G+ + E T G P + + + ++ + +
Sbjct: 196 YTHQSDVWSYGVTVWELMTF---------GSK----------PYDGIPASEISSILEKGE 236
Query: 1008 HFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKI 1047
C V+ + ++C + D R +E++ K+
Sbjct: 237 RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 276
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 3e-36
Identities = 68/290 (23%), Positives = 115/290 (39%), Gaps = 44/290 (15%)
Query: 777 IGRGSFGSVYIARLQNG------IEVAVKTF-DLQHERAFKSFDTECEVMKSIRHRNLTK 829
+G G+FG VY ++ ++VAVKT ++ E+ F E ++ H+N+ +
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 830 IISSCSNEDFKALILEYMRNGSLEKCL------YSGNYILDIFQRLNIMIDVASALEYL- 882
I + +++E M G L+ L S L + L++ D+A +YL
Sbjct: 98 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 883 --HFGYSAPVIHCDLKPSNVLLD---DNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGY 937
HF IH D+ N LL VA + DFG+A+ + + + +
Sbjct: 158 ENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 211
Query: 938 MAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKII 997
M PE EG ++K D +SFG+LL E F+ G M P
Sbjct: 212 MPPEAFMEGIFTSKTDTWSFGVLLWEIFSL---------GYM----------PYPSKSNQ 252
Query: 998 DANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKI 1047
+ +T + C V+ + +C P++R I+ R+
Sbjct: 253 EVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 4e-36
Identities = 74/300 (24%), Positives = 129/300 (43%), Gaps = 55/300 (18%)
Query: 777 IGRGSFGSVYIARLQNG------IEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKI 830
+G G+FG V++A N + VAVK A K F E E++ +++H ++ K
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 831 ISSCSNEDFKALILEYMRNGSL---------------EKCLYSGNYILDIFQRLNIMIDV 875
C + D ++ EYM++G L + L + Q L+I +
Sbjct: 83 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 876 ASALEYL---HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTL 932
AS + YL HF +H DL N L+ N++ + DFG+++ + D T+
Sbjct: 143 ASGMVYLASQHF------VHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 196
Query: 933 ATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLP-- 990
+ +M PE + +T+ DV+SFG++L E FT G+ P
Sbjct: 197 LPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTY---------GKQ----------PWF 237
Query: 991 -ISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKIRD 1049
+S ++I+ IT+ + C V+++ + C P +R+ KEI + L +
Sbjct: 238 QLSNTEVIE---CITQGRVLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYKILHALGK 294
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 7e-36
Identities = 58/299 (19%), Positives = 106/299 (35%), Gaps = 65/299 (21%)
Query: 777 IGRGSFGSVYIARLQN--------GIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLT 828
+G+G+F ++ + EV +K D H +SF +M + H++L
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 829 KIISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYL---HFG 885
C D L+ E+++ GSL+ L ++I +L + +A+A+ +L
Sbjct: 76 LNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTL- 134
Query: 886 YSAPVIHCDLKPSNVLLD--------DNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGY 937
IH ++ N+LL + LSD GI+ ++ +D
Sbjct: 135 -----IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD------------IL 177
Query: 938 ------MAPEYGREGRV-STKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLP 990
+ PE + + D +SFG L E + G+ P
Sbjct: 178 QERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSG---------GDK----------P 218
Query: 991 ISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKIRD 1049
+S + + A + + NL C PD R + + I+R L +
Sbjct: 219 LSALDSQRKLQFYEDRHQLPAPKAA--ELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-35
Identities = 69/284 (24%), Positives = 120/284 (42%), Gaps = 36/284 (12%)
Query: 776 LIGRGSFGSVYIAR-LQNGIEVAVKT--FDLQHERAFKS-FDTECEVMKSIRHRNLTKII 831
+G G +VY+A I+VA+K + + F+ E + H+N+ +I
Sbjct: 18 KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77
Query: 832 SSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVI 891
+D L++EY+ +L + L + +N + +++ H ++
Sbjct: 78 DVDEEDDCYYLVMEYIEGPTL-SEYIESHGPLSVDTAINFTNQILDGIKHAH---DMRIV 133
Query: 892 HCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQT-LATLGYMAPEYGREGRVST 950
H D+KP N+L+D N + DFGIAK L + S+TQT L T+ Y +PE +
Sbjct: 134 HRDIKPQNILIDSNKTLKIFDFGIAKAL--SETSLTQTNHVLGTVQYFSPEQAKGEATDE 191
Query: 951 KGDVYSFGILLMETFTRRKPTDEIFSGE----MTLKHWVNDFLPISMMKIIDANLLITED 1006
D+YS GI+L E P F+GE + +KH + D +P + I +
Sbjct: 192 CTDIYSIGIVLYEMLVGEPP----FNGETAVSIAIKH-IQDSVPNVTTDVRKD---IPQ- 242
Query: 1007 KHFAAKEQCASSVFNLAMECTVESPDER-ITAKEIVRRLLKIRD 1049
S+ N+ + T + R T +E+ L +
Sbjct: 243 -----------SLSNVILRATEKDKANRYKTIQEMKDDLSSVLH 275
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-35
Identities = 69/292 (23%), Positives = 115/292 (39%), Gaps = 44/292 (15%)
Query: 777 IGRGSFGSVYIARLQNG------IEVAVKTF-DLQHERAFKSFDTECEVMKSIRHRNLTK 829
+G G+FG VY ++ ++VAVKT ++ E+ F E ++ H+N+ +
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 830 IISSCSNEDFKALILEYMRNGSLEKCL------YSGNYILDIFQRLNIMIDVASALEYL- 882
I + ++LE M G L+ L S L + L++ D+A +YL
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198
Query: 883 --HFGYSAPVIHCDLKPSNVLLD---DNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGY 937
HF IH D+ N LL VA + DFG+A+ + + + +
Sbjct: 199 ENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKW 252
Query: 938 MAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKII 997
M PE EG ++K D +SFG+LL E F+ G M P
Sbjct: 253 MPPEAFMEGIFTSKTDTWSFGVLLWEIFSL---------GYM----------PYPSKSNQ 293
Query: 998 DANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKIRD 1049
+ +T + C V+ + +C P++R I+ R+
Sbjct: 294 EVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 345
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 3e-35
Identities = 57/225 (25%), Positives = 92/225 (40%), Gaps = 18/225 (8%)
Query: 776 LIGRGSFGSVYIAR-LQNGIEVAVKT--FDLQHERAFKS-FDTECEVMKSIRHRNLTKII 831
L+GRG G VY A VA+K L + F++ E ++ ++ I
Sbjct: 41 LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIH 100
Query: 832 SSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVI 891
+ + + + L L L + + I+ + SAL+ H +A
Sbjct: 101 DFGEIDGQLYVDMRLINGVDLAAML-RRQGPLAPPRAVAIVRQIGSALDAAH---AAGAT 156
Query: 892 HCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQT-LATLGYMAPEYGREGRVST 950
H D+KP N+L+ + A+L DFGIA D+ +TQ + TL YMAPE E +
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASAT--TDEKLTQLGNTVGTLYYMAPERFSESHATY 214
Query: 951 KGDVYSFGILLMETFTRRKPTDEIFSGE---MTLKHWVNDFLPIS 992
+ D+Y+ +L E T P + G+ + H S
Sbjct: 215 RADIYALTCVLYECLTGSPP----YQGDQLSVMGAHINQAIPRPS 255
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 3e-35
Identities = 62/298 (20%), Positives = 113/298 (37%), Gaps = 50/298 (16%)
Query: 775 NLIGRGSFGSVYIARL------QNGIEVAVKTF-DLQHERAFKSFDTECEVMKSI-RHRN 826
+G G+FG V A ++VAVK H ++ +E ++M + +H N
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 827 LTKIISSCSNEDFKALILEYMRNGSL-------------EKCLYSGNYILDIFQRLNIMI 873
+ ++ +C++ +I EY G L + N L+
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171
Query: 874 DVASALEYL---HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQ 930
VA + +L + IH D+ NVLL + VA + DFG+A+ ++ + + +
Sbjct: 172 QVAQGMAFLASKNC------IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGN 225
Query: 931 TLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTR-RKPTDEIFSGEMTLKHWVNDFL 989
+ +MAPE + + + DV+S+GILL E F+ P I K
Sbjct: 226 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKL------ 279
Query: 990 PISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKI 1047
+ + A +++++ C P R T ++I L +
Sbjct: 280 -------------VKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ 324
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 4e-35
Identities = 71/302 (23%), Positives = 122/302 (40%), Gaps = 59/302 (19%)
Query: 777 IGRGSFGSVYIARL--------QNGIEVAVKTF-DLQHERAFKSFDTECEVMKSI-RHRN 826
+G G FG V +A + + VAVK D E+ +E E+MK I +H+N
Sbjct: 89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 827 LTKIISSCSNEDFKALILEYMRNGSL---------------EKCLYSGNYILDIFQRLNI 871
+ ++ +C+ + +I+EY G+L + ++
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 872 MIDVASALEYL---HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQ 928
+A +EYL IH DL NVL+ +N V ++DFG+A+ + D
Sbjct: 209 TYQLARGMEYLASQKC------IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 262
Query: 929 TQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDF 988
T + +MAPE + + + DV+SFG+L+ E FT G
Sbjct: 263 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTL---------GGS--------- 304
Query: 989 LP---ISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLL 1045
P I + ++ L+ E C + ++ + +C P +R T K++V L
Sbjct: 305 -PYPGIPVEELFK---LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 360
Query: 1046 KI 1047
+I
Sbjct: 361 RI 362
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 4e-35
Identities = 62/297 (20%), Positives = 114/297 (38%), Gaps = 49/297 (16%)
Query: 777 IGRGSFGSVYIARLQN------GIEVAVKTF-DLQHERAFKSFDTECEVMKSI-RHRNLT 828
+GRG+FG V A VAVK + ++ +E +++ I H N+
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 829 KIISSCSNEDFKA-LILEYMRNGSL---------------EKCLYSGNYILDIFQRLNIM 872
++ +C+ +I+E+ + G+L L + +
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 873 IDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTL 932
VA +E+L S IH DL N+LL + V + DFG+A+ + + + +
Sbjct: 155 FQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 211
Query: 933 ATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTR-RKPTDEIFSGEMTLKHWVNDFLPI 991
L +MAPE + + + DV+SFG+LL E F+ P + G + + L
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP----YPG-VKIDEEFCRRL-- 264
Query: 992 SMMKIIDANLLITEDKHFAAK-EQCASSVFNLAMECTVESPDERITAKEIVRRLLKI 1047
++ + ++ ++C P +R T E+V L +
Sbjct: 265 -------------KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 4e-35
Identities = 62/294 (21%), Positives = 108/294 (36%), Gaps = 45/294 (15%)
Query: 776 LIGRGSFGSVYIAR-LQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSC 834
+G G F V + L +G A+K ++ + E ++ + H N+ ++++ C
Sbjct: 36 KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95
Query: 835 SNEDFKA----LILEYMRNGSL----EKCLYSGNYILDIFQRLNIMIDVASALEYLHFGY 886
E L+L + + G+L E+ GN+ L Q L +++ + LE +H
Sbjct: 96 LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNF-LTEDQILWLLLGICRGLEAIH--- 151
Query: 887 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLA-------TLGYMA 939
+ H DLKP+N+LL D L D G + Q TL T+ Y A
Sbjct: 152 AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRA 211
Query: 940 PE----YGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMK 995
PE + + DV+S G +L P D +F ++
Sbjct: 212 PELFSVQSHCV-IDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVA------------L 258
Query: 996 IIDANLLITEDKHFAAKEQCASSVF-NLAMECTVESPDERITAKEIVRRLLKIR 1048
+ L I + SS L P +R ++ +L ++
Sbjct: 259 AVQNQLSIPQSPRH-------SSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 8e-35
Identities = 65/307 (21%), Positives = 121/307 (39%), Gaps = 64/307 (20%)
Query: 777 IGRGSFGSVYIARLQNG------IEVAVKTF-DLQHERAFKSFDTECEVMKSIRHRNLTK 829
+G G FG V A + VAVK + + +E V+K + H ++ K
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 830 IISSCSNEDFKALILEYMRNGSL-----------------------EKCLYSGNYILDIF 866
+ +CS + LI+EY + GSL + L +
Sbjct: 91 LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 867 QRLNIMIDVASALEYL---HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGED 923
++ ++ ++YL +H DL N+L+ + +SDFG+++ + ED
Sbjct: 151 DLISFAWQISQGMQYLAEMKL------VHRDLAARNILVAEGRKMKISDFGLSRDVYEED 204
Query: 924 QSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKH 983
+ ++Q + +MA E + +T+ DV+SFG+LL E T G
Sbjct: 205 SYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTL---------GGN---- 251
Query: 984 WVNDFLP---ISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEI 1040
P I ++ + L+ + C+ ++ L ++C + PD+R +I
Sbjct: 252 ------PYPGIPPERLFN---LLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADI 302
Query: 1041 VRRLLKI 1047
+ L K+
Sbjct: 303 SKDLEKM 309
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 9e-35
Identities = 71/302 (23%), Positives = 123/302 (40%), Gaps = 59/302 (19%)
Query: 777 IGRGSFGSVYIARL--------QNGIEVAVKTF-DLQHERAFKSFDTECEVMKSI-RHRN 826
+G G+FG V +A + + VAVK D E+ +E E+MK I +H+N
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 827 LTKIISSCSNEDFKALILEYMRNGSL---------------EKCLYSGNYILDIFQRLNI 871
+ ++ +C+ + +I+EY G+L + ++
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 872 MIDVASALEYL---HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQ 928
+A +EYL IH DL NVL+ +N V ++DFG+A+ + D
Sbjct: 163 TYQLARGMEYLASQKC------IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 216
Query: 929 TQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDF 988
T + +MAPE + + + DV+SFG+L+ E FT G
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTL---------GGS--------- 258
Query: 989 LP---ISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLL 1045
P I + ++ L+ E C + ++ + +C P +R T K++V L
Sbjct: 259 -PYPGIPVEELFK---LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 314
Query: 1046 KI 1047
+I
Sbjct: 315 RI 316
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 9e-35
Identities = 72/299 (24%), Positives = 124/299 (41%), Gaps = 54/299 (18%)
Query: 777 IGRGSFGSVYIARLQNGIE------VAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKI 830
+G G+FG V++A N + VAVK E A + F E E++ ++H+++ +
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 831 ISSCSNEDFKALILEYMRNGSL--------------EKCLYSGNYILDIFQRLNIMIDVA 876
C+ ++ EYMR+G L L + Q L + VA
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 877 SALEYL---HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLA 933
+ + YL HF +H DL N L+ +V + DFG+++ + D +T+
Sbjct: 169 AGMVYLAGLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 222
Query: 934 TLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLP--- 990
+ +M PE + +T+ DV+SFG++L E FT G+ P
Sbjct: 223 PIRWMPPESILYRKFTTESDVWSFGVVLWEIFTY---------GKQ----------PWYQ 263
Query: 991 ISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKIRD 1049
+S + ID IT+ + C V+ + C P +R + K++ RL +
Sbjct: 264 LSNTEAID---CITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 319
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 9e-35
Identities = 56/281 (19%), Positives = 110/281 (39%), Gaps = 39/281 (13%)
Query: 775 NLIGRGSFGSVYIARLQNGIEVAVKTFDLQ--HERAFKSFDTECEVMKSIRHRNLT--KI 830
IG G V+ + A+K +L+ + S+ E + ++ + ++
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 831 ISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPV 890
+ + +++E N L L +D ++R + ++ A+ +H +
Sbjct: 94 YDYEITDQYIYMVMECG-NIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIH---QHGI 148
Query: 891 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPE--------- 941
+H DLKP+N L+ D M+ L DFGIA + + S+ + + T+ YM PE
Sbjct: 149 VHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSR 207
Query: 942 --YGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDA 999
+ ++S K DV+S G +L + P +I + L ++ I I +
Sbjct: 208 ENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEK 267
Query: 1000 NLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEI 1040
+L ++ C P +RI+ E+
Sbjct: 268 DLQ------------------DVLKCCLKRDPKQRISIPEL 290
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-34
Identities = 56/281 (19%), Positives = 109/281 (38%), Gaps = 39/281 (13%)
Query: 775 NLIGRGSFGSVYIARLQNGIEVAVKTFDLQH--ERAFKSFDTECEVMKSIRHRNLT--KI 830
IG G V+ + A+K +L+ + S+ E + ++ + ++
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 831 ISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPV 890
+ + +++E N L L +D ++R + ++ A+ +H +
Sbjct: 122 YDYEITDQYIYMVMECG-NIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIH---QHGI 176
Query: 891 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPE--------- 941
+H DLKP+N L+ D M+ L DFGIA + + S+ + + + YM PE
Sbjct: 177 VHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSR 235
Query: 942 --YGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDA 999
+ ++S K DV+S G +L + P F + + + + IID
Sbjct: 236 ENGKSKSKISPKSDVWSLGCILYYMTYGKTP----FQQ-------IINQISK-LHAIIDP 283
Query: 1000 NLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEI 1040
N I + ++ C P +RI+ E+
Sbjct: 284 NHEIEFPDI------PEKDLQDVLKCCLKRDPKQRISIPEL 318
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 1e-34
Identities = 61/279 (21%), Positives = 107/279 (38%), Gaps = 35/279 (12%)
Query: 777 IGRGSFGSVYIARLQNG----IEVAVKTF-DLQHERAFKSFDTECEVMKSIRHRNLTKII 831
IG G FG V+ + + VA+KT + + + F E M+ H ++ K+I
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 832 SSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYL---HFGYSA 888
+ +I+E G L L + LD+ + +++AL YL F
Sbjct: 458 GVITENPV-WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRF---- 512
Query: 889 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRV 948
+H D+ NVL+ N L DFG+++ + + ++ + +MAPE R
Sbjct: 513 --VHRDIAARNVLVSSNDCVKLGDFGLSRY-MEDSTYYKASKGKLPIKWMAPESINFRRF 569
Query: 949 STKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKH 1008
++ DV+ FG+ + E G P +K D I +
Sbjct: 570 TSASDVWMFGVCMWEILMH---------GVK----------PFQGVKNNDVIGRIENGER 610
Query: 1009 FAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKI 1047
C ++++L +C P R E+ +L I
Sbjct: 611 LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-34
Identities = 71/302 (23%), Positives = 123/302 (40%), Gaps = 59/302 (19%)
Query: 777 IGRGSFGSVYIARLQN--------GIEVAVKTF-DLQHERAFKSFDTECEVMKSI-RHRN 826
+G G+FG V +A +VAVK E+ +E E+MK I +H+N
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 827 LTKIISSCSNEDFKALILEYMRNGSL---------------EKCLYSGNYILDIFQRLNI 871
+ ++ +C+ + +I+EY G+L ++ L ++
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 872 MIDVASALEYL---HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQ 928
VA +EYL IH DL NVL+ ++ V ++DFG+A+ + D
Sbjct: 197 AYQVARGMEYLASKKC------IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 250
Query: 929 TQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDF 988
T + +MAPE + + + DV+SFG+LL E FT G
Sbjct: 251 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTL---------GGS--------- 292
Query: 989 LP---ISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLL 1045
P + + ++ L+ E C + ++ + +C P +R T K++V L
Sbjct: 293 -PYPGVPVEELFK---LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 348
Query: 1046 KI 1047
+I
Sbjct: 349 RI 350
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 3e-34
Identities = 68/288 (23%), Positives = 130/288 (45%), Gaps = 39/288 (13%)
Query: 776 LIGRGSFGSVYIAR-LQNGIEVAVKT--FDLQHERAFKS-FDTECEVMKSIRHRNLTKII 831
++G G V++AR L++ +VAVK DL + +F F E + ++ H + +
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 832 SSCSNEDFKA----LILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYS 887
+ E +++EY+ +L + + + + + ++ D AL + H
Sbjct: 79 DTGEAETPAGPLPYIVMEYVDGVTL-RDIVHTEGPMTPKRAIEVIADACQALNFSH---Q 134
Query: 888 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQT-LATLGYMAPEYGREG 946
+IH D+KP+N+++ + DFGIA+ + S+TQT + T Y++PE R
Sbjct: 135 NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD 194
Query: 947 RVSTKGDVYSFGILLMETFTRRKPTDEIFSGE----MTLKHWVNDFLPISMMKIIDANLL 1002
V + DVYS G +L E T P F+G+ + +H D +P S
Sbjct: 195 SVDARSDVYSLGCVLYEVLTGEPP----FTGDSPVSVAYQHVREDPIPPS---------- 240
Query: 1003 ITEDKHFAAKEQCASSVFNLAMECTVESPDER-ITAKEIVRRLLKIRD 1049
A E ++ + + ++ ++P+ R TA E+ L+++ +
Sbjct: 241 -------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 281
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 3e-34
Identities = 65/298 (21%), Positives = 113/298 (37%), Gaps = 50/298 (16%)
Query: 777 IGRGSFGSVYIARLQNG------IEVAVKTF-DLQHERAFKSFDTECEVMKSIRHRNLTK 829
+G FG VY L VA+KT D + F E + ++H N+
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 830 IISSCSNEDFKALILEYMRNGSL---------------EKCLYSGNYILDIFQRLNIMID 874
++ + + ++I Y +G L + L+ ++++
Sbjct: 77 LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136
Query: 875 VASALEYL---HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQT 931
+A+ +EYL H +H DL NVL+ D + +SD G+ + + D +
Sbjct: 137 IAAGMEYLSSHHV------VHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNS 190
Query: 932 LATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPI 991
L + +MAPE G+ S D++S+G++L E F+ G P
Sbjct: 191 LLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSY---------GLQ----------PY 231
Query: 992 SMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKIRD 1049
D +I + + C + V+ L +EC E P R K+I RL +
Sbjct: 232 CGYSNQDVVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWGN 289
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 5e-34
Identities = 67/289 (23%), Positives = 115/289 (39%), Gaps = 31/289 (10%)
Query: 776 LIGRGSFGSVYIAR-LQNGIEVAVKT---FDLQHERAFKSFDTECEVMKSIRHRNLTKII 831
IGRG F VY A L +G+ VA+K FDL +A E +++K + H N+ K
Sbjct: 39 KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 98
Query: 832 SSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIF---QRLNIMIDVASALEYLHFGYSA 888
+S ++ ++LE G L + + + + + SALE++H S
Sbjct: 99 ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SR 155
Query: 889 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRV 948
V+H D+KP+NV + V L D G+ + + + T YM+PE E
Sbjct: 156 RVMHRDIKPANVFITATGVVKLGDLGLGRFF-SSKTTAAHSLV-GTPYYMSPERIHENGY 213
Query: 949 STKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKH 1008
+ K D++S G LL E + P F G+ +++ + I + +
Sbjct: 214 NFKSDIWSLGCLLYEMAALQSP----FYGD-----------KMNLYSLC---KKIEQCDY 255
Query: 1009 FAAKEQCASSVF-NLAMECTVESPDERITAKEIVRRLLKIRDFLLRNVE 1056
S L C P++R + ++ ++E
Sbjct: 256 PPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSLE 304
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 5e-34
Identities = 73/360 (20%), Positives = 124/360 (34%), Gaps = 84/360 (23%)
Query: 59 CNWTGVTCDINQRRVTAL------NISYLSLTGNI-----PRQLGNLSSLEILDLNFNRL 107
C+ V C + + A+ + + L L N L L L L N++
Sbjct: 33 CHLRVVQC--SDLGLKAVPKEISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKI 90
Query: 108 SGEIPWELGNLAKLEKLLLHNNFLTGTIPFSIFKLSSLLDLKLSDNNLTGTIPSHNLGNL 167
S L KL+KL + N L IP ++ SL++L++ DN + +P L
Sbjct: 91 SKIHEKAFSPLRKLQKLYISKNHLV-EIPPNLPS--SLVELRIHDNRIR-KVPKGVFSGL 146
Query: 168 SSLQLLDLSDNQL-SGSIPSFIFKISSLQALHFGNNRLSGELPANICDNLPFLNFFSVYK 226
++ +++ N L + F L L +L+ I +LP
Sbjct: 147 RNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-----GIPKDLP--------- 192
Query: 227 NMFYGGISSTLSNCKHLRILDLSFNDLWGDIPKEI-GNLTKLKELFLDFNILQGEIPHTV 285
+ L L L N + I E +KL L L N ++ ++
Sbjct: 193 --------------ETLNELHLDHNKI-QAIELEDLLRYSKLYRLGLGHNQIRMIENGSL 237
Query: 286 GNLHNLEYLSLVNNELVGTVPATIFNVSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYL 345
L L L L NN+L VPA + + L L+ +YL
Sbjct: 238 SFLPTLRELHLDNNKLS-RVPAGLPD-------------------------LKLLQVVYL 271
Query: 346 WGNNFSGTLPSFIF-------NASNLSKLSLGDN--SFSGLIPNTFGNLRNLKRLRLYNN 396
NN + + F + + +SL +N + + P TF + + ++ N
Sbjct: 272 HTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-30
Identities = 62/314 (19%), Positives = 110/314 (35%), Gaps = 48/314 (15%)
Query: 338 PNLEELYLWGNNFSGTLPSFIF-NASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNN 396
P+ L L N+ S L F +L L L +N S + F LR L++L + N
Sbjct: 54 PDTTLLDLQNNDIS-ELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKN 112
Query: 397 YLTSPELSFLSSLSNCKYLEIIALSGNPLNGIIPMSAGNLSHSLEELFMPDCNVSGRIPK 456
+L + SS L + + N + + G S
Sbjct: 113 HLVEIPPNLPSS------LVELRIHDNRIRKV---PKGVFS------------------- 144
Query: 457 EIGNLANLVTLDLGGNKF-NGSIPIALGKLQKLQLLNLDDNKLEGSIPDDICGLVELYKL 515
L N+ +++GGN N KL L + + KL IP D+ L +L
Sbjct: 145 ---GLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDL--PETLNEL 198
Query: 516 ALGDNKLSGQIPA-CFGNLASLRELWLGPNELISFIPSTFWNIKDIMYVNFSSNFLTGPL 574
L NK+ I + L L LG N++ + + + ++ +N L+ +
Sbjct: 199 HLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLSR-V 256
Query: 575 PLEIENLKALTTLDFSMNNLSGVIPTTIGGLKG------LQYLFLGHNRLQ-GSIPDSV- 626
P + +LK L + NN++ V + + L +N + + +
Sbjct: 257 PAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATF 316
Query: 627 GDLISLKSLNLSNN 640
+ ++ N
Sbjct: 317 RCVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 9e-30
Identities = 65/360 (18%), Positives = 116/360 (32%), Gaps = 77/360 (21%)
Query: 328 SLPSSTDVQLP-----NLEELYLWGNNFSGTLPSFIFNASNLSKLSLGDNSFSGLIPNTF 382
SLP + P +L + +P I + + L L +N S L + F
Sbjct: 18 SLPPTYSAMCPFGCHCHLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDF 74
Query: 383 GNLRNLKRLRLYNNYLTSPELSFLSSLSNCKYLEIIALSGNPLNGIIPMSAGNLSHSLEE 442
L++L L L NN ++ S L + L +S N L
Sbjct: 75 KGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLY---ISKNHLV---------------- 115
Query: 443 LFMPDCNVSGRIPKEIGNLANLVTLDLGGNKFNGSIPIALGKLQKLQLLNLDDNKL-EGS 501
IP + ++LV L + N+ L+ + + + N L
Sbjct: 116 ----------EIPPNL--PSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSG 163
Query: 502 IPDDICGLVELYKLALGDNKLSGQIPACFGNLASLRELWLGPNELISFIPSTFWNIKDIM 561
++L L + + KL+ IP +L EL L N++ +
Sbjct: 164 FEPGAFDGLKLNYLRISEAKLT-GIPK--DLPETLNELHLDHNKIQAIELEDL------- 213
Query: 562 YVNFSSNFLTGPLPLEIENLKALTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQGS 621
L L N + + ++ L L+ L L +N+L
Sbjct: 214 -----------------LRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-R 255
Query: 622 IPDSVGDLISLKSLNLSNNNLSGPIP-------TSLEKLSDLKELNLSFNKLE-GEIPRG 673
+P + DL L+ + L NN++ + K + ++L N + E+
Sbjct: 256 VPAGLPDLKLLQVVYLHTNNITK-VGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPA 314
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-27
Identities = 61/242 (25%), Positives = 94/242 (38%), Gaps = 24/242 (9%)
Query: 460 NLANLVTLDLGGNKFNGSIPIALGKLQKLQLLNLDDNKLEGSIPDDI-CGLVELYKLALG 518
L +L L L NK + A L+KLQ L + N L IP ++ LVEL +
Sbjct: 76 GLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNLPSSLVELR---IH 131
Query: 519 DNKLSGQIPACFGNLASLRELWLGPNEL--ISFIPSTFWNIKDIMYVNFSSNFLTGPLPL 576
DN++ F L ++ + +G N L F P F +K + Y+ S LTG +
Sbjct: 132 DNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLK-LNYLRISEAKLTG---I 187
Query: 577 EIENLKALTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQGSIPDSV-GDLISLKSL 635
+ + L L N + + + L L LGHN+++ I + L +L+ L
Sbjct: 188 PKDLPETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIR-MIENGSLSFLPTLREL 246
Query: 636 NLSNNNLSGPIPTSLEKLSDLKELNLSFNKLEGEIPRGGPFVNFSAKSFMGNNLLCGSPN 695
+L NN LS +P L L L+ + L N + F
Sbjct: 247 HLDNNKLSR-VPAGLPDLKLLQVVYLHTNNIT----------KVGVNDFCPVGFGVKRAY 295
Query: 696 LQ 697
Sbjct: 296 YN 297
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 8e-14
Identities = 32/140 (22%), Positives = 54/140 (38%), Gaps = 15/140 (10%)
Query: 77 NISYLSLTGN----IPRQ-LGNLSSLEILDLNFNRLSGEIPWELGNLAKLEKLLLHNNFL 131
++ L L N I + L S L L L N++ L L L +L L NN L
Sbjct: 194 TLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKL 253
Query: 132 TGTIPFSIFKLSSLLDLKLSDNNLTGTIPS------HNLGNLSSLQLLDLSDNQLS-GSI 184
+ +P + L L + L NN+T + + + L +N + +
Sbjct: 254 S-RVPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEV 311
Query: 185 PSFIFK-ISSLQALHFGNNR 203
F+ ++ A+ FGN +
Sbjct: 312 QPATFRCVTDRLAIQFGNYK 331
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 5e-34
Identities = 64/297 (21%), Positives = 111/297 (37%), Gaps = 48/297 (16%)
Query: 777 IGRGSFGSVYIARL------QNGIEVAVKTF-DLQHERAFKSFDTECEVMKSI-RHRNLT 828
+G G+FG V A + VAVK H ++ +E +V+ + H N+
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 829 KIISSCSNEDFKALILEYMRNGSL-----------------EKCLYSGNYILDIFQRLNI 871
++ +C+ +I EY G L + LD+ L+
Sbjct: 91 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 872 MIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQT 931
VA + +L S IH DL N+LL + + DFG+A+ + + + +
Sbjct: 151 SYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 207
Query: 932 LATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTR-RKPTDEIFSGEMTLKHWVNDFLP 990
+ +MAPE + + DV+S+GI L E F+ P + K
Sbjct: 208 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM------- 260
Query: 991 ISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKI 1047
I E + E + ++++ C P +R T K+IV+ + K
Sbjct: 261 ------------IKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 5e-34
Identities = 70/309 (22%), Positives = 119/309 (38%), Gaps = 64/309 (20%)
Query: 777 IGRGSFGSVYIARLQNGIE------VAVKTF-DLQHERAFKSFDTECEVMKSIRHRNLTK 829
IG G+FG V+ AR + VAVK + F E +M + N+ K
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 830 IISSCSNEDFKALILEYMRNGSL-----------------------EKCLYSGNYILDIF 866
++ C+ L+ EYM G L + G L
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 867 QRLNIMIDVASALEYL---HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGED 923
++L I VA+ + YL F +H DL N L+ +NMV ++DFG+++ + D
Sbjct: 175 EQLCIARQVAAGMAYLSERKF------VHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 228
Query: 924 QSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKH 983
+ +M PE R +T+ DV+++G++L E F+ G
Sbjct: 229 YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSY---------GLQ---- 275
Query: 984 WVNDFLP---ISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEI 1040
P ++ ++I + + A E C ++NL C + P +R + I
Sbjct: 276 ------PYYGMAHEEVIY---YVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSI 326
Query: 1041 VRRLLKIRD 1049
R L ++ +
Sbjct: 327 HRILQRMCE 335
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 6e-34
Identities = 57/281 (20%), Positives = 110/281 (39%), Gaps = 39/281 (13%)
Query: 775 NLIGRGSFGSVYIARLQNGIEVAVKTFDLQH--ERAFKSFDTECEVMKSIRHRNLT--KI 830
IG G V+ + A+K +L+ + S+ E + ++ + ++
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 831 ISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPV 890
+ + +++E N L L +D ++R + ++ A+ +H +
Sbjct: 75 YDYEITDQYIYMVMECG-NIDLNSWLKKKKS-IDPWERKSYWKNMLEAVHTIH---QHGI 129
Query: 891 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPE--------- 941
+H DLKP+N L+ D M+ L DFGIA + + S+ + + T+ YM PE
Sbjct: 130 VHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSR 188
Query: 942 --YGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDA 999
+ ++S K DV+S G +L + P F + + + + IID
Sbjct: 189 ENGKSKSKISPKSDVWSLGCILYYMTYGKTP----FQQ-------IINQISK-LHAIIDP 236
Query: 1000 NLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEI 1040
N I + ++ C P +RI+ E+
Sbjct: 237 NHEIEFPDI------PEKDLQDVLKCCLKRDPKQRISIPEL 271
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 7e-34
Identities = 71/362 (19%), Positives = 127/362 (35%), Gaps = 83/362 (22%)
Query: 58 VCNWTGVTCDINQRRVTAL------NISYLSLTGNI-----PRQLGNLSSLEILDLNFNR 106
C + + + + + L L N NL +L L L N+
Sbjct: 28 RCQCHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNK 87
Query: 107 LSGEIPWELGNLAKLEKLLLHNNFLTGTIPFSIFKLSSLLDLKLSDNNLTGTIPSHNLGN 166
+S P L KLE+L L N L +P + K +L +L++ +N +T +
Sbjct: 88 ISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMPK--TLQELRVHENEIT-KVRKSVFNG 143
Query: 167 LSSLQLLDLSDNQL-SGSIPSFIFK-ISSLQALHFGNNRLSGELPANICDNLPFLNFFSV 224
L+ + +++L N L S I + F+ + L + + ++ +P + +L
Sbjct: 144 LNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLPPSL-------- 194
Query: 225 YKNMFYGGISSTLSNCKHLRILDLSFNDLWGDIPKEI-GNLTKLKELFLDFNILQGEIPH 283
L L N + + L L +L L FN +
Sbjct: 195 -------------------TELHLDGNKI-TKVDAASLKGLNNLAKLGLSFNSISAVDNG 234
Query: 284 TVGNLHNLEYLSLVNNELVGTVPATIFNVSTLKLIELSNNTFFGSLPSSTDVQLPNLEEL 343
++ N +L L L NN+LV VP + + ++ +
Sbjct: 235 SLANTPHLRELHLNNNKLV-KVPGGLAD-------------------------HKYIQVV 268
Query: 344 YLWGNNFSGTLPSFIF-------NASNLSKLSLGDN--SFSGLIPNTFGNLRNLKRLRLY 394
YL NN S + S F ++ S +SL N + + P+TF + ++L
Sbjct: 269 YLHNNNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLG 327
Query: 395 NN 396
N
Sbjct: 328 NY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 5e-33
Identities = 61/316 (19%), Positives = 112/316 (35%), Gaps = 51/316 (16%)
Query: 338 PNLEELYLWGNNFSGTLPSFIF-NASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNN 396
P+ L L N + + F N NL L L +N S + P F L L+RL L N
Sbjct: 52 PDTALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKN 110
Query: 397 YLTSPELSFLSSLSNCKYLEIIALSGNPLNGIIPMSAGNLSHSLEELFMPDCNVSGRIPK 456
L + L+ + + N + + +
Sbjct: 111 QLKELPEKMPKT------LQELRVHENEITKV---RKSVFN------------------- 142
Query: 457 EIGNLANLVTLDLGGNKFNGSI--PIALGKLQKLQLLNLDDNKLEGSIPDDI-CGLVELY 513
L ++ ++LG N S A ++KL + + D + +IP + L EL+
Sbjct: 143 ---GLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLPPSLTELH 198
Query: 514 KLALGDNKLSGQIPA-CFGNLASLRELWLGPNELISFIPSTFWNIKDIMYVNFSSNFLTG 572
L NK++ ++ A L +L +L L N + + + N + ++ ++N L
Sbjct: 199 ---LDGNKIT-KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVK 254
Query: 573 PLPLEIENLKALTTLDFSMNNLSGVIPTTIG------GLKGLQYLFLGHNRLQ-GSIPDS 625
+P + + K + + NN+S + + L N +Q I S
Sbjct: 255 -VPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPS 313
Query: 626 V-GDLISLKSLNLSNN 640
+ ++ L N
Sbjct: 314 TFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 4e-32
Identities = 66/344 (19%), Positives = 117/344 (34%), Gaps = 71/344 (20%)
Query: 339 NLEELYLWGNNFSGTLPSFIFNASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNYL 398
+L + +P + + + L L +N + + F NL+NL L L NN +
Sbjct: 32 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 88
Query: 399 TSPELSFLSSLSNCKYLEIIALSGNPLNGIIPMSAGNLSHSLEELFMPDCNVSGRIPKEI 458
+ + L LE + LS N L +
Sbjct: 89 SKISPGAFAPLVK---LERLYLSKNQLKEL----------------------------PE 117
Query: 459 GNLANLVTLDLGGNKFNGSIPIALGKLQKLQLLNLDDNKL-EGSIPDDI-CGLVELYKLA 516
L L + N+ L ++ ++ L N L I + G+ +L +
Sbjct: 118 KMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIR 177
Query: 517 LGDNKLSGQIPACFGNLASLRELWLGPNELISFIPSTFWNIKDIMYVNFSSNFLTGPLPL 576
+ D ++ IP G SL EL L N++ ++
Sbjct: 178 IADTNIT-TIPQ--GLPPSLTELHLDGNKITKVDAASL---------------------- 212
Query: 577 EIENLKALTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQGSIPDSVGDLISLKSLN 636
+ L L L S N++S V ++ L+ L L +N+L +P + D ++ +
Sbjct: 213 --KGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVY 269
Query: 637 LSNNNLSG------PIPTSLEKLSDLKELNLSFNKLE-GEIPRG 673
L NNN+S P K + ++L N ++ EI
Sbjct: 270 LHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPS 313
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-27
Identities = 57/242 (23%), Positives = 96/242 (39%), Gaps = 21/242 (8%)
Query: 460 NLANLVTLDLGGNKFNGSIPIALGKLQKLQLLNLDDNKLEGSIPDDI-CGLVELYKLALG 518
NL NL TL L NK + P A L KL+ L L N+L+ +P+ + L EL +
Sbjct: 74 NLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMPKTLQELR---VH 129
Query: 519 DNKLSGQIPACFGNLASLRELWLGPNELISFI--PSTFWNIKDIMYVNFSSNFLTGPLPL 576
+N+++ + F L + + LG N L S F +K + Y+ + +T +
Sbjct: 130 ENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT---I 186
Query: 577 EIENLKALTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQGSIPDSVGDLISLKSLN 636
+LT L N ++ V ++ GL L L L N + S+ + L+ L+
Sbjct: 187 PQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELH 246
Query: 637 LSNNNLSGPIPTSLEKLSDLKELNLSFNKLEGEIPRGGPFVNFSAKSFMGNNLLCGSPNL 696
L+NN L +P L ++ + L N + + F +
Sbjct: 247 LNNNKLVK-VPGGLADHKYIQVVYLHNNNIS----------AIGSNDFCPPGYNTKKASY 295
Query: 697 QV 698
Sbjct: 296 SG 297
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 2e-14
Identities = 33/139 (23%), Positives = 57/139 (41%), Gaps = 13/139 (9%)
Query: 77 NISYLSLTGN----IPRQ-LGNLSSLEILDLNFNRLSGEIPWELGNLAKLEKLLLHNNFL 131
+++ L L GN + L L++L L L+FN +S L N L +L L+NN L
Sbjct: 193 SLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKL 252
Query: 132 TGTIPFSIFKLSSLLDLKLSDNNLT-----GTIPSHNLGNLSSLQLLDLSDNQLS-GSIP 185
+P + + + L +NN++ P +S + L N + I
Sbjct: 253 V-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQ 311
Query: 186 SFIFK-ISSLQALHFGNNR 203
F+ + A+ GN +
Sbjct: 312 PSTFRCVYVRAAVQLGNYK 330
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 9e-34
Identities = 52/272 (19%), Positives = 109/272 (40%), Gaps = 29/272 (10%)
Query: 776 LIGRGSFGSVYIAR-LQNGIEVAVKTFDLQH--ERAFKSFDTECEVMKSIRHRNLTKIIS 832
IG GSFG + + ++G + +K ++ + + E V+ +++H N+ +
Sbjct: 31 KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90
Query: 833 SCSNEDFKALILEYMRNGSL-EKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVI 891
S ++++Y G L ++ + Q L+ + + AL+++H ++
Sbjct: 91 SFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH---DRKIL 147
Query: 892 HCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTK 951
H D+K N+ L + L DFGIA++L + + T Y++PE + K
Sbjct: 148 HRDIKSQNIFLTKDGTVQLGDFGIARVL-NSTVELARACI-GTPYYLSPEICENKPYNNK 205
Query: 952 GDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHFAA 1011
D+++ G +L E T + F SM ++ L I
Sbjct: 206 SDIWALGCVLYELCTLKHA----FEAG-------------SMKNLV---LKIISGSFPPV 245
Query: 1012 KEQCASSVFNLAMECTVESPDERITAKEIVRR 1043
+ + +L + +P +R + I+ +
Sbjct: 246 SLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 138 bits (348), Expect = 1e-33
Identities = 44/213 (20%), Positives = 85/213 (39%), Gaps = 30/213 (14%)
Query: 776 LIGRGSFGSVYIA---RLQNGIEVAVKTFDLQHERAFKS-FDTECEVMKSIRHRNLTKII 831
I G G +Y+A + NG V +K + ++ E + + + H ++ +I
Sbjct: 87 CIAHGGLGWIYLALDRNV-NGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145
Query: 832 SSCSNEDFKA-----LILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGY 886
+ + D +++EY+ SL++ L + + + ++++ AL YLH
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK---LPVAEAIAYLLEILPALSYLH--- 199
Query: 887 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQT-LATLGYMAPEYGRE 945
S +++ DLKP N++L + + L D G + T G+ APE R
Sbjct: 200 SIGLVYNDLKPENIMLTEEQLK-LIDLGAVS-------RINSFGYLYGTPGFQAPEIVR- 250
Query: 946 GRVSTKGDVYSFGILLMETFTRRKPTDEIFSGE 978
+ D+Y+ G L +G
Sbjct: 251 TGPTVATDIYTVGRTLAALTLDLPT----RNGR 279
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 3e-33
Identities = 54/281 (19%), Positives = 113/281 (40%), Gaps = 36/281 (12%)
Query: 771 FSENNLIGRGSFGSVYIARLQNGIEVAVKTFDLQHERAFKSFDTECEVMK-SIRHRNLTK 829
F +++G G+ G++ + + +VAVK + F D E ++++ S H N+ +
Sbjct: 26 FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIR 82
Query: 830 IISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAP 889
+ + F+ + +E +L++ + ++ + + ++ S L +LH S
Sbjct: 83 YFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH---SLN 138
Query: 890 VIHCDLKPSNVLL-----DDNMVAHLSDFGIAKLLIGEDQSMTQTQTLA-TLGYMAPEY- 942
++H DLKP N+L+ + A +SDFG+ K L S ++ + T G++APE
Sbjct: 139 IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEML 198
Query: 943 --GREGRVSTKGDVYSFGILLMETFTRRK-PTDEIFSGEMTLKHWVNDFLPISMMKIIDA 999
+ + D++S G + + P + + + + K D
Sbjct: 199 SEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDV 258
Query: 1000 NLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEI 1040
A+ L + P +R +AK +
Sbjct: 259 ----------IAR--------ELIEKMIAMDPQKRPSAKHV 281
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 6e-33
Identities = 62/302 (20%), Positives = 102/302 (33%), Gaps = 53/302 (17%)
Query: 777 IGRGSFGSVYIARLQNG------IEVAVKTF-DLQHERAFKSFDTECEVMKSI-RHRNLT 828
+G G+FG V A I+VAVK + ++ +E ++M + H N+
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 112
Query: 829 KIISSCSNEDFKALILEYMRNGSL----------------------EKCLYSGNYILDIF 866
++ +C+ LI EY G L +L
Sbjct: 113 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 172
Query: 867 QRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSM 926
L VA +E+L +H DL NVL+ V + DFG+A+ ++ + +
Sbjct: 173 DLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYV 229
Query: 927 TQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTR-RKPTDEIFSGEMTLKHWV 985
+ + +MAPE EG + K DV+S+GILL E F+ P I K
Sbjct: 230 VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKL-- 287
Query: 986 NDFLPISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLL 1045
I ++ + C +R + + L
Sbjct: 288 -----------------IQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 330
Query: 1046 KI 1047
Sbjct: 331 CQ 332
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 1e-32
Identities = 69/299 (23%), Positives = 128/299 (42%), Gaps = 57/299 (19%)
Query: 775 NLIGRGSFGSVYIARLQNG---IEVAVKTF-DLQHERAFKSFDTECEVMKSI-RHRNLTK 829
++IG G+FG V AR++ ++ A+K + + + F E EV+ + H N+
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 830 IISSCSNEDFKALILEYMRNGSL---------------EKCLYSGNYILDIFQRLNIMID 874
++ +C + + L +EY +G+L S L Q L+ D
Sbjct: 91 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 875 VASALEYL---HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQT 931
VA ++YL F IH DL N+L+ +N VA ++DFG+++ G++ + +T
Sbjct: 151 VARGMDYLSQKQF------IHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMG 201
Query: 932 LATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLP- 990
+ +MA E +T DV+S+G+LL E + G P
Sbjct: 202 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSL---------GGT----------PY 242
Query: 991 --ISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKI 1047
++ ++ + + + C V++L +C E P ER + +I+ L ++
Sbjct: 243 CGMTCAELYE---KLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 298
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 2e-32
Identities = 66/305 (21%), Positives = 111/305 (36%), Gaps = 56/305 (18%)
Query: 771 FSENNLIGRGSFGSVYIAR-LQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTK 829
F E LIG G FG V+ A+ +G +K +E+A + E + + + H N+
Sbjct: 13 FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER----EVKALAKLDHVNIVH 68
Query: 830 IISSCSNEDFKA----------------LILEYMRNGSLEKCL-YSGNYILDIFQRLNIM 872
D+ + +E+ G+LE+ + LD L +
Sbjct: 69 YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELF 128
Query: 873 IDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTL 932
+ ++Y+H S +I+ DLKPSN+ L D + DFG+ L +T++
Sbjct: 129 EQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSL---KNDGKRTRSK 182
Query: 933 ATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPIS 992
TL YM+PE + D+Y+ G++L E
Sbjct: 183 GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT-------------------AFE 223
Query: 993 MMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLL---KIRD 1049
K F KE+ L + + P++R EI+R L K +
Sbjct: 224 TSKFFTDLRDGIISDIFDKKEK------TLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE 277
Query: 1050 FLLRN 1054
R+
Sbjct: 278 KNERH 282
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-32
Identities = 69/308 (22%), Positives = 114/308 (37%), Gaps = 52/308 (16%)
Query: 776 LIGRGSFGSVYIAR-LQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIR-HRNLTKIISS 833
++ G F VY A+ + +G E A+K E ++ E MK + H N+ + S+
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 834 CS-------NEDFKALILEYMRNGSLEKCL--YSGNYILDIFQRLNIMIDVASALEYLHF 884
S + L+L + G L + L L L I A++++H
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH- 153
Query: 885 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLA----------T 934
P+IH DLK N+LL + L DFG A + Q A T
Sbjct: 154 RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213
Query: 935 LGYMAPE----YGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLP 990
Y PE Y + K D+++ G +L R+ P F
Sbjct: 214 PMYRTPEIIDLYSNFP-IGEKQDIWALGCILYLLCFRQHP----FEDG------------ 256
Query: 991 ISMMKIIDANLLITEDKHFAAKEQCASSVF-NLAMECTVESPDERITAKEIVRRLLKIRD 1049
+ ++I++ I +VF +L +P+ER++ E+V +L +I
Sbjct: 257 -AKLRIVNGKYSIPPHDTQ-------YTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA 308
Query: 1050 FLLRNVES 1057
N +S
Sbjct: 309 ARNVNPKS 316
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 66/279 (23%), Positives = 106/279 (37%), Gaps = 34/279 (12%)
Query: 776 LIGRGSFGSVYIAR-LQNGIEVAVKTFDLQH--ERAFKSFDTECEVMKSIRHRNLTKIIS 832
IG GS+G R +G + K D E + +E +++ ++H N+ +
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 833 SCSNEDFKAL--ILEYMRNGSL----EKCLYSGNYILDIFQRLNIMIDVASALEYLH--F 884
+ L ++EY G L K Y+ D L +M + AL+ H
Sbjct: 73 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYL-DEEFVLRVMTQLTLALKECHRRS 131
Query: 885 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGR 944
V+H DLKP+NV LD L DFG+A++L D S +T + T YM+PE
Sbjct: 132 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL-NHDTSFAKTF-VGTPYYMSPEQMN 189
Query: 945 EGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLIT 1004
+ K D++S G LL E P F+ S ++ I
Sbjct: 190 RMSYNEKSDIWSLGCLLYELCALMPP----FTAF-------------SQKELA---GKIR 229
Query: 1005 EDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043
E K + + + + R + +EI+
Sbjct: 230 EGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 268
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 8e-32
Identities = 62/259 (23%), Positives = 99/259 (38%), Gaps = 15/259 (5%)
Query: 74 TALNISYLSLTGNIPRQLGNLSSLEILDLNFNRLSGEIPWELGNLAKLEKLLLHNNFLT- 132
T + + LT ++P + SS L+L N+L L +L KL L +N L+
Sbjct: 10 TEIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSF 66
Query: 133 -GTIPFSIFKLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQLSGSIPSFIFK- 190
G S F +SL L LS N + T+ S N L L+ LD + L +F
Sbjct: 67 KGCCSQSDFGTTSLKYLDLSFNGVI-TMSS-NFLGLEQLEHLDFQHSNLKQMSEFSVFLS 124
Query: 191 ISSLQALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGGISS-TLSNCKHLRILDLS 249
+ +L L + I + L L + N F + ++L LDLS
Sbjct: 125 LRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLS 183
Query: 250 FNDLWGDIPKEI-GNLTKLKELFLDFNILQGEIPHTVGNLHNLEYLSLVNNELVGTVPAT 308
L + +L+ L+ L + N L++L+ L N ++ T
Sbjct: 184 QCQLE-QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM-TSKKQ 241
Query: 309 IFN--VSTLKLIELSNNTF 325
S+L + L+ N F
Sbjct: 242 ELQHFPSSLAFLNLTQNDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-29
Identities = 61/330 (18%), Positives = 97/330 (29%), Gaps = 79/330 (23%)
Query: 339 NLEELYLWGNNFSGTLPSFIFNASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNYL 398
+ E+ + ++P+ I S+ ++L L N L F L L +L L +N L
Sbjct: 8 SGTEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGL 64
Query: 399 TSPELSFLSSLSNCKYLEIIALSGNPLNGIIPMSAGNLSHSLEELFMPDCNVSGRIPKEI 458
+ +
Sbjct: 65 SFKGCC--------------------------------------------------SQSD 74
Query: 459 GNLANLVTLDLGGNKFNGSIPIALGKLQKLQLLNLDDNKLEGSIPDDI-CGLVELYKLAL 517
+L LDL N ++ L++L+ L+ + L+ + L L L +
Sbjct: 75 FGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDI 133
Query: 518 GDNKLSGQIPACFGNLASLRELWLGPNELISFIPSTFWNIKDIMYVNFSSNFLTGPLPLE 577
F L+SL L + N +
Sbjct: 134 SHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIF---------------------- 171
Query: 578 IENLKALTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQGSIPDSVGDLISLKSLNL 637
L+ LT LD S L + PT L LQ L + HN L SL+ L+
Sbjct: 172 -TELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDY 230
Query: 638 SNNNLSGPIPTSLEKL-SDLKELNLSFNKL 666
S N++ L+ S L LNL+ N
Sbjct: 231 SLNHIMTSKKQELQHFPSSLAFLNLTQNDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-29
Identities = 62/281 (22%), Positives = 103/281 (36%), Gaps = 37/281 (13%)
Query: 169 SLQLLDLSDNQLSGSIPSFIFKISSLQALHFGNNRLSGELPANICDNLPFLNFFSVYKNM 228
S + + L+ S+P+ I SS L +N+L +LP
Sbjct: 8 SGTEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQ---------SLP----------- 44
Query: 229 FYGGISSTLSNCKHLRILDLSFNDL--WGDIPKEIGNLTKLKELFLDFNILQGEIPHTVG 286
L L LS N L G + T LK L L FN + +
Sbjct: 45 -----HGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFL 98
Query: 287 NLHNLEYLSLVNNELVGTVPATIF-NVSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYL 345
L LE+L ++ L ++F ++ L +++S+ + L +LE L +
Sbjct: 99 GLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHT-RVAFNGIFNGLSSLEVLKM 157
Query: 346 WGNNFSGTLPSFIF-NASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNYLTSPELS 404
GN+F IF NL+ L L L P F +L +L+ L + +N S +
Sbjct: 158 AGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTF 217
Query: 405 FLSSLSNCKYLEIIALSGNPLNGIIPMSAGNLSHSLEELFM 445
L++ L+++ S N + + SL L +
Sbjct: 218 PYKCLNS---LQVLDYSLNHIMTSKKQELQHFPSSLAFLNL 255
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 3e-22
Identities = 44/188 (23%), Positives = 77/188 (40%), Gaps = 11/188 (5%)
Query: 491 LNLDDNKLEGSIPDDICGLVELYKLALGDNKLSGQIPACFGNLASLRELWLGPNEL--IS 548
+ + L S+P I +L L NKL F L L +L L N L
Sbjct: 12 IRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKG 68
Query: 549 FIPSTFWNIKDIMYVNFSSNFLTGPLPLEIENLKALTTLDFSMNNLSGVIPTTI-GGLKG 607
+ + + Y++ S N + + L+ L LDF +NL + ++ L+
Sbjct: 69 CCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRN 127
Query: 608 LQYLFLGHNRLQGSIPDSV-GDLISLKSLNLSNNN-LSGPIPTSLEKLSDLKELNLSFNK 665
L YL + H + + + L SL+ L ++ N+ +P +L +L L+LS +
Sbjct: 128 LIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQ 186
Query: 666 LEGEIPRG 673
LE ++
Sbjct: 187 LE-QLSPT 193
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 9e-32
Identities = 67/449 (14%), Positives = 143/449 (31%), Gaps = 72/449 (16%)
Query: 76 LNISYLSLTGNIPRQLGNLSSLEILDLNFNRLSGEIPWELGNLAKLEKLLLHNNFLTGTI 135
+ + L++L LD + + ++ ++ + L L KL+ +N +T T+
Sbjct: 23 EVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMT-GIEKLTGLTKLICTSNNIT-TL 79
Query: 136 PFSIFKLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQLSGSIPSFIFKISSLQ 195
S + ++L L N LT + ++ L+ L L+ N+L+ + + + L
Sbjct: 80 DLS--QNTNLTYLACDSNKLT----NLDVTPLTKLTYLNCDTNKLT-KLD--VSQNPLLT 130
Query: 196 ALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGGISSTLSNCKHLRILDLSFNDLWG 255
L+ N L+ E+ + L L+ K ++ L LD SFN +
Sbjct: 131 YLNCARNTLT-EIDVSHNTQLTELDCHLNKKI-----TKLDVTPQTQLTTLDCSFNKI-T 183
Query: 256 DIPKEIGNLTKLKELFLDFNILQGEIPHTVGNLHNLEYLSLVNNELVGTVPATIFNVSTL 315
++ + L L D N + ++ + L +L +N+L + + ++ L
Sbjct: 184 ELD--VSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLT-EID--VTPLTQL 235
Query: 316 KLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSGTLPSFIFNASNLSKLSLGDNSFS 375
+ S N L S L L L+ + + + + + L
Sbjct: 236 TYFDCSVNPL-TELDVS---TLSKLTTLHCIQTDLL-EID--LTHNTQLIYFQAEGCRK- 287
Query: 376 GLIPNTFGNLRNLKRLRLYNNYLTSPELSFLSSLSNCKYLEIIALSGNPLNGIIPMSAGN 435
+ + L L +T LS L + L+ L +
Sbjct: 288 -IKELDVTHNTQLYLLDCQAAGITE------LDLSQNPKLVYLYLNNTELTEL------- 333
Query: 436 LSHSLEELFMPDCNVSGRIPKEIGNLANLVTLDLGGNKFNGSIPIALGKLQKLQLLNLDD 495
++ + L +L ++GK+ L +
Sbjct: 334 ---------------------DVSHNTKLKSLSCVNAHIQ-DFS-SVGKIPALNNNFEAE 370
Query: 496 NKLEGSIPDDICGLVELYKLALGDNKLSG 524
+ + + ++ G
Sbjct: 371 GQTITMPKETLTNNSLTIAVSPDLLDQFG 399
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-30
Identities = 75/393 (19%), Positives = 130/393 (33%), Gaps = 54/393 (13%)
Query: 290 NLEYLSLVNNELVGTVPATIFNVSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNN 349
N E+ T + ++TL ++ N+ + +L L +L NN
Sbjct: 19 NFASEVAAAFEMQATDTISEEQLATLTSLDCHNS-SITDMTGIE--KLTGLTKLICTSNN 75
Query: 350 FSGTLPSFIFNASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNYLTSPELSFLSSL 409
+ TL + +NL+ L+ N + L L L L N LT +
Sbjct: 76 IT-TLD--LSQNTNLTYLACDSNKLTNL---DVTPLTKLTYLNCDTNKLTK------LDV 123
Query: 410 SNCKYLEIIALSGNPLNGIIPMSAGNLSHSLEELFMPDCNVSGRIPKEIGNLANLVTLDL 469
S L + + N L I + + L EL ++ L TLD
Sbjct: 124 SQNPLLTYLNCARNTLTEI---DVSHNT-QLTELDCHLNKKIT--KLDVTPQTQLTTLDC 177
Query: 470 GGNKFNGSIPIALGKLQKLQLLNLDDNKLEGSIPDDICGLVELYKLALGDNKLSGQIPAC 529
NK + + + + L LN D N + + D+ ++L L NKL+ +I
Sbjct: 178 SFNKITE---LDVSQNKLLNRLNCDTNNIT-KL--DLNQNIQLTFLDCSSNKLT-EID-- 228
Query: 530 FGNLASLRELWLGPNELISFIPSTFWNIKDI----------------MYVNFSSNFLTGP 573
L L N L ST + + + F +
Sbjct: 229 VTPLTQLTYFDCSVNPLTELDVSTLSKLTTLHCIQTDLLEIDLTHNTQLIYFQAEGCRKI 288
Query: 574 LPLEIENLKALTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQGSIPDSVGDLISLK 633
L++ + L LD ++ + + L YL+L + L + V LK
Sbjct: 289 KELDVTHNTQLYLLDCQAAGITEL---DLSQNPKLVYLYLNNTELT-ELD--VSHNTKLK 342
Query: 634 SLNLSNNNLSGPIPTSLEKLSDLKELNLSFNKL 666
SL+ N ++ S+ K+ L + +
Sbjct: 343 SLSCVNAHIQD-FS-SVGKIPALNNNFEAEGQT 373
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 5e-25
Identities = 60/310 (19%), Positives = 100/310 (32%), Gaps = 56/310 (18%)
Query: 358 IFNASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNYLTSPELSFLSSLSNCKYLEI 417
F N + + L L L +N+ +T ++ + L
Sbjct: 14 WFPDDNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITD-----MTGIEKLTGLTK 68
Query: 418 IALSGNPLNGIIPMSAGNLSHSLEELFMPDCNVSGRIPKEIGNLANLVTLDLGGNKFNGS 477
+ + N + + ++ NL L NK
Sbjct: 69 LICTSNNITTL----------------------------DLSQNTNLTYLACDSNKLTN- 99
Query: 478 IPIALGKLQKLQLLNLDDNKLEGSIPDDICGLVELYKLALGDNKLSGQIPACFGNLASLR 537
+ + L KL LN D NKL D+ L L N L+ +I + L
Sbjct: 100 --LDVTPLTKLTYLNCDTNKLT---KLDVSQNPLLTYLNCARNTLT-EID--VSHNTQLT 151
Query: 538 ELWLGPNELISFIPSTFWNIKDIMYVNFSSNFLTGPLPLEIENLKALTTLDFSMNNLSGV 597
EL N+ I+ + + ++ S N +T L++ K L L+ NN++ +
Sbjct: 152 ELDCHLNKKITKLD--VTPQTQLTTLDCSFNKITE---LDVSQNKLLNRLNCDTNNITKL 206
Query: 598 IPTTIGGLKGLQYLFLGHNRLQGSIPDSVGDLISLKSLNLSNNNLSGPIPTSLEKLSDLK 657
+ L +L N+L I V L L + S N L+ + S LS L
Sbjct: 207 ---DLNQNIQLTFLDCSSNKLT-EID--VTPLTQLTYFDCSVNPLT-ELDVS--TLSKLT 257
Query: 658 ELNLSFNKLE 667
L+ L
Sbjct: 258 TLHCIQTDLL 267
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-31
Identities = 65/304 (21%), Positives = 111/304 (36%), Gaps = 64/304 (21%)
Query: 771 FSENNLIGRGSFGSVYIAR-LQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTK 829
F E ++G+G+FG V AR + A+K E + +E ++ S+ H+ + +
Sbjct: 8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVR 66
Query: 830 IISSCSNEDFKA-------------LILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVA 876
++ + +EY NG+L ++S N + + +
Sbjct: 67 YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQIL 126
Query: 877 SALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLA--- 933
AL Y+H S +IH DLKP N+ +D++ + DFG+AK + +
Sbjct: 127 EALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183
Query: 934 ---------TLGYMAPE-YGREGRVSTKGDVYSFGILLME-------TFTRRKPTDEIFS 976
T Y+A E G + K D+YS GI+ E R ++ S
Sbjct: 184 SDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVNILKKLRS 243
Query: 977 GEMTLKHWVNDFLPISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERIT 1036
+ +D KII LLI D P++R
Sbjct: 244 VSIEFPPDFDDNKMKVEKKII--RLLIDHD------------------------PNKRPG 277
Query: 1037 AKEI 1040
A+ +
Sbjct: 278 ARTL 281
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-31
Identities = 68/272 (25%), Positives = 110/272 (40%), Gaps = 28/272 (10%)
Query: 58 VCNWTGVTCDINQRRVTALNISYLSLTGNIPRQLGNLSSLEILDLNFNRLSGEIPWELGN 117
C+ +R ++ + IP S+ L+L N + +
Sbjct: 51 SCSNQFSKVVCTRRGLS-------EVPQGIP------SNTRYLNLMENNIQMIQADTFRH 97
Query: 118 LAKLEKLLLHNNFLTGTIPFSIFK-LSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLS 176
L LE L L N + I F L+SL L+L DN LT IPS LS L+ L L
Sbjct: 98 LHHLEVLQLGRNSIR-QIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLR 155
Query: 177 DNQLSGSIPSFIFK-ISSLQALHFGN-NRLSGELPANICDNLPFLNFFSVYKNMFYGGIS 234
+N + SIPS+ F + SL L G +L + + L L + ++ I
Sbjct: 156 NNPIE-SIPSYAFNRVPSLMRLDLGELKKLE-YISEGAFEGLFNLKYLNLGMCN----IK 209
Query: 235 S--TLSNCKHLRILDLSFNDLWGDIPKEIGNLTKLKELFLDFNILQGEIPHTVGNLHNLE 292
L+ L L++S N P L+ LK+L++ + + + L +L
Sbjct: 210 DMPNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLV 269
Query: 293 YLSLVNNELVGTVPATIF-NVSTLKLIELSNN 323
L+L +N L ++P +F + L + L +N
Sbjct: 270 ELNLAHNNLS-SLPHDLFTPLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 7e-30
Identities = 69/284 (24%), Positives = 117/284 (41%), Gaps = 36/284 (12%)
Query: 338 PNLEELYLWGNNFSGTLPSFIFNASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNY 397
++ S +P I SN L+L +N+ + +TF +L +L+ L+L N
Sbjct: 54 NQFSKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNS 110
Query: 398 LTSPELSFLSSLSNCKYLEIIALSGNPLNGIIPMSAGNLSHSLEELFMPDCNVSGRIPKE 457
+ E+ + L++ L + L N L I + LS L EL++ + + IP
Sbjct: 111 IRQIEVGAFNGLAS---LNTLELFDNWLTVIPSGAFEYLS-KLRELWLRNNPIE-SIPSY 165
Query: 458 I-GNLANLVTLDLGGNKFNGSIPI-ALGKLQKLQLLNLDDNKLEGSIPDDICGLVELYKL 515
+ +L+ LDLG K I A L L+ LNL ++ +P+ + LV L +L
Sbjct: 166 AFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMPN-LTPLVGLEEL 223
Query: 516 ALGDNKLSGQIPACFGNLASLRELWLGPNELISFIPSTFWNIKDIMYVNFSSNFLTGPLP 575
+ N P F L+SL++LW+ +++ + F
Sbjct: 224 EMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAF--------------------- 262
Query: 576 LEIENLKALTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQ 619
+ L +L L+ + NNLS + L+ L L L HN
Sbjct: 263 ---DGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWN 303
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-27
Identities = 60/232 (25%), Positives = 98/232 (42%), Gaps = 5/232 (2%)
Query: 435 NLSHSLEELFMPDCNVSGRIPKEIGNLANLVTLDLGGNKFNGSIPIALGKLQKLQLLNLD 494
+ + L + + N+ +L +L L LG N A L L L L
Sbjct: 72 GIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELF 131
Query: 495 DNKLEGSIPDDI-CGLVELYKLALGDNKLSGQIPACFGNLASLRELWLGPNELISFIPS- 552
DN L IP L +L +L L +N + F + SL L LG + + +I
Sbjct: 132 DNWLT-VIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEG 190
Query: 553 TFWNIKDIMYVNFSSNFLTGPLPLEIENLKALTTLDFSMNNLSGVIPTTIGGLKGLQYLF 612
F + ++ Y+N + +P + L L L+ S N+ + P + GL L+ L+
Sbjct: 191 AFEGLFNLKYLNLGMCNIKD-MP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLW 248
Query: 613 LGHNRLQGSIPDSVGDLISLKSLNLSNNNLSGPIPTSLEKLSDLKELNLSFN 664
+ ++++ ++ L SL LNL++NNLS L L EL+L N
Sbjct: 249 VMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 5e-26
Identities = 60/280 (21%), Positives = 102/280 (36%), Gaps = 38/280 (13%)
Query: 168 SSLQLLDLSDNQLSGSIPSFIFKISSLQALHFGNNRLSGELPANICDNLPFLNFFSVYKN 227
+ + + LS +P I S+ + L+ N + + A+
Sbjct: 54 NQFSKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQ-MIQAD---------------- 93
Query: 228 MFYGGISSTLSNCKHLRILDLSFNDLWGDIPKEI-GNLTKLKELFLDFNILQGEIPHTVG 286
T + HL +L L N + I L L L L N L
Sbjct: 94 --------TFRHLHHLEVLQLGRNSI-RQIEVGAFNGLASLNTLELFDNWLTVIPSGAFE 144
Query: 287 NLHNLEYLSLVNNELVGTVPATIF-NVSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYL 345
L L L L NN + ++P+ F V +L ++L + L NL+ L L
Sbjct: 145 YLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNL 203
Query: 346 WGNNFSGTLPSFIFNASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNYLTSPELSF 405
N +P+ L +L + N F + P +F L +LK+L + N+ ++ E +
Sbjct: 204 GMCNIK-DMPNLT-PLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNA 261
Query: 406 LSSLSNCKYLEIIALSGNPLNGIIPMSAGNLSHSLEELFM 445
L++ L + L+ N L+ +P L EL +
Sbjct: 262 FDGLAS---LVELNLAHNNLSS-LPHDLFTPLRYLVELHL 297
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-24
Identities = 59/231 (25%), Positives = 88/231 (38%), Gaps = 34/231 (14%)
Query: 447 DCNVSG--RIPKEIGNLANLVTLDLGGNKFNGSIPIALGKLQKLQLLNLDDNKLEGSIPD 504
C G +P+ I +N L+L N L L++L L N + I
Sbjct: 60 VCTRRGLSEVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR-QIEV 116
Query: 505 DI-CGLVELYKLALGDNKLSGQIPACFGNLASLRELWLGPNELISFIPSTFWNIKDIMYV 563
GL L L L DN L+ F L+ LRELWL N + S F
Sbjct: 117 GAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAF--------- 167
Query: 564 NFSSNFLTGPLPLEIENLKALTTLDFS-MNNLSGVIPTTIGGLKGLQYLFLGHNRLQGSI 622
+ +L LD + L + GL L+YL LG ++ +
Sbjct: 168 ---------------NRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DM 211
Query: 623 PDSVGDLISLKSLNLSNNNLSGPIPTSLEKLSDLKELNLSFNKLEGEIPRG 673
P+ + L+ L+ L +S N+ P S LS LK+L + +++ I R
Sbjct: 212 PN-LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVS-LIERN 260
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 4e-13
Identities = 34/110 (30%), Positives = 54/110 (49%), Gaps = 10/110 (9%)
Query: 77 NISYLSLTGN----IPRQLGNLSSLEILDLNFNRLSGEIPWE-LGNLAKLEKLLLHNNFL 131
N+ YL+L +P L L LE L+++ N EI L+ L+KL + N+ +
Sbjct: 197 NLKYLNLGMCNIKDMP-NLTPLVGLEELEMSGNHFP-EIRPGSFHGLSSLKKLWVMNSQV 254
Query: 132 TGTIPFSIFK-LSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQL 180
+ I + F L+SL++L L+ NNL+ ++P L L L L N
Sbjct: 255 S-LIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 52.1 bits (125), Expect = 7e-07
Identities = 24/90 (26%), Positives = 36/90 (40%), Gaps = 4/90 (4%)
Query: 584 LTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQGSIPDSVGDLISLKSLNLSNNNLS 643
+ + + LS +P I +YL L N +Q D+ L L+ L L N++
Sbjct: 56 FSKVVCTRRGLS-EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR 112
Query: 644 GPIPTSLEKLSDLKELNLSFNKLEGEIPRG 673
+ L+ L L L N L IP G
Sbjct: 113 QIEVGAFNGLASLNTLELFDNWLT-VIPSG 141
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-31
Identities = 74/296 (25%), Positives = 120/296 (40%), Gaps = 47/296 (15%)
Query: 58 VCNWTGVTCDINQRRVTALNISYLSLTGNIPRQLGNLSSLEILDLNFNRLSGEIPWELGN 117
C+ ++ + + I ++ +L+L+ N++ +
Sbjct: 40 SCSNQFSKVICVRKNLR-------EVPDGIS------TNTRLLNLHENQIQIIKVNSFKH 86
Query: 118 LAKLEKLLLHNNFLTGTIPFSIFK-LSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLS 176
L LE L L N + TI F L++L L+L DN LT TIP+ LS L+ L L
Sbjct: 87 LRHLEILQLSRNHIR-TIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLR 144
Query: 177 DNQLSGSIPSFIFK-ISSLQALH-FGNNRLSGELPANICDNLPFLNFFSVYKNMFYGGIS 234
+N + SIPS+ F I SL+ L RLS +
Sbjct: 145 NNPIE-SIPSYAFNRIPSLRRLDLGELKRLS-YISEG----------------------- 179
Query: 235 STLSNCKHLRILDLSFNDLWGDIPKEIGNLTKLKELFLDFNILQGEIPHTVGNLHNLEYL 294
+LR L+L+ +L +IP + L KL EL L N L P + L +L+ L
Sbjct: 180 -AFEGLSNLRYLNLAMCNL-REIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKL 236
Query: 295 SLVNNELVGTVPATIFNVSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNF 350
++ +++ N+ +L I L++N LP L +LE ++L N +
Sbjct: 237 WMIQSQIQVIERNAFDNLQSLVEINLAHN-NLTLLPHDLFTPLHHLERIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 6e-31
Identities = 71/311 (22%), Positives = 112/311 (36%), Gaps = 66/311 (21%)
Query: 120 KLEKLLLHNNFLTGTIPFSIFKLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQ 179
+ K++ L +P I + LL+L +N + I ++ +L L++L LS N
Sbjct: 44 QFSKVICVRKNLR-EVPDGISTNTRLLNL--HENQIQ-IIKVNSFKHLRHLEILQLSRNH 99
Query: 180 LSGSIPSFIFK-ISSLQALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGGISSTLS 238
+ +I F +++L L +NRL+ +P L
Sbjct: 100 IR-TIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLS--------------------- 136
Query: 239 NCKHLRILDLSFNDLWGDIPKEI-GNLTKLKELFL-DFNILQGEIPHTVGNLHNLEYLSL 296
L+ L L N + IP + L+ L L + L L NL YL+L
Sbjct: 137 ---KLKELWLRNNPI-ESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNL 192
Query: 297 VNNELVGTVPATIFNVSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSGTLPS 356
L +P L L+EL L GN+ S +
Sbjct: 193 AMCNLR-EIP-----------------NLTP---------LIKLDELDLSGNHLS-AIRP 224
Query: 357 FIF-NASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNYLTSPELSFLSSLSNCKYL 415
F +L KL + + + N F NL++L + L +N LT + L + L
Sbjct: 225 GSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHH---L 281
Query: 416 EIIALSGNPLN 426
E I L NP N
Sbjct: 282 ERIHLHHNPWN 292
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 4e-30
Identities = 70/307 (22%), Positives = 107/307 (34%), Gaps = 60/307 (19%)
Query: 338 PNLEELYLWGNNFSGTLPSFIFNASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNY 397
++ N +P I +N L+L +N + N+F +LR+L+ L+L N+
Sbjct: 43 NQFSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNH 99
Query: 398 LTSPELSFLSSLSNCKYLEIIALSGNPLNGIIPMSAGNLSHSLEELFMPDCNVSGRIPKE 457
+ + E+ + L+N LE L N L I G
Sbjct: 100 IRTIEIGAFNGLANLNTLE---LFDNRLTTI---PNGAFV-------------------- 133
Query: 458 IGNLANLVTLDLGGNKFNGSIPI-ALGKLQKLQLLNLDDNKLEGSIPDDI-CGLVELYKL 515
L+ L L L N SIP A ++ L+ L+L + K I + GL L L
Sbjct: 134 --YLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYL 190
Query: 516 ALGDNKLSGQIPACFGNLASLRELWLGPNELISFIPSTFWNIKDIMYVNFSSNFLTGPLP 575
L L +IP L L EL L N L + P +F
Sbjct: 191 NLAMCNLR-EIPN-LTPLIKLDELDLSGNHLSAIRPGSFQG------------------- 229
Query: 576 LEIENLKALTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQGSIPDSVGDLISLKSL 635
L L L + + + L+ L + L HN L D L L+ +
Sbjct: 230 -----LMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERI 284
Query: 636 NLSNNNL 642
+L +N
Sbjct: 285 HLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 4e-27
Identities = 63/232 (27%), Positives = 106/232 (45%), Gaps = 5/232 (2%)
Query: 435 NLSHSLEELFMPDCNVSGRIPKEIGNLANLVTLDLGGNKFNGSIPIALGKLQKLQLLNLD 494
+S + L + + + +L +L L L N A L L L L
Sbjct: 61 GISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELF 120
Query: 495 DNKLEGSIPDDI-CGLVELYKLALGDNKLSGQIPACFGNLASLRELWLGPNELISFIPS- 552
DN+L +IP+ L +L +L L +N + F + SLR L LG + +S+I
Sbjct: 121 DNRLT-TIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEG 179
Query: 553 TFWNIKDIMYVNFSSNFLTGPLPLEIENLKALTTLDFSMNNLSGVIPTTIGGLKGLQYLF 612
F + ++ Y+N + L +P + L L LD S N+LS + P + GL LQ L+
Sbjct: 180 AFEGLSNLRYLNLAMCNLRE-IP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLW 237
Query: 613 LGHNRLQGSIPDSVGDLISLKSLNLSNNNLSGPIPTSLEKLSDLKELNLSFN 664
+ +++Q ++ +L SL +NL++NNL+ L L+ ++L N
Sbjct: 238 MIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-24
Identities = 61/231 (26%), Positives = 93/231 (40%), Gaps = 34/231 (14%)
Query: 447 DCNVSG--RIPKEIGNLANLVTLDLGGNKFNGSIPIALGKLQKLQLLNLDDNKLEGSIPD 504
C +P I N L+L N+ + L+ L++L L N + +I
Sbjct: 49 ICVRKNLREVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIR-TIEI 105
Query: 505 DI-CGLVELYKLALGDNKLSGQIPACFGNLASLRELWLGPNELISFIPSTFWNIKDIMYV 563
GL L L L DN+L+ F L+ L+ELWL N + S F
Sbjct: 106 GAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAF--------- 156
Query: 564 NFSSNFLTGPLPLEIENLKALTTLDFS-MNNLSGVIPTTIGGLKGLQYLFLGHNRLQGSI 622
+ +L LD + LS + GL L+YL L L+ I
Sbjct: 157 ---------------NRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EI 200
Query: 623 PDSVGDLISLKSLNLSNNNLSGPIPTSLEKLSDLKELNLSFNKLEGEIPRG 673
P+ + LI L L+LS N+LS P S + L L++L + ++++ I R
Sbjct: 201 PN-LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQ-VIERN 249
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 3e-31
Identities = 72/337 (21%), Positives = 121/337 (35%), Gaps = 53/337 (15%)
Query: 62 TGVTCDINQRRVTALNISYLSLTGNIPRQLGNLSSLEILDLNFNRLSGEIPWELGNLAKL 121
++CD N S SL +IP L +++ LDL+ NR++ +L L
Sbjct: 26 ASLSCDRNGI----CKGSSGSLN-SIPSGL--TEAVKSLDLSNNRITYISNSDLQRCVNL 78
Query: 122 EKLLLHNNFLTGTIPFSIF-KLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQL 180
+ L+L +N + TI F L SL L LS N L+ + S LSSL L+L N
Sbjct: 79 QALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPY 136
Query: 181 SGSIPSFIF-KISSLQALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGGISSTLSN 239
+ +F ++ LQ L GN ++ L F
Sbjct: 137 KTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTF--------------------- 175
Query: 240 CKHLRILDLSFNDLWGDIPKEIGNLTKLKELFLDFNILQGEIPHTVGNLHNLEYLSLVNN 299
L L++ +DL PK + ++ + L L + V ++E L L +
Sbjct: 176 ---LEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDT 232
Query: 300 ELVGTVPATIFNVSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSGTLPSFIF 359
+L T ELS + + + + + + +
Sbjct: 233 DL-----------DTFHFSELSTGETNSLI------KKFTFRNVKITDESLF-QVMKLLN 274
Query: 360 NASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNN 396
S L +L N + F L +L+++ L+ N
Sbjct: 275 QISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTN 311
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 5e-29
Identities = 56/308 (18%), Positives = 112/308 (36%), Gaps = 49/308 (15%)
Query: 338 PNLEELYLWGNNFSGTLPSFIF-NASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNN 396
++ L L N + + + NL L L N + + ++F +L +L+ L L N
Sbjct: 52 EAVKSLDLSNNRIT-YISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYN 110
Query: 397 YLTSPELSFLSSLSNCKYLEIIALSGNPLNGIIPMSAGNLSHSLEELFMPDCNVSGRIPK 456
YL++ S+ LS+ L + L GNP + S + L+ L + + + +I +
Sbjct: 111 YLSNLSSSWFKPLSS---LTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQR 167
Query: 457 EI-GNLANLVTLDLGGNKFNGSIPIALGKLQKLQLLNLDDNKLEGSIPDDICGLVELYKL 515
+ L L L++ + P +L +Q + L L + + +
Sbjct: 168 KDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIF--------- 217
Query: 516 ALGDNKLSGQIPACFGNLASLRELWLGPNELISFIPSTFWNIKDIMYVNFSSNFLTGPLP 575
+S+ L L +L +F + ++ +S
Sbjct: 218 --------------VDVTSSVECLELRDTDLDTF------HFSELSTGETNS-------- 249
Query: 576 LEIENLKALTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQGSIPDSV-GDLISLKS 634
+ + + +L + + + GL L N+L+ S+PD + L SL+
Sbjct: 250 --LIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQK 305
Query: 635 LNLSNNNL 642
+ L N
Sbjct: 306 IWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-26
Identities = 59/356 (16%), Positives = 119/356 (33%), Gaps = 55/356 (15%)
Query: 315 LKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSGTLPSFIFNASNLSKLSLGDNSF 374
L + + + S ++ + + + ++PS + + L L +N
Sbjct: 9 WVLGVIISLSKEESSNQAS-LSCDRNGICKGSSGSLN-SIPSGLT--EAVKSLDLSNNRI 64
Query: 375 SGLIPNTFGNLRNLKRLRLYNNYLTSPELSFLSSLSNCKYLEIIALSGNPLNGIIPMSAG 434
+ + + NL+ L L +N + + E SSL + LE + LS N L+ +
Sbjct: 65 TYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGS---LEHLDLSYNYLSNLSS---- 117
Query: 435 NLSHSLEELFMPDCNVSGRIPKEIGNLANLVTLDLGGNKFNGSIP--IALGKLQKLQLLN 492
F L++L L+L GN + ++ L KLQ+L
Sbjct: 118 -------SWF--------------KPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILR 155
Query: 493 LDDNKLEGSIPDDI-CGLVELYKLALGDNKLSGQIPACFGNLASLRELWLGPNELISFIP 551
+ + I GL L +L + + L P ++ ++ L L + I +
Sbjct: 156 VGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLE 215
Query: 552 STFWNIKDIMYVNFSSNFLTGPLPLEIENLKALTTLDFSMNNLSGVIPTTIGGLKGLQYL 611
+ + L F + LS ++ + +
Sbjct: 216 IFVDVTSSVECLELRDTDLDT----------------FHFSELSTGETNSLIKKFTFRNV 259
Query: 612 FLGHNRLQGSIPDSVGDLISLKSLNLSNNNLSGPIPTS-LEKLSDLKELNLSFNKL 666
+ L + + + L L S N L +P ++L+ L+++ L N
Sbjct: 260 KITDESLF-QVMKLLNQISGLLELEFSRNQLKS-VPDGIFDRLTSLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-25
Identities = 63/360 (17%), Positives = 111/360 (30%), Gaps = 93/360 (25%)
Query: 126 LHNNFLTGTIPFSIFKLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQLSGSIP 185
+ L +IP + ++ L LS+N +T I + +L +LQ L L+ N ++ +I
Sbjct: 38 GSSGSLN-SIPSGLT--EAVKSLDLSNNRIT-YISNSDLQRCVNLQALVLTSNGIN-TIE 92
Query: 186 SFIF-KISSLQALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGGISSTLSNCKHLR 244
F + SL+ L N LS L ++ L L
Sbjct: 93 EDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLS------------------------SLT 127
Query: 245 ILDLSFNDLWGDIPKEI--GNLTKLKELFLDFNILQGEIPHTV-GNLHNLEYLSLVNNEL 301
L+L N + + +LTKL+ L + +I L LE L + ++L
Sbjct: 128 FLNLLGNPY-KTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDL 186
Query: 302 VGTVPATIFNVSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSGTLPSFIFNA 361
S + + N+ L L L
Sbjct: 187 Q-------------------------SYEPKSLKSIQNVSHLILHMKQHI-LLL------ 214
Query: 362 SNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNYLTSPELSFLS-----SLSNCKYLE 416
+++ L L + L + S LS SL
Sbjct: 215 -----------------EIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFR 257
Query: 417 IIALSGNPLNGIIPMSAGNLSHSLEELFMPDCNVSGRIPKEI-GNLANLVTLDLGGNKFN 475
+ ++ L ++ + L EL + +P I L +L + L N ++
Sbjct: 258 NVKITDESLFQVMKLLNQI--SGLLELEFSRNQLKS-VPDGIFDRLTSLQKIWLHTNPWD 314
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-23
Identities = 44/226 (19%), Positives = 89/226 (39%), Gaps = 16/226 (7%)
Query: 460 NLANLVTLDLGGNKFNGSIPI-ALGKLQKLQLLNLDDNKLEGSIPDDI-CGLVELYKLAL 517
NL L L N N +I + L L+ L+L N L ++ L L L L
Sbjct: 74 RCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNL 131
Query: 518 GDNKLSGQIPA-CFGNLASLRELWLGPNELISFIPS-TFWNIKDIMYVNFSSNFLTGPLP 575
N F +L L+ L +G + + I F + + + ++ L P
Sbjct: 132 LGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEP 191
Query: 576 LEIENLKALTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQG----SIP----DSVG 627
+++++ ++ L M ++ + ++ L L L + +S+
Sbjct: 192 KSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLI 251
Query: 628 DLISLKSLNLSNNNLSGPIPTSLEKLSDLKELNLSFNKLEGEIPRG 673
+ +++ +++ +L + L ++S L EL S N+L+ +P G
Sbjct: 252 KKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKS-VPDG 295
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 2e-18
Identities = 52/264 (19%), Positives = 86/264 (32%), Gaps = 39/264 (14%)
Query: 448 CNVSGR----IPKEIGNLANLVTLDLGGNKFNGSIPIALGKLQKLQLLNLDDNKLEGSIP 503
C S IP + + +LDL N+ L + LQ L L N + +I
Sbjct: 36 CKGSSGSLNSIPSGL--TEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIE 92
Query: 504 DDI-CGLVELYKLALGDNKLSGQIPACFGNLASLRELWLGPNELISFIPSTFWNIKDIMY 562
+D L L L L N LS + F L+SL L L N + ++ ++
Sbjct: 93 EDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFS------ 146
Query: 563 VNFSSNFLTGPLPLEIENLKALTTLDFSMNN-LSGVIPTTIGGLKGLQYLFLGHNRLQGS 621
+L L L + + + GL L+ L + + LQ S
Sbjct: 147 -----------------HLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQ-S 188
Query: 622 IPDSV-GDLISLKSLNLSNNNLSGPIPTSLEKLSDLKELNLSFNKLEG----EIPRGGPF 676
+ ++ L L + ++ S ++ L L L+ E+ G
Sbjct: 189 YEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELST-GET 247
Query: 677 VNFSAKSFMGNNLLCGSPNLQVPP 700
+ K N + QV
Sbjct: 248 NSLIKKFTFRNVKITDESLFQVMK 271
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 4e-05
Identities = 16/76 (21%), Positives = 29/76 (38%), Gaps = 3/76 (3%)
Query: 82 SLTGNIPRQLGNLSSLEILDLNFNRLSGEIPWELGNLAKLEKLLLHNNFLTGTIPFSIFK 141
L+ L + + + L ++ L ++ L +L N L ++P IF
Sbjct: 241 ELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLK-SVPDGIFD 298
Query: 142 -LSSLLDLKLSDNNLT 156
L+SL + L N
Sbjct: 299 RLTSLQKIWLHTNPWD 314
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-30
Identities = 31/304 (10%), Positives = 70/304 (23%), Gaps = 57/304 (18%)
Query: 776 LIGRGSFGSVYIAR-LQNGIEVAVKTFD---LQHERAFKSFDTECEVMKSIRHRNLTKII 831
+ G V++ R ++ + A+K F + + + +
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 832 SSC----------------------SNEDFKA----LILEYM-----RNGSLEKCLYSGN 860
+D+ L++ S +Y
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188
Query: 861 YILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLI 920
I + + L S ++H P N+ + + L D +
Sbjct: 189 GDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALW-KV 244
Query: 921 GEDQSMTQTQTLATLGYMAPEY--GREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGE 978
G + + Y E+ + + + G+ + + P F
Sbjct: 245 GTRGPASSV----PVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP----F--- 293
Query: 979 MTLKHWVNDFLPISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAK 1038
+ K + T+ F + V L R+
Sbjct: 294 -----GLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPL 348
Query: 1039 EIVR 1042
E +
Sbjct: 349 EAME 352
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 6e-30
Identities = 60/309 (19%), Positives = 114/309 (36%), Gaps = 52/309 (16%)
Query: 776 LIGRGSFGSVYIAR-LQNGIEVAVKTFDLQH-ERAFKSFDTECEVMKSIRHRNLTKIISS 833
+GRG FG V+ A+ + A+K L + E A + E + + + H + + ++
Sbjct: 12 CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 71
Query: 834 CSNEDFKA------------LILEYMRNGSLEKCL--YSGNYILDIFQRLNIMIDVASAL 879
++ + ++ R +L+ + + L+I + +A A+
Sbjct: 72 WLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAV 131
Query: 880 EYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLG--- 936
E+LH S ++H DLKPSN+ + V + DFG+ + +++ T +
Sbjct: 132 EFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHT 188
Query: 937 -------YMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFL 989
YM+PE S K D++S G++L E FS +M
Sbjct: 189 GQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYP-------FSTQMER-------- 233
Query: 990 PISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR-LLKIR 1048
+ + + E + + SP ER A I+ + +
Sbjct: 234 -VRTLTDVRNLKFPPLFTQKYPCEY------VMVQDMLSPSPMERPEAINIIENAVFEDL 286
Query: 1049 DFLLRNVES 1057
DF + V
Sbjct: 287 DFPGKTVLR 295
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 6e-30
Identities = 56/195 (28%), Positives = 94/195 (48%), Gaps = 10/195 (5%)
Query: 771 FSENNLIGRGSFGSVYIAR-LQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTK 829
++ IG+G+ G+VY A + G EVA++ +LQ + + E VM+ ++ N+
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 830 IISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAP 889
+ S D +++EY+ GSL + +D Q + + ALE+LH S
Sbjct: 82 YLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQ 136
Query: 890 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLA-TLGYMAPEYGREGRV 948
VIH D+K N+LL + L+DFG + ++ T+ T +MAPE
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQI---TPEQSKRSTMVGTPYWMAPEVVTRKAY 193
Query: 949 STKGDVYSFGILLME 963
K D++S GI+ +E
Sbjct: 194 GPKVDIWSLGIMAIE 208
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 122 bits (306), Expect = 1e-29
Identities = 37/309 (11%), Positives = 80/309 (25%), Gaps = 70/309 (22%)
Query: 776 LIGRGSFGSVYIAR-LQNGIEVAVKTFDLQHE---RAFKSFDTECEVMKSIRHRNLTKII 831
++G+ + A + G V A K E ++ +R K
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 832 SSCSNEDFKALILE------YMRNGSLEKCLYSGNYI----------------------- 862
F +++ +R E+ ++ +
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 863 ---LDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL 919
L RL + + V L LH ++H L+P +++LD L+ F
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261
Query: 920 IGEDQSMTQTQTLATLGYMAPE-----YGREGRVSTKGDVYSFGILLMETFTRRKPTDEI 974
G + A A ++ D ++ G+ + + P
Sbjct: 262 -GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP---- 316
Query: 975 FSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDER 1034
+ + L + F + + V L ++R
Sbjct: 317 NTDD---------------------AALGGSEWIFRSCKNIPQPVRALLEGFLRYPKEDR 355
Query: 1035 ITAKEIVRR 1043
+ + +
Sbjct: 356 LLPLQAMET 364
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-29
Identities = 55/195 (28%), Positives = 98/195 (50%), Gaps = 10/195 (5%)
Query: 771 FSENNLIGRGSFGSVYIAR-LQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTK 829
IG GS G V +AR +G +VAVK DL+ ++ + E +M+ +H N+ +
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106
Query: 830 IISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAP 889
+ S + +++E+++ G+L + L+ Q + V AL YLH +
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGALTDIVSQV--RLNEEQIATVCEAVLQALAYLH---AQG 161
Query: 890 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLA-TLGYMAPEYGREGRV 948
VIH D+K ++LL + LSDFG + + + + ++L T +MAPE
Sbjct: 162 VIHRDIKSDSILLTLDGRVKLSDFGFCAQI---SKDVPKRKSLVGTPYWMAPEVISRSLY 218
Query: 949 STKGDVYSFGILLME 963
+T+ D++S GI+++E
Sbjct: 219 ATEVDIWSLGIMVIE 233
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 56/278 (20%), Positives = 97/278 (34%), Gaps = 38/278 (13%)
Query: 771 FSENNLIGRGSFGSVYIAR-LQNGIEVAVK--TFDLQHERAFKSFDTECEVMKSI-RHRN 826
F + +G GS+G V+ R ++G AVK + + E + + +H
Sbjct: 59 FQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPC 118
Query: 827 LTKIISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGY 886
++ + L E SL++ + L Q + D AL +LH
Sbjct: 119 CVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH--- 174
Query: 887 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLA-TLGYMAPEYGRE 945
S ++H D+KP+N+ L L DFG+ L + + YMAPE +
Sbjct: 175 SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVEL----GTAGAGEVQEGDPRYMAPELLQG 230
Query: 946 GRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITE 1005
T DV+S G+ ++E + GE ++ L
Sbjct: 231 SY-GTAADVFSLGLTILEVACNMELP---HGGE-------------GWQQLRQGYLPPEF 273
Query: 1006 DKHFAAKEQCASSVF-NLAMECTVESPDERITAKEIVR 1042
SS ++ + P R TA+ ++
Sbjct: 274 TAGL-------SSELRSVLVMMLEPDPKLRATAEALLA 304
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 8e-29
Identities = 58/263 (22%), Positives = 94/263 (35%), Gaps = 38/263 (14%)
Query: 65 TCDINQRRVTALNISYLSLTGNIPRQLGNLSSLEILDLNFNRLSGEIPWELGNLAKLEKL 124
C + + L +P + ++ + + L+ NR+S L L
Sbjct: 7 VCYNEPK--VTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTIL 61
Query: 125 LLHNNFLTGTIPFSIFK-LSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQLSGS 183
LH+N L I + F L+ L L LSDN ++ L L L L L
Sbjct: 62 WLHSNVLA-RIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-E 119
Query: 184 IPSFIF-KISSLQALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGGISSTLSNCKH 242
+ +F +++LQ L+ +N L LP + +L +
Sbjct: 120 LGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLG------------------------N 154
Query: 243 LRILDLSFNDLWGDIPKEI-GNLTKLKELFLDFNILQGEIPHTVGNLHNLEYLSLVNNEL 301
L L L N + +P+ L L L L N + PH +L L L L N L
Sbjct: 155 LTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNL 213
Query: 302 VGTVPATIF-NVSTLKLIELSNN 323
+P + L+ + L++N
Sbjct: 214 S-ALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 66/280 (23%), Positives = 102/280 (36%), Gaps = 64/280 (22%)
Query: 151 SDNNLTGTIPSHNLGNLSSLQLLDLSDNQLSGSIPSFIFK-ISSLQALHFGNNRLSGELP 209
L +P G ++ Q + L N++S +P+ F+ +L L +N L+ +
Sbjct: 19 PQQGLQ-AVPV---GIPAASQRIFLHGNRIS-HVPAASFRACRNLTILWLHSNVLA-RID 72
Query: 210 ANICDNLPFLNFFSVYKNMFYGGISSTLSNCKHLRILDLSFNDLWGDIPKEI-GNLTKLK 268
A L L LDLS N + L +L
Sbjct: 73 AAAFTGLA------------------------LLEQLDLSDNAQLRSVDPATFHGLGRLH 108
Query: 269 ELFLDFNILQGEIPHTV-GNLHNLEYLSLVNNELVGTVPATIFNVSTLKLIELSNNTFFG 327
L LD LQ E+ + L L+YL L +N L +P F
Sbjct: 109 TLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFR---------------- 150
Query: 328 SLPSSTDVQLPNLEELYLWGNNFSGTLPSFIF-NASNLSKLSLGDNSFSGLIPNTFGNLR 386
L NL L+L GN S ++P F +L +L L N + + P+ F +L
Sbjct: 151 --------DLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLG 201
Query: 387 NLKRLRLYNNYLTSPELSFLSSLSNCKYLEIIALSGNPLN 426
L L L+ N L++ L+ L L+ + L+ NP
Sbjct: 202 RLMTLYLFANNLSALPTEALAPLRA---LQYLRLNDNPWV 238
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 59/232 (25%), Positives = 77/232 (33%), Gaps = 34/232 (14%)
Query: 447 DCNVSG--RIPKEIGNLANLVTLDLGGNKFNGSIPIALGKLQKLQLLNLDDNKLEGSIPD 504
C G +P I A + L GN+ + + + L +L L N L I
Sbjct: 17 SCPQQGLQAVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDA 73
Query: 505 DI-CGLVELYKLALGDNKLSGQIPA-CFGNLASLRELWLGPNELISFIPSTFWNIKDIMY 562
GL L +L L DN + F L L L L L P F
Sbjct: 74 AAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLF-------- 125
Query: 563 VNFSSNFLTGPLPLEIENLKALTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQGSI 622
L AL L N L + T L L +LFL NR+ S+
Sbjct: 126 ----------------RGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRIS-SV 168
Query: 623 PDSV-GDLISLKSLNLSNNNLSGPIPTSLEKLSDLKELNLSFNKLEGEIPRG 673
P+ L SL L L N ++ P + L L L L N L +P
Sbjct: 169 PERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLS-ALPTE 219
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 4e-25
Identities = 60/233 (25%), Positives = 84/233 (36%), Gaps = 29/233 (12%)
Query: 435 NLSHSLEELFMPDCNVSGRIPKEIGNLANLVTLDLGGNKFNGSIPIALGKLQKLQLLNLD 494
+ + + +F+ +S NL L L N A L L+ L+L
Sbjct: 29 GIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLS 88
Query: 495 DNKLEGSIPDDI-CGLVELYKLALGDNKLSGQIPA-CFGNLASLRELWLGPNELISFIPS 552
DN S+ GL L+ L L L ++ F LA+L+ L+L N L +
Sbjct: 89 DNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQALPDD 147
Query: 553 TFWNIKDIMYVNFSSNFLTGPLPLEIENLKALTTLDFSMNNLSGVIPTTIGGLKGLQYLF 612
TF +L LT L N +S V GL L L
Sbjct: 148 TF------------------------RDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLL 183
Query: 613 LGHNRLQGSIPDSV-GDLISLKSLNLSNNNLSGPIPTSLEKLSDLKELNLSFN 664
L NR+ + DL L +L L NNLS +L L L+ L L+ N
Sbjct: 184 LHQNRVA-HVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 57/220 (25%), Positives = 92/220 (41%), Gaps = 12/220 (5%)
Query: 256 DIPKEIGNLTKLKELFLDFNILQGEIPHTVGNLHNLEYLSLVNNELVGTVPATIF-NVST 314
+P I + +FL N + + NL L L +N L + A F ++
Sbjct: 25 AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVL-ARIDAAAFTGLAL 81
Query: 315 LKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSGTLPSFIF-NASNLSKLSLGDNS 373
L+ ++LS+N S+ +T L L L+L L +F + L L L DN+
Sbjct: 82 LEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNA 140
Query: 374 FSGLIPNTFGNLRNLKRLRLYNNYLTSPELSFLSSLSNCKYLEIIALSGNPLNGIIPMSA 433
L +TF +L NL L L+ N ++S L + L+ + L N + + P +
Sbjct: 141 LQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHS---LDRLLLHQNRVAHVHPHAF 197
Query: 434 GNLSHSLEELFMPDCNVSGRIPKEI-GNLANLVTLDLGGN 472
+L L L++ N+S +P E L L L L N
Sbjct: 198 RDLG-RLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 7e-13
Identities = 36/110 (32%), Positives = 52/110 (47%), Gaps = 8/110 (7%)
Query: 77 NISYLSLTGN----IPRQ-LGNLSSLEILDLNFNRLSGEIPWELGNLAKLEKLLLHNNFL 131
+ YL L N +P +L +L L L+ NR+S L L++LLLH N +
Sbjct: 130 ALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRV 189
Query: 132 TGTIPFSIF-KLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQL 180
+ F L L+ L L NNL+ +P+ L L +LQ L L+DN
Sbjct: 190 A-HVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDNPW 237
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 4e-28
Identities = 62/284 (21%), Positives = 108/284 (38%), Gaps = 40/284 (14%)
Query: 777 IGRGSFGSVYIAR-LQNGIEVAVKTFDLQ-HERAFKSFDTECEVMKSIRHRNLTKII--- 831
+G G FG V G +VA+K + + + + E ++MK + H N+
Sbjct: 22 LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81
Query: 832 ---SSCSNEDFKALILEYMRNGSLEKCL--YSGNYILDIFQRLNIMIDVASALEYLHFGY 886
+ D L +EY G L K L + L ++ D++SAL YLH
Sbjct: 82 DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH--- 138
Query: 887 SAPVIHCDLKPSNVLLD---DNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYG 943
+IH DLKP N++L ++ + D G AK L + + + TL Y+APE
Sbjct: 139 ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL--DQGELCTEF-VGTLQYLAPELL 195
Query: 944 REGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLI 1003
+ + + D +SFG L E T +P ++ ++ P+ +
Sbjct: 196 EQKKYTVTVDYWSFGTLAFECITGFRP-------------FLPNWQPVQWHGKV------ 236
Query: 1004 TEDKHFAAKEQCASSVFNLAMECTVESPDERIT-AKEIVRRLLK 1046
+K + + +P+ + R L+
Sbjct: 237 -REKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQ 279
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 4e-28
Identities = 61/372 (16%), Positives = 108/372 (29%), Gaps = 70/372 (18%)
Query: 111 IPWELGNLAKLEKLLLHNNFLTGTIPFSIF----KLSSLLDLKLSDNNLTGTIPSHNLGN 166
I + N L + +N ++ F K + N +
Sbjct: 3 IMLPINNNFSLSQNSFYNT-IS-GTYADYFSAWDKWEKQALPGENRNEAVSLLKE---CL 57
Query: 167 LSSLQLLDLSDNQLSGSIPSFIFKISSLQALHFGNNRLSGELPANICDNLPFLNFFSVYK 226
++ L L+ LS S+P + + L N L LP
Sbjct: 58 INQFSELQLNRLNLS-SLPDNLPP--QITVLEITQNALI-SLPELPAS------------ 101
Query: 227 NMFYGGISSTLSNCKHLRILDLSFNDLWGDIPKEIGNLTKLKELFLDFNILQGEIPHTVG 286
L LD N L +P+ + LK L +D N L +P
Sbjct: 102 ----------------LEYLDACDNRL-STLPELPAS---LKHLDVDNNQLT-MLPELPA 140
Query: 287 NLHNLEYLSLVNNELVGTVPATIFNVSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYLW 346
LEY++ NN+L +P + L+++ + NN LP +LE L +
Sbjct: 141 ---LLEYINADNNQLT-MLPELPTS---LEVLSVRNN-QLTFLPE----LPESLEALDVS 188
Query: 347 GNNFSGTLPSFIFNASNLSK----LSLGDNSFSGLIPNTFGNLRNLKRLRLYNNYLTSPE 402
N +LP+ + + +N + + P +L + L +N L+S
Sbjct: 189 TNLLE-SLPAVPVRNHHSEETEIFFRCRENRITHI-PENILSLDPTCTIILEDNPLSSRI 246
Query: 403 LSFLSSLSNCKYLEIIALSGNPLNGIIPMSAGNLSHSLEELFMPDCNVSGRIPKEIGNLA 462
LS + P + ++ +
Sbjct: 247 RESLSQQTA------QPDYHGPRIYFSMSDGQQNTLHRPLADAVTAWFPENKQSDVSQIW 300
Query: 463 NLVTLDLGGNKF 474
+ + N F
Sbjct: 301 HAFEHEEHANTF 312
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 5e-27
Identities = 60/294 (20%), Positives = 113/294 (38%), Gaps = 33/294 (11%)
Query: 383 GNLRNLKRLRLYNNYLTSPELSFLSSLSNCKYLEIIALSGNPLNGIIPMSAGNLSHSLEE 442
N +L + YN ++ + S+ E AL G N + + L + E
Sbjct: 8 NNNFSLSQNSFYNT-ISGTYADYFSAWDK---WEKQALPGENRNEAVSLLKECLINQFSE 63
Query: 443 LFMPDCNVSGRIPKEIGNLANLVTLDLGGNKFNGSIPIALGKLQKLQLLNLDDNKLEGSI 502
L + N+S +P + + L++ N S+P L+ L + DN+L ++
Sbjct: 64 LQLNRLNLS-SLPDNLPP--QITVLEITQNAL-ISLPELPASLEYL---DACDNRLS-TL 115
Query: 503 PDDICGLVELYKLALGDNKLSGQIPACFGNLASLRELWLGPNELISFIPSTFWNIKDIMY 562
P+ L L + +N+L+ +P L + N+L +P +++ +
Sbjct: 116 PELPASLKHLD---VDNNQLT-MLPELPALL---EYINADNNQLTM-LPELPTSLEVL-- 165
Query: 563 VNFSSNFLTGPLPLEIENLKALTTLDFSMNNLSGVIPTTIGGLKGLQ----YLFLGHNRL 618
+ +N LT LP E+L LD S N L +P + + NR+
Sbjct: 166 -SVRNNQLTF-LPELPESL---EALDVSTNLLES-LPAVPVRNHHSEETEIFFRCRENRI 219
Query: 619 QGSIPDSVGDLISLKSLNLSNNNLSGPIPTSLEKLSDLKELNLSFNKLEGEIPR 672
IP+++ L ++ L +N LS I SL + + + + +
Sbjct: 220 T-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQ 272
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 110 bits (275), Expect = 6e-25
Identities = 56/257 (21%), Positives = 98/257 (38%), Gaps = 31/257 (12%)
Query: 94 LSSLEILDLNFNRLSGEIPWELGNLAKLEKLLLHNNFLTGTIPFSIFKLSSLLDLKLSDN 153
++ L LN LS +P L ++ L + N L ++P +SL L DN
Sbjct: 58 INQFSELQLNRLNLS-SLPDNLPP--QITVLEITQNALI-SLPELP---ASLEYLDACDN 110
Query: 154 NLTGTIPSHNLGNLSSLQLLDLSDNQLSGSIPSFIFKISSLQALHFGNNRLSGELPANIC 213
L+ T+P +SL+ LD+ +NQL+ +P + L+ ++ NN+L+ LP
Sbjct: 111 RLS-TLPEL----PASLKHLDVDNNQLT-MLPEL---PALLEYINADNNQLT-MLPELPT 160
Query: 214 DNLPFLNFFSVYKNMFYGGISSTLSNCKHLRILDLSFNDLWGDIPKEIGNLTKLKE---- 269
+L L+ V N + + L LD+S N L +P +E
Sbjct: 161 -SLEVLS---VRNNQL-TFLPELPES---LEALDVSTNLL-ESLPAVPVRNHHSEETEIF 211
Query: 270 LFLDFNILQGEIPHTVGNLHNLEYLSLVNNELVGTVPATIFNVSTLKLIELSNNTFFGSL 329
N + IP + +L + L +N L + ++ + F S
Sbjct: 212 FRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSD 270
Query: 330 PSSTDVQLPNLEELYLW 346
+ P + + W
Sbjct: 271 GQQNTLHRPLADAVTAW 287
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 9e-24
Identities = 80/433 (18%), Positives = 145/433 (33%), Gaps = 55/433 (12%)
Query: 216 LPFLNFFSVYKNMFYGGISST-------LSNCKHLRILDLSFNDLWGDIPKEIGNLTKLK 268
LP N FS+ +N FY IS T + + + N+ + + + +
Sbjct: 5 LPINNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKE--CLINQFS 62
Query: 269 ELFLDFNILQGEIPHTVGNLHNLEYLSLVNNELVGTVPATIFNVSTLKLIELSNNTFFGS 328
EL L+ L +P + + L + N L+ ++P ++ L + +N +
Sbjct: 63 ELQLNRLNLS-SLPDNLPP--QITVLEITQNALI-SLPELPASLEYL---DACDN-RLST 114
Query: 329 LPSSTDVQLPNLEELYLWGNNFSGTLPSFIFNASNLSKLSLGDNSFSGLIPNTFGNLRNL 388
LP +L+ L + N + LP + L ++ +N + L P +L
Sbjct: 115 LPEL----PASLKHLDVDNNQLT-MLPELP---ALLEYINADNNQLTML-PEL---PTSL 162
Query: 389 KRLRLYNNYLTS-PELSFLSSLSNCKYLEIIALSGNPLNGIIPMSAGNLSHSLEELFMPD 447
+ L + NN LT PEL + LE + +S N L + P HS E
Sbjct: 163 EVLSVRNNQLTFLPEL-----PES---LEALDVSTNLLESL-PAVPVRNHHSEETEIFFR 213
Query: 448 C--NVSGRIPKEIGNLANLVTLDLGGNKFNGSIPIALGKLQKLQLLNLDDNKLEGSIPDD 505
C N IP+ I +L T+ L N + I +L + +
Sbjct: 214 CRENRITHIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYF-----SM 268
Query: 506 ICGLVELYKLALGDNKLSGQIPACFGNLASLRELWLGPNELISFIPSTFWNIKDIMYVNF 565
G L D + + + ++W + + + V+
Sbjct: 269 SDGQQNTLHRPLADAVTAWFPENK---QSDVSQIWHAFEHEEHANTFSAFLDRLSDTVSA 325
Query: 566 SSNFLTGP-LPLEIENLKALTTLDFSMNNLSGVIPTTIG-----GLKGLQYLFLGHNRLQ 619
+ + +E L A L ++ + L+ L H +
Sbjct: 326 RNTSGFREQVAAWLEKLSASAELRQQSFAVAADATESCEDRVALTWNNLRKTLLVHQASE 385
Query: 620 GSIPDSVGDLISL 632
G + G L+SL
Sbjct: 386 GLFDNDTGALLSL 398
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 3e-23
Identities = 52/298 (17%), Positives = 106/298 (35%), Gaps = 41/298 (13%)
Query: 360 NASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRL----YNNYLTSPELSFLSSLSNCKYL 415
N +LS+ S N+ SG + F ++ L N ++ + ++
Sbjct: 9 NNFSLSQNSF-YNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECLINQF------ 61
Query: 416 EIIALSGNPLNGIIPMSAGNLSHSLEELFMPDCNVSGRIPKEIGNLANLVTLDLGGNKFN 475
+ L+ L+ +P + + L + + +P+ +L LD N+ +
Sbjct: 62 SELQLNRLNLS-SLPDNLPP---QITVLEITQNALI-SLPELPASL---EYLDACDNRLS 113
Query: 476 GSIPIALGKLQKLQLLNLDDNKLEGSIPDDICGLVELYKLALGDNKLSGQIPACFGNLAS 535
++P L+ L ++D+N+L +P+ L + +N+L+ +P S
Sbjct: 114 -TLPELPASLKHL---DVDNNQLT-MLPELPALLEYIN---ADNNQLT-MLPE---LPTS 161
Query: 536 LRELWLGPNELISFIPSTFWNIKDIMYVNFSSNFLTGPLPLEIENLKALTT----LDFSM 591
L L + N+L +P +++ + + S+N L LP
Sbjct: 162 LEVLSVRNNQLTF-LPELPESLEAL---DVSTNLLES-LPAVPVRNHHSEETEIFFRCRE 216
Query: 592 NNLSGVIPTTIGGLKGLQYLFLGHNRLQGSIPDSVGDLISLKSLNLSNNNLSGPIPTS 649
N ++ IP I L + L N L I +S+ + + S
Sbjct: 217 NRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQ 273
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 98.9 bits (246), Expect = 2e-21
Identities = 57/273 (20%), Positives = 93/273 (34%), Gaps = 46/273 (16%)
Query: 71 RRVTALNISYLSLTGNIPRQLGNLSSLEILDLNFNRLSGEIPWELGNLAKLEKLLLHNNF 130
++T L I+ +L ++P + LE LD NRLS +P + L+ L + NN
Sbjct: 80 PQITVLEITQNALI-SLPELPAS---LEYLDACDNRLS-TLPELPAS---LKHLDVDNNQ 131
Query: 131 LTGTIPFSIFKLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQLSGSIPSFIFK 190
LT +P + L + +N LT +P +SL++L + +NQL+ +P
Sbjct: 132 LT-MLPELP---ALLEYINADNNQLT-MLPE----LPTSLEVLSVRNNQLT-FLPEL--- 178
Query: 191 ISSLQALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGGISSTLSNCKHLRILDLSF 250
SL+AL N L LPA N +
Sbjct: 179 PESLEALDVSTNLLE-SLPAVPVRNHHSE---------------------ETEIFFRCRE 216
Query: 251 NDLWGDIPKEIGNLTKLKELFLDFNILQGEIPHTVGNLHNLEYLSLVNNELVGTVPATIF 310
N + IP+ I +L + L+ N L I ++ ++
Sbjct: 217 NRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYF--SMSDGQQ 273
Query: 311 NVSTLKLIELSNNTFFGSLPSSTDVQLPNLEEL 343
N L + F + S E
Sbjct: 274 NTLHRPLADAVTAWFPENKQSDVSQIWHAFEHE 306
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 77.7 bits (191), Expect = 8e-15
Identities = 37/276 (13%), Positives = 80/276 (28%), Gaps = 27/276 (9%)
Query: 77 NISYLSLTGN----IPRQLGNLSSLEILDLNFNRLSGEIPWELGNLAKLEKLLLHNNFLT 132
+ Y++ N +P +L E+L + N+L+ +P +L E L + N L
Sbjct: 141 LLEYINADNNQLTMLPELPTSL---EVLSVRNNQLT-FLPELPESL---EALDVSTNLLE 193
Query: 133 GTIPFSIFKLSSL----LDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQLSGSIPSFI 188
++P + + + +N +T IP N+ +L + L DN LS I +
Sbjct: 194 -SLPAVPVRNHHSEETEIFFRCRENRIT-HIPE-NILSLDPTCTIILEDNPLSSRIRESL 250
Query: 189 FKISSLQALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGGISSTLSNCKHLRILDL 248
+ ++ H S + + +
Sbjct: 251 SQQTAQPDYHGPRIYFS-------MSDGQQNTLHRPLADAVTAWFPENKQSDVSQIWHAF 303
Query: 249 SFNDLWGDIPKEIGNLTKLKELFLDFNILQGEIPHTVGNLHNLEYLSLVNNELVGTVPAT 308
+ + L+ + + + ++ + L L + + +
Sbjct: 304 EHEEHANTFSAFLDRLSDTVS-ARNTSGFREQVAAWLEKLSASAELRQQSFAVAADATES 362
Query: 309 IFNVSTLKLIELSNNTF-FGSLPSSTDVQLPNLEEL 343
+ L L + D L L
Sbjct: 363 CEDRVALTWNNLRKTLLVHQASEGLFDNDTGALLSL 398
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 4e-28
Identities = 48/200 (24%), Positives = 94/200 (47%), Gaps = 13/200 (6%)
Query: 771 FSENNLIGRGSFGSVYIAR-LQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTK 829
+ +G G+FG VY A+ + G A K + + E + + E E++ + H + K
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 830 IISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAP 889
++ + ++ +++E+ G+++ + + L Q + + AL +LH S
Sbjct: 81 LLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH---SKR 137
Query: 890 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLA-TLGYMAPE-----YG 943
+IH DLK NVL+ L+DFG++ +++ + + T +MAPE
Sbjct: 138 IIHRDLKAGNVLMTLEGDIRLADFGVSAKN---LKTLQKRDSFIGTPYWMAPEVVMCETM 194
Query: 944 REGRVSTKGDVYSFGILLME 963
++ K D++S GI L+E
Sbjct: 195 KDTPYDYKADIWSLGITLIE 214
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 1e-27
Identities = 59/294 (20%), Positives = 109/294 (37%), Gaps = 32/294 (10%)
Query: 771 FSENNLIGRGSFGSVYIARL-QNGIEVAVKTFDLQH-ERAFKSFDTECEVMKSIRHRNLT 828
F + + +G G+ G V+ +G+ +A K L+ E +V+ +
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 94
Query: 829 KIISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSA 888
+ ++ ++ +E+M GSL++ + + + I V L YL +
Sbjct: 95 GFYGAFYSDGEISICMEHMDGGSLDQ-VLKKAGRIPEQILGKVSIAVIKGLTYLREKHK- 152
Query: 889 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRV 948
++H D+KPSN+L++ L DFG++ LI SM + + T YM+PE +
Sbjct: 153 -IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANS-FVGTRSYMSPERLQGTHY 207
Query: 949 STKGDVYSFGILLMETFTRRKP----------------------TDEIFSGEMTLKHWVN 986
S + D++S G+ L+E R P
Sbjct: 208 SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKF 267
Query: 987 DFLPISMMKIIDANLLITEDKHFAAKEQCASSVF-NLAMECTVESPDERITAKE 1039
M I + I + S F + +C +++P ER K+
Sbjct: 268 GMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQ 321
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 59/242 (24%), Positives = 96/242 (39%), Gaps = 57/242 (23%)
Query: 775 NLIGRGSFGSVYIAR-LQNGIEVAVKTFD---LQHERAFKSFDTECEVMKSIRHRNLTKI 830
+G+G FG+VY+AR Q+ +A+K L+ E E+ +RH N+ ++
Sbjct: 15 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 831 ISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLN------IMIDVASALEYLHF 884
+ LILEY G++ + L + + + ++A+AL Y H
Sbjct: 75 YGYFHDATRVYLILEYAPLGTVYRELQKL-------SKFDEQRTATYITELANALSYCH- 126
Query: 885 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTL-ATLGYMAPEYG 943
S VIH D+KP N+LL ++DFG + + L TL Y+ PE
Sbjct: 127 --SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-----RRTDLCGTLDYLPPEM- 178
Query: 944 REGRVSTKG-----DVYSFGILL---------------METFTRRKPTDEIFSGEMTLKH 983
+ + D++S G+L ET+ R I E T
Sbjct: 179 ----IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKR------ISRVEFTFPD 228
Query: 984 WV 985
+V
Sbjct: 229 FV 230
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 53/238 (22%), Positives = 101/238 (42%), Gaps = 44/238 (18%)
Query: 776 LIGRGSFGSVYIAR-LQNGIEVAVKTFD---LQHERAFKSFDTECEVMKSIRHRNLTKII 831
L+G+GSF VY A + G+EVA+K D + + E ++ ++H ++ ++
Sbjct: 18 LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77
Query: 832 SSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVI 891
+ + ++ L+LE NG + + L + + + M + + + YLH S ++
Sbjct: 78 NYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH---SHGIL 134
Query: 892 HCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTL-ATLGYMAPE------YGR 944
H DL SN+LL NM ++DFG+A L + TL T Y++PE +G
Sbjct: 135 HRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKH---YTLCGTPNYISPEIATRSAHG- 190
Query: 945 EGRVSTKGDVYSFGILL---------------METFTRRKPTDEIFSGEMTLKHWVND 987
+ DV+S G + T + + + + +++
Sbjct: 191 -----LESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNK------VVLADYEMPSFLSI 237
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 1e-27
Identities = 63/307 (20%), Positives = 109/307 (35%), Gaps = 67/307 (21%)
Query: 771 FSENNLIGRGSFGSVYIARLQNGIEVAVKTFDLQHERAFKSFDTECEVM-KSIRHRNLTK 829
++G GS G+V G VAVK + E +++ +S H N+ +
Sbjct: 17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIR 73
Query: 830 IISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRL------NIMIDVASALEYLH 883
S + + F + LE N +L+ + S N + + +++ +AS + +LH
Sbjct: 74 YYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH 132
Query: 884 FGYSAPVIHCDLKPSNVLLD-------------DNMVAHLSDFGIAKLLIGEDQSMTQTQ 930
S +IH DLKP N+L+ +N+ +SDFG+ K L S
Sbjct: 133 ---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNL 189
Query: 931 TLA--TLGYMAPE-------YGREGRVSTKGDVYSFGILLMETFTRRKP--------TDE 973
T G+ APE + R++ D++S G + ++ K
Sbjct: 190 NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESN 249
Query: 974 IFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDE 1033
I G +L LI E ++ P +
Sbjct: 250 IIRGIFSLDEMKCLHDR----------SLIAEATDLISQ-------------MIDHDPLK 286
Query: 1034 RITAKEI 1040
R TA ++
Sbjct: 287 RPTAMKV 293
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 56/195 (28%), Positives = 89/195 (45%), Gaps = 10/195 (5%)
Query: 771 FSENNLIGRGSFGSVYIAR-LQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTK 829
F +G GS+GSVY A + G VA+K ++ + + E +M+ ++ K
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD--LQEIIKEISIMQQCDSPHVVK 88
Query: 830 IISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAP 889
S +++EY GS+ + N L + I+ LEYLH
Sbjct: 89 YYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLH---FMR 145
Query: 890 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLA-TLGYMAPEYGREGRV 948
IH D+K N+LL+ A L+DFG+A L +M + T+ T +MAPE +E
Sbjct: 146 KIHRDIKAGNILLNTEGHAKLADFGVAGQL---TDTMAKRNTVIGTPFWMAPEVIQEIGY 202
Query: 949 STKGDVYSFGILLME 963
+ D++S GI +E
Sbjct: 203 NCVADIWSLGITAIE 217
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-27
Identities = 59/295 (20%), Positives = 106/295 (35%), Gaps = 40/295 (13%)
Query: 776 LIGRGSFGSVYIAR-LQNGIEVAVKTFD-LQHERAFKSFDTECEVMKSIRHRNLTKI--I 831
++G+G+ +V+ R + G A+K F+ + R E EV+K + H+N+ K+ I
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 832 SSCSNEDFKALILEYMRNGSLEKCLYS--GNYILDIFQRLNIMIDVASALEYLHFGYSAP 889
+ K LI+E+ GSL L Y L + L ++ DV + +L
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENG 132
Query: 890 VIHCDLKPSNVLL----DDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPE-YGR 944
++H ++KP N++ D V L+DFG A+ L ED + T Y+ P+ Y R
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL--EDDEQFVSL-YGTEEYLHPDMYER 189
Query: 945 EGRVSTKG-------DVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKII 997
D++S G+ T P F + I K
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP----FRPFEGPRRNKEVMYKIITGKPS 245
Query: 998 DANLLITEDKHFAAK------------EQCASSVFNLAMECTVESPDERITAKEI 1040
A + + ++ + + ++ +
Sbjct: 246 GAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQF 300
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 5e-27
Identities = 79/281 (28%), Positives = 122/281 (43%), Gaps = 39/281 (13%)
Query: 771 FSENNLIGRGSFGSVYIAR-LQNGIEVAVKTFDL-QHERAFKSFDTECEVMKSIRHRNLT 828
F++ IG+GSFG V+ + VA+K DL + E + E V+ +T
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 829 KIISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSA 888
K S + +I+EY+ GS L G LD Q I+ ++ L+YLH S
Sbjct: 84 KYYGSYLKDTKLWIIMEYLGGGSALDLLEPG--PLDETQIATILREILKGLDYLH---SE 138
Query: 889 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLA-TLGYMAPEYGREGR 947
IH D+K +NVLL ++ L+DFG+A L + + T T +MAPE ++
Sbjct: 139 KKIHRDIKAANVLLSEHGEVKLADFGVAGQL---TDTQIKRNTFVGTPFWMAPEVIKQSA 195
Query: 948 VSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDK 1007
+K D++S GI +E P E+ H P+ ++ +I N T +
Sbjct: 196 YDSKADIWSLGITAIELARGEPPHSEL--------H------PMKVLFLIPKNNPPTLEG 241
Query: 1008 HFAAKEQCASSVFN--LAMECTVESPDERITAKEIVRRLLK 1046
++ S + C + P R TAKE LLK
Sbjct: 242 NY-------SKPLKEFVEA-CLNKEPSFRPTAKE----LLK 270
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 5e-27
Identities = 58/302 (19%), Positives = 104/302 (34%), Gaps = 58/302 (19%)
Query: 777 IGRGSFGSVYIARLQNGIEVAVKTFD---LQHERAFKSFDT--------------ECEVM 819
+ +G F + + ++ A+K ++ L+ +R F + E +++
Sbjct: 39 LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 820 KSIRHRNLTKIISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRL-------NIM 872
I++ +N D +I EYM N S+ K + + I+
Sbjct: 98 TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157
Query: 873 IDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTL 932
V ++ Y+H + H D+KPSN+L+D N LSDFG ++ ++ + +
Sbjct: 158 KSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKK-----IKGS 210
Query: 933 A-TLGYMAPE--YGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFL 989
T +M PE K D++S GI L F P S
Sbjct: 211 RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFN------- 263
Query: 990 PISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVES-----------PDERITAK 1038
I N+ D++ + E P ERIT++
Sbjct: 264 -----NIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSE 318
Query: 1039 EI 1040
+
Sbjct: 319 DA 320
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 8e-27
Identities = 37/314 (11%), Positives = 87/314 (27%), Gaps = 81/314 (25%)
Query: 776 LIGRGSFGSVYIAR-LQNGIEVAVKTFDLQHERAFKS----------------------- 811
++G+ + A + G V +
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 812 -----FDTECEVMKSIRHRNLTKIISSCSNEDFKALILEYMR-NGSLEKCL------YSG 859
F +++K + + + ++ + + Y R +L+ S
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 860 NYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL 919
+ L RL + + V L LH ++H L+P +++LD L+ F
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV-- 254
Query: 920 IGEDQSMTQTQTLATLGYMAPEY-----------GREGRVSTKGDVYSFGILLMETFTRR 968
D + + + G+ PE R ++ D ++ G+++ +
Sbjct: 255 --RDGARVVSSV--SRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
Query: 969 KPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTV 1028
P + + L + F + + V L
Sbjct: 311 LP----ITKD---------------------AALGGSEWIFRSCKNIPQPVRALLEGFLR 345
Query: 1029 ESPDERITAKEIVR 1042
++R+ + +
Sbjct: 346 YPKEDRLLPLQAME 359
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 58/234 (24%), Positives = 94/234 (40%), Gaps = 43/234 (18%)
Query: 776 LIGRGSFGSVYIAR-LQNGIEVAVKTFD---LQHERAFKSFDTECEVMKSIRHRNLTKII 831
+G+G FG+VY+AR QN +A+K L+ E E E+ +RH N+ ++
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80
Query: 832 SSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLN------IMIDVASALEYLHFG 885
+ + L+LE+ G L K L R + M ++A AL Y H
Sbjct: 81 NYFHDRKRIYLMLEFAPRGELYKELQKH-------GRFDEQRSATFMEELADALHYCH-- 131
Query: 886 YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGRE 945
VIH D+KP N+L+ ++DFG + +T TL Y+ PE
Sbjct: 132 -ERKVIHRDIKPENLLMGYKGELKIADFGWSVH---APSLRRRT-MCGTLDYLPPEM--- 183
Query: 946 GRVSTKG-----DVYSFGILLMETFTRRKPTDE---------IFSGEMTLKHWV 985
+ K D++ G+L E P D I + ++ ++
Sbjct: 184 --IEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFL 235
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-26
Identities = 57/200 (28%), Positives = 87/200 (43%), Gaps = 21/200 (10%)
Query: 777 IGRGSFGSVYIAR-LQNGIEVAVKTFDLQH-ERAFKSFDTECEV-MKSIRHRNLTKIISS 833
IGRG++GSV +G +AVK E+ K + +V M+S + + +
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89
Query: 834 CSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLN------IMIDVASALEYLHFGYS 887
E + +E M + S +K +LD + I + AL +L
Sbjct: 90 LFREGDCWICMELM-STSFDKFYKYVYSVLD--DVIPEEILGKITLATVKALNHLKENLK 146
Query: 888 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPE----YG 943
+IH D+KPSN+LLD + L DFGI+ L+ S+ +T+ YMAPE
Sbjct: 147 --IIHRDIKPSNILLDRSGNIKLCDFGISGQLV---DSIAKTRDAGCRPYMAPERIDPSA 201
Query: 944 REGRVSTKGDVYSFGILLME 963
+ DV+S GI L E
Sbjct: 202 SRQGYDVRSDVWSLGITLYE 221
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-26
Identities = 54/204 (26%), Positives = 91/204 (44%), Gaps = 24/204 (11%)
Query: 776 LIGRGSFGSVYIAR-LQNGIEVAVKTFD-LQHERAFKSFDTECEVMKSIRHRNLTKI--I 831
++G+G+ +V+ R + G A+K F+ + R E EV+K + H+N+ K+ I
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 832 SSCSNEDFKALILEYMRNGSLEKCLYS-GN-YILDIFQRLNIMIDVASALEYLHFGYSAP 889
+ K LI+E+ GSL L N Y L + L ++ DV + +L
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENG 132
Query: 890 VIHCDLKPSNVLL----DDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPE-YGR 944
++H ++KP N++ D V L+DFG A+ L ED + T Y+ P+ Y R
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL--EDDEQFVSL-YGTEEYLHPDMYER 189
Query: 945 EGRVSTKG-------DVYSFGILL 961
D++S G+
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGVTF 213
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 54/304 (17%), Positives = 100/304 (32%), Gaps = 69/304 (22%)
Query: 771 FSENNLIGRGSFGSVYIAR-LQNGIEVAVK--TFDLQHERAFKSFDTECEVMKSI-RHRN 826
F E IG G FGSV+ +G A+K L ++ E + +H +
Sbjct: 13 FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 72
Query: 827 LTKIISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIF---QRLNIMIDVASALEYLH 883
+ + S+ + +D + EY GSL + I+ F + ++++ V L Y+H
Sbjct: 73 VVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH 132
Query: 884 FGYSAPVIHCDLKPSNVLLDDN-------------------MVAHLSDFGIAKLLIGEDQ 924
S ++H D+KPSN+ + ++ + D G +
Sbjct: 133 ---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI----- 184
Query: 925 SMTQTQTLATLG---YMAPEYGREGRV-STKGDVYSFGILLMETFTRRKPTDEIFSGEM- 979
S Q + G ++A E +E K D+++ + ++
Sbjct: 185 SSPQVEE----GDSRFLANEVLQENYTHLPKADIFALALTVV---------------CAA 225
Query: 980 TLKHWVNDFLPISMMKIIDANLLITEDKHFAAKEQCASSVF-NLAMECTVESPDERITAK 1038
+ I Q S F L P+ R +A
Sbjct: 226 GAEPL---PRNGDQWHEIRQG-------RLPRIPQVLSQEFTELLKVMIHPDPERRPSAM 275
Query: 1039 EIVR 1042
+V+
Sbjct: 276 ALVK 279
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 5e-26
Identities = 54/200 (27%), Positives = 90/200 (45%), Gaps = 22/200 (11%)
Query: 777 IGRGSFGSVYIAR-LQNGIEVAVKTFDLQHERA-FKSFDTECEV-MKSIRHRNLTKIISS 833
+GRG++G V R + +G +AVK K + ++ M+++ +
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 834 CSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLN------IMIDVASALEYLHFGYS 887
E + +E M + SL+K ++D Q + I + + ALE+LH S
Sbjct: 75 LFREGDVWICMELM-DTSLDKFY---KQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS 130
Query: 888 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPE----YG 943
VIH D+KPSNVL++ + DFGI+ L+ + + YMAPE
Sbjct: 131 --VIHRDVKPSNVLINALGQVKMCDFGISGYLV---DDVAKDIDAGCKPYMAPERINPEL 185
Query: 944 REGRVSTKGDVYSFGILLME 963
+ S K D++S GI ++E
Sbjct: 186 NQKGYSVKSDIWSLGITMIE 205
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 5e-26
Identities = 49/232 (21%), Positives = 88/232 (37%), Gaps = 33/232 (14%)
Query: 776 LIGRGSFGSVYIAR-LQNGIEVAVKTFD---LQHERAFKSFDTECEVMKSIRHRNLTKII 831
+G+G F + A K L + E + +S+ H+++
Sbjct: 22 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81
Query: 832 SSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVI 891
+ DF ++LE R SL + + + R + + +YLH VI
Sbjct: 82 GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR-YYLRQIVLGCQYLH---RNRVI 137
Query: 892 HCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTL-ATLGYMAPEYGREGRVST 950
H DLK N+ L++++ + DFG+A + + + L T Y+APE + S
Sbjct: 138 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKK---VLCGTPNYIAPEVLSKKGHSF 194
Query: 951 KGDVYSFGILL---------------METFTRRKPTDEIFSGEMTLKHWVND 987
+ DV+S G ++ ET+ R I E ++ +N
Sbjct: 195 EVDVWSIGCIMYTLLVGKPPFETSCLKETYLR------IKKNEYSIPKHINP 240
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 5e-26
Identities = 56/308 (18%), Positives = 103/308 (33%), Gaps = 45/308 (14%)
Query: 777 IGRG--SFGSVYIAR-LQNGIEVAVKTFDL--QHERAFKSFDTECEVMKSIRHRNLTKII 831
IG+G +V +AR G V V+ +L E V K H N+
Sbjct: 33 IGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYR 92
Query: 832 SSCSNEDFKALILEYMRNGSLEKCL-YSGNYILDIFQRLNIMIDVASALEYLHFGYSAPV 890
++ ++ ++ +M GS + + ++ I+ V AL+Y+H
Sbjct: 93 ATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH---HMGY 149
Query: 891 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLA-----TLGYMAPEYGRE 945
+H +K S++L+ + +LS +I Q L +++PE ++
Sbjct: 150 VHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQ 209
Query: 946 GRV--STKGDVYSFGI-------------------LLMETFTRRKPTDEIFSGEMTLKHW 984
K D+YS GI +L+E P S +
Sbjct: 210 NLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELT 269
Query: 985 VNDFLPISMMKIIDANLLITEDKHFAAKEQCA-----SSVF-NLAMECTVESPDERITAK 1038
++ ++ + D+ T S F + +C +PD R +A
Sbjct: 270 MSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSAS 329
Query: 1039 EIVRRLLK 1046
LL
Sbjct: 330 T----LLN 333
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 9e-26
Identities = 49/232 (21%), Positives = 89/232 (38%), Gaps = 33/232 (14%)
Query: 776 LIGRGSFGSVYIAR-LQNGIEVAVKTFD---LQHERAFKSFDTECEVMKSIRHRNLTKII 831
+G+G F + A K L + E + +S+ H+++
Sbjct: 48 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107
Query: 832 SSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVI 891
+ DF ++LE R SL + + + R + + +YLH VI
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR-YYLRQIVLGCQYLH---RNRVI 163
Query: 892 HCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTL-ATLGYMAPEYGREGRVST 950
H DLK N+ L++++ + DFG+A + + + + L T Y+APE + S
Sbjct: 164 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK---KVLCGTPNYIAPEVLSKKGHSF 220
Query: 951 KGDVYSFGILL---------------METFTRRKPTDEIFSGEMTLKHWVND 987
+ DV+S G ++ ET+ R I E ++ +N
Sbjct: 221 EVDVWSIGCIMYTLLVGKPPFETSCLKETYLR------IKKNEYSIPKHINP 266
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 1e-25
Identities = 74/293 (25%), Positives = 113/293 (38%), Gaps = 60/293 (20%)
Query: 771 FSENNLIGRGSFGSVYIAR-LQNGIEVAVKTFDLQHERA---FKSFDTECEVMKSIRHRN 826
FS+ IG GSFG+VY AR ++N VA+K +++ ++ E ++ +RH N
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 827 LTKIISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGY 886
+ E L++EY GS L L + + L YLH
Sbjct: 116 TIQYRGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH--- 171
Query: 887 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLA-TLGYMAPE---Y 942
S +IH D+K N+LL + + L DFG A M + T +MAPE
Sbjct: 172 SHNMIHRDVKAGNILLSEPGLVKLGDFGSA-------SIMAPANSFVGTPYWMAPEVILA 224
Query: 943 GREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLL 1002
EG+ K DV+S GI +E R+ P ++ M +
Sbjct: 225 MDEGQYDGKVDVWSLGITCIELAERKPP-----------------LFNMNAMSAL---YH 264
Query: 1003 IT-------EDKHFAAKEQCASSVFN--LAMECTVESPDERITAKEIVRRLLK 1046
I + H+ S F + C + P +R T++ LLK
Sbjct: 265 IAQNESPALQSGHW-------SEYFRNFVDS-CLQKIPQDRPTSEV----LLK 305
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 3e-25
Identities = 41/260 (15%), Positives = 81/260 (31%), Gaps = 26/260 (10%)
Query: 771 FSENNLIGRGSFGSVYIAR------LQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRH 824
++L+G G+F VY A +N + +K + F E +K
Sbjct: 67 VYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQ 126
Query: 825 RNLTKIISSCSNEDFKALILEYMRNGSL----EKCLYSGNYILDIFQRLNIMIDVASALE 880
K S+ ++ L+ E G+L + ++ ++ + + +E
Sbjct: 127 HMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIE 186
Query: 881 YLHFGYSAPVIHCDLKPSNVLLDDNMVAH-----------LSDFGIAKLLIGEDQSMTQT 929
+H +IH D+KP N +L + + L D G + + + T
Sbjct: 187 QVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFT 243
Query: 930 QTLATLGYMAPEYGREGRVST-KGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDF 988
T G+ E + + D + + + GE +
Sbjct: 244 AKCETSGFQCVEM-LSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRL 302
Query: 989 LPISMMKIIDANLLITEDKH 1008
+ M +L D H
Sbjct: 303 PHLDMWNEFFHVMLNIPDCH 322
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 4e-25
Identities = 50/195 (25%), Positives = 81/195 (41%), Gaps = 14/195 (7%)
Query: 777 IGRGSFGSVYIAR-LQNGIEVAVKTFDLQH-ERAFKSFDTECEV-MKSIRHRNLTKIISS 833
+G G+ G V+ R + G +AVK + K + +V +KS + + +
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92
Query: 834 CSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHC 893
+ +E M EK + + + + AL YL + VIH
Sbjct: 93 FITNTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG--VIHR 149
Query: 894 DLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPE-----YGREGRV 948
D+KPSN+LLD+ L DFGI+ L+ + ++ YMAPE +
Sbjct: 150 DVKPSNILLDERGQIKLCDFGISGRLV---DDKAKDRSAGCAAYMAPERIDPPDPTKPDY 206
Query: 949 STKGDVYSFGILLME 963
+ DV+S GI L+E
Sbjct: 207 DIRADVWSLGISLVE 221
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 52/207 (25%), Positives = 90/207 (43%), Gaps = 42/207 (20%)
Query: 776 LIGRGSFGSVYIAR-LQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSC 834
++G G+F V++ + G A+K S + E V+K I+H N+ +
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 835 SNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRL------------NIMIDVASALEYL 882
+ L+++ + G L F R+ ++ V SA++YL
Sbjct: 76 ESTTHYYLVMQLVSGGEL-------------FDRILERGVYTEKDASLVIQQVLSAVKYL 122
Query: 883 HFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLIGEDQSMTQTQTLA-TLGYM 938
H ++H DLKP N+L ++N ++DFG++K + ++ M+ T T GY+
Sbjct: 123 H---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSK--MEQNGIMS---TACGTPGYV 174
Query: 939 APEYGREGRVSTKGDVYSFG----ILL 961
APE + S D +S G ILL
Sbjct: 175 APEVLAQKPYSKAVDCWSIGVITYILL 201
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 51/209 (24%), Positives = 81/209 (38%), Gaps = 8/209 (3%)
Query: 462 ANLVTLDLGGNKFNGSIPIALGKLQKLQLLNLDDNKLEGSIPDDIC-GLVELYKLALGDN 520
+ LDL N + +LQ+L+L +++ +I D L L L L N
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGN 86
Query: 521 KLSGQIPACFGNLASLRELWLGPNELISFIPSTFWNIKDIMYVNFSSNFLTG-PLPLEIE 579
+ F L+SL++L L S ++K + +N + N + LP
Sbjct: 87 PIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFS 146
Query: 580 NLKALTTLDFSMNNLSGVIPTTIGGLKGLQY----LFLGHNRLQGSIPDSVGDLISLKSL 635
NL L LD S N + + T + L + L L N + I I LK L
Sbjct: 147 NLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKEL 205
Query: 636 NLSNNNLSGPIPTSLEKLSDLKELNLSFN 664
L N L ++L+ L+++ L N
Sbjct: 206 ALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 58/273 (21%), Positives = 98/273 (35%), Gaps = 56/273 (20%)
Query: 127 HNNFLTGTIPFSIFKLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQLSGSIPS 186
IP ++ S +L LS N L + S++ + LQ+LDLS ++ +I
Sbjct: 15 MELNFY-KIPDNLP--FSTKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQ-TIED 69
Query: 187 FIF-KISSLQALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGGISSTLSNCKHLRI 245
+ +S L L N + L L L+
Sbjct: 70 GAYQSLSHLSTLILTGNPIQ-SLALGAFSGLS------------------------SLQK 104
Query: 246 LDLSFNDLWGDIPKEI-GNLTKLKELFLDFNILQG-EIPHTVGNLHNLEYLSLVNNELVG 303
L +L + G+L LKEL + N++Q ++P NL NLE+L L +N++
Sbjct: 105 LVAVETNL-ASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ- 162
Query: 304 TVPATIFNVSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSGTLPSFIFNASN 363
++ T L + L L L N + + F
Sbjct: 163 SIYCTDLR----------------VLHQMPLLNL----SLDLSLNPMN-FIQPGAFKEIR 201
Query: 364 LSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNN 396
L +L+L N + F L +L+++ L+ N
Sbjct: 202 LKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 1e-22
Identities = 52/257 (20%), Positives = 99/257 (38%), Gaps = 41/257 (15%)
Query: 58 VCNWTGVTCDINQRRVTAL------NISYLSLTGN-----IPRQLGNLSSLEILDLNFNR 106
V +T + + + L L+ N + L++LDL+
Sbjct: 4 VEVVPNITYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCE 63
Query: 107 LSGEIPWELGNLAKLEKLLLHNNFLTGTIPFSIF-KLSSLLDLKLSDNNLTGTIPSHNLG 165
+ +L+ L L+L N + ++ F LSSL L + NL ++ + +G
Sbjct: 64 IQTIEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLA-SLENFPIG 121
Query: 166 NLSSLQLLDLSDNQLSGSIPSF-IF-KISSLQALHFGNNRLSGELPANICDNLPFLNFFS 223
+L +L+ L+++ N + S F +++L+ L +N++ + L + +
Sbjct: 122 HLKTLKELNVAHNLIQ-SFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLN 179
Query: 224 VYKNMFYGGISSTLSNCKHLRILDLSFNDLWGDIPKEIGNLTKLKELFLDFNILQGEIPH 283
+ LDLS N + I +LKEL LD N L+ +P
Sbjct: 180 LS--------------------LDLSLNPM-NFIQPGAFKEIRLKELALDTNQLK-SVPD 217
Query: 284 TV-GNLHNLEYLSLVNN 299
+ L +L+ + L N
Sbjct: 218 GIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 2e-20
Identities = 53/240 (22%), Positives = 86/240 (35%), Gaps = 41/240 (17%)
Query: 265 TKLKELFLDFNILQGEIPHTV-GNLHNLEYLSLVNNELVGTVPATIFNVSTLKLIELSNN 323
K L L FN L+ + + L+ L L E+ T+ +
Sbjct: 28 FSTKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEI-QTIEDGAYQ------------ 73
Query: 324 TFFGSLPSSTDVQLPNLEELYLWGNNFSGTLPSFIFNA-SNLSKLSLGDNSFSGLIPNTF 382
L +L L L GN +L F+ S+L KL + + + L
Sbjct: 74 ------------SLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPI 120
Query: 383 GNLRNLKRLRLYNNYLTS-PELSFLSSLSNCKYLEIIALSGNPLNGIIPMSA----GNLS 437
G+L+ LK L + +N + S + S+L+N ++L+ LS N + I + +
Sbjct: 121 GHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLD---LSSNKIQ-SIYCTDLRVLHQMP 176
Query: 438 HSLEELFMPDCNVSGRIPKEIGNLANLVTLDLGGNKFNGSIPI-ALGKLQKLQLLNLDDN 496
L + N I L L L N+ S+P +L LQ + L N
Sbjct: 177 LLNLSLDL-SLNPMNFIQPGAFKEIRLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 3e-16
Identities = 41/175 (23%), Positives = 67/175 (38%), Gaps = 30/175 (17%)
Query: 501 SIPDDICGLVELYKLALGDNKLSGQIPACFGNLASLRELWLGPNELISFIPSTFWNIKDI 560
IPD++ L L N L F + L+ L L E+ + + +
Sbjct: 21 KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQS---- 74
Query: 561 MYVNFSSNFLTGPLPLEIENLKALTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQG 620
L L+TL + N + + GL LQ L L
Sbjct: 75 --------------------LSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLA- 113
Query: 621 SIPDSV-GDLISLKSLNLSNNNL-SGPIPTSLEKLSDLKELNLSFNKLEGEIPRG 673
S+ + G L +LK LN+++N + S +P L++L+ L+LS NK++ I
Sbjct: 114 SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCT 167
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 53/200 (26%), Positives = 88/200 (44%), Gaps = 16/200 (8%)
Query: 777 IGRGSFGSVYIAR-LQNGIEVAVKTFDL-QHERAFKSFDTECEVMKSIRHRNLTKIISSC 834
IG G+ V A +VA+K +L + + + E + M H N+ +S
Sbjct: 23 IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSF 82
Query: 835 SNEDFKALILEYMRNGSL-------EKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYS 887
+D L+++ + GS+ + +LD I+ +V LEYLH
Sbjct: 83 VVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH---K 139
Query: 888 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL--IGEDQSMTQTQTLA-TLGYMAPEYGR 944
IH D+K N+LL ++ ++DFG++ L G+ +T T +MAPE
Sbjct: 140 NGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVME 199
Query: 945 EGRV-STKGDVYSFGILLME 963
+ R K D++SFGI +E
Sbjct: 200 QVRGYDFKADIWSFGITAIE 219
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 52/229 (22%), Positives = 91/229 (39%), Gaps = 52/229 (22%)
Query: 766 QATNGFSEN----NLIGRGSFGSVYIAR-LQNGIEVAVKTFDLQHERAFKSFD------- 813
+T+GF EN ++GRG V E AVK D+ +F + +
Sbjct: 10 HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69
Query: 814 --TECEVMKSI-RHRNLTKIISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRL- 869
E ++++ + H N+ ++ + F L+ + M+ G L F L
Sbjct: 70 TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL-------------FDYLT 116
Query: 870 -----------NIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL 918
IM + + LH ++H DLKP N+LLDD+M L+DFG +
Sbjct: 117 EKVTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSC- 172
Query: 919 LIGEDQSMTQTQTLATLGYMAPE------YGREGRVSTKGDVYSFGILL 961
+ + + + T Y+APE + D++S G+++
Sbjct: 173 QLDPGEKL--REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 4e-24
Identities = 50/202 (24%), Positives = 83/202 (41%), Gaps = 38/202 (18%)
Query: 777 IGRGSFGSVYIAR-LQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIR-HRNLTKIISSC 834
+G GSF ++ AVK +R + E +K H N+ K+
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIIS---KRMEANTQKEITALKLCEGHPNIVKLHEVF 75
Query: 835 SNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRL------------NIMIDVASALEYL 882
++ L++E + G L F+R+ IM + SA+ ++
Sbjct: 76 HDQLHTFLVMELLNGGEL-------------FERIKKKKHFSETEASYIMRKLVSAVSHM 122
Query: 883 HFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMA 939
H V+H DLKP N+L +DN+ + DFG A+L ++Q + TL Y A
Sbjct: 123 H---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPL--KTPCFTLHYAA 177
Query: 940 PEYGREGRVSTKGDVYSFGILL 961
PE + D++S G++L
Sbjct: 178 PELLNQNGYDESCDLWSLGVIL 199
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 61/234 (26%), Positives = 86/234 (36%), Gaps = 39/234 (16%)
Query: 93 NLSSLEILDLNFNRLSGEIPWELGNLAKLEKLLLHNNFLTGTIPFSIF-KLSSLLDLKLS 151
++S ++ + L+ +P +L L L N L T + + L L L
Sbjct: 8 KVASHLEVNCDKRNLT-ALPPDL--PKDTTILHLSENLLY-TFSLATLMPYTRLTQLNLD 63
Query: 152 DNNLTGTIPSHNLGNLSSLQLLDLSDNQLSGSIPSFIFKISSLQALHFGNNRLSGELPAN 211
LT + G L L LDLS NQL S+P + +L L NRL+ LP
Sbjct: 64 RAELT-KLQV--DGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLG 118
Query: 212 ICDNLPFLNFFSVYKNMFYGGISSTLSNCKHLRILDLSFNDLWGDIPKEI-GNLTKLKEL 270
L L+ L L N+L +P + KL++L
Sbjct: 119 ALRGLG------------------------ELQELYLKGNEL-KTLPPGLLTPTPKLEKL 153
Query: 271 FLDFNILQGEIPHTV-GNLHNLEYLSLVNNELVGTVPATIFNVSTLKLIELSNN 323
L N L E+P + L NL+ L L N L T+P F L L N
Sbjct: 154 SLANNNLT-ELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 5e-23
Identities = 56/187 (29%), Positives = 82/187 (43%), Gaps = 9/187 (4%)
Query: 488 LQLLNLDDNKLEGSIPDDICGLVELYKLALGDNKLSGQIPACFGNLASLRELWLGPNELI 547
+N D L ++P D+ + L L +N L A L +L L EL
Sbjct: 12 HLEVNCDKRNL-TALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT 68
Query: 548 SFIPSTFWNIKDIMYVNFSSNFLTGPLPLEIENLKALTTLDFSMNNLSGVIPTTIGGLKG 607
+ + ++ S N L LPL + L ALT LD S N L+ + + GL
Sbjct: 69 KL--QVDGTLPVLGTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGE 125
Query: 608 LQYLFLGHNRLQGSIPDSVGD-LISLKSLNLSNNNLSGPIPTSLEKLSDLKELNLSFNKL 666
LQ L+L N L+ ++P + L+ L+L+NNNL+ L L +L L L N L
Sbjct: 126 LQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSL 184
Query: 667 EGEIPRG 673
IP+G
Sbjct: 185 YT-IPKG 190
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 2e-20
Identities = 46/188 (24%), Positives = 67/188 (35%), Gaps = 8/188 (4%)
Query: 454 IPKEIGNLANLVTLDLGGNKFNGSIPIALGKLQKLQLLNLDDNKLEGSIPDDICGLVELY 513
+P ++ + L L N L +L LNLD +L D L L
Sbjct: 25 LPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDG--TLPVLG 80
Query: 514 KLALGDNKLSGQIPACFGNLASLRELWLGPNELISFIPSTFWNIKDIMYVNFSSNFLTGP 573
L L N+L +P L +L L + N L S + ++ + N L
Sbjct: 81 TLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKT- 138
Query: 574 LPLEI-ENLKALTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQGSIPDSVGDLISL 632
LP + L L + NNL+ + + GL+ L L L N L +IP L
Sbjct: 139 LPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLL 197
Query: 633 KSLNLSNN 640
L N
Sbjct: 198 PFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 7e-20
Identities = 62/230 (26%), Positives = 91/230 (39%), Gaps = 45/230 (19%)
Query: 58 VCNWTGVTCDINQRRVTAL------NISYLSLTGNIPRQL-----GNLSSLEILDLNFNR 106
V + V CD +R +TAL + + L L+ N+ + L L+L+
Sbjct: 9 VASHLEVNCD--KRNLTALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAE 66
Query: 107 LSGEIPWELGNLAKLEKLLLHNNFLTGTIPFSIFKLSSLLDLKLSDNNLTGTIPSHNLGN 166
L+ ++ G L L L L +N L ++P L +L L +S N LT ++P L
Sbjct: 67 LT-KLQ-VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRG 122
Query: 167 LSSLQLLDLSDNQLSGSIPSFIF-KISSLQALHFGNNRLSGELPANICDNLPFLNFFSVY 225
L LQ L L N+L ++P + L+ L NN L+ ELPA + + L
Sbjct: 123 LGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLE-------- 172
Query: 226 KNMFYGGISSTLSNCKHLRILDLSFNDLWGDIPKEIGNLTKLKELFLDFN 275
+L L L N L IPK L FL N
Sbjct: 173 ----------------NLDTLLLQENSL-YTIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 5e-19
Identities = 56/235 (23%), Positives = 89/235 (37%), Gaps = 41/235 (17%)
Query: 337 LPNLEELYLWGNNFSGTLPSFIFNASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNN 396
+ + E+ N + LP + + + L L +N T L +L L
Sbjct: 9 VASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRA 65
Query: 397 YLTSPELSFLSSLSNCKYLEIIALSGNPLNGIIPMSAGNLSHSLEELFMPDCNVSGRIPK 456
LT L +L L+ LS N L +P
Sbjct: 66 ELTK--LQVDGTLPVLGTLD---LSHNQLQ--------------------------SLPL 94
Query: 457 EIGNLANLVTLDLGGNKFNGSIPI-ALGKLQKLQLLNLDDNKLEGSIPDDIC-GLVELYK 514
L L LD+ N+ S+P+ AL L +LQ L L N+L+ ++P + +L K
Sbjct: 95 LGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEK 152
Query: 515 LALGDNKLSGQIPA-CFGNLASLRELWLGPNELISFIPSTFWNIKDIMYVNFSSN 568
L+L +N L+ ++PA L +L L L N L + IP F+ + + N
Sbjct: 153 LSLANNNLT-ELPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 1e-14
Identities = 51/276 (18%), Positives = 71/276 (25%), Gaps = 86/276 (31%)
Query: 246 LDLSFNDLWGDIPKEIGNLTKLKELFLDFNILQGEIPHTVGNLHNLEYLSLVNNELVGTV 305
++ +L +P ++ L L N+L T+ L L+L EL
Sbjct: 15 VNCDKRNL-TALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL---- 67
Query: 306 PATIFNVSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSGTLPSFIFNASNLS 365
L D LP L L L N +LP L+
Sbjct: 68 ---------------------TKLQ--VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALT 103
Query: 366 KLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNYLTSPELSFLSSLSNCKYLEIIALSGNPL 425
L + N + L L L+ L L N L + L+
Sbjct: 104 VLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPK-------------- 149
Query: 426 NGIIPMSAGNLSHSLEELFMPDCNVSGRIPKEIGNLANLVTLDLGGNKFNGSIPI-ALGK 484
L L L N +P L
Sbjct: 150 --------------------------------------LEKLSLANNNLT-ELPAGLLNG 170
Query: 485 LQKLQLLNLDDNKLEGSIPDDICGLVELYKLALGDN 520
L+ L L L +N L +IP G L L N
Sbjct: 171 LENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 6e-24
Identities = 61/264 (23%), Positives = 100/264 (37%), Gaps = 57/264 (21%)
Query: 735 SRYQTRGENVPNEVNVPLEATWRRFSYLELFQATNGFSEN----NLIGRGSFGSVYIAR- 789
+ + + P + L + A F + ++IGRG V
Sbjct: 56 AEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVH 115
Query: 790 LQNGIEVAVKTFDL--------QHERAFKSFDTECEVMKSIR-HRNLTKIISSCSNEDFK 840
G E AVK ++ Q E ++ E +++ + H ++ +I S + F
Sbjct: 116 RATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFM 175
Query: 841 ALILEYMRNGSLEKCLYSGNYILDIFQRL------------NIMIDVASALEYLHFGYSA 888
L+ + MR G L F L +IM + A+ +LH +
Sbjct: 176 FLVFDLMRKGEL-------------FDYLTEKVALSEKETRSIMRSLLEAVSFLH---AN 219
Query: 889 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLA-TLGYMAPE------ 941
++H DLKP N+LLDDNM LSDFG + + + + L T GY+APE
Sbjct: 220 NIVHRDLKPENILLDDNMQIRLSDFGFSC-HLEPGEKLR---ELCGTPGYLAPEILKCSM 275
Query: 942 YGREGRVSTKGDVYSFG----ILL 961
+ D+++ G LL
Sbjct: 276 DETHPGYGKEVDLWACGVILFTLL 299
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 7e-24
Identities = 48/210 (22%), Positives = 80/210 (38%), Gaps = 54/210 (25%)
Query: 777 IGRGSFGSVYIAR-LQNGIEVAVKTFDLQHERAFKSFDTECEVM-KSIRHRNLTKIISSC 834
IG GS+ +E AVK D + E E++ + +H N+ +
Sbjct: 30 IGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE----EIEILLRYGQHPNIITLKDVY 85
Query: 835 SNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRL------------NIMIDVASALEYL 882
+ + ++ E M+ G L ++ ++ + +EYL
Sbjct: 86 DDGKYVYVVTELMKGGEL-------------LDKILRQKFFSEREASAVLFTITKTVEYL 132
Query: 883 HFGYSAPVIHCDLKPSNVLL----DDNMVAHLSDFGIAKLLIGEDQSMTQTQTLA-TLGY 937
H + V+H DLKPSN+L + + DFG AK L E+ + T T +
Sbjct: 133 H---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLM---TPCYTANF 186
Query: 938 MAPE------YGREGRVSTKGDVYSFGILL 961
+APE Y D++S G+LL
Sbjct: 187 VAPEVLERQGYDAA--C----DIWSLGVLL 210
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 57/203 (28%), Positives = 81/203 (39%), Gaps = 36/203 (17%)
Query: 777 IGRGSFGSVYIAR-LQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCS 835
IGRGS+G V IA I A K F E E+MKS+ H N+ ++ +
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 76
Query: 836 NEDFKALILEYMRNGSL-----EKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPV 890
+ L++E G L K ++ + I + DV SA+ Y H V
Sbjct: 77 DNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMK------DVLSAVAYCH---KLNV 127
Query: 891 IHCDLKPSNVLL---DDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPE-----Y 942
H DLKP N L + L DFG+A + M + T Y++P+ Y
Sbjct: 128 AHRDLKPENFLFLTDSPDSPLKLIDFGLAA-RFKPGKMM--RTKVGTPYYVSPQVLEGLY 184
Query: 943 GREGRVSTKGDVYSFG----ILL 961
G E D +S G +LL
Sbjct: 185 GPE------CDEWSAGVMMYVLL 201
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-23
Identities = 45/203 (22%), Positives = 83/203 (40%), Gaps = 29/203 (14%)
Query: 777 IGRGSFGSVYIAR-LQNGIEVAVKT-----FDLQHERAFKSFDTECEVMKSIRHRNLTKI 830
IG+G F V + G + AVK F + + E + ++H ++ ++
Sbjct: 32 IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 831 ISSCSNEDFKALILEYMRNGSL-EKCLYSGNYILDIFQRL--NIMIDVASALEYLHFGYS 887
+ + S++ ++ E+M L + + + + + + M + AL Y H
Sbjct: 92 LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH---D 148
Query: 888 APVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPE--- 941
+IH D+KP VLL +++ L FG+A L + T +MAPE
Sbjct: 149 NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVA--GGRVGTPHFMAPEVVK 206
Query: 942 ---YGREGRVSTKGDVYSFGILL 961
YG+ DV+ G++L
Sbjct: 207 REPYGKP------VDVWGCGVIL 223
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-23
Identities = 50/193 (25%), Positives = 88/193 (45%), Gaps = 17/193 (8%)
Query: 777 IGRGSFGSVYIAR-LQNGIEVAVKTFD---LQHERAFKSFDTECEVMKSIRHRNLTKIIS 832
+G+GSFG V + + G E AVK ++ + +S E +++K + H N+ K+
Sbjct: 34 LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 93
Query: 833 SCSNEDFKALILEYMRNGSL-EKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVI 891
++ + L+ E G L ++ + + I+ V S + Y+H ++
Sbjct: 94 FFEDKGYFYLVGEVYTGGELFDEIISRKRF--SEVDAARIIRQVLSGITYMH---KNKIV 148
Query: 892 HCDLKPSNVLL---DDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRV 948
H DLKP N+LL + + DFG++ + M + T Y+APE G
Sbjct: 149 HRDLKPENLLLESKSKDANIRIIDFGLST-HFEASKKM--KDKIGTAYYIAPEVLH-GTY 204
Query: 949 STKGDVYSFGILL 961
K DV+S G++L
Sbjct: 205 DEKCDVWSTGVIL 217
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 50/205 (24%), Positives = 85/205 (41%), Gaps = 38/205 (18%)
Query: 777 IGRGSFGSVYIAR-LQNGIEVAVKTFD--LQHERAFKSFDTECEVMKSIRHRNLTKIISS 833
+G+GSFG V + E AVK + + + E E++K + H N+ K+
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 834 CSNEDFKALILEYMRNGSL-----EKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSA 888
+ ++ E G L ++ +S + I + V S + Y+H
Sbjct: 90 LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIK------QVFSGITYMH---KH 140
Query: 889 PVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPE---- 941
++H DLKP N+LL + + + DFG++ ++ M + T Y+APE
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLST-CFQQNTKM--KDRIGTAYYIAPEVLRG 197
Query: 942 -YGREGRVSTKGDVYSFG----ILL 961
Y + DV+S G ILL
Sbjct: 198 TYDEK------CDVWSAGVILYILL 216
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 4e-23
Identities = 50/214 (23%), Positives = 87/214 (40%), Gaps = 54/214 (25%)
Query: 777 IGRGSFGSVYIAR-LQNGIEVAVKTFDLQH--ERAFKSFDTECEVMKSIRHRNLTKIISS 833
+G+G+F V + G E A + + R + + E + + ++H N+ ++ S
Sbjct: 19 LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78
Query: 834 CSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRL------------NIMIDVASALEY 881
S E LI + + G L F+ + + + + A+ +
Sbjct: 79 ISEEGHHYLIFDLVTGGEL-------------FEDIVAREYYSEADASHCIQQILEAVLH 125
Query: 882 LHFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLIGEDQSMTQTQTLA-TLGY 937
H V+H +LKP N+LL L+DFG+A + GE Q+ A T GY
Sbjct: 126 CH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWF---GFAGTPGY 179
Query: 938 MAPE------YGREGRVSTKGDVYSFG----ILL 961
++PE YG+ D+++ G ILL
Sbjct: 180 LSPEVLRKDPYGKP------VDLWACGVILYILL 207
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 4e-23
Identities = 65/340 (19%), Positives = 119/340 (35%), Gaps = 91/340 (26%)
Query: 777 IGRGSFGSVYIARL------QNGIEVAVKTF-DLQHERAFKSFDTECEVMKSI-RHRNLT 828
+GRG+FG V A VAVK + ++ +E +++ I H N+
Sbjct: 30 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89
Query: 829 KIISSCSNEDFKA-LILEYMRNGSLEKCL----------------------YSGNYILDI 865
++ +C+ +I+E+ + G+L L Y G +D+
Sbjct: 90 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDL 149
Query: 866 FQRLNIMI------------------------------DVASALEYLHFGY--------- 886
+RL+ + D + + + +
Sbjct: 150 KRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL 209
Query: 887 -SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGRE 945
S IH DL N+LL + V + DFG+A+ + + + + L +MAPE +
Sbjct: 210 ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD 269
Query: 946 GRVSTKGDVYSFGILLMETFTR-RKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLIT 1004
+ + DV+SFG+LL E F+ P + E + +
Sbjct: 270 RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR-------------------RLK 310
Query: 1005 EDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRL 1044
E A + ++ ++C P +R T E+V L
Sbjct: 311 EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 350
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 5e-23
Identities = 53/213 (24%), Positives = 83/213 (38%), Gaps = 43/213 (20%)
Query: 776 LIGRGSFGSVYIAR-LQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIR-HRNLTKIISS 833
++G G+ V L E AVK + Q E E++ + HRN+ ++I
Sbjct: 20 VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79
Query: 834 CSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRL------------NIMIDVASALEY 881
ED L+ E MR GS+ + ++ DVASAL++
Sbjct: 80 FEEEDRFYLVFEKMRGGSI-------------LSHIHKRRHFNELEASVVVQDVASALDF 126
Query: 882 LHFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLL-IGEDQSMTQTQTLA---- 933
LH + + H DLKP N+L + + DF + + + D S T L
Sbjct: 127 LH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCG 183
Query: 934 TLGYMAPEYGREGRVSTKG-----DVYSFGILL 961
+ YMAPE D++S G++L
Sbjct: 184 SAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 6e-23
Identities = 49/192 (25%), Positives = 90/192 (46%), Gaps = 16/192 (8%)
Query: 777 IGRGSFGSVYIAR-LQNGIEVAVKTFDLQH--ERAFKSFDTECEVMKSIRHRNLTKIISS 833
+G G++G V + R +E A+K + E V+K + H N+ K+
Sbjct: 45 LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF 104
Query: 834 CSNEDFKALILEYMRNGSL-EKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIH 892
++ L++E + G L ++ ++ + + I+ V S + YLH ++H
Sbjct: 105 FEDKRNYYLVMECYKGGELFDEIIHRMKF--NEVDAAVIIKQVLSGVTYLH---KHNIVH 159
Query: 893 CDLKPSNVLL---DDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVS 949
DLKP N+LL + + + + DFG++ + + M + L T Y+APE R +
Sbjct: 160 RDLKPENLLLESKEKDALIKIVDFGLSA-VFENQKKM--KERLGTAYYIAPEVLR-KKYD 215
Query: 950 TKGDVYSFGILL 961
K DV+S G++L
Sbjct: 216 EKCDVWSIGVIL 227
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 7e-23
Identities = 60/309 (19%), Positives = 111/309 (35%), Gaps = 50/309 (16%)
Query: 360 NASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNYLTSPELSFLSSLSNCKYLEIIA 419
+N K++ G ++ + + +L + L + +T+ + + L +
Sbjct: 17 ALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTT-----IEGVQYLNNLIGLE 69
Query: 420 LSGNPLNGIIPMSAGNLSHSLEELFMPDCNVSGRIPKEIGNLANLVTLDLGGNKFNGSIP 479
L N + + P+ NL+ + EL + + I L ++ TLDL + P
Sbjct: 70 LKDNQITDLAPLK--NLTK-ITELELSGNPLK--NVSAIAGLQSIKTLDLTSTQITDVTP 124
Query: 480 IALGKLQKLQLLNLDDNKLEGSIPDDICGLVELYKLALGDNKLSGQIPACFGNLASLREL 539
L L LQ+L LD N++ P + GL L L++G+ ++S P NL+ L L
Sbjct: 125 --LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTL 178
Query: 540 WLGPNELISFIPSTFWNIKDIMYVNFSSNFLTGPLPLEIENLKALTTLDFSMNNLSGVIP 599
N++ P + +L L + N +S V P
Sbjct: 179 KADDNKISDISP--------------------------LASLPNLIEVHLKNNQISDVSP 212
Query: 600 TTIGGLKGLQYLFLGHNRLQGSIPDSVGDLISLKSLNLSNNNLSGPI-PTSLEKLSDLKE 658
+ L + L + + V +L N+ PI P ++
Sbjct: 213 --LANTSNLFIVTLTNQTITN---QPVFYNNNLVVPNVVKGPSGAPIAPATISDNGTYAS 267
Query: 659 LNLSFNKLE 667
NL++N
Sbjct: 268 PNLTWNLTS 276
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 8e-21
Identities = 60/318 (18%), Positives = 115/318 (36%), Gaps = 52/318 (16%)
Query: 91 LGNLSSLEILDLNFNRLSGEIPWELGNLAKLEKLLLHNNFLTGTIPFSIFKLSSLLDLKL 150
L++ + + ++ + +L + L +T L++L+ L+L
Sbjct: 15 DPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTIEGVQ--YLNNLIGLEL 70
Query: 151 SDNNLTGTIPSHNLGNLSSLQLLDLSDNQLSGSIPSFIFKISSLQALHFGNNRLSGELPA 210
DN +T + L NL+ + L+LS N L S I + S++ L + +++ P
Sbjct: 71 KDNQIT-DLA--PLKNLTKITELELSGNPL--KNVSAIAGLQSIKTLDLTSTQITDVTP- 124
Query: 211 NICDNLPFLNFFSVYKNMFYGGIS--STLSNCKHLRILDLSFNDLWGDIPKEIGNLTKLK 268
L L + N I+ S L+ +L+ L + + D+ + NL+KL
Sbjct: 125 --LAGLSNLQVLYLDLN----QITNISPLAGLTNLQYLSIGNAQV-SDLT-PLANLSKLT 176
Query: 269 ELFLDFNILQGEIPHTVGNLHNLEYLSLVNNELVGTVPATIFNVSTLKLIELSNNTFFGS 328
L D N + P + +L NL + L NN++ + L+N
Sbjct: 177 TLKADDNKISDISP--LASLPNLIEVHLKNNQIS-------------DVSPLAN------ 215
Query: 329 LPSSTDVQLPNLEELYLWGNNFSGTLPSFIFNASNLSKLSLGDNSFSGLIPNTFGNLRNL 388
NL + L T +N + + + S + + P T +
Sbjct: 216 --------TSNLFIVTLTNQTI--TNQPVFYNNNLVVPNVVKGPSGAPIAPATISDNGTY 265
Query: 389 KRLRL-YNNYLTSPELSF 405
L +N +S+
Sbjct: 266 ASPNLTWNLTSFINNVSY 283
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 1e-20
Identities = 62/295 (21%), Positives = 113/295 (38%), Gaps = 69/295 (23%)
Query: 115 LGNLAKLEKLLLHNNFLTGTIPFSIFKLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLD 174
LA K+ + +T T+ + L + L +T TI + L++L L+
Sbjct: 15 DPALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVT-TIE--GVQYLNNLIGLE 69
Query: 175 LSDNQLSGSIPSFIFKISSLQALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGGIS 234
L DNQ++ + + ++ + L N L N+
Sbjct: 70 LKDNQITD--LAPLKNLTKITELELSGNPLK-----NV---------------------- 100
Query: 235 STLSNCKHLRILDLSFNDLWGDIPKEIGNLTKLKELFLDFNILQGEIPHTVGNLHNLEYL 294
S ++ + ++ LDL+ + D+ + L+ L+ L+LD N + P + L NL+YL
Sbjct: 101 SAIAGLQSIKTLDLTSTQI-TDVT-PLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYL 156
Query: 295 SLVNNELVGTVPATIFNVSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSGTL 354
S+ N ++ L L+N L L L N S
Sbjct: 157 SIGNAQVS-------------DLTPLAN--------------LSKLTTLKADDNKISDI- 188
Query: 355 PSFIFNASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNYLTSPELSFLSSL 409
S + + NL ++ L +N S + P N NL + L N +T+ + + ++L
Sbjct: 189 -SPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQPVFYNNNL 240
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 7e-19
Identities = 53/336 (15%), Positives = 102/336 (30%), Gaps = 96/336 (28%)
Query: 163 NLGNLSSLQLLDLSDNQLSGSIPSFIFKISSLQALHFGNNRLSGELPANICDNLPFLNFF 222
L++ + + ++ + + L ++ I
Sbjct: 14 PDPALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVT-----TI---------- 56
Query: 223 SVYKNMFYGGISSTLSNCKHLRILDLSFNDLWGDIPKEIGNLTKLKELFLDFNILQGEIP 282
+ +L L+L N + D+ + NLTK+ EL L N L +
Sbjct: 57 ------------EGVQYLNNLIGLELKDNQI-TDLA-PLKNLTKITELELSGNPL--KNV 100
Query: 283 HTVGNLHNLEYLSLVNNELVGTVPATIFNVSTLKLIELSNNTFFGSLPSSTDVQLPNLEE 342
+ L +++ L L + ++ + L+ L NL+
Sbjct: 101 SAIAGLQSIKTLDLTSTQI-------------TDVTPLAG--------------LSNLQV 133
Query: 343 LYLWGNNFSGTLPSFIFNASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNYLTSPE 402
LYL N + S + +NL LS+G+ S L P NL L L+ +N ++
Sbjct: 134 LYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKISD-- 187
Query: 403 LSFLSSLSNCKYLEIIALSGNPLNGIIPMSAGNLSHSLEELFMPDCNVSGRIPKEIGNLA 462
+S L++ L + L N ++ + P + N +
Sbjct: 188 ---ISPLASLPNLIEVHLKNNQISDVSP---------------------------LANTS 217
Query: 463 NLVTLDLGGNKFNGSIPIALGKLQKLQLLNLDDNKL 498
NL + L L ++
Sbjct: 218 NLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPSGAP 253
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 1e-17
Identities = 58/251 (23%), Positives = 103/251 (41%), Gaps = 43/251 (17%)
Query: 77 NISYLSLTGNIPRQ---LGNLSSLEILDLNFNRLSGEIPWELGNLAKLEKLLLHNNFLTG 133
I+ LS G + L++L L+L N+++ ++ L NL K+ +L L N L
Sbjct: 42 GITTLSAFGTGVTTIEGVQYLNNLIGLELKDNQIT-DLA-PLKNLTKITELELSGNPLKN 99
Query: 134 TIPFSIFKLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQLSGSIPSFIFKISS 193
+ L S+ L L+ +T P L LS+LQ+L L NQ++ +I + +++
Sbjct: 100 VSAIA--GLQSIKTLDLTSTQITDVTP---LAGLSNLQVLYLDLNQIT-NISP-LAGLTN 152
Query: 194 LQALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGGISSTLSNCKHLRILDLSFNDL 253
LQ L GN ++S ++ + L+N L L N +
Sbjct: 153 LQYLSIGNAQVS-----DL----------------------TPLANLSKLTTLKADDNKI 185
Query: 254 WGDIPKEIGNLTKLKELFLDFNILQGEIPHTVGNLHNLEYLSLVNNELVGTVPATIFNVS 313
DI + +L L E+ L N + P + N NL ++L N + N+
Sbjct: 186 -SDIS-PLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQPVFYNNNLV 241
Query: 314 TLKLIELSNNT 324
+++ +
Sbjct: 242 VPNVVKGPSGA 252
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 2e-16
Identities = 42/186 (22%), Positives = 75/186 (40%), Gaps = 14/186 (7%)
Query: 482 LGKLQKLQLLNLDDNKLEGSIPDDICGLVELYKLALGDNKLSGQIPACFGNLASLRELWL 541
L + + + ++ L + L+ ++ I L +L L L
Sbjct: 15 DPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLEL 70
Query: 542 GPNELISFIPSTFWNIKDIMYVNFSSNFLTGPLPLEIENLKALTTLDFSMNNLSGVIPTT 601
N++ P N+ I + S N L + L+++ TLD + ++ V P
Sbjct: 71 KDNQITDLAP--LKNLTKITELELSGNPLKNVSAI--AGLQSIKTLDLTSTQITDVTP-- 124
Query: 602 IGGLKGLQYLFLGHNRLQGSIPDSVGDLISLKSLNLSNNNLSGPIPTSLEKLSDLKELNL 661
+ GL LQ L+L N++ +I + L +L+ L++ N +S P L LS L L
Sbjct: 125 LAGLSNLQVLYLDLNQIT-NIS-PLAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKA 180
Query: 662 SFNKLE 667
NK+
Sbjct: 181 DDNKIS 186
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 53/240 (22%), Positives = 92/240 (38%), Gaps = 46/240 (19%)
Query: 77 NISYLSLTGN---IPRQLGNLSSLEILDLNFNRLSGEIPWELGNLAKLEKLLLHNNFLTG 133
I+ L L+GN + L S++ LDL +++ P L L+ L+ L L N +T
Sbjct: 86 KITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTP--LAGLSNLQVLYLDLNQITN 143
Query: 134 TIPFSIFKLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQLSGSIPSFIFKISS 193
P + L++L L + + ++ P L NLS L L DN++S I + +
Sbjct: 144 ISPLA--GLTNLQYLSIGNAQVSDLTP---LANLSKLTTLKADDNKIS-DISPLA-SLPN 196
Query: 194 LQALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGGISSTLSNCKHLRILDLSFNDL 253
L +H NN++S P L+N +L I+ L+ +
Sbjct: 197 LIEVHLKNNQISDVSP---------------------------LANTSNLFIVTLTNQTI 229
Query: 254 WGDIPKEIGNLTKLKELFLDFNILQGEIPHTVGNLHNLEYLSLVNNELVGTVPATIFNVS 313
NL N+++G + + + + L + + I NVS
Sbjct: 230 TNQPVFYNNNLVVP-------NVVKGPSGAPIAPATISDNGTYASPNLTWNLTSFINNVS 282
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 2e-04
Identities = 23/121 (19%), Positives = 42/121 (34%), Gaps = 7/121 (5%)
Query: 77 NISYLSLTGN----IPRQLGNLSSLEILDLNFNRLSGEIPWELGNLAKLEKLLLHNNFLT 132
++ L N I L +L +L + L N++S P L N + L + L N +T
Sbjct: 174 KLTTLKADDNKISDIS-PLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTIT 230
Query: 133 GTIPFSIFKLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQLSGSIPSFIFKIS 192
F L +K + G +S L + ++ +F ++
Sbjct: 231 NQPVFYNNNLVVPNVVKGPSGAPIAPATISDNGTYASPNLTWNLTSFINNVSYTFNQSVT 290
Query: 193 S 193
Sbjct: 291 F 291
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 7e-23
Identities = 46/213 (21%), Positives = 87/213 (40%), Gaps = 53/213 (24%)
Query: 777 IGRGSFGSVYIAR-LQNGIEVAVKTFDLQH--ERAFKSFDTECEVMKSIRHRNLTKIISS 833
+G+G+F V G+E A K + + R F+ + E + + ++H N+ ++ S
Sbjct: 14 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73
Query: 834 CSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRL------------NIMIDVASALEY 881
E F L+ + + G L F+ + + + + ++ Y
Sbjct: 74 IQEESFHYLVFDLVTGGEL-------------FEDIVAREFYSEADASHCIQQILESIAY 120
Query: 882 LHFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYM 938
H S ++H +LKP N+LL L+DFG+A + + ++ T GY+
Sbjct: 121 CH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAI-EVNDSEAW--HGFAGTPGYL 174
Query: 939 APE------YGREGRVSTKGDVYSFG----ILL 961
+PE Y + D+++ G ILL
Sbjct: 175 SPEVLKKDPYSKP------VDIWACGVILYILL 201
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-22
Identities = 49/192 (25%), Positives = 85/192 (44%), Gaps = 16/192 (8%)
Query: 777 IGRGSFGSVYIAR-LQNGIEVAVKTFDLQH--ERAFKSFDTECEVMKSIRHRNLTKIISS 833
+G+GSFG V + E AVK + + + E E++K + H N+ K+
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 834 CSNEDFKALILEYMRNGSL-EKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIH 892
+ ++ E G L ++ + + I+ V S + Y+H ++H
Sbjct: 90 LEDSSSFYIVGELYTGGELFDEIIKRKRF--SEHDAARIIKQVFSGITYMH---KHNIVH 144
Query: 893 CDLKPSNVLL---DDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVS 949
DLKP N+LL + + + DFG++ ++ M + T Y+APE R G
Sbjct: 145 RDLKPENILLESKEKDCDIKIIDFGLST-CFQQNTKM--KDRIGTAYYIAPEVLR-GTYD 200
Query: 950 TKGDVYSFGILL 961
K DV+S G++L
Sbjct: 201 EKCDVWSAGVIL 212
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 1e-22
Identities = 52/242 (21%), Positives = 91/242 (37%), Gaps = 49/242 (20%)
Query: 776 LIGRGSFGSVYIAR-LQNGIEVAVKTFD----LQHERAFKSFDTECEVMKSIRHRNLTKI 830
L+G GS+G V + AVK + + E ++++ +RH+N+ ++
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 831 ISSCSNEDFKA--LILEYMRNGSLEKCLYSGNYILD----------IFQRLNIMIDVASA 878
+ NE+ + +++EY G E + + + + F +L
Sbjct: 72 VDVLYNEEKQKMYMVMEYCVCGMQE--ML--DSVPEKRFPVCQAHGYFCQL------IDG 121
Query: 879 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATL--- 935
LEYLH S ++H D+KP N+LL +S G+A+ L T T
Sbjct: 122 LEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEAL----HPFAADDTCRTSQGS 174
Query: 936 -GYMAPE--YGREGRVSTKGDVYSFGILLMETFTRRKPTDE---------IFSGEMTLKH 983
+ PE G + K D++S G+ L T P + I G +
Sbjct: 175 PAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPG 234
Query: 984 WV 985
Sbjct: 235 DC 236
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 1e-22
Identities = 74/248 (29%), Positives = 102/248 (41%), Gaps = 49/248 (19%)
Query: 58 VCNWTGVTCDINQRRVTALNISYLSLT---GNIPRQLGNLSSLEILDLNFNRLSGEIPWE 114
VC +C+ N+ V + S LT NIP + + LDL N+LS
Sbjct: 11 VC-----SCNNNKNSV---DCSSKKLTAIPSNIP------ADTKKLDLQSNKLSSLPSKA 56
Query: 115 LGNLAKLEKLLLHNNFLTGTIPFSIF-KLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLL 173
L KL L L++N L T+P IF +L +L L ++DN L +P L +L L
Sbjct: 57 FHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAEL 114
Query: 174 DLSDNQLSGSIPSFIF-KISSLQALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGG 232
L NQL S+P +F ++ L L G N L LP + D L
Sbjct: 115 RLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLT--------------- 157
Query: 233 ISSTLSNCKHLRILDLSFNDLWGDIPKEI-GNLTKLKELFLDFNILQGEIPHTVGNLHNL 291
L+ L L N L +P+ LT+LK L LD N L+ +L L
Sbjct: 158 ---------SLKELRLYNNQL-KRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKL 207
Query: 292 EYLSLVNN 299
+ L L N
Sbjct: 208 KMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 2e-20
Identities = 66/206 (32%), Positives = 90/206 (43%), Gaps = 30/206 (14%)
Query: 462 ANLVTLDLGGNKFNGSIPIALGKLQKLQLLNLDDNKLEGSIPDDIC-GLVELYKLALGDN 520
A+ LDL NK + A +L KL+LL L+DNKL+ ++P I L L L + DN
Sbjct: 37 ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDN 95
Query: 521 KLSGQIPAC-FGNLASLRELWLGPNELISFIPSTFWNIKDIMYVNFSSNFLTGPLPLEIE 579
KL +P F L +L EL L N+L S P F +
Sbjct: 96 KLQ-ALPIGVFDQLVNLAELRLDRNQLKSLPPRVF------------------------D 130
Query: 580 NLKALTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQGSIPDSVGD-LISLKSLNLS 638
+L LT L N L + L L+ L L +N+L+ +P+ D L LK+L L
Sbjct: 131 SLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLD 189
Query: 639 NNNLSGPIPTSLEKLSDLKELNLSFN 664
NN L + + L LK L L N
Sbjct: 190 NNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 5e-19
Identities = 62/175 (35%), Positives = 86/175 (49%), Gaps = 7/175 (4%)
Query: 501 SIPDDICGLVELYKLALGDNKLSGQIPACFGNLASLRELWLGPNELISFIPSTFWNIKDI 560
+IP +I + KL L NKLS F L LR L+L N+L + F +K++
Sbjct: 30 AIPSNI--PADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNL 87
Query: 561 MYVNFSSNFLTGPLPLEI-ENLKALTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQ 619
+ + N L LP+ + + L L L N L + P L L YL LG+N LQ
Sbjct: 88 ETLWVTDNKLQA-LPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQ 146
Query: 620 GSIPDSVGD-LISLKSLNLSNNNLSGPIPTSLEKLSDLKELNLSFNKLEGEIPRG 673
S+P V D L SLK L L NN L + +KL++LK L L N+L+ +P G
Sbjct: 147 -SLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLK-RVPEG 199
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 6e-19
Identities = 61/194 (31%), Positives = 87/194 (44%), Gaps = 13/194 (6%)
Query: 265 TKLKELFLDFNILQGEIPHTVGNLHNLEYLSLVNNELVGTVPATIFN-VSTLKLIELSNN 323
K+L L N L L L L L +N+L T+PA IF + L+ + +++N
Sbjct: 37 ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDN 95
Query: 324 TFFGSLPSSTDVQLPNLEELYLWGNNFSGTLPSFIFNA-SNLSKLSLGDNSFSGLIPNTF 382
+LP QL NL EL L N +LP +F++ + L+ LSLG N L F
Sbjct: 96 KL-QALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQSLPKGVF 153
Query: 383 GNLRNLKRLRLYNNYLTSPELSFLSSLSNCKYLEIIALSGNPLNGIIPMSAGNLSHSLEE 442
L +LK LRLYNN L L+ L+ + L N L +P A + L+
Sbjct: 154 DKLTSLKELRLYNNQLKRVPEGAFDKLTE---LKTLKLDNNQLKR-VPEGAFDSLEKLKM 209
Query: 443 LFMP----DCNVSG 452
L + DC +G
Sbjct: 210 LQLQENPWDCTCNG 223
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 1e-22
Identities = 58/212 (27%), Positives = 92/212 (43%), Gaps = 47/212 (22%)
Query: 777 IGRGSFGSVYIAR-LQNGIEVAVKTFD--------LQHERAFKSFDTECEVMKSIRHRNL 827
+G G+ G V +A + +VA+K + + +TE E++K + H +
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 828 TKIISSCSNEDFKALILEYMRNGSL-----EKCLYSGNYILDIFQRLNIMIDVASALEYL 882
KI + ED+ ++LE M G L F + A++YL
Sbjct: 78 IKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFY------QMLLAVQYL 130
Query: 883 HFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLIGEDQSMTQTQTLA-TLGYM 938
H +IH DLKP NVLL +++ + ++DFG +K ++GE M TL T Y+
Sbjct: 131 H---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK-ILGETSLMR---TLCGTPTYL 183
Query: 939 APE---------YGREGRVSTKGDVYSFGILL 961
APE Y R V D +S G++L
Sbjct: 184 APEVLVSVGTAGYNRA--V----DCWSLGVIL 209
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 99.5 bits (248), Expect = 2e-22
Identities = 57/293 (19%), Positives = 94/293 (32%), Gaps = 50/293 (17%)
Query: 58 VCNWTGVTCDINQRRVTALNISYLSLTGNIPRQLGNLSSLEILDLNFNRLSGEIPWELGN 117
+C+ + + +VT IP L + L +L
Sbjct: 6 ICHCSNRVFLCQESKVTE-----------IPSDL--PRNAIELRFVLTKLRVIQKGAFSG 52
Query: 118 LAKLEKLLLHNNFLTGTIPFSIFK-LSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLS 176
LEK+ + N + I +F L L ++++ N I NL +LQ L +S
Sbjct: 53 FGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLIS 112
Query: 177 DNQLSGSIPSFIF-KISSLQALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGGISS 235
+ + +P L +N + N L F
Sbjct: 113 NTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFE---------------- 155
Query: 236 TLSNCKHLRILDLSFNDLWGDIPKEIGNLTKLKEL-FLDFNILQGEIPHTV-GNLHNLEY 293
IL L+ N + +I N T+L EL D N L+ E+P+ V
Sbjct: 156 -------SVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVI 206
Query: 294 LSLVNNELVGTVPATIF-NVSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYL 345
L + + ++P+ N+ L+ N LP+ L L E L
Sbjct: 207 LDISRTRIH-SLPSYGLENLKKLRARSTYNLK---KLPTLEK--LVALMEASL 253
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 88.0 bits (218), Expect = 1e-18
Identities = 37/225 (16%), Positives = 72/225 (32%), Gaps = 8/225 (3%)
Query: 447 DCNVSG--RIPKEIGNLANLVTLDLGGNKFNGSIPIALGKLQKLQLLNLDDNKLEGSIPD 504
C S IP ++ N + L K A L+ + + N + I
Sbjct: 15 LCQESKVTEIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEA 72
Query: 505 DI-CGLVELYKLAL-GDNKLSGQIPACFGNLASLRELWLGPNELISFIPSTFWNIKDIMY 562
D+ L +L+++ + N L P F NL +L+ L + + + +
Sbjct: 73 DVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVL 132
Query: 563 VNFSSNF-LTGPLPLEIENLKA-LTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQG 620
++ N + L L + N + + + G + + +N L+
Sbjct: 133 LDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEE 192
Query: 621 SIPDSVGDLISLKSLNLSNNNLSGPIPTSLEKLSDLKELNLSFNK 665
D L++S + LE L L+ + K
Sbjct: 193 LPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 237
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 86.4 bits (214), Expect = 4e-18
Identities = 47/257 (18%), Positives = 90/257 (35%), Gaps = 17/257 (6%)
Query: 339 NLEELYLWGNNFSGTLPSFIFNASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNY- 397
+ + + +PS + N +L + F +L+++ + N
Sbjct: 10 SNRVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDV 66
Query: 398 LTSPELSFLSSLSNCKYLEIIALSGNPLNGIIPMSAGNLSHSLEELFMPDCNVSGRIPKE 457
L E S+L + I N L I P + NL +L+ L + + + +P
Sbjct: 67 LEVIEADVFSNLPKLHEIRI--EKANNLLYINPEAFQNLP-NLQYLLISNTGIK-HLPDV 122
Query: 458 I-GNLANLVTLDLGGNKFNGSIPI-ALGKLQ-KLQLLNLDDNKLEGSIPDDICGLVELYK 514
+ V LD+ N +I + L + +L L+ N ++ I + +L +
Sbjct: 123 HKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDE 181
Query: 515 LALGDNKLSGQIPA-CFGNLASLRELWLGPNELISFIPSTFWNIKDIMYVNFSSNFLTGP 573
L L DN ++P F + L + + S N+K + + +
Sbjct: 182 LNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLKKLPT 241
Query: 574 LPLEIENLKALTTLDFS 590
L E L AL +
Sbjct: 242 L----EKLVALMEASLT 254
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 2e-22
Identities = 48/206 (23%), Positives = 85/206 (41%), Gaps = 39/206 (18%)
Query: 777 IGRGSFGSVYIAR-LQNGIEVAVKTFD--LQHERAFKSFDTECEVMKSIRHRNLTKIISS 833
+G+G+F V G+E A K + R F+ + E + + ++H N+ ++ S
Sbjct: 37 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 96
Query: 834 CSNEDFKALILEYMRNGSL-----EKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSA 888
E F L+ + + G L + YS Q + ++ Y H S
Sbjct: 97 IQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ------QILESIAYCH---SN 147
Query: 889 PVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPE---- 941
++H +LKP N+LL L+DFG+A + + ++ T GY++PE
Sbjct: 148 GIVHRNLKPENLLLASKAKGAAVKLADFGLAI-EVNDSEAW--HGFAGTPGYLSPEVLKK 204
Query: 942 --YGREGRVSTKGDVYSFG----ILL 961
Y + D+++ G ILL
Sbjct: 205 DPYSKP------VDIWACGVILYILL 224
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 2e-22
Identities = 56/218 (25%), Positives = 92/218 (42%), Gaps = 42/218 (19%)
Query: 771 FSENNLIGRGSFGSVYIAR-LQNGIEVAVKTFDLQHERAFKSFDTECEVMKSI-RHRNLT 828
F L+G G++G VY R ++ G A+K D+ + + E ++K HRN+
Sbjct: 26 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-EEEIKQEINMLKKYSHHRNIA 84
Query: 829 K-----IISSCSNEDFKA-LILEYMRNGSLEKCLYSGNYILDIFQRLN-----------I 871
I + D + L++E+ GS+ D+ + I
Sbjct: 85 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSV----------TDLIKNTKGNTLKEEWIAYI 134
Query: 872 MIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQT 931
++ L +LH VIH D+K NVLL +N L DFG++ L D+++ + T
Sbjct: 135 CREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL---DRTVGRRNT 188
Query: 932 LA-TLGYMAPE-----YGREGRVSTKGDVYSFGILLME 963
T +MAPE + K D++S GI +E
Sbjct: 189 FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIE 226
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 2e-22
Identities = 46/230 (20%), Positives = 89/230 (38%), Gaps = 25/230 (10%)
Query: 745 PNEVNVPLEATWRRFSYLELFQATNGFSEN----NLIGRGSFGSVYIAR-LQNGIEVAVK 799
N+ + E W+++ + + +G G+FG V+ G K
Sbjct: 23 INDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAK 82
Query: 800 TFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEYMRNGSL------E 853
+ + + E +M + H L + + ++ LILE++ G L E
Sbjct: 83 FINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAE 142
Query: 854 KCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHL--S 911
S + +N M L+++H ++H D+KP N++ + + +
Sbjct: 143 DYKMSEAEV------INYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKII 193
Query: 912 DFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILL 961
DFG+A + D+ + T AT + APE V D+++ G+L
Sbjct: 194 DFGLAT-KLNPDEIV--KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLG 240
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 2e-22
Identities = 53/195 (27%), Positives = 89/195 (45%), Gaps = 19/195 (9%)
Query: 777 IGRGSFGSVYIAR-LQNGIEVAVKTFD-LQHERAFKSFDTECEVMKSIRHRNLTKIISSC 834
+G G+FG V++ +G+E +KT + + + + + E EV+KS+ H N+ KI
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 835 SNEDFKALILEYMRNGSL-----EKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAP 889
+ +++E G L +M + +AL Y H S
Sbjct: 90 EDYHNMYIVMETCEGGELLERIVSAQARGKALSEG--YVAELMKQMMNALAYFH---SQH 144
Query: 890 VIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREG 946
V+H DLKP N+L + + DFG+A+ L D+ T T YMAPE +
Sbjct: 145 VVHKDLKPENILFQDTSPHSPIKIIDFGLAE-LFKSDEHS--TNAAGTALYMAPEVFK-R 200
Query: 947 RVSTKGDVYSFGILL 961
V+ K D++S G+++
Sbjct: 201 DVTFKCDIWSAGVVM 215
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 5e-22
Identities = 53/222 (23%), Positives = 89/222 (40%), Gaps = 47/222 (21%)
Query: 776 LIGRGSFGSVYIAR-LQNGIEVAVKTFD---LQHERAFKSFDT----------------- 814
IG+GS+G V +A + A+K L + F
Sbjct: 20 EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79
Query: 815 ------ECEVMKSIRHRNLTKIIS--SCSNEDFKALILEYMRNGSLEKCLYSGNYILD-- 864
E ++K + H N+ K++ NED ++ E + G + + D
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQA 139
Query: 865 --IFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGE 922
FQ D+ +EYLH +IH D+KPSN+L+ ++ ++DFG++ G
Sbjct: 140 RFYFQ------DLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGS 190
Query: 923 DQSMTQTQTLATLGYMAPE--YGREGRVS-TKGDVYSFGILL 961
D ++ T+ T +MAPE S DV++ G+ L
Sbjct: 191 D-ALLSN-TVGTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 6e-22
Identities = 54/213 (25%), Positives = 92/213 (43%), Gaps = 49/213 (23%)
Query: 777 IGRGSFGSVYIAR-LQNGIEVAVKTFD--------LQHERAFKSFDTECEVMKSIRHRNL 827
+G G+ G V +A + +VA++ + + +TE E++K + H +
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202
Query: 828 TKIISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRL------------NIMIDV 875
KI + ED+ ++LE M G L F ++ +
Sbjct: 203 IKIKNFFDAEDY-YIVLELMEGGEL-------------FDKVVGNKRLKEATCKLYFYQM 248
Query: 876 ASALEYLHFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLIGEDQSMTQTQTL 932
A++YLH +IH DLKP NVLL +++ + ++DFG +K ++GE M TL
Sbjct: 249 LLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK-ILGETSLMR---TL 301
Query: 933 A-TLGYMAPE---YGREGRVSTKGDVYSFGILL 961
T Y+APE + D +S G++L
Sbjct: 302 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 334
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 99 bits (249), Expect = 8e-22
Identities = 48/194 (24%), Positives = 76/194 (39%), Gaps = 21/194 (10%)
Query: 777 IGRGSFGSVYIAR-LQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCS 835
+G G+FG V+ G A K HE ++ E + M +RH L + +
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 224
Query: 836 NEDFKALILEYMRNGSL------EKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAP 889
+++ +I E+M G L E S + + M V L ++H
Sbjct: 225 DDNEMVMIYEFMSGGELFEKVADEHNKMSEDEA------VEYMRQVCKGLCHMH---ENN 275
Query: 890 VIHCDLKPSNVLLDDNMVAHL--SDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGR 947
+H DLKP N++ L DFG+ + QS+ T T + APE
Sbjct: 276 YVHLDLKPENIMFTTKRSNELKLIDFGLTA-HLDPKQSV--KVTTGTAEFAAPEVAEGKP 332
Query: 948 VSTKGDVYSFGILL 961
V D++S G+L
Sbjct: 333 VGYYTDMWSVGVLS 346
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 8e-22
Identities = 49/205 (23%), Positives = 92/205 (44%), Gaps = 27/205 (13%)
Query: 775 NLIGRGSFGSVYIAR-LQNGIEVAVKT-------------FDLQHERAFKSFDTECEVMK 820
+G G++G V + + E A+K + E+ + E ++K
Sbjct: 42 RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101
Query: 821 SIRHRNLTKIISSCSNEDFKALILEYMRNGSL-EKCLYSGNYILDIFQRLNIMIDVASAL 879
S+ H N+ K+ ++ + L+ E+ G L E+ + + D NIM + S +
Sbjct: 102 SLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKF--DECDAANIMKQILSGI 159
Query: 880 EYLHFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLG 936
YLH ++H D+KP N+LL + + + DFG++ +D + L T
Sbjct: 160 CYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSS-FFSKDYKL--RDRLGTAY 213
Query: 937 YMAPEYGREGRVSTKGDVYSFGILL 961
Y+APE + + + K DV+S G+++
Sbjct: 214 YIAPEVLK-KKYNEKCDVWSCGVIM 237
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 1e-21
Identities = 46/204 (22%), Positives = 86/204 (42%), Gaps = 25/204 (12%)
Query: 771 FSENNLIGRGSFGSVYIAR-LQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTK 829
S+ ++G G FG V+ G+++A K + + + E VM + H NL +
Sbjct: 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQ 150
Query: 830 IISSCSNEDFKALILEYMRNGSL------EKCLYSGNYILDIFQRLNIMIDVASALEYLH 883
+ + +++ L++EY+ G L E + + M + + ++H
Sbjct: 151 LYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTIL------FMKQICEGIRHMH 204
Query: 884 FGYSAPVIHCDLKPSNVLLDDNMVAHL--SDFGIAKLLIGEDQSMTQTQTLATLGYMAPE 941
Y ++H DLKP N+L + + DFG+A+ + + T ++APE
Sbjct: 205 QMY---ILHLDLKPENILCVNRDAKQIKIIDFGLAR-RYKPREKL--KVNFGTPEFLAPE 258
Query: 942 YGREGRVSTKGDVYSFG----ILL 961
VS D++S G +LL
Sbjct: 259 VVNYDFVSFPTDMWSVGVIAYMLL 282
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 96.5 bits (240), Expect = 1e-21
Identities = 48/255 (18%), Positives = 94/255 (36%), Gaps = 37/255 (14%)
Query: 800 TFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEYMRNGSLEKCLYSG 859
+ L + + M +N + S + + + ++ R +L+ +
Sbjct: 96 DWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRR 155
Query: 860 NYI--LDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK 917
+ + L+I I +A A+E+LH S ++H DLKPSN+ + V + DFG+
Sbjct: 156 CSLEDREHGVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVT 212
Query: 918 LLIGEDQSMTQTQTLA----------TLGYMAPEYGREGRVSTKGDVYSFGILLMETFTR 967
+ +++ T + T YM+PE S K D++S G++L E
Sbjct: 213 AMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYS 272
Query: 968 RKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECT 1027
E +++ F + K ++++ +
Sbjct: 273 FSTQMERVRIITDVRN--LKFPLLFTQKYPQEHMMVQ--------------------DML 310
Query: 1028 VESPDERITAKEIVR 1042
SP ER A +I+
Sbjct: 311 SPSPTERPEATDIIE 325
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 15/71 (21%), Positives = 29/71 (40%), Gaps = 2/71 (2%)
Query: 771 FSENNLIGRGSFGSVYIAR-LQNGIEVAVKTFDLQH-ERAFKSFDTECEVMKSIRHRNLT 828
F +GRG FG V+ A+ + A+K L + E A + E + + + H +
Sbjct: 8 FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 67
Query: 829 KIISSCSNEDF 839
+ ++
Sbjct: 68 RYFNAWLETPP 78
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 96.4 bits (240), Expect = 2e-21
Identities = 55/236 (23%), Positives = 85/236 (36%), Gaps = 54/236 (22%)
Query: 777 IGRGSFGSVYIAR-LQNGIEVAVKTFDLQHERAFKSFDT-----ECEVMKSIRHRNLTKI 830
IG+GS+G V +A Q A+K + R D E +MK + H N+ ++
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 831 ISSCSNEDFKALILEYMRNGSL------EKCLYSGNYILDIFQRL--------------- 869
+E + L++E G L +G +D+ +
Sbjct: 94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 870 ------------------NIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHL- 910
NIM + SAL YLH + + H D+KP N L N +
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLFSTNKSFEIK 210
Query: 911 -SDFGIAKLLIGEDQSMTQ--TQTLATLGYMAPE--YGREGRVSTKGDVYSFGILL 961
DFG++K + T T ++APE K D +S G+LL
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 95.7 bits (238), Expect = 2e-21
Identities = 58/280 (20%), Positives = 97/280 (34%), Gaps = 20/280 (7%)
Query: 234 SSTLSNCKHLRILDLSFNDLWGDIPKEIGNLTKLKELFLDFNILQGEIPHT---VGNLHN 290
S L+ +D + +I LK L + + I V +
Sbjct: 40 GGGRSLEYLLKRVDTEADLGQ---FTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISG 96
Query: 291 LEYLSLVNNELVGTVPATIF-----NVSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYL 345
L+ L+L N E+ GT P + +++ L L +S T L P L+ L +
Sbjct: 97 LQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSI 156
Query: 346 WGNNFSGTLPSFIFNASNLSKLSLGDNSFSGLIPNT----FGNLRNLKRLRLYNNYLTSP 401
+ + LS L L DN G L+ L L N + +P
Sbjct: 157 AQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETP 216
Query: 402 ELSFLSSLSNCKYLEIIALSGNPLNGIIPMSAGNLSHSLEELFMPDCNVSGRIPKEIGNL 461
+ + L+ + LS N L + + L L + + ++PK +
Sbjct: 217 SGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGL--P 273
Query: 462 ANLVTLDLGGNKFNGSIPIALGKLQKLQLLNLDDNKLEGS 501
A L LDL N+ + P +L ++ L+L N S
Sbjct: 274 AKLSVLDLSYNRLD-RNPS-PDELPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 93.0 bits (231), Expect = 1e-20
Identities = 56/294 (19%), Positives = 85/294 (28%), Gaps = 65/294 (22%)
Query: 72 RVTALNISYLSLTGNIPRQ---LGNLSSLEILDLNFNRLSGEIPWELGNLA--KLEKLLL 126
+ L + + I + +S L+ L L ++G P L L L L
Sbjct: 69 SLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNL 128
Query: 127 HNNFLTGTIPF----SIFKLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQLSG 182
N + + L L ++ + + +L LDLSDN G
Sbjct: 129 RNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSL-NFSCEQVRVFPALSTLDLSDNPELG 187
Query: 183 SIP----SFIFKISSLQALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGGISSTLS 238
K +LQ L N + G S+ +
Sbjct: 188 ERGLISALCPLKFPTLQVLALRNAGM----------------------ETPSGVCSALAA 225
Query: 239 NCKHLRILDLSFNDLWGDIPKEIGNLTKLKELFLDFNILQGEIPHTVGNLHNLEYLSLVN 298
L+ LDLS N L + L L+L
Sbjct: 226 ARVQLQGLDLSHNSLRDAAGAPSCDWPS-----------------------QLNSLNLSF 262
Query: 299 NELVGTVPATIFNVSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSG 352
L VP + + L +++LS N PS +LP + L L GN F
Sbjct: 263 TGLK-QVPKGLP--AKLSVLDLSYN-RLDRNPSPD--ELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 91.9 bits (228), Expect = 3e-20
Identities = 50/276 (18%), Positives = 89/276 (32%), Gaps = 20/276 (7%)
Query: 142 LSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQLSGSIPSFIFKI---SSLQALH 198
SL L + ++ SL+ L + ++ I ++ S LQ L
Sbjct: 42 GRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELT 101
Query: 199 FGNNRLSGELPANICDN-LPFLNFFSVYKNMFYGGIS--STLSNC--KHLRILDLSFNDL 253
N ++G P + + P LN ++ + + + L L++L ++
Sbjct: 102 LENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHS 161
Query: 254 WGDIPKEIGNLTKLKELFLDFNILQGEIPHT----VGNLHNLEYLSLVNNE---LVGTVP 306
+++ L L L N GE L+ L+L N G
Sbjct: 162 LNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCS 221
Query: 307 ATIFNVSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSGTLPSFIFNASNLSK 366
A L+ ++LS+N+ + + + L L L +P + + LS
Sbjct: 222 ALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP--AKLSV 278
Query: 367 LSLGDNSFSGLIPNTFGNLRNLKRLRLYNNYLTSPE 402
L L N L + L L N E
Sbjct: 279 LDLSYNRLDRNPS--PDELPQVGNLSLKGNPFLDSE 312
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 90.0 bits (223), Expect = 1e-19
Identities = 52/308 (16%), Positives = 82/308 (26%), Gaps = 52/308 (16%)
Query: 367 LSLGDNSFSGLIPNTFGNLRNLKRLRLYNNYLTSPELSFLSSLSNCKYLEIIALSGNPLN 426
L D +LKRL + + S L + L+ + L +
Sbjct: 49 LKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVT 108
Query: 427 GIIPMSAGNLSH-SLEELFMPDCNVSGR--IPKEIGNL--ANLVTLDLGGNKFNGSIPIA 481
G P + L L + + + + R E+ L L +
Sbjct: 109 GTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQ 168
Query: 482 LGKLQKLQLLNLDDNKLEGSIPDDICGLVELYKLALGDNKLSGQIPACFGNLASLRELWL 541
+ L L+L DN G C +L+ L L
Sbjct: 169 VRVFPALSTLDLSDNPELGERGL--------------------ISALCPLKFPTLQVLAL 208
Query: 542 GPNELISFIPSTFWNIKDIMYVNFSSNFLTGPLPLEIENLKALTTLDFSMNNLSGVIPTT 601
+ + +G L LD S N+L
Sbjct: 209 RNAGMET---------------------PSGVCSALAAARVQLQGLDLSHNSLRDAAGAP 247
Query: 602 I-GGLKGLQYLFLGHNRLQGSIPDSVGDLISLKSLNLSNNNLSGPIPTSLEKLSDLKELN 660
L L L L+ +P + L L+LS N L P S ++L + L+
Sbjct: 248 SCDWPSQLNSLNLSFTGLK-QVPKGLPA--KLSVLDLSYNRLDR-NP-SPDELPQVGNLS 302
Query: 661 LSFNKLEG 668
L N
Sbjct: 303 LKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 85.7 bits (212), Expect = 4e-18
Identities = 54/317 (17%), Positives = 92/317 (29%), Gaps = 59/317 (18%)
Query: 339 NLEELYLWGNNFSGTLPSF-IFNASNLSKLSLGDNSFSGLIPNT---FGNLRNLKRLRLY 394
+LE L + + I + +L +L++ I + L+ L L
Sbjct: 44 SLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLE 103
Query: 395 NNYLT--SPELSFLSSLSNCKYLEIIALSGNPLNGIIPMSAGNLSHSLEELFMPDCNVSG 452
N +T +P ++ + L + +S + + L L+ L + +
Sbjct: 104 NLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLN 163
Query: 453 RIPKEIGNLANLVTLDLGGNKFNGSIP----IALGKLQKLQLLNLDDNKLEGSIPDDICG 508
+++ L TLDL N G + K LQ+L L + +
Sbjct: 164 FSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGM---------- 213
Query: 509 LVELYKLALGDNKLSGQIPACFGNLASLRELWLGPNELISFIPSTFWNIKDIMYVNFSSN 568
SG A L+ L L N L
Sbjct: 214 -----------ETPSGVCSALAAARVQLQGLDLSHNSLRDAAG----------------- 245
Query: 569 FLTGPLPLEIENLKALTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQGSIPDSVGD 628
+ L +L+ S L V L L L +NRL P +
Sbjct: 246 ------APSCDWPSQLNSLNLSFTGLKQVPKGL---PAKLSVLDLSYNRLD-RNPSP-DE 294
Query: 629 LISLKSLNLSNNNLSGP 645
L + +L+L N
Sbjct: 295 LPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 84.6 bits (209), Expect = 9e-18
Identities = 54/250 (21%), Positives = 86/250 (34%), Gaps = 21/250 (8%)
Query: 437 SHSLEELFM-PDCNVSGRIPKEIGNLANLVTLDLGGNKFNGSIPIALGKL---QKLQLLN 492
SLE L D +I +L L + + I ++ LQ L
Sbjct: 42 GRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELT 101
Query: 493 LDDNKLEGSIPDDICGLV--ELYKLALGDNKLSGQ---IPACFGNLA-SLRELWLGPNEL 546
L++ ++ G+ P + +L L L + + + + L L+ L +
Sbjct: 102 LENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHS 161
Query: 547 ISFIPSTFWNIKDIMYVNFSSNFLTGPLPLEIE----NLKALTTLDFSMNN---LSGVIP 599
++F + ++ S N G L L L SGV
Sbjct: 162 LNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCS 221
Query: 600 TTIGGLKGLQYLFLGHNRLQGSIPDSVGD-LISLKSLNLSNNNLSGPIPTSLEKLSDLKE 658
LQ L L HN L+ + D L SLNLS L +P L + L
Sbjct: 222 ALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQ-VPKGL--PAKLSV 278
Query: 659 LNLSFNKLEG 668
L+LS+N+L+
Sbjct: 279 LDLSYNRLDR 288
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 69.5 bits (170), Expect = 1e-12
Identities = 37/211 (17%), Positives = 62/211 (29%), Gaps = 16/211 (7%)
Query: 480 IALGKLQKLQLLNLDDNKLEGSIPDDICGLVELYKLALGDNKLSGQIPAC---FGNLASL 536
+ G LL D + + DI + L +L + ++ +I ++ L
Sbjct: 38 LYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGL 97
Query: 537 RELWLGPNEL--ISFIPSTFWNIKDIMYVNFSSNFLTGPLP----LEIENLKALTTLDFS 590
+EL L E+ + P D+ +N + L+ L L +
Sbjct: 98 QELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIA 157
Query: 591 MNNLSGVIPTTIGGLKGLQYLFLGHNRLQGSIP----DSVGDLISLKSLNLSNNN---LS 643
+ + L L L N G +L+ L L N S
Sbjct: 158 QAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPS 217
Query: 644 GPIPTSLEKLSDLKELNLSFNKLEGEIPRGG 674
G L+ L+LS N L
Sbjct: 218 GVCSALAAARVQLQGLDLSHNSLRDAAGAPS 248
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 3e-21
Identities = 51/207 (24%), Positives = 83/207 (40%), Gaps = 43/207 (20%)
Query: 776 LIGRGSFGSVYIAR-LQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSC 834
+GRG+ VY + A+K ++ K TE V+ + H N+ K+
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK--KIVRTEIGVLLRLSHPNIIKLKEIF 117
Query: 835 SNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRL------------NIMIDVASALEYL 882
+L+LE + G L F R+ + + + A+ YL
Sbjct: 118 ETPTEISLVLELVTGGEL-------------FDRIVEKGYYSERDAADAVKQILEAVAYL 164
Query: 883 HFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLIGEDQSMTQTQTLA-TLGYM 938
H ++H DLKP N+L + ++DFG++K ++ M T+ T GY
Sbjct: 165 H---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSK-IVEHQVLMK---TVCGTPGYC 217
Query: 939 APEYGREGRVSTKGDVYSFG----ILL 961
APE R + D++S G ILL
Sbjct: 218 APEILRGCAYGPEVDMWSVGIITYILL 244
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 3e-21
Identities = 51/202 (25%), Positives = 79/202 (39%), Gaps = 26/202 (12%)
Query: 777 IGRGSFGSVYIAR-LQNGIEVAVKTFD------LQHERAFKSFDTECEVMKSIRHRNLTK 829
+G G F V R G E A K + + + + E +++ IRH N+
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 830 IISSCSNEDFKALILEYMRNGSL-EKCLYSGNYI-LDIFQRLNIMIDVASALEYLHFGYS 887
+ N+ LILE + G L + + + + + + YLH S
Sbjct: 73 LHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEA---TQFLKQILDGVHYLH---S 126
Query: 888 APVIHCDLKPSNVLLDDNMVAH----LSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYG 943
+ H DLKP N++L D V + L DFGIA I T ++APE
Sbjct: 127 KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH-KIEAGNEF--KNIFGTPEFVAPEIV 183
Query: 944 REGRVSTKGDVYSFG----ILL 961
+ + D++S G ILL
Sbjct: 184 NYEPLGLEADMWSIGVITYILL 205
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 3e-21
Identities = 53/205 (25%), Positives = 88/205 (42%), Gaps = 34/205 (16%)
Query: 776 LIGRGSFGSVYIARL-QNGIEVAVKTFDLQH---ERAFKSFDTECEVMKSIRHRNLTKII 831
++G GSF +V +AR E A+K + +H E E +VM + H K+
Sbjct: 37 ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY 96
Query: 832 SSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLN----IMIDVA--------SAL 879
+ +++ L Y +NG L + + SAL
Sbjct: 97 FTFQDDEKLYFGLSYAKNGEL-------------LKYIRKIGSFDETCTRFYTAEIVSAL 143
Query: 880 EYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTL-ATLGYM 938
EYLH +IH DLKP N+LL+++M ++DFG AK+L E + + T Y+
Sbjct: 144 EYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR-ANSFVGTAQYV 199
Query: 939 APEYGREGRVSTKGDVYSFGILLME 963
+PE E D+++ G ++ +
Sbjct: 200 SPELLTEKSACKSSDLWALGCIIYQ 224
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 3e-21
Identities = 44/198 (22%), Positives = 76/198 (38%), Gaps = 22/198 (11%)
Query: 777 IGRGSFGSVYIAR-LQNGIEVAVKTFDLQHERAFKSFD------TECEVMKSIRHRNLTK 829
+G G F V R G+E A K + RA + E +++ + H N+
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 830 IISSCSNEDFKALILEYMRNGSL-EKCLYSGNYI-LDIFQRLNIMIDVASALEYLHFGYS 887
+ N LILE + G L + + + + + + + YLH +
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEA---TSFIKQILDGVNYLH---T 133
Query: 888 APVIHCDLKPSNVLL----DDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYG 943
+ H DLKP N++L L DFG+A I + T ++APE
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH-EIEDGVEF--KNIFGTPEFVAPEIV 190
Query: 944 REGRVSTKGDVYSFGILL 961
+ + D++S G++
Sbjct: 191 NYEPLGLEADMWSIGVIT 208
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 4e-21
Identities = 53/235 (22%), Positives = 92/235 (39%), Gaps = 41/235 (17%)
Query: 777 IGRGSFGSVYIAR-LQNGIEVAVKTFD--------LQHERAFKSFDTECEVMKSIRHRNL 827
+G G+FG V+ A + EV VK + E ++ + H N+
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 828 TKIISSCSNEDFKALILEYMRNGSLEKCLYSGNYILD-----------IFQRLNIMIDVA 876
K++ N+ F L++E +G L+ L+ +I IF++L
Sbjct: 92 IKVLDIFENQGFFQLVMEKHGSG-LD--LF--AFIDRHPRLDEPLASYIFRQL------V 140
Query: 877 SALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLG 936
SA+ YL +IH D+K N+++ ++ L DFG A L E + T T+
Sbjct: 141 SAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL--ERGKLFYT-FCGTIE 194
Query: 937 YMAPE-YGREGRVSTKGDVYSFGILLMETFTRRKP---TDEIFSGEMTLKHWVND 987
Y APE + +++S G+ L P +E + + V+
Sbjct: 195 YCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEAAIHPPYLVSK 249
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 97.9 bits (243), Expect = 4e-21
Identities = 59/314 (18%), Positives = 114/314 (36%), Gaps = 54/314 (17%)
Query: 121 LEKLLLHNNFLTGTIPFSIFKLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQL 180
+ + + + + P + + L ++T + L+S+ + +++ +
Sbjct: 1 MGETITVSTPIKQIFPDD--AFAETIKDNLKKKSVTDAVT---QNELNSIDQIIANNSDI 55
Query: 181 SGSIPSFIFKISSLQALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGGISSTLSNC 240
S+ I + ++ L N+L+ +I L+N
Sbjct: 56 K-SV-QGIQYLPNVTKLFLNGNKLT-----DI----------------------KPLTNL 86
Query: 241 KHLRILDLSFNDLWGDIPKEIGNLTKLKELFLDFNILQGEIPHTVGNLHNLEYLSLVNNE 300
K+L L L N + D+ + +L KLK L L+ N + +I + +L LE L L NN+
Sbjct: 87 KNLGWLFLDENKI-KDLS-SLKDLKKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNK 142
Query: 301 LVGTVPATIFNVSTLKLIELSNN--TFFGSLPSSTDVQLPNLEELYLWGNNFSGTLPSFI 358
+ T + ++ L + L +N + L L L+ LYL N+ S +
Sbjct: 143 I--TDITVLSRLTKLDTLSLEDNQISDIVPL-----AGLTKLQNLYLSKNHISDL--RAL 193
Query: 359 FNASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNYLTSPELSFLSSLSNCKYLEII 418
NL L L N NL ++ + L +PE +S+ E
Sbjct: 194 AGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPE-----IISDDGDYEKP 248
Query: 419 ALSGNPLNGIIPMS 432
+ + +S
Sbjct: 249 NVKWHLPEFTNEVS 262
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 94.8 bits (235), Expect = 5e-20
Identities = 56/353 (15%), Positives = 115/353 (32%), Gaps = 50/353 (14%)
Query: 340 LEELYLWGNNFS--GTLPSFIFNASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNY 397
+ E +F + K +L S + + L ++ ++ N+
Sbjct: 1 MGETITVSTPIKQIFPDDAF----AETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSD 54
Query: 398 LTSPELSFLSSLSNCKYLEIIALSGNPLNGIIPMSAGNLSHSLEELFMPDCNVSGRIPKE 457
+ S + + + + L+GN L I P++ NL + L LF+ + + +
Sbjct: 55 IKS-----VQGIQYLPNVTKLFLNGNKLTDIKPLT--NLKN-LGWLFLDENKIK-DLS-S 104
Query: 458 IGNLANLVTLDLGGNKFNGSIPIALGKLQKLQLLNLDDNKLEGSIPDDICGLVELYKLAL 517
+ +L L +L L N + I L L +L+ L L +NK+ + + L +L L+L
Sbjct: 105 LKDLKKLKSLSLEHNGIS-DIN-GLVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSL 160
Query: 518 GDNKLSGQIPACFGNLASLRELWLGPNELISFIPSTFWNIKDIMYVNFSSNFLTGPLPLE 577
DN++S I L L+ L+L N +I D+
Sbjct: 161 EDNQIS-DIVP-LAGLTKLQNLYLSKN-----------HISDLR---------------A 192
Query: 578 IENLKALTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQGSIPDSVGDLISLKSLNL 637
+ LK L L+ L + L S ++
Sbjct: 193 LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKW 252
Query: 638 SNNNLSGPIPTSLEKLSDLKELNLSFNKLEGEIPRGGPFVNFSAKSFMGNNLL 690
+ + + + + F+ + + V++ + +
Sbjct: 253 HLPEFTNEVSFIFYQPVTIGKAKARFHGRVTQPLKEVYTVSYDVDGTVIKTKV 305
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 94.0 bits (233), Expect = 8e-20
Identities = 48/264 (18%), Positives = 92/264 (34%), Gaps = 45/264 (17%)
Query: 235 STLSNCKHLRILDLSFNDLWGDIPKEIGNLTKLKELFLDFNILQGEIPHTVGNLHNLEYL 294
+L + + L + ++ + + ++ + + L N+ L
Sbjct: 15 FPDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQG-IQYLPNVTKL 70
Query: 295 SLVNNELVGTVPATIFNVSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSGTL 354
L N+L I ++ L NL L+L N
Sbjct: 71 FLNGNKL-----TDIKPLT----------------------NLKNLGWLFLDENKIKDL- 102
Query: 355 PSFIFNASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNYLTSPELSFLSSLSNCKY 414
S + + L LSL N S + +L L+ L L NN +T ++ LS
Sbjct: 103 -SSLKDLKKLKSLSLEHNGISDING--LVHLPQLESLYLGNNKITD-----ITVLSRLTK 154
Query: 415 LEIIALSGNPLNGIIPMSAGNLSHSLEELFMPDCNVSGRIPKEIGNLANLVTLDLGGNKF 474
L+ ++L N ++ I+P++ L+ L+ L++ ++S + + L NL L+L +
Sbjct: 155 LDTLSLEDNQISDIVPLA--GLT-KLQNLYLSKNHIS--DLRALAGLKNLDVLELFSQEC 209
Query: 475 NGSIPIALGKLQKLQLLNLDDNKL 498
L + D L
Sbjct: 210 LNKPINHQSNLVVPNTVKNTDGSL 233
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 85.2 bits (210), Expect = 4e-17
Identities = 54/295 (18%), Positives = 102/295 (34%), Gaps = 24/295 (8%)
Query: 77 NISYLSLTGNIPRQ---LGNLSSLEILDLNFNRLSGEIPWELGNLAKLEKLLLHNNFLTG 133
+I + + + + L ++ L LN N+L+ +I L NL L L L N +
Sbjct: 44 SIDQIIANNSDIKSVQGIQYLPNVTKLFLNGNKLT-DIK-PLTNLKNLGWLFLDENKIKD 101
Query: 134 TIPFSIFKLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQLSGSIPSFIFKISS 193
L L L L N ++ I L +L L+ L L +N+++ + + +++
Sbjct: 102 LSSLK--DLKKLKSLSLEHNGIS-DIN--GLVHLPQLESLYLGNNKIT--DITVLSRLTK 154
Query: 194 LQALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGGIS--STLSNCKHLRILDLSFN 251
L L +N++S ++ L L + KN IS L+ K+L +L+L
Sbjct: 155 LDTLSLEDNQIS-DIVP--LAGLTKLQNLYLSKN----HISDLRALAGLKNLDVLELFSQ 207
Query: 252 DLWGDIPKEIGNLTKLKELFLDFNILQGEIPHTVGNLHNLEYLSLVNNELVGTVPATIFN 311
+ NL + L P + + + E ++ + L F
Sbjct: 208 ECLNKPINHQSNLVVPNTVKNTDGSLV--TPEIISDDGDYEKPNVKWH-LPEFTNEVSFI 264
Query: 312 VSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSGTLPSFIFNASNLSK 366
I + F G + ++ + I +K
Sbjct: 265 FYQPVTIGKAKARFHGRVTQPLKEVYTVSYDVDGTVIKTKVEAGTRITAPKPPTK 319
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 5e-21
Identities = 42/198 (21%), Positives = 75/198 (37%), Gaps = 22/198 (11%)
Query: 777 IGRGSFGSVYIAR-LQNGIEVAVKTFD------LQHERAFKSFDTECEVMKSIRHRNLTK 829
+G G F V R G+E A K + + + E +++ + H N+
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 830 IISSCSNEDFKALILEYMRNGSL-EKCLYSGNYI-LDIFQRLNIMIDVASALEYLHFGYS 887
+ N LILE + G L + + + + + + + YLH +
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEA---TSFIKQILDGVNYLH---T 133
Query: 888 APVIHCDLKPSNVLL----DDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYG 943
+ H DLKP N++L L DFG+A I + T ++APE
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH-EIEDGVEF--KNIFGTPEFVAPEIV 190
Query: 944 REGRVSTKGDVYSFGILL 961
+ + D++S G++
Sbjct: 191 NYEPLGLEADMWSIGVIT 208
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 6e-21
Identities = 57/239 (23%), Positives = 88/239 (36%), Gaps = 28/239 (11%)
Query: 763 ELFQATNGFSENNLIGRGSFGSVYIARLQNGIEVAVK--TFDLQHERAFKSFDT------ 814
EL + ++ I GS+G+V GI VA+K + R
Sbjct: 16 ELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKR 75
Query: 815 ---ECEVMKSIRHRNLTK---IISSCSNEDFKA--LILEYMRNGSLEKCLYSGNYILDIF 866
E ++ H N+ I L+ E MR L + ++ ++
Sbjct: 76 VLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQ 134
Query: 867 QRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSM 926
M + L LH A V+H DL P N+LL DN + DF +A+ D +
Sbjct: 135 HIQYFMYHILLGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAR-EDTADANK 190
Query: 927 TQTQTLATLGYMAPEYGREGRVSTKG-DVYSFGILLMETFTRRKPTDEIFSGEMTLKHW 984
T + Y APE + + TK D++S G ++ E F RK +F G
Sbjct: 191 --THYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFN-RKA---LFRGSTFYNQL 243
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 9e-21
Identities = 31/202 (15%), Positives = 58/202 (28%), Gaps = 39/202 (19%)
Query: 776 LIGRGSFGSVYIAR-LQNGIEVAVKTFDLQH---ERAFKSFDTECEVMKSIRHRNLTKII 831
G + A +VA+ D Q + + + + I + +++
Sbjct: 38 FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL 97
Query: 832 SSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVI 891
++ E++R GSL++ + + M +A+A + H A V
Sbjct: 98 DVVHTRAGGLVVAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAH---RAGVA 151
Query: 892 HCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTK 951
PS V + + G LA M + +
Sbjct: 152 LSIDHPSRVRVSID--------GDVV--------------LAYPATMPD-------ANPQ 182
Query: 952 GDVYSFGILLMETFTRRKPTDE 973
D+ G L R P E
Sbjct: 183 DDIRGIGASLYALLVNRWPLPE 204
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 1e-20
Identities = 43/198 (21%), Positives = 77/198 (38%), Gaps = 22/198 (11%)
Query: 777 IGRGSFGSVYIAR-LQNGIEVAVKTFD------LQHERAFKSFDTECEVMKSIRHRNLTK 829
+G G F V R G++ A K + + + + E ++K I+H N+
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 830 IISSCSNEDFKALILEYMRNGSL-EKCLYSGNYI-LDIFQRLNIMIDVASALEYLHFGYS 887
+ N+ LILE + G L + + + + + + + YLH S
Sbjct: 79 LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEA---TEFLKQILNGVYYLH---S 132
Query: 888 APVIHCDLKPSNVLL----DDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYG 943
+ H DLKP N++L + DFG+A I T ++APE
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH-KIDFGNEF--KNIFGTPEFVAPEIV 189
Query: 944 REGRVSTKGDVYSFGILL 961
+ + D++S G++
Sbjct: 190 NYEPLGLEADMWSIGVIT 207
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 2e-20
Identities = 53/200 (26%), Positives = 84/200 (42%), Gaps = 29/200 (14%)
Query: 776 LIGRGSFGSVYIAR-LQNGIEVAVKTFDL-QHERAFKSFDTECEVMKSIRHRNLTKIISS 833
+G G++G V +A VAVK D+ + ++ E + K + H N+ K
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 834 CSNEDFKALILEYMRNGSLEKCLYSGNYILD-----------IFQRLNIMIDVASALEYL 882
+ + L LEY G L + I F +L + + YL
Sbjct: 74 RREGNIQYLFLEYCSGGELF------DRIEPDIGMPEPDAQRFFHQL------MAGVVYL 121
Query: 883 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPE- 941
H + H D+KP N+LLD+ +SDFG+A + ++ + TL Y+APE
Sbjct: 122 H---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 942 YGREGRVSTKGDVYSFGILL 961
R + DV+S GI+L
Sbjct: 179 LKRREFHAEPVDVWSCGIVL 198
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 2e-20
Identities = 57/205 (27%), Positives = 89/205 (43%), Gaps = 43/205 (20%)
Query: 777 IGRGSFGSVYIAR-LQNGIEVAVKTFD---LQHERAFKSFDTECEVMKSIRHRNLTKIIS 832
IG+G+F V +AR + G EVA+K D L K F E +MK + H N+ K+
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLF-REVRIMKILNHPNIVKLFE 81
Query: 833 SCSNEDFKALILEYMRNGSLEKCLYSGNYILD-----------IFQRLNIMIDVASALEY 881
E LI+EY G + +Y++ F+++ SA++Y
Sbjct: 82 VIETEKTLYLIMEYASGGEV------FDYLVAHGRMKEKEARSKFRQI------VSAVQY 129
Query: 882 LHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLAT----LGY 937
H ++H DLK N+LLD +M ++DFG + T L Y
Sbjct: 130 CH---QKRIVHRDLKAENLLLDADMNIKIADFGFS-------NEFTVGGKLDAFCGAPPY 179
Query: 938 MAPE-YGREGRVSTKGDVYSFGILL 961
APE + + + DV+S G++L
Sbjct: 180 AAPELFQGKKYDGPEVDVWSLGVIL 204
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 3e-20
Identities = 66/238 (27%), Positives = 107/238 (44%), Gaps = 52/238 (21%)
Query: 765 FQATNGFSENNLIGRGSFGSVYIARLQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRH 824
Q ++ +IG GSFG V+ A+L EVA+K LQ +R FK+ E ++M+ ++H
Sbjct: 36 EQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKV-LQDKR-FKN--RELQIMRIVKH 91
Query: 825 RNLTK----IISSCSNEDFKA--LILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVA-- 876
N+ S+ +D L+LEY+ + +Y + +L + +
Sbjct: 92 PNVVDLKAFFYSNGDKKDEVFLNLVLEYV-----PETVYR---ASRHYAKLKQTMPMLLI 143
Query: 877 --------SALEYLHFGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLIGEDQSMT 927
+L Y+H S + H D+KP N+LLD + V L DFG AK+LI +
Sbjct: 144 KLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI-AGEPN- 198
Query: 928 QTQTLATLGYMAPE-------YGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGE 978
+ + Y APE Y +T D++S G ++ E +P +F GE
Sbjct: 199 -VSYICSRYYRAPELIFGATNY------TTNIDIWSTGCVMAELMQ-GQP---LFPGE 245
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 3e-20
Identities = 41/191 (21%), Positives = 79/191 (41%), Gaps = 16/191 (8%)
Query: 777 IGRGSFGSVYIAR-LQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCS 835
+GRG FG V+ + K ++ E ++ RHRN+ + S
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ-VLVKKEISILNIARHRNILHLHESFE 71
Query: 836 NEDFKALILEYMRNGSL-EKCLYSGNYI--LDIFQRLNIMIDVASALEYLHFGYSAPVIH 892
+ + +I E++ + E+ S + +I ++ + V AL++LH + H
Sbjct: 72 SMEELVMIFEFISGLDIFERINTSAFELNEREI---VSYVHQVCEALQFLHSHN---IGH 125
Query: 893 CDLKPSNVLLDDNMVAHL--SDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVST 950
D++P N++ + + +FG A+ + + Y APE + VST
Sbjct: 126 FDIRPENIIYQTRRSSTIKIIEFGQAR-QLKPGDNF--RLLFTAPEYYAPEVHQHDVVST 182
Query: 951 KGDVYSFGILL 961
D++S G L+
Sbjct: 183 ATDMWSLGTLV 193
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 4e-20
Identities = 56/206 (27%), Positives = 91/206 (44%), Gaps = 42/206 (20%)
Query: 776 LIGRGSFGSVYIAR-LQNGIEVAVKTFD---LQHERAFKSFDTECEVMKSIRHRNLTKII 831
+G G+FG V I G +VAVK + ++ E + +K RH ++ K+
Sbjct: 18 TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLY 77
Query: 832 SSCSNEDFKALILEYMRNGSLEKCLYSGNYILD-----------IFQRLNIMIDVASALE 880
S +++EY+ G L +YI +FQ++ SA++
Sbjct: 78 QVISTPTDFFMVMEYVSGGEL------FDYICKHGRVEEMEARRLFQQI------LSAVD 125
Query: 881 YLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATL----G 936
Y H V+H DLKP NVLLD +M A ++DFG++ + M+ + L T
Sbjct: 126 YCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNM-------MSDGEFLRTSCGSPN 175
Query: 937 YMAPE-YGREGRVSTKGDVYSFGILL 961
Y APE + D++S G++L
Sbjct: 176 YAAPEVISGRLYAGPEVDIWSCGVIL 201
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 1e-19
Identities = 53/200 (26%), Positives = 84/200 (42%), Gaps = 29/200 (14%)
Query: 776 LIGRGSFGSVYIAR-LQNGIEVAVKTFDL-QHERAFKSFDTECEVMKSIRHRNLTKIISS 833
+G G++G V +A VAVK D+ + ++ E + K + H N+ K
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 834 CSNEDFKALILEYMRNGSLEKCLYSGNYILD-----------IFQRLNIMIDVASALEYL 882
+ + L LEY G L + I F +L + + YL
Sbjct: 74 RREGNIQYLFLEYCSGGELF------DRIEPDIGMPEPDAQRFFHQL------MAGVVYL 121
Query: 883 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPE- 941
H + H D+KP N+LLD+ +SDFG+A + ++ + TL Y+APE
Sbjct: 122 H---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 942 YGREGRVSTKGDVYSFGILL 961
R + DV+S GI+L
Sbjct: 179 LKRREFHAEPVDVWSCGIVL 198
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 2e-19
Identities = 44/199 (22%), Positives = 79/199 (39%), Gaps = 26/199 (13%)
Query: 777 IGRGSFGSVYIAR-LQNGIEVAVKTFDLQH--ERAFKSFDTECEVMKSIRHR-NLTKIIS 832
+GRG F V G E A K + + E V++ + + +
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 833 SCSNEDFKALILEYMRNGSL-EKCLYSGNYILDIFQRL------NIMIDVASALEYLHFG 885
N LILEY G + C + ++ + + ++ + + YLH
Sbjct: 97 VYENTSEIILILEYAAGGEIFSLC------LPELAEMVSENDVIRLIKQILEGVYYLHQN 150
Query: 886 YSAPVIHCDLKPSNVLLDDNMVAH---LSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEY 942
++H DLKP N+LL + DFG+++ IG + + + T Y+APE
Sbjct: 151 N---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSR-KIGHACEL--REIMGTPEYLAPEI 204
Query: 943 GREGRVSTKGDVYSFGILL 961
++T D+++ GI+
Sbjct: 205 LNYDPITTATDMWNIGIIA 223
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 2e-19
Identities = 69/238 (28%), Positives = 109/238 (45%), Gaps = 51/238 (21%)
Query: 765 FQATNGFSENNLIGRGSFGSVYIARL-QNGIEVAVKTFDLQHERAFKSFDTECEVMKSIR 823
+++ +IG GSFG VY A+L +G VA+K LQ +R FK+ E ++M+ +
Sbjct: 50 RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKR-FKN--RELQIMRKLD 105
Query: 824 HRNLTKII------SSCSNEDFKALILEYM--------RNGSLEKCLYSGNYI-LDIFQR 868
H N+ ++ +E + L+L+Y+ R+ S K Y+ L ++Q
Sbjct: 106 HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL 165
Query: 869 LNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLIGEDQSMT 927
+L Y+H S + H D+KP N+LLD D V L DFG AK L+ +
Sbjct: 166 F-------RSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV-RGEPN- 213
Query: 928 QTQTLATLGYMAPE-------YGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGE 978
+ + Y APE Y ++ DV+S G +L E + P IF G+
Sbjct: 214 -VSYICSRYYRAPELIFGATDY------TSSIDVWSAGCVLAELLLGQ-P---IFPGD 260
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 3e-19
Identities = 56/204 (27%), Positives = 79/204 (38%), Gaps = 40/204 (19%)
Query: 776 LIGRGSFGSVYIAR-LQNGIEVAVKTFD---LQHERAFKSFDTECEVMKSIRHRNLTKII 831
IG G+FG + R VAVK + E + E +S+RH N+ +
Sbjct: 27 DIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQR----EIINHRSLRHPNIVRFK 82
Query: 832 SSCSNEDFKALILEYMRNGSLEKCLYSGNYILD-----------IFQRLNIMIDVASALE 880
A+I+EY G L I + FQ+L S +
Sbjct: 83 EVILTPTHLAIIMEYASGGELY------ERICNAGRFSEDEARFFFQQL------LSGVS 130
Query: 881 YLHFGYSAPVIHCDLKPSNVLLDDNMVAHL--SDFGIAKLLIGEDQSMTQTQTLATLGYM 938
Y H S + H DLK N LLD + L DFG +K S ++ T+ T Y+
Sbjct: 131 YCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS--VLHSQPKS-TVGTPAYI 184
Query: 939 APE-YGREGRVSTKGDVYSFGILL 961
APE R+ DV+S G+ L
Sbjct: 185 APEVLLRQEYDGKIADVWSCGVTL 208
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 4e-19
Identities = 58/215 (26%), Positives = 94/215 (43%), Gaps = 40/215 (18%)
Query: 776 LIGRGSFGSVYIARL-QNGIEVAVKTFDLQHERAFKSFD---TECEVMKSIRHRNLTKII 831
IG+GSFG V I + A+K + Q E ++M+ + H L +
Sbjct: 22 AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW 81
Query: 832 SSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMI------------DVASAL 879
S +E+ ++++ + G D+ L + ++ AL
Sbjct: 82 YSFQDEEDMFMVVDLLLGG-------------DLRYHLQQNVHFKEETVKLFICELVMAL 128
Query: 880 EYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLA-TLGYM 938
+YL + +IH D+KP N+LLD++ H++DF IA +L E TQ T+A T YM
Sbjct: 129 DYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE----TQITTMAGTKPYM 181
Query: 939 APE--YGREGRVSTKG-DVYSFGILLMETFTRRKP 970
APE R+G + D +S G+ E R+P
Sbjct: 182 APEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 4e-19
Identities = 47/208 (22%), Positives = 81/208 (38%), Gaps = 46/208 (22%)
Query: 776 LIGRGSFGSVYIAR-LQNGIEVAVKTFDLQHERAFKSFDTECEV---MKSIRHRNLTKII 831
++G G G V + G + A+K S EV ++ ++ I+
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLLY-------DSPKARQEVDHHWQASGGPHIVCIL 88
Query: 832 SSCSNEDFKA----LILEYMRNGSLEKCLYSGNYILD-IFQRLN----------IMIDVA 876
N +I+E M G L I +R + IM D+
Sbjct: 89 DVYENMHHGKRCLLIIMECMEGGEL----------FSRIQERGDQAFTEREAAEIMRDIG 138
Query: 877 SALEYLHFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLIGEDQSMTQTQTLA 933
+A+++LH S + H D+KP N+L + + V L+DFG AK ++
Sbjct: 139 TAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET--TQNAL--QTPCY 191
Query: 934 TLGYMAPEYGREGRVSTKGDVYSFGILL 961
T Y+APE + D++S G+++
Sbjct: 192 TPYYVAPEVLGPEKYDKSCDMWSLGVIM 219
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 4e-19
Identities = 54/206 (26%), Positives = 91/206 (44%), Gaps = 42/206 (20%)
Query: 776 LIGRGSFGSVYIAR-LQNGIEVAVKTFD---LQHERAFKSFDTECEVMKSIRHRNLTKII 831
+G G+FG V + + G +VAVK + ++ E + +K RH ++ K+
Sbjct: 23 TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82
Query: 832 SSCSNEDFKALILEYMRNGSLEKCLYSGNYILD-----------IFQRLNIMIDVASALE 880
S +++EY+ G L +YI +FQ++ S ++
Sbjct: 83 QVISTPSDIFMVMEYVSGGELF------DYICKNGRLDEKESRRLFQQI------LSGVD 130
Query: 881 YLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATL----G 936
Y H V+H DLKP NVLLD +M A ++DFG++ + M+ + L T
Sbjct: 131 YCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNM-------MSDGEFLRTSCGSPN 180
Query: 937 YMAPE-YGREGRVSTKGDVYSFGILL 961
Y APE + D++S G++L
Sbjct: 181 YAAPEVISGRLYAGPEVDIWSSGVIL 206
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 5e-19
Identities = 44/205 (21%), Positives = 79/205 (38%), Gaps = 41/205 (20%)
Query: 777 IGRGSFGSVYIAR-LQNGIEVAVKTFDLQHERAFKSFDTECEVMKSI-RHRNLTKII--- 831
+G G G V + + A+K +A + E E+ + ++ +I+
Sbjct: 70 LGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARR----EVELHWRASQCPHIVRIVDVY 124
Query: 832 -SSCSNEDFKALILEYMRNGSLEKCLYSGNYILD-IFQRLN----------IMIDVASAL 879
+ + +++E + G L I R + IM + A+
Sbjct: 125 ENLYAGRKCLLIVMECLDGGEL----------FSRIQDRGDQAFTEREASEIMKSIGEAI 174
Query: 880 EYLHFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLG 936
+YLH S + H D+KP N+L N + L+DFG AK + T T
Sbjct: 175 QYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT---PCYTPY 228
Query: 937 YMAPEYGREGRVSTKGDVYSFGILL 961
Y+APE + D++S G+++
Sbjct: 229 YVAPEVLGPEKYDKSCDMWSLGVIM 253
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 91.0 bits (226), Expect = 5e-19
Identities = 53/203 (26%), Positives = 91/203 (44%), Gaps = 18/203 (8%)
Query: 771 FSENNLIGRGSFGSVYIARLQNGIEV-AVKTFDLQHERAFKSFDTEC-----EVMKSIRH 824
F + ++GRG FG V+ +++ ++ A K L +R K + +++ +
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKK--LNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 825 RNLTKIISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIF--QRLNIMI-DVASALEY 881
R + + + + L++ M G + +Y+ + F R + S LE+
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 882 LHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLA-TLGYMAP 940
LH +I+ DLKP NVLLDD+ +SD G+A L T+T+ A T G+MAP
Sbjct: 305 LH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ---TKTKGYAGTPGFMAP 358
Query: 941 EYGREGRVSTKGDVYSFGILLME 963
E D ++ G+ L E
Sbjct: 359 ELLLGEEYDFSVDYFALGVTLYE 381
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 5e-19
Identities = 54/298 (18%), Positives = 108/298 (36%), Gaps = 68/298 (22%)
Query: 115 LGNLAKLEKLLLHNNFLTGTIPFSIFKLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLD 174
A+ K L +T + + +L+S+ + +++++ ++ + L ++ L
Sbjct: 20 DDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIK-SVQ--GIQYLPNVTKLF 74
Query: 175 LSDNQLSGSIPSFIFKISSLQALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGGIS 234
L+ N+L+ I + + +L L N++ ++
Sbjct: 75 LNGNKLT-DI-KPLANLKNLGWLFLDENKVK-----DL---------------------- 105
Query: 235 STLSNCKHLRILDLSFNDLWGDIPKEIGNLTKLKELFLDFNILQGEIPHTVGNLHNLEYL 294
S+L + K L+ L L N + DI + +L +L+ L+L N + + L L+ L
Sbjct: 106 SSLKDLKKLKSLSLEHNGI-SDIN-GLVHLPQLESLYLGNN--KITDITVLSRLTKLDTL 161
Query: 295 SLVNNELVGTVPATIFNVSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSGTL 354
SL +N++ ++ L+ L L+ LYL N+ S
Sbjct: 162 SLEDNQIS-------------DIVPLAG--------------LTKLQNLYLSKNHISDL- 193
Query: 355 PSFIFNASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNYLTSPE-LSFLSSLSN 411
+ NL L L N NL ++ + L +PE +S
Sbjct: 194 -RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEK 250
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 2e-17
Identities = 57/272 (20%), Positives = 97/272 (35%), Gaps = 41/272 (15%)
Query: 395 NNYLTSPELSFLSSLSNCKYLEIIALSGNPLNGIIPMSAGNLSHSLEELFMPDCNVSGRI 454
+ + S L + + + L+ ++++ + ++ +
Sbjct: 6 ETITVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQN--ELNS-IDQIIANNSDIK-SV 61
Query: 455 PKEIGNLANLVTLDLGGNKFNGSIPIALGKLQKLQLLNLDDNKLEGSIPDDICGLVELYK 514
+ I L N+ L L GNK I L L+ L L LD+NK++ + + L +L
Sbjct: 62 -QGIQYLPNVTKLFLNGNKLT-DIK-PLANLKNLGWLFLDENKVK-DL-SSLKDLKKLKS 116
Query: 515 LALGDNKLSGQIPACFGNLASLRELWLGPNELISFIPSTFWNIKDIMYVNFSSNFLTGPL 574
L+L N +S I +L L L+LG N I DI
Sbjct: 117 LSLEHNGIS-DING-LVHLPQLESLYLGNN-----------KITDIT------------- 150
Query: 575 PLEIENLKALTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQGSIPDSVGDLISLKS 634
+ L L TL N +S ++P + GL LQ L+L N + S ++ L +L
Sbjct: 151 --VLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHI--SDLRALAGLKNLDV 204
Query: 635 LNLSNNNLSGPIPTSLEKLSDLKELNLSFNKL 666
L L + L + + L
Sbjct: 205 LELFSQECLNKPINHQSNLVVPNTVKNTDGSL 236
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 3e-17
Identities = 48/264 (18%), Positives = 93/264 (35%), Gaps = 45/264 (17%)
Query: 235 STLSNCKHLRILDLSFNDLWGDIPKEIGNLTKLKELFLDFNILQGEIPHTVGNLHNLEYL 294
+ +L + + L + ++ + + ++ + + L N+ L
Sbjct: 18 FSDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQG-IQYLPNVTKL 73
Query: 295 SLVNNELVGTVPATIFNVSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSGTL 354
L N+L I ++ L NL L+L N
Sbjct: 74 FLNGNKLT-----DIKPLA----------------------NLKNLGWLFLDENKVKDL- 105
Query: 355 PSFIFNASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNYLTSPELSFLSSLSNCKY 414
S + + L LSL N S + +L L+ L L NN +T ++ LS
Sbjct: 106 -SSLKDLKKLKSLSLEHNGISDING--LVHLPQLESLYLGNNKITD-----ITVLSRLTK 157
Query: 415 LEIIALSGNPLNGIIPMSAGNLSHSLEELFMPDCNVSGRIPKEIGNLANLVTLDLGGNKF 474
L+ ++L N ++ I+P++ L+ L+ L++ ++S + + L NL L+L +
Sbjct: 158 LDTLSLEDNQISDIVPLA--GLT-KLQNLYLSKNHISD--LRALAGLKNLDVLELFSQEC 212
Query: 475 NGSIPIALGKLQKLQLLNLDDNKL 498
L + D L
Sbjct: 213 LNKPINHQSNLVVPNTVKNTDGSL 236
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 8e-17
Identities = 45/208 (21%), Positives = 86/208 (41%), Gaps = 38/208 (18%)
Query: 460 NLANLVTLDLGGNKFNGSIPIALGKLQKLQLLNLDDNKLEGSIPDDICGLVELYKLALGD 519
A + +L ++ +L + + +++ ++ S+ I L + KL L
Sbjct: 22 AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNG 77
Query: 520 NKLSGQIPACFGNLASLRELWLGPNELISFIPSTFWNIKDIMYVNFSSNFLTGPLPLEIE 579
NKL+ I NL +L L+L N++ ++
Sbjct: 78 NKLT-DIKP-LANLKNLGWLFLDENKVKDLSS--------------------------LK 109
Query: 580 NLKALTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQGSIPDSVGDLISLKSLNLSN 639
+LK L +L N +S + + L L+ L+LG+N++ + + L L +L+L +
Sbjct: 110 DLKKLKSLSLEHNGISDING--LVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLED 165
Query: 640 NNLSGPIPTSLEKLSDLKELNLSFNKLE 667
N +S +P L L+ L+ L LS N +
Sbjct: 166 NQISDIVP--LAGLTKLQNLYLSKNHIS 191
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 5e-16
Identities = 54/264 (20%), Positives = 100/264 (37%), Gaps = 22/264 (8%)
Query: 332 STDVQLPNLEELYLWGNNFSGTLPSFIFNASNLSKLSLGDNSFSGLIPNTFGNLRNLKRL 391
+D + L + + +++ ++ ++ + L N+ +L
Sbjct: 18 FSDDAFAETIKDNLKKKSVTDA--VTQNELNSIDQIIANNSDIKSVQG--IQYLPNVTKL 73
Query: 392 RLYNNYLTSPELSFLSSLSNCKYLEIIALSGNPLNGIIPMSAGNLSHSLEELFMPDCNVS 451
L N LT + L+N K L + L N + + + +L L+ L + +S
Sbjct: 74 FLNGNKLTD-----IKPLANLKNLGWLFLDENKVKDLSSLK--DLKK-LKSLSLEHNGIS 125
Query: 452 GRIPKEIGNLANLVTLDLGGNKFNGSIPIALGKLQKLQLLNLDDNKLEGSIPDDICGLVE 511
I + +L L +L LG NK + L +L KL L+L+DN++ I + GL +
Sbjct: 126 -DIN-GLVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQIS-DIVP-LAGLTK 179
Query: 512 LYKLALGDNKLSGQIPACFGNLASLRELWLGPNELISFIPSTFWNIKDIMYVNFSSNFLT 571
L L L N +S + A L +L L L E ++ + N+ V + L
Sbjct: 180 LQNLYLSKNHIS-DLRA-LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLV 237
Query: 572 GPLPLEIENLKALTTLDFSMNNLS 595
P I + + +
Sbjct: 238 TPEI--ISDDGDYEKPNVKWHLPE 259
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 5e-16
Identities = 57/307 (18%), Positives = 113/307 (36%), Gaps = 72/307 (23%)
Query: 163 NLGNLSSLQLLDLSDNQLSGSIPSFIFKISSLQALHFGNNRLSGELPANICDNLPFLNFF 222
+ + +L ++ ++ +++S+ + N+ + ++
Sbjct: 19 SDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-----SV---------- 61
Query: 223 SVYKNMFYGGISSTLSNCKHLRILDLSFNDLWGDIPKEIGNLTKLKELFLDFNILQGEIP 282
+ ++ L L+ N L DI K + NL L LFLD N ++ ++
Sbjct: 62 ------------QGIQYLPNVTKLFLNGNKL-TDI-KPLANLKNLGWLFLDENKVK-DLS 106
Query: 283 HTVGNLHNLEYLSLVNNELVGTVPATIFNVSTLKLIELSNNTFFGSLPSSTDVQLPNLEE 342
++ +L L+ LSL +N I +++ L LP LE
Sbjct: 107 -SLKDLKKLKSLSLEHNG--------ISDINGLV-------------------HLPQLES 138
Query: 343 LYLWGNNFSGTLPSFIFNASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNYLTSPE 402
LYL N + + + + L LSL DN S ++P L L+ L L N+++
Sbjct: 139 LYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD-- 192
Query: 403 LSFLSSLSNCKYLEIIALSGNPLNGIIPMSAGNLSHSLEELFMPDCNVSGRIPKEIGNLA 462
L +L+ K L+++ L NL + D ++ P+ I +
Sbjct: 193 ---LRALAGLKNLDVLELFSQECLNKPINHQSNLVV-PNTVKNTDGSLVT--PEIISDDG 246
Query: 463 NLVTLDL 469
+ ++
Sbjct: 247 DYEKPNV 253
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 2e-15
Identities = 53/264 (20%), Positives = 94/264 (35%), Gaps = 44/264 (16%)
Query: 91 LGNLSSLEILDLNFNRLSGEIPWELGNLAKLEKLLLHNNFLTGTIPFSIFKLSSLLDLKL 150
+ L ++ L LN N+L+ +I L NL L L L N + L L L L
Sbjct: 64 IQYLPNVTKLFLNGNKLT-DIK-PLANLKNLGWLFLDENKVKDLSSLK--DLKKLKSLSL 119
Query: 151 SDNNLTGTIPSHNLGNLSSLQLLDLSDNQLSGSIPSFIFKISSLQALHFGNNRLSGELPA 210
N ++ I L +L L+ L L +N++ + + + +++ L L +N++S
Sbjct: 120 EHNGIS-DIN--GLVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQIS----- 169
Query: 211 NICDNLPFLNFFSVYKNMFYGGISSTLSNCKHLRILDLSFNDLWGDIPKEIGNLTKLKEL 270
+I L+ L+ L LS N + D+ + + L L L
Sbjct: 170 DI----------------------VPLAGLTKLQNLYLSKNHI-SDL-RALAGLKNLDVL 205
Query: 271 FLDFNILQGEIPHTVGNLHNLEYLSLVNNELVGTVPATIFNVSTLKLIELS-NNTFFGSL 329
L + + NL + + LV P I + + + + F +
Sbjct: 206 ELFSQECLNKPINHQSNLVVPNTVKNTDGSLV--TPEIISDDGDYEKPNVKWHLPEFTNE 263
Query: 330 PSSTDVQLPNLEELYLWGNNFSGT 353
S Q + + F G
Sbjct: 264 VSFIFYQPVTIGKAKA---RFHGR 284
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 4e-13
Identities = 41/175 (23%), Positives = 72/175 (41%), Gaps = 14/175 (8%)
Query: 493 LDDNKLEGSIPDDICGLVELYKLALGDNKLSGQIPACFGNLASLRELWLGPNELISFIPS 552
++ DD E K L ++ + L S+ ++ +++ S
Sbjct: 9 TVPTPIKQIFSDD--AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV--Q 62
Query: 553 TFWNIKDIMYVNFSSNFLTGPLPLEIENLKALTTLDFSMNNLSGVIPTTIGGLKGLQYLF 612
+ ++ + + N LT PL NLK L L N + + + LK L+ L
Sbjct: 63 GIQYLPNVTKLFLNGNKLTDIKPLA--NLKNLGWLFLDENKVKDLSS--LKDLKKLKSLS 118
Query: 613 LGHNRLQGSIPDSVGDLISLKSLNLSNNNLSGPIPTSLEKLSDLKELNLSFNKLE 667
L HN + S + + L L+SL L NN ++ T L +L+ L L+L N++
Sbjct: 119 LEHNGI--SDINGLVHLPQLESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQIS 169
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 26/118 (22%), Positives = 42/118 (35%), Gaps = 9/118 (7%)
Query: 77 NISYLSLTGN----IPRQLGNLSSLEILDLNFNRLSGEIPWELGNLAKLEKLLLHNNFLT 132
+ LSL N I L L+ L+ L L+ N +S ++ L L L+ L L +
Sbjct: 157 KLDTLSLEDNQISDIV-PLAGLTKLQNLYLSKNHIS-DLR-ALAGLKNLDVLELFSQECL 213
Query: 133 GTIPFSIFKLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQLSGSIPSFIFK 190
L +K +D +L + G+ + + SFIF
Sbjct: 214 NKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKW--HLPEFTNEVSFIFY 269
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 6e-19
Identities = 35/210 (16%), Positives = 66/210 (31%), Gaps = 34/210 (16%)
Query: 460 NLANLVTLDLGGNKFNGSIPIALGKLQKLQLLNLDDNKLEGSIPDDICGLVELYKLALGD 519
+ LG + + I ++ L + L + + I + L + +
Sbjct: 21 TFKAYLNGLLGQSS---TANITEAQMNSLTYITLANINVTDLTG--IEYAHNIKDLTINN 75
Query: 520 NKLSGQIPACFGNLASLRELWLGPNELISFIPSTFWNIKDIMYVNFSSNFLTGPLPLEIE 579
+ P L++L L + ++ S +
Sbjct: 76 IHATNYNP--ISGLSNLERLRIMGKDVTSDKIP------------------------NLS 109
Query: 580 NLKALTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQGSIPDSVGDLISLKSLNLSN 639
L +LT LD S + I T I L + + L +N I + L LKSLN+
Sbjct: 110 GLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQF 168
Query: 640 NNLSGPIPTSLEKLSDLKELNLSFNKLEGE 669
+ + +E L +L + G+
Sbjct: 169 DGVHDYRG--IEDFPKLNQLYAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 2e-18
Identities = 34/189 (17%), Positives = 67/189 (35%), Gaps = 11/189 (5%)
Query: 358 IFNASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNYLTSPELSFLSSLSNCKYLEI 417
S G S T + +L + L N +T L+ + ++
Sbjct: 16 NIPDSTFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVTD-----LTGIEYAHNIKD 70
Query: 418 IALSGNPLNGIIPMSAGNLSHSLEELFMPDCNVSGRIPKEIGNLANLVTLDLGGNKFNGS 477
+ ++ P+S LS +LE L + +V+ + L +L LD+ + + S
Sbjct: 71 LTINNIHATNYNPIS--GLS-NLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDS 127
Query: 478 IPIALGKLQKLQLLNLDDNKLEGSIPDDICGLVELYKLALGDNKLSGQIPACFGNLASLR 537
I + L K+ ++L N I + L EL L + + + + L
Sbjct: 128 ILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLN 184
Query: 538 ELWLGPNEL 546
+L+ +
Sbjct: 185 QLYAFSQTI 193
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 2e-17
Identities = 30/185 (16%), Positives = 72/185 (38%), Gaps = 12/185 (6%)
Query: 117 NLAKLEKLLLHNNFLTGTIPFSIFKLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLS 176
LL + T + +++SL + L++ N+T + +++ L ++
Sbjct: 21 TFKAYLNGLLGQS---STANITEAQMNSLTYITLANINVTDLTG---IEYAHNIKDLTIN 74
Query: 177 DNQLSGSIPSFIFKISSLQALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGGISST 236
+ + + I +S+L+ L ++ + N+ L L + + I +
Sbjct: 75 NIHATNY--NPISGLSNLERLRIMGKDVTSDKIPNL-SGLTSLTLLDISHSAHDDSILTK 131
Query: 237 LSNCKHLRILDLSFNDLWGDIPKEIGNLTKLKELFLDFNILQGEIPHTVGNLHNLEYLSL 296
++ + +DLS+N DI + L +LK L + F+ + + + L L
Sbjct: 132 INTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYA 188
Query: 297 VNNEL 301
+ +
Sbjct: 189 FSQTI 193
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 3e-16
Identities = 30/193 (15%), Positives = 63/193 (32%), Gaps = 35/193 (18%)
Query: 236 TLSNCKHLRILDLSFNDLWGDIPKEIGNLTKLKELFLDFNILQGEIPHTVGNLHNLEYLS 295
T + L + L+ ++ D+ I +K+L ++ P + L NLE L
Sbjct: 39 TEAQMNSLTYITLANINV-TDL-TGIEYAHNIKDLTINNIHATNYNP--ISGLSNLERLR 94
Query: 296 LVNNELVGTVPATIFNVSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSGTLP 355
++ +V++ K+ LS L +L L + + ++
Sbjct: 95 IMGK-----------DVTSDKIPNLSG--------------LTSLTLLDISHSAHDDSIL 129
Query: 356 SFIFNASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNYLTSPELSFLSSLSNCKYL 415
+ I ++ + L N I L LK L + + + + + L
Sbjct: 130 TKINTLPKVNSIDLSYNGAITDIMP-LKTLPELKSLNIQFDGVHD-----YRGIEDFPKL 183
Query: 416 EIIALSGNPLNGI 428
+ + G
Sbjct: 184 NQLYAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 2e-14
Identities = 27/134 (20%), Positives = 50/134 (37%), Gaps = 7/134 (5%)
Query: 77 NISYLSLTGNIPRQ---LGNLSSLEILDLNFNRLSGEIPWELGNLAKLEKLLLHNNFLTG 133
NI L++ + LS+LE L + ++ + L L L L + ++
Sbjct: 67 NIKDLTINNIHATNYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDD 126
Query: 134 TIPFSIFKLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQLSGSIPSFIFKISS 193
+I I L + + LS N I L L L+ L++ + + I
Sbjct: 127 SILTKINTLPKVNSIDLSYNGAITDIM--PLKTLPELKSLNIQFDGVHDY--RGIEDFPK 182
Query: 194 LQALHFGNNRLSGE 207
L L+ + + G+
Sbjct: 183 LNQLYAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 1e-13
Identities = 28/213 (13%), Positives = 68/213 (31%), Gaps = 41/213 (19%)
Query: 142 LSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQLSGSIPSFIFKISSLQALHFGN 201
+ L+ L ++ + ++SL + L++ ++ + + I +++ L N
Sbjct: 22 FKAYLNGLLGQSSTANITEA----QMNSLTYITLANINVT-DL-TGIEYAHNIKDLTINN 75
Query: 202 NRLSGELPANICDNLPFLNFFSVYKNMFYGGISSTLSNCKHLRILDLSFNDLWGDIPKEI 261
+ + +S +L L + D+ D +
Sbjct: 76 IHATN---------------------------YNPISGLSNLERLRIMGKDVTSDKIPNL 108
Query: 262 GNLTKLKELFLDFNILQGEIPHTVGNLHNLEYLSLVNNELVGTVPATIFNVSTLKLIELS 321
LT L L + + I + L + + L N + + + + LK + +
Sbjct: 109 SGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP-LKTLPELKSLNIQ 167
Query: 322 NN--TFFGSLPSSTDVQLPNLEELYLWGNNFSG 352
+ + + P L +LY + G
Sbjct: 168 FDGVHDYRGI-----EDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 3e-13
Identities = 24/133 (18%), Positives = 59/133 (44%), Gaps = 6/133 (4%)
Query: 73 VTALNISYLSLTGNIPRQLGNLSSLEILDLNFNRLSGEIPWELGNLAKLEKLLLHNNFLT 132
+T + ++ +++T + +++ L +N + P + L+ LE+L + +T
Sbjct: 46 LTYITLANINVTDLTG--IEYAHNIKDLTINNIHATNYNP--ISGLSNLERLRIMGKDVT 101
Query: 133 GTIPFSIFKLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQLSGSIPSFIFKIS 192
++ L+SL L +S + +I + + L + +DLS N I + +
Sbjct: 102 SDKIPNLSGLTSLTLLDISHSAHDDSILT-KINTLPKVNSIDLSYNGAITDI-MPLKTLP 159
Query: 193 SLQALHFGNNRLS 205
L++L+ + +
Sbjct: 160 ELKSLNIQFDGVH 172
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 4e-13
Identities = 27/218 (12%), Positives = 58/218 (26%), Gaps = 62/218 (28%)
Query: 260 EIGNLTKLKELFLDFNILQGEIPHTVGNLHNLEYLSLVNNELVGTVPATIFNVSTLKLIE 319
+ L + L + + HN++ L++ N N + +
Sbjct: 39 TEAQMNSLTYITLANINVTDLTG--IEYAHNIKDLTINNIH--------ATNYNPIS--- 85
Query: 320 LSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSGTLPSFIFNASNLSKLSLGDNSFSGLIP 379
L NLE L + G + + + ++L+ L + ++ I
Sbjct: 86 ----------------GLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSIL 129
Query: 380 NTFGNLRNLKRLRL-YNNYLTSPELSFLSSLSNCKYLEIIALSGNPLNGIIPMSAGNLSH 438
L + + L YN +T + L L+ + + + ++
Sbjct: 130 TKINTLPKVNSIDLSYNGAITD-----IMPLKTLPELKSLNIQFDGVHDYRG-------- 176
Query: 439 SLEELFMPDCNVSGRIPKEIGNLANLVTLDLGGNKFNG 476
I + L L G
Sbjct: 177 -------------------IEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 7e-12
Identities = 21/109 (19%), Positives = 39/109 (35%), Gaps = 4/109 (3%)
Query: 74 TALNISYLSLTGNIPRQLGNLSSLEILDLNFNRLSGEIPWELGNLAKLEKLLLHNNFLTG 133
L I +T + L L+SL +LD++ + I ++ L K+ + L N
Sbjct: 91 ERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT 150
Query: 134 TIPFSIFKLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQLSG 182
I + L L L + + + + + L L + G
Sbjct: 151 DIM-PLKTLPELKSLNIQFDGVHDYRG---IEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 6e-11
Identities = 15/97 (15%), Positives = 40/97 (41%), Gaps = 4/97 (4%)
Query: 575 PLEIENLKALTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQGSIPDSVGDLISLKS 634
+ + +LT + + N++ + I ++ L + + P + L +L+
Sbjct: 37 NITEAQMNSLTYITLANINVTDLTG--IEYAHNIKDLTINNIHATNYNP--ISGLSNLER 92
Query: 635 LNLSNNNLSGPIPTSLEKLSDLKELNLSFNKLEGEIP 671
L + +++ +L L+ L L++S + + I
Sbjct: 93 LRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSIL 129
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 87.6 bits (218), Expect = 7e-19
Identities = 63/295 (21%), Positives = 101/295 (34%), Gaps = 56/295 (18%)
Query: 777 IGRGSFGSVYIAR-LQNGIEVAVKTFDLQHER-AFKSFDT---ECEVMKSIRHRNLTKII 831
IG GS+G V+ R G VA+K F + K E ++K ++H NL ++
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKK--IALREIRMLKQLKHPNLVNLL 68
Query: 832 SSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVI 891
+ L+ EY + ++ L + +I A+ + H I
Sbjct: 69 EVFRRKRRLHLVFEYC-DHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH---KHNCI 124
Query: 892 HCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPE-------YGR 944
H D+KP N+L+ + V L DFG A+LL G +AT Y +PE Y
Sbjct: 125 HRDVKPENILITKHSVIKLCDFGFARLLTGPSDYY--DDEVATRWYRSPELLVGDTQY-- 180
Query: 945 EGRVSTKGDVYSFGILLMETFTRR--------------------KPTDEIFSGEMTLKHW 984
DV++ G + E + T +++
Sbjct: 181 ----GPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYF 236
Query: 985 VNDFLPISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKE 1039
+P D L + F A L C P ER+T ++
Sbjct: 237 SGVKIP----DPEDMEPL---ELKFPNISYPA---LGLLKGCLHMDPTERLTCEQ 281
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 1e-18
Identities = 39/174 (22%), Positives = 65/174 (37%), Gaps = 27/174 (15%)
Query: 59 CNWTGVTCDINQRRVTALNISYLSLT---GNIPRQLGNLSSLEILDLNFNRLSGEIPWEL 115
C+ V C LT N+P ++ + L N + P
Sbjct: 11 CSNNIVDC------------RGKGLTEIPTNLP------ETITEIRLEQNTIKVIPPGAF 52
Query: 116 GNLAKLEKLLLHNNFLTGTIPFSIF-KLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLD 174
KL ++ L NN ++ + F L SL L L N +T +P L SLQLL
Sbjct: 53 SPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLL 110
Query: 175 LSDNQLSGSIPSFIF-KISSLQALHFGNNRLSGELPANICDNLPFLNFFSVYKN 227
L+ N+++ + F + +L L +N+L + L + + +N
Sbjct: 111 LNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQ-TIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 9e-17
Identities = 38/161 (23%), Positives = 60/161 (37%), Gaps = 32/161 (19%)
Query: 268 KELFLDFNILQGEIPHTV-GNLHNLEYLSLVNNELVGTVPATIFNVSTLKLIELSNNTFF 326
E+ L+ N ++ IP L + L NN++ + F
Sbjct: 35 TEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQ--------------- 77
Query: 327 GSLPSSTDVQLPNLEELYLWGNNFSGTLPSFIF-NASNLSKLSLGDNSFSGLIPNTFGNL 385
L +L L L+GN + LP +F +L L L N + L + F +L
Sbjct: 78 ---------GLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDL 127
Query: 386 RNLKRLRLYNNYLTSPELSFLSSLSNCKYLEIIALSGNPLN 426
NL L LY+N L + S L ++ + L+ NP
Sbjct: 128 HNLNLLSLYDNKLQTIAKGTFSPLRA---IQTMHLAQNPFI 165
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 2e-14
Identities = 35/154 (22%), Positives = 61/154 (39%), Gaps = 30/154 (19%)
Query: 148 LKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQLSGSIPSFIF-KISSLQALHFGNNRLSG 206
++L N + IP L+ +DLS+NQ+S + F + SL +L N+++
Sbjct: 37 IRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKIT- 93
Query: 207 ELPANICDNLPFLNFFSVYKNMFYGGISSTLSNCKHLRILDLSFNDLWGDIPKEI-GNLT 265
ELP ++ + L L++L L+ N + + + +L
Sbjct: 94 ELPKSLFEGLF------------------------SLQLLLLNANKINC-LRVDAFQDLH 128
Query: 266 KLKELFLDFNILQGEIPHTVGNLHNLEYLSLVNN 299
L L L N LQ T L ++ + L N
Sbjct: 129 NLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 2e-14
Identities = 34/156 (21%), Positives = 56/156 (35%), Gaps = 26/156 (16%)
Query: 462 ANLVTLDLGGNKFNGSIPIALGKLQKLQLLNLDDNKLEGSIPDDIC-GLVELYKLALGDN 520
+ + L N P A +KL+ ++L +N++ + D GL L L L N
Sbjct: 32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGN 90
Query: 521 KLSGQIPACFGNLASLRELWLGPNELISFIPSTFWNIKDIMYVNFSSNFLTGPLPLEIEN 580
K++ + F L SL+ L L N++ F ++
Sbjct: 91 KITELPKSLFEGLFSLQLLLLNANKINCLRVDAF------------------------QD 126
Query: 581 LKALTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHN 616
L L L N L + T L+ +Q + L N
Sbjct: 127 LHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 7e-14
Identities = 30/152 (19%), Positives = 56/152 (36%), Gaps = 26/152 (17%)
Query: 514 KLALGDNKLSGQIPACFGNLASLRELWLGPNELISFIPSTFWNIKDIMYVNFSSNFLTGP 573
++ L N + P F LR + L N++ P F
Sbjct: 36 EIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAF------------------- 76
Query: 574 LPLEIENLKALTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQGSIPDSVGD-LISL 632
+ L++L +L N ++ + + GL LQ L L N++ + L +L
Sbjct: 77 -----QGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNL 130
Query: 633 KSLNLSNNNLSGPIPTSLEKLSDLKELNLSFN 664
L+L +N L + L ++ ++L+ N
Sbjct: 131 NLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 4e-13
Identities = 36/160 (22%), Positives = 63/160 (39%), Gaps = 33/160 (20%)
Query: 168 SSLQLLDLSDNQLSGSIPSFIF-KISSLQALHFGNNRLSGELPANICDNLPFLNFFSVYK 226
++ + L N + IP F L+ + NN++S EL + L
Sbjct: 32 ETITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGL---------- 79
Query: 227 NMFYGGISSTLSNCKHLRILDLSFNDLWGDIPKEI-GNLTKLKELFLDFNILQGEIPHTV 285
+ L L L N + ++PK + L L+ L L+ N + +
Sbjct: 80 --------------RSLNSLVLYGNKI-TELPKSLFEGLFSLQLLLLNANKIN-CLRVDA 123
Query: 286 -GNLHNLEYLSLVNNELVGTVPATIF-NVSTLKLIELSNN 323
+LHNL LSL +N+L T+ F + ++ + L+ N
Sbjct: 124 FQDLHNLNLLSLYDNKL-QTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 2e-12
Identities = 37/161 (22%), Positives = 59/161 (36%), Gaps = 32/161 (19%)
Query: 338 PNLEELYLWGNNFSGTLPSFIF-NASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNN 396
+ E+ L N +P F L ++ L +N S L P+ F LR+L L LY N
Sbjct: 32 ETITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN 90
Query: 397 YLTSPELSFLSSLSNCKYLEIIALSGNPLNGIIPMSAGNLSHSLEELFMPDCNVSGRIPK 456
+T S L + L+++ L+ N +N +
Sbjct: 91 KITELPKSLFEGLFS---LQLLLLNANKIN--------------------------CLRV 121
Query: 457 EI-GNLANLVTLDLGGNKFNGSIPIALGKLQKLQLLNLDDN 496
+ +L NL L L NK L+ +Q ++L N
Sbjct: 122 DAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 2e-11
Identities = 21/90 (23%), Positives = 37/90 (41%), Gaps = 3/90 (3%)
Query: 585 TTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQGSIPDSVGD-LISLKSLNLSNNNLS 643
T + N + + P K L+ + L +N++ + L SL SL L N ++
Sbjct: 35 TEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKIT 93
Query: 644 GPIPTSLEKLSDLKELNLSFNKLEGEIPRG 673
+ E L L+ L L+ NK+ +
Sbjct: 94 ELPKSLFEGLFSLQLLLLNANKIN-CLRVD 122
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 4e-10
Identities = 30/95 (31%), Positives = 49/95 (51%), Gaps = 3/95 (3%)
Query: 580 NLKALTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQGSIPDSVGD-LISLKSLNLS 638
K L +D S N +S + P GL+ L L L N++ +P S+ + L SL+ L L+
Sbjct: 54 PYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLN 112
Query: 639 NNNLSGPIPTSLEKLSDLKELNLSFNKLEGEIPRG 673
N ++ + + L +L L+L NKL+ I +G
Sbjct: 113 ANKINCLRVDAFQDLHNLNLLSLYDNKLQ-TIAKG 146
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 2e-18
Identities = 59/240 (24%), Positives = 99/240 (41%), Gaps = 43/240 (17%)
Query: 764 LFQATNGFSENNLIGRGSFGSVYIAR-LQNGIEVAVK----TFDLQHE--RAFKSFDTEC 816
F + IG G+ G V A VA+K F Q RA++ E
Sbjct: 20 TFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR----EL 75
Query: 817 EVMKSIRHRNLTKI----ISSCSNEDFKA--LILEYMRNGSLEKCLYSG------NYILD 864
+MK + H+N+ + S E+F+ +++E M + +L + + +Y+L
Sbjct: 76 VLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQMELDHERMSYLL- 133
Query: 865 IFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ 924
+Q L +++LH SA +IH DLKPSN+++ + + DFG+A+
Sbjct: 134 -YQMLC-------GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGT 179
Query: 925 SMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHW 984
S T + T Y APE D++S G ++ E +F G + W
Sbjct: 180 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGV----LFPGTDHIDQW 235
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 87.2 bits (216), Expect = 2e-18
Identities = 44/186 (23%), Positives = 81/186 (43%), Gaps = 25/186 (13%)
Query: 58 VCNWTGVTCDINQRRVTAL------NISYLSLTGN----IPRQ--LGNLSSLEILDLNFN 105
+C ++C +++++ + + L L+ N + + L++L L L+ N
Sbjct: 17 LCASNILSC--SKQQLPNVPQSLPSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHN 74
Query: 106 RLSGEIPWE-LGNLAKLEKLLLHNNFLTGTIPFSIF-KLSSLLDLKLSDNNLTGTIPSHN 163
L+ I E + L L L +N L T+ +F L +L L L +N++ + +
Sbjct: 75 HLN-FISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNA 131
Query: 164 LGNLSSLQLLDLSDNQLSGSIPSFIF----KISSLQALHFGNNRLSGELPANICDNLPFL 219
+++ LQ L LS NQ+S P + K+ L L +N+L +LP LP
Sbjct: 132 FEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLK-KLPLTDLQKLPAW 189
Query: 220 NFFSVY 225
+Y
Sbjct: 190 VKNGLY 195
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 83.0 bits (205), Expect = 6e-17
Identities = 45/205 (21%), Positives = 75/205 (36%), Gaps = 39/205 (19%)
Query: 127 HNNFLTGTIPFSIFKLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQLSGSIPS 186
L +P S+ ++LLDL S NNL+ L++L L LS N L+ I S
Sbjct: 26 SKQQLP-NVPQSLPSYTALLDL--SHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISS 81
Query: 187 FIF-KISSLQALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGGISSTLSNCKHLRI 245
F + +L+ L +N L L + +L L +
Sbjct: 82 EAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQ------------------------ALEV 116
Query: 246 LDLSFNDLWGDIPKEI-GNLTKLKELFLDFNILQGEIP----HTVGNLHNLEYLSLVNNE 300
L L N + + + ++ +L++L+L N + P L L L L +N+
Sbjct: 117 LLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNK 174
Query: 301 LVGTVPATIFNVSTLKL--IELSNN 323
L + + + L NN
Sbjct: 175 LKKLPLTDLQKLPAWVKNGLYLHNN 199
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 78.7 bits (194), Expect = 1e-15
Identities = 40/141 (28%), Positives = 61/141 (43%), Gaps = 17/141 (12%)
Query: 77 NISYLSLTGN----IPRQ-LGNLSSLEILDLNFNRLSGEIPWE-LGNLAKLEKLLLHNNF 130
N+ L L+ N I + + +L LDL+ N L + +L LE LLL+NN
Sbjct: 65 NLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNH 123
Query: 131 LTGTIPFSIF-KLSSLLDLKLSDNNLTGTIPS---HNLGNLSSLQLLDLSDNQLSGSIPS 186
+ + + F ++ L L LS N ++ P + L L LLDLS N+L +P
Sbjct: 124 IV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLK-KLPL 180
Query: 187 FIFKI---SSLQALHFGNNRL 204
+ L+ NN L
Sbjct: 181 TDLQKLPAWVKNGLYLHNNPL 201
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 78.7 bits (194), Expect = 1e-15
Identities = 43/180 (23%), Positives = 65/180 (36%), Gaps = 37/180 (20%)
Query: 501 SIPDDICGLVELYKLALGDNKLSGQIPA--CFGNLASLRELWLGPNELISFIPSTFWNIK 558
++P + L L N LS ++ A L +L L L N L F
Sbjct: 32 NVPQSL--PSYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLNFISSEAF---- 84
Query: 559 DIMYVNFSSNFLTGPLPLEIENLKALTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRL 618
+ L LD S N+L + L+ L+ L L +N +
Sbjct: 85 --------------------VPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHI 124
Query: 619 QGSIPDSV-GDLISLKSLNLSNNNLSGPIP----TSLEKLSDLKELNLSFNKLEGEIPRG 673
+ + D+ L+ L LS N +S P KL L L+LS NKL+ ++P
Sbjct: 125 V-VVDRNAFEDMAQLQKLYLSQNQISR-FPVELIKDGNKLPKLMLLDLSSNKLK-KLPLT 181
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 77.6 bits (191), Expect = 4e-15
Identities = 52/216 (24%), Positives = 74/216 (34%), Gaps = 45/216 (20%)
Query: 338 PNLEELYLWGNNFSGTLPSFIF-NASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNN 396
L L NN S + +NL L L N + + F + NL+ L L +N
Sbjct: 39 SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSN 98
Query: 397 YLTS-PELSFLSSLSNCKYLEIIALSGNPLNGIIPMSAGNLSHSLEELFMPDCNVSGRIP 455
+L + E F S L LE++ L N + +
Sbjct: 99 HLHTLDEFLF-SDLQA---LEVLLLYNNHIV--------------------------VVD 128
Query: 456 KEI-GNLANLVTLDLGGNKFNGSIP----IALGKLQKLQLLNLDDNKLEGSIPDDICGLV 510
+ ++A L L L N+ + P KL KL LL+L NKL+ D+ L
Sbjct: 129 RNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLP 187
Query: 511 ELYK--LALGDNKLSGQIPACFGNLASLRELWLGPN 544
K L L +N L C L L W
Sbjct: 188 AWVKNGLYLHNNPLE-----CDCKLYQLFSHWQYRQ 218
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 76.4 bits (188), Expect = 8e-15
Identities = 44/196 (22%), Positives = 70/196 (35%), Gaps = 31/196 (15%)
Query: 244 RILDLSFNDLWGDIPKEIGNLTKLKELFLDFNILQGEIPHTV-GNLHNLEYLSLVNNELV 302
IL S L ++P+ + + T L L N L L NL L L +N L
Sbjct: 21 NILSCSKQQL-PNVPQSLPSYTA--LLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHL- 76
Query: 303 GTVPATIFNVSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSGTLPSFIF-NA 361
+ + F +PNL L L N+ TL F+F +
Sbjct: 77 NFISSEAFV------------------------PVPNLRYLDLSSNHLH-TLDEFLFSDL 111
Query: 362 SNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNYLTSPELSFLSSLSNCKYLEIIALS 421
L L L +N + N F ++ L++L L N ++ + + + L ++ LS
Sbjct: 112 QALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLS 171
Query: 422 GNPLNGIIPMSAGNLS 437
N L + L
Sbjct: 172 SNKLKKLPLTDLQKLP 187
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 74.9 bits (184), Expect = 2e-14
Identities = 45/165 (27%), Positives = 66/165 (40%), Gaps = 15/165 (9%)
Query: 242 HLRILDLSFNDLWGDIPKEI--GNLTKLKELFLDFNILQGEIPHTV-GNLHNLEYLSLVN 298
+ +LDLS N+L + E LT L L L N L I + NL YL L +
Sbjct: 40 YTALLDLSHNNL-SRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSS 97
Query: 299 NELVGTVPATIF-NVSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSGTLPSF 357
N L T+ +F ++ L+++ L NN + + + L++LYL N S P
Sbjct: 98 NHLH-TLDEFLFSDLQALEVLLLYNNHI-VVVDRNAFEDMAQLQKLYLSQNQIS-RFPVE 154
Query: 358 IFNA----SNLSKLSLGDNSFSGLIPNTFGNLRNLKR--LRLYNN 396
+ L L L N L L + L L+NN
Sbjct: 155 LIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNN 199
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 3e-18
Identities = 65/292 (22%), Positives = 110/292 (37%), Gaps = 46/292 (15%)
Query: 775 NLIGRGSFGSVYIAR-LQNGIEVAVKTFDLQHER-AFKSFDT---ECEVMKSIRHRNLTK 829
L+G GS+G V R G VA+K F + K E +++K +RH NL
Sbjct: 31 GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKK--IAMREIKLLKQLRHENLVN 88
Query: 830 IISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAP 889
++ C + L+ E++ + ++ L LD + + + + + H S
Sbjct: 89 LLEVCKKKKRWYLVFEFV-DHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCH---SHN 144
Query: 890 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPE--YGREGR 947
+IH D+KP N+L+ + V L DFG A+ L + +AT Y APE G + +
Sbjct: 145 IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY--DDEVATRWYRAPELLVG-DVK 201
Query: 948 VSTKGDVYSFGILLMETFTRR--------------------KPTDEIFSGEMTLKHWVND 987
DV++ G L+ E F +
Sbjct: 202 YGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGV 261
Query: 988 FLPISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKE 1039
LP +I + L ++ + + +LA +C PD+R E
Sbjct: 262 RLP----EIKEREPL---ERRYPKLSEVV---IDLAKKCLHIDPDKRPFCAE 303
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 3e-18
Identities = 47/263 (17%), Positives = 88/263 (33%), Gaps = 44/263 (16%)
Query: 143 SSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQLSGSIPSFIFK-ISSLQALHFGN 201
D +++ ++ IPS S Q L L + L +IPS F + ++ ++
Sbjct: 11 HQEEDFRVTCKDIQ-RIPS----LPPSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSI 64
Query: 202 NRLSGELPANICDNLPFLNFFSVYKNMFYGGISSTLSNCKHLRILDLSFNDLWGDIPKEI 261
+ +L ++ NL + +++ I +
Sbjct: 65 DVTLQQLESHSFYNLS------------------------KVTHIEIRNTRNLTYIDPDA 100
Query: 262 -GNLTKLKELFLDFNILQGEIPHT--VGNLHNLEYLSLVNNELVGTVPATIFN--VSTLK 316
L LK L + L+ P V + L + +N + ++P F +
Sbjct: 101 LKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETL 159
Query: 317 LIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSGTLPSFIFN--ASNLSKLSLGDNSF 374
++L NN F S+ L+ +YL N + + F S S L + S
Sbjct: 160 TLKLYNNGF-TSVQGYA-FNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSV 217
Query: 375 SGLIPNTFGNLRNLKRLRLYNNY 397
+ L +LK L N +
Sbjct: 218 TALPSKGL---EHLKELIARNTW 237
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 1e-17
Identities = 45/232 (19%), Positives = 83/232 (35%), Gaps = 35/232 (15%)
Query: 290 NLEYLSLVNNELVGTVPATIF-NVSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGN 348
+ + L L+ L T+P+ F N+ + I +S + L S + L + + +
Sbjct: 32 STQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNT 90
Query: 349 NFSGTLPSFIFNASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNYLTS-PELSFLS 407
NL+ + P+ L LK L ++N L P+L+ +
Sbjct: 91 R-------------NLTYID----------PDALKELPLLKFLGIFNTGLKMFPDLTKVY 127
Query: 408 SLSNCKYLEIIALSGNPLNGIIPMSA-GNLSHSLEELFMPDCNVSGRIPKEIGNLANLVT 466
S I+ ++ NP IP++A L + L + + + + N L
Sbjct: 128 STDI---FFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDA 183
Query: 467 LDLGGNKFNGSIPIAL--GKLQKLQLLNLDDNKLEGSIPDDIC-GLVELYKL 515
+ L NK+ I G LL++ + ++P L EL
Sbjct: 184 VYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKGLEHLKELIAR 234
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 9e-17
Identities = 33/195 (16%), Positives = 71/195 (36%), Gaps = 11/195 (5%)
Query: 488 LQLLNLDDNKLEGSIPDDI-CGLVELYKLALGDNKLSGQIPA-CFGNLASLRELWLGPNE 545
Q L L + L +IP L + ++ + + Q+ + F NL+ + + +
Sbjct: 33 TQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTR 91
Query: 546 LISFIPS-TFWNIKDIMYVNFSSNFLTG-PLPLEIENLKALTTLDFSMNNLSGVIPT-TI 602
+++I + + ++ + L P ++ + L+ + N IP
Sbjct: 92 NLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYMTSIPVNAF 151
Query: 603 GGL-KGLQYLFLGHNRLQGSIPDSVGDLISLKSLNLSNNNLSGPIPT-SLEKL-SDLKEL 659
GL L L +N S+ + L ++ L+ N I + + S L
Sbjct: 152 QGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLL 210
Query: 660 NLSFNKLEGEIPRGG 674
++S + +P G
Sbjct: 211 DVSQTSVT-ALPSKG 224
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 3e-16
Identities = 36/274 (13%), Positives = 71/274 (25%), Gaps = 66/274 (24%)
Query: 65 TCDINQRRVTAL-----NISYLSLTGN----IPRQ-LGNLSSLEILDLNFNRLSGEIPWE 114
+ + + + + L L IP NL ++ + ++
Sbjct: 15 DFRVTCKDIQRIPSLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVS----------- 63
Query: 115 LGNLAKLEKLLLHNNFLTGTIPFSIFK-LSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLL 173
+ L + F LS + +++ + I L L L+ L
Sbjct: 64 ------------IDVTLQ-QLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFL 110
Query: 174 DLSDNQLSGSIP--SFIFKISSLQALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYG 231
+ + L P + ++ L +N +P N L
Sbjct: 111 GIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLC-------------- 155
Query: 232 GISSTLSNCKHLRILDLSFNDLWGDIPKEIGNLTKLKELFLDFNILQGEIPHTV--GNLH 289
L L N + N TKL ++L+ N I G
Sbjct: 156 ---------NETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYS 205
Query: 290 NLEYLSLVNNELVGTVPATIF-NVSTLKLIELSN 322
L + + +P+ ++ L
Sbjct: 206 GPSLLDVSQTSVT-ALPSKGLEHLKELIARNTWT 238
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 7e-14
Identities = 47/284 (16%), Positives = 88/284 (30%), Gaps = 65/284 (22%)
Query: 339 NLEELYLWGNNFSGTLPSFIFNASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRL-YNNY 397
E+ + + +PS + L L + + + F NL N+ R+ + +
Sbjct: 12 QEEDFRVTCKDIQ-RIPSLP---PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVT 67
Query: 398 LTSPELSFLSSLSNCKYLEIIALSGNPLNGIIPMSAGNLSHSLEELFMPDCNVSGRIPKE 457
L E +LS + I + NL++ +
Sbjct: 68 LQQLESHSFYNLSK---VTHIEIRNTR----------NLTYIDPDALK------------ 102
Query: 458 IGNLANLVTLDLGGNKFNGSIP--IALGKLQKLQLLNLDDNKLEGSIPDDI-CGLV-ELY 513
L L L + P + +L + DN SIP + GL E
Sbjct: 103 --ELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETL 159
Query: 514 KLALGDNKLSGQIPACFGNLASLRELWLGPNELISFIPS-TFWNIKDIMYVNFSSNFLTG 572
L L +N + + N L ++L N+ ++ I F +
Sbjct: 160 TLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVY-------------- 204
Query: 573 PLPLEIENLKALTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHN 616
+ LD S +++ +P+ GL+ L+ L +
Sbjct: 205 ---------SGPSLLDVSQTSVT-ALPS--KGLEHLKELIARNT 236
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 4e-18
Identities = 60/240 (25%), Positives = 101/240 (42%), Gaps = 52/240 (21%)
Query: 776 LIGRGSFGSVYIAR-LQNGIEVAVKTFD---LQHERAFKSFDTECEVMKSIRHRNLTKII 831
+G GSFG V +A + +VA+K L+ + E +K +RH ++ K+
Sbjct: 16 TLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLY 75
Query: 832 SSCSNEDFKALILEYMRNGSLEKCLYSGNYILD-----------IFQRLNIMIDVASALE 880
+ +++EY G L +YI++ FQ++ A+E
Sbjct: 76 DVITTPTDIVMVIEYA-GGEL------FDYIVEKKRMTEDEGRRFFQQI------ICAIE 122
Query: 881 YLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATL----G 936
Y H ++H DLKP N+LLDDN+ ++DFG++ + MT L T
Sbjct: 123 YCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNI-------MTDGNFLKTSCGSPN 172
Query: 937 YMAPE-YGREGRVSTKGDVYSFGILLMETFTRRKPTDE---------IFSGEMTLKHWVN 986
Y APE + + DV+S GI+L R P D+ + S + +++
Sbjct: 173 YAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLS 232
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 5e-18
Identities = 57/242 (23%), Positives = 101/242 (41%), Gaps = 53/242 (21%)
Query: 765 FQATNGFSENNLIGRGSFGSVYIARL-QNGIEVAVKTFDLQHERAFKSFDTECEVMK--- 820
+ + F + G+G+FG+V + + G+ VA+K +Q R F++ E ++M+
Sbjct: 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV-IQDPR-FRN--RELQIMQDLA 74
Query: 821 SIRHRNLTK---IISSCSNEDFK----ALILEYM--------RNGSLEKCLYSGNYI-LD 864
+ H N+ + + D + +++EY+ RN + I +
Sbjct: 75 VLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVF 134
Query: 865 IFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLIGED 923
+FQ + ++ LH S V H D+KP NVL++ + L DFG AK L
Sbjct: 135 LFQLI-------RSIGCLH-LPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL-SPS 185
Query: 924 QSMTQTQTLATLGYMAPE-------YGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFS 976
+ + + Y APE Y +T D++S G + E +P IF
Sbjct: 186 EPN--VAYICSRYYRAPELIFGNQHY------TTAVDIWSVGCIFAEMML-GEP---IFR 233
Query: 977 GE 978
G+
Sbjct: 234 GD 235
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 6e-18
Identities = 72/400 (18%), Positives = 140/400 (35%), Gaps = 64/400 (16%)
Query: 143 SSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQLS----GSIPSFIFKISSLQALH 198
+ L + L+ + L L Q++ L D L+ I S + +L L+
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 199 FGNNRLSGELPANICDNLPFLNF----FSVYKNMF----YGGISSTLSNCKHLRILDLSF 250
+N L + L + S+ G +SSTL L+ L LS
Sbjct: 63 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSD 122
Query: 251 NDLWGDIPKEIG-----NLTKLKELFLDFNILQGE----IPHTVGNLHNLEYLSLVNNEL 301
N L + + +L++L L++ L + + + + L++ NN++
Sbjct: 123 NLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDI 182
Query: 302 VGTVPATIFNVSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFS----GTLPSF 357
N + ++++ L S LE L L + L
Sbjct: 183 ---------NEAGVRVL-------CQGLKDSP----CQLEALKLESCGVTSDNCRDLCGI 222
Query: 358 IFNASNLSKLSLGDNSFSG-----LIPNTFGNLRNLKRLRLYNNYLTSPELSFLSS-LSN 411
+ + ++L +L+LG N L P L+ L ++ +T+ L L
Sbjct: 223 VASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRA 282
Query: 412 CKYLEIIALSGNPL--NGIIPMSAG--NLSHSLEELFMPDCNVSGRIPKEIGNL----AN 463
+ L+ ++L+GN L G + LE L++ C+ + ++
Sbjct: 283 KESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRF 342
Query: 464 LVTLDLGGNKFNGSIPIALGKL-----QKLQLLNLDDNKL 498
L+ L + N+ + L + L++L L D +
Sbjct: 343 LLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDV 382
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 1e-16
Identities = 88/478 (18%), Positives = 154/478 (32%), Gaps = 96/478 (20%)
Query: 76 LNISYLSLTGN------IPRQLGNLSSLEILDLNFNRLSGE----IPWELGNLAKLEKLL 125
L+I L + L L +++ L+ L+ I L L +L
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 126 LHNNFLTGTIPFSIFKL-----SSLLDLKLSDNNLTG---TIPSHNLGNLSSLQLLDLSD 177
L +N L + + + L L + LTG + S L L +LQ L LSD
Sbjct: 63 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSD 122
Query: 178 NQLSGSIPSFIFKI-----SSLQALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGG 232
N L + + + L+ L LS +
Sbjct: 123 NLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLA------------------- 163
Query: 233 ISSTLSNCKHLRILDLSFNDLWGDIPKEIG-----NLTKLKELFLDFNILQGE----IPH 283
S L + L +S ND+ + + + +L+ L L+ + + +
Sbjct: 164 --SVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCG 221
Query: 284 TVGNLHNLEYLSLVNNELVGTVPATIFNVSTLKLIELSNNTFFGSLPSSTDVQLPNLEEL 343
V + +L L+L +N+L + L L L
Sbjct: 222 IVASKASLRELALGSNKL--------------------GDVGMAELCPGLLHPSSRLRTL 261
Query: 344 YLWGNNFSGTLPSFIFNA----SNLSKLSLGDNSFS-----GLIPNTFGNLRNLKRLRLY 394
++W + + +L +LSL N L L+ L +
Sbjct: 262 WIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVK 321
Query: 395 NNYLTSPELSFLSS-LSNCKYLEIIALSGNPL--NGIIPMSAG--NLSHSLEELFMPDCN 449
+ T+ S SS L+ ++L + +S N L G+ + G L L++ DC+
Sbjct: 322 SCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCD 381
Query: 450 VS----GRIPKEIGNLANLVTLDLGGNKFNGSIPIALGKLQK-----LQLLNLDDNKL 498
VS + + +L LDL N + + L + + L+ L L D
Sbjct: 382 VSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYW 439
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 5e-16
Identities = 86/543 (15%), Positives = 164/543 (30%), Gaps = 134/543 (24%)
Query: 168 SSLQLLDLSDNQLS-GSIPSFIFKISSLQALHFGNNRLSGELPANICDNLPFLNFFSVYK 226
+Q LD+ +LS + + Q + + L+
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEA------------------- 43
Query: 227 NMFYGGISSTLSNCKHLRILDLSFNDLWGDIPKEIGNL-----TKLKELFLDFNILQGE- 280
ISS L L L+L N+L + K+++L L L G
Sbjct: 44 --RCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAG 101
Query: 281 ---IPHTVGNLHNLEYLSLVNNELVGTVPATIFNVSTLKLIELSNNTFFGSLPSSTDVQL 337
+ T+ L L+ L L +N L + L L
Sbjct: 102 CGVLSSTLRTLPTLQELHLSDNLLGDA------GLQLLCEGLLDPQC------------- 142
Query: 338 PNLEELYLWGNNFSGTLPSFIFNA----SNLSKLSLGDNSFS---------GLIPNTFGN 384
LE+L L + S + + + +L++ +N + GL +
Sbjct: 143 -RLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPC-- 199
Query: 385 LRNLKRLRLYNNYLTSPELSFLSS-LSNCKYLEIIALSGNPL--NGIIPMSAGNL--SHS 439
L+ L+L + +TS L +++ L +AL N L G+ + G L S
Sbjct: 200 --QLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSR 257
Query: 440 LEELFMPDCNVSGR----IPKEIGNLANLVTLDLGGNKFNGSIPIALGKL-----QKLQL 490
L L++ +C ++ + + + + +L L L GN+ L + +L+
Sbjct: 258 LRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLES 317
Query: 491 LNLDDNKLEGSIPDDICGLVELYKLALGDNKLSGQIPACFGNLASLRELWLGPNELISFI 550
L + L N+ L EL + N
Sbjct: 318 LWVKSCSFT---AACCSHFSS----VLAQNR-------------FLLELQISNN------ 351
Query: 551 PSTFWNIKDIMYVNFSSNFLTGPLPLEIENLKALTTLDFSMNNLSGV----IPTTIGGLK 606
++D + L L + ++S + T+
Sbjct: 352 -----RLEDAGVRELCQGLG--------QPGSVLRVLWLADCDVSDSSCSSLAATLLANH 398
Query: 607 GLQYLFLGHNRLQGSIPDSVGDLI-----SLKSLNLSNNNLS----GPIPTSLEKLSDLK 657
L+ L L +N L + + + + L+ L L + S + + L+
Sbjct: 399 SLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLR 458
Query: 658 ELN 660
++
Sbjct: 459 VIS 461
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 9e-05
Identities = 39/233 (16%), Positives = 72/233 (30%), Gaps = 54/233 (23%)
Query: 463 NLVTLDLGGNKFN-GSIPIALGKLQKLQLLNLDDNKLEGSIPDDICGLVE----LYKLAL 517
++ +LD+ + + L LQ+ Q++ LDD L + DI + L +L L
Sbjct: 4 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 63
Query: 518 GDNKLSGQ-----IPACFGNLASLRELWLGPNEL----ISFIPSTFWNIKDIMYVNFSSN 568
N+L + +++L L L + ST + + ++ S N
Sbjct: 64 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDN 123
Query: 569 FLTGP-----LPLEIENLKALTTLDFSMNNLSGVIPTTIGGLKGLQYLF--LGHNRLQGS 621
L ++ L L +L + L L
Sbjct: 124 LLGDAGLQLLCEGLLDPQCRLEKLQLEYCSL---------SAASCEPLASVLRAKP---- 170
Query: 622 IPDSVGDLISLKSLNLSNNNLSGPIPTSLEKLSD--------LKELNLSFNKL 666
K L +SNN+++ + L L+ L L +
Sbjct: 171 ---------DFKELTVSNNDIN---EAGVRVLCQGLKDSPCQLEALKLESCGV 211
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 84.5 bits (210), Expect = 8e-18
Identities = 53/211 (25%), Positives = 99/211 (46%), Gaps = 23/211 (10%)
Query: 777 IGRGSFGSVYIAR-LQNGIEVAVKTFDLQHER------AFKSFDTECEVMKSIRHRNLTK 829
IG G++G+V+ A+ + VA+K L + A + E ++K ++H+N+ +
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR----EICLLKELKHKNIVR 65
Query: 830 IISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAP 889
+ ++ L+ E+ + L+K S N LD + + + L + H S
Sbjct: 66 LHDVLHSDKKLTLVFEFC-DQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH---SRN 121
Query: 890 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPE--YGREGR 947
V+H DLKP N+L++ N L++FG+A+ + + + TL Y P+ +G +
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY--SAEVVTLWYRPPDVLFGAK-L 178
Query: 948 VSTKGDVYSFGILLMETFTRRKPTDEIFSGE 978
ST D++S G + E +P +F G
Sbjct: 179 YSTSIDMWSAGCIFAELANAGRP---LFPGN 206
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 86.5 bits (214), Expect = 2e-17
Identities = 57/232 (24%), Positives = 94/232 (40%), Gaps = 32/232 (13%)
Query: 771 FSENNLIGRGSFGSVYIARLQNGIEV-AVKTFDLQHERAFKSFDTEC--------EVMKS 821
FS + +IGRG FG VY R + ++ A+K L +R ++ +
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKC--LDKKRIKMKQGETLALNERIMLSLVST 248
Query: 822 IRHRNLTKIISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEY 881
+ + + D + IL+ M G L L + R ++ LE+
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAA-EIILGLEH 307
Query: 882 LHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLA-TLGYMAP 940
+H + V++ DLKP+N+LLD++ +SD G+A + + T GYMAP
Sbjct: 308 MH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-----KPHASVGTHGYMAP 359
Query: 941 EYGREGRVSTKG-DVYSFGILLMETFT--------RRKPTDEIFSGEMTLKH 983
E ++G D +S G +L + + K EI MTL
Sbjct: 360 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID--RMTLTM 409
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 2e-17
Identities = 65/291 (22%), Positives = 110/291 (37%), Gaps = 50/291 (17%)
Query: 777 IGRGSFGSVYIARLQNGIEVAVKTFDLQHER------AFKSFDTECEVMKSIRHRNLTKI 830
+G G++G VY A+ G VA+K L E A + E ++K + H N+ +
Sbjct: 29 VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIR----EISLLKELHHPNIVSL 84
Query: 831 ISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPV 890
I +E L+ E+M L+K L L Q + + + + H +
Sbjct: 85 IDVIHSERCLTLVFEFM-EKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH---QHRI 140
Query: 891 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPE--YGREGRV 948
+H DLKP N+L++ + L+DFG+A+ +S T + TL Y AP+ G + +
Sbjct: 141 LHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY--THEVVTLWYRAPDVLMGSK-KY 197
Query: 949 STKGDVYSFGILLMETFTRR--------------------KPTDEIFSGEMTLKHWVNDF 988
ST D++S G + E T + P + L W
Sbjct: 198 STSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRT 257
Query: 989 LPISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKE 1039
+ K Q +L P++RI+A++
Sbjct: 258 FQVFEKKPW--------SSIIPGFCQEG---IDLLSNMLCFDPNKRISARD 297
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 3e-17
Identities = 54/233 (23%), Positives = 102/233 (43%), Gaps = 18/233 (7%)
Query: 740 RGENVPNEVNVPLEATWRRFSYLELFQAT-NGFSENNLIGRGSFGSVYIARLQNGIEV-A 797
+ ++ + ++ +LE T N F + ++G+G FG V +++ ++ A
Sbjct: 154 SVAPFADYLDSIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYA 213
Query: 798 VKTFDLQHERAFKSFDTEC-----EVMKSIRHRNLTKIISSCSNEDFKALILEYMRNGSL 852
K L+ +R K ++++ + R + + + +D L+L M G L
Sbjct: 214 CKK--LEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDL 271
Query: 853 EKCLY-SGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLS 911
+ +Y G + + ++ LE LH +++ DLKP N+LLDD+ +S
Sbjct: 272 KFHIYHMGQAGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRIS 328
Query: 912 DFGIAKLLIGEDQSMTQTQTLA-TLGYMAPEYGREGRVSTKGDVYSFGILLME 963
D G+A + + T+GYMAPE + R + D ++ G LL E
Sbjct: 329 DLGLAVHVPEGQ----TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYE 377
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 3e-17
Identities = 60/291 (20%), Positives = 114/291 (39%), Gaps = 51/291 (17%)
Query: 777 IGRGSFGSVYIARLQNGIEVAVKTFDLQHER------AFKSFDTECEVMKSIRHRNLTKI 830
IG G++G VY A+ G A+K L+ E + E ++K ++H N+ K+
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIR----EISILKELKHSNIVKL 65
Query: 831 ISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPV 890
+ L+ E++ + L+K L L+ + ++ + + + Y H V
Sbjct: 66 YDVIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRV 121
Query: 891 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPE--YGREGRV 948
+H DLKP N+L++ ++DFG+A+ + T + TL Y AP+ G + +
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY--THEIVTLWYRAPDVLMGSK-KY 178
Query: 949 STKGDVYSFGILLMETFTRR--------------------KPTDEIFSGEMTLKHWVNDF 988
ST D++S G + E P + + L + +F
Sbjct: 179 STTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238
Query: 989 LPISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKE 1039
+ + ++ +L + P++RITAK+
Sbjct: 239 TVYEPLPW---------ESFLKGLDESG---IDLLSKMLKLDPNQRITAKQ 277
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 3e-17
Identities = 53/212 (25%), Positives = 90/212 (42%), Gaps = 46/212 (21%)
Query: 776 LIGRGSFGSVYIARLQNGIEV-AVKTFDLQHERAFKSFDTEC-----EVMKSIRHRNLTK 829
+IGRG+FG V + R ++ +V A+K L K D+ ++M + +
Sbjct: 76 VIGRGAFGEVQLVRHKSTRKVYAMKL--LSKFEMIKRSDSAFFWEERDIMAFANSPWVVQ 133
Query: 830 IISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVA--------SALEY 881
+ + ++ + +++EYM G L +++ ++ A AL+
Sbjct: 134 LFYAFQDDRYLYMVMEYMPGGDL----------VNLMSNYDVPEKWARFYTAEVVLALDA 183
Query: 882 LHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPE 941
+H S IH D+KP N+LLD + L+DFG + E T + T Y++PE
Sbjct: 184 IH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-AVGTPDYISPE 239
Query: 942 ----------YGREGRVSTKGDVYSFGILLME 963
YGRE D +S G+ L E
Sbjct: 240 VLKSQGGDGYYGRE--C----DWWSVGVFLYE 265
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 3e-17
Identities = 55/230 (23%), Positives = 90/230 (39%), Gaps = 33/230 (14%)
Query: 776 LIGRGSFGSVYIAR-LQNGIEVAVKTFDLQHERAFKSFDT------ECEVMKSIRHR--N 826
L+G G FGSVY + + + VA+K + + E ++K +
Sbjct: 50 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109
Query: 827 LTKIISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLN------IMIDVASALE 880
+ +++ D LILE + L+ ++I + L V A+
Sbjct: 110 VIRLLDWFERPDSFVLILERP-EPVQD--LF--DFITE-RGALQEELARSFFWQVLEAVR 163
Query: 881 YLHFGYSAPVIHCDLKPSNVLLDDN-MVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMA 939
+ H + V+H D+K N+L+D N L DFG LL ++ T Y
Sbjct: 164 HCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTD-FDGTRVYSP 216
Query: 940 PEYGREGR-VSTKGDVYSFGILLMETFTRRKP---TDEIFSGEMTLKHWV 985
PE+ R R V+S GILL + P +EI G++ + V
Sbjct: 217 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRV 266
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 4e-17
Identities = 47/211 (22%), Positives = 90/211 (42%), Gaps = 41/211 (19%)
Query: 776 LIGRGSFGSVYIARLQNGIEV-AVKTFDLQHERAFKSFDTEC-----EVMKSIRHRNLTK 829
+IGRG+FG V + +L+N +V A+K L K +T C +V+ + + +T
Sbjct: 81 VIGRGAFGEVAVVKLKNADKVFAMKI--LNKWEMLKRAETACFREERDVLVNGDSKWITT 138
Query: 830 IISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMID----------VASAL 879
+ + +++ L+++Y G L L + + + + A+
Sbjct: 139 LHYAFQDDNNLYLVMDYYVGGDL----------LTLLSKFEDRLPEEMARFYLAEMVIAI 188
Query: 880 EYLHFGYSAPVIHCDLKPSNVLLDDNMVAH--LSDFGIAKLLIGEDQSMTQTQTLATLGY 937
+ +H +H D+KP N+L+D N H L+DFG L+ + + + T Y
Sbjct: 189 DSVH---QLHYVHRDIKPDNILMDMN--GHIRLADFGSCLKLMEDGTVQSSV-AVGTPDY 242
Query: 938 MAPEYGREGRVSTKG-----DVYSFGILLME 963
++PE + D +S G+ + E
Sbjct: 243 ISPEILQAMEGGKGRYGPECDWWSLGVCMYE 273
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 5e-17
Identities = 58/235 (24%), Positives = 103/235 (43%), Gaps = 33/235 (14%)
Query: 764 LFQATNGFSENNLIGRGSFGSVYIAR-LQNGIEVAVKTFDLQHERAFKSFDT------EC 816
+++ + + +G G++GSV A + G+ VAVK + R F+S E
Sbjct: 24 IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYREL 79
Query: 817 EVMKSIRHRNLTKI----ISSCSNEDFKA--LILEYMRNGSLEKCLYSGNYILDIFQRLN 870
++K ++H N+ + + S E+F L+ M L + D Q
Sbjct: 80 RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQ--F 136
Query: 871 IMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQ 930
++ + L+Y+H SA +IH DLKPSN+ ++++ + DFG+A+ M T
Sbjct: 137 LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTADEM--TG 188
Query: 931 TLATLGYMAPEYGREGRVSTKG-DVYSFGILLMETFTRRKPTDEIFSGEMTLKHW 984
+AT Y APE + D++S G ++ E T + +F G +
Sbjct: 189 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-GRT---LFPGTDHIDQL 239
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 6e-17
Identities = 54/238 (22%), Positives = 88/238 (36%), Gaps = 47/238 (19%)
Query: 776 LIGRGSFGSVYIAR-LQNGIEVAVKTFDLQHERAFKSFDT------ECEVMKSIR----H 824
L+G+G FG+V+ L + ++VA+K + E ++ + H
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 825 RNLTKIISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIF------QRL------NIM 872
+ +++ ++ L+LE D+F L
Sbjct: 98 PGVIRLLDWFETQEGFMLVLERPLPAQ------------DLFDYITEKGPLGEGPSRCFF 145
Query: 873 IDVASALEYLHFGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLIGEDQSMTQTQT 931
V +A+++ H S V+H D+K N+L+D A L DFG LL D+ T
Sbjct: 146 GQVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALL--HDEPYTDFD- 199
Query: 932 LATLGYMAPEY-GREGRVSTKGDVYSFGILLMETFTRRKP---TDEIFSGEMTLKHWV 985
T Y PE+ R + V+S GILL + P EI E+ V
Sbjct: 200 -GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILEAELHFPAHV 256
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 83.4 bits (206), Expect = 8e-17
Identities = 59/234 (25%), Positives = 101/234 (43%), Gaps = 31/234 (13%)
Query: 764 LFQATNGFSENNLIGRGSFGSVYIAR-LQNGIEVAVK----TFDLQHE--RAFKSFDTEC 816
F + IG G+ G V A VA+K F Q RA++ E
Sbjct: 57 TFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR----EL 112
Query: 817 EVMKSIRHRNLTKII----SSCSNEDFKA--LILEYMRNGSLEKCLYSGNYILDIFQRLN 870
+MK + H+N+ ++ + E+F+ L++E M + +L + + LD +
Sbjct: 113 VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME---LDHERMSY 168
Query: 871 IMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQ 930
++ + +++LH SA +IH DLKPSN+++ + + DFG+A+ G M T
Sbjct: 169 LLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMM--TP 222
Query: 931 TLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHW 984
+ T Y APE D++S G ++ E K +F G + W
Sbjct: 223 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVR-HKI---LFPGRDYIDQW 272
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 1e-16
Identities = 62/300 (20%), Positives = 120/300 (40%), Gaps = 53/300 (17%)
Query: 777 IGRGSFGSVYIAR-LQNGIEVAVKTFDLQHER-AFKSFDT---ECEVMKSIRHRN---LT 828
IG+G+FG V+ AR + G +VA+K +++E+ F T E ++++ ++H N L
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPI--TALREIKILQLLKHENVVNLI 82
Query: 829 KIISSCSNEDFKA-----LILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLH 883
+I + ++ + L+ ++ + L L + + + +M + + L Y+H
Sbjct: 83 EICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH 141
Query: 884 FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQ--TQTLATLGYMAPE 941
++H D+K +NVL+ + V L+DFG+A+ S T + TL Y PE
Sbjct: 142 ---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPE 198
Query: 942 --YGREGRVSTKGDVYSFGILLMETFTRR--------------------KPTDEIFSGEM 979
G E D++ G ++ E +TR T E++
Sbjct: 199 LLLG-ERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVD 257
Query: 980 TLKHWVNDFLPISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKE 1039
+ + L + K + +L + V P +RI + +
Sbjct: 258 NYELYEKLELVKGQ-----KRKVKDRLKAYVRDPYA----LDLIDKLLVLDPAQRIDSDD 308
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 1e-16
Identities = 54/242 (22%), Positives = 101/242 (41%), Gaps = 36/242 (14%)
Query: 765 FQATNGFSENNLIGRGSFGSVYIAR-LQNGIEVAVKTFDLQHE----RAFKSFDTECEVM 819
F + + + +G G G V+ A VA+K L A + E +++
Sbjct: 7 FDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALR----EIKII 62
Query: 820 KSIRHRNLTKII------------SSCSNEDFKA--LILEYMRNGSLEKCLYSGNYILDI 865
+ + H N+ K+ S + + ++ EYM L L G + +
Sbjct: 63 RRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETDLANVLEQGPLLEEH 121
Query: 866 FQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLIGEDQ 924
+ M + L+Y+H SA V+H DLKP+N+ ++ +++V + DFG+A+++
Sbjct: 122 AR--LFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYS 176
Query: 925 SMTQ-TQTLATLGYMAPEYGREGRVSTKG-DVYSFGILLMETFTRRKPTDEIFSGEMTLK 982
++ L T Y +P TK D+++ G + E T K +F+G L+
Sbjct: 177 HKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLT-GKT---LFAGAHELE 232
Query: 983 HW 984
Sbjct: 233 QM 234
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 1e-16
Identities = 62/297 (20%), Positives = 116/297 (39%), Gaps = 53/297 (17%)
Query: 777 IGRGSFGSVYIAR-LQNGIEVAVKTFDLQHERAFKSFDT---ECEVMKSIRHRNLTKIIS 832
+G G++ +VY G+ VA+K L E S T E +MK ++H N+ ++
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPS--TAIREISLMKELKHENIVRLYD 70
Query: 833 SCSNEDFKALILEYMRNGSLEKCLYSGNYI-----LDIFQRLNIMIDVASALEYLHFGYS 887
E+ L+ E+M + L+K + S L++ + L + H
Sbjct: 71 VIHTENKLTLVFEFM-DNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK- 128
Query: 888 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPE--YGRE 945
++H DLKP N+L++ L DFG+A+ + + + TL Y AP+ G
Sbjct: 129 --ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTF--SSEVVTLWYRAPDVLMGSR 184
Query: 946 GRVSTKGDVYSFGILLMETFTRR--------------------KPTDEIFSGEMTLKHWV 985
ST D++S G +L E T + P + ++ L +
Sbjct: 185 -TYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYN 243
Query: 986 NDFL---PISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKE 1039
+ P + +++ + D + + + +PD R++AK+
Sbjct: 244 PNIQQRPPRDLRQVLQPHTKEPLDGN----------LMDFLHGLLQLNPDMRLSAKQ 290
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 2e-16
Identities = 60/289 (20%), Positives = 113/289 (39%), Gaps = 46/289 (15%)
Query: 777 IGRGSFGSVYIAR-LQNGIEVAVKTFDLQHERAFKSFDT---ECEVMKSIRHRNLTKIIS 832
+G G++ +VY + VA+K L+HE T E ++K ++H N+ +
Sbjct: 10 LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPC--TAIREVSLLKDLKHANIVTLHD 67
Query: 833 SCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIH 892
E L+ EY+ + L++ L I+++ + + L Y H V+H
Sbjct: 68 IIHTEKSLTLVFEYL-DKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH---RQKVLH 123
Query: 893 CDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPE--YGREGRVST 950
DLKP N+L+++ L+DFG+A+ ++ + TL Y P+ G ST
Sbjct: 124 RDLKPQNLLINERGELKLADFGLARAKSIPTKTY--DNEVVTLWYRPPDILLGST-DYST 180
Query: 951 KGDVYSFGILLMETFTRR--------------------KPTDEIFSGEMTLKHWVNDFLP 990
+ D++ G + E T R PT+E + G ++ + + P
Sbjct: 181 QIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYP 240
Query: 991 ISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKE 1039
+ + H + +L + RI+A++
Sbjct: 241 KYRAEAL--------LSHAPRLDSDG---ADLLTKLLQFEGRNRISAED 278
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 2e-16
Identities = 63/234 (26%), Positives = 107/234 (45%), Gaps = 27/234 (11%)
Query: 764 LFQATNGFSENNLIGRGSFGSVYIAR-LQNGIEVAVKTFD-LQHE----RAFKSFDTECE 817
+F ++ + IG G++G V A N + VA+K +H+ R + E +
Sbjct: 22 VFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIK 77
Query: 818 VMKSIRHRNLTK---IISSCSNEDFKA--LILEYMRNGSLEKCLYSGNYILDIFQRLNIM 872
++ RH N+ II + + E K ++ + M L K L + ++ + +
Sbjct: 78 ILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKT-QHLSNDHICY-FL 134
Query: 873 IDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQ-TQT 931
+ L+Y+H SA V+H DLKPSN+LL+ + DFG+A++ + T+
Sbjct: 135 YQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY 191
Query: 932 LATLGYMAPEYGREGRVSTKG-DVYSFGILLMETFTRRKPTDEIFSGEMTLKHW 984
+AT Y APE + TK D++S G +L E + R IF G+ L
Sbjct: 192 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR----PIFPGKHYLDQL 241
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 3e-16
Identities = 45/213 (21%), Positives = 85/213 (39%), Gaps = 43/213 (20%)
Query: 776 LIGRGSFGSVYIARLQNGIEV-AVKTFDLQHERAFKSFDTEC-----EVMKSIRHRNLTK 829
+IGRG+F V + +++ +V A+K + K + C +V+ + R +T+
Sbjct: 68 VIGRGAFSEVAVVKMKQTGQVYAMKI--MNKWDMLKRGEVSCFREERDVLVNGDRRWITQ 125
Query: 830 IISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMID----------VASAL 879
+ + +E++ L++EY G L L + + I + A+
Sbjct: 126 LHFAFQDENYLYLVMEYYVGGDL----------LTLLSKFGERIPAEMARFYLAEIVMAI 175
Query: 880 EYLHFGYSAPVIHCDLKPSNVLLDDNMVAH--LSDFGIAKLLIGEDQSMTQTQTLATLGY 937
+ +H +H D+KP N+LLD H L+DFG L + + + T Y
Sbjct: 176 DSVH---RLGYVHRDIKPDNILLDRC--GHIRLADFGSCLKLRADGTVRSLV-AVGTPDY 229
Query: 938 MAPEYGREGRVSTKGDVY-------SFGILLME 963
++PE + Y + G+ E
Sbjct: 230 LSPEILQAVGGGPGTGSYGPECDWWALGVFAYE 262
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 3e-16
Identities = 59/241 (24%), Positives = 107/241 (44%), Gaps = 46/241 (19%)
Query: 764 LFQATNGFSENNLIGRGSFGSVYIAR-LQNGIEVAVK----TFDLQHE--RAFKSFDTEC 816
++ + +G G++GSV A ++G +VA+K F + RA++ E
Sbjct: 19 AWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR----EL 74
Query: 817 EVMKSIRHRNLTKI----ISSCSNEDFKA--LILEYMRNGSLEKCLYSG------NYILD 864
++K ++H N+ + + S +F L++ +M L+K + Y+
Sbjct: 75 LLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIMGLKFSEEKIQYL-- 131
Query: 865 IFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ 924
++Q L L+Y+H SA V+H DLKP N+ ++++ + DFG+A+ D
Sbjct: 132 VYQMLK-------GLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLAR---HADA 178
Query: 925 SMTQTQTLATLGYMAPE-YGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKH 983
M T + T Y APE + D++S G ++ E T K +F G+ L
Sbjct: 179 EM--TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLT-GKT---LFKGKDYLDQ 232
Query: 984 W 984
Sbjct: 233 L 233
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 4e-16
Identities = 60/231 (25%), Positives = 101/231 (43%), Gaps = 44/231 (19%)
Query: 765 FQATNGFSENNLIGRGSFGSVYIAR-LQNGIEVAVKTFD-LQHE----RAFKSFDTECEV 818
+ ++ F +L+G G++G V A G VA+K + R + E ++
Sbjct: 7 YNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR----EIKI 62
Query: 819 MKSIRHRNLTK---IISSCSNEDFKA--LILEYMRNGSLEKCLYSGNYILDIFQRLNIMI 873
+K +H N+ I S E+F +I E M L + + S + D + +
Sbjct: 63 LKHFKHENIITIFNIQRPDSFENFNEVYIIQELM-QTDLHRVI-STQMLSDDHIQY-FIY 119
Query: 874 DVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQ----- 928
A++ LH + VIH DLKPSN+L++ N + DFG+A+++ ++
Sbjct: 120 QTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQ 176
Query: 929 ---TQTLATLGYMAPE-------YGREGRVSTKG-DVYSFGILLMETFTRR 968
+ +AT Y APE Y ++ DV+S G +L E F RR
Sbjct: 177 SGMVEFVATRWYRAPEVMLTSAKY-------SRAMDVWSCGCILAELFLRR 220
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 4e-16
Identities = 57/229 (24%), Positives = 95/229 (41%), Gaps = 54/229 (23%)
Query: 776 LIGRGSFGSVYIARLQNGIEV-AVKTF---DLQHERAFKSFDTECEVMKSIRHRNLTKII 831
L+G+G+FG V + + + A+K + + TE V+++ RH LT +
Sbjct: 155 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 214
Query: 832 SSCSNEDFKALILEYMRNGSL-----------EK--CLYSGNYILDIFQRLNIMIDVASA 878
S D ++EY G L E Y ++ SA
Sbjct: 215 YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGA--------------EIVSA 260
Query: 879 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTL-ATLGY 937
L+YLH + V++ DLK N++LD + ++DFG+ K I + + +T T Y
Sbjct: 261 LDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT---MKTFCGTPEY 315
Query: 938 MAPE------YGREGRVSTKGDVYSFGILLMETFTRRKP-----TDEIF 975
+APE YGR V D + G+++ E R P +++F
Sbjct: 316 LAPEVLEDNDYGRA--V----DWWGLGVVMYEMMCGRLPFYNQDHEKLF 358
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 5e-16
Identities = 56/234 (23%), Positives = 98/234 (41%), Gaps = 44/234 (18%)
Query: 96 SLEILDLNFNRLSGEIPWELGNLAKLEKLLLHNNFLTGTIPFSIFKLSSLLDLKLSDNNL 155
+L ++ + L +++++ +N+ + L ++ L L N L
Sbjct: 20 ETIKANLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQGIQ--YLPNVRYLALGGNKL 75
Query: 156 TGTIPSHNLG---NLSSLQLLDLSDNQLSGSIPSFIF-KISSLQALHFGNNRLSGELPAN 211
++ L++L L L+ NQL S+P+ +F K+++L+ L N+L LP
Sbjct: 76 H------DISALKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQ-SLPDG 127
Query: 212 ICDNLPFLNFFSVYKNMFYGGISSTLSNCKHLRILDLSFNDLWGDIPKEIGNLTKLKELF 271
+ D L +L L+L+ N L LT L EL
Sbjct: 128 VFDKL------------------------TNLTYLNLAHNQLQSLPKGVFDKLTNLTELD 163
Query: 272 LDFNILQGEIPHTV-GNLHNLEYLSLVNNELVGTVPATIF-NVSTLKLIELSNN 323
L +N LQ +P V L L+ L L N+L +VP +F +++L+ I L +N
Sbjct: 164 LSYNQLQ-SLPEGVFDKLTQLKDLRLYQNQL-KSVPDGVFDRLTSLQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 5e-15
Identities = 57/214 (26%), Positives = 84/214 (39%), Gaps = 35/214 (16%)
Query: 462 ANLVTLDLGGNKFNGSIPIALGKLQKLQLLNLDDNKLEGSIPDDICGLVELYKLALGDNK 521
A + +L +L + + +++ ++ L + LALG NK
Sbjct: 19 AETIKANLKKKSVT-DAV-TQNELNSIDQIIANNSDIKSVQGIQY--LPNVRYLALGGNK 74
Query: 522 LSGQIPACFGNLASLRELWLGPNELISFIPSTFWNIKDIMYVNFSSNFLTGPLPLEIENL 581
L I A L +L L L N+L S F + L
Sbjct: 75 LH-DISA-LKELTNLTYLILTGNQLQSLPNGVF------------------------DKL 108
Query: 582 KALTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQGSIPDSVGD-LISLKSLNLSNN 640
L L N L + L L YL L HN+LQ S+P V D L +L L+LS N
Sbjct: 109 TNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQ-SLPKGVFDKLTNLTELDLSYN 167
Query: 641 NLSGPIPTSL-EKLSDLKELNLSFNKLEGEIPRG 673
L +P + +KL+ LK+L L N+L+ +P G
Sbjct: 168 QLQS-LPEGVFDKLTQLKDLRLYQNQLKS-VPDG 199
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 5e-13
Identities = 45/182 (24%), Positives = 77/182 (42%), Gaps = 22/182 (12%)
Query: 59 CNWTGVTCDINQ-RRVTALN----ISYLSLTGNIPRQLG---NLSSLEILDLNFNRLSGE 110
N I + + + + L ++ L L N+L
Sbjct: 19 AETIKANLKKKSVTDAVTQNELNSIDQIIANNSDIKSVQGIQYLPNVRYLALGGNKLH-- 76
Query: 111 IPWELG---NLAKLEKLLLHNNFLTGTIPFSIF-KLSSLLDLKLSDNNLTGTIPSHNLGN 166
++ L L L+L N L ++P +F KL++L +L L +N L ++P
Sbjct: 77 ---DISALKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDK 131
Query: 167 LSSLQLLDLSDNQLSGSIPSFIF-KISSLQALHFGNNRLSGELPANICDNLPFLNFFSVY 225
L++L L+L+ NQL S+P +F K+++L L N+L LP + D L L +Y
Sbjct: 132 LTNLTYLNLAHNQLQ-SLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDKLTQLKDLRLY 189
Query: 226 KN 227
+N
Sbjct: 190 QN 191
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 7e-12
Identities = 50/156 (32%), Positives = 80/156 (51%), Gaps = 9/156 (5%)
Query: 77 NISYLSLTGNIPRQLG---NLSSLEILDLNFNRLSGEIPWELGNLAKLEKLLLHNNFLTG 133
N+ YL+L GN + L++L L L N+L L L++L+L N L
Sbjct: 64 NVRYLALGGNKLHDISALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQ- 122
Query: 134 TIPFSIF-KLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQLSGSIPSFIF-KI 191
++P +F KL++L L L+ N L ++P L++L LDLS NQL S+P +F K+
Sbjct: 123 SLPDGVFDKLTNLTYLNLAHNQLQ-SLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDKL 180
Query: 192 SSLQALHFGNNRLSGELPANICDNLPFLNFFSVYKN 227
+ L+ L N+L +P + D L L + ++ N
Sbjct: 181 TQLKDLRLYQNQLKS-VPDGVFDRLTSLQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 1e-11
Identities = 64/255 (25%), Positives = 92/255 (36%), Gaps = 63/255 (24%)
Query: 292 EYLSLVNNELVGTVPATIFNVSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFS 351
+L + ++++ I +N+ S+ LPN+ L L GN
Sbjct: 22 IKANLKKKSVT-DAVTQN-ELNSIDQIIANNSDI-KSVQGIQ--YLPNVRYLALGGNKLH 76
Query: 352 GTLPSFIFNASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNYLTSPELSFLSSLSN 411
+ + +NL+ L L N L F L NLK L L N L S L+N
Sbjct: 77 -DISAL-KELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTN 134
Query: 412 CKYLEIIALSGNPLNGIIPMSAGNLSHSLEE-LFMPDCNVSGRIPKEIGNLANLVTLDLG 470
YL L+ N L SL + +F D L NL LDL
Sbjct: 135 LTYLN---LAHNQL------------QSLPKGVF--D------------KLTNLTELDLS 165
Query: 471 GNKFNGSIPI-ALGKLQKLQLLNLDDNKLEGSIPDDICGLVELYKLALGDNKLSGQIPAC 529
N+ S+P KL +L+ L L N+L+ S+PD +
Sbjct: 166 YNQLQ-SLPEGVFDKLTQLKDLRLYQNQLK-SVPDGV----------------------- 200
Query: 530 FGNLASLRELWLGPN 544
F L SL+ +WL N
Sbjct: 201 FDRLTSLQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 4e-11
Identities = 56/186 (30%), Positives = 82/186 (44%), Gaps = 14/186 (7%)
Query: 460 NLANLVTLDLGGNKFNGSIPIALGKLQKLQLLNLDDNKLEGSIP--DDICGLVELYKLAL 517
L ++ + + I L ++ L L NKL I L L L L
Sbjct: 39 ELNSIDQIIANNSDIKSVQGIQ--YLPNVRYLALGGNKLH-DISALK---ELTNLTYLIL 92
Query: 518 GDNKLSGQIPA-CFGNLASLRELWLGPNELISFIPSTFWNIKDIMYVNFSSNFLTGPLPL 576
N+L +P F L +L+EL L N+L S F + ++ Y+N + N L LP
Sbjct: 93 TGNQLQ-SLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQS-LPK 150
Query: 577 EI-ENLKALTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQGSIPDSVGD-LISLKS 634
+ + L LT LD S N L + L L+ L L N+L+ S+PD V D L SL+
Sbjct: 151 GVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLK-SVPDGVFDRLTSLQY 209
Query: 635 LNLSNN 640
+ L +N
Sbjct: 210 IWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 51/201 (25%), Positives = 76/201 (37%), Gaps = 46/201 (22%)
Query: 353 TLPSFIFNASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNYLTSPELSFLSSLSNC 412
P F + K +L S + + L ++ ++ N+ + S + + L N
Sbjct: 12 IFPDDAF--AETIKANLKKKSVTDAVT--QNELNSIDQIIANNSDIKS--VQGIQYLPNV 65
Query: 413 KYLEIIALSGNPLNGIIPMSAGNLSHSLEELFMPDCNVSGRIPKEIG---NLANLVTLDL 469
+YL L GN L +I L NL L L
Sbjct: 66 RYLA---LGGNKL------------------------------HDISALKELTNLTYLIL 92
Query: 470 GGNKFNGSIPI-ALGKLQKLQLLNLDDNKLEGSIPDDIC-GLVELYKLALGDNKLSGQIP 527
GN+ S+P KL L+ L L +N+L+ S+PD + L L L L N+L
Sbjct: 93 TGNQLQ-SLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNLTYLNLAHNQLQSLPK 150
Query: 528 ACFGNLASLRELWLGPNELIS 548
F L +L EL L N+L S
Sbjct: 151 GVFDKLTNLTELDLSYNQLQS 171
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 5e-05
Identities = 30/87 (34%), Positives = 44/87 (50%), Gaps = 3/87 (3%)
Query: 94 LSSLEILDLNFNRLSGEIPWELGNLAKLEKLLLHNNFLTGTIPFSIF-KLSSLLDLKLSD 152
L++L L+L N+L L L +L L N L ++P +F KL+ L DL+L
Sbjct: 132 LTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDKLTQLKDLRLYQ 190
Query: 153 NNLTGTIPSHNLGNLSSLQLLDLSDNQ 179
N L ++P L+SLQ + L DN
Sbjct: 191 NQLK-SVPDGVFDRLTSLQYIWLHDNP 216
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 5e-16
Identities = 55/195 (28%), Positives = 80/195 (41%), Gaps = 18/195 (9%)
Query: 62 TGVTCDINQRRVTALNISYLSLT---GNIPRQLGNLSSLEILDLNFNRLSGEIPWELGNL 118
TG TC+ ++ V + SL IP E LDL L+ L
Sbjct: 8 TGCTCNEGKKEV---DCQGKSLDSVPSGIPA------DTEKLDLQSTGLATLSDATFRGL 58
Query: 119 AKLEKLLLHNNFLTGTIPFSIF-KLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSD 177
KL L L N L T+ +F L+ L L L++N L ++P +L+ L L L
Sbjct: 59 TKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGG 116
Query: 178 NQLSGSIPSFIF-KISSLQALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGGISST 236
NQL S+PS +F +++ L+ L N+L +PA D L L S+ N
Sbjct: 117 NQLK-SLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQSVPHGA 174
Query: 237 LSNCKHLRILDLSFN 251
L+ + L N
Sbjct: 175 FDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 2e-15
Identities = 54/173 (31%), Positives = 78/173 (45%), Gaps = 12/173 (6%)
Query: 257 IPKEIGNLTKLKELFLDFNILQGEIPHTVGNLHNLEYLSLVNNELVGTVPATIFN-VSTL 315
+P I T+ +L L L T L L +L+L N+L T+ A +F+ ++ L
Sbjct: 29 VPSGIPADTE--KLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTEL 85
Query: 316 KLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSGTLPSFIF-NASNLSKLSLGDNSF 374
+ L+NN SLP L L++LYL GN +LPS +F + L +L L N
Sbjct: 86 GTLGLANNQ-LASLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQL 143
Query: 375 SGLIPNTFGNLRNLKRLRLYNNYLTS-PELSFLSSLSNCKYLEIIALSGNPLN 426
+ F L NL+ L L N L S P +F L+ I L GN +
Sbjct: 144 QSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAF----DRLGKLQTITLFGNQFD 192
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 9e-14
Identities = 51/154 (33%), Positives = 71/154 (46%), Gaps = 7/154 (4%)
Query: 246 LDLSFNDLWGDIPKEIGNLTKLKELFLDFNILQGEIPHTV-GNLHNLEYLSLVNNELVGT 304
LDL L LTKL L LD+N LQ + V +L L L L NN+L +
Sbjct: 40 LDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT-LSAGVFDDLTELGTLGLANNQLA-S 97
Query: 305 VPATIFNVST-LKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSGTLPSFIFNA-S 362
+P +F+ T L + L N SLPS +L L+EL L N ++P+ F+ +
Sbjct: 98 LPLGVFDHLTQLDKLYLGGNQ-LKSLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKLT 155
Query: 363 NLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNN 396
NL LSL N + F L L+ + L+ N
Sbjct: 156 NLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 3e-13
Identities = 46/143 (32%), Positives = 72/143 (50%), Gaps = 7/143 (4%)
Query: 534 ASLRELWLGPNELISFIPSTFWNIKDIMYVNFSSNFLTGPLPLEI-ENLKALTTLDFSMN 592
A +L L L + +TF + + ++N N L L + ++L L TL + N
Sbjct: 35 ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT-LSAGVFDDLTELGTLGLANN 93
Query: 593 NLSGVIPTTIGGLKGLQYLFLGHNRLQGSIPDSVGD-LISLKSLNLSNNNLSGPIPTSL- 650
L+ + L L L+LG N+L+ S+P V D L LK L L+ N L IP
Sbjct: 94 QLASLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQS-IPAGAF 151
Query: 651 EKLSDLKELNLSFNKLEGEIPRG 673
+KL++L+ L+LS N+L+ +P G
Sbjct: 152 DKLTNLQTLSLSTNQLQS-VPHG 173
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 5e-13
Identities = 52/189 (27%), Positives = 74/189 (39%), Gaps = 30/189 (15%)
Query: 454 IPKEIGNLANLVTLDLGGNKFNGSIPIALGKLQKLQLLNLDDNKLEGSIPDDI-CGLVEL 512
+P I A+ LDL L KL LNLD N+L+ ++ + L EL
Sbjct: 29 VPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTEL 85
Query: 513 YKLALGDNKLSGQIPACFGNLASLRELWLGPNELISFIPSTFWNIKDIMYVNFSSNFLTG 572
L L +N+L+ F +L L +L+LG N+L S F
Sbjct: 86 GTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVF------------------ 127
Query: 573 PLPLEIENLKALTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQGSIPDSVGD-LIS 631
+ L L L + N L + L LQ L L N+LQ S+P D L
Sbjct: 128 ------DRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQ-SVPHGAFDRLGK 180
Query: 632 LKSLNLSNN 640
L+++ L N
Sbjct: 181 LQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 4e-12
Identities = 46/177 (25%), Positives = 66/177 (37%), Gaps = 26/177 (14%)
Query: 489 QLLNLDDNKLEGSIPDDICGLVELYKLALGDNKLSGQIPACFGNLASLRELWLGPNELIS 548
+ L+L L GL +L L L N+L F +L L L L N+L S
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLAS 97
Query: 549 FIPSTFWNIKDIMYVNFSSNFLTGPLPLEIENLKALTTLDFSMNNLSGVIPTTIGGLKGL 608
F ++L L L N L + L L
Sbjct: 98 LPLGVF------------------------DHLTQLDKLYLGGNQLKSLPSGVFDRLTKL 133
Query: 609 QYLFLGHNRLQGSIPDSVGD-LISLKSLNLSNNNLSGPIPTSLEKLSDLKELNLSFN 664
+ L L N+LQ SIP D L +L++L+LS N L + ++L L+ + L N
Sbjct: 134 KELRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 7e-12
Identities = 52/206 (25%), Positives = 68/206 (33%), Gaps = 56/206 (27%)
Query: 341 EELYLWGNNFSGTLPSFIFNASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNYLTS 400
E+L L + + + L+ L+L N L F +L L L L NN L S
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLAS 97
Query: 401 PELSFLSSLSNCKYLEIIALSGNPLNGIIPMSAGNLSHSLEE-LFMPDCNVSGRIPKEIG 459
L L+ L L GN L SL +F D
Sbjct: 98 LPLGVFDHLTQLDKLY---LGGNQL------------KSLPSGVF--D------------ 128
Query: 460 NLANLVTLDLGGNKFNGSIPI-ALGKLQKLQLLNLDDNKLEGSIPDDICGLVELYKLALG 518
L L L L N+ SIP A KL LQ L+L N+L+ S+P
Sbjct: 129 RLTKLKELRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQ-SVPHGA------------ 174
Query: 519 DNKLSGQIPACFGNLASLRELWLGPN 544
F L L+ + L N
Sbjct: 175 -----------FDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 8e-07
Identities = 31/88 (35%), Positives = 44/88 (50%), Gaps = 3/88 (3%)
Query: 93 NLSSLEILDLNFNRLSGEIPWELGNLAKLEKLLLHNNFLTGTIPFSIF-KLSSLLDLKLS 151
+L+ L+ L L N+L L KL++L L+ N L +IP F KL++L L LS
Sbjct: 105 HLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKLTNLQTLSLS 163
Query: 152 DNNLTGTIPSHNLGNLSSLQLLDLSDNQ 179
N L ++P L LQ + L NQ
Sbjct: 164 TNQLQ-SVPHGAFDRLGKLQTITLFGNQ 190
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 79.5 bits (197), Expect = 7e-16
Identities = 72/293 (24%), Positives = 122/293 (41%), Gaps = 52/293 (17%)
Query: 777 IGRGSFGSVYIAR-LQNGIEVAVKTFDLQHERAFK-SFDT----ECEVMKSIRHRNLTKI 830
+G G F +VY AR VA+K L H K + E ++++ + H N+ +
Sbjct: 18 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 831 ISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPV 890
+ + ++ +L+ ++M LE + + +L M+ LEYLH +
Sbjct: 78 LDAFGHKSNISLVFDFM-ETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QHWI 133
Query: 891 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPE--YGREGRV 948
+H DLKP+N+LLD+N V L+DFG+AK +++ T + T Y APE +G
Sbjct: 134 LHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY--THQVVTRWYRAPELLFGAR-MY 190
Query: 949 STKGDVYSFGILLMETFTRR--------------------KPTDEIFSGEMTLKHWVN-- 986
D+++ G +L E R PT+E + +L +V
Sbjct: 191 GVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 250
Query: 987 DFLPISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKE 1039
F I + I A +D + +L + +P RITA +
Sbjct: 251 SFPGIPLHHIFSA---AGDD------------LLDLIQGLFLFNPCARITATQ 288
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 80.6 bits (199), Expect = 7e-16
Identities = 40/202 (19%), Positives = 85/202 (42%), Gaps = 27/202 (13%)
Query: 765 FQATNGFSENNLIGRGSFGSVYIAR-LQNGIEVAVKTFDLQHERAFKSFDT--------- 814
+Q + + +LIG GS+G V A VA+K + + F+
Sbjct: 49 WQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIK-------KILRVFEDLIDCKRILR 101
Query: 815 ECEVMKSIRHRNLTK---IISSCSNEDFKA--LILEYMRNGSLEKCLYSGNYILDIFQRL 869
E ++ + H ++ K I+ E F ++LE + +K + Y+ ++ +
Sbjct: 102 EIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKT 160
Query: 870 NIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQT 929
++ ++ ++Y+H SA ++H DLKP+N L++ + + DFG+A+ + + +Q
Sbjct: 161 -LLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQL 216
Query: 930 QTLATLGYMAPEYGREGRVSTK 951
M + +
Sbjct: 217 PISPREDDMNLVTFPHTKNLKR 238
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 9e-16
Identities = 58/323 (17%), Positives = 111/323 (34%), Gaps = 73/323 (22%)
Query: 773 ENNLIGRGSFGSVYIAR---LQNGIEVAVKTFDLQHERAFKSFDTECEV--MKSIRHRN- 826
E +GRG++G VY A+ ++ + A+K E S E+ ++ ++H N
Sbjct: 25 EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQI----EGTGISMSACREIALLRELKHPNV 80
Query: 827 --LTKIISSCSNEDFKALILEYMR-------NGSLEKCLYSGNYILDIFQRLNIMIDVAS 877
L K+ S ++ L+ +Y L +++ +
Sbjct: 81 ISLQKVFLSHADRKV-WLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILD 139
Query: 878 ALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAH----LSDFGIAKLLIGEDQSMTQ-TQTL 932
+ YLH + V+H DLKP+N+L+ ++D G A+L + + +
Sbjct: 140 GIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 196
Query: 933 ATLGYMAPE-------YGREGRVSTKGDVYSFGILLMETFTRR----------------- 968
T Y APE Y + D+++ G + E T
Sbjct: 197 VTFWYRAPELLLGARHY------TKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYH 250
Query: 969 ------------KPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHFAAKEQCA 1016
P D+ + + + +L+ +KH + A
Sbjct: 251 HDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKA 310
Query: 1017 SSVFNLAMECTVESPDERITAKE 1039
F+L + P +RIT+++
Sbjct: 311 ---FHLLQKLLTMDPIKRITSEQ 330
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 1e-15
Identities = 58/241 (24%), Positives = 105/241 (43%), Gaps = 47/241 (19%)
Query: 765 FQATNGFSENNLIGRGSFGSVYIAR-LQNGIEVAVKTFDLQHERAFKSFDT------ECE 817
++ + + +G G++G+V A + G +VA+K + R F+S E
Sbjct: 21 WEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIK----KLYRPFQSELFAKRAYRELR 76
Query: 818 VMKSIRHRNLTKII----SSCSNEDFKA--LILEYMRNGSLEKCLYSGN-------YILD 864
++K +RH N+ ++ + +DF L++ +M L K + ++
Sbjct: 77 LLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFL-- 133
Query: 865 IFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ 924
++Q L L Y+H +A +IH DLKP N+ ++++ + DFG+A+ D
Sbjct: 134 VYQMLK-------GLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR---QADS 180
Query: 925 SMTQTQTLATLGYMAPEY-GREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKH 983
M T + T Y APE R + D++S G ++ E T K +F G L
Sbjct: 181 EM--TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMIT-GKT---LFKGSDHLDQ 234
Query: 984 W 984
Sbjct: 235 L 235
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 1e-15
Identities = 59/287 (20%), Positives = 105/287 (36%), Gaps = 69/287 (24%)
Query: 759 FSYLELFQATNGFSENNLIGRGSFGSVYIAR-LQNGIEVAVKTFDLQHERAF-KSFDT-- 814
F ++ + + +LIGRGS+G VY+A VA+K + R F D
Sbjct: 16 FQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIK----KVNRMFEDLIDCKR 71
Query: 815 ---ECEVMKSIRHRNLTK---IISSCSNEDFKA--LILEYMRNGSLEKCLYSGNYILDIF 866
E ++ ++ + + +I F ++LE + L+K + ++ +
Sbjct: 72 ILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA-DSDLKKLFKTPIFLTEEH 130
Query: 867 QRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSM 926
+ I+ ++ ++H + +IH DLKP+N LL+ + + DFG+A+ + E +
Sbjct: 131 IKT-ILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTN 186
Query: 927 TQ--------------------TQTLATLGYMAPE-------YGREGRVSTKG-DVYSFG 958
T + T Y APE Y TK D++S G
Sbjct: 187 IVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENY-------TKSIDIWSTG 239
Query: 959 ILLME----------TFTRRKPTDEIFSGEMTLKHWVNDFLPISMMK 995
+ E T R P +F G + K
Sbjct: 240 CIFAELLNMLQSHINDPTNRFP---LFPGSSCFPLSPDRNSKKVHEK 283
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 2e-15
Identities = 58/231 (25%), Positives = 95/231 (41%), Gaps = 59/231 (25%)
Query: 776 LIGRGSFGSVYIARLQNGIEV-AVKTFDLQHERAFKSFDTEC-----EVMKSIRHRNLTK 829
L+G+G+FG V + R + A+K L+ E + V+++ RH LT
Sbjct: 12 LLGKGTFGKVILVREKATGRYYAMKI--LRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 69
Query: 830 IISSCSNEDFKALILEYMRNGSL-----------EK--CLYSGNYILDIFQRLNIMIDVA 876
+ + D ++EY G L E+ Y ++
Sbjct: 70 LKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGA--------------EIV 115
Query: 877 SALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTL-ATL 935
SALEYLH S V++ D+K N++LD + ++DFG+ K I + + +T T
Sbjct: 116 SALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT---MKTFCGTP 169
Query: 936 GYMAPE------YGREGRVSTKGDVYSFGILLMETFTRRKP-----TDEIF 975
Y+APE YGR V D + G+++ E R P + +F
Sbjct: 170 EYLAPEVLEDNDYGRA--V----DWWGLGVVMYEMMCGRLPFYNQDHERLF 214
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 2e-15
Identities = 40/209 (19%), Positives = 75/209 (35%), Gaps = 15/209 (7%)
Query: 458 IGNLANLVTLDLGGNKFNGSIPIALGKLQKLQLLNLDDNKLEGSIPDDICGLVELYKLAL 517
LAN V +LG + +L +Q N D++ ++ S+ + L +L L
Sbjct: 15 DPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ-SL-AGMQFFTNLKELHL 70
Query: 518 GDNKLSGQIPACFGNLASLRELWLGPNELISFIPSTFWNIKDIMYVNFSSNFLTGPLPLE 577
N++S + +L L EL + N L + + + +N L L
Sbjct: 71 SHNQIS-DLSP-LKDLTKLEELSVNRNRLKNLNGIPSACLSRL---FLDNNELRDTDSLI 125
Query: 578 IENLKALTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQGSIPDSVGDLISLKSLNL 637
+LK L L N L ++ +G L L+ L L N + + + L + ++L
Sbjct: 126 --HLKNLEILSIRNNKLKSIVM--LGFLSKLEVLDLHGNEI--TNTGGLTRLKKVNWIDL 179
Query: 638 SNNNLSGPIPTSLEKLSDLKELNLSFNKL 666
+ +L + +
Sbjct: 180 TGQKCVNEPVKYQPELYITNTVKDPDGRW 208
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 1e-13
Identities = 47/280 (16%), Positives = 93/280 (33%), Gaps = 68/280 (24%)
Query: 123 KLLLHNNFLTGTIPFSIFKLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQLSG 182
+ + + P L++ + L ++T + LS +Q + ++ +
Sbjct: 1 ESIQRPTPINQVFPDP--GLANAVKQNLGKQSVTDLVS---QKELSGVQNFNGDNSNIQ- 54
Query: 183 SIPSFIFKISSLQALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGGISSTLSNCKH 242
S+ + + ++L+ LH +N++S ++ S L +
Sbjct: 55 SL-AGMQFFTNLKELHLSHNQIS-----DL----------------------SPLKDLTK 86
Query: 243 LRILDLSFNDLWGDIPKEIGNLTKLKELFLDFNILQGEIPHTVGNLHNLEYLSLVNNELV 302
L L ++ N L ++ L LFLD N L+ ++ +L NLE LS+ NN+L
Sbjct: 87 LEELSVNRNRL-KNL--NGIPSACLSRLFLDNNELRD--TDSLIHLKNLEILSIRNNKLK 141
Query: 303 GTVPATIFNVSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSGTLPSFIFNAS 362
++ L L LE L L GN + +
Sbjct: 142 -------------SIVMLGF--------------LSKLEVLDLHGNEITN--TGGLTRLK 172
Query: 363 NLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNYLTSPE 402
++ + L L ++ + SP
Sbjct: 173 KVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRWISPY 212
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 4e-12
Identities = 39/284 (13%), Positives = 80/284 (28%), Gaps = 69/284 (24%)
Query: 384 NLRNLKRLRLYNNYLTSPELSFLSSLSNCKYLEIIALSGNPLNGIIPMSAGNLSHSLEEL 443
L N + L +T L S ++ + + +
Sbjct: 17 GLANAVKQNLGKQSVTD-----LVSQKELSGVQNFNGDNSNIQSLAG------------- 58
Query: 444 FMPDCNVSGRIPKEIGNLANLVTLDLGGNKFNGSIPIALGKLQKLQLLNLDDNKLEGSIP 503
+ NL L L N+ + + L L KL+ L+++ N+L+
Sbjct: 59 --------------MQFFTNLKELHLSHNQIS-DLS-PLKDLTKLEELSVNRNRLKNLNG 102
Query: 504 DDICGLVELYKLALGDNKLSGQIPACFGNLASLRELWLGPNELISFIPSTFWNIKDIMYV 563
L L+ L +N+L +L +L L + N +K I+
Sbjct: 103 IPSACLSRLF---LDNNELRDTDS--LIHLKNLEILSIRNN-----------KLKSIV-- 144
Query: 564 NFSSNFLTGPLPLEIENLKALTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQGSIP 623
+ L L LD N ++ + LK + ++ L +
Sbjct: 145 -------------MLGFLSKLEVLDLHGNEITNTGG--LTRLKKVNWIDLTGQKCVNEPV 189
Query: 624 DSVGDLISLKSLNLSNNNLSGPIPTSLEKLSDLKELNLSFNKLE 667
+L ++ + P + + + +
Sbjct: 190 KYQPELYITNTVKDPDGRWISPY--YISNGGSYVDGCVLWELPV 231
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 6e-12
Identities = 49/264 (18%), Positives = 84/264 (31%), Gaps = 68/264 (25%)
Query: 235 STLSNCKHLRILDLSFNDLWGDIPKEIGNLTKLKELFLDFNILQGEIPHTVGNLHNLEYL 294
+ +L + D+ L+ ++ D + +Q + + NL+ L
Sbjct: 13 FPDPGLANAVKQNLGKQSV-TDL-VSQKELSGVQNFNGDNSNIQ-SLAG-MQFFTNLKEL 68
Query: 295 SLVNNELVGTVPATIFNVSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSGTL 354
L +N+ I ++S LK L LEEL + N
Sbjct: 69 HLSHNQ--------ISDLSPLK-------------------DLTKLEELSVNRNR----- 96
Query: 355 PSFIFNASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNYLTSPELSFLSSLSNCKY 414
+ N + + L RL L NN L SL + K
Sbjct: 97 ---LKNLNGIPSA-------------------CLSRLFLDNNELRD-----TDSLIHLKN 129
Query: 415 LEIIALSGNPLNGIIPMSAGNLSHSLEELFMPDCNVSGRIPKEIGNLANLVTLDLGGNKF 474
LEI+++ N L I+ + LS LE L + ++ + L + +DL G K
Sbjct: 130 LEILSIRNNKLKSIVMLG--FLS-KLEVLDLHGNEITN--TGGLTRLKKVNWIDLTGQKC 184
Query: 475 NGSIPIALGKLQKLQLLNLDDNKL 498
+L + D +
Sbjct: 185 VNEPVKYQPELYITNTVKDPDGRW 208
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 2e-11
Identities = 45/262 (17%), Positives = 87/262 (33%), Gaps = 47/262 (17%)
Query: 64 VTCDINQRRVTALNISYLSLTGNIPRQLGNLSSLEILDLNFNRLSGEIPWELGNLAKLEK 123
V D N+ S+T + LS ++ + + + + + + L++
Sbjct: 12 VFPDPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKE 67
Query: 124 LLLHNNFLTGTIPFSIFKLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQL--LDLSDNQLS 181
L L +N ++ P L+ L +L ++ N L NL + S L L L +N+L
Sbjct: 68 LHLSHNQISDLSPLK--DLTKLEELSVNRNRLK------NLNGIPSACLSRLFLDNNELR 119
Query: 182 GSIPSFIFKISSLQALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGGISSTLSNCK 241
+ + +L+ L NN+L +I L
Sbjct: 120 D--TDSLIHLKNLEILSIRNNKLK-----SI----------------------VMLGFLS 150
Query: 242 HLRILDLSFNDLWGDIPKEIGNLTKLKELFLDFNILQGEIPHTVGNLHNLEYLSLVNNEL 301
L +LDL N++ + + L K+ + L E L+ + +
Sbjct: 151 KLEVLDLHGNEI-TNT-GGLTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRW 208
Query: 302 VGTVPATIFNVSTLKLIELSNN 323
+ P I N + +
Sbjct: 209 I--SPYYISNGGSYVDGCVLWE 228
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 2e-15
Identities = 59/233 (25%), Positives = 100/233 (42%), Gaps = 61/233 (26%)
Query: 776 LIGRGSFGSVYIARLQNGIEV----AVKTFDLQHERAFKSFDTECE--VMKSIRHRNLTK 829
++G+GSFG V++ + +G + A+K + T+ E ++ + H + K
Sbjct: 31 VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVK 90
Query: 830 IISSCSNEDFKALILEYMRNGSL-----------EK--CLYSGNYILDIFQRLNIMIDVA 876
+ + E LIL+++R G L E+ Y ++A
Sbjct: 91 LHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA--------------ELA 136
Query: 877 SALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAH--LSDFGIAKLLIGEDQSMTQTQTL-A 933
AL++LH S +I+ DLKP N+LLD+ H L+DFG++K I ++ +
Sbjct: 137 LALDHLH---SLGIIYRDLKPENILLDEE--GHIKLTDFGLSKESIDHEKK---AYSFCG 188
Query: 934 TLGYMAPE------YGREGRVSTKGDVYSFGILLMETFTRRKP-----TDEIF 975
T+ YMAPE + + D +SFG+L+ E T P E
Sbjct: 189 TVEYMAPEVVNRRGHTQS--A----DWWSFGVLMFEMLTGTLPFQGKDRKETM 235
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 76.8 bits (190), Expect = 4e-15
Identities = 55/235 (23%), Positives = 93/235 (39%), Gaps = 63/235 (26%)
Query: 776 LIGRGSFGSVYIARLQNG--------IEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNL 827
++G+G +G V+ R G ++V K +++ + E +++ ++H +
Sbjct: 24 VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 828 TKIISSCSNEDFKALILEYMRNGSL-----------EK--CLYSGNYILDIFQRLNIMID 874
+I + LILEY+ G L E C Y +
Sbjct: 84 VDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLA--------------E 129
Query: 875 VASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAH--LSDFGIAKLLIGEDQSMTQTQTL 932
++ AL +LH +I+ DLKP N++L+ H L+DFG+ K I + T T
Sbjct: 130 ISMALGHLH---QKGIIYRDLKPENIMLNHQ--GHVKLTDFGLCKESIHDGTV---THTF 181
Query: 933 A-TLGYMAPE------YGREGRVSTKGDVYSFGILLMETFTRRKP-----TDEIF 975
T+ YMAPE + R V D +S G L+ + T P +
Sbjct: 182 CGTIEYMAPEILMRSGHNRA--V----DWWSLGALMYDMLTGAPPFTGENRKKTI 230
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 78.6 bits (193), Expect = 5e-15
Identities = 47/218 (21%), Positives = 77/218 (35%), Gaps = 20/218 (9%)
Query: 455 PKEIGNLANLVTLDLGGNKFNGSIPIALGKLQKLQLLNLDDNKLEGSIPDDICGLVELYK 514
++ L +L K + L ++LQ L ++ +I I + L
Sbjct: 342 CRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTI---ILLMRALDP 397
Query: 515 LALGDNKLSGQIPACFGNLASLRELWLGP-----NELISFIPSTFWNIKDIMYVNFSSNF 569
L L F L ++ + ++ + D+ ++ +
Sbjct: 398 LLYEKETLQY-----FSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKD 452
Query: 570 LTGPLPLEIENLKALTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQGSIPDSVGDL 629
LT LE L +T LD S N L +P + L+ L+ L N L+ ++ V +L
Sbjct: 453 LTVLCHLE--QLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVDG-VANL 507
Query: 630 ISLKSLNLSNNNLSG-PIPTSLEKLSDLKELNLSFNKL 666
L+ L L NN L L L LNL N L
Sbjct: 508 PRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSL 545
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 76.3 bits (187), Expect = 2e-14
Identities = 37/153 (24%), Positives = 62/153 (40%), Gaps = 9/153 (5%)
Query: 42 DPTNFFAKNWLTNSTMVCNWTGVTCDINQRRVTALNISYLSLTGNIPRQLGNLSSLEILD 101
DP + L + ++ N + V L++++ LT + L L + LD
Sbjct: 415 DPMRAAYLDDLRSKFLLENSV---LKMEYADVRVLHLAHKDLT-VLC-HLEQLLLVTHLD 469
Query: 102 LNFNRLSGEIPWELGNLAKLEKLLLHNNFLTGTIPFSIFKLSSLLDLKLSDNNLTGTIPS 161
L+ NRL +P L L LE L +N L + + L L +L L +N L +
Sbjct: 470 LSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQQSAAI 526
Query: 162 HNLGNLSSLQLLDLSDNQLSGSIPSFIFKISSL 194
L + L LL+L N L +++ +
Sbjct: 527 QPLVSCPRLVLLNLQGNSLC-QEEGIQERLAEM 558
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 74.8 bits (183), Expect = 8e-14
Identities = 35/189 (18%), Positives = 69/189 (36%), Gaps = 9/189 (4%)
Query: 479 PIALGKLQKLQLLNLDDNKLEGSIPDDICGLVELYKLALGDNKLSGQIPACFGNLASLRE 538
++L L K + ++ EL +L + I + +L
Sbjct: 342 CRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILL---MRALDP 397
Query: 539 LWLGPNELISFIPSTFWNIKDIMYVNFSSNFLTGPLPLEIENLKALTTLDFSMNNLSGVI 598
L L F + Y++ + + + L + +L+ +
Sbjct: 398 LLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLTVLC 457
Query: 599 PTTIGGLKGLQYLFLGHNRLQGSIPDSVGDLISLKSLNLSNNNLSGPIPTSLEKLSDLKE 658
+ L + +L L HNRL+ ++P ++ L L+ L S+N L + + L L+E
Sbjct: 458 H--LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQE 512
Query: 659 LNLSFNKLE 667
L L N+L+
Sbjct: 513 LLLCNNRLQ 521
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 72.9 bits (178), Expect = 3e-13
Identities = 59/340 (17%), Positives = 98/340 (28%), Gaps = 15/340 (4%)
Query: 327 GSLPSSTDVQLPNLEELYLWGNNFSGTLPSFIFNASNLSKLSLGDNSFSGLI-PNTFGNL 385
L + + + S + S + L L + + T
Sbjct: 234 WLLGRAEPHDVLCCVHVSREEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGR 293
Query: 386 RNLKRLRLYNNYLTSPELSFLSSLSNCKYLEIIALSGNPLNGIIPMSAGNLSHSLEELFM 445
+ L + S + + L P S + E+LF
Sbjct: 294 NRPSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFR 353
Query: 446 PD--CNVSGRIPKEIGNLANLVTLDLGGNKFNGSIPIALGKLQKLQLLNLDDNKLEGSIP 503
+ S + E+ + L L+ +I + + L L
Sbjct: 354 CELSVEKSTVLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKA 413
Query: 504 DDICGLVELYKLALGDNKLSGQIPACFGNLASLRELWLGPNELISFIPSTFWNIKDIMYV 563
D L L +K + A +R L L +L + + ++
Sbjct: 414 VDPMRAAYLDDLR---SKFLLENSVLKMEYADVRVLHLAHKDLTVLCHLE--QLLLVTHL 468
Query: 564 NFSSNFLTGPLPLEIENLKALTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQG-SI 622
+ S N L LP + L+ L L S N L V + L LQ L L +NRLQ +
Sbjct: 469 DLSHNRLRA-LPPALAALRCLEVLQASDNALENVDG--VANLPRLQELLLCNNRLQQSAA 525
Query: 623 PDSVGDLISLKSLNLSNNNLSGP---IPTSLEKLSDLKEL 659
+ L LNL N+L E L + +
Sbjct: 526 IQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 565
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 69.0 bits (168), Expect = 4e-12
Identities = 58/352 (16%), Positives = 101/352 (28%), Gaps = 30/352 (8%)
Query: 11 LIHSLIIAASANTSIDIDQDALLALKDHITYDPTNFFAKNWLTNSTMVCNWTGVTCDINQ 70
L+ + + S LL + ++ S +
Sbjct: 214 LVQNAFFTDPNDQSAWFYHRWLLGRAEPHDVLCCVHVSREEACLSV-CFSRPLTVGSRMG 272
Query: 71 RRVTALNISYLSLTGNIPRQLGNLSSLEILDLNFNRLSGEIPWELGNLAKLEKLLLHNNF 130
+ ++ + LS+ P S + + DL L+ ++P +
Sbjct: 273 TLLLMVDEAPLSVEWRTPDGRNRPSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECV 332
Query: 131 L----TGTIPFSIFKLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQLSGSIPS 186
L L +LS T L + LQ L+ + +I
Sbjct: 333 LLKDRPECWCRDSATDEQLFRCELSVEKSTVL--QSELESCKELQELEPENKWCLLTIIL 390
Query: 187 FIFKISSLQALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGGISSTLSNCKHLRIL 246
+ + L S + + S F S +R+L
Sbjct: 391 LMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRS----KFLLENSVLKMEYADVRVL 446
Query: 247 DLSFNDLWGDIPKEIGNLTKLKELFLDFNILQGEIPHTVGNLHNLEYLSLVNNELVGTVP 306
L+ DL + + L + L L N L+ +P + L LE L +N L
Sbjct: 447 HLAHKDL--TVLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE---- 499
Query: 307 ATIFNVSTLKLIE---LSNNTFFGSLPSSTDV----QLPNLEELYLWGNNFS 351
+ V+ L ++ L NN L S + P L L L GN+
Sbjct: 500 -NVDGVANLPRLQELLLCNN----RLQQSAAIQPLVSCPRLVLLNLQGNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 42.4 bits (99), Expect = 7e-04
Identities = 17/78 (21%), Positives = 24/78 (30%), Gaps = 4/78 (5%)
Query: 77 NISYLSLTGNIPRQL---GNLSSLEILDLNFNRLSG-EIPWELGNLAKLEKLLLHNNFLT 132
+ L + N + NL L+ L L NRL L + +L L L N L
Sbjct: 487 CLEVLQASDNALENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC 546
Query: 133 GTIPFSIFKLSSLLDLKL 150
L +
Sbjct: 547 QEEGIQERLAEMLPSVSS 564
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 5e-15
Identities = 53/204 (25%), Positives = 89/204 (43%), Gaps = 37/204 (18%)
Query: 776 LIGRGSFGSVYIARL-QNGIEVAVKTFDLQHERAFKSFD---TECEVMKSIRHRNLTKII 831
+G GSFG V + + ++G A+K D Q K + E +++++ L K+
Sbjct: 48 TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 832 SSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMI------DVASALEYLHFG 885
S + +++EY+ G + L R + + EYLH
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEM-------FSHLRRIGRFSEPHARFYAAQIVLTFEYLH-- 158
Query: 886 YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTL-ATLGYMAPEYGR 944
S +I+ DLKP N+L+D ++DFG AK + G +T TL T +APE
Sbjct: 159 -SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------RTWTLCGTPEALAPEI-- 209
Query: 945 EGRVSTKG-----DVYSFGILLME 963
+ +KG D ++ G+L+ E
Sbjct: 210 ---ILSKGYNKAVDWWALGVLIYE 230
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 6e-15
Identities = 55/257 (21%), Positives = 93/257 (36%), Gaps = 81/257 (31%)
Query: 777 IGRGSFGSVYIAR-LQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKII---- 831
+G GSFG V +++G A+K + E ++MK + H N+ K++
Sbjct: 15 LGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNR----ELDIMKVLDHVNIIKLVDYFY 70
Query: 832 ----------------------------------SSCSNEDFKALILEYMRNGSLEKCLY 857
+ S + +I+EY+ L+
Sbjct: 71 TTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV-----PDTLH 125
Query: 858 --------SGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLD-DNMVA 908
SG I + + + A+ ++H S + H D+KP N+L++ +
Sbjct: 126 KVLKSFIRSGRSIPMNLISI-YIYQLFRAVGFIH---SLGICHRDIKPQNLLVNSKDNTL 181
Query: 909 HLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPE-------YGREGRVSTKGDVYSFGILL 961
L DFG AK LI + + + Y APE Y + D++S G +
Sbjct: 182 KLCDFGSAKKLI-PSEPS--VAYICSRFYRAPELMLGATEY------TPSIDLWSIGCVF 232
Query: 962 METFTRRKPTDEIFSGE 978
E KP +FSGE
Sbjct: 233 GELIL-GKP---LFSGE 245
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 6e-15
Identities = 34/140 (24%), Positives = 56/140 (40%), Gaps = 9/140 (6%)
Query: 290 NLEYLSLVNNELVGTVPATIF-NVSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGN 348
L L NNE IF + L+ I SNN + + E+ L N
Sbjct: 33 YTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKI-TDIEEGAFEGASGVNEILLTSN 91
Query: 349 NFSGTLPSFIF-NASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNYLTS-PELSFL 406
+ +F +L L L N + + ++F L +++ L LY+N +T+ +F
Sbjct: 92 RLE-NVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAF- 149
Query: 407 SSLSNCKYLEIIALSGNPLN 426
+L + L + L NP N
Sbjct: 150 DTLHS---LSTLNLLANPFN 166
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 5e-14
Identities = 34/154 (22%), Positives = 59/154 (38%), Gaps = 27/154 (17%)
Query: 489 QLLNLDDNKLEGSIPDDI-CGLVELYKLALGDNKLSGQIPACFGNLASLRELWLGPNELI 547
L L++N+ I L +L K+ +NK++ F + + E+ L N L
Sbjct: 35 AELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLE 94
Query: 548 SFIPSTFWNIKDIMYVNFSSNFLTGPLPLEIENLKALTTLDFSMNNLSGVIPTTIGGLKG 607
+ F + L++L TL N ++ V + GL
Sbjct: 95 NVQHKMF------------------------KGLESLKTLMLRSNRITCVGNDSFIGLSS 130
Query: 608 LQYLFLGHNRLQGSIPDSVGD-LISLKSLNLSNN 640
++ L L N++ ++ D L SL +LNL N
Sbjct: 131 VRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 7e-13
Identities = 35/166 (21%), Positives = 60/166 (36%), Gaps = 29/166 (17%)
Query: 501 SIPDDICGLVELYKLALGDNKLSGQIP-ACFGNLASLRELWLGPNELISFIPSTFWNIKD 559
IP+ I +L L +N+ + F L LR++ N++ F
Sbjct: 25 KIPEHI--PQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAF----- 77
Query: 560 IMYVNFSSNFLTGPLPLEIENLKALTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQ 619
E + + + N L V GL+ L+ L L NR+
Sbjct: 78 -------------------EGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRIT 118
Query: 620 GSIPDSVGD-LISLKSLNLSNNNLSGPIPTSLEKLSDLKELNLSFN 664
+ + L S++ L+L +N ++ P + + L L LNL N
Sbjct: 119 -CVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 5e-12
Identities = 33/131 (25%), Positives = 56/131 (42%), Gaps = 8/131 (6%)
Query: 122 EKLLLHNNFLTGTIPFSIF-KLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQL 180
+L L+NN T IF KL L + S+N +T I S + + L+ N+L
Sbjct: 35 AELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSNRL 93
Query: 181 SGSIPSFIF-KISSLQALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFY---GGISST 236
++ +F + SL+ L +NR++ + + L + S+Y N G T
Sbjct: 94 E-NVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDT 151
Query: 237 LSNCKHLRILD 247
L + L +L
Sbjct: 152 LHSLSTLNLLA 162
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 2e-11
Identities = 31/179 (17%), Positives = 58/179 (32%), Gaps = 55/179 (30%)
Query: 148 LKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQLSGSIPSFIF-KISSLQALHFGNNRLSG 206
L+L++N T + L L+ ++ S+N+++ I F S + + +NRL
Sbjct: 37 LRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSNRLE- 94
Query: 207 ELPANICDNLPFLNFFSVYKNMFYGGISSTLSNCKHLRILDLSFNDLWGDIPKEIGNLTK 266
+ + L
Sbjct: 95 NVQHKMFKGL------------------------------------------------ES 106
Query: 267 LKELFLDFNILQGEIPHTV-GNLHNLEYLSLVNNELVGTVPATIF-NVSTLKLIELSNN 323
LK L L N + + + L ++ LSL +N++ TV F + +L + L N
Sbjct: 107 LKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 3e-11
Identities = 25/95 (26%), Positives = 46/95 (48%), Gaps = 3/95 (3%)
Query: 580 NLKALTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQGSIPDSVGD-LISLKSLNLS 638
L L ++FS N ++ + G G+ + L NRL+ ++ + L SLK+L L
Sbjct: 55 KLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLR 113
Query: 639 NNNLSGPIPTSLEKLSDLKELNLSFNKLEGEIPRG 673
+N ++ S LS ++ L+L N++ + G
Sbjct: 114 SNRITCVGNDSFIGLSSVRLLSLYDNQIT-TVAPG 147
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 7e-11
Identities = 29/162 (17%), Positives = 53/162 (32%), Gaps = 33/162 (20%)
Query: 338 PNLEELYLWGNNFSGTLPSFIF-NASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNN 396
EL L N F+ + IF L K++ +N + + F + + L +N
Sbjct: 32 QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN 91
Query: 397 YLTSPELSFLSSLSNCKYLEIIALSGNPLNGIIPMSAGNLSHSLEELFMPDCNVSGRIPK 456
L + + L + L+ + L N + +
Sbjct: 92 RLENVQHKMFKGLES---LKTLMLRSNRIT--------------------------CVGN 122
Query: 457 EI-GNLANLVTLDLGGNKFNGSIPI-ALGKLQKLQLLNLDDN 496
+ L+++ L L N+ ++ A L L LNL N
Sbjct: 123 DSFIGLSSVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 4e-10
Identities = 36/186 (19%), Positives = 61/186 (32%), Gaps = 57/186 (30%)
Query: 362 SNLSKLSLGDNSFSGLIPN-TFGNLRNLKRLRLYNNYLTSPELSFLSSLSNCKYLEIIAL 420
++L L +N F+ L F L L+++ NN +T E S + L
Sbjct: 32 QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEI---LL 88
Query: 421 SGNPLNGIIPMSAGNLSHSLEE-LFMPDCNVSGRIPKEIGNLANLVTLDLGGNKFNGSIP 479
+ N L +++ +F L +L TL L N+ +
Sbjct: 89 TSNRL------------ENVQHKMF--------------KGLESLKTLMLRSNRIT-CVG 121
Query: 480 I-ALGKLQKLQLLNLDDNKLEGSIPDDICGLVELYKLALGDNKLSGQIPACFGNLASLRE 538
+ L ++LL+L DN++ ++ F L SL
Sbjct: 122 NDSFIGLSSVRLLSLYDNQIT-TVAPGA-----------------------FDTLHSLST 157
Query: 539 LWLGPN 544
L L N
Sbjct: 158 LNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 5e-10
Identities = 28/111 (25%), Positives = 47/111 (42%), Gaps = 10/111 (9%)
Query: 77 NISYLSLTGNIPRQL-----GNLSSLEILDLNFNRLSGEIPWEL-GNLAKLEKLLLHNNF 130
+ ++ + N + S + + L NRL + ++ L L+ L+L +N
Sbjct: 58 QLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNR 116
Query: 131 LTGTIPFSIF-KLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQL 180
+T + F LSS+ L L DN +T T+ L SL L+L N
Sbjct: 117 IT-CVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLANPF 165
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 3e-09
Identities = 17/91 (18%), Positives = 35/91 (38%), Gaps = 4/91 (4%)
Query: 585 TTLDFSMNNLSGVIPTTI-GGLKGLQYLFLGHNRLQGSIPDSVGD-LISLKSLNLSNNNL 642
L + N + + T I L L+ + +N++ I + + + + L++N L
Sbjct: 35 AELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSNRL 93
Query: 643 SGPIPTSLEKLSDLKELNLSFNKLEGEIPRG 673
+ L LK L L N++ +
Sbjct: 94 ENVQHKMFKGLESLKTLMLRSNRIT-CVGND 123
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 18/77 (23%), Positives = 30/77 (38%), Gaps = 8/77 (10%)
Query: 598 IPTTIGGLKGLQYLFLGHNRLQGSIPDSV-GDLISLKSLNLSNNNLSGPIPTSLEKLSDL 656
IP L L +N + L L+ +N SNN ++ + E S +
Sbjct: 30 IPQYT------AELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGV 83
Query: 657 KELNLSFNKLEGEIPRG 673
E+ L+ N+LE +
Sbjct: 84 NEILLTSNRLE-NVQHK 99
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 9e-15
Identities = 36/171 (21%), Positives = 62/171 (36%), Gaps = 48/171 (28%)
Query: 777 IGRGSFGSVYIAR-LQNGIEVAVKTFDLQHERAFKSFDTECEV---MKSIRHRNLTKII- 831
+G G G V + + A+K EV ++ + ++ +I+
Sbjct: 26 LGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRASQCPHIVRIVD 78
Query: 832 ---SSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRL--------------NIMID 874
+ + +++E + G L F R+ IM
Sbjct: 79 VYENLYAGRKCLLIVMECLDGGEL-------------FSRIQDRGDQAFTEREASEIMKS 125
Query: 875 VASALEYLHFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLIGE 922
+ A++YLH S + H D+KP N+L N + L+DFG AK GE
Sbjct: 126 IGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGE 173
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 2e-14
Identities = 61/215 (28%), Positives = 91/215 (42%), Gaps = 59/215 (27%)
Query: 776 LIGRGSFGSVYIARL-QNGIEVAVKTFDLQHERAFKSFDTEC-----EVMKSIRHRNLTK 829
+G GSFG V++ R NG A+K L+ E + E ++ + H + +
Sbjct: 13 TLGTGSFGRVHLIRSRHNGRYYAMKV--LKKEIVVRLKQVEHTNDERLMLSIVTHPFIIR 70
Query: 830 IISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMI------------DVAS 877
+ + + +I++Y+ G L F L +V
Sbjct: 71 MWGTFQDAQQIFMIMDYIEGGEL-------------FSLLRKSQRFPNPVAKFYAAEVCL 117
Query: 878 ALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAH--LSDFGIAKLLIGEDQSMTQTQTL-AT 934
ALEYLH S +I+ DLKP N+LLD N H ++DFG AK + T TL T
Sbjct: 118 ALEYLH---SKDIIYRDLKPENILLDKN--GHIKITDFGFAKYVP------DVTYTLCGT 166
Query: 935 LGYMAPE------YGREGRVSTKGDVYSFGILLME 963
Y+APE Y + + D +SFGIL+ E
Sbjct: 167 PDYIAPEVVSTKPYNKS--I----DWWSFGILIYE 195
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 2e-14
Identities = 66/300 (22%), Positives = 112/300 (37%), Gaps = 63/300 (21%)
Query: 777 IGRGSFGSVYIAR-LQNGIEVAVKTFDLQHER------AFKSFDTECEVMKSIRHRNLTK 829
+G G++G VY A VA+K L+HE A + E ++K ++HRN+ +
Sbjct: 42 LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIR----EVSLLKELQHRNIIE 97
Query: 830 IISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAP 889
+ S + LI EY L+K + N + + + + + + + + H S
Sbjct: 98 LKSVIHHNHRLHLIFEYA-ENDLKKYMDK-NPDVSMRVIKSFLYQLINGVNFCH---SRR 152
Query: 890 VIHCDLKPSNVLLDDNMVAH-----LSDFGIAKLLIGEDQSMTQTQTLATLGYMAPE--Y 942
+H DLKP N+LL + + + DFG+A+ + T + TL Y PE
Sbjct: 153 CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQF--THEIITLWYRPPEILL 210
Query: 943 GREGRVSTKGDVYSFGILLMETFTRR--------------------KPTDEIFSGEMTLK 982
G ST D++S + E + P D + G L
Sbjct: 211 GSR-HYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALP 269
Query: 983 HWVNDFL---PISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKE 1039
W F ++ +++ A L +L P +RI+AK
Sbjct: 270 DWKQSFPKFRGKTLKRVLGALL--------------DDEGLDLLTAMLEMDPVKRISAKN 315
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 2e-14
Identities = 49/224 (21%), Positives = 93/224 (41%), Gaps = 54/224 (24%)
Query: 777 IGRGSFGSVYIAR-LQNGIEVAVKTFDL-QHERAFKSFDTECEVMKSIR-HRNLTKII-- 831
+GRG + V+ A + N +V VK + ++ + E ++++++R N+ +
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKR----EIKILENLRGGPNIITLADI 99
Query: 832 --SSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVAS-------ALEYL 882
S AL+ E++ N ++ ++Q L D+ AL+Y
Sbjct: 100 VKDPVSRTP--ALVFEHVNNTDFKQ----------LYQTLTDY-DIRFYMYEILKALDYC 146
Query: 883 HFGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPE 941
H S ++H D+KP NV++D ++ L D+G+A+ Q +A+ + PE
Sbjct: 147 H---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH-PGQEY--NVRVASRYFKGPE 200
Query: 942 -------YGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGE 978
Y D++S G +L R++P F G
Sbjct: 201 LLVDYQMY------DYSLDMWSLGCMLASMIFRKEP---FFHGH 235
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 3e-14
Identities = 66/234 (28%), Positives = 97/234 (41%), Gaps = 64/234 (27%)
Query: 776 LIGRGSFGSVYIARLQNGIEV-AVKTFDLQHERAFKSFDTECEVM------KSIRHRNLT 828
+IG+GSFG V +AR + AVK LQ + K + + + K+++H L
Sbjct: 45 VIGKGSFGKVLLARHKAEEVFYAVKV--LQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 102
Query: 829 KIISSCSNEDFKALILEYMRNGSL-----------EK--CLYSGNYILDIFQRLNIMIDV 875
+ S D +L+Y+ G L E Y+ ++
Sbjct: 103 GLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAA--------------EI 148
Query: 876 ASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAH--LSDFGIAKLLIGEDQSMTQTQTL- 932
ASAL YLH S +++ DLKP N+LLD H L+DFG+ K I + + T T
Sbjct: 149 ASALGYLH---SLNIVYRDLKPENILLDSQ--GHIVLTDFGLCKENIEHNST---TSTFC 200
Query: 933 ATLGYMAPE------YGREGRVSTKGDVYSFGILLMETFTRRKP-----TDEIF 975
T Y+APE Y R V D + G +L E P T E++
Sbjct: 201 GTPEYLAPEVLHKQPYDRT--V----DWWCLGAVLYEMLYGLPPFYSRNTAEMY 248
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 75.8 bits (186), Expect = 4e-14
Identities = 61/232 (26%), Positives = 98/232 (42%), Gaps = 60/232 (25%)
Query: 776 LIGRGSFGSVYIARLQNGIEV-AVKTFDLQHERAFKSFDTECEVM------KSIRHRNLT 828
++G+GSFG V ++ + E+ AVK L+ + + D EC ++ + LT
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKI--LKKDVVIQDDDVECTMVEKRVLALPGKPPFLT 405
Query: 829 KIISSCSNEDFKALILEYMRNGSL-----------EK--CLYSGNYILDIFQRLNIMIDV 875
++ S D ++EY+ G L E Y+ ++
Sbjct: 406 QLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAA--------------EI 451
Query: 876 ASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLA-T 934
A L +L S +I+ DLK NV+LD ++DFG+ K I + T+T T
Sbjct: 452 AIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV---TTKTFCGT 505
Query: 935 LGYMAPE------YGREGRVSTKGDVYSFGILLMETFTRRKP-----TDEIF 975
Y+APE YG+ V D ++FG+LL E + P DE+F
Sbjct: 506 PDYIAPEIIAYQPYGKS--V----DWWAFGVLLYEMLAGQAPFEGEDEDELF 551
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 4e-14
Identities = 56/218 (25%), Positives = 95/218 (43%), Gaps = 54/218 (24%)
Query: 776 LIGRGSFGSVYIARLQNGIEV----AVKTFD----LQHERAFKSFDTECEVMKSIRHRN- 826
++G G++G V++ R +G + A+K +Q + + TE +V++ IR
Sbjct: 61 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 120
Query: 827 LTKIISSCSNEDFKALILEYMRNGSL-----------EK--CLYSGNYILDIFQRLNIMI 873
L + + E LIL+Y+ G L E +Y G
Sbjct: 121 LVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVG-------------- 166
Query: 874 DVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAH--LSDFGIAKLLIGEDQSMTQTQT 931
++ ALE+LH +I+ D+K N+LLD N H L+DFG++K + ++
Sbjct: 167 EIVLALEHLH---KLGIIYRDIKLENILLDSN--GHVVLTDFGLSKEFVADETERAYD-F 220
Query: 932 LATLGYMAPE------YGREGRVSTKGDVYSFGILLME 963
T+ YMAP+ G + V D +S G+L+ E
Sbjct: 221 CGTIEYMAPDIVRGGDSGHDKAV----DWWSLGVLMYE 254
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 9e-14
Identities = 62/232 (26%), Positives = 96/232 (41%), Gaps = 60/232 (25%)
Query: 776 LIGRGSFGSVYIARLQNGIEV-AVKTFDLQHERAFKSFDTECEVM------KSIRHRNLT 828
++G+GSFG V +AR++ ++ AVK L+ + + D EC + + H LT
Sbjct: 30 VLGKGSFGKVMLARVKETGDLYAVKV--LKKDVILQDDDVECTMTEKRILSLARNHPFLT 87
Query: 829 KIISSCSNEDFKALILEYMRNGSL-----------EK--CLYSGNYILDIFQRLNIMIDV 875
++ D ++E++ G L E Y+ ++
Sbjct: 88 QLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAA--------------EI 133
Query: 876 ASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTL-AT 934
SAL +LH +I+ DLK NVLLD L+DFG+ K I + T T T
Sbjct: 134 ISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT---TATFCGT 187
Query: 935 LGYMAPE------YGREGRVSTKGDVYSFGILLMETFTRRKP-----TDEIF 975
Y+APE YG V D ++ G+LL E P D++F
Sbjct: 188 PDYIAPEILQEMLYGPA--V----DWWAMGVLLYEMLCGHAPFEAENEDDLF 233
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 71.8 bits (177), Expect = 1e-13
Identities = 51/216 (23%), Positives = 90/216 (41%), Gaps = 36/216 (16%)
Query: 775 NLIGRGSFGSVYIAR-LQNGIEVAVKTFDLQHERAFKSFDTECEV-------------MK 820
IG G++G+VY AR +G VA+K+ + + + ++
Sbjct: 15 AEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGG-----GGGGGLPISTVREVALLRRLE 69
Query: 821 SIRHRN---LTKIISSCSNEDFKA--LILEYMRNGSLEKCLYSGNYI-LDIFQRLNIMID 874
+ H N L + ++ + L+ E++ + L L L ++M
Sbjct: 70 AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLMRQ 128
Query: 875 VASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLAT 934
L++LH + ++H DLKP N+L+ L+DFG+A++ M T + T
Sbjct: 129 FLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIY---SYQMALTPVVVT 182
Query: 935 LGYMAPE--YGREGRVSTKGDVYSFGILLMETFTRR 968
L Y APE +T D++S G + E F R+
Sbjct: 183 LWYRAPEVLLQS--TYATPVDMWSVGCIFAEMFRRK 216
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 71.7 bits (175), Expect = 2e-13
Identities = 26/91 (28%), Positives = 36/91 (39%), Gaps = 5/91 (5%)
Query: 337 LPNLEELYLWGNNFSGTLPSFIF-NASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYN 395
NL ELY+ L L L++ + + P+ F L RL L
Sbjct: 30 AENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89
Query: 396 NYLTSPELSFLSSLSNCKYLEIIALSGNPLN 426
N L S + LS L+ + LSGNPL+
Sbjct: 90 NALESLSWKTVQGLS----LQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 68.2 bits (166), Expect = 3e-12
Identities = 22/132 (16%), Positives = 36/132 (27%), Gaps = 28/132 (21%)
Query: 74 TALNISYLSLTGNIPRQLGNLSSLEILDLNFNRLSGEIPWE-LGNLAKLEKLLLHNNFLT 132
+ L + + L +L L + + + L L +L L + + L
Sbjct: 11 SGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR 69
Query: 133 GTIPFSIFKLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQLSGSIPSFIFKIS 192
+ L L+LS N L S+ +
Sbjct: 70 -------------------------FVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGL 103
Query: 193 SLQALHFGNNRL 204
SLQ L N L
Sbjct: 104 SLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 58.6 bits (141), Expect = 4e-09
Identities = 16/96 (16%), Positives = 31/96 (32%), Gaps = 3/96 (3%)
Query: 280 EIPHTVGNLHNLEYLSLVNNELVGTVPATIF-NVSTLKLIELSNNTFFGSLPSSTDVQLP 338
+ H + NL L + N + + + + L+ + + + + P
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSG-LRFVAPDAFHFTP 80
Query: 339 NLEELYLWGNNFSGTLPSFIFNASNLSKLSLGDNSF 374
L L L N +L +L +L L N
Sbjct: 81 RLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 58.6 bits (141), Expect = 5e-09
Identities = 26/93 (27%), Positives = 39/93 (41%), Gaps = 2/93 (2%)
Query: 575 PLEIENLKALTTLDFSMNNLSGVIPT-TIGGLKGLQYLFLGHNRLQGSIPDSVGDLISLK 633
+ + LT L + + GL L+ L + + L+ PD+ L
Sbjct: 24 LHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLS 83
Query: 634 SLNLSNNNLSGPIPTSLEKLSDLKELNLSFNKL 666
LNLS N L +++ LS L+EL LS N L
Sbjct: 84 RLNLSFNALESLSWKTVQGLS-LQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 58.2 bits (140), Expect = 5e-09
Identities = 14/85 (16%), Positives = 26/85 (30%), Gaps = 3/85 (3%)
Query: 134 TIPFSIFKLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQLSGSIPSFIF-KIS 192
+ +L +L + + + +L L L+ L + + L + F
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTP 80
Query: 193 SLQALHFGNNRLSGELPANICDNLP 217
L L+ N L L L
Sbjct: 81 RLSRLNLSFNALE-SLSWKTVQGLS 104
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 55.1 bits (132), Expect = 5e-08
Identities = 22/124 (17%), Positives = 34/124 (27%), Gaps = 26/124 (20%)
Query: 520 NKLSGQIPACFGNLASLRELWLGPNELISFIPS-TFWNIKDIMYVNFSSNFLTGPLPLEI 578
+ +L EL++ + + +
Sbjct: 17 RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDL------------------------ 52
Query: 579 ENLKALTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQGSIPDSVGDLISLKSLNLS 638
L L L + L V P L L L N L+ S+ +SL+ L LS
Sbjct: 53 RGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLS 111
Query: 639 NNNL 642
N L
Sbjct: 112 GNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 54.7 bits (131), Expect = 6e-08
Identities = 22/96 (22%), Positives = 33/96 (34%), Gaps = 4/96 (4%)
Query: 453 RIPKEIGNLANLVTLDLGGNKFNGSIP-IALGKLQKLQLLNLDDNKLEGSIPDDI-CGLV 510
+ NL L + + + L L +L+ L + + L + D
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTP 80
Query: 511 ELYKLALGDNKLSGQIPACFGNLASLRELWLGPNEL 546
L +L L N L L SL+EL L N L
Sbjct: 81 RLSRLNLSFNALESLSWKTVQGL-SLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 54.7 bits (131), Expect = 7e-08
Identities = 17/92 (18%), Positives = 33/92 (35%), Gaps = 2/92 (2%)
Query: 235 STLSNCKHLRILDLSFNDLWGDIPKE-IGNLTKLKELFLDFNILQGEIPHTVGNLHNLEY 293
L ++L L + + + L +L+ L + + L+ P L
Sbjct: 25 HHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSR 84
Query: 294 LSLVNNELVGTVPATIFNVSTLKLIELSNNTF 325
L+L N L ++ +L+ + LS N
Sbjct: 85 LNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 53.6 bits (128), Expect = 1e-07
Identities = 19/87 (21%), Positives = 35/87 (40%), Gaps = 9/87 (10%)
Query: 77 NISYLSLTGN-----IPRQ-LGNLSSLEILDLNFNRLSGEIPWE-LGNLAKLEKLLLHNN 129
N++ L + + + L L L L + + L + + +L +L L N
Sbjct: 32 NLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTPRLSRLNLSFN 90
Query: 130 FLTGTIPFSIFKLSSLLDLKLSDNNLT 156
L ++ + + SL +L LS N L
Sbjct: 91 ALE-SLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 48.6 bits (115), Expect = 7e-06
Identities = 22/96 (22%), Positives = 34/96 (35%), Gaps = 2/96 (2%)
Query: 477 SIPIALGKLQKLQLLNLDDNKLEGSIPD-DICGLVELYKLALGDNKLSGQIPACFGNLAS 535
L + L L +++ + + D+ GL EL L + + L P F
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81
Query: 536 LRELWLGPNELISFIPSTFWNIKDIMYVNFSSNFLT 571
L L L N L S T + + + S N L
Sbjct: 82 LSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 43.2 bits (101), Expect = 3e-04
Identities = 17/100 (17%), Positives = 30/100 (30%), Gaps = 8/100 (8%)
Query: 378 IPNTFGNLRNLKRLRLYNNYLTSPELSFL--SSLSNCKYLEIIALSGNPLNGIIPMSAGN 435
+ NL L + N L L L L + + + L + P +
Sbjct: 23 SLHHLPGAENLTELYIENQ----QHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHF 78
Query: 436 LSHSLEELFMPDCNVSGRIPKEIGNLANLVTLDLGGNKFN 475
L L + + + + +L L L GN +
Sbjct: 79 T-PRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 42.4 bits (99), Expect = 6e-04
Identities = 8/60 (13%), Positives = 17/60 (28%), Gaps = 2/60 (3%)
Query: 615 HNRLQGSIPDSVGDLISLKSLNLSNNNLSGPIPT-SLEKLSDLKELNLSFNKLEGEIPRG 673
+ +L L + N + L L +L+ L + + L +
Sbjct: 16 TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPD 74
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 3e-13
Identities = 56/229 (24%), Positives = 96/229 (41%), Gaps = 54/229 (23%)
Query: 776 LIGRGSFGSVYIARLQNGIEV-AVKTFDLQHERAFKSFDTECEVM-------KSIRHRNL 827
++G+GSFG V++A + + A+K L+ + D EC M + H L
Sbjct: 24 MLGKGSFGKVFLAEFKKTNQFFAIKA--LKKDVVLMDDDVEC-TMVEKRVLSLAWEHPFL 80
Query: 828 TKIISSCSNEDFKALILEYMRNGSL-----------EK--CLYSGNYILDIFQRLNIMID 874
T + + ++ ++EY+ G L Y+ +
Sbjct: 81 THMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAA--------------E 126
Query: 875 VASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAH--LSDFGIAKLLIGEDQSMTQTQTL 932
+ L++LH S +++ DLK N+LLD + H ++DFG+ K + D T T
Sbjct: 127 IILGLQFLH---SKGIVYRDLKLDNILLDKD--GHIKIADFGMCKENMLGDAK---TNTF 178
Query: 933 -ATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKP-----TDEIF 975
T Y+APE + + D +SFG+LL E + P +E+F
Sbjct: 179 CGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF 227
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 3e-13
Identities = 58/223 (26%), Positives = 88/223 (39%), Gaps = 57/223 (25%)
Query: 776 LIGRGSFGSVYIARLQNGIEV-AVKTFDLQHERAFKSFDTECEVM-------KSIRHRNL 827
+IGRGS+ V + RL+ + A+K ++ E D + V ++ H L
Sbjct: 16 VIGRGSYAKVLLVRLKKTDRIYAMKV--VKKELVNDDEDIDW-VQTEKHVFEQASNHPFL 72
Query: 828 TKIISSCSNEDFKALILEYMRNGSL-----------EK--CLYSGNYILDIFQRLNIMID 874
+ S E ++EY+ G L E+ YS +
Sbjct: 73 VGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA--------------E 118
Query: 875 VASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTL-A 933
++ AL YLH +I+ DLK NVLLD L+D+G+ K + T T
Sbjct: 119 ISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---TTSTFCG 172
Query: 934 TLGYMAPE------YGREGRVSTKGDVYSFGILLMETFTRRKP 970
T Y+APE YG V D ++ G+L+ E R P
Sbjct: 173 TPNYIAPEILRGEDYGFS--V----DWWALGVLMFEMMAGRSP 209
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 3e-13
Identities = 61/232 (26%), Positives = 98/232 (42%), Gaps = 60/232 (25%)
Query: 776 LIGRGSFGSVYIARLQNGIEV-AVKTFDLQHERAFKSFDTECEVM------KSIRHRNLT 828
++G+GSFG V ++ + E+ AVK L+ + + D EC ++ + LT
Sbjct: 27 VLGKGSFGKVMLSERKGTDELYAVKI--LKKDVVIQDDDVECTMVEKRVLALPGKPPFLT 84
Query: 829 KIISSCSNEDFKALILEYMRNGSL-----------EK--CLYSGNYILDIFQRLNIMIDV 875
++ S D ++EY+ G L E Y+ ++
Sbjct: 85 QLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAA--------------EI 130
Query: 876 ASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTL-AT 934
A L +L S +I+ DLK NV+LD ++DFG+ K I + T+T T
Sbjct: 131 AIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV---TTKTFCGT 184
Query: 935 LGYMAPE------YGREGRVSTKGDVYSFGILLMETFTRRKP-----TDEIF 975
Y+APE YG+ V D ++FG+LL E + P DE+F
Sbjct: 185 PDYIAPEIIAYQPYGKS--V----DWWAFGVLLYEMLAGQAPFEGEDEDELF 230
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 4e-13
Identities = 56/222 (25%), Positives = 87/222 (39%), Gaps = 55/222 (24%)
Query: 776 LIGRGSFGSVYIARLQNGIEV-AVKTFDLQHERAFKSFDTECEVM------KSIRHRNLT 828
+IGRGS+ V + RL+ + A++ ++ E D + ++ H L
Sbjct: 59 VIGRGSYAKVLLVRLKKTDRIYAMRV--VKKELVNDDEDIDWVQTEKHVFEQASNHPFLV 116
Query: 829 KIISSCSNEDFKALILEYMRNGSL-----------EK--CLYSGNYILDIFQRLNIMIDV 875
+ S E ++EY+ G L E+ YS ++
Sbjct: 117 GLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA--------------EI 162
Query: 876 ASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTL-AT 934
+ AL YLH +I+ DLK NVLLD L+D+G+ K + T T T
Sbjct: 163 SLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---TTSTFCGT 216
Query: 935 LGYMAPE------YGREGRVSTKGDVYSFGILLMETFTRRKP 970
Y+APE YG V D ++ G+L+ E R P
Sbjct: 217 PNYIAPEILRGEDYGFS--V----DWWALGVLMFEMMAGRSP 252
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 4e-13
Identities = 46/170 (27%), Positives = 76/170 (44%), Gaps = 20/170 (11%)
Query: 59 CNWTGVTCDINQRRVTALNISYLSLTGNIPRQLGNLSSLEILDLNFNRLSGEIPWELGNL 118
C+ T V C +R S+ IP ++ +IL L+ N+++ P +L
Sbjct: 19 CSGTTVDCR--SKRHA-------SVPAGIP------TNAQILYLHDNQITKLEPGVFDSL 63
Query: 119 AKLEKLLLHNNFLTGTIPFSIF-KLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSD 177
L++L L +N L +P +F L+ L L L N LT +PS L L+ L +
Sbjct: 64 INLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLT-VLPSAVFDRLVHLKELFMCC 121
Query: 178 NQLSGSIPSFIFKISSLQALHFGNNRLSGELPANICDNLPFLNFFSVYKN 227
N+L+ +P I +++ L L N+L +P D L L ++ N
Sbjct: 122 NKLT-ELPRGIERLTHLTHLALDQNQLKS-IPHGAFDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 5e-12
Identities = 45/172 (26%), Positives = 68/172 (39%), Gaps = 39/172 (22%)
Query: 257 IPKEIGNLTKLKELFLDFNILQGEIPHTVGNLHNLEYLSLVNNELVGTVPATIFNVSTLK 316
+P I + L+L N + P +L NL+ L L +N+L +P +F+
Sbjct: 34 VPAGIPTNAQ--ILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFD----- 85
Query: 317 LIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSGTLPSFIFNA-SNLSKLSLGDNSFS 375
L L L L N + LPS +F+ +L +L + N +
Sbjct: 86 -------------------SLTQLTVLDLGTNQLT-VLPSAVFDRLVHLKELFMCCNKLT 125
Query: 376 GLIPNTFGNLRNLKRLRLYNNYLTS-PELSF--LSSLSNCKYLEIIALSGNP 424
+P L +L L L N L S P +F LSSL++ L GNP
Sbjct: 126 E-LPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTH------AYLFGNP 170
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 2e-10
Identities = 40/151 (26%), Positives = 56/151 (37%), Gaps = 27/151 (17%)
Query: 467 LDLGGNKFNGSIPIALGKLQKLQLLNLDDNKLEGSIPDDIC-GLVELYKLALGDNKLSGQ 525
L L N+ P L L+ L L N+L ++P + L +L L LG N+L+
Sbjct: 45 LYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLTVL 103
Query: 526 IPACFGNLASLRELWLGPNELISFIPSTFWNIKDIMYVNFSSNFLTGPLPLEIENLKALT 585
A F L L+EL++ N+L LP IE L LT
Sbjct: 104 PSAVFDRLVHLKELFMCCNKLTE-------------------------LPRGIERLTHLT 138
Query: 586 TLDFSMNNLSGVIPTTIGGLKGLQYLFLGHN 616
L N L + L L + +L N
Sbjct: 139 HLALDQNQLKSIPHGAFDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 1e-09
Identities = 44/153 (28%), Positives = 59/153 (38%), Gaps = 27/153 (17%)
Query: 489 QLLNLDDNKLEGSIPDDICGLVELYKLALGDNKLSGQIPACFGNLASLRELWLGPNELIS 548
Q+L L DN++ P L+ L +L LG N+L F +L L L LG N+L
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTV 102
Query: 549 FIPSTFWNIKDIMYVNFSSNFLTGPLPLEIENLKALTTLDFSMNNLSGVIPTTIGGLKGL 608
+ F + L L L N L+ +P I L L
Sbjct: 103 LPSAVF------------------------DRLVHLKELFMCCNKLTE-LPRGIERLTHL 137
Query: 609 QYLFLGHNRLQGSIPDSVGD-LISLKSLNLSNN 640
+L L N+L+ SIP D L SL L N
Sbjct: 138 THLALDQNQLK-SIPHGAFDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 6e-09
Identities = 35/132 (26%), Positives = 59/132 (44%), Gaps = 3/132 (2%)
Query: 534 ASLRELWLGPNELISFIPSTFWNIKDIMYVNFSSNFLTGPLPLEI-ENLKALTTLDFSMN 592
+ + L+L N++ P F ++ ++ + SN L LP+ + ++L LT LD N
Sbjct: 40 TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGA-LPVGVFDSLTQLTVLDLGTN 98
Query: 593 NLSGVIPTTIGGLKGLQYLFLGHNRLQGSIPDSVGDLISLKSLNLSNNNLSGPIPTSLEK 652
L+ + L L+ LF+ N+L +P + L L L L N L + ++
Sbjct: 99 QLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDR 157
Query: 653 LSDLKELNLSFN 664
LS L L N
Sbjct: 158 LSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 7e-09
Identities = 35/111 (31%), Positives = 51/111 (45%), Gaps = 4/111 (3%)
Query: 564 NFSSNFLTGPLPLEIENLKALTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQGSIP 623
N +T P ++L L L N L + L L L LG N+L +P
Sbjct: 46 YLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLT-VLP 104
Query: 624 DSVGD-LISLKSLNLSNNNLSGPIPTSLEKLSDLKELNLSFNKLEGEIPRG 673
+V D L+ LK L + N L+ +P +E+L+ L L L N+L+ IP G
Sbjct: 105 SAVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQLKS-IPHG 153
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 8e-08
Identities = 38/157 (24%), Positives = 53/157 (33%), Gaps = 31/157 (19%)
Query: 341 EELYLWGNNFSGTLPSFIFNA-SNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNYLT 399
+ LYL N + L +F++ NL +L LG N L F +L L L L N LT
Sbjct: 43 QILYLHDNQIT-KLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLT 101
Query: 400 SPELSFLSSLSNCKYLEIIALSGNPLNGIIPMSAGNLSHSLEELFMPDCNVSGRIPKEIG 459
+ L + K L + N L +P+ I
Sbjct: 102 VLPSAVFDRLVHLKELF---MCCNKLT--------------------------ELPRGIE 132
Query: 460 NLANLVTLDLGGNKFNGSIPIALGKLQKLQLLNLDDN 496
L +L L L N+ A +L L L N
Sbjct: 133 RLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 7e-06
Identities = 33/111 (29%), Positives = 45/111 (40%), Gaps = 13/111 (11%)
Query: 77 NISYLSLTGN--------IPRQLGNLSSLEILDLNFNRLSGEIPWELGNLAKLEKLLLHN 128
N+ L L N + L L +LDL N+L+ L L++L +
Sbjct: 65 NLKELYLGSNQLGALPVGVFDSLTQL---TVLDLGTNQLTVLPSAVFDRLVHLKELFMCC 121
Query: 129 NFLTGTIPFSIFKLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQ 179
N LT +P I +L+ L L L N L +IP LSSL L N
Sbjct: 122 NKLT-ELPRGIERLTHLTHLALDQNQLK-SIPHGAFDRLSSLTHAYLFGNP 170
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 7e-13
Identities = 38/151 (25%), Positives = 67/151 (44%), Gaps = 19/151 (12%)
Query: 777 IGRGSFGSVYIAR-LQNGIEVAVKTFDLQHERA-FKSFDTECEVMKSIRH-RNLTKIISS 833
IG G+FG + + + L VA+K L+ ++ E K + + ++
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIK---LEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYF 73
Query: 834 CSNEDFKALILEYMRNG-SLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIH 892
+ A++LE + G SLE + + L I I + S +EY+H S +I+
Sbjct: 74 GPCGKYNAMVLELL--GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVH---SKNLIY 128
Query: 893 CDLKPSNVLL------DDNMVAHLSDFGIAK 917
D+KP N L+ ++ H+ DF +AK
Sbjct: 129 RDVKPENFLIGRPGNKTQQVI-HIIDFALAK 158
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 1e-12
Identities = 52/248 (20%), Positives = 99/248 (39%), Gaps = 68/248 (27%)
Query: 765 FQATNGFSENNLIGRGSFGSVYIAR-LQNGIEVAVK----TFDLQHE--RAFKSFDTECE 817
+ +G+G++G V+ + + G VAVK F + R F+ E
Sbjct: 5 RHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFR----EIM 60
Query: 818 VMKSIR-HRNLTKIISSCSNEDFKA--LILEYMRNGSLEKCLYSGN-------YILDIFQ 867
++ + H N+ +++ ++ + L+ +YM L + + Y+ ++Q
Sbjct: 61 ILTELSGHENIVNLLNVLRADNDRDVYLVFDYM-ETDLHAVIRANILEPVHKQYV--VYQ 117
Query: 868 RLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMT 927
+ ++YLH S ++H D+KPSN+LL+ ++DFG+++ + +
Sbjct: 118 LIK-------VIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTN 167
Query: 928 Q-------------------TQTLATLGYMAPE-------YGREGRVSTKG-DVYSFGIL 960
T +AT Y APE Y TKG D++S G +
Sbjct: 168 NIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKY-------TKGIDMWSLGCI 220
Query: 961 LMETFTRR 968
L E +
Sbjct: 221 LGEILCGK 228
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 1e-12
Identities = 54/215 (25%), Positives = 90/215 (41%), Gaps = 36/215 (16%)
Query: 775 NLIGRGSFGSVYIAR--LQNGIEVAVKTFDLQHER------AFKSFDTECEV-----MKS 821
IG G++G V+ AR G VA+K +Q + EV +++
Sbjct: 17 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR------EVAVLRHLET 70
Query: 822 IRHRN---LTKIISSCSNEDFKA--LILEYMRNGSLEKCLYS-GNYILDIFQRLNIMIDV 875
H N L + + + L+ E++ + L L + ++M +
Sbjct: 71 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQL 129
Query: 876 ASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATL 935
L++LH S V+H DLKP N+L+ + L+DFG+A++ M T + TL
Sbjct: 130 LRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVTL 183
Query: 936 GYMAPE--YGREGRVSTKGDVYSFGILLMETFTRR 968
Y APE +T D++S G + E F R+
Sbjct: 184 WYRAPEVLLQS--SYATPVDLWSVGCIFAEMFRRK 216
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 2e-12
Identities = 51/171 (29%), Positives = 77/171 (45%), Gaps = 21/171 (12%)
Query: 59 CNWTGVTCDINQRRVTALNISYLSLTGNIPRQLGNLSSLEILDLNFNRLSGEIPWELGNL 118
C+ T V C + T S+ IP + LDL N L L
Sbjct: 7 CSGTTVEC--YSQGRT-------SVPTGIP------AQTTYLDLETNSLKSLPNGVFDEL 51
Query: 119 AKLEKLLLHNNFLTGTIPFSIF-KLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSD 177
L +L L N L ++P +F KL+SL L LS N L ++P+ L+ L+ L L+
Sbjct: 52 TSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQLQ-SLPNGVFDKLTQLKELALNT 109
Query: 178 NQLSGSIPSFIF-KISSLQALHFGNNRLSGELPANICDNLPFLNFFSVYKN 227
NQL S+P +F K++ L+ L N+L +P + D L L + ++ N
Sbjct: 110 NQLQ-SLPDGVFDKLTQLKDLRLYQNQLKS-VPDGVFDRLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 7e-12
Identities = 49/172 (28%), Positives = 68/172 (39%), Gaps = 38/172 (22%)
Query: 257 IPKEIGNLTKLKELFLDFNILQGEIPHTVGNLHNLEYLSLVNNELVGTVPATIFNVSTLK 316
+P I T L L+ N L+ L +L L L N+L ++P +FN
Sbjct: 22 VPTGIPAQTT--YLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFN----- 73
Query: 317 LIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSGTLPSFIFNA-SNLSKLSLGDNSFS 375
+L +L L L N +LP+ +F+ + L +L+L N
Sbjct: 74 -------------------KLTSLTYLNLSTNQLQ-SLPNGVFDKLTQLKELALNTNQLQ 113
Query: 376 GLIPNTFGNLRNLKRLRLYNNYLTS-PELSF--LSSLSNCKYLEIIALSGNP 424
L F L LK LRLY N L S P+ F L+SL I L NP
Sbjct: 114 SLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQY------IWLHDNP 159
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 2e-08
Identities = 39/117 (33%), Positives = 57/117 (48%), Gaps = 5/117 (4%)
Query: 559 DIMYVNFSSNFLTGPLPLEIENLKALTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRL 618
Y++ +N L + L +LT L N L + L L YL L N+L
Sbjct: 29 QTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQL 88
Query: 619 QGSIPDSVGD-LISLKSLNLSNNNLSGPIPTSL-EKLSDLKELNLSFNKLEGEIPRG 673
Q S+P+ V D L LK L L+ N L +P + +KL+ LK+L L N+L+ +P G
Sbjct: 89 Q-SLPNGVFDKLTQLKELALNTNQLQS-LPDGVFDKLTQLKDLRLYQNQLKS-VPDG 142
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 4e-08
Identities = 46/171 (26%), Positives = 58/171 (33%), Gaps = 26/171 (15%)
Query: 447 DCNVSGRIPKEIGNLANLVTLDLGGNKFNGSIPIALGKLQKLQLLNLDDNKLEGSIPDDI 506
+C GR G A LDL N +L L L L NKL+ S+P+ +
Sbjct: 13 ECYSQGRTSVPTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGV 71
Query: 507 C-GLVELYKLALGDNKLSGQIPACFGNLASLRELWLGPNELISFIPSTFWNIKDIMYVNF 565
L L L L N+L F L L+EL L N+L S F
Sbjct: 72 FNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVF----------- 120
Query: 566 SSNFLTGPLPLEIENLKALTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHN 616
+ L L L N L V L LQY++L N
Sbjct: 121 -------------DKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 4e-08
Identities = 43/153 (28%), Positives = 58/153 (37%), Gaps = 26/153 (16%)
Query: 489 QLLNLDDNKLEGSIPDDICGLVELYKLALGDNKLSGQIPACFGNLASLRELWLGPNELIS 548
L+L+ N L+ L L +L LG NKL F L SL L L N+L S
Sbjct: 31 TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQS 90
Query: 549 FIPSTFWNIKDIMYVNFSSNFLTGPLPLEIENLKALTTLDFSMNNLSGVIPTTIGGLKGL 608
F + L L L + N L + L L
Sbjct: 91 LPNGVF------------------------DKLTQLKELALNTNQLQSLPDGVFDKLTQL 126
Query: 609 QYLFLGHNRLQGSIPDSVGD-LISLKSLNLSNN 640
+ L L N+L+ S+PD V D L SL+ + L +N
Sbjct: 127 KDLRLYQNQLK-SVPDGVFDRLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 3e-07
Identities = 46/180 (25%), Positives = 61/180 (33%), Gaps = 54/180 (30%)
Query: 366 KLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNYLTSPELSFLSSLSNCKYLEIIALSGNPL 425
L L NS L F L +L +L L N L S + L++ YL LS N L
Sbjct: 32 YLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLN---LSTNQL 88
Query: 426 NGIIPMSAGNLSHSLEELFMPDCNVSGRIPKEIGNLANLVTLDLGGNKFNGSIPI-ALGK 484
SL L L L L N+ S+P K
Sbjct: 89 Q------------SLP-------------NGVFDKLTQLKELALNTNQLQ-SLPDGVFDK 122
Query: 485 LQKLQLLNLDDNKLEGSIPDDICGLVELYKLALGDNKLSGQIPACFGNLASLRELWLGPN 544
L +L+ L L N+L+ S+PD + F L SL+ +WL N
Sbjct: 123 LTQLKDLRLYQNQLK-SVPDGV-----------------------FDRLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 4e-06
Identities = 37/158 (23%), Positives = 51/158 (32%), Gaps = 32/158 (20%)
Query: 341 EELYLWGNNFSGTLPSFIFNASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNYLTS 400
L L N+ ++L++L LG N L F L +L L L N L S
Sbjct: 31 TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQS 90
Query: 401 PELSFLSSLSNCKYLEIIALSGNPLNGIIPMSAGNLSHSLEELFMPDCNVSGRIPKEI-G 459
L+ K L L+ N L +P +
Sbjct: 91 LPNGVFDKLTQLKELA---LNTNQLQ--------------------------SLPDGVFD 121
Query: 460 NLANLVTLDLGGNKFNGSIPI-ALGKLQKLQLLNLDDN 496
L L L L N+ S+P +L LQ + L DN
Sbjct: 122 KLTQLKDLRLYQNQLK-SVPDGVFDRLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 31/87 (35%), Positives = 48/87 (55%), Gaps = 3/87 (3%)
Query: 94 LSSLEILDLNFNRLSGEIPWELGNLAKLEKLLLHNNFLTGTIPFSIF-KLSSLLDLKLSD 152
L+SL L+L+ N+L L +L++L L+ N L ++P +F KL+ L DL+L
Sbjct: 75 LTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQ 133
Query: 153 NNLTGTIPSHNLGNLSSLQLLDLSDNQ 179
N L ++P L+SLQ + L DN
Sbjct: 134 NQLK-SVPDGVFDRLTSLQYIWLHDNP 159
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 3e-12
Identities = 57/330 (17%), Positives = 110/330 (33%), Gaps = 70/330 (21%)
Query: 73 VTALNISYLSLTG----NIPRQLGNLSSLEILDLNFNRLSGE----IPWELGNLAKLEKL 124
+ ++ ++T ++ L S++ + L+ N + E + + + LE
Sbjct: 6 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 65
Query: 125 LLHNNFL----------TGTIPFSIFKLSSLLDLKLSDNNLT--GTIP-SHNLGNLSSLQ 171
+ F + ++ K L ++LSDN P L + L+
Sbjct: 66 EFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLE 125
Query: 172 LLDLSDNQLS-------------GSIPSFIFKISSLQALHFGNNRLSGELPANICDNL-- 216
L L +N L ++ L+++ G NRL
Sbjct: 126 HLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQS 185
Query: 217 -PFLNFFSVYKNMFY-----GGISSTLSNCKHLRILDLSFNDLWGD-----IPKEIGNLT 265
L+ + +N + L+ C+ L++LDL N + + +
Sbjct: 186 HRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTF-THLGSSALAIALKSWP 244
Query: 266 KLKELFLDFNILQGEIPHTVGNLHNLEYLSLVNNELVGTVPATIFNVSTLKLIELSNNTF 325
L+EL L+ +L G ++ S + N L+ + L N
Sbjct: 245 NLRELGLNDCLLSAR-----GAAAVVDAFSKLEN-------------IGLQTLRLQYNEI 286
Query: 326 ----FGSLPSSTDVQLPNLEELYLWGNNFS 351
+L + D ++P+L L L GN FS
Sbjct: 287 ELDAVRTLKTVIDEKMPDLLFLELNGNRFS 316
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 3e-12
Identities = 57/402 (14%), Positives = 115/402 (28%), Gaps = 97/402 (24%)
Query: 144 SLLDLKLSDNNLT--GTIP-SHNLGNLSSLQLLDLSDNQLSG----SIPSFIFKISSLQA 196
S+ L + +T L S++ + LS N + + I L+
Sbjct: 5 SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 64
Query: 197 LHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGGISSTLSNCKHLRILDLSFNDLWGD 256
F + G + I + L + L C L + LS N G
Sbjct: 65 AEFSDIFT-GRVKDEIPEAL--------------RLLLQALLKCPKLHTVRLSDNAF-GP 108
Query: 257 -----IPKEIGNLTKLKELFLDFN-------------ILQGEIPHTVGNLHNLEYLSLVN 298
+ + T L+ L+L N + + + N L +
Sbjct: 109 TAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGR 168
Query: 299 NELVGTVPATIFNVSTLKLIE-LSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSGTLPSF 357
N + N S + + ++ L + + N
Sbjct: 169 NR--------LENGSMKEWAKTFQSHR--------------LLHTVKMVQNG-------- 198
Query: 358 IFNASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNYLTSPELSFLSS-LSNCKYLE 416
+ L+ + LK L L +N T S L+ L + L
Sbjct: 199 -----------IRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLR 247
Query: 417 IIALSGNPL-----NGIIPMSAGNLSHSLEELFMPDCNVSGRIPKEIG-----NLANLVT 466
+ L+ L ++ + + L+ L + + + + + +L+
Sbjct: 248 ELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLF 307
Query: 467 LDLGGNKFN--GSIPIALGK-LQKLQLLNLDDNKLEGSIPDD 505
L+L GN+F+ + + + LD+ + D+
Sbjct: 308 LELNGNRFSEEDDVVDEIREVFSTRGRGELDELDDMEELTDE 349
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 2e-11
Identities = 62/336 (18%), Positives = 108/336 (32%), Gaps = 59/336 (17%)
Query: 364 LSKLSLGDNSFSG----LIPNTFGNLRNLKRLRLYNNYLTSPELSFLSS-LSNCKYLEII 418
+ SL ++ + + ++K + L N + + +LS +++ K LEI
Sbjct: 6 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 65
Query: 419 ALSGNPLNGIIPMSAGNLSHSLEELFMPDCNVSGRIPKEIGNLANLVTLDLGGNKF--NG 476
S + L L+ L L T+ L N F
Sbjct: 66 EFSDIFTGRVKDEIPEALRLLLQAL---------------LKCPKLHTVRLSDNAFGPTA 110
Query: 477 SIPIA--LGKLQKLQLLNLDDNKLEGSIPDDICGLVELYKLALGDNKLSGQIPACFGNLA 534
P+ L K L+ L L +N L G + + N
Sbjct: 111 QEPLIDFLSKHTPLEHLYLHNNGL-----GPQAGA------KIARALQELAVNKKAKNAP 159
Query: 535 SLRELWLGPNEL----ISFIPSTFWNIKDIMYVNFSSNFLT-----GPLPLEIENLKALT 585
LR + G N L + TF + + + V N + L + + L
Sbjct: 160 PLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELK 219
Query: 586 TLDFSMNNLSG----VIPTTIGGLKGLQYLFLGHNRLQG----SIPDS--VGDLISLKSL 635
LD N + + + L+ L L L ++ D+ + I L++L
Sbjct: 220 VLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTL 279
Query: 636 NLSNNNLSGP----IPTSL-EKLSDLKELNLSFNKL 666
L N + + T + EK+ DL L L+ N+
Sbjct: 280 RLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF 315
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 3e-10
Identities = 36/266 (13%), Positives = 87/266 (32%), Gaps = 46/266 (17%)
Query: 439 SLEELFMPDCNVSGR----IPKEIGNLANLVTLDLGGNKFN--GSIPIA--LGKLQKLQL 490
S+E + ++ + + ++ + L GN + ++ + + L++
Sbjct: 5 SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 64
Query: 491 LNLDDN---KLEGSIPDDICGLVE-------LYKLALGDNKLSGQ----IPACFGNLASL 536
D +++ IP+ + L++ L+ + L DN + L
Sbjct: 65 AEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPL 124
Query: 537 RELWLGPNELISFIPSTFWNIKDIMYVNFSSNFLTGPLPLEIENLKALTTLDFSMNNLSG 596
L+L N + + + + +N L ++ N L
Sbjct: 125 EHLYLHNN-----------GLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLEN 173
Query: 597 V----IPTTIGGLKGLQYLFLGHNRL-----QGSIPDSVGDLISLKSLNLSNNNLSGP-- 645
T + L + + N + + + + + LK L+L +N +
Sbjct: 174 GSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGS 233
Query: 646 --IPTSLEKLSDLKELNLSFNKLEGE 669
+ +L+ +L+EL L+ L
Sbjct: 234 SALAIALKSWPNLRELGLNDCLLSAR 259
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 69.5 bits (170), Expect = 3e-12
Identities = 73/512 (14%), Positives = 152/512 (29%), Gaps = 60/512 (11%)
Query: 50 NWLTNSTMVCNWTGVTCDINQRRVTALNISYLSLTGNIPRQLGNLSSLEILDLNFNRLSG 109
W + N V+ RR + + L G NL + +
Sbjct: 42 RWCRRKVFIGNCYAVSPATVIRRFP--KVRSVELKGKPHFADFNLVPDGWGGYVYPWIEA 99
Query: 110 EIPWELGNLAKLEKLLLHNNFLTGTIPFSIFK-LSSLLDLKLSD-NNLTGTIPSHNLGNL 167
+ LE++ L +T I K + L LS + +
Sbjct: 100 M----SSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATC 155
Query: 168 SSLQLLDLSDNQLSGSIPSFIFKISSLQALHFGNNRLSGELPANICDNLPFLNFFSVYKN 227
+L+ LDL ++ + ++ + +L LN +
Sbjct: 156 RNLKELDLRESDVDDVSGHWLSHF------------------PDTYTSLVSLNISCLASE 197
Query: 228 MFYGGISSTLSNCKHLRILDLSFNDLWGDIPKEIGNLTKLKELFLDF------NILQGEI 281
+ + + ++ C +L+ L L+ + + +L+EL + +
Sbjct: 198 VSFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGL 257
Query: 282 PHTVGNLHNLEYLSLVNNELVGTVPATIFNVSTLKLIELSNNTFFGSLPSSTDVQLPNLE 341
+ L LS + + +PA S L + LS T Q P L+
Sbjct: 258 SVALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQ 317
Query: 342 ELYLWGNNFSGTLPSFIFNASNLSKLSLGDNSFSGLIPNT----------FGNLRNLKRL 391
L++ L +L +L + + + PN L+ +
Sbjct: 318 RLWVLDYIEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESV 377
Query: 392 RLYNNYLTSPELSFLSSLSNCKYLEIIALSGNPLNGIIPMSAGNLSHSLEELFMPDCNVS 451
+ +T+ L ++ N + L ++ L +
Sbjct: 378 LYFCRQMTNAALITIAR--NRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVE------ 429
Query: 452 GRIPKEIGNLANLVTLDLGGNKFNGSIPIALGKLQKLQLLNLDDNKL-EGSIPDDICGLV 510
+ +L L L G + +K+++L++ + + + G
Sbjct: 430 --------HCKDLRRLSLSGLLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCD 481
Query: 511 ELYKLALGDNKLSGQ-IPACFGNLASLRELWL 541
L KL + D + + A L ++R LW+
Sbjct: 482 SLRKLEIRDCPFGDKALLANASKLETMRSLWM 513
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 59.5 bits (144), Expect = 4e-09
Identities = 55/376 (14%), Positives = 116/376 (30%), Gaps = 40/376 (10%)
Query: 71 RRVTALNISYLSLTGNIPRQLGNLSSL--EILDLNFNRLSGEIPWE-LGNLAK----LEK 123
R + L++ + L + ++ LN + L+ E+ + L L L+
Sbjct: 156 RNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVTRCPNLKS 215
Query: 124 LLLHNNFLTGTIPFSIFKLSSLLDLKLSD-----NNLTGTIPSHNLGNLSSLQLLDLSDN 178
L L+ + + + L +L + S L L+ L +
Sbjct: 216 LKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWD 275
Query: 179 QLSGSIPSFIFKISSLQALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGGISSTLS 238
+ +P+ S L L+ + + P L V + G+ S
Sbjct: 276 AVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDYIEDAGLEVLAS 335
Query: 239 NCKHLRILDLSFNDLWGDIPKEIGNLTKLKELFLDFNILQGEIPHTVGNLHNLEYL---- 294
CK LR L + ++ + P + + + + LE +
Sbjct: 336 TCKDLRELRVFPSEPFVMEP--------------NVALTEQGLVSVSMGCPKLESVLYFC 381
Query: 295 SLVNNELVGTVPATIFNVSTLKLIELSNNTFFGSLPSSTDVQL-------PNLEELYLWG 347
+ N + T+ N++ +L + D+ +L L L G
Sbjct: 382 RQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG 441
Query: 348 NNFSGTLPSFIFNASNLSKLSLGDNSFSGL-IPNTFGNLRNLKRLRLYNNYLTSPELSFL 406
A + LS+ S L + + +L++L + + L L
Sbjct: 442 LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKAL--L 499
Query: 407 SSLSNCKYLEIIALSG 422
++ S + + + +S
Sbjct: 500 ANASKLETMRSLWMSS 515
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 2e-08
Identities = 76/548 (13%), Positives = 163/548 (29%), Gaps = 96/548 (17%)
Query: 140 FKLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLS-----------DNQLSGSIPSFI 188
+++ K+ N P+ + ++ ++L + G + +I
Sbjct: 38 YEIERWCRRKVFIGNCYAVSPATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWI 97
Query: 189 FKISS----LQALHFGNNRLSGELPANICDNLPFLNFFSVYK--NMFYGGISSTLSNCKH 242
+SS L+ + ++ + I + + G+++ + C++
Sbjct: 98 EAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRN 157
Query: 243 LRILDLSFNDLWGDIPKEIGNLTKLKELFLDFNILQGEIPHTVGNLHNLEYLSLVNNELV 302
L+ LDL +D+ + + +L L++
Sbjct: 158 LKELDLRESDVDDVSGHWLSHFPD--------------------TYTSLVSLNISC---- 193
Query: 303 GTVPATIFNVSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSGTLPSFIFNAS 362
VS L L PNL+ L L L + + A
Sbjct: 194 -----LASEVSFSALERLVTR-------------CPNLKSLKLNRAVPLEKLATLLQRAP 235
Query: 363 NLSKLSLGDNSFS---GLIPNTFGNLRNLKRLRLYNNYLTSPELSFLSSLSNCKYLEIIA 419
L +L G + + L K LR + + + + S C L +
Sbjct: 236 QLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLN 295
Query: 420 LSGNPLNGIIPMSAGNLSHSLEELFMPDCNVSGRIPKEIGNLANLVTLDLGGNKFNGSIP 479
LS + S+ L +L + L L + + +
Sbjct: 296 LSYATVQ----------SYDLVKL--------------LCQCPKLQRLWVLDYIEDAGLE 331
Query: 480 IALGKLQKLQLLNLDDNKLEGSIPDDICGLVELYKLALGDNKLSGQIPACFGNL--ASLR 537
+ + L+ L + ++ P+ L +++G KL + + A+L
Sbjct: 332 VLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLE-SVLYFCRQMTNAALI 390
Query: 538 ELWLGPNELISFIPSTFWNIKDIMYVNFSSNFLTGPLPLEIENLKALTTLDFSMNNLSGV 597
+ + F I+ + L +E+ K L L S L+
Sbjct: 391 TIARNRPNMTRFRLC---IIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLS-GLLTDK 446
Query: 598 IPTTIG-GLKGLQYLFLGHNRL-QGSIPDSVGDLISLKSLNLSNNNLSGP-IPTSLEKLS 654
+ IG K ++ L + + + SL+ L + + + + KL
Sbjct: 447 VFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLE 506
Query: 655 DLKELNLS 662
++ L +S
Sbjct: 507 TMRSLWMS 514
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 6e-06
Identities = 53/349 (15%), Positives = 114/349 (32%), Gaps = 58/349 (16%)
Query: 338 PNLEELYLWGNNFSGTLPSFIFNASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNY 397
P + + L G F NL G + + + L+ +RL
Sbjct: 66 PKVRSVELKGKPH--------FADFNLVPDGWGGYVYPWI-EAMSSSYTWLEEIRLKRMV 116
Query: 398 LTSPELSFLSSLSNCKYLEIIALSGNPL---NGIIPMSAGNLSHSLEELFMPDCNVSGRI 454
+T L ++ + K +++ LS +G+ ++A +L+EL + + +V
Sbjct: 117 VTDDCLELIAK--SFKNFKVLVLSSCEGFSTDGLAAIAAT--CRNLKELDLRESDVDDVS 172
Query: 455 PKEIGNLA----NLVTLDLGGNKFN---GSIPIALGKLQKLQLLNLDDNKLEGSIPDDIC 507
+ + +LV+L++ ++ + + L+ L L ++P +
Sbjct: 173 GHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKL-----NRAVPLE-- 225
Query: 508 GLVELYKLALGDNKLSGQIPACFGNLASLRELWLG------PNELISFIPSTFWNIKDIM 561
L L L EL G ++ S + K++
Sbjct: 226 KLATL-----------------LQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELR 268
Query: 562 YVNFSSNFLTGPLPLEIENLKALTTLDFSMNNLSGV-IPTTIGGLKGLQYLFLGHNRLQG 620
++ + + LP LTTL+ S + + + LQ L++
Sbjct: 269 CLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDYIEDA 328
Query: 621 SIPDSVGDLISLKSLNLSNNNLSGPIPTSLEKLSD--LKELNLSFNKLE 667
+ L+ L + + L++ L +++ KLE
Sbjct: 329 GLEVLASTCKDLRELRVF--PSEPFVMEPNVALTEQGLVSVSMGCPKLE 375
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 4e-12
Identities = 30/149 (20%), Positives = 59/149 (39%), Gaps = 15/149 (10%)
Query: 777 IGRGSFGSVYIAR-LQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRH-RNLTKIISSC 834
IG GSFG ++ L N +VA+K + + E K + + +
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYFG 75
Query: 835 SNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 894
L+++ + SLE L + + + ++ +H +++ D
Sbjct: 76 QEGLHNVLVIDLLGP-SLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRD 131
Query: 895 LKPSNVLL------DDNMVAHLSDFGIAK 917
+KP N L+ + NM+ ++ DFG+ K
Sbjct: 132 IKPDNFLIGRPNSKNANMI-YVVDFGMVK 159
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 5e-12
Identities = 39/147 (26%), Positives = 69/147 (46%), Gaps = 13/147 (8%)
Query: 777 IGRGSFGSVYIAR-LQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRH-RNLTKIISSC 834
IG GSFG +Y+ + G EVA+K ++ + E ++ K ++ + I
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCG 74
Query: 835 SNEDFKALILEYMRNG-SLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHC 893
+ D+ +++E + G SLE + + L + + S +EY+H S IH
Sbjct: 75 AEGDYNVMVMELL--GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHR 129
Query: 894 DLKPSNVLL---DDNMVAHLSDFGIAK 917
D+KP N L+ + ++ DFG+AK
Sbjct: 130 DVKPDNFLMGLGKKGNLVYIIDFGLAK 156
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 68.8 bits (168), Expect = 5e-12
Identities = 56/378 (14%), Positives = 116/378 (30%), Gaps = 39/378 (10%)
Query: 93 NLSSLEILDLNFNRLSGEIPWELGNLAK----LEKLLLHN-NFLTGTIPFSIFKLSSLLD 147
+ +SLE+L+ + P +L +A+ L + + + L F
Sbjct: 190 HNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILELVGFFKAAANLEEFC 249
Query: 148 LKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQLSGSIPSFIFKISSLQALHFGNNRLSGE 207
+ ++ NL L L LS + +P + ++ L L E
Sbjct: 250 GGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNE-MPILFPFAAQIRKLDLLYALLETE 308
Query: 208 LPANICDNLPFLNFFSVYKNMFYGGISSTLSNCKHLRILDLSFNDLWGDIPKEIGNLTK- 266
+ P L + G+ CK L+ L + + E G +++
Sbjct: 309 DHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQR 368
Query: 267 -LKELFLDFNILQGEIPHTVGNLHNLEYLSL----VNNELVGTVPATIFNVSTLKLIELS 321
L L LEY+++ + NE + ++ + N+ +L+ L
Sbjct: 369 GLIALAQ--------------GCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLD 414
Query: 322 NNTFFGSLPSSTDVQ-----LPNLEELYLWGNNFSGTLPSFIF---NASNLSKLSLGDNS 373
LP V+ L + T + + N+ + LG
Sbjct: 415 REERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVG 474
Query: 374 FSGL-IPNTFGNLRNLKRLRLYNNYLTSPELSFLSSLSNCKYLEIIALSGNPLN--GIIP 430
S + NL++L + + ++ ++ L + + G + G
Sbjct: 475 ESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAA--VTKLPSLRYLWVQGYRASMTGQDL 532
Query: 431 MSAGNLSHSLEELFMPDC 448
M ++E +
Sbjct: 533 MQMARPYWNIELIPSRRV 550
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 65.7 bits (160), Expect = 5e-11
Identities = 78/523 (14%), Positives = 158/523 (30%), Gaps = 91/523 (17%)
Query: 161 SHNLGNLSSLQLLDLSDNQLSGSIPSFIFKISS----LQALHFGNNRLS----GELPANI 212
S L + +L G + ++ +IS+ L+++HF +S L
Sbjct: 77 SLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKAR 136
Query: 213 CDNLPFLNFFSVYKNMFYGGISSTLSNCKHLRILDLSFNDLWGDIPKEIGNLTKLKELFL 272
D+L L G+ S +++C+ ++ L + + K + L +
Sbjct: 137 ADDLETLKLDKC-SGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQ------ 189
Query: 273 DFNILQGEIPHTVGNLHNLEYLSLVNNELVGTVPATIFNVSTLKLIELSNNTFFGSLPSS 332
+ +LE L+ E +S L ++ N
Sbjct: 190 --------------HNTSLEVLNFYMTEFA--------KISPKDLETIARN--------- 218
Query: 333 TDVQLPNLEELYLWGNNFSGTLPSFIFNASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLR 392
+L + + L F A+NL + G + +P + NL ++L
Sbjct: 219 ----CRSLVSVKVGDFEIL-ELVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLC 273
Query: 393 LYNNYLTSPELSFLSSLSNCKYLEIIALSGNPLNGIIPMSAGNLSHSLEELFMPDCNVSG 452
P + + L L + +LE L +
Sbjct: 274 RLGLSYMGPN-EMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDR 332
Query: 453 RIPKEIGNLANLVTLDLGGNKFNGSIPIALGKLQKLQLLNLDDNKLEGSIPDDICGLVEL 512
+ L L + + G + + L+ L G EL
Sbjct: 333 GLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIAL------------AQGCQEL 380
Query: 513 YKLALGDNKLSGQ----IPACFGNLASLRELWLGPNELISFIPSTFWNIKDIMYVNFSSN 568
+A+ + ++ + I NL R + L E I+ +P
Sbjct: 381 EYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLP----------------- 423
Query: 569 FLTGPLPLEIENLKALTTLDFSMN--NLSGVIPTTIG-GLKGLQYLFLGHNRLQ-GSIPD 624
L + + K L F + L+ + + IG ++++ LG+ + +
Sbjct: 424 -LDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLME 482
Query: 625 SVGDLISLKSLNLSNNNLSGP-IPTSLEKLSDLKELNLSFNKL 666
+L+ L + S I ++ KL L+ L + +
Sbjct: 483 FSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRA 525
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 51.5 bits (123), Expect = 1e-06
Identities = 48/359 (13%), Positives = 96/359 (26%), Gaps = 65/359 (18%)
Query: 347 GNNFSGTLPSFIFNASNLSKLSL---GDNSFSGLIPNTFG------------NLRNLKRL 391
++ T NL L L + LIP +G NLR LK +
Sbjct: 58 ALCYTATPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSV 117
Query: 392 RLYNNYLTSPELSFLSSLSNCKYLEIIALSGNPL---NGIIPMSAGNLSHSLEELFMPDC 448
++ +L L+ + LE + L +G++ + ++ L M +
Sbjct: 118 HFRRMIVSDLDLDRLAK-ARADDLETLKLDKCSGFTTDGLLSIVTH--CRKIKTLLMEES 174
Query: 449 NVSGRIPKEIGNLA----NLVTLDLGGNKFNG----SIPIALGKLQKLQLLNLDDNKLEG 500
+ S + K + LA +L L+ +F + + L + + D
Sbjct: 175 SFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGD----- 229
Query: 501 SIPDDICGLVELYKLALGDNKLSGQIPACFGNLASLRELWLGPNELISFIPSTFWNIKDI 560
++EL L + E ++ +
Sbjct: 230 ------FEILELVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPN 283
Query: 561 MYVNFSSNFLTGPLPLEIENLKALTTLDFSMNNLSG-VIPTTIGGLKGLQYLFLGHNRLQ 619
+P+ + LD L T I L+ L +
Sbjct: 284 E------------MPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGD 331
Query: 620 GSIPDSVGDLISLKSLNLSNNNLSGPIPTSLEKLSD------------LKELNLSFNKL 666
+ LK L + + +S L+ + + + +
Sbjct: 332 RGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDI 390
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 1e-11
Identities = 36/126 (28%), Positives = 59/126 (46%), Gaps = 13/126 (10%)
Query: 305 VPATIFNVSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSGTLPSFIF-NASN 363
+P I + T +L L++N +LP+L +L L N + + F AS+
Sbjct: 23 IPRDIP-LHTTEL-LLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASH 79
Query: 364 LSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNYLTS-PELSF--LSSLSNCKYLEIIAL 420
+ +L LG+N + F L LK L LY+N ++ SF L+SL++ + L
Sbjct: 80 IQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTS------LNL 133
Query: 421 SGNPLN 426
+ NP N
Sbjct: 134 ASNPFN 139
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 5e-09
Identities = 28/108 (25%), Positives = 53/108 (49%), Gaps = 5/108 (4%)
Query: 122 EKLLLHNNFLTGTIPFSIF-KLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQL 180
+LLL++N L +F +L L+ L+L N LT I + S +Q L L +N++
Sbjct: 32 TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKI 90
Query: 181 SGSIPSFIF-KISSLQALHFGNNRLSGELPANICDNLPFLNFFSVYKN 227
I + +F + L+ L+ +N++S + ++L L ++ N
Sbjct: 91 K-EISNKMFLGLHQLKTLNLYDNQISC-VMPGSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 5e-08
Identities = 24/92 (26%), Positives = 37/92 (40%), Gaps = 6/92 (6%)
Query: 585 TTLDFSMNNLSGVIPTTI-GGLKGLQYLFLGHNRLQGSIPDSVGD-LISLKSLNLSNNNL 642
T L + N L + + G L L L L N+L I + + ++ L L N +
Sbjct: 32 TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKI 90
Query: 643 SGPIPTSL-EKLSDLKELNLSFNKLEGEIPRG 673
I + L LK LNL N++ + G
Sbjct: 91 KE-ISNKMFLGLHQLKTLNLYDNQISC-VMPG 120
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 7e-08
Identities = 30/105 (28%), Positives = 49/105 (46%), Gaps = 5/105 (4%)
Query: 467 LDLGGNKFNGSIPIAL-GKLQKLQLLNLDDNKLEGSIPDDIC-GLVELYKLALGDNKLSG 524
L L N+ L G+L L L L N+L I + G + +L LG+NK+
Sbjct: 34 LLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKIK- 91
Query: 525 QIPA-CFGNLASLRELWLGPNELISFIPSTFWNIKDIMYVNFSSN 568
+I F L L+ L L N++ +P +F ++ + +N +SN
Sbjct: 92 EISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 1e-07
Identities = 35/133 (26%), Positives = 58/133 (43%), Gaps = 17/133 (12%)
Query: 59 CNWTGVTCDINQRRVTAL--NI----SYLSLTGNIPRQL------GNLSSLEILDLNFNR 106
C T V C R + + +I + L L N ++ G L L L+L N+
Sbjct: 8 CEGTTVDC--TGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQ 65
Query: 107 LSGEIPWELGNLAKLEKLLLHNNFLTGTIPFSIF-KLSSLLDLKLSDNNLTGTIPSHNLG 165
L+G P + +++L L N + I +F L L L L DN ++ + +
Sbjct: 66 LTGIEPNAFEGASHIQELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQIS-CVMPGSFE 123
Query: 166 NLSSLQLLDLSDN 178
+L+SL L+L+ N
Sbjct: 124 HLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 6e-07
Identities = 31/87 (35%), Positives = 46/87 (52%), Gaps = 2/87 (2%)
Query: 579 ENLKALTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQGSIPDSVGD-LISLKSLNL 637
L L L+ N L+G+ P G +Q L LG N+++ I + + L LK+LNL
Sbjct: 51 GRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK-EISNKMFLGLHQLKTLNL 109
Query: 638 SNNNLSGPIPTSLEKLSDLKELNLSFN 664
+N +S +P S E L+ L LNL+ N
Sbjct: 110 YDNQISCVMPGSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 9e-06
Identities = 25/85 (29%), Positives = 45/85 (52%), Gaps = 4/85 (4%)
Query: 241 KHLRILDLSFNDLWGDIPKEIGNLTKLKELFLDFNILQGEIPHTV-GNLHNLEYLSLVNN 299
HL L+L N L G P + ++EL L N ++ EI + + LH L+ L+L +N
Sbjct: 54 PHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK-EISNKMFLGLHQLKTLNLYDN 112
Query: 300 ELVGTVPATIF-NVSTLKLIELSNN 323
++ V F ++++L + L++N
Sbjct: 113 QI-SCVMPGSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 36/154 (23%), Positives = 53/154 (34%), Gaps = 51/154 (33%)
Query: 489 QLLNLDDNKLEGSIPDDI-CGLVELYKLALGDNKLSGQIPACFGNLASLRELWLGPNELI 547
L L+DN+L D + L L KL L N+L+G P F + ++EL LG N++
Sbjct: 32 TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK 91
Query: 548 SFIPSTFWNIKDIMYVNFSSNFLTGPLPLEIENLKALTTLDFSMNNLSGVIPTTIGGLKG 607
F GL
Sbjct: 92 EISNKMF------------------------------------------------LGLHQ 103
Query: 608 LQYLFLGHNRLQGSIPDSVGD-LISLKSLNLSNN 640
L+ L L N++ + + L SL SLNL++N
Sbjct: 104 LKTLNLYDNQIS-CVMPGSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 6e-05
Identities = 24/77 (31%), Positives = 31/77 (40%), Gaps = 8/77 (10%)
Query: 598 IPTTIGGLKGLQYLFLGHNRLQGSIPDSVGD-LISLKSLNLSNNNLSGPIPTSLEKLSDL 656
IP L L N L D + L L L L N L+G P + E S +
Sbjct: 27 IPLHT------TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHI 80
Query: 657 KELNLSFNKLEGEIPRG 673
+EL L NK++ EI
Sbjct: 81 QELQLGENKIK-EISNK 96
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 6e-04
Identities = 32/158 (20%), Positives = 44/158 (27%), Gaps = 55/158 (34%)
Query: 389 KRLRLYNNYLTS-PELSFLSSLSNCKYLEIIALSGNPLNGIIPMSAGNLSHSLEELFMPD 447
L L +N L L + LE L N L +E
Sbjct: 32 TELLLNDNELGRISSDGLFGRLPHLVKLE---LKRNQLT------------GIE------ 70
Query: 448 CNVSGRIPKEIGNLANLVTLDLGGNKFNGSIPI-ALGKLQKLQLLNLDDNKLEGSIPDDI 506
P +++ L LG NK I L +L+ LNL DN++ +
Sbjct: 71 -------PNAFEGASHIQELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQIS-CVMPGS 121
Query: 507 CGLVELYKLALGDNKLSGQIPACFGNLASLRELWLGPN 544
F +L SL L L N
Sbjct: 122 -----------------------FEHLNSLTSLNLASN 136
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 6e-11
Identities = 37/167 (22%), Positives = 68/167 (40%), Gaps = 31/167 (18%)
Query: 776 LIGRGSFGSVYIARLQNGIEVAVKTF-----------DLQHERAF-KSFDTECEVMKSIR 823
IG+G FG +Y+A + + V L E F + ++ K IR
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 824 HRNLTKI---------ISSCSNEDFKALILEYMRNG-SLEKCLYSGNYILDIFQRLNIMI 873
R L + + + + ++ +I++ G L+K + L + +
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEANAKRFSRKTVLQLSL 159
Query: 874 DVASALEYLHFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAK 917
+ LEY+H +H D+K SN+LL + + V +L D+G+A
Sbjct: 160 RILDILEYIH---EHEYVHGDIKASNLLLNYKNPDQV-YLVDYGLAY 202
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 63.9 bits (155), Expect = 1e-10
Identities = 36/147 (24%), Positives = 70/147 (47%), Gaps = 13/147 (8%)
Query: 777 IGRGSFGSVYIAR-LQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIR-HRNLTKIISSC 834
IG GSFG +Y+ +Q EVA+K +++ + E ++ + ++ + +
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFG 72
Query: 835 SNEDFKALILEYMRNG-SLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHC 893
D+ L+++ + G SLE + L + L + + + +E++H S +H
Sbjct: 73 VEGDYNVLVMDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH---SKSFLHR 127
Query: 894 DLKPSNVLLDDNMVAH---LSDFGIAK 917
D+KP N L+ A+ + DFG+AK
Sbjct: 128 DIKPDNFLMGLGRRANQVYIIDFGLAK 154
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 2e-10
Identities = 44/156 (28%), Positives = 65/156 (41%), Gaps = 41/156 (26%)
Query: 59 CNWTGVTCDINQRRVTAL------NISYLSLTGN----IPRQLGNLSSLEILDLNFNRLS 108
C T V C + + + L +++ L L GN +P++L N L ++DL+ NR+S
Sbjct: 10 CLDTVVRC--SNKGLKVLPKGIPRDVTELYLDGNQFTLVPKELSNYKHLTLIDLSNNRIS 67
Query: 109 GEIPWELGNLAKLEKLLLHNNFLTGTIPFSIF-KLSSLLDLKLSDNNLTGTIPSHNLGNL 167
T+ F ++ LL L LS N L IP L
Sbjct: 68 -------------------------TLSNQSFSNMTQLLTLILSYNRLR-CIPPRTFDGL 101
Query: 168 SSLQLLDLSDNQLSGSIPSFIF-KISSLQALHFGNN 202
SL+LL L N +S +P F +S+L L G N
Sbjct: 102 KSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 3e-09
Identities = 27/103 (26%), Positives = 49/103 (47%), Gaps = 3/103 (2%)
Query: 467 LDLGGNKFNGSIPIALGKLQKLQLLNLDDNKLEGSIPDDIC-GLVELYKLALGDNKLSGQ 525
L L GN+F +P L + L L++L +N++ ++ + + +L L L N+L
Sbjct: 36 LYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRLRCI 93
Query: 526 IPACFGNLASLRELWLGPNELISFIPSTFWNIKDIMYVNFSSN 568
P F L SLR L L N++ F ++ + ++ +N
Sbjct: 94 PPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 5e-09
Identities = 30/110 (27%), Positives = 52/110 (47%), Gaps = 5/110 (4%)
Query: 122 EKLLLHNNFLTGTIPFSIFKLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQLS 181
+L L N T +P + L + LS+N ++ T+ + + N++ L L LS N+L
Sbjct: 34 TELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRLR 91
Query: 182 GSIPSFIF-KISSLQALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFY 230
IP F + SL+ L N +S +P ++L L+ ++ N Y
Sbjct: 92 -CIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGANPLY 139
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 1e-08
Identities = 23/90 (25%), Positives = 41/90 (45%), Gaps = 4/90 (4%)
Query: 585 TTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQGSIPDSVGD-LISLKSLNLSNNNLS 643
T L N + ++P + K L + L +NR+ ++ + + L +L LS N L
Sbjct: 34 TELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRLR 91
Query: 644 GPIPTSLEKLSDLKELNLSFNKLEGEIPRG 673
P + + L L+ L+L N + +P G
Sbjct: 92 CIPPRTFDGLKSLRLLSLHGNDIS-VVPEG 120
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 5e-08
Identities = 36/142 (25%), Positives = 52/142 (36%), Gaps = 32/142 (22%)
Query: 257 IPKEIGNLTKLKELFLDFNILQGEIPHTVGNLHNLEYLSLVNNELVGTVPATIFNVSTLK 316
+PK I EL+LD N +P + N +L + L NN +
Sbjct: 25 LPKGIPRDVT--ELYLDGNQFT-LVPKELSNYKHLTLIDLSNN----------------R 65
Query: 317 LIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSGTLPSFIFNA-SNLSKLSLGDNSFS 375
+ LSN +F + L L L N +P F+ +L LSL N S
Sbjct: 66 ISTLSNQSF--------S-NMTQLLTLILSYNRLR-CIPPRTFDGLKSLRLLSLHGNDIS 115
Query: 376 GLIPN-TFGNLRNLKRLRLYNN 396
+P F +L L L + N
Sbjct: 116 V-VPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 5e-08
Identities = 29/107 (27%), Positives = 45/107 (42%), Gaps = 22/107 (20%)
Query: 341 EELYLWGNNFSGTLPSFIFNASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNYLTS 400
ELYL GN F+ +P + N +L+ + L +N S L +F N+ L L L N L
Sbjct: 34 TELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRC 92
Query: 401 -PELSF---------------LSSL-----SNCKYLEIIALSGNPLN 426
P +F +S + ++ L +A+ NPL
Sbjct: 93 IPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLY 139
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 7e-08
Identities = 31/100 (31%), Positives = 48/100 (48%), Gaps = 4/100 (4%)
Query: 447 DCNVSGRIPKEIGNLANLVTLDLGGNKFNGSIPIALGKLQKLQLLNLDDNKLEGSIPDDI 506
D N +PKE+ N +L +DL N+ + + + +L L L N+L IP
Sbjct: 39 DGNQFTLVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLR-CIPPRT 97
Query: 507 C-GLVELYKLALGDNKLSGQIP-ACFGNLASLRELWLGPN 544
GL L L+L N +S +P F +L++L L +G N
Sbjct: 98 FDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 4e-07
Identities = 31/88 (35%), Positives = 45/88 (51%), Gaps = 7/88 (7%)
Query: 574 LPLEIENLKALTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQGSIPDSVGD-LISL 632
+P E+ N K LT +D S N +S + + + L L L +NRL+ IP D L SL
Sbjct: 46 VPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLR-CIPPRTFDGLKSL 104
Query: 633 KSLNLSNNNLSGPIP----TSLEKLSDL 656
+ L+L N++S +P L LS L
Sbjct: 105 RLLSLHGNDISV-VPEGAFNDLSALSHL 131
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 3e-06
Identities = 31/128 (24%), Positives = 46/128 (35%), Gaps = 25/128 (19%)
Query: 489 QLLNLDDNKLEGSIPDDICGLVELYKLALGDNKLSGQIPACFGNLASLRELWLGPNELIS 548
L LD N+ +P ++ L + L +N++S F N+ L L L N L
Sbjct: 34 TELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRC 92
Query: 549 FIPSTFWNIKDIMYVNFSSNFLTGPLPLEIENLKALTTLDFSMNNLSGVIPTTIGGLKGL 608
P TF + LK+L L N++S V L L
Sbjct: 93 IPPRTF------------------------DGLKSLRLLSLHGNDISVVPEGAFNDLSAL 128
Query: 609 QYLFLGHN 616
+L +G N
Sbjct: 129 SHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 9e-06
Identities = 31/94 (32%), Positives = 48/94 (51%), Gaps = 6/94 (6%)
Query: 233 ISSTLSNCKHLRILDLSFNDLWGDIPKEI-GNLTKLKELFLDFNILQGEIPHTV-GNLHN 290
+ LSN KHL ++DLS N + + + N+T+L L L +N L+ IP L +
Sbjct: 46 VPKELSNYKHLTLIDLSNNRI-STLSNQSFSNMTQLLTLILSYNRLR-CIPPRTFDGLKS 103
Query: 291 LEYLSLVNNELVGTVPATIF-NVSTLKLIELSNN 323
L LSL N++ VP F ++S L + + N
Sbjct: 104 LRLLSLHGNDI-SVVPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 5e-05
Identities = 21/76 (27%), Positives = 34/76 (44%), Gaps = 8/76 (10%)
Query: 598 IPTTIGGLKGLQYLFLGHNRLQGSIPDSVGDLISLKSLNLSNNNLSGPIPTSLEKLSDLK 657
IP + L+L N+ +P + + L ++LSNN +S S ++ L
Sbjct: 29 IPRDV------TELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLL 81
Query: 658 ELNLSFNKLEGEIPRG 673
L LS+N+L IP
Sbjct: 82 TLILSYNRLR-CIPPR 96
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 2e-10
Identities = 54/317 (17%), Positives = 108/317 (34%), Gaps = 65/317 (20%)
Query: 776 LIGRGSFGSVYIAR-LQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIR--------HRN 826
+G G F +V++A+ + N VA+K + ++ + E ++++ +
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVR-GDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 84
Query: 827 LTKIISSCSNEDFKALILEYMRNGSLEKC----LYSGNYILDIFQRLN------------ 870
I+ + + K ++ + N L +
Sbjct: 85 ANHILKLLDHFNHKGPNGVHV-------VMVFEVLGEN--LLALIKKYEHRGIPLIYVKQ 135
Query: 871 IMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAH------LSDFGIAKLLIGEDQ 924
I + L+Y+H +IH D+KP NVL++ ++D G A D+
Sbjct: 136 ISKQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA---CWYDE 190
Query: 925 SMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHW 984
T ++ T Y +PE D++S L+ E T D +F + +
Sbjct: 191 --HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITG----DFLFEPDEGHSYT 244
Query: 985 VNDFLPISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRL 1044
+D + +II+ LL + + + FN S + ++++
Sbjct: 245 KDDDH---IAQIIE--LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEK 299
Query: 1045 LKIR--------DFLLR 1053
K DFL
Sbjct: 300 YKFSKDEAKEISDFLSP 316
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 3e-10
Identities = 31/166 (18%), Positives = 60/166 (36%), Gaps = 31/166 (18%)
Query: 777 IGRGSFGSVYIAR---------LQNGIEVAVK---------TFDLQHERAFKSFDTECEV 818
R + G +Y A + ++K +RA K
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 819 -MKSIRHRNLTKIISSCSNED-FKALILEYMRNG-SLEKCL-YSGNYILDIFQRLNIMID 874
+ S + + ++D ++ L+L + G SL+ L S ++L L +
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVLSERSVLQVACR 167
Query: 875 VASALEYLHFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAK 917
+ ALE+LH +H ++ N+ + D + V L+ +G A
Sbjct: 168 LLDALEFLH---ENEYVHGNVTAENIFVDPEDQSQV-TLAGYGFAF 209
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 5e-10
Identities = 40/122 (32%), Positives = 52/122 (42%), Gaps = 10/122 (8%)
Query: 305 VPATIFNVSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSGTLPSFIFNA-SN 363
VP I S +L EL +N SLP +L L +L L N +LP +F+ +
Sbjct: 22 VPTGIP-SSATRL-ELESNKL-QSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTK 77
Query: 364 LSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNYLTS-PELSFLSSLSNCKYLEIIALSG 422
L+ L L +N L F L LK L L N L S P+ F L+ I L
Sbjct: 78 LTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIF----DRLTSLQKIWLHT 133
Query: 423 NP 424
NP
Sbjct: 134 NP 135
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 2e-07
Identities = 33/91 (36%), Positives = 45/91 (49%), Gaps = 5/91 (5%)
Query: 585 TTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQGSIPDSVGD-LISLKSLNLSNNNLS 643
T L+ N L + L L L L N++Q S+PD V D L L L L N L
Sbjct: 31 TRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHENKLQ 89
Query: 644 GPIPTSL-EKLSDLKELNLSFNKLEGEIPRG 673
+P + +KL+ LKEL L N+L+ +P G
Sbjct: 90 S-LPNGVFDKLTQLKELALDTNQLKS-VPDG 118
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 3e-07
Identities = 31/103 (30%), Positives = 47/103 (45%), Gaps = 2/103 (1%)
Query: 467 LDLGGNKFNGSIPIALGKLQKLQLLNLDDNKLEGSIPDDIC-GLVELYKLALGDNKLSGQ 525
L+L NK KL +L L+L N+++ S+PD + L +L L L +NKL
Sbjct: 33 LELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHENKLQSL 91
Query: 526 IPACFGNLASLRELWLGPNELISFIPSTFWNIKDIMYVNFSSN 568
F L L+EL L N+L S F + + + +N
Sbjct: 92 PNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 9e-07
Identities = 39/133 (29%), Positives = 60/133 (45%), Gaps = 16/133 (12%)
Query: 59 CNWTGVTCDINQRRVTAL--NI----SYLSLTGNIPRQL-----GNLSSLEILDLNFNRL 107
C+ T + C N + +T++ I + L L N + L L+ L L L+ N++
Sbjct: 7 CSGTEIRC--NSKGLTSVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQI 64
Query: 108 SGEIPWELGNLAKLEKLLLHNNFLTGTIPFSIF-KLSSLLDLKLSDNNLTGTIPSHNLGN 166
L KL L LH N L ++P +F KL+ L +L L N L ++P
Sbjct: 65 QSLPDGVFDKLTKLTILYLHENKLQ-SLPNGVFDKLTQLKELALDTNQLK-SVPDGIFDR 122
Query: 167 LSSLQLLDLSDNQ 179
L+SLQ + L N
Sbjct: 123 LTSLQKIWLHTNP 135
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 1e-06
Identities = 32/86 (37%), Positives = 47/86 (54%), Gaps = 4/86 (4%)
Query: 461 LANLVTLDLGGNKFNGSIPIAL-GKLQKLQLLNLDDNKLEGSIPDDIC-GLVELYKLALG 518
L L L L N+ S+P + KL KL +L L +NKL+ S+P+ + L +L +LAL
Sbjct: 51 LTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHENKLQ-SLPNGVFDKLTQLKELALD 108
Query: 519 DNKLSGQIPACFGNLASLRELWLGPN 544
N+L F L SL+++WL N
Sbjct: 109 TNQLKSVPDGIFDRLTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 4e-06
Identities = 39/135 (28%), Positives = 57/135 (42%), Gaps = 31/135 (22%)
Query: 168 SSLQLLDLSDNQLSGSIPSFIF-KISSLQALHFGNNRLSGELPANICDNLPFLNFFSVYK 226
SS L+L N+L S+P +F K++ L L N++ LP + D L
Sbjct: 28 SSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKL---------- 75
Query: 227 NMFYGGISSTLSNCKHLRILDLSFNDLWGDIPKEI-GNLTKLKELFLDFNILQGEIPHTV 285
L IL L N L +P + LT+LKEL LD N L+ +P +
Sbjct: 76 --------------TKLTILYLHENKL-QSLPNGVFDKLTQLKELALDTNQLKS-VPDGI 119
Query: 286 -GNLHNLEYLSLVNN 299
L +L+ + L N
Sbjct: 120 FDRLTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 6e-06
Identities = 26/81 (32%), Positives = 40/81 (49%), Gaps = 4/81 (4%)
Query: 148 LKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQLSGSIPSFIF-KISSLQALHFGNNRLSG 206
L+L N L ++P L+ L L LS NQ+ S+P +F K++ L L+ N+L
Sbjct: 33 LELESNKLQ-SLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHENKLQ- 89
Query: 207 ELPANICDNLPFLNFFSVYKN 227
LP + D L L ++ N
Sbjct: 90 SLPNGVFDKLTQLKELALDTN 110
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 1e-05
Identities = 31/128 (24%), Positives = 42/128 (32%), Gaps = 24/128 (18%)
Query: 489 QLLNLDDNKLEGSIPDDICGLVELYKLALGDNKLSGQIPACFGNLASLRELWLGPNELIS 548
L L+ NKL+ L +L KL+L N++ F L L L+L N+L S
Sbjct: 31 TRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQS 90
Query: 549 FIPSTFWNIKDIMYVNFSSNFLTGPLPLEIENLKALTTLDFSMNNLSGVIPTTIGGLKGL 608
F + L L L N L V L L
Sbjct: 91 LPNGVF------------------------DKLTQLKELALDTNQLKSVPDGIFDRLTSL 126
Query: 609 QYLFLGHN 616
Q ++L N
Sbjct: 127 QKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 44.9 bits (107), Expect = 3e-05
Identities = 32/98 (32%), Positives = 44/98 (44%), Gaps = 22/98 (22%)
Query: 585 TTLDFSMNNLSGV---IPTTIGGLKGLQYLFLGHNRLQGSIPDSVGD-LISLKSLNLSNN 640
T + + L+ V IP++ L L N+LQ S+P V D L L L+LS N
Sbjct: 10 TEIRCNSKGLTSVPTGIPSS------ATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSQN 62
Query: 641 NLSGPIPTSLE-----KLSDLKELNLSFNKLEGEIPRG 673
+ SL KL+ L L L NKL+ +P G
Sbjct: 63 QI-----QSLPDGVFDKLTKLTILYLHENKLQ-SLPNG 94
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 7e-05
Identities = 35/118 (29%), Positives = 50/118 (42%), Gaps = 12/118 (10%)
Query: 341 EELYLWGNNFSGTLPSFIFNA-SNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNYLT 399
L L N +LP +F+ + L+KLSL N L F L L L L+ N L
Sbjct: 31 TRLELESNKLQ-SLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQ 89
Query: 400 S-PELSFLSSLSNCKYLEIIALSGNPLNGIIPMSAGNLSHSLEELFM---P-DCNVSG 452
S P F L+ K L L N L +P + SL+++++ P DC+
Sbjct: 90 SLPNGVF-DKLTQLKELA---LDTNQLKS-VPDGIFDRLTSLQKIWLHTNPWDCSCPR 142
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 9e-05
Identities = 32/109 (29%), Positives = 49/109 (44%), Gaps = 4/109 (3%)
Query: 534 ASLRELWLGPNELISFIPSTFWNIKDIMYVNFSSNFLTGPLPLEI-ENLKALTTLDFSMN 592
+S L L N+L S F + + ++ S N + LP + + L LT L N
Sbjct: 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQS-LPDGVFDKLTKLTILYLHEN 86
Query: 593 NLSGVIPTTIGGLKGLQYLFLGHNRLQGSIPDSVGD-LISLKSLNLSNN 640
L + L L+ L L N+L+ S+PD + D L SL+ + L N
Sbjct: 87 KLQSLPNGVFDKLTQLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 134
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 1e-09
Identities = 35/165 (21%), Positives = 67/165 (40%), Gaps = 30/165 (18%)
Query: 776 LIGRGSFGSVYIA-RLQNGIEVAVKTF--------DLQHERAF-KSFDTECEVMKSIRHR 825
IG G FG +Y+A + A L E F + + + K I +
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103
Query: 826 NLTKI---------ISSCSNEDFKALILEYMRNG-SLEKCLYSGNYILDIFQRLNIMIDV 875
L + ++ ++ +++E + G L+K + N L + I +
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQK-ISGQNGTFKKSTVLQLGIRM 160
Query: 876 ASALEYLHFGYSAPVIHCDLKPSNVLL---DDNMVAHLSDFGIAK 917
LEY+H +H D+K +N+LL + + V +L+D+G++
Sbjct: 161 LDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQV-YLADYGLSY 201
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 2e-09
Identities = 57/364 (15%), Positives = 110/364 (30%), Gaps = 89/364 (24%)
Query: 164 LGNLSSLQLLDLSDNQLSGSIPSFIFKI-----SSLQALHFGNNRLSGELPANICDNLPF 218
+ LDLS N L + + +S+ +L+ N L + + L
Sbjct: 18 TSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILA- 76
Query: 219 LNFFSVYKNMFYGGISSTLSNCKHLRILDLSFNDLWGDIPKEIGNL-----TKLKELFLD 273
+ ++ L+LS N L E+ + L L
Sbjct: 77 -------------------AIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLG 117
Query: 274 FNILQGE----IPHTVGNLH-NLEYLSLVNNELVGTVPATIFNVSTLKLIELSNNTFFGS 328
+N + NL ++ L+L N+L G + + L +
Sbjct: 118 WNDFSSKSSSEFKQAFSNLPASITSLNLRGNDL-GIKSSDEL-IQILA----AIPA---- 167
Query: 329 LPSSTDVQLPNLEELYLWGNNFSGTLPSFIFNA-----SNLSKLSLGDNSF-----SGLI 378
N+ L L GNN + + + ++++ L L N + L
Sbjct: 168 ----------NVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELA 217
Query: 379 PNTFGNLRNLKRLRLYNNYLTSPELSFLSS-LSNCKYLEIIALSGNPLNGIIPMSAGNLS 437
++ L L N L P L L + K+L+ + L + + + L
Sbjct: 218 YIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALG 277
Query: 438 HSLEELFMPDCNVSGRIPKEIGNLANLVTLDLGGNKFNGSIPIALGKL-----QKLQLLN 492
+ N+ ++ +D G + + S I + L K + +
Sbjct: 278 AAFP------------------NIQKIILVDKNGKEIHPSHSIPISNLIRELSGKADVPS 319
Query: 493 LDDN 496
L +
Sbjct: 320 LLNQ 323
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 1e-08
Identities = 63/362 (17%), Positives = 112/362 (30%), Gaps = 67/362 (18%)
Query: 232 GISSTLSNCKHLRILDLSFNDLWGDIPKEIG-----NLTKLKELFLDFNILQGEIPHTVG 286
+ S + LDLS N+L+ E+ + L L N L + +
Sbjct: 13 PVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELV 72
Query: 287 -----NLHNLEYLSLVNNELVGTVPATIFNVSTLKLIELSNNTFFGSLPSSTDVQLPNLE 341
N+ L+L N L + V TL + +
Sbjct: 73 QILAAIPANVTSLNLSGNFL-SYKSSDEL-VKTLA----AIPF--------------TIT 112
Query: 342 ELYLWGNNFSGTLPSFIFNA-----SNLSKLSLGDNSFS-----GLIPNTFGNLRNLKRL 391
L L N+FS S A ++++ L+L N LI N+ L
Sbjct: 113 VLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSL 172
Query: 392 RLYNNYLTSPELSFLSSL--SNCKYLEIIALSGNPLN--GIIPMSAG--NLSHSLEELFM 445
L N L S + L+ S + + LS N L ++ ++ + + L +
Sbjct: 173 NLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNL 232
Query: 446 PDCNVSGRIPKEIGNL----ANLVTLDLGGNKFNG-------SIPIALGKLQKLQLLNLD 494
+ G + + L +L T+ L + ++ A +QK+ L++ +
Sbjct: 233 CLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKN 292
Query: 495 DNKLEGSIPDDICGLVE-----LYKLALGDNKLS-----GQIPACFGNLASLRELWLGPN 544
++ S I L+ +L + L LRE
Sbjct: 293 GKEIHPSHSIPISNLIRELSGKADVPSLLNQCLIFAQKHQTNIEDLNIPDELRESIQTCK 352
Query: 545 EL 546
L
Sbjct: 353 PL 354
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 3e-08
Identities = 52/325 (16%), Positives = 92/325 (28%), Gaps = 60/325 (18%)
Query: 91 LGNLSSLEILDLNFNRLSGEIPWELG-----NLAKLEKLLLHNNFLTGTIPFSIFKL--- 142
+ LDL+ N L EL A + L L N L + ++
Sbjct: 18 TSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAA 77
Query: 143 --SSLLDLKLSDNNLTGT----IPSHNLGNLSSLQLLDLSDNQLSGS-----IPSFIFKI 191
+++ L LS N L+ + ++ +LDL N S +F
Sbjct: 78 IPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLP 137
Query: 192 SSLQALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGGISST---------LSNCKH 242
+S+ +L+ N L + + L + N+ ++S S
Sbjct: 138 ASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPAS 197
Query: 243 LRILDLSFNDLWGDIPKEIG-----NLTKLKELFLDFNILQGE----IPHTVGNLHNLEY 293
+ LDLS N L E+ + L L N L G + +L +L+
Sbjct: 198 VTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQT 257
Query: 294 LSLVNNELVGTVPATIFNVSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSGT 353
+ L + + + N + + G +
Sbjct: 258 VYLDYDIVKNMSKEQCKALGAA----FPNIQ--------------KIILVDKNGKEIHPS 299
Query: 354 LPSFIFNA-----SNLSKLSLGDNS 373
I N SL +
Sbjct: 300 HSIPISNLIRELSGKADVPSLLNQC 324
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 1e-07
Identities = 61/347 (17%), Positives = 110/347 (31%), Gaps = 61/347 (17%)
Query: 363 NLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNYLTSPELSFLSSL--SNCKYLEIIAL 420
+LS +L S LI ++ L L N L L + + + + L
Sbjct: 28 DLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNL 87
Query: 421 SGNPLN--GIIPMSAG--NLSHSLEELFMPDCNVSGRIPKEIGNL-----ANLVTLDLGG 471
SGN L+ + + ++ L + + S + E A++ +L+L G
Sbjct: 88 SGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRG 147
Query: 472 NKFNGSIPIALGKL-----QKLQLLNLDDNKLEGSIPDDICGLVELYKLALGDNKLSGQI 526
N L ++ + LNL N L EL K
Sbjct: 148 NDLGIKSSDELIQILAAIPANVNSLNLRGNNLASK------NCAELAKFLASIPA----- 196
Query: 527 PACFGNLASLRELWLGPNEL----ISFIPSTFWNIKD-IMYVNFSSNFLTGP----LPLE 577
S+ L L N L + + F +I + ++ +N N L GP L L
Sbjct: 197 --------SVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLL 248
Query: 578 IENLKALTTLDFSMNNLSGV-------IPTTIGGLKGLQYLFLGHNRLQGSIPDSVGDLI 630
++LK L T+ + + + + ++ + + + S + +LI
Sbjct: 249 KDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPISNLI 308
Query: 631 -----SLKSLNLSNNNLS-----GPIPTSLEKLSDLKELNLSFNKLE 667
+L N L L +L+E + L
Sbjct: 309 RELSGKADVPSLLNQCLIFAQKHQTNIEDLNIPDELRESIQTCKPLL 355
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 8e-06
Identities = 46/318 (14%), Positives = 94/318 (29%), Gaps = 60/318 (18%)
Query: 393 LYNNYLTSPELSFLSS-LSNCKYLEIIALSGNPL--NGIIPMSAG--NLSHSLEELFMPD 447
+ P + + S + + LS N L + + N S+ L +
Sbjct: 1 MNYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSG 60
Query: 448 CNVSGRIPKEIG-----NLANLVTLDLGGNKFNGSIPIALGKL-----QKLQLLNLDDNK 497
++ + E+ AN+ +L+L GN + L K + +L+L N
Sbjct: 61 NSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWND 120
Query: 498 LEGSIPDDICGLVE-----LYKLALGDNKLSGQ-----IPACFGNLASLRELWLGPNELI 547
+ + L L N L + I A++ L L N
Sbjct: 121 FSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGN--- 177
Query: 548 SFIPSTFWNIKDIMYVNFSSNFLTGPLPLEIENLKALTTLDFSMNNLSGVIPTTIG-GLK 606
N+ + + P ++T+LD S N L +
Sbjct: 178 --------NLASKNCAELAKFLASIP--------ASVTSLDLSANLLGLKSYAELAYIFS 221
Query: 607 G----LQYLFLGHNRLQGS----IPDSVGDLISLKSLNLSNNNLSGP-------IPTSLE 651
+ L L N L G + L L+++ L + + + +
Sbjct: 222 SIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFP 281
Query: 652 KLSDLKELNLSFNKLEGE 669
+ + ++ + ++
Sbjct: 282 NIQKIILVDKNGKEIHPS 299
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 2e-05
Identities = 37/256 (14%), Positives = 75/256 (29%), Gaps = 41/256 (16%)
Query: 69 NQRRVTALNISYLSLTGNIPRQLGNL-----SSLEILDLNFNRLSGEIPWELGNL----- 118
+T L++ + + + +S+ L+L N L + EL +
Sbjct: 107 IPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIP 166
Query: 119 AKLEKLLLHNNFLTGTIPFSIFKL-----SSLLDLKLSDNNLTGT----IPSHNLGNLSS 169
A + L L N L + K +S+ L LS N L + +
Sbjct: 167 ANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNH 226
Query: 170 LQLLDLSDNQLSGS----IPSFIFKISSLQALHFGNNRLSGELPANICDNLPFLNFFSVY 225
+ L+L N L G + + LQ ++ + +
Sbjct: 227 VVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKA----------- 275
Query: 226 KNMFYGGISSTLSNCKHLRILDLSFNDLWGDIPKEIGNLTKLKELFLDFNILQGEIPHTV 285
+ + N + + ++D + ++ I NL + D L +
Sbjct: 276 -------LGAAFPNIQKIILVDKNGKEIHPSHSIPISNLIRELSGKADVPSLLNQCLIFA 328
Query: 286 GNLHNLEYLSLVNNEL 301
+ +EL
Sbjct: 329 QKHQTNIEDLNIPDEL 344
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 2e-09
Identities = 50/203 (24%), Positives = 85/203 (41%), Gaps = 24/203 (11%)
Query: 776 LIGRGSFGSVYIAR-LQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHR---NLTKII 831
+IG+GSFG V A + VA+K +R + E +++ +R + N +I
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVR-NEKRFHRQAAEEIRILEHLRKQDKDNTMNVI 162
Query: 832 SSCSNEDFKA---LILEYMRNGSLEKCLYSGNYI---LDIFQRLNIMIDVASALEYLHFG 885
N F+ + E + +L + + + L + ++ + L+ LH
Sbjct: 163 HMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRK--FAHSILQCLDALH-- 217
Query: 886 YSAPVIHCDLKPSNVLLDDNMVAH--LSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYG 943
+IHCDLKP N+LL + + DFG + E Q + + + Y APE
Sbjct: 218 -KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY---EHQRV--YTYIQSRFYRAPEVI 271
Query: 944 REGRVSTKGDVYSFGILLMETFT 966
R D++S G +L E T
Sbjct: 272 LGARYGMPIDMWSLGCILAELLT 294
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 3e-09
Identities = 35/168 (20%), Positives = 65/168 (38%), Gaps = 33/168 (19%)
Query: 259 KEIGNLTKLKELFLDFNILQ-GEIPHTVGNLHNLEYLSLVNNELVGTVPATIFNVSTLKL 317
++ T+ +++ L I ++ T+ L ++L+L N + I ++S ++
Sbjct: 17 RKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNI-----EKISSLSGME- 70
Query: 318 IELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSGTLPSFIFNASNLSKLSLGDNSFSGL 377
NL L L N + + A L +L + N + L
Sbjct: 71 ---------------------NLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASL 108
Query: 378 IPNTFGNLRNLKRLRLYNNYLTSPELSFLSSLSNCKYLEIIALSGNPL 425
+ L NL+ L + NN +T + L+ LE + L+GNPL
Sbjct: 109 --SGIEKLVNLRVLYMSNNKIT--NWGEIDKLAALDKLEDLLLAGNPL 152
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 2e-08
Identities = 30/163 (18%), Positives = 63/163 (38%), Gaps = 22/163 (13%)
Query: 86 NIPRQLGNLSSLEILDLNFNRLSGEIPWELGNLAKLEKLLLHNNFLTGTIPFSIFKLSSL 145
+ L L + + L L+ N + +I L + L L L N + I +L
Sbjct: 39 KMDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTL 95
Query: 146 LDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQLSG-SIPSFIFKISSLQALHFGNNRL 204
+L +S N + ++ + L +L++L +S+N+++ + + L+ L N
Sbjct: 96 EELWISYNQIA-SL--SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNP- 151
Query: 205 SGELPANICDNLPFLNFFSVYKNMFYGGISSTLSNCKHLRILD 247
+ ++ N S Y+ + +L+ LD
Sbjct: 152 -------LYNDYKENNATSEYRIE-------VVKRLPNLKKLD 180
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 2e-07
Identities = 26/94 (27%), Positives = 50/94 (53%), Gaps = 5/94 (5%)
Query: 574 LPLEIENLKALTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQGSIPDSVGDLISLK 633
+ + LKA L S NN+ + +++ G++ L+ L LG N ++ I + +L+
Sbjct: 40 MDATLSTLKACKHLALSTNNIEKI--SSLSGMENLRILSLGRNLIK-KIENLDAVADTLE 96
Query: 634 SLNLSNNNLSGPIPTSLEKLSDLKELNLSFNKLE 667
L +S N ++ + +EKL +L+ L +S NK+
Sbjct: 97 ELWISYNQIA--SLSGIEKLVNLRVLYMSNNKIT 128
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 9e-07
Identities = 33/174 (18%), Positives = 62/174 (35%), Gaps = 39/174 (22%)
Query: 510 VELYKLALGDNKLSGQIPACFGNLASLRELWLGPNELISFIPSTFWNIKDIMYVNFSSNF 569
E +L + + A L + + L L N NI+ I S+
Sbjct: 25 AEKVELHGMIPPIEK-MDATLSTLKACKHLALSTN-----------NIEKI------SS- 65
Query: 570 LTGPLPLEIENLKALTTLDFSMNNLSGVIPTTIGGL----KGLQYLFLGHNRLQGSIPDS 625
+ ++ L L N + I L L+ L++ +N++ S+
Sbjct: 66 --------LSGMENLRILSLGRNLI-----KKIENLDAVADTLEELWISYNQIA-SL-SG 110
Query: 626 VGDLISLKSLNLSNNNLSGPIP-TSLEKLSDLKELNLSFNKLEGEIPRGGPFVN 678
+ L++L+ L +SNN ++ L L L++L L+ N L +
Sbjct: 111 IEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSE 164
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 37/158 (23%), Positives = 60/158 (37%), Gaps = 43/158 (27%)
Query: 197 LHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGGIS--STLSNCKHLRILDLSFNDLW 254
LH + ++ A + L ++ N I S+LS ++LRIL L N +
Sbjct: 30 LHGMIPPIE-KMDATL-STLKACKHLALSTNN----IEKISSLSGMENLRILSLGRNLI- 82
Query: 255 GDIPKEIGNL----TKLKELFLDFNILQGEIPHTVGNLHNLEYLSLVNNELVGTVPATIF 310
K+I NL L+EL++ +N + + + L NL L + NN++
Sbjct: 83 ----KKIENLDAVADTLEELWISYNQIA-SLSG-IEKLVNLRVLYMSNNKI-----TNWG 131
Query: 311 NVSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGN 348
+ L L LE+L L GN
Sbjct: 132 EIDKLA-------------------ALDKLEDLLLAGN 150
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 3e-04
Identities = 31/168 (18%), Positives = 50/168 (29%), Gaps = 54/168 (32%)
Query: 453 RIPKEIGNLANLVTLDLGGNKFNGSIPIALGKLQKLQLLNLDDNKLEGSIPDDICGLVEL 512
++ + L L L N I +L ++ L++L+L N ++ I L +
Sbjct: 39 KMDATLSTLKACKHLALSTNNI-EKI-SSLSGMENLRILSLGRNLIK-----KIENLDAV 91
Query: 513 YKLALGDNKLSGQIPACFGNLASLRELWLGPNELISFIPSTFWNIKDIMYVNFSSNFLTG 572
+L ELW+ N I +
Sbjct: 92 --------------------ADTLEELWISYN-----------QIASLS----------- 109
Query: 573 PLPLEIENLKALTTLDFSMNNLSGVIP-TTIGGLKGLQYLFLGHNRLQ 619
IE L L L S N ++ + L L+ L L N L
Sbjct: 110 ----GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLY 153
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 5e-09
Identities = 27/117 (23%), Positives = 40/117 (34%), Gaps = 8/117 (6%)
Query: 311 NVSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFS--GTLPSFIFNASNLSKLS 368
S +K + L N+ + LE L + LP L KL
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSIANLPKLN----KLKKLE 70
Query: 369 LGDNSFSGLIPNTFGNLRNLKRLRLYNNYLTSPELSFLSSLSNCKYLEIIALSGNPL 425
L DN SG + NL L L N + +LS + L + L+ + L +
Sbjct: 71 LSDNRVSGGLEVLAEKCPNLTHLNLSGNKIK--DLSTIEPLKKLENLKSLDLFNCEV 125
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 4e-07
Identities = 36/136 (26%), Positives = 51/136 (37%), Gaps = 29/136 (21%)
Query: 263 NLTKLKELFLDFN-ILQGEIPHTVGNLHNLEYLSLVNNELVGTVPATIFNVSTLKLIELS 321
+ +KEL LD + +G++ LE+LS +N L ++
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT----------------SIA 58
Query: 322 NNTFFGSLPSSTDVQLPNLEELYLWGNNFSGTLPSFIFNASNLSKLSLGDNSFSGL-IPN 380
N LP L L++L L N SG L NL+ L+L N L
Sbjct: 59 N------LPK-----LNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIE 107
Query: 381 TFGNLRNLKRLRLYNN 396
L NLK L L+N
Sbjct: 108 PLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 5e-07
Identities = 23/88 (26%), Positives = 36/88 (40%), Gaps = 3/88 (3%)
Query: 578 IENLKALTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQGSIPDSVGDLISLKSLNL 637
+ + L L L+ + + L L+ L L NR+ G + +L LNL
Sbjct: 38 TDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNL 95
Query: 638 SNNNLSGP-IPTSLEKLSDLKELNLSFN 664
S N + L+KL +LK L+L
Sbjct: 96 SGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 9e-07
Identities = 26/88 (29%), Positives = 37/88 (42%), Gaps = 2/88 (2%)
Query: 91 LGNLSSLEILDLNFNRLSGEIPWELGNLAKLEKLLLHNNFLTGTIPFSIFKLSSLLDLKL 150
LE L L+ I L L KL+KL L +N ++G + K +L L L
Sbjct: 38 TDEFEELEFLSTINVGLT-SIA-NLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNL 95
Query: 151 SDNNLTGTIPSHNLGNLSSLQLLDLSDN 178
S N + L L +L+ LDL +
Sbjct: 96 SGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 4e-06
Identities = 36/165 (21%), Positives = 65/165 (39%), Gaps = 31/165 (18%)
Query: 453 RIPKEIG--NLANLVTLDLGGNKFN-GSIPIALGKLQKLQLLNLDDNKLEGSIPDDICGL 509
RI E+ +++ L L ++ N G + + ++L+ L+ + L SI ++ L
Sbjct: 6 RIHLELRNRTPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKL 63
Query: 510 VELYKLALGDNKLSGQIPACFGNLASLRELWLGPNELISFIPSTFWNIKDIMYVNFSSNF 569
+L KL L DN++SG + +L L L N++ ++ I
Sbjct: 64 NKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKI--------KDLSTIEP------- 108
Query: 570 LTGPLPLEIENLKALTTLDFSMN---NLSGVIPTTIGGLKGLQYL 611
++ L+ L +LD NL+ L L YL
Sbjct: 109 --------LKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYL 145
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 1e-05
Identities = 30/136 (22%), Positives = 55/136 (40%), Gaps = 28/136 (20%)
Query: 117 NLAKLEKLLLHNNFLT-GTIPFSIFKLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDL 175
+ +++L+L N+ G + + L L + LT +I NL L+ L+ L+L
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIA--NLPKLNKLKKLEL 71
Query: 176 SDNQLSGSIPSFIFKISSLQALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGGISS 235
SDN++SG + K +L L+ N++ +L +
Sbjct: 72 SDNRVSGGLEVLAEKCPNLTHLNLSGNKIK---------DLSTIEP-------------- 108
Query: 236 TLSNCKHLRILDLSFN 251
L ++L+ LDL
Sbjct: 109 -LKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 1e-05
Identities = 25/115 (21%), Positives = 38/115 (33%), Gaps = 32/115 (27%)
Query: 237 LSNCKHLRILDLSFNDLWGDIPKEIGNL---TKLKELFLDFNILQGEIPHTVGNLHNLEY 293
+ L L L I NL KLK+L L N + G + NL +
Sbjct: 38 TDEFEELEFLSTINVGL-----TSIANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTH 92
Query: 294 LSLVNNELVGTVPATIFNVSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGN 348
L+L N++ + + LK +L NL+ L L+
Sbjct: 93 LNLSGNKI-----KDLSTIEPLK-------------------KLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 2e-05
Identities = 26/114 (22%), Positives = 49/114 (42%), Gaps = 10/114 (8%)
Query: 532 NLASLRELWLGPNEL-ISFIPSTFWNIKDIMYVNFSSNFLTGPLPLEIENL---KALTTL 587
+ ++EL L + + +++ +++ + LT I NL L L
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-----SIANLPKLNKLKKL 69
Query: 588 DFSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQG-SIPDSVGDLISLKSLNLSNN 640
+ S N +SG + L +L L N+++ S + + L +LKSL+L N
Sbjct: 70 ELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 5e-05
Identities = 30/89 (33%), Positives = 46/89 (51%), Gaps = 4/89 (4%)
Query: 579 ENLKALTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQGSIPDSVGDLISLKSLNLS 638
++K L LD S +N G + + L++L + L SI + + L LK L LS
Sbjct: 17 SDVKELV-LDNSRSNE-GKLEGLTDEFEELEFLSTINVGLT-SIAN-LPKLNKLKKLELS 72
Query: 639 NNNLSGPIPTSLEKLSDLKELNLSFNKLE 667
+N +SG + EK +L LNLS NK++
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIK 101
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 6e-09
Identities = 27/117 (23%), Positives = 40/117 (34%), Gaps = 8/117 (6%)
Query: 311 NVSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFS--GTLPSFIFNASNLSKLS 368
+ ++ + L N + NLE L L LP L KL
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISVSNLPKL----PKLKKLE 77
Query: 369 LGDNSFSGLIPNTFGNLRNLKRLRLYNNYLTSPELSFLSSLSNCKYLEIIALSGNPL 425
L +N G + L NL L L N L ++S L L + L+ + L +
Sbjct: 78 LSENRIFGGLDMLAEKLPNLTHLNLSGNKLK--DISTLEPLKKLECLKSLDLFNCEV 132
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 5e-07
Identities = 26/88 (29%), Positives = 34/88 (38%), Gaps = 3/88 (3%)
Query: 578 IENLKALTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQGSIPDSVGDLISLKSLNL 637
L L L V + + L L+ L L NR+ G + L +L LNL
Sbjct: 45 TAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNL 102
Query: 638 SNNNLSGP-IPTSLEKLSDLKELNLSFN 664
S N L L+KL LK L+L
Sbjct: 103 SGNKLKDISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 49.4 bits (118), Expect = 8e-07
Identities = 32/119 (26%), Positives = 47/119 (39%), Gaps = 6/119 (5%)
Query: 67 DINQRRVTALNISYLSLTGN----IPRQLGNLSSLEILDLNFNRLSGEIPWELGNLAKLE 122
++ R A+ L + I +LE L L L + L L KL+
Sbjct: 17 ELRNRTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVS-NLPKLPKLK 74
Query: 123 KLLLHNNFLTGTIPFSIFKLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQLS 181
KL L N + G + KL +L L LS N L L L L+ LDL + +++
Sbjct: 75 KLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVT 133
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 4e-06
Identities = 30/136 (22%), Positives = 52/136 (38%), Gaps = 28/136 (20%)
Query: 117 NLAKLEKLLLHNNFLT-GTIPFSIFKLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDL 175
A + +L+L N G I + +L L L + L ++ NL L L+ L+L
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVS--NLPKLPKLKKLEL 78
Query: 176 SDNQLSGSIPSFIFKISSLQALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGGISS 235
S+N++ G + K+ +L L+ N+L ++ L
Sbjct: 79 SENRIFGGLDMLAEKLPNLTHLNLSGNKLK---------DISTLEP-------------- 115
Query: 236 TLSNCKHLRILDLSFN 251
L + L+ LDL
Sbjct: 116 -LKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 8e-06
Identities = 28/119 (23%), Positives = 41/119 (34%), Gaps = 32/119 (26%)
Query: 233 ISSTLSNCKHLRILDLSFNDLWGDIPKEIGNL---TKLKELFLDFNILQGEIPHTVGNLH 289
I + +L L L L + NL KLK+L L N + G + L
Sbjct: 41 IEGLTAEFVNLEFLSLINVGL-----ISVSNLPKLPKLKKLELSENRIFGGLDMLAEKLP 95
Query: 290 NLEYLSLVNNELVGTVPATIFNVSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGN 348
NL +L+L N+L I + LK +L L+ L L+
Sbjct: 96 NLTHLNLSGNKL-----KDISTLEPLK-------------------KLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 1e-05
Identities = 36/156 (23%), Positives = 59/156 (37%), Gaps = 29/156 (18%)
Query: 460 NLANLVTLDLGGNKFN-GSIPIALGKLQKLQLLNLDDNKLEGSIPDDICGLVELYKLALG 518
A + L L K N G I + L+ L+L + L S+ ++ L +L KL L
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLELS 79
Query: 519 DNKLSGQIPACFGNLASLRELWLGPNELISFIPSTFWNIKDIMYVNFSSNFLTGPLPLEI 578
+N++ G + L +L L L N+L +I + +
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGNKL--------KDISTLEP---------------L 116
Query: 579 ENLKALTTLDFSMN---NLSGVIPTTIGGLKGLQYL 611
+ L+ L +LD NL+ + L L YL
Sbjct: 117 KKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYL 152
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 44.0 bits (104), Expect = 5e-05
Identities = 29/93 (31%), Positives = 41/93 (44%), Gaps = 3/93 (3%)
Query: 576 LEIENLKALTTLDFSMNNLS-GVIPTTIGGLKGLQYLFLGHNRLQGSIPDSVGDLISLKS 634
L A+ L + G I L++L L + L S+ ++ L LK
Sbjct: 18 LRNRTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKK 75
Query: 635 LNLSNNNLSGPIPTSLEKLSDLKELNLSFNKLE 667
L LS N + G + EKL +L LNLS NKL+
Sbjct: 76 LELSENRIFGGLDMLAEKLPNLTHLNLSGNKLK 108
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 41.3 bits (97), Expect = 4e-04
Identities = 31/110 (28%), Positives = 45/110 (40%), Gaps = 4/110 (3%)
Query: 439 SLEELFMPDC-NVSGRIPKEIGNLANLVTLDLGGNKFNGSIPIALGKLQKLQLLNLDDNK 497
++ EL + +C + G+I NL L L S+ L KL KL+ L L +N+
Sbjct: 25 AVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSN-LPKLPKLKKLELSENR 82
Query: 498 LEGSIPDDICGLVELYKLALGDNKLSG-QIPACFGNLASLRELWLGPNEL 546
+ G + L L L L NKL L L+ L L E+
Sbjct: 83 IFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEV 132
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 40.5 bits (95), Expect = 8e-04
Identities = 26/115 (22%), Positives = 45/115 (39%), Gaps = 9/115 (7%)
Query: 192 SSLQALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGGISS--TLSNCKHLRILDLS 249
++++ L N + + + L F S+ G+ S L L+ L+LS
Sbjct: 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINV----GLISVSNLPKLPKLKKLELS 79
Query: 250 FNDLWGDIPKEIGNLTKLKELFLDFNILQ--GEIPHTVGNLHNLEYLSLVNNELV 302
N ++G + L L L L N L+ + + L L+ L L N E+
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTL-EPLKKLECLKSLDLFNCEVT 133
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 56.4 bits (135), Expect = 2e-08
Identities = 33/201 (16%), Positives = 56/201 (27%), Gaps = 54/201 (26%)
Query: 765 FQATNGFSENNLIGRGSFGSVYIARLQNGIEVAVK--------TFDLQHERAFKSFDTEC 816
T IG G FG V+ + VA+K + H++ F+ E
Sbjct: 16 CLPTEKLQRCEKIGEGVFGEVFQTIADHT-PVAIKIIAIEGPDLVNGSHQKTFEEILPEI 74
Query: 817 EVMKSI---------RHRNLTKIISSC------------------------------SNE 837
+ K + R + S +
Sbjct: 75 IISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKD 134
Query: 838 DFKALILEYMRNG-SLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLK 896
D ++LE+ G LE+ + + +I+ + ++L H DL
Sbjct: 135 DQLFIVLEFEFGGIDLEQMRTK---LSSLATAKSILHQLTASLAVAEASLR--FEHRDLH 189
Query: 897 PSNVLLDDNMVAHLSDFGIAK 917
NVLL + L K
Sbjct: 190 WGNVLLKKTSLKKLHYTLNGK 210
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 4e-08
Identities = 21/94 (22%), Positives = 32/94 (34%), Gaps = 8/94 (8%)
Query: 334 DVQLPNLEELYLWGNNFS--GTLPSFIFNASNLSKLSLGDNSFSGLIPNTFGNLRNLKRL 391
L + + N P L L + +N + L +L L
Sbjct: 38 GATLDQFDAIDFSDNEIRKLDGFPLL----RRLKTLLVNNNRICRIGEGLDQALPDLTEL 93
Query: 392 RLYNNYLTSPELSFLSSLSNCKYLEIIALSGNPL 425
L NN L EL L L++ K L + + NP+
Sbjct: 94 ILTNNSLV--ELGDLDPLASLKSLTYLCILRNPV 125
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 1e-07
Identities = 29/113 (25%), Positives = 43/113 (38%), Gaps = 10/113 (8%)
Query: 532 NLASLRELWLGPNEL--ISFIPSTFWNIKDIMYVNFSSNFLTGPLPLE-IENLKALTTLD 588
N REL L ++ I + +T I +FS N + L+ L+ L TL
Sbjct: 17 NAVRDRELDLRGYKIPVIENLGATLDQFDAI---DFSDNEIR---KLDGFPLLRRLKTLL 70
Query: 589 FSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQG-SIPDSVGDLISLKSLNLSNN 640
+ N + + L L L L +N L D + L SL L + N
Sbjct: 71 VNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 2e-07
Identities = 24/114 (21%), Positives = 39/114 (34%), Gaps = 5/114 (4%)
Query: 90 QLGNLSSLEILDLNFNRLSGEIPWELGNLAKLEKLLLHNNFLTGTIPFSIFKLSSLLDLK 149
Q N LDL ++ I L + + + +N + F L L L
Sbjct: 14 QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGFP--LLRRLKTLL 70
Query: 150 LSDNNLTGTIPSHNLGNLSSLQLLDLSDNQLSG-SIPSFIFKISSLQALHFGNN 202
+++N + I L L L L++N L + + SL L N
Sbjct: 71 VNNNRIC-RIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 4e-06
Identities = 24/152 (15%), Positives = 50/152 (32%), Gaps = 9/152 (5%)
Query: 99 ILDLNFNRLSGEIPWELGNLAKLEKLLLHNNFLTGTIPFSIFKLSSLLDLKLSDNNLTGT 158
++ L + + + N + +L L + I L + SDN +
Sbjct: 1 MVKLTAELIE-QAA-QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-K 56
Query: 159 IPSHNLGNLSSLQLLDLSDNQLSGSIPSFIFKISSLQALHFGNNRLSGELPANICDNLPF 218
+ L L+ L +++N++ + L L NN L + +L
Sbjct: 57 LD--GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKS 114
Query: 219 LNFFSVYKN---MFYGGISSTLSNCKHLRILD 247
L + + +N + +R+LD
Sbjct: 115 LTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD 146
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 6e-06
Identities = 21/119 (17%), Positives = 39/119 (32%), Gaps = 32/119 (26%)
Query: 233 ISSTLSNCKHLRILDLSFNDLWGDIPKEIGN---LTKLKELFLDFNILQGEIPHTVGNLH 289
I + + +D S N++ +++ L +LK L ++ N + L
Sbjct: 34 IENLGATLDQFDAIDFSDNEI-----RKLDGFPLLRRLKTLLVNNNRICRIGEGLDQALP 88
Query: 290 NLEYLSLVNNELVGTVPATIFNVSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGN 348
+L L L NN L + ++ L L +L L + N
Sbjct: 89 DLTELILTNNSL-----VELGDLDPLA-------------------SLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 8e-06
Identities = 25/146 (17%), Positives = 52/146 (35%), Gaps = 15/146 (10%)
Query: 360 NASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNYLTSPELSFLSSLSNCKYLEIIA 419
NA +L L +I N L + +N + L + L+ +
Sbjct: 17 NAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRK-----LDGFPLLRRLKTLL 70
Query: 420 LSGNPLNGIIPMSAGNLSHSLEELFMPDCNVSGRIPKEIGNLA---NLVTLDLGGN---K 473
++ N + I L L EL + + ++ ++ LA +L L + N
Sbjct: 71 VNNNRICRIGEGLDQAL-PDLTELILTNNSLVE--LGDLDPLASLKSLTYLCILRNPVTN 127
Query: 474 FNGSIPIALGKLQKLQLLNLDDNKLE 499
+ K+ ++++L+ KL+
Sbjct: 128 KKHYRLYVIYKVPQVRVLDFQKVKLK 153
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 8e-06
Identities = 25/133 (18%), Positives = 52/133 (39%), Gaps = 15/133 (11%)
Query: 245 ILDLSFNDLWGDIPKEIGNLTKLKELFLDFNILQGEIPHTVGNLHNLEYLSLVNNELVGT 304
++ L+ + + N + +EL L + I + L + + +NE+
Sbjct: 1 MVKLTAELIE-QAA-QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-- 55
Query: 305 VPATIFNVSTLKLIE---LSNNTFFGSLPSSTDVQLPNLEELYLWGNNFS--GTLPSFIF 359
+ L+ ++ ++NN + D LP+L EL L N+ G L +
Sbjct: 56 ---KLDGFPLLRRLKTLLVNNNRIC-RIGEGLDQALPDLTELILTNNSLVELGDL-DPLA 110
Query: 360 NASNLSKLSLGDN 372
+ +L+ L + N
Sbjct: 111 SLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 2e-05
Identities = 22/91 (24%), Positives = 33/91 (36%), Gaps = 3/91 (3%)
Query: 577 EIENLKALTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQGSIPDSVGDLISLKSLN 636
+ N LD VI L + N ++ + D L LK+L
Sbjct: 14 QYTNAVRDRELDLR-GYKIPVIENLGATLDQFDAIDFSDNEIR-KL-DGFPLLRRLKTLL 70
Query: 637 LSNNNLSGPIPTSLEKLSDLKELNLSFNKLE 667
++NN + + L DL EL L+ N L
Sbjct: 71 VNNNRICRIGEGLDQALPDLTELILTNNSLV 101
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 5e-05
Identities = 22/90 (24%), Positives = 33/90 (36%), Gaps = 3/90 (3%)
Query: 460 NLANLVTLDLGGNKFNGSIPIALGKLQKLQLLNLDDNKLEGSIPDDICGLVELYKLALGD 519
N LDL G K I L + ++ DN++ + D L L L + +
Sbjct: 17 NAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KL-DGFPLLRRLKTLLVNN 73
Query: 520 NKLSGQIPACFGNLASLRELWLGPNELISF 549
N++ L L EL L N L+
Sbjct: 74 NRICRIGEGLDQALPDLTELILTNNSLVEL 103
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 3e-04
Identities = 27/127 (21%), Positives = 41/127 (32%), Gaps = 30/127 (23%)
Query: 77 NISYLSLTGNIPRQLGNLSS---LEILDLNFNRLSGEIPWELGNLAKLEKLLLHNNFLTG 133
+ + N R+L L+ L +N NR+ L L +L+L NN
Sbjct: 43 QFDAIDFSDNEIRKLDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNN---- 98
Query: 134 TIPFSIFKLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDN---QLSGSIPSFIFK 190
L L DL L +L SL L + N I+K
Sbjct: 99 -------SLVELGDLD-------------PLASLKSLTYLCILRNPVTNKKHYRLYVIYK 138
Query: 191 ISSLQAL 197
+ ++ L
Sbjct: 139 VPQVRVL 145
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 4e-04
Identities = 22/132 (16%), Positives = 33/132 (25%), Gaps = 33/132 (25%)
Query: 384 NLRNLKRLRLYNNYLTSPELSFLSSLSNCKYLEIIALSGNPLNGIIPMSAGNLSHSLEEL 443
N + L L + E + + + I S N + +
Sbjct: 17 NAVRDRELDLRGYKIPVIE----NLGATLDQFDAIDFSDNEIRKL-----DGFPL----- 62
Query: 444 FMPDCNVSGRIPKEIGNLANLVTLDLGGNKFNGSIPIALGKLQKLQLLNLDDNKLEGSIP 503
L L TL + N+ L L L L +N L
Sbjct: 63 -----------------LRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSL--VEL 103
Query: 504 DDICGLVELYKL 515
D+ L L L
Sbjct: 104 GDLDPLASLKSL 115
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 54.5 bits (130), Expect = 2e-07
Identities = 56/314 (17%), Positives = 106/314 (33%), Gaps = 72/314 (22%)
Query: 4 RLLFIHCLIHSLII---AASANT--SIDIDQDALLALKDHITYDP--TNFFAKNWLTNST 56
RLL + L++ +A + ++ LL T T+F + T+ +
Sbjct: 236 RLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILL-----TTRFKQVTDFLSAATTTHIS 290
Query: 57 MVCNWTGVTCDINQRRVTALNISYLSL-TGNIPRQLGNLSSL------EILDLNFNRLSG 109
+ + +T V +L + YL ++PR++ + E +
Sbjct: 291 LDHHSMTLT----PDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWD- 345
Query: 110 EIPWELGNLAKLEKLLLHNNFLTGTIP---------FSIF----KLSSLLDLKLSDNNLT 156
W+ N KL ++ + L P S+F + ++L L L ++
Sbjct: 346 --NWKHVNCDKLTTII--ESSLNVLEPAEYRKMFDRLSVFPPSAHIPTIL-LSLIWFDVI 400
Query: 157 GTIPSHNLGNLSSLQLLDLSDNQLSGSIPSFIF----KISSLQALHFGNNRL--SGELPA 210
+ + L L++ + + SIPS K+ + ALH + +P
Sbjct: 401 KSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALH---RSIVDHYNIPK 457
Query: 211 NICDNLPFLNFFSVYKNMFYGGISSTLSNCKHLRILDLSFNDLWGDIPKEIGNLTKLKEL 270
+ + Y FY I L N +H + L + +
Sbjct: 458 TFDSDDLIPPYLDQY---FYSHIGHHLKNIEHPERMTL------------------FRMV 496
Query: 271 FLDFNILQGEIPHT 284
FLDF L+ +I H
Sbjct: 497 FLDFRFLEQKIRHD 510
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 47.9 bits (113), Expect = 2e-05
Identities = 54/311 (17%), Positives = 87/311 (27%), Gaps = 111/311 (35%)
Query: 10 CLIHSL---IIAASANTSIDIDQDALLALKDHI-TYDPTNFFAKNWLTNSTMVCNWTGVT 65
+ IIA S ++D + T+D NW V
Sbjct: 323 LTTNPRRLSIIAES--------------IRDGLATWD-----------------NWKHVN 351
Query: 66 CDINQRRVTALNISYLSLTGNIPRQLGNLSSLEILDLNFNRLSGEIP-------WELGN- 117
CD + T + S L R++ L + + + IP W
Sbjct: 352 CD---KLTTIIESSLNVLEPAEYRKM--FDRLSVFPPSAH-----IPTILLSLIWFDVIK 401
Query: 118 ------LAKLEKLLL---HNNFLTGTIPFSIFKLSSLLDLKLSDNNLTG----TIPSHNL 164
+ KL K L T +IP S L+LK+ N + +N+
Sbjct: 402 SDVMVVVNKLHKYSLVEKQPKESTISIP------SIYLELKVKLENEYALHRSIVDHYNI 455
Query: 165 GNLSSLQLLDLSDNQLSGSIPSFI---------------FKISSLQALHFGNNRLSGELP 209
+ DL L S I F++ L F ++ +
Sbjct: 456 --PKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLD-FRFLEQKIRHDST 512
Query: 210 AN-------------------ICDNLP-FLNFFSVYKNMFYGGISSTLSNCKHLRILDLS 249
A ICDN P + + + F I L K+ +L ++
Sbjct: 513 AWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAILD-FLPKIEENLICSKYTDLLRIA 571
Query: 250 FNDLWGDIPKE 260
I +E
Sbjct: 572 LMAEDEAIFEE 582
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 46.4 bits (109), Expect = 6e-05
Identities = 95/594 (15%), Positives = 181/594 (30%), Gaps = 165/594 (27%)
Query: 98 EILDLNFNRLSGEIPWELGNLAKLEKLLL--HNNFLTGTIPFS---------IFKL-SSL 145
E+L +N+ L I E + + ++ + + F+ KL +L
Sbjct: 85 EVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQAL 144
Query: 146 LDLKLSDNNLTGTIPSHNLGNL--SSLQLLDLSDNQLSGSIPSFIFKISSLQALHFGNNR 203
L+L+ + N + + + + L ++ + IF ++ N
Sbjct: 145 LELRPAKN-----VLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLN------LKNCN 193
Query: 204 LSGELPANICDNLPFLNFFSVYKNMFYGGISSTLSNCKHLRILDLSFNDLWGDIPKEIGN 263
+ + + + Y + S H + L + I E+
Sbjct: 194 SPETVLEML-------------QKLLYQIDPNWTSRSDHSSNIKLRIHS----IQAELRR 236
Query: 264 LTKLKE-----LFLDFNILQGEIPHTVGNLHNLEYLSLVNNE---LVGTVPATIFN-VST 314
L K K L L N+ N + + N L+ T + + +S
Sbjct: 237 LLKSKPYENCLLVLL-------------NVQNAKAWNAFNLSCKILLTTRFKQVTDFLSA 283
Query: 315 LKLIELSNNTFFGSLPSSTDVQLPNLEELYL-WGNNFSGTLPSFIFNASNLSKLSLGDNS 373
+S + +L T ++ L L + + LP + L
Sbjct: 284 ATTTHISLDHHSMTL---TP---DEVKSLLLKYLDCRPQDLPR---EVLTTNPRRLS--- 331
Query: 374 FSGLIPNTFGNLRNLKRLRLYNNYLTSPELSFLSSLSNC-KYLEIIALSGNPLNGIIPMS 432
+I ++R+ L ++N+ NC K II S N L P
Sbjct: 332 ---IIAE---SIRD--GLATWDNWKHV----------NCDKLTTIIESSLNVLE---P-- 368
Query: 433 AGNLSHSLEEL--FMPDCNVSGRIPKEIGNLANLVTLDLGGNKFNGSIPIALGKLQKLQL 490
+ L F P + IP + L + + + + + KL K L
Sbjct: 369 -AEYRKMFDRLSVFPPSAH----IPTIL-----LSLI--WFDVIKSDVMVVVNKLHKYSL 416
Query: 491 LNLDDNKLEGSIPD---DICG-----------LVELYKLALGDNKLSGQIPACFGNLAS- 535
+ + SIP ++ +V+ Y + + P S
Sbjct: 417 VEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSH 476
Query: 536 ----LRELWLGPNELISFIPSTFWNIKDIMYVNFSSNFLTGPLPLEIENLKALTTLDFSM 591
L+ + E ++ ++++F FL +I + D +
Sbjct: 477 IGHHLKN--IEHPERMTLFRM--------VFLDF--RFLEQ----KIRH-------DSTA 513
Query: 592 NNLSGVIPTTIGGLKG-LQYLFLGHN---RLQGSIPDSV----GDLISLKSLNL 637
N SG I T+ LK Y+ RL +I D + +LI K +L
Sbjct: 514 WNASGSILNTLQQLKFYKPYICDNDPKYERLVNAILDFLPKIEENLICSKYTDL 567
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 51.4 bits (123), Expect = 9e-07
Identities = 43/197 (21%), Positives = 71/197 (36%), Gaps = 12/197 (6%)
Query: 306 PATIFNVSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFS-GTLPSFIFNASNL 364
P + + +I F P + ++ + L + TL + S L
Sbjct: 61 PDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKL 120
Query: 365 SKLSLGDNSFSGLIPNTFGNLRNLKRLRLYN-NYLTSPELSFLSSLSNCKYLEIIALSGN 423
LSL S I NT NL RL L + + L L S+C L+ + LS
Sbjct: 121 QNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLL--SSCSRLDELNLSWC 178
Query: 424 PL--NGIIPMSAGNLSHSLEELFMPDC--NVSGRIPKEIG-NLANLVTLDLGGNKF--NG 476
+ ++ ++S ++ +L + N+ + NLV LDL + N
Sbjct: 179 FDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKND 238
Query: 477 SIPIALGKLQKLQLLNL 493
+L LQ L+L
Sbjct: 239 CF-QEFFQLNYLQHLSL 254
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 48.3 bits (115), Expect = 8e-06
Identities = 58/313 (18%), Positives = 111/313 (35%), Gaps = 48/313 (15%)
Query: 89 RQLGNLSSL-EILDLNFNRLSGEIPWELGNLAKLEKLLLHNNFLTGTIPFSIFKLSSLLD 147
+L + SL + LDL L ++ L L++ F +
Sbjct: 40 YRLASDESLWQTLDLTGKNLHPDVTGRL--LSQGVIAFRCPRSFMDQPLAEHFSPFRVQH 97
Query: 148 LKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQLSGSIPSFIFKISSLQALHFGNNRLSGE 207
+ LS++ + + L S LQ L L +LS I + + K S+L L+
Sbjct: 98 MDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCS---- 153
Query: 208 LPANICDNLPFLNFFSVYKNMFYGGISSTLSNCKHLRILDLSFNDLWGDIPKEI---GNL 264
+ + + LS+C L L+LS+ + + ++
Sbjct: 154 ---GFSEF----------------ALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVS 194
Query: 265 TKLKELFLD---FNILQGEIPHTVGNLHNLEYLSLVNNELVGTVP-ATIFNVSTLKLIEL 320
+ +L L N+ + ++ V NL +L L ++ ++ F ++ L+ + L
Sbjct: 195 ETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSL 254
Query: 321 SNNTFFGSLPSSTDV------QLPNLEELYLWGNNFSGTLPSFIFNASNLSKLSLGDNSF 374
S ++P L+ L ++G GTL L L + + F
Sbjct: 255 SRCYDI------IPETLLELGEIPTLKTLQVFGIVPDGTLQLL---KEALPHLQINCSHF 305
Query: 375 SGLIPNTFGNLRN 387
+ + T GN +N
Sbjct: 306 TTIARPTIGNKKN 318
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 1e-06
Identities = 29/86 (33%), Positives = 44/86 (51%), Gaps = 5/86 (5%)
Query: 119 AKLEKLLLHNNFLTGTIPFSIF-KLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSD 177
+ L L++N +T + +F +L+ L L L +N LT +P+ L+ L L L+D
Sbjct: 30 TTTQVLYLYDNQIT-KLEPGVFDRLTQLTRLDLDNNQLT-VLPAGVFDKLTQLTQLSLND 87
Query: 178 NQLSGSIPSFIF-KISSLQALHFGNN 202
NQL SIP F + SL + NN
Sbjct: 88 NQLK-SIPRGAFDNLKSLTHIWLLNN 112
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 2e-06
Identities = 36/98 (36%), Positives = 51/98 (52%), Gaps = 22/98 (22%)
Query: 585 TTLDFSMNNLSGV---IPTTIGGLKGLQYLFLGHNRLQGSIPDSVGD-LISLKSLNLSNN 640
TT+D S +L+ V IPTT Q L+L N++ + V D L L L+L NN
Sbjct: 12 TTVDCSGKSLASVPTGIPTT------TQVLYLYDNQIT-KLEPGVFDRLTQLTRLDLDNN 64
Query: 641 NLSGPIPTSL-----EKLSDLKELNLSFNKLEGEIPRG 673
L T L +KL+ L +L+L+ N+L+ IPRG
Sbjct: 65 QL-----TVLPAGVFDKLTQLTQLSLNDNQLKS-IPRG 96
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 2e-06
Identities = 28/90 (31%), Positives = 43/90 (47%), Gaps = 11/90 (12%)
Query: 339 NLEELYLWGNNFSGTLPSFIFNA-SNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNY 397
+ LYL+ N + L +F+ + L++L L +N + L F L L +L L +N
Sbjct: 31 TTQVLYLYDNQIT-KLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQ 89
Query: 398 LTS-PELSF--LSSLSNCKYLEIIALSGNP 424
L S P +F L SL++ I L NP
Sbjct: 90 LKSIPRGAFDNLKSLTH------IWLLNNP 113
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 44.1 bits (105), Expect = 4e-05
Identities = 30/94 (31%), Positives = 46/94 (48%), Gaps = 7/94 (7%)
Query: 305 VPATIFNVSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSGTLPSFIFNA-SN 363
VP I +T +++ L +N L +L L L L N + LP+ +F+ +
Sbjct: 24 VPTGIP--TTTQVLYLYDNQI-TKLEPGVFDRLTQLTRLDLDNNQLT-VLPAGVFDKLTQ 79
Query: 364 LSKLSLGDNSFSGLIPN-TFGNLRNLKRLRLYNN 396
L++LSL DN IP F NL++L + L NN
Sbjct: 80 LTQLSLNDNQLKS-IPRGAFDNLKSLTHIWLLNN 112
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 6e-05
Identities = 32/96 (33%), Positives = 45/96 (46%), Gaps = 12/96 (12%)
Query: 454 IPKEIGNLANLVTLDLGGNKFNGSIPIALGKLQKLQLLNLDDNKLEGSIPDDICG----L 509
+P I L L N+ P +L +L L+LD+N+L +P G L
Sbjct: 24 VPTGI--PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLT-VLPA---GVFDKL 77
Query: 510 VELYKLALGDNKLSGQIP-ACFGNLASLRELWLGPN 544
+L +L+L DN+L IP F NL SL +WL N
Sbjct: 78 TQLTQLSLNDNQLKS-IPRGAFDNLKSLTHIWLLNN 112
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 50.7 bits (120), Expect = 1e-06
Identities = 25/162 (15%), Positives = 59/162 (36%), Gaps = 17/162 (10%)
Query: 524 GQIPACFGNLASLRELWLGPNELISFIPSTFWNIK--DIMYVNFSSNFLTGPLPLEIENL 581
+ + L L + +S N+K +I+ + + L ++ NL
Sbjct: 162 VDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNL 221
Query: 582 KALTTLDFSMNNLSGVIPTTI-------GGLKGLQYLFLGHNRLQGSIPDSVGD---LIS 631
+ L L + + + L++L + Q + + + L
Sbjct: 222 EKLV-LYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQ 280
Query: 632 LKSLNLSNNNLSG----PIPTSLEKLSDLKELNLSFNKLEGE 669
L+++++S L+ + ++K+ LK +N+ +N L E
Sbjct: 281 LETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDE 322
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 50.7 bits (120), Expect = 1e-06
Identities = 30/190 (15%), Positives = 56/190 (29%), Gaps = 28/190 (14%)
Query: 228 MFYGGISSTLSNCKHLRILDLSFNDLWGDIPKEIGNLTKLKELFLDFNILQGEIPHTVG- 286
+ +S L L L + + K LK L + L + +
Sbjct: 159 IEQVDLSPVLDAMPLLNNLKIKGTNNLSIGKKP---RPNLKSLEIISGGLPDSVVEDILG 215
Query: 287 -NLHNLEYLSLVNNELVGTVPATIFNVSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYL 345
+L NLE L L V F+ L + + PNL+ L +
Sbjct: 216 SDLPNLEKL-----VLYVGVEDYGFDGDMNVFRPLFSKD-----------RFPNLKWLGI 259
Query: 346 WGNNFSGTLPSFIFNA---SNLSKLSLGDNSFSG----LIPNTFGNLRNLKRLRLYNNYL 398
+ + L + + + L+ + +++LK + + NYL
Sbjct: 260 VDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYL 319
Query: 399 TSPELSFLSS 408
+ L
Sbjct: 320 SDEMKKELQK 329
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 48.0 bits (113), Expect = 9e-06
Identities = 23/158 (14%), Positives = 51/158 (32%), Gaps = 18/158 (11%)
Query: 42 DPTNFFAKNWLTNSTMVCNWTGVTCDINQR-RVTALNISYLSLTGNIPRQLG--NLSSLE 98
D + L N+ + ++ R + +L I L ++ + +L +LE
Sbjct: 163 DLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLE 222
Query: 99 ILDLNF--NRLSGEIP-------WELGNLAKLEKLLLHNNFLTGTIPFSIFK---LSSLL 146
L L + + L+ L + + + + L L
Sbjct: 223 KLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLE 282
Query: 147 DLKLSDNNLTGTIPSH---NLGNLSSLQLLDLSDNQLS 181
+ +S LT ++ + L+ +++ N LS
Sbjct: 283 TMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS 320
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 47.6 bits (112), Expect = 1e-05
Identities = 31/166 (18%), Positives = 60/166 (36%), Gaps = 17/166 (10%)
Query: 71 RRVTALNISYLSLTGNIPRQLGNLSSLEILDLNFNRLSGEIPWELG-----NLAKLEKLL 125
+ LN + T N+ +L+ L++ L + ++ NL KL +
Sbjct: 169 DAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYV 228
Query: 126 LHNNFLTGTIP------FSIFKLSSLLDLKLSDNNLTGTIPSHNLG--NLSSLQLLDLSD 177
++ FS + +L L + D + L L L+ +D+S
Sbjct: 229 GVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISA 288
Query: 178 NQLSGS----IPSFIFKISSLQALHFGNNRLSGELPANICDNLPFL 219
L+ + + KI L+ ++ N LS E+ + +LP
Sbjct: 289 GVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSLPMK 334
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 42.6 bits (99), Expect = 5e-04
Identities = 26/214 (12%), Positives = 59/214 (27%), Gaps = 48/214 (22%)
Query: 414 YLEIIALSGNPLNGIIPMSAGNLSHSLEELFMPDCNVSGRIPKEIGNLANLVTLDLGGNK 473
+ I ++ I + + ++ L + + NL +L++
Sbjct: 145 FWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGG 204
Query: 474 FNGSIPIALGK-----LQKLQLLNLDDNKLEGSIPDDICGLVELYKLALGDNKLSGQIPA 528
S+ + L+KL L ++ + L
Sbjct: 205 LPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSK---------------- 248
Query: 529 CFGNLASLRELWLGPNELISFIPSTFWNIKDIMYVNFSSNFLTGPLPLEIENLKALTTLD 588
+L+ L + E + + F L L T+D
Sbjct: 249 --DRFPNLKWLGIVDAEEQNVVVEMFLESD---------------------ILPQLETMD 285
Query: 589 FSMNNLSGV----IPTTIGGLKGLQYLFLGHNRL 618
S L+ + + +K L+++ + +N L
Sbjct: 286 ISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYL 319
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 2e-06
Identities = 30/86 (34%), Positives = 44/86 (51%), Gaps = 5/86 (5%)
Query: 119 AKLEKLLLHNNFLTGTIPFSIF-KLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSD 177
++L L+NN +T + +F L +L L + N LT IP+ L+ L LDL+D
Sbjct: 33 TDKQRLWLNNNQIT-KLEPGVFDHLVNLQQLYFNSNKLT-AIPTGVFDKLTQLTQLDLND 90
Query: 178 NQLSGSIPSFIF-KISSLQALHFGNN 202
N L SIP F + SL ++ NN
Sbjct: 91 NHLK-SIPRGAFDNLKSLTHIYLYNN 115
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 2e-06
Identities = 29/98 (29%), Positives = 50/98 (51%), Gaps = 22/98 (22%)
Query: 585 TTLDFSMNNLSGV---IPTTIGGLKGLQYLFLGHNRLQGSIPDSVGD-LISLKSLNLSNN 640
T ++ L+ V IPT Q L+L +N++ + V D L++L+ L ++N
Sbjct: 15 TLVNCQNIRLASVPAGIPTD------KQRLWLNNNQIT-KLEPGVFDHLVNLQQLYFNSN 67
Query: 641 NLSGPIPTSL-----EKLSDLKELNLSFNKLEGEIPRG 673
L T++ +KL+ L +L+L+ N L+ IPRG
Sbjct: 68 KL-----TAIPTGVFDKLTQLTQLDLNDNHLKS-IPRG 99
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 3e-06
Identities = 26/90 (28%), Positives = 41/90 (45%), Gaps = 11/90 (12%)
Query: 339 NLEELYLWGNNFSGTLPSFIFNA-SNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNY 397
+ + L+L N + L +F+ NL +L N + + F L L +L L +N+
Sbjct: 34 DKQRLWLNNNQIT-KLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNH 92
Query: 398 LTS-PELSF--LSSLSNCKYLEIIALSGNP 424
L S P +F L SL++ I L NP
Sbjct: 93 LKSIPRGAFDNLKSLTH------IYLYNNP 116
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 4e-05
Identities = 31/94 (32%), Positives = 48/94 (51%), Gaps = 7/94 (7%)
Query: 305 VPATIFNVSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSGTLPSFIFNA-SN 363
VPA I + + + L+NN L L NL++LY N + +P+ +F+ +
Sbjct: 27 VPAGIP--TDKQRLWLNNNQI-TKLEPGVFDHLVNLQQLYFNSNKLT-AIPTGVFDKLTQ 82
Query: 364 LSKLSLGDNSFSGLIPN-TFGNLRNLKRLRLYNN 396
L++L L DN IP F NL++L + LYNN
Sbjct: 83 LTQLDLNDNHLKS-IPRGAFDNLKSLTHIYLYNN 115
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 42.2 bits (100), Expect = 2e-04
Identities = 32/96 (33%), Positives = 41/96 (42%), Gaps = 12/96 (12%)
Query: 454 IPKEIGNLANLVTLDLGGNKFNGSIPIALGKLQKLQLLNLDDNKLEGSIPDDICG----L 509
+P I + L L N+ P L LQ L + NKL +IP G L
Sbjct: 27 VPAGI--PTDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLT-AIPT---GVFDKL 80
Query: 510 VELYKLALGDNKLSGQIP-ACFGNLASLRELWLGPN 544
+L +L L DN L IP F NL SL ++L N
Sbjct: 81 TQLTQLDLNDNHLKS-IPRGAFDNLKSLTHIYLYNN 115
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 48.0 bits (114), Expect = 1e-05
Identities = 65/363 (17%), Positives = 120/363 (33%), Gaps = 113/363 (31%)
Query: 777 IGRGSFGSVYIAR-LQNGIEVAVKTF-DLQHERAFKSFDTECEVMKSIR-----HRNLTK 829
+G G F +V+++ +Q VA+K +H ++ E ++KS+R N
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYT--ETALDEIRLLKSVRNSDPNDPNREM 102
Query: 830 IISSCSNEDFK---------ALILEYMRNGSLEKCLYSGNYI---LDIFQRLNIMIDVAS 877
++ +DFK ++ E + + L K + NY L ++ I+ V
Sbjct: 103 VVQLL--DDFKISGVNGTHICMVFEVLGH-HLLKWIIKSNYQGLPLPCVKK--IIQQVLQ 157
Query: 878 ALEYLHFGYSAPVIHCDLKPSNVLL----------------------------------- 902
L+YLH +IH D+KP N+LL
Sbjct: 158 GLDYLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPA 215
Query: 903 --------------DDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRV 948
+ + ++D G A + Q T Y + E
Sbjct: 216 TAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQ-----TRQYRSLEVLIGSGY 270
Query: 949 STKGDVYSFGILLMETFTRRK---------------------------PTDEIFSGEMTL 981
+T D++S + E T P I +G+ +
Sbjct: 271 NTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSK 330
Query: 982 KHWVND--FLPISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKE 1039
+ + I+ +K ++ E ++ +E + F L M + P++R TA E
Sbjct: 331 EFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPM-LELI-PEKRATAAE 388
Query: 1040 IVR 1042
+R
Sbjct: 389 CLR 391
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 1e-05
Identities = 47/214 (21%), Positives = 76/214 (35%), Gaps = 40/214 (18%)
Query: 774 NNLIGRGSFGSVYIAR-LQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHR---NLTK 829
++LIG+GSFG V A VA+K + E +++ +
Sbjct: 59 DSLIGKGSFGQVVKAYDRVEQEWVAIKIIK-NKKAFLNQAQIEVRLLELMNKHDTEMKYY 117
Query: 830 IISSCSNEDFKA---LILEYMRNGSLEKCLYSGNYILDIFQRLN------------IMID 874
I+ + F+ L+ E L LY R
Sbjct: 118 IVHLKRHFMFRNHLCLVFE-----MLSYNLYD-------LLRNTNFRGVSLNLTRKFAQQ 165
Query: 875 VASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAH--LSDFGIAKLLIGEDQSMTQTQTL 932
+ +AL +L +IHCDLKP N+LL + + + DFG + Q +
Sbjct: 166 MCTALLFLA-TPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSC-----QLGQRIYQYI 219
Query: 933 ATLGYMAPEYGREGRVSTKGDVYSFGILLMETFT 966
+ Y +PE D++S G +L+E T
Sbjct: 220 QSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHT 253
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 3e-05
Identities = 35/212 (16%), Positives = 69/212 (32%), Gaps = 28/212 (13%)
Query: 94 LSSLEILDLNFNRLSGEIPWELG-----NLAKLEKLLLHNNFLTGTIPFSIFK-LSSLLD 147
LSSL L+L R++ + L+++ L + L ++
Sbjct: 71 LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARK 130
Query: 148 LKLSDNNLTGT----IPSHNLGNLSSLQLLDLSDNQLSGSIPSFIFKI----SSLQALHF 199
L L N+L + L + + L LS+N L+ + + + + +S+ L
Sbjct: 131 LGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSL 190
Query: 200 GNNRLSGELPANICDNL---PFLNFFSVYKNMFYGG----ISSTLSNCKHLRILDLSFND 252
+ L E + L L +V N ++ L +L L FN+
Sbjct: 191 LHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNE 250
Query: 253 LW-------GDIPKEIGNLTKLKELFLDFNIL 277
L D+ ++ + +
Sbjct: 251 LSSEGRQVLRDLGGAAEGGARVVVSLTEGTAV 282
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 3e-05
Identities = 43/228 (18%), Positives = 75/228 (32%), Gaps = 56/228 (24%)
Query: 776 LIGRGSFGSVYIA--RLQNGIEVAVKTFDLQHERAFKSF----DTECEVMKSIRHR---N 826
+G G+FG V + +VA+K R + E V+K I+ + N
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKII-----RNVGKYREAARLEINVLKKIKEKDKEN 80
Query: 827 LTKIISSCSNEDFKA---LILEYMRNGSLEKCLY----SGNYI-LDIFQRLNIMIDVASA 878
+ +F + E L K + N+ + ++ + A
Sbjct: 81 KFLCVLMSDWFNFHGHMCIAFE-----LLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHA 135
Query: 879 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSM------------ 926
L +LH + H DLKP N+L ++ L + + +
Sbjct: 136 LRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFD 192
Query: 927 --TQTQTLATLGYMAPE------YGREGRVSTKGDVYSFGILLMETFT 966
T +AT Y PE + + DV+S G +L E +
Sbjct: 193 HEHHTTIVATRHYRPPEVILELGW------AQPCDVWSIGCILFEYYR 234
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 8e-05
Identities = 55/232 (23%), Positives = 78/232 (33%), Gaps = 60/232 (25%)
Query: 776 LIGRGSFGSVYIAR-LQNGIEVAVKTFDLQHERAFKSF----DTECEVMKSIRHR--NLT 828
+G G+FG V + + + N AVK R K + E +++K I++ N
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVV-----RNIKKYTRSAKIEADILKKIQNDDINNN 96
Query: 829 KIISSCSNEDFKA---LILEYMRNGSLEKCLY----SGNYI-LDIFQRLNIMIDVASALE 880
I+ + LI E L LY NY I I++ AL
Sbjct: 97 NIVKYHGKFMYYDHMCLIFE-----PLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALN 151
Query: 881 YLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQT---LATLG- 936
YL + H DLKP N+LLDD + Q T L G
Sbjct: 152 YLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGC 208
Query: 937 ----------------YMAPE------YGREGRVSTKGDVYSFGILLMETFT 966
Y APE + D++SFG +L E +T
Sbjct: 209 ATFKSDYHGSIINTRQYRAPEVILNLGW------DVSSDMWSFGCVLAELYT 254
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
No hit with probability above 80.00
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 1057 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 4e-65 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-61 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-59 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-58 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-58 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-58 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-57 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 5e-56 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 7e-56 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-55 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-54 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 7e-54 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 9e-54 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-53 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 4e-53 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-52 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 4e-52 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 7e-52 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 8e-52 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 8e-52 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-51 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-51 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-51 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-51 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 6e-51 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-50 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-49 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-49 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 6e-49 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-48 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 5e-48 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-47 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-46 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-46 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-42 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-42 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-41 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-40 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 7e-40 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-39 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 5e-39 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 9e-39 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-38 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-38 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-38 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 6e-38 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 6e-38 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 9e-38 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-37 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-37 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-36 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-36 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-35 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 9e-35 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 9e-34 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-33 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-32 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-32 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-31 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-31 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-28 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-28 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-26 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 4e-19 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 5e-18 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 5e-07 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 9e-26 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-25 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-25 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 8e-21 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 7e-15 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-12 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 9e-08 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-22 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 4e-22 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 6e-21 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-17 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 5e-09 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-08 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 3e-21 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 8e-21 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 4e-19 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 1e-17 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 5e-17 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-16 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-20 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-13 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 6e-12 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 3e-11 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-10 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 4e-07 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 5e-06 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 6e-05 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 4e-04 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 0.003 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 3e-11 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 1e-08 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 3e-08 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 3e-07 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 1e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 9e-10 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 6e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 6e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 3e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 6e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-09 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 8e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 5e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 6e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 4e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 6e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-09 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 6e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 4e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 5e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 0.001 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 0.001 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 8e-09 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 4e-07 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 1e-06 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 2e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 9e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 2e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.003 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 2e-08 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 2e-07 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 3e-06 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 7e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 1e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 2e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 2e-04 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 5e-07 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 6e-07 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 8e-07 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 2e-06 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 2e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 9e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 9e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 7e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.001 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 2e-06 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 2e-04 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 5e-04 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 0.003 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 2e-06 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 6e-06 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 8e-06 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 3e-05 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 7e-05 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 5e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 7e-06 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 8e-06 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 1e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 2e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.003 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 1e-05 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 2e-05 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.002 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 3e-04 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 7e-04 | |
| d1m9la_ | 198 | c.10.3.1 (A:) Outer arm dynein light chain 1 {Gree | 0.002 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (558), Expect = 4e-65
Identities = 63/277 (22%), Positives = 118/277 (42%), Gaps = 22/277 (7%)
Query: 775 NLIGRGSFGSVYIARLQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSC 834
IG GSFG+VY + + V + + ++F E V++ RH N+ +
Sbjct: 14 QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 835 SNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 894
+ A++ ++ SL L+ ++ + ++I A ++YLH +IH D
Sbjct: 74 T-APQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRD 129
Query: 895 LKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEY---GREGRVSTK 951
LK +N+ L +++ + DFG+A + S Q ++ +MAPE + S +
Sbjct: 130 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 189
Query: 952 GDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHFAA 1011
DVY+FGI+L E T + P I + + + +L + K+
Sbjct: 190 SDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKV--------------- 234
Query: 1012 KEQCASSVFNLAMECTVESPDERITAKEIVRRLLKIR 1048
+ C ++ L EC + DER +I+ + +
Sbjct: 235 RSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLA 271
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 210 bits (535), Expect = 1e-61
Identities = 70/306 (22%), Positives = 135/306 (44%), Gaps = 39/306 (12%)
Query: 759 FSYLELFQATNGFSEN---------NLIGRGSFGSVYIARL----QNGIEVAVKTFDLQH 805
F++ + +A F++ +IG G FG V L + I VA+KT +
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 806 -ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEYMRNGSLEKCLYSGNYILD 864
E+ + F +E +M H N+ + + +I E+M NGSL+ L +
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 126
Query: 865 IFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ 924
+ Q + ++ +A+ ++YL +H DL N+L++ N+V +SDFG+++ L +
Sbjct: 127 VIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 183
Query: 925 SMTQTQTL---ATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTL 981
T T L + + APE + + ++ DV+S+GI++ E + +
Sbjct: 184 DPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP---------- 233
Query: 982 KHWVNDFLPISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIV 1041
+ ++ +I+A I +D C S++ L ++C + + R +IV
Sbjct: 234 ------YWDMTNQDVINA---IEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIV 284
Query: 1042 RRLLKI 1047
L K+
Sbjct: 285 NTLDKM 290
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (515), Expect = 3e-59
Identities = 66/275 (24%), Positives = 120/275 (43%), Gaps = 26/275 (9%)
Query: 771 FSENNLIGRGSFGSVYIARLQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKI 830
+G G FG V++ +VAVK+ Q + +F E +MK ++H+ L ++
Sbjct: 15 LKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRL 73
Query: 831 ISSCSNEDFKALILEYMRNGSLEKCLYS-GNYILDIFQRLNIMIDVASALEYLHFGYSAP 889
+ + E +I EYM NGSL L + L I + L++ +A + ++
Sbjct: 74 YAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERN 129
Query: 890 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVS 949
IH DL+ +N+L+ D + ++DFG+A+L I +++ + + + APE G +
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLARL-IEDNEYTAREGAKFPIKWTAPEAINYGTFT 188
Query: 950 TKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHF 1009
K DV+SFGILL E T + + +++ + +
Sbjct: 189 IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR----------------- 231
Query: 1010 AAKEQCASSVFNLAMECTVESPDERITAKEIVRRL 1044
+ C ++ L C E P++R T + L
Sbjct: 232 --PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVL 264
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (508), Expect = 2e-58
Identities = 70/279 (25%), Positives = 120/279 (43%), Gaps = 24/279 (8%)
Query: 771 FSENNLIGRGSFGSVYIARLQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKI 830
+ IG G FG V++ N +VA+KT + F E EVM + H L ++
Sbjct: 7 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQL 65
Query: 831 ISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPV 890
C + L+ E+M +G L L + + L + +DV + YL A V
Sbjct: 66 YGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACV 122
Query: 891 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVST 950
IH DL N L+ +N V +SDFG+ + ++ + + + T + + +PE R S+
Sbjct: 123 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG-TKFPVKWASPEVFSFSRYSS 181
Query: 951 KGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHFA 1010
K DV+SFG+L+ E F+ K E S ++ I+
Sbjct: 182 KSDVWSFGVLMWEVFSEGKIPYENRSNSEVVED-------------------ISTGFRLY 222
Query: 1011 AKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKIRD 1049
++ V+ + C E P++R ++R+L +I +
Sbjct: 223 KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (507), Expect = 2e-58
Identities = 67/277 (24%), Positives = 118/277 (42%), Gaps = 24/277 (8%)
Query: 771 FSENNLIGRGSFGSVYIARLQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKI 830
+ +G G FG V + + +VA+K F E +VM ++ H L ++
Sbjct: 6 LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQL 64
Query: 831 ISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPV 890
C+ + +I EYM NG L L + Q L + DV A+EYL
Sbjct: 65 YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES---KQF 121
Query: 891 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVST 950
+H DL N L++D V +SDFG+++ ++ +D+ + + + + PE + S+
Sbjct: 122 LHRDLAARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMYSKFSS 180
Query: 951 KGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHFA 1010
K D+++FG+L+ E ++ K E F+ T +H I +
Sbjct: 181 KSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH-------------------IAQGLRLY 221
Query: 1011 AKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKI 1047
+ V+ + C E DER T K ++ +L +
Sbjct: 222 RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (507), Expect = 4e-58
Identities = 67/301 (22%), Positives = 121/301 (40%), Gaps = 29/301 (9%)
Query: 763 ELFQATNGFS-ENNLIGRGSFGSVYIARLQ---NGIEVAVKTFDLQHERAF-KSFDTECE 817
+LF + + +G G+FGSV + I+VA+K E+A + E +
Sbjct: 2 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 61
Query: 818 VMKSIRHRNLTKIISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVAS 877
+M + + + ++I C E L++E G L K L + + ++ V+
Sbjct: 62 IMHQLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSM 120
Query: 878 ALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLA-TLG 936
++YL +H DL NVLL + A +SDFG++K L +D T L
Sbjct: 121 GMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK 177
Query: 937 YMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKI 996
+ APE + S++ DV+S+G+ + E + + P MK
Sbjct: 178 WYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK-------------------PYKKMKG 218
Query: 997 IDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKIRDFLLRNVE 1056
+ I + K +C ++ L +C + ++R + +R+ L VE
Sbjct: 219 PEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVE 278
Query: 1057 S 1057
Sbjct: 279 G 279
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (500), Expect = 2e-57
Identities = 79/276 (28%), Positives = 123/276 (44%), Gaps = 32/276 (11%)
Query: 775 NLIGRGSFGSVYIARLQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSC 834
IG+G FG V + G +VAVK ++++ ++F E VM +RH NL +++
Sbjct: 13 QTIGKGEFGDVMLGDY-RGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 69
Query: 835 SNEDFK-ALILEYMRNGSLEKCLYS-GNYILDIFQRLNIMIDVASALEYLHFGYSAPVIH 892
E ++ EYM GSL L S G +L L +DV A+EYL +H
Sbjct: 70 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVH 126
Query: 893 CDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKG 952
DL NVL+ ++ VA +SDFG+ K S TQ + + APE RE + STK
Sbjct: 127 RDLAARNVLVSEDNVAKVSDFGLTKEA-----SSTQDTGKLPVKWTAPEALREKKFSTKS 181
Query: 953 DVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHFAAK 1012
DV+SFGILL E ++ + P + + D + + A
Sbjct: 182 DVWSFGILLWEIYSFGRV-------------------PYPRIPLKDVVPRVEKGYKMDAP 222
Query: 1013 EQCASSVFNLAMECTVESPDERITAKEIVRRLLKIR 1048
+ C +V+ + C R + ++ +L I+
Sbjct: 223 DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 5e-56
Identities = 69/284 (24%), Positives = 124/284 (43%), Gaps = 29/284 (10%)
Query: 771 FSENNLIGRGSFGSVYIARLQNG-----IEVAVKTFDLQH-ERAFKSFDTECEVMKSIRH 824
+ +IG G FG VY L+ + VA+KT + E+ F E +M H
Sbjct: 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH 68
Query: 825 RNLTKIISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHF 884
N+ ++ S +I EYM NG+L+K L + + Q + ++ +A+ ++YL
Sbjct: 69 HNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA- 127
Query: 885 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLI-GEDQSMTQTQTLATLGYMAPEYG 943
+ +H DL N+L++ N+V +SDFG++++L + + T + + + APE
Sbjct: 128 --NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI 185
Query: 944 REGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLI 1003
+ ++ DV+SFGI++ E T + S +K I
Sbjct: 186 SYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKA-------------------I 226
Query: 1004 TEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKI 1047
+ C S+++ L M+C + R +IV L K+
Sbjct: 227 NDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 270
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 7e-56
Identities = 64/291 (21%), Positives = 116/291 (39%), Gaps = 22/291 (7%)
Query: 777 IGRGSFGSVYIARLQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCSN 836
IG+G FG V+ + G EVAVK F + ER++ + E +RH N+ I++ +
Sbjct: 11 IGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWF-REAEIYQTVMLRHENILGFIAADNK 68
Query: 837 EDFKA----LILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLH-----FGYS 887
++ L+ +Y +GSL L Y + + + + + AS L +LH
Sbjct: 69 DNGTWTQLWLVSDYHEHGSLFDYLN--RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGK 126
Query: 888 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMT--QTQTLATLGYMAPEY--- 942
+ H DLK N+L+ N ++D G+A ++ + T YMAPE
Sbjct: 127 PAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDD 186
Query: 943 ---GREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMM-KIID 998
+ + D+Y+ G++ E R ++ V + M K++
Sbjct: 187 SINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVC 246
Query: 999 ANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKIRD 1049
L + + + + EC + R+TA I + L ++
Sbjct: 247 EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (485), Expect = 4e-55
Identities = 69/275 (25%), Positives = 120/275 (43%), Gaps = 26/275 (9%)
Query: 771 FSENNLIGRGSFGSVYIARLQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKI 830
+G+G FG V++ VA+KT + ++F E +VMK +RH L ++
Sbjct: 19 LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQL 77
Query: 831 ISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIF-QRLNIMIDVASALEYLHFGYSAP 889
+ S E ++ EYM GSL L Q +++ +AS + Y+
Sbjct: 78 YAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MN 133
Query: 890 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVS 949
+H DL+ +N+L+ +N+V ++DFG+A+L I +++ + + + APE GR +
Sbjct: 134 YVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPEAALYGRFT 192
Query: 950 TKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHF 1009
K DV+SFGILL E T+ + L +
Sbjct: 193 IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ-------------------VERGYRM 233
Query: 1010 AAKEQCASSVFNLAMECTVESPDERITAKEIVRRL 1044
+C S+ +L +C + P+ER T + + L
Sbjct: 234 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 268
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 2e-54
Identities = 62/278 (22%), Positives = 110/278 (39%), Gaps = 30/278 (10%)
Query: 773 ENNLIGRGSFGSVYIARLQN---GIEVAVKTF--DLQHERAFKSFDTECEVMKSIRHRNL 827
E+ +G G+FG+V Q VAVK + E VM+ + + +
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 828 TKIISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYS 887
++I C E + L++E G L K L + + + ++ V+ ++YL
Sbjct: 71 VRMIGICEAESW-MLVMEMAELGPLNKYLQQNRH-VKDKNIIELVHQVSMGMKYLEE--- 125
Query: 888 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLA-TLGYMAPEYGREG 946
+ +H DL NVLL A +SDFG++K L ++ + + APE
Sbjct: 126 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 185
Query: 947 RVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITED 1006
+ S+K DV+SFG+L+ E F+ + P MK + ++ +
Sbjct: 186 KFSSKSDVWSFGVLMWEAFSYGQK-------------------PYRGMKGSEVTAMLEKG 226
Query: 1007 KHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRL 1044
+ C +++L C + R + RL
Sbjct: 227 ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRL 264
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 187 bits (476), Expect = 7e-54
Identities = 71/279 (25%), Positives = 116/279 (41%), Gaps = 26/279 (9%)
Query: 771 FSENNLIGRGSFGSVYIARLQN-GIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTK 829
+ + +G G +G VY + + VAVKT + F E VMK I+H NL +
Sbjct: 19 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQ 77
Query: 830 IISSCSNEDFKALILEYMRNGSLEKCLY-SGNYILDIFQRLNIMIDVASALEYLHFGYSA 888
++ C+ E +I E+M G+L L + L + ++SA+EYL
Sbjct: 78 LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KK 134
Query: 889 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRV 948
IH DL N L+ +N + ++DFG+++L+ G D + + APE +
Sbjct: 135 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKF 193
Query: 949 STKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKH 1008
S K DV++FG+LL E T P + + L+ +D
Sbjct: 194 SIKSDVWAFGVLLWEIATYGMS-------------------PYPGIDLSQVYELLEKDYR 234
Query: 1009 FAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKI 1047
E C V+ L C +P +R + EI + +
Sbjct: 235 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 9e-54
Identities = 64/306 (20%), Positives = 120/306 (39%), Gaps = 34/306 (11%)
Query: 762 LELFQATNGFSENNLIGRGSFGSVYIAR-LQNGIEVAVKTFDLQHERAFKS-FDTECEVM 819
+EL + F + + +G G+ G V+ +G+ +A K L+ + A ++ E +V+
Sbjct: 1 MEL--KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVL 58
Query: 820 KSIRHRNLTKIISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASAL 879
+ + ++ ++ +E+M GSL++ L + + I V L
Sbjct: 59 HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGL 117
Query: 880 EYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMA 939
YL ++H D+KPSN+L++ L DFG++ L SM + T YM+
Sbjct: 118 TYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFV-GTRSYMS 171
Query: 940 PEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKH---------------- 983
PE + S + D++S G+ L+E R P + E+ L
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR 231
Query: 984 ------WVNDFLPISMMKIIDANLLITEDKHFAAKEQCASSVF-NLAMECTVESPDERIT 1036
M I + I + S F + +C +++P ER
Sbjct: 232 TPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERAD 291
Query: 1037 AKEIVR 1042
K+++
Sbjct: 292 LKQLMV 297
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 2e-53
Identities = 67/288 (23%), Positives = 123/288 (42%), Gaps = 30/288 (10%)
Query: 774 NNLIGRGSFGSVYIARLQN----GIEVAVKTFD-LQHERAFKSFDTECEVMKSIRHRNLT 828
N +IGRG FG VY L + I AVK+ + + F TE +MK H N+
Sbjct: 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 829 KIISSCSNEDFKA-LILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYS 887
++ C + ++L YM++G L + + + + + + VA +++L
Sbjct: 92 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS--- 148
Query: 888 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGED--QSMTQTQTLATLGYMAPEYGRE 945
+H DL N +LD+ ++DFG+A+ + ++ +T + +MA E +
Sbjct: 149 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 208
Query: 946 GRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITE 1005
+ +TK DV+SFG+LL E TR P P + D + + +
Sbjct: 209 QKFTTKSDVWSFGVLLWELMTRGAP-------------------PYPDVNTFDITVYLLQ 249
Query: 1006 DKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKIRDFLLR 1053
+ E C ++ + ++C + R + E+V R+ I +
Sbjct: 250 GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 297
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 4e-53
Identities = 61/292 (20%), Positives = 118/292 (40%), Gaps = 30/292 (10%)
Query: 762 LELFQATNGFSENNLIGRGSFGSVYIARL-----QNGIEVAVKTF-DLQHERAFKSFDTE 815
L + + T F + ++G G+FG+VY + I VA+K + +A K E
Sbjct: 3 LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 61
Query: 816 CEVMKSIRHRNLTKIISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDV 875
VM S+ + ++ +++ C + LI + M G L + + LN + +
Sbjct: 62 AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 120
Query: 876 ASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATL 935
A + YL ++H DL NVL+ ++DFG+AKLL E++ +
Sbjct: 121 AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 177
Query: 936 GYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMK 995
+MA E + + DV+S+G+ + E T P +
Sbjct: 178 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK-------------------PYDGIP 218
Query: 996 IIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKI 1047
+ + ++ + + C V+ + ++C + D R +E++ K+
Sbjct: 219 ASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 184 bits (468), Expect = 2e-52
Identities = 65/279 (23%), Positives = 107/279 (38%), Gaps = 36/279 (12%)
Query: 771 FSENNLIGRGSFGSVYIAR-LQNGIEVAVKTFDL---QHERAFKSFDTECEVMKSIRHRN 826
FS+ IG GSFG+VY AR ++N VA+K Q ++ E ++ +RH N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 827 LTKIISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGY 886
+ E L++EY + + L + + L YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP-LQEVEIAAVTHGALQGLAYLH--- 132
Query: 887 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEY---G 943
S +IH D+K N+LL + + L DFG A ++ + T +MAPE
Sbjct: 133 SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANSFVGTPYWMAPEVILAM 186
Query: 944 REGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLI 1003
EG+ K DV+S GI +E R+ P + + N+ +
Sbjct: 187 DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQ----------- 235
Query: 1004 TEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVR 1042
+ N C + P +R T++ +++
Sbjct: 236 --------SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (464), Expect = 4e-52
Identities = 60/274 (21%), Positives = 111/274 (40%), Gaps = 29/274 (10%)
Query: 775 NLIGRGSFGSVYIAR-LQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISS 833
+G G+FG VY A+ + + A K D + E + + E +++ S H N+ K++ +
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77
Query: 834 CSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHC 893
E+ +++E+ G+++ + L Q + AL YLH +IH
Sbjct: 78 FYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHR 134
Query: 894 DLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEY-----GREGRV 948
DLK N+L + L+DFG++ Q T +MAPE ++
Sbjct: 135 DLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI--GTPYWMAPEVVMCETSKDRPY 192
Query: 949 STKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKH 1008
K DV+S GI L+E P E+ + LK ++ ++ +N
Sbjct: 193 DYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFK------ 246
Query: 1009 FAAKEQCASSVFNLAMECTVESPDERITAKEIVR 1042
+ +C ++ D R T ++++
Sbjct: 247 ------------DFLKKCLEKNVDARWTTSQLLQ 268
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (460), Expect = 7e-52
Identities = 63/277 (22%), Positives = 113/277 (40%), Gaps = 33/277 (11%)
Query: 774 NNLIGRGSFGSVYIARL-QNGIEVAVKTFDLQH--ERAFKSFDTECEVMKSIRHRNLTKI 830
+ IGRGSF +VY + +EVA + + + F E E++K ++H N+ +
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 831 ISSC----SNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGY 886
S + L+ E M +G+L+ L ++ I + + L++LH
Sbjct: 74 YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLHT-R 131
Query: 887 SAPVIHCDLKPSNVLLDD-NMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGRE 945
+ P+IH DLK N+ + + D G+A L S + + T +MAPE E
Sbjct: 132 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK---RASFAKA-VIGTPEFMAPEM-YE 186
Query: 946 GRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITE 1005
+ DVY+FG+ ++E T P E + + + P S K+ +
Sbjct: 187 EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVK--- 243
Query: 1006 DKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVR 1042
+ C ++ DER + K+++
Sbjct: 244 ---------------EIIEGCIRQNKDERYSIKDLLN 265
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (459), Expect = 8e-52
Identities = 65/278 (23%), Positives = 103/278 (37%), Gaps = 32/278 (11%)
Query: 775 NLIGRGSFGSVYIAR-LQNGIEVAVKTFDLQH--ERAFKSFDTECEVMKSIRHRNLTKII 831
IG GS+G R +G + K D E + +E +++ ++H N+ +
Sbjct: 10 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 69
Query: 832 SSCSNEDFKAL--ILEYMRNGSLEKCLYSG---NYILDIFQRLNIMIDVASALEYLH--F 884
+ L ++EY G L + G LD L +M + AL+ H
Sbjct: 70 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 129
Query: 885 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGR 944
V+H DLKP+NV LD L DFG+A++L D S + T YM+PE
Sbjct: 130 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL-NHDTSFAKAFV-GTPYYMSPEQMN 187
Query: 945 EGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLIT 1004
+ K D++S G LL E P F S ++ I
Sbjct: 188 RMSYNEKSDIWSLGCLLYELCALMPP-----------------FTAFSQKELAGK---IR 227
Query: 1005 EDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVR 1042
E K + + + + R + +EI+
Sbjct: 228 EGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 182 bits (462), Expect = 8e-52
Identities = 72/320 (22%), Positives = 122/320 (38%), Gaps = 54/320 (16%)
Query: 758 RFSYLELFQATNGFSENNLIGRGSFGSVYIARL------QNGIEVAVKTFDLQH-ERAFK 810
+ LE N IG G+FG V+ AR + VAVK +
Sbjct: 4 KLLSLEY--PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQA 61
Query: 811 SFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEYMRNGSLEKCLYS------------ 858
F E +M + N+ K++ C+ L+ EYM G L + L S
Sbjct: 62 DFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHS 121
Query: 859 -----------GNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMV 907
G L ++L I VA+ + YL +H DL N L+ +NMV
Sbjct: 122 DLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMV 178
Query: 908 AHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTR 967
++DFG+++ + D + +M PE R +T+ DV+++G++L E F+
Sbjct: 179 VKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSY 238
Query: 968 RKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECT 1027
+ ++ ++I + + A E C ++NL C
Sbjct: 239 GLQP----------------YYGMAHEEVIYY---VRDGNILACPENCPLELYNLMRLCW 279
Query: 1028 VESPDERITAKEIVRRLLKI 1047
+ P +R + I R L ++
Sbjct: 280 SKLPADRPSFCSIHRILQRM 299
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (459), Expect = 1e-51
Identities = 66/280 (23%), Positives = 106/280 (37%), Gaps = 30/280 (10%)
Query: 777 IGRGSFGSVYIARL----QNGIEVAVKTFD---LQHERAFKSFDTECEVMKSIRHRNLTK 829
+G GSFG V + VAVK L A F E M S+ HRNL +
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 830 IISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAP 889
+ K ++ E GSL L + + VA + YL S
Sbjct: 76 LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKR 131
Query: 890 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLI-GEDQSMTQTQTLATLGYMAPEYGREGRV 948
IH DL N+LL + + DFG+ + L +D + Q + APE +
Sbjct: 132 FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTF 191
Query: 949 STKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKH 1008
S D + FG+ L E FT + ++ ++ +I+ + E +
Sbjct: 192 SHASDTWMFGVTLWEMFTYGQEP----------------WIGLNGSQILHK--IDKEGER 233
Query: 1009 FAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKIR 1048
E C ++N+ ++C P++R T + LL+ +
Sbjct: 234 LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 1e-51
Identities = 63/299 (21%), Positives = 112/299 (37%), Gaps = 51/299 (17%)
Query: 776 LIGRGSFGSVYIARLQN------GIEVAVKTFDLQHERAF-KSFDTECEVMKSI-RHRNL 827
++G G+FG V A I+VAVK + + + ++ +E ++M + H N+
Sbjct: 44 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 103
Query: 828 TKIISSCSNEDFKALILEYMRNGSLEKCLYSGN----------------------YILDI 865
++ +C+ LI EY G L L S +L
Sbjct: 104 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 163
Query: 866 FQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS 925
L VA +E+L +H DL NVL+ V + DFG+A+ ++ +
Sbjct: 164 EDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY 220
Query: 926 MTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWV 985
+ + + +MAPE EG + K DV+S+GILL E F+ + G +
Sbjct: 221 VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN---PYPGIPVDAN-- 275
Query: 986 NDFLPISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRL 1044
K+I + + + ++ + C +R + + L
Sbjct: 276 -------FYKLIQNGFKMDQPFY------ATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 321
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 3e-51
Identities = 67/269 (24%), Positives = 114/269 (42%), Gaps = 26/269 (9%)
Query: 775 NLIGRGSFGSVYIAR-LQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISS 833
IG+G+ G+VY A + G EVA++ +LQ + + E VM+ ++ N+ + S
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 834 CSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHC 893
D +++EY+ GSL + D Q + + ALE+LH S VIH
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVVTETCM--DEGQIAAVCRECLQALEFLH---SNQVIHR 140
Query: 894 DLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGD 953
D+K N+LL + L+DFG + E + T +MAPE K D
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVG--TPYWMAPEVVTRKAYGPKVD 198
Query: 954 VYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHFAAKE 1013
++S GI+ +E P + E P+ + +I N E
Sbjct: 199 IWSLGIMAIEMIEGEPP----YLNEN----------PLRALYLIATN----GTPELQNPE 240
Query: 1014 QCASSVFNLAMECTVESPDERITAKEIVR 1042
+ ++ + C ++R +AKE+++
Sbjct: 241 KLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 3e-51
Identities = 66/279 (23%), Positives = 109/279 (39%), Gaps = 29/279 (10%)
Query: 771 FSEN----NLIGRGSFGSVYIAR-LQNGIEVAVKTFDLQHERAF-KSFDTECEVMKSIRH 824
F E+ +G G++G V +A VAVK D++ ++ E + K + H
Sbjct: 3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH 62
Query: 825 RNLTKIISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHF 884
N+ K + + L LEY G L + + + + + + YLH
Sbjct: 63 ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLH- 120
Query: 885 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGR 944
+ H D+KP N+LLD+ +SDFG+A + ++ + TL Y+APE +
Sbjct: 121 --GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 945 EGRVSTKG-DVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLI 1003
+ DV+S GI+L P D+ W ++ K ID+ L
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL- 237
Query: 1004 TEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVR 1042
L + VE+P RIT +I +
Sbjct: 238 -----------------ALLHKILVENPSARITIPDIKK 259
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (456), Expect = 6e-51
Identities = 63/302 (20%), Positives = 110/302 (36%), Gaps = 46/302 (15%)
Query: 771 FSENNLIGRGSFGSVYIARL------QNGIEVAVKTFDL-QHERAFKSFDTECEVMKSI- 822
S +G G+FG V A + VAVK H ++ +E +V+ +
Sbjct: 25 LSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG 84
Query: 823 RHRNLTKIISSCSNEDFKALILEYMRNGSLEKCLY-----------------SGNYILDI 865
H N+ ++ +C+ +I EY G L L LD+
Sbjct: 85 NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 144
Query: 866 FQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS 925
L+ VA + +L S IH DL N+LL + + DFG+A+ + +
Sbjct: 145 EDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 201
Query: 926 MTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWV 985
+ + + +MAPE + + DV+S+GI L E F+ + +
Sbjct: 202 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMI 261
Query: 986 NDFLPISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLL 1045
E + E + ++++ C P +R T K+IV+ +
Sbjct: 262 K------------------EGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 303
Query: 1046 KI 1047
K
Sbjct: 304 KQ 305
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (451), Expect = 1e-50
Identities = 62/279 (22%), Positives = 107/279 (38%), Gaps = 29/279 (10%)
Query: 776 LIGRGSFGSVYIARL----QNGIEVAVKTFDLQHERAFKS-FDTECEVMKSIRHRNLTKI 830
IG G FG V+ + VA+KT + + F E M+ H ++ K+
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 831 ISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPV 890
I + E+ +I+E G L L Y LD+ + +++AL YL S
Sbjct: 74 IGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRF 129
Query: 891 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVST 950
+H D+ NVL+ N L DFG+++ + + ++ + +MAPE R ++
Sbjct: 130 VHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESINFRRFTS 188
Query: 951 KGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHFA 1010
DV+ FG+ + E P +K D I +
Sbjct: 189 ASDVWMFGVCMWEILMHGVK-------------------PFQGVKNNDVIGRIENGERLP 229
Query: 1011 AKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKIRD 1049
C ++++L +C P R E+ +L I +
Sbjct: 230 MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 1e-49
Identities = 69/301 (22%), Positives = 125/301 (41%), Gaps = 45/301 (14%)
Query: 769 NGFSENNLIGRGSFGSVYIARLQNG---IEVAVKTFD-LQHERAFKSFDTECEVMKSI-R 823
N ++IG G+FG V AR++ ++ A+K + + F E EV+ +
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 824 HRNLTKIISSCSNEDFKALILEYMRNGSLEKCLYSGNYI---------------LDIFQR 868
H N+ ++ +C + + L +EY +G+L L + L Q
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 869 LNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQ 928
L+ DVA ++YL IH DL N+L+ +N VA ++DFG+++ G++ + +
Sbjct: 130 LHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKK 183
Query: 929 TQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDF 988
T + +MA E +T DV+S+G+LL E +
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT------------------ 225
Query: 989 LPISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKIR 1048
P M + + + C V++L +C E P ER + +I+ L ++
Sbjct: 226 -PYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 284
Query: 1049 D 1049
+
Sbjct: 285 E 285
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 4e-49
Identities = 63/272 (23%), Positives = 105/272 (38%), Gaps = 33/272 (12%)
Query: 775 NLIGRGSFGSVYIARL-QNGIEVAVKTFD---LQHERAFKSFDTECEVMKSIRHRNLTKI 830
+G+G FG+VY+AR Q+ +A+K L+ E E+ +RH N+ ++
Sbjct: 12 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 71
Query: 831 ISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPV 890
+ LILEY G++ + L + D + + ++A+AL Y H S V
Sbjct: 72 YGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCH---SKRV 127
Query: 891 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVST 950
IH D+KP N+LL ++DFG + ++ TL Y+ PE
Sbjct: 128 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCG----TLDYLPPEMIEGRMHDE 183
Query: 951 KGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHFA 1010
K D++S G+L E + P F K I F
Sbjct: 184 KVDLWSLGVLCYEFLVGKPP----FEANT----------YQETYKRI-------SRVEFT 222
Query: 1011 AKEQCASSVFNLAMECTVESPDERITAKEIVR 1042
+ +L +P +R +E++
Sbjct: 223 FPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 175 bits (445), Expect = 6e-49
Identities = 52/268 (19%), Positives = 99/268 (36%), Gaps = 26/268 (9%)
Query: 776 LIGRGSFGSVYIAR-LQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSC 834
+G G+FG V+ G A K HE ++ E + M +RH L + +
Sbjct: 33 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 92
Query: 835 SNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 894
+++ +I E+M G L + + + + + + M V L ++H +H D
Sbjct: 93 EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLD 149
Query: 895 LKPSNVLL--DDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKG 952
LKP N++ + L DFG+ L + T T + APE V
Sbjct: 150 LKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTG---TAEFAAPEVAEGKPVGYYT 206
Query: 953 DVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHFAAK 1012
D++S G+L + P F GE + ++ + + + +
Sbjct: 207 DMWSVGVLSYILLSGLSP----FGGENDDE---------TLRNVKSCDWNMDDSAF---- 249
Query: 1013 EQCASSVFNLAMECTVESPDERITAKEI 1040
+ + + + P+ R+T +
Sbjct: 250 SGISEDGKDFIRKLLLADPNTRMTIHQA 277
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 3e-48
Identities = 68/274 (24%), Positives = 111/274 (40%), Gaps = 29/274 (10%)
Query: 771 FSENNLIGRGSFGSVYIAR-LQNGIEVAVKTFDLQH---ERAFKSFDTECEVMKSIRHRN 826
F ++G GSF +V +AR L E A+K + +H E E +VM + H
Sbjct: 10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69
Query: 827 LTKIISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGY 886
K+ + +++ L Y +NG L K + D ++ SALEYLH
Sbjct: 70 FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS-FDETCTRFYTAEIVSALEYLH--- 125
Query: 887 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREG 946
+IH DLKP N+LL+++M ++DFG AK+L E + + T Y++PE E
Sbjct: 126 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 185
Query: 947 RVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITED 1006
D+++ G ++ + P F KII E
Sbjct: 186 SACKSSDLWALGCIIYQLVAGLPP----FRAGNEYLI---------FQKIIKLEYDFPEK 232
Query: 1007 KHFAAKEQCASSVFNLAMECTVESPDERITAKEI 1040
A+ +L + V +R+ +E+
Sbjct: 233 FFPKAR--------DLVEKLLVLDATKRLGCEEM 258
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 5e-48
Identities = 62/295 (21%), Positives = 117/295 (39%), Gaps = 38/295 (12%)
Query: 771 FSENNLIGRGSFGSVYIARLQN------GIEVAVKTFDLQH-ERAFKSFDTECEVMKSIR 823
+ + +G+GSFG VY + VA+KT + R F E VMK
Sbjct: 22 ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN 81
Query: 824 HRNLTKIISSCSNEDFKALILEYMRNGSLEKCLYSGNYI---------LDIFQRLNIMID 874
++ +++ S +I+E M G L+ L S + + + + +
Sbjct: 82 CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGE 141
Query: 875 VASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLAT 934
+A + YL+ + +H DL N ++ ++ + DFG+ + + D + L
Sbjct: 142 IADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 198
Query: 935 LGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMM 994
+ +M+PE ++G +T DV+SFG++L E T + + S E L+
Sbjct: 199 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR------------ 246
Query: 995 KIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKIRD 1049
+ E + C +F L C +P R + EI+ + + +
Sbjct: 247 -------FVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 3e-47
Identities = 72/298 (24%), Positives = 124/298 (41%), Gaps = 47/298 (15%)
Query: 775 NLIGRGSFGSVYIARL--------QNGIEVAVKTFDLQH-ERAFKSFDTECEVMKSI-RH 824
+G G+FG V +A +VAVK E+ +E E+MK I +H
Sbjct: 19 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 78
Query: 825 RNLTKIISSCSNEDFKALILEYMRNGSLEKCL---------------YSGNYILDIFQRL 869
+N+ ++ +C+ + +I+EY G+L + L ++ L +
Sbjct: 79 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 138
Query: 870 NIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQT 929
+ VA +EYL S IH DL NVL+ ++ V ++DFG+A+ + D T
Sbjct: 139 SCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 195
Query: 930 QTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFL 989
+ +MAPE + + + DV+SFG+LL E FT
Sbjct: 196 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS------------------- 236
Query: 990 PISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKI 1047
P + + + L+ E C + ++ + +C P +R T K++V L +I
Sbjct: 237 PYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 168 bits (427), Expect = 2e-46
Identities = 52/270 (19%), Positives = 103/270 (38%), Gaps = 26/270 (9%)
Query: 776 LIGRGSFGSVYIAR-LQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSC 834
+G G+FG V+ G K + + + E +M + H L + +
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95
Query: 835 SNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 894
++ LILE++ G L + + +Y + + +N M L+++H ++H D
Sbjct: 96 EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLD 152
Query: 895 LKPSNVLLD--DNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKG 952
+KP N++ + + DFG+A L + T AT + APE V
Sbjct: 153 IKPENIMCETKKASSVKIIDFGLATKL---NPDEIVKVTTATAEFAAPEIVDREPVGFYT 209
Query: 953 DVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHFAAK 1012
D+++ G+L + P F+GE L+ ++ + + ED
Sbjct: 210 DMWAIGVLGYVLLSGLSP----FAGEDDLE---------TLQNVKRCDWEFDEDAF---- 252
Query: 1013 EQCASSVFNLAMECTVESPDERITAKEIVR 1042
+ + + P +R+T + +
Sbjct: 253 SSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 165 bits (419), Expect = 2e-46
Identities = 63/284 (22%), Positives = 123/284 (43%), Gaps = 31/284 (10%)
Query: 776 LIGRGSFGSVYIAR-LQNGIEVAVKTFD---LQHERAFKSFDTECEVMKSIRHRNLTKII 831
++G G V++AR L+ +VAVK + + F E + ++ H + +
Sbjct: 14 ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73
Query: 832 SSCSNEDFKA----LILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYS 887
+ E +++EY+ +L +++ + + + ++ D AL + H
Sbjct: 74 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIADACQALNFSH---Q 129
Query: 888 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLA-TLGYMAPEYGREG 946
+IH D+KP+N+++ + DFGIA+ + S+TQT + T Y++PE R
Sbjct: 130 NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD 189
Query: 947 RVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITED 1006
V + DVYS G +L E T P + +H D +P S
Sbjct: 190 SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPS-------------- 235
Query: 1007 KHFAAKEQCASSVFNLAMECTVESPDERI-TAKEIVRRLLKIRD 1049
A E ++ + + ++ ++P+ R TA E+ L+++ +
Sbjct: 236 ---ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (394), Expect = 2e-42
Identities = 53/270 (19%), Positives = 106/270 (39%), Gaps = 27/270 (10%)
Query: 776 LIGRGSFGSVYIAR-LQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSC 834
+GRG FG V+ + K ++ E ++ RHRN+ + S
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ-VLVKKEISILNIARHRNILHLHESF 70
Query: 835 SNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 894
+ + +I E++ + + + + + L+ + ++ + V AL++LH S + H D
Sbjct: 71 ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFD 127
Query: 895 LKPSNVLLD--DNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKG 952
++P N++ + + +FG A+ L D Y APE + VST
Sbjct: 128 IRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFT---APEYYAPEVHQHDVVSTAT 184
Query: 953 DVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHFAAK 1012
D++S G L+ + P F E + + I++A E+
Sbjct: 185 DMWSLGTLVYVLLSGINP----FLAETNQQ---------IIENIMNAEYTFDEEAF---- 227
Query: 1013 EQCASSVFNLAMECTVESPDERITAKEIVR 1042
++ + + V+ R+TA E ++
Sbjct: 228 KEISIEAMDFVDRLLVKERKSRMTASEALQ 257
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (391), Expect = 2e-42
Identities = 63/301 (20%), Positives = 109/301 (36%), Gaps = 45/301 (14%)
Query: 771 FSENNLIGRGSFGSVYIAR------LQNGIEVAVKTFDLQH-ERAFKSFDTECEVMKSIR 823
+GRG+FG V A VAVK ++ +E +++ I
Sbjct: 15 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG 74
Query: 824 HRNLTKIISSCSNEDFKAL--ILEYMRNGSLEKCLYSGNY---------------ILDIF 866
H + + L I+E+ + G+L L S L +
Sbjct: 75 HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 134
Query: 867 QRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSM 926
+ VA +E+L S IH DL N+LL + V + DFG+A+ + + +
Sbjct: 135 HLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 191
Query: 927 TQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVN 986
+ L +MAPE + + + DV+SFG+LL E F+ + G + +
Sbjct: 192 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS---PYPGVKIDEEFCR 248
Query: 987 DFLPISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLK 1046
+ E A + ++ ++C P +R T E+V L
Sbjct: 249 ---------------RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 293
Query: 1047 I 1047
+
Sbjct: 294 L 294
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 152 bits (384), Expect = 3e-41
Identities = 52/270 (19%), Positives = 101/270 (37%), Gaps = 23/270 (8%)
Query: 775 NLIGRGSFGSVYIAR-LQNGIEVAVKTFDLQH-ERAFKSFDTECEVMKSIRHRNLTKIIS 832
+++G G+F V +A + VA+K + E S + E V+ I+H N+ +
Sbjct: 15 DVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDD 74
Query: 833 SCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIH 892
+ LI++ + G L + + ++ V A++YLH
Sbjct: 75 IYESGGHLYLIMQLVSGGELFDRIVEKGF-YTERDASRLIFQVLDAVKYLHDLGIVHRDL 133
Query: 893 CDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKG 952
LD++ +SDFG++K+ ED + T GY+APE + S
Sbjct: 134 KPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYVAPEVLAQKPYSKAV 190
Query: 953 DVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHFAAK 1012
D +S G++ P F E + K+ + L +
Sbjct: 191 DCWSIGVIAYILLCGYPP----FYDE-------------NDAKLFEQILKAEYEFDSPYW 233
Query: 1013 EQCASSVFNLAMECTVESPDERITAKEIVR 1042
+ + S + + P++R T ++ ++
Sbjct: 234 DDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 147 bits (372), Expect = 4e-40
Identities = 63/291 (21%), Positives = 109/291 (37%), Gaps = 45/291 (15%)
Query: 771 FSEN----NLIGRGSFGSVYIAR-LQNGIEVAVKTFDL---------QHERAFKSFDTEC 816
F EN ++GRG V E AVK D+ + + ++ E
Sbjct: 1 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEV 60
Query: 817 EVMKSIR-HRNLTKIISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDV 875
++++ + H N+ ++ + F L+ + M+ G L L L + IM +
Sbjct: 61 DILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRAL 119
Query: 876 ASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATL 935
+ LH ++H DLKP N+LLDD+M L+DFG + L D + T
Sbjct: 120 LEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL---DPGEKLREVCGTP 173
Query: 936 GYMAPEYGREGRV------STKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFL 989
Y+APE + D++S G+++ P F +
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP----FWHRKQMLM------ 223
Query: 990 PISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEI 1040
+ I+ N + + + +V +L V P +R TA+E
Sbjct: 224 ---LRMIMSGNYQFGSPEW----DDYSDTVKDLVSRFLVVQPQKRYTAEEA 267
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 147 bits (371), Expect = 7e-40
Identities = 60/279 (21%), Positives = 117/279 (41%), Gaps = 17/279 (6%)
Query: 775 NLIGRGSFGSVYIARLQNGIEVAVKTFDLQH--ERAFKSFDTECEVMKSIRHRNLTKIIS 832
IG G++G VY A+ G A+K L+ E + E ++K ++H N+ K+
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 833 SCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIH 892
+ L+ E++ + L+K L L+ + ++ + + + Y H V+H
Sbjct: 68 VIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLH 123
Query: 893 CDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPE-YGREGRVSTK 951
DLKP N+L++ ++DFG+A+ T + TL Y AP+ + ST
Sbjct: 124 RDLKPQNLLINREGELKIADFGLARAF--GIPVRKYTHEIVTLWYRAPDVLMGSKKYSTT 181
Query: 952 GDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLP-------ISMMKIIDANLLIT 1004
D++S G + E + + ++ + P ++ + D N +
Sbjct: 182 IDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVY 241
Query: 1005 EDKHFAAKEQCASSVF-NLAMECTVESPDERITAKEIVR 1042
E + + + +L + P++RITAK+ +
Sbjct: 242 EPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (373), Expect = 1e-39
Identities = 62/296 (20%), Positives = 118/296 (39%), Gaps = 19/296 (6%)
Query: 763 ELFQATNGFSENNLIGRGSFGSVYIAR-LQNGIEVAVKTFD-LQHERAFKSFDTECEVMK 820
++F ++ + IG G++G V A N + VA+K +H+ + E +++
Sbjct: 2 QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 61
Query: 821 SIRHRNLTKIISSCSNEDFKALILEYMRNGSLEKCLYS--GNYILDIFQRLNIMIDVASA 878
RH N+ I + + Y+ + LY L + +
Sbjct: 62 RFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRG 121
Query: 879 LEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLI-GEDQSMTQTQTLATLGY 937
L+Y+H SA V+H DLKPSN+LL+ + DFG+A++ D + T+ +AT Y
Sbjct: 122 LKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 178
Query: 938 MAPEYGREGRVST-KGDVYSFGILLMETFTRRKP-----TDEIFSGEMTLKHWVNDFLPI 991
APE + T D++S G +L E + R + + + + +
Sbjct: 179 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 238
Query: 992 SMMKIIDANLLITEDKHFAAK-----EQCASSVFNLAMECTVESPDERITAKEIVR 1042
++ + N L++ S +L + +P +RI ++ +
Sbjct: 239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 5e-39
Identities = 66/282 (23%), Positives = 115/282 (40%), Gaps = 20/282 (7%)
Query: 775 NLIGRGSFGSVYIAR-LQNGIEVAVKTFDLQH-----ERAFKSFDTECEVMKSIRHRNLT 828
+ +G G F +VY AR VA+K L H + ++ E ++++ + H N+
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 829 KIISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSA 888
++ + ++ +L+ ++M LE + + +L M+ LEYLH
Sbjct: 64 GLLDAFGHKSNISLVFDFM-ETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QH 119
Query: 889 PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRV 948
++H DLKP+N+LLD+N V L+DFG+AK + T + T Y APE R+
Sbjct: 120 WILHRDLKPNNLLLDENGVLKLADFGLAKSF--GSPNRAYTHQVVTRWYRAPELLFGARM 177
Query: 949 -STKGDVYSFGILLMETFTRRKP------TDEIFSGEMTLKHWVNDFLPISMMKIIDANL 1001
D+++ G +L E R D++ TL + P
Sbjct: 178 YGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF 237
Query: 1002 LITEDKHFAAKEQCASSVF-NLAMECTVESPDERITAKEIVR 1042
A +L + +P RITA + ++
Sbjct: 238 KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 144 bits (365), Expect = 9e-39
Identities = 63/275 (22%), Positives = 107/275 (38%), Gaps = 39/275 (14%)
Query: 775 NLIGRGSFGSVYIAR-LQNGIEVAVKTFD---LQHERAFKSFDTECEVMKSIRHRNLTKI 830
+G GSFG V++ R NG A+K + + + + E ++ + H + ++
Sbjct: 10 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69
Query: 831 ISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPV 890
+ + +I++Y+ G L + +V ALEYLH S +
Sbjct: 70 WGTFQDAQQIFMIMDYI-EGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH---SKDI 125
Query: 891 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVST 950
I+ DLKP N+LLD N ++DFG AK + ++ T Y+APE +
Sbjct: 126 IYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCG-----TPDYIAPEVVSTKPYNK 180
Query: 951 KGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHFA 1010
D +SFGIL+ E P F T+K + KI++A L
Sbjct: 181 SIDWWSFGILIYEMLAGYTP----FYDSNTMK---------TYEKILNAELRFPPF---- 223
Query: 1011 AKEQCASSVFNLAMECTVESPDERI-----TAKEI 1040
V +L +R+ +++
Sbjct: 224 ----FNEDVKDLLSRLITRDLSQRLGNLQNGTEDV 254
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 1e-38
Identities = 58/281 (20%), Positives = 111/281 (39%), Gaps = 38/281 (13%)
Query: 771 FSENNLIGRGSFGSVYIAR-LQNGIEVAVKTFD---LQHERAFKSFDTECEVM-KSIRHR 825
F + ++G+GSFG V++A + A+K + + + E V+ + H
Sbjct: 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63
Query: 826 NLTKIISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFG 885
LT + + ++ ++EY+ G L + S + D+ + ++ L++LH
Sbjct: 64 FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK-FDLSRATFYAAEIILGLQFLH-- 120
Query: 886 YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGRE 945
S +++ DLK N+LLD + ++DFG+ K + D T Y+APE
Sbjct: 121 -SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC--GTPDYIAPEILLG 177
Query: 946 GRVSTKGDVYSFGILLMETFTRRKPTDEIFSGE---MTLKHWVNDFLPISMMKIIDANLL 1002
+ + D +SFG+LL E + P F G+ D
Sbjct: 178 QKYNHSVDWWSFGVLLYEMLIGQSP----FHGQDEEELFHSIRMDNPFYP---------- 223
Query: 1003 ITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043
+L ++ V P++R+ + +R+
Sbjct: 224 ----------RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 145 bits (366), Expect = 2e-38
Identities = 59/285 (20%), Positives = 105/285 (36%), Gaps = 39/285 (13%)
Query: 769 NGFSENNLIGRGSFGSVYIAR-LQNGIEVAVKTFDL------QHERAFKSFDTECEVMKS 821
N FS + +IGRG FG VY R G A+K D Q E + ++ +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 822 IRHRNLTKIISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEY 881
+ + + D + IL+ M G L L + ++ LE+
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA-DMRFYAAEIILGLEH 122
Query: 882 LHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPE 941
+H + V++ DLKP+N+LLD++ +SD G+A ++ T GYMAPE
Sbjct: 123 MH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDF----SKKKPHASVGTHGYMAPE 175
Query: 942 YGREGR-VSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDAN 1000
++G + D +S G +L + P + + + + + + +
Sbjct: 176 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPE 235
Query: 1001 LLITEDKHFAAKEQCASSVFNLAMECTVESPDERIT-----AKEI 1040
L +L + R+ A+E+
Sbjct: 236 LR------------------SLLEGLLQRDVNRRLGCLGRGAQEV 262
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 143 bits (361), Expect = 2e-38
Identities = 53/288 (18%), Positives = 90/288 (31%), Gaps = 30/288 (10%)
Query: 776 LIGRGSFGSVYIAR-LQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSC 834
IG GSFG +Y+ + G EVA+K ++ + E ++ K ++ I C
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWC 71
Query: 835 SNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 894
E +++ + SLE + + L + + S +EY+H S IH D
Sbjct: 72 GAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRD 128
Query: 895 LKPSNVL---LDDNMVAHLSDFGIAKLLIGED-----QSMTQTQTLATLGYMAPEYGREG 946
+KP N L + ++ DFG+AK T Y +
Sbjct: 129 VKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGI 188
Query: 947 RVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITED 1006
S + D+ S G +LM W K +
Sbjct: 189 EQSRRDDLESLGYVLMYFNLGS-------------LPWQGLKAATKRQKYERISEKKMST 235
Query: 1007 KHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKIRDFLLRN 1054
+ S C D++ + + R+ R
Sbjct: 236 PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLF---RNLFHRQ 280
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 6e-38
Identities = 69/282 (24%), Positives = 116/282 (41%), Gaps = 17/282 (6%)
Query: 771 FSENNLIGRGSFGSVYIAR-LQNGIEVAVKTF--DLQHERAFKSFDTECEVMKSIRHRNL 827
F + IG G++G VY AR G VA+K D + E + E ++K + H N+
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 828 TKIISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYS 887
K++ E+ L+ E++ + S + + + + + L + H S
Sbjct: 64 VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---S 120
Query: 888 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPE-YGREG 946
V+H DLKP N+L++ L+DFG+A+ ++ T TL Y APE
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILLGCK 178
Query: 947 RVSTKGDVYSFGILLMETFTRRKP------TDEIFSGEMTLKHWVNDFLP-ISMMKIIDA 999
ST D++S G + E TRR D++F TL P ++ M
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238
Query: 1000 NLLITEDKHFAAKEQCASSVF-NLAMECTVESPDERITAKEI 1040
+ + F+ +L + P++RI+AK
Sbjct: 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (360), Expect = 6e-38
Identities = 53/277 (19%), Positives = 98/277 (35%), Gaps = 34/277 (12%)
Query: 776 LIGRGSFGSVYIAR-LQNGIEVAVKTFDLQHERAFKSFDTECEVM-KSIRHRNLTKIISS 833
++G G G V + + A+K + E E+ ++ + ++ +I+
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIVDV 73
Query: 834 C----SNEDFKALILEYMRNGSLEKCLYS-GNYILDIFQRLNIMIDVASALEYLHFGYSA 888
+ +++E + G L + G+ + IM + A++YLH S
Sbjct: 74 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SI 130
Query: 889 PVIHCDLKPSNVLLD---DNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGRE 945
+ H D+KP N+L N + L+DFG AK + T T Y+APE
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY---TPYYVAPEVLGP 187
Query: 946 GRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITE 1005
+ D++S G+++ P F L I M +
Sbjct: 188 EKYDKSCDMWSLGVIMYILLCGYPP----FYSNHGLAISPGMKTRIRMGQY--------- 234
Query: 1006 DKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVR 1042
+ + + V L P +R+T E +
Sbjct: 235 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (360), Expect = 9e-38
Identities = 70/293 (23%), Positives = 118/293 (40%), Gaps = 37/293 (12%)
Query: 771 FSENNLIGRGSFGSVYIARL-QNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTK 829
+++ +IG GSFG VY A+L +G VA+K + E ++M+ + H N+ +
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVR 77
Query: 830 IISSC------SNEDFKALILEYMRNGSLEKCLY--SGNYILDIFQRLNIMIDVASALEY 881
+ +E + L+L+Y+ + L + M + +L Y
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 882 LHFGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAP 940
+H S + H D+KP N+LLD D V L DFG AK L+ + +++ + + Y AP
Sbjct: 138 IH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---YICSRYYRAP 191
Query: 941 -EYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEM---TLKHWVNDFLPISMMKI 996
++ DV+S G +L E + F G+ L + + +I
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPI----FPGDSGVDQLVEIIKVLGTPTREQI 247
Query: 997 IDANLLITEDKHFAAKEQCASSVF---------NLAMECTVESPDERITAKEI 1040
+ N TE K K + VF L +P R+T E
Sbjct: 248 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 1e-37
Identities = 58/278 (20%), Positives = 107/278 (38%), Gaps = 35/278 (12%)
Query: 776 LIGRGSFGSVYIAR-LQNGIEVAVKTFDLQH------ERAFKSFDTECEVMKSIRHRNLT 828
+G G F V R G++ A K + + + + E ++K I+H N+
Sbjct: 17 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 829 KIISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSA 888
+ N+ LILE + G L L L + + + + + YLH S
Sbjct: 77 TLHEVYENKTDVILILELVAGGELFDFLAEKES-LTEEEATEFLKQILNGVYYLH---SL 132
Query: 889 PVIHCDLKPSNVLLDDNMVA----HLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGR 944
+ H DLKP N++L D V + DFG+A + D T ++APE
Sbjct: 133 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEFVAPEIVN 189
Query: 945 EGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLIT 1004
+ + D++S G++ + P F G+ + + A
Sbjct: 190 YEPLGLEADMWSIGVITYILLSGASP----FLGDT----------KQETLANVSAVNYEF 235
Query: 1005 EDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVR 1042
ED++F ++ + V+ P +R+T ++ ++
Sbjct: 236 EDEYF---SNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (352), Expect = 3e-37
Identities = 66/284 (23%), Positives = 111/284 (39%), Gaps = 24/284 (8%)
Query: 775 NLIGRGSFGSVYIAR--LQNGIEVAVKTFDLQ--HERAFKSFDTECEVMK---SIRHRNL 827
IG G++G V+ AR G VA+K +Q E S E V++ + H N+
Sbjct: 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72
Query: 828 TKIISSCSNEDFKA-----LILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYL 882
++ C+ L+ E++ + ++M + L++L
Sbjct: 73 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 132
Query: 883 HFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEY 942
H S V+H DLKP N+L+ + L+DFG+A++ M T + TL Y APE
Sbjct: 133 H---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVTLWYRAPEV 186
Query: 943 GREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLL 1002
+ +T D++S G + E F R+ + K LP D L
Sbjct: 187 LLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALP 246
Query: 1003 ITEDKHFAAK------EQCASSVFNLAMECTVESPDERITAKEI 1040
+A+ +L ++C +P +RI+A
Sbjct: 247 RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 1e-36
Identities = 61/278 (21%), Positives = 98/278 (35%), Gaps = 45/278 (16%)
Query: 776 LIGRGSFGSVYIAR-LQNGIEVAVKTF------DLQHERAFKSFDTECEVMKSIR--HRN 826
L+G G FGSVY + + + VA+K D E ++K +
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 827 LTKIISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGY 886
+ +++ D LILE + L + V A+ + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH--- 127
Query: 887 SAPVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGRE 945
+ V+H D+K N+L+D + L DFG LL + T T Y PE+ R
Sbjct: 128 NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWIRY 183
Query: 946 GRVSTKG-DVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLIT 1004
R + V+S GILL + P F + +II +
Sbjct: 184 HRYHGRSAAVWSLGILLYDMVCGDIP----FEHDE---------------EIIRGQVFF- 223
Query: 1005 EDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVR 1042
+++ +S +L C P +R T +EI
Sbjct: 224 -------RQRVSSECQHLIRWCLALRPSDRPTFEEIQN 254
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (344), Expect = 3e-36
Identities = 54/281 (19%), Positives = 109/281 (38%), Gaps = 19/281 (6%)
Query: 775 NLIGRGSFGSVYIAR-LQNGIEVAVKTFDLQH--ERAFKSFDTECEVMKSIRHRNLTKII 831
IG G++G+V+ A+ + VA+K L E S E ++K ++H+N+ ++
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 832 SSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVI 891
++ L+ E+ + + D + + + L + H V+
Sbjct: 68 DVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL-DPEIVKSFLFQLLKGLGFCHS---RNVL 123
Query: 892 HCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPE-YGREGRVST 950
H DLKP N+L++ N L++FG+A+ + + + TL Y P+ ST
Sbjct: 124 HRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY--SAEVVTLWYRPPDVLFGAKLYST 181
Query: 951 KGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHFA 1010
D++S G + E +P + LK + + L +
Sbjct: 182 SIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPM 241
Query: 1011 AKE---------QCASSVFNLAMECTVESPDERITAKEIVR 1042
+ ++ +L +P +RI+A+E ++
Sbjct: 242 YPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 134 bits (338), Expect = 2e-35
Identities = 40/283 (14%), Positives = 82/283 (28%), Gaps = 29/283 (10%)
Query: 776 LIGRGSFGSVYIAR-LQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSC 834
IG GSFG ++ L N +VA+K + + E K + +
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYF 69
Query: 835 SNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCD 894
E +++ + SLE L + + + ++ +H +++ D
Sbjct: 70 GQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRD 126
Query: 895 LKPSNVLLDDNMVAH-----LSDFGIAKLLIGEDQS-----MTQTQTLATLGYMAPEYGR 944
+KP N L+ + + DFG+ K + T YM+
Sbjct: 127 IKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHL 186
Query: 945 EGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLIT 1004
S + D+ + G + M P + + K+ +I +
Sbjct: 187 GREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYE----------RIGEKKQSTP 236
Query: 1005 EDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKI 1047
+ + + D + K+
Sbjct: 237 LRELC---AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 9e-35
Identities = 59/291 (20%), Positives = 112/291 (38%), Gaps = 29/291 (9%)
Query: 775 NLIGRGSFGSVYIAR-LQNGIEVAVKTFDLQH--ERAFKSFDTECEVMKSIRHRNLTKII 831
IG+G+FG V+ AR + G +VA+K +++ E + E ++++ ++H N+ +I
Sbjct: 16 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75
Query: 832 SSCSNEDFKA--------LILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLH 883
C + L+ ++ + + + +M + + L Y+H
Sbjct: 76 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK-FTLSEIKRVMQMLLNGLYYIH 134
Query: 884 FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQT--LATLGYMAPE 941
++H D+K +NVL+ + V L+DFG+A+ S T + TL Y PE
Sbjct: 135 ---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPE 191
Query: 942 YGREGR-VSTKGDVYSFGILLMETFTRRKPTD-----------EIFSGEMTLKHWVNDFL 989
R D++ G ++ E +TR G +T + W N
Sbjct: 192 LLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDN 251
Query: 990 PISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEI 1040
K+ + K +L + V P +RI + +
Sbjct: 252 YELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 9e-34
Identities = 63/305 (20%), Positives = 115/305 (37%), Gaps = 33/305 (10%)
Query: 759 FSYLELFQATNGFSEN----NLIGRGSFGSVYIAR-LQNGIEVAVKTF--DLQHERAFKS 811
F E+ + +G G++G+V A + G +VA+K Q E K
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63
Query: 812 FDTECEVMKSIRHRNLTKIISSCSNEDFKA------LILEYMRNGSLEKCLYSGNYILDI 865
E ++K +RH N+ ++ + ++ L++ +M + + L
Sbjct: 64 AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGK---LMKHEKLGE 120
Query: 866 FQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS 925
+ ++ + L Y+H +A +IH DLKP N+ ++++ + DFG+A+ + S
Sbjct: 121 DRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR----QADS 173
Query: 926 MTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKP---------TDEIFS 976
+ R + D++S G ++ E T + EI
Sbjct: 174 EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMK 233
Query: 977 GEMTLKHWVNDFLPISMMKIIDANLLITEDKHFAAKEQCASSVF-NLAMECTVESPDERI 1035
T L K L E K FA+ AS + NL + V ++R+
Sbjct: 234 VTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRV 293
Query: 1036 TAKEI 1040
TA E
Sbjct: 294 TAGEA 298
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 1e-33
Identities = 63/281 (22%), Positives = 109/281 (38%), Gaps = 36/281 (12%)
Query: 769 NGFSENNLIGRGSFGSVYIAR-LQNGIEVAVKTFD---LQHERAFKSFDTECEVMKSIRH 824
N F L+G+G+FG V + R G A+K + + TE V+++ RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 825 RNLTKIISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHF 884
LT + + D ++EY G L L + + ++ SALEYLH
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLH- 122
Query: 885 GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGR 944
S V++ D+K N++LD + ++DFG+ K I + +M T Y+APE
Sbjct: 123 --SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KTFCGTPEYLAPEVLE 178
Query: 945 EGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLIT 1004
+ D + G+++ E R P F + ++ + L
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGRLP----FYNQ-------------DHERLFELIL--- 218
Query: 1005 EDKHFAAKEQCASSVFNLAMECTVESPDERI-----TAKEI 1040
+ + +L + P +R+ AKE+
Sbjct: 219 -MEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEV 258
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 127 bits (321), Expect = 1e-32
Identities = 55/273 (20%), Positives = 100/273 (36%), Gaps = 39/273 (14%)
Query: 777 IGRGSFGSVYIAR-LQNGIEVAVKTFDLQH---ERAFKSFDTECEVMKSIRHRNLTKIIS 832
+G GSFG V + + ++G A+K D Q + + E +++++ L K+
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 833 SCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIH 892
S + +++EY+ G + L + EYLH S +I+
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHARFYAAQIVLTFEYLH---SLDLIY 164
Query: 893 CDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKG 952
DLKP N+L+D ++DFG AK + G ++ T +APE +
Sbjct: 165 RDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCG-----TPEALAPEIILSKGYNKAV 219
Query: 953 DVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHFAAK 1012
D ++ G+L+ E P F + PI + + I +
Sbjct: 220 DWWALGVLIYEMAAGYPP----FFADQ----------PIQIYEKIVSG-------KVRFP 258
Query: 1013 EQCASSVFNLAMECTVESPDERI-----TAKEI 1040
+S + +L +R +I
Sbjct: 259 SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDI 291
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 126 bits (317), Expect = 3e-32
Identities = 57/321 (17%), Positives = 120/321 (37%), Gaps = 37/321 (11%)
Query: 744 VPNEVNVPL-EATWRRFSYLELFQATNGFSENNLIGRGSFGSVYIAR-LQNGIEVAVKTF 801
V +VN W S++ + + + +GRG + V+ A + N +V VK
Sbjct: 9 VYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL 68
Query: 802 DLQHERAFKSFDTECEVMKSIR-HRNLTKIISSCSNEDFK--ALILEYMRNGSLEKCLYS 858
++ K E ++++++R N+ + + + AL+ E++ N ++ +
Sbjct: 69 KPVKKKKIKR---EIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT 125
Query: 859 GNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFGIAK 917
L + M ++ AL+Y H S ++H D+KP NV++D ++ L D+G+A+
Sbjct: 126 ----LTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE 178
Query: 918 LLIGEDQSMTQTQTLATLGYMAPEYGREGR-VSTKGDVYSFGILLMETFTRRKPTDEIFS 976
+A+ + PE + + D++S G +L R++P
Sbjct: 179 FY---HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 235
Query: 977 GEMTLKHWVNDFLPISMMKIIDANLLITEDK-----------------HFAAKEQCASSV 1019
L + ID + + + H + +
Sbjct: 236 NYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEA 295
Query: 1020 FNLAMECTVESPDERITAKEI 1040
+ + R+TA+E
Sbjct: 296 LDFLDKLLRYDHQSRLTAREA 316
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 2e-31
Identities = 67/305 (21%), Positives = 118/305 (38%), Gaps = 33/305 (10%)
Query: 759 FSYLELFQATNGFSEN----NLIGRGSFGSVYIAR-LQNGIEVAVKTF--DLQHERAFKS 811
F EL + E + +G G++GSV A + G+ VAVK Q K
Sbjct: 4 FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 63
Query: 812 FDTECEVMKSIRHRNLTKIISSCS-----NEDFKALILEYMRNGSLEKCLYSGNYILDIF 866
E ++K ++H N+ ++ + E ++ ++ L + L
Sbjct: 64 TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDD 121
Query: 867 QRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSM 926
++ + L+Y+H SA +IH DLKPSN+ ++++ + DFG+A+
Sbjct: 122 HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDD 173
Query: 927 TQTQTLATLGYMAPE-YGREGRVSTKGDVYSFGILLMETFTRRKP---------TDEIFS 976
T +AT Y APE + D++S G ++ E T R I
Sbjct: 174 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 233
Query: 977 GEMTLKHWVNDFLPISMMKIIDANLLITEDKHFAAKEQCASSVF-NLAMECTVESPDERI 1035
T + + + +L +FA A+ + +L + V D+RI
Sbjct: 234 LVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI 293
Query: 1036 TAKEI 1040
TA +
Sbjct: 294 TAAQA 298
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (308), Expect = 3e-31
Identities = 60/282 (21%), Positives = 103/282 (36%), Gaps = 38/282 (13%)
Query: 775 NLIGRGSFGSVYIARL----QNGIEVAVKTFD----LQHERAFKSFDTECEVMKSIRHR- 825
++G G++G V++ R G A+K +Q + + TE +V++ IR
Sbjct: 30 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89
Query: 826 NLTKIISSCSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFG 885
L + + E LIL+Y+ G L L F + I V + L
Sbjct: 90 FLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER----FTEHEVQIYVGEIVLALEHL 145
Query: 886 YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGRE 945
+ +I+ D+K N+LLD N L+DFG++K + ++ YMAP+ R
Sbjct: 146 HKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTI-EYMAPDIVRG 204
Query: 946 GR--VSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLI 1003
G D +S G+L+ E T P F
Sbjct: 205 GDSGHDKAVDWWSLGVLMYELLTGASP-----------------FTVDGEKNSQAEISRR 247
Query: 1004 TEDKHFAAKEQCASSVFNLAMECTVESPDERI-----TAKEI 1040
++ ++ +L ++ P +R+ A EI
Sbjct: 248 ILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEI 289
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 115 bits (288), Expect = 3e-28
Identities = 52/309 (16%), Positives = 106/309 (34%), Gaps = 47/309 (15%)
Query: 776 LIGRGSFGSVYIAR-LQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSC 834
+G G F +V++A+ + N VA+K ++ + E ++++ + + TK S
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT-EAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 835 SNEDFK---------------ALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASAL 879
+N K ++ E + L + + + I + L
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 880 EYLHFGYSAPVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYM 938
+Y+H +IH D+KP NVL++ + +L IA L T ++ T Y
Sbjct: 139 DYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196
Query: 939 APEYGREGRVSTKGDVYSFGILLMETFTRRKP---------------------------T 971
+PE D++S L+ E T +
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPS 256
Query: 972 DEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESP 1031
+ +G+ T + + L ++ K+ L + + + A + + P
Sbjct: 257 YLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDP 316
Query: 1032 DERITAKEI 1040
+R A +
Sbjct: 317 RKRADAGGL 325
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 3e-28
Identities = 56/297 (18%), Positives = 111/297 (37%), Gaps = 40/297 (13%)
Query: 776 LIGRGSFGSVYIAR-LQNGIEVAVKTF--DLQHERAFKSFDTECEVMKSIRHRNLTKIIS 832
IG G+ G V A VA+K Q++ K E +MK + H+N+ +++
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 833 SCSNEDFK------ALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGY 886
+ + L++E M + D + ++ + +++LH
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL----DHERMSYLLYQMLCGIKHLH--- 136
Query: 887 SAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREG 946
SA +IH DLKPSN+++ + + DFG+A+ S T + T Y APE
Sbjct: 137 SAGIIHRDLKPSNIVVKSDCTLKILDFGLART---AGTSFMMTPYVVTRYYRAPEVILGM 193
Query: 947 RVSTKGDVYSFGILLMETFTRRKP---------------------TDEIFSGEMTLKHWV 985
D++S G ++ E + + + + T++++V
Sbjct: 194 GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYV 253
Query: 986 NDFLPISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVR 1042
+ + + + AS +L + V P +RI+ + ++
Sbjct: 254 ENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 109 bits (273), Expect = 1e-26
Identities = 87/308 (28%), Positives = 136/308 (44%), Gaps = 35/308 (11%)
Query: 28 DQDALLALKDHITYDPTNFFAKNWLTNSTMVCN--WTGVTCDINQR--RVTALNISYLSL 83
D+ ALL +K + +PT +W +T CN W GV CD + + RV L++S L+L
Sbjct: 7 DKQALLQIKKDLG-NPTTL--SSW-LPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNL 62
Query: 84 TGN--IPRQLGNLSSLEILDL-NFNRLSGEIPWELGNLAKLEKLLLHNNFLTGTIPFSIF 140
IP L NL L L + N L G IP + L +L L + + ++G IP +
Sbjct: 63 PKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLS 122
Query: 141 KLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQLSGSIPSFIFKISSLQA-LHF 199
++ +L+ L S N L+GT+P + +L +L + N++SG+IP S L +
Sbjct: 123 QIKTLVTLDFSYNALSGTLPPS-ISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTI 181
Query: 200 GNNRLSGELPANICDNLPFLNFFSV---------------------YKNMFYGGISSTLS 238
NRL+G++P + S +
Sbjct: 182 SRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVG 241
Query: 239 NCKHLRILDLSFNDLWGDIPKEIGNLTKLKELFLDFNILQGEIPHTVGNLHNLEYLSLVN 298
K+L LDL N ++G +P+ + L L L + FN L GEIP GNL + + N
Sbjct: 242 LSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYAN 300
Query: 299 NELVGTVP 306
N+ + P
Sbjct: 301 NKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 87.1 bits (214), Expect = 4e-19
Identities = 76/297 (25%), Positives = 115/297 (38%), Gaps = 30/297 (10%)
Query: 407 SSLSNCKYLEIIALSGNPLNGI--IPMSAGNLSHSLEELFMPDCNVSGRIPKEIGNLANL 464
+ + + + LSG L IP S NL + N+ G IP I L L
Sbjct: 44 DTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQL 103
Query: 465 VTLDLGGNKFNGSIPIALGKLQKLQLLNLDDNKLEGSIPDDICGLVELYKLALGDNKLSG 524
L + +G+IP L +++ L L+ N L G++P I L L + N++SG
Sbjct: 104 HYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISG 163
Query: 525 QIPACFGNLASLRELWLGPNELISFIPSTFWNIKDIMYVNFSSNFLTGPLPLEIENLKAL 584
IP +G+ + L ++ + ++ +V+ S N L G +
Sbjct: 164 AIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDAS-VLFGSDKN 222
Query: 585 TTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQGSIPDSVGDLISLKSLNLSNNNLSG 644
T N +G K L L L +NR+ G++P + L L SLN+S NNL G
Sbjct: 223 TQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCG 282
Query: 645 PIPTSLEKLSDLKELNLSFNKLEGEIPRGGPFVNFSAKSFMGNNLLCGSPNLQVPPC 701
IP GG F ++ N LCGSP +P C
Sbjct: 283 EIPQ------------------------GGNLQRFDVSAYANNKCLCGSP---LPAC 312
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 84.0 bits (206), Expect = 5e-18
Identities = 61/274 (22%), Positives = 95/274 (34%), Gaps = 8/274 (2%)
Query: 162 HNLGNLSSLQLLDLSDNQLSG--SIPSFIFKISSLQALHFGNNRLSGELPANICDNLPFL 219
+ LDLS L IPS + + L L+ G L L
Sbjct: 44 DTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQL 103
Query: 220 NFFSVYKNMFYGGISSTLSNCKHLRILDLSFNDLWGDIPKEIGNLTKLKELFLDFNILQG 279
++ + G I LS K L LD S+N L G +P I +L L + D N + G
Sbjct: 104 HYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISG 163
Query: 280 EIPHTVGNLHNLEYLSLVNNELVGTVPATIFNVSTLKLIELSNNTFFGSLPSSTDVQLPN 339
IP + G+ L ++ + F L ++LS N G +S
Sbjct: 164 AIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEG--DASVLFGSDK 221
Query: 340 LEELYLWGNNFSGTLPSFIFNASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNYLT 399
+ N + + NL+ L L +N G +P L+ L L + N L
Sbjct: 222 NTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLC 281
Query: 400 SPELSFLSSLSNCKYLEIIALSGNPLNGIIPMSA 433
+ N + ++ A + N P+ A
Sbjct: 282 GE----IPQGGNLQRFDVSAYANNKCLCGSPLPA 311
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 50.5 bits (119), Expect = 5e-07
Identities = 19/67 (28%), Positives = 32/67 (47%), Gaps = 4/67 (5%)
Query: 174 DLSDNQLSGSIPSFIFKISSLQALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGGI 233
DL +N++ G++P + ++ L +L+ N L GE+P NL + + N G
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ--GGNLQRFDVSAYANNKCLCG- 306
Query: 234 SSTLSNC 240
S L C
Sbjct: 307 -SPLPAC 312
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 108 bits (270), Expect = 9e-26
Identities = 71/362 (19%), Positives = 131/362 (36%), Gaps = 53/362 (14%)
Query: 336 QLPNLEELYLWGNNFSGTLPSFIFNASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYN 395
L + L + +NL++++ +N + + P NL L + + N
Sbjct: 42 DLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNN 97
Query: 396 NYLTSPELSF---------------------------------LSSLSNCKYLEIIALSG 422
N + +++S+ L +
Sbjct: 98 NQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQ 157
Query: 423 NPLNGIIPMSAGNLSHSLEELFMPDCNVSGRIPKEIGNLANLVTLDLGGNKFNGSIPIAL 482
G L++ + + + L NL +L N+ + P+ +
Sbjct: 158 QLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGI 217
Query: 483 GKLQKLQLLNLDDNKLEGSIPDDICGLVELYKLALGDNKLSGQIPACFGNLASLRELWLG 542
L L+L+ N+L+ + L L L L +N++S P L L EL LG
Sbjct: 218 LT--NLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLG 271
Query: 543 PNELISFIPSTFWNIKDIMYVNFSSNFLTGPLPLEIENLKALTTLDFSMNNLSGVIPTTI 602
N++ + P + + + + N L P I NLK LT L NN+S + P +
Sbjct: 272 ANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--V 325
Query: 603 GGLKGLQYLFLGHNRLQGSIPDSVGDLISLKSLNLSNNNLSGPIPTSLEKLSDLKELNLS 662
L LQ LF +N++ S+ +L ++ L+ +N +S P L L+ + +L L+
Sbjct: 326 SSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLN 381
Query: 663 FN 664
Sbjct: 382 DQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 107 bits (267), Expect = 2e-25
Identities = 91/394 (23%), Positives = 149/394 (37%), Gaps = 44/394 (11%)
Query: 117 NLAKLEKLLLHNNFLTGTIPFSIFKLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLS 176
LA+ K +L +T T+ + L + L+ + + L++L ++ S
Sbjct: 20 ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKSI---DGVEYLNNLTQINFS 74
Query: 177 DNQLSGSIPSFIFKISSLQALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGGISST 236
+NQL+ P + ++ L + NN+++ P NL L F+ + T
Sbjct: 75 NNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLT 132
Query: 237 LSNCKHLRILDL--------------SFNDLWGDIPKEIGNLTKLKELFLDFNILQGEIP 282
N L + K + NLT L+ L + N +
Sbjct: 133 NLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSN--KVSDI 190
Query: 283 HTVGNLHNLEYLSLVNNELVGTVPATIFNVSTLKLIELSNNTFFGSLPSSTDVQLPNLEE 342
+ L NLE L NN++ P + ++ L + L+ N T L NL +
Sbjct: 191 SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD---IGTLASLTNLTD 245
Query: 343 LYLWGNNFSGTLPSFIFNASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNYLTSPE 402
L L N S P + + L++L LG N S + P L L L L N L
Sbjct: 246 LDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDIS 301
Query: 403 LSFLSSLSNCKYLEIIALSGNPLNGIIPMSAGNLSHSLEELFMPDCNVSGRIPKEIGNLA 462
N K L + L N ++ I P+ +L+ L+ LF + VS + NL
Sbjct: 302 PIS-----NLKNLTYLTLYFNNISDISPV--SSLT-KLQRLFFANNKVSD--VSSLANLT 351
Query: 463 NLVTLDLGGNKFNGSIPIALGKLQKLQLLNLDDN 496
N+ L G N+ + P L L ++ L L+D
Sbjct: 352 NINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 106 bits (265), Expect = 4e-25
Identities = 82/408 (20%), Positives = 142/408 (34%), Gaps = 40/408 (9%)
Query: 137 FSIFKLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQLSGSIPSFIFKISSLQA 196
F+ L+ + L N+T T+ +L +++LQ L + G + +++L
Sbjct: 16 FTDTALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQ 70
Query: 197 LHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGGISSTLSNCKHLRILDLSFNDLWGD 256
++F NN+L+ P L + + + T L ++ D +
Sbjct: 71 INFSNNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKN 130
Query: 257 IPKEIGNLTKLKELFLDFNILQGEIPHTVGNLHNLEYLSLVNNELVGTVPATIFNVSTLK 316
+ + + + + + + ++ L
Sbjct: 131 LTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTD---------------LKPLANLT 175
Query: 317 LIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSGTLPSFIFNASNLSKLSLGDNSFSG 376
+E + + S +L NLE L N S P I +NL +LSL N
Sbjct: 176 TLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKD 233
Query: 377 LIPNTFGNLRNLKRLRLYNNYLTSPELSFLSSLSNCKYLEIIALSGNPLNGIIPMSAGNL 436
T +L NL L L NN +++ L+ LS L + L N ++ I P L
Sbjct: 234 --IGTLASLTNLTDLDLANNQISN-----LAPLSGLTKLTELKLGANQISNISP-----L 281
Query: 437 SHSLEELFMPDCNVSGRIPKEIGNLANLVTLDLGGNKFNGSIPIALGKLQKLQLLNLDDN 496
+ + I NL NL L L N + P+ L KLQ L +N
Sbjct: 282 AGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISPV--SSLTKLQRLFFANN 339
Query: 497 KLEGSIPDDICGLVELYKLALGDNKLSGQIPACFGNLASLRELWLGPN 544
K+ + L + L+ G N++S P NL + +L L
Sbjct: 340 KVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 93.5 bits (231), Expect = 8e-21
Identities = 72/363 (19%), Positives = 135/363 (37%), Gaps = 35/363 (9%)
Query: 72 RVTALNISYLSLTGNIPRQLGNLSSLEILDLNFNRLSGEIPWELGNLAKLEKLLLHNNFL 131
+VT L L + +I + L++L ++ + N+L+ P L NL KL +L++NN +
Sbjct: 45 QVTTLQADRLGIK-SID-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQI 100
Query: 132 TGTIPFSIFKLSSLLDLKLSDNNLTGTIPSH-----------NLGNLSSLQLLDLSDNQL 180
P + + L L + + + + ++S+L L
Sbjct: 101 ADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLS 160
Query: 181 SGSIPSFIFKISSLQALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGGISSTLSNC 240
G+ + + +++L L + + ++ L L N
Sbjct: 161 FGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLG--IL 218
Query: 241 KHLRILDLSFNDLWGDIPKEIGNLTKLKELFLDFNILQGEIPHTVGNLHNLEYLSLVNNE 300
+L L L+ N L + +LT L +L L N + P + L L L L N+
Sbjct: 219 TNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQ 274
Query: 301 LVGTVPATIFNVSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSGTLPSFIFN 360
+ P ++ L + S L NL L L+ NN S P + +
Sbjct: 275 ISNISP-----LAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSS 327
Query: 361 ASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNYLTSPELSFLSSLSNCKYLEIIAL 420
+ L +L +N S ++ NL N+ L +N ++ L+ L+N + + L
Sbjct: 328 LTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISD-----LTPLANLTRITQLGL 380
Query: 421 SGN 423
+
Sbjct: 381 NDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 75.4 bits (184), Expect = 7e-15
Identities = 71/343 (20%), Positives = 124/343 (36%), Gaps = 23/343 (6%)
Query: 333 TDVQLPNLEELYLWGNNFSGTLPSFIFNASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLR 392
TD L + L N + T+ + ++ L + + L NL ++
Sbjct: 17 TDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQIN 72
Query: 393 LYNNYLTS-PELSFLSSLSNCKYLEIIALSGNPLNGIIPMSAGNLSHSLEELFMPDCNVS 451
NN LT L L+ L + PL + ++ L ++ P N++
Sbjct: 73 FSNNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLT 132
Query: 452 GRIPKEIGNLANLVTLDLGGNKFNGSIPIALGKLQKLQLLNLDDNKLEGSIP------DD 505
E+ + L G + L NL +
Sbjct: 133 NLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISV 192
Query: 506 ICGLVELYKLALGDNKLSGQIPACFGNLASLRELWLGPNELISFIPSTFWNIKDIMYVNF 565
+ L L L +N++S P +L EL L N+L T ++ ++ ++
Sbjct: 193 LAKLTNLESLIATNNQISDITPLGILT--NLDELSLNGNQLKD--IGTLASLTNLTDLDL 248
Query: 566 SSNFLTGPLPLEIENLKALTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQGSIPDS 625
++N ++ PL L LT L N +S + P + GL L L L N+L+
Sbjct: 249 ANNQISNLAPLS--GLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLE--DISP 302
Query: 626 VGDLISLKSLNLSNNNLSGPIPTSLEKLSDLKELNLSFNKLEG 668
+ +L +L L L NN+S P + L+ L+ L + NK+
Sbjct: 303 ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD 343
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 68.1 bits (165), Expect = 2e-12
Identities = 38/191 (19%), Positives = 71/191 (37%), Gaps = 29/191 (15%)
Query: 32 LLALKDHITYDPTNFFAKNWLTNSTMVCNWTGVTCDINQRRVTALNISYLSLTGNIPRQL 91
L+A + I+ N S + + +T L+++ ++ P L
Sbjct: 202 LIATNNQISDITPLGILTNLDELSLNGNQLKDIGTLASLTNLTDLDLANNQISNLAP--L 259
Query: 92 GNLSSLEILDLNFNRLSGEIP--------------------WELGNLAKLEKLLLHNNFL 131
L+ L L L N++S P + NL L L L+ N +
Sbjct: 260 SGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNI 319
Query: 132 TGTIPFSIFKLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQLSGSIPSFIFKI 191
+ P S L+ L L ++N ++ + S L NL+++ L NQ+S P + +
Sbjct: 320 SDISPVS--SLTKLQRLFFANNKVSD-VSS--LANLTNINWLSAGHNQISDLTP--LANL 372
Query: 192 SSLQALHFGNN 202
+ + L +
Sbjct: 373 TRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 53.1 bits (126), Expect = 9e-08
Identities = 52/286 (18%), Positives = 99/286 (34%), Gaps = 52/286 (18%)
Query: 423 NPLNGIIPMSAGNLSHSLEELFMPDCNVSGRIPKEIGNLANLVTLDLGGNKFNGSIPIAL 482
P+N I + L+ ++ + + NV+ + + +L + TL SI +
Sbjct: 10 TPINQIFTDT--ALAEKMKTV-LGKTNVTDTVSQT--DLDQVTTLQADRLGIK-SID-GV 62
Query: 483 GKLQKLQLLNLDDNKLEGSIPDDICGLVELYKLALGDNKLSGQIPACFGNLASLRELWLG 542
L L +N +N+L P + L +L + + +N+++ P + L+
Sbjct: 63 EYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNN 120
Query: 543 PNELISFIPSTFWNIKDIMYVN-------------------------------------F 565
I + + + + N
Sbjct: 121 QITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERL 180
Query: 566 SSNFLTGPLPLEIENLKALTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQGSIPDS 625
+ + L L +L + N +S + P I L L L N+L+ +
Sbjct: 181 DISSNKVSDISVLAKLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKD--IGT 236
Query: 626 VGDLISLKSLNLSNNNLSGPIPTSLEKLSDLKELNLSFNKLEGEIP 671
+ L +L L+L+NN +S P L L+ L EL L N++ P
Sbjct: 237 LASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP 280
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 97.0 bits (240), Expect = 2e-22
Identities = 60/285 (21%), Positives = 93/285 (32%), Gaps = 19/285 (6%)
Query: 338 PNLEELYLWGNNFSGTLPSFIFNASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNY 397
P+ L L N + N NL L L +N S + P F L L+RL L N
Sbjct: 31 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 90
Query: 398 LTSPELSFLSSLSNCKYLEIIALSGNPLNGIIPMSAGNLS-HSLEELFMPDCNVSGRIPK 456
L K L+ + + N + + L+ + EL SG
Sbjct: 91 LKELPEKM------PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENG 144
Query: 457 EIGNLANLVTLDLGGNKFNGSIPIALGKLQKLQLLNLDDNKLEGSIPDDICGLVELYKLA 516
+ L + + I G L L+LD NK+ + GL L KL
Sbjct: 145 AFQGMKKLSYIRIADTNIT---TIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLG 201
Query: 517 LGDNKLSGQIPACFGNLASLRELWLGPNELISFIPSTFWNIKDIMYVNFSSNFLTG---- 572
L N +S N LRE N + +P + K I V +N ++
Sbjct: 202 LSFNSISAVDNGSLANTPHLRE-LHLNNNKLVKVPGGLADHKYIQVVYLHNNNISAIGSN 260
Query: 573 --PLPLEIENLKALTTLDFSMNNLS--GVIPTTIGGLKGLQYLFL 613
P + + + N + + P+T + + L
Sbjct: 261 DFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 96.3 bits (238), Expect = 4e-22
Identities = 72/343 (20%), Positives = 123/343 (35%), Gaps = 55/343 (16%)
Query: 59 CNWTGVTCDINQRRVTALNISYLSLTGNIPRQLGNLSSLEILDLNFNRLSGEIPWELGNL 118
C+ V C S L L +P+ L +LDL N+++ + NL
Sbjct: 10 CHLRVVQC------------SDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNL 54
Query: 119 AKLEKLLLHNNFLTGTIPFSIFKLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDN 178
L L+L NN ++ P + L L L LS N L Q L + +N
Sbjct: 55 KNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTL----QELRVHEN 110
Query: 179 QLSGSIPSFIFKISSLQALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGGISSTLS 238
+++ S ++ + + G N L G +
Sbjct: 111 EITKVRKSVFNGLNQMIVVELGTNPLK-----------------------SSGIENGAFQ 147
Query: 239 NCKHLRILDLSFNDLWGDIPKEIGNLTKLKELFLDFNILQGEIPHTVGNLHNLEYLSLVN 298
K L + ++ ++ IP+ G L EL LD N + ++ L+NL L L
Sbjct: 148 GMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSF 204
Query: 299 NELVGTVPATIFNVSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSG------ 352
N + ++ N L+ + L+NN D ++ +YL NN S
Sbjct: 205 NSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLAD--HKYIQVVYLHNNNISAIGSNDF 262
Query: 353 TLPSFIFNASNLSKLSLGDN--SFSGLIPNTFGNLRNLKRLRL 393
P + ++ S +SL N + + P+TF + ++L
Sbjct: 263 CPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 92.8 bits (229), Expect = 6e-21
Identities = 50/259 (19%), Positives = 99/259 (38%), Gaps = 12/259 (4%)
Query: 415 LEIIALSGNPLNGIIPMSAGNLSHSLEELFMPDCNVSGRIPKEIGNLANLVTLDLGGNKF 474
++ L N + I NL + L L + + +S P L L L L N+
Sbjct: 33 TALLDLQNNKITEIKDGDFKNLKN-LHTLILINNKISKISPGAFAPLVKLERLYLSKNQL 91
Query: 475 NGSIPIALGKLQKLQLLNLDDNKLEGSIPDDICGLVELYKLALGDNKLSGQIPACFGNLA 534
LQ+L++ + K+ S+ + + ++ + L K SG F +
Sbjct: 92 KELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVE-LGTNPLKSSGIENGAFQGMK 150
Query: 535 SLRELWLGPNELISFIPSTFWNIKDIMYVNFSSNFLTGPLPLEIENLKALTTLDFSMNNL 594
L + + + + ++ ++ N +T ++ L L L S N++
Sbjct: 151 KLSYIRIADTNITTIPQGLPPSLT---ELHLDGNKITKVDAASLKGLNNLAKLGLSFNSI 207
Query: 595 SGVIPTTIGGLKGLQYLFLGHNRLQGSIPDSVGDLISLKSLNLSNNNLSG------PIPT 648
S V ++ L+ L L +N+L +P + D ++ + L NNN+S P
Sbjct: 208 SAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPG 266
Query: 649 SLEKLSDLKELNLSFNKLE 667
K + ++L N ++
Sbjct: 267 YNTKKASYSGVSLFSNPVQ 285
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 82.0 bits (201), Expect = 2e-17
Identities = 51/233 (21%), Positives = 88/233 (37%), Gaps = 6/233 (2%)
Query: 477 SIPIALGKLQKLQLLNLDDNKLEGSIPDDICGLVELYKLALGDNKLSGQIPACFGNLASL 536
+P L LL+L +NK+ D L L+ L L +NK+S P F L L
Sbjct: 24 KVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81
Query: 537 RELWLGPNELISFIPSTFWNIKDIMYVNFSSNFLTGPLPLEIENLKALTTLDFSMNNLSG 596
L+L N+L ++++ + + N + L + SG
Sbjct: 82 ERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSV-FNGLNQMIVVELGTNPLKSSG 140
Query: 597 VIPTTIGGLKGLQYLFLGHNRLQGSIPDSVGDLISLKSLNLSNNNLSGPIPTSLEKLSDL 656
+ G+K L Y+ + + +IP + SL L+L N ++ SL+ L++L
Sbjct: 141 IENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNL 197
Query: 657 KELNLSFNKLEGEIPRGGPFVNFSAKSFMGNNLLCGSPNLQVPPCRASIDHIS 709
+L LSFN + + + NN L P + ++
Sbjct: 198 AKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLH 250
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 56.6 bits (135), Expect = 5e-09
Identities = 24/129 (18%), Positives = 41/129 (31%)
Query: 584 LTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQGSIPDSVGDLISLKSLNLSNNNLS 643
LD N ++ + LK L L L +N++ P + L+ L+ L LS N L
Sbjct: 33 TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK 92
Query: 644 GPIPTSLEKLSDLKELNLSFNKLEGEIPRGGPFVNFSAKSFMGNNLLCGSPNLQVPPCRA 703
+ L +L+ K+ + G + +
Sbjct: 93 ELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKL 152
Query: 704 SIDHISKKN 712
S I+ N
Sbjct: 153 SYIRIADTN 161
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 54.3 bits (129), Expect = 3e-08
Identities = 30/174 (17%), Positives = 61/174 (35%), Gaps = 8/174 (4%)
Query: 38 HITYDPTNFFAKNWLTNSTMVCNWTGVTCDINQRRVTALNISYLSLTGNIPRQLGNLSSL 97
+ N + + + + + + L+ ++ T G SL
Sbjct: 114 KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSL 173
Query: 98 EILDLNFNRLSGEIPWELGNLAKLEKLLLHNNFLTGTIPFSIFKLSSLLDLKLSDNNLTG 157
L L+ N+++ L L L KL L N ++ S+ L +L L++N L
Sbjct: 174 TELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVK 233
Query: 158 TIPSHNLGNLSSLQLLDLSDNQLSG------SIPSFIFKISSLQALHFGNNRLS 205
+ +Q++ L +N +S P + K +S + +N +
Sbjct: 234 VPGGL--ADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.0 bits (229), Expect = 3e-21
Identities = 59/259 (22%), Positives = 90/259 (34%), Gaps = 7/259 (2%)
Query: 386 RNLKRLRLYNNYLTSPELSFLSSLSNCKYLEIIALSGNPLNGIIPMSAGNLSHSLEELFM 445
+R+ L+ N ++ + + N L I+ L N L I + L+ +
Sbjct: 32 AASQRIFLHGNRISHVPAASFRACRN---LTILWLHSNVLARIDAAAFTGLALLEQLDLS 88
Query: 446 PDCNVSGRIPKEIGNLANLVTLDLGGNKFNGSIPIALGKLQKLQLLNLDDNKLEGSIPDD 505
+ + P L L TL L P L LQ L L DN L+ D
Sbjct: 89 DNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDT 148
Query: 506 ICGLVELYKLALGDNKLSGQIPACFGNLASLRELWLGPNELISFIPSTFWNIKDIMYVNF 565
L L L L N++S F L SL L L N + P F ++ +M +
Sbjct: 149 FRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYL 208
Query: 566 SSNFLTGPLPLEIENLKALTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQGSIPDS 625
+N L+ + L+AL L + N LQ + + S+P
Sbjct: 209 FANNLSALPTEALAPLRALQYLRLNDNPWVCDCR-ARPLWAWLQKFRGSSSEVPCSLPQR 267
Query: 626 VGDLISLKSLNLSNNNLSG 644
L L+ N+L G
Sbjct: 268 ---LAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.8 bits (226), Expect = 8e-21
Identities = 64/255 (25%), Positives = 100/255 (39%), Gaps = 6/255 (2%)
Query: 415 LEIIALSGNPLNGIIPMSAGNLSHSLEELFMPDCNVSGRIPKEIGNLANLVTLDLGGNKF 474
+ I L GN ++ + S + L L++ ++ LA L LDL N
Sbjct: 34 SQRIFLHGNRISHVPAASFRACRN-LTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQ 92
Query: 475 NGSI-PIALGKLQKLQLLNLDDNKLEGSIPDDICGLVELYKLALGDNKLSGQIPACFGNL 533
S+ P L +L L+LD L+ P GL L L L DN L F +L
Sbjct: 93 LRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDL 152
Query: 534 ASLRELWLGPNELISFIPSTFWNIKDIMYVNFSSNFLTGPLPLEIENLKALTTLDFSMNN 593
+L L+L N + S F + + + N + P +L L TL NN
Sbjct: 153 GNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANN 212
Query: 594 LSGVIPTTIGGLKGLQYLFLGHNRLQGSIPDSVGDLISLKSLNLSNNNLSGPIPTSLEKL 653
LS + + L+ LQYL L N + L+ S++ + +P ++L
Sbjct: 213 LSALPTEALAPLRALQYLRLNDNPWVCDC-RARPLWAWLQKFRGSSSEVPCSLP---QRL 268
Query: 654 SDLKELNLSFNKLEG 668
+ L+ N L+G
Sbjct: 269 AGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.8 bits (213), Expect = 4e-19
Identities = 64/287 (22%), Positives = 100/287 (34%), Gaps = 9/287 (3%)
Query: 66 CDINQRRVTALNISYLSLTGNIPRQLGNLSSLEILDLNFNRLSGEIPWELGNLAKLEKLL 125
C + L +P + ++ + + L+ NR+S L L
Sbjct: 6 CVCYNEPKVTTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILW 62
Query: 126 LHNNFLTGTIPFSIFKLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQLSGSIP 185
LH+N L + L+ L L LSDN ++ L L L L L P
Sbjct: 63 LHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGP 122
Query: 186 SFIFKISSLQALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGGISSTLSNCKHLRI 245
+++LQ L+ +N L LP + +L L ++ N L
Sbjct: 123 GLFRGLAALQYLYLQDNALQA-LPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDR 181
Query: 246 LDLSFNDLWGDIPKEIGNLTKLKELFLDFNILQGEIPHTVGNLHNLEYLSLVNNELVGTV 305
L L N + P +L +L L+L N L + L L+YL L +N V
Sbjct: 182 LLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDC 241
Query: 306 PATIFNVSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSG 352
A + L+ S++ SLP L + L N+ G
Sbjct: 242 RARPL-WAWLQKFRGSSSEVPCSLPQR----LAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.2 bits (201), Expect = 1e-17
Identities = 61/268 (22%), Positives = 102/268 (38%), Gaps = 10/268 (3%)
Query: 257 IPKEIGNLTKLKELFLDFNILQGEIPHTVGNLHNLEYLSLVNNELVGTVPATIFNVSTLK 316
+P I ++ +FL N + + NL L L +N L A ++ L+
Sbjct: 26 VPVGIPAASQ--RIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83
Query: 317 LIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSGTLPSFIFNASNLSKLSLGDNSFSG 376
++LS+N S+ +T L L L+L P + L L L DN+
Sbjct: 84 QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQA 143
Query: 377 LIPNTFGNLRNLKRLRLYNNYLTSPELSFLSSLSNCKYLEIIALSGNPLNGIIPMSAGNL 436
L +TF +L NL L L+ N ++S L + L+ + L N + + P + +L
Sbjct: 144 LPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHS---LDRLLLHQNRVAHVHPHAFRDL 200
Query: 437 SHSLEELFMPDCNVSGRIPKEIGNLANLVTLDLGGNKFNGSIPIALGKLQKLQLLNLDDN 496
L++ N+S + + L L L L N + LQ +
Sbjct: 201 GRL-MTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKFRGSSS 258
Query: 497 KLEGSIPDDICGLVELYKLALGDNKLSG 524
++ S+P + G L N L G
Sbjct: 259 EVPCSLPQRLAG---RDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 80.6 bits (197), Expect = 5e-17
Identities = 56/285 (19%), Positives = 88/285 (30%), Gaps = 12/285 (4%)
Query: 143 SSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQLSGSIPSFIFKISSLQALHFGNN 202
+ L +P G ++ Q + L N++S + +L L +N
Sbjct: 11 EPKVTTSCPQQGLQ-AVPV---GIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSN 66
Query: 203 RLSGELPANICDNLPFLNFFSVYKNMFYGGISSTLSNCKHLRILDLSFNDLWGDIPKEIG 262
L+ A +T L L L L P
Sbjct: 67 VLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFR 126
Query: 263 NLTKLKELFLDFNILQGEIPHTVGNLHNLEYLSLVNNELVGTVPATIFNVSTLKLIELSN 322
L L+ L+L N LQ T +L NL +L L N + + +L + L
Sbjct: 127 GLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQ 186
Query: 323 NTFFGSLPSSTDVQLPNLEELYLWGNNFSGTLPSFIFNASNLSKLSLGDNSFSGLIPNTF 382
N P + L L LYL+ NN S + L L L DN +
Sbjct: 187 NRVAHVHPHAFR-DLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRAR- 244
Query: 383 GNLRNLKRLRLYNNYLTSPELSFLSSLSNCKYLEIIALSGNPLNG 427
L++ R ++ + L+ + L+ N L G
Sbjct: 245 PLWAWLQKFRGSSSEVPCSLPQRLAGRD------LKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 78.7 bits (192), Expect = 2e-16
Identities = 65/251 (25%), Positives = 89/251 (35%), Gaps = 5/251 (1%)
Query: 447 DCNVSG--RIPKEIGNLANLVTLDLGGNKFNGSIPIALGKLQKLQLLNLDDNKLEGSIPD 504
C G +P I A + L GN+ + + + L +L L N L
Sbjct: 17 SCPQQGLQAVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAA 74
Query: 505 DICGLVELYKLALGDNKLSGQI-PACFGNLASLRELWLGPNELISFIPSTFWNIKDIMYV 563
GL L +L L DN + PA F L L L L L P F + + Y+
Sbjct: 75 AFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYL 134
Query: 564 NFSSNFLTGPLPLEIENLKALTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQGSIP 623
N L +L LT L N +S V GL L L L NR+ P
Sbjct: 135 YLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHP 194
Query: 624 DSVGDLISLKSLNLSNNNLSGPIPTSLEKLSDLKELNLSFNKLEGEIPRGGPFVNFSAKS 683
+ DL L +L L NNLS +L L L+ L L+ N + +
Sbjct: 195 HAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFR 254
Query: 684 FMGNNLLCGSP 694
+ + C P
Sbjct: 255 GSSSEVPCSLP 265
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 88.7 bits (219), Expect = 1e-20
Identities = 23/154 (14%), Positives = 48/154 (31%), Gaps = 20/154 (12%)
Query: 775 NLIGRGSFGSVYIARLQNGIEVAVKTFDL----------QHERAFKSFDTECEVMKSIRH 824
L+G G +V+ + E VK + + + F
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 825 RNLTKIISSCSNEDFKALILEYMRNGSL-EKCLYSGNYILDIFQRLNIMIDVASALEYLH 883
R L K+ + + + N L E Y + + ++ + + +
Sbjct: 66 RALQKLQGLAVPKVY-----AWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY 120
Query: 884 FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK 917
++H DL NVL+ + + + DF +
Sbjct: 121 ---HRGIVHGDLSQYNVLVSEEGI-WIIDFPQSV 150
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 69.7 bits (169), Expect = 1e-13
Identities = 40/198 (20%), Positives = 65/198 (32%), Gaps = 8/198 (4%)
Query: 447 DCNVSG--RIPKEIGNLANLVTLDLGGNKFNGSIPIALGKLQKLQLLNLDDNKLEGSIPD 504
+C+ +P ++ + L L N L +L LNLD +L D
Sbjct: 16 NCDKRNLTALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD 73
Query: 505 DICGLVELYKLALGDNKLSGQIPACFGNLASLRELWLGPNELISFIPSTFWNIKDIMYVN 564
++ + +P L +L L + N L S + ++ +
Sbjct: 74 GTLPVLGTLD---LSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELY 130
Query: 565 FSSNFLTGPLPLEIENLKALTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQGSIPD 624
N L P + L L + NNL+ + + GL+ L L L N L +IP
Sbjct: 131 LKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPK 189
Query: 625 SVGDLISLKSLNLSNNNL 642
L L N
Sbjct: 190 GFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 64.7 bits (156), Expect = 6e-12
Identities = 44/208 (21%), Positives = 68/208 (32%), Gaps = 25/208 (12%)
Query: 138 SIFKLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQLSGSIPSFIFKISSLQAL 197
+ K++S L++ NLT +P +L +L LS+N L + + + L L
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPP-DLP--KDTTILHLSENLLYTFSLATLMPYTRLTQL 60
Query: 198 HFGNNRLSGELPANICDNLPFLNFFSVYKNMFY--------------------GGISSTL 237
+ L+ L L+ L
Sbjct: 61 NLDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGAL 120
Query: 238 SNCKHLRILDLSFNDLWGDIPKEIGNLTKLKELFLDFNILQGEIPHTVGNLHNLEYLSLV 297
L+ L L N+L P + KL++L L N L + L NL+ L L
Sbjct: 121 RGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQ 180
Query: 298 NNELVGTVPATIFNVSTLKLIELSNNTF 325
N L T+P F L L N +
Sbjct: 181 ENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 62.8 bits (151), Expect = 3e-11
Identities = 41/211 (19%), Positives = 63/211 (29%), Gaps = 10/211 (4%)
Query: 66 CDINQR-RVTALNISYLSLTGNIPRQLGNLSSLEILDLNFNRLSGEIPWELGNLAKLEKL 124
C++++ +N +LT +P L IL L+ N L L +L +L
Sbjct: 4 CEVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQL 60
Query: 125 LLHNNFLTGTIPFSIFKLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQLSGSI 184
L LT + L D + LG + S+
Sbjct: 61 NLDRAELTKLQVDGTLPV-----LGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSL 115
Query: 185 PSFIFKISSLQALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGGISSTLSNCKHLR 244
P + + LP + P L S+ N + L+ ++L
Sbjct: 116 PLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLD 175
Query: 245 ILDLSFNDLWGDIPKEIGNLTKLKELFLDFN 275
L L N IPK L FL N
Sbjct: 176 TLLLQENS-LYTIPKGFFGSHLLPFAFLHGN 205
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 60.5 bits (145), Expect = 2e-10
Identities = 41/249 (16%), Positives = 65/249 (26%), Gaps = 28/249 (11%)
Query: 336 QLPNLEELYLWGNNFSGTLPSFIFNASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYN 395
++ + E+ N + LP + + + L L +N T L +L L
Sbjct: 8 KVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDR 64
Query: 396 -NYLTSPELSFLSSLSNCKYLEIIALSGNPLNGIIPMSAGN---------------LSHS 439
L L S L +P
Sbjct: 65 AELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLG 124
Query: 440 LEELFMPDCNVSGRIPKEIGNLANLVTLDLGG-NKFNGSIPIALGKLQKLQLLNLDDNKL 498
+ N +P + + N L L+ L L L +N L
Sbjct: 125 ELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSL 184
Query: 499 EGSIPDDICGLVELYKLALGDNKLSGQIPACFGNLASLRELWLGPNELISFIPSTFWNIK 558
+IP G L L N C + R WL N ++ ++K
Sbjct: 185 Y-TIPKGFFGSHLLPFAFLHGNPWL-----CNCEILYFRR-WLQDNAENVYVWKQGVDVK 237
Query: 559 DIMYVNFSS 567
M N +S
Sbjct: 238 A-MTSNVAS 245
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.5 bits (119), Expect = 4e-07
Identities = 53/210 (25%), Positives = 78/210 (37%), Gaps = 8/210 (3%)
Query: 483 GKLQKLQLLNLDDNKLEGSIPDDICGLVELYKLALGDNKLSGQIPACFGNLASLRELWLG 542
K+ +N D L ++P D+ L L +N L A L +L L
Sbjct: 7 SKVASHLEVNCDKRNLT-ALPPDLPKDTT--ILHLSENLLYTFSLATLMPYTRLTQLNLD 63
Query: 543 PNELISFIPSTFWNIKDIMYVNFSSNFLTGPLPLEIENLKALTTLDFSMNNLSGVIPTTI 602
EL + + ++ + L + L LD S N L+ + +
Sbjct: 64 RAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALT---VLDVSFNRLTSLPLGAL 120
Query: 603 GGLKGLQYLFLGHNRLQGSIPDSVGDLISLKSLNLSNNNLSGPIPTSLEKLSDLKELNLS 662
GL LQ L+L N L+ P + L+ L+L+NNNL+ L L +L L L
Sbjct: 121 RGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQ 180
Query: 663 FNKLEGEIPRG-GPFVNFSAKSFMGNNLLC 691
N L IP+G GN LC
Sbjct: 181 ENSLY-TIPKGFFGSHLLPFAFLHGNPWLC 209
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.0 bits (110), Expect = 5e-06
Identities = 44/211 (20%), Positives = 59/211 (27%), Gaps = 51/211 (24%)
Query: 260 EIGNLTKLKELFLDFNILQGEIPHTVGNLHNLEYLSLVNNELVGTVPATIFNVSTLKLIE 319
E+ + E+ D L +P + + L L N L AT+ + L +
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 320 LSNN--------------------------------------------TFFGSLPSSTDV 335
L SLP
Sbjct: 62 LDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALR 121
Query: 336 QLPNLEELYLWGNNFSGTLPSFIFNASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYN 395
L L+ELYL GN P + L KLSL +N+ + L L NL L L
Sbjct: 122 GLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQE 181
Query: 396 NYLTSPELSFLSSLSNCKYLEIIALSGNPLN 426
N L + L L GNP
Sbjct: 182 NSLY----TIPKGFFGSHLLPFAFLHGNPWL 208
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.6 bits (101), Expect = 6e-05
Identities = 13/65 (20%), Positives = 23/65 (35%), Gaps = 3/65 (4%)
Query: 577 EIENLKALTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQGSIPDSVGDLISLKSLN 636
E+ + + ++ NL+ +P + K L L N L ++ L LN
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 637 LSNNN 641
L
Sbjct: 62 LDRAE 66
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.9 bits (94), Expect = 4e-04
Identities = 12/62 (19%), Positives = 22/62 (35%), Gaps = 3/62 (4%)
Query: 601 TIGGLKGLQYLFLGHNRLQGSIPDSVGDLISLKSLNLSNNNLSGPIPTSLEKLSDLKELN 660
+ + + L ++P + L+LS N L +L + L +LN
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 661 LS 662
L
Sbjct: 62 LD 63
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.5 bits (88), Expect = 0.003
Identities = 17/53 (32%), Positives = 19/53 (35%), Gaps = 1/53 (1%)
Query: 103 NFNRLSGEIPWELGNLAKLEKLLLHNNFLTGTIPFSIFKLSSLLDLKLSDNNL 155
N L+ L L L+ LLL N L TIP F L L N
Sbjct: 156 ANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 63.2 bits (152), Expect = 3e-11
Identities = 47/275 (17%), Positives = 97/275 (35%), Gaps = 15/275 (5%)
Query: 123 KLLLHNNFLTGTIPFSIFKLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQLSG 182
L L L + + ++ + + + + H + +Q +DLS++ +
Sbjct: 4 TLDLTGKNLHPDVTGRLLSQG-VIAFRCPRSFMDQPLAEH--FSPFRVQHMDLSNSVIEV 60
Query: 183 -SIPSFIFKISSLQALHFGNNRLSGELPANI--CDNLPFLNFFSVYKNMFYGGISST--- 236
++ + + S LQ L RLS + + NL LN + +
Sbjct: 61 STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSC 120
Query: 237 --LSNCKHLRILDLSFNDLWGDIPKEIGNLTKLKELFLDFNILQGEIPHTVGNLHNLEYL 294
L D + + + +T+L N+ + ++ V NL +L
Sbjct: 121 SRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHL 180
Query: 295 SLVNNELV-GTVPATIFNVSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSGT 353
L ++ ++ F ++ L+ + LS ++P L+ L ++G GT
Sbjct: 181 DLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGT 240
Query: 354 LPSFIFNASNLSKLSLGDNSFSGLIPNTFGNLRNL 388
L L L + + F+ + T GN +N
Sbjct: 241 LQLL---KEALPHLQINCSHFTTIARPTIGNKKNQ 272
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.5 bits (132), Expect = 1e-08
Identities = 43/286 (15%), Positives = 95/286 (33%), Gaps = 31/286 (10%)
Query: 371 DNSFSGLIPNTFGNL--RNLKRLRLYNNYLTSPELSFLSSLSNCKYLEIIALSGNPLNGI 428
D + L P+ G L + + R +++ P S ++ + LS + +
Sbjct: 6 DLTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFR----VQHMDLSNSVIEVS 61
Query: 429 IPMSAGNLSHSLEELFMPDCNVSGRIPKEIGNLANLVTLDLGGNKFNGSIPIALGKLQKL 488
+ L+ L + +S I + +NLV L+L G +
Sbjct: 62 TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCS 121
Query: 489 QLLNLDDNKLEGSIPDDICGLVELYKLALGDNKLSGQIPACFGNLASLRELWLGPNELIS 548
+L L+ + + V + LSG N S
Sbjct: 122 RLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSG----------------YRKNLQKS 165
Query: 549 FIPSTFWNIKDIMYVNFSSNFL-TGPLPLEIENLKALTTLDFS-MNNLSGVIPTTIGGLK 606
+ + ++++++ S + + E L L L S ++ +G +
Sbjct: 166 DLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIP 225
Query: 607 GLQYLFLGHNRLQGSIPDSVGDLI--SLKSLNLSNNNLSGPIPTSL 650
L+ L ++ G +PD L+ +L L ++ ++ + ++
Sbjct: 226 TLKTL-----QVFGIVPDGTLQLLKEALPHLQINCSHFTTIARPTI 266
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.3 bits (129), Expect = 3e-08
Identities = 43/266 (16%), Positives = 87/266 (32%), Gaps = 11/266 (4%)
Query: 282 PHTVGNLHNLEYLSL-VNNELVGTVPATIFNVSTLKLIELSNNTFFGSLPSSTDVQLPNL 340
P G L + ++ + A F+ ++ ++LSN+ S Q L
Sbjct: 14 PDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKL 73
Query: 341 EELYLWGNNFSGTLPSFIFNASNLSKLSLG--DNSFSGLIPNTFGNLRNLKRLRLYNNYL 398
+ L L G S + + + SNL +L+L + + L L L +
Sbjct: 74 QNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFD 133
Query: 399 TSPELSFLSSLSNCKYLEIIALSG---NPLNGIIPMSAGNLSHSLEELFMPDCNVSGRIP 455
+ + ++ + + + LSG N + + + +
Sbjct: 134 FTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCF 193
Query: 456 KEIGNLANLVTLDLGG-NKFNGSIPIALGKLQKLQLLNLDDNKLEGSIPDDICGLVELYK 514
+E L L L L + LG++ L+ L + +G++ L
Sbjct: 194 QEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEA---LPH 250
Query: 515 LALGDNKLSGQIPACFGNLASLRELW 540
L + + + GN +E+W
Sbjct: 251 LQINCSHFTTIARPTIGNK-KNQEIW 275
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.3 bits (121), Expect = 3e-07
Identities = 45/260 (17%), Positives = 85/260 (32%), Gaps = 14/260 (5%)
Query: 418 IALSGNPLNGIIPMSAGNLSHSLEELFMPDCNVSGRIPKEIGNLANLVTLDLGGNKFNG- 476
+ L+G L+ + LS + P + + E + + +DL +
Sbjct: 5 LDLTGKNLHPDVTGRL--LSQGVIAFRCPRSFMDQPLA-EHFSPFRVQHMDLSNSVIEVS 61
Query: 477 SIPIALGKLQKLQLLNLDDNKLEGSIPDDICGLVELYKLALGD--NKLSGQIPACFGNLA 534
++ L + KLQ L+L+ +L I + + L +L L + + +
Sbjct: 62 TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCS 121
Query: 535 SLREL------WLGPNELISFIPSTFWNIKDIMYVNFSSNFLTGPLPLEIENLKALTTLD 588
L EL + + I + + N L + L LD
Sbjct: 122 RLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLD 181
Query: 589 FSMN-NLSGVIPTTIGGLKGLQYLFLGH-NRLQGSIPDSVGDLISLKSLNLSNNNLSGPI 646
S + L L LQ+L L + +G++ +LK+L + G +
Sbjct: 182 LSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTL 241
Query: 647 PTSLEKLSDLKELNLSFNKL 666
E L L+ F +
Sbjct: 242 QLLKEALPHLQINCSHFTTI 261
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.9 bits (107), Expect = 1e-05
Identities = 16/89 (17%), Positives = 35/89 (39%), Gaps = 3/89 (3%)
Query: 585 TTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQGSIPDSVGDLISLKSLNLSNNNLSG 644
TLD + NL + + G+ + + + + ++ ++LSN+ +
Sbjct: 3 QTLDLTGKNLHPDVTGRLLSQ-GVIAFRCPRSFMDQPLAEH-FSPFRVQHMDLSNSVIEV 60
Query: 645 -PIPTSLEKLSDLKELNLSFNKLEGEIPR 672
+ L + S L+ L+L +L I
Sbjct: 61 STLHGILSQCSKLQNLSLEGLRLSDPIVN 89
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 57.7 bits (138), Expect = 9e-10
Identities = 38/217 (17%), Positives = 73/217 (33%), Gaps = 22/217 (10%)
Query: 460 NLANLVTLDLGGNKFNGSIPIALGKLQKLQLLNLDDNKLEGSIPDDICGLVELYKLALGD 519
LAN + + G + ++ A L + L+ + + + L L L L D
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKD 72
Query: 520 NKLSGQIPACFGNLASLRELWLGPNELISFIPSTFWNIKDIMYVNFSSNFLTGPLPLEIE 579
N+++ P + EL P + +S I + ++ ++
Sbjct: 73 NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132
Query: 580 NLKALTTLDFSMNNL--------------SGVIPTTIGGLKGLQYLFLGHNRLQGSIPDS 625
L +++ L T + L L L N++ P
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP-- 190
Query: 626 VGDLISLKSLNLSNNNLSGPIPTSLEKLSDLKELNLS 662
+ L +L ++L NN +S P L S+L + L+
Sbjct: 191 LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 48.1 bits (113), Expect = 2e-06
Identities = 34/235 (14%), Positives = 76/235 (32%), Gaps = 21/235 (8%)
Query: 137 FSIFKLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQLSGSIPSFIFKISSLQA 196
F L++ + + +N+T T+ +L + L ++ +I + +++L
Sbjct: 13 FPDPALANAIKIAAGKSNVTDTVT---QADLDGITTLSAFGTGVT-TIEG-VQYLNNLIG 67
Query: 197 LHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGGISSTLSNCKHLRILDLSFNDLWGD 256
L +N+++ P + L L ++
Sbjct: 68 LELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAG 127
Query: 257 IPKEIGNLTKLKELFLDFNILQGEIPHTVGNLHNLEYLSLVNNELVGTVPATIFNVSTLK 316
+ L ++ + + + + + N+S L
Sbjct: 128 LSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQV-----------SDLTPLANLSKLT 176
Query: 317 LIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSGTLPSFIFNASNLSKLSLGD 371
++ +N P + LPNL E++L N S P + N SNL ++L +
Sbjct: 177 TLKADDNKISDISPLA---SLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 47.7 bits (112), Expect = 2e-06
Identities = 39/219 (17%), Positives = 67/219 (30%), Gaps = 48/219 (21%)
Query: 360 NASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNYLTSPELSFLSSLSNCKYLEIIA 419
+N K++ G ++ + + T +L + L + +T+ + + L +
Sbjct: 17 ALANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTT-----IEGVQYLNNLIGLE 69
Query: 420 LSGNPLNGIIPMSAGNLSHSLEELFMPDCNVSGR-------------------------- 453
L N + + P+ LE P NVS
Sbjct: 70 LKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLS 129
Query: 454 -----------IPKEIGNLANLVTLDLGGNKFNGSIPIALGKLQKLQLLNLDDNKLEGSI 502
I L S L L KL L DDNK+
Sbjct: 130 NLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDIS 189
Query: 503 PDDICGLVELYKLALGDNKLSGQIPACFGNLASLRELWL 541
P + L L ++ L +N++S P N ++L + L
Sbjct: 190 P--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 46.2 bits (108), Expect = 6e-06
Identities = 18/66 (27%), Positives = 35/66 (53%), Gaps = 5/66 (7%)
Query: 112 PWELGNLAKLEKLLLHNNFLTGTIPFSIFKLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQ 171
L NL+KL L +N ++ P + L +L+++ L +N ++ P L N S+L
Sbjct: 166 LTPLANLSKLTTLKADDNKISDISPLA--SLPNLIEVHLKNNQISDVSP---LANTSNLF 220
Query: 172 LLDLSD 177
++ L++
Sbjct: 221 IVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 43.1 bits (100), Expect = 6e-05
Identities = 39/202 (19%), Positives = 68/202 (33%), Gaps = 26/202 (12%)
Query: 235 STLSNCKHLRILDLSFNDLWGDIPKEIGNLTKLKELFLDFNILQGEIPHTVGNLHNLEYL 294
T ++ + L + I + L L L L N + + NL + L
Sbjct: 35 VTQADLDGITTLSAFGTGV-TTIE-GVQYLNNLIGLELKDNQIT--DLAPLKNLTKITEL 90
Query: 295 SLVNNELVGTVPATIFNVSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYLW-------- 346
L N L + + T L +++Q+ L+ +
Sbjct: 91 ELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDLNQITNISPLAGL 150
Query: 347 -------GNNFSGTLPSFIFNASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNYLT 399
N + + + N S L+ L DN S + P +L NL + L NN ++
Sbjct: 151 TNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQIS 208
Query: 400 SPELSFLSSLSNCKYLEIIALS 421
+S L+N L I+ L+
Sbjct: 209 D-----VSPLANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 41.6 bits (96), Expect = 3e-04
Identities = 22/97 (22%), Positives = 36/97 (37%), Gaps = 4/97 (4%)
Query: 32 LLALKDHITYDPTNFFAKNWLTNSTMVCNWTGVTCDINQRRVTALNISYLSLTGNIPRQL 91
L + IT N S + +T N ++T L ++ P L
Sbjct: 134 LYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--L 191
Query: 92 GNLSSLEILDLNFNRLSGEIPWELGNLAKLEKLLLHN 128
+L +L + L N++S P L N + L + L N
Sbjct: 192 ASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 40.4 bits (93), Expect = 6e-04
Identities = 30/233 (12%), Positives = 66/233 (28%), Gaps = 23/233 (9%)
Query: 263 NLTKLKELFLDFNILQGEIPHTVGNLHNLEYLSLVNNELVGTVPATIFNVSTLKLIELSN 322
L ++ + + + +L + LS + T + ++ L +EL +
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGV--TTIEGVQYLNNLIGLELKD 72
Query: 323 NTFFGSLPSSTDVQLPNLEELYLWGNNFSGTLPSFIFNASNLSKLSLGDNSFSGLIPNTF 382
N ++ EL + + + + +
Sbjct: 73 NQITDL-APLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNL 131
Query: 383 GNLRNLKRLRLYNNYLTSPELSFLSSLSNCKYLEIIALSGNPLNGIIPMSAGNLSHSLEE 442
L + L S+ N + ++ L+ L
Sbjct: 132 QVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANL--------------SKLTT 177
Query: 443 LFMPDCNVSGRIPKEIGNLANLVTLDLGGNKFNGSIPIALGKLQKLQLLNLDD 495
L D +S P + +L NL+ + L N+ + P L L ++ L +
Sbjct: 178 LKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 58.3 bits (139), Expect = 2e-09
Identities = 56/326 (17%), Positives = 100/326 (30%), Gaps = 21/326 (6%)
Query: 339 NLEELYLWGNNFSGTLPSFIFNASNLSKLSLGDNSFSGLIPNTFGNLR--NLKRLRLYNN 396
EL L S +LP +L L NS + L P +L+ + L
Sbjct: 39 QAHELELNNLGLS-SLPELP---PHLESLVASCNSLTEL-PELPQSLKSLLVDNNNLKAL 93
Query: 397 YLTSPELSFLSSLSNCKYLEIIALSGNPLNGIIPMSAGNLSHSLEELFMPDCNVSGRIPK 456
P L +L +N + + L I + + +
Sbjct: 94 SDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLE 153
Query: 457 EIGNLANLVTLDLGGNKFNGSIPIALGKLQKLQLLNLDDNKLEGSIPDDICGLVELYKL- 515
E+ L NL L N + L ++ ++ E ++ L +Y
Sbjct: 154 ELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADN 213
Query: 516 ----ALGDNKLSGQIPACFGNLASLRELWLGPNELISFIPSTFWNIKDIMYVNFSSNFLT 571
L D S + N + + + F + ++ + N +
Sbjct: 214 NLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASS 273
Query: 572 GPLPLEIENLKALTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQGSIPDSVGDLIS 631
+ + +L L+ S N L +P L + L N L +P+ +
Sbjct: 274 NEIRSLCDLPPSLEELNVSNNKLIE-LPALPPRL---ERLIASFNHLA-EVPELPQ---N 325
Query: 632 LKSLNLSNNNLSGPIPTSLEKLSDLK 657
LK L++ N L P E + DL+
Sbjct: 326 LKQLHVEYNPLRE-FPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 54.8 bits (130), Expect = 3e-08
Identities = 66/326 (20%), Positives = 111/326 (34%), Gaps = 24/326 (7%)
Query: 95 SSLEILDLNFNRLSGEIPWELGNLAKLEKLLLHNNFLTGTIPFSIFKLSSLLDLKLSDNN 154
L+LN LS +P +L E L+ N LT +P L SLL +
Sbjct: 38 RQAHELELNNLGLS-SLPELPPHL---ESLVASCNSLT-ELPELPQSLKSLLVDNNNLKA 92
Query: 155 LTGTIPSHNLGNLSSLQLLDLSDNQLSGSIPSFIFKISSLQALHFGNNRLSGE-LPANIC 213
L+ P +S+ QL L + Q S + +SL+ L L N
Sbjct: 93 LSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQL 152
Query: 214 DNLPFLNFFSVYKNMFYGGISSTLSNCKHLRILDLSFNDLWGDIPKEIGNLTKLKELFLD 273
+ LP L ++ S L + + + + E+ NL L ++ D
Sbjct: 153 EELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYAD 212
Query: 274 -------FNILQGEIPHTVGNLHNLEYLSLVNNELVGTVPATIFNVSTLKLIELSNNTFF 326
++ V + + + L + V IF+ + L
Sbjct: 213 NNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNAS 272
Query: 327 GSLPSSTDVQLPNLEELYLWGNNFSGTLPSFIFNASNLSKLSLGDNSFSGLIPNTFGNLR 386
+ S P+LEEL + N LP+ L +L N + + +
Sbjct: 273 SNEIRSLCDLPPSLEELNVSNNKLI-ELPALP---PRLERLIASFNHLAEVPEL----PQ 324
Query: 387 NLKRLRLYNNYLTS-PELSFLSSLSN 411
NLK+L + N L P++ S+ +
Sbjct: 325 NLKQLHVEYNPLREFPDI--PESVED 348
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 53.3 bits (126), Expect = 8e-08
Identities = 51/333 (15%), Positives = 98/333 (29%), Gaps = 24/333 (7%)
Query: 66 CDINQRRVTALNISYLSLTGNIPRQLGNLSSLEILDLNFNRLSGEIPWELGNLAKLEKLL 125
D R+ L ++ L L+ ++P +L E L + N L+ E+P +L L
Sbjct: 33 RDCLDRQAHELELNNLGLS-SLPELPPHL---ESLVASCNSLT-ELPELPQSLKSLLVDN 87
Query: 126 LHNNFLTGTIPFSIFKLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQLSGSIP 185
+ L+ P + S L+ + + +SL+ L L
Sbjct: 88 NNLKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAA 147
Query: 186 SFIFKISSLQALHFGNNRLSGELPANI-CDNLPFLNFFSVYKNMFYGGISSTLSNCKHLR 244
+ + ++ L+ S+ L N L
Sbjct: 148 GNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLT 207
Query: 245 ILDLSFNDLWGDIPKEIGNLTKLKELFLDFNILQG--------EIPHTVGNLHNLEYLSL 296
+ N L ++ + + L L
Sbjct: 208 TIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLY 267
Query: 297 VNNELVGTVPATIFNVSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSGTLPS 356
N + + +L+ + +SNN LP+ P LE L N+ + +P
Sbjct: 268 YLNASSNEIRSLCDLPPSLEELNVSNN-KLIELPAL----PPRLERLIASFNHLA-EVPE 321
Query: 357 FIFNASNLSKLSLGDNSFSGLIPNTFGNLRNLK 389
NL +L + N P+ ++ +L+
Sbjct: 322 LP---QNLKQLHVEYNPLREF-PDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 51.7 bits (122), Expect = 2e-07
Identities = 56/312 (17%), Positives = 101/312 (32%), Gaps = 16/312 (5%)
Query: 232 GISSTLSNCKHLRILDLSFNDLWGDIPKEIGNLTKLKELFLDFNILQGEIPHTVGNLHNL 291
G+SS HL L S N L ++P+ +L L + L P +
Sbjct: 49 GLSSLPELPPHLESLVASCNSL-TELPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSN 107
Query: 292 EYLSLVNNE--LVGTVPATIFNVSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNN 349
L + + N S KL +L + F + ++ +LP L+ L
Sbjct: 108 NQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLEELPELQNLPFLTAI 167
Query: 350 FSGTLPSFIFNASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNYLTSPELSFLSS- 408
++ LS S+ + NL L + NN L + S
Sbjct: 168 YADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADNNLLKTLPDLPPSLE 227
Query: 409 ---LSNCKYLEIIALSGNPLNGIIPMSAGNLSHSLEELFMPDCNVSGRIPKEIGNLANLV 465
+ + ++ L + + + + L S I +L
Sbjct: 228 ALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLE 287
Query: 466 TLDLGGNKFNGSIPIALGKLQKLQLLNLDDNKLEGSIPDDICGLVELYKLALGDNKLSGQ 525
L++ NK +P +L++ L N L +P+ L +L+ + N L +
Sbjct: 288 ELNVSNNKLI-ELPALPPRLER---LIASFNHLA-EVPELPQNLKQLH---VEYNPLR-E 338
Query: 526 IPACFGNLASLR 537
P ++ LR
Sbjct: 339 FPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 50.6 bits (119), Expect = 5e-07
Identities = 57/328 (17%), Positives = 97/328 (29%), Gaps = 28/328 (8%)
Query: 120 KLEKLLLHNNFLTGTIPFSIFKLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQ 179
+ +L L+N L+ ++P L SL S N+LT +P +L SL + + +
Sbjct: 39 QAHELELNNLGLS-SLPELPPHLESL---VASCNSLT-ELPEL-PQSLKSLLVDNNNLKA 92
Query: 180 LSGSIPSFIFKISSLQALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGGISSTLSN 239
LS P + S L + I + L +
Sbjct: 93 LSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQL 152
Query: 240 CKHLRILDLSFNDLWGDIPKEIGNLTKLKELFLDFNIL---------QGEIPHTVGNLHN 290
+ + +L F + L L +P +
Sbjct: 153 EELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYAD 212
Query: 291 LEYLSLVNNELVGTVPATIFNVSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNF 350
L + + + + L EL + F + + L L + N
Sbjct: 213 NNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNAS 272
Query: 351 SGTLPSFIFNASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNYLTSPELSFLSSLS 410
S + S +L +L++ +N L L+RL N+L
Sbjct: 273 SNEIRSLCDLPPSLEELNVSNNKLIEL----PALPPRLERLIASFNHLA----EVPELPQ 324
Query: 411 NCKYLEIIALSGNPLNGI--IPMSAGNL 436
N K L + NPL IP S +L
Sbjct: 325 NLKQLH---VEYNPLREFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 50.6 bits (119), Expect = 6e-07
Identities = 22/135 (16%), Positives = 42/135 (31%), Gaps = 10/135 (7%)
Query: 38 HITYDPTNFFAKNWLTNSTMVCNWTGVTCDINQRRVTALNISYLSLTGNIPRQLGNLSSL 97
N+ ++ + + + I SL
Sbjct: 227 EALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSL 286
Query: 98 EILDLNFNRLSGEIPWELGNLAKLEKLLLHNNFLTGTIPFSIFKLSSLLDLKLSDNNLTG 157
E L+++ N+L E+P LE+L+ N L +P +L L + N L
Sbjct: 287 EELNVSNNKLI-ELPALPPR---LERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLR- 337
Query: 158 TIPSHNLGNLSSLQL 172
P ++ L++
Sbjct: 338 EFPDI-PESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 49.4 bits (116), Expect = 1e-06
Identities = 22/83 (26%), Positives = 39/83 (46%), Gaps = 9/83 (10%)
Query: 589 FSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQGSIPDSVGDLISLKSLNLSNNNLSGPIPT 648
+ +N S I + L+ L + +N+L +P L+ L S N+L+ +P
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPP---RLERLIASFNHLAE-VP- 320
Query: 649 SLEKLSDLKELNLSFNKLEGEIP 671
E +LK+L++ +N L E P
Sbjct: 321 --ELPQNLKQLHVEYNPLR-EFP 340
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 46.4 bits (108), Expect = 1e-05
Identities = 54/327 (16%), Positives = 100/327 (30%), Gaps = 20/327 (6%)
Query: 240 CKHLRILDLSFNDLWGDIPKEIGNLTKLKELFLDFNILQGEIPHTVGNLHNLEYLSLVNN 299
+ L+L+ L +P+ +L L N L E+P +L +L +
Sbjct: 37 DRQAHELELNNLGL-SSLPELPPHLE---SLVASCNSLT-ELPELPQSLKSLLVDNNNLK 91
Query: 300 ELVGTVPATIFNVSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSGT-----L 354
L P + + +E S DV +L++L +
Sbjct: 92 ALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQ 151
Query: 355 PSFIFNASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNYLTSPELSFLSSLSNCKY 414
+ NL L+ + L L + N PEL L L+
Sbjct: 152 LEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYA 211
Query: 415 LEIIALS-GNPLNGIIPMSAGNLSHSLEELFMPDCNVSGRIPKEIGNLANLVTLDLGGNK 473
+ + + + ++ + + L+ L N
Sbjct: 212 DNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNA 271
Query: 474 FNGSIPIALGKLQKLQLLNLDDNKLEGSIPDDICGLVELYKLALGDNKLSGQIPACFGNL 533
+ I L+ LN+ +NKL +P L L N L+ ++P N
Sbjct: 272 SSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERLI---ASFNHLA-EVPELPQN- 325
Query: 534 ASLRELWLGPNELISFIPSTFWNIKDI 560
L++L + N L P +++D+
Sbjct: 326 --LKQLHVEYNPL-REFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 44.8 bits (104), Expect = 4e-05
Identities = 55/335 (16%), Positives = 98/335 (29%), Gaps = 31/335 (9%)
Query: 315 LKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSGTLPSFIFNASNLSKLSLGDNSF 374
+EL+N SLP P+LE L N+ + LP +L L + +N+
Sbjct: 40 AHELELNNL-GLSSLPEL----PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNL 90
Query: 375 SGLIPNTFGNLRNLKRLRLYNNYLTSPELSFLSS--LSNCKYLEIIALSGNPLNGIIPMS 432
L SFL + N ++ L + +
Sbjct: 91 KALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNN 150
Query: 433 AGNLSHSLEELFMPDCNVSGRIPKEIGNLANLVTLDLGGNKFNGSIPIALGKLQKLQLLN 492
L+ L + + L + L L L +
Sbjct: 151 QLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIY 210
Query: 493 LDDNKLEGSIPDDICGLVELYKLALGDNKLSGQIPACFGNLASLRELW--------LGPN 544
D+N L+ + + F +++ N
Sbjct: 211 ADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLN 270
Query: 545 ELISFIPSTFWNIKDIMYVNFSSNFLTGPLPLEIENLKALTTLDFSMNNLSGVIPTTIGG 604
+ I S + +N S+N L LP L+ L S N+L+ V
Sbjct: 271 ASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPRLE---RLIASFNHLAEVPEL---- 322
Query: 605 LKGLQYLFLGHNRLQGSIPDSVGDLISLKSLNLSN 639
+ L+ L + +N L+ PD S++ L +++
Sbjct: 323 PQNLKQLHVEYNPLR-EFPDIPE---SVEDLRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 44.0 bits (102), Expect = 6e-05
Identities = 25/93 (26%), Positives = 36/93 (38%), Gaps = 9/93 (9%)
Query: 225 YKNMFYGGISSTLSNCKHLRILDLSFNDLWGDIPKEIGNLTKLKELFLDFNILQGEIPHT 284
Y N I S L L++S N L ++P L + L FN L E+P
Sbjct: 268 YLNASSNEIRSLCDLPPSLEELNVSNNKL-IELPALPPRLER---LIASFNHLA-EVP-- 320
Query: 285 VGNLHNLEYLSLVNNELVGTVPATIFNVSTLKL 317
NL+ L + N L P +V L++
Sbjct: 321 -ELPQNLKQLHVEYNPLR-EFPDIPESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 43.3 bits (100), Expect = 1e-04
Identities = 59/350 (16%), Positives = 103/350 (29%), Gaps = 34/350 (9%)
Query: 143 SSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQLSGSIPSFIFKISSLQALHFGNN 202
+L+L++ L+ ++P L+ L S N L+ +P SL++L NN
Sbjct: 38 RQAHELELNNLGLS-SLPE----LPPHLESLVASCNSLT-ELPEL---PQSLKSLLVDNN 88
Query: 203 RLSGELPANICDNLPFLNFFSVYKNMFYGGISSTLSNCKHLRILDLSFNDLWGDIPKEIG 262
L ++ + K S L + G
Sbjct: 89 NLKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAG 148
Query: 263 NLTKLKELFLDFNILQGEIPHTVGNLHNLEYLSLVNNELVGTVPATIFNVSTLKLIELSN 322
N + L I +L L L L +V L L+
Sbjct: 149 NNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTT 208
Query: 323 NTFFGSLPSSTDVQLPNLEELYLWGNNFSGTLPSFIFNASNLSKLSLGDNSFSGLIPNTF 382
+L + P+LE L + N + +F + N F
Sbjct: 209 IYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELP------------QSLTFLDVSENIF 256
Query: 383 GNLRNLKRLRLYNNYLTSPELSFLSSLSNCKYLEIIALSGNPLNGIIPMSAGNLSHSLEE 442
L L Y N ++ S + + L +S N L + L LE
Sbjct: 257 SGLSELPPNLYYLNASSNEIRSLCDLPPSLEELN---VSNNKLIEL-----PALPPRLER 308
Query: 443 LFMPDCNVSGRIPKEIGNLANLVTLDLGGNKFNGSIPIALGKLQKLQLLN 492
L +++ +P+ NL L + N P ++ L++ +
Sbjct: 309 LIASFNHLA-EVPELPQ---NLKQLHVEYNPLR-EFPDIPESVEDLRMNS 353
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 54.3 bits (130), Expect = 2e-09
Identities = 30/119 (25%), Positives = 47/119 (39%), Gaps = 6/119 (5%)
Query: 76 LNISYLSLTGNIPRQLGNLSSLEILDLNFNRLSGEIPWELGNLAKLEKLLLHNNFLTGTI 135
L++++ LT + L L + LDL+ NRL P L L LE L +N L
Sbjct: 3 LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENVD 59
Query: 136 PFSIFKLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQLSGSIPSFIFKISSL 194
+ L L +N L + L + L LL+L N L +++ +
Sbjct: 60 GVANLPRLQELLL--CNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEM 115
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 47.0 bits (111), Expect = 6e-07
Identities = 28/121 (23%), Positives = 46/121 (38%), Gaps = 9/121 (7%)
Query: 148 LKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQLSGSIPSFIFKISSLQALHFGNNRLSGE 207
L L+ +LT +L L + LDLS N+L P+ ++L+ L +
Sbjct: 3 LHLAHKDLTVL---CHLEQLLLVTHLDLSHNRLRALPPAL----AALRCLEVLQASDNAL 55
Query: 208 LPANICDNLPFLNFFSVYKNMFYGGIS-STLSNCKHLRILDLSFNDLWGDIPKEIGNLTK 266
+ NLP L + N + L +C L +L+L N L L +
Sbjct: 56 ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAE 114
Query: 267 L 267
+
Sbjct: 115 M 115
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 46.2 bits (109), Expect = 1e-06
Identities = 29/109 (26%), Positives = 42/109 (38%), Gaps = 5/109 (4%)
Query: 244 RILDLSFNDLWGDIPKEIGNLTKLKELFLDFNILQGEIPHTVGNLHNLEYLSLVNNELVG 303
R+L L+ DL + + L + L L N L+ P + L LE L +N
Sbjct: 1 RVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNA--L 55
Query: 304 TVPATIFNVSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSG 352
+ N+ L+ + L NN S V P L L L GN+
Sbjct: 56 ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 45.9 bits (108), Expect = 2e-06
Identities = 34/107 (31%), Positives = 44/107 (41%), Gaps = 6/107 (5%)
Query: 564 NFSSNFLTGPLPLEIENLKALTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQGSIP 623
+ + LT LE L +T LD S N L + P + L+ L+ L N L+
Sbjct: 4 HLAHKDLTVLCHLE--QLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALE--NV 58
Query: 624 DSVGDLISLKSLNLSNNNL-SGPIPTSLEKLSDLKELNLSFNKLEGE 669
D V +L L+ L L NN L L L LNL N L E
Sbjct: 59 DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 45.1 bits (106), Expect = 4e-06
Identities = 21/128 (16%), Positives = 43/128 (33%), Gaps = 9/128 (7%)
Query: 489 QLLNLDDNKLEGSIPDDICGLVELYKLALGDNKLSGQIPACFGNLASLRELWLGPNELIS 548
++L+L L ++ + L+ + L L N+L P L L L ++
Sbjct: 1 RVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQ--ASDNAL 55
Query: 549 FIPSTFWNIKDIMYVNFSSNFLTG-PLPLEIENLKALTTLDFSMNNLS---GVIPTTIGG 604
N+ + + +N L + + L L+ N+L G+
Sbjct: 56 ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEM 115
Query: 605 LKGLQYLF 612
L + +
Sbjct: 116 LPSVSSIL 123
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 44.7 bits (105), Expect = 5e-06
Identities = 25/128 (19%), Positives = 44/128 (34%), Gaps = 10/128 (7%)
Query: 171 QLLDLSDNQLSGSIPSFIFKISSLQALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFY 230
++L L+ L ++ + ++ + L +NRL PA L L N
Sbjct: 1 RVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPA--LAALRCLEVLQASDNALE 56
Query: 231 GGISSTLSNCKHLRILDLSFNDL-WGDIPKEIGNLTKLKELFLDFNIL---QGEIPHTVG 286
N L+ L L N L + + + +L L L N L +G
Sbjct: 57 NVDGVA--NLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAE 114
Query: 287 NLHNLEYL 294
L ++ +
Sbjct: 115 MLPSVSSI 122
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 40.1 bits (93), Expect = 2e-04
Identities = 28/113 (24%), Positives = 38/113 (33%), Gaps = 10/113 (8%)
Query: 389 KRLRLYNNYLTSPELSFLSSLSNCKYLEIIALSGNPLNGIIPMSAGNLSHSLEELFMPDC 448
+ L L + LT L L + + LS N L + P A + +
Sbjct: 1 RVLHLAHKDLTV-----LCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNAL 55
Query: 449 NVSGRIPKEIGNLANLVTLDLGGNKFNGSIPI-ALGKLQKLQLLNLDDNKLEG 500
+ NL L L L N+ S I L +L LLNL N L
Sbjct: 56 E----NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 37.8 bits (87), Expect = 0.001
Identities = 19/112 (16%), Positives = 37/112 (33%), Gaps = 12/112 (10%)
Query: 367 LSLGDNSFSGLIPNTFGNLRNLKRLRLYNNYLTS--PELSFLSSLSNCKYLEIIALSGNP 424
L L + L L + L L +N L + P L+ L L + + + +
Sbjct: 3 LHLAHKDLTVLCH--LEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDG 60
Query: 425 LNGIIPMSAGNLSHSLEELFMPDCNVSGRIPKEIGNLANLVTLDLGGNKFNG 476
+ + + L + + + + + LV L+L GN
Sbjct: 61 VANLPRLQELLLCN--------NRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 37.8 bits (87), Expect = 0.001
Identities = 24/128 (18%), Positives = 42/128 (32%), Gaps = 9/128 (7%)
Query: 293 YLSLVNNELVGTVPATIFNVSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYLW-GNNFS 351
L L + +L TV + + + ++LS+N P+ L L L + ++ +
Sbjct: 2 VLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPA-----LAALRCLEVLQASDNA 54
Query: 352 GTLPSFIFNASNLSKLSLGDNSFSGL-IPNTFGNLRNLKRLRLYNNYLTSPELSFLSSLS 410
+ N L +L L +N + L L L N L E
Sbjct: 55 LENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAE 114
Query: 411 NCKYLEII 418
+ I
Sbjct: 115 MLPSVSSI 122
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.3 bits (131), Expect = 8e-09
Identities = 39/231 (16%), Positives = 76/231 (32%), Gaps = 7/231 (3%)
Query: 169 SLQLLDLSDNQLSGSIPSFIFKISSLQALHFGNNRLSGELPANICDNLPFLNFFSVYKNM 228
S ++ +++++ IPS + + + L F +L + L + +N
Sbjct: 9 SNRVFLCQESKVT-EIPSDLPR--NAIELRFVLTKLRV-IQKGAFSGFGDLEKIEISQND 64
Query: 229 FYGGISSTLSNCKHLRILDLSFNDL--WGDIPKEIGNLTKLKELFLDFNILQGEIPHTVG 286
I + + + P+ NL L+ L + ++
Sbjct: 65 VLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKI 124
Query: 287 NLHNLEYLSLVNNELVGTVPATIFNVSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYLW 346
+ L + +N + T+ F + + + L N + L+EL L
Sbjct: 125 HSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLS 184
Query: 347 GNNFSGTLPSFIF-NASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNN 396
NN LP+ +F AS L + L NL+ L+ YN
Sbjct: 185 DNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL 235
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.3 bits (118), Expect = 4e-07
Identities = 42/244 (17%), Positives = 73/244 (29%), Gaps = 17/244 (6%)
Query: 59 CNWTGVTCDINQRRVTALNISYLSLTGNIPRQLGNLSSLEILDLNFNRLSGEIPWELGNL 118
C+ C +T IP L + L +L
Sbjct: 8 CSNRVFLC------------QESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGF 52
Query: 119 AKLEKLLLHNNFLTGTI-PFSIFKLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSD 177
LEK+ + N + I L L ++++ N I NL +LQ L +S+
Sbjct: 53 GDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISN 112
Query: 178 NQLSGSIPSFIFKISSLQALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGGISSTL 237
+ L +N + N L F + I +
Sbjct: 113 TGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCA 172
Query: 238 SNCKHLRILDLSFNDLWGDIPKEI-GNLTKLKELFLDFNILQGEIPHTVGNLHNLEYLSL 296
N L L+LS N+ ++P ++ + L + + + + NL L S
Sbjct: 173 FNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST 232
Query: 297 VNNE 300
N +
Sbjct: 233 YNLK 236
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.8 bits (114), Expect = 1e-06
Identities = 29/225 (12%), Positives = 60/225 (26%), Gaps = 8/225 (3%)
Query: 447 DCNVSG--RIPKEIGNLANLVTLDLGGNKFNGSIPIALGKLQKLQLLNLDDNKLEGSIPD 504
C S IP ++ N + L K A L+ + + N + I
Sbjct: 14 LCQESKVTEIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEA 71
Query: 505 DICGLVELYKLALGDNKLSGQIPACFGNLASLRELWLGPNELI----SFIPSTFWNIKDI 560
D+ + + + +L + + K +
Sbjct: 72 DVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVL 131
Query: 561 MYVNFSSNFLTGPLPLEIENLKALTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQG 620
+ + + N T + L + N + + G + + +N L+
Sbjct: 132 LDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEE 191
Query: 621 SIPDSVGDLISLKSLNLSNNNLSGPIPTSLEKLSDLKELNLSFNK 665
D L++S + LE L L+ + K
Sbjct: 192 LPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.9 bits (104), Expect = 2e-05
Identities = 32/250 (12%), Positives = 68/250 (27%), Gaps = 16/250 (6%)
Query: 339 NLEELYLWGNNFSGTLPSFIFNASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNYL 398
+ + + +PS + N +L + F +L+++ + N +
Sbjct: 9 SNRVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDV 65
Query: 399 TSPELSFLSSLSNCKYLEIIALSGNPLNGIIPMSAGNLSHSLEELFMPDCNVSGRIPKEI 458
+ + S + I + N L + + + K
Sbjct: 66 LEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIH 125
Query: 459 GNLANLVTLDLGGNKFNGSIPIALGKLQKLQLLNLDDNKLEGSIPDDICGLVELYKLALG 518
L+ + N +G + +L L+ N ++ G
Sbjct: 126 SLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSD 185
Query: 519 DNKLSGQIPACFGNLASLRELWLGPNELISFIPSTFWNIKDIMYVNFSSNFLTGPLPLEI 578
+N L F + L + + S N+K + +
Sbjct: 186 NNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTY------------ 233
Query: 579 ENLKALTTLD 588
NLK L TL+
Sbjct: 234 -NLKKLPTLE 242
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.0 bits (99), Expect = 9e-05
Identities = 38/232 (16%), Positives = 68/232 (29%), Gaps = 9/232 (3%)
Query: 151 SDNNLTGTIPSHNLGNLSSLQLLDLSDNQLSGSIPSFIFKISSLQALHFGNNRLSGELPA 210
++ +T IPS + L +L L+ + N + + A
Sbjct: 16 QESKVT-EIPS---DLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEA 71
Query: 211 NICDNLPFLNFFSVYKNMFYGGI-SSTLSNCKHLRILDLSFNDLWGDIPKEIGNLTKLKE 269
++ NLP L+ + K I N +L+ L +S + + +
Sbjct: 72 DVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVL 131
Query: 270 LFLDFNILQGEIPHTVGNLHNLEYLSLVNNELVGTVPATIFNVSTLKLIELSNN-TFFGS 328
L + NI I + E + L N+ T ++
Sbjct: 132 LDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEE 191
Query: 329 LPSSTDVQLPNLEELYLWGNNFSGTLPSFIFNASNLSKLSLGDNSFSGLIPN 380
LP+ L + +LPS+ NL KL +P
Sbjct: 192 LPNDVFHGASGPVILDISRTRIH-SLPSYGL--ENLKKLRARSTYNLKKLPT 240
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.2 bits (97), Expect = 2e-04
Identities = 14/92 (15%), Positives = 22/92 (23%)
Query: 38 HITYDPTNFFAKNWLTNSTMVCNWTGVTCDINQRRVTALNISYLSLTGNIPRQLGNLSSL 97
F L + + +L S
Sbjct: 144 ERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGP 203
Query: 98 EILDLNFNRLSGEIPWELGNLAKLEKLLLHNN 129
ILD++ R+ + L NL KL +N
Sbjct: 204 VILDISRTRIHSLPSYGLENLKKLRARSTYNL 235
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (87), Expect = 0.003
Identities = 28/204 (13%), Positives = 51/204 (25%)
Query: 338 PNLEELYLWGNNFSGTLPSFIFNASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNY 397
N EL +L K+ + N +I +
Sbjct: 29 RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA 88
Query: 398 LTSPELSFLSSLSNCKYLEIIALSGNPLNGIIPMSAGNLSHSLEELFMPDCNVSGRIPKE 457
++ + + ++ + + +L L ++ +
Sbjct: 89 NNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSF 148
Query: 458 IGNLANLVTLDLGGNKFNGSIPIALGKLQKLQLLNLDDNKLEGSIPDDICGLVELYKLAL 517
+G V L L N A Q +L D+N LE D G L +
Sbjct: 149 VGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDI 208
Query: 518 GDNKLSGQIPACFGNLASLRELWL 541
++ NL LR
Sbjct: 209 SRTRIHSLPSYGLENLKKLRARST 232
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 53.9 bits (128), Expect = 2e-08
Identities = 40/215 (18%), Positives = 75/215 (34%), Gaps = 22/215 (10%)
Query: 454 IPKEIG------NLANLVTLDLGGNKFNGSIPIALGKLQKLQLLNLDDNKLEGSIPDDIC 507
+P I A + +L ++ +L + + +++ ++ I
Sbjct: 10 VPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--IQ 65
Query: 508 GLVELYKLALGDNKLSGQIPACFGNLASLRELWLGPNELISFIPSTFWNIKDIMYVNFSS 567
L + KL L NKL+ NL +L L+L N++ + + +
Sbjct: 66 YLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNG 123
Query: 568 NFLTGPLPLEIENLKALTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQGSIPDSVG 627
L + + N T + L L L L N++ +P +
Sbjct: 124 ISDINGLVHLPQLE------SLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP--LA 175
Query: 628 DLISLKSLNLSNNNLSGPIPTSLEKLSDLKELNLS 662
L L++L LS N++S +L L +L L L
Sbjct: 176 GLTKLQNLYLSKNHISD--LRALAGLKNLDVLELF 208
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 50.8 bits (120), Expect = 2e-07
Identities = 39/206 (18%), Positives = 66/206 (32%), Gaps = 18/206 (8%)
Query: 67 DINQRRVTALNISYLSLTGNIPRQLGNLSSLEILDLNFNRLSGEIPWELGNLAKLEKLLL 126
D N+ S+T + L+S++ + N + + + L + KL L
Sbjct: 20 DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS--VQGIQYLPNVTKLFL 75
Query: 127 HNNFLTGTIPFSIFKLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQLSGSIPS 186
+ N LT P + L + + S L L L + S
Sbjct: 76 NGNKLTDIKPLA----------NLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGIS 125
Query: 187 FIFKISSLQALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGGISSTLSNCKHLRIL 246
I + L L + + L L+ S+ N + L+ L+ L
Sbjct: 126 DINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNL 183
Query: 247 DLSFNDLWGDIPKEIGNLTKLKELFL 272
LS N + D+ + L L L L
Sbjct: 184 YLSKNHI-SDLR-ALAGLKNLDVLEL 207
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 47.3 bits (111), Expect = 3e-06
Identities = 36/197 (18%), Positives = 71/197 (36%), Gaps = 24/197 (12%)
Query: 117 NLAKLEKLLLHNNFLTGTIPFSIFKLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLS 176
A+ K L +T + + +L+S+ + +++++ L N++ L L+
Sbjct: 22 AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQGIQYLPNVTKLF---LN 76
Query: 177 DNQLSG---------------SIPSFIFKISSLQALHFGNNRLSGELPANICDNLPFLNF 221
N+L+ S + L ++I +
Sbjct: 77 GNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQL 136
Query: 222 FSVYKNMFYGGISSTLSNCKHLRILDLSFNDLWGDIPKEIGNLTKLKELFLDFNILQGEI 281
S+Y + LS L L L N + +P + LTKL+ L+L N + ++
Sbjct: 137 ESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHIS-DL 193
Query: 282 PHTVGNLHNLEYLSLVN 298
+ L NL+ L L +
Sbjct: 194 RA-LAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 43.1 bits (100), Expect = 7e-05
Identities = 30/201 (14%), Positives = 68/201 (33%), Gaps = 24/201 (11%)
Query: 137 FSIFKLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQLSGSIPSFIFKISSLQA 196
FS + + L ++T + L+S+ + +++ + I + ++
Sbjct: 18 FSDDAFAETIKDNLKKKSVTDAVT---QNELNSIDQIIANNSDIKSVQG--IQYLPNVTK 72
Query: 197 LHFGNNRLSG---------------ELPANICDNLPFLNFFSVYKNMFYGGISSTLSNCK 241
L N+L+ + + ++ + GIS
Sbjct: 73 LFLNGNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVH 132
Query: 242 HLRILDLSFNDLWGDIPKEIGNLTKLKELFLDFNILQGEIPHTVGNLHNLEYLSLVNNEL 301
++ L + + LTKL L L+ N + +P + L L+ L L N +
Sbjct: 133 LPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHI 190
Query: 302 VGTVPATIFNVSTLKLIELSN 322
+ + + L ++EL +
Sbjct: 191 --SDLRALAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 41.9 bits (97), Expect = 1e-04
Identities = 34/189 (17%), Positives = 66/189 (34%), Gaps = 18/189 (9%)
Query: 234 SSTLSNCKHLRILDLSFNDLWGDIPKEIGNLTKLKELFLDFNILQGEIPHTVGNLHNLEY 293
+ T + + + + +D+ I L + +LFL+ N L + NL NL +
Sbjct: 39 AVTQNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNKLTD--IKPLANLKNLGW 94
Query: 294 LSLVNNELVGTVPATIFNVSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSGT 353
L L N++ +E + + L ++ L +
Sbjct: 95 LFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLESLYLGNNKITDITVLSR 154
Query: 354 LPSFIFNASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNYLTSPELSFLSSLSNCK 413
L + DN S ++P L L+ L L N+++ L +L+ K
Sbjct: 155 LTKLDTLSLE-------DNQISDIVP--LAGLTKLQNLYLSKNHISD-----LRALAGLK 200
Query: 414 YLEIIALSG 422
L+++ L
Sbjct: 201 NLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 41.5 bits (96), Expect = 2e-04
Identities = 33/196 (16%), Positives = 66/196 (33%), Gaps = 24/196 (12%)
Query: 360 NASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNYLTSPELSFLSSLSNCKYLEIIA 419
+ K +L S + + L ++ ++ N+ + S + + + +
Sbjct: 22 AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKS-----VQGIQYLPNVTKLF 74
Query: 420 LSGNPLNGIIPMS--------------AGNLSHSLEELFMPDCNVSGRIPKEIGNLANLV 465
L+GN L I P++ +LS + + ++ +I L +L
Sbjct: 75 LNGNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLP 134
Query: 466 TLDLGGNKFNGSIPIALGKLQKLQLLNLDDNKLEGSIPDDICGLVELYKLALGDNKLSGQ 525
L+ N I + ++ I + GL +L L L N +S
Sbjct: 135 QLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIV-PLAGLTKLQNLYLSKNHISD- 192
Query: 526 IPACFGNLASLRELWL 541
+ A L +L L L
Sbjct: 193 LRA-LAGLKNLDVLEL 207
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 41.5 bits (96), Expect = 2e-04
Identities = 41/217 (18%), Positives = 79/217 (36%), Gaps = 32/217 (14%)
Query: 297 VNNELVGTVPATIF------NVSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNF 350
+ +E + TVP I + L + ++ + +L +++++ ++
Sbjct: 3 LGSETI-TVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQN---ELNSIDQIIANNSDI 58
Query: 351 SGTLPSFIFNASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRL--------------YNN 396
I N++KL L N + NL+NL L L
Sbjct: 59 KSVQG--IQYLPNVTKLFLNGNKLTD--IKPLANLKNLGWLFLDENKVKDLSSLKDLKKL 114
Query: 397 YLTSPELSFLSSLSNCKYLEIIALSGNPLNGIIPMSAGNLSHSLEELFMPDCNVSGRIPK 456
S E + +S ++ +L + N I ++ + L+ L + D +S +P
Sbjct: 115 KSLSLEHNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP- 173
Query: 457 EIGNLANLVTLDLGGNKFNGSIPIALGKLQKLQLLNL 493
+ L L L L N + + AL L+ L +L L
Sbjct: 174 -LAGLTKLQNLYLSKNHIS-DLR-ALAGLKNLDVLEL 207
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 49.0 bits (115), Expect = 5e-07
Identities = 40/195 (20%), Positives = 66/195 (33%), Gaps = 20/195 (10%)
Query: 59 CNWTGVTCDINQRRVTALNISYLSLTGNIPRQLGNLSSLEILDLNFNRLSGEIPWELGNL 118
C T V C + L IPR + L LN N L L
Sbjct: 8 CEGTTVDC------------TGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGR 52
Query: 119 AKLEKLLLHNNFLTGTIPFSIFKLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDN 178
L I + F+ +S + N I + L L+ L+L DN
Sbjct: 53 LPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDN 112
Query: 179 QLSGSIPSFIFKISSLQALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGGISSTLS 238
Q+S +P ++SL +L+ +N + + +L S+ G S +
Sbjct: 113 QISCVMPGSFEHLNSLTSLNLASNPFNCNCH--LAWFAEWLRKKSLNGGAARCGAPSKVR 170
Query: 239 NCKHLRILDLSFNDL 253
+ ++I DL ++
Sbjct: 171 D---VQIKDLPHSEF 182
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 49.0 bits (115), Expect = 6e-07
Identities = 23/136 (16%), Positives = 42/136 (30%), Gaps = 5/136 (3%)
Query: 51 WLTNSTMVCNWTGVTCDINQRRVTALNISYLSLTGNIPRQLGNLSSLEILDLNFNRLSGE 110
L + L + + + L L+ L+L N++S
Sbjct: 58 KLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCV 117
Query: 111 IPWELGNLAKLEKLLLHNNFLTGTIPFSIFKLSSLLDLKLSDNNLTGTIPSHNLGNLSSL 170
+P +L L L L +N + F L L+ PS + +
Sbjct: 118 MPGSFEHLNSLTSLNLASNPFNCNCHLAWF-AEWLRKKSLNGGAARCGAPSK----VRDV 172
Query: 171 QLLDLSDNQLSGSIPS 186
Q+ DL ++ S +
Sbjct: 173 QIKDLPHSEFKCSSEN 188
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 48.6 bits (114), Expect = 8e-07
Identities = 45/184 (24%), Positives = 75/184 (40%), Gaps = 9/184 (4%)
Query: 447 DCNVSG--RIPKEIGNLANLVTLDLGGNKFNGSIPIAL-GKLQKLQLLNLDDNKLEGSIP 503
DC G IP++I + L L N+ L G+L L L L N+L G P
Sbjct: 14 DCTGRGLKEIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEP 71
Query: 504 DDICGLVELYKLALGDNKLSGQIPACFGNLASLRELWLGPNELISFIPSTFWNIKDIMYV 563
+ G + +L LG+NK+ F L L+ L L N++ +P +F ++ + +
Sbjct: 72 NAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSL 131
Query: 564 NFSSNFLTGPLPLEIENLKALTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQGSIP 623
N +SN L + L + P+ ++ +Q L H+ + S
Sbjct: 132 NLASNPFNCNCHLAW-FAEWLRKKSLNGGAARCGAPSK---VRDVQIKDLPHSEFKCSSE 187
Query: 624 DSVG 627
+S G
Sbjct: 188 NSEG 191
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 47.5 bits (111), Expect = 2e-06
Identities = 37/177 (20%), Positives = 63/177 (35%), Gaps = 8/177 (4%)
Query: 491 LNLDDNKLEGSIPDDICGLVELYKLALGDNKLSGQIPACF-GNLASLRELWLGPNELISF 549
++ L+ IP DI + +L L DN+L G L L +L L N+L
Sbjct: 13 VDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGI 69
Query: 550 IPSTFWNIKDIMYVNFSSNFLTGPLPLEIENLKALTTLDFSMNNLSGVIPTTIGGLKGLQ 609
P+ F I + N + L L TL+ N +S V+P + L L
Sbjct: 70 EPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLT 129
Query: 610 YLFLGHNRLQGSIPDSVGDLISLKSLNLSNNNLSGPIPTSLEKLSDLKELNLSFNKL 666
L + L+ +L+ P+ + D++ +L ++
Sbjct: 130 SLN-LASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPSKV---RDVQIKDLPHSEF 182
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 44.4 bits (103), Expect = 2e-05
Identities = 37/172 (21%), Positives = 68/172 (39%), Gaps = 10/172 (5%)
Query: 304 TVPATIFNVSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSGTLPSFIFNASN 363
+P I + L++N +LP+L +L L N +G P+ AS+
Sbjct: 22 EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASH 79
Query: 364 LSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNYLTSPELSFLSSLSNCKYLEIIALSGN 423
+ +L LG+N + F L LK L LY+N ++ S + L + L+ N
Sbjct: 80 IQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVM---PGSFEHLNSLTSLNLASN 136
Query: 424 PLNGIIPMSAGNLSHSLEELFMPDCNVSGRIPKEIGNLANLVTLDLGGNKFN 475
P N ++ + L + + P + + ++ DL ++F
Sbjct: 137 PFNCNCHLA--WFAEWLRKKSLNGGAARCGAPSK---VRDVQIKDLPHSEFK 183
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.4 bits (118), Expect = 9e-07
Identities = 15/81 (18%), Positives = 28/81 (34%), Gaps = 4/81 (4%)
Query: 144 SLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQLSG----SIPSFIFKISSLQALHF 199
+ L + L+ + L L Q++ L D L+ I S + +L L+
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 200 GNNRLSGELPANICDNLPFLN 220
+N L + L +
Sbjct: 63 RSNELGDVGVHCVLQGLQTPS 83
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.0 bits (112), Expect = 4e-06
Identities = 18/113 (15%), Positives = 35/113 (30%), Gaps = 9/113 (7%)
Query: 554 FWNIKDIMYVNFSSNFLTGPLPLEIENLKALTTLDFSMNNLSGV----IPTTIGGLKGLQ 609
F I + + L L + ++S + T+ L+
Sbjct: 341 FLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLR 400
Query: 610 YLFLGHNRLQGSIPDSVGDLI-----SLKSLNLSNNNLSGPIPTSLEKLSDLK 657
L L +N L + + + + L+ L L + S + L+ L K
Sbjct: 401 ELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDK 453
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.0 bits (112), Expect = 4e-06
Identities = 19/110 (17%), Positives = 35/110 (31%), Gaps = 27/110 (24%)
Query: 169 SLQLLDLSDNQLSGS-IPSFIFKISSLQALHFGNNRLSGELPANICDNLPFLNFFSVYKN 227
+Q LD+ +LS + + + Q + + L+ +I
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDI--------------- 47
Query: 228 MFYGGISSTLSNCKHLRILDLSFNDLWGDIPKEIG-----NLTKLKELFL 272
SS L L L+L N+L + K+++L L
Sbjct: 48 ------SSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSL 91
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.0 bits (112), Expect = 5e-06
Identities = 17/89 (19%), Positives = 31/89 (34%), Gaps = 10/89 (11%)
Query: 584 LTTLDFSMNNLSGV-IPTTIGGLKGLQYLFLGHNRLQG----SIPDSVGDLISLKSLNLS 638
+ +LD LS + L+ Q + L L I ++ +L LNL
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 639 NNNLSGPIPTSL-----EKLSDLKELNLS 662
+N L + +++L+L
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQ 92
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.7 bits (111), Expect = 5e-06
Identities = 15/70 (21%), Positives = 27/70 (38%), Gaps = 5/70 (7%)
Query: 608 LQYLFLGHNRLQGS-IPDSVGDLISLKSLNLSNNNLSG----PIPTSLEKLSDLKELNLS 662
+Q L + L + + + L + + L + L+ I ++L L ELNL
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 663 FNKLEGEIPR 672
N+L
Sbjct: 64 SNELGDVGVH 73
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.9 bits (109), Expect = 1e-05
Identities = 17/93 (18%), Positives = 33/93 (35%), Gaps = 6/93 (6%)
Query: 363 NLSKLSLGDNSFSGL-IPNTFGNLRNLKRLRLYNNYLTSPELSFLSS-LSNCKYLEIIAL 420
++ L + S L+ + +RL + LT +SS L L + L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 421 SGNPLNGI----IPMSAGNLSHSLEELFMPDCN 449
N L + + S +++L + +C
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCC 95
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.7 bits (106), Expect = 2e-05
Identities = 19/112 (16%), Positives = 34/112 (30%), Gaps = 24/112 (21%)
Query: 161 SHNLGNLSSLQLLDLSDNQLSG----SIPSFIFKISSLQALHFGNNRLSGELPANICDNL 216
S L++L L+D +S S+ + + SL+ L NN L + +++
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421
Query: 217 PFLNFFSVYKNMFYGGISSTLSNCKHLRILDLSFNDLWGDIPKEIGNLTKLK 268
L L L ++ + L K K
Sbjct: 422 R--------------------QPGCLLEQLVLYDIYWSEEMEDRLQALEKDK 453
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.6 bits (103), Expect = 5e-05
Identities = 21/132 (15%), Positives = 37/132 (28%), Gaps = 9/132 (6%)
Query: 121 LEKLLLHNNFLTGTIPFSIFK-LSSLLDLKLSDNNLTGTIPSH---NLGNLSSLQLLDLS 176
++ L + L+ + L ++L D LT L +L L+L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 177 DNQLSGSIPSFIFKI-----SSLQALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYG 231
N+L + + +Q L N L+G + L L
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNL 123
Query: 232 GISSTLSNCKHL 243
+ L
Sbjct: 124 LGDAGLQLLCEG 135
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.6 bits (103), Expect = 6e-05
Identities = 22/92 (23%), Positives = 37/92 (40%), Gaps = 11/92 (11%)
Query: 143 SSLLDLKLSDNNLTGTIPSH---NLGNLSSLQLLDLSDNQLSGSIPSFIFKI-----SSL 194
S L L L+D +++ + S L SL+ LDLS+N L + + + L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
Query: 195 QALHFGNNRLSGELP---ANICDNLPFLNFFS 223
+ L + S E+ + + P L S
Sbjct: 429 EQLVLYDIYWSEEMEDRLQALEKDKPSLRVIS 460
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.6 bits (103), Expect = 6e-05
Identities = 17/74 (22%), Positives = 29/74 (39%), Gaps = 9/74 (12%)
Query: 608 LQYLFLGHNRLQG----SIPDSVGDLISLKSLNLSNNNLSGPIPTSL-----EKLSDLKE 658
L+ L+L + S+ ++ SL+ L+LSNN L L + L++
Sbjct: 371 LRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQ 430
Query: 659 LNLSFNKLEGEIPR 672
L L E+
Sbjct: 431 LVLYDIYWSEEMED 444
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.8 bits (101), Expect = 9e-05
Identities = 14/91 (15%), Positives = 26/91 (28%), Gaps = 5/91 (5%)
Query: 559 DIMYVNFSSNFLT-GPLPLEIENLKALTTLDFSMNNLSGV----IPTTIGGLKGLQYLFL 613
DI ++ L+ + L+ + L+ I + + L L L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 614 GHNRLQGSIPDSVGDLISLKSLNLSNNNLSG 644
N L V + S + +L
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.4 bits (100), Expect = 1e-04
Identities = 18/85 (21%), Positives = 32/85 (37%), Gaps = 9/85 (10%)
Query: 438 HSLEELFMPDCNVSGR----IPKEIGNLANLVTLDLGGNKFNGSIPIALGKLQK-----L 488
L L++ DC+VS + + +L LDL N + + L + + L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
Query: 489 QLLNLDDNKLEGSIPDDICGLVELY 513
+ L L D + D + L +
Sbjct: 429 EQLVLYDIYWSEEMEDRLQALEKDK 453
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.4 bits (100), Expect = 1e-04
Identities = 19/104 (18%), Positives = 26/104 (25%), Gaps = 6/104 (5%)
Query: 346 WGNNFSGTLPSFIFNASNLSKLSLGDNSFSGL----IPNTFGNLRNLKRLRLYNNYLTSP 401
S L L L D S + T +L+ L L NN L
Sbjct: 353 EDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDA 412
Query: 402 ELSFLSSL--SNCKYLEIIALSGNPLNGIIPMSAGNLSHSLEEL 443
+ L LE + L + + L L
Sbjct: 413 GILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSL 456
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.0 bits (99), Expect = 1e-04
Identities = 15/85 (17%), Positives = 29/85 (34%), Gaps = 8/85 (9%)
Query: 112 PWELGNLAKLEKLLLHNNFLTGT----IPFSIFKLSSLLDLKLSDNNLTGTIPSHNL--- 164
+ L L L + ++ + + ++ SL +L LS+N L +
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421
Query: 165 -GNLSSLQLLDLSDNQLSGSIPSFI 188
L+ L L D S + +
Sbjct: 422 RQPGCLLEQLVLYDIYWSEEMEDRL 446
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.0 bits (99), Expect = 1e-04
Identities = 16/98 (16%), Positives = 30/98 (30%), Gaps = 10/98 (10%)
Query: 76 LNISYLSLTGN------IPRQLGNLSSLEILDLNFNRLSGE----IPWELGNLAKLEKLL 125
L+I L + L L +++ L+ L+ I L L +L
Sbjct: 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61
Query: 126 LHNNFLTGTIPFSIFKLSSLLDLKLSDNNLTGTIPSHN 163
L +N L + + K+ +L +
Sbjct: 62 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGA 99
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.0 bits (99), Expect = 1e-04
Identities = 17/130 (13%), Positives = 36/130 (27%), Gaps = 15/130 (11%)
Query: 36 KDHITYDPTNFFAKNWLTNSTMVCNWTGVTCDINQRRVTALNISYLSLTGN----IPRQL 91
+ + L ++ ++ + + L
Sbjct: 334 SVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATL 393
Query: 92 GNLSSLEILDLNFNRLSGEIPWELG-----NLAKLEKLLLHNNFLTGTIPFSIFKLSSLL 146
SL LDL+ N L +L LE+L+L++ + + + L
Sbjct: 394 LANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEME------DRLQ 447
Query: 147 DLKLSDNNLT 156
L+ +L
Sbjct: 448 ALEKDKPSLR 457
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.3 bits (97), Expect = 3e-04
Identities = 18/91 (19%), Positives = 33/91 (36%), Gaps = 10/91 (10%)
Query: 338 PNLEELYLWGNNFSGT----LPSFIFNASNLSKLSLGDNSFSGLIPNTFG-----NLRNL 388
L L+L + S + L + + +L +L L +N L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
Query: 389 KRLRLYNNYLTSPELSFLSSLS-NCKYLEII 418
++L LY+ Y + L +L + L +I
Sbjct: 429 EQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 459
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.3 bits (97), Expect = 3e-04
Identities = 21/118 (17%), Positives = 35/118 (29%), Gaps = 21/118 (17%)
Query: 371 DNSFSGLIPNTFGNLRNLKRLRLYNNYLTSPELSFL-SSLSNCKYLEIIALSGNPLNGII 429
D L L+ L L + ++ S L ++L L + LS N L
Sbjct: 354 DAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAG 413
Query: 430 PMSAGNLSHSLEELFMPDCNVSGRIPKEIGNLANLVTLDLGGNKFNGSIPIALGKLQK 487
+ L S+ + L L L ++ + L L+K
Sbjct: 414 ILQ---LVESVRQ-----------------PGCLLEQLVLYDIYWSEEMEDRLQALEK 451
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.9 bits (96), Expect = 3e-04
Identities = 11/97 (11%), Positives = 29/97 (29%), Gaps = 4/97 (4%)
Query: 415 LEIIALSGNPLNGIIPMSAGNLSHSLEELFMPDCNVSGRIPKEIG----NLANLVTLDLG 470
++ + + L+ L + + + DC ++ K+I L L+L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 471 GNKFNGSIPIALGKLQKLQLLNLDDNKLEGSIPDDIC 507
N+ + + + + L+
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAG 100
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.9 bits (96), Expect = 4e-04
Identities = 19/99 (19%), Positives = 31/99 (31%), Gaps = 9/99 (9%)
Query: 444 FMPDCNVSGRIPKEIGNLANLVTLDLGGNKFNG----SIPIALGKLQKLQLLNLDDNKLE 499
+ D V + L L L + S+ L L+ L+L +N L
Sbjct: 351 RLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLG 410
Query: 500 GSIPDDICGLVE-----LYKLALGDNKLSGQIPACFGNL 533
+ + V L +L L D S ++ L
Sbjct: 411 DAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.5 bits (95), Expect = 4e-04
Identities = 16/99 (16%), Positives = 28/99 (28%), Gaps = 5/99 (5%)
Query: 437 SHSLEELFMPDCNVS-GRIPKEIGNLANLVTLDLGGNKFNG----SIPIALGKLQKLQLL 491
S ++ L + +S R + + L + L I AL L L
Sbjct: 1 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 60
Query: 492 NLDDNKLEGSIPDDICGLVELYKLALGDNKLSGQIPACF 530
NL N+L + ++ + L
Sbjct: 61 NLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGA 99
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.1 bits (94), Expect = 7e-04
Identities = 19/102 (18%), Positives = 32/102 (31%), Gaps = 26/102 (25%)
Query: 192 SSLQALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGGISSTLSNCKHLRILDLSFN 251
S L+ L + +S +++ +TL LR LDLS N
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLA---------------------ATLLANHSLRELDLSNN 407
Query: 252 DLWGDIPKEIG-----NLTKLKELFLDFNILQGEIPHTVGNL 288
L ++ L++L L E+ + L
Sbjct: 408 CLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.3 bits (92), Expect = 0.001
Identities = 10/92 (10%), Positives = 30/92 (32%), Gaps = 9/92 (9%)
Query: 315 LKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSG----TLPSFIFNASNLSKLSLG 370
++ +++ + + L + + L + + S + L++L+L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 371 DNSFSGLIPNTFG-----NLRNLKRLRLYNNY 397
N + + +++L L N
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCC 95
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.3 bits (108), Expect = 2e-06
Identities = 21/129 (16%), Positives = 35/129 (27%), Gaps = 1/129 (0%)
Query: 289 HNLEYLSLVNNELVGTVPATIFNVSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGN 348
H L + + + L + + N L L L L + +
Sbjct: 8 HGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKS 66
Query: 349 NFSGTLPSFIFNASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNYLTSPELSFLSS 408
P LS+L+L N+ L T L + + N S L +L
Sbjct: 67 GLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQR 126
Query: 409 LSNCKYLEI 417
+
Sbjct: 127 WEEEGLGGV 135
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.5 bits (93), Expect = 2e-04
Identities = 22/109 (20%), Positives = 40/109 (36%), Gaps = 2/109 (1%)
Query: 584 LTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQGSIPDSV-GDLISLKSLNLSNNNL 642
+ L + + + G + L L++ + + + L L++L + + L
Sbjct: 10 SSGLRCTRDGALD-SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGL 68
Query: 643 SGPIPTSLEKLSDLKELNLSFNKLEGEIPRGGPFVNFSAKSFMGNNLLC 691
P + L LNLSFN LE + ++ GN L C
Sbjct: 69 RFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHC 117
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.4 bits (90), Expect = 5e-04
Identities = 21/111 (18%), Positives = 34/111 (30%), Gaps = 2/111 (1%)
Query: 168 SSLQLLDLSDNQLSGSIPSFIFKISSLQALHFGNNRLSGELPANICDNLPFLNFFSVYKN 227
L + + + +L L+ N + L L L ++ K+
Sbjct: 8 HGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKS 66
Query: 228 MFYGGISSTLSNCKHLRILDLSFNDLWGDIPKEIGNLTKLKELFLDFNILQ 278
L L+LSFN L + + L+EL L N L
Sbjct: 67 GLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.5 bits (85), Expect = 0.003
Identities = 12/83 (14%), Positives = 24/83 (28%), Gaps = 1/83 (1%)
Query: 121 LEKLLLHNNFLTGTIPFSIFKLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQL 180
L + + +L +L + + + +L L L+ L + + L
Sbjct: 10 SSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGL 68
Query: 181 SGSIPSFIFKISSLQALHFGNNR 203
P L L+ N
Sbjct: 69 RFVAPDAFHFTPRLSRLNLSFNA 91
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 48.7 bits (114), Expect = 2e-06
Identities = 43/332 (12%), Positives = 83/332 (25%), Gaps = 17/332 (5%)
Query: 76 LNISYLSLTG--NIPRQLGNLSSLEILDLNFNRLSGE----IPWELGNLAKLEKLLLHNN 129
L + ++ ++ L S++ + L+ N + E + + + LE +
Sbjct: 10 LKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDI 69
Query: 130 FLTGTIPFSIFKLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQLSGSIPSFIF 189
F L LL L L S N ++ + L ++ + ++
Sbjct: 70 FTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLH 129
Query: 190 KISSLQALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGGISSTLSNCKHLRILDLS 249
R EL N + S L
Sbjct: 130 NNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLH 189
Query: 250 FNDLWGDIPKEIGNLTKLKELFLDFNILQGEIPHTVGNLHNLEYLSLVNNELVGTVPATI 309
+ + + G L E L+ H + +
Sbjct: 190 TVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALK-----SWPN 244
Query: 310 FNVSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSGTLPSFIFNA-----SNL 364
L LS + + + ++ L+ L L N + +L
Sbjct: 245 LRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDL 304
Query: 365 SKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNN 396
L L N FS + +R + R
Sbjct: 305 LFLELNGNRFSEE-DDVVDEIREVFSTRGRGE 335
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 47.2 bits (110), Expect = 6e-06
Identities = 37/317 (11%), Positives = 82/317 (25%), Gaps = 19/317 (5%)
Query: 121 LEKLLLHNNFLTG----TIPFSIFKLSSLLDLKLSDNNLTGTIP---SHNLGNLSSLQLL 173
+E L + +T ++ + + S+ ++ LS N + S N+ + L++
Sbjct: 5 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 64
Query: 174 DLSDNQLSGSIPSFIFKISSLQALHFGNNRLS--GELPANICDNLPFLNFFSVYKNMFYG 231
+ SD + L +L + K+
Sbjct: 65 EFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLE 124
Query: 232 GISSTLSNCKHLRILDLSFNDLWGDIPKEIGNLTKLKELFLDFNILQGEIPHTVGNLHNL 291
+ + ++ + K+ N L+ + N L+
Sbjct: 125 HLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQ- 183
Query: 292 EYLSLVNNELVGTVPATIFNVSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFS 351
++ L+ TV + + L N
Sbjct: 184 ------SHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAI 237
Query: 352 GTLPSFIFNASNLSKLSLGDNSFSGLI-PNTFGNLRNLKRLRLYNNYLTSPELSFLSS-- 408
L+ L + ++ + L+ LRL N + + L +
Sbjct: 238 ALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVI 297
Query: 409 LSNCKYLEIIALSGNPL 425
L + L+GN
Sbjct: 298 DEKMPDLLFLELNGNRF 314
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 46.8 bits (109), Expect = 8e-06
Identities = 50/361 (13%), Positives = 103/361 (28%), Gaps = 50/361 (13%)
Query: 169 SLQLLDLSDNQLSGSIPSFIFKISSLQALHFGNNRLSGELPANICDNLPFLNFFSVYKNM 228
SL+L ++ S+ + + + S++ + N + E + +N+
Sbjct: 9 SLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENI------------ 55
Query: 229 FYGGISSTLSNCKHLRILDLSFNDLWGDIPKEIGNLTKLKELFLDFNILQGEIPHTVGNL 288
++ K L I + S + + + +
Sbjct: 56 ---------ASKKDLEIAEFSDIFTG--------------RVKDEIPEALRLLLQALLKC 92
Query: 289 HNLEYLSLVNNELVGTVPATIFNVSTLKLIELSNN-TFFGSLPSSTDVQLPNLEELYLWG 347
L + L +N T + + + G P + L+EL +
Sbjct: 93 PKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNK 152
Query: 348 NNFSGTLPSFIFNASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNYLTSPELSFLS 407
+ I N + + + + + + + L L+
Sbjct: 153 KAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLA 212
Query: 408 SLSNCKYLEIIALSGNPLNGIIPMSAGNLSHSLEELFMPDCNVSGRIPKEIGN------L 461
K L++ + L A +L EL + DC +S R + +
Sbjct: 213 YCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLEN 272
Query: 462 ANLVTLDLGGNKFNGSIPIAL-----GKLQKLQLLNLDDNKL--EGSIPDDICGLVELYK 514
L TL L N+ L K+ L L L+ N+ E + D+I +
Sbjct: 273 IGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDVVDEIREVFSTRG 332
Query: 515 L 515
Sbjct: 333 R 333
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 45.3 bits (105), Expect = 3e-05
Identities = 49/321 (15%), Positives = 95/321 (29%), Gaps = 29/321 (9%)
Query: 366 KLSLGDNSFSGL--IPNTFGNLRNLKRLRLYNNYLTSPELSFLSS-LSNCKYLEIIALSG 422
L L + + ++K + L N + + +LS +++ K LEI S
Sbjct: 9 SLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSD 68
Query: 423 NP---LNGIIPMSAGNLSHSLEELFMPDCNVSGRIPKEIGNLANLVTLDLGGNKFNGSIP 479
+ IP + L +L + V + L + +
Sbjct: 69 IFTGRVKDEIPEALRLLLQALLKCPKL-HTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLY 127
Query: 480 IALGKLQKLQLLNLDDNKLEGSIPDDICGLVELYKLALGDNKLSGQIPACFGNLASLREL 539
+ L + E ++ L + G N+L +
Sbjct: 128 LHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAK------- 180
Query: 540 WLGPNELISFIPSTFWNIKDIMYVNFSSNFLTGPLPLEIENLKALTTLDFSMNNLSGVIP 599
+ L+ + I+ + L L++ + + + S +
Sbjct: 181 TFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLD----LQDNTFTHLGSSALA 236
Query: 600 TTIGGLKGLQYLFLGHNRLQGSIPDSVGD------LISLKSLNLSNNNLSGPIPTSL--- 650
+ L+ L L L +V D I L++L L N + +L
Sbjct: 237 IALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTV 296
Query: 651 --EKLSDLKELNLSFNKLEGE 669
EK+ DL L L+ N+ E
Sbjct: 297 IDEKMPDLLFLELNGNRFSEE 317
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 44.1 bits (102), Expect = 7e-05
Identities = 50/338 (14%), Positives = 92/338 (27%), Gaps = 37/338 (10%)
Query: 336 QLPNLEELYLWGNNFSG----TLPSFIFNASNLSKLSLGDNSFSGLIPNTFGNLRNLKRL 391
+ +++E+ L GN L I + +L D + LR L +
Sbjct: 29 EDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQA 88
Query: 392 RLYNNYLTSPELSFLSSLSNCKYLEIIALSGNPLNGIIPMSAGNLSHSLEELFMPDCNVS 451
L L + LS + + I LS + + + L
Sbjct: 89 LLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQEL 148
Query: 452 GRIPKEIGNLANLVTLDLGGNKFNGSIPIALGKLQKLQLLNLDDNKLEGSIPDDICGLVE 511
K + NGS+ Q +LL+ G P+ I
Sbjct: 149 AVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIE---- 204
Query: 512 LYKLALGDNKLSGQIPACFGNLASLRELWLGPNELISFIPSTFWNIKDIMYVNFSSNFLT 571
+ L + C + + S + + ++ + + L+
Sbjct: 205 --------HLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLS 256
Query: 572 G------PLPLEIENLKALTTLDFSMNNLSGVIPTTI-----GGLKGLQYLFLGHNRLQG 620
L TL N + T+ + L +L L NR
Sbjct: 257 ARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF-S 315
Query: 621 SIPDSVGDLISLKSLNLSNNNLSGPIPTSLEKLSDLKE 658
D V ++ + S L++L D++E
Sbjct: 316 EEDDVVDEIREVFSTRGRGE---------LDELDDMEE 344
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 41.4 bits (95), Expect = 5e-04
Identities = 12/90 (13%), Positives = 29/90 (32%), Gaps = 5/90 (5%)
Query: 606 KGLQYLFLGHNRLQGSIPDSVGDLISLKSLNLSNNNLSGP----IPTSLEKLSDLKELNL 661
K L+ + + S+ + + S+K + LS N + + ++ DL+
Sbjct: 8 KSLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEF 66
Query: 662 SFNKLEGEIPRGGPFVNFSAKSFMGNNLLC 691
S + ++ + L
Sbjct: 67 SDIFTGRVKDEIPEALRLLLQALLKCPKLH 96
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.9 bits (105), Expect = 7e-06
Identities = 26/135 (19%), Positives = 39/135 (28%), Gaps = 7/135 (5%)
Query: 460 NLANLVTLDLGGNKFNGSIPIALGKLQKLQLLNLDDNKLEGSIPDDICGLVELYKLALGD 519
N LDL G K I L + ++ DN++ D L L L + +
Sbjct: 16 NAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR--KLDGFPLLRRLKTLLVNN 72
Query: 520 NKLSGQIPACFGNLASLRELWLGPNELISFIPSTFWNIKDIMYVNFSSN----FLTGPLP 575
N++ L L EL L N L+ +
Sbjct: 73 NRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRL 132
Query: 576 LEIENLKALTTLDFS 590
I + + LDF
Sbjct: 133 YVIYKVPQVRVLDFQ 147
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.9 bits (105), Expect = 8e-06
Identities = 21/147 (14%), Positives = 45/147 (30%), Gaps = 4/147 (2%)
Query: 106 RLSGEI---PWELGNLAKLEKLLLHNNFLTGTIPFSIFKLSSLLDLKLSDNNLTGTIPSH 162
+L+ E+ + N + +L L + I L + SDN +
Sbjct: 2 KLTAELIEQAAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGFP 60
Query: 163 NLGNLSSLQLLDLSDNQLSGSIPSFIFKISSLQALHFGNNRLSGELPANICDNLPFLNFF 222
L L +L + + ++ + + ++ L + L P +L +L
Sbjct: 61 LLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCIL 120
Query: 223 SVYKNMFYGGISSTLSNCKHLRILDLS 249
+ +R+LD
Sbjct: 121 RNPVTNKKHYRLYVIYKVPQVRVLDFQ 147
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.5 bits (96), Expect = 1e-04
Identities = 22/145 (15%), Positives = 41/145 (28%), Gaps = 10/145 (6%)
Query: 154 NLTGTIPSHNLGNLSSLQLLDLSDNQLSGSIPSFIFKISSLQALHFGNNRLSGELPANIC 213
L + N + LDL ++ I + + A+ F +N + +
Sbjct: 6 ELIEQAAQYT--NAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR---KLDGF 59
Query: 214 DNLPFLNFFSVYKNMFYGGISSTLSNCKHLRILDLSFNDLWG-DIPKEIGNLTKLKELFL 272
L L V N L L L+ N L + +L L L +
Sbjct: 60 PLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCI 119
Query: 273 D---FNILQGEIPHTVGNLHNLEYL 294
+ + + + + L
Sbjct: 120 LRNPVTNKKHYRLYVIYKVPQVRVL 144
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (94), Expect = 2e-04
Identities = 25/145 (17%), Positives = 45/145 (31%), Gaps = 8/145 (5%)
Query: 354 LPSFIFNASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNYLTSPELSFLSSLSNCK 413
+ NA +L L I N L + +N + L +
Sbjct: 11 AAQYT-NAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIR-----KLDGFPLLR 63
Query: 414 YLEIIALSGNPLNGIIPMSAGNLSHSLEELFMPDCNVSGRIPKEIGNLANLVTLDLGGNK 473
L+ + ++ N + I L E + + V + +L +L L + N
Sbjct: 64 RLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNP 123
Query: 474 FNGSIPIALGKLQKL-QLLNLDDNK 497
L + K+ Q+ LD K
Sbjct: 124 VTNKKHYRLYVIYKVPQVRVLDFQK 148
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.6 bits (86), Expect = 0.003
Identities = 26/136 (19%), Positives = 53/136 (38%), Gaps = 3/136 (2%)
Query: 68 INQRRVTALNISYLSLTGNIPRQLGNLSSLEILDLNFNRLSGEIPWELGNLAKLEKLLLH 127
N R L++ + I L + +D + N + + L +L+ LL++
Sbjct: 15 TNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGFP--LLRRLKTLLVN 71
Query: 128 NNFLTGTIPFSIFKLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQLSGSIPSF 187
NN + L L +L L++N+L L +L SL L + N ++
Sbjct: 72 NNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYR 131
Query: 188 IFKISSLQALHFGNNR 203
++ I + + + +
Sbjct: 132 LYVIYKVPQVRVLDFQ 147
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 44.7 bits (104), Expect = 1e-05
Identities = 35/201 (17%), Positives = 71/201 (35%), Gaps = 18/201 (8%)
Query: 460 NLANLVTLDLGGNKFNGSIPIA-LGKLQKLQLLNLDDNKLEGSIPDDICGLVELYKLALG 518
LA + LG ++ L ++ LQ L ++G + L L ++
Sbjct: 16 ALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINFS 70
Query: 519 DNKLSGQIPACFGNLASLRELWLGPNELISFIPSTFWNIKDIMYVNFSSNFLTGPLPLEI 578
+N+L+ N + + I + +
Sbjct: 71 NNQLTDIT--PLKN----LTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPL 124
Query: 579 ENLKALTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQGSIPDSVGDLISLKSLNLS 638
+NL L L+ S N +S + + L + Q + + +L +L+ L++S
Sbjct: 125 KNLTNLNRLELSSNTISDISALSGLT----SLQQLNFSSNQVTDLKPLANLTTLERLDIS 180
Query: 639 NNNLSGPIPTSLEKLSDLKEL 659
+N +S + L KL++L+ L
Sbjct: 181 SNKVSD--ISVLAKLTNLESL 199
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 44.7 bits (104), Expect = 2e-05
Identities = 29/191 (15%), Positives = 56/191 (29%), Gaps = 20/191 (10%)
Query: 117 NLAKLEKLLLHNNFLTGTIPFSIFKLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLS 176
LA+ K +L +T T+ + L + L+ + + L++L ++ S
Sbjct: 16 ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKSI---DGVEYLNNLTQINFS 70
Query: 177 DNQLSGSIPSFIFKISSLQALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGGISST 236
+NQL+ P ++ L L + +++
Sbjct: 71 NNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNL 130
Query: 237 LSNCKHLRILDLSFNDLWGDI-------------PKEIGNLTKLKELFLDFNILQGEIPH 283
+ K + NLT L+ L + N +
Sbjct: 131 NRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISSNKVSD--IS 188
Query: 284 TVGNLHNLEYL 294
+ L NLE L
Sbjct: 189 VLAKLTNLESL 199
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.1 bits (87), Expect = 0.002
Identities = 34/195 (17%), Positives = 58/195 (29%), Gaps = 26/195 (13%)
Query: 360 NASNLSKLSLGDNSFSGLIPNTFGNLRNLKRLRLYNNYLTSPELSFLSSLSNCKYLEIIA 419
+ K LG + + + + +L + L+ + S + + L I
Sbjct: 16 ALAEKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGIKS-----IDGVEYLNNLTQIN 68
Query: 420 LSGNPLNGIIPMSAG---------------NLSHSLEELFMPDCNVSGRIPKEIGNLANL 464
S N L I P+ + + +I
Sbjct: 69 FSNNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLT 128
Query: 465 VTLDLGGNKFNGSIPIALGKLQKLQLLNLDDNKLEGSIPDDICGLVELYKLALGDNKLSG 524
L + S AL L LQ LN N++ P + L L +L + NK+S
Sbjct: 129 NLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKP--LANLTTLERLDISSNKVSD 186
Query: 525 QIPACFGNLASLREL 539
+ L +L L
Sbjct: 187 --ISVLAKLTNLESL 199
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.6 bits (94), Expect = 3e-04
Identities = 25/125 (20%), Positives = 41/125 (32%), Gaps = 4/125 (3%)
Query: 86 NIPRQLGNLSSLEILDLNFNRLSGEIPWELGNLAKLEKLLLHNNFLTGTIPFSIFKLSSL 145
+ + L+ L +L L ++ T+ + L
Sbjct: 11 QLKLIMSKRYDGSQQALDLKGLR--SDPDLVAQNIDVVLNRRSSMAA-TLRIIEENIPEL 67
Query: 146 LDLKLSDNNLTGTIP-SHNLGNLSSLQLLDLSDNQLSGSIPSFIFKISSLQALHFGNNRL 204
L L LS+N L S + +L++L+LS N+L K L+ L N L
Sbjct: 68 LSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSL 127
Query: 205 SGELP 209
S
Sbjct: 128 SDTFR 132
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.4 bits (91), Expect = 7e-04
Identities = 29/147 (19%), Positives = 52/147 (35%), Gaps = 5/147 (3%)
Query: 525 QIPACFGNLASLRELWLGPNELISFIPSTFWNIKDIMYVNFSSNFLTGPLPLEIENLKAL 584
Q+ + L L S + +N S+ L + EN+ L
Sbjct: 11 QLKLIMSKRYDGSQQALDLKGLRS--DPDLVAQNIDVVLNRRSSMAAT-LRIIEENIPEL 67
Query: 585 TTLDFSMNNLSGV--IPTTIGGLKGLQYLFLGHNRLQGSIPDSVGDLISLKSLNLSNNNL 642
+L+ S N L + + + + L+ L L N L+ + L+ L L N+L
Sbjct: 68 LSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSL 127
Query: 643 SGPIPTSLEKLSDLKELNLSFNKLEGE 669
S +S ++E +L+G
Sbjct: 128 SDTFRDQSTYISAIRERFPKLLRLDGH 154
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 198 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Score = 38.5 bits (88), Expect = 0.002
Identities = 32/179 (17%), Positives = 53/179 (29%), Gaps = 23/179 (12%)
Query: 134 TIPFSIFKLS---SLLDLKLSDNNLTGTIPS-----HNLGNLSSLQLLDLSDNQLSGSIP 185
TI +I S++ + L G IP L L + + L LS N + I
Sbjct: 6 TIKDAIRIFEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIE-KIS 64
Query: 186 SFIFKISSLQALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGGISSTLSNCKHLRI 245
S S ++ L + + D + +S +
Sbjct: 65 SL----SGMENLRILSLGRNLIKKIENLDAVADTLEELWISYNQIASLSGIEKLVNLRVL 120
Query: 246 LDLSFNDLWGDIPKEIGNLTKLKELFLDFNILQGEIPHT----------VGNLHNLEYL 294
+ ++ L KL++L L N L + V L NL+ L
Sbjct: 121 YMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKL 179
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1057 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 100.0 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 100.0 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 100.0 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 100.0 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 100.0 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 100.0 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.97 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.97 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.96 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.96 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.95 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.95 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.95 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.93 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.91 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.89 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.88 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.87 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.87 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.84 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.82 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.8 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.7 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.69 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.6 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.56 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.56 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 99.22 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.8 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.8 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.47 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 98.32 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 98.27 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 98.26 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 98.19 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 97.89 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=381.78 Aligned_cols=265 Identities=25% Similarity=0.417 Sum_probs=215.2
Q ss_pred HCCCCCCCEECCCCCEEEEEEEECCCCEEEEEEEECC--CHHHHHHHHHHHHHHHHCCCCCCEEEEEEECCCCEEEEEEE
Q ss_conf 0799977154543681899999569958999995052--54679999999999981689772167610016882489999
Q 001544 768 TNGFSENNLIGRGSFGSVYIARLQNGIEVAVKTFDLQ--HERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILE 845 (1057)
Q Consensus 768 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e 845 (1057)
.++|++.+.||+|+||+||+|+.+ ..||||+++.. .....+.+.+|++++++++||||+++++++.+ ...++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred CCCEEEEEEEEECCCCEEEEEEEC--CEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CEEEEEEE
T ss_conf 451899889830788589999999--989999997346998999999999999984799878645679715-58999996
Q ss_pred ECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCCCCCCCCCC
Q ss_conf 74489956787209966799999999999999999987079998198167999866689983999711344123478986
Q 001544 846 YMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS 925 (1057)
Q Consensus 846 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 925 (1057)
|+++|+|.+++...+..+++..+..++.|+++|++||| +++|+||||||+|||++.++.+||+|||+|+........
T Consensus 84 y~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH---~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~ 160 (276)
T d1uwha_ 84 WCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS 160 (276)
T ss_dssp CCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-------
T ss_pred CCCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHH---CCCEECCCCCHHHEEECCCCCEEECCCCCEEECCCCCCC
T ss_conf 58998889998523578999999999999999988875---099951614789979818997887500221333556776
Q ss_pred CCCCCCCCCCCCCCCCCCCC---CCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHCCCC
Q ss_conf 51001223554358344588---888941017879999999960999999544564303344321046357886310011
Q 001544 926 MTQTQTLATLGYMAPEYGRE---GRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLL 1002 (1057)
Q Consensus 926 ~~~~~~~~t~~y~aPE~~~~---~~~~~~~DvwslG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1002 (1057)
.......||+.|+|||++.+ ..++.++|||||||++|||+||+.||.+........ ........
T Consensus 161 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~-------------~~~~~~~~ 227 (276)
T d1uwha_ 161 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQII-------------FMVGRGYL 227 (276)
T ss_dssp -----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHH-------------HHHHHTSC
T ss_pred CCCCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHH-------------HHHHCCCC
T ss_conf 31256655743179999950568999953151635999999997889989989699999-------------99965888
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHH
Q ss_conf 121200587989799999999671437999999999999999976999964
Q 001544 1003 ITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKIRDFLLR 1053 (1057)
Q Consensus 1003 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~~~~~~ 1053 (1057)
..........+++++.+++.+||+.||++|||+.|++++|+.+.+++++
T Consensus 228 --~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~Pk 276 (276)
T d1uwha_ 228 --SPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPK 276 (276)
T ss_dssp --CCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCC
T ss_pred --CCCCHHCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHCCCC
T ss_conf --9860003655549999999997588976892999999999999970989
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=376.61 Aligned_cols=250 Identities=26% Similarity=0.356 Sum_probs=210.4
Q ss_pred CCCCCCCEECCCCCEEEEEEEE-CCCCEEEEEEEECCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEECCCCEEEEEEEEC
Q ss_conf 7999771545436818999995-699589999950525467999999999998168977216761001688248999974
Q 001544 769 NGFSENNLIGRGSFGSVYIARL-QNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEYM 847 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~ 847 (1057)
++|++.+.||+|+||+||+|.. .+|+.||||+++.......+.+.+|++++++++||||+++++++.+++..|+||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred CCCEEEEEEECCCCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEEEC
T ss_conf 05388789812858299999998999899999984301727999999999998679998805857798899989999703
Q ss_pred CCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCCCCCCCCCCCC
Q ss_conf 48995678720996679999999999999999998707999819816799986668998399971134412347898651
Q 001544 848 RNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMT 927 (1057)
Q Consensus 848 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 927 (1057)
++|+|.+++... .+++.++..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+|+.+... ...
T Consensus 100 ~gg~L~~~~~~~--~l~~~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~--~~~ 172 (293)
T d1yhwa1 100 AGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSK 172 (293)
T ss_dssp TTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCST--TCC
T ss_pred CCCCHHHHHHCC--CCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHHHEEECCCCCEEECCCHHHEEECCC--CCC
T ss_conf 798089886415--9999999999999999999999---879722677688868878996864251564132136--664
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHCCCCCCCCH
Q ss_conf 00122355435834458888894101787999999996099999954456430334432104635788631001112120
Q 001544 928 QTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDK 1007 (1057)
Q Consensus 928 ~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1057)
.....||+.|+|||++.+..++.++||||+||++|||++|+.||......+. ........ ..
T Consensus 173 ~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-------------~~~~~~~~-----~~ 234 (293)
T d1yhwa1 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-------------LYLIATNG-----TP 234 (293)
T ss_dssp BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-------------HHHHHHHC-----SC
T ss_pred CCCCCCCCCCCCHHHHCCCCCCCHHCEEHHHHHHHHHHHCCCCCCCCCHHHH-------------HHHHHHCC-----CC
T ss_conf 4444447773682664479988012031372999998048899899799999-------------99998579-----99
Q ss_pred HHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 058798979999999967143799999999999999
Q 001544 1008 HFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 1008 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~ 1043 (1057)
....+..++.++.+++.+||+.||++|||+.|+++|
T Consensus 235 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 235 ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp CCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 888855379999999999866996689099999649
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=375.47 Aligned_cols=259 Identities=27% Similarity=0.429 Sum_probs=213.4
Q ss_pred HCCCCCCCEECCCCCEEEEEEEECCCCEEEEEEEECCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEECCCCEEEEEEEEC
Q ss_conf 07999771545436818999995699589999950525467999999999998168977216761001688248999974
Q 001544 768 TNGFSENNLIGRGSFGSVYIARLQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEYM 847 (1057)
Q Consensus 768 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~ 847 (1057)
.++|+..+.||+|+||+||+|++.+++.||||+++.... ..+++.+|++++++++||||++++|++.+++..++||||+
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~ 82 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 82 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHHCEEEEEEEECCCEEEEEEEECCCCEEEEEEECCCCC-CHHHHHHHHHHHHHCCCCCCCCCCCEECCCCCEEEEEEEC
T ss_conf 699588889820888299999988999999999878867-6899999999999668997565352431599337999836
Q ss_pred CCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCCCCCCCCCCCC
Q ss_conf 48995678720996679999999999999999998707999819816799986668998399971134412347898651
Q 001544 848 RNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMT 927 (1057)
Q Consensus 848 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 927 (1057)
++|+|.+++......+++..+..++.|++.|++|+| +++|+||||||+||+++.++.+||+|||+++...... ...
T Consensus 83 ~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~-~~~ 158 (263)
T d1sm2a_ 83 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTS 158 (263)
T ss_dssp TTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCTTCSGGGEEECGGGCEEECSCC-------------
T ss_pred CCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHH---CCCEEECCCCHHHEEECCCCCEEECCCCHHEECCCCC-CEE
T ss_conf 999189975201347889999999999999877653---1643104431532666688776865532100236887-335
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHCCCCCCCCH
Q ss_conf 00122355435834458888894101787999999996099999954456430334432104635788631001112120
Q 001544 928 QTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDK 1007 (1057)
Q Consensus 928 ~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1057)
.....||..|+|||++.+..++.++||||||+++|||+|++.|+........ ....+....
T Consensus 159 ~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~-------------~~~~i~~~~------ 219 (263)
T d1sm2a_ 159 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE-------------VVEDISTGF------ 219 (263)
T ss_dssp ------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHH-------------HHHHHHHTC------
T ss_pred ECCEECCCCCCCHHHHCCCCCCCHHHHCCHHHHHHHHHHCCCCCCCCCCHHH-------------HHHHHHHCC------
T ss_conf 0430017666785786079998403321059999999878988877899999-------------999998068------
Q ss_pred HHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 0587989799999999671437999999999999999976999
Q 001544 1008 HFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKIRDF 1050 (1057)
Q Consensus 1008 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~~~ 1050 (1057)
+...+..+++++.+++.+||+.||++|||++|++++|+++.++
T Consensus 220 ~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 220 RLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf 8899543679999999997657976891999999999999857
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=0 Score=372.31 Aligned_cols=253 Identities=21% Similarity=0.287 Sum_probs=211.8
Q ss_pred HCCCCCCCEECCCCCEEEEEEEE-CCCCEEEEEEEECCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEECCCCEEEEEEEE
Q ss_conf 07999771545436818999995-69958999995052546799999999999816897721676100168824899997
Q 001544 768 TNGFSENNLIGRGSFGSVYIARL-QNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEY 846 (1057)
Q Consensus 768 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~ 846 (1057)
.++|++.+.||+|+||+||+|+. .+|+.||||++........+.+.+|+.++++++||||+++++++.+++..|+||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEEC
T ss_conf 65758988984076819999998899989999998452431699999999999867997999299999989999999985
Q ss_pred CCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC--CCCCEEEECCCCCCCCCCCCC
Q ss_conf 448995678720996679999999999999999998707999819816799986668--998399971134412347898
Q 001544 847 MRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLD--DNMVAHLSDFGIAKLLIGEDQ 924 (1057)
Q Consensus 847 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~--~~~~~kl~Dfg~a~~~~~~~~ 924 (1057)
+++|+|.+++......+++..+..++.||+.||+||| +++|+||||||+|||++ .++.+||+|||+|+....
T Consensus 105 ~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~--- 178 (350)
T d1koaa2 105 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP--- 178 (350)
T ss_dssp CCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCT---
T ss_pred CCCCCHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHH---HCCCEEEEECHHHEEECCCCCCEEEEEECCHHEECCC---
T ss_conf 7998899999762378999999999999999999997---5697600015467364168898699954521044256---
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHCCCCCC
Q ss_conf 65100122355435834458888894101787999999996099999954456430334432104635788631001112
Q 001544 925 SMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLIT 1004 (1057)
Q Consensus 925 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1057)
........||+.|+|||++.+..++.++||||+||++|||++|+.||......+. . ..+.....
T Consensus 179 ~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~-~------------~~i~~~~~--- 242 (350)
T d1koaa2 179 KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET-L------------RNVKSCDW--- 242 (350)
T ss_dssp TSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-H------------HHHHHTCC---
T ss_pred CCCCCEECCCCCCCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHH-H------------HHHHHCCC---
T ss_conf 5432000686242188997589987267655465999999859899899799999-9------------99984788---
Q ss_pred CCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 120058798979999999967143799999999999999
Q 001544 1005 EDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 1005 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~ 1043 (1057)
.........+++++.+++.+||+.||++|||+.|+++|
T Consensus 243 -~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 243 -NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp -CSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred -CCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf -98942235899999999999756896679089998629
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=375.13 Aligned_cols=259 Identities=24% Similarity=0.446 Sum_probs=212.9
Q ss_pred CCCCCCCEECCCCCEEEEEEEEC-CC---CEEEEEEEECC-CHHHHHHHHHHHHHHHHCCCCCCEEEEEEECCCCEEEEE
Q ss_conf 79997715454368189999956-99---58999995052-546799999999999816897721676100168824899
Q 001544 769 NGFSENNLIGRGSFGSVYIARLQ-NG---IEVAVKTFDLQ-HERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALI 843 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~V~~~~~~-~~---~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV 843 (1057)
++|++.+.||+|+||+||+|+.+ ++ ..||||.+... .....+.+.+|++++++++||||++++|++.+++..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred HHCEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEE
T ss_conf 04278569802788299999995799788999999978445989999999999999857998886189999628877999
Q ss_pred EEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCCCCCCCC
Q ss_conf 99744899567872099667999999999999999999870799981981679998666899839997113441234789
Q 001544 844 LEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGED 923 (1057)
Q Consensus 844 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 923 (1057)
|||+++|+|.+++......+++.++..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+|+......
T Consensus 106 ~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~ 182 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182 (299)
T ss_dssp EECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EEECCCCCCEEEECCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCCCEEEECCCCCEEECCCCCCEECCCCC
T ss_conf 9722798530021045679999999999999999889885---2798357615044898899919988844315756777
Q ss_pred CCC---CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHC
Q ss_conf 865---1001223554358344588888941017879999999960-999999544564303344321046357886310
Q 001544 924 QSM---TQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFT-RRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDA 999 (1057)
Q Consensus 924 ~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 999 (1057)
... ......+|+.|+|||.+.+..++.++|||||||++|||+| |+.||.+....+ ....+..
T Consensus 183 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~--------------~~~~i~~ 248 (299)
T d1jpaa_ 183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD--------------VINAIEQ 248 (299)
T ss_dssp -------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--------------HHHHHHT
T ss_pred CCCEEEECCCCCCCCCCCCHHHHHCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHH--------------HHHHHHC
T ss_conf 76536502566688300387888369978612144535789999867999999999999--------------9999973
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 011121200587989799999999671437999999999999999976999
Q 001544 1000 NLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKIRDF 1050 (1057)
Q Consensus 1000 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~~~ 1050 (1057)
. .+.+.+..++.++.+++.+||+.||++|||+.|+++.|+++.+.
T Consensus 249 ~------~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 249 D------YRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp T------CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred C------CCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHCC
T ss_conf 7------88999742269999999997587976892999999999998418
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=374.64 Aligned_cols=254 Identities=24% Similarity=0.358 Sum_probs=210.1
Q ss_pred HCCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEEECCC-HHHHHHHHHHHHHHHHCCCCCCEEEEEEECCCCEEEEEEE
Q ss_conf 079997715454368189999956-99589999950525-4679999999999981689772167610016882489999
Q 001544 768 TNGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQH-ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILE 845 (1057)
Q Consensus 768 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e 845 (1057)
.++|++.+.||+|+||+||+|+.. +++.||||+++... ....+.+.+|++++++++||||+++++++.+++..|+|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCEEEEEEE
T ss_conf 74608998972174809999999999979999998456641279999999999985799888469654046743679886
Q ss_pred ECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCCCCCCCCCC
Q ss_conf 74489956787209966799999999999999999987079998198167999866689983999711344123478986
Q 001544 846 YMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS 925 (1057)
Q Consensus 846 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 925 (1057)
|+++|+|.+++.... .+++..+..++.|++.|++||| +++|+||||||+|||++.++.+||+|||+|+........
T Consensus 84 y~~gg~L~~~l~~~~-~l~e~~~~~i~~qi~~al~ylH---~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~ 159 (271)
T d1nvra_ 84 YCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 159 (271)
T ss_dssp CCTTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred CCCCCCHHHHHHCCC-CCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHHHEEECCCCCEEECCCHHHEEECCCCCC
T ss_conf 458980899975379-9999999999999999999999---759835754689978878998798323142240468865
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCC-CCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHCCCCCC
Q ss_conf 51001223554358344588888-94101787999999996099999954456430334432104635788631001112
Q 001544 926 MTQTQTLATLGYMAPEYGREGRV-STKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLIT 1004 (1057)
Q Consensus 926 ~~~~~~~~t~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1057)
......+||+.|+|||++.+..+ +.++||||+||++|||++|+.||............+... ..
T Consensus 160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~------------~~--- 224 (271)
T d1nvra_ 160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK------------KT--- 224 (271)
T ss_dssp CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTT------------CT---
T ss_pred CCCCCEEECCCCCCHHHHCCCCCCCCCEEEEHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCC------------CC---
T ss_conf 311132557474287286189999971016173799999982997888898599999998638------------88---
Q ss_pred CCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 120058798979999999967143799999999999999
Q 001544 1005 EDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 1005 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~ 1043 (1057)
.......+++++.+++.+||+.||++|||+.|+++|
T Consensus 225 ---~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 225 ---YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp ---TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ---CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf ---788644699999999999767996689099999619
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=0 Score=371.41 Aligned_cols=253 Identities=19% Similarity=0.269 Sum_probs=212.0
Q ss_pred HCCCCCCCEECCCCCEEEEEEEE-CCCCEEEEEEEECCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEECCCCEEEEEEEE
Q ss_conf 07999771545436818999995-69958999995052546799999999999816897721676100168824899997
Q 001544 768 TNGFSENNLIGRGSFGSVYIARL-QNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEY 846 (1057)
Q Consensus 768 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~ 846 (1057)
.++|++.+.||+|+||+||+|+. .+++.||||+++.........+.+|++++++++||||+++++++.+++..|+||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEEC
T ss_conf 40359989993177829999999899979999998872646799999999999867997989199999989999999982
Q ss_pred CCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC--CCCCEEEECCCCCCCCCCCCC
Q ss_conf 448995678720996679999999999999999998707999819816799986668--998399971134412347898
Q 001544 847 MRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLD--DNMVAHLSDFGIAKLLIGEDQ 924 (1057)
Q Consensus 847 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~--~~~~~kl~Dfg~a~~~~~~~~ 924 (1057)
+++|+|.+++......+++..++.|+.||+.||+||| +++|+||||||+|||++ .++.+||+|||+|..+..
T Consensus 108 ~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~--- 181 (352)
T d1koba_ 108 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP--- 181 (352)
T ss_dssp CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT---
T ss_pred CCCCHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCCCCCCCCCCCCCCCEEEEEECCCCEECCC---
T ss_conf 8998088889863899899999999999999999999---7792651314455311346788489952563034378---
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHCCCCCC
Q ss_conf 65100122355435834458888894101787999999996099999954456430334432104635788631001112
Q 001544 925 SMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLIT 1004 (1057)
Q Consensus 925 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1057)
........|++.|+|||++.+..++.++||||+||++|||++|+.||......+. ...+.....
T Consensus 182 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~-------------~~~i~~~~~--- 245 (352)
T d1koba_ 182 DEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET-------------LQNVKRCDW--- 245 (352)
T ss_dssp TSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-------------HHHHHHCCC---
T ss_pred CCCEEECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHH-------------HHHHHHCCC---
T ss_conf 8720100476453489997479989763338989999999968899899799999-------------999984788---
Q ss_pred CCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 120058798979999999967143799999999999999
Q 001544 1005 EDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 1005 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~ 1043 (1057)
.........+++++.+++.+||+.||++|||+.|+++|
T Consensus 246 -~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 246 -EFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp -CCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred -CCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf -98930024799999999999756996689189999609
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=374.27 Aligned_cols=252 Identities=24% Similarity=0.371 Sum_probs=209.0
Q ss_pred CCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEEECCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEECCCCEEEEEEEEC
Q ss_conf 79997715454368189999956-99589999950525467999999999998168977216761001688248999974
Q 001544 769 NGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEYM 847 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~ 847 (1057)
+.|++.+.||+|+||+||+|+.. +++.||+|+++.......+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred CCEEEEEEEEECCCCEEEEEEECCCCEEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEECC
T ss_conf 37598479930778199999999999399999987289999999999999998679999884988980099589999627
Q ss_pred CCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCCCCCCCCCCCC
Q ss_conf 48995678720996679999999999999999998707999819816799986668998399971134412347898651
Q 001544 848 RNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMT 927 (1057)
Q Consensus 848 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 927 (1057)
++|+|.+++.+....+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+|||+|+.... ....
T Consensus 92 ~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH---~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~--~~~~ 166 (288)
T d2jfla1 92 AGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR--TIQR 166 (288)
T ss_dssp TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECHH--HHHH
T ss_pred CCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEEEECCHHHEEECCCCCEEEEECHHHHCCCC--CCCC
T ss_conf 998188999862899999999999999999999999---88988714070031487899989971612303577--8641
Q ss_pred CCCCCCCCCCCCCCCCC-----CCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHCCCC
Q ss_conf 00122355435834458-----8888941017879999999960999999544564303344321046357886310011
Q 001544 928 QTQTLATLGYMAPEYGR-----EGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLL 1002 (1057)
Q Consensus 928 ~~~~~~t~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1002 (1057)
.....||+.|+|||++. +..++.++||||+||++|||++|+.||......+. . ..+....
T Consensus 167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~-~------------~~i~~~~-- 231 (288)
T d2jfla1 167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV-L------------LKIAKSE-- 231 (288)
T ss_dssp HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH-H------------HHHHHSC--
T ss_pred CCCCCCCCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHH-H------------HHHHCCC--
T ss_conf 001025626479999832025788888066578789999998208899999899999-9------------9997079--
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 12120058798979999999967143799999999999999
Q 001544 1003 ITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 1003 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~ 1043 (1057)
......+..+++++.+++.+||+.||++|||+.|+++|
T Consensus 232 ---~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 232 ---PPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp ---CCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred ---CCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf ---98777656699999999999766996689199999629
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=370.75 Aligned_cols=256 Identities=25% Similarity=0.394 Sum_probs=210.9
Q ss_pred HCCCCCCCEECCCCCEEEEEEEECC------CCEEEEEEEECC-CHHHHHHHHHHHHHHHHC-CCCCCEEEEEEECCCCE
Q ss_conf 0799977154543681899999569------958999995052-546799999999999816-89772167610016882
Q 001544 768 TNGFSENNLIGRGSFGSVYIARLQN------GIEVAVKTFDLQ-HERAFKSFDTECEVMKSI-RHRNLTKIISSCSNEDF 839 (1057)
Q Consensus 768 ~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~ 839 (1057)
.++|++.++||+|+||+||+|+... ...||+|++... .......+.+|+.+++++ +||||+++++++.+.+.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHEEEEEEEEECCCEEEEEEEECCCCCCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCE
T ss_conf 89939701983078819999998578855420499999966335878999999999999971589968687788862995
Q ss_pred EEEEEEECCCCCHHHHHHCCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCC
Q ss_conf 489999744899567872099----------------------6679999999999999999998707999819816799
Q 001544 840 KALILEYMRNGSLEKCLYSGN----------------------YILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKP 897 (1057)
Q Consensus 840 ~~lV~e~~~~g~L~~~l~~~~----------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp 897 (1057)
.++||||+++|+|.+++.... ..+++..++.++.|++.|++||| +++|+||||||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH---~~~IiHRDlKp 192 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAA 192 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCSG
T ss_pred EEEEEECCCCCCHHHHHHHCCCCCCCHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCCCH
T ss_conf 899997279995999998625777510221000012220012577899999999999999999997---39905052703
Q ss_pred CCEEECCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCCCC
Q ss_conf 986668998399971134412347898651001223554358344588888941017879999999960-9999995445
Q 001544 898 SNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFT-RRKPTDEIFS 976 (1057)
Q Consensus 898 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~P~~~~~~ 976 (1057)
+||+++.++.+||+|||+|+...............||+.|+|||++.+..++.++||||+||++|||++ |+.||.....
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~ 272 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred HCCCCCCCCEEEEEECCCCCCCCCCCCEEEECCCCCCCCCCCHHHHCCCCCCCCEECCCHHHHHHHHHHCCCCCCCCCCH
T ss_conf 21443459828985142222045778615623435787657838872799996330300039999998389999999898
Q ss_pred CCCCHHHHHHHCCCHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHH
Q ss_conf 643033443210463578863100111212005879897999999996714379999999999999999
Q 001544 977 GEMTLKHWVNDFLPISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLL 1045 (1057)
Q Consensus 977 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~ 1045 (1057)
.+. ....+.... +.+.+..+++++.+++.+||+.||++|||++|++++|.
T Consensus 273 ~~~-------------~~~~~~~~~------~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 273 DAN-------------FYKLIQNGF------KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp SHH-------------HHHHHHTTC------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHH-------------HHHHHHCCC------CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHH
T ss_conf 999-------------999985699------89988767899999999975889668939999999974
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=374.59 Aligned_cols=266 Identities=21% Similarity=0.323 Sum_probs=208.1
Q ss_pred HCCCCCCCEECCCCCEEEEEEEE-CCCCEEEEEEEECCC-HHHHHHHHHHHHHHHHCCCCCCEEEEEEECCCCEEEEEEE
Q ss_conf 07999771545436818999995-699589999950525-4679999999999981689772167610016882489999
Q 001544 768 TNGFSENNLIGRGSFGSVYIARL-QNGIEVAVKTFDLQH-ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILE 845 (1057)
Q Consensus 768 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e 845 (1057)
.++|++.+.||+|+||+||+|+. .+++.||+|+++... ......+.+|+.++++++||||+++++++.+++..|+|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEE
T ss_conf 56888978971277809999999899969999998754097899999999999986799999949999998999999997
Q ss_pred ECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCC-CEEECCCCCCCEEECCCCCEEEECCCCCCCCCCCCC
Q ss_conf 7448995678720996679999999999999999998707999-819816799986668998399971134412347898
Q 001544 846 YMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSA-PVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ 924 (1057)
Q Consensus 846 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 924 (1057)
|+++|+|.+++.+.+ .+++..+..++.|++.|+.||| ++ +|+||||||+|||++.++.+||+|||+|+....
T Consensus 85 y~~gg~L~~~l~~~~-~l~~~~~~~~~~qil~aL~yLH---~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~--- 157 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--- 157 (322)
T ss_dssp CCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH---
T ss_pred CCCCCCHHHHHHHCC-CCCHHHHHHHHHHHHHHHHHHH---HHCCEECCCCCHHHEEECCCCCEEEEECCCCCCCCC---
T ss_conf 679986899874249-9999999999999999999999---859997144577994687899899954877625678---
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHC----------------
Q ss_conf 6510012235543583445888889410178799999999609999995445643033443210----------------
Q 001544 925 SMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDF---------------- 988 (1057)
Q Consensus 925 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~P~~~~~~~~~~~~~~~~~~---------------- 988 (1057)
......+||+.|+|||++.+..++.++||||+||++|||++|+.||......+..........
T Consensus 158 -~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
T d1s9ja_ 158 -SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236 (322)
T ss_dssp -HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------------
T ss_pred -CCCCCCCCCCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCCCC
T ss_conf -8621113771411946875899894888998999999999888998998878999999887517754577421233322
Q ss_pred ---------CCHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf ---------4635788631001112120058798979999999967143799999999999999
Q 001544 989 ---------LPISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 989 ---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~ 1043 (1057)
......+..+........ .. .....+.++.+++.+||..||++|||+.|+++|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~-~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 237 LSSYGMDSRPPMAIFELLDYIVNEPPP-KL-PSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp ---------CCCCHHHHHHHHHTSCCC-CC-CBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCCCCCCCCCHHHHHHHHHHHCCCCC-CC-CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHC
T ss_conf 111122235413477887665026876-67-644489999999999868994679089999609
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=370.24 Aligned_cols=264 Identities=23% Similarity=0.405 Sum_probs=215.4
Q ss_pred CCCCCCC-EECCCCCEEEEEEEEC---CCCEEEEEEEECC-CHHHHHHHHHHHHHHHHCCCCCCEEEEEEECCCCEEEEE
Q ss_conf 7999771-5454368189999956---9958999995052-546799999999999816897721676100168824899
Q 001544 769 NGFSENN-LIGRGSFGSVYIARLQ---NGIEVAVKTFDLQ-HERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALI 843 (1057)
Q Consensus 769 ~~~~~~~-~lg~G~~g~V~~~~~~---~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV 843 (1057)
++|.+.+ +||+|+||+||+|.++ ++..||||+++.. .....+++.+|++++++++||||++++|++.. +..|+|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred CCEEECCCEEECCCCEEEEEEEEECCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECC-CEEEEE
T ss_conf 4718878487306080999999960897689999998820397899999999999986799888068656036-807999
Q ss_pred EEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCCCCCCCC
Q ss_conf 99744899567872099667999999999999999999870799981981679998666899839997113441234789
Q 001544 844 LEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGED 923 (1057)
Q Consensus 844 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 923 (1057)
|||+++|+|.+++...+..+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||+|+.+....
T Consensus 87 mE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~ 163 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 163 (285)
T ss_dssp EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred EEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCCHHHEEECCCCCEEECCCHHHHCCCCCC
T ss_conf 9807899689975212569999999999999999878998---6881057676466045468854203313421155434
Q ss_pred C-CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHCCC
Q ss_conf 8-651001223554358344588888941017879999999960-99999954456430334432104635788631001
Q 001544 924 Q-SMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFT-RRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANL 1001 (1057)
Q Consensus 924 ~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1001 (1057)
. ........||+.|+|||++.+..++.++|||||||++|||+| |+.||......+ ....+..
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~--------------~~~~i~~-- 227 (285)
T d1u59a_ 164 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--------------VMAFIEQ-- 227 (285)
T ss_dssp CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH--------------HHHHHHT--
T ss_pred CCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCCHHH--------------HHHHHHC--
T ss_conf 321135621137433586887279999541232201789999938999999979999--------------9999981--
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHC
Q ss_conf 1121200587989799999999671437999999999999999976999964203
Q 001544 1002 LITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKIRDFLLRNVE 1056 (1057)
Q Consensus 1002 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~~~~~~~~~ 1056 (1057)
..+.+.+..+++++.+++.+||+.+|++|||+.++++.|+.+..++...++
T Consensus 228 ----~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~~~~~ 278 (285)
T d1u59a_ 228 ----GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVE 278 (285)
T ss_dssp ----TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTCS
T ss_pred ----CCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHHHHCCC
T ss_conf ----899999976789999999997577976890999999999999998541110
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=369.82 Aligned_cols=246 Identities=26% Similarity=0.375 Sum_probs=206.6
Q ss_pred CCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEEECCC---HHHHHHHHHHHHHHHHCCCCCCEEEEEEECCCCEEEEEE
Q ss_conf 79997715454368189999956-99589999950525---467999999999998168977216761001688248999
Q 001544 769 NGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQH---ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALIL 844 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~ 844 (1057)
++|++.+.||+|+||+||+|+.+ +++.||+|++.... ......+.+|++++++++||||+++++++.+++..|+||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEE
T ss_conf 37699889851778589999998999499999981688567689999999999998568888885999999899989998
Q ss_pred EECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCCCCCCCCC
Q ss_conf 97448995678720996679999999999999999998707999819816799986668998399971134412347898
Q 001544 845 EYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ 924 (1057)
Q Consensus 845 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 924 (1057)
||+++|+|.+++.... .+++..+..++.|++.|++||| +++|+||||||+||+++.++.+||+|||+|.....
T Consensus 86 Ey~~~g~L~~~l~~~~-~l~e~~~~~i~~qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~--- 158 (263)
T d2j4za1 86 EYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS--- 158 (263)
T ss_dssp ECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC---
T ss_pred EECCCCCHHHHHHHCC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEEEEECCCCCEECCCCCEEECCCCEEEECCC---
T ss_conf 5047985898875048-9999999999999999999999---88946522023441466899871155563354488---
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHCCCCCC
Q ss_conf 65100122355435834458888894101787999999996099999954456430334432104635788631001112
Q 001544 925 SMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLIT 1004 (1057)
Q Consensus 925 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1057)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||......+ .. ..+....
T Consensus 159 -~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-~~------------~~i~~~~---- 220 (263)
T d2j4za1 159 -SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE-TY------------KRISRVE---- 220 (263)
T ss_dssp -CCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-HH------------HHHHTTC----
T ss_pred -CCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHH-HH------------HHHHCCC----
T ss_conf -85235578876349999758998931440467599999832999988899999-99------------9997189----
Q ss_pred CCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 120058798979999999967143799999999999999
Q 001544 1005 EDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 1005 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~ 1043 (1057)
...+..+++++.+++.+||+.||++|||+.|+++|
T Consensus 221 ----~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 221 ----FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred ----CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf ----99986689999999999764797689099999719
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=367.47 Aligned_cols=255 Identities=25% Similarity=0.425 Sum_probs=215.1
Q ss_pred HCCCCCCCEECCCCCEEEEEEEECCCCEEEEEEEECCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEECCCCEEEEEEEEC
Q ss_conf 07999771545436818999995699589999950525467999999999998168977216761001688248999974
Q 001544 768 TNGFSENNLIGRGSFGSVYIARLQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEYM 847 (1057)
Q Consensus 768 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~ 847 (1057)
.++|+..++||+|+||+||+|+.++++.||||+++.... ..+.+.+|+.++++++||||++++|++.+++..++||||+
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~ 81 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 81 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred HHHCEEEEEEECCCCEEEEEEEECCCCEEEEEEECCCCC-CHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEEEECC
T ss_conf 699799689820788399999988998999999874757-7899999999999668986015889985078169999704
Q ss_pred CCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCCCCCCCCCCCC
Q ss_conf 48995678720996679999999999999999998707999819816799986668998399971134412347898651
Q 001544 848 RNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSMT 927 (1057)
Q Consensus 848 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 927 (1057)
++|++.+++......+++..+.+++.|+++|++||| +++|+||||||+||+++.++.+||+|||+++..... ....
T Consensus 82 ~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH---~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~-~~~~ 157 (258)
T d1k2pa_ 82 ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD-EYTS 157 (258)
T ss_dssp TTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSS-SCCC
T ss_pred CCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCCEEEEECCCCCEEECCCHHHEECCCC-CCEE
T ss_conf 899388864102467768999999999999999875---468434665413588769984798861442023578-7225
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHCCCCCCCC
Q ss_conf 001223554358344588888941017879999999960-9999995445643033443210463578863100111212
Q 001544 928 QTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFT-RRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITED 1006 (1057)
Q Consensus 928 ~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1006 (1057)
.....+|..|+|||++.+..++.++||||||+++|||+| |+.||......+. ...+...
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~--------------~~~i~~~------ 217 (258)
T d1k2pa_ 158 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET--------------AEHIAQG------ 217 (258)
T ss_dssp CCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH--------------HHHHHTT------
T ss_pred ECCCCCCCCCCCCHHHCCCCCCCCEEECCCCHHHHHHHHCCCCCCCCCCHHHH--------------HHHHHHC------
T ss_conf 24657887757807863799885210336432467397559999889999999--------------9999807------
Q ss_pred HHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf 00587989799999999671437999999999999999976
Q 001544 1007 KHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKI 1047 (1057)
Q Consensus 1007 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i 1047 (1057)
.+...+..+++++.+++.+||+.||++|||+.|++++|.+|
T Consensus 218 ~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 218 LRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred CCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHCC
T ss_conf 97899654659999999997668976893999999874188
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=372.86 Aligned_cols=257 Identities=26% Similarity=0.431 Sum_probs=212.0
Q ss_pred HCCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEEECCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEECCCCEEEEEEEE
Q ss_conf 079997715454368189999956-9958999995052546799999999999816897721676100168824899997
Q 001544 768 TNGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEY 846 (1057)
Q Consensus 768 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~ 846 (1057)
.++|++.+.||+|+||+||+|.+. +++.||||+++... ...+++.+|++++++++||||+++++++.+++..++||||
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 94 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 94 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEEECCCC-CHHHHHHHHHHHHHHCCCCCEECCCCCEEECCEEEEEEEC
T ss_conf 799398659820888089999999999699999977761-0399999999999867999882677527457854787631
Q ss_pred CCCCCHHHHHHCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCCCCCCCCCC
Q ss_conf 4489956787209-966799999999999999999987079998198167999866689983999711344123478986
Q 001544 847 MRNGSLEKCLYSG-NYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS 925 (1057)
Q Consensus 847 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 925 (1057)
+++|+|.+++... ...+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+|+.... ...
T Consensus 95 ~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~-~~~ 170 (287)
T d1opja_ 95 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTY 170 (287)
T ss_dssp CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCS-SSS
T ss_pred CCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCCCEEEECCCCCEEECCCCCEEECCC-CCC
T ss_conf 46760677753035541579999999999999788898---78930576045768998999289832445465378-872
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHCCCCCCC
Q ss_conf 51001223554358344588888941017879999999960999999544564303344321046357886310011121
Q 001544 926 MTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITE 1005 (1057)
Q Consensus 926 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1057)
.......|+..|+|||++.+..++.++||||+||++|||++|+.|+....... ...+.+....
T Consensus 171 ~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~-------------~~~~~i~~~~---- 233 (287)
T d1opja_ 171 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-------------QVYELLEKDY---- 233 (287)
T ss_dssp EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-------------HHHHHHHTTC----
T ss_pred EEECCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHH-------------HHHHHHHCCC----
T ss_conf 21035566546669278727999810430217899999986799887742599-------------9999985588----
Q ss_pred CHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 2005879897999999996714379999999999999999769
Q 001544 1006 DKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKIR 1048 (1057)
Q Consensus 1006 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~ 1048 (1057)
+.+.+..+++++.+++.+||+.||++|||+.|+++.|+.+.
T Consensus 234 --~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 234 --RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp --CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred --CCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf --88887433099999999975779768939999999999998
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=366.49 Aligned_cols=252 Identities=21% Similarity=0.321 Sum_probs=207.5
Q ss_pred HCCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEEECCC-HHHHHHHHHHHHHHHHCCCCCCEEEEEEECCCCEEEEEEE
Q ss_conf 079997715454368189999956-99589999950525-4679999999999981689772167610016882489999
Q 001544 768 TNGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQH-ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILE 845 (1057)
Q Consensus 768 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e 845 (1057)
.+.|++.+.||+|+||+||+|+.. +++.||||++.... ......+.+|++++++++||||+++++++.+++..|+|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred CCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEE
T ss_conf 66669988994065839999999999989999998157731289999999999986799899919899998998889885
Q ss_pred ECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC---CCCCEEEECCCCCCCCCCC
Q ss_conf 7448995678720996679999999999999999998707999819816799986668---9983999711344123478
Q 001544 846 YMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLD---DNMVAHLSDFGIAKLLIGE 922 (1057)
Q Consensus 846 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~---~~~~~kl~Dfg~a~~~~~~ 922 (1057)
|++||+|.+++...+ .+++..+..++.|++.|++||| +++|+||||||+||++. +++.+||+|||+|+....
T Consensus 88 ~~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~- 162 (307)
T d1a06a_ 88 LVSGGELFDRIVEKG-FYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP- 162 (307)
T ss_dssp CCCSCBHHHHHHTCS-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCC---------
T ss_pred CCCCCCHHHHHHCCC-CCCHHHHHHHHHHHHHHHHHHH---HCEEEEEEECCCCEEECCCCCCCEEEEECCCEEEECCC-
T ss_conf 268984888653036-7887899999999999987524---13055687046300110468882499831543587258-
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHCCCC
Q ss_conf 98651001223554358344588888941017879999999960999999544564303344321046357886310011
Q 001544 923 DQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLL 1002 (1057)
Q Consensus 923 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1002 (1057)
........||+.|+|||++.+..+++++||||+||++|||++|+.||......+. ...+....
T Consensus 163 --~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~-------------~~~i~~~~-- 225 (307)
T d1a06a_ 163 --GSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKL-------------FEQILKAE-- 225 (307)
T ss_dssp ------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-------------HHHHHTTC--
T ss_pred --CCEEEEEEECCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHH-------------HHHHHCCC--
T ss_conf --9704400328422591887379998078734515999999859799999899999-------------99986168--
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 12120058798979999999967143799999999999999
Q 001544 1003 ITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 1003 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~ 1043 (1057)
.....+....+++++.+++.+||+.||++|||+.|+++|
T Consensus 226 --~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 226 --YEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp --CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred --CCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf --777876666789999999999760897579189998629
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=367.68 Aligned_cols=258 Identities=24% Similarity=0.419 Sum_probs=208.4
Q ss_pred HCCCCCCCEECCCCCEEEEEEEECCCCEEEEEEEECCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEECCCCEEEEEEEEC
Q ss_conf 07999771545436818999995699589999950525467999999999998168977216761001688248999974
Q 001544 768 TNGFSENNLIGRGSFGSVYIARLQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEYM 847 (1057)
Q Consensus 768 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~ 847 (1057)
.++|++.+.||+|+||+||+|.+++++.||||+++... ...+.+.+|++++++++||||++++|++.+ +..++||||+
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~ 89 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HHHEEEEEEEECCCCCEEEEEEECCCCEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCEEEEEEEECC-CCEEEEEEEC
T ss_conf 89938867981079828999999999999999986476-888999999999986799988578731045-9769999957
Q ss_pred CCCCHHHHHHCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCCCCCCCCCCC
Q ss_conf 4899567872099-667999999999999999999870799981981679998666899839997113441234789865
Q 001544 848 RNGSLEKCLYSGN-YILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSM 926 (1057)
Q Consensus 848 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 926 (1057)
++|+|.+++.... ..+++..+..|+.|+++|+.||| +++|+||||||+||+++.++.+||+|||+|+..... ...
T Consensus 90 ~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH---~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~-~~~ 165 (272)
T d1qpca_ 90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN-EYT 165 (272)
T ss_dssp TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSS-CEE
T ss_pred CCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHHHEEEECCCCEEECCCCCEEECCCC-CCC
T ss_conf 8982888875147898878899999999999999997---489546756422515620244042341014773588-644
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHCCCCCCCC
Q ss_conf 10012235543583445888889410178799999999609999995445643033443210463578863100111212
Q 001544 927 TQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITED 1006 (1057)
Q Consensus 927 ~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1006 (1057)
......|++.|+|||++.+..++.++|||||||++|||+||..|+........ ....+...
T Consensus 166 ~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~-------------~~~~i~~~------ 226 (272)
T d1qpca_ 166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-------------VIQNLERG------ 226 (272)
T ss_dssp CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------------HHHHHHTT------
T ss_pred CCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCHHH-------------HHHHHHHC------
T ss_conf 20356774444582898379998245645257999999968988888889999-------------99999706------
Q ss_pred HHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 00587989799999999671437999999999999999976999
Q 001544 1007 KHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKIRDF 1050 (1057)
Q Consensus 1007 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~~~ 1050 (1057)
.+...+..+++++.+++.+||+.||++|||+.|+++.|+++..+
T Consensus 227 ~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 227 YRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf 88889655719999999997588976893999999986113213
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=362.18 Aligned_cols=261 Identities=27% Similarity=0.455 Sum_probs=212.9
Q ss_pred HCCCCCCCEECCCCCEEEEEEEECCC-----CEEEEEEEECC-CHHHHHHHHHHHHHHHHCCCCCCEEEEEEECCCCEEE
Q ss_conf 07999771545436818999995699-----58999995052-5467999999999998168977216761001688248
Q 001544 768 TNGFSENNLIGRGSFGSVYIARLQNG-----IEVAVKTFDLQ-HERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKA 841 (1057)
Q Consensus 768 ~~~~~~~~~lg~G~~g~V~~~~~~~~-----~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 841 (1057)
.+.|+..++||+|+||+||+|.++.. ..||||+++.. .......+.+|++++++++||||++++|++.+.+..+
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHEEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCEE
T ss_conf 89968615981177909999999689987879999999884459689999999999998568987832367783388038
Q ss_pred EEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCCCCCC
Q ss_conf 99997448995678720996679999999999999999998707999819816799986668998399971134412347
Q 001544 842 LILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIG 921 (1057)
Q Consensus 842 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 921 (1057)
+||||++++++.+.+......+++.++..++.|++.|++||| +++|+||||||+|||++.++.+||+|||+|+.+..
T Consensus 86 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 162 (283)
T d1mqba_ 86 IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 162 (283)
T ss_dssp EEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EEEEECCCCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCCCEEEECCCCEEEECCCCHHHCCCC
T ss_conf 999721357402221023454208999999999998541212---12342576564427888998499845510300357
Q ss_pred CCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHCC
Q ss_conf 898-6510012235543583445888889410178799999999609999995445643033443210463578863100
Q 001544 922 EDQ-SMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDAN 1000 (1057)
Q Consensus 922 ~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1000 (1057)
... ........||..|+|||++.+..++.++|||||||++|||+++..|+........ ....+...
T Consensus 163 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~-------------~~~~i~~~ 229 (283)
T d1mqba_ 163 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE-------------VMKAINDG 229 (283)
T ss_dssp -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------------HHHHHHTT
T ss_pred CCCCCEEECCCCCCCCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHH-------------HHHHHHCC
T ss_conf 87652674267777343488887049999735563448989999967988655689999-------------99998635
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 11121200587989799999999671437999999999999999976999
Q 001544 1001 LLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKIRDF 1050 (1057)
Q Consensus 1001 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~~~ 1050 (1057)
. +.+.+..++.++.+++.+||+.+|++|||+.|+++.|+++.+.
T Consensus 230 ~------~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 230 F------RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp C------CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred C------CCCCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf 7------8998504579999999997767976893999999999998669
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=369.42 Aligned_cols=252 Identities=26% Similarity=0.377 Sum_probs=209.8
Q ss_pred HCCCCCCCEECCCCCEEEEEEEE-CCCCEEEEEEEECCC---HHHHHHHHHHHHHHHHCCCCCCEEEEEEECCCCEEEEE
Q ss_conf 07999771545436818999995-699589999950525---46799999999999816897721676100168824899
Q 001544 768 TNGFSENNLIGRGSFGSVYIARL-QNGIEVAVKTFDLQH---ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALI 843 (1057)
Q Consensus 768 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV 843 (1057)
.++|++.+.||+|+||+||+|+. .+++.||||++.... ......+.+|++++++++||||+++++++.+++..|+|
T Consensus 7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv 86 (288)
T d1uu3a_ 7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 86 (288)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEE
T ss_pred CCCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEE
T ss_conf 98778988985087909999999899979999998657755777899999999999876888861799999989988999
Q ss_pred EEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCCCCCCCC
Q ss_conf 99744899567872099667999999999999999999870799981981679998666899839997113441234789
Q 001544 844 LEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGED 923 (1057)
Q Consensus 844 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 923 (1057)
|||+++|+|.+++...+ .+++..+..++.|++.|++||| +++|+||||||+||++++++.+||+|||+|+.+....
T Consensus 87 mEy~~gg~L~~~~~~~~-~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~ 162 (288)
T d1uu3a_ 87 LSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 162 (288)
T ss_dssp ECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EECCCCCCHHHHHHCCC-CCCHHHHHHHHHHHHHHHHHHC---CCCEECCCCCCCCCCCCCCCEEEECCCCCCEECCCCC
T ss_conf 97048987777653159-9999999999999999997621---6508847677412366888538860321024225677
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHCCCCC
Q ss_conf 86510012235543583445888889410178799999999609999995445643033443210463578863100111
Q 001544 924 QSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLI 1003 (1057)
Q Consensus 924 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1003 (1057)
.........||+.|+|||++.+..++.++||||+||++|||++|+.||......+. ...+....
T Consensus 163 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~-------------~~~i~~~~--- 226 (288)
T d1uu3a_ 163 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI-------------FQKIIKLE--- 226 (288)
T ss_dssp -------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------------HHHHHTTC---
T ss_pred CCCCCCCCCCCCCCCCCEEECCCCCCCCCCEEHHHHHHHHHHHCCCCCCCCCHHHH-------------HHHHHCCC---
T ss_conf 64333555677552584400268989666230456999998038899899599999-------------99997189---
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHH
Q ss_conf 21200587989799999999671437999999999999999
Q 001544 1004 TEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRL 1044 (1057)
Q Consensus 1004 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L 1044 (1057)
...+..+++++.+++.+||+.||++|||+.|++++-
T Consensus 227 -----~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~ 262 (288)
T d1uu3a_ 227 -----YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYG 262 (288)
T ss_dssp -----CCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHH
T ss_pred -----CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHCCCH
T ss_conf -----999854799999999998557976891978973778
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=367.59 Aligned_cols=251 Identities=24% Similarity=0.348 Sum_probs=204.8
Q ss_pred HCCCCCCCEECCCCCEEEEEEEE-CCCCEEEEEEEECC--CHHHHHHHHHHHHHHHHCCCCCCEEEEEEECC--CCEEEE
Q ss_conf 07999771545436818999995-69958999995052--54679999999999981689772167610016--882489
Q 001544 768 TNGFSENNLIGRGSFGSVYIARL-QNGIEVAVKTFDLQ--HERAFKSFDTECEVMKSIRHRNLTKIISSCSN--EDFKAL 842 (1057)
Q Consensus 768 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~l 842 (1057)
.++|++.+.||+|+||+||+|+. .+|+.||+|++... .+...+.+.+|++++++++||||+++++++.+ .+..|+
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred CHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEE
T ss_conf 33379967983088919999999999979999998746579799999999999999778999824899999178998999
Q ss_pred EEEECCCCCHHHHHHCC---CCCCCHHHHHHHHHHHHHHHHHHHHCCCCC-----EEECCCCCCCEEECCCCCEEEECCC
Q ss_conf 99974489956787209---966799999999999999999987079998-----1981679998666899839997113
Q 001544 843 ILEYMRNGSLEKCLYSG---NYILDIFQRLNIMIDVASALEYLHFGYSAP-----VIHCDLKPSNVLLDDNMVAHLSDFG 914 (1057)
Q Consensus 843 V~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~-----ivH~Dikp~Nill~~~~~~kl~Dfg 914 (1057)
||||+++|+|.+++... ...+++..++.++.|++.|++||| +++ |+||||||+|||++.++.+||+|||
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH---~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG 159 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH---RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 159 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HHCC---------CCGGGEEECTTSCEEECCHH
T ss_pred EEECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HHCCCCCCEEECCCCHHHCCCCCCCCEEEEECC
T ss_conf 99568999389999851545789999999999999999999999---716778878858676542574788857980010
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCCCHHHH
Q ss_conf 44123478986510012235543583445888889410178799999999609999995445643033443210463578
Q 001544 915 IAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMM 994 (1057)
Q Consensus 915 ~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 994 (1057)
+|+..... ........||+.|+|||++.+..++.++||||+||++|||++|+.||......+. ..
T Consensus 160 ~a~~~~~~--~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~-------------~~ 224 (269)
T d2java1 160 LARILNHD--TSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL-------------AG 224 (269)
T ss_dssp HHHHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-------------HH
T ss_pred CEEECCCC--CCCCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHHHH-------------HH
T ss_conf 00322457--7755667788232799998399999389887527899998018899899899999-------------99
Q ss_pred HHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 8631001112120058798979999999967143799999999999999
Q 001544 995 KIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 995 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~ 1043 (1057)
.+...... ..+..+++++.+++.+||+.||++|||+.|+++|
T Consensus 225 ~i~~~~~~-------~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 225 KIREGKFR-------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp HHHHTCCC-------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHCCCCC-------CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHC
T ss_conf 99718998-------8974359999999999767995579189999729
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=357.23 Aligned_cols=245 Identities=24% Similarity=0.373 Sum_probs=197.4
Q ss_pred CCCCEECCCCCEEEEEEEEC-CCCEEEEEEEECC--CHHHHHHHHHHHHHHHHCCCCCCEEEEEEECC----CCEEEEEE
Q ss_conf 97715454368189999956-9958999995052--54679999999999981689772167610016----88248999
Q 001544 772 SENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQ--HERAFKSFDTECEVMKSIRHRNLTKIISSCSN----EDFKALIL 844 (1057)
Q Consensus 772 ~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lV~ 844 (1057)
+..++||+|+||+||+|... +++.||+|++... .....+.+.+|++++++++||||+++++++.+ ....|+||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EEEEEEECCCCCEEEEEEECCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCEEEEEE
T ss_conf 85169700828499999999999599999985122798999999999999985799985069999840334588899999
Q ss_pred EECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCC--EEECCCCCCCEEEC-CCCCEEEECCCCCCCCCC
Q ss_conf 974489956787209966799999999999999999987079998--19816799986668-998399971134412347
Q 001544 845 EYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAP--VIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLIG 921 (1057)
Q Consensus 845 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~Dikp~Nill~-~~~~~kl~Dfg~a~~~~~ 921 (1057)
||+++|+|.+++.+.. .+++..+..++.|++.|++||| +++ |+||||||+|||++ +++.+||+|||+|+...
T Consensus 92 E~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~gl~yLH---~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~- 166 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR- 166 (270)
T ss_dssp ECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC-
T ss_pred ECCCCCCHHHHHHCCC-CCCHHHHHHHHHHHHHHHHHHH---HCCCCEEECCCCHHHCEEECCCCCEEEEECCCCEECC-
T ss_conf 5789894899975135-5469999999999999999999---7899799687674351166799988980057654236-
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHCCC
Q ss_conf 89865100122355435834458888894101787999999996099999954456430334432104635788631001
Q 001544 922 EDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANL 1001 (1057)
Q Consensus 922 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1001 (1057)
........||+.|+|||++.+ .++.++||||+||++|||++|+.||......+..........
T Consensus 167 ---~~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~------------- 229 (270)
T d1t4ha_ 167 ---ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGV------------- 229 (270)
T ss_dssp ---TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTC-------------
T ss_pred ---CCCCCCCCCCCCCCCHHHHCC-CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCC-------------
T ss_conf ---876677553813008988478-999867110079999999878899987655999999997389-------------
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 112120058798979999999967143799999999999999
Q 001544 1002 LITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 1002 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~ 1043 (1057)
. .......+++++.+++.+||++||++|||+.|+++|
T Consensus 230 ---~--~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 230 ---K--PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp ---C--CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ---C--CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf ---9--865675578999999999763797589299999677
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=357.21 Aligned_cols=252 Identities=21% Similarity=0.294 Sum_probs=208.2
Q ss_pred HCCCCCCCEECCCCCEEEEEEEE-CCCCEEEEEEEECCC------HHHHHHHHHHHHHHHHCCCCCCEEEEEEECCCCEE
Q ss_conf 07999771545436818999995-699589999950525------46799999999999816897721676100168824
Q 001544 768 TNGFSENNLIGRGSFGSVYIARL-QNGIEVAVKTFDLQH------ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFK 840 (1057)
Q Consensus 768 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 840 (1057)
.++|++.+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|++++++++||||+++++++.+++..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEE
T ss_conf 56779827981178959999999999989999998756632134068999999999999867998999388999979989
Q ss_pred EEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCC----CEEEECCCCC
Q ss_conf 899997448995678720996679999999999999999998707999819816799986668998----3999711344
Q 001544 841 ALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNM----VAHLSDFGIA 916 (1057)
Q Consensus 841 ~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~----~~kl~Dfg~a 916 (1057)
|+||||+++|+|.+++...+ .+++..+..++.|++.|++||| +++|+||||||+||+++.++ .+|++|||+|
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~qi~~al~yLH---~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a 164 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 164 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEEECCCCCCCCCHHCCCC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEECCCCCCEEEEECCCCCCCCEEECCHHHH
T ss_conf 99998677864310010356-4215578999999999987666---2542211333012798258986664696433442
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCCCHHHHHH
Q ss_conf 12347898651001223554358344588888941017879999999960999999544564303344321046357886
Q 001544 917 KLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKI 996 (1057)
Q Consensus 917 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 996 (1057)
..... ........|++.|+|||++.+..++.++||||+||++|||++|+.||......+. . ..+
T Consensus 165 ~~~~~---~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~-~------------~~i 228 (293)
T d1jksa_ 165 HKIDF---GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET-L------------ANV 228 (293)
T ss_dssp EECTT---SCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-H------------HHH
T ss_pred HHCCC---CCCCCCCCCCCCCCCHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHH-H------------HHH
T ss_conf 10577---7631224777743099998189999766522140999999708899889999999-9------------999
Q ss_pred HHCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 31001112120058798979999999967143799999999999999
Q 001544 997 IDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 997 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~ 1043 (1057)
. .............+++.+.+++.+||+.||++|||+.|+++|
T Consensus 229 ~----~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 229 S----AVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp H----TTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred H----HCCCCCCCHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 8----168888701047889999999999863896689199999619
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=362.88 Aligned_cols=259 Identities=25% Similarity=0.393 Sum_probs=213.4
Q ss_pred CCCCCCCEECCCCCEEEEEEEEC-CCC----EEEEEEEECC-CHHHHHHHHHHHHHHHHCCCCCCEEEEEEECCCCEEEE
Q ss_conf 79997715454368189999956-995----8999995052-54679999999999981689772167610016882489
Q 001544 769 NGFSENNLIGRGSFGSVYIARLQ-NGI----EVAVKTFDLQ-HERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKAL 842 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 842 (1057)
.+|+..+.||+|+||+||+|... +++ +||+|+++.. .....+.+.+|++++++++||||++++|++.++. .++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~-~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSS-EEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCC-EEE
T ss_conf 9997831982089929999999589988989999999651349799999999999998679988815899996198-369
Q ss_pred EEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCCCCCCC
Q ss_conf 99974489956787209966799999999999999999987079998198167999866689983999711344123478
Q 001544 843 ILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGE 922 (1057)
Q Consensus 843 V~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 922 (1057)
++|++.+|+|.+++......+++..+..++.|++.|++||| +++|+||||||+||+++.++.+||+|||+|+.....
T Consensus 88 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH---~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~ 164 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 164 (317)
T ss_dssp EEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred EEEECCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCHHHCCEECCCCCEEEECCCCCEECCCC
T ss_conf 99842687401011133457999999999999999999998---769504762120311679987586025522233544
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHCCC
Q ss_conf 98651001223554358344588888941017879999999960-99999954456430334432104635788631001
Q 001544 923 DQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFT-RRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANL 1001 (1057)
Q Consensus 923 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1001 (1057)
..........||+.|+|||++.++.++.++|||||||++|||+| |.+||......+ ....+...
T Consensus 165 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~--------------~~~~i~~~- 229 (317)
T d1xkka_ 165 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--------------ISSILEKG- 229 (317)
T ss_dssp CC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG--------------HHHHHHHT-
T ss_pred CCCCCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHH--------------HHHHHHCC-
T ss_conf 453223651058644670887469998356544079999999977999999999899--------------99999759-
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHH
Q ss_conf 11212005879897999999996714379999999999999999769999
Q 001544 1002 LITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKIRDFL 1051 (1057)
Q Consensus 1002 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~~~~ 1051 (1057)
.+.+.+..+++++.+++.+||+.||++|||+.|++++++.+.+..
T Consensus 230 -----~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~~ 274 (317)
T d1xkka_ 230 -----ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 274 (317)
T ss_dssp -----CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSH
T ss_pred -----CCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHCH
T ss_conf -----989998556899999999847899346919999999999987586
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=360.60 Aligned_cols=254 Identities=24% Similarity=0.379 Sum_probs=206.2
Q ss_pred CEECCCCCEEEEEEEEC---CCCEEEEEEEECC--CHHHHHHHHHHHHHHHHCCCCCCEEEEEEECCCCEEEEEEEECCC
Q ss_conf 15454368189999956---9958999995052--546799999999999816897721676100168824899997448
Q 001544 775 NLIGRGSFGSVYIARLQ---NGIEVAVKTFDLQ--HERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEYMRN 849 (1057)
Q Consensus 775 ~~lg~G~~g~V~~~~~~---~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~~ 849 (1057)
++||+|+||+||+|.++ +++.||||+++.. .....+.+.+|++++++++||||++++|++.. +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCCCCCCCEEEEEEEECCCCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEECC-CCEEEEEECCCC
T ss_conf 7834587829999998169738599999988010898999999999999986799898527777505-977999974788
Q ss_pred CCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCCCCCCCCCC-CCC
Q ss_conf 9956787209966799999999999999999987079998198167999866689983999711344123478986-510
Q 001544 850 GSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS-MTQ 928 (1057)
Q Consensus 850 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~~ 928 (1057)
|+|.+++.... .+++..+..++.||+.|++||| +++|+||||||+||+++.++.+|++|||+++.+...... ...
T Consensus 92 g~L~~~l~~~~-~l~~~~~~~i~~qi~~gl~ylH---~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~ 167 (277)
T d1xbba_ 92 GPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 167 (277)
T ss_dssp EEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC-
T ss_pred CCHHHHHHHCC-CCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCCHHHCCCCCCCCCCCCHHHHHHCCCCCCCCCCC
T ss_conf 96899975225-7899999999999999976687---4795567776113102356751234134533134323443224
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHCCCCCCCCH
Q ss_conf 01223554358344588888941017879999999960-99999954456430334432104635788631001112120
Q 001544 929 TQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFT-RRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITEDK 1007 (1057)
Q Consensus 929 ~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1057)
....||+.|+|||++.+..++.++|||||||++|||++ |+.||.+....+ ....+... .
T Consensus 168 ~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~--------------~~~~i~~~------~ 227 (277)
T d1xbba_ 168 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE--------------VTAMLEKG------E 227 (277)
T ss_dssp ---CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--------------HHHHHHTT------C
T ss_pred CCCCCCCEECCCHHHCCCCCCCHHHHCCCHHHHHHHHHCCCCCCCCCCHHH--------------HHHHHHCC------C
T ss_conf 456778420391665379998434430340313289658999999989999--------------99999828------9
Q ss_pred HHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHH
Q ss_conf 0587989799999999671437999999999999999976999964
Q 001544 1008 HFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKIRDFLLR 1053 (1057)
Q Consensus 1008 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~~~~~~ 1053 (1057)
+.+.+..+++++.+++.+||+.||++|||++++.+.|+........
T Consensus 228 ~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~~~ 273 (277)
T d1xbba_ 228 RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN 273 (277)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHCHHHHCCC
T ss_conf 9999865679999999997588976890989999985288750479
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=359.69 Aligned_cols=249 Identities=25% Similarity=0.341 Sum_probs=208.1
Q ss_pred HCCCCCCCEECCCCCEEEEEEEE-CCCCEEEEEEEECC---CHHHHHHHHHHHHHHHHCCCCCCEEEEEEECCCCEEEEE
Q ss_conf 07999771545436818999995-69958999995052---546799999999999816897721676100168824899
Q 001544 768 TNGFSENNLIGRGSFGSVYIARL-QNGIEVAVKTFDLQ---HERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALI 843 (1057)
Q Consensus 768 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV 843 (1057)
.++|++.+.||+|+||.||+|+. .+++.||+|+++.. .......+.+|+.++++++||||+++++++.+.+..|+|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCC
T ss_conf 47428988983176849999999899989999998156544979999999999999867999887787640356421110
Q ss_pred EEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCCCCCCCC
Q ss_conf 99744899567872099667999999999999999999870799981981679998666899839997113441234789
Q 001544 844 LEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGED 923 (1057)
Q Consensus 844 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 923 (1057)
|||+++|+|.+++...+ .+++..++.++.|++.|++||| +++|+||||||+|||++.+|.+||+|||+|+....
T Consensus 84 ~ey~~gg~L~~~~~~~~-~~~e~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~-- 157 (337)
T d1o6la_ 84 MEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS-- 157 (337)
T ss_dssp EECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--
T ss_pred EECCCCCCHHHHHHCCC-CCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHHHEEECCCCCEEEEECCCCCCCCC--
T ss_conf 00357986055553256-7759999999999965211343---15962246477784765899888820565200356--
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHCCCCC
Q ss_conf 86510012235543583445888889410178799999999609999995445643033443210463578863100111
Q 001544 924 QSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLI 1003 (1057)
Q Consensus 924 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1003 (1057)
.........||+.|+|||++.+..++.++|+||+||++|||++|++||......+. ...+....
T Consensus 158 ~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~--------------~~~i~~~~-- 221 (337)
T d1o6la_ 158 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL--------------FELILMEE-- 221 (337)
T ss_dssp TTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH--------------HHHHHHCC--
T ss_pred CCCCCCCCEECHHHHHHHHCCCCCCCHHHCCCCHHHHHHHHHHCCCCCCCCCHHHH--------------HHHHHCCC--
T ss_conf 78620551008899666650489888333102230678899878999999699999--------------99985289--
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCC-----HHHHHHH
Q ss_conf 212005879897999999996714379999999-----9999999
Q 001544 1004 TEDKHFAAKEQCASSVFNLAMECTVESPDERIT-----AKEIVRR 1043 (1057)
Q Consensus 1004 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~eil~~ 1043 (1057)
...+..+++++.+++.+||++||.+|++ +.|+++|
T Consensus 222 -----~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 222 -----IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp -----CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred -----CCCCCCCCHHHHHHHHHHCCCCCHHHCCCCCCCHHHHHCC
T ss_conf -----9898668999999998666389344225652349999729
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=363.22 Aligned_cols=245 Identities=26% Similarity=0.358 Sum_probs=201.3
Q ss_pred CCCCCCEECCCCCEEEEEEEE-CCCCEEEEEEEECCC---HHHHHHHHHHHHHHHHCCCCCCEEEEEEECCCCEEEEEEE
Q ss_conf 999771545436818999995-699589999950525---4679999999999981689772167610016882489999
Q 001544 770 GFSENNLIGRGSFGSVYIARL-QNGIEVAVKTFDLQH---ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILE 845 (1057)
Q Consensus 770 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e 845 (1057)
.|+..+.||+|+||+||+|+. .+++.||||+++... ....+.+.+|++++++++||||+++++++.+++..|+|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEE
T ss_conf 56762797018880999999989993999999844443588999999999999997789998238999998998899998
Q ss_pred ECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCCCCCCCCCC
Q ss_conf 74489956787209966799999999999999999987079998198167999866689983999711344123478986
Q 001544 846 YMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS 925 (1057)
Q Consensus 846 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 925 (1057)
|+++|++..+.... ..+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+|||+|.....
T Consensus 96 ~~~~g~l~~~~~~~-~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~---- 167 (309)
T d1u5ra_ 96 YCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---- 167 (309)
T ss_dssp CCSEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS----
T ss_pred ECCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCCCCEEEECCCCCEEEEECCCCCCCCC----
T ss_conf 06999457899737-99999999999999999999998---68976667884217987999789844365334677----
Q ss_pred CCCCCCCCCCCCCCCCCCCC---CCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHCCCC
Q ss_conf 51001223554358344588---888941017879999999960999999544564303344321046357886310011
Q 001544 926 MTQTQTLATLGYMAPEYGRE---GRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLL 1002 (1057)
Q Consensus 926 ~~~~~~~~t~~y~aPE~~~~---~~~~~~~DvwslG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1002 (1057)
.....||+.|+|||++.+ ..++.++||||+||++|||++|..||......+. ...+......
T Consensus 168 --~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~-------------~~~i~~~~~~ 232 (309)
T d1u5ra_ 168 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-------------LYHIAQNESP 232 (309)
T ss_dssp --BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-------------HHHHHHSCCC
T ss_pred --CCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHH-------------HHHHHHCCCC
T ss_conf --8731347663688998346788867214545589999999878899999799999-------------9999828999
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 12120058798979999999967143799999999999999
Q 001544 1003 ITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 1003 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~ 1043 (1057)
. .....+++++.+++.+||+.||++|||+.|+++|
T Consensus 233 ~------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 233 A------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp C------CSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred C------CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHC
T ss_conf 8------8878889999999999773796579189999719
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=355.11 Aligned_cols=252 Identities=20% Similarity=0.282 Sum_probs=209.4
Q ss_pred HCCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEEECCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEECCCCEEEEEEEE
Q ss_conf 079997715454368189999956-9958999995052546799999999999816897721676100168824899997
Q 001544 768 TNGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEY 846 (1057)
Q Consensus 768 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~ 846 (1057)
.++|++.+.||+|+||+||+|... +++.||||+++..... ...+.+|++++++++||||+++++++.+++..|+||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~-~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH-HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCCC-HHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEEC
T ss_conf 01058878983177839999999899969999997578665-99999999999857997989098999889988999953
Q ss_pred CCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC--CCCEEEECCCCCCCCCCCCC
Q ss_conf 4489956787209966799999999999999999987079998198167999866689--98399971134412347898
Q 001544 847 MRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDD--NMVAHLSDFGIAKLLIGEDQ 924 (1057)
Q Consensus 847 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~--~~~~kl~Dfg~a~~~~~~~~ 924 (1057)
++||+|.+++...+..+++.++..++.|++.|++||| +++|+||||||+||+++. ...+|++|||++.....
T Consensus 83 ~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH---~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~--- 156 (321)
T d1tkia_ 83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP--- 156 (321)
T ss_dssp CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT---
T ss_pred CCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCCCCEEECCCCCEEEEECCCCHHHCCCC---
T ss_conf 8998088998753899999999999999999999998---7699751355444344378851899764411100346---
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHCCCCCC
Q ss_conf 65100122355435834458888894101787999999996099999954456430334432104635788631001112
Q 001544 925 SMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLIT 1004 (1057)
Q Consensus 925 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1057)
........+++.|+|||...+..++.++||||+||++|+|++|..||......+. ...+... .
T Consensus 157 ~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~-------------~~~i~~~----~ 219 (321)
T d1tkia_ 157 GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI-------------IENIMNA----E 219 (321)
T ss_dssp TCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-------------HHHHHHT----C
T ss_pred CCCCCCCCCCCCCCCCHHCCCCCCCCHHHCCCHHHHHHHHHHCCCCCCCCCHHHH-------------HHHHHHC----C
T ss_conf 7753212233222340210487778401130279999999828999999899999-------------9999838----9
Q ss_pred CCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 120058798979999999967143799999999999999
Q 001544 1005 EDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 1005 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~ 1043 (1057)
..........+++++.+++.+|+..||++|||+.|+++|
T Consensus 220 ~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 220 YTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp CCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCCCHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 998802236789999999999866996689099999639
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=0 Score=353.46 Aligned_cols=250 Identities=23% Similarity=0.313 Sum_probs=200.0
Q ss_pred HCCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEEECCC---HHH---HHHHHHHHHHHHHCCCCCCEEEEEEECCCCEE
Q ss_conf 079997715454368189999956-99589999950525---467---99999999999816897721676100168824
Q 001544 768 TNGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQH---ERA---FKSFDTECEVMKSIRHRNLTKIISSCSNEDFK 840 (1057)
Q Consensus 768 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 840 (1057)
.++|++.+.||+|+||.||+|+.. +|+.||||++.... ... .....+++.+++.++||||+++++++.+.+..
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEE
T ss_conf 77685101884288909999999999979999998458754266799999999999998508998588999999989988
Q ss_pred EEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCCCCC
Q ss_conf 89999744899567872099667999999999999999999870799981981679998666899839997113441234
Q 001544 841 ALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLI 920 (1057)
Q Consensus 841 ~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~ 920 (1057)
|+||||+++|+|.+++.... .+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+|+.+.
T Consensus 83 ~ivmE~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~ylH---~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~ 158 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFS 158 (364)
T ss_dssp EEEECCCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred EEEEEECCCCCHHHHHHHCC-CCCHHHHHHHHHHHHHHHHHHH---HCCCCCEEECCCEEEECCCCCEEEEEECEEEECC
T ss_conf 99999148983899987325-5327899999999999999999---7796220444221678588967982201023337
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHC
Q ss_conf 7898651001223554358344588-888941017879999999960999999544564303344321046357886310
Q 001544 921 GEDQSMTQTQTLATLGYMAPEYGRE-GRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDA 999 (1057)
Q Consensus 921 ~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 999 (1057)
.. ......||+.|+|||++.. ..+++++||||+||++|||++|+.||......+.. .....
T Consensus 159 ~~----~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~--------------~~~~~ 220 (364)
T d1omwa3 159 KK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH--------------EIDRM 220 (364)
T ss_dssp SS----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHH--------------HHHHH
T ss_pred CC----CCCCCCCCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHH--------------HHHHH
T ss_conf 88----6433113455421687603899984410467789999998599988889989999--------------99986
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCC-----HHHHHHH
Q ss_conf 0111212005879897999999996714379999999-----9999999
Q 001544 1000 NLLITEDKHFAAKEQCASSVFNLAMECTVESPDERIT-----AKEIVRR 1043 (1057)
Q Consensus 1000 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-----~~eil~~ 1043 (1057)
.... ....+..+++++.+++.+||+.||++||| |.|+++|
T Consensus 221 ~~~~----~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 221 TLTM----AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp SSSC----CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred CCCC----CCCCCCCCCHHHHHHHHHHCCCCHHHHCCCCCCCHHHHHCC
T ss_conf 0468----88788778999999999985669888088743579999749
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=359.83 Aligned_cols=259 Identities=28% Similarity=0.434 Sum_probs=213.6
Q ss_pred HHCCCCCCCEECCCCCEEEEEEEEC------CCCEEEEEEEECCC-HHHHHHHHHHHHHHHHCCCCCCEEEEEEECCCCE
Q ss_conf 7079997715454368189999956------99589999950525-4679999999999981689772167610016882
Q 001544 767 ATNGFSENNLIGRGSFGSVYIARLQ------NGIEVAVKTFDLQH-ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDF 839 (1057)
Q Consensus 767 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 839 (1057)
..++|++.+.||+|+||+||+|+.+ +++.||||+++... ....+++.+|++++++++||||+++++++.+.+.
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 90 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 90 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred CHHHCEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCCCCCCCCCEEEECCCCC
T ss_conf 98893886798207883999999888765778829999998821085799999999999996689976552466605980
Q ss_pred EEEEEEECCCCCHHHHHHCCC-----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCC
Q ss_conf 489999744899567872099-----------------------667999999999999999999870799981981679
Q 001544 840 KALILEYMRNGSLEKCLYSGN-----------------------YILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLK 896 (1057)
Q Consensus 840 ~~lV~e~~~~g~L~~~l~~~~-----------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik 896 (1057)
.++||||+++|+|.+++.... ..+++..+..++.|++.|++||| +++++|||||
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH---~~~ivHrDlK 167 (301)
T d1lufa_ 91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLA 167 (301)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCS
T ss_pred EEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCC---CCCEEEEEEC
T ss_conf 3899981589929999985275542100001110012103467889899999999999999855413---5786854884
Q ss_pred CCCEEECCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCC-CCCCCCC
Q ss_conf 998666899839997113441234789865100122355435834458888894101787999999996099-9999544
Q 001544 897 PSNVLLDDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRR-KPTDEIF 975 (1057)
Q Consensus 897 p~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~-~P~~~~~ 975 (1057)
|+|||++.++.+||+|||+|+...............+++.|+|||.+.+..++.++|||||||++|||++|. +||....
T Consensus 168 p~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~ 247 (301)
T d1lufa_ 168 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 247 (301)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred CCCEEECCCCCEEECCCHHHEECCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCHHHHHCCCHHHHHHHHCCCCCCCCCCC
T ss_conf 01168989992898331442113677641115777767676798997268898056302523629999806899999989
Q ss_pred CCCCCHHHHHHHCCCHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 5643033443210463578863100111212005879897999999996714379999999999999999769
Q 001544 976 SGEMTLKHWVNDFLPISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKIR 1048 (1057)
Q Consensus 976 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~ 1048 (1057)
..+. ...+.+.. ..+.+..+++++.+++.+||+.+|++||||.|+++.|+++.
T Consensus 248 ~~e~-------------~~~v~~~~-------~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 248 HEEV-------------IYYVRDGN-------ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp HHHH-------------HHHHHTTC-------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred HHHH-------------HHHHHCCC-------CCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHC
T ss_conf 9999-------------99997399-------78887325299999999974889657939999999999842
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=349.03 Aligned_cols=278 Identities=23% Similarity=0.287 Sum_probs=205.9
Q ss_pred CCCCCCCEECCCCCEEEEEEEECCCCEEEEEEEECCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEECCCC----EEEEEE
Q ss_conf 7999771545436818999995699589999950525467999999999998168977216761001688----248999
Q 001544 769 NGFSENNLIGRGSFGSVYIARLQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCSNED----FKALIL 844 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~lV~ 844 (1057)
.+|...+.||+|+||.||+|+.. |+.||||+++..... ....+.|+..+++++||||+++++++.+.+ ..++||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~~~~-~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred CEEEEEEEEEECCCEEEEEEEEC-CEEEEEEEECCCCHH-HHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCEEEEEEE
T ss_conf 68999889820788199999999-989999998720046-7999999999962799868326889983798604899999
Q ss_pred EECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHC-----CCCCEEECCCCCCCEEECCCCCEEEECCCCCCCC
Q ss_conf 97448995678720996679999999999999999998707-----9998198167999866689983999711344123
Q 001544 845 EYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFG-----YSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL 919 (1057)
Q Consensus 845 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-----~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~ 919 (1057)
||+++|+|.+++++.. +++..+..++.|++.|++|+|.. .+++|+||||||+|||++.++.+||+|||+++..
T Consensus 81 Ey~~~g~L~~~l~~~~--l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~ 158 (303)
T d1vjya_ 81 DYHEHGSLFDYLNRYT--VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 158 (303)
T ss_dssp ECCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred ECCCCCCHHHHHHCCC--CCHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCCEEECCCCCEEEEECCCCCCC
T ss_conf 6466989899986589--99899999999999999998876652046898661531731357868877688763866234
Q ss_pred CCCCC--CCCCCCCCCCCCCCCCCCCCCCC------CCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCCC-
Q ss_conf 47898--65100122355435834458888------8941017879999999960999999544564303344321046-
Q 001544 920 IGEDQ--SMTQTQTLATLGYMAPEYGREGR------VSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLP- 990 (1057)
Q Consensus 920 ~~~~~--~~~~~~~~~t~~y~aPE~~~~~~------~~~~~DvwslG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~- 990 (1057)
..... ........||+.|+|||++.+.. ++.++|||||||++|||++|..||......+............
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~ 238 (303)
T d1vjya_ 159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238 (303)
T ss_dssp ETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred CCCCCCEECCCCCEECCCCCCCHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHCCCCCCHH
T ss_conf 67776200135525035476782210565454677767501220159999999628998876631124101225564309
Q ss_pred HHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 357886310011121200587989799999999671437999999999999999976999
Q 001544 991 ISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKIRDF 1050 (1057)
Q Consensus 991 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~~~ 1050 (1057)
........................+...+.+++.+||+.||++|||+.|++++|+++.+.
T Consensus 239 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 298 (303)
T d1vjya_ 239 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp HHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHH
T ss_conf 999998750246888776557768999999999997606985895999999999988886
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=352.92 Aligned_cols=258 Identities=26% Similarity=0.453 Sum_probs=210.1
Q ss_pred CCEECCCCCEEEEEEEECC----CCEEEEEEEEC-CCHHHHHHHHHHHHHHHHCCCCCCEEEEEEECC-CCEEEEEEEEC
Q ss_conf 7154543681899999569----95899999505-254679999999999981689772167610016-88248999974
Q 001544 774 NNLIGRGSFGSVYIARLQN----GIEVAVKTFDL-QHERAFKSFDTECEVMKSIRHRNLTKIISSCSN-EDFKALILEYM 847 (1057)
Q Consensus 774 ~~~lg~G~~g~V~~~~~~~----~~~vaiK~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lV~e~~ 847 (1057)
.++||+|+||+||+|++.. ...||||+++. ......+++.+|++++++++||||++++|++.+ +...++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred CEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEEEE
T ss_conf 66981368809999999779987999999998843697899999999999986789998678678980699438999874
Q ss_pred CCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCCCCCCCCC--C
Q ss_conf 48995678720996679999999999999999998707999819816799986668998399971134412347898--6
Q 001544 848 RNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ--S 925 (1057)
Q Consensus 848 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~--~ 925 (1057)
++|+|.+++.......++..+..++.|++.|+.|+| +++|+||||||+|||+++++.+||+|||+++....... .
T Consensus 112 ~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH---~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~ 188 (311)
T d1r0pa_ 112 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 188 (311)
T ss_dssp TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred ECCCHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCHHHEEECCCCCEEEECCCCHHHCCCCCCCCC
T ss_conf 067414421013454048999999999887652003---36762577668757677999889910652322556655531
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHCCCCCCC
Q ss_conf 51001223554358344588888941017879999999960999999544564303344321046357886310011121
Q 001544 926 MTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITE 1005 (1057)
Q Consensus 926 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1057)
.......||..|+|||...+..++.++||||||+++|||++|+.||........ ...++ ...
T Consensus 189 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~-~~~~i-----------~~g------ 250 (311)
T d1r0pa_ 189 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-ITVYL-----------LQG------ 250 (311)
T ss_dssp TCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------CHHHH-----------HTT------
T ss_pred EECCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCHHH-HHHHH-----------HCC------
T ss_conf 002565556455676887437999745746619999999978999988899999-99999-----------808------
Q ss_pred CHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHH
Q ss_conf 200587989799999999671437999999999999999976999964
Q 001544 1006 DKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKIRDFLLR 1053 (1057)
Q Consensus 1006 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~~~~~~ 1053 (1057)
.+...+..+++++.+++.+||+.||++||++.|++++|+.+...+.+
T Consensus 251 -~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~ 297 (311)
T d1r0pa_ 251 -RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 297 (311)
T ss_dssp -CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred -CCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHHHH
T ss_conf -98899644759999999997688976893999999999999975201
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=356.15 Aligned_cols=258 Identities=23% Similarity=0.385 Sum_probs=212.2
Q ss_pred HCCCCCCCEECCCCCEEEEEEEECC----CCEEEEEEEECC-CHHHHHHHHHHHHHHHHCCCCCCEEEEEEECCCCEEEE
Q ss_conf 0799977154543681899999569----958999995052-54679999999999981689772167610016882489
Q 001544 768 TNGFSENNLIGRGSFGSVYIARLQN----GIEVAVKTFDLQ-HERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKAL 842 (1057)
Q Consensus 768 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 842 (1057)
.++|++.+.||+|+||.||+|.... +..||||+++.. .......+.+|++++++++||||+++++++.+ +..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCEE
T ss_pred HHHEEEEEEEEECCCCEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CEEEE
T ss_conf 89969877993078829999999369964499999993656687999999999999986899998569889953-74799
Q ss_pred EEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCCCCCCC
Q ss_conf 99974489956787209966799999999999999999987079998198167999866689983999711344123478
Q 001544 843 ILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGE 922 (1057)
Q Consensus 843 V~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~ 922 (1057)
||||+++|++.+++......+++..+..++.|++.|+.||| +++|+||||||+||+++.++.+|++|||+|+.....
T Consensus 85 v~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~ 161 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 161 (273)
T ss_dssp EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred EEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHC---CCCEECCCCCHHHEEECCCCCEEECCCHHHEECCCC
T ss_conf 99840698077654224789999999999999987752302---267441410265532067896787650342133677
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHCCC
Q ss_conf 98651001223554358344588888941017879999999960-99999954456430334432104635788631001
Q 001544 923 DQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFT-RRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANL 1001 (1057)
Q Consensus 923 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1001 (1057)
.........||+.|+|||++.+..++.++||||+||++|||++ |.+||......+. ...+...
T Consensus 162 -~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~--------------~~~i~~~- 225 (273)
T d1mp8a_ 162 -TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV--------------IGRIENG- 225 (273)
T ss_dssp ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH--------------HHHHHTT-
T ss_pred -CCEECCCEECCCCCCHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHH--------------HHHHHCC-
T ss_conf -623305400583103266751699887452444247899998269999888999999--------------9999818-
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 1121200587989799999999671437999999999999999976999
Q 001544 1002 LITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKIRDF 1050 (1057)
Q Consensus 1002 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~~~ 1050 (1057)
.+.+.+..+++++.+++.+||+.||++|||+.|++++|+.+.+.
T Consensus 226 -----~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 226 -----ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp -----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -----CCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHH
T ss_conf -----99989877799999999997687976892999999999999778
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=353.71 Aligned_cols=261 Identities=25% Similarity=0.398 Sum_probs=209.5
Q ss_pred HCCCCCCCEECCCCCEEEEEEEEC------CCCEEEEEEEECC-CHHHHHHHHHHHHHHHHC-CCCCCEEEEEEECC-CC
Q ss_conf 079997715454368189999956------9958999995052-546799999999999816-89772167610016-88
Q 001544 768 TNGFSENNLIGRGSFGSVYIARLQ------NGIEVAVKTFDLQ-HERAFKSFDTECEVMKSI-RHRNLTKIISSCSN-ED 838 (1057)
Q Consensus 768 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~-~~ 838 (1057)
.++|++.+.||+|+||.||+|+.. +++.||||+++.. .......+.+|...+.++ +|+||+.+++++.+ ..
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~ 91 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 91 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred HHHEEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCEEEEEEEEECCCCC
T ss_conf 79979844984167839999998677755578399999986001717899999999998861499849974115404797
Q ss_pred EEEEEEEECCCCCHHHHHHCCC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC
Q ss_conf 2489999744899567872099---------------6679999999999999999998707999819816799986668
Q 001544 839 FKALILEYMRNGSLEKCLYSGN---------------YILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLD 903 (1057)
Q Consensus 839 ~~~lV~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~ 903 (1057)
..++||||+++|+|.+++.... ..+++..+..++.|++.|++||| +++|+||||||+|||++
T Consensus 92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~ivHrDlKp~NILl~ 168 (299)
T d1ywna1 92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLS 168 (299)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEC
T ss_pred EEEEEEEECCCCCHHHHHHHCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCCCCEEEC
T ss_conf 579999845899299999853666665322202332146899999999999999999887---37971786773106577
Q ss_pred CCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCC-CCCCCCCCCCCCHH
Q ss_conf 99839997113441234789865100122355435834458888894101787999999996099-99995445643033
Q 001544 904 DNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRR-KPTDEIFSGEMTLK 982 (1057)
Q Consensus 904 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~-~P~~~~~~~~~~~~ 982 (1057)
.++.+||+|||+|+...............||+.|+|||++.+..++.++||||+||++|||++|. +||......+.
T Consensus 169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~--- 245 (299)
T d1ywna1 169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--- 245 (299)
T ss_dssp GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH---
T ss_pred CCCCEEECCCCCHHHCCCCCCCCCCCCEEECCCCCCHHHHHCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCHHHH---
T ss_conf 99828984575200113566522247516672102036864688996632213678999998688999989998999---
Q ss_pred HHHHHCCCHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 44321046357886310011121200587989799999999671437999999999999999976999
Q 001544 983 HWVNDFLPISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKIRDF 1050 (1057)
Q Consensus 983 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~~~ 1050 (1057)
....+.... +...+..+++++.+++.+||+.||++|||+.|+++||+++.++
T Consensus 246 ----------~~~~~~~~~------~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 246 ----------FCRRLKEGT------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp ----------HHHHHHHTC------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----------HHHHHHCCC------CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf ----------999996389------8888865789999999997677966791999999999799867
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=0 Score=353.54 Aligned_cols=245 Identities=25% Similarity=0.339 Sum_probs=205.4
Q ss_pred CCCCCCCEECCCCCEEEEEEEE-CCCCEEEEEEEECCC---HHHHHHHHHHHHHHHHCCCCCCEEEEEEECCCCEEEEEE
Q ss_conf 7999771545436818999995-699589999950525---467999999999998168977216761001688248999
Q 001544 769 NGFSENNLIGRGSFGSVYIARL-QNGIEVAVKTFDLQH---ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALIL 844 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~ 844 (1057)
++|++.+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|+.++++++||||+++++++.+++..|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCHHHEEEEEEECCEEEEEE
T ss_conf 47088889720768089999998999799999984577548899999999999998636967533035685288005676
Q ss_pred EECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCCCCCCCCC
Q ss_conf 97448995678720996679999999999999999998707999819816799986668998399971134412347898
Q 001544 845 EYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ 924 (1057)
Q Consensus 845 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 924 (1057)
||++||++.+++.... ..++..+..++.|++.|++||| +++|+||||||+|||++.++.+||+|||+|+....
T Consensus 84 E~~~gg~l~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~--- 156 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD--- 156 (316)
T ss_dssp CCCCSCBHHHHHHHTS-SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS---
T ss_pred EECCCCCCCCCCCCCC-CCCCCHHHHHHHHHHHHHHHHC---CCCEECCCCCCHHEEECCCCCEEEECCCCCEEECC---
T ss_conf 5037863223432222-1110079999999987655412---47677055681050386899889831752167124---
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHCCCCCC
Q ss_conf 65100122355435834458888894101787999999996099999954456430334432104635788631001112
Q 001544 925 SMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLIT 1004 (1057)
Q Consensus 925 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1057)
......||+.|+|||++.+..++.++||||+||++|||++|+.||......+. ...+.....
T Consensus 157 --~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-------------~~~i~~~~~--- 218 (316)
T d1fota_ 157 --VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT-------------YEKILNAEL--- 218 (316)
T ss_dssp --CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-------------HHHHHHCCC---
T ss_pred --CCCCCCCCCCCCCHHHHCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCHHHH-------------HHHHHCCCC---
T ss_conf --56434576343599998389998043046533368999759899999699999-------------999970898---
Q ss_pred CCHHHHHHHHHHHHHHHHHHHCCCCCCCCCC-----CHHHHHHH
Q ss_conf 1200587989799999999671437999999-----99999999
Q 001544 1005 EDKHFAAKEQCASSVFNLAMECTVESPDERI-----TAKEIVRR 1043 (1057)
Q Consensus 1005 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~eil~~ 1043 (1057)
..+..+++++.+++.+|+..||.+|+ |+.++++|
T Consensus 219 -----~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 219 -----RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred -----CCCCCCCHHHHHHHHHHHHHCHHHCCCCCHHHHHHHHCC
T ss_conf -----899778999999999995449976664310219999819
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=354.27 Aligned_cols=245 Identities=22% Similarity=0.285 Sum_probs=205.5
Q ss_pred CCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEEECCC---HHHHHHHHHHHHHHHHCCCCCCEEEEEEECCCCEEEEEE
Q ss_conf 79997715454368189999956-99589999950525---467999999999998168977216761001688248999
Q 001544 769 NGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQH---ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALIL 844 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~ 844 (1057)
++|++.+.||+|+||.||+|+.+ +|+.||||++.... ....+.+.+|++++++++||||+++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCC
T ss_conf 37089889611768089999998999899999982677458899999999999999748772740344443222223222
Q ss_pred EECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCCCCCCCCC
Q ss_conf 97448995678720996679999999999999999998707999819816799986668998399971134412347898
Q 001544 845 EYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQ 924 (1057)
Q Consensus 845 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 924 (1057)
||+.+|+|.+++...+ .+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+|||+|+....
T Consensus 121 e~~~~g~l~~~l~~~~-~l~e~~~~~i~~qi~~aL~yLH---~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~--- 193 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG--- 193 (350)
T ss_dssp ECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS---
T ss_pred CCCCCCCHHHHHHHCC-CCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCCHHHCCCCCCCCEEEEECEEEEECCC---
T ss_conf 2334662266675158-9899999999999999899998---59986176799993607789788610103332256---
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHCCCCCC
Q ss_conf 65100122355435834458888894101787999999996099999954456430334432104635788631001112
Q 001544 925 SMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLIT 1004 (1057)
Q Consensus 925 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1057)
......||+.|+|||++.+..++.++||||+||++|||++|+.||........ ...+.....
T Consensus 194 --~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-------------~~~i~~~~~--- 255 (350)
T d1rdqe_ 194 --RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI-------------YEKIVSGKV--- 255 (350)
T ss_dssp --CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------------HHHHHHCCC---
T ss_pred --CCCCCCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCHHHH-------------HHHHHCCCC---
T ss_conf --66433676356788997179988533114500789999758899899599999-------------999861798---
Q ss_pred CCHHHHHHHHHHHHHHHHHHHCCCCCCCCCC-----CHHHHHHH
Q ss_conf 1200587989799999999671437999999-----99999999
Q 001544 1005 EDKHFAAKEQCASSVFNLAMECTVESPDERI-----TAKEIVRR 1043 (1057)
Q Consensus 1005 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~eil~~ 1043 (1057)
..+..+++++.+++.+||+.||.+|+ |+.++++|
T Consensus 256 -----~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 256 -----RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp -----CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred -----CCCCCCCHHHHHHHHHHHHHCHHHCCCCCCCCHHHHHCC
T ss_conf -----897668999999999983409986065534549999719
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=349.15 Aligned_cols=252 Identities=19% Similarity=0.246 Sum_probs=200.6
Q ss_pred HCCCCCCC-EECCCCCEEEEEEEE-CCCCEEEEEEEECCCHHHHHHHHHHHHHHHHC-CCCCCEEEEEEECC----CCEE
Q ss_conf 07999771-545436818999995-69958999995052546799999999999816-89772167610016----8824
Q 001544 768 TNGFSENN-LIGRGSFGSVYIARL-QNGIEVAVKTFDLQHERAFKSFDTECEVMKSI-RHRNLTKIISSCSN----EDFK 840 (1057)
Q Consensus 768 ~~~~~~~~-~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~----~~~~ 840 (1057)
.++|.+.+ .||+|+||+||+|+. .+++.||||+++.. ..+.+|++++.++ +||||+++++++.+ ....
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred CCCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCC-----HHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCCCEE
T ss_conf 148798107965454869999998899989999998974-----779999999998669999782989995034689789
Q ss_pred EEEEEECCCCCHHHHHHCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC---CCCEEEECCCCC
Q ss_conf 89999744899567872099-66799999999999999999987079998198167999866689---983999711344
Q 001544 841 ALILEYMRNGSLEKCLYSGN-YILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDD---NMVAHLSDFGIA 916 (1057)
Q Consensus 841 ~lV~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~---~~~~kl~Dfg~a 916 (1057)
|+||||++||+|.+++.... ..+++.++..++.|++.|++||| +++|+||||||+||+++. .+.+|++|||+|
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH---~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEE
T ss_conf 99997789984999998627877579999999999999999999---769864441002201135555663113545512
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCCCHHHHHH
Q ss_conf 12347898651001223554358344588888941017879999999960999999544564303344321046357886
Q 001544 917 KLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKI 996 (1057)
Q Consensus 917 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 996 (1057)
+..... .......||+.|+|||++.+..++.++||||+||++|+|++|+.||......+... . .
T Consensus 162 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~-~------------~ 225 (335)
T d2ozaa1 162 KETTSH---NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP-G------------M 225 (335)
T ss_dssp EECCCC---CCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-------------------
T ss_pred EECCCC---CCCCCCCCCCCCCCCHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHHHHHH-H------------H
T ss_conf 333688---86432267756379277748988888888764516778865889988988778899-9------------9
Q ss_pred HHCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 31001112120058798979999999967143799999999999999
Q 001544 997 IDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 997 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~ 1043 (1057)
.............+....+++++.+++.+||+.||++|||+.|+++|
T Consensus 226 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 226 KTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp --CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 99985388888985434699999999999756996579099999709
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=354.76 Aligned_cols=256 Identities=26% Similarity=0.442 Sum_probs=208.4
Q ss_pred HCCCCCCCEECCCCCEEEEEEEECCCCEEEEEEEECCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEECCCCEEEEEEEEC
Q ss_conf 07999771545436818999995699589999950525467999999999998168977216761001688248999974
Q 001544 768 TNGFSENNLIGRGSFGSVYIARLQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEYM 847 (1057)
Q Consensus 768 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~ 847 (1057)
.++|++.+.||+|+||+||+|+.++++.||||+++.... ..+.+.+|+.++++++||||++++|++.+ +..++||||+
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~ 93 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 93 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred HHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEECCCCC-CHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CCEEEEEEEC
T ss_conf 799798469930798099999999999999999880448-88999999999986666788689999823-9759999944
Q ss_pred CCCCHHHHHHCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCCCCCCCCCCC
Q ss_conf 4899567872099-667999999999999999999870799981981679998666899839997113441234789865
Q 001544 848 RNGSLEKCLYSGN-YILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSM 926 (1057)
Q Consensus 848 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 926 (1057)
++|++..++.... ..+++.++..++.|++.|++||| +.+|+||||||+||+++.++.+||+|||+|+.... ....
T Consensus 94 ~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH---~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~-~~~~ 169 (285)
T d1fmka3 94 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYT 169 (285)
T ss_dssp TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred CCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHH---HHHEECCCCCCEEEEECCCCCEEECCCCHHHHCCC-CCCE
T ss_conf 7994354200003553059999999999999999875---41143353123079998999299844255542568-8733
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHCCCCCCCC
Q ss_conf 10012235543583445888889410178799999999609999995445643033443210463578863100111212
Q 001544 927 TQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLITED 1006 (1057)
Q Consensus 927 ~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1006 (1057)
......|++.|+|||++..+.++.++||||+|+++|||++|+.|+......... ...+....
T Consensus 170 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~-------------~~~i~~~~----- 231 (285)
T d1fmka3 170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV-------------LDQVERGY----- 231 (285)
T ss_dssp ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH-------------HHHHHTTC-----
T ss_pred EECCCCCCCCCCCHHHHHCCCCCCHHHHHCCHHHHHHHHHCCCCCCCCCCHHHH-------------HHHHHHCC-----
T ss_conf 524545566545808983799891774132358999998689999988889999-------------99998268-----
Q ss_pred HHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 005879897999999996714379999999999999999769
Q 001544 1007 KHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKIR 1048 (1057)
Q Consensus 1007 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~ 1048 (1057)
+.+.+..++.++.+++.+||+.||++||++.++++.|++..
T Consensus 232 -~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~ 272 (285)
T d1fmka3 232 -RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272 (285)
T ss_dssp -CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred -CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf -99998323799999999975669758919999999876662
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=0 Score=345.80 Aligned_cols=251 Identities=24% Similarity=0.330 Sum_probs=205.9
Q ss_pred CCCCCCCEECCCCCEEEEEEEE-CCCCEEEEEEEECCC---------HHHHHHHHHHHHHHHHCC-CCCCEEEEEEECCC
Q ss_conf 7999771545436818999995-699589999950525---------467999999999998168-97721676100168
Q 001544 769 NGFSENNLIGRGSFGSVYIARL-QNGIEVAVKTFDLQH---------ERAFKSFDTECEVMKSIR-HRNLTKIISSCSNE 837 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~---------~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~ 837 (1057)
++|++.+.||+|+||+||+|+. .+++.||||+++... ....+.+.+|+.++++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred CCCEECEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEECCCC
T ss_conf 63888528841768499999999999899999996244641147888999999999999999850799747997621467
Q ss_pred CEEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCC
Q ss_conf 82489999744899567872099667999999999999999999870799981981679998666899839997113441
Q 001544 838 DFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAK 917 (1057)
Q Consensus 838 ~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~ 917 (1057)
+..|+||||+++|+|.+++.... .+++.++..++.||+.|++||| +++|+||||||+||+++.++.+||+|||.++
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~ 158 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSC 158 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred CCEEEEEECCCCCHHHHHHHHCC-CCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCCCEEEECCCCCEEECCCHHEE
T ss_conf 60599997689866899998659-9999999999999999999998---7599432346254898689983871240316
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCC------CCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCCCH
Q ss_conf 234789865100122355435834458------88889410178799999999609999995445643033443210463
Q 001544 918 LLIGEDQSMTQTQTLATLGYMAPEYGR------EGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPI 991 (1057)
Q Consensus 918 ~~~~~~~~~~~~~~~~t~~y~aPE~~~------~~~~~~~~DvwslG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 991 (1057)
.... ........||..|+|||.+. ...++.++||||+||++|||++|+.||......+. .
T Consensus 159 ~~~~---~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~-~---------- 224 (277)
T d1phka_ 159 QLDP---GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM-L---------- 224 (277)
T ss_dssp ECCT---TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-H----------
T ss_pred ECCC---CCCEEEEECCCCCCCHHHHHCCCCCCCCCCCCHHEECCCCHHHHHHCCCCCCCCCCCHHHH-H----------
T ss_conf 7268---8721345246788898886053445678899233185656023103228889889999999-9----------
Q ss_pred HHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 5788631001112120058798979999999967143799999999999999
Q 001544 992 SMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 992 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~ 1043 (1057)
..+..... ....+....+++++.+++.+||++||++|||+.|+++|
T Consensus 225 --~~i~~~~~----~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 225 --RMIMSGNY----QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp --HHHHHTCC----CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred --HHHHHCCC----CCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf --99981898----88985434689999999999765896689199999739
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=0 Score=346.67 Aligned_cols=260 Identities=21% Similarity=0.388 Sum_probs=210.8
Q ss_pred HCCCCCCCEECCCCCEEEEEEEE-CCCCEEEEEEEECC---CHHHHHHHHHHHHHHHHCCCCCCEEEEEEECCCC----E
Q ss_conf 07999771545436818999995-69958999995052---5467999999999998168977216761001688----2
Q 001544 768 TNGFSENNLIGRGSFGSVYIARL-QNGIEVAVKTFDLQ---HERAFKSFDTECEVMKSIRHRNLTKIISSCSNED----F 839 (1057)
Q Consensus 768 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~ 839 (1057)
.++|++.+.||+|+||+||+|+. .+++.||||+++.. .......+.+|+++++.++||||+++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCCE
T ss_conf 62069868996089929999999999989999998556646989999999999999856999887311435432688766
Q ss_pred EEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCCCC
Q ss_conf 48999974489956787209966799999999999999999987079998198167999866689983999711344123
Q 001544 840 KALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL 919 (1057)
Q Consensus 840 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~ 919 (1057)
.|+||||++|++|.+++...+ .+++.++..++.|++.|++||| +++|+||||||+||+++.++..+++|||.+...
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~-~l~~~~~~~i~~qi~~al~~lH---~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~ 161 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAI 161 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred EEEEEECCCCCEEHHHHCCCC-CCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHH
T ss_conf 999997788987101120358-9999999999999999999998---579527634675566575432010034443221
Q ss_pred CCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHH
Q ss_conf 478-9865100122355435834458888894101787999999996099999954456430334432104635788631
Q 001544 920 IGE-DQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIID 998 (1057)
Q Consensus 920 ~~~-~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 998 (1057)
... ..........||+.|+|||++.+..+++++||||+||++|||++|++||......+.. .....
T Consensus 162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~-------------~~~~~ 228 (277)
T d1o6ya_ 162 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA-------------YQHVR 228 (277)
T ss_dssp C----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-------------HHHHH
T ss_pred CCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCEECCCCHHHHHHHHHCCCCCCCCCHHHHH-------------HHHHH
T ss_conf 23544333346425762436999983999996632026528999997697998996999999-------------99984
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCC-CHHHHHHHHHHHH
Q ss_conf 0011121200587989799999999671437999999-9999999999769
Q 001544 999 ANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERI-TAKEIVRRLLKIR 1048 (1057)
Q Consensus 999 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-s~~eil~~L~~i~ 1048 (1057)
.. ..........+++++.+++.+||++||++|| |++++.+.|.+++
T Consensus 229 ~~----~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 229 ED----PIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp CC----CCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred CC----CCCCCHHCCCCCHHHHHHHHHHCCCCHHHCHHHHHHHHHHHHHHH
T ss_conf 69----999710034789999999999866797677739999999999975
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=347.04 Aligned_cols=262 Identities=24% Similarity=0.362 Sum_probs=213.1
Q ss_pred HCCCCCCCEECCCCCEEEEEEEEC------CCCEEEEEEEECCC-HHHHHHHHHHHHHHHHC-CCCCCEEEEEEECCCCE
Q ss_conf 079997715454368189999956------99589999950525-46799999999999816-89772167610016882
Q 001544 768 TNGFSENNLIGRGSFGSVYIARLQ------NGIEVAVKTFDLQH-ERAFKSFDTECEVMKSI-RHRNLTKIISSCSNEDF 839 (1057)
Q Consensus 768 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~ 839 (1057)
.++|+..++||+|+||.||+|++. +++.||||+++... ......+.+|+.+++.+ +||||+++++++.+.+.
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHEEEEEEEEECCCEEEEEEEEECCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCE
T ss_conf 89969854982068829999998066447788699999987424877999999999998762699988789989831997
Q ss_pred EEEEEEECCCCCHHHHHHCCC-----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEE
Q ss_conf 489999744899567872099-----------------667999999999999999999870799981981679998666
Q 001544 840 KALILEYMRNGSLEKCLYSGN-----------------YILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLL 902 (1057)
Q Consensus 840 ~~lV~e~~~~g~L~~~l~~~~-----------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill 902 (1057)
.++||||+++|+|.++++... ..+++..+..++.||+.|++||| +++++||||||+||++
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH---~~~ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEE
T ss_pred EEEEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCCCCCCCCC
T ss_conf 8999973799879999985356654444453322233458899999999999999999887---5792666241021000
Q ss_pred CCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCHH
Q ss_conf 89983999711344123478986510012235543583445888889410178799999999609999995445643033
Q 001544 903 DDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLK 982 (1057)
Q Consensus 903 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~P~~~~~~~~~~~~ 982 (1057)
+.++.+|++|||.++...............||+.|+|||++.+..++.++||||||+++|||++++.|+.........
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~-- 256 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK-- 256 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH--
T ss_pred CCCCCCCCCCCCHHEECCCCCCCEEEEECCCCHHHCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHH--
T ss_conf 025752102340102336788615862013596876778861799997400102589999998589988778998999--
Q ss_pred HHHHHCCCHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 44321046357886310011121200587989799999999671437999999999999999976999
Q 001544 983 HWVNDFLPISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKIRDF 1050 (1057)
Q Consensus 983 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~~~ 1050 (1057)
....+..... ...+..++.++.+|+.+||++||++|||+.++++.|+++...
T Consensus 257 ----------~~~~i~~~~~------~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 257 ----------FYKMIKEGFR------MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp ----------HHHHHHHTCC------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----------HHHHHHCCCC------CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHCC
T ss_conf ----------9999866898------898543659999999997577965792999999999876534
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=353.15 Aligned_cols=252 Identities=31% Similarity=0.457 Sum_probs=207.6
Q ss_pred HCCCCCCCEECCCCCEEEEEEEECCCCEEEEEEEECCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEECC-CCEEEEEEEE
Q ss_conf 079997715454368189999956995899999505254679999999999981689772167610016-8824899997
Q 001544 768 TNGFSENNLIGRGSFGSVYIARLQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCSN-EDFKALILEY 846 (1057)
Q Consensus 768 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lV~e~ 846 (1057)
.++|++.+.||+|+||.||+|+.+ ++.||||+++... ..+.+.+|++++++++||||++++|++.+ .+..|+||||
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey 82 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 82 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred HHHEEEEEEEECCCCEEEEEEEEC-CEEEEEEEECCHH--HHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEEC
T ss_conf 899488579820798089999999-9099999988577--7999999999998678989854987887238928999963
Q ss_pred CCCCCHHHHHHCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCCCCCCCCCC
Q ss_conf 44899567872099-66799999999999999999987079998198167999866689983999711344123478986
Q 001544 847 MRNGSLEKCLYSGN-YILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS 925 (1057)
Q Consensus 847 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 925 (1057)
+++|+|.+++.... ..+++..+++|+.|++.|++||| +++|+||||||+||+++.++.+|++|||.++....
T Consensus 83 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~---- 155 (262)
T d1byga_ 83 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS---- 155 (262)
T ss_dssp CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred CCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHCCCCC---CCCEECCCCCHHHHEECCCCCEEECCCCCCEECCC----
T ss_conf 69998999987457888899999999999985232113---37655366656760146899776324560034478----
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHCCCCCC
Q ss_conf 51001223554358344588888941017879999999960-99999954456430334432104635788631001112
Q 001544 926 MTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFT-RRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLIT 1004 (1057)
Q Consensus 926 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1057)
......++..|+|||++.+..++.++||||||+++|||++ |++||......+ . ...+..
T Consensus 156 -~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~--~------------~~~i~~----- 215 (262)
T d1byga_ 156 -TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--V------------VPRVEK----- 215 (262)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG--H------------HHHHTT-----
T ss_pred -CCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHH--H------------HHHHHC-----
T ss_conf -77655666467781787279888588777579999999978999999999999--9------------999980-----
Q ss_pred CCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 1200587989799999999671437999999999999999976999
Q 001544 1005 EDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKIRDF 1050 (1057)
Q Consensus 1005 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~~~ 1050 (1057)
..+.+.+..+++++.+++.+||+.||++|||+.|++++|++++..
T Consensus 216 -~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~ 260 (262)
T d1byga_ 216 -GYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 260 (262)
T ss_dssp -TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -CCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf -899999765799999999997566976893999999999999867
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=351.49 Aligned_cols=258 Identities=26% Similarity=0.439 Sum_probs=208.7
Q ss_pred CCCCCCCEECCCCCEEEEEEEEC-CCC--EEEEEEEECC-CHHHHHHHHHHHHHHHHC-CCCCCEEEEEEECCCCEEEEE
Q ss_conf 79997715454368189999956-995--8999995052-546799999999999816-897721676100168824899
Q 001544 769 NGFSENNLIGRGSFGSVYIARLQ-NGI--EVAVKTFDLQ-HERAFKSFDTECEVMKSI-RHRNLTKIISSCSNEDFKALI 843 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~V~~~~~~-~~~--~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lV 843 (1057)
++|++.++||+|+||+||+|+++ ++. .||||+++.. .....+.+.+|+++++++ +||||++++|++.+.+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHCEEEEEEEECCCCEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEE
T ss_conf 99688779820788289999998999699999999782338579999999999998622899883678888418736999
Q ss_pred EEECCCCCHHHHHHCC---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCE
Q ss_conf 9974489956787209---------------9667999999999999999999870799981981679998666899839
Q 001544 844 LEYMRNGSLEKCLYSG---------------NYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVA 908 (1057)
Q Consensus 844 ~e~~~~g~L~~~l~~~---------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~ 908 (1057)
|||+++|+|.++++.. ...+++..+..++.|++.|+.|+| +++|+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH---~~~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCE
T ss_pred EEECCCCCHHHHHHHCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCCCEEEECCCCCE
T ss_conf 9802898699998640355555123101234578999999999999999987663---0895455505204898688763
Q ss_pred EEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCC-CCCCCCCCCCCHHHHHHH
Q ss_conf 9971134412347898651001223554358344588888941017879999999960999-999544564303344321
Q 001544 909 HLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRK-PTDEIFSGEMTLKHWVND 987 (1057)
Q Consensus 909 kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~-P~~~~~~~~~~~~~~~~~ 987 (1057)
||+|||+++... .........||..|+|||.+.+..++.++||||||+++|||++|.. ||......
T Consensus 167 kl~DfG~a~~~~---~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~---------- 233 (309)
T d1fvra_ 167 KIADFGLSRGQE---VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---------- 233 (309)
T ss_dssp EECCTTCEESSC---EECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH----------
T ss_pred EECCCCCCCCCC---CCCCCCCEECCCCCCCHHHHCCCCCCCCCEEEHHHHHHHHHHHCCCCCCCCCCHH----------
T ss_conf 874344322444---2234553013775555387526999962215313889999983689999999999----------
Q ss_pred CCCHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHH
Q ss_conf 04635788631001112120058798979999999967143799999999999999997699996
Q 001544 988 FLPISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKIRDFLL 1052 (1057)
Q Consensus 988 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~~~~~ 1052 (1057)
.....+... .+.+.+..+++++.+++.+||+.||++|||+.|++++|+++.+...
T Consensus 234 ----~~~~~i~~~------~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~ 288 (309)
T d1fvra_ 234 ----ELYEKLPQG------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 288 (309)
T ss_dssp ----HHHHHGGGT------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred ----HHHHHHHHC------CCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHCCC
T ss_conf ----999999826------8888876678999999999767896689499999999999986186
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=349.69 Aligned_cols=259 Identities=28% Similarity=0.451 Sum_probs=213.3
Q ss_pred HCCCCCCCEECCCCCEEEEEEEECC--------CCEEEEEEEECCC-HHHHHHHHHHHHHHHHC-CCCCCEEEEEEECCC
Q ss_conf 0799977154543681899999569--------9589999950525-46799999999999816-897721676100168
Q 001544 768 TNGFSENNLIGRGSFGSVYIARLQN--------GIEVAVKTFDLQH-ERAFKSFDTECEVMKSI-RHRNLTKIISSCSNE 837 (1057)
Q Consensus 768 ~~~~~~~~~lg~G~~g~V~~~~~~~--------~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~ 837 (1057)
.++|++.+.||+|+||.||+|+... +..||||+++... ......+.+|...+.++ +||||+++++++.++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHEEEEEEEEECCCCEEEEEEECCCCCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCCC
T ss_conf 89969700985167828999998578755566754999999881128688999999999999813999697346522018
Q ss_pred CEEEEEEEECCCCCHHHHHHCCC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEE
Q ss_conf 82489999744899567872099---------------667999999999999999999870799981981679998666
Q 001544 838 DFKALILEYMRNGSLEKCLYSGN---------------YILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLL 902 (1057)
Q Consensus 838 ~~~~lV~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill 902 (1057)
+..++||||+++|+|.+++.... ..+++.+++.++.|++.|++||| +++|+||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH---~~~ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEE
T ss_pred CEEEEEEECCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEEEEECCCCEEE
T ss_conf 8689999736999099999860677643222334574346799999999999999998766---3797863022102245
Q ss_pred CCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCCCCCCCCH
Q ss_conf 8998399971134412347898651001223554358344588888941017879999999960-999999544564303
Q 001544 903 DDNMVAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFT-RRKPTDEIFSGEMTL 981 (1057)
Q Consensus 903 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~P~~~~~~~~~~~ 981 (1057)
+.++.+||+|||.++...............+++.|+|||.+.++.++.++||||||+++|||++ |.+||......+
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~--- 245 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE--- 245 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---
T ss_pred CCCCCEEECCCHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCHHH---
T ss_conf 47897676221110113555554314667888466326675179888255547758888874017989899999999---
Q ss_pred HHHHHHCCCHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 34432104635788631001112120058798979999999967143799999999999999997699
Q 001544 982 KHWVNDFLPISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKIRD 1049 (1057)
Q Consensus 982 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~~ 1049 (1057)
....+.... +.+.+..+++++.+++.+||+.||.+|||+.|+++.|+++..
T Consensus 246 -----------~~~~i~~~~------~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 246 -----------LFKLLKEGH------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp -----------HHHHHHTTC------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----------HHHHHHCCC------CCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf -----------999997288------889874352999999999766797679399999999988860
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=351.44 Aligned_cols=248 Identities=23% Similarity=0.349 Sum_probs=202.6
Q ss_pred CCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEEECCC---HHHHHHHHHHHHHHH-HCCCCCCEEEEEEECCCCEEEEE
Q ss_conf 79997715454368189999956-99589999950525---467999999999998-16897721676100168824899
Q 001544 769 NGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQH---ERAFKSFDTECEVMK-SIRHRNLTKIISSCSNEDFKALI 843 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~-~l~h~niv~~~~~~~~~~~~~lV 843 (1057)
++|++.+.||+|+||+||+|+.. +++.||||+++... ......+..|..++. .++||||+++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEE
T ss_conf 97188658940878289999999999899999980555338489999999999999847999687898897049831677
Q ss_pred EEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCCCCCCCC
Q ss_conf 99744899567872099667999999999999999999870799981981679998666899839997113441234789
Q 001544 844 LEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGED 923 (1057)
Q Consensus 844 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~ 923 (1057)
|||+++|+|.+++.... .+++..+..++.||+.|++||| +++|+||||||+|||++.++.+|++|||.++....
T Consensus 82 mEy~~~g~L~~~i~~~~-~~~e~~~~~~~~qi~~al~ylH---~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~-- 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML-- 155 (320)
T ss_dssp EECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC--
T ss_pred EEECCCCCHHHHHHCCC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEECCCCCCCEEECCCCCEECCCCCHHHHCCC--
T ss_conf 75037980899864047-8999999999999999999998---68934034765404444899630155530232356--
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHCCCCC
Q ss_conf 86510012235543583445888889410178799999999609999995445643033443210463578863100111
Q 001544 924 QSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDANLLI 1003 (1057)
Q Consensus 924 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1003 (1057)
.........||+.|+|||++.+..++.++||||+||++|||++|+.||.+....+ ....+....
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~--------------~~~~i~~~~-- 219 (320)
T d1xjda_ 156 GDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE--------------LFHSIRMDN-- 219 (320)
T ss_dssp TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------------HHHHHHHCC--
T ss_pred CCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHH--------------HHHHHHCCC--
T ss_conf 6533454578777689999827998832320112278989873889999989999--------------999997189--
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHH-HHHHH
Q ss_conf 21200587989799999999671437999999999-99999
Q 001544 1004 TEDKHFAAKEQCASSVFNLAMECTVESPDERITAK-EIVRR 1043 (1057)
Q Consensus 1004 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~-eil~~ 1043 (1057)
...+..+++++.+++.+||..||++||++. |+++|
T Consensus 220 -----~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~h 255 (320)
T d1xjda_ 220 -----PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH 255 (320)
T ss_dssp -----CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred -----CCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHHC
T ss_conf -----989756799999999996544898783889999809
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=350.18 Aligned_cols=256 Identities=25% Similarity=0.388 Sum_probs=208.1
Q ss_pred CCCCCCCEECCCCCEEEEEEEEC--C--CCEEEEEEEECC---CHHHHHHHHHHHHHHHHCCCCCCEEEEEEECCCCEEE
Q ss_conf 79997715454368189999956--9--958999995052---5467999999999998168977216761001688248
Q 001544 769 NGFSENNLIGRGSFGSVYIARLQ--N--GIEVAVKTFDLQ---HERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKA 841 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~V~~~~~~--~--~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 841 (1057)
++|++.+.||+|+||.||+|+.. + ...||||+++.. .....+++.+|++++++++||||++++|++.+ ...+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHEEEEEEEECCCCEEEEEEEEECCCCCEEEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEE-CCHH
T ss_conf 891997898038883999999988999079999999983555798999999999999986899998789877740-1001
Q ss_pred EEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCCCCCC
Q ss_conf 99997448995678720996679999999999999999998707999819816799986668998399971134412347
Q 001544 842 LILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIG 921 (1057)
Q Consensus 842 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 921 (1057)
+||||+++|++.+++......+++..++.++.|++.|+.||| +++|+||||||+||+++.++.+|++|||+++....
T Consensus 87 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~ 163 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 163 (273)
T ss_dssp EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred EEEEEECCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEEEEECHHHHCCCCCCCEEECCCHHHHHCCC
T ss_conf 146542386125444212689999999999999999998752---17875205668881565565433256115553035
Q ss_pred CCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHC
Q ss_conf 8986-51001223554358344588888941017879999999960-999999544564303344321046357886310
Q 001544 922 EDQS-MTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFT-RRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDA 999 (1057)
Q Consensus 922 ~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 999 (1057)
.... .......++..|+|||++.+..++.++||||||+++|||++ |..||......+. ...+...
T Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~-------------~~~i~~~ 230 (273)
T d1u46a_ 164 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI-------------LHKIDKE 230 (273)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH-------------HHHHHTS
T ss_pred CCCCCEECCCCCCCCCCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHH-------------HHHHHHC
T ss_conf 887526547632573107999983799994215661489999999689999999699999-------------9999847
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf 011121200587989799999999671437999999999999999976
Q 001544 1000 NLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKI 1047 (1057)
Q Consensus 1000 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i 1047 (1057)
..+.+.+..+++++.+++.+||+.||++|||+.|+.+.|++.
T Consensus 231 ------~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 231 ------GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp ------CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------CCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHC
T ss_conf ------999998544539999999997688966792999999999964
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=343.84 Aligned_cols=270 Identities=24% Similarity=0.280 Sum_probs=204.9
Q ss_pred CCCCCCCEECCCCCEEEEEEEE-CCCCEEEEEEEECCC--HHHHHHHHHHHHHHHHCCCCCCEEEEEEECCCCEEEEEEE
Q ss_conf 7999771545436818999995-699589999950525--4679999999999981689772167610016882489999
Q 001544 769 NGFSENNLIGRGSFGSVYIARL-QNGIEVAVKTFDLQH--ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILE 845 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e 845 (1057)
++|++.+.||+|+||+||+|.. .+++.||||+++... +.....+.+|++++++++||||+++++++.+++..|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEECCEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEEE
T ss_conf 99776517723768099999999999799999980222575899999999999986799838874453322432037886
Q ss_pred ECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCCCCCCCCCC
Q ss_conf 74489956787209966799999999999999999987079998198167999866689983999711344123478986
Q 001544 846 YMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS 925 (1057)
Q Consensus 846 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 925 (1057)
|+.++.+..........+++..+..++.|++.||+||| +++|+||||||+||+++.++.+|++|||.|+.... ..
T Consensus 82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH---~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~--~~ 156 (298)
T d1gz8a_ 82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PV 156 (298)
T ss_dssp CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCC--CS
T ss_pred ECCCCHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHH---CCCEECCCCCCHHEEECCCCCCEECCCCCCEECCC--CC
T ss_conf 23774455544202568888999999999999999865---28899213571140113467621035786134368--86
Q ss_pred CCCCCCCCCCCCCCCCCCCCCC-CCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCCCH-HHHH----HHHC
Q ss_conf 5100122355435834458888-89410178799999999609999995445643033443210463-5788----6310
Q 001544 926 MTQTQTLATLGYMAPEYGREGR-VSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPI-SMMK----IIDA 999 (1057)
Q Consensus 926 ~~~~~~~~t~~y~aPE~~~~~~-~~~~~DvwslG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~-~~~~----~~~~ 999 (1057)
.......|++.|+|||+..... ++.++|+||+||++|+|++|+.||......+.....+.....+. .... ..+.
T Consensus 157 ~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 236 (298)
T d1gz8a_ 157 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236 (298)
T ss_dssp BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred CCCEEECCCCEEEEHHHHCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHCCCCCCCCCC
T ss_conf 41001036521541122136657774221033331342796687998988999999999983289833314442224212
Q ss_pred C---CCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 0---1112120058798979999999967143799999999999999
Q 001544 1000 N---LLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 1000 ~---~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~ 1043 (1057)
. ..............++.++.+++.+|+..||++|||+.|+++|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp CTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 43454322220444166789999999999763995579189999678
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=344.63 Aligned_cols=264 Identities=23% Similarity=0.289 Sum_probs=197.9
Q ss_pred CCCEECCCCCEEEEEEEE-CCCCEEEEEEEECCCH-----HHHHHHHHHHHHHHHCCCCCCEEEEEEECCCCEEEEEEEE
Q ss_conf 771545436818999995-6995899999505254-----6799999999999816897721676100168824899997
Q 001544 773 ENNLIGRGSFGSVYIARL-QNGIEVAVKTFDLQHE-----RAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEY 846 (1057)
Q Consensus 773 ~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~ 846 (1057)
..++||+|+||+||+|+. .+++.||||+++.... .....+.+|+.++++++||||+++++++.+++..|+||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred CCEEECCCCCEEEEEEEECCCCCEEEEEEEEHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEHHHH
T ss_conf 56385127282999999999996999999842021245679999999999999867999986898542258740220455
Q ss_pred CCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCCCCCCCCCCC
Q ss_conf 44899567872099667999999999999999999870799981981679998666899839997113441234789865
Q 001544 847 MRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSM 926 (1057)
Q Consensus 847 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 926 (1057)
++++++.... .....+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|||.|+..... ..
T Consensus 82 ~~~~~~~~~~-~~~~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~--~~ 155 (299)
T d1ua2a_ 82 METDLEVIIK-DNSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP--NR 155 (299)
T ss_dssp CSEEHHHHHT-TCCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC--CC
T ss_pred HCCHHHHHHH-HCCCCCCHHHHHHHHHHHHHHHHHHH---CCCEECCCCCCCEEEECCCCCCCCCCCCCCCCCCCC--CC
T ss_conf 3450776554-12667789999999999999998863---163550357762588537784114657610005787--55
Q ss_pred CCCCCCCCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCCCH--H-H---HHHHHC
Q ss_conf 1001223554358344588-8889410178799999999609999995445643033443210463--5-7---886310
Q 001544 927 TQTQTLATLGYMAPEYGRE-GRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPI--S-M---MKIIDA 999 (1057)
Q Consensus 927 ~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~--~-~---~~~~~~ 999 (1057)
......||+.|+|||++.+ ..++.++||||+||++|||++|.+||......+. ........... . . ......
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~-l~~i~~~~~~~~~~~~~~~~~~~~~ 234 (299)
T d1ua2a_ 156 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ-LTRIFETLGTPTEEQWPDMCSLPDY 234 (299)
T ss_dssp CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCCCCTTTSSSTTSSTTC
T ss_pred CCCCEECCHHHCCHHHHCCCCCCCHHHHHHHCCHHHHHHHHCCCCCCCCCHHHH-HHHHHHHCCCCCHHHCCCHHCCCHH
T ss_conf 433020473336399972677888056436304289999859699999999999-9999985189972545210002134
Q ss_pred -CC-CCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf -01-112120058798979999999967143799999999999999
Q 001544 1000 -NL-LITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 1000 -~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~ 1043 (1057)
.. ..............++++.+|+.+||+.||++||||.|+++|
T Consensus 235 ~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 235 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp CCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred HHHCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 4303478988678565689999999999763894569089999679
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=348.95 Aligned_cols=261 Identities=23% Similarity=0.373 Sum_probs=212.5
Q ss_pred HCCCCCCCEECCCCCEEEEEEEEC------CCCEEEEEEEECC-CHHHHHHHHHHHHHHHHCCCCCCEEEEEEECCCCEE
Q ss_conf 079997715454368189999956------9958999995052-546799999999999816897721676100168824
Q 001544 768 TNGFSENNLIGRGSFGSVYIARLQ------NGIEVAVKTFDLQ-HERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFK 840 (1057)
Q Consensus 768 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 840 (1057)
.++|+..+.||+|+||+||+|.++ +++.||||+++.. .......+.+|++++++++||||+++++++..++..
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHHEEEEEEEEECCCEEEEEEEECCCCCCCCCCEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCE
T ss_conf 89918835982078818999998786447789689999987012868999999999999976999884125478428810
Q ss_pred EEEEEECCCCCHHHHHHCCC---------CCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEE
Q ss_conf 89999744899567872099---------667999999999999999999870799981981679998666899839997
Q 001544 841 ALILEYMRNGSLEKCLYSGN---------YILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLS 911 (1057)
Q Consensus 841 ~lV~e~~~~g~L~~~l~~~~---------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~ 911 (1057)
++||||+++|+|.+++.... ..+++..+.+++.|+++|+.||| +++|+||||||+|||++.++.+||+
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH---~~~ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTCCEEEC
T ss_pred EEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEECEECCCCEEECCCCEEEEE
T ss_conf 6777604899889998750332113444688799999999999999999876---4796543286775403599649994
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCC-CCCCCCCCCCCCHHHHHHHCCC
Q ss_conf 113441234789865100122355435834458888894101787999999996099-9999544564303344321046
Q 001544 912 DFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRR-KPTDEIFSGEMTLKHWVNDFLP 990 (1057)
Q Consensus 912 Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~-~P~~~~~~~~~~~~~~~~~~~~ 990 (1057)
|||+|+...............+++.|+|||.+.+..++.++||||||+++|||+||. +||...... ..
T Consensus 176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~-----~~------ 244 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE-----QV------ 244 (308)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH-----HH------
T ss_pred ECCCCEECCCCCCEEECCCEECCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHH-----HH------
T ss_conf 2454202357763031340231632378888736998833344437899999996899999998999-----99------
Q ss_pred HHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHH
Q ss_conf 3578863100111212005879897999999996714379999999999999999769999
Q 001544 991 ISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKIRDFL 1051 (1057)
Q Consensus 991 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~~~~ 1051 (1057)
...+.+.. +.+.+..+++.+.+++.+||+.+|++|||+.+++++|++..+..
T Consensus 245 --~~~i~~~~-------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~ 296 (308)
T d1p4oa_ 245 --LRFVMEGG-------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG 296 (308)
T ss_dssp --HHHHHTTC-------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTT
T ss_pred --HHHHHHCC-------CCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHCCCC
T ss_conf --99998088-------88886335399999999975779658939999999978761778
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=0 Score=340.59 Aligned_cols=269 Identities=20% Similarity=0.256 Sum_probs=205.8
Q ss_pred CCCCCCCEECCCCCEEEEEEEECCCCEEEEEEEECCC--HHHHHHHHHHHHHHHHCCCCCCEEEEEEECCCCEEEEEEEE
Q ss_conf 7999771545436818999995699589999950525--46799999999999816897721676100168824899997
Q 001544 769 NGFSENNLIGRGSFGSVYIARLQNGIEVAVKTFDLQH--ERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILEY 846 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~ 846 (1057)
++|++.++||+|+||+||+|+.++++.||||+++... +...+++.+|+.++++++||||+++++++..++..++++|+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCCEECCEEECCCCCEEEEEEECCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEECCCCCCEEEEEEE
T ss_conf 99634318722778189999968999999999812326858999999999999867998687660120467731589974
Q ss_pred CCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCCCCCCCCCCC
Q ss_conf 44899567872099667999999999999999999870799981981679998666899839997113441234789865
Q 001544 847 MRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQSM 926 (1057)
Q Consensus 847 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 926 (1057)
+.++.+..+.. ....+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+|++|||.+..... ...
T Consensus 82 ~~~~~~~~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH---~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~--~~~ 155 (286)
T d1ob3a_ 82 LDQDLKKLLDV-CEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGI--PVR 155 (286)
T ss_dssp CSEEHHHHHHT-STTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred EHHHHHHHHHH-HCCCCCHHHHHHHHHHHHHHHHHHC---CCCEEECCCCCCEEEECCCCCEEECCCCCCEECCC--CCC
T ss_conf 00456789986-0477514456899999999999860---57488267877505686899787323664301146--765
Q ss_pred CCCCCCCCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCCC-HH----HHH---HH
Q ss_conf 1001223554358344588-888941017879999999960999999544564303344321046-35----788---63
Q 001544 927 TQTQTLATLGYMAPEYGRE-GRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLP-IS----MMK---II 997 (1057)
Q Consensus 927 ~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~-~~----~~~---~~ 997 (1057)
......+++.|+|||.+.+ ..++.++||||+||++|||++|+.||......+.....+.....+ .. ... ..
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T d1ob3a_ 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235 (286)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred CCCEECCCCHHHHHHHHHCCCCCCCCEEEHHCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCHHHCCCHHHHHHCC
T ss_conf 41010243110137887178888841002111758999977979989889899999999863899711042123332214
Q ss_pred HCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 1001112120058798979999999967143799999999999999
Q 001544 998 DANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 998 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~ 1043 (1057)
..................++.+.+++.+||+.||++|||++|+++|
T Consensus 236 ~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 3333356764666512589999999999866896689099998569
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=331.56 Aligned_cols=272 Identities=21% Similarity=0.221 Sum_probs=203.1
Q ss_pred HHCCCCCCCEECCCCCEEEEEEEE-CCCCEEEEEEEECC-CHHHHHHHHHHHHHHHHCCCCCCEEEEEEECCCC----EE
Q ss_conf 707999771545436818999995-69958999995052-5467999999999998168977216761001688----24
Q 001544 767 ATNGFSENNLIGRGSFGSVYIARL-QNGIEVAVKTFDLQ-HERAFKSFDTECEVMKSIRHRNLTKIISSCSNED----FK 840 (1057)
Q Consensus 767 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~ 840 (1057)
.+.+|++.+.||+|+||+||+|.. .+++.||||+++.. .....+++.+|++++++++||||+++++++.... ..
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred CCCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCE
T ss_conf 38985997899406480999999999994999999803109589999999999999768989885888995056455414
Q ss_pred EEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCCCCC
Q ss_conf 89999744899567872099667999999999999999999870799981981679998666899839997113441234
Q 001544 841 ALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLI 920 (1057)
Q Consensus 841 ~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~ 920 (1057)
+++++++.+|+|.+++... .+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+|....
T Consensus 86 ~~l~~~~~~g~L~~~l~~~--~l~~~~i~~i~~qil~al~yLH---~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~ 160 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 160 (345)
T ss_dssp EEEEEECCCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEEEECCCCHHHHHHCC--CCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCCCEEEECCCCCEEECCCCCEEECC
T ss_conf 9999962598656644058--9999999999999999999999---7898677787643788799977875457056504
Q ss_pred CCCC-CCCCCCCCCCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCCCH-------
Q ss_conf 7898-651001223554358344588-8889410178799999999609999995445643033443210463-------
Q 001544 921 GEDQ-SMTQTQTLATLGYMAPEYGRE-GRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPI------- 991 (1057)
Q Consensus 921 ~~~~-~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~------- 991 (1057)
.... ........|++.|+|||++.. ..++.++||||+||++|||++|+.||......+...........+.
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (345)
T d1pmea_ 161 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 240 (345)
T ss_dssp GGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTC
T ss_pred CCCCCCEEECCCCCCCEECHHHHHHCCCCCCCHHHHHCCCCEEHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHHHHH
T ss_conf 77764101011026520003878604788874101004670133776697997888889999987652069975664234
Q ss_pred ---HHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf ---5788631001112120058798979999999967143799999999999999
Q 001544 992 ---SMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 992 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~ 1043 (1057)
........................++++.+++.+|++.||++|||+.|+++|
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 241 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp CCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHHCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 3322220244677557787778378999999999999764895679089998619
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=337.99 Aligned_cols=269 Identities=24% Similarity=0.283 Sum_probs=200.1
Q ss_pred HCCCCCCCEECCCCCEEEEEEEE-CC-CCEEEEEEEECCC--HHHHHHHHHHHHHHHHC---CCCCCEEEEEEEC-----
Q ss_conf 07999771545436818999995-69-9589999950525--46799999999999816---8977216761001-----
Q 001544 768 TNGFSENNLIGRGSFGSVYIARL-QN-GIEVAVKTFDLQH--ERAFKSFDTECEVMKSI---RHRNLTKIISSCS----- 835 (1057)
Q Consensus 768 ~~~~~~~~~lg~G~~g~V~~~~~-~~-~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~----- 835 (1057)
.++|++.+.||+|+||+||+|+. ++ ++.||||+++... +.....+.+|+.+++.+ +||||+++++++.
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred CCCEEEEEEEECCCCEEEEEEEEECCCCEEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCC
T ss_conf 58979888992155869999999888998999999802324516799999999999987425898802366322146666
Q ss_pred CCCEEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCC
Q ss_conf 68824899997448995678720996679999999999999999998707999819816799986668998399971134
Q 001544 836 NEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGI 915 (1057)
Q Consensus 836 ~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~ 915 (1057)
.....++++|+++++.+..........+++..+..++.|++.||+||| +++|+||||||+|||++.++.+|++|||.
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH---~~~ivHrDiKp~NILi~~~~~~kl~dfg~ 162 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGL 162 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred CCCEEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCCCCCEEEECCCCCEEECCHHH
T ss_conf 674699999740587144444303789998999999999999999997---58898357986278985899754210001
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCCCH--HH
Q ss_conf 4123478986510012235543583445888889410178799999999609999995445643033443210463--57
Q 001544 916 AKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPI--SM 993 (1057)
Q Consensus 916 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~--~~ 993 (1057)
+.... .........||+.|+|||++.+..++.++||||+||++|||++|++||......+ ............ ..
T Consensus 163 ~~~~~---~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~ 238 (305)
T d1blxa_ 163 ARIYS---FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-QLGKILDVIGLPGEED 238 (305)
T ss_dssp CCCCC---GGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCGGG
T ss_pred HHHHC---CCCCCCCCCCCHHHCCCCHHCCCCCCHHEHHHCHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHHHCCCCHHC
T ss_conf 01100---2345777654851148310017988811100032899999987879989989899-9999998407996110
Q ss_pred HH-H----HHCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 88-6----31001112120058798979999999967143799999999999999
Q 001544 994 MK-I----IDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 994 ~~-~----~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~ 1043 (1057)
.. . ...................++.+.+|+.+||++||++|||+.|+++|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp SCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCCCCCCHHHHHCCCCCCCHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 5321111033302234564544044589999999999874896679189999669
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=331.52 Aligned_cols=268 Identities=22% Similarity=0.293 Sum_probs=203.9
Q ss_pred HCCCCCCCEECCCCCEEEEEEEE-CCCCEEEEEEEECC--CHHHHHHHHHHHHHHHHCCCCCCEEEEEEECCCC------
Q ss_conf 07999771545436818999995-69958999995052--5467999999999998168977216761001688------
Q 001544 768 TNGFSENNLIGRGSFGSVYIARL-QNGIEVAVKTFDLQ--HERAFKSFDTECEVMKSIRHRNLTKIISSCSNED------ 838 (1057)
Q Consensus 768 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------ 838 (1057)
.++|++.+.||+|+||+||+|.. .+++.||||+++.. .+...+.+.+|++++++++||||+++++++...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCCC
T ss_conf 77189988980177819999999999989999998522259699999999999998668987547999863576555541
Q ss_pred EEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCCC
Q ss_conf 24899997448995678720996679999999999999999998707999819816799986668998399971134412
Q 001544 839 FKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL 918 (1057)
Q Consensus 839 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~ 918 (1057)
+.|+||||+ +.+|....... .+++..+..++.|++.||+||| +++|+||||||+|||++.++.+|++|||.|+.
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH---~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~ 170 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQ 170 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEEECC-CCCHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCCCHHHCCCCCCCCCCCCCCEEC
T ss_conf 599998405-52189998740--2269999999999999999987---37876456685111121001221134310220
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHH--HCCCHHHH-
Q ss_conf 347898651001223554358344588-88894101787999999996099999954456430334432--10463578-
Q 001544 919 LIGEDQSMTQTQTLATLGYMAPEYGRE-GRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVN--DFLPISMM- 994 (1057)
Q Consensus 919 ~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~P~~~~~~~~~~~~~~~~--~~~~~~~~- 994 (1057)
... ......|++.|+|||++.+ ..++.++||||+||++|||++|++||........ ...... ...+....
T Consensus 171 ~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~ 244 (346)
T d1cm8a_ 171 ADS-----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ-LKEIMKVTGTPPAEFVQ 244 (346)
T ss_dssp CCS-----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCCCCHHHHH
T ss_pred CCC-----CCCCCCCCCCCCCHHHHCCCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCHHHH-HHHHHHCCCCCCHHHHH
T ss_conf 687-----631024553335889981787899650103003899999978699888976899-99998503788488886
Q ss_pred --------HHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH--HHHH
Q ss_conf --------8631001112120058798979999999967143799999999999999--9976
Q 001544 995 --------KIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR--LLKI 1047 (1057)
Q Consensus 995 --------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~--L~~i 1047 (1057)
.....................++.+.+|+.+||..||++|||+.|+++| ++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 245 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred HHCCHHHHHHHCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf 530003443311578666556677556899999999999772995579299999639623758
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=335.25 Aligned_cols=241 Identities=25% Similarity=0.318 Sum_probs=196.2
Q ss_pred HCCCCCCCEECCCCCEEEEEEEE-CCCCEEEEEEEECCCH------HHHHHHHHHHHHHHHCC--CCCCEEEEEEECCCC
Q ss_conf 07999771545436818999995-6995899999505254------67999999999998168--977216761001688
Q 001544 768 TNGFSENNLIGRGSFGSVYIARL-QNGIEVAVKTFDLQHE------RAFKSFDTECEVMKSIR--HRNLTKIISSCSNED 838 (1057)
Q Consensus 768 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~------~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~ 838 (1057)
.++|++.+.||+|+||+||+|+. .+++.||||+++.... ....++.+|+.++++++ ||||+++++++.+++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECC
T ss_conf 88379967984087839999999999979999998568844334556799999999999974358988127999983099
Q ss_pred EEEEEEEECCC-CCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC-CCCEEEECCCCC
Q ss_conf 24899997448-9956787209966799999999999999999987079998198167999866689-983999711344
Q 001544 839 FKALILEYMRN-GSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDD-NMVAHLSDFGIA 916 (1057)
Q Consensus 839 ~~~lV~e~~~~-g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~-~~~~kl~Dfg~a 916 (1057)
..++||||+.+ +++.+++.... .+++..+..++.|++.|++||| +++|+||||||+||+++. ++.+|++|||+|
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~-~l~e~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a 158 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSG 158 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEEEEEECCCCCHHHHHHHCCC-CCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCCCCEEEECCCCEEEECCCCCC
T ss_conf 68999983368622899986158-9999999999999999999998---7797556676111477447884897754653
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCCCHHHHH
Q ss_conf 12347898651001223554358344588888-94101787999999996099999954456430334432104635788
Q 001544 917 KLLIGEDQSMTQTQTLATLGYMAPEYGREGRV-STKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMK 995 (1057)
Q Consensus 917 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 995 (1057)
+... ........||+.|+|||++.+..+ +.++||||+||++|||++|+.||.... .
T Consensus 159 ~~~~----~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-------------------~ 215 (273)
T d1xwsa_ 159 ALLK----DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------------------E 215 (273)
T ss_dssp EECC----SSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------------------H
T ss_pred EECC----CCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCEEEEHHHHHCCCCCCCCH-------------------H
T ss_conf 5324----4455665658774799998489978865332554034536756889988736-------------------7
Q ss_pred HHHCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 631001112120058798979999999967143799999999999999
Q 001544 996 IIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 996 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~ 1043 (1057)
+...... .+..+++++.+++.+||+.||++|||+.|+++|
T Consensus 216 i~~~~~~--------~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 216 IIRGQVF--------FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp HHHCCCC--------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHCCCC--------CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 7615447--------787799999999999760897589399998539
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=325.47 Aligned_cols=273 Identities=19% Similarity=0.270 Sum_probs=201.3
Q ss_pred HCCCCCCCEECCCCCEEEEEEEE-CCCCEEEEEEEECC--CHHHHHHHHHHHHHHHHCCCCCCEEEEEEECC--------
Q ss_conf 07999771545436818999995-69958999995052--54679999999999981689772167610016--------
Q 001544 768 TNGFSENNLIGRGSFGSVYIARL-QNGIEVAVKTFDLQ--HERAFKSFDTECEVMKSIRHRNLTKIISSCSN-------- 836 (1057)
Q Consensus 768 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-------- 836 (1057)
.++|++.+.||+|+||+||+|+. .+++.||||++... .+....++.+|++++++++|||++++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCCCCC
T ss_conf 27988999972274829999999899979999998422246378999999999999835999660676540246544445
Q ss_pred CCEEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCC
Q ss_conf 88248999974489956787209966799999999999999999987079998198167999866689983999711344
Q 001544 837 EDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIA 916 (1057)
Q Consensus 837 ~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a 916 (1057)
.++.++||||++++.+... ......+++..++.++.|++.|+.||| +++|+||||||+|||++.++.+|++|||++
T Consensus 89 ~~~~~iv~e~~~~~~~~~~-~~~~~~~~~~~~~~i~~qil~~l~~lH---~~~ivHrDlKp~NILl~~~~~~kl~dfg~~ 164 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLL-SNVLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLA 164 (318)
T ss_dssp --CEEEEEECCCEEHHHHH-TCTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred CCEEEEEEECCCCCCCCHH-HHCCCCCCCHHHHHHHHHHHHHHHHHC---CCCEEECCCCCHHEEECCCCCEEEEECCEE
T ss_conf 7638999853578741012-220344330899999999999998852---299885676722203668996876313500
Q ss_pred CCCCCCCC--CCCCCCCCCCCCCCCCCCCCCC-CCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCH--HHHHHHCCC-
Q ss_conf 12347898--6510012235543583445888-88941017879999999960999999544564303--344321046-
Q 001544 917 KLLIGEDQ--SMTQTQTLATLGYMAPEYGREG-RVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTL--KHWVNDFLP- 990 (1057)
Q Consensus 917 ~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~P~~~~~~~~~~~--~~~~~~~~~- 990 (1057)
........ ........||+.|+|||++.+. .+++++||||+||++|||++|+.||......+... ........+
T Consensus 165 ~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 244 (318)
T d3blha1 165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 244 (318)
T ss_dssp EECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred EECCCCCCCCCCCCCCEECCHHHHHHHHHCCCCCCCCHHHCCCCCCEEEEHHHCCCCCCCCCHHHHHHHHHHHCCCCCHH
T ss_conf 22355444321135660249787428997079998917870067864661744879989989999999999841899825
Q ss_pred -------HHHHHHHHCCCCCCCCH-HHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHH
Q ss_conf -------35788631001112120-0587989799999999671437999999999999999
Q 001544 991 -------ISMMKIIDANLLITEDK-HFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRL 1044 (1057)
Q Consensus 991 -------~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L 1044 (1057)
................. ........++.+.+|+.+||++||++|||+.|+++|=
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hp 306 (318)
T d3blha1 245 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 306 (318)
T ss_dssp TSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred HCCCCCHHHHHHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCH
T ss_conf 53443203444332013344555033404445998999999998738965890999997495
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=327.85 Aligned_cols=267 Identities=23% Similarity=0.311 Sum_probs=194.7
Q ss_pred CCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEEECCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEECC------CCEEEE
Q ss_conf 9997715454368189999956-995899999505254679999999999981689772167610016------882489
Q 001544 770 GFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNLTKIISSCSN------EDFKAL 842 (1057)
Q Consensus 770 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------~~~~~l 842 (1057)
+|+..++||+|+||+||+|+.. +++.||||++..... ...+|++++++++||||+++++++.. ..+.++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CCEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCCCH----HHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEEEEE
T ss_conf 76751698217683999999999997999999881606----89999999986689898738789974476577318999
Q ss_pred EEEECCCCCHHHHH--HCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCC-CEEEECCCCCCCC
Q ss_conf 99974489956787--20996679999999999999999998707999819816799986668998-3999711344123
Q 001544 843 ILEYMRNGSLEKCL--YSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNM-VAHLSDFGIAKLL 919 (1057)
Q Consensus 843 V~e~~~~g~L~~~l--~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~-~~kl~Dfg~a~~~ 919 (1057)
||||++++.+.... ......+++.++..++.|++.||+||| +++|+||||||+|||++.++ .+||+|||++...
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH---~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEECCCCCCHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCCCEEEEECCCCCEEEECCCCHHHC
T ss_conf 9841688607888863103689999999999999999999998---6687645788603787358971167336605440
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHC--CCHHHHHH
Q ss_conf 47898651001223554358344588-8889410178799999999609999995445643033443210--46357886
Q 001544 920 IGEDQSMTQTQTLATLGYMAPEYGRE-GRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDF--LPISMMKI 996 (1057)
Q Consensus 920 ~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~P~~~~~~~~~~~~~~~~~~--~~~~~~~~ 996 (1057)
... .......|+..|+|||...+ ..++.++||||+||++|||++|+.||......+. ........ ........
T Consensus 174 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~-l~~i~~~~g~~~~~~~~~ 249 (350)
T d1q5ka_ 174 VRG---EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ-LVEIIKVLGTPTREQIRE 249 (350)
T ss_dssp CTT---SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHH-HHHHHHHHCCCCHHHHHH
T ss_pred CCC---CCCCCCCCCCCCCCHHHHHCCCCCCCCEEECCCCEEEEEHHHCCCCCCCCCHHHH-HHHHHHHHCCCHHHHHHH
T ss_conf 477---6532002555556827764046888210002465277855028799898799999-999999748981776543
Q ss_pred HHCC-----CCCCCCH--HHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH--HHHH
Q ss_conf 3100-----1112120--058798979999999967143799999999999999--9976
Q 001544 997 IDAN-----LLITEDK--HFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR--LLKI 1047 (1057)
Q Consensus 997 ~~~~-----~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~--L~~i 1047 (1057)
.... ....... ........++++.+|+.+||..||++|||+.|+++| ++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309 (350)
T ss_dssp HCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred HCCCHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf 062101103554456744443156899999999999765895579299999669845246
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=326.10 Aligned_cols=265 Identities=21% Similarity=0.230 Sum_probs=203.4
Q ss_pred HCCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEEECC--CHHHHHHHHHHHHHHHHCCCCCCEEEEEEEC------CCC
Q ss_conf 079997715454368189999956-9958999995052--5467999999999998168977216761001------688
Q 001544 768 TNGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQ--HERAFKSFDTECEVMKSIRHRNLTKIISSCS------NED 838 (1057)
Q Consensus 768 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~------~~~ 838 (1057)
.++|++.++||+|+||+||+|.+. +++.||||++... ......++.+|+.++++++||||+++++++. ...
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCCCCCC
T ss_conf 37759988962175859999999999989999998823369799999999999998648987648998970256434576
Q ss_pred EEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCCC
Q ss_conf 24899997448995678720996679999999999999999998707999819816799986668998399971134412
Q 001544 839 FKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL 918 (1057)
Q Consensus 839 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~ 918 (1057)
+.|+||||+.++.+.. +. ..+++..++.++.|++.|++||| +.||+||||||+||+++.++.++++|||.++.
T Consensus 96 ~~~iv~Ey~~~~l~~~-~~---~~~~~~~i~~~~~qil~gl~~LH---~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~ 168 (355)
T d2b1pa1 96 DVYLVMELMDANLCQV-IQ---MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_dssp EEEEEEECCSEEHHHH-HT---SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEEEEECCCHHHHHH-HH---CCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCCCCCCCCCCCCEEEECHHHHHC
T ss_conf 2699984144677876-50---38999999999999999998865---22112456776321136544313201023211
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCHH----------HHHHHC
Q ss_conf 3478986510012235543583445888889410178799999999609999995445643033----------443210
Q 001544 919 LIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLK----------HWVNDF 988 (1057)
Q Consensus 919 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~P~~~~~~~~~~~~----------~~~~~~ 988 (1057)
.. .........+|+.|+|||++.+..+++++||||+||++|||++|+.||........... .+...
T Consensus 169 ~~---~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~- 244 (355)
T d2b1pa1 169 AG---TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK- 244 (355)
T ss_dssp ---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTT-
T ss_pred CC---CCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHHHH-
T ss_conf 46---66553322146555581331477778774333566257898659899888977889999997205898799987-
Q ss_pred CCHHHHHHHHCCCC------------CCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 46357886310011------------12120058798979999999967143799999999999999
Q 001544 989 LPISMMKIIDANLL------------ITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 989 ~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~ 1043 (1057)
.........+.... .............++++.+|+.+|+..||++||||+|+++|
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp SCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 6566777764175435666421264333543210133379999999999876994579089999669
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=323.53 Aligned_cols=264 Identities=20% Similarity=0.225 Sum_probs=204.6
Q ss_pred HCCCCCCCEECCCCCEEEEEEEE-CCCCEEEEEEEECCCHHHHHHHHHHHHHHHHCCCCC-CEEEEEEECCCCEEEEEEE
Q ss_conf 07999771545436818999995-699589999950525467999999999998168977-2167610016882489999
Q 001544 768 TNGFSENNLIGRGSFGSVYIARL-QNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRN-LTKIISSCSNEDFKALILE 845 (1057)
Q Consensus 768 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~lV~e 845 (1057)
.++|++.+.||+|+||+||+|+. .+++.||||++...... ..+..|+++++.++|++ |+.+.+++.+++..++|||
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme 83 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 83 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS--CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCEEEEEEEEEECCCCEEEEEEECCCCCEEEEEEECHHCCC--HHHHHHHHHHHHCCCCCCCCEEEEEEECCCEEEEEEE
T ss_conf 88899968985078809999999889989999997210058--8899999999970389960179999951987789998
Q ss_pred ECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC---CCCEEEECCCCCCCCCCC
Q ss_conf 74489956787209966799999999999999999987079998198167999866689---983999711344123478
Q 001544 846 YMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDD---NMVAHLSDFGIAKLLIGE 922 (1057)
Q Consensus 846 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~---~~~~kl~Dfg~a~~~~~~ 922 (1057)
|+ ++++.+.+......+++..+..++.|++.|++||| +++|+||||||+||+++. +..++++|||+|+.+...
T Consensus 84 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~ 159 (299)
T d1ckia_ 84 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159 (299)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred EC-CCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCCCHHHCCCCCCCCCCEEEEECCCCCEECCCC
T ss_conf 73-87133324430688768999999999999999999---799442667876606433577761565046751342554
Q ss_pred CC-----CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHH
Q ss_conf 98-----6510012235543583445888889410178799999999609999995445643033443210463578863
Q 001544 923 DQ-----SMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKII 997 (1057)
Q Consensus 923 ~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 997 (1057)
.. ........||+.|+|||...+..+++++||||+||++|||++|+.||.............. ..
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~----------~~ 229 (299)
T d1ckia_ 160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYER----------IS 229 (299)
T ss_dssp TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHH----------HH
T ss_pred CCCCCEECCCCCCCCCCCCCCCHHHHHCCCCCCHHHEEECCHHHHHHHHCCCCCCCCCHHHHHHHHHH----------HH
T ss_conf 45541000135776787353299999189989832188617789999849876655305779999998----------52
Q ss_pred HCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 10011121200587989799999999671437999999999999999976999
Q 001544 998 DANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKIRDF 1050 (1057)
Q Consensus 998 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~~~ 1050 (1057)
.... ..........+++++.+++.+||+.+|++||++.++.+.|+++...
T Consensus 230 ~~~~---~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 230 EKKM---STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp HHHH---HSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred CCCC---CCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHH
T ss_conf 3567---8983575347889999999998439955791999999999999997
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=0 Score=324.32 Aligned_cols=263 Identities=20% Similarity=0.269 Sum_probs=198.4
Q ss_pred HCCCCCCCEECCCCCEEEEEEEE-CCCCEEEEEEEECCCHHHHHHHHHHHHHHHHCC-CCCCEEEEEEECC--CCEEEEE
Q ss_conf 07999771545436818999995-699589999950525467999999999998168-9772167610016--8824899
Q 001544 768 TNGFSENNLIGRGSFGSVYIARL-QNGIEVAVKTFDLQHERAFKSFDTECEVMKSIR-HRNLTKIISSCSN--EDFKALI 843 (1057)
Q Consensus 768 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~--~~~~~lV 843 (1057)
.++|++.++||+|+||+||+|+. .+++.||||+++... .+++.+|+++++.++ ||||+++++++.. ....++|
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v 110 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 110 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHHCCCCCCCCEEEEEEEECCCCCEEEE
T ss_conf 867189789831748199999988999799999988899---99999999999851579987679999981687712688
Q ss_pred EEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCC-CEEEECCCCCCCCCCC
Q ss_conf 997448995678720996679999999999999999998707999819816799986668998-3999711344123478
Q 001544 844 LEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNM-VAHLSDFGIAKLLIGE 922 (1057)
Q Consensus 844 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~-~~kl~Dfg~a~~~~~~ 922 (1057)
|||+++++|.++. ..+++..+..++.||+.||+||| +++|+||||||+|||++.++ .+|++|||+|+.....
T Consensus 111 ~e~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH---~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~ 183 (328)
T d3bqca1 111 FEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 183 (328)
T ss_dssp EECCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred EEECCCCCHHHHH----CCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCCCCEEECCCCCEEEECCCCCCEECCCC
T ss_conf 8631798589974----68999999999999999998876---4334434564412377489983664156542664688
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHC--
Q ss_conf 986510012235543583445888-88941017879999999960999999544564303344321046357886310--
Q 001544 923 DQSMTQTQTLATLGYMAPEYGREG-RVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKIIDA-- 999 (1057)
Q Consensus 923 ~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 999 (1057)
.......+|..|+|||...+. .++.++|+||+||++||+++|+.||............................
T Consensus 184 ---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 260 (328)
T d3bqca1 184 ---QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 260 (328)
T ss_dssp ---CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred ---CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCHHHHHHHHCC
T ss_conf ---74443224864247610268888884523233545558760488999887601899999999878841555554225
Q ss_pred -------------C--CCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf -------------0--1112120058798979999999967143799999999999999
Q 001544 1000 -------------N--LLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 1000 -------------~--~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~ 1043 (1057)
. ..............+++++.+|+.+||..||++|||++|+++|
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp CCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCCCCCCHHCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 44474300000333433112115521124489999999999866995689089999649
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=0 Score=320.04 Aligned_cols=264 Identities=15% Similarity=0.150 Sum_probs=210.1
Q ss_pred HCCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEEEECCCHHHHHHHHHHHHHHHHCCC-CCCEEEEEEECCCCEEEEEEE
Q ss_conf 079997715454368189999956-995899999505254679999999999981689-772167610016882489999
Q 001544 768 TNGFSENNLIGRGSFGSVYIARLQ-NGIEVAVKTFDLQHERAFKSFDTECEVMKSIRH-RNLTKIISSCSNEDFKALILE 845 (1057)
Q Consensus 768 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~lV~e 845 (1057)
.++|++.+.||+|+||+||+|+.. +++.||||++...... ..+.+|++.++.++| ++++.+++++.++...++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS--CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCCC--HHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEEEE
T ss_conf 98069979984178829999999889979999997502582--9999999999996489998779999601881179999
Q ss_pred ECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC-----CCCEEEECCCCCCCCC
Q ss_conf 74489956787209966799999999999999999987079998198167999866689-----9839997113441234
Q 001544 846 YMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDD-----NMVAHLSDFGIAKLLI 920 (1057)
Q Consensus 846 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~-----~~~~kl~Dfg~a~~~~ 920 (1057)
|+ +++|.+++......++...+..++.|++.|++||| +++|+||||||+||+++. ++.+|++|||+|+.+.
T Consensus 82 ~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH---~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~ 157 (293)
T d1csna_ 82 LL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157 (293)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred EC-CCCHHHHHHHHCCCHHHHHHHHHHHHHHHHHHHHH---HCCCEECCCCCCCEEECCCCCCCCCCEEECCCCEEEECC
T ss_conf 64-88879999752031106899999999999999999---779662667713152347543447956872366057714
Q ss_pred CCCC-----CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCCCHHHHH
Q ss_conf 7898-----65100122355435834458888894101787999999996099999954456430334432104635788
Q 001544 921 GEDQ-----SMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMK 995 (1057)
Q Consensus 921 ~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 995 (1057)
.... ........||+.|+|||++.+..+++++||||+|+++|||++|+.||............ ..
T Consensus 158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~----------~~ 227 (293)
T d1csna_ 158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY----------ER 227 (293)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHH----------HH
T ss_pred CCCCCCCEEECCCCCEEECHHHCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH----------HH
T ss_conf 67665411102467627751026798964888886999898319999998698767885302199999----------99
Q ss_pred HHHCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 6310011121200587989799999999671437999999999999999976999
Q 001544 996 IIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRRLLKIRDF 1050 (1057)
Q Consensus 996 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~~~ 1050 (1057)
+..... ..........+|+++.+++..|+..+|++||+++.+.+.++++.+.
T Consensus 228 i~~~~~---~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~ 279 (293)
T d1csna_ 228 IGEKKQ---STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER 279 (293)
T ss_dssp HHHHHH---HSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred HHHCCC---CCCHHHHCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHH
T ss_conf 970567---9995896579989999999998439930085999999999999997
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=0 Score=319.67 Aligned_cols=276 Identities=33% Similarity=0.538 Sum_probs=196.4
Q ss_pred CCCCCHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCC--CCCEEEECCCC--CCEEEEEEECCCCCC--CCCCCCCCCCC
Q ss_conf 9991019999999873135999866689789999986--54103841799--831477531146755--56643469887
Q 001544 23 TSIDIDQDALLALKDHITYDPTNFFAKNWLTNSTMVC--NWTGVTCDINQ--RRVTALNISYLSLTG--NIPRQLGNLSS 96 (1057)
Q Consensus 23 ~~~~~~~~~l~~~k~~~~~~~~~~~~~~w~~~~~~~c--~w~gv~c~~~~--~~v~~l~l~~~~l~g--~~~~~l~~l~~ 96 (1057)
-|.+.|++||++||+++. ||. .+ .+|. .++||| .|.||+|+..+ .||+.|+|++++++| .+|+.+++|++
T Consensus 2 ~c~~~e~~aLl~~k~~~~-~~~-~l-~sW~-~~~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~ 77 (313)
T d1ogqa_ 2 LCNPQDKQALLQIKKDLG-NPT-TL-SSWL-PTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPY 77 (313)
T ss_dssp CSCHHHHHHHHHHHHHTT-CCG-GG-TTCC-TTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTT
T ss_pred CCCHHHHHHHHHHHHHCC-CCC-CC-CCCC-CCCCCCCCCCCCEEEECCCCCEEEEEEECCCCCCCCCCCCCHHHHCCCC
T ss_conf 989899999999999779-998-67-7889-9999988948896974899947988998989988888879847846753
Q ss_pred CCEEECCC-CCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCEEEC
Q ss_conf 86884788-87556678132364434333212532348789000034998938646897989978664668878862672
Q 001544 97 LEILDLNF-NRLSGEIPWELGNLAKLEKLLLHNNFLTGTIPFSIFKLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDL 175 (1057)
Q Consensus 97 L~~L~L~~-n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L 175 (1057)
|++|+|++ |+++|.+|..++++++|++|+|++|++.+..+..+..+..|+.+++++|++.+.+|. .+.+++.|+.+++
T Consensus 78 L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~-~l~~l~~L~~l~l 156 (313)
T d1ogqa_ 78 LNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPP-SISSLPNLVGITF 156 (313)
T ss_dssp CSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCG-GGGGCTTCCEEEC
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCH-HHCCCCCCCEEEC
T ss_conf 352020265433300243114542001102035643443322222011100111122455556851-2206740000002
Q ss_pred CCCCCCCCCCHHHHCCCCC-CEEEEECCCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCC
Q ss_conf 5884656685222113467-756853367732269432277896328983044123474311238887758985588776
Q 001544 176 SDNQLSGSIPSFIFKISSL-QALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGGISSTLSNCKHLRILDLSFNDLW 254 (1057)
Q Consensus 176 ~~n~l~~~~~~~l~~l~~L-~~L~L~~N~l~~~~p~~~~~~l~~L~~L~l~~n~~~~~~~~~l~~~~~L~~L~Ls~n~l~ 254 (1057)
++|.+.+.+|..+..+..+ +.++++.|++++..|..+ ..+. ...++++.+...
T Consensus 157 ~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~-------------------------~~l~-~~~l~l~~~~~~ 210 (313)
T d1ogqa_ 157 DGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTF-------------------------ANLN-LAFVDLSRNMLE 210 (313)
T ss_dssp CSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGG-------------------------GGCC-CSEEECCSSEEE
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-------------------------CCCC-CCCCCCCCCCCC
T ss_conf 35533562031214431123231022464353324332-------------------------2222-223333334332
Q ss_pred CCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCC
Q ss_conf 8944001374787489622133245448333466642299956472444458642245421099802873346899
Q 001544 255 GDIPKEIGNLTKLKELFLDFNILQGEIPHTVGNLHNLEYLSLVNNELVGTVPATIFNVSTLKLIELSNNTFFGSLP 330 (1057)
Q Consensus 255 ~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~ 330 (1057)
+.+|..+..++.++.+++++|.+.+.++ .++.+++|+.|++++|++++.+|..+.++++|+.|+|++|+++|.+|
T Consensus 211 ~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP 285 (313)
T d1ogqa_ 211 GDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP 285 (313)
T ss_dssp ECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECC
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCEECCCCCHHHHCCCCCCEEECCCCCCCCCCC
T ss_conf 2222222222221112222222222222-22245544444476570666087688479999989795883516689
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=322.92 Aligned_cols=269 Identities=22% Similarity=0.256 Sum_probs=205.5
Q ss_pred CCCCCCCEECCCCCEEEEEEEE-CCCCEEEEEEEECC--CHHHHHHHHHHHHHHHHCCCCCCEEEEEEECCCCEEEEEEE
Q ss_conf 7999771545436818999995-69958999995052--54679999999999981689772167610016882489999
Q 001544 769 NGFSENNLIGRGSFGSVYIARL-QNGIEVAVKTFDLQ--HERAFKSFDTECEVMKSIRHRNLTKIISSCSNEDFKALILE 845 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lV~e 845 (1057)
++|++.+.||+|+||+||+|+. .+++.||||+++.. .+....++.+|+.+++.++||||+++++++.+....++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEEE
T ss_conf 99786269712868199999999999699999980321786899999999999985675788821354444431158863
Q ss_pred ECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCCCCCCCCCC
Q ss_conf 74489956787209966799999999999999999987079998198167999866689983999711344123478986
Q 001544 846 YMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLIGEDQS 925 (1057)
Q Consensus 846 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 925 (1057)
++.++++..+.... ..+++..+..++.|++.||+||| +++|+||||||+||+++.++.+|++|||.+...... .
T Consensus 82 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~q~~~aL~~lH---~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~--~ 155 (292)
T d1unla_ 82 FCDQDLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP--V 155 (292)
T ss_dssp CCSEEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSC--C
T ss_pred ECCCCCCCCCCCCC-CCCCHHHHHHHHHHHHHHHHHHH---CCCEEEECCCCCCCCCCCCCCEEEEECCHHHCCCCC--C
T ss_conf 02332221121235-65403678999999999987743---399860014676121133782665204601104688--7
Q ss_pred CCCCCCCCCCCCCCCCCCCCCC-CCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCCC--H----HHHHHHH
Q ss_conf 5100122355435834458888-8941017879999999960999999544564303344321046--3----5788631
Q 001544 926 MTQTQTLATLGYMAPEYGREGR-VSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLP--I----SMMKIID 998 (1057)
Q Consensus 926 ~~~~~~~~t~~y~aPE~~~~~~-~~~~~DvwslG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~--~----~~~~~~~ 998 (1057)
.......++..|+|||++.... ++.++||||+||++|||++|+.||................... . ......+
T Consensus 156 ~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (292)
T d1unla_ 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235 (292)
T ss_dssp SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred CCCEEECCCCCHHHHHHHCCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCCHHHHHHHHHHHCCCCCHHHHHHHHHCCC
T ss_conf 51001034431014667506988880444026541889985189999889999999999986118997355134432221
Q ss_pred CC---CCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 00---1112120058798979999999967143799999999999999
Q 001544 999 AN---LLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 999 ~~---~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~ 1043 (1057)
.. ...............++.+.+|+.+|++.||++||||+|+++|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 133444544310433065689999999999864996689099999649
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=323.25 Aligned_cols=267 Identities=22% Similarity=0.251 Sum_probs=201.7
Q ss_pred HHCCCCCCCEECCCCCEEEEEEEE-CCCCEEEEEEEECC--CHHHHHHHHHHHHHHHHCCCCCCEEEEEEECC-----CC
Q ss_conf 707999771545436818999995-69958999995052--54679999999999981689772167610016-----88
Q 001544 767 ATNGFSENNLIGRGSFGSVYIARL-QNGIEVAVKTFDLQ--HERAFKSFDTECEVMKSIRHRNLTKIISSCSN-----ED 838 (1057)
Q Consensus 767 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-----~~ 838 (1057)
..++|++.+.||+|+||+||+|+. .+++.||||+++.. .....+++.+|++++++++|||++++++++.. ..
T Consensus 16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCC
T ss_conf 89871888898317883999999999997999999882002868999999999999866898742599999634645668
Q ss_pred EEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCCC
Q ss_conf 24899997448995678720996679999999999999999998707999819816799986668998399971134412
Q 001544 839 FKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL 918 (1057)
Q Consensus 839 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~ 918 (1057)
..+++++++.+|+|.+++..+ .+++..+..++.|++.||+||| +++|+||||||+||+++.++.+|++|||.+..
T Consensus 96 ~~~~i~~~~~gg~L~~~~~~~--~l~e~~~~~i~~qil~aL~~LH---~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~ 170 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARH 170 (348)
T ss_dssp CCCEEEEECCSEEHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCC----C
T ss_pred CEEEEEEEECCCCHHHHCCCC--CCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCCCCCCCCCCCCCCCCCCCHHCC
T ss_conf 649999962588623200224--5309999999999999999997---38876516677633455432200132100012
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHH----------HHHH
Q ss_conf 3478986510012235543583445888-8894101787999999996099999954456430334----------4321
Q 001544 919 LIGEDQSMTQTQTLATLGYMAPEYGREG-RVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKH----------WVND 987 (1057)
Q Consensus 919 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~P~~~~~~~~~~~~~----------~~~~ 987 (1057)
. ........|+..|+|||...+. .++.++||||+||++|+|++|+.||............ +...
T Consensus 171 ~-----~~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~ 245 (348)
T d2gfsa1 171 T-----DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 245 (348)
T ss_dssp C-----TGGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred C-----CCCCCCCCCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHHHH
T ss_conf 5-----75444434543555835533775678551243205899999768899788988999999997307997577320
Q ss_pred CCCHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 04635788631001112120058798979999999967143799999999999999
Q 001544 988 FLPISMMKIIDANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERITAKEIVRR 1043 (1057)
Q Consensus 988 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~eil~~ 1043 (1057)
...........................+++++.+|+.+|+..||++|||+.|+++|
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 246 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp CCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCHHHHHHHHHCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 01024454443035578755566267899999999999775883459389998559
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=325.92 Aligned_cols=253 Identities=25% Similarity=0.345 Sum_probs=202.7
Q ss_pred CCCCCCCEECCCCCEEEEEEEEC----CCCEEEEEEEECC----CHHHHHHHHHHHHHHHHCCC-CCCEEEEEEECCCCE
Q ss_conf 79997715454368189999956----9958999995052----54679999999999981689-772167610016882
Q 001544 769 NGFSENNLIGRGSFGSVYIARLQ----NGIEVAVKTFDLQ----HERAFKSFDTECEVMKSIRH-RNLTKIISSCSNEDF 839 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~V~~~~~~----~~~~vaiK~~~~~----~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~ 839 (1057)
++|++.+.||+|+||+||+|+.. +|+.||||+++.. .....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred HCEEEEEEEECCCCEEEEEEEECCCCCCCCEEEEEEEEHHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCC
T ss_conf 02599989832878399999987658879489999983677210168999999999999864679839996200024873
Q ss_pred EEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCCCC
Q ss_conf 48999974489956787209966799999999999999999987079998198167999866689983999711344123
Q 001544 840 KALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL 919 (1057)
Q Consensus 840 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~ 919 (1057)
.++|+||+++|+|.+++...+. .++..+..++.|++.|+.|+| +.+|+||||||+||+++.++.+||+|||+++.+
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~~-~~e~~~~~~~~Qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~ 179 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRER-FTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 179 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHSC-CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred EEEEEECCCCCHHHHHHHHCCC-CCHHHHHHHHHHHHHHHHHHH---CCCEEECCCCCCCEEECCCCCEEEEECCCHHHH
T ss_conf 0012312341179999873045-437888888999999998851---499896547732012469998887413202220
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCC--CCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHH
Q ss_conf 478986510012235543583445888--889410178799999999609999995445643033443210463578863
Q 001544 920 IGEDQSMTQTQTLATLGYMAPEYGREG--RVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMTLKHWVNDFLPISMMKII 997 (1057)
Q Consensus 920 ~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~DvwslG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 997 (1057)
... .........|++.|+|||.+.+. .++.++||||+||++|||++|+.||......+....... ...
T Consensus 180 ~~~-~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~---------~~~ 249 (322)
T d1vzoa_ 180 VAD-ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR---------RIL 249 (322)
T ss_dssp CGG-GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHH---------HHH
T ss_pred CCC-CCCCCCCCCCCCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHH---------HCC
T ss_conf 344-4432212223333310687605776887132517777999999768999888877779999998---------335
Q ss_pred HCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCC-----CHHHHHHH
Q ss_conf 10011121200587989799999999671437999999-----99999999
Q 001544 998 DANLLITEDKHFAAKEQCASSVFNLAMECTVESPDERI-----TAKEIVRR 1043 (1057)
Q Consensus 998 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-----s~~eil~~ 1043 (1057)
.. ....+..+++++.+++.+||++||++|| |++|+++|
T Consensus 250 ~~--------~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 250 KS--------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp HC--------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred CC--------CCCCCCCCCHHHHHHHHHHCCCCHHHCCCCCCCCHHHHHCC
T ss_conf 68--------99886547999999999974458988199974509999749
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=0 Score=290.75 Aligned_cols=266 Identities=17% Similarity=0.214 Sum_probs=191.2
Q ss_pred CCCCCCCEECCCCCEEEEEEEE-CCCCEEEEEEEECCCHHHHHHHHHHHHHHHHCC-----------CCCCEEEEEEECC
Q ss_conf 7999771545436818999995-699589999950525467999999999998168-----------9772167610016
Q 001544 769 NGFSENNLIGRGSFGSVYIARL-QNGIEVAVKTFDLQHERAFKSFDTECEVMKSIR-----------HRNLTKIISSCSN 836 (1057)
Q Consensus 769 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~~~~~~~~ 836 (1057)
.+|++.++||+|+||+||+|+. .+|+.||||+++... ...+.+.+|+++++.++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCC-CCHHHHHHHHHHHHHHCCHHHHHHHHCCCCCEEEEEEEEEE
T ss_conf 85799899750778189999999999799999983431-33689999999999840145555542276764789987631
Q ss_pred --CCEEEEEEEECCCCCHHH--HHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCC-CCEEECCCCCCCEEECCCC-----
Q ss_conf --882489999744899567--872099667999999999999999999870799-9819816799986668998-----
Q 001544 837 --EDFKALILEYMRNGSLEK--CLYSGNYILDIFQRLNIMIDVASALEYLHFGYS-APVIHCDLKPSNVLLDDNM----- 906 (1057)
Q Consensus 837 --~~~~~lV~e~~~~g~L~~--~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~Dikp~Nill~~~~----- 906 (1057)
....+.++++...+.... .........++..+..++.|++.|++||| + .+|+||||||+|||++.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh---~~~~IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMH---RRCGIIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECSCCSGGGEEEEEEETTTTE
T ss_pred CCCCCEEEEEEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HHCCCCCCCCCHHHEEEECCCCCCCC
T ss_conf 256520234320003542000001223467868999999999999988876---40586465677057056305765644
Q ss_pred -CEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCC-----
Q ss_conf -39997113441234789865100122355435834458888894101787999999996099999954456430-----
Q 001544 907 -VAHLSDFGIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLMETFTRRKPTDEIFSGEMT----- 980 (1057)
Q Consensus 907 -~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~P~~~~~~~~~~----- 980 (1057)
.++++|||.+.... .......|++.|+|||+..+..++.++|+||+||++++|++|+.||.........
T Consensus 169 ~~~kl~dfg~s~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~ 243 (362)
T d1q8ya_ 169 IQIKIADLGNACWYD-----EHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 243 (362)
T ss_dssp EEEEECCCTTCEETT-----BCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred CEEEEEECCCCCCCC-----CCCCCCCCCCCCCCHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCHHHH
T ss_conf 305675314421234-----454223665210571321466777643201237899999878899898755432102689
Q ss_pred HHHHHHH--CCCHHHH-------HHHHCC-----CCC-CC-------CHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHH
Q ss_conf 3344321--0463578-------863100-----111-21-------200587989799999999671437999999999
Q 001544 981 LKHWVND--FLPISMM-------KIIDAN-----LLI-TE-------DKHFAAKEQCASSVFNLAMECTVESPDERITAK 1038 (1057)
Q Consensus 981 ~~~~~~~--~~~~~~~-------~~~~~~-----~~~-~~-------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ 1038 (1057)
....... ..+.... ...+.. ... .. ..........++++.+|+.+|+..||++|||++
T Consensus 244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~ 323 (362)
T d1q8ya_ 244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 323 (362)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred HHHHHHHHCCCCHHHHHCCCCCCCCCCCCHHHHCCCCCCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHH
T ss_conf 99999983799878862453220001320122024323577644421000156743589999999998779945790899
Q ss_pred HHHHH
Q ss_conf 99999
Q 001544 1039 EIVRR 1043 (1057)
Q Consensus 1039 eil~~ 1043 (1057)
|+++|
T Consensus 324 e~L~H 328 (362)
T d1q8ya_ 324 GLVNH 328 (362)
T ss_dssp HHHTC
T ss_pred HHHCC
T ss_conf 99669
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=6.4e-42 Score=246.07 Aligned_cols=253 Identities=34% Similarity=0.552 Sum_probs=124.3
Q ss_pred CCEEECCCCCCCC--CCCCCCCCCCCCCEEECCC-CCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEE
Q ss_conf 6489867872333--2660113745786898138-868988880001644466563335657666884434653435287
Q 001544 440 LEELFMPDCNVSG--RIPKEIGNLANLVTLDLGG-NKFNGSIPIALGKLQKLQLLNLDDNKLEGSIPDDICGLVELYKLA 516 (1057)
Q Consensus 440 L~~L~l~~~~l~~--~~p~~~~~l~~L~~L~L~~-n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 516 (1057)
+++|+++++++.+ .+|..+.++++|+.|+|++ |.+++.+|..|.++++|++|++++|++.+..+..+..+..|+.++
T Consensus 52 v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~ 131 (313)
T d1ogqa_ 52 VNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLD 131 (313)
T ss_dssp EEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEE
T ss_pred EEEEECCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCHHHHCCCC
T ss_conf 88998989988888879847846753352020265433300243114542001102035643443322222011100111
Q ss_pred ECCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CEEEECCCCCCCCCCHHHCCCCCCCEECCCCCCCC
Q ss_conf 06806520378655676336301367764322366542234435-29990366336989021113534461224455011
Q 001544 517 LGDNKLSGQIPACFGNLASLRELWLGPNELISFIPSTFWNIKDI-MYVNFSSNFLTGPLPLEIENLKALTTLDFSMNNLS 595 (1057)
Q Consensus 517 l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L-~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 595 (1057)
+++|++....|..+..++.++.+++++|.+....|..+..+..+ ..++++.|++++..+..+..+. ...++++.|...
T Consensus 132 l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~-~~~l~l~~~~~~ 210 (313)
T d1ogqa_ 132 FSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLE 210 (313)
T ss_dssp CCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEE
T ss_pred CCCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCC
T ss_conf 1224555568512206740000002355335620312144311232310224643533243322222-223333334332
Q ss_pred CCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 22543434753464111112112233584334567666301467611487842224756454212688735476999998
Q 001544 596 GVIPTTIGGLKGLQYLFLGHNRLQGSIPDSVGDLISLKSLNLSNNNLSGPIPTSLEKLSDLKELNLSFNKLEGEIPRGGP 675 (1057)
Q Consensus 596 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~~~p~~~~ 675 (1057)
+.+|..+..++.++.+++++|.+.+.++ .+..+++|+.|++++|++++.+|..+..+++|++|++++|+++|.+|....
T Consensus 211 ~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~ 289 (313)
T d1ogqa_ 211 GDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGN 289 (313)
T ss_dssp ECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTT
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCEECCCCCHHHHCCCCCCEEECCCCCCCCCCCCCCC
T ss_conf 2222222222221112222222222222-222455444444765706660876884799999897958835166898666
Q ss_pred CCCCCCCCCCCCCCCCCCC
Q ss_conf 7546755556775567999
Q 001544 676 FVNFSAKSFMGNNLLCGSP 694 (1057)
Q Consensus 676 ~~~~~~~~~~~n~~~c~~p 694 (1057)
+.++....+.+|+.+||.|
T Consensus 290 L~~L~~l~l~~N~~l~g~p 308 (313)
T d1ogqa_ 290 LQRFDVSAYANNKCLCGSP 308 (313)
T ss_dssp GGGSCGGGTCSSSEEESTT
T ss_pred CCCCCHHHHCCCCCCCCCC
T ss_conf 7998978868895001989
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=100.00 E-value=2.8e-39 Score=231.44 Aligned_cols=80 Identities=33% Similarity=0.552 Sum_probs=33.2
Q ss_pred CCCCCCCEECCCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 13534461224455011225434347534641111121122335843345676663014676114878422247564542
Q 001544 579 ENLKALTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQGSIPDSVGDLISLKSLNLSNNNLSGPIPTSLEKLSDLKE 658 (1057)
Q Consensus 579 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~ 658 (1057)
..+++++.+++++|+++++.+ +..+++|++|++++|+++. ++ .+..+++|+.|++++|++++..| +..+++|+.
T Consensus 304 ~~~~~l~~L~ls~n~l~~l~~--l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~ 377 (384)
T d2omza2 304 SNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQ 377 (384)
T ss_dssp GGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSE
T ss_pred CHHCCCCEEECCCCCCCCCCC--CCCCCCCCEEECCCCCCCC-CH-HHCCCCCCCEEECCCCCCCCCHH--HCCCCCCCE
T ss_conf 000246767777887789845--3668988989898998999-74-67089999989897995899800--003999999
Q ss_pred CCCCCC
Q ss_conf 126887
Q 001544 659 LNLSFN 664 (1057)
Q Consensus 659 l~l~~N 664 (1057)
|++++|
T Consensus 378 L~L~~N 383 (384)
T d2omza2 378 LGLNDQ 383 (384)
T ss_dssp EECCCE
T ss_pred EECCCC
T ss_conf 639789
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=100.00 E-value=3.6e-38 Score=225.24 Aligned_cols=77 Identities=25% Similarity=0.480 Sum_probs=35.4
Q ss_pred CCCCEEEECCCCCCCCCCHHHCCCCCCCEECCCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCCEECC
Q ss_conf 43529990366336989021113534461224455011225434347534641111121122335843345676663014
Q 001544 558 KDIMYVNFSSNFLTGPLPLEIENLKALTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQGSIPDSVGDLISLKSLNL 637 (1057)
Q Consensus 558 ~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l 637 (1057)
+.++.+++++|++++.. .+..+++|+.|++++|+|+++ + .+.++++|++|++++|++++..| +..+++|+.|++
T Consensus 307 ~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~l-~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L 380 (384)
T d2omza2 307 KNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSDV-S-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGL 380 (384)
T ss_dssp TTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCCCC-G-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEEC
T ss_pred CCCCEEECCCCCCCCCC--CCCCCCCCCEEECCCCCCCCC-H-HHCCCCCCCEEECCCCCCCCCHH--HCCCCCCCEEEC
T ss_conf 24676777788778984--536689889898989989997-4-67089999989897995899800--003999999639
Q ss_pred CCC
Q ss_conf 676
Q 001544 638 SNN 640 (1057)
Q Consensus 638 s~N 640 (1057)
++|
T Consensus 381 ~~N 383 (384)
T d2omza2 381 NDQ 383 (384)
T ss_dssp CCE
T ss_pred CCC
T ss_conf 789
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.5e-34 Score=205.09 Aligned_cols=249 Identities=25% Similarity=0.371 Sum_probs=154.2
Q ss_pred CCCCCCCEEEECCCCCCEEEEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCC
Q ss_conf 99865410384179983147753114675556643469887868847888755667813236443433321253234878
Q 001544 56 TMVCNWTGVTCDINQRRVTALNISYLSLTGNIPRQLGNLSSLEILDLNFNRLSGEIPWELGNLAKLEKLLLHNNFLTGTI 135 (1057)
Q Consensus 56 ~~~c~w~gv~c~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~ 135 (1057)
.+.|.|.+|.|+. .+++ .+|+.+. +++++|+|++|+|+...+..|.++++|++|++++|.++...
T Consensus 7 ~c~c~~~~~~C~~------------~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~ 71 (305)
T d1xkua_ 7 RCQCHLRVVQCSD------------LGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKIS 71 (305)
T ss_dssp TCEEETTEEECTT------------SCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBC
T ss_pred CCEECCCEEEECC------------CCCC-CCCCCCC--CCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCC
T ss_conf 8895599998559------------9988-5198889--99798978499189869657604656523112344344523
Q ss_pred CCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCEEEEECCCCCCCCCCCCCCC
Q ss_conf 90000349989386468979899786646688788626725884656685222113467756853367732269432277
Q 001544 136 PFSIFKLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQLSGSIPSFIFKISSLQALHFGNNRLSGELPANICDN 215 (1057)
Q Consensus 136 p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~ 215 (1057)
|..|..+++|+.|++++|+++ .+|.. ..+.++.|+++.|.+.+..+..+.....+..+....|.....
T Consensus 72 ~~~f~~l~~L~~L~l~~n~l~-~l~~~---~~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~-------- 139 (305)
T d1xkua_ 72 PGAFAPLVKLERLYLSKNQLK-ELPEK---MPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSS-------- 139 (305)
T ss_dssp TTTTTTCTTCCEEECCSSCCS-BCCSS---CCTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGG--------
T ss_pred HHHHHCCCCCCEECCCCCCCC-CCCCC---HHHHHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCC--------
T ss_conf 566527985578315687567-67640---011132321024610234444540133110000123333346--------
Q ss_pred CCCCCEEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEE
Q ss_conf 89632898304412347431123888775898558877689440013747874896221332454483334666422999
Q 001544 216 LPFLNFFSVYKNMFYGGISSTLSNCKHLRILDLSFNDLWGDIPKEIGNLTKLKELFLDFNILQGEIPHTVGNLHNLEYLS 295 (1057)
Q Consensus 216 l~~L~~L~l~~n~~~~~~~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~ 295 (1057)
......+..++.|+.+++++|.+.. ++..+ .++|+.|++++|.++...+..|.+++.++.|+
T Consensus 140 ---------------~~~~~~~~~l~~L~~l~l~~n~l~~-l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~ 201 (305)
T d1xkua_ 140 ---------------GIENGAFQGMKKLSYIRIADTNITT-IPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLG 201 (305)
T ss_dssp ---------------GBCTTGGGGCTTCCEEECCSSCCCS-CCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEE
T ss_pred ---------------CCCCCCCCCCCCCCCCCCCCCCCCC-CCCCC--CCCCCEEECCCCCCCCCCHHHHHCCCCCCCCC
T ss_conf ---------------7776422345656712034677451-67101--77667898978867788826764134133015
Q ss_pred EECCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCC
Q ss_conf 56472444458642245421099802873346899774567998754872186333
Q 001544 296 LVNNELVGTVPATIFNVSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFS 351 (1057)
Q Consensus 296 L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~ 351 (1057)
+++|.+.+..+..+.++++|+.|+|++|.++ .+|..+ ..+++|+.|+|++|+++
T Consensus 202 ~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l-~~l~~L~~L~Ls~N~i~ 255 (305)
T d1xkua_ 202 LSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGL-ADHKYIQVVYLHNNNIS 255 (305)
T ss_dssp CCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTT-TTCSSCCEEECCSSCCC
T ss_pred CCCCCCCCCCCCCCCCCCCCEEEECCCCCCC-CCCCCC-CCCCCCCEEECCCCCCC
T ss_conf 4455332223454334433224302554002-463110-33467898989898657
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-36 Score=212.74 Aligned_cols=233 Identities=24% Similarity=0.278 Sum_probs=132.9
Q ss_pred EEEECCCCCCEEEEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCC
Q ss_conf 03841799831477531146755566434698878688478887556678132364434333212532348789000034
Q 001544 63 GVTCDINQRRVTALNISYLSLTGNIPRQLGNLSSLEILDLNFNRLSGEIPWELGNLAKLEKLLLHNNFLTGTIPFSIFKL 142 (1057)
Q Consensus 63 gv~c~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l 142 (1057)
+..|.... -..++.++.+++ .+|..+. +++++|+|++|+|+...+..|.++++|++|++++|.+....+..+..+
T Consensus 5 ~C~C~~~~--~~~v~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~ 79 (284)
T d1ozna_ 5 ACVCYNEP--KVTTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGL 79 (284)
T ss_dssp TCEEECSS--SCEEECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTC
T ss_pred CCEECCCC--CEEEECCCCCCC-CCCCCCC--CCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 88986999--969984799989-4497889--998889774881798797786414213000013445433211121222
Q ss_pred CCCCEEECCCC-CCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCEEEEECCCCCCCCCCCCCCCCCCCCE
Q ss_conf 99893864689-79899786646688788626725884656685222113467756853367732269432277896328
Q 001544 143 SSLLDLKLSDN-NLTGTIPSHNLGNLSSLQLLDLSDNQLSGSIPSFIFKISSLQALHFGNNRLSGELPANICDNLPFLNF 221 (1057)
Q Consensus 143 ~~L~~L~L~~n-~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~ 221 (1057)
..+..++...+ .++ .++...++++++|++|++++|.+....+..+....+|+.+++++|+++ .+|..
T Consensus 80 ~~~~~l~~~~~~~~~-~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~-~i~~~---------- 147 (284)
T d1ozna_ 80 ALLEQLDLSDNAQLR-SVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ-ALPDD---------- 147 (284)
T ss_dssp TTCCEEECCSCTTCC-CCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTT----------
T ss_pred CCCCCCCCCCCCCCC-CCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCHHCCCCHHHHCCCCCC-CCCHH----------
T ss_conf 222222222102235-446201010102778756885443201353320001211020014314-45805----------
Q ss_pred EEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEEEECCCC
Q ss_conf 98304412347431123888775898558877689440013747874896221332454483334666422999564724
Q 001544 222 FSVYKNMFYGGISSTLSNCKHLRILDLSFNDLWGDIPKEIGNLTKLKELFLDFNILQGEIPHTVGNLHNLEYLSLVNNEL 301 (1057)
Q Consensus 222 L~l~~n~~~~~~~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l 301 (1057)
.|+.++.|+.|++++|.++...+..|.++++|+++++++|.+++..|..|.++++|++|++++|++
T Consensus 148 --------------~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i 213 (284)
T d1ozna_ 148 --------------TFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNL 213 (284)
T ss_dssp --------------TTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred --------------HHCCCCCHHHCCCCCCCCCCCCHHHHCCCCCCCHHHHHHCCCCCCCHHHHHHHHHCCCCCCCCCCC
T ss_conf --------------740434050223141765662566654656341314211434662816766532000233333522
Q ss_pred CCCCCCCCCCCCCCCEEEECCCCCC
Q ss_conf 4445864224542109980287334
Q 001544 302 VGTVPATIFNVSTLKLIELSNNTFF 326 (1057)
Q Consensus 302 ~~~~~~~l~~l~~L~~L~L~~n~l~ 326 (1057)
.+..+..|..+++|+.|++++|.+.
T Consensus 214 ~~~~~~~~~~~~~L~~L~l~~N~l~ 238 (284)
T d1ozna_ 214 SALPTEALAPLRALQYLRLNDNPWV 238 (284)
T ss_dssp SCCCHHHHTTCTTCCEEECCSSCEE
T ss_pred CCCCCCCCCCCCCCCEEEECCCCCC
T ss_conf 1000002355465688981199887
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.3e-33 Score=198.59 Aligned_cols=57 Identities=28% Similarity=0.269 Sum_probs=18.3
Q ss_pred CCEEEEECCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEEECCC
Q ss_conf 748962213324544833346664229995647244445864224542109980287
Q 001544 267 LKELFLDFNILQGEIPHTVGNLHNLEYLSLVNNELVGTVPATIFNVSTLKLIELSNN 323 (1057)
Q Consensus 267 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n 323 (1057)
+++|++++|+|+...+.+|.++++|++|++++|++....+..|.+++.|+.|++++|
T Consensus 33 l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n 89 (305)
T d1xkua_ 33 TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKN 89 (305)
T ss_dssp CCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSS
T ss_pred CCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCEECCCCC
T ss_conf 798978499189869657604656523112344344523566527985578315687
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-34 Score=203.04 Aligned_cols=210 Identities=27% Similarity=0.299 Sum_probs=125.5
Q ss_pred CCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEEC-CEEEEECCCCCCCCCCCCCCCCC
Q ss_conf 78689813886898888000164446656333565766688443465343528706-80652037865567633630136
Q 001544 463 NLVTLDLGGNKFNGSIPIALGKLQKLQLLNLDDNKLEGSIPDDICGLVELYKLALG-DNKLSGQIPACFGNLASLRELWL 541 (1057)
Q Consensus 463 ~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~-~N~l~~~~~~~~~~l~~L~~L~L 541 (1057)
+++.|+|++|+|+...+.+|.++++|+.|++++|++..+.+..+.+...+..+... .|.+....+..|.++++|+.|++
T Consensus 33 ~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~l 112 (284)
T d1ozna_ 33 ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHL 112 (284)
T ss_dssp TCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHCCCCCCCEEEC
T ss_conf 98889774881798797786414213000013445433211121222222222222102235446201010102778756
Q ss_pred CCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCHHHCCCCCCCEECCCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCC
Q ss_conf 77643223665422344352999036633698902111353446122445501122543434753464111112112233
Q 001544 542 GPNELISFIPSTFWNIKDIMYVNFSSNFLTGPLPLEIENLKALTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQGS 621 (1057)
Q Consensus 542 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 621 (1057)
++|.+..+.+..+.....|+.+++++|.++++.+..|..+++|+.|++++|.++.+.+..|.++++|+.+++++|++++.
T Consensus 113 ~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i 192 (284)
T d1ozna_ 113 DRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHV 192 (284)
T ss_dssp TTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEE
T ss_pred CCCCCCCCCCCCCCHHCCCCHHHHCCCCCCCCCHHHHCCCCCHHHCCCCCCCCCCCCHHHHCCCCCCCHHHHHHCCCCCC
T ss_conf 88544320135332000121102001431445805740434050223141765662566654656341314211434662
Q ss_pred CCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 584334567666301467611487842224756454212688735476999
Q 001544 622 IPDSVGDLISLKSLNLSNNNLSGPIPTSLEKLSDLKELNLSFNKLEGEIPR 672 (1057)
Q Consensus 622 ~~~~~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~~~p~ 672 (1057)
.|..|..+++|+.|++++|++++..+..+..+++|+++++++|+|.|.++.
T Consensus 193 ~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~~ 243 (284)
T d1ozna_ 193 HPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA 243 (284)
T ss_dssp CTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGG
T ss_pred CHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCC
T ss_conf 816766532000233333522100000235546568898119988787564
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.5e-31 Score=187.27 Aligned_cols=87 Identities=25% Similarity=0.174 Sum_probs=30.9
Q ss_pred CCCCCEECCCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 53446122445501122543434753464111112112233584334567666301467611487842224756454212
Q 001544 581 LKALTTLDFSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQGSIPDSVGDLISLKSLNLSNNNLSGPIPTSLEKLSDLKELN 660 (1057)
Q Consensus 581 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~l~ 660 (1057)
+.+++.|++++|.++.+.+..+..++.++.+++++|++++..+..|..+++|+.|+|++|+|+ .+|..+..+++|+.|+
T Consensus 123 l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~ 201 (266)
T d1p9ag_ 123 LGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAF 201 (266)
T ss_dssp CTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEE
T ss_pred CCCCCCCCCCCCCCCEECCCCCCCCCCCHHCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCC-CCCHHHCCCCCCCEEE
T ss_conf 211112212434210221233322111000000015652237200134212423430139785-5686677788899998
Q ss_pred CCCCCCCC
Q ss_conf 68873547
Q 001544 661 LSFNKLEG 668 (1057)
Q Consensus 661 l~~N~l~~ 668 (1057)
+++|+|.|
T Consensus 202 L~~Np~~C 209 (266)
T d1p9ag_ 202 LHGNPWLC 209 (266)
T ss_dssp CCSCCBCC
T ss_pred ECCCCCCC
T ss_conf 36999878
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=5.1e-30 Score=180.01 Aligned_cols=125 Identities=29% Similarity=0.247 Sum_probs=58.6
Q ss_pred EEEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCC
Q ss_conf 47753114675556643469887868847888755667813236443433321253234878900003499893864689
Q 001544 74 TALNISYLSLTGNIPRQLGNLSSLEILDLNFNRLSGEIPWELGNLAKLEKLLLHNNFLTGTIPFSIFKLSSLLDLKLSDN 153 (1057)
Q Consensus 74 ~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n 153 (1057)
..++.++.+++ .+|+.+. +++++|+|++|.|++..+..|.++++|++|+|++|+++. ++ .++.+++|++|+|++|
T Consensus 13 ~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~Ls~N 87 (266)
T d1p9ag_ 13 LEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQ-VDGTLPVLGTLDLSHN 87 (266)
T ss_dssp CEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE-EE-CCSCCTTCCEEECCSS
T ss_pred EEEECCCCCCC-EECCCCC--CCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCC-CC-CCCCCCCCCCCCCCCC
T ss_conf 69980699988-6196757--688989884992898597786345655221356654444-31-1111223211111222
Q ss_pred CCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCEEEEECCCCC
Q ss_conf 7989978664668878862672588465668522211346775685336773
Q 001544 154 NLTGTIPSHNLGNLSSLQLLDLSDNQLSGSIPSFIFKISSLQALHFGNNRLS 205 (1057)
Q Consensus 154 ~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~ 205 (1057)
++++ ++. .+.++++|++|++++|.+....+..+..+.+++.|++++|.++
T Consensus 88 ~l~~-~~~-~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~ 137 (266)
T d1p9ag_ 88 QLQS-LPL-LGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELK 137 (266)
T ss_dssp CCSS-CCC-CTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCC
T ss_pred CCCC-CCC-CCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCC
T ss_conf 2211-111-2122222222222223110110011222211112212434210
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.96 E-value=4e-26 Score=158.39 Aligned_cols=33 Identities=36% Similarity=0.549 Sum_probs=12.4
Q ss_pred CCEEECCCCCCCCCCCHHHHCCCCCCEEEEECCCC
Q ss_conf 86267258846566852221134677568533677
Q 001544 170 LQLLDLSDNQLSGSIPSFIFKISSLQALHFGNNRL 204 (1057)
Q Consensus 170 L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l 204 (1057)
|++|++++|.+.. +|. ++.+++|++|++++|.+
T Consensus 100 L~~L~L~~n~l~~-lp~-~~~l~~L~~L~l~~~~~ 132 (353)
T d1jl5a_ 100 LEYLGVSNNQLEK-LPE-LQNSSFLKIIDVDNNSL 132 (353)
T ss_dssp CCEEECCSSCCSS-CCC-CTTCTTCCEEECCSSCC
T ss_pred CCCCCCCCCCCCC-CCC-HHHHCCCEEECCCCCCC
T ss_conf 1111334554322-210-01101312311356510
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.96 E-value=1.6e-25 Score=155.06 Aligned_cols=95 Identities=32% Similarity=0.430 Sum_probs=42.5
Q ss_pred CEEEEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECC
Q ss_conf 31477531146755566434698878688478887556678132364434333212532348789000034998938646
Q 001544 72 RVTALNISYLSLTGNIPRQLGNLSSLEILDLNFNRLSGEIPWELGNLAKLEKLLLHNNFLTGTIPFSIFKLSSLLDLKLS 151 (1057)
Q Consensus 72 ~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~ 151 (1057)
+++.|||++++++ .+|+. .++|++|++++|+|+ .+|..+ .+|+.|++++|+++ .++.- .+.|++|+++
T Consensus 39 ~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L~ 106 (353)
T d1jl5a_ 39 QAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSDL---PPLLEYLGVS 106 (353)
T ss_dssp TCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCSC---CTTCCEEECC
T ss_pred CCCEEEECCCCCC-CCCCC---CCCCCEEECCCCCCC-CCCCCH---HHHHHHHHHHCCCC-HHHHH---CCCCCCCCCC
T ss_conf 9989993799988-78898---789888989999796-336203---32033266551432-03210---2211111334
Q ss_pred CCCCCCCCCCCCCCCCCCCCEEECCCCCCC
Q ss_conf 897989978664668878862672588465
Q 001544 152 DNNLTGTIPSHNLGNLSSLQLLDLSDNQLS 181 (1057)
Q Consensus 152 ~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~ 181 (1057)
+|.+. .+|. ++.+++|+.|++++|.+.
T Consensus 107 ~n~l~-~lp~--~~~l~~L~~L~l~~~~~~ 133 (353)
T d1jl5a_ 107 NNQLE-KLPE--LQNSSFLKIIDVDNNSLK 133 (353)
T ss_dssp SSCCS-SCCC--CTTCTTCCEEECCSSCCS
T ss_pred CCCCC-CCCC--HHHHCCCEEECCCCCCCC
T ss_conf 55432-2210--011013123113565100
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=3e-32 Score=192.35 Aligned_cols=14 Identities=29% Similarity=0.142 Sum_probs=6.6
Q ss_pred CCCEECCCCCCCCC
Q ss_conf 66630146761148
Q 001544 631 SLKSLNLSNNNLSG 644 (1057)
Q Consensus 631 ~L~~L~ls~N~l~~ 644 (1057)
.|+.|++++|.+..
T Consensus 427 ~L~~l~l~~~~~~~ 440 (460)
T d1z7xw1 427 LLEQLVLYDIYWSE 440 (460)
T ss_dssp CCCEEECTTCCCCH
T ss_pred CCCEEECCCCCCCH
T ss_conf 66789898987898
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.95 E-value=2.9e-28 Score=170.26 Aligned_cols=170 Identities=16% Similarity=0.174 Sum_probs=120.5
Q ss_pred CCCCEECCCCCEEEEEEEECCCCEEEEEEEECCC------------------HHHHHHHHHHHHHHHHCCCCCCEEEEEE
Q ss_conf 9771545436818999995699589999950525------------------4679999999999981689772167610
Q 001544 772 SENNLIGRGSFGSVYIARLQNGIEVAVKTFDLQH------------------ERAFKSFDTECEVMKSIRHRNLTKIISS 833 (1057)
Q Consensus 772 ~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~------------------~~~~~~~~~e~~~l~~l~h~niv~~~~~ 833 (1057)
.+.++||+|+||+||+|...+|+.||||+++... .........|...+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred HHCCEEEECCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEE
T ss_conf 22778024856599999979999999999860443466655656300088899999977899999998169991449986
Q ss_pred ECCCCEEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECC
Q ss_conf 01688248999974489956787209966799999999999999999987079998198167999866689983999711
Q 001544 834 CSNEDFKALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHFGYSAPVIHCDLKPSNVLLDDNMVAHLSDF 913 (1057)
Q Consensus 834 ~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~Nill~~~~~~kl~Df 913 (1057)
.. .+++|||+++..+.+ ++......++.|++.+++||| +++|+||||||+|||++++ .++++||
T Consensus 83 ~~----~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH---~~giiHrDiKP~NILv~~~-~~~liDF 146 (191)
T d1zara2 83 EG----NAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVSEE-GIWIIDF 146 (191)
T ss_dssp ET----TEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEETT-EEEECCC
T ss_pred CC----CEEEEEEECCCCCCC--------HHHHHHHHHHHHHHHHHHHHH---HCCEEECCCCHHHEEEECC-CEEEEEC
T ss_conf 28----889999504565420--------015789999999999999982---6888983689036114289-8999877
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHH
Q ss_conf 3441234789865100122355435834458888894101787999999
Q 001544 914 GIAKLLIGEDQSMTQTQTLATLGYMAPEYGREGRVSTKGDVYSFGILLM 962 (1057)
Q Consensus 914 g~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ 962 (1057)
|.|+................ . -.+. ....++.++|+||..--+.
T Consensus 147 G~a~~~~~~~~~~~l~rd~~---~-~~~~-f~r~y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 147 PQSVEVGEEGWREILERDVR---N-IITY-FSRTYRTEKDINSAIDRIL 190 (191)
T ss_dssp TTCEETTSTTHHHHHHHHHH---H-HHHH-HHHHHCCCCCHHHHHHHHH
T ss_pred CCCCCCCCCCCHHHHHHHHH---H-HHHH-HCCCCCCCCCHHHHHHHHH
T ss_conf 88430899870999987799---9-9999-7578998446899999874
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=1e-31 Score=189.38 Aligned_cols=36 Identities=25% Similarity=0.206 Sum_probs=13.2
Q ss_pred CCEEECCCCCCCCC-CCCCCCCCCCCCEEECCCCCCC
Q ss_conf 86884788875566-7813236443433321253234
Q 001544 97 LEILDLNFNRLSGE-IPWELGNLAKLEKLLLHNNFLT 132 (1057)
Q Consensus 97 L~~L~L~~n~l~~~-~~~~l~~l~~L~~L~L~~n~l~ 132 (1057)
|+.||++.|++++. +..-+..+++++.|+|++|.++
T Consensus 4 l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~ 40 (460)
T d1z7xw1 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLT 40 (460)
T ss_dssp EEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCC
T ss_pred CCEEEEECCCCCHHHHHHHHHHCCCCCEEEECCCCCC
T ss_conf 7779820895886899999976779999982899998
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=3.1e-25 Score=153.44 Aligned_cols=102 Identities=23% Similarity=0.266 Sum_probs=43.2
Q ss_pred EEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCC-CCCCCCCCCCCEEECCC-C
Q ss_conf 753114675556643469887868847888755667813236443433321253234878-90000349989386468-9
Q 001544 76 LNISYLSLTGNIPRQLGNLSSLEILDLNFNRLSGEIPWELGNLAKLEKLLLHNNFLTGTI-PFSIFKLSSLLDLKLSD-N 153 (1057)
Q Consensus 76 l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~-p~~l~~l~~L~~L~L~~-n 153 (1057)
++.++.+++ .+|..+. +++++|++++|.++...+..|.++++|++|++++|.+...+ +..|..+..++++.+.. |
T Consensus 13 i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n 89 (242)
T d1xwdc1 13 FLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKAN 89 (242)
T ss_dssp EEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCT
T ss_pred EEEECCCCC-CCCCCCC--CCCCEEECCCCCCCCCCHHHHHCCCHHHHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCC
T ss_conf 998189988-7688889--9889998769918964966861464323211022112420100112222222221111123
Q ss_pred CCCCCCCCCCCCCCCCCCEEECCCCCCC
Q ss_conf 7989978664668878862672588465
Q 001544 154 NLTGTIPSHNLGNLSSLQLLDLSDNQLS 181 (1057)
Q Consensus 154 ~l~~~~~~~~~~~l~~L~~L~L~~n~l~ 181 (1057)
.+. .++...+.++++|++|++++|.+.
T Consensus 90 ~l~-~~~~~~~~~l~~L~~l~l~~~~l~ 116 (242)
T d1xwdc1 90 NLL-YINPEAFQNLPNLQYLLISNTGIK 116 (242)
T ss_dssp TCC-EECTTSEECCTTCCEEEEESCCCC
T ss_pred CCC-CCCCCCCCCCCCCCCCCCCHHHHC
T ss_conf 432-222221222222222234211112
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.91 E-value=9.4e-24 Score=145.21 Aligned_cols=209 Identities=28% Similarity=0.412 Sum_probs=0.0
Q ss_pred CCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCEE
Q ss_conf 44343332125323487890000349989386468979899786646688788626725884656685222113467756
Q 001544 118 LAKLEKLLLHNNFLTGTIPFSIFKLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQLSGSIPSFIFKISSLQAL 197 (1057)
Q Consensus 118 l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L 197 (1057)
+.++..++++.+++++.+ .++.+.+|+.|++.+|.++ .++. +..+++|++|++++|.+.+..+ +..+++++.+
T Consensus 18 l~~~~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~-~l~~--l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l 90 (227)
T d1h6ua2 18 LANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVT-TIEG--VQYLNNLIGLELKDNQITDLAP--LKNLTKITEL 90 (227)
T ss_dssp HHHHHHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCC-CCTT--GGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEE
T ss_pred HHHHHHHHHCCCCCCCCC--CHHHCCCCCEEECCCCCCC-CCHH--HHCCCCCCEEECCCCEEECCCC--CCCCCCCCCC
T ss_conf 999999984888767757--9878488689977799997-6645--7448888376357853202543--1123343201
Q ss_pred EEECCCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEEECCCC
Q ss_conf 85336773226943227789632898304412347431123888775898558877689440013747874896221332
Q 001544 198 HFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGGISSTLSNCKHLRILDLSFNDLWGDIPKEIGNLTKLKELFLDFNIL 277 (1057)
Q Consensus 198 ~L~~N~l~~~~p~~~~~~l~~L~~L~l~~n~~~~~~~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~L~~n~l 277 (1057)
++++|.++ ....++.++.|+.++++++...+. ..+...+.+..+.++.+.+
T Consensus 91 ~~~~n~~~---------------------------~i~~l~~l~~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~ 141 (227)
T d1h6ua2 91 ELSGNPLK---------------------------NVSAIAGLQSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQI 141 (227)
T ss_dssp ECCSCCCS---------------------------CCGGGTTCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECCSSCC
T ss_pred CCCCCCCC---------------------------CCCCCCCCCCCCCCCCCCCCCCCC--CHHCCCCCHHHHHCHHHHH
T ss_conf 21112222---------------------------222222222221221222443311--0000023012220000000
Q ss_pred CCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCC
Q ss_conf 45448333466642299956472444458642245421099802873346899774567998754872186333447852
Q 001544 278 QGEIPHTVGNLHNLEYLSLVNNELVGTVPATIFNVSTLKLIELSNNTFFGSLPSSTDVQLPNLEELYLWGNNFSGTLPSF 357 (1057)
Q Consensus 278 ~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 357 (1057)
....+ +.+.++|+.|++++|.+.+..+ +.++++|+.|++++|.+. .++. +..+++|++|++++|++++..+
T Consensus 142 ~~~~~--~~~~~~L~~L~l~~n~~~~~~~--l~~l~~L~~L~Ls~n~l~-~l~~--l~~l~~L~~L~Ls~N~lt~i~~-- 212 (227)
T d1h6ua2 142 TNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKIS-DISP--LASLPNLIEVHLKNNQISDVSP-- 212 (227)
T ss_dssp CCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC-CCGG--GGGCTTCCEEECTTSCCCBCGG--
T ss_pred CHHHH--HCCCCCCCCCCCCCCCCCCCHH--HCCCCCCEECCCCCCCCC-CCHH--HCCCCCCCEEECCCCCCCCCCC--
T ss_conf 00000--0102111002333333331001--056463356445888417-7853--4479999989795996899802--
Q ss_pred CCCCCCCCCCCCCC
Q ss_conf 23344454001335
Q 001544 358 IFNASNLSKLSLGD 371 (1057)
Q Consensus 358 l~~l~~L~~L~Ls~ 371 (1057)
+..+++|+.|++++
T Consensus 213 l~~l~~L~~L~lsn 226 (227)
T d1h6ua2 213 LANTSNLFIVTLTN 226 (227)
T ss_dssp GTTCTTCCEEEEEE
T ss_pred CCCCCCCCEEEEEC
T ss_conf 03699989897129
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.89 E-value=5.4e-23 Score=140.99 Aligned_cols=183 Identities=22% Similarity=0.205 Sum_probs=0.0
Q ss_pred CCCEEEECCEEEEECCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCEEEECCCCCCCCCCHHHCCCCCCCEECC
Q ss_conf 43528706806520378655676336301367764322-36654223443529990366336989021113534461224
Q 001544 511 ELYKLALGDNKLSGQIPACFGNLASLRELWLGPNELIS-FIPSTFWNIKDIMYVNFSSNFLTGPLPLEIENLKALTTLDF 589 (1057)
Q Consensus 511 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L 589 (1057)
..+.++.+++++..++.+.+ +++++|+|++|+++. +.+..|.++++|+.|++++|.++...+..|..+++|+.|+|
T Consensus 9 ~~~~v~Cs~~~L~~iP~~lp---~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~L 85 (192)
T d1w8aa_ 9 EGTTVDCTGRGLKEIPRDIP---LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQL 85 (192)
T ss_dssp ETTEEECTTSCCSSCCSCCC---TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEEC
T ss_pred CCCEEEEECCCCCCCCCCCC---CCCCEEEECCCCCCCCCCCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCEEEE
T ss_conf 69999970899670298989---787889848987755302002578762721301363221212122211222210100
Q ss_pred CCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 45501122543434753464111112112233584334567666301467611487842224756454212688735476
Q 001544 590 SMNNLSGVIPTTIGGLKGLQYLFLGHNRLQGSIPDSVGDLISLKSLNLSNNNLSGPIPTSLEKLSDLKELNLSFNKLEGE 669 (1057)
Q Consensus 590 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~~ 669 (1057)
++|+|+.+.+..|.++++|++|+|++|+|+++.+..|..+++|+.|++++|.+. .......-...++.+.++.|.++|.
T Consensus 86 s~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~-~~~~~~~~~~~l~~~~l~~~~~~c~ 164 (192)
T d1w8aa_ 86 GENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFN-CNCHLAWFAEWLRKKSLNGGAARCG 164 (192)
T ss_dssp CSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBC-CSGGGHHHHHHHHHHCCSGGGCBBC
T ss_pred CCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCC-CCCCHHHHHHHHHHHCCCCCCEEEC
T ss_conf 355344349799807974655245774535359778568753342000364434-3530277764235403568982768
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 99999875467555567755679999899998
Q 001544 670 IPRGGPFVNFSAKSFMGNNLLCGSPNLQVPPC 701 (1057)
Q Consensus 670 ~p~~~~~~~~~~~~~~~n~~~c~~p~~~~~~c 701 (1057)
.|. .+..........|...|.++... -|
T Consensus 165 ~p~--~l~~~~l~~L~~n~l~C~~~~~~--g~ 192 (192)
T d1w8aa_ 165 APS--KVRDVQIKDLPHSEFKCSSENSE--GC 192 (192)
T ss_dssp SST--TTTTSBGGGSCTTTCCCCCC-----CC
T ss_pred CCH--HHCCCEEEECCHHHCCCCCCCCC--CC
T ss_conf 984--33698861448755758998888--89
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.88 E-value=4.4e-22 Score=135.91 Aligned_cols=180 Identities=24% Similarity=0.342 Sum_probs=0.0
Q ss_pred ECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCC
Q ss_conf 47888755667813236443433321253234878900003499893864689798997866466887886267258846
Q 001544 101 DLNFNRLSGEIPWELGNLAKLEKLLLHNNFLTGTIPFSIFKLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQL 180 (1057)
Q Consensus 101 ~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l 180 (1057)
++..+.+++.++. ..+..|++|++++|.++...+ +..+++|++|++++|+++ .++. ++.+++|++|++++|++
T Consensus 30 ~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~l~~--l~~l~~L~~L~L~~n~i~-~l~~--~~~l~~L~~L~l~~n~i 102 (210)
T d1h6ta2 30 NLKKKSVTDAVTQ--NELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNKLT-DIKP--LANLKNLGWLFLDENKV 102 (210)
T ss_dssp HTTCSCTTSEECH--HHHHTCCEEECTTSCCCCCTT--GGGCTTCCEEECCSSCCC-CCGG--GTTCTTCCEEECCSSCC
T ss_pred HHCCCCCCCCCCH--HHHCCCCEEECCCCCCCCCHH--HHHCCCCCEEECCCCCCC-CCCC--CCCCCCCCCCCCCCCCC
T ss_conf 8575765775188--795484589782798887444--764899898769896025-8601--13586212014333332
Q ss_pred CCCCCHHHHCCCCCCEEEEECCCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCC
Q ss_conf 56685222113467756853367732269432277896328983044123474311238887758985588776894400
Q 001544 181 SGSIPSFIFKISSLQALHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGGISSTLSNCKHLRILDLSFNDLWGDIPKE 260 (1057)
Q Consensus 181 ~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~l~~L~~L~l~~n~~~~~~~~~l~~~~~L~~L~Ls~n~l~~~~~~~ 260 (1057)
+ .++ .+..+++|+.|++++|.+. ....+..++.++.+++++|.+++. ..
T Consensus 103 ~-~l~-~l~~l~~L~~L~l~~~~~~---------------------------~~~~l~~l~~l~~l~~~~n~l~~~--~~ 151 (210)
T d1h6ta2 103 K-DLS-SLKDLKKLKSLSLEHNGIS---------------------------DINGLVHLPQLESLYLGNNKITDI--TV 151 (210)
T ss_dssp C-CGG-GGTTCTTCCEEECTTSCCC---------------------------CCGGGGGCTTCCEEECCSSCCCCC--GG
T ss_pred C-CCC-CCCCCCCCCCCCCCCCCCC---------------------------CCCCCCCCCCCCCCCCCCCCCCCC--CC
T ss_conf 1-222-1212221112234565322---------------------------112201111122211222333454--31
Q ss_pred CCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEEECC
Q ss_conf 13747874896221332454483334666422999564724444586422454210998028
Q 001544 261 IGNLTKLKELFLDFNILQGEIPHTVGNLHNLEYLSLVNNELVGTVPATIFNVSTLKLIELSN 322 (1057)
Q Consensus 261 l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~ 322 (1057)
+..+++|+++++++|.+++..+ ++++++|+.|++++|+++ .++ .+.++++|++|+|++
T Consensus 152 ~~~l~~L~~l~l~~n~l~~i~~--l~~l~~L~~L~Ls~N~i~-~l~-~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 152 LSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHIS-DLR-ALAGLKNLDVLELFS 209 (210)
T ss_dssp GGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC-BCG-GGTTCTTCSEEEEEE
T ss_pred CCCCCCCCCCCCCCCCCCCCCC--CCCCCCCCEEECCCCCCC-CCH-HHCCCCCCCEEECCC
T ss_conf 0001332100134643025645--367898999989799899-872-116999989997118
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.87 E-value=7.5e-22 Score=134.65 Aligned_cols=184 Identities=23% Similarity=0.342 Sum_probs=0.0
Q ss_pred CCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCE
Q ss_conf 64434333212532348789000034998938646897989978664668878862672588465668522211346775
Q 001544 117 NLAKLEKLLLHNNFLTGTIPFSIFKLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQLSGSIPSFIFKISSLQA 196 (1057)
Q Consensus 117 ~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~ 196 (1057)
++.++..+.++.+.+++.++.. .+.+++.|++++|.++ .++. +..+++|++|++++|++++..+ ++++++|++
T Consensus 16 ~l~~~i~~~l~~~~~~~~~~~~--~l~~l~~L~l~~~~i~-~l~~--l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~ 88 (199)
T d2omxa2 16 ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK-SIDG--VEYLNNLTQINFSNNQLTDITP--LKNLTKLVD 88 (199)
T ss_dssp HHHHHHHHHTTCSSTTSEECHH--HHTTCCEEECTTSCCC-CCTT--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCE
T ss_pred HHHHHHHHHHCCCCCCCCCCHH--HHCCCCEEECCCCCCC-CCCC--CCCCCCCCCCCCCCCCCCCCCC--CCCCCCCCC
T ss_conf 9999999996778778855987--9468789989999997-7520--2137886757545655667640--167752231
Q ss_pred EEEECCCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEEECCC
Q ss_conf 68533677322694322778963289830441234743112388877589855887768944001374787489622133
Q 001544 197 LHFGNNRLSGELPANICDNLPFLNFFSVYKNMFYGGISSTLSNCKHLRILDLSFNDLWGDIPKEIGNLTKLKELFLDFNI 276 (1057)
Q Consensus 197 L~L~~N~l~~~~p~~~~~~l~~L~~L~l~~n~~~~~~~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~L~~n~ 276 (1057)
|++++|.+. .++. +.+++.|+.+++..+......+ +..+++|+.|++++|.+... ..+..+++|++|++++|.
T Consensus 89 L~l~~n~~~-~~~~--l~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~~~~L~~L~l~~n~ 161 (199)
T d2omxa2 89 ILMNNNQIA-DITP--LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDI--SALSGLTSLQQLNFSSNQ 161 (199)
T ss_dssp EECCSSCCC-CCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSC
T ss_pred CCCCCCCCC-CCCC--CCCCCCCCCCCCCCCCCCCCCC--CCHHHHHHHHHHHHHHHCCC--CCCCCCCCCCCCCCCCCC
T ss_conf 111222222-2211--1112232221112222223210--00122367764311110023--433321111112234555
Q ss_pred CCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEE
Q ss_conf 245448333466642299956472444458642245421099
Q 001544 277 LQGEIPHTVGNLHNLEYLSLVNNELVGTVPATIFNVSTLKLI 318 (1057)
Q Consensus 277 l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L 318 (1057)
+++..+ ++++++|++|++++|++++ ...+..+++|+.|
T Consensus 162 l~~l~~--l~~l~~L~~L~ls~N~i~~--i~~l~~L~~L~~L 199 (199)
T d2omxa2 162 VTDLKP--LANLTTLERLDISSNKVSD--ISVLAKLTNLESL 199 (199)
T ss_dssp CCCCGG--GTTCTTCCEEECCSSCCCC--CGGGGGCTTCSEE
T ss_pred CCCCCC--CCCCCCCCEEECCCCCCCC--CCCCCCCCCCCCC
T ss_conf 567701--1679989999787997998--8101278998949
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.87 E-value=1.5e-23 Score=144.11 Aligned_cols=37 Identities=32% Similarity=0.311 Sum_probs=12.9
Q ss_pred CCCCCCCEEECCCCCCCCCCCHHHHCCCCCCEEEEEC
Q ss_conf 6887886267258846566852221134677568533
Q 001544 165 GNLSSLQLLDLSDNQLSGSIPSFIFKISSLQALHFGN 201 (1057)
Q Consensus 165 ~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~ 201 (1057)
.++++|++|++++|.+++..+..++.+++|++|++++
T Consensus 68 ~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~ 104 (284)
T d2astb2 68 SQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSG 104 (284)
T ss_dssp TTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTT
T ss_pred HHCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCCCC
T ss_conf 7487765145234679867899985189975715100
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.84 E-value=5.5e-23 Score=140.93 Aligned_cols=14 Identities=36% Similarity=0.420 Sum_probs=5.5
Q ss_pred CCCCCEEEEECCCC
Q ss_conf 34677568533677
Q 001544 191 ISSLQALHFGNNRL 204 (1057)
Q Consensus 191 l~~L~~L~L~~N~l 204 (1057)
.++|++|++++|.+
T Consensus 120 ~~~L~~L~l~~n~l 133 (344)
T d2ca6a1 120 HTPLEHLYLHNNGL 133 (344)
T ss_dssp CTTCCEEECCSSCC
T ss_pred CCCCHHEECCCCCC
T ss_conf 34321000002466
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.82 E-value=1.9e-22 Score=137.90 Aligned_cols=10 Identities=50% Similarity=0.926 Sum_probs=3.1
Q ss_pred CCEEECCCCC
Q ss_conf 8689813886
Q 001544 464 LVTLDLGGNK 473 (1057)
Q Consensus 464 L~~L~L~~n~ 473 (1057)
|+.|++++|.
T Consensus 304 L~~L~l~~N~ 313 (344)
T d2ca6a1 304 LLFLELNGNR 313 (344)
T ss_dssp CCEEECTTSB
T ss_pred CCEEECCCCC
T ss_conf 9989787980
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.80 E-value=3.7e-21 Score=130.76 Aligned_cols=39 Identities=31% Similarity=0.343 Sum_probs=16.4
Q ss_pred CCCCCEEECCCCCCCCC-CCHHHHCCCCCCEEEEECCCCC
Q ss_conf 87886267258846566-8522211346775685336773
Q 001544 167 LSSLQLLDLSDNQLSGS-IPSFIFKISSLQALHFGNNRLS 205 (1057)
Q Consensus 167 l~~L~~L~L~~n~l~~~-~~~~l~~l~~L~~L~L~~N~l~ 205 (1057)
..+|++||+++|.+++. +...+.++++|++|++++|.++
T Consensus 45 ~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~ 84 (284)
T d2astb2 45 PFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLS 84 (284)
T ss_dssp CBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCC
T ss_pred CCCCCEEECCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCC
T ss_conf 7878878898984577799999974877651452346798
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.70 E-value=2.3e-17 Score=109.75 Aligned_cols=83 Identities=19% Similarity=0.188 Sum_probs=28.1
Q ss_pred CCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCEE
Q ss_conf 44343332125323487890000349989386468979899786646688788626725884656685222113467756
Q 001544 118 LAKLEKLLLHNNFLTGTIPFSIFKLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSDNQLSGSIPSFIFKISSLQAL 197 (1057)
Q Consensus 118 l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L 197 (1057)
...+++|+|++|+|+ .++..+..+++|+.|+|++|+++ .++. +..+++|++|++++|.++...+..+..+++|++|
T Consensus 17 ~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l~~--~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L 92 (162)
T d1a9na_ 17 AVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLDG--FPLLRRLKTLLVNNNRICRIGEGLDQALPDLTEL 92 (162)
T ss_dssp TTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EECC--CCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEE
T ss_pred CCCCCEEECCCCCCC-CCCCCCCCCCCCCEEECCCCCCC-CCCC--CCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 574848978899788-65762004145998989799787-6477--4457613064310213457776322334534434
Q ss_pred EEECCCC
Q ss_conf 8533677
Q 001544 198 HFGNNRL 204 (1057)
Q Consensus 198 ~L~~N~l 204 (1057)
++++|++
T Consensus 93 ~L~~N~i 99 (162)
T d1a9na_ 93 ILTNNSL 99 (162)
T ss_dssp ECCSCCC
T ss_pred EECCCCC
T ss_conf 2030001
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.69 E-value=1.3e-16 Score=105.63 Aligned_cols=102 Identities=29% Similarity=0.349 Sum_probs=49.6
Q ss_pred CEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCEEECCC
Q ss_conf 68847888755667813236443433321253234878900003499893864689798997866466887886267258
Q 001544 98 EILDLNFNRLSGEIPWELGNLAKLEKLLLHNNFLTGTIPFSIFKLSSLLDLKLSDNNLTGTIPSHNLGNLSSLQLLDLSD 177 (1057)
Q Consensus 98 ~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~ 177 (1057)
|.|+|++|+++ .++ .++.+++|++|++++|+++ .+|..++.+++|+.|++++|+++ .+|. +..+++|++|++++
T Consensus 1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~~--~~~l~~L~~L~l~~ 74 (124)
T d1dcea3 1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVDG--VANLPRLQELLLCN 74 (124)
T ss_dssp SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCGG--GTTCSSCCEEECCS
T ss_pred CEEECCCCCCC-CCC-CCCCCCCCCEEECCCCCCC-CCHHHHHHHHCCCCCCCCCCCCC-CCCC--CCCCCCCCEEECCC
T ss_conf 98986899898-871-0105898898979787168-65215655431354532432112-3574--12335557688889
Q ss_pred CCCCCCC-CHHHHCCCCCCEEEEECCCCC
Q ss_conf 8465668-522211346775685336773
Q 001544 178 NQLSGSI-PSFIFKISSLQALHFGNNRLS 205 (1057)
Q Consensus 178 n~l~~~~-~~~l~~l~~L~~L~L~~N~l~ 205 (1057)
|+++... ...+..+++|+.|++++|+++
T Consensus 75 N~i~~~~~~~~l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 75 NRLQQSAAIQPLVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp SCCCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred CCCCCCCCCHHHCCCCCCCEEECCCCCCC
T ss_conf 86588888256537999999989799688
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.60 E-value=3.4e-17 Score=108.78 Aligned_cols=147 Identities=22% Similarity=0.276 Sum_probs=0.0
Q ss_pred CCCCCCEEECCCC--CCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEECCEEEEECCCCCCCCCCCCC
Q ss_conf 7457868981388--68988880001644466563335657666884434653435287068065203786556763363
Q 001544 460 NLANLVTLDLGGN--KFNGSIPIALGKLQKLQLLNLDDNKLEGSIPDDICGLVELYKLALGDNKLSGQIPACFGNLASLR 537 (1057)
Q Consensus 460 ~l~~L~~L~L~~n--~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~ 537 (1057)
....++.+++.++ .+. ..+..+..+++|+.|+|++|+|+.+ ..+.++++|+.|++++|+|. .++..+..+++|+
T Consensus 21 ~~~~~~~~~l~~~~~~i~-~l~~sl~~L~~L~~L~Ls~n~I~~i--~~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~ 96 (198)
T d1m9la_ 21 VATEAEKVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIEKI--SSLSGMENLRILSLGRNLIK-KIENLDAVADTLE 96 (198)
T ss_dssp CCTTCSCEECCBCCTTCC-CCHHHHHHTTTCCEEECSEEEESCC--CCHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCC
T ss_pred CCCCCCEEEEECCCCCHH-HHHHHHHCCCCCCEEECCCCCCCCC--CCCCCCCCCCCHHHCCCCCC-CCCCCCCCCCCCC
T ss_conf 545331002555568520-0246776260461519944689986--44247825357341353432-1000033221233
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCC-HHHCCCCCCCEECCCCCCCCCCCCCC----------CCCCC
Q ss_conf 01367764322366542234435299903663369890-21113534461224455011225434----------34753
Q 001544 538 ELWLGPNELISFIPSTFWNIKDIMYVNFSSNFLTGPLP-LEIENLKALTTLDFSMNNLSGVIPTT----------IGGLK 606 (1057)
Q Consensus 538 ~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~p~~----------~~~l~ 606 (1057)
.|++++|++..+ ..+..+++|+.|++++|.++.... ..+..+++|+.|++++|.+....+.. +..++
T Consensus 97 ~L~l~~N~i~~l--~~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp 174 (198)
T d1m9la_ 97 ELWISYNQIASL--SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLP 174 (198)
T ss_dssp EEECSEEECCCH--HHHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCS
T ss_pred CCCCCCCCCCCC--CCCCCCCCCCCCCCCCCHHCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCHHHHHHHHHHHCC
T ss_conf 333333222222--222222234111234102125542212367776302342798434676322220558999998788
Q ss_pred CCCEEC
Q ss_conf 464111
Q 001544 607 GLQYLF 612 (1057)
Q Consensus 607 ~L~~L~ 612 (1057)
+|+.||
T Consensus 175 ~L~~LD 180 (198)
T d1m9la_ 175 NLKKLD 180 (198)
T ss_dssp SCCEES
T ss_pred CCCEEC
T ss_conf 958769
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.56 E-value=4.4e-15 Score=97.04 Aligned_cols=66 Identities=24% Similarity=0.161 Sum_probs=23.4
Q ss_pred CCCCCCCCEEECCCC-CCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCC
Q ss_conf 469887868847888-755667813236443433321253234878900003499893864689798
Q 001544 91 LGNLSSLEILDLNFN-RLSGEIPWELGNLAKLEKLLLHNNFLTGTIPFSIFKLSSLLDLKLSDNNLT 156 (1057)
Q Consensus 91 l~~l~~L~~L~L~~n-~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~ 156 (1057)
+..+++|++|++++| .++..-+..|.++++|+.|+|++|+++...+.+|..+++|++|+|++|+++
T Consensus 27 l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~ 93 (156)
T d2ifga3 27 LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE 93 (156)
T ss_dssp SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCS
T ss_pred CCCCCCCCEEECCCCCCCCCCCCHHHCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEECCCCCCC
T ss_conf 2576565743168986644369212256666672162021247742011124554333322678785
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.56 E-value=1.4e-14 Score=94.35 Aligned_cols=106 Identities=25% Similarity=0.187 Sum_probs=57.7
Q ss_pred EEECCCCCCCCCCHHHCCCCCCCEECCCCC-CCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCCEECCCCCC
Q ss_conf 990366336989021113534461224455-0112254343475346411111211223358433456766630146761
Q 001544 563 VNFSSNFLTGPLPLEIENLKALTTLDFSMN-NLSGVIPTTIGGLKGLQYLFLGHNRLQGSIPDSVGDLISLKSLNLSNNN 641 (1057)
Q Consensus 563 L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~ 641 (1057)
++.+++.++. .|..+..+++|++|++++| .|+.+.+..|.++++|+.|+|++|+|+.+.+.+|..+++|+.|+|++|+
T Consensus 13 l~c~~~~~~~-~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~ 91 (156)
T d2ifga3 13 LRCTRDGALD-SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNA 91 (156)
T ss_dssp EECCSSCCCT-TTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSC
T ss_pred EEECCCCCCC-CCCCCCCCCCCCEEECCCCCCCCCCCCHHHCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEECCCCC
T ss_conf 9852899765-860025765657431689866443692122566666721620212477420111245543333226787
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 14878422247564542126887354769
Q 001544 642 LSGPIPTSLEKLSDLKELNLSFNKLEGEI 670 (1057)
Q Consensus 642 l~~~~p~~l~~l~~L~~l~l~~N~l~~~~ 670 (1057)
|+...+..+..+ .|+.|++++|+|.|.+
T Consensus 92 l~~l~~~~~~~~-~l~~L~L~~Np~~C~C 119 (156)
T d2ifga3 92 LESLSWKTVQGL-SLQELVLSGNPLHCSC 119 (156)
T ss_dssp CSCCCSTTTCSC-CCCEEECCSSCCCCCG
T ss_pred CCCCCHHHHCCC-CCCCCCCCCCCCCCCC
T ss_conf 851574563353-2124335798633881
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=99.22 E-value=4.6e-11 Score=74.71 Aligned_cols=150 Identities=15% Similarity=0.102 Sum_probs=103.6
Q ss_pred HHHHHHHCCCCCCCEECCCCCEEEEEEEECCCCEEEEEEEECCCHHHHHHHHHHHHHHHHCC-CCCCEEEEEEECCCCEE
Q ss_conf 89998707999771545436818999995699589999950525467999999999998168-97721676100168824
Q 001544 762 LELFQATNGFSENNLIGRGSFGSVYIARLQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIR-HRNLTKIISSCSNEDFK 840 (1057)
Q Consensus 762 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~ 840 (1057)
.++....+.|+..+..+.++.+.||+.... ++.+.+|+...........+.+|...+..+. +--+.+++.+...++..
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~~-~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHHHHHCEEEEECCCCCCCCCEEEEEEC-CCEEEEEECCCCCCCCHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCE
T ss_conf 999975135279976789987718999908-9869999848876532556999999999876069987289997508964
Q ss_pred EEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHH------------------------------------
Q ss_conf 89999744899567872099667999999999999999999870------------------------------------
Q 001544 841 ALILEYMRNGSLEKCLYSGNYILDIFQRLNIMIDVASALEYLHF------------------------------------ 884 (1057)
Q Consensus 841 ~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~------------------------------------ 884 (1057)
++||++++|.++.+..... .....++.++++.++.+|.
T Consensus 86 ~lv~~~l~G~~~~~~~~~~------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYEDE------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EEEEECCSSEEHHHHTTTC------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGS
T ss_pred EEEEEECCCCCCCCCCCCC------CCHHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHCCC
T ss_conf 9999860433435433440------2699999989999999855684214357644656555778998776555543033
Q ss_pred --------------------CCCCCEEECCCCCCCEEECCCCCEEEECCCCCCC
Q ss_conf --------------------7999819816799986668998399971134412
Q 001544 885 --------------------GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL 918 (1057)
Q Consensus 885 --------------------~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~ 918 (1057)
.....++|+|+.|.||++++++.+.++||+.+..
T Consensus 160 ~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp TTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred CCCCCHHHHHHHHHHHHCCCCCCCEEEEEECCCCCEEECCCCEEEEEECHHCCC
T ss_conf 232005799999999844986781789860047642364996599960231441
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.80 E-value=4.6e-10 Score=69.17 Aligned_cols=122 Identities=18% Similarity=0.041 Sum_probs=0.0
Q ss_pred CCCCEEEECCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCC--HHHCCCCCCCEE
Q ss_conf 343528706806520378655676336301367764322366542234435299903663369890--211135344612
Q 001544 510 VELYKLALGDNKLSGQIPACFGNLASLRELWLGPNELISFIPSTFWNIKDIMYVNFSSNFLTGPLP--LEIENLKALTTL 587 (1057)
Q Consensus 510 ~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~--~~~~~l~~L~~L 587 (1057)
...+.|+++++ .....+..+..+..+...++....+ ...+..++.|+.|++++|+++.+.+ ..+..+++|+.|
T Consensus 22 ~~~~~Ldls~l----~~~~~l~~~~~~~~l~~~~~~~~~l-~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L 96 (162)
T d1koha1 22 GSQQALDLKGL----RSDPDLVAQNIDVVLNRRSSMAATL-RIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKIL 96 (162)
T ss_dssp SSSCCBCCCCC----SSCTTTTTTTCCCCTTSHHHHHHHH-HHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCC
T ss_pred HHHCEEECCCC----CCCCHHHHCCCHHHCCHHHHHHHHH-HHHHHHCCCCCEEECCCCCCCCCCHHHHHHHHCCCCCCC
T ss_conf 33086534359----8982155466401122555676660-788974878788637776666773158898658856100
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCC-------CCCCCCCCEEC
Q ss_conf 24455011225434347534641111121122335843-------34567666301
Q 001544 588 DFSMNNLSGVIPTTIGGLKGLQYLFLGHNRLQGSIPDS-------VGDLISLKSLN 636 (1057)
Q Consensus 588 ~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~-------~~~l~~L~~L~ 636 (1057)
+|++|.|+...+..+.+...|+.|++++|.+....... +..+|+|+.||
T Consensus 97 ~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i~~~~P~L~~LD 152 (162)
T d1koha1 97 NLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD 152 (162)
T ss_dssp CCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHHHTTSTTCCEET
T ss_pred CCCCCCCCCCHHHHHHHCCCCCEEECCCCCCCCCCCCCHHHHHHHHHHCCCCCEEC
T ss_conf 04357213423442220331042664899767676661569999999889978799
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.80 E-value=2.7e-08 Score=59.38 Aligned_cols=132 Identities=17% Similarity=0.114 Sum_probs=87.0
Q ss_pred CEECCCCC-EEEEEEEECCCCEEEEEEEECCCHHHHHHHHHHHHHHHHCC--CCCCEEEEEEECCCCEEEEEEEECCCCC
Q ss_conf 15454368-18999995699589999950525467999999999998168--9772167610016882489999744899
Q 001544 775 NLIGRGSF-GSVYIARLQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIR--HRNLTKIISSCSNEDFKALILEYMRNGS 851 (1057)
Q Consensus 775 ~~lg~G~~-g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~lV~e~~~~g~ 851 (1057)
+.+..|.. +.||+.....+..+.+|....... ..+..|...++.+. .-.+.+++++..+++..++||++++|.+
T Consensus 16 ~~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~ 92 (255)
T d1nd4a_ 16 AQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQD 92 (255)
T ss_dssp EECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEE
T ss_pred EECCCCCCCCEEEEEEECCCCEEEEEECCCCCH---HHHHHHHHHHHHHHHCCCCCCCEEEECCCCCCEEEEEEEEECCC
T ss_conf 876786547758999938987899995896677---68999999999998659998861322245661599987441355
Q ss_pred HHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHH-----------------------------------------------
Q ss_conf 567872099667999999999999999999870-----------------------------------------------
Q 001544 852 LEKCLYSGNYILDIFQRLNIMIDVASALEYLHF----------------------------------------------- 884 (1057)
Q Consensus 852 L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~----------------------------------------------- 884 (1057)
+.+.. ... ...+.++.+.++.||.
T Consensus 93 ~~~~~------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (255)
T d1nd4a_ 93 LLSSH------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA 163 (255)
T ss_dssp TTTSC------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred CCCCC------CCH---HHHHHHHHHHHHHHCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHHH
T ss_conf 43221------268---999999999999873688544887554124688999999875411011340112137999999
Q ss_pred --------CCCCCEEECCCCCCCEEECCCCCEEEECCCCCCC
Q ss_conf --------7999819816799986668998399971134412
Q 001544 885 --------GYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL 918 (1057)
Q Consensus 885 --------~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~ 918 (1057)
.....++|+|+.|.||+++.+..+.++||+.+..
T Consensus 164 ~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 164 RLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHCCCCCCCEEEECCCCCCCEEEECCCEEEEEECHHCCC
T ss_conf 998718765795678678887635773796589998533265
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.47 E-value=4.4e-07 Score=52.65 Aligned_cols=140 Identities=15% Similarity=0.162 Sum_probs=80.4
Q ss_pred CCEECCCCCEEEEEEEECC-CCEEEEEEEECCC-------HHHHHHHHHHHHHHHHCC-C--CCCEEEEEEECCCCEEEE
Q ss_conf 7154543681899999569-9589999950525-------467999999999998168-9--772167610016882489
Q 001544 774 NNLIGRGSFGSVYIARLQN-GIEVAVKTFDLQH-------ERAFKSFDTECEVMKSIR-H--RNLTKIISSCSNEDFKAL 842 (1057)
Q Consensus 774 ~~~lg~G~~g~V~~~~~~~-~~~vaiK~~~~~~-------~~~~~~~~~e~~~l~~l~-h--~niv~~~~~~~~~~~~~l 842 (1057)
.+.||.|....||++...+ ++.+++|.-.+.. .....+...|.+.++.+. + ..+++++.+. ++..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred EEEECCCCEEEEEEEEECCCCEEEEEECCCCHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCEEEEEC--CCCCEE
T ss_conf 998079852768999957998489996177130346777888778999999999986505798855289985--988779
Q ss_pred EEEECCCCCHH-HHHHCCCCCCCHHHHHHHHHHHHH--------------------------------------------
Q ss_conf 99974489956-787209966799999999999999--------------------------------------------
Q 001544 843 ILEYMRNGSLE-KCLYSGNYILDIFQRLNIMIDVAS-------------------------------------------- 877 (1057)
Q Consensus 843 V~e~~~~g~L~-~~l~~~~~~~~~~~~~~i~~~i~~-------------------------------------------- 877 (1057)
|||++++..+. ..+......... ...+...+++
T Consensus 109 vmE~L~~~~~~~~~l~~~~~~~~~--a~~lg~~La~~h~~~~~~~~~~~~~~~~~~~~~n~~l~~~~e~~~~~~py~~~~ 186 (392)
T d2pula1 109 VMEDLSHLKIARKGLIEGENYPHL--SQHIGEFLGKTLFYSSDYALEPKVKKQLVKQFTNPELCDITERLVFTDPFFDHD 186 (392)
T ss_dssp EECCCTTSEEHHHHHHHTCCCTTH--HHHHHHHHHHHHHHTSTTTSCHHHHHHHHHHTCCHHHHHHHHHHTTTGGGTTCT
T ss_pred EEECCCCCCCCHHHHCCCCHHHHH--HHHHHHHHHHHHHHHCCCCCCCHHHCCCCCCCCCHHHHHHHHHHHCCHHHHHHH
T ss_conf 871357765302220154212899--999999999999873503344211101233446578887777640104788988
Q ss_pred -----------------------HHHHHH---HCCCCCEEECCCCCCCEEECCCCCEEEECCCCCCC
Q ss_conf -----------------------999987---07999819816799986668998399971134412
Q 001544 878 -----------------------ALEYLH---FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL 918 (1057)
Q Consensus 878 -----------------------~l~~LH---~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~ 918 (1057)
....+. ......++|||+.+.|||++++ .++++||..+.+
T Consensus 187 ~~~~~~~~~~~~~~l~~d~~l~~~~~~l~~~~~~~~~~LiHGDl~~gNIlv~~~-~~~vID~E~a~~ 252 (392)
T d2pula1 187 TNDFEEELRPFVEKLWNNDSVKIEAAKLKKSFLTSAETLIHGDLHTGSIFASEH-ETKVIDPEFAFY 252 (392)
T ss_dssp TCCCCGGGHHHHHHHHTCHHHHHHHHHHHHHHHHBCCEEECSCCCGGGEEECSS-CEEECCCTTCEE
T ss_pred HHHCCHHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCCCEECCCCCCCCEEECCC-CEEEECHHHCCC
T ss_conf 741065455778765520789999999874323688600335776784667599-308952265222
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=98.32 E-value=1.4e-07 Score=55.41 Aligned_cols=116 Identities=14% Similarity=0.092 Sum_probs=0.0
Q ss_pred CCCCCCCEEECCCCCCCCCCCCC----CCCCCCCCCEEECCCCCCC----CCCCHHHHCCCCCCEEEEECCCCCCCCCCC
Q ss_conf 03499893864689798997866----4668878862672588465----668522211346775685336773226943
Q 001544 140 FKLSSLLDLKLSDNNLTGTIPSH----NLGNLSSLQLLDLSDNQLS----GSIPSFIFKISSLQALHFGNNRLSGELPAN 211 (1057)
Q Consensus 140 ~~l~~L~~L~L~~n~l~~~~~~~----~~~~l~~L~~L~L~~n~l~----~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~ 211 (1057)
...++|++|+|++++-.+.-... .+...+.|++|++++|.+. ..+...+...+.|++|++++|.+++.....
T Consensus 12 ~n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~ 91 (167)
T d1pgva_ 12 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLAR 91 (167)
T ss_dssp TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHH
T ss_pred HCCCCCCEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEECCCCCCCHHHHHHHHHHHHHCCCCCCEEEEHHHCCHHHHHH
T ss_conf 28999819782799998989999999997637764540120156215679887531000234330033010214599999
Q ss_pred CCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCC-------CCCCCCCCCCCCEEEEECCC
Q ss_conf 227789632898304412347431123888775898558877689-------44001374787489622133
Q 001544 212 ICDNLPFLNFFSVYKNMFYGGISSTLSNCKHLRILDLSFNDLWGD-------IPKEIGNLTKLKELFLDFNI 276 (1057)
Q Consensus 212 ~~~~l~~L~~L~l~~n~~~~~~~~~l~~~~~L~~L~Ls~n~l~~~-------~~~~l~~l~~L~~L~L~~n~ 276 (1057)
++. .+...+.|++|++++|.+... +...+...+.|+.|+++.+.
T Consensus 92 l~~---------------------aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~ 142 (167)
T d1pgva_ 92 LLR---------------------STLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFAS 142 (167)
T ss_dssp HHH---------------------HTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCC
T ss_pred HHH---------------------HHHHCCCCCEEECCCCCCCCCCHHHHHHHHHHHHHCCCCCEEECCCCC
T ss_conf 999---------------------998489389877887768886579999999999729985386486888
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=98.27 E-value=2.4e-06 Score=48.54 Aligned_cols=136 Identities=12% Similarity=0.131 Sum_probs=77.8
Q ss_pred CCCEEEEEEEECCCCEEEEEEEECCCHHHHHHHHHHHHHHHHCCCCCC--EEEEE-----EECCCCEEEEEEEECCCCCH
Q ss_conf 368189999956995899999505254679999999999981689772--16761-----00168824899997448995
Q 001544 780 GSFGSVYIARLQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRHRNL--TKIIS-----SCSNEDFKALILEYMRNGSL 852 (1057)
Q Consensus 780 G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni--v~~~~-----~~~~~~~~~lV~e~~~~g~L 852 (1057)
+.--.||+++..+|+.|++|+.+... ....++..|...+..+...++ +..+. .+...+..+.++++++|..+
T Consensus 33 s~EN~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~ 111 (325)
T d1zyla1 33 SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQF 111 (325)
T ss_dssp CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEEC
T ss_pred CCCCEEEEEECCCCCEEEEEEECCCC-CCHHHHHHHHHHHHHHHHCCCCCCCCEECCCCEEEEEEEEEEEEEEECCCCCC
T ss_conf 61202699983899979999847877-88999999999999998559987875206898056653479999865277688
Q ss_pred H-----HH---------HHC--------CCCCCCHH----------------------HHHHHHHHHHHHHHHH-HHCCC
Q ss_conf 6-----78---------720--------99667999----------------------9999999999999998-70799
Q 001544 853 E-----KC---------LYS--------GNYILDIF----------------------QRLNIMIDVASALEYL-HFGYS 887 (1057)
Q Consensus 853 ~-----~~---------l~~--------~~~~~~~~----------------------~~~~i~~~i~~~l~~L-H~~~~ 887 (1057)
. ++ ++. .+...+.. .....+..+...+... .....
T Consensus 112 ~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p 191 (325)
T d1zyla1 112 EADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFT 191 (325)
T ss_dssp CSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSC
T ss_pred CCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCC
T ss_conf 99999999998999999886303578655677897887665689998747699889899999999999999984545687
Q ss_pred CCEEECCCCCCCEEECCCCCEEEECCCCCCC
Q ss_conf 9819816799986668998399971134412
Q 001544 888 APVIHCDLKPSNVLLDDNMVAHLSDFGIAKL 918 (1057)
Q Consensus 888 ~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~ 918 (1057)
.+++|+|+.+.||+++++ ..++||+-+..
T Consensus 192 ~~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 192 VLRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred CEEECCCCCCCCEEEECC--CEEEECHHCCC
T ss_conf 120247888042878389--35886520146
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=98.26 E-value=2.8e-06 Score=48.17 Aligned_cols=74 Identities=16% Similarity=0.193 Sum_probs=50.9
Q ss_pred CCEECCCCCEEEEEEEECC--------CCEEEEEEEECCCHHHHHHHHHHHHHHHHCC-CCCCEEEEEEECCCCEEEEEE
Q ss_conf 7154543681899999569--------9589999950525467999999999998168-977216761001688248999
Q 001544 774 NNLIGRGSFGSVYIARLQN--------GIEVAVKTFDLQHERAFKSFDTECEVMKSIR-HRNLTKIISSCSNEDFKALIL 844 (1057)
Q Consensus 774 ~~~lg~G~~g~V~~~~~~~--------~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lV~ 844 (1057)
.+.++.|-.-.+|++...+ ...|.+++.... . ......+|..+++.+. +.-..++++++.+ ..|+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~-~-~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ 120 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-E-TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 120 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-C-CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEECCCCCCCCEEEEEECCCCCCCCCCCCCEEEEECCCC-C-HHHHHHHHHHHHHHHHHCCCCCEEEEECCC----CEEE
T ss_conf 999178533434899968877544578981799965996-1-165899999999999757999808998189----5699
Q ss_pred EECCCCCHH
Q ss_conf 974489956
Q 001544 845 EYMRNGSLE 853 (1057)
Q Consensus 845 e~~~~g~L~ 853 (1057)
||++|.++.
T Consensus 121 efi~g~~l~ 129 (395)
T d1nw1a_ 121 EYIPSRPLS 129 (395)
T ss_dssp CCCCEEECC
T ss_pred EEECCCCCC
T ss_conf 973455488
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=98.19 E-value=3.4e-06 Score=47.68 Aligned_cols=158 Identities=16% Similarity=0.105 Sum_probs=86.2
Q ss_pred CCCHHHHHHHHCCCCCCCE-----ECCCCCEEEEEEEECCCCEEEEEEEECCCHHHHHHHHHHHHHHHHCCC-----CCC
Q ss_conf 6798899987079997715-----454368189999956995899999505254679999999999981689-----772
Q 001544 758 RFSYLELFQATNGFSENNL-----IGRGSFGSVYIARLQNGIEVAVKTFDLQHERAFKSFDTECEVMKSIRH-----RNL 827 (1057)
Q Consensus 758 ~~~~~~~~~~~~~~~~~~~-----lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h-----~ni 827 (1057)
..+.+++.....+|...+. |..|.--+.|+.+..+| .+++|++....+ ...+..|.+++..+.. |..
T Consensus 2 ~ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~~--~~~l~~~~~~l~~L~~~g~pvp~p 78 (316)
T d2ppqa1 2 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVE--KNDLPFFLGLMQHLAAKGLSCPLP 78 (316)
T ss_dssp CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred CCCHHHHHHHHHHCCCCCCEEEECCCCCCCCCEEEEEECCC-CEEEEECCCCCC--HHHHHHHHHHHHHHHHCCCCCCCC
T ss_conf 88999999999867999856852378885267389997897-289998078999--889999999987543025554556
Q ss_pred EEEEE---EECCCCEEEEEEEECCCCCHHH-----H---------HHC----C----CCCCCHH----------------
Q ss_conf 16761---0016882489999744899567-----8---------720----9----9667999----------------
Q 001544 828 TKIIS---SCSNEDFKALILEYMRNGSLEK-----C---------LYS----G----NYILDIF---------------- 866 (1057)
Q Consensus 828 v~~~~---~~~~~~~~~lV~e~~~~g~L~~-----~---------l~~----~----~~~~~~~---------------- 866 (1057)
+...+ ..........++.+..+..... . ++. . .......
T Consensus 79 i~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (316)
T d2ppqa1 79 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV 158 (316)
T ss_dssp CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred CEECCCCCCEEEECCCCEEEEECCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHCCHHHHHHHHHHHHC
T ss_conf 41048976213412550245311465533320467888889987645444320245310111012002456777765311
Q ss_pred --HHHHHHHHHHHHHHHHH-HCCCCCEEECCCCCCCEEECCCCCEEEECCCCCCC
Q ss_conf --99999999999999987-07999819816799986668998399971134412
Q 001544 867 --QRLNIMIDVASALEYLH-FGYSAPVIHCDLKPSNVLLDDNMVAHLSDFGIAKL 918 (1057)
Q Consensus 867 --~~~~i~~~i~~~l~~LH-~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~ 918 (1057)
.....+......+...+ .....|++|+|+.+.||+++.+...-++||+.+..
T Consensus 159 ~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 159 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHCCCCCCEEEECCCCCCC
T ss_conf 4127999999987642048554545033378636564020454126742221236
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.89 E-value=2.5e-07 Score=54.00 Aligned_cols=125 Identities=10% Similarity=0.088 Sum_probs=0.0
Q ss_pred CCCCCCCHHHHCCCCCCEEEEEC-CCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCC-
Q ss_conf 46566852221134677568533-6773226943227789632898304412347431123888775898558877689-
Q 001544 179 QLSGSIPSFIFKISSLQALHFGN-NRLSGELPANICDNLPFLNFFSVYKNMFYGGISSTLSNCKHLRILDLSFNDLWGD- 256 (1057)
Q Consensus 179 ~l~~~~~~~l~~l~~L~~L~L~~-N~l~~~~p~~~~~~l~~L~~L~l~~n~~~~~~~~~l~~~~~L~~L~Ls~n~l~~~- 256 (1057)
.+...+.......+.|++|++++ +.++...-..++. .+...+.|++|++++|.++..
T Consensus 4 ~i~~~l~~~~~~~~~L~~L~L~~~~~i~~~~~~~l~~---------------------al~~n~~L~~L~Ls~n~l~~~~ 62 (166)
T d1io0a_ 4 DVEETLKRIQNNDPDLEEVNLNNIMNIPVPTLKACAE---------------------ALKTNTYVKKFSIVGTRSNDPV 62 (166)
T ss_dssp CHHHHHHHHHTTCTTCCEEECTTCTTCCHHHHHHHHH---------------------HHTTCCSCCEEECTTSCCCHHH
T ss_pred CHHHHHHHHHHCCCCCCEEECCCCCCCCHHHHHHHHH---------------------HHHCCCCCCEEECCCCCCCHHH
T ss_conf 3999999999559998688768999989899999998---------------------8841982574301589611778
Q ss_pred ---CCCCCCCCCCCCEEEEECCCCCC----CCCCCCCCCCCCCE--EEEECCCCCC----CCCCCCCCCCCCCEEEECCC
Q ss_conf ---44001374787489622133245----44833346664229--9956472444----45864224542109980287
Q 001544 257 ---IPKEIGNLTKLKELFLDFNILQG----EIPHTVGNLHNLEY--LSLVNNELVG----TVPATIFNVSTLKLIELSNN 323 (1057)
Q Consensus 257 ---~~~~l~~l~~L~~L~L~~n~l~~----~~p~~~~~l~~L~~--L~L~~n~l~~----~~~~~l~~l~~L~~L~L~~n 323 (1057)
+...+...+.++.+++++|.++. .+...+...++|+. |+++.|++.. .+...+...++|+.|+++.+
T Consensus 63 ~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~ 142 (166)
T d1io0a_ 63 AFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFT 142 (166)
T ss_dssp HHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCS
T ss_pred HHHHHHHHHHCCCCHHHHHCCCCCCCHHHHHHHHHHHHCCCCCEEEECCCCCCCCHHHHHHHHHHHHHCCCCCEEECCCC
T ss_conf 99999877521221012102543220147889999984865247732167786767999999999984998478858189
Q ss_pred C
Q ss_conf 3
Q 001544 324 T 324 (1057)
Q Consensus 324 ~ 324 (1057)
.
T Consensus 143 ~ 143 (166)
T d1io0a_ 143 Q 143 (166)
T ss_dssp S
T ss_pred C
T ss_conf 8
|